Citrus Sinensis ID: 002250
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 947 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LJM4 | 991 | Receptor-like protein kin | no | no | 0.984 | 0.940 | 0.582 | 0.0 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.968 | 0.920 | 0.402 | 0.0 | |
| P47735 | 999 | Receptor-like protein kin | no | no | 0.965 | 0.914 | 0.411 | 1e-180 | |
| C0LGX3 | 993 | LRR receptor-like serine/ | no | no | 0.935 | 0.892 | 0.387 | 1e-175 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.932 | 0.880 | 0.383 | 1e-159 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.951 | 0.899 | 0.370 | 1e-156 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.950 | 0.918 | 0.355 | 1e-151 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.938 | 0.779 | 0.350 | 1e-151 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.926 | 0.865 | 0.362 | 1e-148 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.881 | 0.802 | 0.361 | 1e-148 |
| >sp|Q9LJM4|IKU2_ARATH Receptor-like protein kinase HAIKU2 OS=Arabidopsis thaliana GN=IKU2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1052 bits (2721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 558/958 (58%), Positives = 687/958 (71%), Gaps = 26/958 (2%)
Query: 1 MNLKSKI-EKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGV-------- 51
+ LKS E VF +WT NS C+F GIVC+S+G V EINL + L+
Sbjct: 31 LKLKSTFGETKSDDVFKTWTHRNSACEFAGIVCNSDGNVVEINLGSRSLINRDDDGRFTD 90
Query: 52 VPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELS 111
+PFDSIC L+ L+K+ LG N L G I L C RL+ LDLG N+FSGE P + L L
Sbjct: 91 LPFDSICDLKLLEKLVLGNNSLRGQIGTNLGKCNRLRYLDLGINNFSGEFPAIDSLQLLE 150
Query: 112 FLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVT 171
FL+LN+SGISG FPW SL++L L FLS+GDN F PFP E+L L L W+YL+N S+T
Sbjct: 151 FLSLNASGISGIFPWSSLKDLKRLSFLSVGDNRFGSHPFPREILNLTALQWVYLSNSSIT 210
Query: 172 GQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTN 231
G+IPEGI NL +LQNLELSDN++ GEIP IV+L L QLE+Y+N L+G+LP+GF NLTN
Sbjct: 211 GKIPEGIKNLVRLQNLELSDNQISGEIPKEIVQLKNLRQLEIYSNDLTGKLPLGFRNLTN 270
Query: 232 LMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTG 291
L NFD S N LEGDLSELRFL L SL +FEN+ +GEIP+EFG+FK L LSLY N+LTG
Sbjct: 271 LRNFDASNNSLEGDLSELRFLKNLVSLGMFENRLTGEIPKEFGDFKSLAALSLYRNQLTG 330
Query: 292 TLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSL 351
LP++LGSW F Y+DVSEN L G IPP MCK G MT LL+LQN F G PE+YA CK+L
Sbjct: 331 KLPRRLGSWTAFKYIDVSENFLEGQIPPYMCKKGVMTHLLMLQNRFTGQFPESYAKCKTL 390
Query: 352 IRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSG 411
IR RV+NNSLSG IP GIW LPNL +DL++N FEG +T DIGNAKSL L L+NNRFSG
Sbjct: 391 IRLRVSNNSLSGMIPSGIWGLPNLQFLDLASNYFEGNLTGDIGNAKSLGSLDLSNNRFSG 450
Query: 412 ELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSL 471
LP +IS A+SLVS+ L +N+FSG +P GKLK+LSSL L N SG +P S+G C SL
Sbjct: 451 SLPFQISGANSLVSVNLRMNKFSGIVPESFGKLKELSSLILDQNNLSGAIPKSLGLCTSL 510
Query: 472 TDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGP 531
D+NFA NSLS +IP+SLGSL LNSLNLS NK SG IP+ L+ KLSLLDLSNNQL G
Sbjct: 511 VDLNFAGNSLSEEIPESLGSLKLLNSLNLSGNKLSGMIPVGLSALKLSLLDLSNNQLTGS 570
Query: 532 IPEPLNIKAFIDSFTGNPGLCSKTDEYFKSCSSG----SGRSHHVSTFVWCLIAITMVLL 587
+PE L SF GN GLCS Y + C G G+ H+S C I ++ L
Sbjct: 571 VPESL----VSGSFEGNSGLCSSKIRYLRPCPLGKPHSQGKRKHLSKVDMCFIVAAILAL 626
Query: 588 VLLASYFVVKLKQNNLKHSL-KQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVY 646
L SY + K++++ L ++ K+N W + SFR+L+F+E EIID +K EN+IG+GG GNVY
Sbjct: 627 FFLFSYVIFKIRRDKLNKTVQKKNDWQVSSFRLLNFNEMEIIDEIKSENIIGRGGQGNVY 686
Query: 647 KVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSS--EYDAEVATLSAVRHVNV 704
KV L SG+ LAVKHIW S +RSSTA+LS ++RS+ E++AEVATLS ++H+NV
Sbjct: 687 KVSLRSGETLAVKHIWCPESSHE-SFRSSTAMLSDGNNRSNNGEFEAEVATLSNIKHINV 745
Query: 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH-KIEMDWVVRYAIAVGAAKGLEYLHHG 763
VKL+CSIT EDS LLVYEY+PNGSLW++LH + E+ W VR A+A+GAAKGLEYLHHG
Sbjct: 746 VKLFCSITCEDSKLLVYEYMPNGSLWEQLHERRGEQEIGWRVRQALALGAAKGLEYLHHG 805
Query: 764 FDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG-DLTH-VIAGTHGYIAPEYA 821
DRPVIHRDVKSSNILLD EW+PRIADFGLAKI+Q D + ++ GT GYIAPEYA
Sbjct: 806 LDRPVIHRDVKSSNILLDEEWRPRIADFGLAKIIQADSVQRDFSAPLVKGTLGYIAPEYA 865
Query: 822 YTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY--SKMDSRDSMLTVVDP 879
YT K+NEKSDVYSFGVVLMELVTGK+P+ +FG++ DIV WV+ SK +R+ M+ ++D
Sbjct: 866 YTTKVNEKSDVYSFGVVLMELVTGKKPLETDFGENNDIVMWVWSVSKETNREMMMKLIDT 925
Query: 880 NISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKVGESS 937
+I + KEDALKVL IA+ CT+K P RP M+ VV MLE+ EP N GES+
Sbjct: 926 SIEDEYKEDALKVLTIALLCTDKSPQARPFMKSVVSMLEKIEPSYNKNSGEASYGESA 983
|
Modulates the seed size by negatively regulating the cellularization of syncytial endosperm. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 682 bits (1759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/962 (40%), Positives = 573/962 (59%), Gaps = 45/962 (4%)
Query: 15 FSSWTEAN-SVCKFNGIVCDSN-GLVAEINLPEQQLLGVVPFDS-ICGLQALQKINLGTN 71
SSW + S C+++G+ C + V ++L L G PF S IC L L ++L N
Sbjct: 37 LSSWNSNDASPCRWSGVSCAGDFSSVTSVDLSSANLAG--PFPSVICRLSNLAHLSLYNN 94
Query: 72 FLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFP----- 125
+ T+ + +C LQ LDL N +GE+P L+ + L L+L + SG P
Sbjct: 95 SINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPTLVHLDLTGNNFSGDIPASFGK 154
Query: 126 WKSLE------------------NLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTN 167
+++LE N++ L+ L+L NPF PS P E L L ++LT
Sbjct: 155 FENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVMWLTE 214
Query: 168 CSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFS 227
C + GQIP+ +G L++L +L+L+ N+L G IP + L + Q+ELYNNSL+G +P
Sbjct: 215 CHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELG 274
Query: 228 NLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTN 287
NL +L D S N+L G + + L SL+L+EN GE+P +L E+ ++ N
Sbjct: 275 NLKSLRLLDASMNQLTGKIPDELCRVPLESLNLYENNLEGELPASIALSPNLYEIRIFGN 334
Query: 288 RLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYAN 347
RLTG LP+ LG + ++DVSEN +G +P D+C G + +LL++ N+F+G +PE+ A+
Sbjct: 335 RLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLAD 394
Query: 348 CKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANN 407
C+SL R R+ N SG++P G W LP++++++L N F G ++ IG A +L+LL+L+NN
Sbjct: 395 CRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGEISKSIGGASNLSLLILSNN 454
Query: 408 RFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGS 467
F+G LP +I +L + S N+FSG +P + L +L +L LH N FSG L I S
Sbjct: 455 EFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKS 514
Query: 468 CVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQ 527
L ++N A N +GKIPD +GSL LN L+LS N FSG+IP+SL KL+ L+LS N+
Sbjct: 515 WKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSLKLNQLNLSYNR 574
Query: 528 LAGPIPEPLNIKAFIDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIAI-TMVL 586
L+G +P L + +SF GNPGLC S + R +VW L +I +
Sbjct: 575 LSGDLPPSLAKDMYKNSFIGNPGLCGDIKGLCGSENEAKKRG-----YVWLLRSIFVLAA 629
Query: 587 LVLLA--SYFVVKLKQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGN 644
+VLLA ++F K + +++++ W + SF L FSE EI++++ +N+IG G SG
Sbjct: 630 MVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSEHEILESLDEDNVIGAGASGK 689
Query: 645 VYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704
VYKVVL +G+ +AVK +W + GD K + ++AEV TL +RH N+
Sbjct: 690 VYKVVLTNGETVAVKRLWTGSVKETGDCDPEKGY--KPGVQDEAFEAEVETLGKIRHKNI 747
Query: 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGF 764
VKL+C ++ D LLVYEY+PNGSL D LH+ + W R+ I + AA+GL YLHH
Sbjct: 748 VKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGMLGWQTRFKIILDAAEGLSYLHHDS 807
Query: 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ-TGEAGDLTHVIAGTHGYIAPEYAYT 823
P++HRD+KS+NIL+D ++ R+ADFG+AK V TG+A VIAG+ GYIAPEYAYT
Sbjct: 808 VPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYT 867
Query: 824 CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISE 883
++NEKSD+YSFGVV++E+VT KRP+ PE G+ KD+V WV S +D + + V+DP +
Sbjct: 868 LRVNEKSDIYSFGVVILEIVTRKRPVDPELGE-KDLVKWVCSTLDQK-GIEHVIDPKLDS 925
Query: 884 ILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE---AEPCSVTNIVVKKVGESSPSF 940
KE+ K+L + + CT+ LP RPSMR VV+ML+E + S+ I K G+ +P +
Sbjct: 926 CFKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQEIGGGDEDSLHKIRDDKDGKLTPYY 985
Query: 941 SR 942
+
Sbjct: 986 NE 987
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 634 bits (1634), Expect = e-180, Method: Compositional matrix adjust.
Identities = 402/977 (41%), Positives = 563/977 (57%), Gaps = 63/977 (6%)
Query: 15 FSSWTEANSV--CKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSI-CGLQALQKINLGTN 71
SSW++ N V CK+ G+ CD+ V ++L L+G PF SI C L +L ++L N
Sbjct: 42 LSSWSDNNDVTPCKWLGVSCDATSNVVSVDLSSFMLVG--PFPSILCHLPSLHSLSLYNN 99
Query: 72 FLYGTIT-EGLKSCTRLQVLDLGNNSFSGEVP--------------------------DL 104
+ G+++ + +C L LDL N G +P
Sbjct: 100 SINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLPNLKFLEISGNNLSDTIPSSF 159
Query: 105 SMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLY 164
+L LNL + +SG P SL N+T L+ L L N F PS P ++ L +L L+
Sbjct: 160 GEFRKLESLNLAGNFLSGTIP-ASLGNVTTLKELKLAYNLFSPSQIPSQLGNLTELQVLW 218
Query: 165 LTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPV 224
L C++ G IP + LT L NL+L+ N+L G IP+ I +L + Q+EL+NNS SG LP
Sbjct: 219 LAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQLKTVEQIELFNNSFSGELPE 278
Query: 225 GFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSL 284
N+T L FD S N+L G + + L L SL+LFEN G +PE K L+EL L
Sbjct: 279 SMGNMTTLKRFDASMNKLTGKIPDNLNLLNLESLNLFENMLEGPLPESITRSKTLSELKL 338
Query: 285 YTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPET 344
+ NRLTG LP +LG+ + YVD+S N +G IP ++C G + L+++ N+F+G +
Sbjct: 339 FNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEGKLEYLILIDNSFSGEISNN 398
Query: 345 YANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLL 404
CKSL R R++NN LSG IP G W LP LS+++LS N F G + I AK+L+ L +
Sbjct: 399 LGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSFTGSIPKTIIGAKNLSNLRI 458
Query: 405 ANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYS 464
+ NRFSG +P++I + ++ I + N FSG+IP + KLK+LS L L N SG +P
Sbjct: 459 SKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVKLKQLSRLDLSKNQLSGEIPRE 518
Query: 465 IGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLS 524
+ +L ++N A N LSG+IP +G LP LN L+LS+N+FSGEIP+ L KL++L+LS
Sbjct: 519 LRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSGEIPLELQNLKLNVLNLS 578
Query: 525 NNQLAGPIPEPLNIKAFIDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIAITM 584
N L+G IP K + F GNPGLC D + + RS ++ +VW L+ I +
Sbjct: 579 YNHLSGKIPPLYANKIYAHDFIGNPGLCVDLDGLCRKIT----RSKNIG-YVWILLTIFL 633
Query: 585 ---VLLVLLASYFVVKLKQ-NNLKHS-LKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGK 639
++ V+ F+ K ++ LK S L + W +SF L FSE EI D + +N+IG
Sbjct: 634 LAGLVFVVGIVMFIAKCRKLRALKSSTLAASKW--RSFHKLHFSEHEIADCLDEKNVIGF 691
Query: 640 GGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV 699
G SG VYKV L G+ +AVK + S G +Y S S + AEV TL +
Sbjct: 692 GSSGKVYKVELRGGEVVAVKKLNKSVKGGDDEYSSD-------SLNRDVFAAEVETLGTI 744
Query: 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK--IEMDWVVRYAIAVGAAKGL 757
RH ++V+L+C +S D LLVYEY+PNGSL D LH K + + W R IA+ AA+GL
Sbjct: 745 RHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGVVLGWPERLRIALDAAEGL 804
Query: 758 EYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT--GEAGDLTHVIAGTHGY 815
YLHH P++HRDVKSSNILLD ++ ++ADFG+AK+ Q + + IAG+ GY
Sbjct: 805 SYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMSGSKTPEAMSGIAGSCGY 864
Query: 816 IAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLT 875
IAPEY YT ++NEKSD+YSFGVVL+ELVTGK+P E GD KD+ WV + +D + +
Sbjct: 865 IAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGD-KDMAKWVCTALD-KCGLEP 922
Query: 876 VVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE---AEPCSVTNIV--V 930
V+DP + KE+ KV+ I + CT+ LP RPSMR VV ML+E A PCS N
Sbjct: 923 VIDPKLDLKFKEEISKVIHIGLLCTSPLPLNRPSMRKVVIMLQEVSGAVPCSSPNTSKRS 982
Query: 931 KKVGESSPSFSRHYNST 947
K G+ SP ++ NS
Sbjct: 983 KTGGKLSPYYTEDLNSV 999
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 615 bits (1586), Expect = e-175, Method: Compositional matrix adjust.
Identities = 376/970 (38%), Positives = 537/970 (55%), Gaps = 84/970 (8%)
Query: 13 GVFSSWT---EANSVCKFNGIVCD----SNGLVAEINLPEQQLLGVVPFDSICGLQALQK 65
G W + S C + GI C S+ V I+L + G P+ C ++ L
Sbjct: 44 GNLQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDLSGYNISGGFPY-GFCRIRTLIN 102
Query: 66 INLGTNFLYGTITEG-LKSCTRLQVLDLGNNSFSGEVPDLS-MLHELSFLNLNSSGISGK 123
I L N L GTI L C++LQ L L N+FSG++P+ S +L L L S+ +G+
Sbjct: 103 ITLSQNNLNGTIDSAPLSLCSKLQNLILNQNNFSGKLPEFSPEFRKLRVLELESNLFTGE 162
Query: 124 FPWKSLENLTNLEFLSLGDNP------------------------FDPSPFPMEVLKLEK 159
P +S LT L+ L+L NP FDPSP P + L
Sbjct: 163 IP-QSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDLAYISFDPSPIPSTLGNLSN 221
Query: 160 LYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLS 219
L L LT+ ++ G+IP+ I NL L+NL+L+ N L GEIP I +L ++Q+ELY+N LS
Sbjct: 222 LTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESIGRLESVYQIELYDNRLS 281
Query: 220 GRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHL 279
G+LP NLT L NFDVSQN L G+L E QL S +L +N F+G +P+ +L
Sbjct: 282 GKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQLISFNLNDNFFTGGLPDVVALNPNL 341
Query: 280 TELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNG 339
E ++ N TGTLP+ LG +++ + DVS N +G +PP +C + ++ N +G
Sbjct: 342 VEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLCYRRKLQKIITFSNQLSG 401
Query: 340 TVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSL 399
+PE+Y +C SL R+ +N LSG +P W LP + + NQ +G + I A+ L
Sbjct: 402 EIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLELANNNQLQGSIPPSISKARHL 461
Query: 400 ALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSG 459
+ L ++ N FSG +P K+ + L I LS N F G IP I KLK L + + +NM G
Sbjct: 462 SQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERVEMQENMLDG 521
Query: 460 PLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLS 519
+P S+ SC LT++N + N L G IP LG LP LN L+LSNN+ +GEIP L KL+
Sbjct: 522 EIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAELLRLKLN 581
Query: 520 LLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCL 579
++S+N+L G IP F SF GNP LC+ + + C S + + + C+
Sbjct: 582 QFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPIRPCRSKRETRYILPISILCI 641
Query: 580 IAITMVLLVLLASYFVVKLKQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGK 639
+A+T L+ L +K L + + + F+ + F+E++I + +N+IG
Sbjct: 642 VALTGALVWLF-------IKTKPLFKRKPKRTNKITIFQRVGFTEEDIYPQLTEDNIIGS 694
Query: 640 GGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV 699
GGSG VY+V L SG+ LAVK +W G G +++ S + +EV TL V
Sbjct: 695 GGSGLVYRVKLKSGQTLAVKKLW----GETG----------QKTESESVFRSEVETLGRV 740
Query: 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT--CHKI--EMDWVVRYAIAVGAAK 755
RH N+VKL E+ LVYE++ NGSL D LH+ H+ +DW R++IAVGAA+
Sbjct: 741 RHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQ 800
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV----IAG 811
GL YLHH P++HRDVKS+NILLD E KPR+ADFGLAK ++ + ++ V +AG
Sbjct: 801 GLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAG 860
Query: 812 THGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV------YS 865
++GYIAPEY YT K+NEKSDVYSFGVVL+EL+TGKRP FG++KDIV + Y
Sbjct: 861 SYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYP 920
Query: 866 KMDSRDSMLT------------VVDP--NISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
+ D + +VDP +S E+ KVL +A+ CT+ P RP+MR
Sbjct: 921 SPSAEDGAMNQDSLGNYRDLSKLVDPKMKLSTREYEEIEKVLDVALLCTSSFPINRPTMR 980
Query: 912 VVVQMLEEAE 921
VV++L+E +
Sbjct: 981 KVVELLKEKK 990
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 564 bits (1453), Expect = e-159, Method: Compositional matrix adjust.
Identities = 362/943 (38%), Positives = 523/943 (55%), Gaps = 60/943 (6%)
Query: 15 FSSWTEANSVCKFNGIVCD-SNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFL 73
SSW + S C + G+ CD S V ++L L G + D + L+ LQ ++L N +
Sbjct: 47 LSSWKVSTSFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSPD-VSHLRLLQNLSLAENLI 105
Query: 74 YGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKFPWKSLEN 131
G I + S + L+ L+L NN F+G PD S L L L++ ++ ++G P S+ N
Sbjct: 106 SGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPV-SVTN 164
Query: 132 LTNLEFLSLGDNPF----DPS-------------------PFPMEVLKLEKLYWLYLT-- 166
LT L L LG N F PS P E+ L L LY+
Sbjct: 165 LTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYY 224
Query: 167 NCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGF 226
N G PE IGNL++L + ++ L GEIP I KL KL L L N SG L
Sbjct: 225 NAFEDGLPPE-IGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWEL 283
Query: 227 SNLTNLMNFDVSQNRLEGDL-SELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLY 285
L++L + D+S N G++ + L L+ L+LF N+ GEIPE G+ L L L+
Sbjct: 284 GTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLW 343
Query: 286 TNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETY 345
N TG++PQKLG N VD+S N LTG +PP+MC + L+ L N G++P++
Sbjct: 344 ENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSL 403
Query: 346 ANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLA 405
C+SL R R+ N L+G+IP G++ LP L+ ++L N G + G + +L + L+
Sbjct: 404 GKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLS 463
Query: 406 NNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSI 465
NN+ SG LP I + + + L N+F G IP ++GKL++LS + N+FSG + I
Sbjct: 464 NNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEI 523
Query: 466 GSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL-TYPKLSLLDLS 524
C LT ++ ++N LSG+IP+ + ++ LN LNLS N G IP S+ + L+ LD S
Sbjct: 524 SRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFS 583
Query: 525 NNQLAGPIPEPLNIKAF-IDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIA-- 581
N L+G +P F SF GNP LC Y C G + H S L A
Sbjct: 584 YNNLSGLVPGTGQFSYFNYTSFLGNPDLCGP---YLGPCKDGVAKGGHQSHSKGPLSASM 640
Query: 582 ----ITMVLLVLLASYFVVKLKQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLI 637
+ +L+ +A V +K +LK + + +W + +F+ L F+ +++D++K +N+I
Sbjct: 641 KLLLVLGLLVCSIAFAVVAIIKARSLKKASESRAWRLTAFQRLDFTCDDVLDSLKEDNII 700
Query: 638 GKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLS 697
GKGG+G VYK V+ +G +AVK + A +S+ SS ++AE+ TL
Sbjct: 701 GKGGAGIVYKGVMPNGDLVAVKRL---------------AAMSRGSSHDHGFNAEIQTLG 745
Query: 698 AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGL 757
+RH ++V+L ++ ++NLLVYEY+PNGSL + LH + W RY IA+ AAKGL
Sbjct: 746 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGL 805
Query: 758 EYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIA 817
YLHH ++HRDVKS+NILLD ++ +ADFGLAK +Q + IAG++GYIA
Sbjct: 806 CYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIA 865
Query: 818 PEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS-RDSMLTV 876
PEYAYT K++EKSDVYSFGVVL+ELVTG++P V EFGD DIV WV DS +DS+L V
Sbjct: 866 PEYAYTLKVDEKSDVYSFGVVLLELVTGRKP-VGEFGDGVDIVQWVRKMTDSNKDSVLKV 924
Query: 877 VDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
+DP +S I + V +A+ C + RP+MR VVQ+L E
Sbjct: 925 LDPRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTE 967
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 553 bits (1424), Expect = e-156, Method: Compositional matrix adjust.
Identities = 360/971 (37%), Positives = 528/971 (54%), Gaps = 70/971 (7%)
Query: 14 VFSSWTEANSVCKFNGIVCD-SNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNF 72
+ +SW + + C + G+ CD S V ++L L G + D + L LQ ++L N
Sbjct: 46 LLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSD-VAHLPLLQNLSLAANQ 104
Query: 73 LYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKFPWKSLE 130
+ G I + + L+ L+L NN F+G PD S L L L+L ++ ++G P SL
Sbjct: 105 ISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPV-SLT 163
Query: 131 NLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNL--- 187
NLT L L LG N F P L +L ++ +TG+IP IGNLT L+ L
Sbjct: 164 NLTQLRHLHLGGNYFS-GKIPATYGTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIG 222
Query: 188 ----------------------ELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVG 225
+ ++ L GEIP I KL KL L L N+ +G +
Sbjct: 223 YYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQE 282
Query: 226 FSNLTNLMNFDVSQNRLEGDL-SELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSL 284
+++L + D+S N G++ + L L+ L+LF N+ G IPE GE L L L
Sbjct: 283 LGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQL 342
Query: 285 YTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPET 344
+ N TG++PQKLG +D+S N LTG +PP+MC + L+ L N G++P++
Sbjct: 343 WENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDS 402
Query: 345 YANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEG--PVTDDIGNAKSLALL 402
C+SL R R+ N L+G+IP ++ LP LS ++L N G P++ G + L +
Sbjct: 403 LGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGG-GVSGDLGQI 461
Query: 403 LLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLP 462
L+NN+ SG LP+ I S + + L N+FSG IP +IG+L++LS L N+FSG +
Sbjct: 462 SLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIA 521
Query: 463 YSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL-TYPKLSLL 521
I C LT ++ ++N LSG IP+ L + LN LNLS N G IP+++ + L+ +
Sbjct: 522 PEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSV 581
Query: 522 DLSNNQLAGPIPEPLNIKAF-IDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLI 580
D S N L+G +P F SF GN LC Y C G+ +SH V L
Sbjct: 582 DFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGP---YLGPCGKGTHQSH-----VKPLS 633
Query: 581 AITMVLLVLLASY------FVVKLKQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPE 634
A T +LLVL + V +K +L+++ + +W + +F+ L F+ +++D++K +
Sbjct: 634 ATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLDFTCDDVLDSLKED 693
Query: 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
N+IGKGG+G VYK + G +AVK + A +S SS ++AE+
Sbjct: 694 NIIGKGGAGIVYKGTMPKGDLVAVKRL---------------ATMSHGSSHDHGFNAEIQ 738
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA 754
TL +RH ++V+L ++ ++NLLVYEY+PNGSL + LH + W RY IA+ AA
Sbjct: 739 TLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAA 798
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
KGL YLHH ++HRDVKS+NILLD ++ +ADFGLAK +Q + IAG++G
Sbjct: 799 KGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYG 858
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS-RDSM 873
YIAPEYAYT K++EKSDVYSFGVVL+EL+TGK+P V EFGD DIV WV S DS +D +
Sbjct: 859 YIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKP-VGEFGDGVDIVQWVRSMTDSNKDCV 917
Query: 874 LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE--PCSVTNIVVK 931
L V+D +S + + V +A+ C + RP+MR VVQ+L E P S
Sbjct: 918 LKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEIPKIPLSKQQAAES 977
Query: 932 KVGESSPSFSR 942
V E +P+ +
Sbjct: 978 DVTEKAPAINE 988
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 538 bits (1385), Expect = e-151, Method: Compositional matrix adjust.
Identities = 348/978 (35%), Positives = 541/978 (55%), Gaps = 78/978 (7%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSV---CKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSI 57
+NLKS + W ++S C F+G+ CD + V +N+ L G + I
Sbjct: 32 LNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLNVSFTPLFGTIS-PEI 90
Query: 58 CGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNN-----SFSGEV----------- 101
L L + L N G + +KS T L+VL++ NN +F GE+
Sbjct: 91 GMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAMVDLEVLD 150
Query: 102 -----------PDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSL-GDNPFDPSP 149
P++S L +L +L+ + SG+ P +S ++ +LE+L L G SP
Sbjct: 151 TYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIP-ESYGDIQSLEYLGLNGAGLSGKSP 209
Query: 150 FPMEVLK-LEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKL 208
+ LK L ++Y Y S TG +P G LT+L+ L+++ L GEIP + L L
Sbjct: 210 AFLSRLKNLREMYIGYYN--SYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSNLKHL 267
Query: 209 WQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLN--QLSSLHLFENQFS 266
L L+ N+L+G +P S L +L + D+S N+L G++ + F+N ++ ++LF N
Sbjct: 268 HTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQ-SFINLGNITLINLFRNNLY 326
Query: 267 GEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGA 326
G+IPE GE L ++ N T LP LG + +DVS+N LTG IP D+C+ G
Sbjct: 327 GQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCR-GE 385
Query: 327 MTDLLVLQNNFN-GTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQF 385
++L+L NNF G +PE CKSL + R+ N L+GT+P G+++LP ++II+L+ N F
Sbjct: 386 KLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDNFF 445
Query: 386 EG--PVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGK 443
G PVT + L + L+NN FSGE+P I +L ++ L N+F G IP +I +
Sbjct: 446 SGELPVTM---SGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFE 502
Query: 444 LKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNN 503
LK LS + N +G +P SI C +L ++ ++N ++G+IP + ++ +L +LN+S N
Sbjct: 503 LKHLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGN 562
Query: 504 KFSGEIPISL-TYPKLSLLDLSNNQLAGPIPEPLNIKAFID-SFTGNPGLCSKTDEYFKS 561
+ +G IP + L+ LDLS N L+G +P F + SF GN LC + S
Sbjct: 563 QLTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLP---HRVS 619
Query: 562 CSSGSGRS---HHVSTFVWCLIAITMVLLVLLASYFVVKLKQNNLKHSLKQNSWDMKSFR 618
C + G++ +H + F I IT++ + V ++Q N K + K +W + +F+
Sbjct: 620 CPTRPGQTSDHNHTALFSPSRIVITVIAAITGLILISVAIRQMNKKKNQKSLAWKLTAFQ 679
Query: 619 VLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI 678
L F +++++ +K EN+IGKGG+G VY+ + + ++A+K + +G R D+
Sbjct: 680 KLDFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTG-RSDH------ 732
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK 738
+ AE+ TL +RH ++V+L + ++D+NLL+YEY+PNGSL + LH
Sbjct: 733 ---------GFTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKG 783
Query: 739 IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798
+ W R+ +AV AAKGL YLHH ++HRDVKS+NILLD +++ +ADFGLAK +
Sbjct: 784 GHLQWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLV 843
Query: 799 TGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858
G A + IAG++GYIAPEYAYT K++EKSDVYSFGVVL+EL+ GK+P V EFG+ D
Sbjct: 844 DGAASECMSSIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP-VGEFGEGVD 902
Query: 859 IVNWVYSKMDSRDS------MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRV 912
IV WV + + ++ +VDP ++ + V +IA+ C + A RP+MR
Sbjct: 903 IVRWVRNTEEEITQPSDAAIVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMRE 962
Query: 913 VVQMLEEAEPCSVTNIVV 930
VV ML P SV N++
Sbjct: 963 VVHMLTNP-PKSVANLIA 979
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 536 bits (1380), Expect = e-151, Method: Compositional matrix adjust.
Identities = 358/1022 (35%), Positives = 547/1022 (53%), Gaps = 133/1022 (13%)
Query: 30 IVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQV 89
I C S G + +I++ L +P ++ ++LQK+ + L GT+ E L C L+V
Sbjct: 75 ITCSSQGFITDIDIESVPLQLSLP-KNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKV 133
Query: 90 LDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFP--------WKSL----------- 129
LDL +N G++P LS L L L LNS+ ++GK P KSL
Sbjct: 134 LDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSI 193
Query: 130 ----ENLTNLEFLSLGDNPFDPSPFPMEVL------------------------KLEKLY 161
L+ LE + +G N P E+ KL+KL
Sbjct: 194 PTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLE 253
Query: 162 WLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGR 221
L + ++G+IP +GN ++L +L L +N L G IP I +L KL QL L+ NSL G
Sbjct: 254 TLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGG 313
Query: 222 LPVGFSNLTNLMNFDVSQNRLEGDL----SELRFLNQ---------------------LS 256
+P N +NL D+S N L G + L FL + L
Sbjct: 314 IPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLV 373
Query: 257 SLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGP 316
L L +NQ SG IP E G LT ++N+L G++P L D +D+S N LTG
Sbjct: 374 QLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGT 433
Query: 317 IPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLS 376
IP + +T LL++ N+ +G +P+ NC SL+R R+ N ++G IP GI SL ++
Sbjct: 434 IPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKIN 493
Query: 377 IIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQ 436
+D S+N+ G V D+IG+ L ++ L+NN G LP+ +S S L + +S NQFSG+
Sbjct: 494 FLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGK 553
Query: 437 IPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLN 496
IP +G+L L+ L L N+FSG +P S+G C L ++ N LSG+IP LG + +L
Sbjct: 554 IPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLE 613
Query: 497 -SLNLSNNKFSGEIPISL-TYPKLSLLDLSNNQLAGPIPEPLNIKAFI------DSFT-- 546
+LNLS+N+ +G+IP + + KLS+LDLS+N L G + NI+ + +SF+
Sbjct: 614 IALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGY 673
Query: 547 ----------------GNPGLCSKT-DEYFKSCSSGSG--------RSHHVSTFVWCLIA 581
GN LCS T D F + G+G R+ + + LI
Sbjct: 674 LPDNKLFRQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLIT 733
Query: 582 ITMVLLVLLASYFVVKLKQN--NLKHSL--KQNSWDMKSFRVLSFSEKEIIDAVKPENLI 637
+T+VL++ L + V++ ++N N + S + W F+ L+FS +II + N+I
Sbjct: 734 LTVVLMI-LGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVI 792
Query: 638 GKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLS 697
GKG SG VY+ +++G+ +AVK +WP+ D ++ ++ R S + AEV TL
Sbjct: 793 GKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKT-------KNVRDS-FSAEVKTLG 844
Query: 698 AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGL 757
+RH N+V+ + ++ LL+Y+Y+PNGSL LH +DW +RY I +GAA+GL
Sbjct: 845 TIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGL 904
Query: 758 EYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIA 817
YLHH P++HRD+K++NIL+ L+++P IADFGLAK+V G+ G ++ +AG++GYIA
Sbjct: 905 AYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIA 964
Query: 818 PEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVV 877
PEY Y+ KI EKSDVYS+GVV++E++TGK+PI P + +V+WV S L V+
Sbjct: 965 PEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGS----LEVL 1020
Query: 878 DPNI---SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML----EEAEPCSVTNIVV 930
D + +E ++ ++VL A+ C N P RP+M+ V ML +E E + ++++
Sbjct: 1021 DSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEIKQEREEYAKVDLLL 1080
Query: 931 KK 932
KK
Sbjct: 1081 KK 1082
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 526 bits (1356), Expect = e-148, Method: Compositional matrix adjust.
Identities = 345/953 (36%), Positives = 510/953 (53%), Gaps = 76/953 (7%)
Query: 25 CKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSC 84
C + G+ C+SNG V +++L L G + DSI L +L N+ N + KS
Sbjct: 60 CNWTGVRCNSNGNVEKLDLAGMNLTGKIS-DSISQLSSLVSFNISCNGFESLLP---KSI 115
Query: 85 TRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSG--ISGKFPWKSLENLTNLEFLSLGD 142
L+ +D+ NSFSG + S L ++LN+SG +SG + L NL +LE L L
Sbjct: 116 PPLKSIDISQNSFSGSLFLFSN-ESLGLVHLNASGNNLSGNLT-EDLGNLVSLEVLDLRG 173
Query: 143 NPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQ------------------------IPEGI 178
N F S P L+KL +L L+ ++TG+ IP
Sbjct: 174 NFFQGS-LPSSFKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEF 232
Query: 179 GNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVS 238
GN+ L+ L+L+ +L GEIP+ + KL L L LY N+ +G +P ++T L D S
Sbjct: 233 GNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFS 292
Query: 239 QNRLEGDLS-ELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKL 297
N L G++ E+ L L L+L N+ SG IP L L L+ N L+G LP L
Sbjct: 293 DNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDL 352
Query: 298 GSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVN 357
G + ++DVS N +G IP +C G +T L++ N F G +P T + C+SL+R R+
Sbjct: 353 GKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQ 412
Query: 358 NNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKI 417
NN L+G+IP G L L ++L+ N+ G + DI ++ SL+ + + N+ LPS I
Sbjct: 413 NNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTI 472
Query: 418 SEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFA 477
+L + ++ N SG++P LS+L L N +G +P SI SC L +N
Sbjct: 473 LSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLR 532
Query: 478 QNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL-TYPKLSLLDLSNNQLAGPIPEPL 536
N+L+G+IP + ++ +L L+LSNN +G +P S+ T P L LL++S N+L GP+P
Sbjct: 533 NNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVP--- 589
Query: 537 NIKAFI-----DSFTGNPGLCSKT---DEYFKSCSSGSGRSHHVSTFVWCLIAITMVL-- 586
I F+ D GN GLC F+ +S H LI I VL
Sbjct: 590 -INGFLKTINPDDLRGNSGLCGGVLPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLAL 648
Query: 587 --LVLLASYFVVKLKQNNL----KHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKG 640
L ++ K N S + W + +F L F+ +I+ +K N+IG G
Sbjct: 649 GILTIVTRTLYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMG 708
Query: 641 GSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV 699
+G VYK ++ S LAVK +W RS+ I + ++ EV L +
Sbjct: 709 ATGIVYKAEMSRSSTVLAVKKLW----------RSAADI---EDGTTGDFVGEVNLLGKL 755
Query: 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLH---TCHKIEMDWVVRYAIAVGAAKG 756
RH N+V+L + ++ + ++VYE++ NG+L D +H ++ +DWV RY IA+G A G
Sbjct: 756 RHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHG 815
Query: 757 LEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYI 816
L YLHH PVIHRD+KS+NILLD RIADFGLA+++ + ++AG++GYI
Sbjct: 816 LAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM--ARKKETVSMVAGSYGYI 873
Query: 817 APEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTV 876
APEY YT K++EK D+YS+GVVL+EL+TG+RP+ PEFG+S DIV WV K+ S+
Sbjct: 874 APEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEA 933
Query: 877 VDPNIS--EILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTN 927
+DPN+ ++E+ L VL+IA+ CT KLP RPSMR V+ ML EA+P +N
Sbjct: 934 LDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGEAKPRRKSN 986
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 525 bits (1353), Expect = e-148, Method: Compositional matrix adjust.
Identities = 331/915 (36%), Positives = 496/915 (54%), Gaps = 80/915 (8%)
Query: 54 FDS-----ICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSML 107
FDS I L+ L+ N +N G + + L+ L+ G + F GE+P L
Sbjct: 141 FDSSFPPGISKLKFLKVFNAFSNNFEGLLPSDVSRLRFLEELNFGGSYFEGEIPAAYGGL 200
Query: 108 HELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTN 167
L F++L + + GK P + L LT L+ + +G N F+ + P E L L + ++N
Sbjct: 201 QRLKFIHLAGNVLGGKLPPR-LGLLTELQHMEIGYNHFNGN-IPSEFALLSNLKYFDVSN 258
Query: 168 CSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFS 227
CS++G +P+ +GNL+ L+ L L N GEIP L L L+ +N LSG +P GFS
Sbjct: 259 CSLSGSLPQELGNLSNLETLFLFQNGFTGEIPESYSNLKSLKLLDFSSNQLSGSIPSGFS 318
Query: 228 NLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTN 287
L NL + L L N SGE+PE GE LT L L+ N
Sbjct: 319 TLKNL-----------------------TWLSLISNNLSGEVPEGIGELPELTTLFLWNN 355
Query: 288 RLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYAN 347
TG LP KLGS +DVS N TG IP +C + L++ N F G +P++
Sbjct: 356 NFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEGELPKSLTR 415
Query: 348 CKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANN 407
C+SL RFR NN L+GTIP G SL NL+ +DLS N+F + D A L L L+ N
Sbjct: 416 CESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAPVLQYLNLSTN 475
Query: 408 RFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGS 467
F +LP I +A +L S + G+IP +G K + L N +G +P+ IG
Sbjct: 476 FFHRKLPENIWKAPNLQIFSASFSNLIGEIPNYVG-CKSFYRIELQGNSLNGTIPWDIGH 534
Query: 468 CVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPK-LSLLDLSNN 526
C L +N +QN L+G IP + +LPS+ ++LS+N +G IP K ++ ++S N
Sbjct: 535 CEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTITTFNVSYN 594
Query: 527 QLAGPIPEPLNIKAFIDSFTGNPGLCSKTDEYFKSCSS---GSGRS----HH-------- 571
QL GPIP F+ N GLC D K C+S +G + HH
Sbjct: 595 QLIGPIPSGSFAHLNPSFFSSNEGLCG--DLVGKPCNSDRFNAGNADIDGHHKEERPKKT 652
Query: 572 VSTFVWCLIA-ITMVLLVLLASYFVVKLKQNN-----LKHSLKQNSWDMKSFRVLSFSEK 625
VW L A I + VL+A+ + N ++ W + +F+ L+F+
Sbjct: 653 AGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWKLTAFQRLNFTAD 712
Query: 626 EIIDAV-KPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSS 684
++++ + K +N++G G +G VYK + +G+ +AVK +W N R + +L
Sbjct: 713 DVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENGKIRRRKSGVL----- 767
Query: 685 RSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKI---EM 741
AEV L VRH N+V+L T+ D +L+YEY+PNGSL D LH K
Sbjct: 768 ------AEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAA 821
Query: 742 DWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGE 801
+W Y IA+G A+G+ YLHH D ++HRD+K SNILLD +++ R+ADFG+AK++QT E
Sbjct: 822 EWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQTDE 881
Query: 802 AGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861
+ V+AG++GYIAPEYAYT ++++KSD+YS+GV+L+E++TGKR + PEFG+ IV+
Sbjct: 882 S---MSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGNSIVD 938
Query: 862 WVYSKMDSRDSMLTVVDPNISE---ILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918
WV SK+ +++ + V+D ++ +++E+ ++LRIA+ CT++ P RP MR V+ +L+
Sbjct: 939 WVRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQ 998
Query: 919 EAEPCSVT---NIVV 930
EA+P T N++V
Sbjct: 999 EAKPKRKTVGDNVIV 1013
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 947 | ||||||
| 224105823 | 969 | predicted protein [Populus trichocarpa] | 0.982 | 0.959 | 0.719 | 0.0 | |
| 255562060 | 996 | Receptor protein kinase CLAVATA1 precurs | 0.990 | 0.941 | 0.691 | 0.0 | |
| 359475504 | 975 | PREDICTED: receptor-like protein kinase | 0.990 | 0.962 | 0.676 | 0.0 | |
| 147774267 | 1253 | hypothetical protein VITISV_033329 [Viti | 0.985 | 0.744 | 0.678 | 0.0 | |
| 356546726 | 964 | PREDICTED: receptor-like protein kinase | 0.977 | 0.960 | 0.677 | 0.0 | |
| 357446137 | 979 | Receptor-like protein kinase HAIKU2 [Med | 0.976 | 0.944 | 0.657 | 0.0 | |
| 359492994 | 984 | PREDICTED: receptor-like protein kinase | 0.985 | 0.948 | 0.650 | 0.0 | |
| 449527753 | 985 | PREDICTED: LOW QUALITY PROTEIN: receptor | 0.969 | 0.931 | 0.651 | 0.0 | |
| 255537884 | 973 | Receptor protein kinase CLAVATA1 precurs | 0.987 | 0.960 | 0.628 | 0.0 | |
| 356507963 | 983 | PREDICTED: receptor-like protein kinase | 0.986 | 0.950 | 0.589 | 0.0 |
| >gi|224105823|ref|XP_002313944.1| predicted protein [Populus trichocarpa] gi|222850352|gb|EEE87899.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1354 bits (3505), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 670/931 (71%), Positives = 788/931 (84%), Gaps = 1/931 (0%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGL 60
+ KS ++ S T VF++WT+ NSVC F GIVC+ N V EINLP+QQL GV+PFD+ICGL
Sbjct: 16 LKFKSAVQHSKTNVFTTWTQENSVCSFTGIVCNKNRFVTEINLPQQQLEGVLPFDAICGL 75
Query: 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGI 120
++L+KI++G+N L+G ITE LK CT LQVLDLGNNSF+G+VPDL L +L L+LN+SG
Sbjct: 76 RSLEKISMGSNSLHGGITEDLKHCTSLQVLDLGNNSFTGKVPDLFTLQKLKILSLNTSGF 135
Query: 121 SGKFPWKSLENLTNLEFLSLGDNPFD-PSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIG 179
SG FPW+SLENLTNL FLSLGDN FD S FP+E+LKL+KLYWLYL+NCS+ GQIPEGI
Sbjct: 136 SGPFPWRSLENLTNLAFLSLGDNLFDVTSSFPVELLKLDKLYWLYLSNCSIKGQIPEGIS 195
Query: 180 NLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQ 239
NLT L+NLELSDN+LFGEIPAGI KL+KL QLELYNNSL+G+LP GF NLT+L+NFD S
Sbjct: 196 NLTLLENLELSDNQLFGEIPAGIGKLSKLRQLELYNNSLTGKLPTGFGNLTSLVNFDASH 255
Query: 240 NRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGS 299
NRLEG+L EL+ L L+SLHLFENQF+GEIPEEFGE K+L E SLYTN+LTG LPQKLGS
Sbjct: 256 NRLEGELVELKPLKLLASLHLFENQFTGEIPEEFGELKYLEEFSLYTNKLTGPLPQKLGS 315
Query: 300 WADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNN 359
WADF Y+DVSEN LTG IPPDMCK G MTDLL+LQNNF G VPE+YANCKSL+RFRV+ N
Sbjct: 316 WADFAYIDVSENFLTGRIPPDMCKNGKMTDLLILQNNFTGQVPESYANCKSLVRFRVSKN 375
Query: 360 SLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISE 419
SLSG IP GIW +PNL I+D S NQFEGPVT DIGNAKSLA++ LANNRFSG LPS IS+
Sbjct: 376 SLSGYIPAGIWGMPNLFIVDFSMNQFEGPVTPDIGNAKSLAIVNLANNRFSGTLPSTISQ 435
Query: 420 ASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479
SSLVS+QLS N+FSG+IP IG+LKKL+SLYL NMFSG +P S+GSCVSLTDIN + N
Sbjct: 436 TSSLVSVQLSSNRFSGEIPSTIGELKKLNSLYLTGNMFSGAIPDSLGSCVSLTDINLSGN 495
Query: 480 SLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIK 539
S SG IP+SLGSLP+LNSLNLSNNK SGEIP+SL++ KLS LDLSNNQL GP+P+ +++
Sbjct: 496 SFSGNIPESLGSLPTLNSLNLSNNKLSGEIPVSLSHLKLSNLDLSNNQLIGPVPDSFSLE 555
Query: 540 AFIDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIAITMVLLVLLASYFVVKLK 599
AF + F GNPGLCS+ + + CS + S+ + FV C +A +VL++ + +KL+
Sbjct: 556 AFREGFDGNPGLCSQNLKNLQPCSRNARTSNQLRVFVSCFVAGLLVLVIFSCCFLFLKLR 615
Query: 600 QNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVK 659
QNNL H LKQ+SW MKSFR+LSFSE ++IDA+K ENLIGKGGSGNVYKVVL++G ELAVK
Sbjct: 616 QNNLAHPLKQSSWKMKSFRILSFSESDVIDAIKSENLIGKGGSGNVYKVVLDNGNELAVK 675
Query: 660 HIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLL 719
HIW +NS R +RSS+A+L+KR+SRS EYDAEVATLS VRHVNVVKLYCSITS+D NLL
Sbjct: 676 HIWTANSIDRTGFRSSSAMLTKRNSRSPEYDAEVATLSNVRHVNVVKLYCSITSDDCNLL 735
Query: 720 VYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779
VYEYLPNGSLWDRLH+CHKI+M W +RY+IA GAA+GLEYLHHGFDRPVIHRDVKSSNIL
Sbjct: 736 VYEYLPNGSLWDRLHSCHKIKMGWELRYSIAAGAARGLEYLHHGFDRPVIHRDVKSSNIL 795
Query: 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839
LD EWKPRIADFGLAKIVQ G GD THVIAGTHGYIAPEYAYTCK+NEKSDVYSFGVVL
Sbjct: 796 LDEEWKPRIADFGLAKIVQAGGQGDWTHVIAGTHGYIAPEYAYTCKVNEKSDVYSFGVVL 855
Query: 840 MELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHC 899
MELVTGKRPI PEFG++KDIV WV SK++S++S L VVD NISE+ KEDA+K+LRIAIHC
Sbjct: 856 MELVTGKRPIEPEFGENKDIVYWVCSKLESKESALQVVDSNISEVFKEDAIKMLRIAIHC 915
Query: 900 TNKLPAFRPSMRVVVQMLEEAEPCSVTNIVV 930
T+K+PA RPSMR+VV MLEE EP +T++VV
Sbjct: 916 TSKIPALRPSMRMVVHMLEEVEPLQLTDVVV 946
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562060|ref|XP_002522038.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223538637|gb|EEF40238.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1289 bits (3336), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 653/944 (69%), Positives = 779/944 (82%), Gaps = 6/944 (0%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGL 60
+N KS ++ S+T VFSSWTE +SVCKF GIVC ++G V EI+LPE++L GVVPF SIC L
Sbjct: 39 LNFKSSLKDSETNVFSSWTEQSSVCKFTGIVCTADGFVKEISLPEKKLQGVVPFGSICAL 98
Query: 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGI 120
Q L+KI+LG+NFL G IT+ L++C LQVLDLGNN FSG+VPDLS LH+L LNLN SG
Sbjct: 99 QYLEKISLGSNFLRGVITDDLRNCRNLQVLDLGNNFFSGQVPDLSSLHKLRILNLNGSGF 158
Query: 121 SGKFPWKSLENLTNLEFLSLGDNPFDP-SPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIG 179
SG FPWKSLENLTNLEFLSLGDN FD S FP EV+K KLYWLYLTNCS+ G+IPEGI
Sbjct: 159 SGSFPWKSLENLTNLEFLSLGDNRFDATSSFPAEVIKFNKLYWLYLTNCSIKGKIPEGIS 218
Query: 180 NLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQ 239
NLT L+NLELSDNELFGEIP GI KL+KLWQLE+YNN+LSG+LP G NLTNL+NFD S
Sbjct: 219 NLTLLENLELSDNELFGEIPEGIGKLSKLWQLEIYNNALSGKLPAGLGNLTNLVNFDAST 278
Query: 240 NRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGS 299
N+LEG++ L L +L+SL LFENQFSGEIP EFGEFK+L+E SLY N+ TG+LP+KLGS
Sbjct: 279 NKLEGEIGVLISLKKLASLQLFENQFSGEIPAEFGEFKYLSEFSLYRNKFTGSLPEKLGS 338
Query: 300 WADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNN 359
W+DF Y+DVSEN LTGPIPPDMCK G MTDLL+LQN F G VPE+YANCKSL R RVNNN
Sbjct: 339 WSDFGYIDVSENFLTGPIPPDMCKNGKMTDLLILQNKFTGQVPESYANCKSLNRLRVNNN 398
Query: 360 SLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISE 419
SLSGT+P GIW LPNL+IIDL+ NQFEGP+T DIG AKSL L L NN+FSGELP+ IS
Sbjct: 399 SLSGTVPAGIWGLPNLTIIDLTMNQFEGPLTADIGYAKSLGSLALDNNQFSGELPAAISS 458
Query: 420 ASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479
ASSLVSIQLS NQF+G+IP +IG+LKKL+ L+L N+F G +P S+GSCVSL DIN + N
Sbjct: 459 ASSLVSIQLSSNQFTGRIPENIGELKKLNRLHLDGNLFFGTIPDSLGSCVSLDDINLSGN 518
Query: 480 SLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIK 539
S+SG+IP++LGSLP+LNSLNLS+NK SG+IP+SL+ +LS LDLSNNQL GPIP L++
Sbjct: 519 SISGEIPETLGSLPTLNSLNLSSNKLSGQIPVSLSSLRLSNLDLSNNQLVGPIPNSLSLG 578
Query: 540 AFIDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIAITMVLLVLLASYFVVKLK 599
F + F GNPGLCS T + CSS + S H+ + C A +VL++ +K K
Sbjct: 579 VFREGFNGNPGLCSNTLWNIRPCSSTARNSSHLRVLLSCFAAGLLVLVISAGYLLYLKSK 638
Query: 600 QNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVK 659
NNL H LK++SWDMKSFRVLSFSE++IID++K ENLIGKGGSGNVYKV+L +G ELAVK
Sbjct: 639 PNNLNHPLKRSSWDMKSFRVLSFSERDIIDSIKSENLIGKGGSGNVYKVLLRNGNELAVK 698
Query: 660 HIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLL 719
HIW S+S R +SS+A+L+KR+ RS EYDAEVA LS VRHVNVVKL+CSITSEDSNLL
Sbjct: 699 HIWTSHSSDRKSCQSSSAMLTKRNFRSLEYDAEVAALSTVRHVNVVKLFCSITSEDSNLL 758
Query: 720 VYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779
VYEYLPNGSLWD+LH+C+KI++ W +RYAIA+GAA+GLEYLHHGFDRPVIHRDVKSSNIL
Sbjct: 759 VYEYLPNGSLWDQLHSCNKIQIGWELRYAIALGAARGLEYLHHGFDRPVIHRDVKSSNIL 818
Query: 780 LDLEWKPRIADFGLAKIVQ----TGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSF 835
LD +WKPRIADFGLAKIVQ G G+ +++IAGT+GY+APEYAYTCK+NEKSDVYSF
Sbjct: 819 LDEDWKPRIADFGLAKIVQGGGGGGGGGEWSNMIAGTYGYMAPEYAYTCKVNEKSDVYSF 878
Query: 836 GVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRI 895
GVVLMELVTGKRP PEFG++KDIV WV+SK+ +++ L +VD NISE LKEDA+KVL+I
Sbjct: 879 GVVLMELVTGKRPTEPEFGENKDIVYWVHSKISRKENSLDIVDSNISERLKEDAIKVLQI 938
Query: 896 AIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTN-IVVKKVGESSP 938
A+HCT K+PA RP+MR+VVQMLEEAE +++ IVVKK G SSP
Sbjct: 939 AVHCTAKIPALRPTMRLVVQMLEEAESHQLSDIIVVKKEGGSSP 982
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475504|ref|XP_002271143.2| PREDICTED: receptor-like protein kinase HAIKU2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1287 bits (3331), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 637/941 (67%), Positives = 756/941 (80%), Gaps = 3/941 (0%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGL 60
+ KS +EKS+T VF +WT+ NSV F GIVC+SNG V EI LPEQQL GV+PFDSIC L
Sbjct: 35 LKFKSALEKSNTSVFDTWTQGNSVRNFTGIVCNSNGFVTEILLPEQQLEGVLPFDSICEL 94
Query: 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGI 120
++L+KI+LG N L+G I EGLK+C++LQ LDLG N F+G VP+LS L L FLNLN SG
Sbjct: 95 KSLEKIDLGANVLHGGIGEGLKNCSQLQYLDLGVNFFTGTVPELSSLSGLKFLNLNCSGF 154
Query: 121 SGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGN 180
SG FPWKSLENLTNLEFLSLGDN F+ S FP+E+LKL+KLYWLYLTN S+ GQ+PEGIGN
Sbjct: 155 SGSFPWKSLENLTNLEFLSLGDNQFERSSFPLEILKLDKLYWLYLTNSSLEGQVPEGIGN 214
Query: 181 LTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQN 240
LTQLQNLELSDN L GEIP GI KL+KLWQLELY+N SG+ P GF NLTNL+NFD S N
Sbjct: 215 LTQLQNLELSDNYLHGEIPVGIGKLSKLWQLELYDNRFSGKFPEGFGNLTNLVNFDASNN 274
Query: 241 RLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSW 300
LEGDLSELRFL +L+SL LFENQFSGE+P+EFGEFK+L E SLYTN LTG LPQKLGSW
Sbjct: 275 SLEGDLSELRFLTKLASLQLFENQFSGEVPQEFGEFKYLEEFSLYTNNLTGPLPQKLGSW 334
Query: 301 ADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNS 360
D ++DVSEN LTG IPP+MCK G + L VL+N F G +P YANC L R RVNNN
Sbjct: 335 GDLTFIDVSENFLTGAIPPEMCKQGKLGALTVLKNKFTGEIPANYANCLPLKRLRVNNNF 394
Query: 361 LSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEA 420
LSG +P GIWSLPNLS+ID N F GPVT DIGNAKSLA L LA+N FSGELP +IS+A
Sbjct: 395 LSGIVPAGIWSLPNLSLIDFRVNHFHGPVTSDIGNAKSLAQLFLADNEFSGELPEEISKA 454
Query: 421 SSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNS 480
S LV I LS N+FSG+IP IG+LK L+SL L +N FSGP+P S+GSCVSL D+N + NS
Sbjct: 455 SLLVVIDLSSNKFSGKIPATIGELKALNSLNLQENKFSGPIPESLGSCVSLDDVNLSGNS 514
Query: 481 LSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKA 540
LSG+IP+SLG+L +LNSLNLSNN+ SGEIP SL+ +LSLLDL+NN+L+G +PE L+ A
Sbjct: 515 LSGEIPESLGTLSTLNSLNLSNNQLSGEIPSSLSSLRLSLLDLTNNKLSGRVPESLS--A 572
Query: 541 FIDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIAITMVLLVLLASYFVVKLKQ 600
+ SF+GNP LCS+T +F+SCSS G S + + C +A+ V+L+ A + +VK++
Sbjct: 573 YNGSFSGNPDLCSETITHFRSCSSNPGLSGDLRRVISCFVAVAAVMLICTACFIIVKIRS 632
Query: 601 NNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKH 660
+ +K +SWD+KS+R LSFSE EII+++K +NLIGKG SGNVYKVVL +G ELAVKH
Sbjct: 633 KDHDRLIKSDSWDLKSYRSLSFSESEIINSIKQDNLIGKGASGNVYKVVLGNGTELAVKH 692
Query: 661 IWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLV 720
+W S SG R RS+TA+L KR+ R SEY+AEVATLS+VRH+NVVKLYCSITSEDS+LLV
Sbjct: 693 MWKSASGDRRACRSTTAMLGKRNRRPSEYEAEVATLSSVRHMNVVKLYCSITSEDSDLLV 752
Query: 721 YEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780
YEYL NGSLWDRLHTC K+EMDW VRY IAVGA +GLEYLHHG DR VIHRDVKSSNILL
Sbjct: 753 YEYLRNGSLWDRLHTCQKMEMDWDVRYDIAVGAGRGLEYLHHGCDRTVIHRDVKSSNILL 812
Query: 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLM 840
D++ KPRIADFGLAK++ GD THVIAGTHGYIAPEYAYTCK+ EKSDVYSFGVVLM
Sbjct: 813 DVDLKPRIADFGLAKMLHGAAGGDTTHVIAGTHGYIAPEYAYTCKVTEKSDVYSFGVVLM 872
Query: 841 ELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCT 900
ELVTGKRPI PEFG++KDIV WVY+ M SR+ + +VD ISE KEDA+KVL+I+IHCT
Sbjct: 873 ELVTGKRPIEPEFGENKDIVYWVYNNMKSREDAVGLVDSAISEAFKEDAVKVLQISIHCT 932
Query: 901 NKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKVGE-SSPSF 940
K+P RPSMR+VVQMLE+ +PC +TNIVV K GE S+PS
Sbjct: 933 AKIPVLRPSMRMVVQMLEDFKPCKLTNIVVSKGGEGSAPSL 973
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147774267|emb|CAN65551.1| hypothetical protein VITISV_033329 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1281 bits (3316), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 634/935 (67%), Positives = 752/935 (80%), Gaps = 2/935 (0%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGL 60
+ KS +EKS+T VF +WT+ NSV F GIVC+SNG V EI LPEQQL GV+PFDSIC L
Sbjct: 35 LKFKSALEKSNTSVFDTWTQGNSVRNFTGIVCNSNGFVTEILLPEQQLEGVLPFDSICEL 94
Query: 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGI 120
++L+KI+LG N L+G I EGLK+C++LQ LDLG N F+G VP+LS L L FLNLN SG
Sbjct: 95 KSLEKIDLGANVLHGGIGEGLKNCSQLQYLDLGVNFFTGTVPELSSLSGLKFLNLNCSGF 154
Query: 121 SGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGN 180
SG FPWKSLENLTNLEFLSLGDN F+ S FP+E+LKL+KLYWLYLTN S+ GQ+PEGIGN
Sbjct: 155 SGSFPWKSLENLTNLEFLSLGDNQFERSSFPLEILKLDKLYWLYLTNSSLEGQVPEGIGN 214
Query: 181 LTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQN 240
LTQLQNLELSDN L GEIP GI KL+KLWQLELY+N SG+ P GF NLTNL+NFD S N
Sbjct: 215 LTQLQNLELSDNYLHGEIPVGIGKLSKLWQLELYDNRFSGKFPEGFGNLTNLVNFDASNN 274
Query: 241 RLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSW 300
LEGDLSELRFL +L+SL LFENQFSGE+P+EFGEFK+L E SLYTN LTG LPQKLGSW
Sbjct: 275 SLEGDLSELRFLTKLASLQLFENQFSGEVPQEFGEFKYLEEFSLYTNNLTGPLPQKLGSW 334
Query: 301 ADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNS 360
D ++DVSEN LTG IPP+MCK G + L VL+N F G +P YANC L R RVNNN
Sbjct: 335 GDLTFIDVSENFLTGAIPPEMCKQGKLGALTVLKNKFTGEIPANYANCLPLKRLRVNNNF 394
Query: 361 LSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEA 420
LSG +P GIWSLPNLS+ID N F GPVT DIGNAKSLA L LA+N FSGELP +IS+A
Sbjct: 395 LSGIVPAGIWSLPNLSLIDFRVNHFHGPVTSDIGNAKSLAQLFLADNEFSGELPEEISKA 454
Query: 421 SSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNS 480
S LV I LS N+FSG+IP IG+LK L+SL L +N FSGP+P S+GSCVSL D+N + NS
Sbjct: 455 SLLVVIDLSSNKFSGKIPATIGELKALNSLNLQENKFSGPIPESLGSCVSLDDVNLSGNS 514
Query: 481 LSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKA 540
LSG+IP+SLG+L +LNSLNLSNN+ SGEIP SL+ +LSLLDL+NN+L+G +PE L+ A
Sbjct: 515 LSGEIPESLGTLSTLNSLNLSNNQLSGEIPSSLSSLRLSLLDLTNNKLSGRVPESLS--A 572
Query: 541 FIDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIAITMVLLVLLASYFVVKLKQ 600
+ SF+GNP LCS+T +F+SCSS G S + + C +A+ V+L+ A + +VK++
Sbjct: 573 YNGSFSGNPDLCSETITHFRSCSSNPGLSGDLRRVISCFVAVAAVMLICTACFIIVKIRS 632
Query: 601 NNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKH 660
+ +K +SWD+KS+R LSFSE EII+++K +NLIGKG SGNVYKVVL +G ELAVKH
Sbjct: 633 KDHDRLIKSDSWDLKSYRSLSFSESEIINSIKQDNLIGKGASGNVYKVVLGNGTELAVKH 692
Query: 661 IWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLV 720
+W S SG R RS+TA+L KR+ R SEY+AEVATLS+VRH+NVVKLYCSITSEDS+LLV
Sbjct: 693 MWKSASGDRRACRSTTAMLGKRNRRPSEYEAEVATLSSVRHMNVVKLYCSITSEDSDLLV 752
Query: 721 YEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780
YEYL NGSLWDRLHTC K+EMDW VRY IAVGA +GLEYLHHG DR VIHRDVKSSNILL
Sbjct: 753 YEYLRNGSLWDRLHTCQKMEMDWDVRYDIAVGAGRGLEYLHHGCDRTVIHRDVKSSNILL 812
Query: 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLM 840
D++ KPRIADFGLAK++ GD THVIAGTHGYIAPEYAYTCK+ EKSDVYSFGVVLM
Sbjct: 813 DVDLKPRIADFGLAKMLHGAAGGDTTHVIAGTHGYIAPEYAYTCKVTEKSDVYSFGVVLM 872
Query: 841 ELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCT 900
ELVTGKRPI PEFG++KDIV WVY+ M SR+ + +VD ISE KEDA+KVL+I+IHCT
Sbjct: 873 ELVTGKRPIEPEFGENKDIVYWVYNNMKSREDAVGLVDSAISEAFKEDAVKVLQISIHCT 932
Query: 901 NKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKVGE 935
K+P RPSMR+VVQMLE+ +PC +TNIVV K GE
Sbjct: 933 AKIPVLRPSMRMVVQMLEDFKPCKLTNIVVSKGGE 967
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546726|ref|XP_003541774.1| PREDICTED: receptor-like protein kinase HAIKU2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1227 bits (3175), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 631/932 (67%), Positives = 750/932 (80%), Gaps = 6/932 (0%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGL 60
M KS I+ S+ VFSSWT+ANS C+F GIVC+S G V+EINL EQQL G VPFDS+C L
Sbjct: 33 MKFKSSIQSSNANVFSSWTQANSPCQFTGIVCNSKGFVSEINLAEQQLKGTVPFDSLCEL 92
Query: 61 QALQKINLGTN-FLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSG 119
Q+L+KI+LG+N +L+G+I+E L+ CT L+ LDLGNNSF+GEVPDLS LH+L L+LNSSG
Sbjct: 93 QSLEKISLGSNVYLHGSISEDLRKCTNLKQLDLGNNSFTGEVPDLSSLHKLELLSLNSSG 152
Query: 120 ISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIG 179
ISG FPWKSLENLT+LEFLSLGDN + +PFP+EVLKLE LYWLYLTNCS+TG IP GIG
Sbjct: 153 ISGAFPWKSLENLTSLEFLSLGDNLLEKTPFPLEVLKLENLYWLYLTNCSITGNIPLGIG 212
Query: 180 NLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQ 239
NLT+LQNLELSDN L GEIP IVKL +LWQLELY+N LSG++ VGF NLT+L+NFD S
Sbjct: 213 NLTRLQNLELSDNHLSGEIPPDIVKLQRLWQLELYDNYLSGKIAVGFGNLTSLVNFDASY 272
Query: 240 NRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGS 299
N+LEGDLSELR L +L+SLHLF N+FSGEIP+E G+ K+LTELSLY N TG LPQKLGS
Sbjct: 273 NQLEGDLSELRSLTKLASLHLFGNKFSGEIPKEIGDLKNLTELSLYGNNFTGPLPQKLGS 332
Query: 300 WADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNN 359
W Y+DVS+N +GPIPP +CK + +L +L N+F+GT+PETYANC SL RFR++ N
Sbjct: 333 WVGMQYLDVSDNSFSGPIPPHLCKHNQIDELALLNNSFSGTIPETYANCTSLARFRLSRN 392
Query: 360 SLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISE 419
SLSG +P GIW L NL + DL+ NQFEGPVT DI AKSLA LLL+ N+FSGELP +ISE
Sbjct: 393 SLSGVVPSGIWGLANLKLFDLAMNQFEGPVTTDIAKAKSLAQLLLSYNKFSGELPLEISE 452
Query: 420 ASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479
ASSLVSIQLS NQFSG IP IGKLKKL+SL L+ N SG +P SIGSC SL +IN A N
Sbjct: 453 ASSLVSIQLSSNQFSGHIPETIGKLKKLTSLTLNGNNLSGIVPDSIGSCTSLNEINLAGN 512
Query: 480 SLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIK 539
SLSG IP S+GSLP+LNSLNLS+N+ SGEIP SL+ +LSLLDLSNNQL G IPEPL I
Sbjct: 513 SLSGAIPASVGSLPTLNSLNLSSNRLSGEIPSSLSSLRLSLLDLSNNQLFGSIPEPLAIS 572
Query: 540 AFIDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIAITMVLLVLLASYFVVKLK 599
AF D FTGNPGLCSK + F+ CS S S + C IA+ MVLL A + KL+
Sbjct: 573 AFRDGFTGNPGLCSKALKGFRPCSMESSSSKRFRNLLVCFIAVVMVLLG--ACFLFTKLR 630
Query: 600 QNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVK 659
QN + LK SW++K + VL F+E EI+D +K ENLIGKGGSGNVY+VVL SG E AVK
Sbjct: 631 QNKFEKQLKTTSWNVKQYHVLRFNENEIVDGIKAENLIGKGGSGNVYRVVLKSGAEFAVK 690
Query: 660 HIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLL 719
HIW SN RG RS++++ +RSSRS E+DAEVATLS++RHVNVVKLYCSITSEDS+LL
Sbjct: 691 HIWTSNLSERGSCRSTSSM-LRRSSRSPEFDAEVATLSSIRHVNVVKLYCSITSEDSSLL 749
Query: 720 VYEYLPNGSLWDRLHTC-HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778
VYE+LPNGSLWDRLHTC +K EM W VRY IA+GAA+GLEYLHHG DRPVIHRDVKSSNI
Sbjct: 750 VYEFLPNGSLWDRLHTCKNKSEMGWEVRYDIALGAARGLEYLHHGCDRPVIHRDVKSSNI 809
Query: 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVV 838
LLD EWKPRIADFGLAKI+Q G AG+ T+VIAGT GY+ PEYAYTC++ EKSDVYSFGVV
Sbjct: 810 LLDEEWKPRIADFGLAKILQGG-AGNWTNVIAGTVGYMPPEYAYTCRVTEKSDVYSFGVV 868
Query: 839 LMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIH 898
LMELVTGKRP+ PEFG++ DIV WV + + SR+ L +VDP I++ +KEDA+KVL+IA
Sbjct: 869 LMELVTGKRPMEPEFGENHDIVYWVCNNIRSREDALELVDPTIAKHVKEDAMKVLKIATL 928
Query: 899 CTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVV 930
CT K+PA RPSMR++VQMLEEA+P + T ++V
Sbjct: 929 CTGKIPASRPSMRMLVQMLEEADPFTTTKMIV 960
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357446137|ref|XP_003593346.1| Receptor-like protein kinase HAIKU2 [Medicago truncatula] gi|355482394|gb|AES63597.1| Receptor-like protein kinase HAIKU2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1206 bits (3121), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 613/933 (65%), Positives = 741/933 (79%), Gaps = 8/933 (0%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGL 60
MN KS I+ S +F+SW + S C F G++C+S G V +INL + L+G +PFDSIC +
Sbjct: 48 MNFKSSIQTSLPNIFTSWNTSTSPCNFTGVLCNSEGFVTQINLANKNLVGTLPFDSICKM 107
Query: 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGI 120
+ L+KI+L +NFL+G+I E LK+CT L+ LDLG NSF+G VP+ S L +L +LNLN SG+
Sbjct: 108 KYLEKISLESNFLHGSINEKLKNCTNLKYLDLGGNSFNGTVPEFSSLSKLEYLNLNLSGV 167
Query: 121 SGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGN 180
SGKFPWKSLENLT+L FLSLGDN F+ S FP+E+LKLEKLYWLYLTNCS+ G+IP GIGN
Sbjct: 168 SGKFPWKSLENLTSLTFLSLGDNIFEKSSFPLEILKLEKLYWLYLTNCSIFGEIPVGIGN 227
Query: 181 LTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQN 240
LTQLQ+LELSDN L GEIP I KL L QLE+Y+N LSG+ P F NLTNL+ FD S N
Sbjct: 228 LTQLQHLELSDNNLSGEIPHDIGKLKNLRQLEIYDNYLSGKFPFRFGNLTNLVQFDASNN 287
Query: 241 RLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSW 300
LEGDLSEL+ L L SL LF+N+FSGEIP+EFG+FK+LTELSLY N+LTG LPQKLGSW
Sbjct: 288 HLEGDLSELKSLENLQSLQLFQNKFSGEIPQEFGDFKNLTELSLYDNKLTGFLPQKLGSW 347
Query: 301 ADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNS 360
++DVS+N L+GPIPPDMCK +TD+ +L N+F G++PE+YANC +L+RFR+ NS
Sbjct: 348 VGMLFIDVSDNSLSGPIPPDMCKNNQITDIALLNNSFTGSIPESYANCTALVRFRLTKNS 407
Query: 361 LSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEA 420
LSG +P GIW LPNL + DL N+FEG ++ DIG AKSLA L L++N+FSGELP +ISEA
Sbjct: 408 LSGIVPRGIWGLPNLELFDLGRNKFEGSISSDIGKAKSLAQLFLSDNQFSGELPMEISEA 467
Query: 421 SSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNS 480
SSLVSIQLS N+ SG IP IGKLKKL+SL L++N SG LP SIGSCVSL ++N A+NS
Sbjct: 468 SSLVSIQLSSNRISGHIPETIGKLKKLTSLTLNNNNVSGILPDSIGSCVSLNEVNLAENS 527
Query: 481 LSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKA 540
+SG IP S+GSLP+LNSLNLS+NKFSGEIP SL+ KLSLLDLSNNQ G IP+ L I A
Sbjct: 528 ISGVIPTSIGSLPTLNSLNLSSNKFSGEIPSSLSSLKLSLLDLSNNQFFGSIPDSLAISA 587
Query: 541 FIDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIAITMVLLVLLASYFVVKLKQ 600
F D F GNPGLCS+ + F+ CS SG S V V+ IA MV+LV LA + +++LKQ
Sbjct: 588 FKDGFMGNPGLCSQILKNFQPCSLESGSSRRVRNLVFFFIAGLMVMLVSLAFFIIMRLKQ 647
Query: 601 NNL--KHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAV 658
NN K LK NSW+ K + VL+ +E EIID +K EN+IGKGGSGNVYKV L SG+ AV
Sbjct: 648 NNKFEKQVLKTNSWNFKQYHVLNINENEIIDGIKAENVIGKGGSGNVYKVELKSGEVFAV 707
Query: 659 KHIWPSNSGFRGD-YRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSN 717
KHIW SN R D YRSS+A+L KRSS S E+DAEVA LS++RHVNVVKLYCSITSEDS+
Sbjct: 708 KHIWTSNP--RNDHYRSSSAML-KRSSNSPEFDAEVAALSSIRHVNVVKLYCSITSEDSS 764
Query: 718 LLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777
LLVYE+LPNGSLW+RLHTC+K +M W VRY IA+GAA+GLEYLHHG DRPV+HRDVKSSN
Sbjct: 765 LLVYEFLPNGSLWERLHTCNKTQMVWEVRYDIALGAARGLEYLHHGCDRPVMHRDVKSSN 824
Query: 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGV 837
ILLD EWKPRIADFGLAKIVQ G G+ THVIAGT GY+APEYAYTCK+ EKSDVYSFGV
Sbjct: 825 ILLDEEWKPRIADFGLAKIVQGG--GNWTHVIAGTLGYMAPEYAYTCKVTEKSDVYSFGV 882
Query: 838 VLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAI 897
VLMELVTGKRP+ PEFG++KDIV+WV S + S++S L +VD I++ KEDA+KVLRIA
Sbjct: 883 VLMELVTGKRPVEPEFGENKDIVSWVCSNIRSKESALELVDSTIAKHFKEDAIKVLRIAT 942
Query: 898 HCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVV 930
CT K P+ RPSMR +VQMLEEAEPC+ + ++V
Sbjct: 943 LCTAKAPSSRPSMRTLVQMLEEAEPCAPSKVIV 975
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492994|ref|XP_002283604.2| PREDICTED: receptor-like protein kinase HAIKU2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1204 bits (3115), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 608/935 (65%), Positives = 730/935 (78%), Gaps = 2/935 (0%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGL 60
+ +K++++ DT VF SW +S C F GI C+S+G V EI L Q+L GVVP +SIC L
Sbjct: 35 LKVKAELQNFDTYVFDSWESNDSACNFRGITCNSDGRVREIELSNQRLSGVVPLESICQL 94
Query: 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGI 120
++L+K++LG NFL GTI+ L C LQ LDLGNN F+G +PD S L L L LNSSG
Sbjct: 95 ESLEKLSLGFNFLQGTISGDLNKCVGLQYLDLGNNLFTGPLPDFSSLSGLKHLYLNSSGF 154
Query: 121 SGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGN 180
SG FPWKSL+N++ L LSLGDNPF PSP EV KL L WLYL+NCS+ G +P IGN
Sbjct: 155 SGLFPWKSLQNMSGLISLSLGDNPFQPSPIAEEVFKLYDLNWLYLSNCSINGTLPPEIGN 214
Query: 181 LTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQN 240
L +L NLELSDN L GEIPA I KL+KLWQLELY N L+G++PVGF NLTNL NFD S N
Sbjct: 215 LNKLINLELSDNYLSGEIPAEIGKLSKLWQLELYANELTGKIPVGFRNLTNLENFDASDN 274
Query: 241 RLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSW 300
LEGDLSELRFLNQL SL LFEN FSG+IPEEFGEF+ L LSL++N+L+G +PQKLGSW
Sbjct: 275 NLEGDLSELRFLNQLVSLQLFENSFSGQIPEEFGEFRRLVNLSLFSNKLSGPIPQKLGSW 334
Query: 301 ADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNS 360
ADF+Y+DVSEN LTGPIPPDMCK G M +LL+LQN F G +P TYA+C +L RFRVNNNS
Sbjct: 335 ADFDYIDVSENSLTGPIPPDMCKNGKMKELLMLQNKFTGEIPVTYASCSTLTRFRVNNNS 394
Query: 361 LSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEA 420
LSGT+P GIW LPN++IID++ N FEG +T DI AKSL L + NNR SGELP +IS+A
Sbjct: 395 LSGTVPAGIWGLPNVNIIDITMNAFEGSITSDIAKAKSLGQLFVGNNRLSGELPVEISKA 454
Query: 421 SSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNS 480
SSLVSI LS NQFS +IP IG+LK L SL+L +NMFSG +P +GSC SL+D+N A N
Sbjct: 455 SSLVSIDLSNNQFSREIPATIGELKNLGSLHLQNNMFSGSIPKELGSCDSLSDLNIAHNL 514
Query: 481 LSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKA 540
LSGKIP SLGSLP+LNSLNLS N+ SGEIP SL+ +LSLLDLS+N+L G +P+ L+I+A
Sbjct: 515 LSGKIPSSLGSLPTLNSLNLSENQLSGEIPASLSSLRLSLLDLSHNRLTGRVPQSLSIEA 574
Query: 541 FIDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIAITMVLLVLLASYFVVKLKQ 600
+ SF GN GLCS +F+ C S S T + C I +MVLL LA +F +K K+
Sbjct: 575 YNGSFAGNAGLCSPNISFFRRCPPDSRISREQRTLIVCFIIGSMVLLGSLAGFFFLKSKE 634
Query: 601 NNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKH 660
+ SLK +SWD+KSF +LSF+E EI++++K ENLIGKGG GNVYKV L++G ELAVKH
Sbjct: 635 KD-DRSLKDDSWDVKSFHMLSFTEDEILNSIKQENLIGKGGCGNVYKVSLSNGNELAVKH 693
Query: 661 IWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLV 720
IW S+SG R RS+T +L+KRS +SSE+DAEV TLS++RHVNVVKLYCSITSEDS+LLV
Sbjct: 694 IWNSDSGGRKKTRSTTPMLAKRSGKSSEFDAEVQTLSSIRHVNVVKLYCSITSEDSSLLV 753
Query: 721 YEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780
YEYLPNGSLWDRLHT K+E+DW RY IA+GAAKGLEYLHH +RPVIHRDVKSSNILL
Sbjct: 754 YEYLPNGSLWDRLHTSRKMELDWETRYEIALGAAKGLEYLHHSCERPVIHRDVKSSNILL 813
Query: 781 DLEWKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839
D KPRIADFGLAKIVQ G D THVIAGTHGYIAPEY YT K+NEKSDVYSFGVVL
Sbjct: 814 DEFLKPRIADFGLAKIVQANGGGKDSTHVIAGTHGYIAPEYGYTYKVNEKSDVYSFGVVL 873
Query: 840 MELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHC 899
MELVTGKRPI P++G+++DIV+WV S + +R+S+L++VD I E LKEDA+KVLRIAI C
Sbjct: 874 MELVTGKRPIEPDYGENRDIVSWVCSNIKTRESVLSIVDSRIPEALKEDAVKVLRIAILC 933
Query: 900 TNKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKVG 934
T +LPA RP+MR VVQM+EEAEPC + I+V K G
Sbjct: 934 TARLPALRPTMRGVVQMIEEAEPCRLVGIIVNKDG 968
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449527753|ref|XP_004170874.1| PREDICTED: LOW QUALITY PROTEIN: receptor-like protein kinase HAIKU2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1176 bits (3043), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 603/926 (65%), Positives = 731/926 (78%), Gaps = 8/926 (0%)
Query: 18 WTEANSVCK-FNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGT 76
W + VC F+GIVC+SNG V EINLP Q L G++PFDSIC L++L+K++ G N LYG
Sbjct: 59 WIKGKDVCSSFHGIVCNSNGFVVEINLPAQNLSGIIPFDSICSLKSLEKLSFGFNXLYGK 118
Query: 77 ITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLE 136
+++GL++C++L+ LDLG N FSGEVPDLS L L FL+LN+SG SG FPWKSL NLT+LE
Sbjct: 119 VSDGLRNCSKLKYLDLGENFFSGEVPDLSSLVGLRFLSLNNSGFSGDFPWKSLVNLTDLE 178
Query: 137 FLSLGDNPFDPS-PFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELF 195
FLSLGDN F+P+ FP+ +L+L+ L+WLYL+NC++ G+IP IGNL+ L+NLELS N+L
Sbjct: 179 FLSLGDNTFNPTTSFPLAILELKNLHWLYLSNCTIYGEIPSRIGNLSLLENLELSQNKLT 238
Query: 196 GEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQL 255
GEIP IV L LWQLEL+ NSL+G+LPVG NLT L NFD S N LEGDL ELR L L
Sbjct: 239 GEIPYEIVNLKNLWQLELHENSLTGKLPVGLGNLTGLRNFDASSNNLEGDLMELRSLTNL 298
Query: 256 SSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315
SL LFEN+FSG IPEEFG+FK L ELSLY N L G+LPQ++GSWA F ++DVSEN L+G
Sbjct: 299 KSLQLFENRFSGTIPEEFGDFKDLIELSLYRNNLIGSLPQRIGSWAAFVFIDVSENFLSG 358
Query: 316 PIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNL 375
PIPPDMCK G MTDLL+LQNNF G +PE+Y NCKSL RFRVNNNSLSG +P GIWSLPNL
Sbjct: 359 PIPPDMCKQGRMTDLLMLQNNFIGGIPESYTNCKSLNRFRVNNNSLSGVVPTGIWSLPNL 418
Query: 376 SIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSG 435
SIIDLS NQFEGPVT DIG AK+LA L L+NNRFSG LP+++ EASSLVSI+L NQF G
Sbjct: 419 SIIDLSMNQFEGPVTSDIGKAKALAQLFLSNNRFSGNLPAELGEASSLVSIKLDSNQFVG 478
Query: 436 QIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSL 495
IP +GKLK LSSL L+DN FSG +P S+GSC SL+ I+ + NS SG+I ++LG LP L
Sbjct: 479 PIPESLGKLKDLSSLALNDNKFSGNIPSSLGSCTSLSTIDLSMNSFSGRISENLGYLPIL 538
Query: 496 NSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGLCSKT 555
NSLNLS+N+ SGEIP S + KLS DLSNN+L G +P+ L I+AF +SF GNPGLCS++
Sbjct: 539 NSLNLSSNELSGEIPTSFSKLKLSSFDLSNNRLIGQVPDSLAIQAFDESFMGNPGLCSES 598
Query: 556 DEYF-KSCSSGSGRSHHVSTFVWCLIAITMVLLVLLASYFVVKLKQN-NLKHSLKQNSWD 613
+Y + S H+++ + C IA ++L+V VK K+N + KH L SWD
Sbjct: 599 IKYLSSCSPTSRSSSSHLTSLLSCTIAGILLLIVSFLCLLFVKWKRNKDGKHLLNSKSWD 658
Query: 614 MKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYR 673
MK F ++ F+EKEIID++ NLIGKGGSGNVYKVVL++GKELAVKHIW S+S + +
Sbjct: 659 MKLFHMVRFTEKEIIDSINSHNLIGKGGSGNVYKVVLSNGKELAVKHIWQSSSRDQANSG 718
Query: 674 SSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL 733
+S +L+KR +RSSEYDAEVATLS+VRH NVVKLYCSI+SEDSNLLVYEYLPNGSLWD+L
Sbjct: 719 TSATMLTKRKTRSSEYDAEVATLSSVRHNNVVKLYCSISSEDSNLLVYEYLPNGSLWDQL 778
Query: 734 HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793
HT KIEM W +RYAIAVGAA+GLEYLHHG DRPVIHRDVKSSNILLD +WKPRIADFGL
Sbjct: 779 HTSRKIEMGWQIRYAIAVGAARGLEYLHHGCDRPVIHRDVKSSNILLDSDWKPRIADFGL 838
Query: 794 AKIVQTGEA---GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIV 850
AKI+Q G GD +HVIAGT GYIAPEYAYTCKINEKSDVYSFGVVLMEL TGK+P
Sbjct: 839 AKILQDGNGHGVGDSSHVIAGTLGYIAPEYAYTCKINEKSDVYSFGVVLMELATGKQPNE 898
Query: 851 PEFGDSKDIVNWVYSKM-DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS 909
EFG++KDIV W +S+M + + ++ +VDP+ISE E+A+KVLRIA+ CT K+P+ RPS
Sbjct: 899 AEFGENKDIVQWAHSRMRELKGNLKEMVDPSISEAQVENAVKVLRIALRCTAKIPSTRPS 958
Query: 910 MRVVVQMLEEAEPCSVTNIVVKKVGE 935
MR+VV MLEEAEPC+ +IVVKK E
Sbjct: 959 MRMVVHMLEEAEPCNFIDIVVKKECE 984
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255537884|ref|XP_002510007.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223550708|gb|EEF52194.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1170 bits (3028), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 588/936 (62%), Positives = 713/936 (76%), Gaps = 1/936 (0%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGL 60
+NLK+ ++ S T VF SW N +C F GI C S+ V EI L + L GV+P D +C L
Sbjct: 30 LNLKTSLQNSHTNVFDSWDSTNFICDFTGITCTSDNSVKEIELSSRNLSGVLPLDRVCNL 89
Query: 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGI 120
Q+L+K++LG N L G I+ L CT+LQ LDLGNN FSG P+ L +L L LN SG
Sbjct: 90 QSLEKLSLGFNSLSGVISVDLNKCTKLQYLDLGNNLFSGPFPEFPALSQLQHLFLNQSGF 149
Query: 121 SGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGN 180
SG FPWKSL+N+T+L LS+GDN FDP+PFP +++KL KL WLYL+NCS++G IP+GI N
Sbjct: 150 SGVFPWKSLDNITDLVTLSVGDNLFDPTPFPPQIVKLTKLNWLYLSNCSISGTIPQGIRN 209
Query: 181 LTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQN 240
L++L N E SDN L GEIP+ I L LWQLELYNNSL+G LP G NLT L NFD S N
Sbjct: 210 LSELINFEASDNNLSGEIPSEIGMLKNLWQLELYNNSLTGELPFGLRNLTKLENFDASMN 269
Query: 241 RLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSW 300
L+G+LSELRFL L SL LF N SGEIP EFG FK L LSLY N+LTG LPQ++GSW
Sbjct: 270 NLKGNLSELRFLTNLVSLQLFYNGLSGEIPAEFGLFKKLVNLSLYGNKLTGPLPQQIGSW 329
Query: 301 ADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNS 360
A F++VDVSEN LTG IPP+MCK G M LL+LQNN G +P +YA+CK+L RFRV+ NS
Sbjct: 330 AKFHFVDVSENFLTGTIPPNMCKQGTMQQLLMLQNNLTGEIPASYASCKTLKRFRVSKNS 389
Query: 361 LSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEA 420
LSGT+P GIW LP+++IID+ NQ EGPVT DIGNAK+L L L NNR SGELP +ISEA
Sbjct: 390 LSGTVPAGIWGLPDVNIIDVEENQLEGPVTLDIGNAKALGQLFLGNNRLSGELPEEISEA 449
Query: 421 SSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNS 480
+SLVSI+L+ NQFSG+IP +IG+LK LSSL L +NMFSG +P S+G+C SLTDIN A NS
Sbjct: 450 TSLVSIKLNDNQFSGKIPQNIGELKHLSSLNLQNNMFSGSIPESLGTCDSLTDINIAYNS 509
Query: 481 LSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKA 540
LSG+IP SLGSLPSLNSLNLS N SGEIP SL+ +LSLLDL+NN+L G IP+ L+I+A
Sbjct: 510 LSGEIPSSLGSLPSLNSLNLSENHLSGEIPDSLSSLRLSLLDLTNNRLTGRIPQSLSIEA 569
Query: 541 FIDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIAITMVLLVLLASYFVVKLKQ 600
+ SF GN GLCS+T F+ C SG S V T + C I +L++ L +K K+
Sbjct: 570 YNGSFAGNSGLCSQTVSTFQRCKPQSGMSKEVRTLIACFIVGAAILVMSLVYSLHLKKKE 629
Query: 601 NNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKH 660
+ SLK+ SWD+KSF VL+F E EI+D++K EN+IGKGGSGNVY+V L +GKELAVKH
Sbjct: 630 KDHDRSLKEESWDVKSFHVLTFGEDEILDSIKEENVIGKGGSGNVYRVSLGNGKELAVKH 689
Query: 661 IWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLV 720
IW ++SG R S+T +L+K +S E+DAEV TLS++RHVNVVKLYCSITSEDS+LLV
Sbjct: 690 IWNTDSGGRKKSWSTTPMLAKGRGKSKEFDAEVQTLSSIRHVNVVKLYCSITSEDSSLLV 749
Query: 721 YEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780
YEY+PNGSLWDRLHT K+E+DW RY IAVGAAKGLEYLHHG DRP+IHRDVKSSNILL
Sbjct: 750 YEYMPNGSLWDRLHTSKKMELDWETRYEIAVGAAKGLEYLHHGCDRPIIHRDVKSSNILL 809
Query: 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLM 840
D KPRIADFGLAKI G D T VIAGTHGYIAPEY YT K+NEKSDVYSFGVVLM
Sbjct: 810 DELLKPRIADFGLAKIKADG-GKDSTQVIAGTHGYIAPEYGYTYKVNEKSDVYSFGVVLM 868
Query: 841 ELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCT 900
ELV+GKRPI PE+GD+KDIV+W+ S + S++ +L++VD I E+ +EDA+KVLRIAI CT
Sbjct: 869 ELVSGKRPIEPEYGDNKDIVDWISSNLKSKERVLSIVDSRIPEVFREDAVKVLRIAILCT 928
Query: 901 NKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKVGES 936
+LP RP+MR VVQMLE+AEPC + IV+ K G S
Sbjct: 929 ARLPTLRPTMRSVVQMLEDAEPCKLVGIVISKDGAS 964
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507963|ref|XP_003522732.1| PREDICTED: receptor-like protein kinase HAIKU2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1113 bits (2879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 556/943 (58%), Positives = 693/943 (73%), Gaps = 9/943 (0%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGL 60
+NLKS ++ S++ + SW NSVC F+G+ C+S V EINL Q L GV+PFDS+C L
Sbjct: 31 LNLKSSLQNSNSKLLHSWNATNSVCTFHGVTCNSLNSVTEINLSNQTLSGVLPFDSLCKL 90
Query: 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGI 120
+LQK+ G N L G ++E +++C L+ LDLGNN FSG PD+S L +L +L LN SG
Sbjct: 91 PSLQKLVFGFNNLNGNVSEDIRNCVNLRYLDLGNNLFSGPFPDISPLKQLQYLFLNRSGF 150
Query: 121 SGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGN 180
SG FPW+SL N+T L LS+GDNPFD +PFP EV+ L+ L WLYL+NC++ G++P G+GN
Sbjct: 151 SGTFPWQSLLNMTGLLQLSVGDNPFDLTPFPKEVVSLKNLNWLYLSNCTLRGKLPVGLGN 210
Query: 181 LTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQN 240
LT+L LE SDN L G+ PA IV L KLWQL +NNS +G++P+G NLT L D S N
Sbjct: 211 LTELTELEFSDNFLTGDFPAEIVNLRKLWQLVFFNNSFTGKIPIGLRNLTRLEFLDGSMN 270
Query: 241 RLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSW 300
+LEGDLSEL++L L SL FEN SGEIP E GEFK L LSLY NRL G +PQK+GSW
Sbjct: 271 KLEGDLSELKYLTNLVSLQFFENNLSGEIPVEIGEFKRLEALSLYRNRLIGPIPQKVGSW 330
Query: 301 ADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNS 360
A+F Y+DVSEN LTG IPPDMCK GAM LLVLQN +G +P TY +C SL RFRV+NNS
Sbjct: 331 AEFAYIDVSENFLTGTIPPDMCKKGAMWALLVLQNKLSGEIPATYGDCLSLKRFRVSNNS 390
Query: 361 LSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEA 420
LSG +P +W LPN+ IID+ NQ G V+ +I NAK+LA + NR SGE+P +IS+A
Sbjct: 391 LSGAVPASVWGLPNVEIIDIELNQLSGSVSWNIKNAKTLASIFARQNRLSGEIPEEISKA 450
Query: 421 SSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNS 480
+SLV++ LS NQ SG IP IG+LK+L SL+L N SG +P S+GSC SL D++ ++NS
Sbjct: 451 TSLVNVDLSENQISGNIPEGIGELKQLGSLHLQSNKLSGSIPESLGSCNSLNDVDLSRNS 510
Query: 481 LSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKA 540
LSG+IP SLGS P+LNSLNLS NK SGEIP SL + +LSL DLS N+L GPIP+ L ++A
Sbjct: 511 LSGEIPSSLGSFPALNSLNLSANKLSGEIPKSLAFLRLSLFDLSYNRLTGPIPQALTLEA 570
Query: 541 FIDSFTGNPGLCS-KTDEYFKSCSSGSGRSHHVSTFVWCLIAITMVLLVLLASYFVVKLK 599
+ S +GNPGLCS + F C + SG S + + C + +++LL L Y +K +
Sbjct: 571 YNGSLSGNPGLCSVDANNSFPRCPASSGMSKDMRALIICFVVASILLLSCLGVYLQLKRR 630
Query: 600 QNN----LKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKE 655
+ + SLK+ +WD+KSF VLSFSE EI+D++K ENLIGKGGSGNVY+V L++GKE
Sbjct: 631 KEEGEKYGERSLKKETWDVKSFHVLSFSEGEILDSIKQENLIGKGGSGNVYRVTLSNGKE 690
Query: 656 LAVKHIWPSN-SGFRGDYRSSTAILSKR--SSRSSEYDAEVATLSAVRHVNVVKLYCSIT 712
LAVKHIW ++ R SST +L + + +S E+DAEV LS++RHVNVVKLYCSIT
Sbjct: 691 LAVKHIWNTDVPARRKSSWSSTPMLGNKFAAGKSKEFDAEVQALSSIRHVNVVKLYCSIT 750
Query: 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRD 772
SEDS+LLVYEYLPNGSLWDRLHT K+E+DW RY IAVGAAKGLEYLHHG +RPVIHRD
Sbjct: 751 SEDSSLLVYEYLPNGSLWDRLHTSRKMELDWETRYEIAVGAAKGLEYLHHGCERPVIHRD 810
Query: 773 VKSSNILLDLEWKPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSD 831
VKSSNILLD KPRIADFGLAK+VQ D T VIAGTHGYIAPEY YT K+NEKSD
Sbjct: 811 VKSSNILLDEFLKPRIADFGLAKLVQANVGKDSSTRVIAGTHGYIAPEYGYTYKVNEKSD 870
Query: 832 VYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALK 891
VYSFGVVLMELVTGKRPI PEFG++KDIV+WV++K S++ + + VD I E+ E+ K
Sbjct: 871 VYSFGVVLMELVTGKRPIEPEFGENKDIVSWVHNKARSKEGLRSAVDSRIPEMYTEETCK 930
Query: 892 VLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKVG 934
VLR A+ CT LPA RP+MR VVQ LE+AEPC + IV+ K G
Sbjct: 931 VLRTAVLCTGTLPALRPTMRAVVQKLEDAEPCKLVGIVISKDG 973
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 947 | ||||||
| TAIR|locus:2024432 | 977 | LRR XI-23 [Arabidopsis thalian | 0.978 | 0.948 | 0.573 | 1.6e-285 | |
| TAIR|locus:2091206 | 991 | IKU2 "HAIKU2" [Arabidopsis tha | 0.984 | 0.940 | 0.563 | 1.1e-275 | |
| TAIR|locus:2032553 | 996 | HSL1 "HAESA-like 1" [Arabidops | 0.971 | 0.923 | 0.391 | 3.2e-175 | |
| TAIR|locus:2207036 | 977 | AT1G72180 [Arabidopsis thalian | 0.949 | 0.920 | 0.396 | 2.1e-171 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.951 | 0.901 | 0.407 | 1.5e-168 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.861 | 0.821 | 0.389 | 4.9e-155 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.931 | 0.879 | 0.376 | 5.1e-145 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.970 | 0.917 | 0.351 | 6.3e-140 | |
| TAIR|locus:2204350 | 980 | CLV1 "AT1G75820" [Arabidopsis | 0.951 | 0.919 | 0.351 | 1.9e-138 | |
| TAIR|locus:2180617 | 1005 | AT5G25930 [Arabidopsis thalian | 0.911 | 0.858 | 0.362 | 4.6e-137 |
| TAIR|locus:2024432 LRR XI-23 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2743 (970.6 bits), Expect = 1.6e-285, P = 1.6e-285
Identities = 538/938 (57%), Positives = 680/938 (72%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSV--CKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSIC 58
+ LKS S+ VF SW + + C F G+ C+S G V EI+L + L G PFDS+C
Sbjct: 35 LKLKSSFADSNLAVFDSWKLNSGIGPCSFIGVTCNSRGNVTEIDLSRRGLSGNFPFDSVC 94
Query: 59 GLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSS 118
+Q+L+K++LG N L G I LK+CT L+ LDLGNN FSG P+ S L++L FL LN+S
Sbjct: 95 EIQSLEKLSLGFNSLSGIIPSDLKNCTSLKYLDLGNNLFSGAFPEFSSLNQLQFLYLNNS 154
Query: 119 GISGKFPWKSLENLTNLEFLSLGDNPFDPSP-FPMEVLKLEKLYWLYLTNCSVTGQIPEG 177
SG FPWKSL N T+L LSLGDNPFD + FP+EV+ L+KL WLYL+NCS+ G+IP
Sbjct: 155 AFSGVFPWKSLRNATSLVVLSLGDNPFDATADFPVEVVSLKKLSWLYLSNCSIAGKIPPA 214
Query: 178 IGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDV 237
IG+LT+L+NLE+SD+ L GEIP+ I KL LWQLELYNNSL+G+LP GF NL NL D
Sbjct: 215 IGDLTELRNLEISDSGLTGEIPSEISKLTNLWQLELYNNSLTGKLPTGFGNLKNLTYLDA 274
Query: 238 SQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKL 297
S N L+GDLSELR L L SL +FEN+FSGEIP EFGEFK L LSLYTN+LTG+LPQ L
Sbjct: 275 STNLLQGDLSELRSLTNLVSLQMFENEFSGEIPLEFGEFKDLVNLSLYTNKLTGSLPQGL 334
Query: 298 GSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVN 357
GS ADF+++D SENLLTGPIPPDMCK G M LL+LQNN G++PE+YANC +L RFRV+
Sbjct: 335 GSLADFDFIDASENLLTGPIPPDMCKNGKMKALLLLQNNLTGSIPESYANCLTLQRFRVS 394
Query: 358 NNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSXXXXXXXXXRFSGELPSKI 417
N+L+GT+P G+W LP L IID+ N FEGP+T DI N K + S ELP +I
Sbjct: 395 ENNLNGTVPAGLWGLPKLEIIDIEMNNFEGPITADIKNGKMLGALYLGFNKLSDELPEEI 454
Query: 418 SEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFA 477
+ SL ++L+ N+F+G+IP IGKLK LSSL + N FSG +P SIGSC L+D+N A
Sbjct: 455 GDTESLTKVELNNNRFTGKIPSSIGKLKGLSSLKMQSNGFSGEIPDSIGSCSMLSDVNMA 514
Query: 478 QNSLSGKIPDXXXXXXXXXXXXXXXXKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLN 537
QNS+SG+IP K SG IP SL+ +LSLLDLSNN+L+G IP L+
Sbjct: 515 QNSISGEIPHTLGSLPTLNALNLSDNKLSGRIPESLSSLRLSLLDLSNNRLSGRIP--LS 572
Query: 538 IKAFIDSFTGNPGLCSKTDEYFKSCSSGSGRSH-HVSTFVWCLIAITMVLLVLLASYFVV 596
+ ++ SF GNPGLCS T + F C + S RSH FV C++ ++LL L + +
Sbjct: 573 LSSYNGSFNGNPGLCSTTIKSFNRCINPS-RSHGDTRVFVLCIVFGLLILLASLVFFLYL 631
Query: 597 KLKQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKEL 656
K + SLK SW +KSFR +SF+E +IID++K ENLIG+GG G+VY+VVL GKE+
Sbjct: 632 KKTEKKEGRSLKHESWSIKSFRKMSFTEDDIIDSIKEENLIGRGGCGDVYRVVLGDGKEV 691
Query: 657 AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDS 716
AVKHI S++ + ++ S+ IL++R RS E++ EV TLS++RH+NVVKLYCSITS+DS
Sbjct: 692 AVKHIRCSST--QKNFSSAMPILTEREGRSKEFETEVQTLSSIRHLNVVKLYCSITSDDS 749
Query: 717 NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776
+LLVYEYLPNGSLWD LH+C K + W RY IA+GAAKGLEYLHHG++RPVIHRDVKSS
Sbjct: 750 SLLVYEYLPNGSLWDMLHSCKKSNLGWETRYDIALGAAKGLEYLHHGYERPVIHRDVKSS 809
Query: 777 NILLDLEWKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAP-EYAYTCKINEKSDVYS 834
NILLD KPRIADFGLAKI+Q G + THV+AGT+GYIAP EY Y K+ EK DVYS
Sbjct: 810 NILLDEFLKPRIADFGLAKILQASNGGPESTHVVAGTYGYIAPAEYGYASKVTEKCDVYS 869
Query: 835 FGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLR 894
FGVVLMELVTGK+PI EFG+SKDIVNWV + + S++S++ +VD I E+ +EDA+K+LR
Sbjct: 870 FGVVLMELVTGKKPIEAEFGESKDIVNWVSNNLKSKESVMEIVDKKIGEMYREDAVKMLR 929
Query: 895 IAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKK 932
IAI CT +LP RP+MR VVQM+E+AEPC + IV+ K
Sbjct: 930 IAIICTARLPGLRPTMRSVVQMIEDAEPCRLMGIVISK 967
|
|
| TAIR|locus:2091206 IKU2 "HAIKU2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2650 (937.9 bits), Expect = 1.1e-275, P = 1.1e-275
Identities = 540/958 (56%), Positives = 669/958 (69%)
Query: 1 MNLKSKI-EKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGV-------- 51
+ LKS E VF +WT NS C+F GIVC+S+G V EINL + L+
Sbjct: 31 LKLKSTFGETKSDDVFKTWTHRNSACEFAGIVCNSDGNVVEINLGSRSLINRDDDGRFTD 90
Query: 52 VPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELS 111
+PFDSIC L+ L+K+ LG N L G I L C RL+ LDLG N+FSGE P + L L
Sbjct: 91 LPFDSICDLKLLEKLVLGNNSLRGQIGTNLGKCNRLRYLDLGINNFSGEFPAIDSLQLLE 150
Query: 112 FLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVT 171
FL+LN+SGISG FPW SL++L L FLS+GDN F PFP E+L L L W+YL+N S+T
Sbjct: 151 FLSLNASGISGIFPWSSLKDLKRLSFLSVGDNRFGSHPFPREILNLTALQWVYLSNSSIT 210
Query: 172 GQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTN 231
G+IPEGI NL +LQNLELSDN++ GEIP IV+L L QLE+Y+N L+G+LP+GF NLTN
Sbjct: 211 GKIPEGIKNLVRLQNLELSDNQISGEIPKEIVQLKNLRQLEIYSNDLTGKLPLGFRNLTN 270
Query: 232 LMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTG 291
L NFD S N LEGDLSELRFL L SL +FEN+ +GEIP+EFG+FK L LSLY N+LTG
Sbjct: 271 LRNFDASNNSLEGDLSELRFLKNLVSLGMFENRLTGEIPKEFGDFKSLAALSLYRNQLTG 330
Query: 292 TLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSL 351
LP++LGSW F Y+DVSEN L G IPP MCK G MT LL+LQN F G PE+YA CK+L
Sbjct: 331 KLPRRLGSWTAFKYIDVSENFLEGQIPPYMCKKGVMTHLLMLQNRFTGQFPESYAKCKTL 390
Query: 352 IRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSXXXXXXXXXRFSG 411
IR RV+NNSLSG IP GIW LPNL +DL++N FEG +T DIGNAKS RFSG
Sbjct: 391 IRLRVSNNSLSGMIPSGIWGLPNLQFLDLASNYFEGNLTGDIGNAKSLGSLDLSNNRFSG 450
Query: 412 ELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSL 471
LP +IS A+SLVS+ L +N+FSG +P GKLK+LSSL L N SG +P S+G C SL
Sbjct: 451 SLPFQISGANSLVSVNLRMNKFSGIVPESFGKLKELSSLILDQNNLSGAIPKSLGLCTSL 510
Query: 472 TDINFAQNSLSGKIPDXXXXXXXXXXXXXXXXKFSGEIPISLTYPKLSLLDLSNNQLAGP 531
D+NFA NSLS +IP+ K SG IP+ L+ KLSLLDLSNNQL G
Sbjct: 511 VDLNFAGNSLSEEIPESLGSLKLLNSLNLSGNKLSGMIPVGLSALKLSLLDLSNNQLTGS 570
Query: 532 IPEPLNIKAFIDSFTGNPGLCSKTDEYFKSCSSGS----GRSHHVSTFVWCLIAITMVLL 587
+PE L + SF GN GLCS Y + C G G+ H+S C I ++ L
Sbjct: 571 VPESL-VSG---SFEGNSGLCSSKIRYLRPCPLGKPHSQGKRKHLSKVDMCFIVAAILAL 626
Query: 588 VLLASYFVVKLKQNNLKHSL-KQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVY 646
L SY + K++++ L ++ K+N W + SFR+L+F+E EIID +K EN+IG+GG GNVY
Sbjct: 627 FFLFSYVIFKIRRDKLNKTVQKKNDWQVSSFRLLNFNEMEIIDEIKSENIIGRGGQGNVY 686
Query: 647 KVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSS--EYDAEVATLSAVRHVNV 704
KV L SG+ LAVKHIW S +RSSTA+LS ++RS+ E++AEVATLS ++H+NV
Sbjct: 687 KVSLRSGETLAVKHIWCPESSHES-FRSSTAMLSDGNNRSNNGEFEAEVATLSNIKHINV 745
Query: 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH-KIEMDWVVRYAIAVGAAKGLEYLHHG 763
VKL+CSIT EDS LLVYEY+PNGSLW++LH + E+ W VR A+A+GAAKGLEYLHHG
Sbjct: 746 VKLFCSITCEDSKLLVYEYMPNGSLWEQLHERRGEQEIGWRVRQALALGAAKGLEYLHHG 805
Query: 764 FDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG-DLTH-VIAGTHGYIAPEYA 821
DRPVIHRDVKSSNILLD EW+PRIADFGLAKI+Q D + ++ GT GYIAPEYA
Sbjct: 806 LDRPVIHRDVKSSNILLDEEWRPRIADFGLAKIIQADSVQRDFSAPLVKGTLGYIAPEYA 865
Query: 822 YTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS--KMDSRDSMLTVVDP 879
YT K+NEKSDVYSFGVVLMELVTGK+P+ +FG++ DIV WV+S K +R+ M+ ++D
Sbjct: 866 YTTKVNEKSDVYSFGVVLMELVTGKKPLETDFGENNDIVMWVWSVSKETNREMMMKLIDT 925
Query: 880 NISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKVGESS 937
+I + KEDALKVL IA+ CT+K P RP M+ VV MLE+ EP N GES+
Sbjct: 926 SIEDEYKEDALKVLTIALLCTDKSPQARPFMKSVVSMLEKIEPSYNKNSGEASYGESA 983
|
|
| TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1702 (604.2 bits), Expect = 3.2e-175, P = 3.2e-175
Identities = 370/945 (39%), Positives = 547/945 (57%)
Query: 10 SDTGVFSSWTE-----ANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQ 64
S G FSS T AN F ++C + L A ++L + +P + I ++LQ
Sbjct: 54 SCAGDFSSVTSVDLSSANLAGPFPSVICRLSNL-AHLSLYNNSINSTLPLN-IAACKSLQ 111
Query: 65 KINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGK 123
++L N L G + + L L LDL N+FSG++P L L+L + + G
Sbjct: 112 TLDLSQNLLTGELPQTLADIPTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGT 171
Query: 124 FPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQ 183
P L N++ L+ L+L NPF PS P E L L ++LT C + GQIP+ +G L++
Sbjct: 172 IP-PFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSK 230
Query: 184 LQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLE 243
L +L+L+ N+L G IP + L + Q+ELYNNSL+G +P NL +L D S N+L
Sbjct: 231 LVDLDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLT 290
Query: 244 GDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADF 303
G + + L SL+L+EN GE+P +L E+ ++ NRLTG LP+ LG +
Sbjct: 291 GKIPDELCRVPLESLNLYENNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPL 350
Query: 304 NYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSG 363
++DVSEN +G +P D+C G + +LL++ N+F+G +PE+ A+C+SL R R+ N SG
Sbjct: 351 RWLDVSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSG 410
Query: 364 TIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSXXXXXXXXXRFSGELPSKISEASSL 423
++P G W LP++++++L N F G ++ IG A + F+G LP +I +L
Sbjct: 411 SVPTGFWGLPHVNLLELVNNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNL 470
Query: 424 VSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSG 483
+ S N+FSG +P + L +L +L LH N FSG L I S L ++N A N +G
Sbjct: 471 NQLSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTG 530
Query: 484 KIPDXXXXXXXXXXXXXXXXKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKAFID 543
KIPD FSG+IP+SL KL+ L+LS N+L+G +P L + +
Sbjct: 531 KIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSLKLNQLNLSYNRLSGDLPPSLAKDMYKN 590
Query: 544 SFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIAI-TMVLLVLLA--SYFVVKLKQ 600
SF GNPGLC C GS +VW L +I + +VLLA ++F K +
Sbjct: 591 SFIGNPGLCGDIKGL---C--GSENEAKKRGYVWLLRSIFVLAAMVLLAGVAWFYFKYRT 645
Query: 601 NNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKH 660
+++++ W + SF L FSE EI++++ +N+IG G SG VYKVVL +G+ +AVK
Sbjct: 646 FKKARAMERSKWTLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKVVLTNGETVAVKR 705
Query: 661 IWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLV 720
+W + GD K + ++AEV TL +RH N+VKL+C ++ D LLV
Sbjct: 706 LWTGSVKETGDCDPEKGY--KPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLV 763
Query: 721 YEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780
YEY+PNGSL D LH+ + W R+ I + AA+GL YLHH P++HRD+KS+NIL+
Sbjct: 764 YEYMPNGSLGDLLHSSKGGMLGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILI 823
Query: 781 DLEWKPRIADFGLAKIVQ-TGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839
D ++ R+ADFG+AK V TG+A VIAG+ GYIAPEYAYT ++NEKSD+YSFGVV+
Sbjct: 824 DGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVI 883
Query: 840 MELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHC 899
+E+VT KRP+ PE G+ KD+V WV S +D + + V+DP + KE+ K+L + + C
Sbjct: 884 LEIVTRKRPVDPELGE-KDLVKWVCSTLDQK-GIEHVIDPKLDSCFKEEISKILNVGLLC 941
Query: 900 TNKLPAFRPSMRVVVQMLEE---AEPCSVTNIVVKKVGESSPSFS 941
T+ LP RPSMR VV+ML+E + S+ I K G+ +P ++
Sbjct: 942 TSPLPINRPSMRRVVKMLQEIGGGDEDSLHKIRDDKDGKLTPYYN 986
|
|
| TAIR|locus:2207036 AT1G72180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1666 (591.5 bits), Expect = 2.1e-171, P = 2.1e-171
Identities = 377/951 (39%), Positives = 560/951 (58%)
Query: 4 KSKIEKSDTGVFSSWTEANSVCKFNGIVCDS-NGLVAEINLPEQQLLGVVPFDSICGLQA 62
K++++ S + SW ++S C F GI CD +G V I+L L G + SI L
Sbjct: 42 KNRLDDSHN-ILQSWKPSDSPCVFRGITCDPLSGEVIGISLGNVNLSGTIS-PSISALTK 99
Query: 63 LQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISG 122
L ++L +NF+ G I + +C L+VL+L +N SG +P+LS L L L+++ + ++G
Sbjct: 100 LSTLSLPSNFISGRIPPEIVNCKNLKVLNLTSNRLSGTIPNLSPLKSLEILDISGNFLNG 159
Query: 123 KFP-WKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNL 181
+F W + N+ L L LG+N ++ P + L+KL WL+L ++TG+IP I +L
Sbjct: 160 EFQSW--IGNMNQLVSLGLGNNHYEEGIIPESIGGLKKLTWLFLARSNLTGKIPNSIFDL 217
Query: 182 TQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNR 241
L ++++N + + P I +L L ++EL+NNSL+G++P NLT L FD+S N+
Sbjct: 218 NALDTFDIANNAISDDFPILISRLVNLTKIELFNNSLTGKIPPEIKNLTRLREFDISSNQ 277
Query: 242 LEGDL-SELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSW 300
L G L EL L +L H EN F+GE P FG+ HLT LS+Y N +G P +G +
Sbjct: 278 LSGVLPEELGVLKELRVFHCHENNFTGEFPSGFGDLSHLTSLSIYRNNFSGEFPVNIGRF 337
Query: 301 ADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNS 360
+ + VD+SEN TGP P +C+ + LL LQN F+G +P +Y CKSL+R R+NNN
Sbjct: 338 SPLDTVDISENEFTGPFPRFLCQNKKLQFLLALQNEFSGEIPRSYGECKSLLRLRINNNR 397
Query: 361 LSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSXXXXXXXXXRFSGELPSKISEA 420
LSG + G WSLP +IDLS N+ G V+ IG + RFSG++P ++
Sbjct: 398 LSGQVVEGFWSLPLAKMIDLSDNELTGEVSPQIGLSTELSQLILQNNRFSGKIPRELGRL 457
Query: 421 SSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNS 480
+++ I LS N SG+IP+++G LK+LSSL+L +N +G +P + +CV L D+N A+N
Sbjct: 458 TNIERIYLSNNNLSGEIPMEVGDLKELSSLHLENNSLTGFIPKELKNCVKLVDLNLAKNF 517
Query: 481 LSGKIPDXXXXXXXXXXXXXXXXKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKA 540
L+G+IP+ + +GEIP SL KLS +DLS NQL+G IP L
Sbjct: 518 LTGEIPNSLSQIASLNSLDFSGNRLTGEIPASLVKLKLSFIDLSGNQLSGRIPPDLLAVG 577
Query: 541 FIDSFTGNPGLC-----SKTDEYF--KSCSSGSGRSHHVS---TFVWCLIAITMVLLV-- 588
+F+ N LC +KT++ CS + S T ++ +AI +V+LV
Sbjct: 578 GSTAFSRNEKLCVDKENAKTNQNLGLSICSGYQNVKRNSSLDGTLLFLALAIVVVVLVSG 637
Query: 589 LLA-SYFVVKLKQNNLKHSLKQNSWDMKSFRVLSFSEKEI-IDAV---KPENLIGKGGSG 643
L A Y VVK+++ + ++ N D K +++ SF + E+ +D + +++IG G +G
Sbjct: 638 LFALRYRVVKIRELDSENR-DINKADAK-WKIASFHQMELDVDEICRLDEDHVIGSGSAG 695
Query: 644 NVYKVVLNSGK-ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702
VY+V L G +AVK W G G+ T + AE+ L +RH
Sbjct: 696 KVYRVDLKKGGGTVAVK--WLKRGG--GEEGDGTEVSV----------AEMEILGKIRHR 741
Query: 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK---IEMDWVVRYAIAVGAAKGLEY 759
NV+KLY + S LV+E++ NG+L+ L K E+DW+ RY IAVGAAKG+ Y
Sbjct: 742 NVLKLYACLVGRGSRYLVFEFMENGNLYQALGNNIKGGLPELDWLKRYKIAVGAAKGIAY 801
Query: 760 LHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE 819
LHH P+IHRD+KSSNILLD +++ +IADFG+AK+ G +AGTHGY+APE
Sbjct: 802 LHHDCCPPIIHRDIKSSNILLDGDYESKIADFGVAKVADKGYEWSC---VAGTHGYMAPE 858
Query: 820 YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM--DSRDSMLTVV 877
AY+ K EKSDVYSFGVVL+ELVTG RP+ EFG+ KDIV++VYS++ D R+ + V+
Sbjct: 859 LAYSFKATEKSDVYSFGVVLLELVTGLRPMEDEFGEGKDIVDYVYSQIQQDPRN-LQNVL 917
Query: 878 DPNI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTN 927
D + S ++E ++VL++ + CT KLP RPSMR VV+ L++A+PC V+N
Sbjct: 918 DKQVLSTYIEESMIRVLKMGLLCTTKLPNLRPSMREVVRKLDDADPC-VSN 967
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1639 (582.0 bits), Expect = 1.5e-168, P = 1.5e-168
Identities = 382/937 (40%), Positives = 537/937 (57%)
Query: 27 FNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLK-SCT 85
F I+C L + ++L + G + D L ++L N L G+I + L +
Sbjct: 81 FPSILCHLPSLHS-LSLYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLP 139
Query: 86 RLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNP 144
L+ L++ N+ S +P +L LNL + +SG P SL N+T L+ L L N
Sbjct: 140 NLKFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGTIP-ASLGNVTTLKELKLAYNL 198
Query: 145 FDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVK 204
F PS P ++ L +L L+L C++ G IP + LT L NL+L+ N+L G IP+ I +
Sbjct: 199 FSPSQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQ 258
Query: 205 LNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSE-LRFLNQLSSLHLFEN 263
L + Q+EL+NNS SG LP N+T L FD S N+L G + + L LN L SL+LFEN
Sbjct: 259 LKTVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTGKIPDNLNLLN-LESLNLFEN 317
Query: 264 QFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCK 323
G +PE K L+EL L+ NRLTG LP +LG+ + YVD+S N +G IP ++C
Sbjct: 318 MLEGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCG 377
Query: 324 TGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTN 383
G + L+++ N+F+G + CKSL R R++NN LSG IP G W LP LS+++LS N
Sbjct: 378 EGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDN 437
Query: 384 QFEGPVTDDIGNAKSXXXXXXXXXRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGK 443
F G + I AK+ RFSG +P++I + ++ I + N FSG+IP + K
Sbjct: 438 SFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVK 497
Query: 444 LKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDXXXXXXXXXXXXXXXX 503
LK+LS L L N SG +P + +L ++N A N LSG+IP
Sbjct: 498 LKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSN 557
Query: 504 KFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGLCSKTDEYFKSCS 563
+FSGEIP+ L KL++L+LS N L+G IP K + F GNPGLC D + +
Sbjct: 558 QFSGEIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGLCVDLDGLCRKIT 617
Query: 564 SGSGRSHHVSTFVWCLIAITMVL-LVLLASY--FVVKLKQ-NNLKHS-LKQNSWDMKSFR 618
RS ++ +VW L+ I ++ LV + F+ K ++ LK S L + W +SF
Sbjct: 618 ----RSKNIG-YVWILLTIFLLAGLVFVVGIVMFIAKCRKLRALKSSTLAASKW--RSFH 670
Query: 619 VLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI 678
L FSE EI D + +N+IG G SG VYKV L G+ +AVK + S G GD S+
Sbjct: 671 KLHFSEHEIADCLDEKNVIGFGSSGKVYKVELRGGEVVAVKKLNKSVKG--GDDEYSSDS 728
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK 738
L++ + AEV TL +RH ++V+L+C +S D LLVYEY+PNGSL D LH K
Sbjct: 729 LNR-----DVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRK 783
Query: 739 --IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
+ + W R IA+ AA+GL YLHH P++HRDVKSSNILLD ++ ++ADFG+AK+
Sbjct: 784 GGVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKV 843
Query: 797 VQ-TG-EAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG 854
Q +G + + IAG+ GYIAPEY YT ++NEKSD+YSFGVVL+ELVTGK+P E G
Sbjct: 844 GQMSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELG 903
Query: 855 DSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVV 914
D KD+ WV + +D + + V+DP + KE+ KV+ I + CT+ LP RPSMR VV
Sbjct: 904 D-KDMAKWVCTALD-KCGLEPVIDPKLDLKFKEEISKVIHIGLLCTSPLPLNRPSMRKVV 961
Query: 915 QMLEE---AEPCSVTNIVV--KKVGESSPSFSRHYNS 946
ML+E A PCS N K G+ SP ++ NS
Sbjct: 962 IMLQEVSGAVPCSSPNTSKRSKTGGKLSPYYTEDLNS 998
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1447 (514.4 bits), Expect = 4.9e-155, Sum P(2) = 4.9e-155
Identities = 342/879 (38%), Positives = 487/879 (55%)
Query: 23 SVCKFNGIVCD----SNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTIT 78
S C + GI C S+ V I+L + G P+ C ++ L I L N L GTI
Sbjct: 57 SPCNWTGITCHIRKGSSLAVTTIDLSGYNISGGFPY-GFCRIRTLINITLSQNNLNGTID 115
Query: 79 EG-LKSCTRLQVLDLGNNSFSGEVPDLSM-LHELSFLNLNSSGISGKFPWKSLENLTNLE 136
L C++LQ L L N+FSG++P+ S +L L L S+ +G+ P +S LT L+
Sbjct: 116 SAPLSLCSKLQNLILNQNNFSGKLPEFSPEFRKLRVLELESNLFTGEIP-QSYGRLTALQ 174
Query: 137 FLSLGDNP------------------------FDPSPFPMEVLKLEKLYWLYLTNCSVTG 172
L+L NP FDPSP P + L L L LT+ ++ G
Sbjct: 175 VLNLNGNPLSGIVPAFLGYLTELTRLDLAYISFDPSPIPSTLGNLSNLTDLRLTHSNLVG 234
Query: 173 QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNL 232
+IP+ I NL L+NL+L+ N L GEIP I +L ++Q+ELY+N LSG+LP NLT L
Sbjct: 235 EIPDSIMNLVLLENLDLAMNSLTGEIPESIGRLESVYQIELYDNRLSGKLPESIGNLTEL 294
Query: 233 MNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGT 292
NFDVSQN L G+L E QL S +L +N F+G +P+ +L E ++ N TGT
Sbjct: 295 RNFDVSQNNLTGELPEKIAALQLISFNLNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGT 354
Query: 293 LPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLI 352
LP+ LG +++ + DVS N +G +PP +C + ++ N +G +PE+Y +C SL
Sbjct: 355 LPRNLGKFSEISEFDVSTNRFSGELPPYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLN 414
Query: 353 RFRVNNNSLSGTIPPGIWSLPNLSIIDLSTN-QFEGPVTDDIGNAKSXXXXXXXXXRFSG 411
R+ +N LSG +P W LP L+ ++L+ N Q +G + I A+ FSG
Sbjct: 415 YIRMADNKLSGEVPARFWELP-LTRLELANNNQLQGSIPPSISKARHLSQLEISANNFSG 473
Query: 412 ELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSL 471
+P K+ + L I LS N F G IP I KLK L + + +NM G +P S+ SC L
Sbjct: 474 VIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERVEMQENMLDGEIPSSVSSCTEL 533
Query: 472 TDINFAQNSLSGKIPDXXXXXXXXXXXXXXXXKFSGEIPISLTYPKLSLLDLSNNQLAGP 531
T++N + N L G IP + +GEIP L KL+ ++S+N+L G
Sbjct: 534 TELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAELLRLKLNQFNVSDNKLYGK 593
Query: 532 IPEPLNIKAFIDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIAITMVLLVLLA 591
IP F SF GNP LC+ + + C S + + + C++A+T L+ L
Sbjct: 594 IPSGFQQDIFRPSFLGNPNLCAPNLDPIRPCRSKRETRYILPISILCIVALTGALVWLF- 652
Query: 592 SYFVVKLKQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLN 651
+K K K K+ + + F+ + F+E++I + +N+IG GGSG VY+V L
Sbjct: 653 ----IKTKPL-FKRKPKRTN-KITIFQRVGFTEEDIYPQLTEDNIIGSGGSGLVYRVKLK 706
Query: 652 SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSI 711
SG+ LAVK +W G G +++ S + +EV TL VRH N+VKL
Sbjct: 707 SGQTLAVKKLW----GETG----------QKTESESVFRSEVETLGRVRHGNIVKLLMCC 752
Query: 712 TSEDSNLLVYEYLPNGSLWDRLHTC--HKI--EMDWVVRYAIAVGAAKGLEYLHHGFDRP 767
E+ LVYE++ NGSL D LH+ H+ +DW R++IAVGAA+GL YLHH P
Sbjct: 753 NGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPP 812
Query: 768 VIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV----IAGTHGYIAPEYAYT 823
++HRDVKS+NILLD E KPR+ADFGLAK ++ + ++ V +AG++GYIAPEY YT
Sbjct: 813 IVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAPEYGYT 872
Query: 824 CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862
K+NEKSDVYSFGVVL+EL+TGKRP FG++KDIV +
Sbjct: 873 SKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKF 911
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1417 (503.9 bits), Expect = 5.1e-145, P = 5.1e-145
Identities = 355/942 (37%), Positives = 509/942 (54%)
Query: 16 SSWTEANSVCKFNGIVCD-SNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLY 74
SSW + S C + G+ CD S V ++L L G + D + L+ LQ ++L N +
Sbjct: 48 SSWKVSTSFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSPD-VSHLRLLQNLSLAENLIS 106
Query: 75 GTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKFPWKSLENL 132
G I + S + L+ L+L NN F+G PD S L L L++ ++ ++G P S+ NL
Sbjct: 107 GPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLP-VSVTNL 165
Query: 133 TNLEFLSLGDNPF----DPS----P---------------FPMEVLKLEKLYWLYLT--N 167
T L L LG N F PS P P E+ L L LY+ N
Sbjct: 166 TQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYN 225
Query: 168 CSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFS 227
G PE IGNL++L + ++ L GEIP I KL KL L L N SG L
Sbjct: 226 AFEDGLPPE-IGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELG 284
Query: 228 NLTNLMNFDVSQNRLEGDL-SELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYT 286
L++L + D+S N G++ + L L+ L+LF N+ GEIPE G+ L L L+
Sbjct: 285 TLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWE 344
Query: 287 NRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYA 346
N TG++PQKLG N VD+S N LTG +PP+MC + L+ L N G++P++
Sbjct: 345 NNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLG 404
Query: 347 NCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSXXXXXXXX 406
C+SL R R+ N L+G+IP G++ LP L+ ++L N G + G + +
Sbjct: 405 KCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSN 464
Query: 407 XRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIG 466
+ SG LP I + + + L N+F G IP ++GKL++LS + N+FSG + I
Sbjct: 465 NQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEIS 524
Query: 467 SCVSLTDINFAQNSLSGKIPDXXXXXXXXXXXXXXXXKFSGEIPISLT-YPKLSLLDLSN 525
C LT ++ ++N LSG+IP+ G IP S++ L+ LD S
Sbjct: 525 RCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSY 584
Query: 526 NQLAGPIPEPLNIKAF-IDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWCLIAITM 584
N L+G +P F SF GNP LC Y C G + H S L A
Sbjct: 585 NNLSGLVPGTGQFSYFNYTSFLGNPDLCGP---YLGPCKDGVAKGGHQSHSKGPLSASMK 641
Query: 585 VLLVL------LASYFVVKLKQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIG 638
+LLVL +A V +K +LK + + +W + +F+ L F+ +++D++K +N+IG
Sbjct: 642 LLLVLGLLVCSIAFAVVAIIKARSLKKASESRAWRLTAFQRLDFTCDDVLDSLKEDNIIG 701
Query: 639 KGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSA 698
KGG+G VYK V+ +G +AVK + A +S+ SS ++AE+ TL
Sbjct: 702 KGGAGIVYKGVMPNGDLVAVKRL---------------AAMSRGSSHDHGFNAEIQTLGR 746
Query: 699 VRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLE 758
+RH ++V+L ++ ++NLLVYEY+PNGSL + LH + W RY IA+ AAKGL
Sbjct: 747 IRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLC 806
Query: 759 YLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAP 818
YLHH ++HRDVKS+NILLD ++ +ADFGLAK +Q + IAG++GYIAP
Sbjct: 807 YLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 866
Query: 819 EYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS-RDSMLTVV 877
EYAYT K++EKSDVYSFGVVL+ELVTG++P V EFGD DIV WV DS +DS+L V+
Sbjct: 867 EYAYTLKVDEKSDVYSFGVVLLELVTGRKP-VGEFGDGVDIVQWVRKMTDSNKDSVLKVL 925
Query: 878 DPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
DP +S I + V +A+ C + RP+MR VVQ+L E
Sbjct: 926 DPRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTE 967
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1369 (487.0 bits), Expect = 6.3e-140, P = 6.3e-140
Identities = 344/978 (35%), Positives = 518/978 (52%)
Query: 1 MNLKSKIEKSD-TGVFSSWTEANSVCKFNGIVCD-SNGLVAEINLPEQQLLGVVPFDSIC 58
++LKS + + + +SW + + C + G+ CD S V ++L L G + D +
Sbjct: 32 LSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSD-VA 90
Query: 59 GLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSM-LHELSFLNLN 116
L LQ ++L N + G I + + L+ L+L NN F+G PD LS L L L+L
Sbjct: 91 HLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDLY 150
Query: 117 SSGISGKFPWKSLENLTNLEFLSLGDNPFD---PSPF--------------------PME 153
++ ++G P SL NLT L L LG N F P+ + P E
Sbjct: 151 NNNLTGDLP-VSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPE 209
Query: 154 VLKLEKLYWLYLT--NCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQL 211
+ L L LY+ N G PE IGNL++L + ++ L GEIP I KL KL L
Sbjct: 210 IGNLTTLRELYIGYYNAFENGLPPE-IGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTL 268
Query: 212 ELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDL-SELRFLNQLSSLHLFENQFSGEIP 270
L N+ +G + +++L + D+S N G++ + L L+ L+LF N+ G IP
Sbjct: 269 FLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIP 328
Query: 271 EEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL 330
E GE L L L+ N TG++PQKLG +D+S N LTG +PP+MC + L
Sbjct: 329 EFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTL 388
Query: 331 LVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEG--P 388
+ L N G++P++ C+SL R R+ N L+G+IP ++ LP LS ++L N G P
Sbjct: 389 ITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELP 448
Query: 389 VTDDIGNAKSXXXXXXXXXRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLS 448
++ G + + SG LP+ I S + + L N+FSG IP +IG+L++LS
Sbjct: 449 ISGG-GVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLS 507
Query: 449 SLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDXXXXXXXXXXXXXXXXKFSGE 508
L N+FSG + I C LT ++ ++N LSG IP+ G
Sbjct: 508 KLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGS 567
Query: 509 IPISL-TYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGLCSKTDEYFKSCSSGSG 567
IP+++ + L+ +D S N L+G +P F ++T G Y C G+
Sbjct: 568 IPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYF--NYTSFVGNSHLCGPYLGPCGKGTH 625
Query: 568 RSHHVSTFVWCLIAITMVLLVLLASYFVVKL-KQNNLKHSLKQNSWDMKSFRVLSFSEKE 626
+SH + + + LL + +V + K +L+++ + +W + +F+ L F+ +
Sbjct: 626 QSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLDFTCDD 685
Query: 627 IIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS 686
++D++K +N+IGKGG+G VYK + G +AVK + A +S SS
Sbjct: 686 VLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRL---------------ATMSHGSSHD 730
Query: 687 SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
++AE+ TL +RH ++V+L ++ ++NLLVYEY+PNGSL + LH + W R
Sbjct: 731 HGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTR 790
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
Y IA+ AAKGL YLHH ++HRDVKS+NILLD ++ +ADFGLAK +Q +
Sbjct: 791 YKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECM 850
Query: 807 HVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866
IAG++GYIAPEYAYT K++EKSDVYSFGVVL+EL+TGK+P V EFGD DIV WV S
Sbjct: 851 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKP-VGEFGDGVDIVQWVRSM 909
Query: 867 MDS-RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE--PC 923
DS +D +L V+D +S + + V +A+ C + RP+MR VVQ+L E P
Sbjct: 910 TDSNKDCVLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEIPKIPL 969
Query: 924 SVTNIVVKKVGESSPSFS 941
S V E +P+ +
Sbjct: 970 SKQQAAESDVTEKAPAIN 987
|
|
| TAIR|locus:2204350 CLV1 "AT1G75820" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1355 (482.0 bits), Expect = 1.9e-138, P = 1.9e-138
Identities = 343/975 (35%), Positives = 533/975 (54%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSV---CKFNGIVCDSNGLVAEINL----------PEQQ 47
+NLKS + W ++S C F+G+ CD + V +N+ PE
Sbjct: 32 LNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLNVSFTPLFGTISPEIG 91
Query: 48 LL--------------GVVPFDSICGLQALQKINLGTNF-LYGTIT-EGLKSCTRLQVLD 91
+L G +P + + L +L+ +N+ N L GT E LK+ L+VLD
Sbjct: 92 MLTHLVNLTLAANNFTGELPLE-MKSLTSLKVLNISNNGNLTGTFPGEILKAMVDLEVLD 150
Query: 92 LGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSL-GDNPFDPSP 149
NN+F+G++P ++S L +L +L+ + SG+ P +S ++ +LE+L L G SP
Sbjct: 151 TYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIP-ESYGDIQSLEYLGLNGAGLSGKSP 209
Query: 150 FPMEVLK-LEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKL 208
+ LK L ++Y Y S TG +P G LT+L+ L+++ L GEIP + L L
Sbjct: 210 AFLSRLKNLREMYIGYYN--SYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSNLKHL 267
Query: 209 WQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLN--QLSSLHLFENQFS 266
L L+ N+L+G +P S L +L + D+S N+L G++ + F+N ++ ++LF N
Sbjct: 268 HTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQ-SFINLGNITLINLFRNNLY 326
Query: 267 GEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGA 326
G+IPE GE L ++ N T LP LG + +DVS+N LTG IP D+C+ G
Sbjct: 327 GQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCR-GE 385
Query: 327 MTDLLVLQNNFN-GTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQF 385
++L+L NNF G +PE CKSL + R+ N L+GT+P G+++LP ++II+L+ N F
Sbjct: 386 KLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDNFF 445
Query: 386 EGPVTDDIGNAKSXXXXXXXXXRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLK 445
G + + + FSGE+P I +L ++ L N+F G IP +I +LK
Sbjct: 446 SGELPVTM-SGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFELK 504
Query: 446 KLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDXXXXXXXXXXXXXXXXKF 505
LS + N +G +P SI C +L ++ ++N ++G+IP +
Sbjct: 505 HLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQL 564
Query: 506 SGEIPISL-TYPKLSLLDLSNNQLAGPIPEPLNIKAFID-SFTGNPGLCSKTDEYFKSCS 563
+G IP + L+ LDLS N L+G +P F + SF GN LC + SC
Sbjct: 565 TGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLP---HRVSCP 621
Query: 564 SGSGRS--H-HVSTFVWCLIAITMVLLVLLASYFVVKLKQNNLKHSLKQNSWDMKSFRVL 620
+ G++ H H + F I IT++ + V ++Q N K + K +W + +F+ L
Sbjct: 622 TRPGQTSDHNHTALFSPSRIVITVIAAITGLILISVAIRQMNKKKNQKSLAWKLTAFQKL 681
Query: 621 SFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILS 680
F +++++ +K EN+IGKGG+G VY+ + + ++A+K + +G R D+
Sbjct: 682 DFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTG-RSDHG------- 733
Query: 681 KRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIE 740
+ AE+ TL +RH ++V+L + ++D+NLL+YEY+PNGSL + LH
Sbjct: 734 --------FTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGH 785
Query: 741 MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG 800
+ W R+ +AV AAKGL YLHH ++HRDVKS+NILLD +++ +ADFGLAK + G
Sbjct: 786 LQWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDG 845
Query: 801 EAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860
A + IAG++GYIAPEYAYT K++EKSDVYSFGVVL+EL+ GK+P V EFG+ DIV
Sbjct: 846 AASECMSSIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP-VGEFGEGVDIV 904
Query: 861 NWVYSKMDS----RDSMLTV--VDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVV 914
WV + + D+ + V VDP ++ + V +IA+ C + A RP+MR VV
Sbjct: 905 RWVRNTEEEITQPSDAAIVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVV 964
Query: 915 QMLEEAEPCSVTNIV 929
ML P SV N++
Sbjct: 965 HMLTNP-PKSVANLI 978
|
|
| TAIR|locus:2180617 AT5G25930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1342 (477.5 bits), Expect = 4.6e-137, P = 4.6e-137
Identities = 330/910 (36%), Positives = 495/910 (54%)
Query: 31 VCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCT-RLQV 89
+CD + L ++L G P + LQ ++L N L G++ + + L
Sbjct: 83 ICDLSNLNF-LDLSFNYFAGEFP-TVLYNCTKLQYLDLSQNLLNGSLPVDIDRLSPELDY 140
Query: 90 LDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNP-FDP 147
LDL N FSG++P L + +L LNL S G FP + +L+ LE L L N F P
Sbjct: 141 LDLAANGFSGDIPKSLGRISKLKVLNLYQSEYDGTFP-SEIGDLSELEELRLALNDKFTP 199
Query: 148 SPFPMEVLKLEKLYWLYLTNCSVTGQI-PEGIGNLTQLQNLELSDNELFGEIPAGIVKLN 206
+ P+E KL+KL +++L ++ G+I P N+T L++++LS N L G IP + L
Sbjct: 200 AKIPIEFGKLKKLKYMWLEEMNLIGEISPVVFENMTDLEHVDLSVNNLTGRIPDVLFGLK 259
Query: 207 KLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLS-ELRFLNQLSSLHLFENQF 265
L + L+ N L+G +P S TNL+ D+S N L G + + L +L L+LF N+
Sbjct: 260 NLTEFYLFANGLTGEIPKSIS-ATNLVFLDLSANNLTGSIPVSIGNLTKLQVLNLFNNKL 318
Query: 266 SGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTG 325
+GEIP G+ L E ++ N+LTG +P ++G + +VSEN LTG +P ++CK G
Sbjct: 319 TGEIPPVIGKLPGLKEFKIFNNKLTGEIPAEIGVHSKLERFEVSENQLTGKLPENLCKGG 378
Query: 326 AMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQF 385
+ ++V NN G +PE+ +C +L+ ++ NN SG P IW+ ++ + +S N F
Sbjct: 379 KLQGVVVYSNNLTGEIPESLGDCGTLLTVQLQNNDFSGKFPSRIWNASSMYSLQVSNNSF 438
Query: 386 EGPVTDDIGNAKSXXXXXXXXXRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLK 445
G + +++ A + RFSGE+P KI SSLV + NQFSG+ P ++ L
Sbjct: 439 TGELPENV--AWNMSRIEIDNNRFSGEIPKKIGTWSSLVEFKAGNNQFSGEFPKELTSLS 496
Query: 446 KLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDXXXXXXXXXXXXXXXXKF 505
L S++L +N +G LP I S SL ++ ++N LSG+IP +F
Sbjct: 497 NLISIFLDENDLTGELPDEIISWKSLITLSLSKNKLSGEIPRALGLLPRLLNLDLSENQF 556
Query: 506 SGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGLCSKTDEY-FKSCSS 564
SG IP + KL+ ++S+N+L G IPE L+ A+ SF N LC+ C
Sbjct: 557 SGGIPPEIGSLKLTTFNVSSNRLTGGIPEQLDNLAYERSFLNNSNLCADNPVLSLPDCRK 616
Query: 565 ---GS-GRSHHVSTFVWCLIAITMVLLVLLASYFVVK-LKQNNLKHSLKQNSWDMKSFRV 619
GS G + + +IA+ ++ + L ++FVV+ + + L+ +W + SF
Sbjct: 617 QRRGSRGFPGKILAMI-LVIAVLLLTITLFVTFFVVRDYTRKQRRRGLE--TWKLTSFHR 673
Query: 620 LSFSEKEIIDAVKPENLIGKGGSGNVYKV-VLNSGKELAVKHIWPSNSGFRGDYRSSTAI 678
+ F+E +I+ + +IG GGSG VYK+ V +SG+ +AVK IW S
Sbjct: 674 VDFAESDIVSNLMEHYVIGSGGSGKVYKIFVESSGQCVAVKRIWDSKK------------ 721
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK 738
L ++ + E+ AEV L +RH N+VKL C I+ EDS LLVYEYL SL LH K
Sbjct: 722 LDQKLEK--EFIAEVEILGTIRHSNIVKLLCCISREDSKLLVYEYLEKRSLDQWLHGKKK 779
Query: 739 ---IE---MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792
+E + W R IAVGAA+GL Y+HH +IHRDVKSSNILLD E+ +IADFG
Sbjct: 780 GGTVEANNLTWSQRLNIAVGAAQGLCYMHHDCTPAIIHRDVKSSNILLDSEFNAKIADFG 839
Query: 793 LAKI-VQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
LAK+ ++ + +AG+ GYIAPEYAYT K++EK DVYSFGVVL+ELVTG+
Sbjct: 840 LAKLLIKQNQEPHTMSAVAGSFGYIAPEYAYTSKVDEKIDVYSFGVVLLELVTGREG--- 896
Query: 852 EFGDSK-DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALK-VLRIAIHCTNKLPAFRPS 909
GD ++ +W + S D +I E +A+ V ++ + CTN LP+ RPS
Sbjct: 897 NNGDEHTNLADWSWKHYQSGKPTAEAFDEDIKEASTTEAMTTVFKLGLMCTNTLPSHRPS 956
Query: 910 MRVVVQMLEE 919
M+ V+ +L +
Sbjct: 957 MKEVLYVLRQ 966
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.10.2 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 947 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-130 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-21 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.002 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.002 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 417 bits (1073), Expect = e-130
Identities = 304/973 (31%), Positives = 468/973 (48%), Gaps = 138/973 (14%)
Query: 16 SSWTEANSVCKFNGIVCDSNGLVAE------------------------INLPEQQLLGV 51
S+W + VC + GI C+++ V INL QL G
Sbjct: 49 SNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGP 108
Query: 52 VPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP-DLSMLHEL 110
+P D +L+ +NL N G+I G L+ LDL NN SGE+P D+ L
Sbjct: 109 IPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN--LETLDLSNNMLSGEIPNDIGSFSSL 166
Query: 111 SFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSV 170
L+L + + GK P SL NLT+LEFL+L N P E+ +++ L W+YL ++
Sbjct: 167 KVLDLGGNVLVGKIP-NSLTNLTSLEFLTLASNQL-VGQIPRELGQMKSLKWIYLGYNNL 224
Query: 171 TGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLT 230
+G+IP IG LT L +L+L N L G IP+ + L L L LY N LSG +P +L
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQ 284
Query: 231 NLMNFDVSQNRLEGDLSELRF-LNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRL 289
L++ D+S N L G++ EL L L LHLF N F+G+IP L L L++N+
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 290 TGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCK 349
+G +P+ LG + +D+S N LTG IP +C +G + L++ N+ G +P++ C+
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404
Query: 350 SLIRFRVNNNSLSGTIPPGI------------------------WSLPNLSIIDLSTNQF 385
SL R R+ +NS SG +P W +P+L ++ L+ N+F
Sbjct: 405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464
Query: 386 EGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLK 445
G + D G +K L L L+ N+FSG +P K+ S L+ ++LS N+ SG+IP ++ K
Sbjct: 465 FGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCK 523
Query: 446 KLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKF 505
KL SL L N SG +P S L+ ++ +QN LSG+IP +LG++ SL +N+S+N
Sbjct: 524 KLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583
Query: 506 SGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGLCSKTDEYFKSCSSG 565
G +P + + L I A + GN LC +
Sbjct: 584 HGSLPSTGAF--------------------LAINA--SAVAGNIDLCGG--------DTT 613
Query: 566 SG----RSHHVSTFVWCLIAITMVLLVLL---ASYFVVKLKQNNLKHSLKQN---SWDMK 615
SG + + W I T+ ++L A FV +NNL+ +N +W+++
Sbjct: 614 SGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQ 673
Query: 616 SFR---VLSFSEKEIIDAVKPENLIGKGGSGNVYK-VVLNSGKELAVKHIWPSNSGFRGD 671
F S + +I+ ++K EN+I +G G YK + +G + VK I N
Sbjct: 674 FFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN------ 727
Query: 672 YRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWD 731
S +E+A + ++H N+VKL SE L++EY+ +L +
Sbjct: 728 ---------------SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSE 772
Query: 732 RLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791
L + W R IA+G AK L +LH V+ ++ I++D + +P +
Sbjct: 773 VLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826
Query: 792 GLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
L ++ T D I+ Y+APE T I EKSD+Y FG++L+EL+TGK P
Sbjct: 827 SLPGLLCT----DTKCFISS--AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880
Query: 852 EFGDSKDIVNWV-YSKMDSRDSMLTVVDPNISE---ILKEDALKVLRIAIHCTNKLPAFR 907
EFG IV W Y D M +DP+I + + + ++V+ +A+HCT P R
Sbjct: 881 EFGVHGSIVEWARYCYSDCHLDMW--IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTAR 938
Query: 908 PSMRVVVQMLEEA 920
P V++ LE A
Sbjct: 939 PCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 2e-45
Identities = 77/280 (27%), Positives = 121/280 (43%), Gaps = 41/280 (14%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA-- 691
+G+G G VY +GK +A+K ++ K+ +
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIK------------------VIKKKKIKKDRERILR 46
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
E+ L ++H N+V+LY ED LV EY G L+D L ++ D Y +
Sbjct: 47 EIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQI 106
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
LEYLH + ++HRD+K NILLD + ++ADFGLA+ + GE G
Sbjct: 107 --LSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVG 158
Query: 812 THGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRD 871
T Y+APE + D++S GV+L EL+TGK P F ++ ++ K+
Sbjct: 159 TPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLE-LFKKIGKPK 213
Query: 872 SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
+ +IS +A ++R K P R +
Sbjct: 214 PPFPPPEWDIS----PEAKDLIR---KLLVKDPEKRLTAE 246
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 74/209 (35%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+G+GG G VY +GK++A+K I SS E E+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII----------------KKEDSSSLLEELLREIEI 44
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
L + H N+VKLY E+ LV EY GSL D L ++ I + +
Sbjct: 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILE 103
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLD-LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
GLEYLH +IHRD+K NILLD K ++ADFGL+K++ L I GT
Sbjct: 104 GLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPA 158
Query: 815 YIAPE-YAYTCKINEKSDVYSFGVVLMEL 842
Y+APE +EKSD++S GV+L EL
Sbjct: 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 8e-42
Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 36/278 (12%)
Query: 635 NLIGKGGSGNVYK-VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
L+G+G G+VY + ++G+ +AVK + + + E+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSV---------------ELSGDSEEELEALEREI 50
Query: 694 ATLSAVRHVNVVK-LYCSITSEDSNLLVY-EYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
LS+++H N+V+ E + L ++ EY+ GSL L K+ + +Y +
Sbjct: 51 RILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI 110
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
+GL YLH ++HRD+K +NIL+D + ++ADFG AK + E G+ T + G
Sbjct: 111 --LEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 812 THGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRD 871
T ++APE + +D++S G ++E+ TGK P + + + + K+ S
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP----WSELGNPM-AALYKIGSSG 220
Query: 872 SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS 909
P I E L E+A LR C + P RP+
Sbjct: 221 EP-----PEIPEHLSEEAKDFLR---KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 73/214 (34%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+G G G VYK +GK +AVK + S++S + E+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKR---------------SEKSKKDQTARREIRI 51
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
L + H N+V+L + +D LV EY G L+D L + D + A+ + +
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQI--LR 109
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
GLEYLH +IHRD+K NILLD +IADFGLAK + ++ GT Y
Sbjct: 110 GLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWY 164
Query: 816 IAPE-YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+APE K DV+S GV+L EL+TGK P
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 83/289 (28%), Positives = 125/289 (43%), Gaps = 68/289 (23%)
Query: 637 IGKGGSGNVYKV-VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IGKGG G VYK +GKE+A+K I S + + E+
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVI---------KLESKE--------KKEKIINEIQI 50
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL-HTCHKIEMDWVVRYAIAVGAA 754
L +H N+VK Y S +D +V E+ GSL D L T + + +
Sbjct: 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIA--YVCKELL 108
Query: 755 KGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
KGLEYLH +G +IHRD+K++NILL + + ++ DFGL+ + +A + + GT
Sbjct: 109 KGLEYLHSNG----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTP 161
Query: 814 GYIAPEY----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS 869
++APE Y K+D++S G+ +EL GK P YS++
Sbjct: 162 YWMAPEVINGKPYDY----KADIWSLGITAIELAEGKPP---------------YSELPP 202
Query: 870 RDSMLTVV--DP-------NISEILKEDALKVLRIAIHCTNKLPAFRPS 909
++ + P S+ K D LK C K P RP+
Sbjct: 203 MKALFKIATNGPPGLRNPEKWSDEFK-DFLK------KCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 55/294 (18%)
Query: 637 IGKGGSGNVYKVVLNSGK-----ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS--SEY 689
+G+G G VYK L E+AVK L + +S E+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVK------------------TLKEDASEQQIEEF 48
Query: 690 DAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
E + + H N+VKL T E+ ++V EY+P G L D L E+ +
Sbjct: 49 LREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSF 108
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
A+ A+G+EYL + IHRD+ + N L+ +I+DFGL++
Sbjct: 109 ALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR------DLYDDDYY 159
Query: 810 AGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWV 863
G + APE K KSDV+SFGV+L E+ T G+ P
Sbjct: 160 KVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--------------- 204
Query: 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML 917
Y M + + + + ++ ++ + C + P RP+ +V++L
Sbjct: 205 YPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 72/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 637 IGKGGSGNVYKVVLNSGKEL-----AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA 691
+G+G G VYK L E AVK + S L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-----EEREEFLE----------- 50
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC-HKIEMDWVVRYAIA 750
E + + + H N+V+L T + +V EY+P G L D L K+ + +++ A+
Sbjct: 51 EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ 110
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ AKG+EYL + +HRD+ + N L+ +I+DFGL++ + + +
Sbjct: 111 I--AKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD-----YYRK 160
Query: 811 GTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVY 864
G + APE K KSDV+SFGV+L E+ T G++P Y
Sbjct: 161 RGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP---------------Y 205
Query: 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML 917
M + + + + D + ++ + + C P RP+ +V+ L
Sbjct: 206 PGMSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 72/294 (24%), Positives = 122/294 (41%), Gaps = 56/294 (19%)
Query: 637 IGKGGSGNVYKVVLNSGK-----ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS--SEY 689
+G+G G VYK L E+AVK L + +S E+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVK------------------TLKEDASEQQIEEF 48
Query: 690 DAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
E + + H NVVKL T E+ +V EY+ G L L ++ ++ +
Sbjct: 49 LREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSF 107
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
A+ A+G+EYL + IHRD+ + N L+ +I+DFGL++ + +
Sbjct: 108 ALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD------YY 158
Query: 810 AGTHG-----YIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWV 863
G ++APE K KSDV+SFGV+L E+ T G++P
Sbjct: 159 RKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP--------------- 203
Query: 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML 917
Y M + + + + + ++ + + C + P RP+ +V++L
Sbjct: 204 YPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 71/220 (32%), Positives = 103/220 (46%), Gaps = 36/220 (16%)
Query: 637 IGKGGSGNVYKV-VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS-SRSSEYD---A 691
+GKG G V V ++GK A+K +L K+ + E +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMK------------------VLKKKKIIKRKEVEHTLT 42
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA--I 749
E LS + H +VKL+ + +E+ LV EY P G L+ L + + YA I
Sbjct: 43 ERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI 102
Query: 750 AVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+ LEYLH G +I+RD+K NILLD + ++ DFGLAK + G T+
Sbjct: 103 VL----ALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKEL--SSEGSRTNT 152
Query: 809 IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT Y+APE + D +S GV+L E++TGK P
Sbjct: 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 82/285 (28%), Positives = 121/285 (42%), Gaps = 69/285 (24%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEY-DAE 692
IGKG G VY V + GK +K I LS S + E E
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEI----------------DLSNMSEKEREDALNE 49
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC---------HKIEMDW 743
V L + H N++K Y S + +V EY G L ++ +I +DW
Sbjct: 50 VKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-LDW 108
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG 803
V+ +A L+YLH R ++HRD+K NI L ++ DFG++K++
Sbjct: 109 FVQLCLA------LKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS--STV 157
Query: 804 DLTHVIAGTHGYIAPE----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEF-GDS-- 856
DL + GT Y++PE Y N KSD++S G VL EL T K P F G++
Sbjct: 158 DLAKTVVGTPYYLSPELCQNKPY----NYKSDIWSLGCVLYELCTLKHP----FEGENLL 209
Query: 857 ---KDIVNWVYSKMDSR---------DSMLTVVD---PNISEILK 886
I+ Y + S+ S+L P+I++IL+
Sbjct: 210 ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 75/311 (24%), Positives = 114/311 (36%), Gaps = 76/311 (24%)
Query: 635 NLIGKGGSGNVYKVVLNSGKEL----AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+G+G G VYK L AVK K + E
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVK-------------------TLKEDASEEERK 41
Query: 691 A---EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC-------HKIE 740
E + + H NVV+L T E+ LV EY+ G L D L K
Sbjct: 42 DFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKST 101
Query: 741 MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG 800
+ + A+ AKG+EYL + +HRD+ + N L+ + +I+DFGL++ V
Sbjct: 102 LSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158
Query: 801 EAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFG 854
+ + T G + APE KSDV+SFGV+L E+ T G P
Sbjct: 159 D-----YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP------ 207
Query: 855 DSKDIVNWVYSKMDSRDSMLTVVD-------PNISEILKEDALKVLRIAIHCTNKLPAFR 907
Y + + + + + + L E + + C P R
Sbjct: 208 ---------YPGLSNEEVLEYLRKGYRLPKPEYCPDELYE-------LMLSCWQLDPEDR 251
Query: 908 PSMRVVVQMLE 918
P+ +V+ LE
Sbjct: 252 PTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 78/283 (27%), Positives = 120/283 (42%), Gaps = 52/283 (18%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
+LIG+G G VYK + L +G +A+K I + E+
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEK---------------IKEEALKSIMQEI 50
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
L ++H N+VK SI + DS ++ EY NGSL + V Y V
Sbjct: 51 DLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV-- 108
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
+GL YLH ++ VIHRD+K++NIL + ++ADFG+A + + + GT
Sbjct: 109 LQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTP 163
Query: 814 GYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSM 873
++APE + SD++S G ++EL+TG P Y ++ ++
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP---------------YYDLNPMAAL 208
Query: 874 LTVVD-------PNISEILKEDALKVLRIAIHCTNKLPAFRPS 909
+V IS LK D L C K P RP+
Sbjct: 209 FRIVQDDHPPLPEGISPELK-DFLM------QCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 85/293 (29%), Positives = 130/293 (44%), Gaps = 57/293 (19%)
Query: 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+G+G SG VYKV +GK A+K I + ++R E+ T
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLL-------------RELKT 52
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKI-EMDWVVRYAIAVGAA 754
L + VVK Y + E +V EY+ GSL D L KI E V IA
Sbjct: 53 LRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPE---PVLAYIARQIL 109
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
KGL+YLH R +IHRD+K SN+L++ + + +IADFG++K+++ T V GT
Sbjct: 110 KGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVT 165
Query: 815 YIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868
Y++PE Y+Y +D++S G+ L+E GK P +P ++
Sbjct: 166 YMSPERIQGESYSY------AADIWSLGLTLLECALGKFPFLP-----PGQPSFF----- 209
Query: 869 SRDSMLTVVD---PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918
+ M + D P++ + C K P RPS ++L+
Sbjct: 210 --ELMQAICDGPPPSLPAEEFSPEFR--DFISACLQKDPKKRPS---AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 73/245 (29%), Positives = 113/245 (46%), Gaps = 49/245 (20%)
Query: 620 LSFSEKEIIDAVKPENL------IGKGGSGNVYK-VVLNSGKELAVKHIWPSNSGFRGDY 672
L + K+I+ P L IG+G SG VYK +GKE+A+K + R
Sbjct: 4 LKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-----RLRKQN 58
Query: 673 RSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDR 732
+ E+ + +H N+V Y S D +V EY+ GSL D
Sbjct: 59 KELIIN-------------EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDI 105
Query: 733 LHTCHKIEMD-----WVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787
+ T + + M+ +V R + +GLEYLH + VIHRD+KS NILL + +
Sbjct: 106 I-TQNFVRMNEPQIAYVCREVL-----QGLEYLH---SQNVIHRDIKSDNILLSKDGSVK 156
Query: 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE----YAYTCKINEKSDVYSFGVVLMELV 843
+ADFG A Q + + + GT ++APE Y K+ D++S G++ +E+
Sbjct: 157 LADFGFA--AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV----DIWSLGIMCIEMA 210
Query: 844 TGKRP 848
G+ P
Sbjct: 211 EGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 42/229 (18%)
Query: 635 NLIGKGGSGNVYKVVL-----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEY 689
+G+G G V N+G+++AVK + S S++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----------------QHRSDF 53
Query: 690 DAEVATLSAVRHVNVVKL--YCSITSEDSNLLVYEYLPNGSLWDRLH-TCHKIEMDWVVR 746
+ E+ L + H N+VK C S L+ EYLP+GSL D L +I + ++
Sbjct: 54 EREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL 113
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG------ 800
++ + KG++YL + IHRD+ + NIL++ E +I+DFGLAK++
Sbjct: 114 FSSQI--CKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYV 168
Query: 801 -EAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
E G+ + APE T K + SDV+SFGV L EL T P
Sbjct: 169 KEPGESPIF------WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 75/233 (32%), Positives = 104/233 (44%), Gaps = 40/233 (17%)
Query: 629 DAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSS 687
D + +IG G + VY + L + +++A+K I L K +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI----------------DLEKCQTSVD 44
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
E EV +S H NVVK Y S D LV YL GSL D + +
Sbjct: 45 ELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK--SSYPRGGLDEA 102
Query: 748 AIAV---GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGD 804
IA KGLEYLH IHRD+K+ NILL + +IADFG++ + G GD
Sbjct: 103 IIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG--GD 157
Query: 805 LT----HVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
T GT ++APE + Y + K+D++SFG+ +EL TG P
Sbjct: 158 RTRKVRKTFVGTPCWMAPEVMEQVHGY----DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 62/241 (25%), Positives = 94/241 (39%), Gaps = 47/241 (19%)
Query: 632 KPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKR--SSRSSE 688
K +IG+G V + KE A+K IL KR
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIK------------------ILDKRQLIKEKKV 45
Query: 689 YDA--EVATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVV 745
E L+ + H ++KLY + E++ V EY PNG L + ++
Sbjct: 46 KYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR 105
Query: 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI-------VQ 798
YA + LEYLH + +IHRD+K NILLD + +I DFG AK+
Sbjct: 106 FYAAEI--LLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160
Query: 799 TGEAGDLTHVIA-----------GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKR 847
GT Y++PE + SD+++ G ++ +++TGK
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
Query: 848 P 848
P
Sbjct: 221 P 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 67/215 (31%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 635 NLIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
+IGKG G V V K++ A+K Y + + K S R+ E
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMK------------YMNKQKCVEKGSVRNVL--NER 51
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
L + H +V L+ S E++ LV + L G L R H K++
Sbjct: 52 RILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICEI 109
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
LEYLH + +IHRD+K NILLD + I DF +A V LT +GT
Sbjct: 110 VLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTP 163
Query: 814 GYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GY+APE + D +S GV E + GKRP
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 67/215 (31%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 635 NLIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
N IGKG G V+KVV + K + A+K I D R R D E
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQI---------DLSKMN-----RREREEAID-EA 50
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
L+ + +++ Y S + +V EY NG L L + + +
Sbjct: 51 RVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQI 110
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
GL +LH + ++HRD+KS N+ LD +I D G+AK++ + + + I GT
Sbjct: 111 LLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTP 165
Query: 814 GYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
Y++PE NEKSDV++ GVVL E TGK P
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 70/229 (30%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNS--GFRGDYRSSTAILSKRSSRSSEYDAEV 693
IG+G G VYK +G+ +A+K I N GF I + R E+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGF--------PITAIR---------EI 49
Query: 694 ATLSAVRHVNVVKLYCSITSEDSN--LLVYEYLP---NGSLWDRLHTCHKIEMDWVVRYA 748
L +RH N+V+L +TS+ +V+EY+ G L K + Y
Sbjct: 50 KLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLL---DSPEVKFTESQIKCYM 106
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT-H 807
+ +GL+YLH ++HRD+K SNIL++ + ++ADFGLA+ + D T
Sbjct: 107 KQL--LEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 808 VIAGTHGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
VI T Y PE Y ++ D++S G +L EL GK PI
Sbjct: 162 VI--TLWYRPPELLLGATRYGPEV----DMWSVGCILAELFLGK-PIFQ 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (258), Expect = 1e-23
Identities = 80/287 (27%), Positives = 119/287 (41%), Gaps = 36/287 (12%)
Query: 636 LIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+G+G G VY K +A+K + L +S + E+
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKK--------------LESKSKEVERFLREIQI 50
Query: 696 LSAVRH-VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH---KIEMDWVVRYAIAV 751
L+++ H N+VKLY E S LV EY+ GSL D L + + +
Sbjct: 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI 110
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE-WKPRIADFGLAKIV----QTGEAGDLT 806
LEYLH + +IHRD+K NILLD + ++ DFGLAK++ T L
Sbjct: 111 --LSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165
Query: 807 HVIAGTHGYIAPEYA---YTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863
GT GY+APE + SD++S G+ L EL+TG P E S
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225
Query: 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910
S+ + + P+ E++ + A +L+ K P R S
Sbjct: 226 IILELPTPSLASPLSPSNPELISKAASDLLK---KLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 36/222 (16%)
Query: 636 LIGKGGSGNVYK-VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
L+G G G+VY+ + L+ G AVK + ++ G + + E+A
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG------------QTGQEAVKQLEQEIA 54
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW------VVR-Y 747
LS ++H N+V+ + ED+ + E +P GSL K+ + V+R Y
Sbjct: 55 LLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSL-------AKLLKKYGSFPEPVIRLY 107
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
+ GLEYLH DR +HRD+K +NIL+D ++ADFG+AK V
Sbjct: 108 TRQI--LLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAK 159
Query: 808 VIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRP 848
G+ ++APE +D++S G ++E+ TGK P
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 71/224 (31%), Positives = 108/224 (48%), Gaps = 34/224 (15%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
N IG G G VY V L++G+ +AVK I D ++ I E+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQ----DNDPKTIKEIAD-----------EM 50
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVY-EYLPNGSLWDRLHTCHKIEMDWVV--RYAIA 750
L ++H N+VK Y + + ++ EY G+L + L H +D V Y +
Sbjct: 51 KVLELLKHPNLVKYY-GVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQ 107
Query: 751 VGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ--TGEAGDLTH 807
+ +GL YLH HG ++HRD+K +NI LD ++ DFG A ++ T G+
Sbjct: 108 L--LEGLAYLHSHG----IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ 161
Query: 808 VIAGTHGYIAPEYAYTCKINEK---SDVYSFGVVLMELVTGKRP 848
+AGT Y+APE K +D++S G V++E+ TGKRP
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 70/228 (30%), Positives = 101/228 (44%), Gaps = 32/228 (14%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+G G SG V KV+ +GK +AVK I + K+ R E+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTI----------RLEINEAIQKQILR------ELDI 52
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
L +V Y + + + EY+ GSL L + + IAV K
Sbjct: 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQG-RIPERILGKIAVAVLK 111
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA----G 811
GL YLH +IHRDVK SNIL++ + ++ DFG+ +G L + +A G
Sbjct: 112 GLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGV--------SGQLVNSLAKTFVG 161
Query: 812 THGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859
T Y+APE + KSD++S G+ L+EL TG+ P PE I
Sbjct: 162 TSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
+G+G G+VYK + +G+ +A+K + P E E++
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDL------------------QEIIKEIS 50
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA 754
L +VK Y S +V EY GS+ D + +K + AI
Sbjct: 51 ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTL 109
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
KGLEYLH IHRD+K+ NILL+ E + ++ADFG++ Q + + + GT
Sbjct: 110 KGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPF 164
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
++APE N K+D++S G+ +E+ GK P
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 7e-22
Identities = 69/222 (31%), Positives = 118/222 (53%), Gaps = 18/222 (8%)
Query: 631 VKPENLIGKGGSGNVYKVV-LNSGKELAVKHI-WPSNSGFRGDYRSSTAILSKRSSRSSE 688
VK E LIGKG G VY + + +G+ +AVK + P+ R D S++
Sbjct: 4 VKGE-LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHD--------SRQKDMVKA 54
Query: 689 YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA 748
+E+ TL + H+N+V+ T+E+ + EY+P GS+ L T + E V +
Sbjct: 55 LRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFT 114
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
V +GL YLH + ++HRD+K+ N+L+D + +I+DFG++K D
Sbjct: 115 EQV--LEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169
Query: 809 IAGTHGYIAPE--YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+ G+ ++APE ++Y+ + K D++S G V++E+ G+RP
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 9e-22
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 636 LIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++GKG G V+ L + + A+K + +L + + V
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKAL------------KKDVVLMDDDVECTMVEKRVL 49
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA 754
+L A H + LYC+ ++++ V EYL G L + +CHK ++ YA +
Sbjct: 50 SL-AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEI--I 106
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
GL++LH + +++RD+K NILLD + +IADFG+ K G+A T GT
Sbjct: 107 CGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPD 161
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
YIAPE K N D +SFGV+L E++ G+ P
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 77/290 (26%), Positives = 136/290 (46%), Gaps = 55/290 (18%)
Query: 636 LIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IGKG G+V G+++AVK + + D ++ A L AE +
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCL-------KDDSTAAQAFL-----------AEASV 53
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT--CHKIEMDWVVRYAIAVGA 753
++ +RH N+V+L + + +V EY+ GSL D L + I + + +A+ V
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV-- 111
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
+G+EYL ++ +HRD+ + N+L+ + +++DFGLAK G+ V
Sbjct: 112 CEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV----- 163
Query: 814 GYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKR---PIVPEFGDSKDIVNWVYS--KMD 868
+ APE K + KSDV+SFG++L E+ + R P +P KD+V V +M+
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPHVEKGYRME 219
Query: 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918
+ + P + +++K+ C PA RP+ + + + L
Sbjct: 220 APEG----CPPEVYKVMKD-----------CWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 82/290 (28%), Positives = 126/290 (43%), Gaps = 70/290 (24%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL 696
+G G G V+ N ++AVK + P S A L E +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-------SPEAFL-----------QEAQIM 55
Query: 697 SAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT--CHKIEMDWVVRYAIAVGAA 754
+RH +V+LY + E+ +V EY+ GSL D L + K+ + +V A + A
Sbjct: 56 KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--A 113
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
+G+ YL R IHRD+ + NIL+ +IADFGLA++++ E G
Sbjct: 114 EGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-------YTAREG 163
Query: 815 ------YIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867
+ APE A + KSDV+SFG++L E+VT G+ P Y M
Sbjct: 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP---------------YPGM 208
Query: 868 DSRDSMLTVVD--------PNISEILKEDALKVLRIAIHCTNKLPAFRPS 909
+R+ +L V+ PN E L + + + C +K P RP+
Sbjct: 209 TNRE-VLEQVERGYRMPRPPNCPEELYD-------LMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 60/177 (33%), Positives = 88/177 (49%), Gaps = 18/177 (10%)
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNL-LVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
E L ++RH +V LY S +DSNL LV EY+P G L+ L + YA
Sbjct: 50 NEKRILQSIRHPFLVNLYGS-FQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA 108
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
V A LEYLH +++RD+K N+LLD + +I DFG AK V+ T+ +
Sbjct: 109 QVVLA--LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTL 158
Query: 810 AGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866
GT Y+APE + + D ++ G+++ E++ G P F D I +Y K
Sbjct: 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG----YPPFFDDNPIQ--IYEK 209
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 4e-21
Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 49/233 (21%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVK--HIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
+G+G G VYK +G+ +A+K + G STA+ R E+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI-----PSTAL------R------EI 49
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH-KIEMDWVVRYAIAVG 752
+ L ++H N+VKL I +E LV+EY L L + + + +
Sbjct: 50 SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQL- 107
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI----VQTGEAGDLTHV 808
+GL Y H ++HRD+K NIL++ + ++ADFGLA+ ++T TH
Sbjct: 108 -LRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-----YTHE 158
Query: 809 IAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
+ T Y APE Y+ + D++S G + E++TGK P+ P GDS
Sbjct: 159 VV-TLWYRAPEILLGSKHYSTAV----DIWSVGCIFAEMITGK-PLFP--GDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 64/229 (27%), Positives = 101/229 (44%), Gaps = 39/229 (17%)
Query: 637 IGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+G GG G V V + S A+K + + I S++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV-KKRHIV--ETGQQEHIFSEKE-----------I 46
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
L H +VKLY + + ++ EY G LW L + ++ R+ IA
Sbjct: 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARFYIA-CVVL 104
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
EYLH+ R +I+RD+K N+LLD ++ DFG AK +++G+ T GT Y
Sbjct: 105 AFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEY 158
Query: 816 IAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858
+APE Y ++ D +S G++L EL+TG+ P FG+ +
Sbjct: 159 VAPEIILNKGYDFSV------DYWSLGILLYELLTGRPP----FGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 57/173 (32%), Positives = 79/173 (45%), Gaps = 17/173 (9%)
Query: 690 DAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
E LS + VVKLY S + + LV EYLP G L L ++ D Y
Sbjct: 41 LTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA 100
Query: 750 AVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI------VQTGEA 802
+ A LEYLH +G +IHRD+K NIL+D ++ DFGL+K+ + +
Sbjct: 101 EIVLA--LEYLHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154
Query: 803 GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855
I GT YIAPE ++ D +S G +L E + G +P F
Sbjct: 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG----IPPFHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 631 VKPENLIGKGGSGNVY---KVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSS 687
+KP I KG G+VY K +G A+K + S+ + T + ++R+
Sbjct: 1 LKP---ISKGAFGSVYLAKKRS--TGDYFAIKVLKKSDMIAK---NQVTNVKAERAIMMI 52
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
+ ++ V KLY S S+D LV EYL G + T + DW +Y
Sbjct: 53 QGESP----------YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY 102
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
V G+E LH R +IHRD+K N+L+D ++ DFGL+ G
Sbjct: 103 IAEV--VLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENK 151
Query: 808 VIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT Y+APE ++ SD +S G V+ E + G P
Sbjct: 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 51/151 (33%), Positives = 77/151 (50%), Gaps = 7/151 (4%)
Query: 698 AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGL 757
A H + L+C+ +++ V EYL G L + + + + YA + GL
Sbjct: 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEI--ICGL 109
Query: 758 EYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIA 817
++LH + +I+RD+K N+LLD + +IADFG+ K GE GT YIA
Sbjct: 110 QFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIA 164
Query: 818 PEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
PE K NE D +SFGV+L E++ G+ P
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 65/220 (29%), Positives = 115/220 (52%), Gaps = 22/220 (10%)
Query: 636 LIGKGGSGNVYKVVLN--SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
LIG G G+VY + +N SG+ +AVK + + R + + E+
Sbjct: 7 LIGSGSFGSVY-LGMNASSGELMAVKQVELPSVSASSKDRKRSML--------DALAREI 57
Query: 694 ATLSAVRHVNVVK-LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVG 752
A L ++H N+V+ L S+ ++ N+ + EY+P GS+ L+ E V + +
Sbjct: 58 ALLKELQHENIVQYLGSSLDADHLNIFL-EYVPGGSVAALLNNYGAFEETLVRNFVRQI- 115
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ----TGEAGDLTHV 808
KGL YLH +R +IHRD+K +NIL+D + +I+DFG++K ++ + +
Sbjct: 116 -LKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 809 IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+ G+ ++APE K+D++S G +++E++TGK P
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-20
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 29/215 (13%)
Query: 634 ENLIGKGGSGNVYKVVLNS-GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
++ +G G G VY+ V +AVK L + + E+ E
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVK------------------TLKEDTMEVEEFLKE 52
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVG 752
A + ++H N+V+L T E ++ E++ G+L D L C++ E++ VV +A
Sbjct: 53 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 112
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGT 812
+ +EYL + IHRD+ + N L+ ++ADFGL++++ GD AG
Sbjct: 113 ISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGA 165
Query: 813 H---GYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
+ APE K + KSDV++FGV+L E+ T
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-20
Identities = 69/221 (31%), Positives = 110/221 (49%), Gaps = 43/221 (19%)
Query: 641 GSGNVYKVVL--------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
G G+ KV L N+G+++AVK + P + G + ++ E
Sbjct: 13 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG----------------NHIADLKKE 56
Query: 693 VATLSAVRHVNVVKLYCSITSEDSN---LLVYEYLPNGSLWDRL-HTCHKIEMDWVVRYA 748
+ L + H N+VK Y I +ED L+ E+LP+GSL + L +KI + ++YA
Sbjct: 57 IEILRNLYHENIVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA-----G 803
+ + KG++YL R +HRD+ + N+L++ E + +I DFGL K ++T +
Sbjct: 116 VQI--CKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 170
Query: 804 DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
DL + + APE K SDV+SFGV L EL+T
Sbjct: 171 DLDSPVF----WYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
L+G+G G VY +++G+ELAVK + + + + E+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS------------PETKKEVNALECEIQ 56
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA 754
L ++H +V+ Y + +++ + EY+P GS+ D+L + +Y +
Sbjct: 57 LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI--L 114
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT-GEAGDLTHVIAGTH 813
+G+EYLH ++HRD+K +NIL D ++ DFG +K +QT +G + GT
Sbjct: 115 EGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 814 GYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+++PE K+DV+S G ++E++T K P
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 62/234 (26%), Positives = 110/234 (47%), Gaps = 33/234 (14%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVY-EYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
E+ ++ + H +++++ + T EDS+ ++ E++ GS+ L + ++ Y
Sbjct: 53 EIRLMARLNHPHIIRMLGA-TCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ 111
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP-RIADFGLA-KIVQTGE-AGDLTH 807
+ +GL YLH + +IHRDVK +N+L+D + RIADFG A ++ G AG+
Sbjct: 112 L--LRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG 166
Query: 808 VIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867
+ GT ++APE + DV+S G V++E+ T K P W K
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP-------------WNAEKH 213
Query: 868 DSRDSML-----TVVDPNISEILKEDALKVLR-IAIHCTNKLPAFRPSMRVVVQ 915
+ +++ P+I E L LR + + C P RP R +++
Sbjct: 214 SNHLALIFKIASATTAPSIPEHLSPG----LRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 67/226 (29%), Positives = 99/226 (43%), Gaps = 47/226 (20%)
Query: 637 IGKGGSGNVYK-VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG G G+VYK + +G+ +A+K I GD I+ + E++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFE---IIQQ----------EISM 53
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLH-TCHKIEMD---WVVRYAIAV 751
L RH N+V + S D +V EY GSL D T + +V R +
Sbjct: 54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-- 111
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA- 810
KGL YLH IHRD+K +NILL + ++ADFG+ + LT IA
Sbjct: 112 ---KGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGV--------SAQLTATIAK 157
Query: 811 -----GTHGYIAPEYA---YTCKINEKSDVYSFGVVLMELVTGKRP 848
GT ++APE A + K D+++ G+ +EL + P
Sbjct: 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 69/226 (30%), Positives = 102/226 (45%), Gaps = 38/226 (16%)
Query: 637 IGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+G+G G+V K L N+G A+K I L K+ R E+
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTI----------TTDPNPDLQKQILR------ELEI 52
Query: 696 LSAVRHVNVVKLYCSITSE-DSNL-LVYEYLPNGSLWDRLHTCHKIEMDWVVRYA---IA 750
+ + +VK Y + E S++ + EY GSL D ++ K + IA
Sbjct: 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIA 111
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
KGL YLH R +IHRD+K SNILL + + ++ DFG++ + AG T
Sbjct: 112 ESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---- 164
Query: 811 GTHGYIAPEY----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
GT Y+APE Y+ SDV+S G+ L+E+ + P PE
Sbjct: 165 GTSFYMAPERIQGKPYSI----TSDVWSLGLTLLEVAQNRFPFPPE 206
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 82/303 (27%), Positives = 133/303 (43%), Gaps = 48/303 (15%)
Query: 636 LIGKGGSGNVYKVVL-----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+GKG G+V N+G+ +AVK + S + R +++
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---------------TAEHLR--DFE 53
Query: 691 AEVATLSAVRHVNVVKL--YCSITSEDSNLLVYEYLPNGSLWDRLHTC-HKIEMDWVVRY 747
E+ L +++H N+VK C + LV EYLP GSL D L +++ ++ Y
Sbjct: 54 REIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY 113
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV-QTGEAGDLT 806
A + KG+EYL + +HRD+ + NIL++ E + +I DFGL K++ Q E +
Sbjct: 114 ASQI--CKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR 168
Query: 807 HVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866
+ APE K + SDV+SFGVVL EL T + D + +
Sbjct: 169 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT--------YSDKSCSPPAEFMR 220
Query: 867 MDSRDSMLTVVDPNISEILKEDA---------LKVLRIAIHCTNKLPAFRPSMRVVVQML 917
M D ++ ++ E+LK + ++ I C N P+ RPS + +
Sbjct: 221 MMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280
Query: 918 EEA 920
E
Sbjct: 281 EAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 637 IGKGGSGNVYK-VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG+G G V+K +G+ +A+K + G + ++ R E+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGG--------IPNQALR------EIKA 52
Query: 696 LSAVRHVNVVKLYCSITSEDSNL-LVYEYLPNGSLWDRLHTC-HKIEMDWVVRYAIAVGA 753
L A +H VVKL + S LV EY+P L + L + V Y +
Sbjct: 53 LQACQHPYVVKLL-DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML-- 108
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
KG+ Y+H ++HRD+K +N+L+ + +IADFGLA++ E +H +A T
Sbjct: 109 LKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TR 164
Query: 814 GYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859
Y APE Y K + D+++ G + EL+ G P+ P G++ DI
Sbjct: 165 WYRAPELLYGARKYDPGVDLWAVGCIFAELLNG-SPLFP--GEN-DI 207
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 5e-19
Identities = 84/304 (27%), Positives = 127/304 (41%), Gaps = 61/304 (20%)
Query: 641 GSGNVYKVVL--------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
G G+ KV L +G+ +AVK + +S + E
Sbjct: 13 GEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG----------------QQNTSGWKKE 56
Query: 693 VATLSAVRHVNVVKLY--CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
+ L + H N+VK CS L+ EY+P GSL D L HK+ + ++ +A
Sbjct: 57 INILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQ 115
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG-------EAG 803
+ +G+ YLH + IHRD+ + N+LLD + +I DFGLAK V G E G
Sbjct: 116 I--CEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170
Query: 804 DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863
D + V + A E K + SDV+SFGV L EL+T DSK
Sbjct: 171 D-SPVF-----WYAVECLKENKFSYASDVWSFGVTLYELLT--------HCDSKQSPPKK 216
Query: 864 YSKMDSRDSMLTVVDPNISEILKEDAL--------KVLRIAIHCTNKLPAFRPSMRVVVQ 915
+ +M V I + + L +V + +C FRP+ R ++
Sbjct: 217 FEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276
Query: 916 MLEE 919
+L+E
Sbjct: 277 ILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 8e-19
Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 7/151 (4%)
Query: 698 AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGL 757
A +H + +L+ ++D V EY+ G L + + + YA + GL
Sbjct: 52 AGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGL 109
Query: 758 EYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIA 817
++LH +R +I+RD+K N+LLD E +IADFG+ K G G T GT YIA
Sbjct: 110 QFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTSTFCGTPDYIA 164
Query: 818 PEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
PE D ++ GV+L E++ G+ P
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 76/295 (25%), Positives = 119/295 (40%), Gaps = 75/295 (25%)
Query: 634 ENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
IGKG G VYK + + + +A+K I D L + + E
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVI---------D-------LEEAEDEIEDIQQE 49
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNL-LVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAI 749
+ LS R + K Y S + S L ++ EY GS D L + + +++R +
Sbjct: 50 IQFLSQCRSPYITKYYGSFL-KGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL 108
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
GLEYLH + IHRD+K++NILL E ++ADFG+ +G LT +
Sbjct: 109 -----LGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGV--------SGQLTSTM 152
Query: 810 ------AGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863
GT ++APE +EK+D++S G+ +EL G+ P
Sbjct: 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP--------------- 197
Query: 864 YSKMDSRDSML--------TVVDPNISEILKEDALKVLRIAIH-CTNKLPAFRPS 909
S + + ++ S+ K+ + C NK P RPS
Sbjct: 198 LSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKD--------FVSLCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 649 VLNSGKELAV-KHIW-PSNSGFRGDYRSSTAILSKRSSRSS--EYDAEVATLSAVRHVNV 704
VL SG V K +W P + + +L + +S + E E +++V H +V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVK--IPVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71
Query: 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGF 764
V+L S L+ + +P G L D + HK + V AKG+ YL
Sbjct: 72 VRLLGICLSS-QVQLITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLE--- 126
Query: 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH--GYIAPEYAY 822
++ ++HRD+ + N+L+ +I DFGLAK++ E H G ++A E
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE--KEYHAEGGKVPIKWMALESIL 184
Query: 823 TCKINEKSDVYSFGVVLMELVT-GKRP 848
KSDV+S+GV + EL+T G +P
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 50/160 (31%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKI--EMDWVVRYAI 749
EV L+ ++H N+V + S +V EY G L R++ + D ++ + +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK-PRIADFGLAKIVQTGEAGDLTHV 808
+ + GL+++H DR ++HRD+KS NI L ++ DFG+A+ Q ++ +L +
Sbjct: 109 QI--SLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYT 161
Query: 809 IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT Y++PE N K+D++S G VL EL T K P
Sbjct: 162 CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 69/236 (29%), Positives = 112/236 (47%), Gaps = 42/236 (17%)
Query: 637 IGKGGSGNVYKVVL----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS-SEYDA 691
+ K G G+ K +L GK+ +K I +SK S + E
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEIN----------------ISKMSPKEREESRK 48
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNL-LVYEYLPNGSLWDRLHTCHKIE------MDWV 744
EVA LS ++H N+V+ Y E+ NL +V +Y G L+ +++ + +DW
Sbjct: 49 EVAVLSNMKHPNIVQ-YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF 107
Query: 745 VRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGD 804
V+ +A L H DR ++HRD+KS NI L + ++ DFG+A+++ + +
Sbjct: 108 VQICLA---------LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--TVE 156
Query: 805 LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860
L GT Y++PE N KSD+++ G VL E+ T K E G+ K++V
Sbjct: 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF--EAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 26/225 (11%)
Query: 633 PEN-----LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS 686
P N L+G+G G VY ++G+ELAVK + P + + + A+
Sbjct: 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQV-PFDPDSQETSKEVNAL-------- 51
Query: 687 SEYDAEVATLSAVRHVNVVKLY-CSITSEDSNLLVY-EYLPNGSLWDRLHTCHKIEMDWV 744
+ E+ L +RH +V+ Y C E+ L ++ EY+P GS+ D+L + +
Sbjct: 52 ---ECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVT 108
Query: 745 VRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT-GEAG 803
RY + +G+ YLH ++HRD+K +NIL D ++ DFG +K +QT +G
Sbjct: 109 RRYTRQI--LQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG 163
Query: 804 DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+ GT +++PE K+DV+S ++E++T K P
Sbjct: 164 TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 636 LIGKGGSGNVYKV--VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
+G G G VYKV N LA+K I N F D R R V
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRE----------RDKSIGDIV 56
Query: 694 ATLSAV----RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC----HKIEMDWVV 745
+ ++ + RH N+V+ Y + D +V + + L + ++ + + +
Sbjct: 57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI- 115
Query: 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
+ I V L YLH ++ ++HRD+ +NI+L + K I DFGLAK Q L
Sbjct: 116 -WNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL 170
Query: 806 THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
T V GT Y PE EK+DV++FG +L ++ T + P
Sbjct: 171 TSV-VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 63/233 (27%), Positives = 110/233 (47%), Gaps = 37/233 (15%)
Query: 628 IDA--VKPENLIGKGGSGNVYK--VVLNSGKEL--AVKHIWPSNSGFRGDYRSSTAILSK 681
ID V E +IG G G V + + L KE+ A+K + +S
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD-------------- 46
Query: 682 RSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEM 741
+ ++ E + + H N+++L +T +++ EY+ NGSL D+ + +
Sbjct: 47 --KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKF 103
Query: 742 DWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGE 801
+ G A G++YL + +HRD+ + NIL++ +++DFGL++ ++ E
Sbjct: 104 TVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160
Query: 802 AGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
A T+ G G I APE K SDV+SFG+V+ E+++ G+RP
Sbjct: 161 A---TYTTKG--GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 71/221 (32%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IGKG G V KV + GK L K I DY + T + +EV
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEI---------DYGNMT------EKEKQQLVSEVNI 52
Query: 696 LSAVRHVNVVKLYCSITSEDSNLL--VYEYLPNGSLWDRLHTCHK----IEMDWVVRYAI 749
L ++H N+V+ Y I + L V EY G L + C K IE +++ R I
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR--I 110
Query: 750 AVGAAKGLEYLHHGFD--RPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
L H+ D V+HRD+K +NI LD ++ DFGLAKI+ + T+
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 808 VIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
V GT Y++PE +EKSD++S G ++ EL P
Sbjct: 171 V--GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 39/221 (17%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL 696
+G G G V++ + N+ +AVK + P + ++ AE +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPG------------------TMDPKDFLAEAQIM 55
Query: 697 SAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT--CHKIEMDWVVRYAIAVGAA 754
+RH +++LY T E+ +V E + GSL + L +++ ++ A V A
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV--A 113
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
G+ YL + IHRD+ + N+L+ ++ADFGLA++++ G
Sbjct: 114 SGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-------YEAREG 163
Query: 815 ------YIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ APE A + + KSDV+SFG++L E+VT G+ P
Sbjct: 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 72/257 (28%), Positives = 122/257 (47%), Gaps = 33/257 (12%)
Query: 670 GDYRSSTAILS--KRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNL-LVYEYLPN 726
GDYR + + K + + + AE + ++ +RH N+V+L I E L +V EY+
Sbjct: 25 GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84
Query: 727 GSLWDRLHTCHK--IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784
GSL D L + + + D ++++++ V + +EYL +HRD+ + N+L+ +
Sbjct: 85 GSLVDYLRSRGRSVLGGDCLLKFSLDV--CEAMEYLE---ANNFVHRDLAARNVLVSEDN 139
Query: 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
+++DFGL K EA + APE K + KSDV+SFG++L E+ +
Sbjct: 140 VAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
Query: 845 GKRPIVPEFGDSKDIVNWVYS--KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNK 902
R P KD+V V KMD+ D P + +++K+ C +
Sbjct: 195 FGRVPYPRIP-LKDVVPRVEKGYKMDAPDG----CPPVVYDVMKQ-----------CWHL 238
Query: 903 LPAFRPSMRVVVQMLEE 919
A RPS + + LE
Sbjct: 239 DAATRPSFLQLREQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 78/297 (26%), Positives = 128/297 (43%), Gaps = 49/297 (16%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE 688
++++ +G G G V+ N ++AVK + P S + L
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-------MSPESFLE-------- 50
Query: 689 YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA 748
E + +RH +V+LY ++ SE+ +V EY+ GSL D L +
Sbjct: 51 ---EAQIMKKLRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVD 106
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+A A G+ Y+ IHRD++S+NIL+ +IADFGLA++++ E
Sbjct: 107 MAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE------- 156
Query: 809 IAGTHG------YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862
G + APE A + KSDV+SFG++L ELVT R VP
Sbjct: 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR--VP----------- 203
Query: 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
Y M++R+ + V ++ + + + + C K P RP+ + LE+
Sbjct: 204 -YPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 83/312 (26%), Positives = 131/312 (41%), Gaps = 62/312 (19%)
Query: 622 FSEKEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILS 680
F+ +++ D IG+G G V K++ SG +AVK I RS +
Sbjct: 1 FTAEDLKD----LGEIGRGAFGTVNKMLHKPSGTIMAVKRI-----------RS---TVD 42
Query: 681 KRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSL---WDRLHTCH 737
++ + D +V + + +VK Y ++ E + E L + SL + ++
Sbjct: 43 EKEQKRLLMDLDV-VMRSSDCPYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEVL 100
Query: 738 KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
K + + IAV K L YL + +IHRDVK SNILLD ++ DFG+
Sbjct: 101 KSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGI---- 154
Query: 798 QTGEAGDLTHVIAGTHG-----YIAPEYAYTCKINE---KSDVYSFGVVLMELVTGKRPI 849
+G L IA T Y+APE + +SDV+S G+ L E+ TGK P
Sbjct: 155 ----SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP- 209
Query: 850 VPEFGDSKDIVNWVYSKMDSR-DSMLTVV--DPNI--SEILKEDALKVLRIAIHCTNKLP 904
Y K +S D + VV DP I + +E + + C K
Sbjct: 210 --------------YPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDE 255
Query: 905 AFRPSMRVVVQM 916
+ RP + +++
Sbjct: 256 SKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG+G SG VY + + +G+E+A+K + L ++ + + E+
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM----------------NLQQQPKKELIIN-EILV 69
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL-HTCHKIEMDWVVRYAIAVGAA 754
+ +H N+V S D +V EYL GSL D + TC MD A+
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECL 125
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
+ LE+LH VIHRD+KS NILL ++ ++ DFG + ++ T V GT
Sbjct: 126 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPY 180
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
++APE K D++S G++ +E+V G+ P + E
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 54/172 (31%), Positives = 79/172 (45%), Gaps = 14/172 (8%)
Query: 683 SSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMD 742
S ++ E A + ++ H N+++LY + ++V E P GSL DRL
Sbjct: 37 SDIMDDFLKEAAIMHSLDHENLIRLY-GVVLTHPLMMVTELAPLGSLLDRLRKDALGHFL 95
Query: 743 WVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA 802
AV A G+ YL + IHRD+ + NILL + K +I DFGL + + E
Sbjct: 96 ISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE- 151
Query: 803 GDLTHVIAGTH-----GYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
H + H + APE T + SDV+ FGV L E+ T G+ P
Sbjct: 152 ---DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
L+G+G G VY +++G+ELA K + + D S + S S + E+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQV-------QFDPESP-----ETSKEVSALECEIQ 56
Query: 695 TLSAVRHVNVVKLY-CSITSEDSNLLVY-EYLPNGSLWDRLHTCHKIEMDWVVRYAIAVG 752
L ++H +V+ Y C + L ++ EY+P GS+ D+L + +Y +
Sbjct: 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI- 115
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT-GEAGDLTHVIAG 811
+G+ YLH ++HRD+K +NIL D ++ DFG +K +QT +G + G
Sbjct: 116 -LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 812 THGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
T +++PE K+DV+S G ++E++T K P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 59/220 (26%), Positives = 111/220 (50%), Gaps = 22/220 (10%)
Query: 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++GKG G VY + N G+ +AVK + + +S + +++ + EV
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQV---------ELDTSNVLAAEKEYE--KLQEEVD 54
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVY-EYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
L +++HVN+V+ Y +D+ + ++ E++P GS+ L+ + +Y +
Sbjct: 55 LLKSLKHVNIVQ-YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI-- 111
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK-IVQTGEAGDLTHVIAGT 812
G+ YLH + V+HRD+K +N++L ++ DFG A+ + G G ++++
Sbjct: 112 LDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168
Query: 813 HG---YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPI 849
HG ++APE KSD++S G + E+ TGK P+
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 11/171 (6%)
Query: 681 KRSSRSSEYDA--EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL-HTCH 737
R S DA E+ LS ++H N++ Y +++ L+ EY G+L+D++
Sbjct: 36 TRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG 95
Query: 738 KI-EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
++ E + V+ Y + +A + Y+H ++HRD+K+ NI L ++ DFG++KI
Sbjct: 96 QLFEEEMVLWYLFQIVSA--VSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI 150
Query: 797 VQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKR 847
+ + + T V GT Y++PE K N KSD+++ G VL EL+T KR
Sbjct: 151 LGSEYSMAETVV--GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 79/292 (27%), Positives = 129/292 (44%), Gaps = 47/292 (16%)
Query: 631 VKPENL-----IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSR 685
++ E+L +G G G+V KV KHI P+ + + I +K S R
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKV----------KHI-PTGTVMA---KKVVHIGAKSSVR 47
Query: 686 SSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVV 745
+ E+ + R +V Y + +E++ + E++ GSL I ++ +
Sbjct: 48 K-QILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG 106
Query: 746 RYAIAVGAAKGLEYL---HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA 802
+ IAV +GL YL H ++HRD+K SNIL++ + ++ DFG++
Sbjct: 107 K--IAVAVVEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVS-------- 151
Query: 803 GDLTHVIA----GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858
G+L + IA GT Y++PE K KSDV+S G+ ++EL GK P F S
Sbjct: 152 GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP----FAFSNI 207
Query: 859 IVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIH-CTNKLPAFRPS 909
+ M D + +V + D + LR + C K P RP+
Sbjct: 208 DDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 72/289 (24%), Positives = 136/289 (47%), Gaps = 53/289 (18%)
Query: 637 IGKGGSGNVYKVVLNS-GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+GKG G V V + GK+ +K + N+ S+R +++E +A++
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-------------SRRERKAAEQEAQL-- 52
Query: 696 LSAVRHVNVVKLYCSITSEDSNL-LVYEYLPNGSLWDRLHTCHKIE-------MDWVVRY 747
LS ++H N+V S ED L +V + G L+ +L K + ++W V+
Sbjct: 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE-QKGKLLPENQVVEWFVQI 111
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
A+A L+YLH ++ ++HRD+K+ N+ L ++ D G+A++++ D+
Sbjct: 112 AMA------LQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMAS 160
Query: 808 VIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867
+ GT Y++PE N KSDV++ G + E+ T K ++KD+ + VY +
Sbjct: 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF-----NAKDMNSLVYRII 215
Query: 868 DSR-DSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
+ + M P + E++ +K P RPS++ +++
Sbjct: 216 EGKLPPMPKDYSPELGELIAT-----------MLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 8e-17
Identities = 69/237 (29%), Positives = 109/237 (45%), Gaps = 43/237 (18%)
Query: 620 LSFSEKEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAI 678
S SE E + N IG G G VYKV+ +G+ A+K I+ G++ +
Sbjct: 71 KSLSELERV------NRIGSGAGGTVYKVIHRPTGRLYALKVIY-------GNHEDTVRR 117
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK 738
R E+ L V H NVVK + ++ E++ GSL H +
Sbjct: 118 QICR---------EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT-HIADE 167
Query: 739 IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV- 797
+ V R ++ G+ YLH R ++HRD+K SN+L++ +IADFG+++I+
Sbjct: 168 QFLADVARQILS-----GIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219
Query: 798 QTGEAGDLTHVIAGTHGYIAPEYAYTCKINE------KSDVYSFGVVLMELVTGKRP 848
QT D + GT Y++PE T +N D++S GV ++E G+ P
Sbjct: 220 QT---MDPCNSSVGTIAYMSPERINT-DLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 49/159 (30%), Positives = 87/159 (54%), Gaps = 11/159 (6%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT-CHK-IEMDWVVRYAI 749
E L + H N+++ Y + + + ++V EY P G+L + + C+ ++ D ++ + +
Sbjct: 49 ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP-RIADFGLAKIVQTGEAGDLTHV 808
+ L LHH + ++HRD+K+ NILLD +I DFG++KI+ + +
Sbjct: 109 QI-----LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YT 160
Query: 809 IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKR 847
+ GT YI+PE N+KSD+++ G VL EL + KR
Sbjct: 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 49/228 (21%)
Query: 636 LIGKGGSGNVYKVVLNS-GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA--E 692
+GKG G+VYKV S + A+K + D S S+ DA E
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEV---------DLGSM--------SQKEREDAVNE 49
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLL--VYEYLPNGSLWDRLHTCHK----IEMDWVVR 746
+ L++V H N++ + D N L V EY P G L + K I + R
Sbjct: 50 IRILASVNHPNIISYKEA--FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR 107
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
I + +GL+ LH ++ ++HRD+KS+NILL +I D G++K++ ++
Sbjct: 108 IFIQL--LRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMA 158
Query: 807 HVIAGTHGYIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT Y+APE Y+Y D++S G +L E+ T P
Sbjct: 159 KTQIGTPHYMAPEVWKGRPYSYKS------DIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 35/239 (14%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE 688
+ +K +G G G V+ N ++A+K L + S
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKS------------------LKQGSMSPEA 47
Query: 689 YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA 748
+ AE + ++H +V+LY +T E ++ EY+ NGSL D L T I++
Sbjct: 48 FLAEANLMKQLQHPRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+A A+G+ ++ + IHRD++++NIL+ +IADFGLA++++ E
Sbjct: 107 MAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE------- 156
Query: 809 IAGTHG------YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861
G + APE KSDV+SFG++L E+VT R P + + I N
Sbjct: 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN 215
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 636 LIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IGKG G+VYK VL E+AVK RS+ KR ++ E
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTC-----------RSTLPPDLKR-----KFLQEAEI 45
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
L H N+VKL + +V E +P GSL L K + +++ AA
Sbjct: 46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK-KKNRLTVKKLLQMSLDAAA 104
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH-- 813
G+EYL + IHRD+ + N L+ +I+DFG+++ E G + V G
Sbjct: 105 GMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQI 157
Query: 814 --GYIAPEYAYTCKINEKSDVYSFGVVLMELVTG 845
+ APE + +SDV+S+G++L E +
Sbjct: 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-16
Identities = 45/118 (38%), Positives = 60/118 (50%), Gaps = 20/118 (16%)
Query: 435 GQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPS 494
G IP DI KL+ L S+ L N G +P S+GS SL ++ + NS +G IP+SLG L S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 495 LNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGLC 552
L LNL+ N SG +P +L L+ +F +FT N GLC
Sbjct: 492 LRILNLNGNSLSGRVPAALG------------------GRLLHRASF--NFTDNAGLC 529
|
Length = 623 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG+G G VYK +G+ +A+K I F + TA+ E+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKL---RFESEGIPKTAL------------REIKL 51
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
L + H N++KL + LV+E++ + L+ + + + +++ +
Sbjct: 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKS-YLYQLLQ 109
Query: 756 GLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
GL + H HG ++HRD+K N+L++ E ++ADFGLA+ + TH + T
Sbjct: 110 GLAFCHSHG----ILHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVV-TRW 163
Query: 815 YIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
Y APE K + D++S G + EL++ RP+ P G S
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSR-RPLFP--GKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 24/221 (10%)
Query: 636 LIGKGGSGNVYKVVL----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA 691
++GKGG G V++V ++GK A+K + + +T + +++ + ++ A
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVL-----------KKATIVRNQKDTAHTK--A 49
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
E L AV+H +V L + + L+ EYL G L+ L D Y +
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
A LE+LH + +I+RD+K NILLD + ++ DFGL K ++ G +TH G
Sbjct: 110 SLA--LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCG 162
Query: 812 THGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
T Y+APE + D +S G ++ +++TG P E
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 12/158 (7%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNL-LVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
E L V H +++L+ + + L ++ EY+P G L+ L + + YA
Sbjct: 51 EKRVLKEVSHPFIIRLFWT-EHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ A LEYLH + +++RD+K NILLD E ++ DFG AK + D T +
Sbjct: 110 IVCA--LEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLC 159
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT Y+APE + N+ D ++ G+++ E++ G P
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 4e-16
Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 45/230 (19%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+GKG G V+K + + + +A+K I+ +R++T ++R+ R E+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIF-------DAFRNATD--AQRTFR------EIMF 59
Query: 696 LSAVR-HVNVVKLYCSITSE-DSNL-LVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIA 750
L + H N+VKL I +E D ++ LV+EY+ D LH I D RY I
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET----D-LHAVIRANILEDVHKRY-IM 113
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG----DLT 806
K L+Y+H G VIHRD+K SNILL+ + + ++ADFGLA+ + E LT
Sbjct: 114 YQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
Query: 807 HVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
+A T Y APE YT + D++S G +L E++ GK P+ P
Sbjct: 171 DYVA-TRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK-PLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 55/177 (31%), Positives = 82/177 (46%), Gaps = 19/177 (10%)
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWD------- 731
L K SS + E L+ ++H N+V S ++ +V EY G L
Sbjct: 35 LPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRG 94
Query: 732 RLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791
+L I + W V+ + V H ++ V+HRD+KS NI L K ++ DF
Sbjct: 95 KLFPEDTI-LQWFVQMCLGV---------QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDF 144
Query: 792 GLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
G A+++ + A T+V GT Y+ PE N KSD++S G +L EL T K P
Sbjct: 145 GSARLLTSPGAYACTYV--GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 6e-16
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG+G SG V+ + + +G+E+A+K I L K+ + + E+
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI----------------NLQKQPKKELIIN-EILV 69
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL-HTCHKIEMDWVVRYAIAVGAA 754
+ +++ N+V S D +V EYL GSL D + TC MD A+
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC----MDEAQIAAVCRECL 125
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
+ LE+LH VIHRD+KS N+LL ++ ++ DFG + ++ T V GT
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPY 180
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
++APE K D++S G++ +E+V G+ P + E
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 7e-16
Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 39/231 (16%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE 688
++++ E +G+G G V+ N +A+K + P S A L
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-------MSPEAFLQ-------- 50
Query: 689 YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL--HTCHKIEMDWVVR 746
E + +RH +V+LY ++ SE+ +V EY+ GSL D L + + +V
Sbjct: 51 ---EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 106
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
A + A G+ Y+ +HRD++++NIL+ ++ADFGLA++++ E
Sbjct: 107 MAAQI--ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE----- 156
Query: 807 HVIAGTHG------YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
G + APE A + KSDV+SFG++L EL T R P
Sbjct: 157 --YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 63/229 (27%), Positives = 110/229 (48%), Gaps = 39/229 (17%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE 688
+++K +G G G V+ N+ ++AVK + P S A L
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-------MSVQAFLE-------- 50
Query: 689 YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--KIEMDWVVR 746
E + ++H +V+LY +T E+ ++ EY+ GSL D L + K+ + ++
Sbjct: 51 ---EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID 107
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
++ + A+G+ Y+ + IHRD++++N+L+ +IADFGLA++++ E
Sbjct: 108 FSAQI--AEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----- 157
Query: 807 HVIAGTHG------YIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
G + APE KSDV+SFG++L E+VT GK P
Sbjct: 158 --YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 8e-16
Identities = 65/239 (27%), Positives = 109/239 (45%), Gaps = 43/239 (17%)
Query: 632 KPENLIGKGGSGNVYK-VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+ +G+G VYK +G+ +A+K I D + TA+ R
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL------R----- 51
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNL-LVYEYLPNGSLWDRLHTCHKIEMDWVVRY-- 747
E+ L ++H N++ L + SN+ LV+E++ D K+ D +
Sbjct: 52 -EIKLLQELKHPNIIGLL-DVFGHKSNINLVFEFME----TD----LEKVIKDKSIVLTP 101
Query: 748 ----AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG 803
+ + +GLEYLH + ++HRD+K +N+L+ + ++ADFGLA+ G
Sbjct: 102 ADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPN 156
Query: 804 D-LTH-VIAGTHGYIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859
+TH V+ T Y APE + + D++S G + EL+ P +P GDS DI
Sbjct: 157 RKMTHQVV--TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLP--GDS-DI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 9e-16
Identities = 51/152 (33%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 698 AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGL 757
A +H + L+C ++D V EY+ G L ++ K + YA V A L
Sbjct: 52 AAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--L 109
Query: 758 EYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYI 816
+LH HG VI+RD+K NILLD E ++ADFG+ K G T GT YI
Sbjct: 110 MFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTTTFCGTPDYI 163
Query: 817 APEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
APE + D ++ GV++ E++ G+ P
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-15
Identities = 51/182 (28%), Positives = 90/182 (49%), Gaps = 19/182 (10%)
Query: 760 LHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE 819
+HH + +IHRD+KS+NILL ++ DFG +K+ + D+ GT Y+APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 820 YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDP 879
++K+D++S GV+L EL+T KRP D +++ ++ + R DP
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPF-----DGENMEEVMHKTLAGR------YDP 264
Query: 880 NISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKVGESSPS 939
I E ++ + A+ ++ P RPS ++ M C + + ++ ++ P
Sbjct: 265 LPPSISPE--MQEIVTALLSSD--PKRRPSSSKLLNM----PICKLFISGLLEIVQTQPG 316
Query: 940 FS 941
FS
Sbjct: 317 FS 318
|
Length = 496 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
L+G+G G VY ++G+ELAVK + + D S + S + + E+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQV-------QFDPESP-----ETSKEVNALECEIQ 56
Query: 695 TLSAVRHVNVVKLY-CSITSEDSNLLVY-EYLPNGSLWDRLHTCHKIEMDWVVRYAIAVG 752
L + H +V+ Y C + L ++ E++P GS+ D+L + + + +Y +
Sbjct: 57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI- 115
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT-GEAGDLTHVIAG 811
+G+ YLH ++HRD+K +NIL D ++ DFG +K +QT +G + G
Sbjct: 116 -LEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 812 THGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
T +++PE K+D++S G ++E++T K P
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 49/170 (28%), Positives = 86/170 (50%), Gaps = 22/170 (12%)
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT--------CHKI 739
++ EV L +RH +++ L+ + + ++ E + GSL L + I
Sbjct: 48 DFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLI 107
Query: 740 EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT 799
+M V A+G+ YL ++ IHRD+ + NIL+ + ++ADFGLA++++
Sbjct: 108 DMACQV--------AEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIK- 155
Query: 800 GEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
E L+ + + APE A + KSDV+SFG++L E+ T G+ P
Sbjct: 156 -EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 52/238 (21%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE--YDAEVA 694
+G+G G V+ + K + + L + +S + ++ E
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKEL------------VAVKTLKETASNDARKDFEREAE 60
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWD--RLHTCH--------------- 737
L+ +H N+VK Y T D ++V+EY+ +G L R H
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 738 KIEMDWVVRYAIAVGAAKGLEYL--HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795
++ IAV A G+ YL H +HRD+ + N L+ + +I DFG+++
Sbjct: 121 LSQLLQ-----IAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR 170
Query: 796 IVQTGEAGDLTHVIAGTH----GYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
V T + + + G ++ PE K +SDV+SFGVVL E+ T GK+P
Sbjct: 171 DVYTTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 63/230 (27%), Positives = 94/230 (40%), Gaps = 42/230 (18%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
+IG+G G VYK +G+ +A+K I+ E E
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK------------------IMDIIEDEEEEIKEEYN 54
Query: 695 TLSAV-RHVNVVKLY-CSITSEDSNL-----LVYEYLPNGSLWD---RLHTCHK-IEMDW 743
L H N+ Y I LV E GS+ D L K ++ +W
Sbjct: 55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW 114
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG 803
+ Y I +GL YLH + VIHRD+K NILL + ++ DFG++ + +
Sbjct: 115 IA-Y-ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169
Query: 804 DLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
T + GT ++APE + +SDV+S G+ +EL GK P
Sbjct: 170 RNTFI--GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 35/230 (15%)
Query: 628 IDAVKPENLIGKGGSGNVYKV-VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS 686
++ ++ IG G G VYK+ +G +AVK + R+ +KR
Sbjct: 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM----------RRTGNKEENKRILM- 62
Query: 687 SEYDAEVATLSAVRHV--NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWV 744
D +V S H +VK Y ++ + E + + D+L + +
Sbjct: 63 ---DLDVVLKS---HDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPED 114
Query: 745 VRYAIAVGAAKGLEYL--HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA 802
+ + V K L YL HG VIHRDVK SNILLD ++ DFG++ + +A
Sbjct: 115 ILGKMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170
Query: 803 GDLTHVIAGTHGYIAPEYAYTCKINEK----SDVYSFGVVLMELVTGKRP 848
+ AG Y+APE N K +DV+S G+ L+EL TG+ P
Sbjct: 171 KTRS---AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 61/230 (26%), Positives = 109/230 (47%), Gaps = 38/230 (16%)
Query: 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGF----RGDYRSSTAILSKRSSR 685
+ + +IG G G V++ +L G++ I G+ R D+ S +I+ + S
Sbjct: 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-- 64
Query: 686 SSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVV 745
H N+++L +T +++ EY+ NG+L D+ H E
Sbjct: 65 ---------------HHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQ 108
Query: 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
+ G A G++YL D +HRD+ + NIL++ + +++DFGL+++++ G
Sbjct: 109 LVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY 165
Query: 806 THVIAGTHG------YIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
T T G + APE K SDV+SFG+V+ E+++ G+RP
Sbjct: 166 T-----TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 77/293 (26%), Positives = 130/293 (44%), Gaps = 52/293 (17%)
Query: 633 PENL------IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSR 685
PE L IGKG G V+K + N + K +A+K I L +
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII----------------DLEEAEDE 45
Query: 686 SSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT--CHKIEMDW 743
+ E+ LS V K Y S + ++ EYL GS D L + ++
Sbjct: 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT 105
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG 803
++R + KGL+YLH IHRD+K++N+LL + ++ADFG+A Q +
Sbjct: 106 ILREIL-----KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQ 155
Query: 804 DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863
+ GT ++APE + K+D++S G+ +EL G+ P
Sbjct: 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP--------------- 200
Query: 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIH-CTNKLPAFRPSMRVVVQ 915
+S++ +L ++ N L+ + K L+ + C NK P+FRP+ + +++
Sbjct: 201 HSELHPM-KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 7e-15
Identities = 47/145 (32%), Positives = 72/145 (49%), Gaps = 7/145 (4%)
Query: 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG 763
+ +L+ + D V EY+ G L + K + V YA + A GL +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI--AIGLFFLH-- 118
Query: 764 FDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT 823
+ +I+RD+K N++LD E +IADFG+ K + G T GT YIAPE
Sbjct: 119 -SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIAY 175
Query: 824 CKINEKSDVYSFGVVLMELVTGKRP 848
+ D ++FGV+L E++ G+ P
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 636 LIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
LIG+G G VY+ +G+ +A+K I N L S+ EVA
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKII---N-------------LDTPDDDVSDIQREVA 51
Query: 695 TLSAVRHV---NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW---VVRYA 748
LS +R N+ K Y S ++ EY GS+ L I + ++R
Sbjct: 52 LLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREV 110
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+ L+Y+H VIHRD+K++NIL+ ++ DFG+A ++ + T V
Sbjct: 111 LV-----ALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV 162
Query: 809 IAGTHGYIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRP 848
GT ++APE K + K+D++S G+ + E+ TG P
Sbjct: 163 --GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 54/166 (32%), Positives = 79/166 (47%), Gaps = 30/166 (18%)
Query: 701 HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYL 760
+ N +KLY S+T+ ++L+ +Y+ +G L+D L K+ V + + + L L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQL--VEALNDL 125
Query: 761 H-HGFDRPVIHRDVKSSNILLDLEWKPRI--ADFGLAKIVQTGEAGDLTHVIAGTHGYIA 817
H H IH D+K N+L D K RI D+GL KI+ T D GT Y +
Sbjct: 126 HKHNI----IHNDIKLENVLYD-RAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174
Query: 818 PEYAYTCKINEKSDVYSF-----GVVLMELVTGKRPIVPEFGDSKD 858
PE KI + SF GV+ EL+TGK P F + +D
Sbjct: 175 PE-----KIKGHNYDVSFDWWAVGVLTYELLTGKHP----FKEDED 211
|
Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 72/223 (32%), Positives = 106/223 (47%), Gaps = 31/223 (13%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
N IG+G G VY+ SG+ +A+K + N R I S R E+
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE------RDGIPISSLR---------EI 57
Query: 694 ATLSAVRHVNVVKLYCSITSE--DSNLLVYEYLPN--GSLWDRLHTCHKIEMDWVVRYAI 749
L +RH N+V+L + + DS LV EY SL D + T V+ +
Sbjct: 58 TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ---VK-CL 113
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
+ +GL+YLH F +IHRD+K SN+LL + +IADFGLA+ A +T +
Sbjct: 114 MLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL-PAKPMTPKV 169
Query: 810 AGTHGYIAPEYAYTCKINEKS-DVYSFGVVLMELVTGKRPIVP 851
T Y APE C + D+++ G +L EL+ K P++P
Sbjct: 170 V-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK-PLLP 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 637 IGKGGSGNV-YKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG+G +G V ++G+++AVK + D L K+ R ++ EV
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVK---------KMD-------LRKQQRRELLFN-EVVI 69
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
+ +H N+V++Y S D +V E+L G+L D + T ++ + + + + K
Sbjct: 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIA--TVCLAVLK 126
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
L +LH + VIHRD+KS +ILL + + +++DFG Q + + GT +
Sbjct: 127 ALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYW 181
Query: 816 IAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+APE + D++S G++++E+V G+ P
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 636 LIGKGGSGNVYKV-VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++G+G G V K +G+ +A+K F+ + K + R EV
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIK-------KFKESE--DDEDVKKTALR------EVK 52
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK-IEMDWVVRYAIAVGA 753
L +RH N+V L + + LV+EY+ +L + L + D V Y +
Sbjct: 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL-- 109
Query: 754 AKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGT 812
+ + Y H H +IHRD+K NIL+ ++ DFG A+ ++ A LT +A T
Sbjct: 110 LQAIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-T 164
Query: 813 HGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
Y APE Y + DV++ G ++ EL+ G P+ P GDS
Sbjct: 165 RWYRAPELLVGDTNYGKPV----DVWAIGCIMAELLDG-EPLFP--GDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 35/220 (15%)
Query: 637 IGKGGSGNVYKV-VLNSGKELAVKHIWPSNSGFRGDYRSS---TAILSKRSSRSSEYDAE 692
+GKGG G V V +GK A K + R + + IL K SSR
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF------ 54
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK----IEMDWVVRYA 748
+V L + ++D LV + G L + H + + YA
Sbjct: 55 -----------IVSLAYAFETKDDLCLVMTLMNGGDL--KYHIYNVGEPGFPEARAIFYA 101
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+ GLE+LH R +++RD+K N+LLD RI+D GLA ++ G+
Sbjct: 102 AQI--ICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKG 153
Query: 809 IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
AGT GY+APE + D ++ G L E++ G+ P
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 43/117 (36%), Positives = 58/117 (49%), Gaps = 35/117 (29%)
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG--------LAKIVQTG 800
IAV K LEYLH VIHRDVK SN+L++ + ++ DFG +AK +
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID-- 163
Query: 801 EAGDLTHVIAGTHGYIAPEYAYTCKINE---------KSDVYSFGVVLMELVTGKRP 848
AG Y+APE +IN KSDV+S G+ ++EL TG+ P
Sbjct: 164 ---------AGCKPYMAPE-----RINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-14
Identities = 43/176 (24%), Positives = 81/176 (46%), Gaps = 14/176 (7%)
Query: 681 KRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLL-VYEYLPNGSLWDRLHTCHKI 739
+ + + + E A + + H N+V L S + L V+EY+P +L + L +
Sbjct: 17 EEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGAL 76
Query: 740 EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL---DLEWKPRIADFGLAKI 796
R + V L+ L ++ ++HRD+K NI++ + ++ DFG+ +
Sbjct: 77 PAGETGRLMLQV-----LDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTL 131
Query: 797 VQTGEAGD-----LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKR 847
+ D T + GT Y APE + SD+Y++G++ +E +TG+R
Sbjct: 132 LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 39/231 (16%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE 688
+++K E +G G G V+ N ++AVK + P + S A L+
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-------MSVEAFLA-------- 50
Query: 689 YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT--CHKIEMDWVVR 746
E + ++H +VKL+ +T E ++ E++ GSL D L + K + ++
Sbjct: 51 ---EANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLID 106
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
++ + A+G+ ++ R IHRD++++NIL+ +IADFGLA++++ E
Sbjct: 107 FSAQI--AEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----- 156
Query: 807 HVIAGTHG------YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
G + APE KSDV+SFG++LME+VT R P
Sbjct: 157 --YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 205
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 10/162 (6%)
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
E + L + H +V + CS E+ + E++ G L+ L + D Y
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE 126
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ A EYLH + +I+RD+K N+LLD + ++ DFG AK V D T +
Sbjct: 127 LVLA--FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-----DRTFTLC 176
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
GT Y+APE + + D ++ GV+L E + G P +
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218
|
Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 49/158 (31%), Positives = 74/158 (46%), Gaps = 7/158 (4%)
Query: 698 AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGL 757
A H + +LYC + D V E++ G L + + + YA + +A L
Sbjct: 52 ARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--L 109
Query: 758 EYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIA 817
+LH D+ +I+RD+K N+LLD E ++ADFG+ K + G T GT YIA
Sbjct: 110 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIA 164
Query: 818 PEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855
PE D ++ GV+L E++ G P E D
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 58/190 (30%), Positives = 91/190 (47%), Gaps = 20/190 (10%)
Query: 669 RGDYRSS--TAILSKRSSRSSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYL 724
G +R AI R SE D E + + H N+V+LY T + +V EY+
Sbjct: 22 LGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81
Query: 725 PNGSLWDRLHTC-HKIEMDWVVRYAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDL 782
NG L + L K+ +W++ V + +EYL +GF IHRD+ + N L+
Sbjct: 82 ANGCLLNYLRERKGKLGTEWLLDMCSDV--CEAMEYLESNGF----IHRDLAARNCLVGE 135
Query: 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYI---APEYAYTCKINEKSDVYSFGVVL 839
+ +++DFGLA+ V + GT + PE + + KSDV+SFGV++
Sbjct: 136 DNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLM 191
Query: 840 MELVT-GKRP 848
E+ + GK P
Sbjct: 192 WEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/229 (27%), Positives = 103/229 (44%), Gaps = 35/229 (15%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE 688
++++ + +G+G G V+ N ++A+K + P A L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-------MMPEAFLQ-------- 50
Query: 689 YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA 748
E + +RH +V LY ++ SE+ +V E++ GSL D L +
Sbjct: 51 ---EAQIMKKLRHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD 106
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+A A G+ Y+ IHRD++++NIL+ +IADFGLA++++ E
Sbjct: 107 MAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE------- 156
Query: 809 IAGTHG------YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
G + APE A + KSDV+SFG++L ELVT R P
Sbjct: 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 637 IGKGGSGNV-YKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG+G +G V V +SGK +AVK + D R K+ R ++ EV
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM---------DLR-------KQQRRELLFN-EVVI 70
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL-HTCHKIEMDWVVRYAIAVGAA 754
+ +H NVV++Y S D +V E+L G+L D + HT M+ A+ +
Sbjct: 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVL 126
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
K L LH + VIHRD+KS +ILL + + +++DFG Q + + GT
Sbjct: 127 KALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPY 181
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
++APE + D++S G++++E+V G+ P E
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL 696
+G G G VYK A I I + ++ E+ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKI----------------IQIESEEELEDFMVEIDIL 56
Query: 697 SAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKG 756
S +H N+V LY + E+ ++ E+ G+L + + + +RY + +
Sbjct: 57 SECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEA 115
Query: 757 LEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL-AKIVQTGEAGDLTHVIAGTHGY 815
L +LH VIHRD+K+ NILL L+ ++ADFG+ AK T + GT +
Sbjct: 116 LNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK---RDTFIGTPYW 169
Query: 816 IAPEYAYTCKI------NEKSDVYSFGVVLMELVTGKRP 848
+APE C+ + K+D++S G+ L+EL + P
Sbjct: 170 MAPE-VVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 70/224 (31%), Positives = 108/224 (48%), Gaps = 32/224 (14%)
Query: 675 STAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSI---TSEDSNLLVYEYLPNGSLWD 731
ST +L+KR+ R E+ L +RH N++ L I ED V E L G+
Sbjct: 48 STPVLAKRTYR------ELKLLKHLRHENIISL-SDIFISPLEDI-YFVTELL--GTDLH 97
Query: 732 RLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791
RL T +E ++ + + +GL+Y+H V+HRD+K SNIL++ +I DF
Sbjct: 98 RLLTSRPLEKQFIQYFLYQI--LRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDF 152
Query: 792 GLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIV 850
GLA+I G ++ T Y APE T K + + D++S G + E++ GK P+
Sbjct: 153 GLARIQDPQMTGYVS-----TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK-PLF 206
Query: 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLR 894
P KD VN D + T D I+ I E+ L+ ++
Sbjct: 207 P----GKDHVNQFSIIT---DLLGTPPDDVINTICSENTLRFVQ 243
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 72/233 (30%), Positives = 111/233 (47%), Gaps = 46/233 (19%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRS----STAILSKRSSRSSEYDA 691
IG+G G VYK +G+ +A+K I R D + STAI
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAI------------R 48
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK--IEMDWVVRYAI 749
E++ L + H N+VKL I +E+ LV+E+L + L + I + + Y
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLF 107
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI----VQTGEAGDL 805
+ +GL + H V+HRD+K N+L++ E ++ADFGLA+ V+T
Sbjct: 108 QL--LQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-----Y 157
Query: 806 THVIAGTHGYIAPEYAYTCKINEKS-DVYSFGVVLMELVTGKRPIVPEFGDSK 857
TH + T Y APE CK + D++S G + E+VT +R + P GDS+
Sbjct: 158 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFP--GDSE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG+G SG VY + + +G+E+A+K + ++ + E+
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-----------------NLQQQPKKELIINEILV 69
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL-HTCHKIEMDWVVRYAIAVGAA 754
+ ++ N+V S D +V EYL GSL D + TC MD A+
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECL 125
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
+ L++LH VIHRD+KS NILL ++ ++ DFG + ++ T V GT
Sbjct: 126 QALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPY 180
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
++APE K D++S G++ +E+V G+ P + E
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 78/291 (26%), Positives = 123/291 (42%), Gaps = 48/291 (16%)
Query: 633 PENL------IGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSR 685
PE L IGKG G VYK + N KE+ A+K I L +
Sbjct: 2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKII----------------DLEEAEDE 45
Query: 686 SSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVV 745
+ E+ LS + + Y S ++ EYL GS D L +E ++
Sbjct: 46 IEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIA 104
Query: 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
I KGL+YLH IHRD+K++N+LL + ++ADFG+A + +
Sbjct: 105 --TILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159
Query: 806 THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865
T V GT ++APE + K+D++S G+ +EL G+ P S
Sbjct: 160 TFV--GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP---------------NS 202
Query: 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIH-CTNKLPAFRPSMRVVVQ 915
+ +L ++ N L+ K + + C NK P FRP+ + +++
Sbjct: 203 DLHPM-RVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-14
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW------V 744
+E+ L+A H +VK + S+D LL+ EY G L ++ K + + +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 745 VRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGD 804
+ Y I + L+ +H R ++HRD+KS+NI L ++ DFG +K + D
Sbjct: 174 LFYQIVLA----LDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226
Query: 805 LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV- 863
+ GT Y+APE + ++K+D++S GV+L EL+T RP + ++I+ V
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF--KGPSQREIMQQVL 284
Query: 864 YSKMDS-----RDSMLTVVDPNISE 883
Y K D M ++DP +S+
Sbjct: 285 YGKYDPFPCPVSSGMKALLDPLLSK 309
|
Length = 478 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 637 IGKGGSGNV-YKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG+G +G V ++GK++AVK + D R K+ R ++ EV
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM---------DLR-------KQQRRELLFN-EVVI 72
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL-HTCHKIEMDWVVRYAIAVGAA 754
+ H NVV +Y S D +V E+L G+L D + HT M+ + +
Sbjct: 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLSVL 128
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
+ L YLH ++ VIHRD+KS +ILL + + +++DFG Q + + GT
Sbjct: 129 RALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPY 183
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
++APE + D++S G++++E++ G+ P E
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDR 766
LYC+ +++ V E+L G L + + ++ YA + GL++LH +
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQFLH---SK 115
Query: 767 PVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKI 826
+I+RD+K N++LD + +IADFG+ K G+ T GT YIAPE K
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKY 173
Query: 827 NEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858
D +SFGV+L E++ G+ P GD +D
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPF---HGDDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 70/262 (26%), Positives = 102/262 (38%), Gaps = 62/262 (23%)
Query: 632 KPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS----SRS 686
K L+GKG G V+ V L +GK A+K +L K+ ++
Sbjct: 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALK------------------VLDKKEMIKRNKV 45
Query: 687 SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT-CHKIEMDWVV 745
E L+ + H + LY S +E LV +Y P G L+ L K + V
Sbjct: 46 KRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVA 105
Query: 746 R-YAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK-------- 795
R YA V A LEYLH G ++RD+K NILL ++DF L+K
Sbjct: 106 RFYAAEVLLA--LEYLHLLGI----VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159
Query: 796 ---IVQTGEAGDLTHVIA----------------GTHGYIAPEYAYTCKINEKSDVYSFG 836
++ G + I GT YIAPE D ++ G
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLG 219
Query: 837 VVLMELVTGKRPIVPEFGDSKD 858
++L E++ G P G ++D
Sbjct: 220 ILLYEMLYGTTPF---KGSNRD 238
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-14
Identities = 42/109 (38%), Positives = 59/109 (54%), Gaps = 6/109 (5%)
Query: 18 WTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTI 77
W+ A+ C+F+ + + L Q L G +P + I L+ LQ INL N + G I
Sbjct: 404 WSGAD--CQFDSTK--GKWFIDGLGLDNQGLRGFIP-NDISKLRHLQSINLSGNSIRGNI 458
Query: 78 TEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFP 125
L S T L+VLDL NSF+G +P+ L L L LNLN + +SG+ P
Sbjct: 459 PPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 55/164 (33%), Positives = 81/164 (49%), Gaps = 28/164 (17%)
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR---YAIAV 751
T ++ RH +V L+ +ED V EY G L +HT ++ R YA V
Sbjct: 55 TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACV 110
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA---GDLTHV 808
GL+YLH + +++RD+K N+LLD E +IADFGL K E GD T
Sbjct: 111 --VLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTST 160
Query: 809 IAGTHGYIAPEY----AYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT ++APE +YT + D + GV++ E++ G+ P
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAV----DWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 80/296 (27%), Positives = 127/296 (42%), Gaps = 51/296 (17%)
Query: 635 NLIGKGGSGNVY--KVVLNSGKEL--AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+IGKG G VY ++ + G+++ AVK S I ++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVK--------------SLNRITDLEEV--EQFL 44
Query: 691 AEVATLSAVRHVNVVKLY-CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
E + H NV+ L + SE S L+V Y+ +G D + + V+ I
Sbjct: 45 KEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHG---DLRNFIRSETHNPTVKDLI 101
Query: 750 AVG--AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
G AKG+EYL + +HRD+ + N +LD + ++ADFGLA+ + E
Sbjct: 102 GFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE---YYS 155
Query: 808 VIAGTHG-----YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862
V T ++A E T K KSDV+SFGV+L EL+T P P+ DS DI +
Sbjct: 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVY 214
Query: 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918
+ + R + P+ + + + C + P RP+ +V +E
Sbjct: 215 L---LQGRRLLQPEYCPD----------PLYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 77/293 (26%), Positives = 119/293 (40%), Gaps = 52/293 (17%)
Query: 633 PENL------IGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSR 685
PE L IGKG G V+K + N +++ A+K I L +
Sbjct: 2 PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII----------------DLEEAEDE 45
Query: 686 SSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVV 745
+ E+ LS V K Y S ++ EYL GS D L E
Sbjct: 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDE----- 100
Query: 746 RYAIAVGAA---KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA 802
+ IA KGL+YLH IHRD+K++N+LL + ++ADFG+A + +
Sbjct: 101 -FQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156
Query: 803 GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862
T V GT ++APE + K+D++S G+ +EL G+ P
Sbjct: 157 KRNTFV--GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP-------------- 200
Query: 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
S M + + N + E + C NK P+FRP+ + +++
Sbjct: 201 -NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG+G SG VY + + +G+E+A++ + ++ + E+
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-----------------NLQQQPKKELIINEILV 70
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL-HTCHKIEMDWVVRYAIAVGAA 754
+ ++ N+V S D +V EYL GSL D + TC MD A+
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECL 126
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
+ LE+LH VIHRD+KS NILL ++ ++ DFG + T E + ++ GT
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMV-GTPY 181
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
++APE K D++S G++ +E++ G+ P + E
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 68/230 (29%), Positives = 107/230 (46%), Gaps = 42/230 (18%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRS----STAILSKRSSRSSEYDA 691
IG+G G VYK +G+ +A+K I R + STAI
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAI------------R 47
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
E++ L + H N+V+L + SE+ LV+E+L + L + + +D + +
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI----VQTGEAGDLTH 807
+G+ Y H V+HRD+K N+L+D E ++ADFGLA+ V+T TH
Sbjct: 107 QLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-----YTH 158
Query: 808 VIAGTHGYIAPEYAYTCKINEKS-DVYSFGVVLMELVTGKRPIVPEFGDS 856
+ T Y APE + D++S G + E+V +RP+ P GDS
Sbjct: 159 EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPLFP--GDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 16/187 (8%)
Query: 668 FRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNG 727
+RG Y + ++ + S E+ E + + H +V+LY T + +V EY+ NG
Sbjct: 25 WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84
Query: 728 SLWDRLH-TCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786
L + L + + ++ V +G+ YL + IHRD+ + N L+D +
Sbjct: 85 CLLNYLREHGKRFQPSQLLEMCKDV--CEGMAYLE---SKQFIHRDLAARNCLVDDQGCV 139
Query: 787 RIADFGLAKIV----QTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMEL 842
+++DFGL++ V T G V + PE K + KSDV++FGV++ E+
Sbjct: 140 KVSDFGLSRYVLDDEYTSSVGSKFPV-----RWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
Query: 843 VT-GKRP 848
+ GK P
Sbjct: 195 YSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 70/287 (24%), Positives = 126/287 (43%), Gaps = 64/287 (22%)
Query: 669 RGDYRSSTAILSKRSSRSSEYDA---EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLP 725
R Y + + K ++ SSE E L V H +V+KLY + + + LL+ EY
Sbjct: 27 RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 86
Query: 726 NGSLWDRLHTCHKIEMDWVVRY--------------AIAVG--------AAKGLEYLHHG 763
GSL L K+ ++ A+ +G ++G++YL
Sbjct: 87 YGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA-- 144
Query: 764 FDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG-----YIAP 818
+ ++HRD+ + N+L+ K +I+DFGL++ V ++ + + G ++A
Sbjct: 145 -EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS-----YVKRSKGRIPVKWMAI 198
Query: 819 EYAYTCKINEKSDVYSFGVVLMELVT-GKRP---IVPEFGDSKDIVNWVYS--KMDSRDS 872
E + +SDV+SFGV+L E+VT G P I PE + N + + +M+ +
Sbjct: 199 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-----RLFNLLKTGYRMERPE- 252
Query: 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
N SE ++ + + C + P RP+ + + LE+
Sbjct: 253 -------NCSE-------EMYNLMLTCWKQEPDKRPTFADISKELEK 285
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 637 IGKGGSGNV-YKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG+G +G V +SG+++AVK + D R K+ R ++ EV
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM---------DLR-------KQQRRELLFN-EVVI 71
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
+ +H NVV++Y S + ++ E+L G+L D + ++ + +
Sbjct: 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD---IVSQTRLNEEQIATVCESVLQ 128
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
L YLH + VIHRD+KS +ILL L+ + +++DFG Q + + GT +
Sbjct: 129 ALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYW 183
Query: 816 IAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
+APE + D++S G++++E+V G+ P F DS
Sbjct: 184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY---FSDS 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 1/103 (0%)
Query: 402 LLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPL 461
L L N G +P+ IS+ L SI LS N G IP +G + L L L N F+G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 462 PYSIGSCVSLTDINFAQNSLSGKIPDSLGSLP-SLNSLNLSNN 503
P S+G SL +N NSLSG++P +LG S N ++N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 3e-13
Identities = 61/193 (31%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 668 FRGDYRSSTAILSKRSSRSSEYDAE--------VATLSAVRHVNVVKLYCSITSEDSNLL 719
F D R++ + K+ S S + E V L ++H N ++ E + L
Sbjct: 43 FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102
Query: 720 VYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779
V EY GS D L HK + V AI GA +GL YLH +IHRD+K+ NIL
Sbjct: 103 VMEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNIL 157
Query: 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC---KINEKSDVYSFG 836
L + ++ADFG A I + GT ++APE + + K DV+S G
Sbjct: 158 LTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 211
Query: 837 VVLMELVTGKRPI 849
+ +EL K P+
Sbjct: 212 ITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 62/193 (32%), Positives = 86/193 (44%), Gaps = 22/193 (11%)
Query: 668 FRGDYRSSTAILSKRSSRSSEYD--------AEVATLSAVRHVNVVKLYCSITSEDSNLL 719
F D R+S + K+ S S + EV L +RH N ++ E + L
Sbjct: 33 FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92
Query: 720 VYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779
V EY GS D L HK + V A+ GA +GL YLH +IHRDVK+ NIL
Sbjct: 93 VMEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNIL 147
Query: 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC---KINEKSDVYSFG 836
L ++ DFG A I+ GT ++APE + + K DV+S G
Sbjct: 148 LSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 201
Query: 837 VVLMELVTGKRPI 849
+ +EL K P+
Sbjct: 202 ITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 22/182 (12%)
Query: 676 TAILSKRSSRSSEYD-AEVATLSAVRHVN-VVKLYCSITSEDSNLLVYEYLPNGSLWDRL 733
I+ K +++E+ E L AVR +V L+ + ++ L+ +Y+ G L+ L
Sbjct: 39 ATIVQKA--KTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHL 96
Query: 734 HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793
+ V Y + A L++LH +I+RD+K NILLD E + DFGL
Sbjct: 97 YQREHFTESEVRVYIAEIVLA--LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGL 151
Query: 794 AKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKS-------DVYSFGVVLMELVTGK 846
+K E + + GT Y+APE I S D +S GV+ EL+TG
Sbjct: 152 SKEFLAEE-EERAYSFCGTIEYMAPEV-----IRGGSGGHDKAVDWWSLGVLTFELLTGA 205
Query: 847 RP 848
P
Sbjct: 206 SP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 70/267 (26%), Positives = 106/267 (39%), Gaps = 69/267 (25%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
+IG+G G V+ V ++ A+K + R S I + ++ + AE
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVL-----------RKSDMI---KRNQIAHVRAERD 53
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA 754
L+ +VKLY S E+ LV EY+P G L + L + Y + A
Sbjct: 54 ILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 755 KGLEYLHH-GFDRPVIHRDVKSSNILLDLEWKPRIADFGLA-KIVQTGEAGDLT------ 806
L+ +H GF IHRD+K NIL+D + ++ADFGL K+ + +
Sbjct: 114 --LDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 807 --------------------HVIAGTHGYIAPE------YAYTCKINEKSDVYSFGVVLM 840
+ GT YIAPE Y C D +S GV+L
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC------DWWSLGVILY 221
Query: 841 ELVTGKRPIVPEFGDS-----KDIVNW 862
E++ G P + D+ I+NW
Sbjct: 222 EMLYG---FPPFYSDTLQETYNKIINW 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 16/168 (9%)
Query: 687 SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
E+ E + ++ + H +V+L + + +LV E P G L L +I + +
Sbjct: 41 KEFLREASVMAQLDHPCIVRLI-GVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE 99
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
A V A G+ YL + +HRD+ + N+LL + +I+DFG+++ + G
Sbjct: 100 LAHQV--AMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS----D 150
Query: 807 HVIAGTHG-----YIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ A T G + APE K + KSDV+S+GV L E + G +P
Sbjct: 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 12/169 (7%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
E+ L +V Y + S+ + E++ GSL L +I + + + +IAV
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGD-LTHVIA 810
+GL YL ++HRDVK SNIL++ + ++ DFG+ +G+ D + +
Sbjct: 113 --LRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 163
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859
GT Y++PE + +SD++S G+ L+EL G+ PI P D+K++
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP--DAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 62/291 (21%)
Query: 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+GKG G+VYKV+ +G +A+K I L S+ ++ E+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR----------------LELDESKFNQIIMELDI 52
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLH----TCHKIEMDWVVRYAIAV 751
L +V Y + E + + EY+ GSL D+L+ I D + R AV
Sbjct: 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAV 111
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA- 810
KGL++L + +IHRDVK +N+L++ + ++ DFG+ +G+L +A
Sbjct: 112 --VKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGV--------SGNLVASLAK 159
Query: 811 ---GTHGYIAPEYAYTCKINE------KSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861
G Y+APE + N+ +SDV+S G+ ++E+ G+ P PE +
Sbjct: 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----- 214
Query: 862 WVYSKMDSRDSMLTVVD---PNISEILKEDALKVLRIAIHCTNKLPAFRPS 909
+++++ + +VD P + +DA + C NK+P RP+
Sbjct: 215 -IFAQLSA------IVDGDPPTLPSGYSDDAQDFVAK---CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 57/162 (35%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
EV L +RH N ++ E + LV EY GS D L HK + V AI
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV-HKKPLQEVEIAAICH 122
Query: 752 GAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
GA +GL YLH H IHRD+K+ NILL ++ADFG A +V +
Sbjct: 123 GALQGLAYLHSHE----RIHRDIKAGNILLTEPGTVKLADFGSASLV------SPANSFV 172
Query: 811 GTHGYIAPEYAYTC---KINEKSDVYSFGVVLMELVTGKRPI 849
GT ++APE + + K DV+S G+ +EL K P+
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 71/303 (23%), Positives = 135/303 (44%), Gaps = 49/303 (16%)
Query: 628 IDA--VKPENLIGKGGSGNVY--KVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS 683
IDA +K E +IG G G V ++ L +E+ V ++ A +++
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVA------------IKTLKAGYTEKQ 48
Query: 684 SRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW 743
R ++ +E + + H N++ L +T ++V EY+ NGSL D H +
Sbjct: 49 RR--DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTV 105
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG 803
+ + G A G++YL D +HRD+ + NIL++ +++DFGL+++++
Sbjct: 106 IQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162
Query: 804 DLTHVIAGTHG------YIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDS 856
T T G + APE K SDV+S+G+V+ E+++ G+RP
Sbjct: 163 AYT-----TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------- 209
Query: 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916
Y +M ++D + + + + + ++ + C K RP +V +
Sbjct: 210 -------YWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSI 262
Query: 917 LEE 919
L++
Sbjct: 263 LDK 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 73/228 (32%), Positives = 100/228 (43%), Gaps = 39/228 (17%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IGKG G VYKV G AVK IL S E +AE
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK------------------ILDPISDVDEEIEAEYNI 71
Query: 696 LSAV-RHVNVVKLYCSITSEDSNL-----LVYEYLPNGS---LWDRLHTCHKIEMDWVVR 746
L ++ H NVVK Y D + LV E GS L L C + + ++
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
Y I GA GL++LH + +IHRDVK +NILL E ++ DFG++ + + T
Sbjct: 132 Y-ILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 807 HVIAGTHGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPI 849
V GT ++APE Y + + DV+S G+ +EL G P+
Sbjct: 188 SV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
EV L ++H N ++ E + LV EY GS D L HK + V AI
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV-HKKPLQEVEIAAITH 128
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
GA +GL YLH +IHRD+K+ NILL + ++ADFG A + G
Sbjct: 129 GALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVG 179
Query: 812 THGYIAPEYAYTC---KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868
T ++APE + + K DV+S G+ +EL K P+ M+
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---------------NMN 224
Query: 869 SRDSMLTVV---DPNISEILKEDALKVLRIAIHCTNKLPAFRPS 909
+ ++ + P + D+ + +C K+P RP+
Sbjct: 225 AMSALYHIAQNDSPTLQSNEWTDSFR--GFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 42/132 (31%), Positives = 71/132 (53%), Gaps = 10/132 (7%)
Query: 722 EYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781
E++ GSL L +I + + + +IAV +GL YL ++HRDVK SNIL++
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILGKISIAV--LRGLTYLRE--KHKIMHRDVKPSNILVN 134
Query: 782 LEWKPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLM 840
+ ++ DFG+ +G+ D + + GT Y++PE +SD++S G+ L+
Sbjct: 135 SRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189
Query: 841 ELVTGKRPIVPE 852
E+ G+ PI P
Sbjct: 190 EMAIGRYPIPPP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 30/213 (14%)
Query: 637 IGKGGSGNVYK-VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+G G G VYK L + + LAVK I L + +E+
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI----------------PLDITVELQKQIMSELEI 52
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
L ++ Y + E+ + E++ GSL KI + R A+AV K
Sbjct: 53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAV--VK 106
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
GL YL + ++HRDVK SN+L++ + ++ DFG V T + GT+ Y
Sbjct: 107 GLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFG----VSTQLVNSIAKTYVGTNAY 159
Query: 816 IAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+APE + SDV+S G+ MEL G+ P
Sbjct: 160 MAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 65/245 (26%), Positives = 101/245 (41%), Gaps = 62/245 (25%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
IG+G G VYK LN+G+ +A+K + S + + R E+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS------EEGIPLSTLR---------EI 49
Query: 694 ATLSAVR---HVNVVKLY-----CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVV 745
A L + H N+V+L E LV+E++ D L T +
Sbjct: 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD----QD-LATY----LSKCP 100
Query: 746 RYAIAVGAAK--------GLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
+ + K G+++LH H ++HRD+K NIL+ + + +IADFGLA+I
Sbjct: 101 KPGLPPETIKDLMRQLLRGVDFLHSHR----IVHRDLKPQNILVTSDGQVKIADFGLARI 156
Query: 797 VQTGEAGDLTHVIAGTHGYIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRPIV 850
LT V+ T Y APE YA D++S G + EL +RP+
Sbjct: 157 Y--SFEMALTSVVV-TLWYRAPEVLLQSSYATPV------DMWSVGCIFAELFR-RRPLF 206
Query: 851 PEFGD 855
+
Sbjct: 207 RGTSE 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 46/159 (28%), Positives = 83/159 (52%), Gaps = 10/159 (6%)
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
E A ++ + H N+V+L I + +V E + G+L + L T + + + +
Sbjct: 48 EETAVMTKLHHKNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS 106
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ A+G+EYL + ++HRD+ + NIL+ + +++DFGLA++ G V
Sbjct: 107 LDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-- 161
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ APE K + KSDV+S+GV+L E+ + G+ P
Sbjct: 162 ---KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 7/151 (4%)
Query: 698 AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGL 757
A H +V L+ +E V EY+ G L + K+ + Y+ + A L
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--L 109
Query: 758 EYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIA 817
YLH +R +I+RD+K N+LLD E ++ D+G+ K + GD T GT YIA
Sbjct: 110 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIA 164
Query: 818 PEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
PE D ++ GV++ E++ G+ P
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 7/145 (4%)
Query: 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG 763
+ +L+ + D V EY+ G L + K + V YA + + GL +LH
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEI--SVGLFFLH-- 118
Query: 764 FDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT 823
R +I+RD+K N++LD E +IADFG+ K + G T GT YIAPE
Sbjct: 119 -RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAY 175
Query: 824 CKINEKSDVYSFGVVLMELVTGKRP 848
+ D +++GV+L E++ G+ P
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 23/229 (10%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK----IEMDWVVRY 747
E+ L + H NV+K Y S ++ +V E G L + K I V +Y
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
+ + +A LE++H R V+HRD+K +N+ + ++ D GL + + H
Sbjct: 112 FVQLCSA--LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AH 164
Query: 808 VIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867
+ GT Y++PE + N KSD++S G +L E+ + P +GD ++ + + K+
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLYS-LCKKI 220
Query: 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916
+ D P S+ E+ +++ + C N P RP + V +
Sbjct: 221 EQCD-----YPPLPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 57/230 (24%), Positives = 107/230 (46%), Gaps = 37/230 (16%)
Query: 636 LIGKGGSGNVYKVVLN----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA 691
++G+G G+V + L+ S ++AVK + + D + + I E+ +
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-------KLDIHTYSEI--------EEFLS 50
Query: 692 EVATLSAVRHVNVVKLY-CSITSEDSN-----LLVYEYLPNGSL-----WDRLHTC-HKI 739
E A + H NV+KL + +++ ++ +G L + RL K+
Sbjct: 51 EAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKL 110
Query: 740 EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT 799
+ ++++ + + A G+EYL +R IHRD+ + N +L + +ADFGL+K + +
Sbjct: 111 PLQTLLKFMVDI--ALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYS 165
Query: 800 GEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
G+ + +IA E KSDV++FGV + E+ T G+ P
Sbjct: 166 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 52/154 (33%), Positives = 81/154 (52%), Gaps = 9/154 (5%)
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT-CHKIEMDWVVRYAIAVGAA 754
L+ V H +VKL+ + +E L+ ++L G L+ RL E D V++ +A A
Sbjct: 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYLA-ELA 108
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
L++LH +I+RD+K NILLD E ++ DFGL+K E + GT
Sbjct: 109 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVE 163
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
Y+APE + +D +SFGV++ E++TG P
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 75/316 (23%), Positives = 135/316 (42%), Gaps = 67/316 (21%)
Query: 625 KEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSS 684
+ + AV+ +G+G G VYK L P+ +S AI + + +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGEL----------TGPNE----RLSATSVAIKTLKEN 46
Query: 685 RS----SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL------- 733
E+ E +S ++H N+V L T E +++EYL +G L + L
Sbjct: 47 AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHS 106
Query: 734 ---------HTCHKIEMDWVVRYAIAVGAAKGLEYL--HHGFDRPVIHRDVKSSNILLDL 782
++ + AI + A G+EYL HH +HRD+ + N L+
Sbjct: 107 DVGAESGDETVKSSLDCSDFLHIAIQIAA--GMEYLSSHH-----FVHRDLAARNCLVGE 159
Query: 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMEL 842
+I+DFGL++ + + + + ++ PE K +SD++SFGVVL E+
Sbjct: 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
Query: 843 VT-GKRPIVPEFGDS-KDIVNWVYSKMDSRDSMLTVVDPNISEIL--KEDA-LKVLRIAI 897
+ G +P +G S ++++ + S+ ++L ED +V + I
Sbjct: 220 FSYGLQPY---YGFSNQEVIEMIRSR----------------QLLPCPEDCPARVYALMI 260
Query: 898 HCTNKLPAFRPSMRVV 913
C N++PA RP + +
Sbjct: 261 ECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 87/298 (29%), Positives = 132/298 (44%), Gaps = 51/298 (17%)
Query: 599 KQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKEL-A 657
K N+ + L + ++ R L + E D VK +IG+G G V V S +++ A
Sbjct: 17 KNKNIDNFLNRYEKIVRKIRKLQM-KAEDYDVVK---VIGRGAFGEVQLVRHKSSQKVYA 72
Query: 658 VKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSN 717
+K + S F RS +A + E ++ VV+L+C+ +
Sbjct: 73 MKLL----SKFEMIKRSDSAFFWE----------ERDIMAFANSPWVVQLFCAFQDDKYL 118
Query: 718 LLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777
+V EY+P G L + L + + + W Y V A L+ +H +IHRDVK N
Sbjct: 119 YMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLA--LDAIH---SMGLIHRDVKPDN 172
Query: 778 ILLDLEWKPRIADFGLA-KIVQTGEAGDLTHVIAGTHGYIAPE----------YAYTCKI 826
+LLD ++ADFG K+ +TG T V GT YI+PE Y C
Sbjct: 173 MLLDKHGHLKLADFGTCMKMDETGMVRCDTAV--GTPDYISPEVLKSQGGDGYYGREC-- 228
Query: 827 NEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK-MDSRDSMLTVVDPNISE 883
D +S GV L E++ G P + DS + YSK MD ++S+ D IS+
Sbjct: 229 ----DWWSVGVFLFEMLVGDTPF---YADS---LVGTYSKIMDHKNSLNFPEDVEISK 276
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 7e-12
Identities = 66/236 (27%), Positives = 97/236 (41%), Gaps = 55/236 (23%)
Query: 632 KPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+ IG G G V V +G+++A+K I ++ F I +KR R
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI---SNVFD------DLIDAKRILR----- 48
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSN-----LLVYEYLP--------NGSLWDRLHTCH 737
E+ L +RH N++ L + +V E + + H
Sbjct: 49 -EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDH--- 104
Query: 738 KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
++Y +GL+YLH VIHRD+K SNIL++ +I DFGLA+ V
Sbjct: 105 -------IQY-FLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153
Query: 798 QTGEA--GDLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGK 846
E G LT + T Y APE YT I D++S G + EL+T K
Sbjct: 154 DPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 73/250 (29%), Positives = 102/250 (40%), Gaps = 61/250 (24%)
Query: 637 IGKGGSGNVYKVVL---NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
IG+G G VYK GKE A+K + G S +A R E+
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG--ISQSAC------R------EI 53
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVY------EYLPNGSLWD--RLHTCHKIEM--DW 743
A L ++H NVV L + E ++ VY E+ LW + H K
Sbjct: 54 ALLRELKHENVVSLV-EVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPS 108
Query: 744 VVR---YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR----IADFGLAKI 796
+V+ + I G+ YLH + V+HRD+K +NIL+ E R I D GLA++
Sbjct: 109 MVKSLLWQIL----NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
Query: 797 VQTGEAG--DLTHVIAGTHGYIAPEYA-----YTCKINEKSDVYSFGVVLMELVTGKRPI 849
DL V+ T Y APE YT I D+++ G + EL+T PI
Sbjct: 162 FNAPLKPLADLDPVVV-TIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT-LEPI 215
Query: 850 VPEFGDSKDI 859
G I
Sbjct: 216 FK--GREAKI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-12
Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 12/157 (7%)
Query: 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG 763
+V Y + S+ + E++ GSL L +I + + +IAV KGL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLRE- 121
Query: 764 FDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAY 822
++HRDVK SNIL++ + ++ DFG+ +G+ D + + GT Y++PE
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPERLQ 175
Query: 823 TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859
+ +SD++S G+ L+E+ G+ PI P D+K++
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPIPPP--DAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-12
Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 7/216 (3%)
Query: 105 SMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLY 164
++L+ L +L+ + + L LTNL L L +N P P+ L L L
Sbjct: 88 NLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIP-PLIGLLKSNLKELD 146
Query: 165 LTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPV 224
L++ + +P + NL L+NL+LS N+L ++P + L+ L L+L N +S LP
Sbjct: 147 LSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPP 203
Query: 225 GFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSL 284
L+ L D+S N + LS L L LS L L N+ ++PE G +L L L
Sbjct: 204 EIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDL 262
Query: 285 YTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPD 320
N+++ LGS + +D+S N L+ +P
Sbjct: 263 SNNQISS--ISSLGSLTNLRELDLSGNSLSNALPLI 296
|
Length = 394 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 44/222 (19%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIE--------MDW 743
E LS + H +VK + S D+ ++ EY L +L +W
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG 803
++ + G+ Y+H R ++HRD+K+ NI L +I DFG+++++ +
Sbjct: 112 FIQLLL------GVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG--SC 159
Query: 804 DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMEL-------------------VT 844
DL GT Y++PE + KSD++S G +L E+ V
Sbjct: 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219
Query: 845 GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILK 886
G P +PE + +N + M ++D L P+ +EIL+
Sbjct: 220 GPTPSLPETYSRQ--LNSIMQSMLNKDPSLR---PSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 55/176 (31%), Positives = 81/176 (46%), Gaps = 10/176 (5%)
Query: 671 DYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLW 730
D R+ + K +SSEY E T+ N+V L+ I SEDS LV ++ G LW
Sbjct: 14 DTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73
Query: 731 DRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790
+ I + V R+A + A L+ LH ++ RD+ +NILLD ++
Sbjct: 74 SHISKFLNIPEECVKRWAAEMVVA--LDALH---REGIVCRDLNPNNILLDDRGHIQLTY 128
Query: 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGK 846
F V+ G+ A + Y APE + E D +S G +L EL+TGK
Sbjct: 129 FSRWSEVEDSCDGE-----AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 39/100 (39%), Positives = 58/100 (58%), Gaps = 8/100 (8%)
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV--QTGEAGDLTHVIAGT 812
+GL+Y+H V+HRD+K SN+LL+ +I DFGLA+I + G LT +A T
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA-T 172
Query: 813 HGYIAPEYAYTCKINEKS-DVYSFGVVLMELVTGKRPIVP 851
Y APE K K+ D++S G +L E+++ RP+ P
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFP 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 65/197 (32%), Positives = 92/197 (46%), Gaps = 34/197 (17%)
Query: 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHH- 762
+V+L+ + + +V EY+P G L + L + + I W Y V A L+ +H
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLA--LDAIHSM 161
Query: 763 GFDRPVIHRDVKSSNILLDLEWKPRIADFGLA-KIVQTGEAGDLTHVIAGTHGYIAPE-- 819
GF IHRDVK N+LLD ++ADFG K+ G T V GT YI+PE
Sbjct: 162 GF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV--GTPDYISPEVL 215
Query: 820 --------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK-MDSR 870
Y C D +S GV L E++ G P + DS +V YSK MD +
Sbjct: 216 KSQGGDGYYGREC------DWWSVGVFLYEMLVGDTPF---YADS--LVG-TYSKIMDHK 263
Query: 871 DSMLTVVDPNISEILKE 887
+S+ D IS+ K+
Sbjct: 264 NSLTFPDDIEISKQAKD 280
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 56/227 (24%), Positives = 109/227 (48%), Gaps = 24/227 (10%)
Query: 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSS 687
+ VK E +IG G G V + L K + I+ + + Y +++ R
Sbjct: 3 VSCVKIEEVIGAGEFGEVCRGRL---KLPGKREIFVAIKTLKSGY-------TEKQRR-- 50
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
++ +E + + H N++ L +T +++ E++ NG+L D + + +
Sbjct: 51 DFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLV 109
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
+ G A G++YL + +HRD+ + NIL++ +++DFGL++ ++ D T+
Sbjct: 110 GMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD-TSDPTY 165
Query: 808 VIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ G I APE K SDV+S+G+V+ E+++ G+RP
Sbjct: 166 T-SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 46/145 (31%), Positives = 73/145 (50%), Gaps = 7/145 (4%)
Query: 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG 763
+ +L+ + D V EY+ G L ++ + + V YA + A GL +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEI--AIGLFFLH-- 118
Query: 764 FDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT 823
+ +I+RD+K N++LD E +IADFG+ K + G T GT YIAPE
Sbjct: 119 -SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAY 175
Query: 824 CKINEKSDVYSFGVVLMELVTGKRP 848
+ D ++FGV+L E++ G+ P
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 34/250 (13%)
Query: 681 KRSSRSSEYDAEVATLSAV----RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC 736
K ++ SSE +A ++ L + H N+V L + T L++ EY G L + L
Sbjct: 74 KPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK 133
Query: 737 HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
+ + + + AKG+ +L + IHRD+ + N+LL +I DFGLA+
Sbjct: 134 RESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190
Query: 797 VQTGEAGDLTHVIAGTH----GYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVP 851
+ D +V+ G ++APE + C +SDV+S+G++L E+ + G P
Sbjct: 191 IMN----DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
Query: 852 EFGDSKDIVNWVYSKMDSRDSMLTVV--DPNISEILKEDALKVLRIAIHCTNKLPAFRPS 909
DSK Y + M I +I+K C + P RP+
Sbjct: 247 MPVDSK-----FYKLIKEGYRMAQPEHAPAEIYDIMKT-----------CWDADPLKRPT 290
Query: 910 MRVVVQMLEE 919
+ +VQ++ +
Sbjct: 291 FKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 57/203 (28%), Positives = 84/203 (41%), Gaps = 50/203 (24%)
Query: 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHH- 762
VVKLY S +D+ V +Y+P G + L E D + R+ IA +E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED-LARFYIA-ELTCAIESVHKM 120
Query: 763 GFDRPVIHRDVKSSNILLDLEWKPRIADFGL---------AKIVQTG------------E 801
GF IHRD+K NIL+D + ++ DFGL +K Q G E
Sbjct: 121 GF----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 802 AGD--------------------LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLME 841
+ L H + GT YIAPE + D +S GV+L E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 842 LVTGKRPIVPE--FGDSKDIVNW 862
++ G+ P + + ++NW
Sbjct: 237 MLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 36/231 (15%)
Query: 628 IDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS 686
+ K E IGKG VYK + L G+ +A+K + I +++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV---------------QIFEMMDAKA 45
Query: 687 SEYDA--EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL--HTCHK---I 739
+ D E+ L + H NV+K S + +V E G L R+ H + I
Sbjct: 46 RQ-DCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLI 103
Query: 740 EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV-- 797
+ +Y + + LE++H + ++HRD+K +N+ + ++ D GL +
Sbjct: 104 PERTIWKYFVQL--CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158
Query: 798 QTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+T A H + GT Y++PE + N KSD++S G +L E+ + P
Sbjct: 159 KTTAA----HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL 696
+G G G+VYK ELA I G D+ S E+ +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDF--------------SLIQQEIFMV 60
Query: 697 SAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC---HKIEMDWVVRYAIAVGA 753
+H N+V + S S + + EY GSL D H ++++ +V R +
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---- 116
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
+GL YLH + +HRD+K +NILL ++ADFG+A + A + + GT
Sbjct: 117 -QGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTP 170
Query: 814 GYIAPEYAYTCK---INEKSDVYSFGVVLMELVTGKRPI 849
++APE A K N+ D+++ G+ +EL + P+
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 47/228 (20%)
Query: 637 IGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSRS-SEYDA--E 692
+G G G+VY EL A+K + K+ S E E
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------------------KKKFYSWEECMNLRE 47
Query: 693 VATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWD--RLHTCHKIEMDWVVRYAI 749
V +L + H N+VKL D V+EY+ G+L+ + V+R I
Sbjct: 48 VKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSES-VIRS-I 104
Query: 750 AVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+GL ++H HGF HRD+K N+L+ +IADFGLA+ ++ T
Sbjct: 105 IYQILQGLAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREIR--SRPPYTDY 158
Query: 809 IAGTHGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
+ T Y APE +Y+ + D+++ G ++ EL T RP+ P
Sbjct: 159 V-STRWYRAPEILLRSTSYSSPV----DIWALGCIMAELYTL-RPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL 696
+G G G VYK KE G ++ I +K +Y E+ L
Sbjct: 20 LGDGAFGKVYKA---KNKE-------------TGALAAAKVIETKSEEELEDYMVEIEIL 63
Query: 697 SAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMD-WVVRYAIAVGAAK 755
+ H +VKL + + ++ E+ P G++ +E+D + I V +
Sbjct: 64 ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV-----DAIMLELDRGLTEPQIQVICRQ 118
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL-AKIVQTGEAGDLTHVIAGTHG 814
LE L + +IHRD+K+ N+LL L+ ++ADFG+ AK V+T + D GT
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD---SFIGTPY 175
Query: 815 YIAPEYAYTCKINE-----KSDVYSFGVVLMELVTGKRP 848
++APE + + K+D++S G+ L+E+ + P
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 50/236 (21%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE-YDAEV 693
++GKG G VY L++ +A+K I +R SR + E+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEI------------------PERDSRYVQPLHEEI 56
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT------CHKIEMDWVVRY 747
A S ++H N+V+ S + + E +P GSL L + ++ + + +
Sbjct: 57 ALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD-LEWKPRIADFGLAKIVQTGEAGDLT 806
+ +GL+YLH D ++HRD+K N+L++ +I+DFG +K + T
Sbjct: 117 IL-----EGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCT 166
Query: 807 HVIAGTHGYIAPEYAYTCKINE-------KSDVYSFGVVLMELVTGKRPIVPEFGD 855
GT Y+APE I++ +D++S G ++E+ TGK P + E G+
Sbjct: 167 ETFTGTLQYMAPEV-----IDKGPRGYGAPADIWSLGCTIVEMATGKPPFI-ELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 7/145 (4%)
Query: 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG 763
+V L+ + LV EY+ G L + K+ + YA + A L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNFLH-- 113
Query: 764 FDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT 823
+R +I+RD+K N+LLD + ++ D+G+ K + GD T GT YIAPE
Sbjct: 114 -ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRG 170
Query: 824 CKINEKSDVYSFGVVLMELVTGKRP 848
+ D ++ GV++ E++ G+ P
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 697 SAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKG 756
+A H +V L+ +E V E++ G L + K+ + Y+ + A
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA-- 108
Query: 757 LEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYI 816
L +LH +R +I+RD+K N+LLD E ++ D+G+ K + GD T GT YI
Sbjct: 109 LNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYI 163
Query: 817 APEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
APE D ++ GV++ E++ G+ P
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
GLE+LH R +I+RD+K N+LLD + RI+D GLA V+ + T AGT G+
Sbjct: 109 GLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGF 163
Query: 816 IAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+APE + + D ++ GV L E++ + P
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 71/237 (29%), Positives = 107/237 (45%), Gaps = 54/237 (22%)
Query: 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNS--GFRGDYRSSTAILSKRSSRSSEYDA 691
IG+G G VYK +G+ +A+K + N GF TAI
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGF-----PITAI------------R 55
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNL----------LVYEYLPN---GSLWDRLHTCHK 738
E+ L + H N+V L +T + L LV+EY+ + G L L +
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 739 IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798
+ ++ + +GL Y H + +HRD+K SNILL+ + + ++ADFGLA++
Sbjct: 116 DHIKSFMKQLL-----EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 799 TGEAGDLTH-VIAGTHGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPI 849
+ E+ T+ VI T Y PE Y I DV+S G +L EL T K+PI
Sbjct: 168 SEESRPYTNKVI--TLWYRPPELLLGEERYGPAI----DVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 33/230 (14%)
Query: 637 IGKGGSGNVYKV-VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+GKGG G V V V N+GK A K + + A+L K
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKL--DKKRLKKKSGEKMALLEKE------------I 46
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH----KIEMDWVVRYAIAV 751
L V +V L + S+ LV + G L + H + +EM+ V+ Y+ +
Sbjct: 47 LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL--KYHIYNVGERGLEMERVIHYSAQI 104
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
G+ +LH +++RD+K N+LLD + R++D GLA V+ + +T AG
Sbjct: 105 --TCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQR-AG 156
Query: 812 THGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861
T+GY+APE + D ++ G + E+V G+ P F D K+ V
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP----FKDHKEKVA 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 36/242 (14%)
Query: 687 SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL-----HT---CHK 738
E+ E + ++ + H N+V L +T E +++EYL G L + L H+ C
Sbjct: 52 GEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSS 111
Query: 739 IEMDWVVRYA--------IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790
E D V+ + IA+ A G+EYL F +H+D+ + NIL+ + +I+D
Sbjct: 112 DE-DGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISD 167
Query: 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPI 849
GL++ + + + + ++ PE K + SD++SFGVVL E+ + G +P
Sbjct: 168 LGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP- 226
Query: 850 VPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS 909
Y +++ + V + ++ ++ + C + P+ RP
Sbjct: 227 --------------YYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPR 272
Query: 910 MR 911
+
Sbjct: 273 FK 274
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 47/157 (29%), Positives = 66/157 (42%), Gaps = 7/157 (4%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
E L RH + L S + D V EY G L+ L D Y +
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
+A L YLH V++RD+K N++LD + +I DFGL K + G G
Sbjct: 105 VSA--LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCG 157
Query: 812 THGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
T Y+APE D + GVV+ E++ G+ P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 42/234 (17%)
Query: 632 KPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
KP IG G G V + SGK++A+K I ++ L+KR+ R
Sbjct: 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKI--PHA-------FDVPTLAKRTLR----- 53
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDS---NLLVYEYLPNGSLWDRLHTCHKIEMDWV--V 745
E+ L +H N++ + + + ++ V L L +H+ + + +
Sbjct: 54 -ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYF 112
Query: 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV---QTGEA 802
Y + +GL+Y+H VIHRD+K SN+L++ + + RI DFG+A+ + T
Sbjct: 113 LYQLL----RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165
Query: 803 GDLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
+T +A T Y APE YT I D++S G + E++ G+R + P
Sbjct: 166 YFMTEYVA-TRWYRAPELLLSLPEYTTAI----DMWSVGCIFAEML-GRRQLFP 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 19/172 (11%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
E++ L ++H N+V+L + SE LV+EYL + L + + + +
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP-RIADFGLAKI----VQTGEAGDLT 806
+G+ Y H V+HRD+K N+L+D ++ADFGLA+ V+T T
Sbjct: 110 QILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT-----FT 161
Query: 807 HVIAGTHGYIAPEYAY-TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857
H + T Y APE + + D++S G + E+V ++P+ P GDS+
Sbjct: 162 HEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFP--GDSE 209
|
Length = 294 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 25/216 (11%)
Query: 636 LIGKGGSGNVYKV-VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++GKGG G V V +GK A K + + KR S + E
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKR-------------IKKRKGESMALN-EKQ 52
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA- 753
L V VV L + ++D+ LV + G L + H H E + A+ A
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL--KFHIYHMGEAGFEEGRAVFYAAE 110
Query: 754 -AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGT 812
GLE LH +++RD+K NILLD RI+D GLA V G+ GT
Sbjct: 111 ICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 164
Query: 813 HGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GY+APE + D ++ G +L E++ G+ P
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 64/219 (29%), Positives = 93/219 (42%), Gaps = 31/219 (14%)
Query: 636 LIGKGGSGNVYKV-VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++GKGG G V V +GK A K R + KR S + E
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACK-------------RLEKKRIKKRKGESMALN-EKQ 52
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK----IEMDWVVRYAIA 750
L V VV L + ++D+ LV + G L + H + E + + YA
Sbjct: 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDL--KFHIYNMGNPGFEEERALFYAAE 110
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA-KIVQTGEAGDLTHVI 809
+ GLE LH ++RD+K NILLD RI+D GLA KI + G+
Sbjct: 111 ILC--GLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE----GESIRGR 161
Query: 810 AGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT GY+APE + D + G ++ E++ G+ P
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
GLE++H+ F V++RD+K +NILLD RI+D GLA + H GTHGY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGY 161
Query: 816 IAPE-YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+APE + +D +S G +L +L+ G P
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 30/74 (40%), Positives = 43/74 (58%)
Query: 150 FPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLW 209
P ++ KL L + L+ S+ G IP +G++T L+ L+LS N G IP + +L L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 210 QLELYNNSLSGRLP 223
L L NSLSGR+P
Sbjct: 494 ILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 63/214 (29%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 636 LIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
L+GKG G V V SGK A+K + I++K + ++ V
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKIL------------KKEVIIAKDEVAHTLTESRV- 48
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA 754
L RH + L S ++D V EY+ G L+ L D Y + +A
Sbjct: 49 -LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA 107
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
L+YLH G +++RD+K N++LD + +I DFGL K T A T GT
Sbjct: 108 --LDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPE 160
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
Y+APE D + GVV+ E++ G+ P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 14/170 (8%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
E+ L +RH N+V L + LV+E++ + L D + ++ V +Y +
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI 109
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT-GEAGDLTHVIA 810
+G+E+ H +IHRD+K NIL+ ++ DFG A+ + GE T +A
Sbjct: 110 --LRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVA 162
Query: 811 GTHGYIAPEYAY-TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859
T Y APE K D+++ G ++ E++TG+ P+ P GDS DI
Sbjct: 163 -TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE-PLFP--GDS-DI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 50/232 (21%), Positives = 106/232 (45%), Gaps = 27/232 (11%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNL----LVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
E+ L + N++K+Y I +L L+ EY G L + L + ++ + +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD--KEKDLSFKTKL 125
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
+A+ KGL L+ ++P ++++ S + L+ +K +I GL KI+ + ++
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183
Query: 808 VIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867
++ ++ + ++ + K D+YS GVVL E+ TGK P + +
Sbjct: 184 MVYFSYKMLNDIFS---EYTIKDDIYSLGVVLWEIFTGKIP---------------FENL 225
Query: 868 DSRDSMLTVVDPNISEILKEDALKVLR-IAIHCTNKLPAFRPSMRVVVQMLE 918
+++ +++ N S L D ++ I CT+ RP+++ ++ L
Sbjct: 226 TTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL 696
+G G G VYK LA ++ I +K +Y E+ L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLA----------------AAKVIDTKSEEELEDYMVEIDIL 56
Query: 697 SAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW-VVRYAIAVGAAK 755
++ H N+VKL + E++ ++ E+ G++ +E++ + I V +
Sbjct: 57 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-----DAVMLELERPLTEPQIRVVCKQ 111
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL-AKIVQTGEAGDLTHVIAGTHG 814
LE L++ + +IHRD+K+ NIL L+ ++ADFG+ AK +T + D GT
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD---SFIGTPY 168
Query: 815 YIAPEYAYTCKINE------KSDVYSFGVVLMELVTGKRP 848
++APE C+ ++ K+DV+S G+ L+E+ + P
Sbjct: 169 WMAPE-VVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 47/157 (29%), Positives = 68/157 (43%), Gaps = 7/157 (4%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
E L RH + L + + D V EY G L+ L + Y +
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
+A LEYLH R V++RD+K N++LD + +I DFGL K + A G
Sbjct: 105 VSA--LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCG 157
Query: 812 THGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
T Y+APE D + GVV+ E++ G+ P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 62/224 (27%)
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEM----DWVVR 746
AE L+ + VVKLY S +D+ V +Y+P G + L I M + + R
Sbjct: 50 AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-----IRMEVFPEVLAR 104
Query: 747 YAIAVGAAKGLEYLHH-GFDRPVIHRDVKSSNILLDLEWKPRIADFGL---------AKI 796
+ IA +E +H GF IHRD+K NIL+DL+ ++ DFGL +K
Sbjct: 105 FYIA-ELTLAIESVHKMGF----IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159
Query: 797 VQTG--------------------EAGD----------------LTHVIAGTHGYIAPEY 820
Q G GD L H + GT YIAPE
Sbjct: 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219
Query: 821 AYTCKINEKSDVYSFGVVLMELVTGKRP-IVPEFGDSK-DIVNW 862
+ D +S GV+L E++ G+ P + P +++ ++NW
Sbjct: 220 LLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 16/98 (16%)
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
GLE++H+ F V++RD+K +NILLD RI+D GLA + H GTHGY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGY 161
Query: 816 IAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRP 848
+APE AY + +D +S G +L +L+ G P
Sbjct: 162 MAPEVLQKGTAY----DSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 58/252 (23%), Positives = 107/252 (42%), Gaps = 39/252 (15%)
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC----------- 736
++ E A ++ H N+VKL L++EY+ G L + L
Sbjct: 54 DFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHS 113
Query: 737 ---------HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787
+ + + + IA A G+ YL +R +HRD+ + N L+ +
Sbjct: 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 170
Query: 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GK 846
IADFGL++ + + + + A ++ PE + + +SDV+++GVVL E+ + G
Sbjct: 171 IADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM 230
Query: 847 RPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAF 906
+P Y M + + V D N+ L++ + C +KLP+
Sbjct: 231 QP---------------YYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSD 275
Query: 907 RPSMRVVVQMLE 918
RPS + ++L+
Sbjct: 276 RPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA---E 692
IG G G+VYK +N+G+ A+K I + ++ E
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI--------------------KLEPGEDFAVVQQE 56
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC---HKIEMDWVVRYAI 749
+ + +H N+V + S D + E+ GSL D H + ++ +V R +
Sbjct: 57 IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL 116
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
+GL YLH + +HRD+K +NILL ++ADFG++ + A + +
Sbjct: 117 -----QGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI- 167
Query: 810 AGTHGYIAPEYAYTCK---INEKSDVYSFGVVLMELVTGKRPI 849
GT ++APE A + N+ D+++ G+ +EL + P+
Sbjct: 168 -GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 53/215 (24%)
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW----VVR 746
AE L+ + VVKLY S E+ L+ EYLP G + L ++ D R
Sbjct: 50 AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL-----MKKDTFTEEETR 104
Query: 747 YAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK---------- 795
+ IA ++ +H G+ IHRD+K N+LLD + +++DFGL
Sbjct: 105 FYIA-ETILAIDSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159
Query: 796 ---------------IVQTGEAGDLTH-------VIA----GTHGYIAPEYAYTCKINEK 829
I + + +A GT YIAPE N++
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE 219
Query: 830 SDVYSFGVVLMELVTGKRPIVPEFGDS--KDIVNW 862
D +S GV++ E++ G P + + I+NW
Sbjct: 220 CDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 27/217 (12%)
Query: 636 LIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
L+GKG G V V KE A + + IL K + + A T
Sbjct: 2 LLGKGTFGKVILV-----KEKATGRYY------------AMKILKKEVIVAKDEVAHTLT 44
Query: 696 ----LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
L RH + L S + D V EY G L+ L D Y +
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
+A L+YLH ++ V++RD+K N++LD + +I DFGL K + + G G
Sbjct: 105 VSA--LDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCG 158
Query: 812 THGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
T Y+APE D + GVV+ E++ G+ P
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 75/277 (27%), Positives = 112/277 (40%), Gaps = 41/277 (14%)
Query: 636 LIGKGGSGNVYKV-VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++GKGG G V V +GK A K + + KR + + E
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACK-------------KLEKKRIKKRKGEAMALN-EKQ 52
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH----KIEMDWVVRYAIA 750
L V VV L + ++D+ LV + G L + H + + + V YA
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL--KFHIYNMGNPGFDEERAVFYAAE 110
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ GLE LH +++RD+K NILLD RI+D GLA V+ E G+
Sbjct: 111 ITC--GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPE-GETIRGRV 162
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSR 870
GT GY+APE + D + G ++ E++ GK P F K+ V +
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP----FRQRKEKVKR-----EEV 213
Query: 871 DSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFR 907
+ + SE E A + R + K P FR
Sbjct: 214 ERRVKEDQEEYSEKFSEAARSICRQLLT---KDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-10
Identities = 28/89 (31%), Positives = 45/89 (50%)
Query: 378 IDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQI 437
+ L G + +DI + L + L+ N G +P + +SL + LS N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 438 PLDIGKLKKLSSLYLHDNMFSGPLPYSIG 466
P +G+L L L L+ N SG +P ++G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 64/213 (30%), Positives = 89/213 (41%), Gaps = 21/213 (9%)
Query: 637 IGKGGSGNVYKVVLNS-GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IGKG G V + GK AVK + AIL K+ + + V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVL------------QKKAILKKKEQKHIMAERNV-L 49
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
L V+H +V L+ S + D V +Y+ G L+ L YA + +A
Sbjct: 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASAL 109
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
G YLH +I+RD+K NILLD + + DFGL K + E T GT Y
Sbjct: 110 G--YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEY 162
Query: 816 IAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+APE + D + G VL E++ G P
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL 696
IG G G V+ +++A+K I G + ++ E +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSE---------------EDFIEEAQVM 53
Query: 697 SAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKG 756
+ H +V+LY T LV+E++ +G L D L + + + + +G
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA-QRGKFSQETLLGMCLDVCEG 112
Query: 757 LEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG-- 814
+ YL VIHRD+ + N L+ +++DFG+ + V L + G
Sbjct: 113 MAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFV-------LDDQYTSSTGTK 162
Query: 815 ----YIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ +PE K + KSDV+SFGV++ E+ + GK P
Sbjct: 163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 72/229 (31%), Positives = 101/229 (44%), Gaps = 41/229 (17%)
Query: 637 IGKGGSGNVYKVVLN--SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
IGKG G V+KV LN +G + AVK IL E +AE
Sbjct: 26 IGKGTYGKVFKV-LNKKNGSKAAVK------------------ILDPIHDIDEEIEAEYN 66
Query: 695 TLSAVR-HVNVVKLYC-----SITSEDSNLLVYEYLPNGSLWDRLHTCHKI--EMDWVVR 746
L A+ H NVVK Y + + D LV E GS+ D + K M+ +
Sbjct: 67 ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
I A GL++LH IHRDVK +NILL E ++ DFG++ + + T
Sbjct: 127 AYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 183
Query: 807 HVIAGTHGYIAPEYAYTCK------INEKSDVYSFGVVLMELVTGKRPI 849
V GT ++APE C+ + + DV+S G+ +EL G P+
Sbjct: 184 SV--GTPFWMAPE-VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 70/235 (29%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 637 IGKGGSGNVYKV-VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IGKG G V +V ++ + A+K I ++ I+S+ SE +A
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH------------IVSR-----SEVTHTLAE 43
Query: 696 LSAVRHVN---VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVG 752
+ + VN +V L S S + LV ++ G L+ L + ++ Y +
Sbjct: 44 RTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELL 103
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGT 812
A LE LH F+ VI+RD+K NILLD + + DFGL K+ + D T+ GT
Sbjct: 104 CA--LENLHK-FN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGT 156
Query: 813 HGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867
Y+APE + D ++ GV+L E++TG +P F D VN +Y K+
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG----LPPFYDEN--VNEMYRKI 205
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC-HKIEMDWVVRYAIA 750
EV+ L ++H N+V L+ I +E S LV+EYL + L L C + I M V +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ +GL Y H R V+HRD+K N+L++ + ++ADFGLA+ V+
Sbjct: 113 L--LRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV- 166
Query: 811 GTHGYIAPEYAY-TCKINEKSDVYSFGVVLMELVTGKRPIVP 851
T Y P+ + + + D++ G + E+ TG RP+ P
Sbjct: 167 -TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG-RPLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 10/158 (6%)
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
+E L+ + H V LY S E LV E++ G + L + D YA
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ 139
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ EYL +++RD+K N+LLD + ++ DFG AK+V T T+ +
Sbjct: 140 IVLI--FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLC 189
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT YIAPE + +D ++ G+ + E++ G P
Sbjct: 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 8/178 (4%)
Query: 677 AILSKRSSRSSEYDAEVATLSAVRHVN-VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT 735
A L +++ E L VR +V L+ + +E L+ +Y+ G ++ L+
Sbjct: 39 AALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ 98
Query: 736 CHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795
D V Y+ + A LE+LH +++RD+K NILLD E + DFGL+K
Sbjct: 99 RDNFSEDEVRFYSGEIILA--LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSK 153
Query: 796 IVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKS-DVYSFGVVLMELVTGKRPIVPE 852
+ E + T+ GT Y+APE + K+ D +S G+++ EL+TG P E
Sbjct: 154 EFLS-EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKI-EMDWVVRYAIA 750
EV+ L ++H N+V L+ I +E LV+EYL + L L C + M V +
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ +GL Y H R ++HRD+K N+L++ + + ++ADFGLA+ V+
Sbjct: 112 L--LRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV- 165
Query: 811 GTHGYIAPEYAY-TCKINEKSDVYSFGVVLMELVTGKRPIVP 851
T Y P+ + + + D++ G +L E+ TG RP+ P
Sbjct: 166 -TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-10
Identities = 39/122 (31%), Positives = 53/122 (43%), Gaps = 28/122 (22%)
Query: 191 DNE-LFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSEL 249
DN+ L G IP I KL L + L NS+ G +P ++T+L D+S N
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS-------- 477
Query: 250 RFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSW----ADFNY 305
F+G IPE G+ L L+L N L+G +P LG A FN+
Sbjct: 478 ---------------FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522
Query: 306 VD 307
D
Sbjct: 523 TD 524
|
Length = 623 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 30/173 (17%)
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
AKG+ +L + IHRD+ + NILL +I DFGLA+ ++ D +V+ G
Sbjct: 224 AKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN----DSNYVVKGNA 276
Query: 814 ----GYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMD 868
++APE + C +SDV+S+G++L E+ + G P DSK Y +
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-----FYKMIK 331
Query: 869 SRDSMLT--VVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
ML+ + +I+K C + P RP+ + +VQ++E+
Sbjct: 332 EGYRMLSPECAPSEMYDIMKS-----------CWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 1/90 (1%)
Query: 329 DLLVLQNN-FNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEG 387
D L L N G +P + + L ++ NS+ G IPP + S+ +L ++DLS N F G
Sbjct: 421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480
Query: 388 PVTDDIGNAKSLALLLLANNRFSGELPSKI 417
+ + +G SL +L L N SG +P+ +
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 33/226 (14%)
Query: 632 KPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA 691
K ++G G G VYK + E + AI R + S + +
Sbjct: 10 KKIKVLGSGAFGTVYKGLWIPEGE---------------KVKIPVAIKELREATSPKANK 54
Query: 692 EVA----TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWD--RLHTCHKIEMDWVV 745
E+ +++V + +V +L I + L+ + +P G L D R H I +++
Sbjct: 55 EILDEAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLL 112
Query: 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
+ + + AKG+ YL +R ++HRD+ + N+L+ +I DFGLAK++ E
Sbjct: 113 NWCVQI--AKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE-- 165
Query: 806 THVIAGTH--GYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
H G ++A E +SDV+S+GV + EL+T G +P
Sbjct: 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 58/213 (27%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 636 LIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+IGKG + GK L K S+ F + K+ ++
Sbjct: 2 VIGKG----------SFGKVLLAKR--KSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL 49
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
L ++H +V L+ S + + V +Y+ G L+ L YA V +A
Sbjct: 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAI 109
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
G YLH +I+RD+K NILLD + + DFGL K + E + T GT Y
Sbjct: 110 G--YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEY 162
Query: 816 IAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+APE + D + G VL E++ G P
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 52/239 (21%), Positives = 95/239 (39%), Gaps = 50/239 (20%)
Query: 631 VKPENL-----IGKGGSGNVYKVVLNS------GKELAVKHIWPSNSGFRGDYRSSTAIL 679
+ E + +G+G G VY+ + +A+K + + A +
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV------------NENASM 50
Query: 680 SKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKI 739
+R E+ E + + +VV+L +++ L+V E + G L L + +
Sbjct: 51 RERI----EFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRS-RRP 105
Query: 740 EMDWVVRYAI---------AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790
E + A A G+ YL + +HRD+ + N ++ + +I D
Sbjct: 106 EAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD 162
Query: 791 FGLAKIVQTGEAGDLTHVIAGTHG-----YIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
FG+ + + + + G G ++APE KSDV+SFGVVL E+ T
Sbjct: 163 FGMTRDIYETD-----YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 59/220 (26%), Positives = 88/220 (40%), Gaps = 54/220 (24%)
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
AE L+ + VV+LY S +D+ V +Y+P G + L D Y
Sbjct: 50 AERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE 109
Query: 751 VGAAKGLEYLHH-GFDRPVIHRDVKSSNILLDLEWKPRIADFGL---------AKIVQTG 800
+ A +E +H GF IHRD+K NIL+D + ++ DFGL +K Q+G
Sbjct: 110 LTCA--VESVHKMGF----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG 163
Query: 801 ------------EAGD------------------------LTHVIAGTHGYIAPEYAYTC 824
E GD L H + GT YIAPE
Sbjct: 164 DHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223
Query: 825 KINEKSDVYSFGVVLMELVTGKRPIVPE--FGDSKDIVNW 862
+ D +S GV+L E++ G+ P + + ++NW
Sbjct: 224 GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 68/252 (26%)
Query: 629 DAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSS 687
D K E IG+G G VYK +G+ +A+K I + + STAI
Sbjct: 1 DYTKIEK-IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE---EGVPSTAI--------- 47
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
E++ L ++H N+V L + E L++E+L MD + +Y
Sbjct: 48 ---REISLLKELQHPNIVCLQDVLMQESRLYLIFEFL---------------SMD-LKKY 88
Query: 748 AIAVGAAKGLE------YLHHGFD-------RPVIHRDVKSSNILLDLEWKPRIADFGLA 794
++ + ++ YL+ R V+HRD+K N+L+D + ++ADFGLA
Sbjct: 89 LDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148
Query: 795 KI----VQTGEAGDLTHVIAGTHGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTG 845
+ V+ TH + T Y APE Y+ + D++S G + E+ T
Sbjct: 149 RAFGIPVRV-----YTHEVV-TLWYRAPEVLLGSPRYSTPV----DIWSIGTIFAEMAT- 197
Query: 846 KRPIVPEFGDSK 857
K+P+ GDS+
Sbjct: 198 KKPLF--HGDSE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 8/177 (4%)
Query: 675 STAILSKRSSRSS--EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDR 732
+ + RS R + E + + ++ H +V+L I S LV + P GSL D
Sbjct: 40 AIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLL-GICPGASLQLVTQLSPLGSLLDH 98
Query: 733 LHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792
+ H+ +D V AKG+ YL + ++HR++ + NILL + +IADFG
Sbjct: 99 VRQ-HRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFG 154
Query: 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+A ++ + ++A E + +SDV+S+GV + E+++ G P
Sbjct: 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 47/162 (29%), Positives = 85/162 (52%), Gaps = 6/162 (3%)
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
E+ E ++++ H ++V+L + + LV + +P+G L D +H HK + +
Sbjct: 55 EFMDEALIMASMDHPHLVRLL-GVCLSPTIQLVTQLMPHGCLLDYVHE-HKDNIGSQLLL 112
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
V AKG+ YL +R ++HRD+ + N+L+ +I DFGLA++++ E
Sbjct: 113 NWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
Query: 808 VIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
++A E + K +SDV+S+GV + EL+T G +P
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 30/206 (14%)
Query: 328 TDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEG 387
T L + NN P +L +++N + ++P + +LPNL +DLS N
Sbjct: 119 TSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD 177
Query: 388 PVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKL 447
+ + N +L L L+ N+ S +LP +I S+L + LS N ++ + LK L
Sbjct: 178 -LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234
Query: 448 SSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSG 507
S L L +N +P+S+G+L +L +L+LSNN+ S
Sbjct: 235 SGLELSNN-------------------------KLEDLPESIGNLSNLETLDLSNNQIS- 268
Query: 508 EIPISLTYPKLSLLDLSNNQLAGPIP 533
I + L LDLS N L+ +P
Sbjct: 269 SISSLGSLTNLRELDLSGNSLSNALP 294
|
Length = 394 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 45/174 (25%), Positives = 81/174 (46%), Gaps = 14/174 (8%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK----IEMDWVVRY 747
E+ L + H NV+K S ++ +V E G L + K I V +Y
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
+ + +A +E++H R V+HRD+K +N+ + ++ D GL + + H
Sbjct: 112 FVQLCSA--VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AH 164
Query: 808 VIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861
+ GT Y++PE + N KSD++S G +L E+ + P +GD ++ +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLFS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 58/239 (24%), Positives = 106/239 (44%), Gaps = 54/239 (22%)
Query: 631 VKPENLIGKGGSGNVYKVVLNS-GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEY 689
+K E++IG+G G V + ++ G ++ ++ +L + +S +
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMN----------------AAIKMLKEFASENDHR 47
Query: 690 D--AEVATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMD---- 742
D E+ L + H N++ L + + + EY P G+L D L +E D
Sbjct: 48 DFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA 107
Query: 743 ------------WVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790
++++A A G++YL ++ IHRD+ + N+L+ +IAD
Sbjct: 108 KEHGTASTLTSQQLLQFA--SDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIAD 162
Query: 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKIN-----EKSDVYSFGVVLMELVT 844
FGL++ G+ +V T G + + +N KSDV+SFGV+L E+V+
Sbjct: 163 FGLSR-------GEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 52/170 (30%), Positives = 77/170 (45%), Gaps = 29/170 (17%)
Query: 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY-AIAVGAAKGLEYLH- 761
VV ++CS ++ +V EY+ G L + +D Y A V A LEYLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA---LEYLHN 119
Query: 762 HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI---------------VQTGEAGDLT 806
+G ++HRD+K N+L+ ++ DFGL+KI T E D
Sbjct: 120 YG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD-- 173
Query: 807 HVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
+ GT YIAPE + D ++ G++L E + G VP FGD+
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG---CVPFFGDT 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 53/189 (28%), Positives = 92/189 (48%), Gaps = 34/189 (17%)
Query: 739 IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798
+++D ++R++ V A+G+++L + IHRDV + N+LL +I DFGLA+ +
Sbjct: 209 LDLDDLLRFSSQV--AQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM 263
Query: 799 TGEAGDLTHVIAGTH----GYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEF 853
D +V+ G ++APE + C +SDV+S+G++L E+ + GK P
Sbjct: 264 N----DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319
Query: 854 GDSKDIVNWVYSKMDSRDSMLTVVD---PNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910
+SK + KM R ++ D P I I+K C N P RP+
Sbjct: 320 VNSK------FYKMVKRGYQMSRPDFAPPEIYSIMKM-----------CWNLEPTERPTF 362
Query: 911 RVVVQMLEE 919
+ Q+++
Sbjct: 363 SQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 22/190 (11%)
Query: 670 GDYRS--STAILSKRSSRSSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLP 725
G +R+ AI + SE D E + + H +V+LY T + +V E++
Sbjct: 23 GKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82
Query: 726 NGSLWDRLHTCH-KIEMDWVVRYAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLE 783
NG L + L K+ D + ++ +G+EYL + F IHRD+ + N L+
Sbjct: 83 NGCLLNYLRQRQGKLSKD--MLLSMCQDVCEGMEYLERNSF----IHRDLAARNCLVSST 136
Query: 784 WKPRIADFGLAKIV----QTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839
+++DFG+ + V T +G V + PE K + KSDV+SFGV++
Sbjct: 137 GVVKVSDFGMTRYVLDDEYTSSSGAKFPV-----KWSPPEVFNFSKYSSKSDVWSFGVLM 191
Query: 840 MELVT-GKRP 848
E+ T GK P
Sbjct: 192 WEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 52/172 (30%), Positives = 77/172 (44%), Gaps = 8/172 (4%)
Query: 677 AILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC 736
AIL K+ + + V L V+H +V L+ S + D V +Y+ G L+ L
Sbjct: 32 AILKKKEEKHIMSERNV-LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE 90
Query: 737 HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
YA + +A G YLH +++RD+K NILLD + + DFGL K
Sbjct: 91 RCFLEPRARFYAAEIASALG--YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK- 144
Query: 797 VQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+ E T GT Y+APE + + D + G VL E++ G P
Sbjct: 145 -ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 41/108 (37%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
+GL+Y+H V+HRD+K SN+LL+ +I DFGLA+ T E GD T
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRW 173
Query: 815 YIAPEYAYTCKINEKS-DVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861
Y APE C + DV+S G + EL+ K P+ P KD V+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK-PLFP----GKDYVH 216
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 30/186 (16%)
Query: 684 SRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH------ 737
+ ++ E L+ ++H ++VK Y D ++V+EY+ +G L ++ H
Sbjct: 49 AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMI 107
Query: 738 ---------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788
K E+ IA A G+ YL + +HRD+ + N L+ +I
Sbjct: 108 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKI 164
Query: 789 ADFGLAKIVQTGEAGDLTHVIAGTHG-----YIAPEYAYTCKINEKSDVYSFGVVLMELV 843
DFG+++ V + + + G H ++ PE K +SDV+SFGV+L E+
Sbjct: 165 GDFGMSRDVYSTD-----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219
Query: 844 T-GKRP 848
T GK+P
Sbjct: 220 TYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 63/231 (27%), Positives = 110/231 (47%), Gaps = 39/231 (16%)
Query: 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRS-STAILSKRS 683
E+ D + + +G G G V +G+++A+K + R +AI +KR+
Sbjct: 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL----------SRPFQSAIHAKRT 61
Query: 684 SRSSEYDAEVATLSAVRHVNVVKL---YCSITSEDSNLLVYEYLPNGSLWDR-LHTCHKI 739
R E+ L + H NV+ L + +S + VY L L+ K
Sbjct: 62 YR------ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH---LMGADLNNIVKC 112
Query: 740 EM--DWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
+ D +++ + +GL+Y+H +IHRD+K SNI ++ + + +I DFGLA+
Sbjct: 113 QKLSDDHIQF-LVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR-- 166
Query: 798 QTGEAGDLTHVIAGTHGYIAPEYAYTCKI--NEKSDVYSFGVVLMELVTGK 846
T + ++T +A T Y APE + N+ D++S G ++ EL+TGK
Sbjct: 167 HTDD--EMTGYVA-TRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 30/87 (34%), Positives = 49/87 (56%)
Query: 356 VNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPS 415
++N L G IP I L +L I+LS N G + +G+ SL +L L+ N F+G +P
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 416 KISEASSLVSIQLSLNQFSGQIPLDIG 442
+ + +SL + L+ N SG++P +G
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-09
Identities = 71/246 (28%), Positives = 106/246 (43%), Gaps = 57/246 (23%)
Query: 636 LIGKGGSGNVY----KVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA 691
LIGKGG G VY V + +A+K I R D S +L KR R +A
Sbjct: 9 LIGKGGMGEVYLAYDPVC---SRRVALKKI-------REDL-SENPLLKKRFLR----EA 53
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLP--NG--------SLW--DRLHTCHKI 739
++A + + H +V +Y SI S+ VY +P G S+W + L
Sbjct: 54 KIA--ADLIHPGIVPVY-SICSDGD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE 108
Query: 740 EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT 799
+ +I +EY+H + V+HRD+K NILL L + I D+G A +
Sbjct: 109 KTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKK- 164
Query: 800 GEAGDLTHV-----------------IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMEL 842
E DL + I GT Y+APE +E +D+Y+ GV+L ++
Sbjct: 165 LEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224
Query: 843 VTGKRP 848
+T P
Sbjct: 225 LTLSFP 230
|
Length = 932 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 71/261 (27%), Positives = 103/261 (39%), Gaps = 30/261 (11%)
Query: 636 LIGKGGSGNVYKV-VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++GKGG G V V +GK A K + + KR + + E
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKR-------------IKKRKGEAMALN-EKR 52
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA 754
L V VV L + ++D+ LV + G L ++ D A
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELC 112
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
GLE L +++RD+K NILLD RI+D GLA VQ E G+ GT G
Sbjct: 113 CGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPE-GETVRGRVGTVG 166
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSML 874
Y+APE K D + G ++ E++ G+ P F K+ V + D +
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP----FRKRKERVKR-----EEVDRRV 217
Query: 875 TVVDPNISEILKEDALKVLRI 895
SE EDA + R+
Sbjct: 218 KEDQEEYSEKFSEDAKSICRM 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 15/101 (14%)
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
G+ +LH D ++HRD+K+SN+LL+ +I DFGLA+ T ++ T Y
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVV-TLWY 172
Query: 816 IAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
APE Y+ I D++S G + EL+T K+P+ P
Sbjct: 173 RAPELLLGAKEYSTAI----DMWSVGCIFAELLT-KKPLFP 208
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 30/175 (17%)
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
++ EV LS + N+ +L T + ++ EY+ NG L L H E +
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQK-HVAETSGLACN 123
Query: 748 A----------IAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
+ +A A G+ YL F +HRD+ + N L+ + +IADFG+++
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLNF----VHRDLATRNCLVGKNYTIKIADFGMSRN 179
Query: 797 VQTGEAGDLTHVIAGTHG-------YIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
+ + + + G ++A E K KSDV++FGV L E++T
Sbjct: 180 LYSSDYYRV-------QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 29/189 (15%)
Query: 681 KRSSRSSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSL--WDRLH-- 734
K +S S+ D E L+ ++H ++V+ Y T L+V+EY+ +G L + R H
Sbjct: 44 KEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGP 103
Query: 735 -----------TCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783
++ + ++ AIA A G+ YL +HRD+ + N L+
Sbjct: 104 DAKILAGGEDVAPGQLTLGQML--AIASQIASGMVYLA---SLHFVHRDLATRNCLVGQG 158
Query: 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTH---GYIAPEYAYTCKINEKSDVYSFGVVLM 840
+I DFG+++ + + D V T ++ PE K +SD++SFGVVL
Sbjct: 159 LVVKIGDFGMSRDIYST---DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215
Query: 841 ELVT-GKRP 848
E+ T GK+P
Sbjct: 216 EIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 31/166 (18%)
Query: 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW---------------- 743
+H N++ L T E +V EY +G+L D L
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG 803
+V +A V A+G+E+L + IHRD+ + N+L+ + +IADFGLA+ +
Sbjct: 134 LVSFAYQV--ARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH----- 183
Query: 804 DLTHVIAGTHG-----YIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
+ + T+G ++APE + +SDV+SFGV+L E+ T
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 32/164 (19%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLV--------YEYLPNGSLWDRLHTCHKIEMD- 742
E L V H +V+++ ++ S +V Y YL S + +D
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS--------RPLPIDQ 158
Query: 743 -WVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK--IVQT 799
++ I +GL YLH + +IHRDVK+ NI ++ + I D G A+ +V
Sbjct: 159 ALIIEKQIL----EGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211
Query: 800 GEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELV 843
G +AGT APE K N K+D++S G+VL E++
Sbjct: 212 AFLG-----LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 27/164 (16%)
Query: 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR------------- 746
+H N++ L T E ++ EY G+L + L D+
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 747 -YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
+ A A+G+EYL R IHRD+ + N+L+ + +IADFGLA+ V D+
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH-----DI 187
Query: 806 THVIAGTHG-----YIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
+ ++G ++APE + +SDV+SFG+++ E+ T
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR------------- 746
+H N++ L + T + ++ EY G+L + L MD+
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 747 -YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
+ A A+G+EYL + IHRD+ + N+L+ + +IADFGLA+ V ++
Sbjct: 136 LVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH-----NI 187
Query: 806 THVIAGTHG-----YIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
+ T+G ++APE + +SDV+SFGV+L E+ T
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 25/178 (14%)
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSL--WDRLHTCHKI------ 739
++ E L+ ++H ++VK Y D ++V+EY+ +G L + R H +
Sbjct: 53 DFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 112
Query: 740 ---EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
E+ IA A G+ YL + +HRD+ + N L+ +I DFG+++
Sbjct: 113 RPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRD 169
Query: 797 VQTGEAGDLTHVIAGTHG-----YIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
V + + + G H ++ PE K +SDV+S GVVL E+ T GK+P
Sbjct: 170 VYSTD-----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 12/170 (7%)
Query: 687 SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIE------ 740
SE+ E+ + H NVV+L + + ++ EY G L L +
Sbjct: 53 SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP 112
Query: 741 -MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT 799
+ + A+ A G+++L + +HRD+ + N L+ + + +++ L+K V
Sbjct: 113 PLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169
Query: 800 GEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
E L + + ++APE + KSDV+SFGV++ E+ T G+ P
Sbjct: 170 SEYYKLRNALIPLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW---VVRY--------- 747
+H N++ L + T + ++ EY G+L + L M++ + R
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 748 --AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
+ A+G+EYL + IHRD+ + N+L+ +IADFGLA+ V ++
Sbjct: 139 LVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVN-----NI 190
Query: 806 THVIAGTHG-----YIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
+ T+G ++APE + +SDV+SFGV++ E+ T
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 9e-09
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 22/219 (10%)
Query: 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IGKG G VY+V + + A+K + S I++K+ + + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------------SKKEIVAKKEVAHTIGERNILV 48
Query: 696 LSAVRHVN-VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA 754
+ + +V L S ++ LV +Y+ G L+ L + D Y + A
Sbjct: 49 RTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA 108
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
LE+LH +++RD+K NILLD + DFGL+K T T+ GT
Sbjct: 109 --LEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCGTTE 161
Query: 815 YIAPEYAYTCKINEKS-DVYSFGVVLMELVTGKRPIVPE 852
Y+APE K K D +S GV++ E+ G P E
Sbjct: 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 48/229 (20%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIW--------PSNSGFRGDYRSSTAILSKRSSRSS 687
IG+G G V+K + + +A+K + PS S R
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS-SALR------------------ 48
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
E+ L ++H N+V+LY + S+ LV+EY + L +C+ ++D +
Sbjct: 49 ----EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNG-DIDPEIVK 102
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI----VQTGEAG 803
+ KGL + H V+HRD+K N+L++ + ++ADFGLA+ V+ A
Sbjct: 103 SFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA- 158
Query: 804 DLTHVIAGTHGYIAPEYAYTCKINEKS-DVYSFGVVLMELVTGKRPIVP 851
V+ T Y P+ + K+ S D++S G + EL RP+ P
Sbjct: 159 ---EVV--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 37/99 (37%), Positives = 54/99 (54%), Gaps = 16/99 (16%)
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG---EAGDLTHVIAGT 812
GL+Y+H V+HRD+K N+L++ + + +I DFGLA+ AG +T +A T
Sbjct: 117 GLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-T 172
Query: 813 HGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGK 846
Y APE +YT I DV+S G +L EL+ K
Sbjct: 173 RWYRAPEIMLSFQSYTKAI----DVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 60/243 (24%), Positives = 98/243 (40%), Gaps = 55/243 (22%)
Query: 637 IGKGGSGNVYKVVL----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS---SEY 689
+G+GG G V+ L ++G+ +A+K R ++L K + +E
Sbjct: 9 VGQGGYGQVF---LAKKKDTGEIVALK-------------RMKKSLLFKLNEVRHVLTER 52
Query: 690 DAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
D L+ + +VKL + ++ L EY+P G L+ + D Y
Sbjct: 53 D----ILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA 108
Query: 750 ----AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
AV A L Y IHRD+K N L+D ++ DFGL+K + T
Sbjct: 109 EMFEAVDALHELGY---------IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----Y 154
Query: 806 THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEF-GDSKD-----I 859
+ + G+ Y+APE + D +S G +L E + G P F G + + +
Sbjct: 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG----FPPFSGSTPNETWENL 210
Query: 860 VNW 862
W
Sbjct: 211 KYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 36/115 (31%), Positives = 53/115 (46%), Gaps = 24/115 (20%)
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG---- 811
G+ YLH + ++HRD+K++NIL+D + +IADFGLA+ G + G
Sbjct: 127 GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPY-DGPPPNPKGGGGGGTRK 182
Query: 812 ------THGYIAPEYA-----YTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855
T Y PE YT + D++ G V E+ T RPI+ D
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTR-RPILQGKSD 232
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 63/196 (32%), Positives = 92/196 (46%), Gaps = 35/196 (17%)
Query: 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHH- 762
VV+L+ + + +V EY+P G L + L + + + W Y V A L+ +H
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLA--LDAIHSM 161
Query: 763 GFDRPVIHRDVKSSNILLDLEWKPRIADFGLA-KIVQTGEAGDLTHVIAGTHGYIAPE-- 819
GF IHRDVK N+LLD ++ADFG K+ + G T V GT YI+PE
Sbjct: 162 GF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV--GTPDYISPEVL 215
Query: 820 --------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRD 871
Y C D +S GV L E++ G P + DS + YSK+ +
Sbjct: 216 KSQGGDGYYGREC------DWWSVGVFLYEMLVGDTPF---YADS---LVGTYSKIMNHK 263
Query: 872 SMLTVVDPNISEILKE 887
+ LT P+ ++I KE
Sbjct: 264 NSLTF--PDDNDISKE 277
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKI-EMDWVVRYAIA 750
EV+ L ++H N+V L+ + ++ S LV+EYL + L + C I M V +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ 112
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ +GL Y H R V+HRD+K N+L++ + ++ADFGLA+ V+
Sbjct: 113 I--LRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV- 166
Query: 811 GTHGYIAPEYAY-TCKINEKSDVYSFGVVLMELVTGKRPIVP 851
T Y P+ + + + + D++ G + E+ +G RP+ P
Sbjct: 167 -TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG-RPLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 52/234 (22%)
Query: 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD--AE 692
++IG+G G V K + G R D ++ + + +S+ D E
Sbjct: 1 DVIGEGNFGQVLKARIK-------------KDGLRMD--AAIKRMKEYASKDDHRDFAGE 45
Query: 693 VATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMD--------- 742
+ L + H N++ L + L EY P+G+L D L +E D
Sbjct: 46 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 105
Query: 743 -------WVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795
++ +A A+G++YL + IHRD+ + NIL+ + +IADFGL++
Sbjct: 106 ASTLSSQQLLHFA--ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 160
Query: 796 IVQTGEAGDLTHVIAGTHGYIAPEYAYTCKIN-----EKSDVYSFGVVLMELVT 844
G +V T G + + +N SDV+S+GV+L E+V+
Sbjct: 161 -------GQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 44/173 (25%), Positives = 86/173 (49%), Gaps = 15/173 (8%)
Query: 683 SSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMD 742
+ +++ E+ +S +++ N+++L S+D ++ EY+ NG L ++ + +IE
Sbjct: 58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL-NQFLSQREIEST 116
Query: 743 WV-------VRYA----IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791
+ V A +AV A G++YL +HRD+ + N L+ + +IADF
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADF 173
Query: 792 GLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
G+++ + +G+ + ++A E K SDV++FGV L E+ T
Sbjct: 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 29/84 (34%), Positives = 43/84 (51%)
Query: 163 LYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRL 222
L L N + G IP I L LQ++ LS N + G IP + + L L+L NS +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 223 PVGFSNLTNLMNFDVSQNRLEGDL 246
P LT+L +++ N L G +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 636 LIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
L+GKG G V+K L +AVK + D I ++ +E
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTC-------KEDLPQELKI---------KFLSEARI 45
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
L H N+VKL T +V E +P G L K E+ A+ AA
Sbjct: 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK-KKDELKTKQLVKFALDAAA 104
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG--EAGDLTHVIAGTH 813
G+ YL + IHRD+ + N L+ +I+DFG+++ G + L +
Sbjct: 105 GMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-- 159
Query: 814 GYIAPEYAYTCKINEKSDVYSFGVVLME 841
+ APE + + +SDV+S+G++L E
Sbjct: 160 -WTAPEALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 24/174 (13%)
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV--QTGEAGDLTHVIAGT 812
+ L+Y+H V HRD+K NIL + + K +I DFGLA++ T A T +A T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-T 169
Query: 813 HGYIAPEY--AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSR 870
Y APE ++ K D++S G + E++TGK P+ P K++V+ ++D
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFP----GKNVVH----QLDLI 220
Query: 871 DSMLTVVDPN-ISEILKEDALKVL-----RIAIHCTNKLPAFRP-SMRVVVQML 917
+L P IS + E A + L + + + K P P ++R++ ++L
Sbjct: 221 TDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLL 274
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 17/166 (10%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT-CHKIEMDWVVRYAIA 750
E++ + ++H N+V+L+ I +E+ +LV+EY+ + L + T + +D +
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFT 106
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
KG+ + H + V+HRD+K N+L++ + ++ADFGLA+ V+
Sbjct: 107 YQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV- 162
Query: 811 GTHGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
T Y AP+ Y+ I D++S G ++ E++TG RP+ P
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSI----DIWSVGCIMAEMITG-RPLFP 202
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 61/232 (26%), Positives = 90/232 (38%), Gaps = 37/232 (15%)
Query: 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS--SEYDAE 692
N +G G G VY E I SG R + L K ++ E+ E
Sbjct: 1 NFLGSGAFGEVY--------EGTATDILGPGSG---PIRVAVKTLRKGATDQEKKEFLKE 49
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIE-----MDWVVRY 747
+S H N+VKL + ++ E + G L L +
Sbjct: 50 AHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELL 109
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR-----IADFGLAKIVQTG-- 800
I + AKG YL IHRD+ + N L+ + I DFGLA+ +
Sbjct: 110 DICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166
Query: 801 ---EAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
E L V ++APE K +SDV+SFGV++ E++T G++P
Sbjct: 167 YRKEGEGLLPV-----RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 33/167 (19%)
Query: 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR------------- 746
+H N++ L + T + ++ EY G+L + L M++
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 747 -YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
+ A A+G+EYL + IHRD+ + N+L+ + +IADFGLA+ D+
Sbjct: 142 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DI 190
Query: 806 THV---IAGTHG-----YIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
H+ T+G ++APE + +SDV+SFGV+L E+ T
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 65/266 (24%), Positives = 112/266 (42%), Gaps = 43/266 (16%)
Query: 668 FRGDYRSSTAILSKRSSRSS-------EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLV 720
F G R+ ++ +S R + ++ E L H N+V+L T + +V
Sbjct: 12 FSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71
Query: 721 YEYLPNGSLWDRLHT-CHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779
E + G L T ++++ +++ + AA G+EYL + IHRD+ + N L
Sbjct: 72 MELVQGGDFLTFLRTEGPRLKVKELIQ--MVENAAAGMEYLE---SKHCIHRDLAARNCL 126
Query: 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG-------YIAPEYAYTCKINEKSDV 832
+ + +I+DFG+++ + G V A T G + APE + + +SDV
Sbjct: 127 VTEKNVLKISDFGMSREEEDG-------VYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 833 YSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALK 891
+SFG++L E + G P S +R+++ V E+ +
Sbjct: 180 WSFGILLWEAFSLGAVPYAN------------LSNQQTREAIEQGVRLPCPELCPDA--- 224
Query: 892 VLRIAIHCTNKLPAFRPSMRVVVQML 917
V R+ C P RPS V Q L
Sbjct: 225 VYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-08
Identities = 38/114 (33%), Positives = 52/114 (45%), Gaps = 27/114 (23%)
Query: 90 LDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPS 148
L L N G +P D+S L L +NL+ + I G P SL ++T+LE L L N F+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP-PSLGSITSLEVLDLSYNSFN-- 479
Query: 149 PFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGI 202
G IPE +G LT L+ L L+ N L G +PA +
Sbjct: 480 -----------------------GSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 53/177 (29%), Positives = 91/177 (51%), Gaps = 27/177 (15%)
Query: 678 ILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSIT-----SEDSNLLVYEYLPNGSLWDR 732
I +KR+ R E+ L ++H NV+ L T E +++ + +L L +
Sbjct: 58 IHAKRTYR------ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NN 110
Query: 733 LHTCHKIEMDWV--VRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790
+ C K+ D V + Y I +GL+Y+H +IHRD+K SN+ ++ + + +I D
Sbjct: 111 IVKCQKLTDDHVQFLIYQIL----RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 163
Query: 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGK 846
FGLA+ T + ++T +A T Y APE N+ D++S G ++ EL+TG+
Sbjct: 164 FGLAR--HTDD--EMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 15/100 (15%)
Query: 756 GLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
G++YL F +HRD+ + N+LL + +I+DFGL+K + E + A THG
Sbjct: 107 GMKYLEETNF----VHRDLAARNVLLVTQHYAKISDFGLSKALGADE----NYYKAKTHG 158
Query: 815 -----YIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ APE K + KSDV+SFGV++ E + G++P
Sbjct: 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 11/162 (6%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
E+ L ++H N+V L + LV+EY + L + + + + I
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK--IIW 107
Query: 752 GAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ + + H H IHRDVK NIL+ + + ++ DFG A+I+ TG D T +A
Sbjct: 108 QTLQAVNFCHKHN----CIHRDVKPENILITKQGQIKLCDFGFARIL-TGPGDDYTDYVA 162
Query: 811 GTHGYIAPEYAY-TCKINEKSDVYSFGVVLMELVTGKRPIVP 851
T Y APE + DV++ G V EL+TG+ P+ P
Sbjct: 163 -TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ-PLWP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 59/233 (25%), Positives = 107/233 (45%), Gaps = 44/233 (18%)
Query: 630 AVKPENLIGKGGSGNVYK--VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSS 687
++K E ++G G G + + + L S +EL V AI + R+ S
Sbjct: 6 SIKIERILGTGRFGELCRGCLKLPSKRELPV------------------AIHTLRAGCSD 47
Query: 688 E----YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW 743
+ + AE TL H N+V+L IT ++ ++V EY+ NG+L D H+ ++
Sbjct: 48 KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVA 106
Query: 744 VVRYAIAVGAAKGLEYLHH-GFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA 802
+ G A G++YL G+ +H+ + + +L++ + +I+ F +
Sbjct: 107 GQLMGMLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFRRLQ------- 155
Query: 803 GDLTHVIAGTHG------YIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
D + I T + APE + SDV+SFG+V+ E+++ G+RP
Sbjct: 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 40/229 (17%)
Query: 636 LIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
L+G G G VYK G+ + + ++ ++ E E+
Sbjct: 13 LVGNGTYGQVYK-----GRHVKTGQL------------AAIKVMDVTGDEEEEIKQEINM 55
Query: 696 LSAV-RHVNVVKLYCSITS------EDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVR 746
L H N+ Y + +D LV E+ GS+ D + + ++ +W+
Sbjct: 56 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 115
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
I +GL +LH VIHRD+K N+LL + ++ DFG++ Q
Sbjct: 116 --ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRR 168
Query: 807 HVIAGTHGYIAPEYAYTCKINE------KSDVYSFGVVLMELVTGKRPI 849
+ GT ++APE C N KSD++S G+ +E+ G P+
Sbjct: 169 NTFIGTPYWMAPE-VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 636 LIGKGGSGNVYKVVLNS----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA 691
+IGKG G KV+L GK AVK + +L+++ + +
Sbjct: 2 VIGKGSFG---KVLLAKRKLDGKCYAVKVL------------QKKIVLNRKEQKHIMAER 46
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
V L V+H +V L+ S + + V +++ G L+ L YA +
Sbjct: 47 NV-LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEI 105
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
+A G YLH +++RD+K NILLD + + DFGL K + D T G
Sbjct: 106 ASALG--YLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCG 158
Query: 812 THGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
T Y+APE + D + G VL E++ G P
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 5e-08
Identities = 68/243 (27%), Positives = 104/243 (42%), Gaps = 47/243 (19%)
Query: 636 LIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+I K G+G +V L K W + S +RG L +R S+ EV
Sbjct: 17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAIS-YRG--------LKER--EKSQLVIEVNV 65
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVY---EYLPNGSLWDRLHTCHK----IEMDWVVRYA 748
+ ++H N+V+ Y +N +Y E+ G L + C+K IE +V
Sbjct: 66 MRELKHKNIVR-YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD-- 122
Query: 749 IAVGAAKGLEYLHHGFDRP----VIHRDVKSSNILL---------------DLEWKP--R 787
I L Y H+ D P V+HRD+K NI L +L +P +
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY--TCKINEKSDVYSFGVVLMELVTG 845
I DFGL+K + + H GT Y +PE T ++KSD+++ G ++ EL +G
Sbjct: 183 IGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 846 KRP 848
K P
Sbjct: 240 KTP 242
|
Length = 1021 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 71/307 (23%), Positives = 121/307 (39%), Gaps = 71/307 (23%)
Query: 636 LIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+IG+G G V V ++ HI+ + D + R+ R +A+ A
Sbjct: 8 VIGRGAFGEVRLV-----QKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMD----WVVRYAIAV 751
VVK++ S + + L+ E+LP G + L + + ++ +A+
Sbjct: 63 --------VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAI 114
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA----KIVQTGEAGDLTH 807
A L GF IHRD+K N+LLD + +++DFGL K +T +LTH
Sbjct: 115 DAIHQL-----GF----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165
Query: 808 -----------------------------VIAGTHGYIAPEYAYTCKINEKSDVYSFGVV 838
GT YIAPE N+ D +S GV+
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 839 LMELVTGKRPIVPEFGDS--KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIA 896
+ E++ G P E + ++NW +++++ + ISE K+ +LR
Sbjct: 226 MYEMLIGYPPFCSETPQETYRKVMNW-------KETLVFPPEVPISEKAKD---LILRFC 275
Query: 897 IHCTNKL 903
N++
Sbjct: 276 TDSENRI 282
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 8e-08
Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 9/93 (9%)
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
+GL+Y+H +IHRD+K SN+ ++ + + RI DFGLA+ Q + ++T +A T
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR--QADD--EMTGYVA-TRW 180
Query: 815 YIAPEYAYT-CKINEKSDVYSFGVVLMELVTGK 846
Y APE N+ D++S G ++ EL+ GK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 59/233 (25%), Positives = 107/233 (45%), Gaps = 43/233 (18%)
Query: 626 EIIDAVKPENLIGKGGSGNV-YKVVLNSGKELAVKHIWPSNSGFRGDYRS-STAILSKRS 683
E+ D + +G G G V + +G ++A+K + YR + + +KR+
Sbjct: 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL----------YRPFQSELFAKRA 61
Query: 684 SRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNL-------LVYEYLPNGSLWDRLHTC 736
R E+ L ++H NV+ L + + D +L LV ++ G+ +L
Sbjct: 62 YR------ELRLLKHMKHENVIGLL-DVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKH 112
Query: 737 HKIEMDWV--VRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA 794
K+ D + + Y + KGL+Y+H +IHRD+K N+ ++ + + +I DFGLA
Sbjct: 113 EKLSEDRIQFLVYQML----KGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165
Query: 795 KIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGK 846
+ + G + T Y APE + D++S G ++ E++TGK
Sbjct: 166 RQTDSEMTGYVV-----TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 636 LIGKGGSGNVYKVVL----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA 691
++G G G V+ V +SGK A+K + + +T + +++ + +
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVL-----------KKATIVQKAKTTEHTRTER 55
Query: 692 EVATLSAVRHVN-VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
+V L +R +V L+ + ++ L+ +Y+ G L+ L + + V Y+
Sbjct: 56 QV--LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ A LE+LH +I+RD+K NILLD + DFGL+K E + +
Sbjct: 114 IVLA--LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFC 167
Query: 811 GTHGYIAPEYAYTCKI--NEKSDVYSFGVVLMELVTGKRP 848
GT Y+AP+ ++ D +S GV++ EL+TG P
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 33/223 (14%)
Query: 637 IGKGGSGNVYKV--VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
IG+G G V+K + N G+ +A+K + R T S E A +
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV-----------RVQTGEEGMPLSTIREV-AVLR 56
Query: 695 TLSAVRHVNVVKLY--CSITSEDSNL---LVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
L H NVV+L+ C+++ D LV+E++ D K+ V I
Sbjct: 57 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTETI 112
Query: 750 A---VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
+GL++LH V+HRD+K NIL+ + ++ADFGLA+I A
Sbjct: 113 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---L 166
Query: 807 HVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPI 849
+ T Y APE D++S G + E+ ++P+
Sbjct: 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 18/178 (10%)
Query: 684 SRSSEYDAEVATLSAVRHVNVVKL--YCSITSED----SNLLVYEYLPNGSL-----WDR 732
S ++ +E + H NV++L C T E S +++ ++ +G L + R
Sbjct: 42 SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR 101
Query: 733 LHTCHK-IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791
L C + + +V++ + A G+EYL + IHRD+ + N +L+ +ADF
Sbjct: 102 LGDCPQYLPTQMLVKFMTDI--ASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADF 156
Query: 792 GLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
GL+K + G+ + +IA E KSDV+SFGV + E+ T G+ P
Sbjct: 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 21/112 (18%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
E + L ++H N+V L+ I ++ + LV+EYL T K MD +++
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL---------DTDLKQYMDDCGG-GLSM 102
Query: 752 GAAK--------GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795
+ GL Y H R V+HRD+K N+L+ + ++ADFGLA+
Sbjct: 103 HNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 13/97 (13%)
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
+GL+YLH ++HRD+K N+L++ +I DFGLA++ + E+ +T + T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 815 YIAPEYA-----YTCKINEKSDVYSFGVVLMELVTGK 846
Y APE YT + D++S G + EL+ +
Sbjct: 170 YRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 48/236 (20%)
Query: 631 VKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+K +++IG+G G V K + G R D ++ + + +S+ D
Sbjct: 9 IKFQDVIGEGNFGQVLKARIK-------------KDGLRMD--AAIKRMKEYASKDDHRD 53
Query: 691 --AEVATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
E+ L + H N++ L + L EY P+G+L D L +E D
Sbjct: 54 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 113
Query: 748 A--------------IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793
A A A+G++YL + IHRD+ + NIL+ + +IADFGL
Sbjct: 114 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 170
Query: 794 AKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKIN-----EKSDVYSFGVVLMELVT 844
++ G +V T G + + +N SDV+S+GV+L E+V+
Sbjct: 171 SR-------GQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
+G G G+V + +G+++A+K + + F+ + I +KR+ R E+
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKL---SRPFQSE------IFAKRAYR------ELT 66
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYE-YLPNGSLWDRLHTC--HKIEMDWVVRYAIAV 751
L ++H NV+ L TS S + YL + L H + D V+Y +
Sbjct: 67 LLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED-KVQYLV-Y 124
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
GL+Y+H +IHRD+K N+ ++ + + +I DFGLA+ G +V+
Sbjct: 125 QMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG---YVV-- 176
Query: 812 THGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGK 846
T Y APE N+ D++S G ++ E++TGK
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 42/230 (18%)
Query: 636 LIGKGGSGNVYK-VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++G G G VYK + +G+ A+K ++ E E+
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIK------------------VMDVTEDEEEEIKLEIN 64
Query: 695 TLSAV-RHVNVVKLYCSITS------EDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVV 745
L H N+ Y + +D LV E+ GS+ D + + ++ DW+
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124
Query: 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
I +GL +LH VIHRD+K N+LL + ++ DFG++ Q
Sbjct: 125 Y--ICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGR 177
Query: 806 THVIAGTHGYIAPEYAYTCKINE------KSDVYSFGVVLMELVTGKRPI 849
+ GT ++APE C N +SD++S G+ +E+ G P+
Sbjct: 178 RNTFIGTPYWMAPE-VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 17/148 (11%)
Query: 714 EDSNL-LVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA--VGAAKGLEYLHHGFDRPVIH 770
+++NL LV +Y G L L + + R+ +A V A + LH+ +H
Sbjct: 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY------VH 125
Query: 771 RDVKSSNILLDLEWKPRIADFG-LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC----- 824
RD+K NIL+D+ R+ADFG K+++ G + V GT YI+PE
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ--SSVAVGTPDYISPEILQAMEDGKG 183
Query: 825 KINEKSDVYSFGVVLMELVTGKRPIVPE 852
K + D +S GV + E++ G+ P E
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 21/171 (12%)
Query: 680 SKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDS-----NLLVYEYLPNGSLWDRLH 734
+KR+ R E+ L V H N++ L T + S ++ + L + +L +H
Sbjct: 64 AKRAYR------ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH 117
Query: 735 TCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA 794
+E+D + G+++LH +IHRD+K SNI++ + +I DFGLA
Sbjct: 118 ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170
Query: 795 KIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTG 845
+ T +T + T Y APE E D++S G ++ ELV G
Sbjct: 171 RTACTNFM--MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 13/108 (12%)
Query: 741 MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG 800
++ ++ Y+ V A+G+E+L R IHRD+ + NILL +I DFGLA+ +
Sbjct: 172 LEDLISYSFQV--ARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK- 225
Query: 801 EAGDLTHVIAGTH----GYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
D +V G ++APE + +SDV+SFGV+L E+ +
Sbjct: 226 ---DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 65/237 (27%), Positives = 96/237 (40%), Gaps = 8/237 (3%)
Query: 22 NSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGL 81
S + L+ +L + L L ++L N +
Sbjct: 77 PSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIG 136
Query: 82 KSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLG 141
+ L+ LDL +N L L L L+L+ + +S L NL+NL L L
Sbjct: 137 LLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPK--LLSNLSNLNNLDLS 194
Query: 142 DNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAG 201
N S P E+ L L L L+N S+ ++ + NL L LELS+N+L ++P
Sbjct: 195 GN--KISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES 250
Query: 202 IVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSL 258
I L+ L L+L NN +S +LTNL D+S N L L + L L L
Sbjct: 251 IGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLEL 305
|
Length = 394 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 75/303 (24%), Positives = 128/303 (42%), Gaps = 58/303 (19%)
Query: 636 LIGKGGSGNVYKVVL----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA 691
++GKG G+V + L S +++AVK + + D SS+ I E+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKML-------KADIFSSSDI--------EEFLR 50
Query: 692 EVATLSAVRHVNVVKLY-CSITSEDSN-----LLVYEYLPNGSLWDRLHTCH------KI 739
E A + H NV+KL S+ S +++ ++ +G L L +
Sbjct: 51 EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTL 110
Query: 740 EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT 799
+ +VR+ I + A G+EYL + IHRD+ + N +L+ +ADFGL+K + +
Sbjct: 111 PLQTLVRFMIDI--ASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165
Query: 800 GEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG-DSKD 858
G+ ++A E SDV++FGV + E++T R P G ++ +
Sbjct: 166 GDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--RGQTPYAGVENSE 223
Query: 859 IVNWVYSKMDSRDSMLTVVDPNISEILKE--DAL-KVLRIAIHCTNKLPAFRPSMRVVVQ 915
I N++ LK+ D L V + C + P RPS + +
Sbjct: 224 IYNYLIK----------------GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267
Query: 916 MLE 918
LE
Sbjct: 268 QLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 39/107 (36%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
AE L+ + +V LY S+ S ++ LV EYL G + LH + + V+Y
Sbjct: 53 AERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE 112
Query: 751 VGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
V A L+YLH HG +IHRD+K N+L+ E ++ DFGL+K+
Sbjct: 113 VALA--LDYLHRHG----IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA--VGAAKGLEYLH 761
+ L+ + E+ LV +Y G L L + + R+ IA V A + LH
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 762 HGFDRPVIHRDVKSSNILLDLEWKPRIADFG-LAKIVQTGEAGDLTHVIAGTHGYIAPEY 820
+ +HRD+K N+LLD+ R+ADFG K+ Q G + V GT YI+PE
Sbjct: 123 Y------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ--SSVAVGTPDYISPEI 174
Query: 821 AYTC-----KINEKSDVYSFGVVLMELVTGKRPIVPE 852
K + D +S GV + E++ G+ P E
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 54/241 (22%), Positives = 102/241 (42%), Gaps = 37/241 (15%)
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL-----HT-CHKIEM 741
E+ E S ++H N+V L +T E +++ Y + L + L H+ +
Sbjct: 54 EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 742 DWVVRYA--------IAVGAAKGLEYL--HHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791
D V+ I A G+E+L HH V+H+D+ + N+L+ + +I+D
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDL 168
Query: 792 GLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIV 850
GL + V + L +++PE K + SD++S+GVVL E+ + G +P
Sbjct: 169 GLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-- 226
Query: 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910
Y ++D + + + + + V + + C N+ P+ RP
Sbjct: 227 -------------YCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRF 273
Query: 911 R 911
+
Sbjct: 274 K 274
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 282 LSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQ---NNFN 338
L L L G +P + +++S N + G IPP + G++T L VL N+FN
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL---GSITSLEVLDLSYNSFN 479
Query: 339 GTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLP 373
G++PE+ SL +N NSLSG +P +
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 64/247 (25%), Positives = 101/247 (40%), Gaps = 48/247 (19%)
Query: 629 DAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSS 687
DA + IG+G G VYK N+GK +A+K T +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK---------------KTRLEMDEEGIPP 45
Query: 688 EYDAEVATLSAVRHVN-VVKLYCSITSEDSN-----LLVYEYLPNG--SLWDRLH--TCH 737
E++ L + +V+L E+ N LV+EYL + D
Sbjct: 46 TALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGR 105
Query: 738 KIEMDWVVRYAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLE-WKPRIADFGLAK 795
+ + + + KG+ + H HG V+HRD+K N+L+D + +IAD GL +
Sbjct: 106 PLPAKTIKSFMYQL--LKGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
Query: 796 IVQTGEAGDLTHVIAGTHGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPIV 850
+ TH I T Y APE Y+ + D++S G + E+ K+P+
Sbjct: 160 AF-SIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSR-KQPLF 212
Query: 851 PEFGDSK 857
P GDS+
Sbjct: 213 P--GDSE 217
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 44/232 (18%)
Query: 637 IGKGGSGNVYKVVLNSGK---ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
+G+G G+VYK GK E A+K I T I S + R E+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI------------EGTGI-SMSACR------EI 49
Query: 694 ATLSAVRHVNVVKLYCSITSEDSN--LLVYEYLPNGSLWD--RLHTCHK-----IEMDWV 744
A L ++H NV+ L S L+++Y + LW + H K +++
Sbjct: 50 ALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRS 108
Query: 745 VRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR----IADFGLAKIVQT- 799
+ ++ G+ YLH + V+HRD+K +NIL+ E R IAD G A++ +
Sbjct: 109 MVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 800 -GEAGDLTHVIAGTHGYIAPEYAYTCKINEKS-DVYSFGVVLMELVTGKRPI 849
DL V+ T Y APE + K+ D+++ G + EL+T + PI
Sbjct: 166 LKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 39/115 (33%), Positives = 62/115 (53%), Gaps = 14/115 (12%)
Query: 739 IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798
+ M+ ++ Y+ V A+G+E+L R IHRD+ + NILL +I DFGLA+ +
Sbjct: 171 LTMEDLICYSFQV--ARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225
Query: 799 TGEAGDLTHVIAGTH----GYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
D +V G+ ++APE + +SDV+SFGV+L E+ + G P
Sbjct: 226 K----DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 73/287 (25%), Positives = 106/287 (36%), Gaps = 91/287 (31%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
+IGKG G V V ++GK A+K + S F+ D + + AE
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKD-------------QLAHVKAERD 53
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLL--VYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA-- 750
L+ VV LY S +D+ L + E+LP G L L D V R+ +A
Sbjct: 54 VLAESDSPWVVSLYYSF--QDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-VTRFYMAEC 110
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA---------------- 794
V A + + L GF IHRD+K NIL+D +++DFGL+
Sbjct: 111 VLAIEAVHKL--GF----IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164
Query: 795 --KIVQTGEAGDLTHVI---------------------------AGTHGYIAPE------ 819
K + + + GT YIAPE
Sbjct: 165 QGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG 224
Query: 820 YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD----IVNW 862
Y C D +S G ++ E + G P E +S + I+NW
Sbjct: 225 YGQEC------DWWSLGAIMFECLIGWPPFCSE--NSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 30/99 (30%), Positives = 55/99 (55%), Gaps = 13/99 (13%)
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG- 814
G++YL + +HRD+ + N+LL + +I+DFGL+K + D ++ A + G
Sbjct: 107 GMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL----GADDSYYKARSAGK 159
Query: 815 ----YIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ APE K + +SDV+S+G+ + E + G++P
Sbjct: 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-07
Identities = 51/195 (26%), Positives = 80/195 (41%), Gaps = 42/195 (21%)
Query: 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHH- 762
VVK++ S + + L+ E+LP G + L + + Y A ++ +H
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLA--IDSIHQL 120
Query: 763 GFDRPVIHRDVKSSNILLDLEWKPRIADFGLA----KIVQTGEAGDLTHVI--------- 809
GF IHRD+K N+LLD + +++DFGL K +T +L H +
Sbjct: 121 GF----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 810 --------------------AGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPI 849
GT YIAPE N+ D +S GV++ E++ G P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 850 VPEFGDS--KDIVNW 862
E K ++NW
Sbjct: 237 CSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 39/134 (29%), Positives = 69/134 (51%), Gaps = 11/134 (8%)
Query: 719 LVYEYLPNGSLWDRLHTCH-KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777
LV + +P G L D + +I ++ + + + AKG+ YL + ++HRD+ + N
Sbjct: 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI--AKGMSYLE---EVRLVHRDLAARN 139
Query: 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH--GYIAPEYAYTCKINEKSDVYSF 835
+L+ +I DFGLA+++ E H G ++A E + +SDV+S+
Sbjct: 140 VLVKSPNHVKITDFGLARLLDIDETE--YHADGGKVPIKWMALESILHRRFTHQSDVWSY 197
Query: 836 GVVLMELVT-GKRP 848
GV + EL+T G +P
Sbjct: 198 GVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 680 SKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITS---EDSNL--LVYEYLPNGSLWDRLH 734
R + +++ R ++ S +S E+ +L + E L+ ++
Sbjct: 117 DARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVL 176
Query: 735 TCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA 794
T ++ ++ Y+ V AKG+E+L R IHRD+ + NILL +I DFGLA
Sbjct: 177 T-----LEDLICYSFQV--AKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLA 226
Query: 795 KIVQTGEAGDLTHVIAGTH----GYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ + D +V G ++APE + +SDV+SFGV+L E+ + G P
Sbjct: 227 RDIYK----DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 44/232 (18%)
Query: 637 IGKGGSGNVYKVVLNSGKE---LAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
+G+G G+VYK GK+ A+K I T I S + R E+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI------------EGTGI-SMSACR------EI 49
Query: 694 ATLSAVRHVNVVKLYCSITSEDSN--LLVYEYLPNGSLWD--RLHTCHK-----IEMDWV 744
A L ++H NV+ L S L+++Y + LW + H K +++
Sbjct: 50 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRG 108
Query: 745 VRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR----IADFGLAKIVQT- 799
+ ++ G+ YLH + V+HRD+K +NIL+ E R IAD G A++ +
Sbjct: 109 MVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 800 -GEAGDLTHVIAGTHGYIAPEYAYTCKINEKS-DVYSFGVVLMELVTGKRPI 849
DL V+ T Y APE + K+ D+++ G + EL+T + PI
Sbjct: 166 LKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 42/173 (24%), Positives = 80/173 (46%), Gaps = 33/173 (19%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYL-----------PNGSLWDRLHTCH-KI 739
E + L ++H N+V L+ I ++++ V+EY+ P G LH + ++
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRL 107
Query: 740 EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT 799
M ++R GL Y+H + ++HRD+K N+L+ + ++ADFGLA+
Sbjct: 108 FMFQLLR---------GLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155
Query: 800 GEAGDLTHVIAGTHGYIAPEYAY-TCKINEKSDVYSFGVVLMELVTGKRPIVP 851
+ V+ T Y P+ + D++ G + +E++ G+ P P
Sbjct: 156 PSQTYSSEVV--TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ-PAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 20/177 (11%)
Query: 719 LVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778
LV EY P G L L+ + + ++ +A + + +H +HRD+K N+
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA----ELVLAIHSVHQMGYVHRDIKPENV 133
Query: 779 LLDLEWKPRIADFG-LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKS------D 831
L+D ++ADFG A++ V GT YIAPE T + K D
Sbjct: 134 LIDRTGHIKLADFGSAARLTANKMVNSKLPV--GTPDYIAPEVLTTMNGDGKGTYGVECD 191
Query: 832 VYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTV-VDPNISEILKE 887
+S GV+ E++ G+ P + Y+ + + L DP +S +
Sbjct: 192 WWSLGVIAYEMIYGRSPF------HEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLD 242
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 42/182 (23%), Positives = 72/182 (39%), Gaps = 51/182 (28%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEY-----------LPNGSLWDR-------- 732
E+ L ++ N+V+L + LV+EY +PNG ++
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL 109
Query: 733 ---LHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789
+H CHK + ++HRD+K N+L+ ++
Sbjct: 110 IKAIHWCHKND---------------------------IVHRDIKPENLLISHNDVLKLC 142
Query: 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPI 849
DFG A+ + G + T +A T Y +PE + D++S G +L EL G+ P+
Sbjct: 143 DFGFARNLSEGSNANYTEYVA-TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ-PL 200
Query: 850 VP 851
P
Sbjct: 201 FP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT-HVIAGTHG 814
G+++LH +IHRD+K SNI++ + +I DFGLA+ G + +T +V+ T
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVV--TRY 182
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGK 846
Y APE E D++S G ++ E++ G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 62/257 (24%), Positives = 98/257 (38%), Gaps = 41/257 (15%)
Query: 679 LSKRSSRSSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC 736
L + S E D E +S H N+V+L ++ E + G L L
Sbjct: 44 LPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLREN 103
Query: 737 H-------KIEMDWVVRYAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPR- 787
+ M ++ A V AKG +YL + F IHRD+ + N LL + R
Sbjct: 104 RPRPERPSSLTMKDLLFCARDV--AKGCKYLEENHF----IHRDIAARNCLLTCKGPGRV 157
Query: 788 --IADFGLAKIVQTGE---AGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMEL 842
IADFG+A+ + G + ++ PE K+DV+SFGV+L E+
Sbjct: 158 AKIADFGMARDIYRASYYRKGGRAMLPIK---WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
Query: 843 VT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTN 901
+ G P Y +++ M V + K V RI C
Sbjct: 215 FSLGYMP---------------YPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQ 259
Query: 902 KLPAFRPSMRVVVQMLE 918
P RP+ +++ ++
Sbjct: 260 HTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 39/168 (23%), Positives = 83/168 (49%), Gaps = 14/168 (8%)
Query: 687 SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWV-- 744
+++ E+ +S ++ N+++L + D ++ EY+ NG L ++ + H+ +
Sbjct: 64 NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKA 122
Query: 745 ----VRYA----IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
+ Y+ +A A G++YL +HRD+ + N L+ + +IADFG+++
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRN 179
Query: 797 VQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
+ +G+ + +++ E K SDV++FGV L E++T
Sbjct: 180 LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-06
Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 11/169 (6%)
Query: 681 KRSSRSSEY-DAEVATLSAVRHVNVVKLYCSITSEDSNLLV---YEYLPNGSLWDRLHTC 736
K SR++ + E+ L + H N++K+ + SE + ++ Y++ ++D
Sbjct: 201 KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260
Query: 737 HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
+ R AI +EY+H D+ +IHRD+K NI L+ + K + DFG A
Sbjct: 261 KDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 797 VQTG-EAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
+ EA D V GT +PE E +D++S G++L+++++
Sbjct: 317 FEKEREAFDYGWV--GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 56/246 (22%), Positives = 98/246 (39%), Gaps = 45/246 (18%)
Query: 622 FSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNS--GFRGDYRSSTAI 678
F + + + IG+G G V+K + + +A+K + N GF TA+
Sbjct: 5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF-----PITAL 59
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLY--CSITSEDSN------LLVYEYLPNGSLW 730
E+ L ++H NVV L C + N LV+E+ +
Sbjct: 60 ------------REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH---- 103
Query: 731 D--RLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788
D L + ++ + GL Y+H ++HRD+K++NIL+ + ++
Sbjct: 104 DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL 160
Query: 789 ADFGLAKIVQTGEAGD----LTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELV 843
ADFGLA+ + V+ T Y PE + D++ G ++ E+
Sbjct: 161 ADFGLARAFSLSKNSKPNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218
Query: 844 TGKRPI 849
T + PI
Sbjct: 219 T-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 50/232 (21%)
Query: 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+G G +G V+ V + K +AVK I D +S L E+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI------VLTDPQSVKHALR-----------EIKI 55
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA- 754
+ + H N+VK+Y + S+L E + + + + ++ + M+ + + G
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDL--TEDVGSLTELNSVYIVQEY-METDLANVLEQGPLS 112
Query: 755 ------------KGLEYLHHGFDRPVIHRDVKSSNILLDLE-WKPRIADFGLAKIVQT-- 799
+GL+Y+H V+HRD+K +N+ ++ E +I DFGLA+IV
Sbjct: 113 EEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169
Query: 800 GEAGDLTHVIAGTHGYIAPEYA-----YTCKINEKSDVYSFGVVLMELVTGK 846
G L+ + T Y +P YT I D+++ G + E++TGK
Sbjct: 170 SHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 65/243 (26%), Positives = 100/243 (41%), Gaps = 50/243 (20%)
Query: 632 KPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNS--GFRGDYRSSTAILSKRSSRSSE 688
+P IG G G VYK +SG +A+K + + G A+L +
Sbjct: 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKR------- 55
Query: 689 YDAEVATLSAVRHVNVVKLY--CSITSEDSNL---LVYEYLPNGSLWDRLHTCHKIEMDW 743
L A H N+V+L C+ + D LV+E++ + +D
Sbjct: 56 -------LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDL---------RTYLDK 99
Query: 744 VVRYAIAVGAAK--------GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795
V + K GL++LH ++HRD+K NIL+ + ++ADFGLA+
Sbjct: 100 VPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156
Query: 796 IVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEF-G 854
I A LT V+ T Y APE D++S G + E+ K P F G
Sbjct: 157 IYSCQMA--LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFCG 209
Query: 855 DSK 857
+S+
Sbjct: 210 NSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 31/177 (17%)
Query: 692 EVATLSAVRHVNVVKLYC-SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW------- 743
E L + H N++ + I + ++Y Y+ G+L L C E +
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 744 -VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA 802
+V AI + A G+ YLH R VIH+D+ + N ++D E + +I D L++
Sbjct: 118 QLVHMAIQI--ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR------- 165
Query: 803 GDL----THVIAGTHG----YIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIV 850
DL H + ++A E + + SDV+SFGV+L EL+T G+ P V
Sbjct: 166 -DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV 221
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 49/215 (22%), Positives = 84/215 (39%), Gaps = 25/215 (11%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEM---DWVVRYA 748
EV + H NV++ LLV E+ P G L + L + + V
Sbjct: 45 EVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR 104
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA--KIVQTGEAGDLT 806
+A A GL +LH IH D+ N L + +I D+GLA + +
Sbjct: 105 MACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC 161
Query: 807 HVIAGTHGYIAPEYA-------YTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKD 858
H + ++APE +KS+++S GV + EL T +P P+ D +
Sbjct: 162 HAVPLR--WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-YPDLSD-EQ 217
Query: 859 IVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVL 893
++ V R+ + + P + + +V+
Sbjct: 218 VLKQVV-----REQDIKLPKPQLDLKYSDRWYEVM 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 42/174 (24%), Positives = 78/174 (44%), Gaps = 20/174 (11%)
Query: 687 SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIE------ 740
+++ EV LS ++ N+++L ED ++ EY+ NG L L + H +
Sbjct: 64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123
Query: 741 -----------MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789
+ + +A+ A G++YL +HRD+ + N L+ +IA
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIA 180
Query: 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELV 843
DFG+++ + G+ + ++A E K SDV++FGV L E++
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 245 DLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFN 304
D+S+LR L S++L N G IP G L L L N G++P+ LG
Sbjct: 437 DISKLR---HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 305 YVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGT 340
++++ N L+G +P A+ L+ + +FN T
Sbjct: 494 ILNLNGNSLSGRVP------AALGGRLLHRASFNFT 523
|
Length = 623 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 54/229 (23%), Positives = 95/229 (41%), Gaps = 35/229 (15%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGK----ELAVKHIWPSNSGFRGDYRSSTAILSKRSS 684
+ + IG+G G+VY+ V S + +AVK T S
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVK----------------TCKNCTSPS 49
Query: 685 RSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWV 744
++ E + H ++VKL + +E+ +V E P G L L +K +D
Sbjct: 50 VREKFLQEAYIMRQFDHPHIVKL-IGVITENPVWIVMELAPLGELRSYLQV-NKYSLDLA 107
Query: 745 VRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGD 804
+ + L YL + +HRD+ + N+L+ ++ DFGL++ ++ D
Sbjct: 108 SLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-----D 159
Query: 805 LTHVIAGTHG----YIAPEYAYTCKINEKSDVYSFGVVLME-LVTGKRP 848
++ A ++APE + SDV+ FGV + E L+ G +P
Sbjct: 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 20/96 (20%)
Query: 769 IHRDVKSSNILLDLEWKPRIADFG-LAKIVQTGEAGDLTHVIAGTHGYIAPE-------- 819
+HRD+K N+LLD R+ADFG +++ G ++V GT YI+PE
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV--QSNVAVGTPDYISPEILQAMEDG 181
Query: 820 ---YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
Y C D +S GV + E++ G+ P E
Sbjct: 182 KGRYGPEC------DWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 62/247 (25%), Positives = 111/247 (44%), Gaps = 42/247 (17%)
Query: 615 KSFRVLSFSEKEIIDAV-----KPENL--IGKGGSGNV---YKVVLNSGKELAVKHIWPS 664
+S R +F EI D+ + +NL IG G G V Y +L + +A+K +
Sbjct: 3 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKL--- 57
Query: 665 NSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDS-----NLL 719
+++ T +KR+ R E+ + V H N++ L T + S ++
Sbjct: 58 ----SRPFQNQTH--AKRAYR------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 720 VYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779
+ L + +L + ++E+D + G+++LH +IHRD+K SNI+
Sbjct: 106 IVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIV 158
Query: 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839
+ + +I DFGLA+ G + +T + T Y APE E D++S G ++
Sbjct: 159 VKSDCTLKILDFGLAR--TAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIM 215
Query: 840 MELVTGK 846
E++ G
Sbjct: 216 GEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEY 759
RH N++ + T+ ++ ++ GS L T M + I GA +GL Y
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNY 116
Query: 760 LHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG-LAKIVQTGE----AGDLTHVIAGTHG 814
LH IHR++K+S+IL+ + ++ L +V+ G+ D
Sbjct: 117 LHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP 173
Query: 815 YIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+++PE Y Y N KSD+YS G+ EL TG+ P
Sbjct: 174 WLSPELLRQDLYGY----NVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 44/170 (25%), Positives = 71/170 (41%), Gaps = 20/170 (11%)
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
E+ T ++H N++ S + +V + GS D L T + + I
Sbjct: 48 QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFIL 107
Query: 751 VGAAKGLEYLHH-GFDRPVIHRDVKSSNILLDLEWKPRIADFGLA-KIVQTGEAG----D 804
L+Y+H GF IHR VK+S+ILL + K ++ + +++ G+ D
Sbjct: 108 KDVLNALDYIHSKGF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163
Query: 805 LTHVIAGTHGYIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+++PE Y NEKSD+YS G+ EL G P
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGY----NEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 32/103 (31%), Positives = 45/103 (43%), Gaps = 7/103 (6%)
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
I + L YLH R +IHRDVK+ NI LD + DFG A + D
Sbjct: 190 IQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA--CKLDAHPDTPQC 244
Query: 809 I--AGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPI 849
+GT +PE K+D++S G+VL E+ +
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 26/174 (14%)
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
A+G+E+L + +HRD+ + N+LL +I DFGLA+ + D +V G+
Sbjct: 247 ARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH----DSNYVSKGST 299
Query: 814 ----GYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMD 868
++APE + SDV+S+G++L E+ + G P DS Y+K+
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-----FYNKIK 354
Query: 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922
S M P+ +V I + C N P RPS + ++E P
Sbjct: 355 SGYRM---AKPD------HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
G+++LH +IHRD+K SNI++ + +I DFGLA+ G + +T + T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV-TRYY 184
Query: 816 IAPEYAYTCKINEKSDVYSFGVVLMELVTGK 846
APE E D++S G ++ E+V K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 10/92 (10%)
Query: 755 KGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
K L+++H +G + HRD+K NIL+ + ++ADFG + + + T I+ T
Sbjct: 111 KSLDHMHRNG----IFHRDIKPENILIKDD-ILKLADFGSCRGIYS--KPPYTEYIS-TR 162
Query: 814 GYIAPEYAYTCKI-NEKSDVYSFGVVLMELVT 844
Y APE T K D+++ G V E+++
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 42/167 (25%), Positives = 65/167 (38%), Gaps = 31/167 (18%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLV--------YEYLPNGSLWDRLHTCHKIEMDW 743
E L A+ H ++++L + T L+ Y YL + C +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKR---NIAICDIL---- 185
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA----KIVQT 799
AI + ++YLH + +IHRD+K+ NI ++ + DFG A I
Sbjct: 186 ----AIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238
Query: 800 GEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGK 846
G AGT APE D++S G+VL E+ T
Sbjct: 239 KYYG-----WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 30/178 (16%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT--CHKIEM-------D 742
E + L ++H N+V L+ I ++++ LV+EY+ HT C ++ +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYV---------HTDLCQYMDKHPGGLHPE 103
Query: 743 WVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA 802
V + + +GL Y+H R ++HRD+K N+L+ + ++ADFGLA+
Sbjct: 104 NVKLFLFQL--LRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158
Query: 803 GDLTHVIAGTHGYIAPEYAY-TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859
V+ T Y P+ + + + D++ G + +E++ G V F KDI
Sbjct: 159 TYSNEVV--TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG----VAAFPGMKDI 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 6e-05
Identities = 19/60 (31%), Positives = 30/60 (50%), Gaps = 1/60 (1%)
Query: 470 SLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQL 528
+L ++ + N L+ + LP+L L+LS N + P + + P L LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 56/240 (23%), Positives = 98/240 (40%), Gaps = 48/240 (20%)
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSL--WDRLHTCHKIEMDWVVRYAIA 750
+ +S + H ++VKLY + D N++V EY+ G L + + + + W + +A
Sbjct: 52 ASLMSQLSHKHLVKLY-GVCVRDENIMVEEYVKFGPLDVFLHREKNN-VSLHW--KLDVA 107
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILL---DLEWKP----RIADFGLAKIVQTGEAG 803
A L YL D+ ++H +V NIL+ L +++D G+ V + E
Sbjct: 108 KQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-- 162
Query: 804 DLTHVIAGTHGYIAPEYAYTCKINEKS-----DVYSFGVVLMELVT-GKRPIVPEFGDSK 857
+ I +IAPE + + S D +SFG L+E+ + G+ P+
Sbjct: 163 ERVERIP----WIAPEC---IRNGQASLTIAADKWSFGTTLLEICSNGEEPL-------- 207
Query: 858 DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML 917
S + S + D + + L L C P RPS R +++ L
Sbjct: 208 -------STLSSSEKERFYQDQHRLPMPDCAELANL--INQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 60/252 (23%), Positives = 103/252 (40%), Gaps = 40/252 (15%)
Query: 678 ILSKRSSRSSEYDAEVATL-SAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL-HT 735
+L K SE E A++ S + H ++V Y D +++V EY+ GSL L
Sbjct: 34 VLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN 93
Query: 736 CHKIEMDWVVRYAIAVGAAKGLEY-LHHGFDRPVIHRDVKSSNILLDLEWKP-------- 786
+ I + W + AK L + LH D+ + H +V + N+LL E
Sbjct: 94 KNLINISWKLE------VAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFI 147
Query: 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTG 845
+++D G++ V E L I ++ PE + ++ +D +SFG L E+ +G
Sbjct: 148 KLSDPGISITVLPKEI--LLERIP----WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
Query: 846 KRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPA 905
+ K K+ + + P +E+ I C + P
Sbjct: 202 GDKPLSALDSQK--------KLQFYEDRHQLPAPKWTEL-------ANLIN-QCMDYEPD 245
Query: 906 FRPSMRVVVQML 917
FRPS R +++ L
Sbjct: 246 FRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 16/158 (10%)
Query: 701 HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYL 760
H N+V + +++ +V ++ GS D + T M + I G K L+Y+
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI 117
Query: 761 HH-GFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY---- 815
HH G+ +HR VK+S+IL+ ++ K ++ GL + G V+ Y
Sbjct: 118 HHMGY----VHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKV 171
Query: 816 ---IAPEYAYTC--KINEKSDVYSFGVVLMELVTGKRP 848
++PE + KSD+YS G+ EL G P
Sbjct: 172 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 27/165 (16%)
Query: 637 IGKGGSGNVYKVVLNSG---KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
IG G G V +NSG ++ VK + R S ++ + ++ E
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKEL-----------RVSASVQEQM-----KFLEEA 46
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEM---DWVVRYAIA 750
+++H N+++ T LLV E+ P G L L +C K E+ D +A
Sbjct: 47 QPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMA 106
Query: 751 VGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA 794
A GL +LH + F IH D+ N LL + +I D+GL+
Sbjct: 107 CEIALGLLHLHKNNF----IHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 7/203 (3%)
Query: 331 LVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVT 390
L L +N +P + + SL + S S + +L L +DL+ N+ ++
Sbjct: 52 LNLSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNIS 110
Query: 391 DDIGNAKSLALLLLANNRFSGELPSKISE-ASSLVSIQLSLNQFSGQIPLDIGKLKKLSS 449
+ + +L L L NN + ++P I S+L + LS N+ +P + L L +
Sbjct: 111 E-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKN 167
Query: 450 LYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEI 509
L L N S LP + + +L +++ + N +S +P + L +L L+LSNN +
Sbjct: 168 LDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELL 225
Query: 510 PISLTYPKLSLLDLSNNQLAGPI 532
LS L+LSNN+L
Sbjct: 226 SSLSNLKNLSGLELSNNKLEDLP 248
|
Length = 394 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 11/98 (11%)
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
A+A ++Y+H +IHRD+K+ N+L++ + DFG A + + +
Sbjct: 264 AVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320
Query: 808 VIAGTHGYIAPEY----AYTCKINEKSDVYSFGVVLME 841
IAGT APE YT + D++S G+V+ E
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSV----DIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 57/278 (20%), Positives = 91/278 (32%), Gaps = 67/278 (24%)
Query: 61 QALQKINLGTNFLYGTIT------EGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLN 114
+L+++ L N +GL LQ LDL +N+ PD
Sbjct: 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALG---PDGCG-------- 99
Query: 115 LNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPM--EVLK--LEKLYWLYLTNCSV 170
+SL ++L+ L L +N + + LK L L L +
Sbjct: 100 ----------VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRL 149
Query: 171 TGQIPEGIGNL----TQLQNLELSDNELFGEIPAGIVKL-------NKLWQLELYNNSL- 218
G E + L+ L L++N + GI L L L+L NN L
Sbjct: 150 EGASCEALAKALRANRDLKELNLANNGIGDA---GIRALAEGLKANCNLEVLDLNNNGLT 206
Query: 219 ---SGRLPVGFSNLTNLMNFDVSQNRL-EGDLSEL-----RFLNQLSSLHLFEN------ 263
+ L ++L +L ++ N L + + L L +L L N
Sbjct: 207 DEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDG 266
Query: 264 --QFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGS 299
+ + E + L EL L N+ Q L
Sbjct: 267 AKDLAEVLA----EKESLLELDLRGNKFGEEGAQLLAE 300
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 33/110 (30%), Positives = 50/110 (45%), Gaps = 17/110 (15%)
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA-KIVQTGEAGDLTHVIAG-- 811
GL LH + +HRD+ +NI ++ + +IADFGLA + + L+
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 812 ---------THGYIAPEYAY-TCKINEKSDVYSFGVVLMELVTGKRPIVP 851
T Y APE K + D++S G + EL+TGK P+ P
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFP 235
|
Length = 335 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
A G+E+L + +HRD+ + N+L+ +I DFGLA+ + D ++ G+
Sbjct: 249 ANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR----DSNYISKGST 301
Query: 814 ----GYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
++APE + SDV+SFG++L E+ T
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 8e-04
Identities = 18/60 (30%), Positives = 30/60 (50%)
Query: 446 KLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKF 505
L SL L +N + + +L ++ + N+L+ P++ LPSL SL+LS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 32/166 (19%), Positives = 50/166 (30%), Gaps = 37/166 (22%)
Query: 636 LIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
L+ G + VY + +K + D EVA
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLK--INPSREKGADRER-----------------EVAI 44
Query: 696 LSAVRHVNVV--KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
L + + K+ S S+ + L+ E++ G D + K A +
Sbjct: 45 LQLLARKGLPVPKVLASGESDGWSYLLMEWIE-GETLDEVSEEEK------EDIAEQLA- 96
Query: 754 AKGLEYLH--HGFDRPV-IHRDVKSSNILLDLEWKPRIADFGLAKI 796
E L H V H D+ NIL+D I D+ A
Sbjct: 97 ----ELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 24/82 (29%), Positives = 42/82 (51%)
Query: 313 LTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSL 372
L G IP D+ K + + + N+ G +P + + SL ++ NS +G+IP + L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 373 PNLSIIDLSTNQFEGPVTDDIG 394
+L I++L+ N G V +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 60/222 (27%), Positives = 88/222 (39%), Gaps = 36/222 (16%)
Query: 79 EGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFL 138
+G+ S T L+ +DL + E+PDLSM L L L+ + P S++ L LE L
Sbjct: 628 DGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELP-SSIQYLNKLEDL 686
Query: 139 SLG--DNPFDPSPFPMEVL----KLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDN 192
+ +N +E+L L+ LY L L+ CS P+ N++ L E +
Sbjct: 687 DMSRCEN--------LEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE 738
Query: 193 ELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFL 252
E + L L +L L S +L LT LM L L+ L FL
Sbjct: 739 EFPSNLR-----LENLDELILCEMK-SEKLWERVQPLTPLMTM------LSPSLTRL-FL 785
Query: 253 NQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLP 294
+ + SL E+P L L + TLP
Sbjct: 786 SDIPSLV--------ELPSSIQNLHKLEHLEIENCINLETLP 819
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 21/170 (12%)
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR- 746
E+ E + + +VV+L ++ L++ E + G L L + + V+
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 747 -------YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT 799
+A A G+ YL+ +HRD+ + N ++ ++ +I DFG+ T
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM-----T 166
Query: 800 GEAGDLTHVIAGTHG-----YIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
+ + + G G +++PE SDV+SFGVVL E+ T
Sbjct: 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 947 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.36 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.33 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.3 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.23 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.22 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.2 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.2 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.15 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.15 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.14 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.97 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.89 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.86 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.74 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.66 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.54 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.5 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.37 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.37 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-111 Score=1063.49 Aligned_cols=882 Identities=32% Similarity=0.570 Sum_probs=646.7
Q ss_pred CCcccccccCCccccccccCCCCCcccceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchh
Q 002250 1 MNLKSKIEKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEG 80 (947)
Q Consensus 1 ~~~k~~~~~~~~~~~~sw~~~~~~C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~ 80 (947)
+.||.++. ++.+.+++|+.++|||.|.||+|++.++|+.|+|+++++.|.++ .++..+++|+.|+|++|.+.+.+|..
T Consensus 35 ~~~~~~~~-~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~-~~~~~l~~L~~L~Ls~n~~~~~ip~~ 112 (968)
T PLN00113 35 LSFKSSIN-DPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKIS-SAIFRLPYIQTINLSNNQLSGPIPDD 112 (968)
T ss_pred HHHHHhCC-CCcccCCCCCCCCCCCcCcceecCCCCcEEEEEecCCCccccCC-hHHhCCCCCCEEECCCCccCCcCChH
Confidence 35888884 67788999998899999999999988999999999999999886 68999999999999999999888876
Q ss_pred hh-cCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhccccc
Q 002250 81 LK-SCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEK 159 (947)
Q Consensus 81 l~-~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~ 159 (947)
+. .+++|++|+|++|.+++.+|. +.+++|++|+|++|.+.+.+| ..+.++++|++|+|++|.+.. .+|..+.++++
T Consensus 113 ~~~~l~~L~~L~Ls~n~l~~~~p~-~~l~~L~~L~Ls~n~~~~~~p-~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~ 189 (968)
T PLN00113 113 IFTTSSSLRYLNLSNNNFTGSIPR-GSIPNLETLDLSNNMLSGEIP-NDIGSFSSLKVLDLGGNVLVG-KIPNSLTNLTS 189 (968)
T ss_pred HhccCCCCCEEECcCCccccccCc-cccCCCCEEECcCCcccccCC-hHHhcCCCCCEEECccCcccc-cCChhhhhCcC
Confidence 65 888999999988888765553 446666666666666665555 456666666666666666543 23555556666
Q ss_pred CcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccC
Q 002250 160 LYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQ 239 (947)
Q Consensus 160 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 239 (947)
|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..+.++++|++|+|++|.+++.+|..|+++++|++|+|++
T Consensus 190 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 269 (968)
T PLN00113 190 LEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ 269 (968)
T ss_pred CCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcC
Confidence 66666666666555555555555666666665555555555555555555555555555555555555555555555555
Q ss_pred CCCCCC-Cccc------------------------cccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCC
Q 002250 240 NRLEGD-LSEL------------------------RFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLP 294 (947)
Q Consensus 240 N~l~~~-~~~l------------------------~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 294 (947)
|++.+. +..+ ..+++|+.|++++|.+.+..|..+..+++|+.|++++|.+++.+|
T Consensus 270 n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p 349 (968)
T PLN00113 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349 (968)
T ss_pred CeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCC
Confidence 555432 2234 444455555555555555555555555555555555555555555
Q ss_pred cCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCC
Q 002250 295 QKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPN 374 (947)
Q Consensus 295 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 374 (947)
..++.+++|+.|++++|.+++.+|..++.+..++.|.+.+|++.+.+|..+..+++|+.|++++|.+++..|..+..+++
T Consensus 350 ~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~ 429 (968)
T PLN00113 350 KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429 (968)
T ss_pred hHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCC
Confidence 55555666666666666666666666666666666666666666777777777788888888888888888888888888
Q ss_pred cceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccc
Q 002250 375 LSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHD 454 (947)
Q Consensus 375 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (947)
|+.|++++|++.+.++..+..+++|+.|++++|++.+.+|..+ ..++|+.|++++|++++.+|..+.++++|+.|+|++
T Consensus 430 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 508 (968)
T PLN00113 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSE 508 (968)
T ss_pred CCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcC
Confidence 8888888888888888778888888888888888887777765 457899999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc-ccccceeeCCCCcCCCCCC
Q 002250 455 NMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQLAGPIP 533 (947)
Q Consensus 455 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N~l~~~~p 533 (947)
|++.+.+|..++.+++|+.|+|++|++++.+|..+.++++|+.|+|++|+++|.+|..+. +++|+.|++++|+++|.+|
T Consensus 509 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 509 NKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred CcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 999999999999999999999999999999999999999999999999999999998775 5899999999999999999
Q ss_pred Cccc-ccccccccccCCCCCCCCcc-ccCccCCCCCCCcccchhhhHHHHHHHHHHHHHHHHHhhhhhhhccc-ccc--c
Q 002250 534 EPLN-IKAFIDSFTGNPGLCSKTDE-YFKSCSSGSGRSHHVSTFVWCLIAITMVLLVLLASYFVVKLKQNNLK-HSL--K 608 (947)
Q Consensus 534 ~~~~-~~~~~~~~~gN~~~c~~~~~-~~~~~~s~~~~~~~~~~~i~~~i~~~~~~~vl~~~~~~~~~~~~~~~-~~~--~ 608 (947)
+... ..+...++.|||.+|+.... ..+.|..... .....+++++++++++++++++++++++++++..+ ++. .
T Consensus 589 ~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (968)
T PLN00113 589 STGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENE 666 (968)
T ss_pred CcchhcccChhhhcCCccccCCccccCCCCCccccc--cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccc
Confidence 7655 33455689999999986532 2345533211 11111222222222222222222222222222111 111 1
Q ss_pred cCcccccccc---cccccHHHHhhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccC
Q 002250 609 QNSWDMKSFR---VLSFSEKEIIDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSS 684 (947)
Q Consensus 609 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (947)
...|...... ...+..+++...++..+.||+|+||.||+|+. .+++.||||++...
T Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-------------------- 726 (968)
T PLN00113 667 DGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV-------------------- 726 (968)
T ss_pred cccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCC--------------------
Confidence 1112211110 11123355667788889999999999999996 47899999987311
Q ss_pred ChhhHHHHHHHHhhccccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCC
Q 002250 685 RSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGF 764 (947)
Q Consensus 685 ~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~ 764 (947)
.....+|++++++++|||||+++|+|.+++..|+||||+++|+|.++++. ++|..+.+++.|+|+||+|||+.+
T Consensus 727 -~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~ 800 (968)
T PLN00113 727 -NSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRC 800 (968)
T ss_pred -ccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCC
Confidence 01123568899999999999999999999999999999999999999974 799999999999999999999766
Q ss_pred CCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh
Q 002250 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844 (947)
Q Consensus 765 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt 844 (947)
+++|+||||||+||+++.++.+++. ||.+...... ....+|+.|+|||++.+..++.++|||||||++|||+|
T Consensus 801 ~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~t 873 (968)
T PLN00113 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT 873 (968)
T ss_pred CCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHh
Confidence 7899999999999999999888875 6655433211 12357899999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcccHHHHHHhhccccccccccccCCC---CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 845 GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNI---SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 845 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
|+.||.........+.+|......... ....+|+.+ .....++..++.+++.+||+.||++||||.||+++|+++.
T Consensus 874 g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 874 GKSPADAEFGVHGSIVEWARYCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCCCCcccCCCCcHHHHHHHhcCccc-hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 999997766667778887765433222 233445544 2334566778999999999999999999999999999876
Q ss_pred CCC
Q 002250 922 PCS 924 (947)
Q Consensus 922 ~~~ 924 (947)
...
T Consensus 953 ~~~ 955 (968)
T PLN00113 953 RSS 955 (968)
T ss_pred ccc
Confidence 644
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-57 Score=572.57 Aligned_cols=491 Identities=33% Similarity=0.514 Sum_probs=420.3
Q ss_pred cccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCC--cccccccceeecCCCCccCccCcccccccCCCcee
Q 002250 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFL 138 (947)
Q Consensus 61 ~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~--l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L 138 (947)
.+++.|+|++|.+.+.++..+..+++|+.|+|++|++++..|. +..+++|++|+|++|++++.+| ...+++|++|
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p---~~~l~~L~~L 145 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP---RGSIPNLETL 145 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccC---ccccCCCCEE
Confidence 4789999999999999999999999999999999999986664 4599999999999999998877 3568999999
Q ss_pred eCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccc
Q 002250 139 SLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSL 218 (947)
Q Consensus 139 ~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l 218 (947)
+|++|.+.. .+|..+..+++|++|+|++|.+.+.+|..++++++|++|+|++|.+.+.+|..+.++++|++|+|++|.+
T Consensus 146 ~Ls~n~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 224 (968)
T PLN00113 146 DLSNNMLSG-EIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224 (968)
T ss_pred ECcCCcccc-cCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc
Confidence 999999974 4688899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCccCCCCCCccEEeccCCCCCC-CCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCc
Q 002250 219 SGRLPVGFSNLTNLMNFDVSQNRLEG-DLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKL 297 (947)
Q Consensus 219 ~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l 297 (947)
++.+|..|.++++|++|+|++|++++ .+..+..+++|+.|+|++|++.+.+|..+..+++|++|+|++|.+++.+|..+
T Consensus 225 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~ 304 (968)
T PLN00113 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304 (968)
T ss_pred CCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhH
Confidence 99999999999999999999999986 45578999999999999999999999999999999999999999999999999
Q ss_pred cCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcce
Q 002250 298 GSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSI 377 (947)
Q Consensus 298 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 377 (947)
..+++|+.|++++|.+++.+|..+..+++|+.|.+.+|++.+.+|..++.+++|+.|++++|.+++.+|..++.+++|+.
T Consensus 305 ~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~ 384 (968)
T PLN00113 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384 (968)
T ss_pred cCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCE
Confidence 99999999999999999999999999999999999999999999988888899999999998888877777776666666
Q ss_pred eccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccc---------------
Q 002250 378 IDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIG--------------- 442 (947)
Q Consensus 378 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--------------- 442 (947)
|++++|++.+..|..+..+++|+.|++++|++++.+|..+..++.|+.|++++|++++.+|..+.
T Consensus 385 L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~ 464 (968)
T PLN00113 385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464 (968)
T ss_pred EECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCcee
Confidence 66666666666666666666666666666666555555555555555555555555544443322
Q ss_pred --------cccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc
Q 002250 443 --------KLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT 514 (947)
Q Consensus 443 --------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 514 (947)
..++|+.|+|++|++++.+|..|..+++|+.|+|++|++++.+|..+.++++|+.|+|++|+++|.+|..+.
T Consensus 465 ~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 544 (968)
T PLN00113 465 FGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS 544 (968)
T ss_pred eeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHh
Confidence 245677788888888888888999999999999999999999999999999999999999999999998876
Q ss_pred -ccccceeeCCCCcCCCCCCCcccc--cccccccccCCCCCCCC
Q 002250 515 -YPKLSLLDLSNNQLAGPIPEPLNI--KAFIDSFTGNPGLCSKT 555 (947)
Q Consensus 515 -~~~L~~L~ls~N~l~~~~p~~~~~--~~~~~~~~gN~~~c~~~ 555 (947)
+++|+.|||++|+++|.+|..+.. ......+.+|+..+..+
T Consensus 545 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 545 EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred CcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 599999999999999999976642 23344677888766443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-50 Score=436.52 Aligned_cols=287 Identities=43% Similarity=0.709 Sum_probs=245.1
Q ss_pred ccccccccH-HHHhhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCC-hhhHHHHH
Q 002250 616 SFRVLSFSE-KEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSR-SSEYDAEV 693 (947)
Q Consensus 616 ~~~~~~~~~-~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~E~ 693 (947)
....+++.+ +.++++|...+.||+|+||.||+|.+++|+.||||++.... .. ..+|.+|+
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~------------------~~~~~eF~~Ei 122 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNS------------------GQGEREFLNEV 122 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCC------------------CcchhHHHHHH
Confidence 345566666 78889999999999999999999999999999999873211 11 45699999
Q ss_pred HHHhhccccccceEEEEEecCCc-cEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecc
Q 002250 694 ATLSAVRHVNVVKLYCSITSEDS-NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRD 772 (947)
Q Consensus 694 ~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~D 772 (947)
.++.+++|||+|+++|||.+.+. .++|||||++|+|.++++.....+++|..|++||.++|+||+|||+.+.++|||||
T Consensus 123 ~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrD 202 (361)
T KOG1187|consen 123 EILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRD 202 (361)
T ss_pred HHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCC
Confidence 99999999999999999999995 99999999999999999975433789999999999999999999988888999999
Q ss_pred CCCCCeEecCCCCeEEeccccceecccCCCCcceecc-cccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 773 VKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI-AGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 773 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
|||+|||+|+++++||+|||+|+..+..... .... .||.+|+|||++..+..+.|+|||||||++.|++||++|.+.
T Consensus 203 iKssNILLD~~~~aKlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 203 IKSSNILLDEDFNAKLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred CCHHHeeECCCCCEEccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence 9999999999999999999999765441111 1112 799999999999999999999999999999999999998875
Q ss_pred CC-CCcccHHHHHHhhccccccccccccCCCC--ccCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 852 EF-GDSKDIVNWVYSKMDSRDSMLTVVDPNIS--EILK-EDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 852 ~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~~~--~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
.. .....+.+|........ .+.+++|+.+. +... +....+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 281 ~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 281 SRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 54 34455899987777666 56899999984 4443 6888899999999999999999999999999665543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=382.14 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=215.0
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.+.+....||+|..|+|||++++ +++.+|+|+++.. ......+++.+|++++++.+||+||++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~----------------~~~~~~~Qi~rEl~il~~~~spyIV~~ 142 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN----------------IDPALQKQILRELEILRSCQSPYIVGF 142 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc----------------CCHHHHHHHHHHHHHHhhCCCCCeeeE
Confidence 34556788999999999999976 7889999998321 122345678899999999999999999
Q ss_pred EEEEecCCc-cEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 708 YCSITSEDS-NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 708 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
||.|..++. ..|+||||++|+|.+.++.. ..+++...-+++.+|++||.|||+ +++||||||||+|||++..|++
T Consensus 143 ygaF~~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeV 218 (364)
T KOG0581|consen 143 YGAFYSNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEV 218 (364)
T ss_pred eEEEEeCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCE
Confidence 999999995 99999999999999999975 448888999999999999999995 5899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||||||.++..-.. .....+||..|||||.+.+..|+.++||||||++++|+++|+.||.+......+..+.+...
T Consensus 219 KicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I 294 (364)
T KOG0581|consen 219 KICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI 294 (364)
T ss_pred EeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH
Confidence 99999999876554 23456899999999999999999999999999999999999999977644455555554433
Q ss_pred ccccccccccccCCCCccCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKE-DALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
. +...+..+.+ ..+++..++-.|+++||.+||++.|++++
T Consensus 295 v----------~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 295 V----------DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred h----------cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 3 3333444443 67789999999999999999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=399.07 Aligned_cols=259 Identities=36% Similarity=0.472 Sum_probs=212.3
Q ss_pred ccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
.....+.+|+|+||+||+|.++....||||++.....+ .....+|.+|+.++++++|||||+++|
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~---------------~~~~~~f~~E~~il~~l~HpNIV~f~G 106 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFD---------------DESRKAFRREASLLSRLRHPNIVQFYG 106 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcC---------------hHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 34455669999999999999994444999998432211 011568999999999999999999999
Q ss_pred EEecCC-ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEeccCCCCCeEecCCC-Ce
Q 002250 710 SITSED-SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRP-VIHRDVKSSNILLDLEW-KP 786 (947)
Q Consensus 710 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~-ivH~Dlkp~NIll~~~~-~~ 786 (947)
+|.++. ..++||||+++|+|.++++......+++..++++|.|||+||+||| +.+ ||||||||+|||++.++ ++
T Consensus 107 ~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~ 183 (362)
T KOG0192|consen 107 ACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTL 183 (362)
T ss_pred EEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEE
Confidence 999987 7899999999999999998865678999999999999999999999 777 99999999999999998 99
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccc--cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY--TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
||+|||+++...... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ...+.
T Consensus 184 KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~ 256 (362)
T KOG0192|consen 184 KIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVAS 256 (362)
T ss_pred EECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHH
Confidence 999999998765432 2233468999999999999 56899999999999999999999999954321 22222
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
.... ....++++.+++..+..++.+||+.||++||++.+++..|+.+..
T Consensus 257 ~v~~---------~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 257 AVVV---------GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred HHHh---------cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 2211 122234445577889999999999999999999999999997543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=395.57 Aligned_cols=255 Identities=29% Similarity=0.397 Sum_probs=214.4
Q ss_pred ccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
.++..+.||+|.||+||.|.++....||||.+.+. ....+.|.+|+++|++|+|++||+++|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~------------------~m~~~~f~~Ea~iMk~L~H~~lV~l~g 268 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG------------------SMSPEAFLREAQIMKKLRHEKLVKLYG 268 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc------------------ccChhHHHHHHHHHHhCcccCeEEEEE
Confidence 45567889999999999999997779999998432 244578889999999999999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
+|..++..|||||||+.|+|.++++..++..+...+.+.++.|||+||+||+ ++++|||||.++||||+++..+||+
T Consensus 269 V~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIs 345 (468)
T KOG0197|consen 269 VCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKIS 345 (468)
T ss_pred EEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEc
Confidence 9999999999999999999999999877778999999999999999999999 9999999999999999999999999
Q ss_pred ccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcc
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
|||+|+...++.+.... ...-...|.|||.+..++++.|||||||||++|||+| |+.||... ...+..+.+ +
T Consensus 346 DFGLAr~~~d~~Y~~~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--sn~ev~~~l----e 418 (468)
T KOG0197|consen 346 DFGLARLIGDDEYTASE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--SNEEVLELL----E 418 (468)
T ss_pred ccccccccCCCceeecC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC--CHHHHHHHH----h
Confidence 99999955444432222 2234678999999999999999999999999999999 88887422 122222221 1
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
.+..-+.+..++..+.++|..||+.+|++|||+..+...++++.
T Consensus 419 ---------~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 419 ---------RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred ---------ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 12223456678889999999999999999999999998888754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=366.98 Aligned_cols=200 Identities=31% Similarity=0.462 Sum_probs=177.3
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|...+.||+|+||+||+|+++ ++..||||.+.... ......+-+..|+++++.++|||||+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~---------------l~~k~~e~L~~Ei~iLkel~H~nIV~ 73 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK---------------LNKKLVELLLSEIKILKELKHPNIVR 73 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc---------------cCHHHHHHHHHHHHHHHhcCCcceee
Confidence 467888888999999999999966 68999999983111 12233456789999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC---
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE--- 783 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~--- 783 (947)
+++++..++..|+|||||+||+|.+++++.+ .+++.....++.|+|.||++|| +++||||||||+|||++..
T Consensus 74 l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~ 148 (429)
T KOG0595|consen 74 LLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARN 148 (429)
T ss_pred EEEEEecCCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCC
Confidence 9999999999999999999999999999854 5899999999999999999999 8999999999999999865
Q ss_pred ---CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 002250 784 ---WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 784 ---~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
..+||+|||+|+...+... ....+|++.|||||+++.++|+.|+|+||+|+++|||++|+.||.
T Consensus 149 ~~~~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 149 DTSPVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred CCCceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 5689999999998875543 335689999999999999999999999999999999999999995
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=381.72 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=212.0
Q ss_pred hccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.+|+..+.||+|+|+.||+++. .+|+.||+|++... ........+...+||+|.+.|+|||||++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~--------------~l~k~~~reKv~~EIeIHr~L~HpnIV~f 83 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKK--------------LLKKPKQREKVLNEIEIHRSLKHPNIVQF 83 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehH--------------HhcCcchHHHHHHHHHHHHhcCCCcEEee
Confidence 5799999999999999999996 78999999999422 12233455778899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++|++.+.+|||.|+|+.++|..+++. +.++++..+..+..||+.||.||| +.+|+|||||..|++++++.++|
T Consensus 84 ~~~FEDs~nVYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VK 158 (592)
T KOG0575|consen 84 YHFFEDSNNVYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVK 158 (592)
T ss_pred eeEeecCCceEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEE
Confidence 9999999999999999999999999984 567899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||+|..+...+. .....+|||.|+|||++....++..+||||+|||+|-|+.|++||+ ..++-+......
T Consensus 159 IgDFGLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe-----tk~vkety~~Ik 231 (592)
T KOG0575|consen 159 IGDFGLATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE-----TKTVKETYNKIK 231 (592)
T ss_pred ecccceeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc-----cchHHHHHHHHH
Confidence 999999998865432 2235689999999999998889999999999999999999999994 333444333332
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..... ++.....+..+++.++++.+|.+|||+.+|+..
T Consensus 232 ~~~Y~-----------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 232 LNEYS-----------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred hcCcc-----------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22222 223444567788889999999999999999953
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=365.94 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=207.6
Q ss_pred HHHhhccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.+.+.|.+.+.+|+|+||.|-+|. .++|+.||||+++........ .........++|+++|++++|||
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s----------~~~~~~~~v~~EieILkkL~HP~ 237 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCS----------RAIAKTRDVQNEIEILKKLSHPN 237 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccc----------ccccchhhhHHHHHHHHhcCCCC
Confidence 3456778889999999999999999 458999999999644322110 00112234679999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
||+++++|..++..||||||++||.|.+++-..+. +.+..-..++.|++.|+.||| ++||+||||||+|||+..+
T Consensus 238 IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~ 312 (475)
T KOG0615|consen 238 IVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSND 312 (475)
T ss_pred EEEEeeeeecCCceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccC
Confidence 99999999999999999999999999999987544 555556779999999999999 9999999999999999866
Q ss_pred ---CCeEEeccccceecccCCCCcceecccccccccCccccccCC---CCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 784 ---WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK---INEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 784 ---~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
..+||+|||+|+..+.. ..+...+||+.|.|||++.+.. +..++|+||+||++|-+++|.+||-....+..
T Consensus 313 ~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s 389 (475)
T KOG0615|consen 313 AEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS 389 (475)
T ss_pred CcceEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc
Confidence 77999999999987643 3455679999999999997654 33478999999999999999999965443321
Q ss_pred cHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 858 DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
- .+ ....++.. ..+....+..++..+++.+|+..||++|||+.|++++
T Consensus 390 l-~e---QI~~G~y~-------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 390 L-KE---QILKGRYA-------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred H-HH---HHhcCccc-------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1 11 11111111 1134455667788899999999999999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=349.91 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=210.3
Q ss_pred hhccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
...|++.++||+|+||+|||+. ..+|..||.|.++-+. ....+.+....|+.++++|+|||||+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~---------------md~k~rq~~v~Ei~lLkQL~HpNIVq 82 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM---------------MDAKARQDCVKEISLLKQLNHPNIVQ 82 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh---------------ccHHHHHHHHHHHHHHHhcCCchHHH
Confidence 3568889999999999999999 6689999999884222 12244567889999999999999999
Q ss_pred EEE-EEecCCc-cEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCCeEec
Q 002250 707 LYC-SITSEDS-NLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFD-RPVIHRDVKSSNILLD 781 (947)
Q Consensus 707 l~~-~~~~~~~-~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~Dlkp~NIll~ 781 (947)
+++ .+.++.. .+|||||++.|+|..+++.. ....+++..++++..|++.||.++|..+. .-|+||||||.||+++
T Consensus 83 Yy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~ 162 (375)
T KOG0591|consen 83 YYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT 162 (375)
T ss_pred HHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc
Confidence 998 4555555 78999999999999999754 45679999999999999999999994222 2399999999999999
Q ss_pred CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
.+|.+||+|||++++...... .....+|||.||+||.+.+..|+.||||||+||++|||+.=++||.+. .+.+
T Consensus 163 ~~gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~ 235 (375)
T KOG0591|consen 163 ANGVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLS 235 (375)
T ss_pred CCCceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHH
Confidence 999999999999998866543 334678999999999999999999999999999999999999999543 4444
Q ss_pred HHHhhccccccccccccCCCCccC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEIL-KEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
......+ ...++.+ ......+..++..|+..||+.||+...+++.++
T Consensus 236 L~~KI~q----------gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 236 LCKKIEQ----------GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHHHHHc----------CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 3322222 2334455 456678899999999999999998555554444
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=400.59 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=221.2
Q ss_pred hccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
.+.+..+.||+|.||+||+|+.. +.+-||||.++.. ...+..++|++|++.++.++||
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~----------------a~~~~~~dF~REaeLla~l~H~ 549 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK----------------AENQARQDFRREAELLAELQHP 549 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc----------------ccHHHHHHHHHHHHHHHhccCC
Confidence 34556788999999999999843 3567999988422 1223568999999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------Cc----cCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------KI----EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIH 770 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~----~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 770 (947)
|||+++|+|.+++..++|+|||..|+|.++|.... .. +++..+.+.||.|||.||+||. ++.+||
T Consensus 550 nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVH 626 (774)
T KOG1026|consen 550 NIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVH 626 (774)
T ss_pred CeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccc
Confidence 99999999999999999999999999999997541 12 3888999999999999999999 899999
Q ss_pred ccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCC
Q 002250 771 RDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPI 849 (947)
Q Consensus 771 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~ 849 (947)
|||..+|+||.++..|||+|||+++.....+++.......-..+|||||.++.++|+.+||||||||++||+++ |+.||
T Consensus 627 RDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy 706 (774)
T KOG1026|consen 627 RDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPY 706 (774)
T ss_pred cchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcc
Confidence 99999999999999999999999998877777655434445789999999999999999999999999999999 99998
Q ss_pred CCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 850 VPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
++. ..++..+. +-++.+-+.++.++.++++||+.||+..|++||+++||-..|+.+....
T Consensus 707 ~gl--Sn~EVIe~-------------i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 707 YGL--SNQEVIEC-------------IRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ccc--chHHHHHH-------------HHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 543 22222222 2233445678889999999999999999999999999999999876554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=354.12 Aligned_cols=260 Identities=25% Similarity=0.316 Sum_probs=207.0
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.+.|++.+.||+|+||+||+++.+ +++.+|+|++..... ....+.....+|..++.+++||+||+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~i--------------v~~~e~~~~~~Er~IL~~v~hPFiv~ 89 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKI--------------VEKKEVRHTKAERNILSKIKHPFIVK 89 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHh--------------hhhhhHHHHHHHHHHHHhCCCCcEee
Confidence 478999999999999999999955 689999999943221 11245567889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
++-.|++++..|+|+||+.||.|..++.+.+ .+++....-.+..|+.||.||| +.+||||||||+|||+|.+|.+
T Consensus 90 l~ysFQt~~kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi 164 (357)
T KOG0598|consen 90 LIYSFQTEEKLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHI 164 (357)
T ss_pred eEEecccCCeEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcE
Confidence 9999999999999999999999999999754 4777777778889999999999 9999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
+|+|||+++....... .+..++||+.|||||++.+..|+..+|.||+|+++|||++|.+||. ..+...+....
T Consensus 165 ~LtDFgL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~-----~~~~~~~~~~I 237 (357)
T KOG0598|consen 165 KLTDFGLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY-----AEDVKKMYDKI 237 (357)
T ss_pred EEeccccchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc-----CccHHHHHHHH
Confidence 9999999985443322 2345799999999999999999999999999999999999999995 33444444333
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
.... +...+.-...+..+++.+.+..||++|.....=.+.+++..-.
T Consensus 238 ~~~k----------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF 284 (357)
T KOG0598|consen 238 LKGK----------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFF 284 (357)
T ss_pred hcCc----------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccc
Confidence 3332 1111222334567778899999999997432223334444333
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.86 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=213.9
Q ss_pred hhccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.+.|+..+.||.|..++||+|+ .+.+..||||++. ..+.......+.+|+..++.++||||++
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~in----------------LEkc~~~ld~l~kE~~~msl~~HPNIv~ 88 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIIN----------------LEKCNNDLDALRKEVQTMSLIDHPNIVT 88 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEee----------------hhhhhhhHHHHHHHHHHhhhcCCCCcce
Confidence 3679999999999999999999 5678999999993 3334455788999999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
++..|..+...|+||.||.+|++.+.++......+++..+..|..++++||.||| .+|.||||||+.|||++.+|.|
T Consensus 89 ~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~V 165 (516)
T KOG0582|consen 89 YHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTV 165 (516)
T ss_pred EEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcE
Confidence 9999999999999999999999999999887778999999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCc-ce-ecccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 787 RIADFGLAKIVQTGEAGD-LT-HVIAGTHGYIAPEYAYT--CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
||+|||.+..+....... .. ...+||+.|||||+++. ..|+.|+||||||++..|+.+|..||. ...-...
T Consensus 166 kLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~-----k~pPmkv 240 (516)
T KOG0582|consen 166 KLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS-----KYPPMKV 240 (516)
T ss_pred EEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc-----cCChHHH
Confidence 999999887655443211 11 34589999999999643 349999999999999999999999983 2233334
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
+...+++...... ....-.+........+.+++..|+.+||.+|||+.++++
T Consensus 241 Ll~tLqn~pp~~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 241 LLLTLQNDPPTLL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHHHhcCCCCCcc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 4444444332111 000112222334457889999999999999999999985
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.41 Aligned_cols=262 Identities=28% Similarity=0.406 Sum_probs=211.7
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.+.+.+.+.||+|+||+||+|++. ..||||++..+. ......+.|+.|+.++++-+|.||+=|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~---------------pt~~qlqaFKnEVa~lkkTRH~NIlLF 453 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDD---------------PTPEQLQAFKNEVAVLKKTRHENILLF 453 (678)
T ss_pred HHHhhccceeccccccceeecccc--cceEEEEEecCC---------------CCHHHHHHHHHHHHHHhhcchhhheee
Confidence 356678899999999999999998 469999994322 122356889999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
.|||..+.. .||+.|++|-+|+.+++..+ ..++..+...||.|||+||.||| .++|||||||..||++.+++.||
T Consensus 454 MG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVk 528 (678)
T KOG0193|consen 454 MGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVK 528 (678)
T ss_pred ehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEE
Confidence 999999877 99999999999999999743 56899999999999999999999 99999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC---KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
|+|||++................|...|||||+++.. .|++.+||||||+|+|||+||..||.....+. .++
T Consensus 529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-----Iif 603 (678)
T KOG0193|consen 529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-----IIF 603 (678)
T ss_pred EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-----eEE
Confidence 9999999755433222222233577899999999754 48899999999999999999999984211110 000
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
...++ -..+.......+++.++.+|+..||.+++++||.+.+++..|+++.+
T Consensus 604 mVGrG------~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 604 MVGRG------YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred Eeccc------ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 00000 01123345566778889999999999999999999999999988776
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=373.25 Aligned_cols=470 Identities=25% Similarity=0.367 Sum_probs=330.6
Q ss_pred EeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCC
Q 002250 40 EINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSG 119 (947)
Q Consensus 40 ~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~ 119 (947)
.+.++++.+...- +.+..+..|+.|++++|++ ...|.+++++..++.|+.++|+++..++.++.+.+|..|+.++|.
T Consensus 49 ~lils~N~l~~l~--~dl~nL~~l~vl~~~~n~l-~~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~ 125 (565)
T KOG0472|consen 49 KLILSHNDLEVLR--EDLKNLACLTVLNVHDNKL-SQLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNE 125 (565)
T ss_pred hhhhccCchhhcc--HhhhcccceeEEEeccchh-hhCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhccccc
Confidence 4556666554333 3577888888888888888 566778888888888888888888777788888888888888888
Q ss_pred ccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccC
Q 002250 120 ISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIP 199 (947)
Q Consensus 120 i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 199 (947)
+.... ..++.+..|+.|+..+|++.. .|..+..+.+|..|++.+|+++...|+.+. ++.|++||...|.++ .+|
T Consensus 126 ~~el~--~~i~~~~~l~dl~~~~N~i~s--lp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP 199 (565)
T KOG0472|consen 126 LKELP--DSIGRLLDLEDLDATNNQISS--LPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLP 199 (565)
T ss_pred eeecC--chHHHHhhhhhhhcccccccc--CchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCC
Confidence 87443 478888888888888888865 677788888888888888888855444444 888888888888885 788
Q ss_pred ccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCcc-ccccCCCCEEEccCccCcccCCCCccCCCc
Q 002250 200 AGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSE-LRFLNQLSSLHLFENQFSGEIPEEFGEFKH 278 (947)
Q Consensus 200 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 278 (947)
..++.+.+|.-|+|.+|+|. .+| .|.++..|.+|+++.|.|+..+.+ .+.+++|..|||+.|+++ ..|+.++-+.+
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrs 276 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRS 276 (565)
T ss_pred hhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhh
Confidence 88888888888888888888 566 788888888888888888877765 457888888888888888 78888888888
Q ss_pred CcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCc---cceeee------ccccc-----CCcCC-c
Q 002250 279 LTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGA---MTDLLV------LQNNF-----NGTVP-E 343 (947)
Q Consensus 279 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~---l~~L~l------~~n~~-----~~~~p-~ 343 (947)
|+.||+++|.|+ .+|..++++ .|+.|-+.+|++.. +..++...+. +.+|.- .++.- ....| .
T Consensus 277 L~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~ 353 (565)
T KOG0472|consen 277 LERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSE 353 (565)
T ss_pred hhhhcccCCccc-cCCcccccc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCC
Confidence 888888888888 778888888 88888888888762 2222111111 000000 00000 00111 1
Q ss_pred c---ccCCCCccEEEcccccccccCCCCCCCCCC---cceeccccCCcCCCCCCcccccccccE-EEccCccccccCCCC
Q 002250 344 T---YANCKSLIRFRVNNNSLSGTIPPGIWSLPN---LSIIDLSTNQFEGPVTDDIGNAKSLAL-LLLANNRFSGELPSK 416 (947)
Q Consensus 344 ~---~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~p~~ 416 (947)
. ...+.+.+.|++++-+++ .+|+..+...+ ....+++.|++.. .|..+..+..+.. +.+++|.+. .+|..
T Consensus 354 ~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~e-lPk~L~~lkelvT~l~lsnn~is-fv~~~ 430 (565)
T KOG0472|consen 354 SFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLCE-LPKRLVELKELVTDLVLSNNKIS-FVPLE 430 (565)
T ss_pred cccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHhh-hhhhhHHHHHHHHHHHhhcCccc-cchHH
Confidence 1 223456677777777777 56665554444 6667777777763 5555555555443 344444443 67777
Q ss_pred CCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCc
Q 002250 417 ISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLN 496 (947)
Q Consensus 417 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 496 (947)
++.+++|..|+|++|-+. .+|.+++.+..|+.|++|.|++. .+|..+..+..|+.+-.++|++....|+.+.+|.+|.
T Consensus 431 l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~ 508 (565)
T KOG0472|consen 431 LSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLT 508 (565)
T ss_pred HHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcc
Confidence 777777777777777776 67777777777777777777776 5666666666666665566777655555577777777
Q ss_pred EEECCCCccCCccCCcccccccceeeCCCCcCC
Q 002250 497 SLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLA 529 (947)
Q Consensus 497 ~L~Ls~N~l~~~~p~~~~~~~L~~L~ls~N~l~ 529 (947)
+|||.+|.+...+|..-.+.+|++|++++|++.
T Consensus 509 tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 509 TLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred eeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 777777777755555445677777777777776
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=356.43 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=205.9
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
..+|.+++.||+|+|++|++|+. ..++.+|||++.. ....++....-..+|-.+|.+| .||.|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K--------------~~Iike~KvkYV~~Ek~~l~~L~~hPgiv 137 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDK--------------RYIIKEKKVKYVTREKEALTQLSGHPGIV 137 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhH--------------HHHHhhcccchhhHHHHHHHHhhCCCCeE
Confidence 36789999999999999999994 4799999999821 1122334455677899999999 899999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
+++..|+++...|+|+||+++|+|.+++++.+ .+++...+-++.+|+.|++||| +.|||||||||+|||+|+|+.
T Consensus 138 kLy~TFQD~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmh 212 (604)
T KOG0592|consen 138 KLYFTFQDEESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGH 212 (604)
T ss_pred EEEEEeecccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCc
Confidence 99999999999999999999999999999865 4777777789999999999999 999999999999999999999
Q ss_pred eEEeccccceecccCCCC-----------cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 002250 786 PRIADFGLAKIVQTGEAG-----------DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG 854 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~ 854 (947)
++|+|||.|+.+.+.... .....++||..|.+||++..+..++.+|+|||||++|+|+.|++||.+..
T Consensus 213 ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N- 291 (604)
T KOG0592|consen 213 IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN- 291 (604)
T ss_pred EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-
Confidence 999999999877643221 11135789999999999999999999999999999999999999995432
Q ss_pred CcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 855 DSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
-.-...+.+.-.. . +++.-++.+.+|+.+.+..||.+|+|..||.++
T Consensus 292 ----eyliFqkI~~l~y--------~---fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 292 ----EYLIFQKIQALDY--------E---FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----HHHHHHHHHHhcc--------c---CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1112222222111 1 122223556778889999999999999888765
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=376.99 Aligned_cols=276 Identities=22% Similarity=0.369 Sum_probs=224.2
Q ss_pred hccCCcccccccCceeEEEEEeCC----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
...++.+.||.|.||+||+|+++- ...||||.++.. ..+.+..+|..|+.||.+++||||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G----------------ytekqrrdFL~EAsIMGQFdHPNI 692 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG----------------YTEKQRRDFLSEASIMGQFDHPNI 692 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC----------------ccHHHHhhhhhhhhhcccCCCCcE
Confidence 345678899999999999999762 457999998421 123455789999999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++.|+......++||.|||++|+|..+|+...+ ++.+.+...|..+||.||.||. +.++|||||.++|||++.+.
T Consensus 693 IrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnL 768 (996)
T KOG0196|consen 693 IRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNL 768 (996)
T ss_pred EEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccce
Confidence 9999999999999999999999999999998654 5999999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccc--cccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAG--THGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~ 861 (947)
.+|++|||+++...++. ....+...| ..+|.|||.+...+++.+|||||||+++||.++ |.+||...
T Consensus 769 vCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--------- 838 (996)
T KOG0196|consen 769 VCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------- 838 (996)
T ss_pred EEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc---------
Confidence 99999999999775543 222212222 478999999999999999999999999999998 99998432
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC-cceeeecccccCCCCc
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS-VTNIVVKKVGESSPSF 940 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~-~~~~~~~~~~~~~~~~ 940 (947)
...+.+..+.+...-+-+.+++..+.+||+.||++|-.+||.+.|++.+|.++--.| +.+.+..-.++.|.++
T Consensus 839 ------SNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~l 912 (996)
T KOG0196|consen 839 ------SNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQPL 912 (996)
T ss_pred ------chHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcccc
Confidence 222333333344334556688999999999999999999999999999999866555 3444444444444443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=333.41 Aligned_cols=264 Identities=22% Similarity=0.258 Sum_probs=198.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|+...++|+|+||+|||++.+ +|+.||||++..+. ....-.+-..||++++++++|||+|.+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese---------------dd~~VkKIAlREIrmLKqLkH~NLVnL 66 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE---------------DDPVVKKIALREIRMLKQLKHENLVNL 66 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC---------------ccHHHHHHHHHHHHHHHhcccchHHHH
Confidence 46777889999999999999977 69999999993211 111223446799999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++|......++|+||++. ++.+.+... ....+.....++..|++.|+.|+| ++++|||||||+|||++.++.+|
T Consensus 67 iEVFrrkrklhLVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvK 141 (396)
T KOG0593|consen 67 IEVFRRKRKLHLVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVK 141 (396)
T ss_pred HHHHHhcceeEEEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEE
Confidence 9999999999999999965 555555543 345788889999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH--
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY-- 864 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~-- 864 (947)
|||||+|+...... ...+..+.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-|.+.. +-+.+.....
T Consensus 142 LCDFGFAR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S-DiDQLy~I~ktL 218 (396)
T KOG0593|consen 142 LCDFGFARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS-DIDQLYLIRKTL 218 (396)
T ss_pred eccchhhHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc-hHHHHHHHHHHH
Confidence 99999999887322 22334578999999999987 679999999999999999999997764321 1111111111
Q ss_pred --------hhccccccccccccCCC--C----ccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 865 --------SKMDSRDSMLTVVDPNI--S----EILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 865 --------~~~~~~~~~~~~~d~~~--~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
........+.-+.-|.. . .-......-+++++..|++.||++|++-+|++.
T Consensus 219 G~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 219 GNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111111111111 1 111223346889999999999999999998874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=351.00 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=206.3
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.+|...+.||+|+||+||++... +|...|||.+... .....+.+++|+.++++++|||||++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~-----------------~~~~~~~l~~Ei~iL~~l~~p~IV~~ 79 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE-----------------DSPTSESLEREIRILSRLNHPNIVQY 79 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecc-----------------cchhHHHHHHHHHHHHhCCCCCEEee
Confidence 45777889999999999999965 5899999987211 01115668999999999999999999
Q ss_pred EEEEecCC--ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC-CC
Q 002250 708 YCSITSED--SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL-EW 784 (947)
Q Consensus 708 ~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~-~~ 784 (947)
+|.....+ .+++.|||+++|+|.+++.+.+. .+++..+...+.||++||+||| +++||||||||+|||++. ++
T Consensus 80 ~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~ 155 (313)
T KOG0198|consen 80 YGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNG 155 (313)
T ss_pred CCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCC
Confidence 99865555 58899999999999999999776 7999999999999999999999 999999999999999999 79
Q ss_pred CeEEeccccceeccc-CCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 785 KPRIADFGLAKIVQT-GEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
.+||+|||+++.... ...........||+.|||||++..+. ...++||||+||++.||+||++||... ....++
T Consensus 156 ~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~ 231 (313)
T KOG0198|consen 156 DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEA 231 (313)
T ss_pred eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHH
Confidence 999999999986653 11122233568999999999999643 345999999999999999999998432 122222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
........ ..+.++...+....+++.+|+..+|++||||.+++++-.-..
T Consensus 232 ~~~ig~~~---------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 232 LLLIGRED---------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHhccC---------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 22221111 223445556667788888999999999999999998765443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=354.01 Aligned_cols=266 Identities=21% Similarity=0.243 Sum_probs=208.7
Q ss_pred HHhhccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVN 703 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n 703 (947)
.+.++|...++||.|+||.||+|+ ..+|..||||+++.. ....+.---.||++.+++++ |||
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~K----------------f~s~ee~~nLREvksL~kln~hpn 70 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKK----------------FYSWEECMNLREVKSLRKLNPHPN 70 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhh----------------hccHHHHHHHHHHHHHHhcCCCCc
Confidence 456889999999999999999999 447999999998421 11122223458999999998 999
Q ss_pred cceEEEEEecCC-ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 704 VVKLYCSITSED-SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 704 iv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
||++.+++.+.+ ..|+||||| ..+|.+.++.. +..+++..+..|+.||.+||+|+| .+|+.|||+||+|||+..
T Consensus 71 iikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~ 145 (538)
T KOG0661|consen 71 IIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISG 145 (538)
T ss_pred chhhHHHhhccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecc
Confidence 999999999988 889999999 56999999985 778999999999999999999999 899999999999999999
Q ss_pred CCCeEEeccccceecccCCCCcceecccccccccCccccc-cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
...+||+|||+||........ +..+.|.+|.|||++. .+.|+.++||||+|||++|+.+=++-|.+.. +-+.+..
T Consensus 146 ~~~iKiaDFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s-E~Dqi~K 221 (538)
T KOG0661|consen 146 NDVIKIADFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS-EIDQIYK 221 (538)
T ss_pred cceeEecccccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc-HHHHHHH
Confidence 999999999999987665443 3457899999999884 5679999999999999999999887764321 1112221
Q ss_pred HHHhhcc---------------ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 862 WVYSKMD---------------SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 862 ~~~~~~~---------------~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....... ....+..+.-..+.........+..+++.+|+.+||++|||+.|.+++
T Consensus 222 Ic~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 222 ICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111100 001111111122233444577789999999999999999999999975
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=350.46 Aligned_cols=265 Identities=23% Similarity=0.332 Sum_probs=218.5
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+...+.++||+|-||+|..+....+..||||.+++++.. ....+|.+|+++|.+++|||||+++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~----------------~~r~~F~kEIkiLsqLkhPNIveLv 601 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK----------------NARNDFLKEIKILSRLKHPNIVELL 601 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccch----------------hHHHHHHHHHHHHhccCCCCeeEEE
Confidence 345677899999999999999988899999999765421 2347899999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
|+|..++.+++|+|||++|+|.+++.+.......-..-.+|+.|||.||+||. +..+||||+.++|+|++.++++||
T Consensus 602 GVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKi 678 (807)
T KOG1094|consen 602 GVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKI 678 (807)
T ss_pred eeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEe
Confidence 99999999999999999999999999864444455666779999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh--CCCCCCCCCCCcccHHHHHHhh
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT--GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
+|||+++....++++......+-..+|||||.+..++++.++|||+||+++||+++ ...||... .+++.++-....
T Consensus 679 adfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l--t~e~vven~~~~ 756 (807)
T KOG1094|consen 679 ADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL--TDEQVVENAGEF 756 (807)
T ss_pred cCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh--hHHHHHHhhhhh
Confidence 99999998888887777666777899999999999999999999999999999886 67787432 222222222111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.+.... .-....+.-++..++++|.+||+.|.++||+++++...|++.
T Consensus 757 ~~~~~~------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 757 FRDQGR------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCCc------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111110 111334556677899999999999999999999999998864
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=362.35 Aligned_cols=376 Identities=22% Similarity=0.223 Sum_probs=252.9
Q ss_pred EEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCC
Q 002250 162 WLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNR 241 (947)
Q Consensus 162 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 241 (947)
.|++++|.+....+..|.++++|+.++|..|.++ .+|.......+|+.|+|.+|.|+..-...+..++.|+.||||.|.
T Consensus 82 ~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~ 160 (873)
T KOG4194|consen 82 TLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNL 160 (873)
T ss_pred eeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhch
Confidence 3555555555555555555555555555555554 445444444445555555555555444555555666666666666
Q ss_pred CCCCCc-cccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCC
Q 002250 242 LEGDLS-ELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPD 320 (947)
Q Consensus 242 l~~~~~-~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 320 (947)
|+.++. .+..-.++++|+|++|.|+....+.|..+.+|..|.|+.|+++...+..|.+++.|+.|||..|+|.-.-
T Consensus 161 is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive--- 237 (873)
T KOG4194|consen 161 ISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE--- 237 (873)
T ss_pred hhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh---
Confidence 555442 3444556666666777776666667777777777777777777444455666777777777777765110
Q ss_pred cccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCccccccccc
Q 002250 321 MCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLA 400 (947)
Q Consensus 321 ~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 400 (947)
--+|.++.+|+.|.|..|.+.......|+.+.+++.|+|+.|++..+-..++-+++.|+
T Consensus 238 ---------------------~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~ 296 (873)
T KOG4194|consen 238 ---------------------GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLE 296 (873)
T ss_pred ---------------------hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhh
Confidence 12466667777777777777766666677777777777777777777777777777777
Q ss_pred EEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCce
Q 002250 401 LLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNS 480 (947)
Q Consensus 401 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 480 (947)
.|+||+|.|...-++.+...++|++|+|++|+|+...+..|..|..|+.|+|++|.+...--..|..+.+|+.|||++|.
T Consensus 297 ~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ 376 (873)
T KOG4194|consen 297 QLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNE 376 (873)
T ss_pred hhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCe
Confidence 77777777777777777778888888888888887777778888888888888888887777778888888888888888
Q ss_pred eeeecCC---CCCccCcCcEEECCCCccCCccCCcc-cccccceeeCCCCcCCCCCCCccc-ccccccccccCCCCCCCC
Q 002250 481 LSGKIPD---SLGSLPSLNSLNLSNNKFSGEIPISL-TYPKLSLLDLSNNQLAGPIPEPLN-IKAFIDSFTGNPGLCSKT 555 (947)
Q Consensus 481 l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~~~L~~L~ls~N~l~~~~p~~~~-~~~~~~~~~gN~~~c~~~ 555 (947)
|++.|-+ .|.+|++|+.|+|.+|+|....-..+ .++.|+.|||.+|.|...-|..+. ......-+.--..+|+|.
T Consensus 377 ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 377 LSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQ 456 (873)
T ss_pred EEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEecc
Confidence 8876654 46678888888888888884444444 368888888888888776666553 222223344445799999
Q ss_pred ccccCcc
Q 002250 556 DEYFKSC 562 (947)
Q Consensus 556 ~~~~~~~ 562 (947)
+.|+..+
T Consensus 457 l~Wl~qW 463 (873)
T KOG4194|consen 457 LKWLAQW 463 (873)
T ss_pred HHHHHHH
Confidence 9885433
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=354.72 Aligned_cols=244 Identities=28% Similarity=0.421 Sum_probs=207.6
Q ss_pred CCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEE
Q 002250 632 KPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSI 711 (947)
Q Consensus 632 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 711 (947)
...+-+|.|+-|.||.|+++ ++.||||+++ +.-+.+|+.|++|+||||++|.|+|
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~------------------------elkETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVR------------------------ELKETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHh------------------------hhhhhhHHHHHhccCcceeeEeeee
Confidence 34567999999999999998 7899999872 1224689999999999999999999
Q ss_pred ecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecc
Q 002250 712 TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791 (947)
Q Consensus 712 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 791 (947)
.....++|||||++.|.|...++. +.++.......+..+||.||.||| .+.|||||||.-||||..+..+||+||
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDF 256 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDF 256 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccc
Confidence 999999999999999999999997 456777788889999999999999 899999999999999999999999999
Q ss_pred ccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccc
Q 002250 792 GLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRD 871 (947)
Q Consensus 792 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 871 (947)
|.++...... ..-.++||..|||||+++....++|+||||||||+|||+||..||... +...
T Consensus 257 GTS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV---------------dssA 318 (904)
T KOG4721|consen 257 GTSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV---------------DSSA 318 (904)
T ss_pred cchHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc---------------chhe
Confidence 9998665442 233678999999999999999999999999999999999999998432 1122
Q ss_pred cccccccCCC-CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 872 SMLTVVDPNI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 872 ~~~~~~d~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
.+.-+-...+ -..+..++..+.-++..||+..|..||++.+++.+|+-+.|-
T Consensus 319 IIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 319 IIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred eEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 2222222222 446778888999999999999999999999999999977653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=389.06 Aligned_cols=273 Identities=25% Similarity=0.363 Sum_probs=220.6
Q ss_pred hccCCcccccccCceeEEEEEeCC--Cc----EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS--GK----ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
+..+..+.||+|.||.||.|...+ |. .||||.+.+. ...++..+|.+|+.+|++++||
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----------------~~~~~~~~Fl~Ea~~m~~f~Hp 755 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----------------SSEQEVSDFLKEALLMSKFDHP 755 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc----------------CCHHHHHHHHHHHHHHhcCCCc
Confidence 345567889999999999999653 33 4899988422 2235678899999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcC-----CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH-----KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
|||+++|.+-+.+..+|++|||++|+|..++++.+ ...+.....+.++.|||+|++||+ ++++|||||.++|
T Consensus 756 Niv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRN 832 (1025)
T KOG1095|consen 756 NIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARN 832 (1025)
T ss_pred ceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhh
Confidence 99999999999999999999999999999999752 346788899999999999999999 8999999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCc
Q 002250 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDS 856 (947)
Q Consensus 778 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~ 856 (947)
+|++....|||+|||+|+.....++........-..+|||||.++++.++.|+|||||||++||++| |..||... ..
T Consensus 833 CLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~--~n 910 (1025)
T KOG1095|consen 833 CLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR--SN 910 (1025)
T ss_pred eeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc--ch
Confidence 9999999999999999996655554433322233578999999999999999999999999999999 88998432 11
Q ss_pred ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCcceeeeccccc
Q 002250 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKVGE 935 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~ 935 (947)
.++.. .+.....-+.+..++..++++|..||+.+|++||++..+++.+.++.+.....+.+..++.
T Consensus 911 ~~v~~-------------~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~a~ 976 (1025)
T KOG1095|consen 911 FEVLL-------------DVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLPAD 976 (1025)
T ss_pred HHHHH-------------HHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccccccc
Confidence 11211 1112222345667788899999999999999999999999999987766555555554443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=345.64 Aligned_cols=267 Identities=28% Similarity=0.344 Sum_probs=204.5
Q ss_pred hhccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.+.|+..++||+|.||.||||+ ..+|+.||+|++.-+. .......-..+||.||++|+||||++
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~---------------~~~~~~~t~~REI~ILr~l~HpNIik 180 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN---------------EKEGFPITAIREIKILRRLDHPNIIK 180 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc---------------CCCcchHHHHHHHHHHHhcCCCcccc
Confidence 3667788899999999999999 5689999999994322 12233445679999999999999999
Q ss_pred EEEEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 707 LYCSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 707 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+.+...+. ...|||+|||+. +|.-++.. ....++..++..++.|++.||+|+| +++|+|||||.+|||+|.+|
T Consensus 181 L~eivt~~~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G 255 (560)
T KOG0600|consen 181 LEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNG 255 (560)
T ss_pred eeeEEEecCCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCC
Confidence 99998876 789999999965 78777765 4567999999999999999999999 99999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCC--------
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGD-------- 855 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-------- 855 (947)
.+||+|||+|+++........+ ..+-|.+|.|||.+.+. .|+.++|+||.|||+.||++|++.|.+..+-
T Consensus 256 ~LKiaDFGLAr~y~~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk 334 (560)
T KOG0600|consen 256 VLKIADFGLARFYTPSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK 334 (560)
T ss_pred CEEeccccceeeccCCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH
Confidence 9999999999988766544433 45679999999999875 5999999999999999999999887543210
Q ss_pred ---cccHHHHHHhhcccccccc--ccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 856 ---SKDIVNWVYSKMDSRDSML--TVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 856 ---~~~~~~~~~~~~~~~~~~~--~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
......|....+.....+. ......+.+.....+...++++..++..||++|.|+.++++
T Consensus 335 lcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 335 LCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0011112211111111100 00011112222233456788899999999999999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=316.02 Aligned_cols=265 Identities=22% Similarity=0.336 Sum_probs=205.9
Q ss_pred hccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|...+++|+|.||.||+|+ ..+|+.||||++.... ....-.....|||+.++.++|+||+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~---------------~kdGi~~talREIK~Lqel~h~nIi~L 66 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGN---------------AKDGINRTALREIKLLQELKHPNIIEL 66 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccc---------------cccCccHHHHHHHHHHHHccCcchhhh
Confidence 467788999999999999999 5589999999995331 111223456789999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++|...+..-+|+|||+ .+|+..++. ....+...++..++.++.+|++|+| ++.|+|||+||.|+|++.+|.+|
T Consensus 67 iD~F~~~~~l~lVfEfm~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lK 141 (318)
T KOG0659|consen 67 IDVFPHKSNLSLVFEFMP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLK 141 (318)
T ss_pred hhhccCCCceEEEEEecc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEE
Confidence 999999999999999995 489998887 4567899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||+|+.+........ ..+-|.+|.|||.+++.+ |+..+||||.||++.||+-|. ||.+...+-+.+.......
T Consensus 142 iADFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~L 218 (318)
T KOG0659|consen 142 IADFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRAL 218 (318)
T ss_pred eecccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHc
Confidence 999999998876554332 336799999999998865 999999999999999999886 4544333333333222222
Q ss_pred cccc-ccccccc------------cCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSR-DSMLTVV------------DPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~-~~~~~~~------------d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... +.+.++. .+........+....++++..++.+||.+|+|++|++++
T Consensus 219 GTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111 1111100 011112334455667999999999999999999999964
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=351.25 Aligned_cols=268 Identities=23% Similarity=0.335 Sum_probs=217.0
Q ss_pred hhccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
...|...+.||+|+.|.||.|. ..+++.||||++.. ..+...+-+..|+.+|+..+|+|||+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l-----------------~~Q~~keLilnEi~Vm~~~~H~NiVn 334 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDL-----------------RKQPKKELLLNEILVMRDLHHPNIVN 334 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEe-----------------ccCCchhhhHHHHHHHHhccchHHHH
Confidence 3567778899999999999999 55789999999832 22344566789999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++.|...+..|+|||||+||+|.|.+... .+++.++..|+.++++||+||| .++|+|||||.+|||++.+|.+
T Consensus 335 fl~Sylv~deLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~v 408 (550)
T KOG0578|consen 335 FLDSYLVGDELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSV 408 (550)
T ss_pred HHHHhcccceeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcE
Confidence 999999999999999999999999999873 4899999999999999999999 9999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||++........ .....+||+.|||||+.....|++|+||||||++++||+.|.+||..+ +-.+-++-.
T Consensus 409 KltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE-----~PlrAlyLI 481 (550)
T KOG0578|consen 409 KLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE-----NPLRALYLI 481 (550)
T ss_pred EEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC-----ChHHHHHHH
Confidence 9999999987766554 233568999999999999999999999999999999999999999532 111111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCcceeeeccc
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKV 933 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~ 933 (947)
..... +. -..++.....+.++..+|+..||++||++.|++++=--..+++...+.+-+.
T Consensus 482 a~ng~-------P~-lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~pLi~ 540 (550)
T KOG0578|consen 482 ATNGT-------PK-LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPESSLNPLIL 540 (550)
T ss_pred hhcCC-------CC-cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCHHHhHHHHH
Confidence 11111 11 1234455677888999999999999999999997633344555545544433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=362.62 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=202.2
Q ss_pred hccCCcccccccCceeEEEEEe------CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RH 701 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 701 (947)
++|++.+.||+|+||.||+|.. .+++.||||++.... .......+.+|+.+++++ +|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~h 70 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----------------TASEHKALMSELKILIHIGNH 70 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc----------------chHHHHHHHHHHHHHHHhccC
Confidence 6789999999999999999974 235689999883110 112345688999999999 89
Q ss_pred cccceEEEEEecCC-ccEEEEeccCCCChHHHhhhcC-------------------------------------------
Q 002250 702 VNVVKLYCSITSED-SNLLVYEYLPNGSLWDRLHTCH------------------------------------------- 737 (947)
Q Consensus 702 ~niv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~------------------------------------------- 737 (947)
|||+++++++...+ ..++||||+++|+|.+++....
T Consensus 71 ~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (338)
T cd05102 71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQ 150 (338)
T ss_pred cceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccc
Confidence 99999999887654 5789999999999999987532
Q ss_pred -----------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccC
Q 002250 738 -----------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG 800 (947)
Q Consensus 738 -----------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 800 (947)
..++++.....++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~ 227 (338)
T cd05102 151 PSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227 (338)
T ss_pred cccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccC
Confidence 124778888999999999999999 899999999999999999999999999999865433
Q ss_pred CCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhccccccccccccC
Q 002250 801 EAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDP 879 (947)
Q Consensus 801 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 879 (947)
..........++..|+|||++.+..++.++|||||||++|||++ |..||..... ...+.. ......
T Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~-~~~~~~----~~~~~~-------- 294 (338)
T cd05102 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-NEEFCQ----RLKDGT-------- 294 (338)
T ss_pred cchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHH----HHhcCC--------
Confidence 22222223346788999999999899999999999999999997 9999854221 111111 111111
Q ss_pred CCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 880 NISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 880 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
....+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 295 -~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 295 -RMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11112233456889999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=365.07 Aligned_cols=480 Identities=27% Similarity=0.364 Sum_probs=384.6
Q ss_pred ccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCC
Q 002250 55 DSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTN 134 (947)
Q Consensus 55 ~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~ 134 (947)
+....-..|++|.+++|.+ ..+.+.+.++..|++|++++|.++..++.++.+.+++.|+.++|+++ .+| ..+..+.+
T Consensus 39 e~wW~qv~l~~lils~N~l-~~l~~dl~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls-~lp-~~i~s~~~ 115 (565)
T KOG0472|consen 39 ENWWEQVDLQKLILSHNDL-EVLREDLKNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLS-ELP-EQIGSLIS 115 (565)
T ss_pred hhhhhhcchhhhhhccCch-hhccHhhhcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHh-hcc-HHHhhhhh
Confidence 3455666788999999998 45566788899999999999999988999999999999999999997 555 57888999
Q ss_pred CceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEee
Q 002250 135 LEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELY 214 (947)
Q Consensus 135 L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 214 (947)
|+.|+.++|.+.. .+..++.+-.|+.|+..+|+++ ..|+.+.++.+|..|++.+|++... |+..-.++.|++||+.
T Consensus 116 l~~l~~s~n~~~e--l~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~ 191 (565)
T KOG0472|consen 116 LVKLDCSSNELKE--LPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCN 191 (565)
T ss_pred hhhhhccccceee--cCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccc
Confidence 9999999998865 6778889999999999999998 6788888999999999999999744 4444448999999999
Q ss_pred cccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCcc-CCCcCcEEEccCccccccC
Q 002250 215 NNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFG-EFKHLTELSLYTNRLTGTL 293 (947)
Q Consensus 215 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~ 293 (947)
+|.++ .+|..++.+.+|.-|+|.+|++...| +|..+..|++|+++.|+|. .+|.+.. ++++|..|||.+|+++ +.
T Consensus 192 ~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~ 267 (565)
T KOG0472|consen 192 SNLLE-TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EV 267 (565)
T ss_pred hhhhh-cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cC
Confidence 99998 78888999999999999999998766 8888999999999999998 6666655 8899999999999998 88
Q ss_pred CcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCcccc-----CCCCccEE----Eccccc----
Q 002250 294 PQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYA-----NCKSLIRF----RVNNNS---- 360 (947)
Q Consensus 294 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~-----~l~~L~~L----~L~~n~---- 360 (947)
|+.+.-+.+|.+||+|+|.|+ .+|.+++++ .+..|.+.+|.+.+.--+.+. -++.|+.- .++...
T Consensus 268 Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e 345 (565)
T KOG0472|consen 268 PDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTE 345 (565)
T ss_pred chHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccc
Confidence 999999999999999999998 678888887 788888888876432111111 11112110 011110
Q ss_pred ccccCCC----CCCCCCCcceeccccCCcCCCCCCcccccc--cccEEEccCccccccCCCCCCCCCcceE-EEcccCcc
Q 002250 361 LSGTIPP----GIWSLPNLSIIDLSTNQFEGPVTDDIGNAK--SLALLLLANNRFSGELPSKISEASSLVS-IQLSLNQF 433 (947)
Q Consensus 361 l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l 433 (947)
=.+..|. ....+.+.+.|+++.-+++.++.+.|.... -....+++.|++. ++|..+..+..+.+ +.+++|.+
T Consensus 346 ~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i 424 (565)
T KOG0472|consen 346 TAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI 424 (565)
T ss_pred ccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc
Confidence 0001111 122356789999999999976555554432 3788999999998 89998888877655 45566666
Q ss_pred cCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCcc
Q 002250 434 SGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL 513 (947)
Q Consensus 434 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 513 (947)
. -+|..+..+++|..|+|++|.+. .+|..++.+..|+.||+|+|+|. .+|..+..+..|+.+-.++|++....|..+
T Consensus 425 s-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l 501 (565)
T KOG0472|consen 425 S-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGL 501 (565)
T ss_pred c-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHh
Confidence 5 89999999999999999999997 79999999999999999999999 899999989999999999999998887755
Q ss_pred c-ccccceeeCCCCcCCCCCCCccc-ccccccccccCCCC
Q 002250 514 T-YPKLSLLDLSNNQLAGPIPEPLN-IKAFIDSFTGNPGL 551 (947)
Q Consensus 514 ~-~~~L~~L~ls~N~l~~~~p~~~~-~~~~~~~~~gN~~~ 551 (947)
. +.+|.+|||.+|.+...+|.-.+ .........|||+.
T Consensus 502 ~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 502 KNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 4 69999999999999987776555 34456678999977
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=360.04 Aligned_cols=263 Identities=27% Similarity=0.373 Sum_probs=210.0
Q ss_pred hccCCcccccccCceeEEEEEeCC--C---cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS--G---KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
++....+.||+|+||.||+|+++. + ..||||....+. ........+|.+|++++++++|||
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~--------------~~~~~~~~e~m~EArvMr~l~H~N 222 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS--------------ELTKEQIKEFMKEARVMRQLNHPN 222 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc--------------cccHHHHHHHHHHHHHHHhCCCCC
Confidence 445556899999999999999653 2 238999874211 112345678999999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
||++||++..+...|+|||+++||+|.+++++.+. .++...+..++.++|.||+||| +++++||||.++|+|++.+
T Consensus 223 VVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~ 298 (474)
T KOG0194|consen 223 VVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKK 298 (474)
T ss_pred EEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCC
Confidence 99999999999999999999999999999998544 6899999999999999999999 9999999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||+++....-.... ....-..+|+|||.+..+.|++++|||||||++||+++ |..||.+.. ..+...+
T Consensus 299 ~~vKISDFGLs~~~~~~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~--~~~v~~k 374 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGSQYVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK--NYEVKAK 374 (474)
T ss_pred CeEEeCccccccCCcceeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC--HHHHHHH
Confidence 999999999987543111111 11234679999999999999999999999999999999 888985431 1111111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCc
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSV 925 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 925 (947)
+ ... ......+...+..+..++.+||..+|++||+|.++.+.++.+..+..
T Consensus 375 I---~~~---------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 375 I---VKN---------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred H---Hhc---------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1 011 11122333566778888889999999999999999999999887754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=346.31 Aligned_cols=248 Identities=27% Similarity=0.356 Sum_probs=208.2
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|.+.+.||+|+||.||||+-+ +.+.||+|.+.+. .+...+...+.+|++++++++|||||.+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~---------------gr~~k~l~~l~~ev~i~r~lkHpniv~m 66 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS---------------GRNEKELKNLRQEVRILRSLKHPNIVEM 66 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhc---------------CCchHHHHHHHHHHHHHHhcCCcchhhH
Confidence 56888899999999999999965 6889999998321 2223455678999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++|+...+.++|.||+.| +|..++... ..+++..++.++.+++.||.||| +.+|.|||+||+||+++..+.+|
T Consensus 67 ~esfEt~~~~~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~K 140 (808)
T KOG0597|consen 67 LESFETSAHLWVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLK 140 (808)
T ss_pred HHhhcccceEEEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCcee
Confidence 9999999999999999976 999999874 45889999999999999999999 99999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+||||+|+.+..... ..+.+.|||-|||||...++.|+..+|+||+||++||+++|++||. ...+...+....
T Consensus 141 lcdFg~Ar~m~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~-----a~si~~Lv~~I~ 213 (808)
T KOG0597|consen 141 LCDFGLARAMSTNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY-----ARSITQLVKSIL 213 (808)
T ss_pred echhhhhhhcccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch-----HHHHHHHHHHHh
Confidence 999999997765432 2345689999999999999999999999999999999999999994 334444433332
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.+... .+......+..++...+.+||.+|.|-.+++.
T Consensus 214 ~d~v~-----------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 214 KDPVK-----------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cCCCC-----------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 22211 22355667888999999999999999888764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=318.70 Aligned_cols=263 Identities=24% Similarity=0.294 Sum_probs=206.9
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|+..+.+|.|+||.|..++.+ +|..+|+|++... ...+....+....|..+++.+.||++++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~--------------~vVklKQveH~~nEk~vL~~v~~PFlv~ 108 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQ--------------KVVKLKQVEHTHNEKRVLKAVSHPFLVK 108 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHH--------------HHHHHHHHHHHhhHHHHHhhccCceeEE
Confidence 467888999999999999999966 6889999998311 1112234566778999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++.|.+.+..||||||++||.|..++++.++ +++...+-+|.+|+.|++||| +..|++||+||+|||+|.+|.+
T Consensus 109 l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~i 183 (355)
T KOG0616|consen 109 LYGTFKDNSNLYMVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHI 183 (355)
T ss_pred EEEeeccCCeEEEEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcE
Confidence 99999999999999999999999999998655 777788889999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||.|+.+... +-..+|||.|+|||++....|..++|.|||||++|||+.|.+||..... .......
T Consensus 184 KitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~iY~KI 253 (355)
T KOG0616|consen 184 KITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQIYEKI 253 (355)
T ss_pred EEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHHHHHH
Confidence 99999999876543 3356899999999999999999999999999999999999999964322 2332333
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHhhccCCCCcceeee
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFR-PSMRVVVQMLEEAEPCSVTNIVV 930 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~ev~~~L~~~~~~~~~~~~~ 930 (947)
....-. ++.--...+.+++...++.|-.+| =++..=.+-++......++++..
T Consensus 254 ~~~~v~-----------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 254 LEGKVK-----------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred HhCccc-----------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 333322 222233446667778888888888 33332333344444444444433
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=341.92 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=210.8
Q ss_pred hccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
..|+..+.||+|+||.||||.. ..++.||+|++. ........+++++|+.++..++++||.++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~----------------Le~~~deIediqqei~~Ls~~~~~~it~y 76 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIID----------------LEEAEDEIEDIQQEISVLSQCDSPNITEY 76 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEec----------------hhhcchhhHHHHHHHHHHHhcCcchHHhh
Confidence 3566778999999999999995 478999999983 22334556789999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
||.+..+...+++|||+.||++.+.++... .+++.....+..++..|+.|+| ..+.+|||||+.||++..+|.+|
T Consensus 77 ygsyl~g~~LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vk 151 (467)
T KOG0201|consen 77 YGSYLKGTKLWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVK 151 (467)
T ss_pred hhheeecccHHHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEE
Confidence 999999999999999999999999998742 3366666778889999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
++|||.+..+....... ..++||+.|||||+++...|+.|+||||+|++.+||++|.+|+.. .
T Consensus 152 l~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~---------------~ 214 (467)
T KOG0201|consen 152 LADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK---------------L 214 (467)
T ss_pred EEecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc---------------c
Confidence 99999998776554332 467899999999999988999999999999999999999999732 2
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhccCCC
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEAEPC 923 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~~~~ 923 (947)
+....+.-+-....+.......+.+.+++..|+++||+.||++.+++++ ++...++
T Consensus 215 hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~ 272 (467)
T KOG0201|consen 215 HPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKT 272 (467)
T ss_pred CcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCc
Confidence 2222222222223333444556678899999999999999999999853 4554433
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.45 Aligned_cols=388 Identities=19% Similarity=0.189 Sum_probs=230.6
Q ss_pred ccEEeCcCccCcCCCCC-ccc-c-cccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEE
Q 002250 87 LQVLDLGNNSFSGEVPD-LSM-L-HELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWL 163 (947)
Q Consensus 87 L~~L~Ls~n~i~~~~~~-l~~-l-~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L 163 (947)
-+.||.+.+.+...... +.. | ..-+.||+++|+++..-+ ..|.++++|++++|.+|.++. +|........|+.|
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~-~~f~nl~nLq~v~l~~N~Lt~--IP~f~~~sghl~~L 130 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDF-EFFYNLPNLQEVNLNKNELTR--IPRFGHESGHLEKL 130 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcH-HHHhcCCcceeeeeccchhhh--cccccccccceeEE
Confidence 34577777777643111 111 1 233456667666664322 456666666666666666654 34444444456666
Q ss_pred EccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCC
Q 002250 164 YLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLE 243 (947)
Q Consensus 164 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 243 (947)
+|.+|.|+.+-.+.++.++.|+.||||.|.|+.+.-..|..-.++++|+|++|+|+......|..+.+|..|.|+.|+++
T Consensus 131 ~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit 210 (873)
T KOG4194|consen 131 DLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT 210 (873)
T ss_pred eeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc
Confidence 66666666555566666666666666666665444445555555666666666666555566666666666666666666
Q ss_pred CCCc-cccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcc
Q 002250 244 GDLS-ELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMC 322 (947)
Q Consensus 244 ~~~~-~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 322 (947)
.++. .|+.+++|+.|+|..|+|.-.---.|.++++|+.|.|..|.+...-...|..+.++++|+|+.|+++.
T Consensus 211 tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~------- 283 (873)
T KOG4194|consen 211 TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQA------- 283 (873)
T ss_pred ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhh-------
Confidence 5554 34556666666666666652224455666666666666666654444455555555555555555553
Q ss_pred cCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEE
Q 002250 323 KTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALL 402 (947)
Q Consensus 323 ~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 402 (947)
.-..++-++++|+.|+|++|.|..+.++.+.-.++|++||||+|+|+...+..|..+..|+.|
T Consensus 284 -----------------vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~L 346 (873)
T KOG4194|consen 284 -----------------VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEEL 346 (873)
T ss_pred -----------------hhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhh
Confidence 233445556666666666666666656655556666666666666666666666666666666
Q ss_pred EccCccccccCCCCCCCCCcceEEEcccCcccCCCCc---ccccccccchhhccccccCCCCCcccccccccceeeccCc
Q 002250 403 LLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPL---DIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479 (947)
Q Consensus 403 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 479 (947)
+|++|++...-...|..+++|+.|||++|.|...+.+ .|.+|++|+.|.|.+|+|..+...+|.++.+|++|||.+|
T Consensus 347 nLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~N 426 (873)
T KOG4194|consen 347 NLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDN 426 (873)
T ss_pred cccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCC
Confidence 6666666655555566666666666666666654432 3555666666666666666555566666666666666666
Q ss_pred eeeeecCCCCCccCcCcEEECCC
Q 002250 480 SLSGKIPDSLGSLPSLNSLNLSN 502 (947)
Q Consensus 480 ~l~~~~p~~~~~l~~L~~L~Ls~ 502 (947)
.|..+-|++|..+ .|+.|.++.
T Consensus 427 aiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 427 AIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred cceeecccccccc-hhhhhhhcc
Confidence 6666666666666 666665443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.70 Aligned_cols=265 Identities=28% Similarity=0.391 Sum_probs=204.0
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHh--hccccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLS--AVRHVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~ 706 (947)
+.....+.||+|.||.||||++. ++.||||++. ..+.+.|+.|-.|.+ .++|+||++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp--------------------~~~kqs~~~Ek~Iy~lp~m~h~nIl~ 268 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP--------------------EQEKQSFQNEKNIYSLPGMKHENILQ 268 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecC--------------------HHHHHHHHhHHHHHhccCccchhHHH
Confidence 45566788999999999999998 5999999983 234556666666655 668999999
Q ss_pred EEEEEecCC----ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcC------CCCCeEeccCCCC
Q 002250 707 LYCSITSED----SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG------FDRPVIHRDVKSS 776 (947)
Q Consensus 707 l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~------~~~~ivH~Dlkp~ 776 (947)
|+++-.... .+++|+||.+.|+|.+|++. ...+|....+|+..+++||+|||+. +.++|+|||||++
T Consensus 269 Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSk 345 (534)
T KOG3653|consen 269 FIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSK 345 (534)
T ss_pred hhchhccCCccccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccccccc
Confidence 999877766 78999999999999999997 5789999999999999999999953 4678999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCC------CCccchHHHHHHHHHHHhCCCCCC
Q 002250 777 NILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKI------NEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 777 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
|||+..|+++.|+|||+|..+..+.........+||.+|||||++.+..- -.+.||||+|.|+|||++....++
T Consensus 346 NVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 346 NVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred ceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 99999999999999999998887766555556899999999999976432 236899999999999999766543
Q ss_pred C--------CC----CCcccHHHHHHhhccccccccccccCCCCccCH--HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 851 P--------EF----GDSKDIVNWVYSKMDSRDSMLTVVDPNISEILK--EDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 851 ~--------~~----~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~--~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+ .| +....+.++-.-.++ +...|.+++... ..+..+.+.+..||+.||+.|.|+.=|-+.
T Consensus 426 ~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~------kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR 499 (534)
T KOG3653|consen 426 PGPVPEYQLPFEAEVGNHPTLEEMQELVVR------KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEER 499 (534)
T ss_pred CCCCCcccCchhHHhcCCCCHHHHHHHHHh------hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence 2 11 111122111111111 111122322211 345568889999999999999999988888
Q ss_pred hhccCCC
Q 002250 917 LEEAEPC 923 (947)
Q Consensus 917 L~~~~~~ 923 (947)
+.++.-.
T Consensus 500 ~~~l~~~ 506 (534)
T KOG3653|consen 500 MAELMML 506 (534)
T ss_pred HHHHhcc
Confidence 8776533
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=345.53 Aligned_cols=254 Identities=23% Similarity=0.316 Sum_probs=205.9
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-cccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNV 704 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni 704 (947)
..+.|.+.+.||+|+||+|+.|... +++.||||++...... ... ....+.+.+|+.++++++ ||||
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~-----------~~~-~~~~~~i~rEi~~~~~~~~HpnI 82 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVS-----------SKS-QKLDELIKREISILRRLRSHPNI 82 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhccc-----------ccc-cccchhhHHHHHHHHHhccCCCE
Confidence 3578999999999999999999854 7899999976322100 001 123455668999999999 9999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC-
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE- 783 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~- 783 (947)
+++++++......|+||||+.||+|.+++... .++.+.....++.|++.|++|+| +++|+||||||+||+++.+
T Consensus 83 ~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~ 157 (370)
T KOG0583|consen 83 IRLLEVFATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNE 157 (370)
T ss_pred eEEEEEEecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCC
Confidence 99999999999999999999999999999983 45777888999999999999999 9999999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCC-CC-CccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-IN-EKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
+++||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||.. .+...
T Consensus 158 ~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~~~ 230 (370)
T KOG0583|consen 158 GNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNVPN 230 (370)
T ss_pred CCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccHHH
Confidence 999999999998774 1222344678999999999999877 76 789999999999999999999953 34444
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVV 914 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 914 (947)
........... ++.... ..++..++.+|+..+|.+|+|+.+++
T Consensus 231 l~~ki~~~~~~--------~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 231 LYRKIRKGEFK--------IPSYLL--SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHHhcCCcc--------CCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 33332222222 122221 56788899999999999999999999
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=343.41 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=201.6
Q ss_pred hccCCcccccccCceeEEEEEeCC-----------------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHH
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS-----------------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA 691 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (947)
++|++.+.||+|+||.||+|..++ +..||||++.+.. .......+.+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~ 68 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA----------------NKNARNDFLK 68 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC----------------CHHHHHHHHH
Confidence 578889999999999999998542 3369999874211 1122356889
Q ss_pred HHHHHhhccccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC-----------------CccCCHHHHHHHHHHHH
Q 002250 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH-----------------KIEMDWVVRYAIAVGAA 754 (947)
Q Consensus 692 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~~i~~~ia 754 (947)
|++++++++||||+++++++...+..++||||+++|+|.+++.... ...+++....+++.|++
T Consensus 69 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 148 (304)
T cd05096 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIA 148 (304)
T ss_pred HHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999986531 12467888999999999
Q ss_pred HHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHH
Q 002250 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYS 834 (947)
Q Consensus 755 ~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 834 (947)
.||+||| +.+|+||||||+||+++.++.+||+|||+++...............++..|+|||++..+.++.++||||
T Consensus 149 ~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 225 (304)
T cd05096 149 SGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225 (304)
T ss_pred HHHHHHH---HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHH
Confidence 9999999 8999999999999999999999999999998654433222222334578999999998889999999999
Q ss_pred HHHHHHHHHh--CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 002250 835 FGVVLMELVT--GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRV 912 (947)
Q Consensus 835 lGv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 912 (947)
||+++|||++ +..||... .................. ... ...+..++..+.+++.+||+.||++|||+.|
T Consensus 226 lG~~l~el~~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~ 297 (304)
T cd05096 226 FGVTLWEILMLCKEQPYGEL--TDEQVIENAGEFFRDQGR--QVY----LFRPPPCPQGLYELMLQCWSRDCRERPSFSD 297 (304)
T ss_pred HHHHHHHHHHccCCCCCCcC--CHHHHHHHHHHHhhhccc--ccc----ccCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 9999999997 45566322 122222222111111110 000 0111233457899999999999999999999
Q ss_pred HHHHhhc
Q 002250 913 VVQMLEE 919 (947)
Q Consensus 913 v~~~L~~ 919 (947)
|.+.|++
T Consensus 298 i~~~l~~ 304 (304)
T cd05096 298 IHAFLTE 304 (304)
T ss_pred HHHHHhC
Confidence 9998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=341.99 Aligned_cols=252 Identities=26% Similarity=0.350 Sum_probs=213.8
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.+.|+.++.||.|+.|.|-.|++. +|+.+|||++.... .........+++|+-+|+.+.||||++
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~--------------~~s~s~~~~IerEIviMkLi~HpnVl~ 76 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS--------------ELSSSQPAGIEREIVIMKLIEHPNVLR 76 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeecccc--------------ccccccccchhhhhHHHHHhcCCCeee
Confidence 467899999999999999999954 89999999994321 112234567889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+|+++++..++|+|.||+++|.|++++-..+ ++++....+++.||+.|+.|+| ..+|+|||+||+|+|+|..+++
T Consensus 77 LydVwe~~~~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nI 151 (786)
T KOG0588|consen 77 LYDVWENKQHLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNI 151 (786)
T ss_pred eeeeeccCceEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCE
Confidence 9999999999999999999999999998754 4777778889999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCC-CccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKIN-EKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||+|..-.++.-. ...+|.+.|.|||++.+..|+ .++||||.|||+|-++||+.||+ ++++...+.+
T Consensus 152 KIADFGMAsLe~~gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdNir~LLlK 223 (786)
T KOG0588|consen 152 KIADFGMASLEVPGKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDNIRVLLLK 223 (786)
T ss_pred eeeccceeecccCCccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----CccHHHHHHH
Confidence 99999999876555432 245899999999999999886 78999999999999999999994 5566655555
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML 917 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 917 (947)
..++... ++...+.+..+++.+|+..||++|.|++||.++-
T Consensus 224 V~~G~f~-----------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 224 VQRGVFE-----------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HHcCccc-----------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 4444443 3345556788899999999999999999999863
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=352.75 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=202.7
Q ss_pred hhccCCcccccccCceeEEEEEe------CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-c
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-R 700 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 700 (947)
.++|++.+.||+|+||.||+|.. .++..||||++.+.. .....+.+.+|+++++.+ +
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~~Ei~il~~l~~ 97 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA----------------HLTEREALMSELKVLSYLGN 97 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc----------------CcHHHHHHHHHHHHHHHhcC
Confidence 35789999999999999999973 235689999884221 112345688999999999 8
Q ss_pred ccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC-------------------------------------------
Q 002250 701 HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH------------------------------------------- 737 (947)
Q Consensus 701 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------- 737 (947)
||||+++++++..++..++||||+++|+|.++++...
T Consensus 98 HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 177 (375)
T cd05104 98 HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSY 177 (375)
T ss_pred CcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccc
Confidence 9999999999999999999999999999999986432
Q ss_pred ------------------------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 738 ------------------------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 738 ------------------------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
...+++..+.+++.||+.||+||| +.+|+||||||+||+++.++.+|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~k 254 (375)
T cd05104 178 VVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITK 254 (375)
T ss_pred ccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEE
Confidence 124788899999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ...+......
T Consensus 255 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-~~~~~~~~~~- 332 (375)
T cd05104 255 ICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-DSKFYKMIKE- 332 (375)
T ss_pred EecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-hHHHHHHHHh-
Confidence 999999986644322211222335678999999999999999999999999999998 8888743211 1122222111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
... ...+...+.++.+++.+||+.||++||+|.|++++|++
T Consensus 333 ---~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 333 ---GYR---------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---Ccc---------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 100 00111224568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=327.34 Aligned_cols=272 Identities=23% Similarity=0.247 Sum_probs=205.7
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
....+.|++.+.||+|.||.|-+|+.. +++.||||++............ ...+......+...+||.+|+++.|||
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~---~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFP---RQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccc---cccccccCcHHHHHHHHHHHHhcCCcC
Confidence 445688999999999999999999954 7999999999643321111110 011222334568899999999999999
Q ss_pred cceEEEEEecC--CccEEEEeccCCCChHHHhhhcCCcc-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 704 VVKLYCSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIE-MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 704 iv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
||+++++..++ +..|||+||+..|.+...=. ..+ ++..+.+++..+++.||+||| .++||||||||+|+|+
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl 243 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLL 243 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEE
Confidence 99999999874 56799999999887643222 233 888999999999999999999 8999999999999999
Q ss_pred cCCCCeEEeccccceecccCC---CCcceecccccccccCccccccCC----CCCccchHHHHHHHHHHHhCCCCCCCCC
Q 002250 781 DLEWKPRIADFGLAKIVQTGE---AGDLTHVIAGTHGYIAPEYAYTCK----INEKSDVYSFGVVLMELVTGKRPIVPEF 853 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slGv~l~elltg~~p~~~~~ 853 (947)
+++|.+||+|||.+.....+. .+......+|||.|+|||...++. .+.+.||||+||++|.|+.|+.||.+++
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 999999999999997663331 122233468999999999987743 3467899999999999999999996432
Q ss_pred CCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 854 GDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
..+...+.....-. .+..++..+.+.+++.+++.+||+.|.+..+|..+..-
T Consensus 324 -----~~~l~~KIvn~pL~---------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 324 -----ELELFDKIVNDPLE---------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred -----HHHHHHHHhcCccc---------CCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 22222222211111 11222456678899999999999999999999877653
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.07 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=197.7
Q ss_pred ccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEec-
Q 002250 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITS- 713 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 713 (947)
..||+|++|.||+|... |+.||||++..... ......+.+.+|+.++++++||||++++|++.+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHK--------------GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEecccccc--------------ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 57899999999999985 89999999842110 001113668899999999999999999999876
Q ss_pred ---CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEec
Q 002250 714 ---EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790 (947)
Q Consensus 714 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 790 (947)
....++||||+++|+|.+++... ..+++.....++.+++.|++|||. ..+++||||||+||++++++.+||+|
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~d 166 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIIC 166 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcc
Confidence 34678999999999999999864 458899999999999999999993 24888999999999999999999999
Q ss_pred cccceecccCCCCcceecccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT--CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 791 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||... ...+.......
T Consensus 167 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~-----~~~~~~~~i~~ 236 (283)
T PHA02988 167 HGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-----TTKEIYDLIIN 236 (283)
T ss_pred cchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHh
Confidence 99997654322 13457899999999976 67999999999999999999999999532 11122111111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
.... ...+...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 237 ~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 237 KNNS---------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCC---------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111 11122345678899999999999999999999999988654
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=352.78 Aligned_cols=260 Identities=24% Similarity=0.346 Sum_probs=202.6
Q ss_pred hhccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-c
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-R 700 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 700 (947)
.++|++.+.||+|+||.||+|+.. ++..||||++.... .......+.+|+++++++ +
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~il~~l~~ 100 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA----------------HTDEREALMSELKILSHLGQ 100 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC----------------CHHHHHHHHHHHHHHHhhcc
Confidence 367899999999999999998842 24579999984211 112245688999999999 8
Q ss_pred ccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC-------------------------------------------
Q 002250 701 HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH------------------------------------------- 737 (947)
Q Consensus 701 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------- 737 (947)
|+||+++++++...+..++||||+++|+|.+++....
T Consensus 101 h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (374)
T cd05106 101 HKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDT 180 (374)
T ss_pred CCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccc
Confidence 9999999999999999999999999999999986421
Q ss_pred -------------------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 738 -------------------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 738 -------------------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
..++++....+++.|++.||+||| +++|+||||||+||++++++.+||+|||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfG 257 (374)
T cd05106 181 YVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFG 257 (374)
T ss_pred ccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeece
Confidence 124788889999999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRD 871 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 871 (947)
+++...............++..|+|||++....++.++|||||||++|||++ |+.||...... ...... .....
T Consensus 258 la~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-~~~~~~----~~~~~ 332 (374)
T cd05106 258 LARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SKFYKM----VKRGY 332 (374)
T ss_pred eeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-HHHHHH----HHccc
Confidence 9976543322211222335678999999998899999999999999999997 99998543211 111111 11110
Q ss_pred cccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 872 SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 872 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
....+ ...+..+.+++.+||+.||++|||+.+++++|+++
T Consensus 333 ------~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 333 ------QMSRP---DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ------CccCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00111 11245688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.80 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=207.7
Q ss_pred hccCCcccccccCceeEEEEEeCC------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
++|++.+.||+|+||.||+|.... ...||+|.+.... .......+.+|+.++++++||
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~----------------~~~~~~~~~~ei~~l~~l~h~ 68 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA----------------EPKVQQEFRQEAELMSDLQHP 68 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC----------------CHHHHHHHHHHHHHHHhcCCc
Confidence 578899999999999999998542 2579999873211 112235688999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC--------------ccCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK--------------IEMDWVVRYAIAVGAAKGLEYLHHGFDRPV 768 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~i 768 (947)
||+++++++...+..+++|||+++++|.+++..... ..+++.....++.|++.||+||| +.++
T Consensus 69 ~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i 145 (283)
T cd05048 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHF 145 (283)
T ss_pred ccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 999999999999999999999999999999976422 45788899999999999999999 8999
Q ss_pred EeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCC
Q 002250 769 IHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKR 847 (947)
Q Consensus 769 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~ 847 (947)
+||||||+||++++++.++|+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..
T Consensus 146 ~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~ 225 (283)
T cd05048 146 VHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQ 225 (283)
T ss_pred eccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999986644433222334456889999999998899999999999999999998 999
Q ss_pred CCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 848 PIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 848 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
||.... ..++...+. . ......+...+..+.+++.+||+.||++||++.||+++|+++
T Consensus 226 p~~~~~--~~~~~~~i~----~---------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 226 PYYGFS--NQEVIEMIR----S---------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred CCCCCC--HHHHHHHHH----c---------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 985321 122222111 1 111223445567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.49 Aligned_cols=253 Identities=26% Similarity=0.273 Sum_probs=200.3
Q ss_pred cCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 631 VKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
|+..+.||+|+||+||+|.. .+++.||||.+.... .........+.+|+.++++++|+||+++++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~~E~~il~~l~~~~iv~~~~ 67 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--------------IKKRKGEAMALNEKRILEKVNSRFVVSLAY 67 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhh--------------hhhhhhHHHHHHHHHHHHhcCCCcEEEEEE
Confidence 66778999999999999995 479999999883211 011122345778999999999999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
++.+++..++||||+++|+|.+++.......+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+
T Consensus 68 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~ 144 (285)
T cd05631 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRIS 144 (285)
T ss_pred EEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEe
Confidence 9999999999999999999999887655556899999999999999999999 8999999999999999999999999
Q ss_pred ccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccc
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS 869 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 869 (947)
|||++........ .....||..|+|||++.+..++.++|||||||++|||++|+.||...... ...+........
T Consensus 145 Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~ 219 (285)
T cd05631 145 DLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--VKREEVDRRVKE 219 (285)
T ss_pred eCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc--hhHHHHHHHhhc
Confidence 9999986543321 22346899999999999999999999999999999999999999643211 011111111100
Q ss_pred cccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 002250 870 RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-----MRVVVQ 915 (947)
Q Consensus 870 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 915 (947)
.......+....+.+++.+|++.||++||+ ++++++
T Consensus 220 ----------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 220 ----------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ----------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 001122233456788999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.68 Aligned_cols=256 Identities=21% Similarity=0.309 Sum_probs=202.3
Q ss_pred hccCCcccccccCceeEEEEEeC----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|++.+.||+|+||.||+|.++ .+..||+|++.... .......+.+|+.++++++||||
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i 68 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----------------SDKQRRGFLAEALTLGQFDHSNI 68 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC----------------CHHHHHHHHHHHHHHhcCCCCCc
Confidence 56888999999999999999853 35689999884211 11223568899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++..++..++||||+++|+|.+++... ...+++..++.++.|++.|++||| +.+++||||||+||+++.++
T Consensus 69 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~ 144 (266)
T cd05064 69 VRLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDL 144 (266)
T ss_pred CeEEEEEecCCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCC
Confidence 99999999999999999999999999999864 246889999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 863 (947)
.++++|||.+......... ......++..|+|||++.+..++.++|||||||++||+++ |+.||.... ..+....
T Consensus 145 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~--~~~~~~~- 220 (266)
T cd05064 145 VCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS--GQDVIKA- 220 (266)
T ss_pred cEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHH-
Confidence 9999999987653222111 1112235678999999999999999999999999999875 999985321 1111111
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
. ... ...+.+...+..+.+++.+||+.+|++||++.++.+.|++.
T Consensus 221 --~-~~~---------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 --V-EDG---------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --H-HCC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1 111 11112334556788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=334.22 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=217.5
Q ss_pred cCCcccccccCceeEEEEEeCC---Cc--EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 631 VKPENLIGKGGSGNVYKVVLNS---GK--ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
....++||+|.||.||+|...+ |+ .||||.-+.+ ......+.|..|+.+|++++|||||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d----------------~t~d~tekflqEa~iMrnfdHphIi 454 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD----------------CTPDDTEKFLQEASIMRNFDHPHII 454 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC----------------CChhhHHHHHHHHHHHHhCCCcchh
Confidence 4456889999999999999543 33 4888876321 1234467899999999999999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
+++|.|.+ ...+||||.++-|.|..+++.. ...++......++.|+..||+||| +.++|||||.++|||+.....
T Consensus 455 kLIGv~~e-~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~C 529 (974)
T KOG4257|consen 455 KLIGVCVE-QPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQC 529 (974)
T ss_pred heeeeeec-cceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcce
Confidence 99999987 4679999999999999999974 456888899999999999999999 999999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 864 (947)
+|++|||+++.+....+...+ ...-...|||||.+.-.+++.++|||.|||.+||++. |..||.+
T Consensus 530 VKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg------------- 595 (974)
T KOG4257|consen 530 VKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG------------- 595 (974)
T ss_pred eeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc-------------
Confidence 999999999998877765554 3345678999999999999999999999999999998 9999853
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
+...+.+..+..+...+.++.|++.++.+|.+||.++|.+||++.|+...|.++.
T Consensus 596 --vkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 596 --VKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred --ccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 3444555666667778889999999999999999999999999999998887643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.94 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=199.3
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
.++|.....||+|+||+|++|..+ +++.+|||+++.+..-. ..+.+..+.|.+|+... +||.++
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~--------------~d~Ve~~~~EkrI~~la~~HPFL~ 432 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ--------------RDEVESLMCEKRIFELANRHPFLV 432 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec--------------cccHHHHHHHHHHHHHhccCCeEe
Confidence 467889999999999999999976 68899999996554322 24556677888888777 599999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
.+++.|+.+++.|.||||+.||++..+.+ ...+++....-+|..|+.||.||| +++||+||||.+|||+|.+|.
T Consensus 433 ~L~~~fQT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 433 NLFSCFQTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred ecccccccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCc
Confidence 99999999999999999999999544444 356899999999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+||+|||+++..-.. ...+...+||+.|||||++.+..|+..+|.|||||++|||+.|+.||.++. .+++.+ +
T Consensus 507 ~kiADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd--Eee~Fd---s 579 (694)
T KOG0694|consen 507 VKIADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD--EEEVFD---S 579 (694)
T ss_pred EEecccccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHH---H
Confidence 999999999854322 234567899999999999999999999999999999999999999995431 222221 1
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
.+.. |+.+ +.-...+.+.++.+.+.++|++|.-+
T Consensus 580 I~~d--------~~~y---P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVND--------EVRY---PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcC--------CCCC---CCcccHHHHHHHHHHhccCcccccCC
Confidence 1111 1222 33344567788889999999999866
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=306.74 Aligned_cols=267 Identities=21% Similarity=0.203 Sum_probs=199.8
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
-++.|+..+.|++|+||.||+|+.+ +++.||+|+++.+. ....-.-...|||.++.+++|||||
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek---------------ek~GFPItsLREIniLl~~~H~NIV 138 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK---------------EKEGFPITSLREINILLKARHPNIV 138 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc---------------ccCCCcchhHHHHHHHHhcCCCCee
Confidence 3577888999999999999999955 78999999995332 1112223456899999999999999
Q ss_pred eEEEEEec--CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 706 KLYCSITS--EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 706 ~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
.+-.+... -+..|+||||++. +|...+.... +++....+..+..|+++|++||| ...|+|||||++|+|+.+.
T Consensus 139 ~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~ 213 (419)
T KOG0663|consen 139 EVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHK 213 (419)
T ss_pred eeEEEEeccccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccC
Confidence 99887654 4568999999965 8888888744 67888999999999999999999 8899999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
|.+||+|||+|+.+..... ..+..+-|.+|.|||.+.+.+ |++++|+||+|||+.||+++++-|.+... .+.+...
T Consensus 214 G~lKiaDFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-~dQl~~I 290 (419)
T KOG0663|consen 214 GILKIADFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-IDQLDKI 290 (419)
T ss_pred CcEEecccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-HHHHHHH
Confidence 9999999999998876532 233456799999999998765 89999999999999999999987744321 1111111
Q ss_pred HHhhcccccccccccc-------CCCC---------ccCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVD-------PNIS---------EILKE-DALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d-------~~~~---------~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
........+....-++ -.++ .+... ....-++++...+.+||.+|.|+.|.+++
T Consensus 291 f~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 291 FKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred HHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111111111000000 0000 11111 22456788889999999999999999864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=334.55 Aligned_cols=253 Identities=28% Similarity=0.394 Sum_probs=214.9
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+..+.++||-|.||.||.|.|+ -.-.||||.++ ......++|..|+.+|+.++|||+|+++
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK------------------EDtMeveEFLkEAAvMKeikHpNLVqLL 329 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------------------EDTMEVEEFLKEAAVMKEIKHPNLVQLL 329 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhh------------------hcchhHHHHHHHHHHHHhhcCccHHHHh
Confidence 3456789999999999999987 35679999874 2335678999999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
|+|..+...|||+|||..|+|.+|++.+.+...+....+.||.||+.||+||. .+.+|||||.++|+|+.++..+|+
T Consensus 330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKv 406 (1157)
T KOG4278|consen 330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKV 406 (1157)
T ss_pred hhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEe
Confidence 99999999999999999999999999998888999999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||+++.+..+.+.. .....-...|.|||-+....++.|+|||+|||++||+.| |-.||.+ .++. .++...
T Consensus 407 ADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-----idlS-qVY~LL 479 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-----IDLS-QVYGLL 479 (1157)
T ss_pred eccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-----ccHH-HHHHHH
Confidence 9999999886553321 112223578999999999999999999999999999999 8888742 2222 233333
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
+.... .+.++.|++.++++|++||+.+|.+||+++|+-+.++.
T Consensus 480 EkgyR---------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 480 EKGYR---------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred hcccc---------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 33322 34567788999999999999999999999999988875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=298.84 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=209.2
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++++.||+|-||.||.|+.+ ++-.||+|++... ++ ....-...+.+|++|-+.|+||||++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKs------------qi--~~~~v~~qlrREiEIqs~L~hpnilr 86 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS------------QI--LKTQVEHQLRREIEIQSHLRHPNILR 86 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHH------------HH--HHhcchhhhhheeEeecccCCccHHh
Confidence 478999999999999999999955 6788999998421 11 12234567899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+|++|.+....|+++||.++|++...+.......++......+..|+|.|+.|+| .++|+||||||+|+|++.++..
T Consensus 87 lY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~l 163 (281)
T KOG0580|consen 87 LYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGEL 163 (281)
T ss_pred hhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCe
Confidence 9999999999999999999999999999766777888888999999999999999 9999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|++|||-+...+.. .....+||.-|.|||+..+..++..+|+|++|++.||++.|.+||.... .. -.++.
T Consensus 164 kiAdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~----etYkr 233 (281)
T KOG0580|consen 164 KIADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HS----ETYKR 233 (281)
T ss_pred eccCCCceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--hH----HHHHH
Confidence 99999998755422 2335689999999999999999999999999999999999999995432 11 11222
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+...+ -. ++........+++.+|+.++|.+|.+..|++.+
T Consensus 234 I~k~~-------~~---~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 234 IRKVD-------LK---FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHcc-------cc---CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 21111 11 223444567788889999999999999999875
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=336.45 Aligned_cols=251 Identities=32% Similarity=0.475 Sum_probs=194.4
Q ss_pred CcccccccCceeEEEEEeC-----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 633 PENLIGKGGSGNVYKVVLN-----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 633 ~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
..+.||+|.||.||+|.+. .+..|+||++... ......+.|.+|++.+++++||||+++
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~ni~~~ 66 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS----------------SSEEEEEEFLNEIQILRKLRHPNIVKL 66 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT----------------SSHHHHHHHHHHHHHHHTHSBTTBE-E
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc----------------cccccceeeeecccccccccccccccc
Confidence 4568999999999999976 3568999998321 111235788999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+|++...+..++||||+++|+|.+++.......+++..+..++.|+|+||+||| +.+++|+||+++||+++.++.+|
T Consensus 67 ~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~K 143 (259)
T PF07714_consen 67 YGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVK 143 (259)
T ss_dssp EEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccc
Confidence 999998888999999999999999999865667999999999999999999999 78999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||++................+...|+|||.+....++.++||||||+++|||++ |+.||... ...++...+
T Consensus 144 l~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~~~~~--- 218 (259)
T PF07714_consen 144 LSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEIIEKL--- 218 (259)
T ss_dssp EESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHHHHHH---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc---
Confidence 999999987633222222223346788999999999889999999999999999999 67887432 222222221
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML 917 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 917 (947)
.+.. ..+.+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 219 ~~~~----------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 KQGQ----------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HTTE----------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccc----------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111 1122233456688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=329.73 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=206.9
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||.||+|...+++.||+|.+.+. ....+.+.+|+.++++++|+||++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~ 67 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG------------------TMSVQAFLEEANLMKTLQHDKLVRLY 67 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC------------------chhHHHHHHHHHHHHhCCCCCeeeEE
Confidence 678899999999999999999888889999987321 12346788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++++|.++++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|
T Consensus 68 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l 144 (261)
T cd05072 68 AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKI 144 (261)
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEE
Confidence 99999999999999999999999998765667899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.++........ ......++..|+|||+...+.++.++|||||||++|||+| |+.||... ..........
T Consensus 145 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~--- 218 (261)
T cd05072 145 ADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM--SNSDVMSALQ--- 218 (261)
T ss_pred CCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC--CHHHHHHHHH---
Confidence 999999865433211 1112345678999999988889999999999999999999 89998432 1111222111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.... .+.....+..+.+++.+|++.+|++||++.++.++|+++
T Consensus 219 -~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 219 -RGYR---------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -cCCC---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1110 011112345688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=317.76 Aligned_cols=273 Identities=24% Similarity=0.321 Sum_probs=207.8
Q ss_pred ccHHHHhhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHh--hc
Q 002250 622 FSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLS--AV 699 (947)
Q Consensus 622 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~--~l 699 (947)
+-..++.++..+.+.||+|.||+||+|.++ |+.||||+|. . .+.....+|.+|++ -|
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~------------------s--rdE~SWfrEtEIYqTvmL 262 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS------------------S--RDERSWFRETEIYQTVML 262 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEec------------------c--cchhhhhhHHHHHHHHHh
Confidence 344677788899999999999999999999 8999999982 1 22334445555555 56
Q ss_pred cccccceEEEEEecCC----ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEe
Q 002250 700 RHVNVVKLYCSITSED----SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHH-----GFDRPVIH 770 (947)
Q Consensus 700 ~h~niv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~-----~~~~~ivH 770 (947)
+|+||+.|++.-..+. ..++|.+|.+.|||.||+.. .+++....++++..+|.||+|||. .-.+.|.|
T Consensus 263 RHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH 339 (513)
T KOG2052|consen 263 RHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH 339 (513)
T ss_pred ccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence 9999999998765543 35899999999999999987 568999999999999999999993 23678999
Q ss_pred ccCCCCCeEecCCCCeEEeccccceecccCC--CCcceecccccccccCccccccCC----C--CCccchHHHHHHHHHH
Q 002250 771 RDVKSSNILLDLEWKPRIADFGLAKIVQTGE--AGDLTHVIAGTHGYIAPEYAYTCK----I--NEKSDVYSFGVVLMEL 842 (947)
Q Consensus 771 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~slGv~l~el 842 (947)
||||+.|||+..++.+.|+|+|+|..+.... ........+||.+|||||++...- + -..+||||||.|+||+
T Consensus 340 RDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEi 419 (513)
T KOG2052|consen 340 RDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEI 419 (513)
T ss_pred cccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHH
Confidence 9999999999999999999999998766542 123345678999999999985432 1 1368999999999999
Q ss_pred HhC----------CCCCCCCCCCcccHHHHHHhhccccccccccccCCCCc--cCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 843 VTG----------KRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISE--ILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 843 ltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
+-. +.||.+.-..+..+.++.... -.+-+.|.++. ...+....+.++|..||..+|..|-|+
T Consensus 420 arRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVV------Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 420 ARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVV------CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred HHHhhcCCEehhhcCCcccCCCCCCCHHHHhcce------eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 842 456654333333333321110 01112222322 234567789999999999999999999
Q ss_pred HHHHHHhhccCCCC
Q 002250 911 RVVVQMLEEAEPCS 924 (947)
Q Consensus 911 ~ev~~~L~~~~~~~ 924 (947)
-.+.+.|.++...+
T Consensus 494 LriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 494 LRIKKTLAKLSNSD 507 (513)
T ss_pred HHHHHHHHHHhcCh
Confidence 99999999887644
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=347.16 Aligned_cols=261 Identities=25% Similarity=0.347 Sum_probs=204.9
Q ss_pred hhccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR- 700 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 700 (947)
.++|.+.+.||+|+||.||+|... .+..||||++.+.. .....+.+.+|+++++++.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~~Ei~~l~~l~~ 99 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA----------------RSSEKQALMSELKIMTHLGP 99 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC----------------ChHHHHHHHHHHHHHHhcCC
Confidence 367888999999999999999853 13469999984321 1123457889999999996
Q ss_pred ccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC-------------------------------------------
Q 002250 701 HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH------------------------------------------- 737 (947)
Q Consensus 701 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------- 737 (947)
||||+++++++.+.+..|+||||+++|+|.+++....
T Consensus 100 HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (400)
T cd05105 100 HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMD 179 (400)
T ss_pred CCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccc
Confidence 9999999999999999999999999999999986531
Q ss_pred ---------------------------------------------------CccCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 002250 738 ---------------------------------------------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDR 766 (947)
Q Consensus 738 ---------------------------------------------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~ 766 (947)
...+++..+..++.|++.|++||| +.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~ 256 (400)
T cd05105 180 MKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SK 256 (400)
T ss_pred cccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 123678888999999999999999 89
Q ss_pred CeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-C
Q 002250 767 PVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-G 845 (947)
Q Consensus 767 ~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g 845 (947)
+|+||||||+||++++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |
T Consensus 257 ~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g 336 (400)
T cd05105 257 NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG 336 (400)
T ss_pred CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCC
Confidence 999999999999999999999999999986544332222223456788999999998889999999999999999997 8
Q ss_pred CCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 846 KRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 846 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
..||.....+ ..+. ........ ...+...+..+.+++.+||+.+|++|||+.++.++|+++-
T Consensus 337 ~~P~~~~~~~-~~~~----~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 337 GTPYPGMIVD-STFY----NKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred CCCCcccchh-HHHH----HHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 8998532111 1111 11111110 1122334567889999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.02 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=194.9
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|+....||+|+||.||.|+-+ +|..+|+|+++...+- ...+......|-.+|....+|.||+
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~--------------~~~Qv~hV~aERdiL~~~ds~~vVK 205 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML--------------KKNQVEHVRAERDILAEVDSPWVVK 205 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH--------------hhhhHHHHHHHHHHhhhcCCCcEEE
Confidence 477999999999999999999955 6999999999644322 2244567888999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+|-.|++.+..|+||||+|||++..+|.+.+. +++......+.+++.|++-+| ..|+|||||||+|+|||..|++
T Consensus 206 LyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 206 LYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred EEEEecCCCeeEEEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCE
Confidence 99999999999999999999999999987544 555556667888899999999 8999999999999999999999
Q ss_pred EEeccccceeccc----------------------CCCC-----cc------------------eecccccccccCcccc
Q 002250 787 RIADFGLAKIVQT----------------------GEAG-----DL------------------THVIAGTHGYIAPEYA 821 (947)
Q Consensus 787 kl~DfG~a~~~~~----------------------~~~~-----~~------------------~~~~~gt~~y~aPE~~ 821 (947)
||+|||++.-... .+.. .. ....+|||-|||||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 9999999842211 0000 00 0135699999999999
Q ss_pred ccCCCCCccchHHHHHHHHHHHhCCCCCCCCC--CCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhc
Q 002250 822 YTCKINEKSDVYSFGVVLMELVTGKRPIVPEF--GDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHC 899 (947)
Q Consensus 822 ~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~c 899 (947)
.+..|+..+|.||+|||+|||+.|.+||..+. .....+..|........ +. ....+..++|.+|
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-------~~-------~~s~eA~DLI~rl 426 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-------EV-------DLSDEAKDLITRL 426 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-------cC-------cccHHHHHHHHHH
Confidence 99999999999999999999999999996442 22223333322111111 11 1125677888899
Q ss_pred cCCCCCCCCC
Q 002250 900 TNKLPAFRPS 909 (947)
Q Consensus 900 l~~dP~~RPt 909 (947)
+. ||++|.-
T Consensus 427 l~-d~~~RLG 435 (550)
T KOG0605|consen 427 LC-DPENRLG 435 (550)
T ss_pred hc-CHHHhcC
Confidence 98 9999976
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=317.94 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=209.7
Q ss_pred hhccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.-+|++.+.+|+|.||.|-+|. ...|+.||||.++.+. .+..++...+.+||+||+.|+||||+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk--------------IkdeqDlvhIRREIeIMSsLNHPhII~ 117 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK--------------IKDEQDLVHIRREIEIMSSLNHPHIIQ 117 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhh--------------cccHHHHHHHHHHHHHHhhcCCCceee
Confidence 4578889999999999999999 4789999999985332 233455677899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+|++|+..+...|||||..+|.|.||+..+ ..+++.....++.||..|+.|+| .+++||||||.+|||+|.++++
T Consensus 118 IyEVFENkdKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~Ni 192 (668)
T KOG0611|consen 118 IYEVFENKDKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNI 192 (668)
T ss_pred hhhhhcCCceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCe
Confidence 999999999999999999999999999975 45888889999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCC-CccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKIN-EKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||++..+..... ...++|++-|.+||++.+..|. +.+|.||+||++|.++.|..||++ .+.-..+..
T Consensus 193 KIADFGLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-----~Dhk~lvrQ 264 (668)
T KOG0611|consen 193 KIADFGLSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-----RDHKRLVRQ 264 (668)
T ss_pred eeeccchhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-----chHHHHHHH
Confidence 9999999987765543 3457999999999999988874 789999999999999999999953 334344333
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
.-.+... + ++. +....-++++|+..+|++|.|..+|..+..
T Consensus 265 Is~GaYr-----E---P~~----PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 265 ISRGAYR-----E---PET----PSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred hhccccc-----C---CCC----CchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 3222211 0 112 223445778999999999999999998764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=326.63 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=201.8
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+.|++.+.||+|+||.||+|..+++..+|+|.+... ......+.+|+.++++++||||++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~ 65 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG------------------AMSEEDFIEEAKVMMKLSHPKLVQLY 65 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC------------------CccHHHHHHHHHHHHHCCCCCceeEE
Confidence 467888999999999999999988889999987311 12345788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++|+|.++++... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+++
T Consensus 66 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl 141 (256)
T cd05114 66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKV 141 (256)
T ss_pred EEEccCCCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEE
Confidence 99999999999999999999999997632 35889999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.++........ ......++..|+|||++....++.++||||||+++|||++ |+.||... +..+......
T Consensus 142 ~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~-----~~~~~~~~i~ 215 (256)
T cd05114 142 SDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK-----SNYEVVEMIS 215 (256)
T ss_pred CCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHH
Confidence 999999765432221 1112235668999999988889999999999999999999 88898432 1122222111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
..... ..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 216 ~~~~~----------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 216 RGFRL----------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11110 011122356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=319.60 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=197.3
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
-.|...+.+|.|+||.||+|... +++.||||+++++.. .-.+|+++|++++|||||++
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---------------------~knrEl~im~~l~HpNIV~L 82 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---------------------YKNRELQIMRKLDHPNIVRL 82 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---------------------cCcHHHHHHHhcCCcCeeeE
Confidence 45777899999999999999955 579999999975431 12369999999999999999
Q ss_pred EEEEecCCc-----cEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 708 YCSITSEDS-----NLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 708 ~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
.-+|....+ ..+||||||. +|.+.++.. .+..++...+..+..|+.+||+||| +.+|+||||||.|+|+
T Consensus 83 ~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLv 158 (364)
T KOG0658|consen 83 LYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLV 158 (364)
T ss_pred EEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEE
Confidence 888755322 2489999965 899998853 3456777788889999999999999 8999999999999999
Q ss_pred cCC-CCeEEeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 781 DLE-WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 781 ~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
|.+ |.+||||||.|+....++... ....|..|.|||.+.+.. |+.+.||||.|||+.||+-|++-|.+.. ....
T Consensus 159 D~~tg~LKicDFGSAK~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQ 234 (364)
T KOG0658|consen 159 DPDTGVLKICDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQ 234 (364)
T ss_pred cCCCCeEEeccCCcceeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHH
Confidence 976 999999999999887766543 235688999999998865 9999999999999999999998875432 2222
Q ss_pred HHHHHHhhcccccccccccc--------CCC-----Cc-cCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 859 IVNWVYSKMDSRDSMLTVVD--------PNI-----SE-ILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~d--------~~~-----~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
+...+.........-..... +.+ .+ +.....++..+++.+++.++|.+|.++.|++.
T Consensus 235 L~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 235 LVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 33332222111110001111 111 11 33456678999999999999999999999884
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.48 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=206.0
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+.|++.+.||+|++|.||+|...+++.||||.+... ....+.+.+|+.++++++||||++++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~ 67 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG------------------TMDPKDFLAEAQIMKKLRHPKLIQLY 67 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC------------------cccHHHHHHHHHHHHHCCCCCcccee
Confidence 568889999999999999999887889999988421 12345688999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++...+..++||||+++++|.+++.......+++..+..++.|++.|+.||| +.+|+||||||+||++++++.++|
T Consensus 68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l 144 (261)
T cd05068 68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKV 144 (261)
T ss_pred EEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEE
Confidence 99999999999999999999999998755557899999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||+++......... ......+..|+|||+..+..++.++||||||+++|||++ |+.||.... ...... .+
T Consensus 145 ~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~----~~ 217 (261)
T cd05068 145 ADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--NAEVLQ----QV 217 (261)
T ss_pred CCcceEEEccCCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHH----HH
Confidence 9999998765332111 111223457999999998889999999999999999999 888884321 111111 11
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
..... .......+..+.+++.+|++.+|++||++.++.+.|+++
T Consensus 218 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 218 DQGYR---------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HcCCC---------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11110 011223346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=333.73 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=199.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|... +++.||||++.... .........+.+|+.++++++||||+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 66 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE--------------VIRLKQEQHVHNEKRVLKEVSHPFIIRL 66 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH--------------HhhhHHHHHHHHHHHHHHhCCCCcHhhh
Confidence 36888999999999999999965 68999999983110 0011234568899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.++...++||||+++|+|.+++... ..+++.....++.|++.||+||| +++|+||||||+||+++.++.+|
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~k 141 (291)
T cd05612 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIK 141 (291)
T ss_pred HhhhccCCeEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEE
Confidence 99999999999999999999999999864 35788888999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||... ..........
T Consensus 142 l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~-----~~~~~~~~i~ 211 (291)
T cd05612 142 LTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD-----NPFGIYEKIL 211 (291)
T ss_pred EEecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHH
Confidence 99999997654321 2346899999999999888999999999999999999999998532 1111111111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-----MRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~ 916 (947)
.... +++......+.+++.+|++.||.+||+ +.|++++
T Consensus 212 ~~~~-----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 212 AGKL-----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred hCCc-----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1111 112222456788999999999999995 7777755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=330.94 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=205.0
Q ss_pred hccCCcccccccCceeEEEEEeCC------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
+.|.+.+.||+|+||.||+|...+ ++.||||.+.... .....+.+.+|++++++++||
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~l~~l~~~ 68 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA----------------SNDARKDFEREAELLTNFQHE 68 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC----------------CHHHHHHHHHHHHHHHhcCCC
Confidence 567888999999999999998643 4789999873211 112346789999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcC------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIH 770 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 770 (947)
||+++++++......++||||+++++|.+++...+ ...+++.....++.|++.|++||| +.+++|
T Consensus 69 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h 145 (280)
T cd05049 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVH 145 (280)
T ss_pred CchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeec
Confidence 99999999999999999999999999999997542 245788899999999999999999 899999
Q ss_pred ccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCC
Q 002250 771 RDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPI 849 (947)
Q Consensus 771 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~ 849 (947)
|||||+||+++.++.++|+|||.++...............+++.|+|||++.++.++.++|||||||++|||++ |..||
T Consensus 146 ~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~ 225 (280)
T cd05049 146 RDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225 (280)
T ss_pred cccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999976543332222223346788999999999999999999999999999999 99998
Q ss_pred CCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 850 VPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
.... .....+... . ......+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 226 ~~~~--~~~~~~~~~---~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 226 YGLS--NEEVIECIT---Q----------GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred CCCC--HHHHHHHHH---c----------CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 5321 112222111 1 11111222345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=338.41 Aligned_cols=249 Identities=21% Similarity=0.295 Sum_probs=200.0
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .........+.+|+.++++++||||++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~hp~iv~ 82 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE--------------ILKMKQVQHVAQEKSILMELSHPFIVN 82 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--------------HhhhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 367888999999999999999966 68999999984210 111233467889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~ 157 (329)
T PTZ00263 83 MMCSFQDENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHV 157 (329)
T ss_pred EEEEEEcCCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCE
Confidence 999999999999999999999999999864 34778888889999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.....
T Consensus 158 kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-----~~~~~~~~i 227 (329)
T PTZ00263 158 KVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD-----TPFRIYEKI 227 (329)
T ss_pred EEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC-----CHHHHHHHH
Confidence 999999998654322 1346899999999999988999999999999999999999998532 111111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-----MRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~ 916 (947)
...... ++......+.+++.+|++.||.+||+ +.+++++
T Consensus 228 ~~~~~~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 228 LAGRLK-----------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred hcCCcC-----------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111111 11112345778999999999999996 5777644
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=340.12 Aligned_cols=261 Identities=25% Similarity=0.343 Sum_probs=203.0
Q ss_pred hccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RH 701 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 701 (947)
++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.+++++ +|
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~----------------~~~~~~~~~~E~~~~~~l~~h 70 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA----------------TASEYKALMTELKILIHIGHH 70 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC----------------CHHHHHHHHHHHHHHHhhccC
Confidence 57999999999999999999732 25789999883111 112234677899999999 89
Q ss_pred cccceEEEEEecC-CccEEEEeccCCCChHHHhhhcC-------------------------------------------
Q 002250 702 VNVVKLYCSITSE-DSNLLVYEYLPNGSLWDRLHTCH------------------------------------------- 737 (947)
Q Consensus 702 ~niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------- 737 (947)
+||+++++++... ...++||||+++++|.+++....
T Consensus 71 ~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (337)
T cd05054 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIED 150 (337)
T ss_pred cchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccC
Confidence 9999999988654 55789999999999999986432
Q ss_pred ----------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCC
Q 002250 738 ----------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGE 801 (947)
Q Consensus 738 ----------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 801 (947)
..+++|..+.+++.||+.||+||| +.+|+||||||+||++++++.++|+|||+++......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~ 227 (337)
T cd05054 151 KSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 227 (337)
T ss_pred cchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc
Confidence 126789999999999999999999 8999999999999999999999999999998664433
Q ss_pred CCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhccccccccccccCC
Q 002250 802 AGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPN 880 (947)
Q Consensus 802 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 880 (947)
.........++..|+|||++.+..++.++|||||||++|||++ |..||..... ...+.... .....
T Consensus 228 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~-~~~~~~~~----~~~~~-------- 294 (337)
T cd05054 228 DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-DEEFCRRL----KEGTR-------- 294 (337)
T ss_pred chhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc-cHHHHHHH----hccCC--------
Confidence 2222233456778999999999999999999999999999998 9999854221 11111111 11110
Q ss_pred CCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 881 ISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 881 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
...+......+.+++.+||+.+|++||++.|++++|+++-.
T Consensus 295 -~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 295 -MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred -CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 01122334568899999999999999999999999997644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=334.09 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=203.9
Q ss_pred hccCCcccccccCceeEEEEEeC-CCc----EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGK----ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
.+|+..+.||+|+||.||+|++. +++ .||||++.... .....+++.+|+.+++.++|||
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~n 70 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----------------SPKANKEILDEAYVMASVDNPH 70 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 46888999999999999999854 343 48999873211 1123457889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|++++|++..+ ..++|+||+++|+|.+++... ...+++...+.++.||+.||+||| +.+|+||||||+||+++.+
T Consensus 71 iv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~ 145 (316)
T cd05108 71 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTP 145 (316)
T ss_pred CCeEEEEEcCC-CceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCC
Confidence 99999999864 578999999999999999864 335788999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |+.||... ....+...
T Consensus 146 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~--~~~~~~~~ 223 (316)
T cd05108 146 QHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSI 223 (316)
T ss_pred CcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHHH
Confidence 9999999999987654332222222234678999999999899999999999999999998 99998432 11112111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCcc
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVT 926 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 926 (947)
. ..... ...+..+...+.+++.+||..+|++||++.+++..+.++...+..
T Consensus 224 ~----~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~ 274 (316)
T cd05108 224 L----EKGER---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 274 (316)
T ss_pred H----hCCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence 1 11111 011122345688999999999999999999999999987765543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.76 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=204.6
Q ss_pred hccCCcccccccCceeEEEEEeCC----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|++.+.||+|+||+||+|.++. ...||||.+.... .......|.+|+.++++++||||
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i 67 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS----------------SDKQRLDFLTEASIMGQFDHPNI 67 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC----------------ChHHHHHHHHHHHHHHhCCCCCc
Confidence 578899999999999999999752 4579999874211 11234568899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++...+..++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++
T Consensus 68 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~ 143 (266)
T cd05033 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNL 143 (266)
T ss_pred ceEeEEEecCCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCC
Confidence 999999999999999999999999999997643 36899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 863 (947)
.++|+|||+++...............++..|+|||.+....++.++||||||+++|||++ |..||... ....+....
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~--~~~~~~~~~ 221 (266)
T cd05033 144 VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM--SNQDVIKAV 221 (266)
T ss_pred CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC--CHHHHHHHH
Confidence 999999999987652222111112235678999999998889999999999999999998 99998432 111111111
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.... ..+.+...+..+.+++.+|++.+|++||++.|++++|+++
T Consensus 222 ----~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 ----EDGY---------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----HcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1110 0111223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.88 Aligned_cols=254 Identities=25% Similarity=0.323 Sum_probs=216.0
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.+.|...+.+|+|+||.++.++.+ +++.+++|.+...... .........|+.+++++.|||||.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t---------------~~~r~~A~~E~~lis~~~hP~iv~ 67 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT---------------EPERRSAIQEMDLLSKLLHPNIVE 67 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC---------------chhhHHHHHHHHHHHhccCCCeee
Confidence 367888999999999999999966 6889999998533221 122236778999999999999999
Q ss_pred EEEEEecCCc-cEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 707 LYCSITSEDS-NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 707 l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
+++.|.+++. .+|||+|++||++.+.+.+..+..+++....+++.|++.|++||| +..|+|||||+.||+++.++.
T Consensus 68 y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~ 144 (426)
T KOG0589|consen 68 YKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKK 144 (426)
T ss_pred eccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCc
Confidence 9999999998 899999999999999999887788999999999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
|+|+|||+|+....... ....++||+-||.||.+.+..|..|+||||+||++|||++-+++|... +....+.+
T Consensus 145 VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~k 217 (426)
T KOG0589|consen 145 VKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILK 217 (426)
T ss_pred eeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHH
Confidence 99999999998876652 234578999999999999999999999999999999999999999532 33333322
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..+. ...+.+.....++..++..|++.+|+.||++.+++.+
T Consensus 218 i~~~----------~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 218 INRG----------LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred Hhhc----------cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2222 2344556667788999999999999999999999976
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=336.92 Aligned_cols=245 Identities=24% Similarity=0.275 Sum_probs=195.4
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEec
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITS 713 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 713 (947)
+.||+|+||.||+|+.+ +|+.||||++.... .........+.+|+.++++++||||+++++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~ 66 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEV--------------IIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT 66 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc
Confidence 46899999999999965 78999999984211 0111234567789999999999999999999999
Q ss_pred CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecccc
Q 002250 714 EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793 (947)
Q Consensus 714 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 793 (947)
++..++||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 67 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 141 (323)
T cd05571 67 HDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999999863 45788999999999999999999 89999999999999999999999999999
Q ss_pred ceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccc
Q 002250 794 AKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSM 873 (947)
Q Consensus 794 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 873 (947)
++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +............
T Consensus 142 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~~~~~~~~~~~--- 211 (323)
T cd05571 142 CKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILMEE--- 211 (323)
T ss_pred CcccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC-----CHHHHHHHHHcCC---
Confidence 87532221 1123456999999999999989999999999999999999999998532 1111111111111
Q ss_pred cccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 874 LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 874 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
..++......+.+++.+|++.||++|| ++.+++++
T Consensus 212 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 --------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred --------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 111223345678899999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.94 Aligned_cols=255 Identities=27% Similarity=0.378 Sum_probs=205.2
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
..|.+.+.||+|+||.||+|... .++.||+|.+... ......+.+|++++++++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~ 67 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------------TMEVEEFLKEAAVMKEIKHPNLVQL 67 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------------------chHHHHHHHHHHHHHhCCCCChhhe
Confidence 45778889999999999999965 5889999987311 1234568899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||+++++|.+++.......+++..++.++.|++.||+||| +.+++||||||+||++++++.+|
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~k 144 (263)
T cd05052 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVK 144 (263)
T ss_pred EEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEE
Confidence 999999999999999999999999998766667899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||.+......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||... +..+....
T Consensus 145 l~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~~~~- 217 (263)
T cd05052 145 VADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYEL- 217 (263)
T ss_pred eCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH-
Confidence 9999999765443211 1112234568999999988889999999999999999998 88887432 11111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
...... .+.+...+..+.+++.+|++.+|++|||+.++.++|+.+
T Consensus 218 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 218 LEKGYR---------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHCCCC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111100 112223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=330.43 Aligned_cols=258 Identities=20% Similarity=0.326 Sum_probs=201.9
Q ss_pred hhccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.++|++.+.||+|+||.||+|... .+..||||++.... ......++.+|+.+++.++|
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----------------~~~~~~~~~~e~~~l~~l~~ 68 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA----------------SMRERIEFLNEASVMKEFNC 68 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC----------------CHHHHHHHHHHHHHHHhCCC
Confidence 477999999999999999998753 25679999873110 01123568899999999999
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccC
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDV 773 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl 773 (947)
|||+++++++..+...++||||+++++|.+++.... ....++..+..++.|++.|++||| +.+++||||
T Consensus 69 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dl 145 (277)
T cd05062 69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDL 145 (277)
T ss_pred CCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCc
Confidence 999999999999999999999999999999997532 124678889999999999999999 889999999
Q ss_pred CCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 002250 774 KSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPE 852 (947)
Q Consensus 774 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~ 852 (947)
||+||++++++.++|+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||...
T Consensus 146 kp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 146 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred chheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999875543322111112345788999999998889999999999999999999 67887432
Q ss_pred CCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
. ....... .... .....+...+..+.+++.+|++.+|++|||+.|++++|++
T Consensus 226 ~--~~~~~~~---~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 226 S--NEQVLRF---VMEG----------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred C--HHHHHHH---HHcC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1 1111111 1111 1111222345578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=297.63 Aligned_cols=262 Identities=25% Similarity=0.322 Sum_probs=205.3
Q ss_pred hccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.+|+|||+-||.++ ..+++.+|+|++. . ...++.+...+|++..++++|||++++
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~----------------c-~~~~~~e~~~rEid~~rkf~s~~vl~l 83 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKIL----------------C-HSQEDIEEALREIDNHRKFNSPNVLRL 83 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheee----------------c-cchHHHHHHHHHHHHHHhhCCcchHHH
Confidence 689999999999999999999 6789999999982 1 113456778899999999999999999
Q ss_pred EEEEecCC-----ccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 708 YCSITSED-----SNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 708 ~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
+++...+. ..|++++|...|+|.+.+... ++..+++.+.++++.+|++||++||.. ..+++||||||.||++
T Consensus 84 ~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILl 162 (302)
T KOG2345|consen 84 VDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILL 162 (302)
T ss_pred HHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEe
Confidence 98875543 379999999999999999765 445789999999999999999999932 3459999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcc-------eecccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCC
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDL-------THVIAGTHGYIAPEYAY---TCKINEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
++++.+++.|||.++..+-...... ......|.-|.|||.+. +...++++|||||||++|+|+.|..||.
T Consensus 163 s~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 163 SDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred cCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence 9999999999999875432111100 11123688899999874 4557899999999999999999999996
Q ss_pred CCCCCcccHHHHHHhhccccccccccccCCC-CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVDPNI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
..++.++ ..-..+..+.+ .+.....++.+.+++.+|++.||.+||++.+++..++.+-
T Consensus 243 ~~~~~Gg-------------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 243 RIYQQGG-------------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HHhhcCC-------------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 4433222 11122333222 1111125667889999999999999999999999987653
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=330.11 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=203.6
Q ss_pred hccCCcccccccCceeEEEEEe-----CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.|++.+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|+.++++++|||
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~n 68 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN----------------NPQQWGEFQQEASLMAELHHPN 68 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC----------------CHHHHHHHHHHHHHHhhCCCCC
Confidence 5678889999999999999984 246789999883111 1122356889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcC---------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH---------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPV 768 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~i 768 (947)
|+++++++..+...++||||+++++|.+++.... ...+++.....++.|++.||+||| +.++
T Consensus 69 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i 145 (283)
T cd05090 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFF 145 (283)
T ss_pred eeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCe
Confidence 9999999999999999999999999999986321 234788899999999999999999 8899
Q ss_pred EeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCC
Q 002250 769 IHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKR 847 (947)
Q Consensus 769 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~ 847 (947)
+||||||+||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..
T Consensus 146 ~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~ 225 (283)
T cd05090 146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQ 225 (283)
T ss_pred ehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999986544332222223446778999999988889999999999999999999 888
Q ss_pred CCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 848 PIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 848 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
||.... ...+.+.+. .... ...+...+..+.+++.+|++.||++||++.++.++|+++
T Consensus 226 p~~~~~--~~~~~~~~~----~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 226 PYYGFS--NQEVIEMVR----KRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred CCCCCC--HHHHHHHHH----cCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 884321 112222211 1111 112223445688899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.63 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=201.7
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|...++..+|||.+... ......+.+|+.++++++||||++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~ 65 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------------------SMSEDEFIEEAKVMMKLSHEKLVQLY 65 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC------------------cccHHHHHHHHHHHhcCCCCCeeeEE
Confidence 467888999999999999999887778999987311 12245688999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++...+..++||||+++|+|.+++..... .+++..++.++.|++.|++||| +.+++|+||||+||++++++.+||
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl 141 (256)
T cd05113 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKV 141 (256)
T ss_pred EEEccCCCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEE
Confidence 999999999999999999999999976433 6899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.++........ ......++..|+|||+.....++.++||||||+++|||++ |+.||.... ...... ...
T Consensus 142 ~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~---~~~ 215 (256)
T cd05113 142 SDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--NSETVE---KVS 215 (256)
T ss_pred CCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--HHHHHH---HHh
Confidence 999998765433211 1112235678999999988889999999999999999999 999984221 111111 111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
..... ..+......+.+++.+||+.+|++||++.++++.|+
T Consensus 216 ~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 216 QGLRL----------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred cCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11110 011122467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=332.94 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=201.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|+.. ++..||+|++.... .......+.+|++++++++||||+++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~ 68 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----------------KPAIRNQIIRELQVLHECNSPYIVGF 68 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----------------CHHHHHHHHHHHHHHHHCCCCCCCeE
Confidence 67889999999999999999966 68899999883210 11223568899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||+++|+|.+++... ..+++.....++.|++.||+|||+ ..+|+||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~k 144 (331)
T cd06649 69 YGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIK 144 (331)
T ss_pred EEEEEECCEEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEE
Confidence 99999999999999999999999999864 357888999999999999999993 24699999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..++........
T Consensus 145 l~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--~~~~~~~~~~~~ 218 (331)
T cd06649 145 LCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD--AKELEAIFGRPV 218 (331)
T ss_pred EccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhcccc
Confidence 99999987553322 223468999999999998889999999999999999999999995321 111111110000
Q ss_pred -ccccccc--------------------------------ccccCCCCcc-CHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 002250 868 -DSRDSML--------------------------------TVVDPNISEI-LKEDALKVLRIAIHCTNKLPAFRPSMRVV 913 (947)
Q Consensus 868 -~~~~~~~--------------------------------~~~d~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 913 (947)
....... .+.....+.. .......+.+++.+||+.||++|||+.|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el 298 (331)
T cd06649 219 VDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML 298 (331)
T ss_pred cccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH
Confidence 0000000 0000000010 11234568999999999999999999999
Q ss_pred HHHh
Q 002250 914 VQML 917 (947)
Q Consensus 914 ~~~L 917 (947)
+++-
T Consensus 299 l~h~ 302 (331)
T cd06649 299 MNHT 302 (331)
T ss_pred hcCh
Confidence 8753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=314.52 Aligned_cols=262 Identities=23% Similarity=0.265 Sum_probs=207.2
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|+..+.||+|.-|+||.+++. ++..+|+|++..... .......+.+.|-+||+.++||.++.+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l--------------~~rkKl~Ra~tE~eIL~~lDHPFlPTL 142 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL--------------ASRKKLKRAQTEREILSLLDHPFLPTL 142 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH--------------hhhhHHHHHHHHHHHHHhcCCCccchh
Confidence 56777889999999999999977 468999999942221 112445678889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
|+.|+.+...|+|||||+||+|....+++....++.....-++..|+-||+||| ..|||+|||||+|||+.++|.+.
T Consensus 143 Ya~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIM 219 (459)
T KOG0610|consen 143 YASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIM 219 (459)
T ss_pred hheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEE
Confidence 999999999999999999999999999998888999999999999999999999 89999999999999999999999
Q ss_pred Eeccccceeccc---------------------------------C-CC--------------------Ccceecccccc
Q 002250 788 IADFGLAKIVQT---------------------------------G-EA--------------------GDLTHVIAGTH 813 (947)
Q Consensus 788 l~DfG~a~~~~~---------------------------------~-~~--------------------~~~~~~~~gt~ 813 (947)
|+||.++..... . .. ......++||-
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 999998742210 0 00 01122457999
Q ss_pred cccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHH
Q 002250 814 GYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVL 893 (947)
Q Consensus 814 ~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~ 893 (947)
.|.|||++.+...+.++|.|+|||++|||+.|+.||.+... .+.+...+.+. ..+++.+ +....+.
T Consensus 300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~-~~Tl~NIv~~~------------l~Fp~~~-~vs~~ak 365 (459)
T KOG0610|consen 300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN-KETLRNIVGQP------------LKFPEEP-EVSSAAK 365 (459)
T ss_pred ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc-hhhHHHHhcCC------------CcCCCCC-cchhHHH
Confidence 99999999999999999999999999999999999965432 22222222111 1122222 4556788
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 894 RIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 894 ~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
++|++.+.+||.+|.....=...+++..
T Consensus 366 DLIr~LLvKdP~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 366 DLIRKLLVKDPSKRLGSKRGAAEIKRHP 393 (459)
T ss_pred HHHHHHhccChhhhhccccchHHhhcCc
Confidence 9999999999999998333333344433
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.69 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=195.2
Q ss_pred ccCCcccccccCceeEEEEEeC--CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc---ccccc
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN--SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV---RHVNV 704 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~ni 704 (947)
+|++.+.||+|+||+||+|+.. +++.||||++..... .......+.+|+.+++.+ +||||
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~hpni 66 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---------------EEGMPLSTIREVAVLRHLETFEHPNV 66 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC---------------CCCchHHHHHHHHHHHhhcccCCCCc
Confidence 6888999999999999999863 468899998842211 112224456777777766 69999
Q ss_pred ceEEEEEec-----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 705 VKLYCSITS-----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 705 v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
+++++++.. ....++||||++ ++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 67 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil 142 (290)
T cd07862 67 VRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNIL 142 (290)
T ss_pred ceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEE
Confidence 999999853 445789999996 69999998765566899999999999999999999 899999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 780 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
++.++.+||+|||+++...... ......||+.|+|||++....++.++|||||||++|||++|+.||..... .+.
T Consensus 143 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~--~~~ 217 (290)
T cd07862 143 VTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQ 217 (290)
T ss_pred EcCCCCEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH--HHH
Confidence 9999999999999998654332 22345689999999999888899999999999999999999999864321 111
Q ss_pred HHHHHhhcc--ccccc-------cccccCC----CCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 860 VNWVYSKMD--SRDSM-------LTVVDPN----ISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 860 ~~~~~~~~~--~~~~~-------~~~~d~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
......... ....+ ...+.+. +.....+....+.+++.+|++.||++|||+.|+++
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 218 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 111111000 00000 0001100 01112233456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.92 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=208.7
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
..+|++.+.||.|+||.||+|...+++.+|+|++... .......+.+|+.+++.++||||+++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~-----------------~~~~~~~~~~e~~~l~~l~~~~i~~~ 67 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD-----------------DLLKQQDFQKEVQALKRLRHKHLISL 67 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc-----------------chhhHHHHHHHHHHHhcCCCcchhhe
Confidence 3578889999999999999999888999999987321 11234578899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++...+..++||||+++++|.++++......+++..+..++.|++.|++||| +.+++||||+|+||++++++.+|
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~k 144 (261)
T cd05148 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCK 144 (261)
T ss_pred eeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEE
Confidence 999999999999999999999999998766667899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||.+......... .....++..|+|||+.....++.++||||||+++|||++ |+.||.... .........
T Consensus 145 l~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~~-- 218 (261)
T cd05148 145 VADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQIT-- 218 (261)
T ss_pred EccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHH--
Confidence 9999999765433211 112345678999999988889999999999999999998 888984321 111222111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
... ....+...+..+.+++.+|++.||++|||+.++.+.|+.+
T Consensus 219 -~~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 219 -AGY----------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -hCC----------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 110 0112233446688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=300.98 Aligned_cols=253 Identities=25% Similarity=0.312 Sum_probs=202.6
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.+.|++.+.||+|.|+.||++.. ++|+.+|+|.+.. ........+++++|+.|.+.++|||||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~---------------~k~~~~~~e~l~rEarIC~~LqHP~Ivr 74 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT---------------KKLSARDFQKLEREARICRKLQHPNIVR 74 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhh---------------hhhccccHHHHHHHHHHHHhcCCCcEee
Confidence 46788889999999999999884 4799999998831 2223346788999999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC---C
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL---E 783 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~ 783 (947)
+.+.+.+....|+|+|+|+|++|..-+-.. ...++...-....||+.++.|+| .++|||||+||+|+++.. .
T Consensus 75 L~~ti~~~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~ 149 (355)
T KOG0033|consen 75 LHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKG 149 (355)
T ss_pred hhhhhcccceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCC
Confidence 999999999999999999999998766542 44677777788999999999999 899999999999999963 3
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
.-+|++|||+|..+..+. .....+|||+|||||+++..+|+..+|||+.||++|-++.|..||.+. +..++.+
T Consensus 150 A~vKL~~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~--~~~rlye-- 222 (355)
T KOG0033|consen 150 AAVKLADFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYE-- 222 (355)
T ss_pred CceeecccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc--cHHHHHH--
Confidence 458999999999887332 233568999999999999999999999999999999999999999542 2222222
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
........+ + +.......++..+++++|+..||.+|.|+.|.++
T Consensus 223 -~I~~g~yd~----~---~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 223 -QIKAGAYDY----P---SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -HHhccccCC----C---CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 222222211 1 1122233445677888999999999999998774
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=336.56 Aligned_cols=255 Identities=20% Similarity=0.254 Sum_probs=201.7
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|+||.||+|+.. +++.||||++.... .........+.+|++++..++||||++++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~h~~iv~~~ 67 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL--------------LFKLNEVRHVLTERDILTTTKSEWLVKLL 67 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHH--------------HhhhhHHHHHHHHHHHHHhCCCCCCccEE
Confidence 5888999999999999999976 58999999983210 11123345688899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 68 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL 142 (333)
T cd05600 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKL 142 (333)
T ss_pred EEEEcCCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999999763 35788889999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+...... .
T Consensus 143 ~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--~~~~~~~i~---~ 212 (333)
T cd05600 143 TDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST--PNETWENLK---Y 212 (333)
T ss_pred EeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC--HHHHHHHHH---h
Confidence 99999975543 1224568999999999998899999999999999999999999985321 111111111 1
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...... .+............+.+++.+|+..+|.+||++.+++++
T Consensus 213 ~~~~~~---~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 213 WKETLQ---RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccc---CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 010000 011111112334567889999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=335.37 Aligned_cols=260 Identities=26% Similarity=0.370 Sum_probs=211.2
Q ss_pred hccCCcccccccCceeEEEEEeC--CCc--EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN--SGK--ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++.+..+.||+|+||+|++|.|. +|+ .||||.+..+... ....+|.+|+.+|.+|+|||+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~----------------~~mddflrEas~M~~L~H~hl 173 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN----------------AIMDDFLREASHMLKLQHPHL 173 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc----------------hhHHHHHHHHHHHHhccCcce
Confidence 34556788999999999999976 344 5899999543321 256789999999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++||+..+ ....||||.++.|+|.+.+++.....+-......++.|||.||.||. +++.|||||.++|+++...-
T Consensus 174 iRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllaspr 249 (1039)
T KOG0199|consen 174 IRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPR 249 (1039)
T ss_pred eEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccc
Confidence 999999988 67889999999999999999866777889999999999999999999 99999999999999999999
Q ss_pred CeEEeccccceecccCCCCcc-eecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDL-THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
.+||+|||+++-+...+.... .....-.+.|+|||.++...++.++|||+|||++|||+| |..||.+-. -...
T Consensus 250 tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----g~qI 324 (1039)
T KOG0199|consen 250 TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----GIQI 324 (1039)
T ss_pred eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----HHHH
Confidence 999999999998766544322 122234578999999999999999999999999999999 788974321 1111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
+..+-+.+.-+-++.+++.++++|..||...|++|||+..+.+.+-..++.
T Consensus 325 ----------L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaq 375 (1039)
T KOG0199|consen 325 ----------LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQ 375 (1039)
T ss_pred ----------HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcC
Confidence 111222333455667888999999999999999999999998555444433
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=327.07 Aligned_cols=263 Identities=21% Similarity=0.278 Sum_probs=197.3
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|.+.+.||+|+||+||+|+.. +++.||+|++.... .......+.+|+.++++++||||+++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~niv~~ 68 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH----------------EEGAPCTAIREVSLLKNLKHANIVTL 68 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc----------------cCCcchhHHHHHHHHHhCCCCCEeeE
Confidence 56888999999999999999965 68999999984211 11223457789999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||++ ++|.+++.... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~k 143 (288)
T cd07871 69 HDIIHTERCLTLVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELK 143 (288)
T ss_pred EEEEcCCCeEEEEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEE
Confidence 999999999999999997 48999887643 35788889999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||+++....... ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+........
T Consensus 144 l~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~ 219 (288)
T cd07871 144 LADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST--VKEELHLIFRL 219 (288)
T ss_pred ECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHH
Confidence 999999976433221 1223467899999998875 458899999999999999999999985432 11111111111
Q ss_pred cc-----------ccccccccccCCCC-----ccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MD-----------SRDSMLTVVDPNIS-----EILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~-----------~~~~~~~~~d~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. ....+.....+... ........+..+++.+|++.||.+|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 220 LGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000000111100 0011223457889999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=324.22 Aligned_cols=264 Identities=21% Similarity=0.311 Sum_probs=203.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CCc----EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGK----ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
++|+..+.||+|+||+||+|.+. +++ .+|+|.+... .......++..|+.++++++|||
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~----------------~~~~~~~~~~~~~~~l~~l~h~~ 70 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR----------------SGRQTFQEITDHMLAMGSLDHAY 70 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc----------------cchHHHHHHHHHHHHHhcCCCCC
Confidence 56788899999999999999964 454 4677765210 01123456788899999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++.. ...++++||+++|+|.+++... ...+++.....++.|++.||+||| +.+++||||||+||+++++
T Consensus 71 iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~ 145 (279)
T cd05111 71 IVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSD 145 (279)
T ss_pred cceEEEEECC-CccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCC
Confidence 9999998764 5578999999999999999763 346899999999999999999999 8899999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||+++...............++..|+|||++..+.++.++||||||+++||+++ |+.||.... .....+.
T Consensus 146 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~~~~ 223 (279)
T cd05111 146 SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR--PHEVPDL 223 (279)
T ss_pred CcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH
Confidence 9999999999987654432222233457789999999998899999999999999999998 999985321 1112222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCccee
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNI 928 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 928 (947)
. ..... ...+..+...+.+++.+||..+|++|||+.|+.+.|+.+...|...+
T Consensus 224 ~----~~~~~---------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~~ 276 (279)
T cd05111 224 L----EKGER---------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRYL 276 (279)
T ss_pred H----HCCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCccee
Confidence 1 11111 00111123457788999999999999999999999998776554443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=326.09 Aligned_cols=256 Identities=23% Similarity=0.254 Sum_probs=199.3
Q ss_pred ccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecCC
Q 002250 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSED 715 (947)
Q Consensus 637 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 715 (947)
||+|+||+||+++.+ +|+.||+|++.... .........+..|++++++++||||+++++++..+.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------------~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~ 66 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR--------------LKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT 66 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHH--------------hhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC
Confidence 699999999999965 68999999983211 011122344567999999999999999999999999
Q ss_pred ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 716 SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 716 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
..++||||+++++|.+++.......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||++.
T Consensus 67 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~ 143 (277)
T cd05607 67 HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAV 143 (277)
T ss_pred eEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeee
Confidence 9999999999999999987766667899999999999999999999 8999999999999999999999999999997
Q ss_pred ecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccc
Q 002250 796 IVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLT 875 (947)
Q Consensus 796 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 875 (947)
....... .....|+..|+|||++.+..++.++||||+||++|||++|+.||..... ..............
T Consensus 144 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~------ 213 (277)
T cd05607 144 ELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE-KVAKEELKRRTLED------ 213 (277)
T ss_pred ecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc-hhhHHHHHHHhhcc------
Confidence 6543321 2234689999999999988899999999999999999999999853211 11111111111111
Q ss_pred cccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 876 VVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 876 ~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
............+.+++.+|++.||++||+++|+++........
T Consensus 214 ----~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 214 ----EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred ----ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 11001112344578899999999999999998887666654444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=312.56 Aligned_cols=266 Identities=22% Similarity=0.270 Sum_probs=201.8
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+...|...+.||+|+||.|++|..+ +|+.||||++.. ........++..+|++.++.++|+||+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~---------------~F~~~~~akRtlRElklLr~~~HeNIi 84 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN---------------PFENQIDAKRTLRELKLLRHLRHENII 84 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh---------------hhhchHHHHHHHHHHHHHHHhcCCCcc
Confidence 3455666789999999999999955 799999999831 122334556778999999999999999
Q ss_pred eEEEEEec-----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 706 KLYCSITS-----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 706 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
.+++.+.. -...|+|+|+| +.+|...++.. ..++..+..-+..|+++||.|+| +.+|+|||+||+|+++
T Consensus 85 ~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~ 158 (359)
T KOG0660|consen 85 GLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLL 158 (359)
T ss_pred eEEeecccccccccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheee
Confidence 99999866 45679999999 66899999873 44888899999999999999999 9999999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCC-----
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFG----- 854 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~----- 854 (947)
+.+...||+|||+|+...........+..+.|.+|.|||++.. ..|+.+.||||.||++.||++|++-|.+...
T Consensus 159 n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~ 238 (359)
T KOG0660|consen 159 NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ 238 (359)
T ss_pred ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH
Confidence 9999999999999998865422333445678999999998864 4699999999999999999999998854320
Q ss_pred -------C-cccHHHHHH-----hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 855 -------D-SKDIVNWVY-----SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 855 -------~-~~~~~~~~~-----~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
. ..+....+. ..+... ...-...+........+..++++.+|+..||.+|+|+.|++++
T Consensus 239 lI~~~lGtP~~e~l~~i~s~~ar~yi~sl---p~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 239 LILELLGTPSEEDLQKIRSEKARPYIKSL---PQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhcCCCCHHHHHHhccHHHHHHHHhC---CCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 001111000 000000 0000001122223445567889999999999999999999864
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=352.29 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=201.5
Q ss_pred hccCCcccccccCceeEEEEEeC-C-CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-S-GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
..|.+.+.||+|+||.||+|... + ++.||+|.+... .......+.+|+.+++.++|||||+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-----------------~~~~~~~~~~E~~~l~~l~Hpniv~ 129 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-----------------DERQAAYARSELHCLAACDHFGIVK 129 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-----------------CHHHHHHHHHHHHHHHhCCCCCEeE
Confidence 35888999999999999999854 4 678899876211 1122346778999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++..++..|+||||+++|+|.++++.. ...++++.....++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 130 ~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~ 206 (478)
T PTZ00267 130 HFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTG 206 (478)
T ss_pred EEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCC
Confidence 999999999999999999999999988643 3456888999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+...
T Consensus 207 ~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~-----~~~~~~~ 281 (478)
T PTZ00267 207 IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP-----SQREIMQ 281 (478)
T ss_pred cEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHH
Confidence 99999999998765433222233457999999999999889999999999999999999999998432 1122222
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
..... .....+......+.+++.+|++.||++||++.+++.
T Consensus 282 ~~~~~----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 282 QVLYG----------KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHhC----------CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11111 111122233456889999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=332.32 Aligned_cols=242 Identities=26% Similarity=0.319 Sum_probs=192.9
Q ss_pred ccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecCC
Q 002250 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSED 715 (947)
Q Consensus 637 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 715 (947)
||+|+||.||+|+.. +++.||+|++.... .........+.+|+.++++++||||+++++++..++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 66 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH--------------IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE 66 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC
Confidence 699999999999965 68899999983110 011233456788999999999999999999999999
Q ss_pred ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 716 SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 716 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||+++
T Consensus 67 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~ 141 (312)
T cd05585 67 KLYLVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCK 141 (312)
T ss_pred eEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccc
Confidence 999999999999999999863 35888999999999999999999 8999999999999999999999999999997
Q ss_pred ecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccc
Q 002250 796 IVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLT 875 (947)
Q Consensus 796 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 875 (947)
....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+..........
T Consensus 142 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~~~~~~~~~~---- 210 (312)
T cd05585 142 LNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEMYRKILQEPL---- 210 (312)
T ss_pred cCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHHHHHHHcCCC----
Confidence 5432221 223456999999999999988999999999999999999999998532 22222222221111
Q ss_pred cccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 002250 876 VVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS---MRVVVQ 915 (947)
Q Consensus 876 ~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~ev~~ 915 (947)
.++......+.+++.+|++.||++||+ +.|+++
T Consensus 211 -------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 211 -------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 112233456788999999999999985 555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=343.26 Aligned_cols=262 Identities=24% Similarity=0.318 Sum_probs=208.9
Q ss_pred ccCCcccccccCceeEEEEEeCCC-cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccceE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLNSG-KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVKL 707 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l 707 (947)
++++.+.|.+|||+.||.|+...+ .+||+|++. ...+.+.....+||++|++|+ |+|||.+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~-----------------~~de~~L~~v~~EI~~MK~L~gh~nIV~y 100 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMY-----------------VNDEEALNAVKREIDIMKLLSGHKNIVSY 100 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeee-----------------cCCHHHHHHHHHHHHHHHHhcCCCceeeE
Confidence 466788999999999999997655 999999982 123455678899999999996 9999999
Q ss_pred EEE-Eec------CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 708 YCS-ITS------EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 708 ~~~-~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
++. ... ..+++|.||||+||.|-|++.......+++..+++|+.|+++|+++||.. ..+|||||||-+|||+
T Consensus 101 idss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLl 179 (738)
T KOG1989|consen 101 IDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLL 179 (738)
T ss_pred eccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEE
Confidence 993 322 13467999999999999999876666699999999999999999999953 6779999999999999
Q ss_pred cCCCCeEEeccccceecccCCC-Ccc------eecccccccccCcccc---ccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 002250 781 DLEWKPRIADFGLAKIVQTGEA-GDL------THVIAGTHGYIAPEYA---YTCKINEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~-~~~------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
+.++..||||||.|........ ... .-....|+.|+|||++ .+...++|+||||+||+||-++....||+
T Consensus 180 s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe 259 (738)
T KOG1989|consen 180 SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE 259 (738)
T ss_pred cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence 9999999999999864332221 000 1122368999999988 45568999999999999999999999995
Q ss_pred CCCCCcccHHHHHHhhccccccccccccCCC--CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC--CCCcc
Q 002250 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVDPNI--SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE--PCSVT 926 (947)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~--~~~~~ 926 (947)
.... ..+++..+ ++. ......+.+||..|++.||++||++.+|++.+.++. +|+..
T Consensus 260 ~sg~-------------------laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 260 ESGK-------------------LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred cCcc-------------------eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 3211 23444443 222 467778999999999999999999999999998865 55555
Q ss_pred eee
Q 002250 927 NIV 929 (947)
Q Consensus 927 ~~~ 929 (947)
++.
T Consensus 320 ~~~ 322 (738)
T KOG1989|consen 320 DIY 322 (738)
T ss_pred ccc
Confidence 554
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=299.35 Aligned_cols=263 Identities=26% Similarity=0.388 Sum_probs=207.9
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHV 702 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 702 (947)
+..-..|...+.+|+|..++|-++..+ +|+++|+|++...+-...+.. ...-.++-.+|+.|++++ .||
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~---------~~~~~EaT~~Ev~ILRqv~GHP 83 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGET---------PYEMREATRQEISILRQVMGHP 83 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCcc---------HHHHHHHHHHHHHHHHHhcCCC
Confidence 445577888899999999999998855 789999999843222111110 001124456799999998 799
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
+|+++.++|+.+...++|+|.|+.|.|.|++.. ...+++....+|+.|+..|++||| ...||||||||+|||+++
T Consensus 84 ~II~l~D~yes~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILldd 158 (411)
T KOG0599|consen 84 YIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDD 158 (411)
T ss_pred cEEEeeeeccCcchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeecc
Confidence 999999999999999999999999999999986 467888999999999999999999 899999999999999999
Q ss_pred CCCeEEeccccceecccCCCCcceecccccccccCccccc------cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 002250 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY------TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 856 (947)
+.++||+|||+|....+++. ....+|||+|.|||.++ ...|+..+|+||.||++|.++.|++||+..
T Consensus 159 n~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---- 231 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---- 231 (411)
T ss_pred ccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----
Confidence 99999999999998877654 33568999999999884 234788999999999999999999999421
Q ss_pred ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.-.-++...+++...+ -++...+......+++.+|++.||.+|.|++|++++
T Consensus 232 -kQmlMLR~ImeGkyqF-------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 232 -KQMLMLRMIMEGKYQF-------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -HHHHHHHHHHhccccc-------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1111112222222221 133445566678889999999999999999999853
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=335.29 Aligned_cols=249 Identities=22% Similarity=0.252 Sum_probs=199.1
Q ss_pred hhccCCcccccccCceeEEEEEeCC--CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNS--GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
.++|++.+.||+|+||.||+|..+. +..||+|++.... .........+.+|+.+++.++||||+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~hp~Iv 94 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK--------------IIKQKQVDHVFSERKILNYINHPFCV 94 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHH--------------hhhhhhHHHHHHHHHHHHhCCCCCCc
Confidence 4678999999999999999998543 3689999883110 11123346788999999999999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++.+++..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ 169 (340)
T PTZ00426 95 NLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGF 169 (340)
T ss_pred ceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCC
Confidence 9999999999999999999999999999864 35788899999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... -......
T Consensus 170 ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~ 239 (340)
T PTZ00426 170 IKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-----PLLIYQK 239 (340)
T ss_pred EEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-----HHHHHHH
Confidence 999999999865432 123568999999999998889999999999999999999999995321 1111111
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
...... .++ ......+.+++.+|++.||++|+ +++++.++
T Consensus 240 i~~~~~--------~~p---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 240 ILEGII--------YFP---KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HhcCCC--------CCC---CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111111 111 12234567889999999999995 78888765
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=328.51 Aligned_cols=265 Identities=20% Similarity=0.253 Sum_probs=196.2
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.. +++.||||++... ........+.+|+.+++.++||||++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~niv~ 67 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ----------------EEEGTPFTAIREASLLKGLKHANIVL 67 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccc----------------cccccchhHHHHHHHHhhCCCCCcCe
Confidence 367899999999999999999966 7899999998321 11122345678999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..+...++||||++ ++|.+++... ...++...+..++.|++.||+||| +.+|+||||||+||++++++.+
T Consensus 68 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 142 (303)
T cd07869 68 LHDIIHTKETLTLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGEL 142 (303)
T ss_pred EEEEEecCCeEEEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCE
Confidence 9999999999999999995 6888888753 345788888999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||+++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........+......
T Consensus 143 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 220 (303)
T cd07869 143 KLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV 220 (303)
T ss_pred EECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHH
Confidence 9999999975432211 1223467899999998865 457889999999999999999999996432111111111110
Q ss_pred hccccc-cccc-----cccCC-C----CccCH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 866 KMDSRD-SMLT-----VVDPN-I----SEILK------EDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 866 ~~~~~~-~~~~-----~~d~~-~----~~~~~------~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
...... .+.. ..++. . +.... .....+.+++.+|++.||++|||+.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 221 LGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 0000 00000 0 00000 01245778999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=328.68 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=204.5
Q ss_pred hccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
.+|.+.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~ 67 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----------------SDNARKDFHREAELLTNLQHE 67 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-----------------CHHHHHHHHHHHHHHHhCCCC
Confidence 56888999999999999999842 3456899987311 112345688999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcC-----------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH-----------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHR 771 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~ 771 (947)
||+++++++...+..++||||+++++|.+++...+ ...+++..+..++.|++.||+||| +.+++||
T Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~ 144 (288)
T cd05093 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHR 144 (288)
T ss_pred CcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 99999999999999999999999999999997532 234899999999999999999999 8999999
Q ss_pred cCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 002250 772 DVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIV 850 (947)
Q Consensus 772 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~ 850 (947)
||||+||++++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 145 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~ 224 (288)
T cd05093 145 DLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 224 (288)
T ss_pred ccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999975543322212223345778999999998889999999999999999999 888884
Q ss_pred CCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
... ...... ...... ........+..+.+++.+||+.+|.+|||+.++.+.|+++...
T Consensus 225 ~~~--~~~~~~---~i~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 225 QLS--NNEVIE---CITQGR----------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCC--HHHHHH---HHHcCC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 321 111111 111111 0111112345689999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.60 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=202.6
Q ss_pred hccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
..|++.+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~~~~l~h~ 68 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----------------EGPLREEFKHEAMMRSRLQHP 68 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC----------------CHHHHHHHHHHHHHHhcCCCC
Confidence 45777889999999999999854 25789999983110 011235688999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhc--------------CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC--------------HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPV 768 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~i 768 (947)
||+++++++...+..++++||+++++|.+++... ....+++..+..++.|++.||+|+| +.+|
T Consensus 69 ~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi 145 (283)
T cd05091 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHV 145 (283)
T ss_pred CcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCc
Confidence 9999999999999999999999999999998532 1234788889999999999999999 8999
Q ss_pred EeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCC
Q 002250 769 IHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKR 847 (947)
Q Consensus 769 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~ 847 (947)
+||||||+||++++++.+||+|||+++...............+++.|+|||++..+.++.++||||||+++|||++ |..
T Consensus 146 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 225 (283)
T cd05091 146 VHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 225 (283)
T ss_pred cccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999876543332222223345789999999988889999999999999999998 777
Q ss_pred CCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 848 PIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 848 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
||.... ..++.+ .... ......+...+..+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 226 p~~~~~--~~~~~~---~i~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 226 PYCGYS--NQDVIE---MIRN----------RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred CCCCCC--HHHHHH---HHHc----------CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 874321 111211 1111 111222334556788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=320.55 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=203.2
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||.||+|...+...||+|++... ....+.+.+|++++++++||||++++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~------------------~~~~~~~~~E~~~l~~l~~~~i~~~~ 67 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG------------------TMSPEAFLQEAQVMKKLRHEKLVQLY 67 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC------------------ccCHHHHHHHHHHHHhCCCCCcceEE
Confidence 568999999999999999999877778999988311 12235788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++.+ ...++||||+++|+|.+++.......+++..+..++.|++.||+|+| +.+++||||||+||++++++.++|
T Consensus 68 ~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L 143 (262)
T cd05071 68 AVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKV 143 (262)
T ss_pred EEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEe
Confidence 98754 56799999999999999998754556799999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.++........ ......++..|+|||+..+..++.++||||||+++|||++ |..||.... ..... ...
T Consensus 144 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~--~~~~~----~~~ 216 (262)
T cd05071 144 ADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVL----DQV 216 (262)
T ss_pred ccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--hHHHH----HHH
Confidence 999999765433221 1112346678999999988889999999999999999999 777874321 11111 111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.... ......+.+..+.+++.+|++.+|++||++.++.+.|++.
T Consensus 217 ~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 217 ERGY---------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred hcCC---------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1110 0112234556788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=320.58 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=203.9
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.++|++.+.||+|+||.||+|..+++..||+|.+.+.. ...+.+.+|+.++++++|+|++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~------------------~~~~~~~~E~~~l~~l~~~~i~~~ 66 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT------------------MSPESFLEEAQIMKKLRHDKLVQL 66 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC------------------CCHHHHHHHHHHHHhcCCCceEEE
Confidence 36788999999999999999998888899999884221 223568899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++. ....++||||+++++|.++++......+++..+..++.|++.|++||| +.+++||||||+||++++++.++
T Consensus 67 ~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~ 142 (260)
T cd05070 67 YAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCK 142 (260)
T ss_pred EeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEE
Confidence 99885 456899999999999999998755556899999999999999999999 88999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||.+.......... .....++..|+|||+..+..++.++||||||+++|||++ |..||... ...+..+..
T Consensus 143 l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--~~~~~~~~~--- 216 (260)
T cd05070 143 IADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--NNREVLEQV--- 216 (260)
T ss_pred eCCceeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHH---
Confidence 99999998654432211 112235678999999988889999999999999999999 88888432 111122211
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
.. .. ..+.+...+..+.+++.+|++.+|++|||+.++.+.|++
T Consensus 217 ~~-~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 ER-GY---------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred Hc-CC---------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11 10 011223345678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=332.07 Aligned_cols=245 Identities=24% Similarity=0.283 Sum_probs=194.4
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEec
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITS 713 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 713 (947)
+.||+|+||.||+|+.. +|+.||+|++.... .........+.+|++++++++||||+++++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~ 66 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEV--------------IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 66 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence 46899999999999965 78999999984211 1112234567789999999999999999999999
Q ss_pred CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecccc
Q 002250 714 EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793 (947)
Q Consensus 714 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 793 (947)
++..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 67 ~~~~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 141 (323)
T cd05595 67 HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHH
Confidence 99999999999999999988763 35889999999999999999999 89999999999999999999999999999
Q ss_pred ceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccc
Q 002250 794 AKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSM 873 (947)
Q Consensus 794 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 873 (947)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 142 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~~~~~~~~~~~-- 212 (323)
T cd05595 142 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELILMEEI-- 212 (323)
T ss_pred hccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCCC--
Confidence 875322211 1223568999999999998899999999999999999999999985321 1111111111111
Q ss_pred cccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 874 LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 874 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
..+......+.+++.+|++.||++|| ++.+++++
T Consensus 213 ---------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 ---------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 11223345678899999999999998 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=327.63 Aligned_cols=265 Identities=18% Similarity=0.207 Sum_probs=199.0
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.+ +++.||||++.... ........+.+|+++++.++||||+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 65 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE---------------ENEEVKETTLRELKMLRTLKQENIVEL 65 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc---------------ccccchhhHHHHHHHHHhCCCccccch
Confidence 36888999999999999999976 68899999984221 111234567889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||++++.+..+... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 66 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~k 140 (287)
T cd07848 66 KEAFRRRGKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLK 140 (287)
T ss_pred hhhEecCCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEE
Confidence 9999999999999999998776655433 345888899999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh-
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK- 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~- 866 (947)
|+|||++......... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...........
T Consensus 141 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~ 218 (287)
T cd07848 141 LCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE-IDQLFTIQKVLG 218 (287)
T ss_pred EeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhhC
Confidence 9999999865433221 12234689999999999988899999999999999999999999854321 11111100000
Q ss_pred ---------ccccccccccccCCC-------CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 867 ---------MDSRDSMLTVVDPNI-------SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 867 ---------~~~~~~~~~~~d~~~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
............+.. ..........+.+++.+|++.||++|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 219 PLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000000 0011123456899999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.21 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=195.6
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEec
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITS 713 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 713 (947)
+.||+|+||.||+|... +++.||+|.+... ........+.+|++++++++||||+++++++..
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 64 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----------------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 64 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc----------------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 46899999999999965 7899999987311 011233568899999999999999999999999
Q ss_pred CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecccc
Q 002250 714 EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793 (947)
Q Consensus 714 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 793 (947)
+...++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+
T Consensus 65 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 140 (252)
T cd05084 65 KQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGM 140 (252)
T ss_pred CCCeEEEEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECcccc
Confidence 99999999999999999999753 345789999999999999999999 89999999999999999999999999999
Q ss_pred ceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 794 AKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 794 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
+.................+..|+|||.+.++.++.++||||||+++|||++ |..||.... ...... ......
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~--~~~~~~----~~~~~~- 213 (252)
T cd05084 141 SREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS--NQQTRE----AIEQGV- 213 (252)
T ss_pred CcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC--HHHHHH----HHHcCC-
Confidence 875433211111111123457999999998889999999999999999998 888874321 111111 111100
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
....+...+..+.+++.+|++.+|++|||+.++.++|++
T Consensus 214 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 214 --------RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred --------CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 011222345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=320.34 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=205.3
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.+.|++.++||+|+||.||+|..++++.||+|.+... ......+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~------------------~~~~~~~~~E~~~l~~l~h~~i~~~ 66 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG------------------SMSPEAFLAEANLMKQLQHPRLVRL 66 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCC------------------CCcHHHHHHHHHHHHhcCCcCeeeE
Confidence 3678899999999999999999888999999988321 1234578899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++. .+..++||||+++++|.+++.......+++..+..++.|++.|++||| +.+++||||||+||++++++.++
T Consensus 67 ~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~ 142 (260)
T cd05067 67 YAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCK 142 (260)
T ss_pred EEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEE
Confidence 99874 457899999999999999998766667899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
++|||++......... ......++..|+|||++....++.++||||||+++|||++ |+.||.... ..+.....
T Consensus 143 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~--- 216 (260)
T cd05067 143 IADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNL--- 216 (260)
T ss_pred EccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHH---
Confidence 9999999765532221 1112345678999999988889999999999999999999 999985321 11121111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
..... .+.....+..+.+++.+|++.+|++||+++++.+.|+.+
T Consensus 217 -~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 217 -ERGYR---------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred -HcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 11100 111122345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=349.83 Aligned_cols=256 Identities=24% Similarity=0.317 Sum_probs=204.0
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|.+.+.||+|+||+||+|+. .+|+.||||++..... .......+.+|+.++..++|+||++
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---------------~~~~~~~~~~Ei~~l~~~~h~~iv~ 95 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---------------SEADKNRAQAEVCCLLNCDFFSIVK 95 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---------------CHHHHHHHHHHHHHHhcCCCCcEEE
Confidence 46899999999999999999985 4799999999842211 1123456788999999999999999
Q ss_pred EEEEEecCC--------ccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 002250 707 LYCSITSED--------SNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776 (947)
Q Consensus 707 l~~~~~~~~--------~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 776 (947)
+++.+...+ ..++||||+++|+|.++++.. ....+++.....++.|++.||+||| +.+|+||||||+
T Consensus 96 ~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~ 172 (496)
T PTZ00283 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSA 172 (496)
T ss_pred eecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHH
Confidence 988775433 257999999999999999753 2346889999999999999999999 899999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 002250 777 NILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856 (947)
Q Consensus 777 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 856 (947)
||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~---- 248 (496)
T PTZ00283 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE---- 248 (496)
T ss_pred HEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC----
Confidence 9999999999999999998765433333333457999999999999989999999999999999999999998432
Q ss_pred ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+..+.+...... .....+...+..+.+++.+||+.||++||++.+++++
T Consensus 249 -~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 249 -NMEEVMHKTLAG----------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -CHHHHHHHHhcC----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 222222222211 1112223345678899999999999999999999864
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.28 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=205.0
Q ss_pred hccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
++|.+.+.||+|+||.||+|+.. ++..+|+|.+... .......+.+|++++++++||
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~ 67 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-----------------TLAARKDFQREAELLTNLQHE 67 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-----------------cHHHHHHHHHHHHHHhcCCCC
Confidence 45778899999999999999843 3556899987311 112235688999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPV 768 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~i 768 (947)
||+++++++...+..++||||+++++|.+++.... ...+++..++.++.|++.|++||| +.+|
T Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i 144 (291)
T cd05094 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHF 144 (291)
T ss_pred CcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 99999999999999999999999999999997532 234789999999999999999999 8999
Q ss_pred EeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCC
Q 002250 769 IHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKR 847 (947)
Q Consensus 769 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~ 847 (947)
+||||||+||+++.++.++|+|||++................++..|+|||++....++.++||||||+++|||+| |+.
T Consensus 145 ~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 224 (291)
T cd05094 145 VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224 (291)
T ss_pred eecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999976544322222223456788999999998889999999999999999999 999
Q ss_pred CCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 848 PIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 848 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
||.... .....+. .. . ....+.....+..+.+++.+||+.+|++|||+.+|+++|+++..
T Consensus 225 p~~~~~--~~~~~~~---~~-~---------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 225 PWFQLS--NTEVIEC---IT-Q---------GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCCCCC--HHHHHHH---Hh-C---------CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 985321 1111111 11 1 11111122335678899999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.48 Aligned_cols=272 Identities=22% Similarity=0.261 Sum_probs=204.9
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc-cc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN-VV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv 705 (947)
...|...++||+|+||+||+|+. .+|+.||+|++.-.. ..+.......+|+.+++.++|+| ||
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~---------------~~EG~P~taiREisllk~L~~~~~iv 74 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEF---------------EEEGVPSTAIREISLLKRLSHANHIV 74 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccc---------------cccCCCchhhHHHHHHHHhCCCcceE
Confidence 45677778899999999999995 479999999994221 11223455678999999999999 99
Q ss_pred eEEEEEecCC------ccEEEEeccCCCChHHHhhhcCC--ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 706 KLYCSITSED------SNLLVYEYLPNGSLWDRLHTCHK--IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 706 ~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
++++++.... ..++|+||+ .-+|.+++..... ...+...+..++.|++.||+||| +++|+||||||+|
T Consensus 75 ~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQN 150 (323)
T KOG0594|consen 75 RLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQN 150 (323)
T ss_pred EEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcce
Confidence 9999998877 788999999 5599999987653 35677889999999999999999 9999999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 002250 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856 (947)
Q Consensus 778 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 856 (947)
|+++++|.+||+|||+|+...-.. ...+..++|..|.|||++.+. .|+..+||||+||+++||++++.-|.+..+ .
T Consensus 151 lLi~~~G~lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~ 227 (323)
T KOG0594|consen 151 LLISSSGVLKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-I 227 (323)
T ss_pred EEECCCCcEeeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-H
Confidence 999999999999999998654222 123455789999999999887 589999999999999999998877754322 2
Q ss_pred ccHHHHHHhhcc-ccccccccc---cCC--C---------CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhc
Q 002250 857 KDIVNWVYSKMD-SRDSMLTVV---DPN--I---------SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEE 919 (947)
Q Consensus 857 ~~~~~~~~~~~~-~~~~~~~~~---d~~--~---------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~ 919 (947)
+.+......... ....+..+. +.. . ............+++.+|++++|.+|.|++.++++ +..
T Consensus 228 ~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 228 DQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE 307 (323)
T ss_pred HHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence 222222111111 111111111 100 1 11111222468899999999999999999999987 665
Q ss_pred cC
Q 002250 920 AE 921 (947)
Q Consensus 920 ~~ 921 (947)
..
T Consensus 308 ~~ 309 (323)
T KOG0594|consen 308 LP 309 (323)
T ss_pred cc
Confidence 54
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=333.68 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=214.2
Q ss_pred CCcccccccCceeEEEEEe-CCC----cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 632 KPENLIGKGGSGNVYKVVL-NSG----KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 632 ~~~~~iG~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
+..++||.|+||+||||.+ +.| -+||||++. .....+...++.+|+.+|.+++|||+++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~----------------~~t~~~~s~e~LdeAl~masldHpnl~R 762 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLI----------------EFTSPKASIELLDEALRMASLDHPNLLR 762 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEee----------------ccCCchhhHHHHHHHHHHhcCCCchHHH
Confidence 3467899999999999984 444 368999872 2333456788999999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
++|+|.... ..||++|+|.|+|.|+++. .+..+.....+.+..|||+||.||| .+++|||||.++|||+..-..+
T Consensus 763 LLgvc~~s~-~qlvtq~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hv 837 (1177)
T KOG1025|consen 763 LLGVCMLST-LQLVTQLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHV 837 (1177)
T ss_pred Hhhhcccch-HHHHHHhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeE
Confidence 999999876 8899999999999999997 4556888889999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 865 (947)
||.|||+|+....++.........-.+.|||-|.+....|+.++|||||||++||++| |..|++... .+++.+.+
T Consensus 838 kitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~--~~eI~dll-- 913 (1177)
T KOG1025|consen 838 KITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP--AEEIPDLL-- 913 (1177)
T ss_pred EEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC--HHHhhHHH--
Confidence 9999999998877655443333334678999999999999999999999999999999 999985431 12222211
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCcceee
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIV 929 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 929 (947)
+ ++..-..++.+..+++.++.+||..|++.||+++++...+.+...-|-.+.+
T Consensus 914 --e---------~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~ 966 (1177)
T KOG1025|consen 914 --E---------KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLV 966 (1177)
T ss_pred --h---------ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEee
Confidence 1 1222345667778899999999999999999999999999987665544443
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.00 Aligned_cols=270 Identities=26% Similarity=0.360 Sum_probs=201.2
Q ss_pred hcc-CCcccccccCceeEEEEEe-----CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAV-KPENLIGKGGSGNVYKVVL-----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~-~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
++| +..+.||+|+||+||++.. .+++.||+|++.... .......+.+|++++++++||
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~ 66 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC----------------GQQNTSGWKKEINILKTLYHE 66 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc----------------ChHHHHHHHHHHHHHHhCCCC
Confidence 345 7889999999999988652 357899999884211 012345678899999999999
Q ss_pred ccceEEEEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 703 NVVKLYCSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 703 niv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
||+++++++... ...++||||+++++|.+++.. ..+++..+..++.|++.|++||| +.+|+||||||+||++
T Consensus 67 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili 140 (283)
T cd05080 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLL 140 (283)
T ss_pred CEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEE
Confidence 999999988664 357899999999999999976 34899999999999999999999 8999999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCc-ceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
++++.++|+|||+++......... ......++..|+|||++....++.++||||||+++|||++|+.||........+.
T Consensus 141 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~ 220 (283)
T cd05080 141 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM 220 (283)
T ss_pred cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh
Confidence 999999999999998654332211 1112235667999999988889999999999999999999999975332111111
Q ss_pred HHHHHhhccccccccccccCC-CCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 860 VNWVYSKMDSRDSMLTVVDPN-ISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~d~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
........... ......+.. ..+.+...+..+.+++.+||+.+|++|||+++++++|+++.
T Consensus 221 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 221 IGPKQGQMTVV-RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcccccccchh-hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11000000000 000111111 11223344567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=319.69 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=201.0
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.+|++.+.||+|+||.||+|..+++..+|+|.+... ......+.+|++++++++||||++++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~------------------~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG------------------AMSEDDFIEEAKVMMKLSHPNLVQLY 65 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC------------------CCCHHHHHHHHHHHHhCCCCCEEEEE
Confidence 457888999999999999999887788999987311 12335688899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++...+..++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+||
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl 141 (256)
T cd05059 66 GVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKV 141 (256)
T ss_pred EEEcCCCceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEE
Confidence 99999999999999999999999997643 36899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.++......... .....++..|+|||.+....++.++||||||+++|||++ |+.||... .........
T Consensus 142 ~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~---- 214 (256)
T cd05059 142 SDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF--SNSEVVESV---- 214 (256)
T ss_pred CCcccceecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHH----
Confidence 9999998654322111 111223457999999998889999999999999999999 78888432 111111111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
.... .. ..+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 215 ~~~~------~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 215 SAGY------RL---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred HcCC------cC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1110 00 111224557889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=331.23 Aligned_cols=245 Identities=24% Similarity=0.283 Sum_probs=195.5
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEec
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITS 713 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 713 (947)
+.||+|+||.||+|+.. +++.||||++.... .........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 66 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEV--------------IIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT 66 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc
Confidence 36899999999999965 68999999984211 1112334677889999999999999999999999
Q ss_pred CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecccc
Q 002250 714 EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793 (947)
Q Consensus 714 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 793 (947)
++..++||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 67 ~~~~~lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~ 141 (328)
T cd05593 67 KDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGL 141 (328)
T ss_pred CCEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcC
Confidence 99999999999999999998763 35889999999999999999999 89999999999999999999999999999
Q ss_pred ceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccc
Q 002250 794 AKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSM 873 (947)
Q Consensus 794 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 873 (947)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +............
T Consensus 142 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-----~~~~~~~~~~~~~--- 211 (328)
T cd05593 142 CKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILMED--- 211 (328)
T ss_pred CccCCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC-----CHHHHHHHhccCC---
Confidence 87532221 1122456999999999999888999999999999999999999998532 1111111111111
Q ss_pred cccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 874 LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 874 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
. .++......+.+++.+|++.||++|| ++.|++++
T Consensus 212 -----~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 -----I---KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -----c---cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1 11222345678899999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=342.77 Aligned_cols=372 Identities=27% Similarity=0.404 Sum_probs=287.7
Q ss_pred cCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEE
Q 002250 132 LTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQL 211 (947)
Q Consensus 132 l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 211 (947)
|+-.+-.|+++|.++...+|.....+++++||.|...++. .+|+.++.|.+|++|.+++|++. .+-..+..++.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 4556778999999998889999999999999999999999 79999999999999999999997 667789999999999
Q ss_pred Eeecccccc-cCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccc
Q 002250 212 ELYNNSLSG-RLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 212 ~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 290 (947)
.+.+|+++. -+|..+..+..|..||||+|+++..|..+...+++-.|+|++|+|..+.-..|.+++.|-.|||++|++.
T Consensus 84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 999999964 4677788999999999999999999999999999999999999999554455778999999999999998
Q ss_pred ccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEccccccc-ccCCCCC
Q 002250 291 GTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLS-GTIPPGI 369 (947)
Q Consensus 291 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~-~~~p~~~ 369 (947)
.+|..+..+..|++|+|++|++...--.. +-.+++|+.|.+++.+-+ .-+|.++
T Consensus 164 -~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQ------------------------LPsmtsL~vLhms~TqRTl~N~Ptsl 218 (1255)
T KOG0444|consen 164 -MLPPQIRRLSMLQTLKLSNNPLNHFQLRQ------------------------LPSMTSLSVLHMSNTQRTLDNIPTSL 218 (1255)
T ss_pred -hcCHHHHHHhhhhhhhcCCChhhHHHHhc------------------------CccchhhhhhhcccccchhhcCCCch
Confidence 88988999999999999999986211111 123445555566554432 2456666
Q ss_pred CCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccch
Q 002250 370 WSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSS 449 (947)
Q Consensus 370 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 449 (947)
-.+.+|..+|||.|.+. .+|+++-++.+|+.|+||+|+|+ .+....+...+|++|+||.|+++ .+|.++++|++|+.
T Consensus 219 d~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k 295 (1255)
T KOG0444|consen 219 DDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK 295 (1255)
T ss_pred hhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH
Confidence 66667777777777766 45666666677777777777776 55555566667777777777777 67777777777777
Q ss_pred hhccccccCCC-CCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc-ccccceeeCCCCc
Q 002250 450 LYLHDNMFSGP-LPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQ 527 (947)
Q Consensus 450 L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N~ 527 (947)
|++.+|+++-. +|..++.+.+|+.+..++|.|. .+|+.++.+..|+.|.|++|++- .+|..+. ++.|+.|||..|+
T Consensus 296 Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 296 LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred HHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 77777776532 6777777777777777777776 67777777777777777777776 4454444 4777777777776
Q ss_pred CCCCCCCc
Q 002250 528 LAGPIPEP 535 (947)
Q Consensus 528 l~~~~p~~ 535 (947)
--..+|.+
T Consensus 374 nLVMPPKP 381 (1255)
T KOG0444|consen 374 NLVMPPKP 381 (1255)
T ss_pred CccCCCCc
Confidence 55445533
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=336.24 Aligned_cols=257 Identities=20% Similarity=0.218 Sum_probs=196.4
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.+|++.+.||+|+||.||+|... +++.||+|... ...+.+|++++++++||||+++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------------------~~~~~~E~~il~~l~HpnIv~~ 148 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------------------RGGTATEAHILRAINHPSIIQL 148 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------------------hhhhHHHHHHHHhCCCCCCCCE
Confidence 56999999999999999999954 78999999641 1346789999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..+...++|+|++. ++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 149 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vk 222 (391)
T PHA03212 149 KGTFTYNKFTCLILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVC 222 (391)
T ss_pred eEEEEECCeeEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEE
Confidence 999999999999999994 7898888763 35788999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc------ccHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS------KDIVN 861 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~------~~~~~ 861 (947)
|+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..
T Consensus 223 L~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~ 301 (391)
T PHA03212 223 LGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301 (391)
T ss_pred EEeCCccccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH
Confidence 9999999754322211 1224579999999999998889999999999999999999998875432110 01111
Q ss_pred HHHhhccccccc--------cc---------cccCCC---CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 862 WVYSKMDSRDSM--------LT---------VVDPNI---SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 862 ~~~~~~~~~~~~--------~~---------~~d~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
............ .. ...+.. .....+.+..+.+++.+|++.||++|||+.|+++
T Consensus 302 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 302 IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 110000000000 00 000000 0111234567889999999999999999999985
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.23 Aligned_cols=262 Identities=22% Similarity=0.309 Sum_probs=207.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|+.. +++.||||.+.... .........+.+|+++++.++||||+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 67 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE--------------MMDAKARQDCVKEIDLLKQLNHPNVIKY 67 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccc--------------cCCHHHHHHHHHHHHHHHhCCCcceeee
Confidence 57888999999999999999954 78999999873211 0111234568889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++...+..++|+||+++++|.+++... ....+++.....++.|++.||+||| +.+++||||||+||+++.++.
T Consensus 68 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~ 144 (267)
T cd08228 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGV 144 (267)
T ss_pred eeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCC
Confidence 99999999999999999999999988643 2345788899999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
++|+|||.+........ ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||..... +...+...
T Consensus 145 ~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~ 219 (267)
T cd08228 145 VKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQK 219 (267)
T ss_pred EEECccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHH
Confidence 99999999986543321 11234578899999999888899999999999999999999999854322 22222211
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
..... .+ +......+..+.+++.+||+.+|++||++.+|++.++++.
T Consensus 220 ~~~~~-------~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 220 IEQCD-------YP--PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HhcCC-------CC--CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11100 01 1112234567889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=325.72 Aligned_cols=259 Identities=21% Similarity=0.304 Sum_probs=203.0
Q ss_pred hhccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.++|++.+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+.++++++|
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~e~~~l~~l~~ 68 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA----------------SLRERIEFLNEASVMKGFTC 68 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC----------------CHHHHHHHHHHHHHHHhCCC
Confidence 478999999999999999999753 24589999873111 01123457789999999999
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccC
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDV 773 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl 773 (947)
|||+++++++...+..++||||+++|+|.+++.... ....++..+..++.|++.|++||| +++|+||||
T Consensus 69 ~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~di 145 (288)
T cd05061 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDL 145 (288)
T ss_pred CCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCC
Confidence 999999999999999999999999999999997532 234567788899999999999999 899999999
Q ss_pred CCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 002250 774 KSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPE 852 (947)
Q Consensus 774 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~ 852 (947)
||+||++++++.++|+|||+++...............++..|+|||.+..+.++.++|||||||++|||++ |..||...
T Consensus 146 kp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 146 AARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred ChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986543332222222345678999999998889999999999999999999 78887432
Q ss_pred CCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
...+...... +......+...+..+.+++.+|++.+|++|||+.++++.|++.
T Consensus 226 -----~~~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 226 -----SNEQVLKFVM----------DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -----CHHHHHHHHH----------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111111111 1111122233456799999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.87 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=202.7
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|.+.+.||+|++|.||+|....+..+|+|.+.+. ....+.+.+|+.++++++|||+++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~------------------~~~~~~~~~E~~~l~~l~h~~i~~~~ 67 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG------------------TMMPEAFLQEAQIMKKLRHDKLVPLY 67 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC------------------CccHHHHHHHHHHHHhCCCCCeeeEE
Confidence 568888999999999999999887778999987321 12235688999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++. .+..++||||+++++|.++++......+++..+..++.|++.||+||| +.+++||||||+||++++++.++|
T Consensus 68 ~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l 143 (260)
T cd05069 68 AVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKI 143 (260)
T ss_pred EEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEE
Confidence 9885 456789999999999999998755556899999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.++........ ......++..|+|||+..+..++.++||||||+++|||++ |..||.... .....+...
T Consensus 144 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~--- 217 (260)
T cd05069 144 ADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NREVLEQVE--- 217 (260)
T ss_pred CCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH---
Confidence 999999765433211 1112245678999999988889999999999999999999 888885321 111111111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
... ....+...+..+.+++.+|++.+|++||+++++.+.|++
T Consensus 218 -~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 218 -RGY---------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -cCC---------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 110 011223345678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=335.59 Aligned_cols=249 Identities=27% Similarity=0.371 Sum_probs=193.0
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|+..+.||+|+||+||+|+.. +++.||||++.... .......+.+|++++++++|+||+++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~ 137 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH----------------EDTVRRQICREIEILRDVNHPNVVKC 137 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC----------------cHHHHHHHHHHHHHHHhCCCCCccee
Confidence 56777889999999999999965 78999999983211 11223568899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||+++|+|.+.. ..++.....++.||+.||+||| +.+|+||||||+||++++++.+|
T Consensus 138 ~~~~~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~k 208 (353)
T PLN00034 138 HDMFDHNGEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVK 208 (353)
T ss_pred eeEeccCCeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEE
Confidence 99999999999999999999986532 2456677889999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-----CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
|+|||+++....... ......||..|+|||++.. ...+.++|||||||++|||++|+.||.... ..+....
T Consensus 209 L~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~--~~~~~~~ 284 (353)
T PLN00034 209 IADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR--QGDWASL 284 (353)
T ss_pred Ecccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CccHHHH
Confidence 999999986543221 1223468999999998743 223468999999999999999999996221 1121111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....... ............+.+++.+||+.||++|||+.|++++
T Consensus 285 ~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 285 MCAICMS----------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHhcc----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111100 0111222345568899999999999999999999975
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=334.87 Aligned_cols=260 Identities=23% Similarity=0.329 Sum_probs=202.4
Q ss_pred hhccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR- 700 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 700 (947)
.++|.+.+.||+|+||.||+|++. .++.||||++.... .....+.+.+|++++.++.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~~E~~~l~~l~~ 99 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA----------------RSSEKQALMSELKIMSHLGP 99 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC----------------ChhHHHHHHHHHHHHHhcCC
Confidence 357888899999999999999864 24689999984211 1122356889999999997
Q ss_pred ccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC------------------------------------------
Q 002250 701 HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK------------------------------------------ 738 (947)
Q Consensus 701 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------ 738 (947)
||||+++++++..++..++||||+++|+|.++++..+.
T Consensus 100 H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (401)
T cd05107 100 HLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYM 179 (401)
T ss_pred CCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccc
Confidence 99999999999999999999999999999999975321
Q ss_pred ------------------------------------------------------ccCCHHHHHHHHHHHHHHHHHHhcCC
Q 002250 739 ------------------------------------------------------IEMDWVVRYAIAVGAAKGLEYLHHGF 764 (947)
Q Consensus 739 ------------------------------------------------------~~~~~~~~~~i~~~ia~~l~yLH~~~ 764 (947)
..+++.....++.|++.||+|||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--- 256 (401)
T cd05107 180 DMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--- 256 (401)
T ss_pred ccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---
Confidence 13567778899999999999999
Q ss_pred CCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh
Q 002250 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844 (947)
Q Consensus 765 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt 844 (947)
+.+++||||||+||++++++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++
T Consensus 257 ~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~ 336 (401)
T cd05107 257 SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336 (401)
T ss_pred cCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 89999999999999999999999999999986543322111223356789999999998889999999999999999998
Q ss_pred -CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 845 -GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 845 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
|+.||.... ...... ........ ...+......+.+++.+||+.+|.+||++.++++.|+++
T Consensus 337 ~g~~P~~~~~-~~~~~~----~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 337 LGGTPYPELP-MNEQFY----NAIKRGYR---------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred cCCCCCCCCC-chHHHH----HHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 888874321 111111 11111100 111222345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=321.53 Aligned_cols=257 Identities=25% Similarity=0.343 Sum_probs=201.3
Q ss_pred cCCcccccccCceeEEEEEeCC----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 631 VKPENLIGKGGSGNVYKVVLNS----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
|++.+.||+|+||.||+|.... +..||||++..... .......+.+|+.+++.++||||++
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~ 65 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH---------------TYSEIEEFLSEAACMKDFDHPNVMK 65 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC---------------CHHHHHHHHHHHHHHHhCCCCCeee
Confidence 5678899999999999998642 36799999842110 1122457889999999999999999
Q ss_pred EEEEEecCCc------cEEEEeccCCCChHHHhhhc----CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 002250 707 LYCSITSEDS------NLLVYEYLPNGSLWDRLHTC----HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776 (947)
Q Consensus 707 l~~~~~~~~~------~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 776 (947)
+++++..... .++||||+++|+|.+++... ....+++.....++.|++.||+||| +.+++||||||+
T Consensus 66 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~ 142 (273)
T cd05035 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAAR 142 (273)
T ss_pred EEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchh
Confidence 9998876554 68999999999999998543 2346899999999999999999999 899999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 002250 777 NILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGD 855 (947)
Q Consensus 777 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~ 855 (947)
||++++++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |..||....
T Consensus 143 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-- 220 (273)
T cd05035 143 NCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-- 220 (273)
T ss_pred eEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--
Confidence 99999999999999999987654433222223345678999999988889999999999999999999 888874321
Q ss_pred cccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 856 SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
...+.+.. ... .....+...+..+.+++.+|++.||++|||+.|+++.|+++
T Consensus 221 ~~~~~~~~---~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 221 NHEIYDYL---RHG----------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHHHH---HcC----------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11222211 111 11112233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=329.35 Aligned_cols=246 Identities=25% Similarity=0.355 Sum_probs=193.6
Q ss_pred ccccccCceeEEEEEe----CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEE
Q 002250 635 NLIGKGGSGNVYKVVL----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 710 (947)
+.||+|+||.||+|+. .+++.||||++.... ..........+.+|+.+++.++||||++++++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~-------------~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~ 68 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKAT-------------IVRNQKDTAHTKAERNILEAVKHPFIVDLIYA 68 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHH-------------HHhhhhhHHHHHHHHHHHHhCCCCchhceeeE
Confidence 5799999999999985 257899999983210 11112234567889999999999999999999
Q ss_pred EecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEec
Q 002250 711 ITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790 (947)
Q Consensus 711 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 790 (947)
+..++..|+||||+++++|.+++... ..+.+.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 69 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 143 (323)
T cd05584 69 FQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTD 143 (323)
T ss_pred EecCCeEEEEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEee
Confidence 99999999999999999999999764 34677888889999999999999 89999999999999999999999999
Q ss_pred cccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccc
Q 002250 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSR 870 (947)
Q Consensus 791 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 870 (947)
||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... +............
T Consensus 144 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~-----~~~~~~~~~~~~~ 216 (323)
T cd05584 144 FGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE-----NRKKTIDKILKGK 216 (323)
T ss_pred CcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC-----CHHHHHHHHHcCC
Confidence 999875432221 122356899999999999888999999999999999999999998532 1112222211111
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 871 DSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 871 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
. ..+......+.+++.+|++.||++|| ++.+++++
T Consensus 217 ~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 L-----------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred C-----------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1 11122345678899999999999999 78887653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.50 Aligned_cols=243 Identities=27% Similarity=0.371 Sum_probs=189.0
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 712 (947)
+.||+|+||.||+|+.. +++.||||++.... .......+.+..|..++... +||||+++++++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~ 66 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDV--------------VLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ 66 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE
Confidence 36899999999999965 68899999984211 01112334556677777654 8999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
.++..++||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~~lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg 141 (316)
T cd05592 67 TKEHLFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFG 141 (316)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCc
Confidence 999999999999999999999764 35788888999999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+.........
T Consensus 142 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~-----~~~~~~~~i~~~~-- 212 (316)
T cd05592 142 MCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE-----DEDELFDSILNDR-- 212 (316)
T ss_pred CCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCC--
Confidence 997543322 1223457899999999999888999999999999999999999998532 1111111111111
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVV 914 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 914 (947)
...+......+.+++.+|++.||++||++.+.+
T Consensus 213 ---------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 213 ---------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence 111222344577889999999999999876433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=326.11 Aligned_cols=255 Identities=26% Similarity=0.294 Sum_probs=201.7
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.|+..+.||+|+||+||++... +++.||||++.... .........+.+|+.++++++||||++++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 66 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--------------IKKRKGEAMALNEKQILEKVNSRFVVSLA 66 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhh--------------hhhhhhHHHHHHHHHHHHhcCCCCEeeee
Confidence 3677889999999999999964 68999999983211 01112234567899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++|+|.+++.......+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|
T Consensus 67 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l 143 (285)
T cd05605 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRI 143 (285)
T ss_pred eeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999987655556899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||++........ .....|+..|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.....
T Consensus 144 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~--~~~~~~~~~~~~ 218 (285)
T cd05605 144 SDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE--KVKREEVERRVK 218 (285)
T ss_pred eeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch--hhHHHHHHHHhh
Confidence 99999986543221 1234689999999999988899999999999999999999999953211 111111111111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
......+......+.+++.+|++.||++|| ++.++.++
T Consensus 219 ----------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 219 ----------EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ----------hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111122233456688999999999999999 77787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=324.96 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=204.5
Q ss_pred hhccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-c
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-R 700 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 700 (947)
.++|.+.+.||+|+||.||+|... ++..||||++.... .....+.+.+|+.+++++ +
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~ 97 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA----------------HSSEREALMSELKIMSHLGN 97 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC----------------ChHHHHHHHHHHHHHHhccC
Confidence 467889999999999999999742 35579999873211 112345788999999999 7
Q ss_pred ccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 701 HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 701 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
||||+++++++...+..++||||+++|+|.++++......+++.....++.|++.|++||| +.+|+|+||||+||++
T Consensus 98 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~ 174 (302)
T cd05055 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLL 174 (302)
T ss_pred CCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEE
Confidence 9999999999999999999999999999999998654445899999999999999999999 8999999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccH
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDI 859 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~ 859 (947)
+.++.++++|||+++...............++..|+|||++..+.++.++||||+||++|||++ |..||..... ...+
T Consensus 175 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-~~~~ 253 (302)
T cd05055 175 THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-DSKF 253 (302)
T ss_pred cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-hHHH
Confidence 9999999999999976543322111122345778999999999899999999999999999998 9999853221 1111
Q ss_pred HHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.... ..... ...+...+..+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 254 ~~~~----~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 254 YKLI----KEGYR---------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHH----HcCCc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111 11100 011112245688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=324.01 Aligned_cols=258 Identities=22% Similarity=0.329 Sum_probs=204.4
Q ss_pred hhccCCcccccccCceeEEEEEeCC------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNS------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.++|++.+.||+|+||.||+|..+. +..||+|.+.... .......+.+|+.+++.++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----------------~~~~~~~~~~e~~~l~~~~~ 68 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----------------SMRERIEFLNEASVMKEFNC 68 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc----------------CHHHHHHHHHHHHHHHhCCC
Confidence 3678889999999999999998642 4689999873211 11223567889999999999
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccC
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDV 773 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl 773 (947)
|||+++++++......++||||+++|+|.+++.... ...+++..++.++.|++.|++||| +.+++||||
T Consensus 69 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di 145 (277)
T cd05032 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDL 145 (277)
T ss_pred CceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccc
Confidence 999999999999999999999999999999997532 224688899999999999999999 899999999
Q ss_pred CCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 002250 774 KSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPE 852 (947)
Q Consensus 774 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~ 852 (947)
||+||+++.++.+||+|||+++...............++..|+|||.+..+.++.++|||||||++||+++ |..||...
T Consensus 146 ~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 146 AARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred ChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 99999999999999999999976544332222223456789999999988889999999999999999998 88888422
Q ss_pred CCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
......+... . ......+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 226 --~~~~~~~~~~----~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 226 --SNEEVLKFVI----D---------GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --CHHHHHHHHh----c---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1222222211 1 11111222235678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=307.85 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=211.3
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|.+++++|+|+||.||||.++ +|+.||||.+.. ..+.+++..|+.++++++.|++|++
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-------------------~sDLQEIIKEISIMQQC~S~yVVKY 93 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-------------------DTDLQEIIKEISIMQQCKSKYVVKY 93 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-------------------cchHHHHHHHHHHHHHcCCchhhhh
Confidence 45667899999999999999976 799999998832 2567889999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
||.|-.....++|||||-.|++.|.++. ++.++.+...-.+....++||+||| ..+-+|||||+.|||+..+|.+|
T Consensus 94 YGSYFK~sDLWIVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AK 169 (502)
T KOG0574|consen 94 YGSYFKHSDLWIVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAK 169 (502)
T ss_pred hhhhccCCceEeehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhh
Confidence 9999999999999999999999999986 5678999999999999999999999 78889999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
++|||.|..+.+... ....+.||+.|||||++..-.|+.++||||+|++..||..|++||.+.
T Consensus 170 LADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI--------------- 232 (502)
T KOG0574|consen 170 LADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI--------------- 232 (502)
T ss_pred hhhccccchhhhhHH--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc---------------
Confidence 999999976544322 123568999999999999989999999999999999999999998422
Q ss_pred ccccccccccc--CCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhccCCC
Q 002250 868 DSRDSMLTVVD--PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEAEPC 923 (947)
Q Consensus 868 ~~~~~~~~~~d--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~~~~ 923 (947)
+..+.+.-+-. |..-.-+++...++-++++.|+-+.|++|.|+.++.++ ++.+++|
T Consensus 233 HPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 233 HPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred cccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 11111110101 11122356667789999999999999999999999875 4455555
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=326.68 Aligned_cols=199 Identities=27% Similarity=0.425 Sum_probs=171.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|... ++..+|+|++... ........+.+|++++++++||||+++
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 68 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE----------------IKPAIRNQIIRELQVLHECNSPYIVGF 68 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc----------------cCHHHHHHHHHHHHHHHHCCCCcccce
Confidence 67899999999999999999966 6888999987321 011234568899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++|..++..++||||+++|+|.+++... ..+++.....++.|++.|++|||+ ..+|+||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~k 144 (333)
T cd06650 69 YGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIK 144 (333)
T ss_pred eEEEEECCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEE
Confidence 99999999999999999999999999864 347888889999999999999993 24799999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
|+|||++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 145 L~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 145 LCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred EeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999987543321 1234689999999999988899999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=327.41 Aligned_cols=259 Identities=25% Similarity=0.353 Sum_probs=203.6
Q ss_pred hhccCCcccccccCceeEEEEEeCC------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-c
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNS------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-R 700 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 700 (947)
.++|+..+.||+|+||.||+|.... ...+|+|.+.... .......+.+|+.+++++ +
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~----------------~~~~~~~~~~E~~~l~~l~~ 74 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----------------TEKDLSDLVSEMEMMKMIGK 74 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC----------------CHHHHHHHHHHHHHHHhhcC
Confidence 3578888999999999999998642 3679999873210 112335688999999999 8
Q ss_pred ccccceEEEEEecCCccEEEEeccCCCChHHHhhhc--------------CCccCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 002250 701 HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC--------------HKIEMDWVVRYAIAVGAAKGLEYLHHGFDR 766 (947)
Q Consensus 701 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~ 766 (947)
|+||+++++++..++..++||||+++|+|.++++.. ....+++..++.++.|++.|++||| +.
T Consensus 75 h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~ 151 (293)
T cd05053 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SK 151 (293)
T ss_pred CCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HC
Confidence 999999999999999999999999999999999642 2346889999999999999999999 89
Q ss_pred CeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-C
Q 002250 767 PVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-G 845 (947)
Q Consensus 767 ~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g 845 (947)
+|+||||||+||++++++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |
T Consensus 152 ~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 231 (293)
T cd05053 152 KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 231 (293)
T ss_pred CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCC
Confidence 999999999999999999999999999986654332221222235678999999988889999999999999999998 8
Q ss_pred CCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 846 KRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 846 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
..||.... .....+. ..... ..+.+......+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 232 ~~p~~~~~--~~~~~~~----~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 232 GSPYPGIP--VEELFKL----LKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred CCCCCCCC--HHHHHHH----HHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 88874221 1111111 11111 1112223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=322.50 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=200.6
Q ss_pred hhccCCcccccccCceeEEEEEeCC------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNS------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.+.|.+.+.||+|+||.||+|...+ +..||+|.+... ........+.+|+.++++++|
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~----------------~~~~~~~~~~~e~~~l~~l~~ 68 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES----------------CSEQDESDFLMEALIMSKFNH 68 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC----------------CCHHHHHHHHHHHHHHHhCCC
Confidence 3678889999999999999999653 567899977311 011223568889999999999
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC-----ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK-----IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 776 (947)
+||+++++++.+.+..++||||+++++|.+++..... ..+++..+..++.||+.|++||| +.+++||||||+
T Consensus 69 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~ 145 (277)
T cd05036 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAAR 145 (277)
T ss_pred CCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchh
Confidence 9999999999999999999999999999999976432 35899999999999999999999 889999999999
Q ss_pred CeEecCCC---CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 002250 777 NILLDLEW---KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPE 852 (947)
Q Consensus 777 NIll~~~~---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~ 852 (947)
||+++.++ .+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 146 nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 146 NCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred eEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99998754 599999999986533222111112233568999999998899999999999999999997 88898432
Q ss_pred CCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
....+..... .... ...+...+..+.+++.+|++.+|++||++.+|+++|++
T Consensus 226 --~~~~~~~~~~---~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 226 --TNQEVMEFVT---GGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred --CHHHHHHHHH---cCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1112222111 1100 11122334678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.23 Aligned_cols=264 Identities=21% Similarity=0.301 Sum_probs=200.4
Q ss_pred hccCCcccccccCceeEEEEEeCC---------------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHH
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS---------------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 693 (947)
++|++.+.||+|+||.||+|.... ...||||.+++.. .......+.+|+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~ei 68 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----------------TKTARNDFLKEI 68 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----------------CHHHHHHHHHHH
Confidence 578999999999999999987542 2358999874221 012235688999
Q ss_pred HHHhhccccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC----------CccCCHHHHHHHHHHHHHHHHHHhcC
Q 002250 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH----------KIEMDWVVRYAIAVGAAKGLEYLHHG 763 (947)
Q Consensus 694 ~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~i~~~ia~~l~yLH~~ 763 (947)
+++++++|||++++++++......++||||+++++|.+++.... ....++..++.++.|++.|++|||
T Consensus 69 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-- 146 (295)
T cd05097 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA-- 146 (295)
T ss_pred HHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH--
Confidence 99999999999999999999999999999999999999986532 124688899999999999999999
Q ss_pred CCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHH
Q 002250 764 FDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELV 843 (947)
Q Consensus 764 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell 843 (947)
+.+++||||||+||++++++.+||+|||++................++..|+|||+...+.++.++|||||||++|||+
T Consensus 147 -~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~ 225 (295)
T cd05097 147 -SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225 (295)
T ss_pred -hcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHH
Confidence 8999999999999999999999999999997654433222222334577899999999888999999999999999999
Q ss_pred h--CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 844 T--GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 844 t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
+ |..||.... ................. ..........+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 226 ~~~~~~p~~~~~--~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 226 TLCKEQPYSLLS--DEQVIENTGEFFRNQGR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HcCCCCCCcccC--hHHHHHHHHHhhhhccc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 8 556764321 11222111111110000 00011111234579999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=323.00 Aligned_cols=256 Identities=24% Similarity=0.331 Sum_probs=201.5
Q ss_pred hccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
++|...+.||+|+||.||+|... ++..+|+|.+... .......+.+|++++++++|+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~ 67 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----------------SESARQDFQREAELLTVLQHQ 67 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-----------------CHHHHHHHHHHHHHHhcCCCC
Confidence 56778899999999999999742 3567899987311 112345789999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC-------------ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK-------------IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVI 769 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iv 769 (947)
||+++++++......++||||+++++|.+++..... ..+++..++.++.|++.|++||| +.+++
T Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~ 144 (280)
T cd05092 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFV 144 (280)
T ss_pred CCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence 999999999999999999999999999999976432 34789999999999999999999 89999
Q ss_pred eccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCC
Q 002250 770 HRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848 (947)
Q Consensus 770 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p 848 (947)
||||||+||++++++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 145 H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 224 (280)
T cd05092 145 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224 (280)
T ss_pred cccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999976543322111222345678999999998889999999999999999998 8888
Q ss_pred CCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 849 IVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
|.... .. +......... ..+.+...+..+.+++.+||+.||.+||++.|+.+.|++
T Consensus 225 ~~~~~--~~---~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 225 WYQLS--NT---EAIECITQGR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred CccCC--HH---HHHHHHHcCc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 84321 11 1111111111 011122344568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=326.64 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=205.7
Q ss_pred hhccCCcccccccCceeEEEEEeC--------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN--------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV 699 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 699 (947)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+... ........+.+|+.+++.+
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----------------~~~~~~~~~~~E~~~l~~l 77 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----------------ATEKDLSDLVSEMEMMKMI 77 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----------------cchHHHHHHHHHHHHHHhh
Confidence 467889999999999999999741 2457999987311 1112346788999999999
Q ss_pred -cccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------------CccCCHHHHHHHHHHHHHHHHHHhcCC
Q 002250 700 -RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------------KIEMDWVVRYAIAVGAAKGLEYLHHGF 764 (947)
Q Consensus 700 -~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~ia~~l~yLH~~~ 764 (947)
+||||+++++++......++||||+++|+|.+++.... ...+++..+..++.|++.||+|||
T Consensus 78 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--- 154 (304)
T cd05101 78 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--- 154 (304)
T ss_pred ccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---
Confidence 89999999999999999999999999999999997642 235788889999999999999999
Q ss_pred CCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh
Q 002250 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844 (947)
Q Consensus 765 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt 844 (947)
+.+++||||||+||++++++.+||+|||.++...............+++.|+|||++.+..++.++||||||+++|||++
T Consensus 155 ~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 234 (304)
T cd05101 155 SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234 (304)
T ss_pred HCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHc
Confidence 89999999999999999999999999999987654332222223345678999999988889999999999999999998
Q ss_pred -CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 845 -GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 845 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
|..||... ...++.... ..... ...+...+..+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 235 ~g~~p~~~~-----~~~~~~~~~-~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 235 LGGSPYPGI-----PVEELFKLL-KEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CCCCCcccC-----CHHHHHHHH-HcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 77787321 122222111 11111 111223456788899999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=317.64 Aligned_cols=252 Identities=27% Similarity=0.350 Sum_probs=205.0
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|.+.+.||+|++|.||+|..+ +++.|++|.+.... .......++.+|++++++++||||++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 65 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK---------------MNRREREEAIDEARVLAKLDSSYIIRYY 65 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh---------------CCHHHHHHHHHHHHHHHhcCCCCeehhe
Confidence 3667789999999999999965 68999999883211 1123456788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++++|.+++.......+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l 142 (256)
T cd08529 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKI 142 (256)
T ss_pred eeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEE
Confidence 99999999999999999999999998765567899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||.++........ .....|++.|+|||+..+..++.++|+||||+++|||++|+.||.... .. ........
T Consensus 143 ~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~---~~~~~~~~ 215 (256)
T cd08529 143 GDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--QG---ALILKIIR 215 (256)
T ss_pred cccccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HH---HHHHHHHc
Confidence 999998866543221 223468899999999998889999999999999999999999985321 11 11111111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...+.........+.+++.+||+.+|++||++.++++.
T Consensus 216 ----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 216 ----------GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----------CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11122233445678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=314.53 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=209.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|... +|+.||+|.++.... ........+.+|++++++++|+|++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------------~~~~~~~~~~~ei~~l~~~~~~~i~~~ 67 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM--------------MDAKARQDCLKEIDLLKQLDHPNVIKY 67 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc--------------cchhhHHHHHHHHHHHHhCCCCCeeee
Confidence 57888999999999999999976 899999998842111 111234678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++..++..++||||+++++|.+++... ....+++..+..++.+++.|++||| +.+|+||||+|+||+++.++.
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~ 144 (267)
T cd08224 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGV 144 (267)
T ss_pred eeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCc
Confidence 99999999999999999999999998753 2355789999999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
++++|||++......... .....++..|+|||.+.+..++.++|||||||++|||++|+.||.... .+..+....
T Consensus 145 ~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~ 219 (267)
T cd08224 145 VKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKK 219 (267)
T ss_pred EEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhh
Confidence 999999998765433211 123457889999999988889999999999999999999999985332 222222111
Q ss_pred hccccccccccccCCCCccCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 866 KMDSRDSMLTVVDPNISEILK-EDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
... ....+.+. .....+.+++.+|++.+|++|||+.+++++|+++.
T Consensus 220 ~~~----------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 220 IEK----------CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhc----------CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111 11111222 34557889999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=321.54 Aligned_cols=264 Identities=21% Similarity=0.303 Sum_probs=203.6
Q ss_pred hccCCcccccccCceeEEEEEeCC-----------------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHH
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS-----------------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA 691 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (947)
.+|++.+.||+|+||.||+|.... +..||+|++.... .......+.+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~----------------~~~~~~~~~~ 68 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA----------------SDNAREDFLK 68 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc----------------CHHHHHHHHH
Confidence 578899999999999999988542 2458999873211 1123467889
Q ss_pred HHHHHhhccccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC---------CccCCHHHHHHHHHHHHHHHHHHhc
Q 002250 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH---------KIEMDWVVRYAIAVGAAKGLEYLHH 762 (947)
Q Consensus 692 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~ia~~l~yLH~ 762 (947)
|++++++++||||+++++++..++..++||||+++++|.+++.... ...+++...+.++.|++.||+|||
T Consensus 69 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH- 147 (296)
T cd05051 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE- 147 (296)
T ss_pred HHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 9999999999999999999999999999999999999999997643 126899999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHH
Q 002250 763 GFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMEL 842 (947)
Q Consensus 763 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~el 842 (947)
+.+|+||||||+||+++.++.++|+|||+++...............++..|+|||++..+.++.++|||||||++|||
T Consensus 148 --~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 225 (296)
T cd05051 148 --SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225 (296)
T ss_pred --HcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHH
Confidence 899999999999999999999999999999865443322223334567889999999888899999999999999999
Q ss_pred Hh--CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 843 VT--GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 843 lt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
++ |..||... .................. ......+...+.++.+++.+|++.||++|||+.|+++.|++
T Consensus 226 ~~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 226 LTLCREQPYEHL--TDQQVIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HhcCCCCCCCCc--ChHHHHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 98 66676321 111222211111100000 00011122334678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.24 Aligned_cols=259 Identities=25% Similarity=0.332 Sum_probs=202.2
Q ss_pred ccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+|++.+.||+|+||.||+|... ....+|+|.+.... .......+.+|+.+++.++|||
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~ 64 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----------------SSSELRDLLSEFNLLKQVNHPH 64 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC----------------CHHHHHHHHHHHHHHhhCCCCC
Confidence 3677889999999999999853 23568888873211 0122356889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcC----------------------CccCCHHHHHHHHHHHHHHHHHHh
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH----------------------KIEMDWVVRYAIAVGAAKGLEYLH 761 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~ia~~l~yLH 761 (947)
|+++++.+..++..++||||+++++|.+++.... ...+++..++.++.|++.|++|||
T Consensus 65 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 144 (290)
T cd05045 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA 144 (290)
T ss_pred EeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999986431 135789999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHH
Q 002250 762 HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLME 841 (947)
Q Consensus 762 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~e 841 (947)
+.+++||||||+||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++||
T Consensus 145 ---~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~e 221 (290)
T cd05045 145 ---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 221 (290)
T ss_pred ---HCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHH
Confidence 89999999999999999999999999999976543322222223345678999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 842 LVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 842 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
|++ |..||... ....+..... .... .+.+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 222 l~t~g~~p~~~~--~~~~~~~~~~----~~~~---------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 222 IVTLGGNPYPGI--APERLFNLLK----TGYR---------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred HHhcCCCCCCCC--CHHHHHHHHh----CCCC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 999 99888432 1112222211 1100 111223345688999999999999999999999999986
Q ss_pred CC
Q 002250 921 EP 922 (947)
Q Consensus 921 ~~ 922 (947)
-.
T Consensus 287 ~~ 288 (290)
T cd05045 287 MV 288 (290)
T ss_pred Hh
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=312.70 Aligned_cols=249 Identities=26% Similarity=0.360 Sum_probs=201.0
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||.||+|... |+.||+|.+.. ....+.+.+|+.++++++|+|+++++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~-------------------~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN-------------------DATAQAFLAEASVMTQLRHSNLVQLL 65 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCC-------------------CchHHHHHHHHHHHHhCCCCCeeeEE
Confidence 57888999999999999999876 78899998721 12245688999999999999999999
Q ss_pred EEEe-cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 709 CSIT-SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 709 ~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++. .++..++||||+++++|.++++......+++.....++.|++.|++||| +.+++||||||+||++++++.+|
T Consensus 66 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~k 142 (256)
T cd05082 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAK 142 (256)
T ss_pred EEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEE
Confidence 9764 4566899999999999999998765556899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
++|||++........ ...++..|+|||++....++.++||||||+++|||++ |+.||... ...+.....
T Consensus 143 l~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~ 212 (256)
T cd05082 143 VSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRV 212 (256)
T ss_pred ecCCccceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHH
Confidence 999999875433221 2234678999999988889999999999999999998 99888422 222221111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
..... .......+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 213 -~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 213 -EKGYK---------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -hcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11110 111223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.12 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=203.5
Q ss_pred hhccCCcccccccCceeEEEEEeC--------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN--------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV 699 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 699 (947)
.++|.+.+.||+|+||.||+|+.. ++..+|+|.+.+.. .......+.+|+.+++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----------------~~~~~~~~~~e~~~l~~l 80 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----------------TEKDLSDLISEMEMMKMI 80 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----------------ChHHHHHHHHHHHHHHHh
Confidence 367999999999999999999853 23569999884211 112345688899999999
Q ss_pred -cccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC--------------ccCCHHHHHHHHHHHHHHHHHHhcCC
Q 002250 700 -RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK--------------IEMDWVVRYAIAVGAAKGLEYLHHGF 764 (947)
Q Consensus 700 -~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~ia~~l~yLH~~~ 764 (947)
+||||+++++++..++..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||
T Consensus 81 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--- 157 (307)
T cd05098 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--- 157 (307)
T ss_pred cCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---
Confidence 799999999999999999999999999999999976421 34789999999999999999999
Q ss_pred CCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh
Q 002250 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844 (947)
Q Consensus 765 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt 844 (947)
+.+++||||||+||++++++.++|+|||.++...............++..|+|||++.+..++.++|||||||++|||++
T Consensus 158 ~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~ 237 (307)
T cd05098 158 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237 (307)
T ss_pred HCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHc
Confidence 89999999999999999999999999999876543221111112234568999999998889999999999999999998
Q ss_pred -CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 845 -GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 845 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
|..||... ...+.... ..... ..+.+......+.+++.+|++.+|++|||+.++++.|+++.+
T Consensus 238 ~g~~p~~~~-----~~~~~~~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 238 LGGSPYPGV-----PVEELFKL-LKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred CCCCCCCcC-----CHHHHHHH-HHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 88887321 11111111 11111 112223345678889999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.45 Aligned_cols=247 Identities=25% Similarity=0.319 Sum_probs=192.7
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHH---hhccccccce
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL---SAVRHVNVVK 706 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~ 706 (947)
|++.+.||+|+||.||+|... +++.||||++.... .......+.+.+|+.++ ++++||||++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~ 66 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGD--------------IIARDEVESLMCEKRIFETANSERHPFLVN 66 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhccccCCCChhc
Confidence 567889999999999999965 68999999984211 01112345566676655 5668999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..|+||||+++|+|..+++. ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 67 ~~~~~~~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~ 140 (324)
T cd05589 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFV 140 (324)
T ss_pred eeeEEEcCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcE
Confidence 99999999999999999999999988865 35899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+.....
T Consensus 141 kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~-----~~~~~~~~i 213 (324)
T cd05589 141 KIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD-----DEEEVFDSI 213 (324)
T ss_pred EeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC-----CHHHHHHHH
Confidence 999999987432221 1223457899999999999989999999999999999999999998532 111211111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQ 915 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 915 (947)
..... ..+......+.+++.+|++.||.+|| ++.++++
T Consensus 214 ~~~~~-----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 214 VNDEV-----------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HhCCC-----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11111 11122345678899999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=325.21 Aligned_cols=239 Identities=26% Similarity=0.341 Sum_probs=189.6
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 712 (947)
+.||+|+||+||+|+.+ +++.||||++.... .........+..|..++..+ +||||+++++++.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 66 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDV--------------ILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ 66 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHH--------------HhhccHHHHHHHHHHHHHhccCCCchhceeeEEE
Confidence 46899999999999965 68899999983210 11123445677888888876 6999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
..+..|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG 141 (320)
T cd05590 67 TPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFG 141 (320)
T ss_pred cCCEEEEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCC
Confidence 999999999999999999998764 35788899999999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... +.............
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-----~~~~~~~~i~~~~~- 213 (320)
T cd05590 142 MCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE-----NEDDLFEAILNDEV- 213 (320)
T ss_pred CCeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC-----CHHHHHHHHhcCCC-
Confidence 9875432211 123456899999999999888999999999999999999999999532 11122111111111
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
..+......+.+++.+|++.||++||++
T Consensus 214 ----------~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 ----------VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1111234567889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.81 Aligned_cols=240 Identities=26% Similarity=0.298 Sum_probs=187.3
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHH-HHhhccccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA-TLSAVRHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~ 712 (947)
+.||+|+||+||+|+.. +|+.||||++.... .........+..|.. +++.++||||+++++++.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~ 66 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKA--------------ILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ 66 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------HhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE
Confidence 46899999999999965 78999999983211 011122234445544 567889999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
.++..++||||+++|+|.+++... ..+++.....++.||+.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg 141 (323)
T cd05575 67 TADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFG 141 (323)
T ss_pred eCCEEEEEEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccC
Confidence 999999999999999999999763 45788888999999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+...........
T Consensus 142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~ 214 (323)
T cd05575 142 LCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DTAEMYDNILNKPLR 214 (323)
T ss_pred CCcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-----CHHHHHHHHHcCCCC
Confidence 987532221 1223456899999999999989999999999999999999999998532 222222221111110
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 911 (947)
........+.+++.+|++.||.+||++.
T Consensus 215 -----------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 -----------LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -----------CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1112245678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.12 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=203.0
Q ss_pred hhccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.++|++.+.||+|+||.||+|..+ ++..||+|++.... .......+.+|+.++++++|
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~----------------~~~~~~~~~~ei~~l~~l~h 67 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----------------SADMQADFQREAALMAEFDH 67 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc----------------CHHHHHHHHHHHHHHHhcCC
Confidence 367889999999999999999853 46789999873211 11224568899999999999
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------------------CccCCHHHHHHHHHHHHHHHHHHh
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------------------KIEMDWVVRYAIAVGAAKGLEYLH 761 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~~ia~~l~yLH 761 (947)
|||+++++++..+...++||||+++|+|.+++.... ...+++..++.++.|++.||+|||
T Consensus 68 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH 147 (288)
T cd05050 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS 147 (288)
T ss_pred CchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999997431 134688889999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHH
Q 002250 762 HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLME 841 (947)
Q Consensus 762 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~e 841 (947)
+.+++||||||+||++++++.++|+|||.+.................+..|+|||.+.+..++.++|||||||++||
T Consensus 148 ---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 224 (288)
T cd05050 148 ---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 224 (288)
T ss_pred ---hCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHH
Confidence 89999999999999999999999999999876543322111222234678999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 842 LVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 842 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
|++ |..||... ...+....... ......+...+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 225 l~~~~~~p~~~~-----~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 225 IFSYGMQPYYGM-----AHEEVIYYVRD----------GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHhCCCCCCCCC-----CHHHHHHHHhc----------CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 998 88887432 11122211111 11111222345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.81 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=206.5
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.++|.+.+.||+|+||.||+|..++++.||||.+... .....++.+|+.++++++|+||+++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG------------------TMSPEAFLQEAQIMKKLRHDKLVQL 66 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC------------------ccCHHHHHHHHHHHhhCCCCCEeee
Confidence 3678899999999999999999888889999988421 1234578899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..+...++||||+++++|.+++.......+++..+..++.|++.|++||| +.+++||||||+||++++++.++
T Consensus 67 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~ 143 (261)
T cd05034 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCK 143 (261)
T ss_pred eeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEE
Confidence 999999899999999999999999998765567899999999999999999999 88999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
++|||.+......... ......++..|+|||.+.+..++.++||||+|+++||+++ |+.||... ......+..
T Consensus 144 l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~~~~~~~~~--- 217 (261)
T cd05034 144 IADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM--TNREVLEQV--- 217 (261)
T ss_pred ECccccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHH---
Confidence 9999999765432211 1112234568999999998889999999999999999999 89998432 111111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
..... ...+...+..+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 218 ~~~~~----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 218 ERGYR----------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HcCCC----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 11000 011112245688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.94 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=194.2
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|+||.||+|+.. +++.||||++.... ........+.+|+.++++++||||++++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~hpniv~~~ 65 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF---------------EHVSDATRILREIKLLRLLRHPDIVEIK 65 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh---------------ccchhHHHHHHHHHHHHhCCCCCEeeec
Confidence 4778899999999999999955 78999999883110 1112335678999999999999999999
Q ss_pred EEEecCC-----ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 709 CSITSED-----SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 709 ~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
+++.... ..|+||||++ ++|.+++... ..+++.....++.|+++||+||| +.+|+||||||+||+++.+
T Consensus 66 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~ 139 (338)
T cd07859 66 HIMLPPSRREFKDIYVVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANAD 139 (338)
T ss_pred ceEeccCCCCCceEEEEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCC
Confidence 9885432 4699999995 6899988763 35889999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCC-CcceecccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 784 WKPRIADFGLAKIVQTGEA-GDLTHVIAGTHGYIAPEYAYT--CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....
T Consensus 140 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~ 217 (338)
T cd07859 140 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQL 217 (338)
T ss_pred CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHH
Confidence 9999999999975433221 111223468999999999865 5788999999999999999999999854211 0111
Q ss_pred HHHHhhccc-----------cc--cccccccC----CCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 NWVYSKMDS-----------RD--SMLTVVDP----NISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 ~~~~~~~~~-----------~~--~~~~~~d~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..+...... .. ........ ............+.+++.+|++.||++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 218 DLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 111000000 00 00000000 0001111233567899999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=338.45 Aligned_cols=385 Identities=25% Similarity=0.373 Sum_probs=246.7
Q ss_pred CCcccceeeccCcccc-CcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCce
Q 002250 59 GLQALQKINLGTNFLY-GTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEF 137 (947)
Q Consensus 59 ~l~~L~~L~L~~n~i~-~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~ 137 (947)
-|+.++-.++++|.++ +..|.....++.++.|-|...++...+..++.|.+|++|.+++|++.... ..++.|+.|+.
T Consensus 5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vh--GELs~Lp~LRs 82 (1255)
T KOG0444|consen 5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLISVH--GELSDLPRLRS 82 (1255)
T ss_pred ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhChHHHHHHhhhhhhhhhhhhhHhhh--hhhccchhhHH
Confidence 3455667777777777 45777777777777777777777766666777777777777777765333 35677777777
Q ss_pred eeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeeccc
Q 002250 138 LSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNS 217 (947)
Q Consensus 138 L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~ 217 (947)
+++.+|++...++|..+..+.. |+.||||+|++. +.|..+...+++-.|+||+|+
T Consensus 83 v~~R~N~LKnsGiP~diF~l~d------------------------Lt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~ 137 (1255)
T KOG0444|consen 83 VIVRDNNLKNSGIPTDIFRLKD------------------------LTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNN 137 (1255)
T ss_pred HhhhccccccCCCCchhccccc------------------------ceeeecchhhhh-hcchhhhhhcCcEEEEcccCc
Confidence 7777777766655555554444 445555555543 444455555555555555555
Q ss_pred ccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccc-ccCCcC
Q 002250 218 LSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT-GTLPQK 296 (947)
Q Consensus 218 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~ 296 (947)
|..++-..|-+++.|-.||||+|++..+|+.+..+..|+.|.|++|.+....-..+..+++|+.|.+++.+-+ ..+|.+
T Consensus 138 IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Pts 217 (1255)
T KOG0444|consen 138 IETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTS 217 (1255)
T ss_pred cccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCc
Confidence 5533333455566666666666666666666666666666666666665443444555666777777766544 355666
Q ss_pred ccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcc
Q 002250 297 LGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLS 376 (947)
Q Consensus 297 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 376 (947)
+..+.+|..+|+|.|.+. .+|+++.++.+|++|+|++|.|+ .+
T Consensus 218 ld~l~NL~dvDlS~N~Lp-------------------------~vPecly~l~~LrrLNLS~N~it-eL----------- 260 (1255)
T KOG0444|consen 218 LDDLHNLRDVDLSENNLP-------------------------IVPECLYKLRNLRRLNLSGNKIT-EL----------- 260 (1255)
T ss_pred hhhhhhhhhccccccCCC-------------------------cchHHHhhhhhhheeccCcCcee-ee-----------
Confidence 666666666666666655 33444444444444444444444 22
Q ss_pred eeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCccc-CCCCcccccccccchhhcccc
Q 002250 377 IIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFS-GQIPLDIGKLKKLSSLYLHDN 455 (947)
Q Consensus 377 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N 455 (947)
.-..+...+|+.|+||.|+++ .+|.+++.+++|+.|.+.+|+++ .-+|..+++|.+|+.+..++|
T Consensus 261 -------------~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN 326 (1255)
T KOG0444|consen 261 -------------NMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANN 326 (1255)
T ss_pred -------------eccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcc
Confidence 222333445555555555555 56666666666666666666655 247888888888888888888
Q ss_pred ccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCcccc-cccceeeC
Q 002250 456 MFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTY-PKLSLLDL 523 (947)
Q Consensus 456 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~L~~L~l 523 (947)
.+. ..|..+..|..|+.|.|++|+|- .+|+++.-|+.|+.|||.+|.=---+|..-.. .+|+.-++
T Consensus 327 ~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 327 KLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred ccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeec
Confidence 887 78888999999999999999998 88999999999999999999754344443322 45555443
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=329.98 Aligned_cols=204 Identities=25% Similarity=0.390 Sum_probs=172.9
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +++.||||++.... .........+.+|+.++.+++||||+++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~E~~il~~~~~~~iv~~ 66 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD--------------MLEKEQVGHIRAERDILVEADSLWVVKM 66 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH--------------HHHhhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36888999999999999999965 68999999983110 0111234567889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++.+.++...|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 67 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vk 141 (363)
T cd05628 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVK 141 (363)
T ss_pred EEEEecCCeEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEE
Confidence 99999999999999999999999999864 45888999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCC---------------------------------cceecccccccccCccccccCCCCCccchHH
Q 002250 788 IADFGLAKIVQTGEAG---------------------------------DLTHVIAGTHGYIAPEYAYTCKINEKSDVYS 834 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 834 (947)
|+|||+++........ ......+||+.|+|||++.+..++.++||||
T Consensus 142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwS 221 (363)
T cd05628 142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (363)
T ss_pred EeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhh
Confidence 9999998754321100 0012347999999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCC
Q 002250 835 FGVVLMELVTGKRPIVP 851 (947)
Q Consensus 835 lGv~l~elltg~~p~~~ 851 (947)
|||++|||++|+.||..
T Consensus 222 lGvil~ell~G~~Pf~~ 238 (363)
T cd05628 222 LGVIMYEMLIGYPPFCS 238 (363)
T ss_pred hHHHHHHHHhCCCCCCC
Confidence 99999999999999953
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.79 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=202.8
Q ss_pred hccCCcccccccCceeEEEEEeC-CCc----EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGK----ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
++|+..+.||+|+||+||+|++. +++ .||+|++.... .......+.+|+.+++.+.|||
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~----------------~~~~~~~~~~e~~~l~~~~~~~ 70 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT----------------SPKANKEILDEAYVMAGVGSPY 70 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC----------------CHHHHHHHHHHHHHHHhcCCCC
Confidence 56888899999999999999853 454 48999873111 1123456889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++.. ...+++|||+++|+|.++++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++++
T Consensus 71 i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~ 145 (279)
T cd05109 71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSP 145 (279)
T ss_pred CceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCC
Confidence 9999999975 4578999999999999999763 345889999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||+++...............+++.|+|||...+..++.++|||||||++|||++ |..||... ....+..+
T Consensus 146 ~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~ 223 (279)
T cd05109 146 NHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI--PAREIPDL 223 (279)
T ss_pred CcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHH
Confidence 9999999999987654322211112234678999999988889999999999999999998 88887432 12222222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
... ... .+.....+..+.+++.+||+.||++||++.++++.|+++...|
T Consensus 224 ~~~----~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 224 LEK----GER---------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHC----CCc---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 211 100 1111233456889999999999999999999999998876555
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.83 Aligned_cols=259 Identities=24% Similarity=0.322 Sum_probs=204.8
Q ss_pred hccCCcccccccCceeEEEEEeCC-----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS-----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
++|++.+.||+|+||.||+|...+ +..||+|++... ........+.+|+.++++++|||
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~n 69 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH----------------ASEIQVTLLLQESCLLYGLSHQN 69 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC----------------CCHHHHHHHHHHHHHHHhCCCCC
Confidence 678889999999999999999765 688999987311 11123466888999999999999
Q ss_pred cceEEEEEec-CCccEEEEeccCCCChHHHhhhcCC------ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 002250 704 VVKLYCSITS-EDSNLLVYEYLPNGSLWDRLHTCHK------IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776 (947)
Q Consensus 704 iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 776 (947)
|+++++++.. +...++++||+++++|.+++..... ..+++..+..++.|++.||+||| +.+++||||||+
T Consensus 70 i~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~ 146 (280)
T cd05043 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAAR 146 (280)
T ss_pred CCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHh
Confidence 9999998766 5678999999999999999976422 46899999999999999999999 899999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 002250 777 NILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGD 855 (947)
Q Consensus 777 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~ 855 (947)
||++++++.+||+|||+++.+.............++..|+|||++....++.++||||||+++||+++ |+.||... .
T Consensus 147 nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~ 224 (280)
T cd05043 147 NCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI--D 224 (280)
T ss_pred hEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--C
Confidence 99999999999999999986544332211222345778999999988889999999999999999999 99998432 1
Q ss_pred cccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 856 SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
..++..+.. .... .......+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 225 ~~~~~~~~~----~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 225 PFEMAAYLK----DGYR---------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HHHHHHHHH----cCCC---------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 112222111 1110 0111223456889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.05 Aligned_cols=261 Identities=22% Similarity=0.333 Sum_probs=206.9
Q ss_pred hccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|.. .+++.+|||.+.... ........++.+|+.+++.++||||+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~h~~i~~~ 67 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD--------------LMDAKARADCIKEIDLLKQLNHPNVIKY 67 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh--------------hhhHHHHHHHHHHHHHHHHccCCchhhh
Confidence 4678889999999999999995 479999999873211 0111233578899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++..++..++||||+++++|.+++... ....+++.....++.|++.|++||| +.+++|+||||+||+++.++.
T Consensus 68 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~ 144 (267)
T cd08229 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGV 144 (267)
T ss_pred hheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCC
Confidence 99999999999999999999999998743 2346899999999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
++++|||++........ ......|+..|+|||++.+..++.++||||||+++|||++|..||..... +.......
T Consensus 145 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~ 219 (267)
T cd08229 145 VKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKK 219 (267)
T ss_pred EEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---hHHHHhhh
Confidence 99999999876543321 11234688999999999888899999999999999999999999853321 11121111
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
... ...+.. ........+.+++.+||+.+|++||||.+|+++++++
T Consensus 220 ~~~-------~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 220 IEQ-------CDYPPL--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred hhc-------CCCCCC--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 110 000111 1123455788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=334.46 Aligned_cols=256 Identities=25% Similarity=0.323 Sum_probs=202.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +++.||||++.... .........+.+|+++++.++||||+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~i~~~ 66 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSD--------------MIKRNQIAHVRAERDILADADSPWIVKL 66 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHH--------------HhhccHHHHHHHHHHHHHhcCCCCccch
Confidence 36888999999999999999966 78999999984211 1112345678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.+++..++||||+++++|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~k 141 (350)
T cd05573 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIK 141 (350)
T ss_pred hhheecCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEE
Confidence 99999999999999999999999999874 45888899999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCC---------------------------CCcceecccccccccCccccccCCCCCccchHHHHHHHH
Q 002250 788 IADFGLAKIVQTGE---------------------------AGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLM 840 (947)
Q Consensus 788 l~DfG~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ 840 (947)
|+|||++....... .........||+.|+|||++.+..++.++|||||||++|
T Consensus 142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 221 (350)
T cd05573 142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221 (350)
T ss_pred eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhh
Confidence 99999997654432 001122346899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 002250 841 ELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-MRVVVQM 916 (947)
Q Consensus 841 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~~~ 916 (947)
||++|+.||.... ............... .++... ..+..+.+++.+|+. ||.+||+ +.+++++
T Consensus 222 ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~------~~p~~~-~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 222 EMLYGFPPFYSDT-----LQETYNKIINWKESL------RFPPDP-PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred hhccCCCCCCCCC-----HHHHHHHHhccCCcc------cCCCCC-CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9999999985432 111111111110100 011111 134567888999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=349.31 Aligned_cols=263 Identities=26% Similarity=0.333 Sum_probs=202.4
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|... +++.||||++..... .......++.+|++++++++||||+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~--------------~~e~~~~rflrEi~ILs~L~HPNIVkl 67 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS--------------ENPLLKKRFLREAKIAADLIHPGIVPV 67 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc--------------cCHHHHHHHHHHHHHHHhCCCcCcCeE
Confidence 57889999999999999999965 689999999842210 111224578899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcC---------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCH---------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
++++.+++..++||||++||+|.+++.... ....++..+..++.||++||+||| +.+|+||||||+||
T Consensus 68 ~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNI 144 (932)
T PRK13184 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNI 144 (932)
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheE
Confidence 999999999999999999999999986421 134567788899999999999999 89999999999999
Q ss_pred EecCCCCeEEeccccceecccCCC----------------CcceecccccccccCccccccCCCCCccchHHHHHHHHHH
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEA----------------GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMEL 842 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~el 842 (947)
+++.++.++|+|||+++....... .......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 145 LLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyEL 224 (932)
T PRK13184 145 LLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224 (932)
T ss_pred EEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHH
Confidence 999999999999999986521110 0011234699999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhccC
Q 002250 843 VTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-SMRVVVQMLEEAE 921 (947)
Q Consensus 843 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~~~ 921 (947)
+||+.||..... .... ... ...++.......+.+..+.+++.+|++.||++|| ++.++.+.|+...
T Consensus 225 LTG~~PF~~~~~--~ki~---~~~--------~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 225 LTLSFPYRRKKG--RKIS---YRD--------VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred HHCCCCCCCcch--hhhh---hhh--------hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999999854211 1110 000 0000000001123445688899999999999995 6777777777654
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.79 Aligned_cols=256 Identities=23% Similarity=0.274 Sum_probs=197.4
Q ss_pred ccCCcccccccCceeEEEEEe----CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccccc
Q 002250 630 AVKPENLIGKGGSGNVYKVVL----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNV 704 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 704 (947)
+|++.+.||+|+||+||+|+. .+++.||+|++.... ........+.+.+|+.+++++ .||||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-------------~~~~~~~~~~~~~e~~~l~~l~~~~~i 67 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAA-------------LVQKAKTVEHTRTERNVLEHVRQSPFL 67 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHH-------------HhhhhhHHHHHHHHHHHHHhccCCCCc
Confidence 377889999999999999885 258899999983211 111223345678899999999 59999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++..++..++||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEG 142 (332)
T ss_pred ccEEEEEecCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCC
Confidence 99999999999999999999999999999763 45788899999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
.+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... .......
T Consensus 143 ~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~~~ 220 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER-NTQSEVS 220 (332)
T ss_pred CEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC-CCHHHHH
Confidence 9999999999765433222 122456999999999987654 788999999999999999999999543211 1111111
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
...... ++.+ +......+.+++.+|++.||++|| ++.+++++
T Consensus 221 ~~~~~~--------~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 221 RRILKC--------DPPF---PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHhcC--------CCCC---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111111 1111 222345577889999999999999 67777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.21 Aligned_cols=245 Identities=22% Similarity=0.303 Sum_probs=191.0
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 712 (947)
+.||+|+||.||+|+.+ +++.||+|++.... .........+.+|+.++.++ +||||+++++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~ 66 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKEL--------------VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 66 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhH--------------hcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE
Confidence 46899999999999965 68899999984211 11112345677899988877 8999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
.++..++||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG 141 (329)
T cd05618 67 TESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYG 141 (329)
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCC
Confidence 999999999999999999988763 45888999999999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC---CcccHHHHHHhhccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG---DSKDIVNWVYSKMDS 869 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~---~~~~~~~~~~~~~~~ 869 (947)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......+.......
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 219 (329)
T cd05618 142 MCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred ccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc
Confidence 9875322211 12245789999999999998999999999999999999999999953211 111222222222211
Q ss_pred cccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 870 RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 870 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
.. ...+......+.+++.+|++.||++||++
T Consensus 220 ~~----------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 220 KQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CC----------CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11 11222334567789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=329.20 Aligned_cols=245 Identities=24% Similarity=0.270 Sum_probs=194.0
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEec
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITS 713 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 713 (947)
+.||+|+||.||+|+.. +++.||+|++.... .........+.+|+++++.++||||+++++++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~ 66 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEV--------------IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT 66 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc
Confidence 46899999999999954 78999999984211 1111234567789999999999999999999999
Q ss_pred CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 714 EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFD-RPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 714 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
++..++||||+++|+|.+++... ..+++..+..++.|++.||+||| + .+|+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg 141 (325)
T cd05594 67 HDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFG 141 (325)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCC
Confidence 99999999999999999988763 35889999999999999999999 6 799999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-----~~~~~~~i~~~~~- 213 (325)
T cd05594 142 LCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILMEEI- 213 (325)
T ss_pred CCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-----HHHHHHHHhcCCC-
Confidence 9875432211 1223469999999999998899999999999999999999999985321 1111111111110
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
..+......+.+++.+|++.||++|+ ++.+++++
T Consensus 214 ----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 ----------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ----------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11122345678899999999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.90 Aligned_cols=257 Identities=24% Similarity=0.321 Sum_probs=196.5
Q ss_pred cCCcccccccCceeEEEEEeCC-Cc--EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 631 VKPENLIGKGGSGNVYKVVLNS-GK--ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
|.+.+.||+|+||.||+|+..+ ++ .||||.+.... ......+.+.+|+++++.++||||+++
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 65 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---------------CTRSEMEDFLSEAVCMKEFDHPNVMRL 65 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---------------CCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 3567889999999999999764 33 68999873211 111234678899999999999999999
Q ss_pred EEEEecC------CccEEEEeccCCCChHHHhhhc----CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 708 YCSITSE------DSNLLVYEYLPNGSLWDRLHTC----HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 708 ~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
++++... ...++||||+++|+|.+++... ....+++.....++.|++.|++||| +++|+||||||+|
T Consensus 66 ~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~N 142 (272)
T cd05075 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARN 142 (272)
T ss_pred EEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhh
Confidence 9987432 2468999999999999987532 2345789999999999999999999 8999999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCc
Q 002250 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDS 856 (947)
Q Consensus 778 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~ 856 (947)
|++++++.++|+|||+++...............+++.|+|||+.....++.++||||||+++|||++ |+.||... ..
T Consensus 143 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~ 220 (272)
T cd05075 143 CMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--EN 220 (272)
T ss_pred eEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--CH
Confidence 9999999999999999986644332211223345778999999998889999999999999999999 78887432 11
Q ss_pred ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
..+.+. ...... .......+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 221 ~~~~~~----~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 221 SEIYDY----LRQGNR---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHH----HHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112111 111111 011123345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=359.47 Aligned_cols=463 Identities=25% Similarity=0.364 Sum_probs=343.4
Q ss_pred eeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCC
Q 002250 38 VAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNS 117 (947)
Q Consensus 38 v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~ 117 (947)
++.++++.+-+.. .|.+.+.+.-.|+.|+|++|.+ +..|..+..+.+|+.|+++.|-|...+..++++++|++|+|.+
T Consensus 23 ~~~ln~~~N~~l~-~pl~~~~~~v~L~~l~lsnn~~-~~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~ 100 (1081)
T KOG0618|consen 23 LQILNLRRNSLLS-RPLEFVEKRVKLKSLDLSNNQI-SSFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKN 100 (1081)
T ss_pred HHhhhcccccccc-CchHHhhheeeeEEeecccccc-ccCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheecc
Confidence 5555554433322 2233344444477777777777 6666677777777777777777776666677777777777777
Q ss_pred CCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccc
Q 002250 118 SGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGE 197 (947)
Q Consensus 118 n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 197 (947)
|.+. ..| ..+..+.+|++||+|.|.+.. +|..+..++.++++..++|..... ++... .+.++|..|.+.+.
T Consensus 101 n~l~-~lP-~~~~~lknl~~LdlS~N~f~~--~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~ 171 (1081)
T KOG0618|consen 101 NRLQ-SLP-ASISELKNLQYLDLSFNHFGP--IPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGS 171 (1081)
T ss_pred chhh-cCc-hhHHhhhcccccccchhccCC--CchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccc
Confidence 7765 344 467777777777777777754 556666777777777777732212 22222 66777777777777
Q ss_pred cCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCC
Q 002250 198 IPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFK 277 (947)
Q Consensus 198 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~ 277 (947)
++..+..+.. .|+|.+|.+. . ..+..+.+|+.|....|++..... ..++|+.|+.++|.+....+ .+. -.
T Consensus 172 ~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~~---~g~~l~~L~a~~n~l~~~~~-~p~-p~ 241 (1081)
T KOG0618|consen 172 FLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELEI---SGPSLTALYADHNPLTTLDV-HPV-PL 241 (1081)
T ss_pred hhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEEe---cCcchheeeeccCcceeecc-ccc-cc
Confidence 6666666655 6777777776 2 345667777777777777754221 23567888888888873222 222 24
Q ss_pred cCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcc
Q 002250 278 HLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVN 357 (947)
Q Consensus 278 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~ 357 (947)
+|++++++.|+++ .+|++++.+.+|+.|+..+|.++ .+|..+....++..|....|.+. .+|....++++|+.|+|.
T Consensus 242 nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence 6889999999998 67788899999999999999995 78888888888888888877776 566677888899999999
Q ss_pred cccccccCCCCCCC-CC-CcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccC
Q 002250 358 NNSLSGTIPPGIWS-LP-NLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSG 435 (947)
Q Consensus 358 ~n~l~~~~p~~~~~-l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 435 (947)
.|.|. ..|+.+.. +. .|+.|..+.|++...+.-.=..+..|+.|++.+|.++...-+.+.+...|+.|+|++|+|..
T Consensus 319 ~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~ 397 (1081)
T KOG0618|consen 319 SNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS 397 (1081)
T ss_pred hcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc
Confidence 99998 55654433 22 37788888888876554334456789999999999998888889999999999999999995
Q ss_pred CCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCC-ccCCccc
Q 002250 436 QIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSG-EIPISLT 514 (947)
Q Consensus 436 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~ 514 (947)
.....+.++..|+.|+||+|+++ .+|.++..+..|+.|...+|++. ..| ++..++.|+.+|+|.|+|+. .+|....
T Consensus 398 fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p 474 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP 474 (1081)
T ss_pred CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC
Confidence 44456889999999999999999 68899999999999999999999 888 79999999999999999984 4555555
Q ss_pred ccccceeeCCCCcC
Q 002250 515 YPKLSLLDLSNNQL 528 (947)
Q Consensus 515 ~~~L~~L~ls~N~l 528 (947)
.++|++|||++|.-
T Consensus 475 ~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 475 SPNLKYLDLSGNTR 488 (1081)
T ss_pred CcccceeeccCCcc
Confidence 68999999999983
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=329.71 Aligned_cols=256 Identities=24% Similarity=0.315 Sum_probs=196.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +++.||+|++... ..........+.+|+.+++.++||||++
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~e~~i~~~~~hp~iv~ 107 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF--------------EMIKRSDSAFFWEERDIMAFANSPWVVQ 107 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--------------HhhhhhhHHHHHHHHHHHHhCCCCCEee
Confidence 367999999999999999999966 6889999988311 0111223456789999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..|+||||+++|+|.+++... .+++.....++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~ 181 (370)
T cd05621 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHL 181 (370)
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCE
Confidence 999999999999999999999999999752 4788888899999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC----KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
||+|||+|......... ......||+.|+|||++... .++.++||||+||++|||++|+.||... +....
T Consensus 182 kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~-----~~~~~ 255 (370)
T cd05621 182 KLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD-----SLVGT 255 (370)
T ss_pred EEEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC-----CHHHH
Confidence 99999999866433221 12245699999999998653 3778999999999999999999999532 11111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAF--RPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~ 916 (947)
..........+ .+++ .......+.+++..|+..+|.+ ||++.|++++
T Consensus 256 ~~~i~~~~~~~------~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 256 YSKIMDHKNSL------NFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHhCCccc------CCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111111110 0111 1122345667777888765544 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=318.23 Aligned_cols=249 Identities=23% Similarity=0.270 Sum_probs=194.3
Q ss_pred ccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecCC
Q 002250 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSED 715 (947)
Q Consensus 637 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 715 (947)
||+|+||+||+|... +++.||||++.... .......+.+..|++++++++||||+++.+++..+.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~ 66 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKR--------------LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT 66 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHH--------------HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC
Confidence 699999999999965 78999999883211 011123356788999999999999999999999999
Q ss_pred ccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecccc
Q 002250 716 SNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793 (947)
Q Consensus 716 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 793 (947)
..++||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 67 ~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~ 143 (280)
T cd05608 67 DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGL 143 (280)
T ss_pred eEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 999999999999999887543 2346899999999999999999999 89999999999999999999999999999
Q ss_pred ceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccc
Q 002250 794 AKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSM 873 (947)
Q Consensus 794 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 873 (947)
+......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 144 ~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~------ 214 (280)
T cd05608 144 AVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRIL------ 214 (280)
T ss_pred ceecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhc------
Confidence 9765443221 223468999999999999999999999999999999999999985432111 0111111110
Q ss_pred cccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 874 LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 874 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
.. ....+...+..+.+++.+|++.||++|| ++.+++++
T Consensus 215 ----~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 ----ND-SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ----cc-CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 00 0112233456688999999999999999 66677653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.17 Aligned_cols=245 Identities=24% Similarity=0.294 Sum_probs=192.8
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 712 (947)
+.||+|+||.||+|+.. +++.||||++.... .........+..|.+++..+ +||||+++++++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~ 66 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDV--------------ILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ 66 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHH--------------hhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE
Confidence 46899999999999965 58899999984211 11123345677888998866 7999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
.++..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg 141 (321)
T cd05591 67 TKDRLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFG 141 (321)
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecc
Confidence 999999999999999999998764 35788889999999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
++........ ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..............
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-----~~~~~~~i~~~~~~ 214 (321)
T cd05591 142 MCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-----EDDLFESILHDDVL 214 (321)
T ss_pred cceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCCCC
Confidence 9875432221 1224568999999999998889999999999999999999999995321 11221111111111
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHHH
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-------SMRVVVQM 916 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------t~~ev~~~ 916 (947)
.+......+.+++.+|++.||++|| ++.+++++
T Consensus 215 -----------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 -----------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -----------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1111234678899999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=325.74 Aligned_cols=244 Identities=27% Similarity=0.397 Sum_probs=200.8
Q ss_pred cccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecC
Q 002250 636 LIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSE 714 (947)
Q Consensus 636 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 714 (947)
.+|+|.||+||-|+.. +...+|||.+. .+.....+.+..||...+.++|.|||+++|.+.++
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIp-----------------ekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen 644 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIP-----------------EKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN 644 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecc-----------------cccchhhccHHHHHHHHHHHhhHhHHHHhhccCCC
Confidence 5899999999999965 56678999873 23345667899999999999999999999999999
Q ss_pred CccEEEEeccCCCChHHHhhhc-CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec-CCCCeEEeccc
Q 002250 715 DSNLLVYEYLPNGSLWDRLHTC-HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD-LEWKPRIADFG 792 (947)
Q Consensus 715 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG 792 (947)
+..-|.||-+|||+|.+.++.. ++..-.+..+--...||++||.||| ++.|||||||-+|||++ -.|.+||+|||
T Consensus 645 Gf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFG 721 (1226)
T KOG4279|consen 645 GFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFG 721 (1226)
T ss_pred CeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccc
Confidence 9889999999999999999864 4444477777778899999999999 89999999999999997 57899999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK--INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSR 870 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 870 (947)
.++....- ...+..+.||..|||||++..+. |+.++|||||||++.||.||++||........
T Consensus 722 TsKRLAgi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------------- 786 (1226)
T KOG4279|consen 722 TSKRLAGI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------------- 786 (1226)
T ss_pred cchhhccC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-------------
Confidence 99866432 33444678999999999997664 88899999999999999999999943221111
Q ss_pred ccccccc-cCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 871 DSMLTVV-DPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 871 ~~~~~~~-d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.|..+. -..-++++++..++...++.+|+..||.+||+++++++
T Consensus 787 -AMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 787 -AMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -hhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 111111 11226778888899999999999999999999999984
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=329.17 Aligned_cols=240 Identities=25% Similarity=0.324 Sum_probs=191.4
Q ss_pred ccccccCceeEEEEEe----CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEE
Q 002250 635 NLIGKGGSGNVYKVVL----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 710 (947)
+.||+|+||.||+++. .+|+.||+|++... .........+..|++++++++||||++++++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 66 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA---------------TLKVRDRVRTKMERDILAEVNHPFIVKLHYA 66 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHH---------------HhhhhhHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 5799999999999874 35889999998321 1111234557789999999999999999999
Q ss_pred EecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEec
Q 002250 711 ITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790 (947)
Q Consensus 711 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 790 (947)
+..++..|+||||+++|+|.+++.+. ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 67 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~D 141 (318)
T cd05582 67 FQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTD 141 (318)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEee
Confidence 99999999999999999999999763 45899999999999999999999 89999999999999999999999999
Q ss_pred cccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccc
Q 002250 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSR 870 (947)
Q Consensus 791 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 870 (947)
||+++....... ......||+.|+|||++....++.++|||||||++|||++|+.||... +............
T Consensus 142 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-----~~~~~~~~i~~~~ 214 (318)
T cd05582 142 FGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK-----DRKETMTMILKAK 214 (318)
T ss_pred ccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC-----CHHHHHHHHHcCC
Confidence 999976543321 222457899999999998888999999999999999999999998532 1111111111111
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 002250 871 DSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRV 912 (947)
Q Consensus 871 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 912 (947)
. ..+......+.+++.+|++.||++||++.+
T Consensus 215 ~-----------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 L-----------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C-----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 112223456788999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=329.54 Aligned_cols=256 Identities=22% Similarity=0.278 Sum_probs=198.7
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .........+.+|+.+++.++||||++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~il~~~~h~~iv~ 107 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE--------------MIKRSDSAFFWEERDIMAHANSEWIVQ 107 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhhHHHHHHHHHHHHhCCCCCcce
Confidence 467889999999999999999965 68899999983110 011123455788999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.++...|+||||+++|+|.+++... .++......++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~ 181 (370)
T cd05596 108 LHYAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL 181 (370)
T ss_pred EEEEEecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCE
Confidence 999999999999999999999999998752 4677778888999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC----KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
||+|||++......... ......||+.|+|||++... .++.++|||||||++|||++|+.||... +....
T Consensus 182 kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~ 255 (370)
T cd05596 182 KLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----SLVGT 255 (370)
T ss_pred EEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC-----CHHHH
Confidence 99999999865433211 12245699999999998653 3788999999999999999999999532 11211
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAF--RPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~ 916 (947)
.......... ...+. .......+.+++.+|++.+|.+ ||++.|++++
T Consensus 256 ~~~i~~~~~~------~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 256 YSKIMDHKNS------LTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHcCCCc------CCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111111111 00111 1123456778899999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=312.56 Aligned_cols=248 Identities=24% Similarity=0.319 Sum_probs=196.4
Q ss_pred ccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecC
Q 002250 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSE 714 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 714 (947)
+.||+|+||.||+|...+++.+|+|.+.... .......+.+|++++++++||||+++++++...
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 64 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL----------------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR 64 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC----------------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC
Confidence 4689999999999998889999999874211 011234688999999999999999999999999
Q ss_pred CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccc
Q 002250 715 DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA 794 (947)
Q Consensus 715 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 794 (947)
+..++||||+++++|.+++.... ..+++..+..++.|++.|+.|+| +.+++||||||+||+++.++.++++|||++
T Consensus 65 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~ 140 (250)
T cd05085 65 QPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMS 140 (250)
T ss_pred CccEEEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccc
Confidence 99999999999999999987633 45789999999999999999999 899999999999999999999999999999
Q ss_pred eecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhccccccc
Q 002250 795 KIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSM 873 (947)
Q Consensus 795 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 873 (947)
......... ......++..|+|||+...+.++.++||||||+++||+++ |..||.... ..... ........
T Consensus 141 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~-----~~~~~-~~~~~~~~- 212 (250)
T cd05085 141 RQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT-----NQQAR-EQVEKGYR- 212 (250)
T ss_pred eeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHH-HHHHcCCC-
Confidence 754332211 1112234678999999998889999999999999999999 888984321 11111 11111110
Q ss_pred cccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 874 LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 874 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
.......+..+.+++.+|++.+|++||++.|++++|+
T Consensus 213 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 213 --------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0111223467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.44 Aligned_cols=261 Identities=24% Similarity=0.327 Sum_probs=199.6
Q ss_pred hccCCcccccccCceeEEEEEe------CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RH 701 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 701 (947)
++|++.+.||+|+||+||+|.. .+++.||||++.... .......+.+|+.++.++ +|
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~h 70 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----------------THSEHRALMSELKILIHIGHH 70 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----------------ChHHHHHHHHHHHHHHhccCC
Confidence 6899999999999999999973 347889999984211 112235678899999999 68
Q ss_pred cccceEEEEEecC-CccEEEEeccCCCChHHHhhhcC-------------------------------------------
Q 002250 702 VNVVKLYCSITSE-DSNLLVYEYLPNGSLWDRLHTCH------------------------------------------- 737 (947)
Q Consensus 702 ~niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------- 737 (947)
|||+++++++... ...++||||+++|+|.+++....
T Consensus 71 ~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (343)
T cd05103 71 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASS 150 (343)
T ss_pred ccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccc
Confidence 9999999988654 45789999999999999986531
Q ss_pred ----------------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 738 ----------------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 738 ----------------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~ 227 (343)
T cd05103 151 GFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLAR 227 (343)
T ss_pred cccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEeccccc
Confidence 123678888999999999999999 8999999999999999999999999999997
Q ss_pred ecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcccccccc
Q 002250 796 IVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSML 874 (947)
Q Consensus 796 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 874 (947)
...............++..|+|||++.+..++.++||||||+++|||++ |..||..... ...+... ......
T Consensus 228 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~----~~~~~~-- 300 (343)
T cd05103 228 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRR----LKEGTR-- 300 (343)
T ss_pred ccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc-cHHHHHH----HhccCC--
Confidence 6533322112222345678999999988889999999999999999997 8888843211 1111111 111110
Q ss_pred ccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 875 TVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 875 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
...+ ......+.+++.+||+.+|++|||+.|++++|+.+..
T Consensus 301 ----~~~~---~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 301 ----MRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ----CCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0111 1123468899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=323.98 Aligned_cols=243 Identities=26% Similarity=0.354 Sum_probs=189.6
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 712 (947)
+.||+|+||.||+|+.+ +|+.||||++.... .........+..|..++... +||||+++++++.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 66 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDV--------------VLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ 66 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE
Confidence 46899999999999966 68899999984211 01112345566788888754 8999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
.++..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.++|+|||
T Consensus 67 ~~~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05620 67 TKEHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFG 141 (316)
T ss_pred eCCEEEEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccC
Confidence 999999999999999999998763 35788888899999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .....+ ......
T Consensus 142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--~~~~~~---~~~~~~-- 212 (316)
T cd05620 142 MCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--EDELFE---SIRVDT-- 212 (316)
T ss_pred CCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHH---HHHhCC--
Confidence 987432221 12234578999999999999899999999999999999999999995321 111111 111111
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR-VVV 914 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~ 914 (947)
+.++ ......+.+++.+|++.||++||++. ++.
T Consensus 213 ------~~~~---~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 213 ------PHYP---RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ------CCCC---CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111 12334577899999999999999985 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=326.02 Aligned_cols=248 Identities=23% Similarity=0.258 Sum_probs=189.2
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHH-HHHhhccccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV-ATLSAVRHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~ 712 (947)
+.||+|+||+||+|+.. +++.||+|++.... .........+..|. .+++.++||||+++++++.
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~ 66 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKA--------------ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ 66 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------HHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE
Confidence 36899999999999965 67889999983110 00112223344444 4567889999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
.++..|+||||+++|+|.+++... ..+.......++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG 141 (325)
T cd05602 67 TADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFG 141 (325)
T ss_pred cCCeEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCC
Confidence 999999999999999999999863 34677778889999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+..........
T Consensus 142 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~i~~~~~- 213 (325)
T cd05602 142 LCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----NTAEMYDNILNKPL- 213 (325)
T ss_pred CCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC-----CHHHHHHHHHhCCc-
Confidence 9975432211 223456999999999999989999999999999999999999999532 11122111111110
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
.........+.+++.+|++.||.+||++.+.+..+.+
T Consensus 214 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 214 ----------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 1112234567888999999999999998765544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=325.82 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=194.6
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 712 (947)
+.||+|+||.||+|+.. +++.||||++.... .........+.+|+.++.++ +||||+++++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~--------------~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~ 66 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKEL--------------VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ 66 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE
Confidence 46899999999999965 68899999984211 11122345678899999998 7999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
.++..|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg 141 (329)
T cd05588 67 TESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYG 141 (329)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCc
Confidence 999999999999999999988763 45899999999999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC---CcccHHHHHHhhccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG---DSKDIVNWVYSKMDS 869 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~---~~~~~~~~~~~~~~~ 869 (947)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......++.......
T Consensus 142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (329)
T cd05588 142 MCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred cccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc
Confidence 987432211 122345789999999999998999999999999999999999999953211 111122222222211
Q ss_pred cccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 002250 870 RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS------MRVVVQ 915 (947)
Q Consensus 870 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~ev~~ 915 (947)
.. ...+......+.+++.+|++.||.+||+ +.++++
T Consensus 220 ~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 220 KQ----------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CC----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11 1112223456788999999999999997 567664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=323.46 Aligned_cols=245 Identities=25% Similarity=0.299 Sum_probs=194.1
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 712 (947)
+.||+|+||+||+|+.+ +++.||||++.... .........+.+|+++++.+ +||||+++++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~ 66 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV--------------ILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ 66 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------HhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE
Confidence 46899999999999966 58899999984211 11123345677899999888 6999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
..+..++||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||++++++.+||+|||
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg 141 (318)
T cd05570 67 TKDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFG 141 (318)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccC
Confidence 999999999999999999998764 35889999999999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 142 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~~~i~~~~~- 213 (318)
T cd05570 142 MCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELFQSILEDEV- 213 (318)
T ss_pred CCeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHHHHHHcCCC-
Confidence 9875322221 1223468999999999999999999999999999999999999985321 1111111111111
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM-----RVVVQM 916 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~~ 916 (947)
..+......+.+++.+|++.||++||++ .+++++
T Consensus 214 ----------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 ----------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ----------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1112234567899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=321.37 Aligned_cols=262 Identities=26% Similarity=0.369 Sum_probs=201.7
Q ss_pred hccCCcccccccCceeEEEEEe-----CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+-|++.+.||+|+||.||+|+. .++..||+|.+.+.. .......+.+|++++++++|||
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~ 67 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----------------GGNHIADLKKEIEILRNLYHEN 67 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----------------cHHHHHHHHHHHHHHHhCCCCC
Confidence 3467889999999999999974 357889999884221 1123457889999999999999
Q ss_pred cceEEEEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 704 VVKLYCSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 704 iv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
|+++++++... ...++||||+++++|.+++.+.. ..+++..+..++.|++.||+||| +.+++||||||+||+++
T Consensus 68 i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~ 143 (284)
T cd05079 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVE 143 (284)
T ss_pred eeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEc
Confidence 99999998875 56789999999999999997632 35899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCCC-cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC-----
Q 002250 782 LEWKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD----- 855 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~----- 855 (947)
.++.++|+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++++.|+......
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~ 223 (284)
T cd05079 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMI 223 (284)
T ss_pred CCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhc
Confidence 9999999999999865433221 1112344677899999998888999999999999999999988775332110
Q ss_pred -----cccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 856 -----SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 856 -----~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.......... .. +....+.....+..+.+++.+|++.+|++|||+.++++.++++
T Consensus 224 ~~~~~~~~~~~~~~~-~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 224 GPTHGQMTVTRLVRV-LE---------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccccccHHHHHHH-HH---------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0001111100 00 0111112223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=330.32 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=193.4
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.|+..+.||+|+||+||+|+.. +++.||||++.... .........+.+|+.++++++||||++++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~--------------~~~~~~~~~~~~E~~il~~l~h~~iv~l~ 67 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKD--------------VLNRNQVAHVKAERDILAEADNEWVVKLY 67 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhHHHHHHHHHHHHHHhcCCCCeeeeE
Confidence 4778899999999999999954 68899999983210 01112345788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++.+++..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 68 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL 142 (381)
T cd05626 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKL 142 (381)
T ss_pred EEEecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEE
Confidence 9999999999999999999999999864 34788888889999999999999 899999999999999999999999
Q ss_pred eccccceecccCCC---------------------------------------------CcceecccccccccCcccccc
Q 002250 789 ADFGLAKIVQTGEA---------------------------------------------GDLTHVIAGTHGYIAPEYAYT 823 (947)
Q Consensus 789 ~DfG~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~ 823 (947)
+|||+++....... .......+||+.|+|||++.+
T Consensus 143 ~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (381)
T cd05626 143 TDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222 (381)
T ss_pred eeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC
Confidence 99999753311000 000123469999999999988
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHh--ccC
Q 002250 824 CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIH--CTN 901 (947)
Q Consensus 824 ~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~--cl~ 901 (947)
..++.++|||||||++|||++|+.||..... ............. ...+. ......++.+++.+ |+.
T Consensus 223 ~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-----~~~~~~i~~~~~~------~~~~~-~~~~s~~~~dli~~ll~~~ 290 (381)
T cd05626 223 KGYTQLCDWWSVGVILFEMLVGQPPFLAPTP-----TETQLKVINWENT------LHIPP-QVKLSPEAVDLITKLCCSA 290 (381)
T ss_pred CCCCCccceeehhhHHHHHHhCCCCCcCCCH-----HHHHHHHHccccc------cCCCC-CCCCCHHHHHHHHHHccCc
Confidence 8899999999999999999999999954321 1111111111100 00111 00122345566655 666
Q ss_pred CCCCCCCCHHHHHHH
Q 002250 902 KLPAFRPSMRVVVQM 916 (947)
Q Consensus 902 ~dP~~RPt~~ev~~~ 916 (947)
.+|..||++.|++++
T Consensus 291 ~~~~~R~~~~~~l~h 305 (381)
T cd05626 291 EERLGRNGADDIKAH 305 (381)
T ss_pred ccccCCCCHHHHhcC
Confidence 677779999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.19 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=202.7
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|+||.||++... +++.+|+|.+... ......+.+.+|+.+++.++||||++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 64 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP----------------KSSSAVEDSRKEAVLLAKMKHPNIVAFK 64 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcC----------------cchHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4677899999999999999965 6899999987311 1112346778899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+.+..++..++||||+++++|.+++.......+++.....++.|++.||+||| +.+|+|+||||+||++++++.+++
T Consensus 65 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l 141 (255)
T cd08219 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKL 141 (255)
T ss_pred EEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEE
Confidence 99999999999999999999999987655566889999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||.++....... ......|++.|+|||+..+..++.++|+||||+++|+|++|+.||... +..........
T Consensus 142 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~~~~~~ 214 (255)
T cd08219 142 GDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLILKVCQ 214 (255)
T ss_pred cccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHHHHHhc
Confidence 99999976643322 122346889999999998888999999999999999999999998532 22222211111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. ....+......+.+++.+||+.||++|||+.+++..
T Consensus 215 ~~----------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 GS----------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC----------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11 111222334567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=319.15 Aligned_cols=264 Identities=20% Similarity=0.308 Sum_probs=200.1
Q ss_pred hccCCcccccccCceeEEEEEeC-----------------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHH
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-----------------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA 691 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (947)
++|++.+.||+|+||.||+|... ++..||+|++.... .......+.+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~----------------~~~~~~~~~~ 68 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA----------------NKNARNDFLK 68 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC----------------CHHHHHHHHH
Confidence 56899999999999999998643 23468888873210 1123457889
Q ss_pred HHHHHhhccccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC---------ccCCHHHHHHHHHHHHHHHHHHhc
Q 002250 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK---------IEMDWVVRYAIAVGAAKGLEYLHH 762 (947)
Q Consensus 692 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~i~~~ia~~l~yLH~ 762 (947)
|+.+++.++|+||+++++++..++..++||||+++++|.+++..... ..+++.....++.|++.|++|||
T Consensus 69 E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH- 147 (296)
T cd05095 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS- 147 (296)
T ss_pred HHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH-
Confidence 99999999999999999999999999999999999999999976422 24678889999999999999999
Q ss_pred CCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHH
Q 002250 763 GFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMEL 842 (947)
Q Consensus 763 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~el 842 (947)
+.+++||||||+||+++.++.++|+|||+++...............++..|+|||+...+.++.++|||||||++|||
T Consensus 148 --~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el 225 (296)
T cd05095 148 --SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225 (296)
T ss_pred --HCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHH
Confidence 889999999999999999999999999999765443322222223346789999998888899999999999999999
Q ss_pred Hh--CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 843 VT--GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 843 lt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
++ |..||.... ................ ... ..+.+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus 226 ~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 226 LTLCKEQPYSQLS--DEQVIENTGEFFRDQG--RQV----YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHhCCCCCccccC--hHHHHHHHHHHHhhcc--ccc----cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 98 667774321 1111111111000000 000 011112234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.30 Aligned_cols=249 Identities=24% Similarity=0.300 Sum_probs=194.5
Q ss_pred cccccCceeEEEEEeC---CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEe
Q 002250 636 LIGKGGSGNVYKVVLN---SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSIT 712 (947)
Q Consensus 636 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 712 (947)
.||+|+||.||+|.++ +++.+|+|++.... ......+++.+|+.++++++||||+++++++.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 66 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---------------NDPALKDELLREANVMQQLDNPYIVRMIGICE 66 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---------------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 5899999999999743 57889999873211 01123467889999999999999999999886
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
.+..++||||+++|+|.+++... ..+++.....++.|++.|++||| +++|+||||||+||++++++.+||+|||
T Consensus 67 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg 140 (257)
T cd05116 67 -AESWMLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFG 140 (257)
T ss_pred -CCCcEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCc
Confidence 45678999999999999999763 35889999999999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCc-ceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcccc
Q 002250 793 LAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSR 870 (947)
Q Consensus 793 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 870 (947)
+++......... ......++..|+|||.+....++.++||||||+++|||++ |+.||.... ...+.... ...
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~i----~~~ 214 (257)
T cd05116 141 LSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--GNEVTQMI----ESG 214 (257)
T ss_pred cccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH----HCC
Confidence 997654332211 1112234578999999988889999999999999999998 999985321 11222221 111
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 871 DSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 871 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.. .+.+...+..+.+++.+||+.||++||++.+|++.|++.
T Consensus 215 ~~---------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 215 ER---------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CC---------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 10 112223456688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.03 Aligned_cols=256 Identities=22% Similarity=0.254 Sum_probs=199.8
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +++.||||++.... .........+.+|+.+++.++||||+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~i~~~~~~~~i~~~ 66 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV--------------LLAQETVSFFEEERDILSISNSPWIPQL 66 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhCCCCCCcce
Confidence 36888999999999999999965 78999999984211 1112344668899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.+++..++||||+++|+|.+++... ...+++.....++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~k 142 (330)
T cd05601 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIK 142 (330)
T ss_pred eeEEecCCeEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEE
Confidence 99999999999999999999999999874 246888999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccc------cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY------TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
|+|||++......... ......||+.|+|||++. ...++.++|||||||++|||++|+.||... ....
T Consensus 143 L~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-----~~~~ 216 (330)
T cd05601 143 LADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-----TSAK 216 (330)
T ss_pred eccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-----CHHH
Confidence 9999999876543322 222346899999999986 456788999999999999999999998532 1111
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
............ ..+. .......+.+++..|++ +|++|||+.+++++
T Consensus 217 ~~~~i~~~~~~~------~~~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 217 TYNNIMNFQRFL------KFPE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHcCCCcc------CCCC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111111111110 0011 11233457788889997 99999999998853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.67 Aligned_cols=257 Identities=28% Similarity=0.347 Sum_probs=210.8
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-cc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HV 702 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ 702 (947)
..+.+.|.+.+.||+|.||.||+++.+ +|+.+|+|++...... .......+.+|+.+|+++. ||
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~--------------~~~~~~~v~~Ev~il~~l~~hp 96 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLR--------------GKEDREDVRREVAILQQLSGHP 96 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcc--------------ccccHHHHHHHHHHHHhccCCC
Confidence 445678999999999999999999976 5999999999533221 1124568899999999998 99
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
|||.++++|+....+++|||+++||.|.+.+... .+++.....++.|++.+++||| +.+|+|||+||+|+|+..
T Consensus 97 niv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~ 170 (382)
T KOG0032|consen 97 NIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLAS 170 (382)
T ss_pred CEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeecc
Confidence 9999999999999999999999999999999875 3899999999999999999999 899999999999999964
Q ss_pred C----CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 783 E----WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 783 ~----~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
. +.+|++|||+|...... ......+||+.|+|||++....|+..+||||+||++|.|++|.+||........
T Consensus 171 ~~~~~~~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~- 246 (382)
T KOG0032|consen 171 KDEGSGRIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI- 246 (382)
T ss_pred ccCCCCcEEEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-
Confidence 3 57999999999987762 234567899999999999999999999999999999999999999965422111
Q ss_pred HHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 859 IVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. ........ . ..+..........+++..|+..||.+|+|+.+++++
T Consensus 247 ~~----~i~~~~~~---f----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 247 FL----AILRGDFD---F----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HH----HHHcCCCC---C----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11 11111110 0 122333445677888899999999999999999996
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=323.59 Aligned_cols=244 Identities=25% Similarity=0.290 Sum_probs=192.3
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc-ccceE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV-NVVKL 707 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l 707 (947)
+|++.+.||+|+||.||+|+.. +++.||||++.... .......+.+..|+++++.++|+ +|+++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~~i~~~ 66 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--------------IIQDDDVECTMVEKRVLALPGKPPFLTQL 66 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhcCCCCceeee
Confidence 4778899999999999999965 57899999984211 11123446678899999999765 68889
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++...+..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 67 ~~~~~~~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~k 141 (324)
T cd05587 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIK 141 (324)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEE
Confidence 99999999999999999999999999764 34788889999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||++........ ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..... ....
T Consensus 142 L~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--~~~~~---~~i~ 214 (324)
T cd05587 142 IADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--EDELF---QSIM 214 (324)
T ss_pred EeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHH---HHHH
Confidence 999999874322211 2234579999999999999889999999999999999999999985321 11111 1111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
.... ..+......+.+++.+|++.||.+|++.
T Consensus 215 ~~~~-----------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 215 EHNV-----------SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred cCCC-----------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1111 1112234567889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=312.44 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=202.2
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|+..+.||+|++|.||+|... ++++||+|.++..... .........+.+|++++++++||||+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 69 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS------------PETKKEVNALECEIQLLKNLQHERIVQY 69 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc------------hhhHHHHHHHHHHHHHHHhCCCCCeeee
Confidence 46888999999999999999954 6899999988432110 0011224568899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||+++++|.+++... ..+++.....++.|++.|++||| +.+++||||+|+||++++++.++
T Consensus 70 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~ 144 (263)
T cd06625 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVK 144 (263)
T ss_pred EEEEccCCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999999999864 34788888999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcc-eecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDL-THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||.++.......... .....|+..|+|||++.+..++.++||||+|+++|||++|+.||... ... ......
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~-~~~~~~ 219 (263)
T cd06625 145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF----EAM-AAIFKI 219 (263)
T ss_pred EeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc----chH-HHHHHH
Confidence 999999976543221111 12345788999999999988999999999999999999999998432 111 111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... .....+......+.+++.+|++.+|.+|||+.|++++
T Consensus 220 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 220 ATQP---------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred hccC---------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1110 1112233345568889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=332.14 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=197.1
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +++.||||++.... .........+.+|+.+++.++||||+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~E~~il~~l~h~~iv~~ 66 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE--------------MLEKEQVAHVRAERDILAEADNPWVVKL 66 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhCCCCCCcce
Confidence 36888999999999999999965 68999999983110 0111234567889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.+++..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.++
T Consensus 67 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~k 141 (364)
T cd05599 67 YYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIK 141 (364)
T ss_pred EEEEEcCCeEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEE
Confidence 99999999999999999999999999864 35889999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCc------------------------------------ceecccccccccCccccccCCCCCccc
Q 002250 788 IADFGLAKIVQTGEAGD------------------------------------LTHVIAGTHGYIAPEYAYTCKINEKSD 831 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 831 (947)
|+|||++.......... .....+||+.|+|||++....++.++|
T Consensus 142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 221 (364)
T cd05599 142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221 (364)
T ss_pred EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeee
Confidence 99999987543211000 001246999999999999888999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC--
Q 002250 832 VYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-- 909 (947)
Q Consensus 832 v~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-- 909 (947)
||||||++|||++|..||... +..+............. .+... .....+.+++.+|+. +|.+|++
T Consensus 222 iwSlG~il~el~~G~~Pf~~~-----~~~~~~~~i~~~~~~~~---~~~~~----~~s~~~~~li~~ll~-~p~~R~~~~ 288 (364)
T cd05599 222 WWSLGVIMYEMLVGYPPFCSD-----NPQETYRKIINWKETLQ---FPDEV----PLSPEAKDLIKRLCC-EAERRLGNN 288 (364)
T ss_pred eecchhHHHHhhcCCCCCCCC-----CHHHHHHHHHcCCCccC---CCCCC----CCCHHHHHHHHHHcc-CHhhcCCCC
Confidence 999999999999999999532 11121111111111100 00000 123456677888886 8999997
Q ss_pred -HHHHHHH
Q 002250 910 -MRVVVQM 916 (947)
Q Consensus 910 -~~ev~~~ 916 (947)
+.|++++
T Consensus 289 ~~~~ll~h 296 (364)
T cd05599 289 GVNEIKSH 296 (364)
T ss_pred CHHHHhcC
Confidence 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.21 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=202.5
Q ss_pred hccCCcccccccCceeEEEEEeC--------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN--------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV- 699 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 699 (947)
++|.+.+.||+|+||.||+|+.. ....||+|.+.... .......+.+|+.+++++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~ 75 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA----------------TDKDLADLISEMELMKLIG 75 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC----------------ChHHHHHHHHHHHHHHhcc
Confidence 67889999999999999999742 24579999873110 112235678899999999
Q ss_pred cccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------------CccCCHHHHHHHHHHHHHHHHHHhcCCC
Q 002250 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------------KIEMDWVVRYAIAVGAAKGLEYLHHGFD 765 (947)
Q Consensus 700 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~ 765 (947)
+||||+++++++..++..++||||+++|+|.+++.... ...+++.....++.|++.||+||| +
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~ 152 (314)
T cd05099 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---S 152 (314)
T ss_pred CCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---H
Confidence 69999999999999999999999999999999997632 235788999999999999999999 8
Q ss_pred CCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-
Q 002250 766 RPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT- 844 (947)
Q Consensus 766 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt- 844 (947)
.+++||||||+||++++++.+||+|||.++...............++..|+|||++.+..++.++||||||+++|||++
T Consensus 153 ~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~ 232 (314)
T cd05099 153 RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232 (314)
T ss_pred CCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhC
Confidence 9999999999999999999999999999986543322111112234567999999998889999999999999999999
Q ss_pred CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 845 GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 845 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
|..||... ....+.... .... ..+.+...+..+.+++.+|++.+|++|||+.|+++.|+++..
T Consensus 233 g~~p~~~~--~~~~~~~~~----~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 233 GGSPYPGI--PVEELFKLL----REGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred CCCCCCCC--CHHHHHHHH----HcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 88887422 111122211 1111 011222334568889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=351.66 Aligned_cols=461 Identities=25% Similarity=0.271 Sum_probs=384.5
Q ss_pred eeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCC
Q 002250 38 VAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNS 117 (947)
Q Consensus 38 v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~ 117 (947)
..+||++++.+.. .| ..++.+.+|+.|+++.|.| ...|.....+.+|++|+|.+|.+...+..+..+++|++|++|.
T Consensus 47 L~~l~lsnn~~~~-fp-~~it~l~~L~~ln~s~n~i-~~vp~s~~~~~~l~~lnL~~n~l~~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQISS-FP-IQITLLSHLRQLNLSRNYI-RSVPSSCSNMRNLQYLNLKNNRLQSLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeecccccccc-CC-chhhhHHHHhhcccchhhH-hhCchhhhhhhcchhheeccchhhcCchhHHhhhcccccccch
Confidence 6788898877654 44 5699999999999999999 5667889999999999999999998888999999999999999
Q ss_pred CCccCccCcccccccCCCceeeCCCC-CCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCccccc
Q 002250 118 SGISGKFPWKSLENLTNLEFLSLGDN-PFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFG 196 (947)
Q Consensus 118 n~i~~~~~~~~l~~l~~L~~L~Ls~n-~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 196 (947)
|++. .+| ..+..++.++.++.++| ++.. ++... ++.++|..|.+.+.++..+.+++. .|+|.+|.+.
T Consensus 124 N~f~-~~P-l~i~~lt~~~~~~~s~N~~~~~------lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~- 191 (1081)
T KOG0618|consen 124 NHFG-PIP-LVIEVLTAEEELAASNNEKIQR------LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME- 191 (1081)
T ss_pred hccC-CCc-hhHHhhhHHHHHhhhcchhhhh------hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-
Confidence 9997 555 68999999999999999 2222 22222 889999999999999999888877 8999999985
Q ss_pred ccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCC
Q 002250 197 EIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEF 276 (947)
Q Consensus 197 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l 276 (947)
...+..+.+|+.|....|+++.. --..++|+.|+.++|.++.. ..-....+|+.+++++|+++ .+|++++.+
T Consensus 192 --~~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~-~~~p~p~nl~~~dis~n~l~-~lp~wi~~~ 263 (1081)
T KOG0618|consen 192 --VLDLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTL-DVHPVPLNLQYLDISHNNLS-NLPEWIGAC 263 (1081)
T ss_pred --hhhhhhccchhhhhhhhcccceE----EecCcchheeeeccCcceee-ccccccccceeeecchhhhh-cchHHHHhc
Confidence 34678889999999999999842 23458899999999999832 23344568999999999999 567999999
Q ss_pred CcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCC-ccEEE
Q 002250 277 KHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKS-LIRFR 355 (947)
Q Consensus 277 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~-L~~L~ 355 (947)
.+|+.|+..+|+++ .+|..+....+|+.|++..|.+. -+|+...+...+++|++..|++....+..+.-... |..|+
T Consensus 264 ~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln 341 (1081)
T KOG0618|consen 264 ANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLN 341 (1081)
T ss_pred ccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHh
Confidence 99999999999997 89999999999999999999998 78888999999999999999998666655555544 88888
Q ss_pred cccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccC
Q 002250 356 VNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSG 435 (947)
Q Consensus 356 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 435 (947)
.+.|.+.......=..++.|+.|++.+|.++......+.++..|+.|+|++|++.......+.++..|++|+||+|+++
T Consensus 342 ~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~- 420 (1081)
T KOG0618|consen 342 VSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT- 420 (1081)
T ss_pred hhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-
Confidence 8999988333222234678999999999999888788999999999999999998444456899999999999999999
Q ss_pred CCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc-
Q 002250 436 QIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT- 514 (947)
Q Consensus 436 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~- 514 (947)
.+|..+.+++.|++|...+|++. ..| .+..+++|+.+|+|.|+|+...-..-...++|++|||++|.-.-..-..+.
T Consensus 421 ~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~ 498 (1081)
T KOG0618|consen 421 TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKV 498 (1081)
T ss_pred hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHH
Confidence 89999999999999999999998 677 899999999999999999864333333348999999999984322222222
Q ss_pred ccccceeeCCCC
Q 002250 515 YPKLSLLDLSNN 526 (947)
Q Consensus 515 ~~~L~~L~ls~N 526 (947)
+..+..++++-|
T Consensus 499 l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 499 LKSLSQMDITLN 510 (1081)
T ss_pred hhhhhheecccC
Confidence 355666666655
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.98 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=200.4
Q ss_pred hccCCcccccccCceeEEEEEeCC-Cc--EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS-GK--ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 704 (947)
++|++.+.||+|+||.||+|..++ +. .+|+|.+... ......+.+.+|+.+++++ +||||
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~----------------~~~~~~~~~~~E~~~l~~l~~hp~i 65 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF----------------ASENDHRDFAGELEVLCKLGHHPNI 65 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc----------------CCHHHHHHHHHHHHHHHhhcCCCch
Confidence 578889999999999999998753 33 4788877310 0112235688999999999 79999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCC--------------ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK--------------IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIH 770 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 770 (947)
+++++++...+..++||||+++++|.+++..... ..+++.....++.|++.|++||| +.+|+|
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH 142 (297)
T cd05089 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIH 142 (297)
T ss_pred hheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 9999999999999999999999999999975321 24788899999999999999999 899999
Q ss_pred ccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCC
Q 002250 771 RDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPI 849 (947)
Q Consensus 771 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~ 849 (947)
|||||+||++++++.+||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||
T Consensus 143 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf 219 (297)
T cd05089 143 RDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219 (297)
T ss_pred CcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999986322111 1111123567999999988889999999999999999998 99998
Q ss_pred CCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 850 VPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
... ...+......... ....+......+.+++.+|++.+|.+|||+.++++.|+++....
T Consensus 220 ~~~-----~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 220 CGM-----TCAELYEKLPQGY----------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCC-----CHHHHHHHHhcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 432 1111111111110 01112223456889999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.61 Aligned_cols=247 Identities=25% Similarity=0.286 Sum_probs=190.0
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHH-HHhhccccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA-TLSAVRHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~ 712 (947)
+.||+|+||+||+|+.. +|+.||||++.... .........+..|.. +++.++||||+++++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~ 66 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI--------------VLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ 66 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 46899999999999965 78999999983210 011122344555554 467789999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
.++..++||||+++|+|.+++... ..+++.....++.||+.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG 141 (325)
T cd05604 67 TTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFG 141 (325)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecC
Confidence 999999999999999999988763 45888899999999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+...........
T Consensus 142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~-----~~~~~~~~~~~~~~~ 214 (325)
T cd05604 142 LCKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR-----DVAEMYDNILHKPLV 214 (325)
T ss_pred CcccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC-----CHHHHHHHHHcCCcc
Confidence 987532221 1223456899999999999999999999999999999999999998532 222222222111110
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
........+.+++.+|++.+|.+||++.+.++.+.
T Consensus 215 -----------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 215 -----------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred -----------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 11123345778899999999999998865444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=319.16 Aligned_cols=243 Identities=28% Similarity=0.410 Sum_probs=189.5
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 712 (947)
+.||+|+||+||+|+.. +++.||||++.... .........+..|..++... +||||+++++++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~ 66 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDV--------------VLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ 66 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE
Confidence 36899999999999965 57899999984211 01112344566788888764 8999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
+++..++||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05619 67 TKENLFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFG 141 (316)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCC
Confidence 999999999999999999999864 35788888999999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .....+.+ ....
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--~~~~~~~i---~~~~-- 212 (316)
T cd05619 142 MCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--EEELFQSI---RMDN-- 212 (316)
T ss_pred cceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--HHHHHHHH---HhCC--
Confidence 9875322221 1224568999999999998889999999999999999999999985321 11111111 1010
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR-VVV 914 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~ 914 (947)
+.+ +......+.+++.+|++.||++||++. ++.
T Consensus 213 ------~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 213 ------PCY---PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ------CCC---CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111 112334577889999999999999997 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.39 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=204.3
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.++|++.+.||+|+||.||+|...++..+|+|.+... ......+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~------------------~~~~~~~~~e~~~l~~l~~~~i~~~ 66 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------------------SMSVEAFLAEANVMKTLQHDKLVKL 66 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC------------------hhHHHHHHHHHHHHHhcCCCCcceE
Confidence 3678899999999999999999877888999987321 1234578899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.. ...++||||+++++|.+++.+......++..+..++.|++.|++||| +.+++||||||+||+++.++.++
T Consensus 67 ~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~ 142 (260)
T cd05073 67 HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCK 142 (260)
T ss_pred EEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEE
Confidence 999887 77899999999999999998765567899999999999999999999 88999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||.+......... ......++..|+|||++..+.++.++|+|||||++||+++ |+.||... ...+..+..
T Consensus 143 l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~--- 216 (260)
T cd05073 143 IADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRAL--- 216 (260)
T ss_pred ECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC--CHHHHHHHH---
Confidence 9999999765433221 1112345678999999988889999999999999999999 88888432 111122211
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
..... .+.....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 217 -~~~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 217 -ERGYR---------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -hCCCC---------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11110 01112344568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=313.96 Aligned_cols=255 Identities=25% Similarity=0.321 Sum_probs=199.0
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++++++||||++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-----------------~~~~~~~~~~e~~~l~~~~h~~ii~ 70 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-----------------PGDDFSLIQQEIFMVKECKHCNIVA 70 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC-----------------ccchHHHHHHHHHHHHhcCCCCeee
Confidence 46799999999999999999996 47889999988321 1123346788999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||+++++|.++++.. ..+++..+..++.|++.|++||| +.+|+|||++|+||+++.++.+
T Consensus 71 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~ 145 (267)
T cd06646 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDV 145 (267)
T ss_pred eeEEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCE
Confidence 999999999999999999999999999753 35788999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY---TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
+|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....... ..
T Consensus 146 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-~~---- 218 (267)
T cd06646 146 KLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-AL---- 218 (267)
T ss_pred EECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-hh----
Confidence 9999999986543221 112346889999999874 3447789999999999999999999984321100 00
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML 917 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 917 (947)
. ...... ..+............+.+++.+|++.+|++|||+.++++.+
T Consensus 219 ~-~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 219 F-LMSKSN-----FQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred e-eeecCC-----CCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 000000 00000111122345788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.27 Aligned_cols=269 Identities=27% Similarity=0.358 Sum_probs=199.2
Q ss_pred hccCCcccccccCceeEEEEEeC-----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
..|++.+.||+|+||.||+|..+ +++.||||++... .......+.+|++++++++|||
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~ 66 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----------------TAEHLRDFEREIEILKSLQHDN 66 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 46788899999999999999743 5789999987321 1122457889999999999999
Q ss_pred cceEEEEEec--CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 704 VVKLYCSITS--EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 704 iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
|+++++++.. ....++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 67 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~ 142 (284)
T cd05081 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVE 142 (284)
T ss_pred eeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEEC
Confidence 9999998754 34578999999999999999763 335899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCCCcc-eecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGDL-THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+++.++|+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++|..|+..... ...
T Consensus 143 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~ 219 (284)
T cd05081 143 SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFM 219 (284)
T ss_pred CCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhh
Confidence 999999999999987644322111 1111234569999999888899999999999999999998877532210 000
Q ss_pred HHHHhhcccccc---cccccc-CCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 861 NWVYSKMDSRDS---MLTVVD-PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 861 ~~~~~~~~~~~~---~~~~~d-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
+........... +.+... ..........+..+.+++.+||+.+|++||||.|+++.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 220 RMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred hhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 000000000000 000000 0011112234457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.83 Aligned_cols=248 Identities=21% Similarity=0.296 Sum_probs=193.0
Q ss_pred ccccCceeEEEEEeC---CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEec
Q 002250 637 IGKGGSGNVYKVVLN---SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITS 713 (947)
Q Consensus 637 iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 713 (947)
||+|+||.||+|.+. .+..||+|++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~ 66 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN----------------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA 66 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc----------------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC
Confidence 899999999999854 35579999873211 11223568899999999999999999998864
Q ss_pred CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecccc
Q 002250 714 EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793 (947)
Q Consensus 714 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 793 (947)
...++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+
T Consensus 67 -~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~ 141 (257)
T cd05115 67 -EALMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGL 141 (257)
T ss_pred -CCeEEEEEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCc
Confidence 5779999999999999998753 346899999999999999999999 88999999999999999999999999999
Q ss_pred ceecccCCCCc-ceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhccccc
Q 002250 794 AKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRD 871 (947)
Q Consensus 794 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 871 (947)
+.......... ......++..|+|||++....++.++||||||+++||+++ |+.||.... ..+....+ ....
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~---~~~~- 215 (257)
T cd05115 142 SKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK--GPEVMSFI---EQGK- 215 (257)
T ss_pred cccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHH---HCCC-
Confidence 97554332211 1111223578999999988889999999999999999997 999985321 11111111 1111
Q ss_pred cccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 872 SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 872 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
....+..++..+.+++.+||..+|++||++.+|.+.|+..
T Consensus 216 ---------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 ---------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1122233456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=315.34 Aligned_cols=257 Identities=24% Similarity=0.383 Sum_probs=202.3
Q ss_pred hccCCcccccccCceeEEEEEeC-C---CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-S---GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
.+|++.+.||+|+||.||+|... + +..+|+|.+.... .......+.+|+.++++++||||
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i 67 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----------------TEKQRRDFLSEASIMGQFDHPNI 67 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----------------CHHHHHHHHHHHHHHHhCCCCCc
Confidence 57888999999999999999854 2 3379999873211 01224578899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++..++..++||||+++++|.+++.... ..+++.....++.|++.|++||| +.+++||||||+||+++.++
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~ 143 (267)
T cd05066 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNL 143 (267)
T ss_pred ceEEEEEecCCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCC
Confidence 999999999999999999999999999998643 45799999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcc-eecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDL-THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
.++++|||++........... .....++..|+|||++.+..++.++|+||||+++||+++ |..||.... ..+....
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~--~~~~~~~ 221 (267)
T cd05066 144 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS--NQDVIKA 221 (267)
T ss_pred eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC--HHHHHHH
Confidence 999999999986644322111 111223568999999998889999999999999999887 999984321 1112221
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.. +. .. .+.....+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 222 ~~---~~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 222 IE---EG-YR---------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred Hh---CC-Cc---------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11 11 00 111223355688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=331.02 Aligned_cols=261 Identities=20% Similarity=0.196 Sum_probs=198.0
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
...|.+.+.||+|+||.||+|... .++.||||... ...+.+|++++++++|+|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----------------------~~~~~~E~~iL~~L~HpnIv~ 224 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----------------------YASSVHEARLLRRLSHPAVLA 224 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----------------------ccCHHHHHHHHHHCCCCCCCc
Confidence 346888999999999999999966 58899999541 123568999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++|||++ .++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 225 l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~v 299 (461)
T PHA03211 225 LLDVRVVGGLTCLVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDI 299 (461)
T ss_pred EEEEEEECCEEEEEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCE
Confidence 999999999999999999 47898888753 236899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC------CcccHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG------DSKDIV 860 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~------~~~~~~ 860 (947)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|..|+..... ....+.
T Consensus 300 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~ 379 (461)
T PHA03211 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL 379 (461)
T ss_pred EEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHH
Confidence 99999999865433222222245699999999999998999999999999999999998877643221 111222
Q ss_pred HHHHhhccccccccccc----------------cCCC-CccC---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVV----------------DPNI-SEIL---KEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~----------------d~~~-~~~~---~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+.+.........+.... .+.. .... ......+.+++.+|++.||.+|||+.|++++
T Consensus 380 ~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 380 RIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 22221110000000000 0000 0000 0122357889999999999999999999975
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=336.84 Aligned_cols=259 Identities=19% Similarity=0.288 Sum_probs=190.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|... +++.||||++.. ......+|+.+++.++||||+++
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~---------------------~~~~~~~Ei~il~~l~h~niv~l 124 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ---------------------DPQYKNRELLIMKNLNHINIIFL 124 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEec---------------------CcchHHHHHHHHHhcCCCCCcce
Confidence 57889999999999999999965 689999998731 11234579999999999999999
Q ss_pred EEEEecC--------CccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 708 YCSITSE--------DSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 708 ~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
++++... ...++||||++ +++.+++... ....+++.....++.|++.||+||| +.+|+||||||+|
T Consensus 125 ~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~N 200 (440)
T PTZ00036 125 KDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQN 200 (440)
T ss_pred eeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHH
Confidence 9887432 13568999997 4787777542 3456889999999999999999999 8999999999999
Q ss_pred eEecCCC-CeEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 778 ILLDLEW-KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 778 Ill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
|+++.++ .+||+|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.....
T Consensus 201 ILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~- 276 (440)
T PTZ00036 201 LLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS- 276 (440)
T ss_pred EEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-
Confidence 9999664 799999999986543322 1234689999999998764 689999999999999999999999854311
Q ss_pred cccHHHHHHhhccccc--------cccccccCC-----C-CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 856 SKDIVNWVYSKMDSRD--------SMLTVVDPN-----I-SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 856 ~~~~~~~~~~~~~~~~--------~~~~~~d~~-----~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...+............ ......-+. + ..++...+.++.+++.+|+.+||.+|||+.|++++
T Consensus 277 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 277 VDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 1111111111100000 000000000 0 01122234578899999999999999999999844
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=316.20 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=201.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CC---cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SG---KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
..|++.+.||+|+||.||+|... ++ ..||||++... ........|..|+.++++++||||
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~ni 67 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----------------YTEKQRRDFLSEASIMGQFDHPNI 67 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----------------CCHHHHHHHHHHHHHHHhCCCcCc
Confidence 45788899999999999999965 33 36999987311 011234678999999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++..++..++||||+++++|.+++... ...+++..++.++.|++.|++||| +.+++||||||+||+++.++
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~ 143 (269)
T cd05065 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNL 143 (269)
T ss_pred ceEEEEECCCCceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCC
Confidence 99999999999999999999999999999764 345899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCccee-ccc--ccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTH-VIA--GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIV 860 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~ 860 (947)
.++++|||.+............. ... .+..|+|||++....++.++||||||+++|||++ |..||.... ..+..
T Consensus 144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--~~~~~ 221 (269)
T cd05065 144 VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVI 221 (269)
T ss_pred cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--HHHHH
Confidence 99999999987654332211111 111 2457999999998899999999999999999987 999985321 11222
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.++. .. .. .+.+.+.+..+.+++.+||+.+|++||++.+++++|+++
T Consensus 222 ~~i~---~~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 222 NAIE---QD-YR---------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHH---cC-Cc---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2221 11 00 111223456688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=323.40 Aligned_cols=240 Identities=25% Similarity=0.304 Sum_probs=186.1
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHH-HHhhccccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA-TLSAVRHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~ 712 (947)
+.||+|+||.||+|+.. +++.||+|++.... .........+.+|.. +++.++||||+++++++.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~ 66 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKT--------------ILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ 66 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------------HHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 46899999999999965 68899999983110 011122344555554 578899999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
..+..|+||||+++|+|.+++... ..+++.....++.||+.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 141 (321)
T cd05603 67 TAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFG 141 (321)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCC
Confidence 999999999999999999988753 45778888889999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +............
T Consensus 142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~i~~~~-- 212 (321)
T cd05603 142 LCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DVSQMYDNILHKP-- 212 (321)
T ss_pred CCccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-----CHHHHHHHHhcCC--
Confidence 987532221 1223456899999999999888999999999999999999999999532 2222221111111
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 911 (947)
...+......+.+++.+|++.||.+||++.
T Consensus 213 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 ---------LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111122344678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=311.65 Aligned_cols=250 Identities=28% Similarity=0.428 Sum_probs=204.6
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+.|++.+.||+|+||.||+|... |+.||||.+... ....+++.+|+.++++++|+||++++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~------------------~~~~~~~~~e~~~l~~l~~~~i~~~~ 66 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDD------------------STAAQAFLAEASVMTTLRHPNLVQLL 66 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccc------------------hhHHHHHHHHHHHHHhcCCcceeeeE
Confidence 57888999999999999999876 789999998311 01346788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++...+..++||||+++++|.+++.......+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|
T Consensus 67 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l 143 (256)
T cd05039 67 GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKV 143 (256)
T ss_pred EEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEE
Confidence 99999999999999999999999998765557899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.++....... ...++..|+|||++..+.++.++||||||+++|||++ |..||... ...++.....
T Consensus 144 ~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~--- 213 (256)
T cd05039 144 SDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPHVE--- 213 (256)
T ss_pred cccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHh---
Confidence 99999986633221 2234678999999998889999999999999999998 99888432 1111211111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.... ...+...+..+.+++.+|++.+|++|||+.|++++|+.+
T Consensus 214 -~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 214 -KGYR---------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -cCCC---------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1100 111223356788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=314.46 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=201.8
Q ss_pred hccCCcccccccCceeEEEEEeC-CCc---EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGK---ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
..|+..+.||+|+||.||+|+.+ +++ .+|||.+.... .....+.+..|++++++++||||
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i 68 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY----------------TEKQRQDFLSEASIMGQFSHHNI 68 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC----------------CHHHHHHHHHHHHHHhcCCCCCe
Confidence 46778899999999999999965 333 69999873210 11224568899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++.+++...+..++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~ 144 (268)
T cd05063 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNL 144 (268)
T ss_pred eEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCC
Confidence 999999999999999999999999999997632 45899999999999999999999 88999999999999999999
Q ss_pred CeEEeccccceecccCCCCcce-ecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLT-HVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
.++++|||++............ .....+..|+|||++....++.++|||||||++|||++ |+.||.... ..+....
T Consensus 145 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--~~~~~~~ 222 (268)
T cd05063 145 ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--NHEVMKA 222 (268)
T ss_pred cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--HHHHHHH
Confidence 9999999999765433221111 11123457999999988889999999999999999998 999985321 1112211
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
. ... .. .+...+.+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 223 i---~~~-~~---------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 223 I---NDG-FR---------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred H---hcC-CC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 111 00 111223456688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=320.69 Aligned_cols=265 Identities=28% Similarity=0.350 Sum_probs=212.5
Q ss_pred hccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
..|...+.||.|+||.||-|+. .+.+.||||++...+.. ....-+++..|+..+++++|||+|.+
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ--------------s~EKWqDIlKEVrFL~~l~HPntieY 91 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--------------SNEKWQDILKEVRFLRQLRHPNTIEY 91 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccc--------------cHHHHHHHHHHHHHHHhccCCCcccc
Confidence 4566778899999999999994 47889999998432211 11234678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
.|+|-.+...|+||||| -|+-.|.+.- ...++.+..+..|+.+++.||+||| +.+.||||||+.|||+++.|.||
T Consensus 92 kgCyLre~TaWLVMEYC-lGSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VK 166 (948)
T KOG0577|consen 92 KGCYLREHTAWLVMEYC-LGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVK 166 (948)
T ss_pred cceeeccchHHHHHHHH-hccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeee
Confidence 99999999999999999 6688888765 3457888888999999999999999 99999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY---TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
|+|||.|.+..+.. .++|||.|||||++. .|.|+-|+||||+|++-.|+...++|++... ...-++
T Consensus 167 LaDFGSAsi~~PAn------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-----AMSALY 235 (948)
T KOG0577|consen 167 LADFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALY 235 (948)
T ss_pred eccccchhhcCchh------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-----HHHHHH
Confidence 99999998776554 578999999999984 5789999999999999999999999975331 112122
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCcceeeecc
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKK 932 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~ 932 (947)
-..+... |-+. -.+....+..++-.|+++-|.+|||..+++++---.++.|++-|+.-+
T Consensus 236 HIAQNes-------PtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLI 294 (948)
T KOG0577|consen 236 HIAQNES-------PTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLI 294 (948)
T ss_pred HHHhcCC-------CCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHH
Confidence 1111111 1111 234456677888899999999999999999987777777776655443
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=312.91 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=189.7
Q ss_pred ccccccCceeEEEEEeCC---CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEE
Q 002250 635 NLIGKGGSGNVYKVVLNS---GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSI 711 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 711 (947)
+.||+|+||.||+|...+ +..+|+|.+.... .......+.+|+.++++++||||+++++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 64 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA----------------SVQEQMKFLEEAQPYRSLQHSNLLQCLGQC 64 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC----------------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 358999999999998653 4579999873211 012234688899999999999999999999
Q ss_pred ecCCccEEEEeccCCCChHHHhhhcC---CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 712 TSEDSNLLVYEYLPNGSLWDRLHTCH---KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 712 ~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
.+....++||||+++|+|.+++.... ....++..+..++.|++.|++||| +.+++||||||+||+++.++.++|
T Consensus 65 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL 141 (269)
T cd05087 65 TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKI 141 (269)
T ss_pred cCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEE
Confidence 99999999999999999999997532 235677888889999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccC-------CCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHH
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-------KINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIV 860 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~ 860 (947)
+|||.+................++..|+|||++... .++.++||||||+++|||++ |+.||.... ..+..
T Consensus 142 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~--~~~~~ 219 (269)
T cd05087 142 GDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS--DEQVL 219 (269)
T ss_pred CCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC--hHHHH
Confidence 999999754433222222234577889999988542 35789999999999999997 999984321 11111
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
... .... .....++.+.. .....+.+++..|| .+|++|||+.||++.|+
T Consensus 220 ~~~---~~~~--~~~~~~~~~~~---~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 220 TYT---VREQ--QLKLPKPRLKL---PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHH---hhcc--cCCCCCCccCC---CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111 1110 01111222211 12334677888999 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.05 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=199.1
Q ss_pred hccCCcccccccCceeEEEEEeC-CCc--EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGK--ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 704 (947)
++|++.+.||+|+||.||+|..+ ++. .+|+|.+... ........+.+|++++.++ +||||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~----------------~~~~~~~~~~~Ei~~l~~l~~h~~i 70 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----------------ASKDDHRDFAGELEVLCKLGHHPNI 70 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc----------------CCHHHHHHHHHHHHHHHHhcCCCCc
Confidence 57888899999999999999965 454 4577766210 0112345788899999999 89999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIH 770 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 770 (947)
+++++++..++..++||||+++++|.++++... ...+++..++.++.|++.|++||| +.+++|
T Consensus 71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H 147 (303)
T cd05088 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIH 147 (303)
T ss_pred ceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence 999999999999999999999999999997542 135788999999999999999999 899999
Q ss_pred ccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCC
Q 002250 771 RDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPI 849 (947)
Q Consensus 771 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~ 849 (947)
|||||+||+++.++.+||+|||++....... ......++..|+|||++....++.++|||||||++|||+| |..||
T Consensus 148 ~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 224 (303)
T cd05088 148 RDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224 (303)
T ss_pred cccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCc
Confidence 9999999999999999999999986322111 1111234678999999988889999999999999999998 99998
Q ss_pred CCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 850 VPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
.... ..+.... ...... .+.+...+..+.+++.+|++.+|++||++.+++++++++...
T Consensus 225 ~~~~--~~~~~~~----~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 225 CGMT--CAELYEK----LPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred ccCC--hHHHHHH----HhcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 4321 1111111 111000 011112345678999999999999999999999999875433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=322.72 Aligned_cols=244 Identities=25% Similarity=0.270 Sum_probs=192.1
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKL 707 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 707 (947)
+|++.+.||+|+||.||+|+.. +++.||||++.... .........+..|..++..+ .|++|+++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~~i~~~ 66 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--------------VIQDDDVECTMVEKRVLALSGKPPFLTQL 66 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhccCCCeEeeE
Confidence 3678899999999999999966 67899999984211 11112334566788888877 58999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++...+..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 67 ~~~~~~~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~k 141 (323)
T cd05616 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred EEEEecCCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEE
Confidence 99999999999999999999999998764 34788899999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||+++....... ......||+.|+|||++....++.++|||||||++|||++|+.||.... .........
T Consensus 142 L~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-----~~~~~~~i~ 214 (323)
T cd05616 142 IADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELFQSIM 214 (323)
T ss_pred EccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-----HHHHHHHHH
Confidence 999999975432221 1224568999999999999999999999999999999999999995321 111111111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
.... ..+......+.+++.+|++.||++|++.
T Consensus 215 ~~~~-----------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 215 EHNV-----------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred hCCC-----------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111 1122234567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=323.95 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=203.0
Q ss_pred hccCCcccccccCceeEEEEEeC--------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN--------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV- 699 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 699 (947)
.+|++.+.||+|+||.||+|... .+..||+|.+... ........+.+|+.+++++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~ 75 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----------------ATDKDLSDLVSEMEMMKMIG 75 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----------------cCHHHHHHHHHHHHHHHhhc
Confidence 46889999999999999999742 1236899987311 1112345788999999999
Q ss_pred cccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------------CccCCHHHHHHHHHHHHHHHHHHhcCCC
Q 002250 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------------KIEMDWVVRYAIAVGAAKGLEYLHHGFD 765 (947)
Q Consensus 700 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~ 765 (947)
+||||+++++++..++..++||||+++|+|.+++.... ...+++..+..++.|++.||+||| +
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~ 152 (334)
T cd05100 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---S 152 (334)
T ss_pred CCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---H
Confidence 89999999999999999999999999999999997532 235788999999999999999999 8
Q ss_pred CCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-
Q 002250 766 RPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT- 844 (947)
Q Consensus 766 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt- 844 (947)
.+++||||||+||+++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++
T Consensus 153 ~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 153 QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred CCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhc
Confidence 9999999999999999999999999999986544322222222234568999999999889999999999999999999
Q ss_pred CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 845 GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 845 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
|..||... ...+........ ...+.+...+..+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 233 g~~p~~~~-----~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 233 GGSPYPGI-----PVEELFKLLKEG----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred CCCCCCCC-----CHHHHHHHHHcC----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 88887422 222222111111 111122233457889999999999999999999999999866
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=317.88 Aligned_cols=263 Identities=23% Similarity=0.259 Sum_probs=194.3
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc---cccccc
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV---RHVNVV 705 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv 705 (947)
+|++.+.||+|+||+||+|+.. +++.||+|.+..... .......+.+|+.+++.+ +||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~h~ni~ 65 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN---------------EDGLPLSTVREVALLKRLEAFDHPNIV 65 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC---------------CCCCchHHHHHHHHHHHhhhcCCCCee
Confidence 4778899999999999999965 689999998842210 111223455677777665 699999
Q ss_pred eEEEEEecC-----CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 706 KLYCSITSE-----DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 706 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
++++++... ...++||||++ ++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 66 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili 141 (288)
T cd07863 66 RLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILV 141 (288)
T ss_pred eeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 999988642 34689999997 58999988765566899999999999999999999 8999999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+.++.+||+|||+++....... .....||..|+|||++.+..++.++||||+||++|||++|++||..... ...+.
T Consensus 142 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~-~~~~~ 217 (288)
T cd07863 142 TSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLG 217 (288)
T ss_pred CCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH-HHHHH
Confidence 9999999999999986543221 1234678999999999988899999999999999999999999853311 11111
Q ss_pred HHHHhhcc-cccccc-------ccccCC----CCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 861 NWVYSKMD-SRDSML-------TVVDPN----ISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 861 ~~~~~~~~-~~~~~~-------~~~d~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
........ ....+. ....+. ......+....+.+++.+|++.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 218 KIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11110000 000000 000000 11122234456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=323.08 Aligned_cols=258 Identities=21% Similarity=0.265 Sum_probs=196.9
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+++.+ +++.+|+|++... ..........+..|+.++..++|++|+++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~ 66 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--------------EMLKRAETACFREERDVLVNGDNQWITTL 66 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHH--------------HHHHhhHHHHHHHHHHHHhhCCCCCEeeE
Confidence 36888999999999999999966 5788999988310 01112234568889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||+++|+|.+++.+. ...+++.....++.|++.|++||| +.+|+||||||+||+++.++.+|
T Consensus 67 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~k 142 (332)
T cd05623 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIR 142 (332)
T ss_pred EEEEecCCEEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999863 235788888999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
|+|||++......... ......||+.|+|||++. ...++.++|||||||++|||++|+.||... +..+.
T Consensus 143 L~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-----~~~~~ 216 (332)
T cd05623 143 LADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVET 216 (332)
T ss_pred EeecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-----CHHHH
Confidence 9999999755332221 122356999999999986 345788999999999999999999999532 22222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAF--RPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~ 916 (947)
.......... ..++.........+.+++.+|+..+|.+ |+++.|++++
T Consensus 217 ~~~i~~~~~~------~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 217 YGKIMNHKER------FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHhCCCcc------ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 2222211111 0112222233456777777877655444 7899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=329.93 Aligned_cols=256 Identities=23% Similarity=0.295 Sum_probs=194.4
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|... +++.||||++.... .........+.+|++++++++||||+++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~E~~il~~l~hp~iv~~ 66 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE--------------MFKKDQLAHVKAERDVLAESDSPWVVSL 66 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--------------HHHhHHHHHHHHHHHHHHhCCCCCcceE
Confidence 36888999999999999999854 78999999883110 0111234568899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.+++..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 67 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~k 141 (377)
T cd05629 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIK 141 (377)
T ss_pred EEEEEcCCeeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999764 35788888889999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCC------------c---------------------------------ceecccccccccCccccc
Q 002250 788 IADFGLAKIVQTGEAG------------D---------------------------------LTHVIAGTHGYIAPEYAY 822 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~ 822 (947)
|+|||+++........ . .....+||+.|+|||++.
T Consensus 142 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 221 (377)
T cd05629 142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221 (377)
T ss_pred EeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc
Confidence 9999998633211000 0 001246999999999999
Q ss_pred cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCC
Q 002250 823 TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNK 902 (947)
Q Consensus 823 ~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~ 902 (947)
+..++.++|||||||++|||++|+.||.... ..+...........+ .++. .......+.+++.+|+.
T Consensus 222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~------~~p~-~~~~s~~~~dli~~lL~- 288 (377)
T cd05629 222 QQGYGQECDWWSLGAIMFECLIGWPPFCSEN-----SHETYRKIINWRETL------YFPD-DIHLSVEAEDLIRRLIT- 288 (377)
T ss_pred cCCCCCceeeEecchhhhhhhcCCCCCCCCC-----HHHHHHHHHccCCcc------CCCC-CCCCCHHHHHHHHHHhc-
Confidence 8889999999999999999999999995321 111111111111110 0011 01123457788889997
Q ss_pred CCCCC---CCHHHHHHH
Q 002250 903 LPAFR---PSMRVVVQM 916 (947)
Q Consensus 903 dP~~R---Pt~~ev~~~ 916 (947)
+|.+| +++.|++++
T Consensus 289 ~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 289 NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CHhhcCCCCCHHHHhcC
Confidence 66664 699998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=322.22 Aligned_cols=258 Identities=20% Similarity=0.269 Sum_probs=194.8
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +++.||||++... ..........+.+|+.++..++|+||+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~ 66 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW--------------EMLKRAETACFREERDVLVNGDRRWITNL 66 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--------------HHhhhhhHHHHHHHHHHHHhCCCCCCCce
Confidence 36888999999999999999965 6899999998311 01112334568899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..|+||||+++|+|.+++.+. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+|
T Consensus 67 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~k 142 (331)
T cd05597 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIR 142 (331)
T ss_pred EEEEecCCeEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999763 345788888999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-----CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
|+|||++......... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||... ...+.
T Consensus 143 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-----~~~~~ 216 (331)
T cd05597 143 LADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVET 216 (331)
T ss_pred EEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-----CHHHH
Confidence 9999998765433221 1223468999999999863 45788999999999999999999998432 22222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCC--CCCCCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKL--PAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~d--P~~RPt~~ev~~~ 916 (947)
.......... . .++......+..+.+++.+|+..+ +..||++.+++++
T Consensus 217 ~~~i~~~~~~-~-----~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 217 YGKIMNHKEH-F-----QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHcCCCc-c-----cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 2222111111 0 111111123345566666766543 3448899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=324.83 Aligned_cols=257 Identities=22% Similarity=0.291 Sum_probs=196.7
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.+ +++.||+|++... ..........+.+|+.+++.++||||++
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~--------------~~~~~~~~~~~~~e~~i~~~~~hp~iv~ 107 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--------------EMIKRSDSAFFWEERDIMAFANSPWVVQ 107 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHH--------------HhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 478999999999999999999966 6889999988311 0111123456788999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..+...++||||+++|+|.+++... .++......++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~i 181 (371)
T cd05622 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL 181 (371)
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCE
Confidence 999999999999999999999999999752 4678888889999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC----KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
||+|||+++........ ......||+.|+|||++... .++.++|||||||++|||++|+.||... +....
T Consensus 182 kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~ 255 (371)
T cd05622 182 KLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----SLVGT 255 (371)
T ss_pred EEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC-----CHHHH
Confidence 99999999866433221 12245799999999998653 3788999999999999999999999532 22222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHh
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAF--RPSMRVVVQML 917 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~L 917 (947)
........... .++. .......+.+++.+|+..++.+ ||++.|++++.
T Consensus 256 ~~~i~~~~~~~------~~~~-~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 256 YSKIMNHKNSL------TFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHHHHcCCCcc------cCCC-cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 22211111110 0111 1123445777888999844443 78999988764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=314.70 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=196.1
Q ss_pred ccccccCceeEEEEEeCC-------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 635 NLIGKGGSGNVYKVVLNS-------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.||+|+||.||+|+..+ ++.+|||.+... ........+.+|+.+++.++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 64 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----------------ATDQEKKEFLKEAHLMSNFNHPNIVKL 64 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc----------------cchhhHHHHHHHHHHHHhcCCCCeeeE
Confidence 368999999999998652 257899976311 111234578899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcC-----CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCH-----KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
++++...+..++||||+++++|.+++.... ...+++..+..++.|++.|++||| +.+++|+||||+||+++.
T Consensus 65 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~ 141 (269)
T cd05044 65 LGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSE 141 (269)
T ss_pred eeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEec
Confidence 999999999999999999999999997532 234788999999999999999999 889999999999999998
Q ss_pred CC-----CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCc
Q 002250 783 EW-----KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDS 856 (947)
Q Consensus 783 ~~-----~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~ 856 (947)
++ .++++|||+++...............++..|+|||++.++.++.++|||||||++|||++ |+.||.... .
T Consensus 142 ~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--~ 219 (269)
T cd05044 142 KGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--N 219 (269)
T ss_pred CCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--H
Confidence 77 899999999976543332222222345688999999999999999999999999999998 999984221 1
Q ss_pred ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
.+.... .... .........+..+.+++.+||..+|.+||++.++.++|++
T Consensus 220 ~~~~~~----~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 220 QEVLQH----VTAG---------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHHHH----HhcC---------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111 1111 0111223345678899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=316.46 Aligned_cols=253 Identities=26% Similarity=0.277 Sum_probs=199.2
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
|+..+.||+|+||.||+|... +++.||||.+.... .........+..|+.++++++|++|+++++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~~E~~il~~l~~~~i~~~~~ 67 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--------------IKKRKGESMALNEKQILEKVNSRFVVSLAY 67 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhh--------------ccchHHHHHHHHHHHHHHhCCCCCeeeeeE
Confidence 567788999999999999965 78999999884211 011122345678999999999999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
.+..++..++||||+++++|.+++.......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+
T Consensus 68 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~ 144 (285)
T cd05630 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRIS 144 (285)
T ss_pred EEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEe
Confidence 9999999999999999999999997655567899999999999999999999 8999999999999999999999999
Q ss_pred ccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccc
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS 869 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 869 (947)
|||++........ .....|+..|+|||++.+..++.++||||+|+++|||++|+.||....... ..+........
T Consensus 145 Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~~~~~~~ 219 (285)
T cd05630 145 DLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKE 219 (285)
T ss_pred eccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHHHHhhhhh
Confidence 9999976543321 123468999999999998889999999999999999999999996432110 00111111000
Q ss_pred cccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 002250 870 RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-----MRVVVQ 915 (947)
Q Consensus 870 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 915 (947)
. ...........+.+++.+|++.||++||| +.|+++
T Consensus 220 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 V----------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred h----------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0 00112223455788999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=311.32 Aligned_cols=250 Identities=28% Similarity=0.401 Sum_probs=202.4
Q ss_pred ccccccCceeEEEEEeCC----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEE
Q 002250 635 NLIGKGGSGNVYKVVLNS----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 710 (947)
+.||+|+||.||+|.... +..||+|+++.... ......+.+|+++++.++|+||++++++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~----------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 64 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS----------------EEERKDFLKEARVMKKLGHPNVVRLLGV 64 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc----------------hhHHHHHHHHHHHHhhcCCCChheeeee
Confidence 468999999999999653 78999999842211 1135678899999999999999999999
Q ss_pred EecCCccEEEEeccCCCChHHHhhhcC-------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 711 ITSEDSNLLVYEYLPNGSLWDRLHTCH-------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 711 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
+..+...++||||+++++|.+++.... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.+
T Consensus 65 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~ 141 (262)
T cd00192 65 CTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGED 141 (262)
T ss_pred ecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCC
Confidence 999999999999999999999998742 356899999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.++|+|||.+................++..|+|||.+....++.++||||+|+++|||++ |..||... ....+.+.
T Consensus 142 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~ 219 (262)
T cd00192 142 LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEEVLEY 219 (262)
T ss_pred CcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--CHHHHHHH
Confidence 9999999999987655432222334457889999999988889999999999999999999 68888533 11112111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
. .. ......+...+..+.+++.+|++.+|++|||+.|++++|+
T Consensus 220 ~---~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 220 L---RK----------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred H---Hc----------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 11 1111222333567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=315.01 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=197.0
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNV 704 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 704 (947)
..+.|+..+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++++ +||||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~------------------~~~~~~~~~e~~~l~~~~~h~~i 65 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------------GDEEEEIKQEINMLKKYSHHRNI 65 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC------------------CccHHHHHHHHHHHHHhcCCCCe
Confidence 3467888899999999999999965 6889999987311 12345678899999998 69999
Q ss_pred ceEEEEEecC------CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 705 VKLYCSITSE------DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 705 v~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++++++... ...++||||+++++|.+++.......+++.....++.|++.|++||| +.+|+||||||+||
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~ni 142 (272)
T cd06637 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNV 142 (272)
T ss_pred eeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHE
Confidence 9999998753 34789999999999999998755567899999999999999999999 88999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRPIVPEF 853 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~ 853 (947)
++++++.++|+|||++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 143 li~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 143 LLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred EECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 999999999999999976543221 122456899999999986 3457889999999999999999999984321
Q ss_pred CCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 854 GDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
....... ..... .... .....+..+.+++.+||..+|.+|||+.++++
T Consensus 221 ----~~~~~~~-~~~~~-------~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 221 ----PMRALFL-IPRNP-------APRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----HHHHHHH-HhcCC-------CCCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111110 00000 0000 11123346789999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=312.87 Aligned_cols=252 Identities=28% Similarity=0.346 Sum_probs=190.7
Q ss_pred ccccccCceeEEEEEeC----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEE
Q 002250 635 NLIGKGGSGNVYKVVLN----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 710 (947)
+.||+|+||.||+|... ++..||+|++... ........+.+|+.+++.++||||++++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 64 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI----------------TDLEEVEQFLKEGIIMKDFSHPNVLSLLGI 64 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc----------------CCHHHHHHHHHHHHHHccCCCCCcceEEEE
Confidence 46899999999999853 2457999987210 111234578889999999999999999997
Q ss_pred Ee-cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 711 IT-SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 711 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
+. .++..++||||+++|+|.+++.... ...++.....++.|++.|++||| +.+++||||||+||++++++.+||+
T Consensus 65 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~ 140 (262)
T cd05058 65 CLPSEGSPLVVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVA 140 (262)
T ss_pred eecCCCCcEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEEC
Confidence 75 4556789999999999999997643 34677788889999999999999 8899999999999999999999999
Q ss_pred ccccceecccCCCC--cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCC-CCCCCCCCcccHHHHHHhh
Q 002250 790 DFGLAKIVQTGEAG--DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKR-PIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 790 DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~-p~~~~~~~~~~~~~~~~~~ 866 (947)
|||+++........ .......++..|+|||++....++.++||||||+++|||++|+. ||... ...+.... .
T Consensus 141 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~---~ 215 (262)
T cd05058 141 DFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDITVY---L 215 (262)
T ss_pred CccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHH---H
Confidence 99999754332110 11112345778999999988889999999999999999999654 44221 11112111 1
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
.... ....+...+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 216 ~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 216 LQGR----------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred hcCC----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1111 11111223456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.77 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=202.6
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 707 (947)
..|++.+.||+||.+.||++...+.+.+|+|++. ...........|..|+..|.++ .|.+||++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~---------------~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL 425 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVV---------------LLEADNQTLDGYRNEIALLNKLKGHDKIIQL 425 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHH---------------HhhcCHHHHHHHHHHHHHHHHhcCCceEEEE
Confidence 4588899999999999999999888889998772 2223334567899999999999 59999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++|-..++..||||||= ..+|..++++......+| .++.+..|++.|+.++| ..+|||.||||.|+|+= .|.+|
T Consensus 426 ~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LK 499 (677)
T KOG0596|consen 426 YDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLK 499 (677)
T ss_pred eeeeccCceEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEE
Confidence 99999999999999987 569999999876666667 56678889999999999 89999999999999884 57999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCC-----------CCCccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-----------INEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 856 (947)
|+|||+|.....+.........+||+.||+||.+.... .+.++||||+||++|+|+.|+.||..
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~----- 574 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ----- 574 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-----
Confidence 99999999888777666677789999999999985332 45789999999999999999999832
Q ss_pred ccHHHHHHhhccccccccccccCC----CCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 857 KDIVNWVYSKMDSRDSMLTVVDPN----ISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~d~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+... +.+ +..+.||. +++.++.. +++++|..|+..||.+|||..|++++
T Consensus 575 --~~n~-~aK------l~aI~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 575 --IINQ-IAK------LHAITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHHH-HHH------HHhhcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1111 111 12333331 23333222 28999999999999999999999864
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=305.71 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=200.7
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.+|++.+.||+|+||.||+|...+++.+|+|.+... ......+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~------------------~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG------------------AMSEEDFIEEAQVMMKLSHPKLVQLY 65 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC------------------CCCHHHHHHHHHHHHhCCCCCeeeEE
Confidence 467788999999999999999877889999987311 12345688999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++......++||||+++++|.+++.... ..+++..+..++.+++.|++||| +.+++||||||+||+++.++.++|
T Consensus 66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l 141 (256)
T cd05112 66 GVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKV 141 (256)
T ss_pred EEEccCCceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEE
Confidence 99999999999999999999999997632 35789999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.+......... ......++.+|+|||++.++.++.++||||||+++|||++ |..||... ...+......
T Consensus 142 ~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-----~~~~~~~~~~ 215 (256)
T cd05112 142 SDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR-----SNSEVVETIN 215 (256)
T ss_pred CCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC-----CHHHHHHHHh
Confidence 999998765433211 1112234678999999988889999999999999999998 89998432 1112221111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
.... ...+. ..+..+.+++.+||+.+|++|||+.|++++|+
T Consensus 216 ~~~~----~~~~~------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 216 AGFR----LYKPR------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCC----CCCCC------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1100 01111 12356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=308.26 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=198.0
Q ss_pred ccccccCceeEEEEEeCC--C--cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEE
Q 002250 635 NLIGKGGSGNVYKVVLNS--G--KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 710 (947)
+.||+|++|.||+|.+.+ + ..||||.+..... ....+.+.+|+.++++++||||++++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 64 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL----------------SDIMDDFLKEAAIMHSLDHENLIRLYGV 64 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc----------------HHHHHHHHHHHHHHhhcCCCCccceeEE
Confidence 468999999999999643 3 3699998842210 0334678899999999999999999999
Q ss_pred EecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEec
Q 002250 711 ITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790 (947)
Q Consensus 711 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 790 (947)
+.. ...++||||+++++|.+++.......+++.....++.|++.||+||| +.+++||||+|+||+++.++.+||+|
T Consensus 65 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~d 140 (257)
T cd05040 65 VLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGD 140 (257)
T ss_pred EcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecc
Confidence 988 88899999999999999998754356899999999999999999999 89999999999999999999999999
Q ss_pred cccceecccCCCC-cceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcc
Q 002250 791 FGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 791 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
||+++........ .......++..|+|||++....++.++||||||+++|||++ |+.||... ...+... ....
T Consensus 141 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~---~~~~ 215 (257)
T cd05040 141 FGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--SGSQILK---KIDK 215 (257)
T ss_pred ccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC--CHHHHHH---HHHh
Confidence 9999876543221 11123456789999999998889999999999999999999 99998432 1111211 1111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
.... ...+...+..+.+++.+|++.+|++||++.++++.|.+
T Consensus 216 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 216 EGER---------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred cCCc---------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 1110 11122345678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=329.49 Aligned_cols=261 Identities=20% Similarity=0.233 Sum_probs=198.2
Q ss_pred hhccCCcccccccCceeEEEEEeC---CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN---SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
..+|++.+.||+|+||.||+|... .++.||||.+. ......+|++++++++||||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~----------------------~~~~~~~E~~il~~l~h~~i 148 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT----------------------GGKTPGREIDILKTISHRAI 148 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecc----------------------ccccHHHHHHHHHhcCCCCc
Confidence 357889999999999999999754 36789999872 11235689999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++......++|||++. ++|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 149 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~ 222 (392)
T PHA03207 149 INLIHAYRWKSTVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPE 222 (392)
T ss_pred cceeeeEeeCCEEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCC
Confidence 999999999999999999995 688888854 346899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC--cccHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD--SKDIVNW 862 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~--~~~~~~~ 862 (947)
.++|+|||++................||+.|+|||++....++.++|||||||++|||++|+.||.+.... ...+...
T Consensus 223 ~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i 302 (392)
T PHA03207 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI 302 (392)
T ss_pred CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHH
Confidence 99999999997655443322233457999999999999889999999999999999999999999654321 1111111
Q ss_pred HHhhccccccccc---------------cccCC--CCccC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLT---------------VVDPN--ISEIL--KEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~---------------~~d~~--~~~~~--~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
............. ...+. .++.. ......+.+++.+|+..||++|||+.|++.+
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 303 IRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1110000000000 00000 00000 1123467788999999999999999999975
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.14 Aligned_cols=265 Identities=24% Similarity=0.282 Sum_probs=196.0
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
.+.++|++.+.||+|+||.||+|... +|+.||||++.... ........+.+|+.+++.++||||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~ni 82 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF---------------QNQTHAKRAYRELVLLKCVNHKNI 82 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc---------------cchhHHHHHHHHHHHHHhCCCCCE
Confidence 45689999999999999999999964 68999999984221 111234567789999999999999
Q ss_pred ceEEEEEecCC------ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 705 VKLYCSITSED------SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 705 v~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++++++.... ..|+||||+++ ++.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||
T Consensus 83 v~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NI 154 (359)
T cd07876 83 ISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNI 154 (359)
T ss_pred eeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHE
Confidence 99999986543 46899999965 66666643 3778888899999999999999 89999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc--
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS-- 856 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~-- 856 (947)
+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus 155 l~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~ 231 (359)
T cd07876 155 VVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW 231 (359)
T ss_pred EECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999997543321 1223468999999999999899999999999999999999999996431100
Q ss_pred -----------ccHHHH----HHhhcccccccc-----ccc----cCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 002250 857 -----------KDIVNW----VYSKMDSRDSML-----TVV----DPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRV 912 (947)
Q Consensus 857 -----------~~~~~~----~~~~~~~~~~~~-----~~~----d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 912 (947)
..+... +........... +.. .+............+.+++.+|+..||++|||+.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 311 (359)
T cd07876 232 NKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311 (359)
T ss_pred HHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHH
Confidence 000000 000000000000 000 00001111122456789999999999999999999
Q ss_pred HHHH
Q 002250 913 VVQM 916 (947)
Q Consensus 913 v~~~ 916 (947)
++++
T Consensus 312 ~l~h 315 (359)
T cd07876 312 ALRH 315 (359)
T ss_pred HhcC
Confidence 9975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.12 Aligned_cols=262 Identities=21% Similarity=0.278 Sum_probs=196.2
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|...+.||+|+||.||+|+.+ +++.||+|++.... .......+.+|+.++++++||||+++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~ 69 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH----------------EEGAPCTAIREVSLLKDLKHANIVTL 69 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc----------------cCCcchhHHHHHHHHHhCCCCCcceE
Confidence 56888999999999999999965 68899999984221 11223456789999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||+++ +|.+++.... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 70 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~k 144 (309)
T cd07872 70 HDIVHTDKSLTLVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELK 144 (309)
T ss_pred EEEEeeCCeEEEEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEE
Confidence 9999999999999999975 8888887643 35788889999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||+++....... ......+|+.|+|||++.+ ..++.++||||+||++|||+||+.||.... ..+........
T Consensus 145 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~--~~~~~~~~~~~ 220 (309)
T cd07872 145 LADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST--VEDELHLIFRL 220 (309)
T ss_pred ECccccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHH
Confidence 999999975433221 1123457899999998865 458899999999999999999999985431 11111111111
Q ss_pred cc-----------ccccccccccCCC-----CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 867 MD-----------SRDSMLTVVDPNI-----SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 867 ~~-----------~~~~~~~~~d~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.. ........-.+.. ..........+.+++.+|++.||.+|||+.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 221 LGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 0000000000000 0011123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=330.11 Aligned_cols=255 Identities=22% Similarity=0.277 Sum_probs=193.7
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.|++.+.||+|+||.||+|+.. +++.||||++... ..........+.+|++++++++||||++++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~--------------~~~~~~~~~~~~~E~~il~~l~h~~iv~~~ 67 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKA--------------DVLMRNQAAHVKAERDILAEADNEWVVKLY 67 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHH--------------HHHhhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence 5888999999999999999955 6899999998311 011123346688999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+.+.+++..|+||||+++|+|.+++... ..++......++.||+.||+||| +.+|+||||||+||+++.++.+||
T Consensus 68 ~~~~~~~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999999864 34778888889999999999999 899999999999999999999999
Q ss_pred eccccceecccCCC-----------------------------------------CcceecccccccccCccccccCCCC
Q 002250 789 ADFGLAKIVQTGEA-----------------------------------------GDLTHVIAGTHGYIAPEYAYTCKIN 827 (947)
Q Consensus 789 ~DfG~a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 827 (947)
+|||+|........ .......+||+.|+|||++.+..++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 99999753210000 0001134699999999999998899
Q ss_pred CccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCC
Q 002250 828 EKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFR 907 (947)
Q Consensus 828 ~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 907 (947)
.++|||||||++|||++|+.||.... ..+............ ..+... .....+.+++.+|+ .+|.+|
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~~---~~~~~~----~~s~~~~~li~~l~-~~p~~R 289 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLADT-----PAETQLKVINWETTL---HIPSQA----KLSREASDLILRLC-CGAEDR 289 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCCCC-----HHHHHHHHhccCccc---cCCCCC----CCCHHHHHHHHHHh-cCHhhc
Confidence 99999999999999999999995431 111111111111100 001111 12334556666765 499999
Q ss_pred C---CHHHHHHH
Q 002250 908 P---SMRVVVQM 916 (947)
Q Consensus 908 P---t~~ev~~~ 916 (947)
+ ++.|++++
T Consensus 290 ~~~~t~~ell~h 301 (376)
T cd05598 290 LGKNGADEIKAH 301 (376)
T ss_pred CCCCCHHHHhCC
Confidence 9 88888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.43 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=201.9
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.|++.+.||+|++|.||+|..+ +++.||+|++.... ......+.+.+|++++++++|+|+++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN---------------ASRRERKAAEQEAQLLSQLKHPNIVAYR 65 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh---------------cCHHHHHHHHHHHHHHHhCCCCCeeeee
Confidence 4788899999999999999965 57899999983211 1112345688999999999999999999
Q ss_pred EEEecC-CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 709 CSITSE-DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 709 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+.+... ...++||||+++++|.+++.......+++..+..++.+++.|++||| +.+++||||||+||+++.++.++
T Consensus 66 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~ 142 (257)
T cd08223 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIK 142 (257)
T ss_pred eeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEE
Confidence 988654 45789999999999999998755566899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||++........ ......+++.|+|||+..+..++.++||||+|+++|||++|+.||... +.........
T Consensus 143 l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-----~~~~~~~~~~ 215 (257)
T cd08223 143 VGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DMNSLVYRII 215 (257)
T ss_pred EecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHH
Confidence 999999986643221 122346789999999999988999999999999999999999998532 2222222211
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. .++.........+.+++.+|++.+|++|||+.+++++
T Consensus 216 ~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 216 EG----------KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred hc----------CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11 1112233445678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=311.62 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=195.7
Q ss_pred ccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 65 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----------------TVELQKQIMSELEILYKCDSPYIIGFY 65 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----------------ChHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 577889999999999999995 478999999883210 112235688999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++++|..+. .+++.....++.|++.|++||| +.+|+|+||||+||+++.++.++|
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l 136 (279)
T cd06619 66 GAFFVENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKL 136 (279)
T ss_pred EEEEECCEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999986542 3578888899999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc--HHHHHHhh
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD--IVNWVYSK 866 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~ 866 (947)
+|||++....... .....||..|+|||++.+..++.++||||||+++|||++|+.||......... ...+....
T Consensus 137 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 212 (279)
T cd06619 137 CDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI 212 (279)
T ss_pred eeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH
Confidence 9999997654322 22346899999999999888999999999999999999999999643322111 11111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..... +... .......+.+++.+|++.+|++||++.|++++
T Consensus 213 ~~~~~-------~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 213 VDEDP-------PVLP--VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred hccCC-------CCCC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11100 0110 11233467899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.06 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=196.0
Q ss_pred ccccccCceeEEEEEeC--C--CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEE
Q 002250 635 NLIGKGGSGNVYKVVLN--S--GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 710 (947)
+.||+|+||.||+|... + +..+|+|.+..... ......+.+|+++++.+.||||++++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 64 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI----------------AAGKKEFLREASVMAQLDHPCIVRLIGV 64 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc----------------hHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 46999999999999843 2 26899998842211 1234578899999999999999999998
Q ss_pred EecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEec
Q 002250 711 ITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790 (947)
Q Consensus 711 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 790 (947)
+. ....++||||+++|+|.+++.... .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|
T Consensus 65 ~~-~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~d 138 (257)
T cd05060 65 CK-GEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISD 138 (257)
T ss_pred Ec-CCceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEecc
Confidence 76 456799999999999999998743 6899999999999999999999 88999999999999999999999999
Q ss_pred cccceecccCCCCcc-eecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcc
Q 002250 791 FGLAKIVQTGEAGDL-THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 791 fG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
||.++.......... .....++..|+|||......++.++||||||+++|||++ |..||... ...++..+...
T Consensus 139 f~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~--~~~~~~~~~~~--- 213 (257)
T cd05060 139 FGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM--KGAEVIAMLES--- 213 (257)
T ss_pred ccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHc---
Confidence 999986644332111 111123567999999998899999999999999999998 99998532 12222222211
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
. .. .+.+...+..+.+++.+|++.+|++||++.++.+.|+++.
T Consensus 214 ~-~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 214 G-ER---------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred C-Cc---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1 10 1112233457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.80 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=201.2
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
..+|+..+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||++
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~-----------------~~~~~~~~~~e~~~l~~~~h~~v~~ 81 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-----------------QQPKKELIINEILVMRENKNPNIVN 81 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecC-----------------CcchHHHHHHHHHHHHhCCCCCEee
Confidence 367888999999999999999954 6899999988311 1123466889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++.+..+...++||||+++++|.+++.. ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~ 155 (296)
T cd06654 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSV 155 (296)
T ss_pred EEEEEEeCCEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCE
Confidence 99999999999999999999999999875 34788899999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
+|+|||++........ ......|++.|+|||.+....++.++|||||||++|||++|+.||..... .......
T Consensus 156 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-----~~~~~~~ 228 (296)
T cd06654 156 KLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLI 228 (296)
T ss_pred EECccccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-----HHhHHHH
Confidence 9999999875543221 11234688999999999888899999999999999999999999954321 1111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..... +. ...+......+.+++.+|+..+|++|||+.++++.
T Consensus 229 ~~~~~-------~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 229 ATNGT-------PE-LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred hcCCC-------CC-CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 10000 00 11123344568889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.53 Aligned_cols=260 Identities=24% Similarity=0.351 Sum_probs=200.8
Q ss_pred hccCCcccccccCceeEEEEEeC-CCc----EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGK----ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.|+..+.||+|+||.||+|... +++ .||+|.+.... .......+.+|+.++++++|||
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~~~~l~h~n 70 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT----------------GPKANVEFMDEALIMASMDHPH 70 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 56778889999999999999854 444 47888773211 1122346889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++..+ ..++|+||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 71 iv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~ 145 (303)
T cd05110 71 LVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSP 145 (303)
T ss_pred cccEEEEEcCC-CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCC
Confidence 99999998754 467999999999999998763 335788999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||.... .....++
T Consensus 146 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~ 223 (303)
T cd05110 146 NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDL 223 (303)
T ss_pred CceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH
Confidence 9999999999986644332222223345778999999988889999999999999999998 889984321 1222222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
.. .... ..........+.+++.+||..+|++||++.++++.|+++...+
T Consensus 224 ~~----~~~~---------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 224 LE----KGER---------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HH----CCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 21 1111 0011123356788999999999999999999999999865444
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.16 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=204.7
Q ss_pred ccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|+||.||.++. .+++.+++|.+.... ........+.+|++++++++|+||++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~---------------~~~~~~~~~~~e~~~l~~~~h~~i~~~~ 65 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR---------------LSEKERRDALNEIVILSLLQHPNIIAYY 65 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc---------------cchhHHHHHHHHHHHHHhCCCCCeeEEE
Confidence 477889999999999999994 468999999873211 1123345688999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++.+++..++||||+++++|.+++.......+++..+..++.|++.|++||| +.+++||||+|+||++++++.+||
T Consensus 66 ~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl 142 (256)
T cd08221 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKL 142 (256)
T ss_pred eEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEE
Confidence 99999999999999999999999998754567899999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||.+........ ......|++.|+|||+..+..++.++||||||+++|||++|..||... ...+.......
T Consensus 143 ~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~ 215 (256)
T cd08221 143 GDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-----NPLNLVVKIVQ 215 (256)
T ss_pred CcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHc
Confidence 99999986644332 122346899999999998888899999999999999999999998432 22222222211
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML 917 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 917 (947)
. ............+.+++.+|++.+|++||++.++++++
T Consensus 216 ~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 216 G----------NYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred C----------CCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1 11112233445688899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=320.76 Aligned_cols=245 Identities=22% Similarity=0.285 Sum_probs=191.3
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 712 (947)
+.||+|+||+||+|+.. +++.||||++.... .........+.+|+.++.++ +||||+++++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 66 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL--------------VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ 66 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE
Confidence 46999999999999965 67899999984211 11123345678899999888 6999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
..+..|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg 141 (327)
T cd05617 67 TTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYG 141 (327)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccc
Confidence 999999999999999999988763 35899999999999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-CcccHHHHHHhhccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG-DSKDIVNWVYSKMDSRD 871 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~ 871 (947)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......++.........
T Consensus 142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (327)
T cd05617 142 MCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP 219 (327)
T ss_pred cceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC
Confidence 987532221 122345799999999999999999999999999999999999999954221 11112222222221111
Q ss_pred cccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 872 SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 872 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
...+......+.+++.+|++.||++|+++
T Consensus 220 ----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 220 ----------IRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ----------CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11122233557789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=328.67 Aligned_cols=203 Identities=26% Similarity=0.356 Sum_probs=169.8
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.|+..+.||+|+||+||+|+.. +++.||||++.... .........+.+|+.++++++||||++++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~--------------~~~~~~~~~~~~E~~il~~~~h~~iv~~~ 67 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD--------------VLLRNQVAHVKAERDILAEADNEWVVRLY 67 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH--------------hhhHHHHHHHHHHHHHHHhCCCCcCCeEE
Confidence 4778899999999999999964 68899999983110 01112345788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+.+.+++..|+||||+++|+|.+++.+. ..+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 68 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL 142 (382)
T cd05625 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKL 142 (382)
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999999764 34778888889999999999999 899999999999999999999999
Q ss_pred eccccceecccCCC---------------------------------------------CcceecccccccccCcccccc
Q 002250 789 ADFGLAKIVQTGEA---------------------------------------------GDLTHVIAGTHGYIAPEYAYT 823 (947)
Q Consensus 789 ~DfG~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~ 823 (947)
+|||+++....... .......+||+.|+|||++.+
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (382)
T cd05625 143 TDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222 (382)
T ss_pred eECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC
Confidence 99999753210000 000113468999999999998
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 824 CKINEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 824 ~~~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
..++.++||||+||++|||++|+.||..
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 223 TGYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred CCCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 8999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.53 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=186.7
Q ss_pred cccccCceeEEEEEeCC---CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEe
Q 002250 636 LIGKGGSGNVYKVVLNS---GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSIT 712 (947)
Q Consensus 636 ~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 712 (947)
.||+|+||+||+|...+ ...+|+|.+... ........+.+|+.+++.++||||+++++++.
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----------------~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~ 65 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----------------ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI 65 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc----------------CChHHHHHHHHHHHHHHhCCCCCcceEEEEEC
Confidence 58999999999997543 346888876211 01123456788999999999999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCC---ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHK---IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
..+..++||||+++|+|.+++..... ...++.....++.|++.|++||| +.+|+||||||+||+++.++.+||+
T Consensus 66 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 142 (269)
T cd05042 66 ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIG 142 (269)
T ss_pred CCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEe
Confidence 99999999999999999999976432 23467788899999999999999 8999999999999999999999999
Q ss_pred ccccceecccCCCCcceecccccccccCcccccc-------CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHH
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-------CKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~ 861 (947)
|||++................++..|+|||+... ..++.++|||||||++|||++ |..||.... ..+.
T Consensus 143 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~-- 218 (269)
T cd05042 143 DYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS--DEQV-- 218 (269)
T ss_pred ccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC--HHHH--
Confidence 9999875433322111223346778999998743 346789999999999999999 677774221 1111
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
......... .....+ .........+.+++..|| .||++|||+.+|++.|.
T Consensus 219 -~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 219 -LKQVVREQD--IKLPKP---QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -HHHHhhccC--ccCCCC---cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111111 111111 122233455667888898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.62 Aligned_cols=265 Identities=23% Similarity=0.245 Sum_probs=197.1
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|++|.||+|+.. +++.||||++.... ........+.+|+.++++++||||++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 65 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---------------EEEGVPSTAIREISLLKELQHPNIVCLQ 65 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc---------------ccCCchHHHHHHHHHHHhcCCCCEeeeE
Confidence 3677889999999999999965 68999999884211 1122345678899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcC-CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCH-KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++..++..++||||++ ++|.+++.... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++
T Consensus 66 ~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~ 141 (285)
T cd07861 66 DVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIK 141 (285)
T ss_pred EEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEE
Confidence 99999999999999997 68988887543 356899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||++........ ......+++.|+|||++.+. .++.++||||||+++|||+||+.||...... ..........
T Consensus 142 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~~~~~~~~~~ 218 (285)
T cd07861 142 LADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRIL 218 (285)
T ss_pred ECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHh
Confidence 999999975533211 11233568899999988654 4788999999999999999999998543210 0011100000
Q ss_pred ccc--------------cccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDS--------------RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~--------------~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... .....................++.+++.+|++.||++|||+.+++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 219 GTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred CCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 00000000011111111234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.37 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=203.8
Q ss_pred hccCCcccccccCceeEEEEEeC-CCc----EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGK----ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
++|++.+.||+|+||.||+|..+ +|+ .||+|.+.... .......+.+|+.++++++|||
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~ 70 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET----------------SPKANKEILDEAYVMASVDHPH 70 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 57888899999999999999965 333 58999873221 1123467889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++.. ...++||||+++|+|.+++.... ..+++.....++.|++.|++||| +.+++||||||+||+++++
T Consensus 71 i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~ 145 (279)
T cd05057 71 VVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTP 145 (279)
T ss_pred cceEEEEEec-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCC
Confidence 9999999987 78899999999999999998643 34899999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||.++...............++..|+|||......++.++|+||||+++||+++ |+.||... ...++...
T Consensus 146 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~ 223 (279)
T cd05057 146 QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI--PAVEIPDL 223 (279)
T ss_pred CeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHH
Confidence 9999999999986653322211112224568999999988889999999999999999999 99998432 11122221
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCc
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSV 925 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 925 (947)
+ ... .. ...+..+...+.+++.+||..+|.+||++.++++.|+++..-+.
T Consensus 224 ~---~~~-~~---------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 224 L---EKG-ER---------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred H---hCC-CC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 1 111 10 11111233467889999999999999999999999998755443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.91 Aligned_cols=253 Identities=25% Similarity=0.268 Sum_probs=197.3
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
|+..+.||+|+||+||+|... +++.||+|.+.... .........+.+|++++++++|+||+++.+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~E~~il~~l~~~~i~~~~~ 67 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKR--------------IKKRKGESMALNEKQILEKVNSQFVVNLAY 67 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhh--------------hhhhhHHHHHHHHHHHHHHcCCcCceeEEE
Confidence 556788999999999999965 78999999883211 011122345778999999999999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
++..++..++||||+++++|.+++.......+++.....++.|++.||+||| +.+|+||||||+||++++++.++|+
T Consensus 68 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~ 144 (285)
T cd05632 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred EEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEe
Confidence 9999999999999999999999987655557999999999999999999999 8999999999999999999999999
Q ss_pred ccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccc
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS 869 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 869 (947)
|||++........ .....|+..|+|||++.+..++.++|+||||+++|||++|+.||..... .....-.......
T Consensus 145 Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~--~~~~~~~~~~~~~ 219 (285)
T cd05632 145 DLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE--KVKREEVDRRVLE 219 (285)
T ss_pred cCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhhhc
Confidence 9999976543221 1234689999999999988899999999999999999999999853211 0001111111111
Q ss_pred cccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 002250 870 RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-----MRVVVQ 915 (947)
Q Consensus 870 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 915 (947)
.. ..........+.+++..|++.||++||+ +.++++
T Consensus 220 ~~----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 220 TE----------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cc----------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00 0112223445788999999999999999 455554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.29 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=192.0
Q ss_pred ccccccCceeEEEEEeC-CCc--EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEEEE
Q 002250 635 NLIGKGGSGNVYKVVLN-SGK--ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCS 710 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 710 (947)
+.||+|+||.||+|..+ ++. .+|+|.+... ........+.+|+++++++ +||||++++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----------------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 64 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----------------ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 64 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----------------CCHHHHHHHHHHHHHHHhhccCCCeeeEEEE
Confidence 46899999999999975 343 4688877311 0112235688999999999 79999999999
Q ss_pred EecCCccEEEEeccCCCChHHHhhhcC--------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 002250 711 ITSEDSNLLVYEYLPNGSLWDRLHTCH--------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776 (947)
Q Consensus 711 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 776 (947)
+...+..++||||+++|+|.+++.... ...+++..+..++.|++.|++||| +.+++||||||+
T Consensus 65 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~ 141 (270)
T cd05047 65 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAAR 141 (270)
T ss_pred EecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccc
Confidence 999999999999999999999997532 124788999999999999999999 899999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 002250 777 NILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGD 855 (947)
Q Consensus 777 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~ 855 (947)
||++++++.+|++|||++....... .......+..|+|||++....++.++||||||+++|||++ |..||...
T Consensus 142 nili~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~--- 215 (270)
T cd05047 142 NILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--- 215 (270)
T ss_pred eEEEcCCCeEEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc---
Confidence 9999999999999999985322110 1111223567999999988889999999999999999997 99998432
Q ss_pred cccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 856 SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
+..+.... ...... .+.+......+.+++.+|++.+|.+|||+.++++.|+++
T Consensus 216 --~~~~~~~~-~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 216 --TCAELYEK-LPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred --CHHHHHHH-HhCCCC---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 11111111 111100 111122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.23 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=203.9
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|+||.||++... +|+.||+|++.... .......++.+|+.++++++||||++++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK---------------MSPKEREESRKEVAVLSNMKHPNIVQYQ 65 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHh---------------CChHHHHHHHHHHHHHHhCCCCCeeeeE
Confidence 4778899999999999999954 78999999883111 1112345788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++...+..++||||+++++|.+++.......+++.....++.|++.|++||| +.+++|+||+|+||+++.++.+++
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l 142 (256)
T cd08218 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKL 142 (256)
T ss_pred eeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999998755556789999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||.+......... .....|++.|+|||+..+..++.++|+|||||++|||++|+.||... +..+.+.....
T Consensus 143 ~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~ 215 (256)
T cd08218 143 GDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLVLKIIR 215 (256)
T ss_pred eeccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHHHHHhc
Confidence 999999765433211 12345788999999998888999999999999999999999998432 22222222221
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
. .....+......+.+++.+|++.+|++||++.+|+++
T Consensus 216 ~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 216 G----------SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred C----------CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 1112233345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.99 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=196.8
Q ss_pred ccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecC
Q 002250 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSE 714 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 714 (947)
+.||+|+||.||+|...+++.||+|.+.... .......+.+|++++++++||||+++++++...
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~----------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 64 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTL----------------PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK 64 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccC----------------CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Confidence 4689999999999997779999999873211 012345788999999999999999999999999
Q ss_pred CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccc
Q 002250 715 DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA 794 (947)
Q Consensus 715 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 794 (947)
...++||||+++++|.+++... ...+++.....++.+++.|++||| +++++||||+|+||+++.++.++|+|||.+
T Consensus 65 ~~~~~v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~ 140 (251)
T cd05041 65 QPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMS 140 (251)
T ss_pred CCeEEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeecccc
Confidence 9999999999999999999763 235788999999999999999999 899999999999999999999999999999
Q ss_pred eecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhccccccc
Q 002250 795 KIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSM 873 (947)
Q Consensus 795 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 873 (947)
................++..|+|||++.++.++.++|+||||+++|||+| |..||.... ........ .....
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~--~~~~~~~~----~~~~~- 213 (251)
T cd05041 141 REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS--NQQTRERI----ESGYR- 213 (251)
T ss_pred ccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC--HHHHHHHH----hcCCC-
Confidence 75542221111112234567999999988889999999999999999999 788874321 11111111 11000
Q ss_pred cccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 874 LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 874 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
...+...+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 214 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 214 --------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred --------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 11122345578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=306.10 Aligned_cols=240 Identities=23% Similarity=0.350 Sum_probs=185.1
Q ss_pred ccccccCceeEEEEEeCC-------------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 635 NLIGKGGSGNVYKVVLNS-------------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
+.||+|+||.||+|+..+ ...||+|++... .......+.+|+.+++.++|
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----------------~~~~~~~~~~~~~~l~~l~h 63 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-----------------HRDISLAFFETASMMRQVSH 63 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-----------------hhhHHHHHHHHHHHHHhCCC
Confidence 468999999999998542 225888876311 11234568889999999999
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
|||+++++++..+...++||||+++|+|..++... ...+++..+..++.|+++||+||| +.+|+||||||+||+++
T Consensus 64 p~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~ 139 (262)
T cd05077 64 KHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLA 139 (262)
T ss_pred CCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEe
Confidence 99999999999999999999999999999888753 345889999999999999999999 89999999999999998
Q ss_pred CCCC-------eEEeccccceecccCCCCcceecccccccccCccccc-cCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 002250 782 LEWK-------PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-TCKINEKSDVYSFGVVLMELVT-GKRPIVPE 852 (947)
Q Consensus 782 ~~~~-------~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~ 852 (947)
.++. ++++|||++...... ....++..|+|||++. ...++.++|||||||++|||++ |..||...
T Consensus 140 ~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 140 REGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred cCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 7654 899999998654322 1235788999999886 4568899999999999999984 77776422
Q ss_pred CCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
...+.. ........ ........+.+++.+||+.||.+||++.++++.++
T Consensus 214 -----~~~~~~-~~~~~~~~-----------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 214 -----TLAEKE-RFYEGQCM-----------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -----chhHHH-HHHhcCcc-----------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111110 00000000 01112346789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.70 Aligned_cols=258 Identities=25% Similarity=0.364 Sum_probs=201.3
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|.+...||+|++|.||+|... +++.||+|.+........ .........+.+.+|+.++++++||||++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~--------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 72 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSAS--------SKDRKRSMLDALAREIALLKELQHENIVQYL 72 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccc--------hhHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 3677889999999999999864 688999998853322110 0111112235788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++++|.+++... ..+++.....++.|++.|++||| +.+++||||+|+||++++++.++|
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 73 GSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred EEEEeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEe
Confidence 9999999999999999999999999864 45788888999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCC----cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 789 ADFGLAKIVQTGEAG----DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
+|||.++........ .......|+..|+|||.+.+..++.++||||+|+++|||++|+.||.... . .....
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~-~~~~~ 222 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT----Q-LQAIF 222 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc----H-HHHHH
Confidence 999999766432111 11123457889999999998889999999999999999999999985321 1 11111
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.... ...+..+...+..+.+++.+||+.||.+||++.|+++
T Consensus 223 ~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 KIGE----------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHhc----------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 1112223344567888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=304.63 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=198.8
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+.|++.+.||+|+||.||++.. .++.||+|.+... .....+.+|+.++++++|||+++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-------------------~~~~~~~~e~~~l~~~~~~~i~~~~ 65 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-------------------VTAQAFLEETAVMTKLHHKNLVRLL 65 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc-------------------chHHHHHHHHHHHHhCCCCCcCeEE
Confidence 5688899999999999999975 4788999987311 1235788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..+ ..++||||+++++|.+++.......+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|
T Consensus 66 ~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl 141 (254)
T cd05083 66 GVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKV 141 (254)
T ss_pred EEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEE
Confidence 998764 5799999999999999998765566899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.+....... .....+..|+|||++.++.++.++|+||||+++|||++ |+.||... +..+.....
T Consensus 142 ~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-----~~~~~~~~~- 210 (254)
T cd05083 142 SDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-----SLKEVKECV- 210 (254)
T ss_pred CCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC-----CHHHHHHHH-
Confidence 9999997543321 12234568999999988889999999999999999998 88888432 111111111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
..... .+.....+..+.+++.+|++.+|++||+++++++.|++
T Consensus 211 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 211 EKGYR---------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred hCCCC---------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11110 01112334668899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=314.11 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=199.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~~ 67 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----------------AEDEIEDIQQEITVLSQCDSPYITRY 67 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----------------chHHHHHHHHHHHHHHcCCCCccHhh
Confidence 45667788999999999999865 67899999873110 11234578899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..+...++||||+++++|.+++.. ..+++..+..++.|++.|++||| +.+++|+||+|+||++++++.++
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~ 141 (277)
T cd06642 68 YGSYLKGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVK 141 (277)
T ss_pred hcccccCCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEE
Confidence 9999999999999999999999999865 45788999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
++|||++........ ......|+..|+|||++.+..++.++||||||+++|||++|+.||..... .......
T Consensus 142 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-----~~~~~~~- 213 (277)
T cd06642 142 LADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-----MRVLFLI- 213 (277)
T ss_pred EccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-----hhHHhhh-
Confidence 999999976543221 11234578899999999988899999999999999999999999843211 0111100
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.....+......+..+.+++.+|++.+|++||+|.+++++
T Consensus 214 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 214 ---------PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---------hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0011112223445678899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.00 Aligned_cols=261 Identities=24% Similarity=0.326 Sum_probs=206.1
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|... +++.||+|++... ........+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~~i~~~ 68 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG----------------AKSSVRKQILRELQIMHECRSPYIVSF 68 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec----------------CcchHHHHHHHHHHHHHHcCCCCcceE
Confidence 56888899999999999999955 6889999987321 112234678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++...+..++||||+++++|.+++... ..+++.....++.+++.|+.|||+ ..+++||||+|+||++++++.++
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~ 144 (284)
T cd06620 69 YGAFLNENNICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIK 144 (284)
T ss_pred eeeEecCCEEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEE
Confidence 99999999999999999999999998763 358899999999999999999994 36899999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC------cccHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD------SKDIVN 861 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~------~~~~~~ 861 (947)
|+|||++....... .....|+..|+|||++.++.++.++|||||||++|||++|+.||...... ...+.+
T Consensus 145 l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd06620 145 LCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220 (284)
T ss_pred EccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH
Confidence 99999986543221 12346899999999998888999999999999999999999999643321 111112
Q ss_pred HHHhhccccccccccccCCCCccC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEIL-KEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
+........ ..... .+.+..+.+++.+|++.||++|||+.|++++..-++.+
T Consensus 221 ~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 221 LLQQIVQEP----------PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred HHHHHhhcc----------CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 221111111 11111 12456788999999999999999999999975544444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=320.77 Aligned_cols=198 Identities=24% Similarity=0.316 Sum_probs=170.6
Q ss_pred HHhhccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-cc-
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HV- 702 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~- 702 (947)
.+..+|.+.+.||+|+||.|-||. .++++.||||+++- ......+-..|+.+|..++ |.
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN------------------~k~f~~Q~~~Ei~iL~~ln~~d~ 244 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN------------------KKRFLRQAQIEIRILELLNKHDP 244 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc------------------ChHHHHHHHHHHHHHHHHhccCC
Confidence 334588999999999999999999 45799999999831 1122344567999999997 53
Q ss_pred ----ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 703 ----NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 703 ----niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
|+|+++++|...++.|||+|.+ .-+|.++++......++......++.||+.||.+|| +.+|||+||||+||
T Consensus 245 ~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENI 320 (586)
T KOG0667|consen 245 DDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENI 320 (586)
T ss_pred CCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhhe
Confidence 8999999999999999999999 569999999988888999999999999999999999 89999999999999
Q ss_pred EecCC--CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 002250 779 LLDLE--WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 779 ll~~~--~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
|+.+- ..+||+|||.|.+...... ..+-+..|.|||++.+.+|+.+.||||||||++||++|.+-|.
T Consensus 321 LL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 321 LLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred eeccCCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 99743 4799999999987655432 2345788999999999999999999999999999999966653
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.08 Aligned_cols=264 Identities=23% Similarity=0.258 Sum_probs=196.1
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
.+.++|+..+.||+|+||.||+|... .++.||||++.... ........+.+|+.+++.++||||
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~ni 78 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---------------QNQTHAKRAYRELVLMKCVNHKNI 78 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc---------------cChHHHHHHHHHHHHHHHhCCCch
Confidence 45689999999999999999999854 68999999884211 111234567789999999999999
Q ss_pred ceEEEEEecCC------ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 705 VKLYCSITSED------SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 705 v~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++++++.... ..++||||+++ ++.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||
T Consensus 79 v~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Ni 150 (355)
T cd07874 79 ISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNI 150 (355)
T ss_pred hceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHE
Confidence 99999886543 46899999965 67776653 4788888999999999999999 89999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
+++.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 151 ll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~ 226 (355)
T cd07874 151 VVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQ 226 (355)
T ss_pred EECCCCCEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHH
Confidence 999999999999999976543221 2234689999999999988899999999999999999999999853210 000
Q ss_pred HHHHH------------------HhhccccccccccccC-----CC----CccCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 002250 859 IVNWV------------------YSKMDSRDSMLTVVDP-----NI----SEILKEDALKVLRIAIHCTNKLPAFRPSMR 911 (947)
Q Consensus 859 ~~~~~------------------~~~~~~~~~~~~~~d~-----~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 911 (947)
..... ...............+ .. ..........+.+++.+|++.||++|||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ 306 (355)
T cd07874 227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306 (355)
T ss_pred HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHH
Confidence 00000 0000000000000000 00 111112345678999999999999999999
Q ss_pred HHHHH
Q 002250 912 VVVQM 916 (947)
Q Consensus 912 ev~~~ 916 (947)
|++++
T Consensus 307 ell~h 311 (355)
T cd07874 307 EALQH 311 (355)
T ss_pred HHhcC
Confidence 99985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.86 Aligned_cols=243 Identities=24% Similarity=0.274 Sum_probs=191.1
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccceEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVKLY 708 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~ 708 (947)
|+..+.||+|+||+||+|+.+ +|+.||||++... ..........+..|+.+++.+. |++|++++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~ 67 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD--------------VVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--------------HhhhhhHHHHHHHHHHHHHhccCCCchhhee
Confidence 567789999999999999965 6899999998311 0111233456778899998886 57788899
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 68 ~~~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL 142 (323)
T cd05615 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred eEEecCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEE
Confidence 9999999999999999999999999764 35889999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..........
T Consensus 143 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~~~~~~i~~ 215 (323)
T cd05615 143 ADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-----EDELFQSIME 215 (323)
T ss_pred eccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh
Confidence 99999875432221 1223468999999999998889999999999999999999999985321 1111111111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
... ..+......+.+++.+|++.+|.+|++.
T Consensus 216 ~~~-----------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 216 HNV-----------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCC-----------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111 1112233467889999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=317.49 Aligned_cols=265 Identities=18% Similarity=0.241 Sum_probs=194.1
Q ss_pred Cccccccc--CceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 633 PENLIGKG--GSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 633 ~~~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
+.+.||+| +||+||++..+ +|+.||||++.... ........+++|+++++.++||||+++++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~hpniv~~~~ 66 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA---------------CTNEMVTFLQGELHVSKLFNHPNIVPYRA 66 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhh---------------ccHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 45789999 78999999854 78999999983211 01122356778999999999999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
++..++..++||||+++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~ 143 (327)
T cd08227 67 TFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLS 143 (327)
T ss_pred EEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEc
Confidence 9999999999999999999999997654456899999999999999999999 8999999999999999999999999
Q ss_pred ccccceecccCCC-----CcceecccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 790 DFGLAKIVQTGEA-----GDLTHVIAGTHGYIAPEYAYT--CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 790 DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
|||.+........ ........++..|+|||++.. ..++.++|||||||++|||++|+.||...... ......
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~ 222 (327)
T cd08227 144 GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT-QMLLEK 222 (327)
T ss_pred ccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh-HHHHHH
Confidence 9986543221110 011122356778999999875 35889999999999999999999999532110 001000
Q ss_pred HHhhcccc---------c----ccccccc------------------CCCCccCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 002250 863 VYSKMDSR---------D----SMLTVVD------------------PNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911 (947)
Q Consensus 863 ~~~~~~~~---------~----~~~~~~d------------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 911 (947)
........ . ......+ ....+........+.+++.+|++.||++|||+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 302 (327)
T cd08227 223 LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAS 302 (327)
T ss_pred hcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHH
Confidence 00000000 0 0000000 000112223455788999999999999999999
Q ss_pred HHHHH
Q 002250 912 VVVQM 916 (947)
Q Consensus 912 ev~~~ 916 (947)
|++++
T Consensus 303 ell~~ 307 (327)
T cd08227 303 TLLNH 307 (327)
T ss_pred HHhcC
Confidence 99863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=325.87 Aligned_cols=262 Identities=20% Similarity=0.247 Sum_probs=195.1
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|+||.||+|... +++.||||++.... ........+.+|+++++.++||||++++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~niv~~~ 65 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---------------QNLVSCKRVFRELKMLCFFKHDNVLSAL 65 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc---------------cchHHHHHHHHHHHHHHhCCCCCcCCHh
Confidence 3678899999999999999964 78999999873110 0112235678999999999999999999
Q ss_pred EEEecCC-----ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 709 CSITSED-----SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 709 ~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
+++..++ ..|+||||+. ++|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 66 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~ 139 (372)
T cd07853 66 DILQPPHIDPFEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSN 139 (372)
T ss_pred heecCCCccccceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCC
Confidence 9998876 7899999996 578888765 345889999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||+++........ ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||..... .+....
T Consensus 140 ~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~ 216 (372)
T cd07853 140 CVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP--IQQLDL 216 (372)
T ss_pred CCEEeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH--HHHHHH
Confidence 99999999999865433221 12234578999999998764 478999999999999999999999954321 011110
Q ss_pred HHhhcc-------------------ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMD-------------------SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~-------------------~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+..... ........ ..............+.+++.+|++.||++|||+.|++++
T Consensus 217 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 217 ITDLLGTPSLEAMRSACEGARAHILRGPHKPPS-LPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCc-hHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 00000000 000001112234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.85 Aligned_cols=258 Identities=20% Similarity=0.255 Sum_probs=196.8
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+++.. +++.||+|++... ..........+.+|+.++..++|++|+++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~~~~~~i~~l 66 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--------------EMLKRAETACFREERNVLVNGDCQWITTL 66 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH--------------HHHhhHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 46888999999999999999965 6889999988310 01112234567889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..|+||||+++|+|.+++... ...+++.....++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 67 ~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~k 142 (331)
T cd05624 67 HYAFQDENYLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIR 142 (331)
T ss_pred EEEEEcCCEEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEE
Confidence 99999999999999999999999999863 235788888899999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-----CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
|+|||++......... ......||+.|+|||++.. +.++.++|||||||++|||++|+.||... +..+.
T Consensus 143 l~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-----~~~~~ 216 (331)
T cd05624 143 LADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVET 216 (331)
T ss_pred EEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC-----CHHHH
Confidence 9999999765443221 1223569999999999865 46788999999999999999999999532 12222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAF--RPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~ 916 (947)
.......... ..++....+....+.+++.+|+..++.+ |+++.++.++
T Consensus 217 ~~~i~~~~~~------~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 217 YGKIMNHEER------FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHcCCCc------ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1111111110 0111222223456777888888866544 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=313.72 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=198.9
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|+||.||+|... ++..+|+|.+.... .......+.+|++++++++||||++++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 65 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----------------KPAIRNQIIRELKVLHECNSPYIVGFY 65 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc----------------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 5888999999999999999965 68889999873110 112235678899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++++|.++++.. ..+++.....++.|+++||+|||+ ..+++||||||+||+++.++.++|
T Consensus 66 ~~~~~~~~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l 141 (308)
T cd06615 66 GAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKL 141 (308)
T ss_pred EEEeeCCEEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEE
Confidence 9999999999999999999999999864 457888899999999999999993 258999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||++....... .....|+..|+|||++.+..++.++||||||+++|||++|+.||.... ......+......
T Consensus 142 ~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~ 215 (308)
T cd06615 142 CDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVS 215 (308)
T ss_pred ccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccc
Confidence 9999987543322 123468899999999988889999999999999999999999985321 1111111110000
Q ss_pred cccc-----------------------ccccccCCCCccC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 869 SRDS-----------------------MLTVVDPNISEIL-KEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 869 ~~~~-----------------------~~~~~d~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... .........+..+ ......+.+++.+|++.+|++|||+.|++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0000000000000 0134568899999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.87 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=215.4
Q ss_pred HHHhhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
..+..-|...+.||+|.|++|-.|++ -+|..||||++..- .........+..|++.|+.++|||
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKT---------------KlD~~st~hlfqEVRCMKLVQHpN 78 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKT---------------KLDTLSTGHLFQEVRCMKLVQHPN 78 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccc---------------ccchhhhhHHHHHHHHHHHhcCcC
Confidence 44567788899999999999999994 47999999999321 122234456778999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec-C
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD-L 782 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~-~ 782 (947)
||++|++...+...|+|+|.=++|+|.||+-+. ...+.+....+++.||+.|+.|+| ...+|||||||+||.+- .
T Consensus 79 iVRLYEViDTQTKlyLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEK 154 (864)
T KOG4717|consen 79 IVRLYEVIDTQTKLYLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEK 154 (864)
T ss_pred eeeeeehhcccceEEEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeee
Confidence 999999999999999999999999999999874 345788888999999999999999 78899999999999775 5
Q ss_pred CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCC-CccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKIN-EKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
-|-+||+|||++..+.+++.. ...+|...|.|||++.+..|+ +++||||+||++|-+++|+.||... +-.+
T Consensus 155 lGlVKLTDFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA-----NDSE 226 (864)
T KOG4717|consen 155 LGLVKLTDFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA-----NDSE 226 (864)
T ss_pred cCceEeeeccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc-----cchh
Confidence 688999999999877666543 345899999999999999998 5789999999999999999999422 1122
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HhhccCCCCcce
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ--MLEEAEPCSVTN 927 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~--~L~~~~~~~~~~ 927 (947)
.+...++... ..+.....++.++|..|+..||.+|.+..||+. .|+...+.+.++
T Consensus 227 TLTmImDCKY-----------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~ 283 (864)
T KOG4717|consen 227 TLTMIMDCKY-----------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA 283 (864)
T ss_pred hhhhhhcccc-----------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcccc
Confidence 2222233222 245566778899999999999999999999984 466666666554
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.04 Aligned_cols=257 Identities=22% Similarity=0.320 Sum_probs=200.8
Q ss_pred hccCCcccccccCceeEEEEEeCC----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|.+.+.||+|+||.||+|...+ ...||||...... .....+.+.+|+.++++++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~----------------~~~~~~~~~~e~~~l~~~~h~~i 69 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT----------------SPSVREKFLQEAYIMRQFDHPHI 69 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC----------------CHHHHHHHHHHHHHHHhCCCCch
Confidence 457788999999999999998643 3468999873211 01234578899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++.. ...++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++
T Consensus 70 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~ 144 (270)
T cd05056 70 VKLIGVITE-NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPD 144 (270)
T ss_pred hceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCC
Confidence 999999875 45789999999999999997643 35899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 863 (947)
.++++|||+++........... ...++..|+|||.+....++.++||||||+++||+++ |..||..... .+.....
T Consensus 145 ~~~l~d~g~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~~~ 221 (270)
T cd05056 145 CVKLGDFGLSRYLEDESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--NDVIGRI 221 (270)
T ss_pred CeEEccCceeeecccccceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHH
Confidence 9999999999865443221111 2234568999999988889999999999999999996 9999853321 1111111
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
... .. ...+...+..+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 222 ---~~~-~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 222 ---ENG-ER---------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---HcC-Cc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111 10 01122345578889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=316.14 Aligned_cols=196 Identities=25% Similarity=0.387 Sum_probs=159.0
Q ss_pred cccccccCceeEEEEEeC---CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEE
Q 002250 634 ENLIGKGGSGNVYKVVLN---SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 710 (947)
.++||+|+||+||+|+.. +++.||+|.+... .....+.+|+.++++++||||++++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-------------------~~~~~~~~E~~~l~~l~h~niv~~~~~ 66 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-------------------GISMSACREIALLRELKHPNVISLQKV 66 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC-------------------CCcHHHHHHHHHHHhcCCCCCcceeee
Confidence 467999999999999864 4678999988311 123456789999999999999999999
Q ss_pred Eec--CCccEEEEeccCCCChHHHhhhc-------CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe-
Q 002250 711 ITS--EDSNLLVYEYLPNGSLWDRLHTC-------HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL- 780 (947)
Q Consensus 711 ~~~--~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll- 780 (947)
+.. +...++||||++ ++|.+++... ....+++.....++.|++.||+||| +.+|+||||||+||++
T Consensus 67 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~ 142 (317)
T cd07868 67 FLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVM 142 (317)
T ss_pred EecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEe
Confidence 865 445789999995 5888887532 1235888899999999999999999 8999999999999999
Q ss_pred ---cCCCCeEEeccccceecccCCCC-cceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 002250 781 ---DLEWKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 781 ---~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
+.++.+||+|||+|+........ .......||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 143 ~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 143 GEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 45678999999999865433211 122345689999999998764 5889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.20 Aligned_cols=262 Identities=21% Similarity=0.280 Sum_probs=196.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|.+.+.||+|+||.||+|+.. +++.||+|.+.... .......+.+|+.++++++||||+++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~nI~~~ 69 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH----------------EEGAPCTAIREVSLLKDLKHANIVTL 69 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc----------------ccCchhHHHHHHHHHHhcCCCCcceE
Confidence 57888999999999999999965 68899999884221 11223456789999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||++ ++|.+++... ...+++.....++.|++.||+||| +.+|+||||||+||+++.++.++
T Consensus 70 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~k 144 (301)
T cd07873 70 HDIIHTEKSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELK 144 (301)
T ss_pred EEEEecCCeEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEE
Confidence 999999999999999996 5899888764 335788899999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||++........ ......+++.|+|||++.+. .++.++|||||||++|||++|+.||.... ..+........
T Consensus 145 l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~--~~~~~~~~~~~ 220 (301)
T cd07873 145 LADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST--VEEQLHFIFRI 220 (301)
T ss_pred ECcCcchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHH
Confidence 999999975433221 11233568899999988654 47889999999999999999999985331 11111111111
Q ss_pred ccc--cccccccc------cCCCC--------ccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 867 MDS--RDSMLTVV------DPNIS--------EILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 867 ~~~--~~~~~~~~------d~~~~--------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
... ...+.... ....+ .........+.+++.+|++.||.+|||+.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 221 LGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 100 00000000 00001 111123446788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=306.12 Aligned_cols=253 Identities=18% Similarity=0.269 Sum_probs=185.3
Q ss_pred cccccCceeEEEEEeCCCc---EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEe
Q 002250 636 LIGKGGSGNVYKVVLNSGK---ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSIT 712 (947)
Q Consensus 636 ~iG~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 712 (947)
.||+|+||+||+|...++. .+++|.+... ........+.+|+.+++.++||||+++++++.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----------------~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 65 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----------------ASSKEQNEFLQQGDPYRILQHPNILQCLGQCV 65 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC----------------CChHHHHHHHHHHHHHhccCCcchhheEEEec
Confidence 5899999999999854433 4566665211 11123467889999999999999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcC--CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEec
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCH--KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 790 (947)
.....++||||+++|+|.++++... ....++.....++.|++.||+||| +.+++||||||+||+++.++.++|+|
T Consensus 66 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~D 142 (268)
T cd05086 66 EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGD 142 (268)
T ss_pred CCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecc
Confidence 9999999999999999999998642 234667778889999999999999 88999999999999999999999999
Q ss_pred cccceecccCCCCcceecccccccccCcccccc-------CCCCCccchHHHHHHHHHHHhC-CCCCCCCCCCcccHHHH
Q 002250 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-------CKINEKSDVYSFGVVLMELVTG-KRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 791 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~elltg-~~p~~~~~~~~~~~~~~ 862 (947)
||++................++..|+|||++.. ..++.++||||||+++|||+++ ..||... . . .+.
T Consensus 143 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~-~---~~~ 217 (268)
T cd05086 143 YGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-S-D---REV 217 (268)
T ss_pred cccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-C-H---HHH
Confidence 999864322211111223467889999998753 2357789999999999999984 5676321 1 1 111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
......... ....++.+... ....+.+++..|| .+|++||++.++++.|.
T Consensus 218 ~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 218 LNHVIKDQQ--VKLFKPQLELP---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHhhcc--cccCCCccCCC---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111111111 12222332221 2345677888999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=310.49 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=201.2
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|+..+.||.|++|.||+|+.. +++.||+|++... ........+.+|++++++++|+||+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 64 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE----------------EAEDEIEDIQQEIQFLSQCRSPYITKY 64 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecc----------------ccchHHHHHHHHHHHHHHcCCCCeeee
Confidence 36788899999999999999965 6899999988311 112334568899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.++...++|+||+++++|.+++... .+++.....++.|++.|++||| +.+++||||+|+||++++++.++
T Consensus 65 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~ 138 (274)
T cd06609 65 YGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVK 138 (274)
T ss_pred eEEEEECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999863 6899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||+++....... ......+++.|+|||++.+..++.++||||||+++|||++|+.||.... .........
T Consensus 139 l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-----~~~~~~~~~ 211 (274)
T cd06609 139 LADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-----PMRVLFLIP 211 (274)
T ss_pred Ecccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-----hHHHHHHhh
Confidence 999999987654321 1223467889999999998889999999999999999999999985321 111111110
Q ss_pred cccccccccccCCCCccCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKE-DALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. ..+..... .+..+.+++.+|+..+|++|||+.+++++
T Consensus 212 ~~----------~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 212 KN----------NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred hc----------CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00 00111111 34568889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.56 Aligned_cols=263 Identities=27% Similarity=0.363 Sum_probs=203.3
Q ss_pred hccCCcccccccCceeEEEEEeC-----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.|+..+.||+|+||.||+|... +++.||||++..... ......+.+|+++++.++|||
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~----------------~~~~~~~~~ei~~l~~l~~~~ 67 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE----------------EQHRSDFEREIEILRTLDHEN 67 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc----------------hHHHHHHHHHHHHHHhCCCCC
Confidence 45777899999999999999854 367899999842210 023467899999999999999
Q ss_pred cceEEEEEec--CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 704 VVKLYCSITS--EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 704 iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
|+++++++.. +...++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++
T Consensus 68 i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~ 143 (284)
T cd05038 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVE 143 (284)
T ss_pred hheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEc
Confidence 9999999887 557899999999999999998743 35899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCCC-cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc--
Q 002250 782 LEWKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD-- 858 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~-- 858 (947)
.++.++|+|||.+......... .......++..|+|||...+..++.++||||||+++|||++|+.|+.........
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~ 223 (284)
T cd05038 144 SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI 223 (284)
T ss_pred CCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccc
Confidence 9999999999999876533221 1111223456799999998888999999999999999999999997543211100
Q ss_pred -------HHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 859 -------IVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 859 -------~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.............. ......++..+.+++.+|++.+|++||||.|++++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 224 GIAQGQMIVTRLLELLKEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccccccccHHHHHHHHHcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00001111111100 111223446789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=322.62 Aligned_cols=264 Identities=21% Similarity=0.243 Sum_probs=195.7
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
.+.++|++.+.||+|+||.||+|... .++.||||++.... ........+.+|+.+++.++||||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~i 85 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---------------QNQTHAKRAYRELVLMKCVNHKNI 85 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc---------------cCchhHHHHHHHHHHHHhcCCCCc
Confidence 35688999999999999999999955 68899999984211 111234567789999999999999
Q ss_pred ceEEEEEecC------CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 705 VKLYCSITSE------DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 705 v~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++++++... ...|+||||+++ ++.+++.. .+++..+..++.|++.||+||| +++|+||||||+||
T Consensus 86 i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NI 157 (364)
T cd07875 86 IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNI 157 (364)
T ss_pred cccceeecccccccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHE
Confidence 9999987653 346999999964 77777753 3788889999999999999999 89999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
+++.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 158 ll~~~~~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~ 233 (364)
T cd07875 158 VVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQ 233 (364)
T ss_pred EECCCCcEEEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHH
Confidence 999999999999999976543221 2234689999999999998999999999999999999999999953210 000
Q ss_pred HHHHHH------------------hhcccccccc-----ccc----cCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 002250 859 IVNWVY------------------SKMDSRDSML-----TVV----DPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911 (947)
Q Consensus 859 ~~~~~~------------------~~~~~~~~~~-----~~~----d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 911 (947)
...... .......... ... -+............+.+++.+|++.||.+|||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~ 313 (364)
T cd07875 234 WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313 (364)
T ss_pred HHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHH
Confidence 000000 0000000000 000 0000111111234678999999999999999999
Q ss_pred HHHHH
Q 002250 912 VVVQM 916 (947)
Q Consensus 912 ev~~~ 916 (947)
|++++
T Consensus 314 e~L~h 318 (364)
T cd07875 314 EALQH 318 (364)
T ss_pred HHhcC
Confidence 99875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=310.81 Aligned_cols=254 Identities=29% Similarity=0.423 Sum_probs=196.6
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
|++.+.||+|+||+||+|+.. +++.||+|++..... .........+|+.++++++||||+++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~---------------~~~~~~~~~~e~~~~~~l~~~~i~~~~~ 65 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI---------------EEEEREENIREIKILRRLRHPNIVQILD 65 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH---------------HHHHHHHHHHHHHHHHHHTBTTBCHEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc---------------cccccchhhhhhhccccccccccccccc
Confidence 567889999999999999976 567899999842210 0011123345999999999999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
++..+...++||||+++++|.+++.. ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++|+
T Consensus 66 ~~~~~~~~~~v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~ 140 (260)
T PF00069_consen 66 VFQDDNYLYIVMEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLI 140 (260)
T ss_dssp EEEESSEEEEEEEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEES
T ss_pred cccccccccccccccccccccccccc--cccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence 99999999999999999999999983 345799999999999999999999 7899999999999999999999999
Q ss_pred ccccceecccCCCCcceecccccccccCccccc-cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
|||.+..... .........++..|+|||++. ...++.++||||+|+++|+|++|..||... ...+..........
T Consensus 141 Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~--~~~~~~~~~~~~~~ 216 (260)
T PF00069_consen 141 DFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES--NSDDQLEIIEKILK 216 (260)
T ss_dssp SGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS--SHHHHHHHHHHHHH
T ss_pred cccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccc--cchhhhhhhhhccc
Confidence 9999976411 122233456899999999998 788999999999999999999999998543 11111111111111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.... .... ........+.+++.+|++.||++||++.++++
T Consensus 217 ~~~~------~~~~-~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 217 RPLP------SSSQ-QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp THHH------HHTT-SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccc------cccc-ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000 00011267999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=306.60 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=200.4
Q ss_pred ccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
+|+..+.||+|+||+||+|...+++.+|||.+....... .........+.+|++++++++|+||+++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~-----------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 69 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV-----------LAAEKEYEKLQEEVDLLKSLKHVNIVQYLG 69 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccch-----------hhHHHHHHHHHHHHHHHHhcCCCCEeeEee
Confidence 477889999999999999998889999999884321100 001122356889999999999999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
++.+.+..++||||+++++|.+++.+. ..+++.....++.|++.|++||| +.+|+|+||+|+||++++++.++|+
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~ 144 (265)
T cd06631 70 TCLDDNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLI 144 (265)
T ss_pred EeecCCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEec
Confidence 999999999999999999999999764 34788889999999999999999 8899999999999999999999999
Q ss_pred ccccceecccCCC----CcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 790 DFGLAKIVQTGEA----GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 790 DfG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
|||.+........ ........|+..|+|||+..+..++.++||||||+++|||++|+.||.... ...... .
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~-~ 219 (265)
T cd06631 145 DFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD----RLAAMF-Y 219 (265)
T ss_pred cchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC----hHHHHH-H
Confidence 9999875432111 111223458899999999998889999999999999999999999985321 111111 1
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
...... ..+..+......+.+++.+|++.+|++||++.|+++
T Consensus 220 ~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 220 IGAHRG--------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhhccC--------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 100000 011122234556788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=308.11 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=202.2
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
..|+..+.||.|+||.||+|... +++.||||++... ........+.+|++++++++||||+++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 67 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE----------------EAEDEIEDIQQEITVLSQCDSPYVTKY 67 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc----------------ccHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 45777888999999999999965 6889999987311 111234678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..+...++||||+++++|.+++.. ..+++.....++.|++.|++|+| +.+++|+||+|+||+++.++.++
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~ 141 (277)
T cd06640 68 YGSYLKGTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVK 141 (277)
T ss_pred EEEEEECCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEE
Confidence 9999999999999999999999999875 35788888999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
++|||++........ ......++..|+|||++.+..++.++|+|||||++|||++|+.||..... ...... .
T Consensus 142 l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-----~~~~~~-~ 213 (277)
T cd06640 142 LADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP-----MRVLFL-I 213 (277)
T ss_pred EcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh-----HhHhhh-h
Confidence 999999976543321 12234578899999999888899999999999999999999999853211 111100 0
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.....+......+..+.+++.+||+.+|++||++.+++++
T Consensus 214 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 214 ---------PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---------hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0011133445567789999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=340.25 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=199.0
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+...++|.+.+.||+|+||+||+|+.. +++.||+|.+.... ........+..|+.++++++|||
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~---------------l~e~~~~~~~~EI~IL~~L~HPN 73 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG---------------LKEREKSQLVIEVNVMRELKHKN 73 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc---------------cCHHHHHHHHHHHHHHHHcCCCC
Confidence 344578999999999999999999965 57889999884221 11123456889999999999999
Q ss_pred cceEEEEEec--CCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCC----CCCeEeccCCC
Q 002250 704 VVKLYCSITS--EDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGF----DRPVIHRDVKS 775 (947)
Q Consensus 704 iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~----~~~ivH~Dlkp 775 (947)
||+++++|.. ....|+||||+++|+|.+++... ....+++..++.|+.||+.||+|||... ..+||||||||
T Consensus 74 IVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKP 153 (1021)
T PTZ00266 74 IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKP 153 (1021)
T ss_pred cCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcH
Confidence 9999998855 35578999999999999999763 2346899999999999999999999421 14699999999
Q ss_pred CCeEecC-----------------CCCeEEeccccceecccCCCCcceecccccccccCcccccc--CCCCCccchHHHH
Q 002250 776 SNILLDL-----------------EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT--CKINEKSDVYSFG 836 (947)
Q Consensus 776 ~NIll~~-----------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG 836 (947)
+|||++. .+.+||+|||++........ .....||+.|+|||++.. ..++.++||||||
T Consensus 154 eNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG 230 (1021)
T PTZ00266 154 QNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230 (1021)
T ss_pred HHeEeecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHH
Confidence 9999964 23489999999976543221 223468999999999854 4588999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHH--
Q 002250 837 VVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVV-- 914 (947)
Q Consensus 837 v~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~-- 914 (947)
|++|||++|+.||... ......... +..... ++ ....+..+.+++..||+.+|.+||++.|++
T Consensus 231 ~ILYELLTGk~PF~~~----~~~~qli~~-lk~~p~--------lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 231 CIIYELCSGKTPFHKA----NNFSQLISE-LKRGPD--------LP--IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHHHHHCCCCCCcC----CcHHHHHHH-HhcCCC--------CC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 9999999999998532 122222111 111110 00 012245688999999999999999999998
Q ss_pred HHhhcc
Q 002250 915 QMLEEA 920 (947)
Q Consensus 915 ~~L~~~ 920 (947)
..++..
T Consensus 296 ~~ik~i 301 (1021)
T PTZ00266 296 QIIKNV 301 (1021)
T ss_pred HHHhhc
Confidence 445433
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.13 Aligned_cols=258 Identities=26% Similarity=0.351 Sum_probs=204.2
Q ss_pred HhhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
..++|++.+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.+++.++||||+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~~~~~e~~~l~~~~h~~i~ 79 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ-----------------QQPKKELIINEILVMRENKNPNIV 79 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC-----------------ccchHHHHHHHHHHHHhCCCCCEe
Confidence 347899999999999999999995 47999999988321 112345678999999999999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..++..++||||+++++|.+++.+ ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~ 153 (297)
T cd06656 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGS 153 (297)
T ss_pred eEEEEEecCCEEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCC
Confidence 999999999999999999999999999875 34788899999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
++|+|||.+......... .....+++.|+|||...+..++.++|||||||++|||++|+.||....... ....
T Consensus 154 ~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-----~~~~ 226 (297)
T cd06656 154 VKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYL 226 (297)
T ss_pred EEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-----heee
Confidence 999999999765433221 123468899999999988889999999999999999999999995322110 0000
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HhhccCC
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ--MLEEAEP 922 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~--~L~~~~~ 922 (947)
..... ......+......+.+++.+|++.+|++||++.++++ .++..++
T Consensus 227 ~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 227 IATNG--------TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred eccCC--------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 00000 0001112234456788999999999999999999997 4444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=304.91 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=201.3
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|+..+.||+|+||.||+|... +++.+|+|.+... ...+.+.+|++++++++||||+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------------------~~~~~~~~e~~~~~~l~~~~i~~~ 63 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------------------EDLQEIIKEISILKQCDSPYIVKY 63 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------------------HHHHHHHHHHHHHHhCCCCcEeee
Confidence 57888999999999999999976 4889999987311 115689999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..+...|+++||+++++|.+++... ...+++.....++.|++.|++||| ..+++||||+|+||+++.++.++
T Consensus 64 ~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~ 139 (256)
T cd06612 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAK 139 (256)
T ss_pred eeeeecCCcEEEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEE
Confidence 99999999999999999999999999753 346899999999999999999999 88999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||.+........ ......++..|+|||++.+..++.++||||||+++|||++|+.||...... +......
T Consensus 140 l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-----~~~~~~~ 212 (256)
T cd06612 140 LADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-----RAIFMIP 212 (256)
T ss_pred EcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-----hhhhhhc
Confidence 999999986544321 122345788999999998888999999999999999999999998532111 0000000
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.. ..............+.+++.+|++.+|++|||+.|+++
T Consensus 213 ~~--------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 213 NK--------PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cC--------CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00 00001112233456889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=310.33 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=200.1
Q ss_pred hccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.+|+..+.||.|++|.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~iv~~ 81 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-----------------KQPKKELIINEILVMKELKNPNIVNF 81 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc-----------------cCchHHHHHHHHHHHHhcCCCceeee
Confidence 5688889999999999999985 47899999988311 11234567899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++|+||+++++|.+++.. ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~k 155 (296)
T cd06655 82 LDSFLVGDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVK 155 (296)
T ss_pred eeeEecCceEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999999875 35799999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||++......... .....++..|+|||.+.+..++.++|||||||++|||++|+.||..... .+......
T Consensus 156 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-----~~~~~~~~ 228 (296)
T cd06655 156 LTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALYLIA 228 (296)
T ss_pred EccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Confidence 9999998765433221 1234688999999999888899999999999999999999999854321 11111111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.... .....+......+.+++.+||..||++||++.++++
T Consensus 229 ~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 229 TNGT--------PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred hcCC--------cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1000 001112233456788999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=306.63 Aligned_cols=257 Identities=22% Similarity=0.315 Sum_probs=200.6
Q ss_pred hccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
++|+..+.||+|+||+||+|+.+ +.+.||+|.+... ........+.+|++++++++|+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~ 68 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT----------------KDENLQSEFRRELDMFRKLSHK 68 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc----------------cchHHHHHHHHHHHHHHhcCCc
Confidence 56888899999999999999964 2467999977211 0111246788999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC-------ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCC
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK-------IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKS 775 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp 775 (947)
||+++++++.+.+..++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||
T Consensus 69 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp 145 (275)
T cd05046 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAA 145 (275)
T ss_pred ceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCcc
Confidence 999999999999999999999999999999986541 25899999999999999999999 89999999999
Q ss_pred CCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCC
Q 002250 776 SNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFG 854 (947)
Q Consensus 776 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~ 854 (947)
+||+++.++.++++|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 146 ~Nili~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~- 223 (275)
T cd05046 146 RNCLVSSQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS- 223 (275)
T ss_pred ceEEEeCCCcEEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-
Confidence 9999999999999999998654322211 1123346778999999988888999999999999999999 778874321
Q ss_pred CcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 855 DSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
....... ....... .......+..+.+++.+|++.+|++|||+.|++++|++
T Consensus 224 -~~~~~~~---~~~~~~~---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 224 -DEEVLNR---LQAGKLE---------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred -hHHHHHH---HHcCCcC---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 1111111 1111100 00111234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=305.93 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=201.7
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|+||.||+|... +++.+|||++.... ........+.+|++++++++||||++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~ 65 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ---------------MTKDERLAAQNECQVLKLLSHPNIIEYY 65 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc---------------cccHHHHHHHHHHHHHhhCCCCchhhee
Confidence 4778899999999999999964 68899999984221 1112346788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC-CCeE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE-WKPR 787 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~k 787 (947)
+.+..++..++||||+++++|.+++.......+++..+..++.+++.|++||| +++++||||+|+||+++++ +.++
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~ 142 (256)
T cd08220 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVK 142 (256)
T ss_pred eeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999998765566899999999999999999999 8999999999999999865 4589
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
++|||.+........ .....++..|+|||.+....++.++||||||+++|||++|+.||... +.........
T Consensus 143 l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-----~~~~~~~~~~ 214 (256)
T cd08220 143 IGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-----NLPALVLKIM 214 (256)
T ss_pred EccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-----chHHHHHHHH
Confidence 999999986644322 12346789999999998888899999999999999999999998432 1222221111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. ...+.+...+..+.+++.+||+.+|++|||+.|++++
T Consensus 215 ~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 215 SG----------TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred hc----------CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11 1111222345568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=307.57 Aligned_cols=253 Identities=28% Similarity=0.382 Sum_probs=204.2
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|+||.||+|..+ +++.||+|++.... ......++.+|++++++++||||++++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 65 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI----------------NEAIQKQILRELDILHKCNSPYIVGFY 65 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc----------------ChHHHHHHHHHHHHHHHCCCCchhhhh
Confidence 5777889999999999999976 68999999884211 113345688999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCCeEecCCCCeE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFD-RPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++..+...++|+||+++++|.+++.... ..++......++.|++.|++||| + .+++||||||+||++++++.++
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~ 141 (265)
T cd06605 66 GAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIK 141 (265)
T ss_pred eeeecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999998643 56888899999999999999999 7 8999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||.+......... ...++..|+|||++.+..++.++||||||+++|||++|+.||...........+......
T Consensus 142 l~d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 217 (265)
T cd06605 142 LCDFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV 217 (265)
T ss_pred EeecccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh
Confidence 9999998755332211 156888999999999889999999999999999999999998654333333333332222
Q ss_pred cccccccccccCCCCccCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKE-DALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... .+..... ....+.+++.+|+..+|++|||+.+++++
T Consensus 218 ~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 218 NEP----------PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cCC----------CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111 1111222 45568899999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=319.07 Aligned_cols=191 Identities=25% Similarity=0.283 Sum_probs=163.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
..|++.+.||+|+||.||+|+.. +++.||+|+.. ......|+.++++++||||+++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~-----------------------~~~~~~E~~~l~~l~h~~iv~~ 122 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQ-----------------------KGTTLIEAMLLQNVNHPSVIRM 122 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCC-----------------------ccccHHHHHHHHhCCCCCCcCh
Confidence 46889999999999999999966 57889999641 1123469999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..+...++||||+ .++|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+|
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~k 197 (357)
T PHA03209 123 KDTLVSGAITCMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVC 197 (357)
T ss_pred hheEEeCCeeEEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999 56888888763 346899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
|+|||.++...... ......||+.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 198 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 198 IGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred EecCccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 99999997533221 1223468999999999999899999999999999999999766553
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=304.39 Aligned_cols=252 Identities=27% Similarity=0.385 Sum_probs=200.5
Q ss_pred cCCcccccccCceeEEEEEeCC-----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 631 VKPENLIGKGGSGNVYKVVLNS-----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.+.+.||+|+||.||+|...+ +..||+|++..... ......+..|+++++.++|+||+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----------------~~~~~~~~~e~~~l~~l~~~~i~ 64 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD----------------EQQIEEFLREARIMRKLDHPNIV 64 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC----------------hHHHHHHHHHHHHHHhcCCCchh
Confidence 3567889999999999999663 38899998842210 11456788999999999999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++...+..+++|||+++++|.+++.......+++..+..++.|++.|++||| +.+++||||+|+||++++++.
T Consensus 65 ~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~ 141 (258)
T smart00219 65 KLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLV 141 (258)
T ss_pred eEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCe
Confidence 99999999999999999999999999998754433899999999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 864 (947)
++|+|||++............ ...+++.|+|||.+.+..++.++||||+|+++|||++ |..||... .......
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~ 215 (258)
T smart00219 142 VKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLE 215 (258)
T ss_pred EEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHH
Confidence 999999999876654332221 2236789999999988889999999999999999999 77777431 1111111
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML 917 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 917 (947)
...... ........+..+.+++.+|++.+|++|||+.|+++.|
T Consensus 216 ~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 216 YLKKGY----------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHhcCC----------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111111 1111222456788999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=307.15 Aligned_cols=239 Identities=22% Similarity=0.319 Sum_probs=183.1
Q ss_pred cccccCceeEEEEEeCC-------------------------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHH
Q 002250 636 LIGKGGSGNVYKVVLNS-------------------------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690 (947)
Q Consensus 636 ~iG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (947)
.||+|+||.||+|.+.. ...||+|++... ......++.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----------------~~~~~~~~~ 64 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-----------------HRDIALAFF 64 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-----------------HHHHHHHHH
Confidence 58999999999997421 134778876211 112235688
Q ss_pred HHHHHHhhccccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 002250 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIH 770 (947)
Q Consensus 691 ~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 770 (947)
+|+.++++++||||+++++++..+...++||||+++|+|.+++... ...+++..+..++.|+++||+||| +.+|+|
T Consensus 65 ~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH 140 (274)
T cd05076 65 ETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLE---DKNLVH 140 (274)
T ss_pred HHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---cCCccC
Confidence 8999999999999999999999999999999999999999998753 345788889999999999999999 899999
Q ss_pred ccCCCCCeEecCCC-------CeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHH
Q 002250 771 RDVKSSNILLDLEW-------KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMEL 842 (947)
Q Consensus 771 ~Dlkp~NIll~~~~-------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~el 842 (947)
|||||+||+++..+ .++++|||.+....... ...++..|+|||.+.+ ..++.++||||||+++|||
T Consensus 141 ~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el 214 (274)
T cd05076 141 GNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214 (274)
T ss_pred CCCCcccEEEeccCcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999997643 37999999886432211 2356788999998865 5688999999999999999
Q ss_pred H-hCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 843 V-TGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 843 l-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
+ +|+.||..... .....+.. ... .. +......+.+++.+||+.+|++|||+.++++.|.
T Consensus 215 ~~~g~~p~~~~~~--~~~~~~~~----~~~--------~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 215 CFDGEVPLKERTP--SEKERFYE----KKH--------RL---PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HhCCCCCccccCh--HHHHHHHH----hcc--------CC---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 5 68888853211 11111111 000 01 1111245888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=323.35 Aligned_cols=204 Identities=26% Similarity=0.386 Sum_probs=172.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|+..+.||+|+||+||+|+.. +++.||||++... ..........+.+|+.++..++||+|+++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~l~~~~iv~~ 66 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKA--------------DMLEKEQVAHIRAERDILVEADGAWVVKM 66 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--------------HHhhhhhHHHHHHHHHHHHhCCCCCEeeE
Confidence 35788899999999999999965 6899999998311 01112345678889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.+++..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.++
T Consensus 67 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vk 141 (360)
T cd05627 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVK 141 (360)
T ss_pred EEEEEcCCEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999764 35788889999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCC---------------------------------cceecccccccccCccccccCCCCCccchHH
Q 002250 788 IADFGLAKIVQTGEAG---------------------------------DLTHVIAGTHGYIAPEYAYTCKINEKSDVYS 834 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 834 (947)
|+|||++......... ......+||+.|+|||++.+..++.++||||
T Consensus 142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 221 (360)
T cd05627 142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (360)
T ss_pred EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecc
Confidence 9999998744321100 0011346999999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCC
Q 002250 835 FGVVLMELVTGKRPIVP 851 (947)
Q Consensus 835 lGv~l~elltg~~p~~~ 851 (947)
|||++|||++|+.||..
T Consensus 222 lGvilyel~tG~~Pf~~ 238 (360)
T cd05627 222 LGVIMYEMLIGYPPFCS 238 (360)
T ss_pred ccceeeecccCCCCCCC
Confidence 99999999999999953
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=304.43 Aligned_cols=257 Identities=29% Similarity=0.424 Sum_probs=203.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||.|+||+||+|... ++..+|+|++..+. .......+.+|+++++.++|+||+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~~e~~~l~~l~~~~i~~~ 64 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK----------------CQTSVDELRKEVQAMSQCNHPNVVKY 64 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCC----------------cchHHHHHHHHHHHHHhcCCCCEEEE
Confidence 46888999999999999999954 68899999883211 11244678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCC-ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHK-IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
++.+..++..++||||+++++|.++++.... ..+++.....++.|++.|++||| +.+++||||+|+||++++++.+
T Consensus 65 ~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~ 141 (267)
T cd06610 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSV 141 (267)
T ss_pred EEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCE
Confidence 9999999999999999999999999986433 56899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCc--ceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 787 RIADFGLAKIVQTGEAGD--LTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
+|+|||++.......... ......|+..|+|||++... .++.++|+|||||++|||++|+.||..... .....+.
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~- 219 (267)
T cd06610 142 KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKVLMLT- 219 (267)
T ss_pred EEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhhHHHH-
Confidence 999999987665433221 22334688999999998877 788999999999999999999999853211 1111111
Q ss_pred HhhccccccccccccCCCCcc--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEI--LKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..... +.+... .......+.+++.+|++.||++||++.+++++
T Consensus 220 ---~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 220 ---LQNDP-------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ---hcCCC-------CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11110 111111 12344668899999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.33 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=202.7
Q ss_pred ccCCcccccccCceeEEEEEeCC--CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhh-ccccccce
Q 002250 630 AVKPENLIGKGGSGNVYKVVLNS--GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSA-VRHVNVVK 706 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~ 706 (947)
.|++.+.||+|+||.||+|.... ++.+|||.+......... ..........++.+|+.++.+ ++||||++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~-------~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~ 73 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGK-------DKRERDKSIGDIVSEVTIIKEQLRHPNIVR 73 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeecccccccc-------ccccchHHHHHHHHHHHHHhhcCCCCCeee
Confidence 36778899999999999999764 788999988433221110 001122334567788888875 79999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++..++..++||||+++++|.+++... ....+++..++.++.|++.|+.|||+ ..+++||||+|+||+++.++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 74 YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred EEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCC
Confidence 999999999999999999999999988542 34568899999999999999999993 36899999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
.++|+|||.+....... ......|+..|+|||+..+..++.++||||||+++|||++|+.||... +......
T Consensus 152 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~~~~~~ 223 (269)
T cd08528 152 KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSLAT 223 (269)
T ss_pred cEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CHHHHHH
Confidence 99999999998654432 223446889999999999888999999999999999999999998432 2222211
Q ss_pred hhccccccccccccCCCCccC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 865 SKMDSRDSMLTVVDPNISEIL-KEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
...... ..+.. ......+.+++.+|++.||++||++.|+.+++++
T Consensus 224 ~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 224 KIVEAV----------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HHhhcc----------CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111111 01111 1234568899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.04 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=196.7
Q ss_pred cCCcccccccCceeEEEEEeC----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 631 VKPENLIGKGGSGNVYKVVLN----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
|++.+.||+|+||+||+|... +++.||||++.... ......+++.+|++++++++||||++
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~i~~ 65 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI---------------FSSSDIEEFLREAACMKEFDHPNVIK 65 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc---------------CChHHHHHHHHHHHHHhcCCCCCcce
Confidence 567789999999999999854 36889999884211 11123456889999999999999999
Q ss_pred EEEEEecCC------ccEEEEeccCCCChHHHhhhc----CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 002250 707 LYCSITSED------SNLLVYEYLPNGSLWDRLHTC----HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776 (947)
Q Consensus 707 l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 776 (947)
+++++.... ..++++||+++|+|.+++... ....+++.....++.|++.|++||| +.+|+||||||+
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~ 142 (273)
T cd05074 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAAR 142 (273)
T ss_pred EEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchh
Confidence 999886532 237899999999999887532 1235788899999999999999999 889999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 002250 777 NILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGD 855 (947)
Q Consensus 777 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~ 855 (947)
||+++.++.+|++|||.++...............+++.|++||.+....++.++||||||+++|||++ |+.||....
T Consensus 143 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-- 220 (273)
T cd05074 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-- 220 (273)
T ss_pred hEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--
Confidence 99999999999999999986543322211222345678999999988889999999999999999999 888874321
Q ss_pred cccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 856 SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
..++..+.. .... ..........+.+++.+|++.+|++||++.++++.|+++
T Consensus 221 ~~~~~~~~~---~~~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 221 NSEIYNYLI---KGNR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHHHHH---cCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 112222111 1110 001122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=307.14 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=195.9
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.|++.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+++++.++||||++++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~ii~~~ 68 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----------------SEEELEDYMVEIDILASCDHPNIVKLL 68 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-----------------CHHHHHHHHHHHHHHHHCCCCCeeeEE
Confidence 3677888999999999999966 5788899987311 112345688899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+++
T Consensus 69 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl 144 (282)
T cd06643 69 DAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKL 144 (282)
T ss_pred EEEeeCCEEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEE
Confidence 9999999999999999999999988652 346899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
+|||++....... .......++..|+|||++. ...++.++|||||||++|||++|+.||.... ..+..
T Consensus 145 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~ 217 (282)
T cd06643 145 ADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-----PMRVL 217 (282)
T ss_pred ccccccccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-----HHHHH
Confidence 9999987543221 1122346899999999974 3457789999999999999999999984321 11111
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
......... . ...+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 218 ~~~~~~~~~-------~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 218 LKIAKSEPP-------T-LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHhhcCCC-------C-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111100 0 01112234568899999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.50 Aligned_cols=253 Identities=26% Similarity=0.343 Sum_probs=201.3
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|++++++++||||+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~-----------------~~~~~~~~~~e~~~l~~~~h~~i~~~ 65 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE-----------------PGDDFEIIQQEISMLKECRHPNIVAY 65 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC-----------------chhhHHHHHHHHHHHHhCCCCChhce
Confidence 57888899999999999999965 6788999998421 11245678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..+++|||+++++|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||++++++.++
T Consensus 66 ~~~~~~~~~~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~ 141 (262)
T cd06613 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVK 141 (262)
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEE
Confidence 99999999999999999999999998763 245889999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC---KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
|+|||.+........ ......++..|+|||.+... .++.++||||||+++|||++|+.||..... .....
T Consensus 142 l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~-----~~~~~ 214 (262)
T cd06613 142 LADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-----MRALF 214 (262)
T ss_pred ECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHH
Confidence 999999876543221 11234678899999998776 788999999999999999999999853211 11111
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
...... ..+.........+..+.+++.+||..+|.+|||+.++++
T Consensus 215 ~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 215 LISKSN------FPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHhcc------CCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111000 001111122344567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=307.32 Aligned_cols=254 Identities=23% Similarity=0.312 Sum_probs=197.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++||||++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----------------~~~~~~~~~e~~~~~~l~h~~ii~ 70 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----------------GEDFAVVQQEIIMMKDCKHSNIVA 70 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----------------hhHHHHHHHHHHHHHhCCCCCeee
Confidence 457888899999999999999954 68999999883211 122345778999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||+++++|.+++... ..+++.....++.|++.|++||| +.+++|+||||+||+++.++.+
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~ 145 (267)
T cd06645 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHV 145 (267)
T ss_pred EEEEEEeCCEEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999998764 35789999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY---TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
+|+|||.+....... .......|+..|+|||++. ...++.++||||+||++|||++|+.||...... ...
T Consensus 146 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-~~~---- 218 (267)
T cd06645 146 KLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RAL---- 218 (267)
T ss_pred EECcceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-hhH----
Confidence 999999987654321 1122446899999999874 455888999999999999999999998532211 000
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
......... .+.... ....+..+.+++.+|++.+|++||++.+++++
T Consensus 219 ~~~~~~~~~-----~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 219 FLMTKSNFQ-----PPKLKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HhhhccCCC-----CCcccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000000000 001100 01123457889999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=318.34 Aligned_cols=243 Identities=24% Similarity=0.273 Sum_probs=184.4
Q ss_pred ccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc---cccccceEEEEEe
Q 002250 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV---RHVNVVKLYCSIT 712 (947)
Q Consensus 637 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~ 712 (947)
||+|+||+||+|+.. +++.||||++.... .........+..|..++.+. +||||+++++++.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~ 66 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE--------------IVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ 66 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHH--------------HhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe
Confidence 699999999999965 68999999983110 01112233455677777665 6999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
.+...|+||||+++|+|.+++... ..+++.....++.||+.||+||| +.+|+||||||+||+++.++.++|+|||
T Consensus 67 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg 141 (330)
T cd05586 67 TDSDLYLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFG 141 (330)
T ss_pred cCCeEEEEEcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCC
Confidence 999999999999999999998763 45788999999999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRD 871 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 871 (947)
+++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||... +..+..........
T Consensus 142 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~~ 214 (330)
T cd05586 142 LSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-----DTQQMYRNIAFGKV 214 (330)
T ss_pred cCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-----CHHHHHHHHHcCCC
Confidence 9875332221 12245699999999998765 4789999999999999999999998532 12221111111111
Q ss_pred cccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 002250 872 SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS----MRVVVQ 915 (947)
Q Consensus 872 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~ev~~ 915 (947)
.++. ......+.+++.+|++.||.+||+ +.++++
T Consensus 215 --------~~~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 215 --------RFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --------CCCC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1111 112345678899999999999985 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=317.90 Aligned_cols=263 Identities=20% Similarity=0.242 Sum_probs=194.3
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++.++|++.+.||+|+||+||+|... +++.||||++.... ........+.+|+.++++++||||
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~i 76 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---------------QSLIHARRTYRELRLLKHMKHENV 76 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---------------hhhHHHHHHHHHHHHHHhcCCCch
Confidence 34578999999999999999999954 68899999883211 011233557789999999999999
Q ss_pred ceEEEEEecC------CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 705 VKLYCSITSE------DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 705 v~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++++++... ...|+++|++ +++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||
T Consensus 77 v~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Ni 149 (343)
T cd07878 77 IGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNV 149 (343)
T ss_pred hhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhE
Confidence 9999887543 3468999998 7899888764 35889999999999999999999 89999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
+++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 150 l~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~ 223 (343)
T cd07878 150 AVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-ID 223 (343)
T ss_pred EECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HH
Confidence 9999999999999999865432 123468999999999876 4688999999999999999999999853210 01
Q ss_pred cHHHHHHhhcccccc----------------ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 858 DIVNWVYSKMDSRDS----------------MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 858 ~~~~~~~~~~~~~~~----------------~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.+..+.......... +.......+..........+.+++.+|++.||++|||+.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 224 QLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111111000000000 00000000001111123357799999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.44 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=197.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~i~~~ 74 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----------------SEEELEDYMVEIEILATCNHPYIVKL 74 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----------------CHHHHHHHHHHHHHHHhCCCCcEeee
Confidence 56889999999999999999965 5899999987311 11234668889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||+++++|..++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.++
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~k 150 (292)
T cd06644 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIK 150 (292)
T ss_pred EEEEEeCCeEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEE
Confidence 99999999999999999999998887653 245899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
|+|||.+....... .......+++.|+|||++. ...++.++|||||||++|||++|+.||.... ..+.
T Consensus 151 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~~~ 223 (292)
T cd06644 151 LADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRV 223 (292)
T ss_pred EccCccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-----HHHH
Confidence 99999987543221 1122345788999999984 3446789999999999999999999984321 1111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
......... +. ...+......+.+++.+||+.+|++||++.+++++
T Consensus 224 ~~~~~~~~~-------~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 224 LLKIAKSEP-------PT-LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHhcCCC-------cc-CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111111110 00 01122334568889999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=343.02 Aligned_cols=254 Identities=28% Similarity=0.402 Sum_probs=205.4
Q ss_pred hccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
-++.-..+||.|.||.||-|. ..+|.-.|||.+.... ..........+|+.++..++|||+|++
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~---------------~~~k~~~~i~eEm~vlE~lnHpNlV~Y 1299 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQD---------------SDHKTFKLIAEEMKVLEGLNHPNLVRY 1299 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCc---------------cccccCcchHHHHHHHHhccCcccccc
Confidence 356677899999999999999 4578899999874211 113445677899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
||+-.+.+..+|.||||++|+|.+.+... .-.++.....+..|++.|++||| +.+||||||||.||+++.+|.+|
T Consensus 1300 yGVEvHRekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK 1374 (1509)
T KOG4645|consen 1300 YGVEVHREKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIK 1374 (1509)
T ss_pred CceeecHHHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEE
Confidence 99999999999999999999999999863 33667777778889999999999 89999999999999999999999
Q ss_pred EeccccceecccCCC--CcceecccccccccCccccccCC---CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 788 IADFGLAKIVQTGEA--GDLTHVIAGTHGYIAPEYAYTCK---INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 788 l~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
++|||.|........ ........||+.|||||++.+.. ..-+.||||+|||+.||+||++||.... + +|
T Consensus 1375 ~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d----n--e~ 1448 (1509)
T KOG4645|consen 1375 YGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD----N--EW 1448 (1509)
T ss_pred eecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc----c--hh
Confidence 999999987655421 11223557999999999997643 4568899999999999999999984221 1 11
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..|..+.-++.+.+++.....-.+++.+|+..||++|+++.|++++
T Consensus 1449 --------aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1449 --------AIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------HHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1234444555667777777777888899999999999999987764
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.06 Aligned_cols=265 Identities=23% Similarity=0.291 Sum_probs=198.4
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|++|.||+|+.. +++.||||++.... ........+.+|++++++++||||++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 65 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---------------ETEGVPSTAIREISLLKELNHPNIVKLL 65 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc---------------cccccchHHHHHHHHHHhcCCCCCcchh
Confidence 3778889999999999999965 68999999884221 1112335688999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++.+++..++||||++ ++|.+++.......+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|
T Consensus 66 ~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l 141 (284)
T cd07860 66 DVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKL 141 (284)
T ss_pred hhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEE
Confidence 99999999999999995 68999988766667899999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||++........ ......++..|+|||+..+.. ++.++||||||+++|||+||+.||..... .....+......
T Consensus 142 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~ 218 (284)
T cd07860 142 ADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLG 218 (284)
T ss_pred eeccchhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhC
Confidence 99999875543221 112234688999999887654 57889999999999999999999854321 111111111000
Q ss_pred cccc--------------cccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRD--------------SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~--------------~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... ....................+.+++.+|++.||++|||+.+++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 219 TPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred CCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 000000011111112233557789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=312.92 Aligned_cols=195 Identities=26% Similarity=0.391 Sum_probs=158.0
Q ss_pred cccccccCceeEEEEEeC---CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEE
Q 002250 634 ENLIGKGGSGNVYKVVLN---SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 710 (947)
..+||+|+||+||+|+.+ ++..||+|.+... .....+.+|++++++++||||++++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-------------------~~~~~~~~E~~~l~~l~h~niv~~~~~ 66 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-------------------GISMSACREIALLRELKHPNVIALQKV 66 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC-------------------CCcHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 357999999999999965 3578999987311 123457789999999999999999999
Q ss_pred Eec--CCccEEEEeccCCCChHHHhhhc-------CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe-
Q 002250 711 ITS--EDSNLLVYEYLPNGSLWDRLHTC-------HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL- 780 (947)
Q Consensus 711 ~~~--~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll- 780 (947)
+.. +...++||||++ ++|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 67 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~ 142 (317)
T cd07867 67 FLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVM 142 (317)
T ss_pred EeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEc
Confidence 854 456789999986 5788877532 2235788999999999999999999 8999999999999999
Q ss_pred ---cCCCCeEEeccccceecccCCCC-cceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 781 ---DLEWKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 781 ---~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
+.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 143 ~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 143 GEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 46678999999999866443221 112234689999999998764 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=304.89 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=192.9
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|+||.||+|... +++.||+|++...... .........+.+|+.++++++||||++++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 70 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES------------PETSKEVSALECEIQLLKNLQHERIVQYY 70 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC------------chhHHHHHHHHHHHHHHHHcCCCCeeeEE
Confidence 5788899999999999999965 6899999987422100 00112335688999999999999999999
Q ss_pred EEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 709 CSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 709 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++... ...+++|||+++++|.+++.... .+++.....++.|++.||+||| +.+|+||||+|+||+++.++.+
T Consensus 71 ~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~ 145 (266)
T cd06651 71 GCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNV 145 (266)
T ss_pred EEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCE
Confidence 998763 56689999999999999997643 4788888999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCC-CcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEA-GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++|+.||.... .......
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~-----~~~~~~~ 220 (266)
T cd06651 146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE-----AMAAIFK 220 (266)
T ss_pred EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc-----hHHHHHH
Confidence 9999999875533211 111123457899999999988889999999999999999999999985321 1111111
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.... ...+ ..+......+..++ +||..+|++||+|.|+++
T Consensus 221 ~~~~------~~~~---~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 221 IATQ------PTNP---QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HhcC------CCCC---CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1100 0111 12222334455555 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=307.28 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=199.9
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|..+ +++.||+|.+... ........+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----------------~~~~~~~~~~~e~~~l~~~~~~~i~~~ 64 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE----------------LDESKFNQIIMELDILHKAVSPYIVDF 64 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc----------------cCHHHHHHHHHHHHHHHhcCCCcHHhh
Confidence 36788899999999999999976 7899999987311 011224568899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcC-CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCH-KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
++++..++..++||||+++++|.+++.... ...+++..+..++.|++.|++|||+ +.+|+||||||+||+++.++.+
T Consensus 65 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~ 142 (286)
T cd06622 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQV 142 (286)
T ss_pred hhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCE
Confidence 999999999999999999999999887632 2368999999999999999999993 3589999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCC------CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK------INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+|+|||.+....... .....+++.|+|||++.+.. ++.++|+|||||++|||++|+.||.... .....
T Consensus 143 ~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~ 216 (286)
T cd06622 143 KLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET--YANIF 216 (286)
T ss_pred EEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc--hhhHH
Confidence 999999987553322 12345788999999985543 4789999999999999999999985321 11111
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..... +.+......+......+.+++.+|++.+|++||++.+++..
T Consensus 217 ~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 217 AQLSA----------IVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHH----------HhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111 11111222333456678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=305.02 Aligned_cols=240 Identities=21% Similarity=0.333 Sum_probs=185.2
Q ss_pred ccccccCceeEEEEEeCC--------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 635 NLIGKGGSGNVYKVVLNS--------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
+.||+|+||.||+|.... ..+||+|.+.. ......+.+.+|+.+++.++||||++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----------------~~~~~~~~~~~e~~~l~~~~h~~iv~ 63 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----------------SHRNYSESFFEAASMMSQLSHKHLVL 63 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc-----------------hhHHHHHHHHHHHHHHHhCCCCChhh
Confidence 469999999999998642 23477776521 11123457888999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC-
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK- 785 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~- 785 (947)
+++++..++..++||||+++|+|.++++..+ ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.
T Consensus 64 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~ 139 (258)
T cd05078 64 NYGVCVCGDESIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDR 139 (258)
T ss_pred eeeEEEeCCCcEEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEeccccc
Confidence 9999999999999999999999999998643 36789999999999999999999 899999999999999987765
Q ss_pred -------eEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCC-CCCCCCCCCc
Q 002250 786 -------PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGK-RPIVPEFGDS 856 (947)
Q Consensus 786 -------~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~-~p~~~~~~~~ 856 (947)
++++|||.+...... ....++..|+|||++.+. .++.++||||||+++|||++|. .||... .
T Consensus 140 ~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~-~-- 210 (258)
T cd05078 140 KTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL-D-- 210 (258)
T ss_pred ccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc-c--
Confidence 599999988654322 234578899999999764 4789999999999999999985 444211 1
Q ss_pred ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
...... ...... . .+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 211 --~~~~~~-~~~~~~--------~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 211 --SQKKLQ-FYEDRH--------Q---LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --HHHHHH-HHHccc--------c---CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111100 000000 1 11112245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=304.67 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=194.9
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.+.....||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++|+||+++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~iv~~ 70 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-----------------DSRYVQPLHEEIALHSYLKHRNIVQY 70 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-----------------CHHHHHHHHHHHHHHHhcCCCCeeee
Confidence 44555678999999999999955 6788999987321 11234578899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhc-CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC-CCC
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTC-HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL-EWK 785 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~-~~~ 785 (947)
++++..++..++|+||+++++|.+++... .....++..+..++.|++.|++||| +.+|+||||||+||+++. ++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~ 147 (268)
T cd06624 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGV 147 (268)
T ss_pred eeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCe
Confidence 99999999999999999999999999863 2222378888889999999999999 899999999999999986 679
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK--INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
++|+|||.+........ ......|++.|+|||++.... ++.++||||||+++|||++|+.||....... ...+.
T Consensus 148 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~ 223 (268)
T cd06624 148 VKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFK 223 (268)
T ss_pred EEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhh
Confidence 99999999876543221 122335789999999986543 7889999999999999999999984321111 11110
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. .....+..+......+.+++.+||+.+|++|||+.|++++
T Consensus 224 ~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 224 VG-----------MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hh-----------hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00 0001112233344568889999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=308.32 Aligned_cols=264 Identities=22% Similarity=0.315 Sum_probs=196.3
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|+||.||+|+.. +|+.||+|++.... ........+.+|++++++++||||++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~---------------~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 65 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---------------DDEGVPSSALREICLLKELKHKNIVRLY 65 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccc---------------ccccCccchhHHHHHHHhcCCCCeeeHH
Confidence 4777889999999999999965 68999999884221 1112234577899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++.+....++|+||++ ++|.+++... ...+++.....++.||++||+||| +.+|+||||||+||+++.++.++|
T Consensus 66 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l 140 (284)
T cd07839 66 DVLHSDKKLTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKL 140 (284)
T ss_pred HHhccCCceEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEE
Confidence 99999999999999996 5888887753 345899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||+++....... ......++..|+|||++.+.. ++.++|||||||++|||+||+.|+.........+ +......
T Consensus 141 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~~ 217 (284)
T cd07839 141 ADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLL 217 (284)
T ss_pred CccchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH-HHHHHHh
Confidence 99999975543221 112335788999999987654 6889999999999999999999975432211111 1111100
Q ss_pred c-----------cccccc--ccccCCC--CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 D-----------SRDSML--TVVDPNI--SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~-----------~~~~~~--~~~d~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
. ...... ....... ..........+.+++.+|++.||.+|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 218 GTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 000000 0000000 01112234567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.15 Aligned_cols=265 Identities=22% Similarity=0.235 Sum_probs=198.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|+..+.||+|+||.||+|+.+ +++.||+|++.... ......+.+.+|+.++++++|||++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------------~~~~~~~~~~~e~~~l~~~~h~~i~~~ 65 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE---------------DDPVIKKIALREIRMLKQLKHPNLVNL 65 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc---------------cCccccHHHHHHHHHHHhCCCCCEeee
Confidence 36888899999999999999976 68999999883211 111223457899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..+...++||||++++.+..+.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++
T Consensus 66 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~ 140 (286)
T cd07847 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIK 140 (286)
T ss_pred eeEEeeCCEEEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEE
Confidence 99999999999999999998888777642 35899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||++........ ......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... +.........
T Consensus 141 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~ 217 (286)
T cd07847 141 LCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-DQLYLIRKTL 217 (286)
T ss_pred ECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh
Confidence 999999987644321 1123357889999999876 45788999999999999999999998543211 1111111000
Q ss_pred ccc----------cccccccccCCC------CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDS----------RDSMLTVVDPNI------SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~----------~~~~~~~~d~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... .........+.. ..........+.+++.+|++.+|++||++.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 218 GDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 000000000000 01112234678899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.29 Aligned_cols=265 Identities=26% Similarity=0.383 Sum_probs=199.6
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|...+.||+|+||.||+|... +++.||||.+......... .........+.+.+|+.++++++|||+++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~-------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 74 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGR-------HDSRQKDMVKALRSEIETLKDLDHLNIVQYL 74 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcc-------cchHHHHHHHHHHHHHHHHHhcCCCCcceEE
Confidence 4677889999999999999854 6899999987422110000 0000111235688899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++++|.+++... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.+++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 75 GFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred EEeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEE
Confidence 9999999999999999999999999875 45788889999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK--INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
+|||.++...............|+..|+|||...... ++.++|+||||+++||+++|..||... ... ......
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~----~~~-~~~~~~ 224 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE----EAI-AAMFKL 224 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc----chH-HHHHHh
Confidence 9999997654322222222345789999999987654 788999999999999999999998421 111 111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..... ...+. .......+..+.+++.+|++.+|++|||+.+++++
T Consensus 225 ~~~~~--~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 225 GNKRS--APPIP---PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hcccc--CCcCC---ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11100 00011 11222345678889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=299.69 Aligned_cols=238 Identities=25% Similarity=0.376 Sum_probs=186.4
Q ss_pred ccccccCceeEEEEEeCCCc-----------EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 635 NLIGKGGSGNVYKVVLNSGK-----------ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.||+|+||.||+|...+.. .|++|.+... ......+.+|+.++++++|||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~------------------~~~~~~~~~e~~~l~~l~h~~ 62 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD------------------HRDSLAFFETASLMSQLSHKH 62 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc------------------hhhHHHHHHHHHHHHcCCCcc
Confidence 46899999999999976432 4677765211 111578889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++.. ...++||||+++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 63 i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~ 137 (259)
T cd05037 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARY 137 (259)
T ss_pred hhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecC
Confidence 9999999988 778999999999999999987432 6889999999999999999999 8999999999999999988
Q ss_pred C-------CeEEeccccceecccCCCCcceecccccccccCccccccC--CCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 002250 784 W-------KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC--KINEKSDVYSFGVVLMELVT-GKRPIVPEF 853 (947)
Q Consensus 784 ~-------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ellt-g~~p~~~~~ 853 (947)
+ .+|++|||++...... ....++..|+|||++... .++.++||||||+++|||++ |..||....
T Consensus 138 ~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 138 GLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred ccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 7 7999999999765431 123567789999998876 78899999999999999999 466663321
Q ss_pred CCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 854 GDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
......+.. . ... .+ .+ ....+.+++.+||..+|++|||+.++++.|+
T Consensus 212 --~~~~~~~~~---~-~~~--------~~-~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 212 --SSEKERFYQ---D-QHR--------LP-MP--DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --chhHHHHHh---c-CCC--------CC-CC--CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111111110 0 000 00 00 1157889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=300.22 Aligned_cols=252 Identities=28% Similarity=0.398 Sum_probs=200.2
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|+||.||+|... +++.||+|.+....... ......+.+.+|++++++++|+||++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~~~~e~~~l~~~~h~~i~~~~ 68 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ------------TGQEAVKQLEQEIALLSKLQHPNIVQYL 68 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccc------------cchHHHHHHHHHHHHHHhcCCCCchhee
Confidence 3677789999999999999976 78999999884221100 0112346788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..+...++||||+++++|.+++... ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.+||
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl 143 (258)
T cd06632 69 GTEREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKL 143 (258)
T ss_pred eeEecCCeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999999864 34789999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.+....... ......|+..|+|||.+.... ++.++|+||||+++|||++|+.||.... .........
T Consensus 144 ~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~ 215 (258)
T cd06632 144 ADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-----GVAAVFKIG 215 (258)
T ss_pred ccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-----HHHHHHHHH
Confidence 9999987654332 122346889999999987766 8899999999999999999999985321 111111111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.. ...+..+......+.+++.+|++.+|++||++.++++
T Consensus 216 ~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 216 RS---------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred hc---------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 10 0111222234466788999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.77 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=198.8
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~i~~~ 67 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----------------SEEELEDFMVEIDILSECKHPNIVGL 67 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----------------CHHHHHHHHHHHHHHHhCCCCceeEE
Confidence 57888999999999999999965 6899999988311 11234568899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..+...++||||+++++|.+++... ...+++.....++.|++.|+.||| +.+|+||||+|+||+++.++.++
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~ 143 (280)
T cd06611 68 YEAYFYENKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVK 143 (280)
T ss_pred EEEEecCCeEEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEE
Confidence 99999999999999999999999998763 245889999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
|+|||.+........ ......+++.|+|||++. ...++.++||||||+++|||++|+.||... +..+.
T Consensus 144 l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-----~~~~~ 216 (280)
T cd06611 144 LADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-----NPMRV 216 (280)
T ss_pred EccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-----CHHHH
Confidence 999998865433221 122346899999999875 334677999999999999999999998532 11111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
......... +. ...+......+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~-------~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 217 LLKILKSEP-------PT-LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHhcCCC-------CC-cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111111110 00 01122234567889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.22 Aligned_cols=257 Identities=28% Similarity=0.335 Sum_probs=197.2
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHV 702 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 702 (947)
.+..++|++.+.||+|+||.||+|... +++.+|+|++.. .......+.+|+.+++++ +||
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~------------------~~~~~~~~~~e~~~l~~l~~h~ 75 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP------------------IHDIDEEIEAEYNILKALSDHP 75 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecc------------------ccchHHHHHHHHHHHHHHhcCC
Confidence 345688999999999999999999965 688999998721 112235678899999999 699
Q ss_pred ccceEEEEEe-----cCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCC
Q 002250 703 NVVKLYCSIT-----SEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKS 775 (947)
Q Consensus 703 niv~l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp 775 (947)
||+++++++. .++..++||||+++++|.+++... ....+++..+..++.|++.|+.||| +.+++||||||
T Consensus 76 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp 152 (286)
T cd06638 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKG 152 (286)
T ss_pred CeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCH
Confidence 9999999874 345679999999999999988642 2346788999999999999999999 89999999999
Q ss_pred CCeEecCCCCeEEeccccceecccCCCCcceecccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCC
Q 002250 776 SNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-----CKINEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 776 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
+||++++++.++|+|||+++....... ......|++.|+|||++.. ..++.++||||+||++|||++|+.||.
T Consensus 153 ~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~ 230 (286)
T cd06638 153 NNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230 (286)
T ss_pred HhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence 999999999999999999976543221 1223468999999998753 447889999999999999999999985
Q ss_pred CCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 002250 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML 917 (947)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 917 (947)
... ..+.......... ....+ +......+.+++.+|++.||++|||+.|++++.
T Consensus 231 ~~~-----~~~~~~~~~~~~~--~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 231 DLH-----PMRALFKIPRNPP--PTLHQ------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCc-----hhHHHhhccccCC--CcccC------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 321 1111111100000 00001 111234688899999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=306.64 Aligned_cols=252 Identities=29% Similarity=0.375 Sum_probs=197.5
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
..+.|+..+.||+|+||+||+|... +++.||+|++..... ........+.+|+++++.++||||+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--------------~~~~~~~~~~~Ei~~l~~l~h~niv 78 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK--------------QSNEKWQDIIKEVRFLQQLRHPNTI 78 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc--------------CcHHHHHHHHHHHHHHHhCCCCCEE
Confidence 3466888999999999999999965 689999998832110 0112235688999999999999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..++..++||||++ |++.+++... ...+++..+..++.|++.||.||| +.+|+||||+|+||++++++.
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~ 153 (307)
T cd06607 79 EYKGCYLREHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGT 153 (307)
T ss_pred EEEEEEEeCCeEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCC
Confidence 99999999999999999996 6777777643 245899999999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY---TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
++|+|||++....... ...+++.|+|||++. .+.++.++||||||+++|||++|+.||... +....
T Consensus 154 ~kL~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-----~~~~~ 222 (307)
T cd06607 154 VKLADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSA 222 (307)
T ss_pred EEEeecCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc-----cHHHH
Confidence 9999999987654321 345788999999874 456888999999999999999999998432 11111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML 917 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 917 (947)
......... +.. ........+.+++.+||+.+|++||++.+++++-
T Consensus 223 ~~~~~~~~~-------~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 223 LYHIAQNDS-------PTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHHHhcCCC-------CCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 111111100 001 1223456789999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=307.37 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=196.2
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNV 704 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 704 (947)
..+.|++.+.||+|+||.||+|... +++.+|+|++.. .......+..|+.+++++ +||||
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~------------------~~~~~~~~~~e~~~l~~~~~h~~i 75 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV------------------TEDEEEEIKLEINMLKKYSHHRNI 75 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEec------------------ChHHHHHHHHHHHHHHHhcCCCcE
Confidence 3478889999999999999999964 688999998721 112335678899999998 69999
Q ss_pred ceEEEEEec------CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 705 VKLYCSITS------EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 705 v~l~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++++++.. ....++||||+++|+|.+++.......+++..+..++.|++.|++||| +.+|+||||+|+||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~ni 152 (282)
T cd06636 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNV 152 (282)
T ss_pred EEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHE
Confidence 999999853 456789999999999999998755566888889999999999999999 89999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRPIVPEF 853 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~ 853 (947)
++++++.++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....
T Consensus 153 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 153 LLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred EECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 999999999999999875432211 122346889999999875 3457889999999999999999999985321
Q ss_pred CCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 854 GDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
. ... ....... . .........+..+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~----~~~-~~~~~~~-------~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 231 P----MRA-LFLIPRN-------P--PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred H----Hhh-hhhHhhC-------C--CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1 000 0000000 0 001111234557899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=282.02 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=193.3
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 706 (947)
+..+....||.|+.|.||+++.+ +|...|||.+.... ...+.+++...+.++.+- ..|.||+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~----------------Nkee~kRILmDldvv~~s~dcpyIV~ 155 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG----------------NKEENKRILMDLDVVLKSHDCPYIVQ 155 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC----------------CHHHHHHHHHhhhHHhhccCCCeeee
Confidence 45566778999999999999966 68999999984221 123345566667766555 4899999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
.+|||..+..+++.||.|. ......++. -..++++...-++...+++||.||.+ .++|+|||+||+|||+|+.|.+
T Consensus 156 c~GyFi~n~dV~IcMelMs-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~Gni 231 (391)
T KOG0983|consen 156 CFGYFITNTDVFICMELMS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNI 231 (391)
T ss_pred eeeEEeeCchHHHHHHHHH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCE
Confidence 9999999999999999993 344444444 44568888888899999999999996 7899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT---CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
|+||||++..+-+...+. ...|-+.|||||.+.- ..|+-++||||||+.++|+.||+.||..- ....+.+
T Consensus 232 KlCDFGIsGrlvdSkAht---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c----~tdFe~l 304 (391)
T KOG0983|consen 232 KLCDFGISGRLVDSKAHT---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC----KTDFEVL 304 (391)
T ss_pred Eeecccccceeecccccc---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC----CccHHHH
Confidence 999999998776655443 4478999999999853 46899999999999999999999998532 1122222
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....+... |.++... .-...+.+++..|+.+|+.+||...+++++
T Consensus 305 tkvln~eP-------P~L~~~~-gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 305 TKVLNEEP-------PLLPGHM-GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHhcCC-------CCCCccc-CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 22222111 1111111 134568899999999999999999998864
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=326.34 Aligned_cols=257 Identities=19% Similarity=0.207 Sum_probs=187.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc-----
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH----- 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----- 701 (947)
.++|++.+.||+|+||+||+|... .++.||||++... ......+..|+++++.++|
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~------------------~~~~~~~~~e~~~l~~l~~~~~~~ 189 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV------------------PKYTRDAKIEIQFMEKVRQADPAD 189 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc------------------hhhHHHHHHHHHHHHHHhhcCccc
Confidence 467999999999999999999965 6889999998310 0122345667777777755
Q ss_pred -cccceEEEEEecC-CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCCe
Q 002250 702 -VNVVKLYCSITSE-DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFD-RPVIHRDVKSSNI 778 (947)
Q Consensus 702 -~niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~Dlkp~NI 778 (947)
.+++++++++..+ ...++|||++ +++|.+++.+. ..+++..+..++.||+.||+||| + .+||||||||+||
T Consensus 190 ~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NI 263 (467)
T PTZ00284 190 RFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENI 263 (467)
T ss_pred CcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHE
Confidence 4588999998765 4678999988 78899998764 45889999999999999999999 6 5999999999999
Q ss_pred EecCCC----------------CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHH
Q 002250 779 LLDLEW----------------KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMEL 842 (947)
Q Consensus 779 ll~~~~----------------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~el 842 (947)
|++.++ .+||+|||.+...... ....+||+.|+|||++.+..++.++|||||||++|||
T Consensus 264 Ll~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el 338 (467)
T PTZ00284 264 LMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338 (467)
T ss_pred EEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence 998765 4999999987543221 2245799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCcccHHHHHHhhcc--------------------ccccccccccCC-C------Ccc-CHHHHHHHHH
Q 002250 843 VTGKRPIVPEFGDSKDIVNWVYSKMD--------------------SRDSMLTVVDPN-I------SEI-LKEDALKVLR 894 (947)
Q Consensus 843 ltg~~p~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~d~~-~------~~~-~~~~~~~l~~ 894 (947)
++|+.||..... .+....+..... .........++. + ... .......+.+
T Consensus 339 ltG~~pf~~~~~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 416 (467)
T PTZ00284 339 YTGKLLYDTHDN--LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCD 416 (467)
T ss_pred HhCCCCCCCCCh--HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHH
Confidence 999999954321 111111100000 000000000000 0 000 0011245779
Q ss_pred HHHhccCCCCCCCCCHHHHHH
Q 002250 895 IAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 895 l~~~cl~~dP~~RPt~~ev~~ 915 (947)
++.+|++.||++|||+.|+++
T Consensus 417 li~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 417 LIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHHhCCcChhhCCCHHHHhc
Confidence 999999999999999999997
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.18 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=194.8
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|+..+.||+|++|+||+|..+ +++.||||.+.... .......+.+|++++++++||||+++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~i~~~ 68 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEH----------------EEGAPFTAIREASLLKDLKHANIVTL 68 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccc----------------ccCCchhHHHHHHHHhhCCCcceeeE
Confidence 67888999999999999999965 68999999984221 11222346689999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||++ ++|.+++.... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.++
T Consensus 69 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~k 143 (291)
T cd07844 69 HDIIHTKKTLTLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELK 143 (291)
T ss_pred EEEEecCCeEEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEE
Confidence 999999999999999997 49999987643 36788999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||+++....... ......++..|+|||+..+ ..++.++||||+|+++|||++|+.||....... +........
T Consensus 144 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~ 220 (291)
T cd07844 144 LADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRV 220 (291)
T ss_pred ECccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHh
Confidence 999999875432211 1112346889999998875 457889999999999999999999985332111 111111111
Q ss_pred ccc--ccccccc------c--------cCCCCccCHH--HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 867 MDS--RDSMLTV------V--------DPNISEILKE--DALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 867 ~~~--~~~~~~~------~--------d~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
... ...+... . ...+...... ....+.+++.+|++.+|++|||+.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 221 LGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000000 0 0000000001 1256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.07 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=201.6
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|+||.||+|..+ +|..||+|.+.... ........+.+|+.++++++|+||++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~E~~~l~~~~h~~i~~~~ 65 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK---------------MPVKEKEASKKEVILLAKMKHPNIVTFF 65 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh---------------ccchhhHHHHHHHHHHHhCCCCChhhhh
Confidence 4677889999999999999965 68899999883211 1112345678999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC-CeE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW-KPR 787 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~k 787 (947)
+.+..++..++|+||+++++|.+++.......+++..+..++.|++.|++||| +.+++|+||||+||++++++ .++
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~ 142 (257)
T cd08225 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAK 142 (257)
T ss_pred heeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEE
Confidence 99999999999999999999999998755556899999999999999999999 89999999999999999885 469
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
++|||.+........ ......|++.|+|||+.....++.++|+||||+++|||++|+.||... ...++.....
T Consensus 143 l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~ 215 (257)
T cd08225 143 LGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKIC 215 (257)
T ss_pred ecccccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHh
Confidence 999999976543321 122345889999999998888999999999999999999999998432 2222222222
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... ..+........+.+++.+|+..+|++|||+.|++++
T Consensus 216 ~~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 216 QGY----------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ccc----------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111 111122233568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.22 Aligned_cols=247 Identities=25% Similarity=0.346 Sum_probs=197.1
Q ss_pred ccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc---ccccc
Q 002250 630 AVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR---HVNVV 705 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv 705 (947)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|+.++++++ |||++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~----------------~~~~~~~~~~e~~~l~~l~~~~~~~vi 65 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----------------PDDDVSDIQREVALLSQLRQSQPPNIT 65 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC----------------CchhHHHHHHHHHHHHHhccCCCCCee
Confidence 467788999999999999996 478999999873211 1133456889999999996 99999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..+...++||||+++++|.+++.. ..+++.....++.|++.|++||| +.+++||||+|+||++++++.
T Consensus 66 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~ 139 (277)
T cd06917 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGN 139 (277)
T ss_pred eEeeeeeeCCEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCC
Confidence 999999999999999999999999999865 26889999999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
++++|||.+......... .....|+..|+|||++.++. ++.++|||||||++|||++|+.||.... ......
T Consensus 140 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-----~~~~~~ 212 (277)
T cd06917 140 VKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-----AFRAMM 212 (277)
T ss_pred EEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-----hhhhhh
Confidence 999999999876544321 22346889999999987644 6889999999999999999999985321 111111
Q ss_pred hhccccccccccccCCCCccCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 865 SKMDSRDSMLTVVDPNISEILK-EDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.. ... ..+.... ..+..+.+++.+|++.||++||++.|+++
T Consensus 213 ~~-~~~---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 213 LI-PKS---------KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred cc-ccC---------CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 00 000 0111111 13456889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.20 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=194.2
Q ss_pred CCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEE
Q 002250 632 KPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710 (947)
Q Consensus 632 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 710 (947)
+..+.||+|+|-+||||... +|.+||--.+. .....+.....++|..|+.+|+.|+|||||++|.+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk-------------~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~S 109 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVK-------------IRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDS 109 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHh-------------HHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeh
Confidence 44678999999999999965 67788754331 11223334455889999999999999999999999
Q ss_pred EecCCc--cEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC-CCCeE
Q 002250 711 ITSEDS--NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL-EWKPR 787 (947)
Q Consensus 711 ~~~~~~--~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~k 787 (947)
|.+... ..+|+|.+..|+|..|.++.++ .+......++.||++||.|||.. .++|+|||||-.||+++. .|.||
T Consensus 110 W~d~~n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VK 186 (632)
T KOG0584|consen 110 WVDTDNKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVK 186 (632)
T ss_pred eecCCCceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCcee
Confidence 988665 5689999999999999998654 67778999999999999999964 689999999999999985 49999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|+|+|........ ..++|||.|||||+.. ..|++.+||||||+.++||+|+.+||- ...+-.+. |+++
T Consensus 187 IGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs----EC~n~AQI-YKKV 256 (632)
T KOG0584|consen 187 IGDLGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS----ECTNPAQI-YKKV 256 (632)
T ss_pred ecchhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh----hhCCHHHH-HHHH
Confidence 999999998765543 2478999999999876 679999999999999999999999982 22222222 2222
Q ss_pred cccccccccccCCCCccCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKE-DALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
..+. .+..... .-+++.++|.+|+.. .++|||+.|+++
T Consensus 257 ~SGi---------KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 257 TSGI---------KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HcCC---------CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1111 1111111 124577888899999 899999999985
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.12 Aligned_cols=249 Identities=27% Similarity=0.403 Sum_probs=200.0
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+-|+..+.||+|+||.||+|... +++.||||.+... ........+.+|+.++++++||||+++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~iv~~ 67 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----------------EAEDEIEDIQQEITVLSQCDSPYVTKY 67 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc----------------cchHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 35677889999999999999864 6889999987211 111234578899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..+...++||||+++++|.+++.. ..+++.....++.|++.|++||| +.+++|+||+|+||+++.++.++
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~ 141 (277)
T cd06641 68 YGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVK 141 (277)
T ss_pred EEEEEeCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEE
Confidence 9999999999999999999999999875 35789999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
++|||++........ ......++..|+|||++.+..++.++|+|||||++|||++|..||.... ....... .
T Consensus 142 l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~~~~~~~-~ 213 (277)
T cd06641 142 LADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-----PMKVLFL-I 213 (277)
T ss_pred Eeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-----hHHHHHH-H
Confidence 999999876543221 1123457889999999988888999999999999999999999984321 1111111 1
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. ...+......+..+.+++.+|++.+|++||++.+++++
T Consensus 214 ~~---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 214 PK---------NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred hc---------CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 10 11112223345668889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=308.00 Aligned_cols=255 Identities=24% Similarity=0.275 Sum_probs=200.2
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|+||+||+|... +++.||+|.+...... .......+.+|+++++.++||||++++
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~--------------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 67 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI--------------KRNKVKRVLTEQEILATLDHPFLPTLY 67 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc--------------hHHHHHHHHHHHHHHHhCCCCCchhhe
Confidence 5788899999999999999966 5899999998432110 012345688999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+.+..+...++||||+++++|.+++.......+++.....++.|++.||+||| +.+++||||||+||+++.++.++|
T Consensus 68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l 144 (316)
T cd05574 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIML 144 (316)
T ss_pred eeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEE
Confidence 99999999999999999999999998755567899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCc---------------------------ceecccccccccCccccccCCCCCccchHHHHHHHHH
Q 002250 789 ADFGLAKIVQTGEAGD---------------------------LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLME 841 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~e 841 (947)
+|||++.......... ......||..|+|||++.+..++.++||||||+++||
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~ 224 (316)
T cd05574 145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224 (316)
T ss_pred eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence 9999986543221100 0112357889999999998889999999999999999
Q ss_pred HHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 002250 842 LVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS----MRVVVQ 915 (947)
Q Consensus 842 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~ev~~ 915 (947)
|++|+.||..... ............ ..+. ....+..+.+++.+|+..||++||| +.|+++
T Consensus 225 l~~g~~pf~~~~~-----~~~~~~~~~~~~--------~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 225 MLYGTTPFKGSNR-----DETFSNILKKEV--------TFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HhhCCCCCCCCch-----HHHHHHHhcCCc--------cCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 9999999853211 111111111111 0111 1114567899999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=301.24 Aligned_cols=260 Identities=25% Similarity=0.316 Sum_probs=198.9
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|...+.||.|++|.||+|... +++.+|+|.+.... .......+.+|++++++++||||++++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~iv~~~ 65 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP----------------NPDLQKQILRELEINKSCKSPYIVKYY 65 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC----------------chHHHHHHHHHHHHHHhCCCCCeeeee
Confidence 5777889999999999999975 68899999884211 112346688999999999999999999
Q ss_pred EEEecC--CccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 709 CSITSE--DSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 709 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++... ...++||||+++++|.+++... ....+++.....++.|++.||+||| +.+++|+||+|+||+++.++
T Consensus 66 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~ 142 (287)
T cd06621 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKG 142 (287)
T ss_pred eEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCC
Confidence 998653 4679999999999999987642 2345788899999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
.++|+|||++........ ....++..|+|||.+.+..++.++||||+|+++|||++|+.||...........+...
T Consensus 143 ~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (287)
T cd06621 143 QVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218 (287)
T ss_pred eEEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH
Confidence 999999999875433221 1335788999999999888999999999999999999999999654211111112211
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....... ... ... ..........+.+++.+|++.+|++|||+.|+++.
T Consensus 219 ~~~~~~~--~~~-~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 219 YIVNMPN--PEL-KDE-PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred HHhcCCc--hhh-ccC-CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1111110 000 000 11111235678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=303.85 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=190.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHH-Hhhccccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT-LSAVRHVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~ 706 (947)
++|++.+.||+|+||.||+|..+ +|+.||+|++.... .......+..|+.+ ++..+||||++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~~~~~~~~~~iv~ 64 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV----------------NSQEQKRLLMDLDISMRSVDCPYTVT 64 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC----------------CcHHHHHHHHHHHHHHHHcCCCCeee
Confidence 35788899999999999999965 69999999884221 01122344456554 56678999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEeccCCCCCeEecCC
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDR-PVIHRDVKSSNILLDLE 783 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~Dlkp~NIll~~~ 783 (947)
+++++..++..++||||++ |+|.+++... ....+++..+..++.|++.|++||| ++ +++||||||+||+++.+
T Consensus 65 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~ 140 (283)
T cd06617 65 FYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRN 140 (283)
T ss_pred eeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCC
Confidence 9999999999999999996 6888887653 2356899999999999999999999 65 99999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCcccccc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT----CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
+.+||+|||.+....... ......++..|+|||++.+ ..++.++|+||||+++|||++|+.||.........+
T Consensus 141 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 217 (283)
T cd06617 141 GQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL 217 (283)
T ss_pred CCEEEeeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH
Confidence 999999999987653321 1123457889999998864 446889999999999999999999984321111111
Q ss_pred HHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
........ +.++ ....+..+.+++.+|+..+|++||++.++++
T Consensus 218 ----~~~~~~~~-------~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 218 ----KQVVEEPS-------PQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ----HHHHhcCC-------CCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111100 1110 1123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.42 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=195.9
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.+|++.+.||+|+||.||+|... +++.||||++...... .........+.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~------------~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 69 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES------------PETSKEVNALECEIQLLKNLLHERIVQY 69 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC------------cccHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 46788899999999999999965 6899999987321100 0011234578899999999999999999
Q ss_pred EEEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 708 YCSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 708 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++.++ ...++||||+++++|.+++... ..+++....+++.|++.||+||| +.+++|+||||+||+++.++.
T Consensus 70 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~ 144 (265)
T cd06652 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGN 144 (265)
T ss_pred EeEeccCCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCC
Confidence 9998764 4567999999999999999764 34678888899999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCC-cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 786 PRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
++|+|||+++........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||... ...... .
T Consensus 145 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~----~~~~~~-~ 219 (265)
T cd06652 145 VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF----EAMAAI-F 219 (265)
T ss_pred EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc----chHHHH-H
Confidence 999999998755332111 1122345889999999998888999999999999999999999998432 111111 1
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... .+.....+......+.+++.+|+. +|++||++.|++++
T Consensus 220 ~~~~---------~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 220 KIAT---------QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHhc---------CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1110 011122334445567788888984 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.25 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=197.9
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
.++|++.+.||+|++|.||+|..+ +++.+|+|++... ......+.+|+.+++++ +|+||+
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~------------------~~~~~~~~~e~~~l~~~~~h~~i~ 66 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------------------EDEEEEIKEEYNILRKYSNHPNIA 66 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC------------------chhHHHHHHHHHHHHHhcCCCChh
Confidence 478999999999999999999975 6789999987321 12346788999999999 799999
Q ss_pred eEEEEEecCC------ccEEEEeccCCCChHHHhhhcC--CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 706 KLYCSITSED------SNLLVYEYLPNGSLWDRLHTCH--KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 706 ~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
++++++.... ..++||||+++++|.+++.... ...+++..+..++.|++.||+||| +.+++||||+|+|
T Consensus 67 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~n 143 (275)
T cd06608 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQN 143 (275)
T ss_pred eEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHH
Confidence 9999997654 3799999999999999987643 457899999999999999999999 8999999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCcceecccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 002250 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-----CKINEKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 778 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
|++++++.++|+|||.+........ ......|+..|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 144 i~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 144 ILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred EEEccCCeEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 9999999999999999876543221 1223458899999998753 34678999999999999999999998532
Q ss_pred CCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
. ..... ....... .+.. .........+.+++.+|+..||++|||+.++++
T Consensus 222 ~-~~~~~----~~~~~~~-------~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 222 H-PMRAL----FKIPRNP-------PPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c-hHHHH----HHhhccC-------CCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11111 1111100 0011 111224557889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.19 Aligned_cols=255 Identities=27% Similarity=0.376 Sum_probs=201.6
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||.|+||.||+|... +++.||+|++.... ......+.+..|++++++++||||++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---------------MTEKEKQQLVSEVNILRELKHPNIVRYY 65 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc---------------CCHHHHHHHHHHHHHHHhcCCCccceee
Confidence 4777889999999999999854 78899999884211 0112345688899999999999999999
Q ss_pred EEEec--CCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEeccCCCCCeEecC
Q 002250 709 CSITS--EDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGF--DRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 709 ~~~~~--~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~Dlkp~NIll~~ 782 (947)
+++.. +...+++|||+++++|.+++... ....+++...+.++.|++.|++|||... +.+++||||+|+||+++.
T Consensus 66 ~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~ 145 (265)
T cd08217 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA 145 (265)
T ss_pred eeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec
Confidence 98764 44578999999999999999764 2456899999999999999999999443 578999999999999999
Q ss_pred CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
++.+|++|||++......... .....+++.|+|||++....++.++|+||||+++|+|++|+.||.... .....+
T Consensus 146 ~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~- 220 (265)
T cd08217 146 NNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLAS- 220 (265)
T ss_pred CCCEEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHH-
Confidence 999999999999876543321 123468999999999998889999999999999999999999985321 111111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... ....+..+...+..+.+++.+|++.+|++||++.+|+++
T Consensus 221 ---~~~---------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 221 ---KIK---------EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---HHh---------cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 111222334455678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.98 Aligned_cols=265 Identities=22% Similarity=0.302 Sum_probs=198.0
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+.+|+++++.++||||+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 65 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE---------------DDKMVKKIAMREIRMLKQLRHENLVNL 65 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhcc---------------CcchhhHHHHHHHHHHHhcCCcchhhH
Confidence 35788899999999999999976 58999999873211 111233567889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||++++++.++.... ..+++.....++.|++.|++||| +.+++||||+|+||++++++.++
T Consensus 66 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~ 140 (286)
T cd07846 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVK 140 (286)
T ss_pred HHhcccCCeEEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEE
Confidence 99999999999999999999988877653 34899999999999999999999 88999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh-
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS- 865 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~- 865 (947)
|+|||++........ ......++..|+|||+..+ ..++.++||||||+++|||++|++||..... .....+....
T Consensus 141 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~ 217 (286)
T cd07846 141 LCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCL 217 (286)
T ss_pred EEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHh
Confidence 999999986544321 1123457899999999865 3477899999999999999999988843211 0000010000
Q ss_pred ---------hccccccccccccCCC------CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 866 ---------KMDSRDSMLTVVDPNI------SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 866 ---------~~~~~~~~~~~~d~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.............+.. .......+..+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred CCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000000110 01112335678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=303.59 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=200.1
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|+||.||+|... +|+.||||++..... .......+.+|+.++++++||||++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---------------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 65 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL---------------EGGIPNQALREIKALQACQHPYVVKLL 65 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc---------------cchhhHHHHHHHHHHHhCCCCCCccee
Confidence 4778899999999999999965 789999999842210 112345788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..+...++||||+ +++|.+++.... ..+++..+..++.|+++||+||| +.+++|+||||+||+++.++.+++
T Consensus 66 ~~~~~~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l 140 (286)
T cd07832 66 DVFPHGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKI 140 (286)
T ss_pred eEEecCCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEE
Confidence 9999999999999999 999999987643 56899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.+........ .......|+..|+|||++.+.. ++.++||||+|+++|||++|.+||.... .. ..........
T Consensus 141 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-~~-~~~~~~~~~~ 217 (286)
T cd07832 141 ADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-DI-EQLAIVFRTL 217 (286)
T ss_pred eeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-HH-HHHHHHHHHc
Confidence 99999986654332 1122346889999999986544 6889999999999999999977764321 11 1111111111
Q ss_pred ccc-----------ccccccccCC-----CCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSR-----------DSMLTVVDPN-----ISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~-----------~~~~~~~d~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... ........+. +.+...+....+.+++.+|++.+|++|||+.+++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 218 GTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000000000 011122334778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.06 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=196.8
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|.....||+|+||.||++... ++..||||++... .....+.+.+|+.++++++||||+++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~ii~~ 84 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----------------KQQRRELLFNEVVIMRDYHHENVVDM 84 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----------------hHHHHHHHHHHHHHHHhCCCCcHHHH
Confidence 44555677999999999999964 6889999987311 11234568899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++.+..++..++||||+++++|.+++.. ..+++.....++.|++.|++||| +.+|+||||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~k 158 (292)
T cd06658 85 YNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIK 158 (292)
T ss_pred HHheecCCeEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEE
Confidence 9999999999999999999999998864 34788999999999999999999 88999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||++........ ......|+..|+|||+.....++.++||||||+++|||++|+.||.... ..........
T Consensus 159 L~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~-- 232 (292)
T cd06658 159 LSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP--PLQAMRRIRD-- 232 (292)
T ss_pred EccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHh--
Confidence 999999875433221 1123468899999999988889999999999999999999999985321 1111111100
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...+... ........+.+++.+|+..||.+|||+.|++++
T Consensus 233 --------~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 233 --------NLPPRVK-DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --------cCCCccc-cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111111 111233457788999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.14 Aligned_cols=247 Identities=25% Similarity=0.275 Sum_probs=192.8
Q ss_pred ccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecCC
Q 002250 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSED 715 (947)
Q Consensus 637 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 715 (947)
||+|+||+||+|... +|+.||+|.+.... .........+.+|++++++++||||+++++++...+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 66 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKR--------------LKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD 66 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhh--------------hhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC
Confidence 699999999999855 68999999884211 111123455678999999999999999999999999
Q ss_pred ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 716 SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 716 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
..|+||||+++++|.+++.......+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++|+|||.+.
T Consensus 67 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~ 143 (277)
T cd05577 67 DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAV 143 (277)
T ss_pred eEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchh
Confidence 9999999999999999998765557899999999999999999999 8999999999999999999999999999987
Q ss_pred ecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccc
Q 002250 796 IVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLT 875 (947)
Q Consensus 796 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 875 (947)
...... ......++..|+|||+..+..++.++||||+|+++|||++|+.||....... ..... .....
T Consensus 144 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~-~~~~~------- 211 (277)
T cd05577 144 ELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEEL-KRRTL------- 211 (277)
T ss_pred hhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHH-Hhccc-------
Confidence 654321 1223457889999999988889999999999999999999999985432110 01111 00000
Q ss_pred cccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 002250 876 VVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQ 915 (947)
Q Consensus 876 ~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 915 (947)
......+......+.+++.+|++.+|++|| ++.++++
T Consensus 212 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 212 ---EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ---cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 001112222355688999999999999999 5555553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=311.84 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=200.3
Q ss_pred hccCCcccccccCceeEEEEEeCC-CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS-GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+-|.++..||.|+||.||+|..++ +-..|.|++ ..+.....++|.-||+|++.+.||+||++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI-----------------etkseEELEDylVEIeILa~CdHP~ivkL 94 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI-----------------ETKSEEELEDYLVEIEILAECDHPVIVKL 94 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhh-----------------cccchhHHhhhhhhhhhhhcCCChHHHHH
Confidence 456677789999999999999774 334566765 12233556788999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++.|..++..+|+.|||.||.....+-..+ ..+...++.-++.|++.||.||| ++.|||||||+.|||++-+|.++
T Consensus 95 l~ayy~enkLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdir 170 (1187)
T KOG0579|consen 95 LSAYYFENKLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIR 170 (1187)
T ss_pred HHHHhccCceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEe
Confidence 999999999999999999999988877643 46888899999999999999999 99999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCcccc-----ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYA-----YTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
|+|||.+..... .....+.+.|||.|||||+. +...|++++||||||+++.||..+.+|-. .-...+.
T Consensus 171 LADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh-----elnpMRV 243 (1187)
T KOG0579|consen 171 LADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH-----ELNPMRV 243 (1187)
T ss_pred eecccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc-----ccchHHH
Confidence 999998753221 12234567899999999987 45679999999999999999999999952 2222222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+...... +|..--.+......+.++..+|+.++|..||++++++++
T Consensus 244 llKiaKS--------ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 244 LLKIAKS--------EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHhhc--------CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2221111 111122345666778999999999999999999998753
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=303.86 Aligned_cols=264 Identities=23% Similarity=0.285 Sum_probs=197.5
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
|+..+.||.|++|.||+|..+ +|+.||||++.... ........+.+|++++++++|||++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~E~~~l~~l~~~~iv~~~~ 65 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET---------------EDEGVPSTAIREISLLKELNHPNIVRLLD 65 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccc---------------ccccchhHHHHHHHHHHhcCCCCccCHhh
Confidence 567789999999999999965 79999999884221 11123356788999999999999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
++..++..++||||++ ++|.+++.......+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+
T Consensus 66 ~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~ 141 (283)
T cd07835 66 VVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLA 141 (283)
T ss_pred eeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEe
Confidence 9999999999999995 69999998765557899999999999999999999 8899999999999999999999999
Q ss_pred ccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
|||++........ ......++..|+|||++.+. .++.++||||||+++|||++|+.||..... .............
T Consensus 142 df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~ 218 (283)
T cd07835 142 DFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLFRIFRTLGT 218 (283)
T ss_pred ecccccccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCC
Confidence 9999975433211 11223568899999988664 468899999999999999999999853311 1111111111000
Q ss_pred ccc--------------cccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 869 SRD--------------SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 869 ~~~--------------~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... ....................+.+++.+|++.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 219 PDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred CChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000000011111122233568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=330.57 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=190.5
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
...+|+..+.||+|+||.|||++.+ ||+.+|||++.-. . .......+.+|+..+++|+|||||
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~---------------~-s~~~~skI~rEVk~LArLnHpNVV 540 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLK---------------A-SDKLYSKILREVKLLARLNHPNVV 540 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCc---------------h-HHHHHHHHHHHHHHHhhcCCccee
Confidence 4567788899999999999999988 8999999998421 1 234456788999999999999999
Q ss_pred eEEEEEec-----------------------------------------------------------------C------
Q 002250 706 KLYCSITS-----------------------------------------------------------------E------ 714 (947)
Q Consensus 706 ~l~~~~~~-----------------------------------------------------------------~------ 714 (947)
+++..+.+ +
T Consensus 541 RYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~ 620 (1351)
T KOG1035|consen 541 RYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEEN 620 (1351)
T ss_pred eeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccc
Confidence 99821100 0
Q ss_pred ------------------------------------------------CccEEEEeccCCCChHHHhhhcCCccCCHHHH
Q 002250 715 ------------------------------------------------DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746 (947)
Q Consensus 715 ------------------------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 746 (947)
...||-||||+...+.++++...... .....
T Consensus 621 ~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~ 699 (1351)
T KOG1035|consen 621 DDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEA 699 (1351)
T ss_pred ccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHH
Confidence 11478999999888888887643211 46677
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecc----------------cCCCCcceeccc
Q 002250 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ----------------TGEAGDLTHVIA 810 (947)
Q Consensus 747 ~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~----------------~~~~~~~~~~~~ 810 (947)
++++.+|+.||+|+| +++||||||||.||+++++..|||+|||+|+... .+......+..+
T Consensus 700 wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~V 776 (1351)
T KOG1035|consen 700 WRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQV 776 (1351)
T ss_pred HHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccccc
Confidence 889999999999999 8999999999999999999999999999998622 011111234668
Q ss_pred ccccccCccccccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHH
Q 002250 811 GTHGYIAPEYAYTC---KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKE 887 (947)
Q Consensus 811 gt~~y~aPE~~~~~---~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 887 (947)
||.-|+|||++.+. .|+.|+|+||+|||++||+ +||...+ +-...+.... .... |..+.+..+
T Consensus 777 GTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsM----ERa~iL~~LR-~g~i------P~~~~f~~~ 842 (1351)
T KOG1035|consen 777 GTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSM----ERASILTNLR-KGSI------PEPADFFDP 842 (1351)
T ss_pred ceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchH----HHHHHHHhcc-cCCC------CCCcccccc
Confidence 99999999998654 4999999999999999998 4664322 2222221111 1111 111333455
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 888 DALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 888 ~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.++.=.++++++++.||.+|||+.|++.
T Consensus 843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 843 EHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 5556678899999999999999999985
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=301.94 Aligned_cols=254 Identities=29% Similarity=0.349 Sum_probs=196.5
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNV 704 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 704 (947)
..++|.+.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.+++++ +|||+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~------------------~~~~~~~~~e~~~l~~l~~h~ni 81 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI------------------SDVDEEIEAEYNILQSLPNHPNV 81 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc------------------ccHHHHHHHHHHHHHHhcCCCCe
Confidence 4578999999999999999999964 6889999987311 12235677899999999 89999
Q ss_pred ceEEEEEecC-----CccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 705 VKLYCSITSE-----DSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 705 v~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
+++++++... +..++||||+++++|.++++.. ....+++..+..++.|++.||+||| +.+++||||||+|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~n 158 (291)
T cd06639 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNN 158 (291)
T ss_pred EEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHH
Confidence 9999998754 3579999999999999988642 3356899999999999999999999 8899999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCC-----CCCccchHHHHHHHHHHHhCCCCCCCC
Q 002250 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-----INEKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 778 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
|+++.++.++|+|||.+......... .....|+..|+|||++.... ++.++|||||||++|||++|+.||...
T Consensus 159 ili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 159 ILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999998765432211 12346889999999875432 678999999999999999999998532
Q ss_pred CCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. ...+..+ ..... ... ....+....+.+++.+|++.+|++||++.|++++
T Consensus 237 ~~-~~~~~~~----~~~~~--~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 237 HP-VKTLFKI----PRNPP--PTL------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cH-HHHHHHH----hcCCC--CCC------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 1111111 00000 001 0112334568899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=303.13 Aligned_cols=265 Identities=18% Similarity=0.209 Sum_probs=193.8
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.+.|.+.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.+++.++|+||++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~ni~~ 67 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT----------------EEGVPFTAIREASLLKGLKHANIVL 67 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC----------------cCCCcHHHHHHHHHHHhcCCCCEeE
Confidence 367888999999999999999854 68999999983211 1122345678999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||++ +++.+++... ...+.+.....++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 68 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~ 142 (291)
T cd07870 68 LHDIIHTKETLTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGEL 142 (291)
T ss_pred EEEEEecCCeEEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcE
Confidence 9999999999999999995 6787777653 234677888889999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+|+|||+++....... ......++..|+|||++.+. .++.++|||||||++|||++|+.||.........+.+....
T Consensus 143 ~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~ 220 (291)
T cd07870 143 KLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220 (291)
T ss_pred EEeccccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHH
Confidence 9999999875433221 11233578999999998754 47889999999999999999999986432111111111000
Q ss_pred hc----------ccccccccccc-----CCCCccCH--HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 866 KM----------DSRDSMLTVVD-----PNISEILK--EDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 866 ~~----------~~~~~~~~~~d-----~~~~~~~~--~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.. ........... ........ .....+.+++.+|+..||++|||+.|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 221 LGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 00000000000 00000000 12456788999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=305.47 Aligned_cols=258 Identities=22% Similarity=0.272 Sum_probs=199.6
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.|+..+.||+|+||.||++... +++.||+|.+.... .........+.+|+.+++.++||||++++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~ 67 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN--------------LILRNQIQQVFVERDILTFAENPFVVSMF 67 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh--------------hhhHHHHHHHHHHHHHHHhCCCCCeeeeE
Confidence 5788899999999999999965 68899999873211 01112345778999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+.+..++..++||||+++++|.+++... ..+++.....++.|++.|++||| +.+++||||||+||+++.++.+++
T Consensus 68 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l 142 (305)
T cd05609 68 CSFETKRHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKL 142 (305)
T ss_pred EEEecCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEE
Confidence 9999999999999999999999999764 35788888999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCC-------------cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 789 ADFGLAKIVQTGEAG-------------DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
+|||+++........ .......++..|+|||++....++.++|+||||+++|||++|+.||...
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--- 219 (305)
T cd05609 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--- 219 (305)
T ss_pred eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---
Confidence 999998642111000 0011235788999999998888999999999999999999999998532
Q ss_pred cccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 856 SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
...+........... .+. .....+..+.+++.+|++.+|++||++.++.+.++.
T Consensus 220 --~~~~~~~~~~~~~~~-----~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 220 --TPEELFGQVISDDIE-----WPE---GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --CHHHHHHHHHhcccC-----CCC---ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111221111111100 011 111234567899999999999999998777777766
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=304.28 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=196.5
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.|.....||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||++++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~-----------------~~~~~~~~~~e~~~l~~l~hp~i~~~~ 84 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR-----------------KQQRRELLFNEVVIMRDYQHQNVVEMY 84 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec-----------------ccchHHHHHHHHHHHHhCCCCchhhhh
Confidence 3444567999999999999965 7899999988321 112345678899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++++|.+++.. ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|
T Consensus 85 ~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL 158 (297)
T cd06659 85 KSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKL 158 (297)
T ss_pred hheeeCCeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEE
Confidence 999999999999999999999998765 35789999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||++........ ......|+..|+|||++.+..++.++|||||||++|||++|+.||.... . .........
T Consensus 159 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~---~~~~~~~~~ 231 (297)
T cd06659 159 SDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--P---VQAMKRLRD 231 (297)
T ss_pred eechhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--H---HHHHHHHhc
Confidence 99999875433221 1223468899999999988889999999999999999999999985321 1 111111111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... ...........+.+++.+|++.+|++||++.+++++
T Consensus 232 ~~~~--------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 232 SPPP--------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCC--------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 001111223457889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=301.95 Aligned_cols=246 Identities=24% Similarity=0.323 Sum_probs=197.7
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|+||.||+|... +++.||+|++.... .........+.+|++++++++||||++++
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 67 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAK--------------IVKLKQVEHVLNEKRILQSIRHPFLVNLY 67 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhCCCCCcccee
Confidence 5788899999999999999965 68999999884211 01112346688999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..+...++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||+|+||+++.++.+||
T Consensus 68 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl 142 (290)
T cd05580 68 GSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKI 142 (290)
T ss_pred eEEEcCCeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999999874 45788899999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||++...... .....|++.|+|||.+.+...+.++||||||+++|||++|+.||.... ..........
T Consensus 143 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~ 212 (290)
T cd05580 143 TDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEKILE 212 (290)
T ss_pred eeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhc
Confidence 999999765443 123468899999999988888899999999999999999999985321 1111111111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQ 915 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 915 (947)
... ..+......+.+++.+|+..+|.+|+ ++.|+++
T Consensus 213 ~~~-----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 213 GKV-----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCc-----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111 11222245678899999999999998 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.27 Aligned_cols=276 Identities=23% Similarity=0.317 Sum_probs=204.8
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.|...+.||+|+||.||+|+.+ +|+.||||.+..-. .....+...+|++++++++|+|||+++
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----------------~~r~~e~~~~EieilkKLnh~NIVk~f 77 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----------------SLRPRERWCREIEILKKLNHPNIVKLF 77 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc----------------ccchHHHHHHHHHHHHHcCchhhhhhc
Confidence 3455678999999999999955 79999999884221 123456678999999999999999999
Q ss_pred EEEecCC------ccEEEEeccCCCChHHHhhhc-CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 709 CSITSED------SNLLVYEYLPNGSLWDRLHTC-HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 709 ~~~~~~~------~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
+.-++.. ...+|||||++|+|...+.+. ....+++...+.+..+++.||.||| +++||||||||.||++-
T Consensus 78 ~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~ 154 (732)
T KOG4250|consen 78 DIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQ 154 (732)
T ss_pred ccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEe
Confidence 8866544 457999999999999999864 3456899999999999999999999 89999999999999984
Q ss_pred --CCC--CeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 002250 782 --LEW--KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856 (947)
Q Consensus 782 --~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 856 (947)
.+| ..||+|||+|+...+.. ....++||..|.+||+... +.|+..+|.|||||++||++||..||.+..+..
T Consensus 155 ~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk 231 (732)
T KOG4250|consen 155 IGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK 231 (732)
T ss_pred ecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence 333 37999999999876655 3456789999999999984 789999999999999999999999997765432
Q ss_pred ccHHHHHHhhc-cccccccccc----cCC------C---CccCHHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHhhcc
Q 002250 857 KDIVNWVYSKM-DSRDSMLTVV----DPN------I---SEILKEDALKVLRIAIHCTNKLPAFRP--SMRVVVQMLEEA 920 (947)
Q Consensus 857 ~~~~~~~~~~~-~~~~~~~~~~----d~~------~---~~~~~~~~~~l~~l~~~cl~~dP~~RP--t~~ev~~~L~~~ 920 (947)
. ..+.++... .......-.. .+. + ....+.....+......++..+|.+|. .+.+....+..+
T Consensus 232 ~-~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 232 N-NKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred c-cchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 1 111111111 1110000000 000 0 112233445566667778888899998 777777766665
Q ss_pred CCCCccee
Q 002250 921 EPCSVTNI 928 (947)
Q Consensus 921 ~~~~~~~~ 928 (947)
...-...+
T Consensus 311 L~~~vvhi 318 (732)
T KOG4250|consen 311 LNLKVVHI 318 (732)
T ss_pred HhhheeEE
Confidence 55444443
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=298.04 Aligned_cols=259 Identities=23% Similarity=0.366 Sum_probs=201.4
Q ss_pred ccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|++|.||+|.. .+++.||+|++...... ..........+.+|++++++++|+||++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~-----------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 69 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT-----------SSEQEEVVEALRKEIRLMARLNHPHIIRML 69 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCC-----------chhHHHHHHHHHHHHHHHHHcCCCceehhh
Confidence 367788999999999999995 57899999998422110 001112346788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC-CeE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW-KPR 787 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~k 787 (947)
+++.+.+..++||||+++++|.+++... .++++.....++.|++.||+||| +.+++||||+|+||+++.++ .++
T Consensus 70 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~ 144 (268)
T cd06630 70 GATCEDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLR 144 (268)
T ss_pred ceeccCCeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999999999764 35788999999999999999999 89999999999999998775 599
Q ss_pred EeccccceecccCCCC--cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 788 IADFGLAKIVQTGEAG--DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
|+|||.+......... .......++..|+|||++.+..++.++||||+|+++|||++|..||..... .........
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~ 222 (268)
T cd06630 145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH--SNHLALIFK 222 (268)
T ss_pred EcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--cchHHHHHH
Confidence 9999999766443211 112234688999999999888899999999999999999999999853211 111111111
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.... ....+.+......+.+++.+|+..+|++||++.++++
T Consensus 223 ~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 IASA---------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred Hhcc---------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1000 0112333445677889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=302.74 Aligned_cols=266 Identities=21% Similarity=0.270 Sum_probs=198.6
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|+||.||+|... +++.||||++....... ........+..|++++++++|+||++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~------------~~~~~~~~~~~e~~~l~~~~h~~i~~~~ 68 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE------------AKDGINFTALREIKLLQELKHPNIIGLL 68 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc------------ccchhhHHHHHHHHHHhhcCCCCChhhh
Confidence 3677889999999999999965 68999999985322110 1112335567899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+ +++|.+++.... ..+++..+..++.|+++||+||| +.+|+||||+|+||+++.++.++|
T Consensus 69 ~~~~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l 143 (298)
T cd07841 69 DVFGHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKL 143 (298)
T ss_pred heeecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEE
Confidence 9999999999999999 999999998643 36899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||+++....... ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||.... ....+.... ...
T Consensus 144 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-~~~~~~~~~-~~~ 219 (298)
T cd07841 144 ADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-DIDQLGKIF-EAL 219 (298)
T ss_pred ccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-cHHHHHHHH-HHc
Confidence 99999986654321 1122346788999998865 457889999999999999999977764321 111111111 000
Q ss_pred ccc-c-------cccccc------cCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSR-D-------SMLTVV------DPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~-~-------~~~~~~------d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... . ...... ..............+.+++.+|++.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 220 GTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred CCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 0 000000 000111223345678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=302.62 Aligned_cols=251 Identities=26% Similarity=0.366 Sum_probs=200.3
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|... +++.||+|.+.. ......+.+.+|+.++++++||||++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~-----------------~~~~~~~~~~~e~~~l~~l~hp~i~~ 80 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-----------------QQQPKKELIINEILVMRENKHPNIVN 80 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecc-----------------ccchHHHHHHHHHHHHhhcCCCCeee
Confidence 378899999999999999999854 688999998721 11123466888999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++|+||+++++|.+++.+ ..+++..+..++.|++.|++||| +.+++||||+|+||+++.++.+
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~ 154 (293)
T cd06647 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSV 154 (293)
T ss_pred hhheeeeCCcEEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCE
Confidence 99999999999999999999999999975 24788899999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
+|+|||++......... .....|++.|+|||.+....++.++||||||+++||+++|+.||...... ..+...
T Consensus 155 kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~-----~~~~~~ 227 (293)
T cd06647 155 KLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYLI 227 (293)
T ss_pred EEccCcceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-----hheeeh
Confidence 99999998765433221 12346888999999998888999999999999999999999998532110 000000
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..... +. ..........+.+++.+||..+|++||++.+++.+
T Consensus 228 ~~~~~-------~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 228 ATNGT-------PE-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred hcCCC-------CC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00 11122334568889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=303.21 Aligned_cols=255 Identities=26% Similarity=0.332 Sum_probs=193.8
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~ 706 (947)
++|...+.||+|+||.||++... +++.||||.+.... .......+.+|+.++.++. ||||++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~----------------~~~~~~~~~~e~~~l~~~~~~~~iv~ 67 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV----------------DEKEQKRLLMDLDVVMRSSDCPYIVK 67 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc----------------ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34566788999999999999965 68999999883211 1123456889999999996 999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHh---hhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRL---HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l---~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
+++++..++..+++|||++ +++.++. .......+++.....++.+++.||+|||+ ..+++||||||+||+++.+
T Consensus 68 ~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~ 144 (288)
T cd06616 68 FYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRN 144 (288)
T ss_pred eeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccC
Confidence 9999999999999999985 4655543 33234568999999999999999999993 3589999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC---KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+.++|+|||+++....... .....|+..|+|||++... .++.++|||||||++|||++|+.||.... ...
T Consensus 145 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~ 217 (288)
T cd06616 145 GNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVF 217 (288)
T ss_pred CcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHH
Confidence 9999999999975543221 1223578899999998776 68899999999999999999999984321 121
Q ss_pred HHHHhhccccccccccccCCC-CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
........... +.+ ..........+.+++.+|++.+|++|||+.+|+++
T Consensus 218 ~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 218 DQLTQVVKGDP-------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHHhhhcCCCC-------CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 21111111110 111 11112345678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=326.08 Aligned_cols=287 Identities=18% Similarity=0.229 Sum_probs=192.2
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC--CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN--SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
..+.++|++.+.||+|+||+||++..+ .+..+++|.+.....+.....................+.+|+.++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 445688999999999999999998854 233344442211111000000000000111112345688999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcC---CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH---KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
||+++++++..++..|+|+|++ ++++.+++.... ...........++.|++.||+||| +.+||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 9999999999999999999999 457777775421 112334556789999999999999 899999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-C-cc
Q 002250 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG-D-SK 857 (947)
Q Consensus 780 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~-~-~~ 857 (947)
++.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|..++..... . ..
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 999999999999999876543221 12235799999999999998999999999999999999998765432211 1 11
Q ss_pred cHHHHHHhhcccccccc-------cccc--------CCCCccCH--HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 858 DIVNWVYSKMDSRDSML-------TVVD--------PNISEILK--EDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 858 ~~~~~~~~~~~~~~~~~-------~~~d--------~~~~~~~~--~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.+.+...........+. ..++ ..++.... .....+.+++.+|++.||.+|||+.|++++
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111111000000000 0000 00000000 112356778889999999999999999864
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=300.62 Aligned_cols=262 Identities=22% Similarity=0.304 Sum_probs=196.7
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|++|.||+|+.. +|+.||||++.... .......+.+|++++++++||||++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~i~~~~ 64 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA----------------EEGTPSTAIREISLMKELKHENIVRLH 64 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccc----------------cccchHHHHHHHHHHHhhcCCCEeeee
Confidence 4778899999999999999975 68999999984221 112345677899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcC-CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCH-KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++...+..++||||+++ +|.+++.... ...+++..+..++.|++.||+||| +.+++||||+|+||++++++.++
T Consensus 65 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~ 140 (284)
T cd07836 65 DVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELK 140 (284)
T ss_pred eeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEE
Confidence 999999999999999975 8888887543 346899999999999999999999 88999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
++|||+++....... ......++..|+|||++.+. .++.++||||||+++|||++|+.||..... .+........
T Consensus 141 l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~ 216 (284)
T cd07836 141 LADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN--EDQLLKIFRI 216 (284)
T ss_pred EeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHH
Confidence 999999975433211 11223568899999988654 468899999999999999999999854321 1111110000
Q ss_pred c-----------cccccccc----cccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 867 M-----------DSRDSMLT----VVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 867 ~-----------~~~~~~~~----~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
. ........ ..+.............+.+++.+|++.||++||++.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 217 MGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 00000000 0000001112233556889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=297.89 Aligned_cols=252 Identities=30% Similarity=0.414 Sum_probs=204.5
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|++|.||+|... +++.||||++.... .......+.+|+.++.+++|+||++++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~----------------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG----------------DEEFRKQLLRELKTLRSCESPYVVKCY 65 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc----------------chHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 5778899999999999999976 59999999984221 012346789999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCCeEecCCCCeE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFD-RPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++..++..++||||+++++|.+++... ..+++..+..++.|+++|++||| + .+++||||+|+||+++.++.++
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~ 140 (264)
T cd06623 66 GAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVK 140 (264)
T ss_pred EEEccCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999999864 56899999999999999999999 8 9999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||.+.......... ....++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ....+......
T Consensus 141 l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~ 216 (264)
T cd06623 141 IADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAIC 216 (264)
T ss_pred EccCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHh
Confidence 99999998665433221 134578899999999988899999999999999999999999854321 12222221111
Q ss_pred cccccccccccCCCCccCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKE-DALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
. ......... .+..+.+++.+|++.+|++||++.|++++
T Consensus 217 ~----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 D----------GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred c----------CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 111122222 45678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.51 Aligned_cols=259 Identities=19% Similarity=0.213 Sum_probs=192.9
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccceEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVKLY 708 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~ 708 (947)
|++.+.||+|+||.||+|... +++.||+|++.... .........+|+.+++++. |+|+++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~----------------~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 64 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF----------------KSLEQVNNLREIQALRRLSPHPNILRLI 64 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhcc----------------CCchhhhHHHHHHHHhhcCCCCCccceE
Confidence 567788999999999999954 68999999874211 1112223457888999885 99999999
Q ss_pred EEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 709 CSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 709 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++.++ +..++||||++ +++.+++.... ..+++..+..++.|++.||+||| +.+++||||+|+||+++. +.+
T Consensus 65 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~ 138 (282)
T cd07831 65 EVLFDRKTGRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DIL 138 (282)
T ss_pred EEEecCCCCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCe
Confidence 999987 88999999996 58888887532 46899999999999999999999 889999999999999999 999
Q ss_pred EEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||.++........ ....++..|+|||++.. +.++.++||||+||++|||++|+.||.... ..+.......
T Consensus 139 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~--~~~~~~~~~~ 213 (282)
T cd07831 139 KLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN--ELDQIAKIHD 213 (282)
T ss_pred EEEecccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC--HHHHHHHHHH
Confidence 99999999765433221 12357889999997654 457889999999999999999999985321 1111111111
Q ss_pred hccc-----------ccc----ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 866 KMDS-----------RDS----MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 866 ~~~~-----------~~~----~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... ... ........+.......+..+.+++.+|++.+|++||++.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 214 VLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 1100 000 00001111112223456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=297.93 Aligned_cols=254 Identities=28% Similarity=0.387 Sum_probs=199.9
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|+||.||+|... +++.||+|.+..... .......+.+|+.++++++|+||++++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------~~~~~~~~~~e~~~~~~l~~~~i~~~~ 65 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN---------------DPKTIKEIADEMKVLELLKHPNLVKYY 65 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc---------------chHHHHHHHHHHHHHHhCCCCChhhee
Confidence 4778899999999999999965 789999999842211 113457789999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++...+..++|+||+++++|.+++... ..+++..+..++.++++|++||| +.+++|+||+|+||++++++.+||
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl 140 (264)
T cd06626 66 GVEVHREKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKL 140 (264)
T ss_pred eeEecCCEEEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999999863 34788889999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcc--eecccccccccCccccccCC---CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 789 ADFGLAKIVQTGEAGDL--THVIAGTHGYIAPEYAYTCK---INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
+|||.+........... .....++..|+|||++.... ++.++||||||+++|||++|+.||..... -....
T Consensus 141 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~----~~~~~ 216 (264)
T cd06626 141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----EFQIM 216 (264)
T ss_pred cccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc----hHHHH
Confidence 99999987654332111 11245788999999998766 88999999999999999999999853221 11111
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
....... .+.++.. ......+.+++.+|++.+|++|||+.+++.
T Consensus 217 ~~~~~~~-------~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 217 FHVGAGH-------KPPIPDS-LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHhcCC-------CCCCCcc-cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111100 1111111 122456778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=303.18 Aligned_cols=264 Identities=21% Similarity=0.242 Sum_probs=198.9
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|+||.||+|..+ +++.||||++.... ........+.+|++++++++|+||++++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 66 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE---------------DDEDVKKTALREVKVLRQLRHENIVNLK 66 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc---------------ccccchhHHHHHHHHHHhcCCCCeeehh
Confidence 5788899999999999999966 68899999873211 1123346788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||++++.+..+... ...+++.....++.|++.|++||| ..+++||||+|+||++++++.++|
T Consensus 67 ~~~~~~~~~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl 141 (288)
T cd07833 67 EAFRRKGRLYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKL 141 (288)
T ss_pred heEEECCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEE
Confidence 999999999999999998777665554 244789999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh-
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK- 866 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~- 866 (947)
+|||.+.......... .....++..|+|||++.+. .++.++||||||+++|||++|+.||..... ...+.......
T Consensus 142 ~d~g~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~ 219 (288)
T cd07833 142 CDFGFARALRARPASP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-IDQLYLIQKCLG 219 (288)
T ss_pred EeeecccccCCCcccc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhC
Confidence 9999998665443211 1234678899999999888 788999999999999999999999853211 11111100000
Q ss_pred ---------cccccc-----ccccccCCC--CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 867 ---------MDSRDS-----MLTVVDPNI--SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 867 ---------~~~~~~-----~~~~~d~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
...... +....++.. ...+...+..+.+++.+||+.+|++||+++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 220 PLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 000000000 0112223677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=301.00 Aligned_cols=265 Identities=22% Similarity=0.234 Sum_probs=196.9
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.+.|+..+.||+|+||.||+|..+ +++.+|+|.+..... .......+.+|+.++++++||||++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~ni~~ 68 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE---------------KEGFPITSLREINILLKLQHPNIVT 68 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc---------------cccchhhHHHHHHHHHhcCCCCEEE
Confidence 367888999999999999999976 688999999842211 1122345678999999999999999
Q ss_pred EEEEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 707 LYCSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 707 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++..+ ...|+||||++ ++|.+++.... ..+++.....++.|++.||+||| +.+++||||||+||+++.++
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~ 143 (293)
T cd07843 69 VKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRG 143 (293)
T ss_pred EEEEEEecCCCcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCC
Confidence 99998877 88999999996 59999887643 36899999999999999999999 88999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
.++|+|||++........ ......+++.|+|||.+.+.. ++.++|+||+|+++|||++|+.||..... .+...-.
T Consensus 144 ~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~--~~~~~~~ 219 (293)
T cd07843 144 ILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE--IDQLNKI 219 (293)
T ss_pred cEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHH
Confidence 999999999986654321 112335788999999887544 68899999999999999999999853211 0000000
Q ss_pred Hhhcc-----------cc-----ccccccccCCC-CccCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 864 YSKMD-----------SR-----DSMLTVVDPNI-SEILKE-DALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 864 ~~~~~-----------~~-----~~~~~~~d~~~-~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..... .. ..........+ ..+... ....+.+++.+|++.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 220 FKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 00 00000000011 111111 25567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=297.94 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=197.7
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.|...+.||+|++|.||+|... +++.+|+|++... .....+.+.+|+.+++.++||||++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-----------------~~~~~~~~~~e~~~l~~~~h~~vv~~~ 82 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-----------------KQQRRELLFNEVVIMRDYQHPNIVEMY 82 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-----------------chhHHHHHHHHHHHHHHcCCCChheEE
Confidence 4555678999999999999954 7899999987311 112235578999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++|+||+++++|.+++.. ..+++..+..++.|++.|++||| +.+++||||+|+||+++.++.+++
T Consensus 83 ~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l 156 (285)
T cd06648 83 SSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKL 156 (285)
T ss_pred EEEEcCCeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEE
Confidence 999999999999999999999999876 35788999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||.+........ ......|++.|+|||...+..++.++||||||+++|||++|+.||... +..........
T Consensus 157 ~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~-----~~~~~~~~~~~ 229 (285)
T cd06648 157 SDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE-----PPLQAMKRIRD 229 (285)
T ss_pred cccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC-----CHHHHHHHHHh
Confidence 99998875433221 112345889999999998888999999999999999999999998532 11222211111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... +.. ......+..+.+++.+|++.+|++|||+.+++++
T Consensus 230 ~~~-------~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 230 NLP-------PKL-KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCC-------CCC-cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 110 011 1111234578999999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.07 Aligned_cols=254 Identities=28% Similarity=0.398 Sum_probs=205.8
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|+..+.||+|++|.||+|... +++.|++|++..... .....+.+.+|++++++++||||++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD---------------SEEELEALEREIRILSSLQHPNIVRYY 65 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc---------------chHHHHHHHHHHHHHHHcCCCCEeeEE
Confidence 3677889999999999999976 789999999842211 123457789999999999999999999
Q ss_pred EEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 709 CSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 709 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+.+... ...++|+||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.+
T Consensus 66 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~ 140 (260)
T cd06606 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVV 140 (260)
T ss_pred EEEecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCE
Confidence 999988 88999999999999999998744 7899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
+|+|||.+................++..|+|||.......+.++||||||+++|||++|..||.... +........
T Consensus 141 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~ 216 (260)
T cd06606 141 KLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKI 216 (260)
T ss_pred EEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhc
Confidence 9999999987665443211234568899999999988889999999999999999999999985432 111111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... ......+...+..+.+++.+|++.+|++||++.++++.
T Consensus 217 ~~~---------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 217 GSS---------GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ccc---------CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 110 11122333446778999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=280.11 Aligned_cols=259 Identities=21% Similarity=0.264 Sum_probs=205.6
Q ss_pred ccHHHHhhccCCc-ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc
Q 002250 622 FSEKEIIDAVKPE-NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV 699 (947)
Q Consensus 622 ~~~~~~~~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 699 (947)
+.+-.++++|++. ++||-|-.|.|-.+..+ +++.+|+|++ .+....++|++..-..
T Consensus 54 ~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL----------------------~Ds~KARrEVeLHw~~ 111 (400)
T KOG0604|consen 54 FKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVL----------------------LDSPKARREVELHWMA 111 (400)
T ss_pred hhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHH----------------------hcCHHHHhHhhhhhhh
Confidence 3445567888774 67999999999999966 7899999988 3445667888876555
Q ss_pred -cccccceEEEEEec----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCC
Q 002250 700 -RHVNVVKLYCSITS----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVK 774 (947)
Q Consensus 700 -~h~niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlk 774 (947)
.|||||.++++|+. .....+|||.|+||.|.+.+...+...+++...-.|+.||+.|+.||| +..|.|||||
T Consensus 112 s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlK 188 (400)
T KOG0604|consen 112 SGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLK 188 (400)
T ss_pred cCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCC
Confidence 69999999998865 345679999999999999999988889999999999999999999999 8999999999
Q ss_pred CCCeEec---CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 775 SSNILLD---LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 775 p~NIll~---~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
|+|+|.. .+..+||+|||+|+.-..... ....+-|+.|.|||++-..+|+...|+||+||++|-|++|.+||+.
T Consensus 189 pENLLyt~t~~na~lKLtDfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 189 PENLLYTTTSPNAPLKLTDFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred hhheeeecCCCCcceEecccccccccCCCcc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 9999996 456799999999986543222 2234679999999999999999999999999999999999999976
Q ss_pred CCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 852 EFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..+ ..+..-++.++....- ....+......+...++++..++.+|++|.|+.|++.+
T Consensus 266 ~hg--~aispgMk~rI~~gqy------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 266 NHG--LAISPGMKRRIRTGQY------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCC--ccCChhHHhHhhccCc------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 543 2222222222211110 01123345566778889999999999999999999853
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=301.20 Aligned_cols=257 Identities=27% Similarity=0.353 Sum_probs=200.1
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
..|+..+.||+|+||.||+|+.. +++.||+|++..... ........+.+|++++++++|||++++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~iv~~ 90 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK--------------QSNEKWQDIIKEVKFLQRIKHPNSIEY 90 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--------------CchHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 44778889999999999999965 688999998832110 011233568889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..+...++||||++ |++.+.+... ...+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.++
T Consensus 91 ~~~~~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~k 165 (317)
T cd06635 91 KGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVK 165 (317)
T ss_pred EEEEeeCCeEEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEE
Confidence 999999999999999996 5788877643 345899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY---TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
|+|||++...... ....|++.|+|||++. .+.++.++|||||||++|||++|+.||... +......
T Consensus 166 l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-----~~~~~~~ 234 (317)
T cd06635 166 LADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALY 234 (317)
T ss_pred EecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-----cHHHHHH
Confidence 9999998754332 2345788999999974 456889999999999999999999998532 1111111
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
....... ...........+.+++.+|++.+|.+||++.+++++...+...+
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 235 HIAQNES---------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHhccC---------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 1111110 01111233456888999999999999999999999876655544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=295.13 Aligned_cols=248 Identities=25% Similarity=0.304 Sum_probs=198.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|+.-++||+|+||.||-++.+ +|+-+|.|++.. ..+ +......-...|-.|+++++.+.||.+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~K------------KRi--Kkr~ge~maLnEk~iL~kV~s~FiVsl 250 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDK------------KRI--KKRKGETMALNEKQILEKVSSPFIVSL 250 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHH------------HHH--HHhhhhHHhhHHHHHHHHhccCcEEEE
Confidence 45677789999999999999865 689999998721 111 122333455689999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
--.|+.++..++|+..|.||+|.-++...+...+++..+.-.|.+|+.||++|| ..+||.||+||+|||+|+.|+++
T Consensus 251 aYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 251 AYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred eeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeE
Confidence 888999999999999999999999998888778999999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc--ccHHHHHHh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS--KDIVNWVYS 865 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~--~~~~~~~~~ 865 (947)
|+|.|+|..+..++... ..+||.+|||||++.++.|+...|.||+||++|||+.|+.||...-... .++.+.
T Consensus 328 ISDLGLAvei~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr--- 401 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR--- 401 (591)
T ss_pred eeccceEEecCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH---
Confidence 99999999887766533 3489999999999999999999999999999999999999995431110 011110
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
..... .++.+.-.++..++....+.+||++|...
T Consensus 402 ~~~~~-----------~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 402 TLEDP-----------EEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred Hhcch-----------hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 00000 12223334456677778899999999743
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=297.77 Aligned_cols=262 Identities=24% Similarity=0.261 Sum_probs=196.4
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc---cccccce
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV---RHVNVVK 706 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~ 706 (947)
|++.+.||+|+||.||+|+.+ +++.||||++..... .......+.+|+.+++++ +|||+++
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~h~~i~~ 65 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS---------------EEGIPLSTLREIALLKQLESFEHPNIVR 65 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc---------------cchhhhhHHHHHHHHHHhhccCCCCcce
Confidence 567789999999999999976 589999999842211 111223456677777666 5999999
Q ss_pred EEEEEecCCc-----cEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 707 LYCSITSEDS-----NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 707 l~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
+++++...+. .+++|||++ ++|.+++.......+++..+..++.|++.||+||| +.+++|+||+|+||+++
T Consensus 66 ~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~ 141 (287)
T cd07838 66 LLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVT 141 (287)
T ss_pred EEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEc
Confidence 9999988776 899999996 58999988755556899999999999999999999 88999999999999999
Q ss_pred CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
.++.++|+|||.+......... ....++..|+|||++.+..++.++||||||+++|||++|+.||.... ....+..
T Consensus 142 ~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~-~~~~~~~ 217 (287)
T cd07838 142 SDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS-EADQLDK 217 (287)
T ss_pred cCCCEEEeccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC-hHHHHHH
Confidence 9999999999999776443221 12347889999999998889999999999999999999998885321 1111111
Q ss_pred HHHhhcc-c-----------cccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 862 WVYSKMD-S-----------RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 862 ~~~~~~~-~-----------~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
+...... . .................+....+.+++.+||+.||++||++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 218 IFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 1110000 0 0000000111112223344567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=306.37 Aligned_cols=268 Identities=24% Similarity=0.320 Sum_probs=198.2
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVN 703 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 703 (947)
.+.++|++.+.||+|+||.||+|... +++.+|||++.... ........+.+|+.+++++ +|||
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~~h~n 68 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF---------------RNATDAQRTFREIMFLQELGDHPN 68 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc---------------CcchhhhhhhHHHHHHHHhcCCCC
Confidence 45688999999999999999999965 68899999884211 0112234567899999999 9999
Q ss_pred cceEEEEEecCC--ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 704 VVKLYCSITSED--SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 704 iv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
|+++++++...+ ..++||||++ ++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 69 i~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~ 141 (337)
T cd07852 69 IVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLN 141 (337)
T ss_pred ccceeeeeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEc
Confidence 999999986543 5799999996 5999988763 6788999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCCC---cceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 782 LEWKPRIADFGLAKIVQTGEAG---DLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
.++.+||+|||++......... .......|+..|+|||++.. ..++.++||||||+++|||++|+.||...... .
T Consensus 142 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-~ 220 (337)
T cd07852 142 SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-N 220 (337)
T ss_pred CCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-H
Confidence 9999999999999865443221 12223468899999998755 45788999999999999999999998532110 0
Q ss_pred cHHHHHHhhc------------cccc-ccccccc---CCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 858 DIVNWVYSKM------------DSRD-SMLTVVD---PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 858 ~~~~~~~~~~------------~~~~-~~~~~~d---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.......... .... .+..... ..........+..+.+++.+|++.||++|||+.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000 0000 0000000 01111122245678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=301.20 Aligned_cols=265 Identities=22% Similarity=0.268 Sum_probs=195.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|+..+.||+|++|+||+|..+ +++.||+|.+.... ........+.+|++++++++||||+++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 66 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ---------------EDEGVPSTAIREISLLKEMQHGNIVRL 66 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcc---------------ccccchHHHHHHHHHHHhccCCCEeeE
Confidence 46888899999999999999965 78999999873211 111234567889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC-CCCe
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL-EWKP 786 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ 786 (947)
++++..+...++||||++ +++.+++........++.....++.|++.||+||| +.+++||||+|+||+++. ++.+
T Consensus 67 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~ 142 (294)
T PLN00009 67 QDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNAL 142 (294)
T ss_pred EEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEE
Confidence 999999999999999995 58888887655555788888899999999999999 889999999999999985 5679
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||++........ ......+++.|+|||++.+. .++.++||||+|+++|||+||+.||..... ...+......
T Consensus 143 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~-~~~~~~~~~~ 219 (294)
T PLN00009 143 KLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-IDELFKIFRI 219 (294)
T ss_pred EEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH
Confidence 9999999975433211 11233578899999988664 478899999999999999999999853211 1111111100
Q ss_pred hcccccccc--------------ccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 866 KMDSRDSML--------------TVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 866 ~~~~~~~~~--------------~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
......... .................+.+++.+|++.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 220 LGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000 00000001111223455788999999999999999999986
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=303.13 Aligned_cols=269 Identities=22% Similarity=0.261 Sum_probs=195.3
Q ss_pred ccCCcccccccCceeEEEEEeC---CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN---SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
+|++.+.||+|+||.||+|... +++.||+|.+..... ........+.+|+.++++++||||++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~~ 66 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--------------QYTGISQSACREIALLRELKHENVVS 66 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--------------cccCccHHHHHHHHHHHhcCCCCccc
Confidence 3677889999999999999965 478999999853221 11122356778999999999999999
Q ss_pred EEEEEecC--CccEEEEeccCCCChHHHhhhcC---CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 707 LYCSITSE--DSNLLVYEYLPNGSLWDRLHTCH---KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 707 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
+++++... ...++||||+++ ++.+++.... ...++......++.|++.|++||| +.+|+||||||+||+++
T Consensus 67 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~ 142 (316)
T cd07842 67 LVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVM 142 (316)
T ss_pred eEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEc
Confidence 99999988 778999999964 7777765332 236788999999999999999999 89999999999999999
Q ss_pred C----CCCeEEeccccceecccCCC-CcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 782 L----EWKPRIADFGLAKIVQTGEA-GDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 782 ~----~~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
. ++.+||+|||+++....... ........++..|+|||++.+. .++.++||||||+++|||++|+.||......
T Consensus 143 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 143 GEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred CCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 9 89999999999986543322 1122234678899999988764 4789999999999999999999999654322
Q ss_pred cc--------cHHHHHHhhcc----------ccccccc---cc-cCCCC-ccCH-------HHHHHHHHHHHhccCCCCC
Q 002250 856 SK--------DIVNWVYSKMD----------SRDSMLT---VV-DPNIS-EILK-------EDALKVLRIAIHCTNKLPA 905 (947)
Q Consensus 856 ~~--------~~~~~~~~~~~----------~~~~~~~---~~-d~~~~-~~~~-------~~~~~l~~l~~~cl~~dP~ 905 (947)
.. .+...+..... ....... .. ..... .... .....+.+++.+|++.||+
T Consensus 223 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 302 (316)
T cd07842 223 IKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPT 302 (316)
T ss_pred ccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcc
Confidence 10 00000000000 0000000 00 00000 0000 2334688999999999999
Q ss_pred CCCCHHHHHHH
Q 002250 906 FRPSMRVVVQM 916 (947)
Q Consensus 906 ~RPt~~ev~~~ 916 (947)
+|||+.|++++
T Consensus 303 ~Rps~~eil~~ 313 (316)
T cd07842 303 KRITAEEALEH 313 (316)
T ss_pred cCcCHHHHhcC
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=293.11 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=194.8
Q ss_pred ccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecCC
Q 002250 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSED 715 (947)
Q Consensus 637 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 715 (947)
||.|++|.||+|+.. +++.||+|++..... ......+.+.+|+.++++++||||+++++++.++.
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 66 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI--------------VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK 66 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc--------------hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC
Confidence 699999999999965 589999999842210 11123467889999999999999999999999999
Q ss_pred ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 716 SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 716 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
..++||||+++++|.+++.+. ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+.
T Consensus 67 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~ 141 (262)
T cd05572 67 YIYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAK 141 (262)
T ss_pred ccEEEEecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCccc
Confidence 999999999999999999864 34788899999999999999999 8999999999999999999999999999998
Q ss_pred ecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccc
Q 002250 796 IVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLT 875 (947)
Q Consensus 796 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 875 (947)
...... ......++..|+|||.+....++.++|+||+|+++|||++|+.||..... +..+..........
T Consensus 142 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~---- 211 (262)
T cd05572 142 KLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---DPMEIYNDILKGNG---- 211 (262)
T ss_pred ccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---CHHHHHHHHhccCC----
Confidence 665432 12234678999999999888899999999999999999999999854322 12222222111111
Q ss_pred cccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 002250 876 VVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-----MRVVVQ 915 (947)
Q Consensus 876 ~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 915 (947)
....+......+.+++.+||+.+|++||+ +.|+++
T Consensus 212 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 212 -----KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -----CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11122223567899999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=295.71 Aligned_cols=245 Identities=25% Similarity=0.288 Sum_probs=186.0
Q ss_pred cccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhh---ccccccceEEEEE
Q 002250 636 LIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSA---VRHVNVVKLYCSI 711 (947)
Q Consensus 636 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~h~niv~l~~~~ 711 (947)
.||+|+||.||+|... +++.+|+|.+...... .......+.+|..+++. ..||||+.+++++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 66 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--------------MKQGETLALNERIMLSLVSTGDCPFIVCMTYAF 66 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccc--------------cchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE
Confidence 4899999999999965 6899999988432110 01112233444444433 4799999999999
Q ss_pred ecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecc
Q 002250 712 TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791 (947)
Q Consensus 712 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 791 (947)
..++..++||||+++++|.+++... ..+++.....++.|++.|++||| +.+|+||||||+||++++++.++++||
T Consensus 67 ~~~~~~~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~df 141 (279)
T cd05633 67 HTPDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDL 141 (279)
T ss_pred ecCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccC
Confidence 9999999999999999999998764 35899999999999999999999 899999999999999999999999999
Q ss_pred ccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccc
Q 002250 792 GLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSR 870 (947)
Q Consensus 792 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 870 (947)
|++....... .....||..|+|||.... ..++.++||||+||++|||++|..||......... ........
T Consensus 142 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~-- 213 (279)
T cd05633 142 GLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT-- 213 (279)
T ss_pred CcceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHHhhc--
Confidence 9987543322 123468999999998864 45789999999999999999999999643221111 11010000
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 871 DSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 871 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
.. ...+......+.+++.+|++.||++|| +++|++++
T Consensus 214 ------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 214 ------VN---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ------CC---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 01 112233455788899999999999999 59888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=325.36 Aligned_cols=259 Identities=26% Similarity=0.386 Sum_probs=208.2
Q ss_pred hccCCcccccccCceeEEEEEeC----C----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN----S----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV- 699 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 699 (947)
++.++.+.+|+|.||.|++|... . ...||||.++... ...+.+.+..|++++..+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~----------------~~~~~~~~~~El~~m~~~g 359 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA----------------SSSEKKDLMSELNVLKELG 359 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc----------------CcHHHHHHHHHHHHHHHhc
Confidence 33456669999999999999843 1 4579999984221 224567899999999999
Q ss_pred cccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC------------C--ccCCHHHHHHHHHHHHHHHHHHhcCCC
Q 002250 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH------------K--IEMDWVVRYAIAVGAAKGLEYLHHGFD 765 (947)
Q Consensus 700 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~~ia~~l~yLH~~~~ 765 (947)
.|+||+.++|+|..++..++|+||++.|+|.++++..+ . ..+.....+.++.|||.||+||+ +
T Consensus 360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~ 436 (609)
T KOG0200|consen 360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---S 436 (609)
T ss_pred CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---h
Confidence 59999999999999999999999999999999998754 0 13788899999999999999999 8
Q ss_pred CCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecc-cccccccCccccccCCCCCccchHHHHHHHHHHHh
Q 002250 766 RPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI-AGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844 (947)
Q Consensus 766 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt 844 (947)
.++|||||.++|||+.++..+||+|||+|+.............. .-...|||||.+....|+.++|||||||++|||+|
T Consensus 437 ~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eifs 516 (609)
T KOG0200|consen 437 VPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFT 516 (609)
T ss_pred CCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhh
Confidence 99999999999999999999999999999976655443322111 12457999999999999999999999999999999
Q ss_pred -CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 845 -GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 845 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
|..||.. .....++.+++. ++...+.+..+..+++++|+.||+.+|++||++.|+++.++..
T Consensus 517 LG~~PYp~-~~~~~~l~~~l~-------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 517 LGGTPYPG-IPPTEELLEFLK-------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCCCCCCC-CCcHHHHHHHHh-------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 8889843 111233333222 1222344556677899999999999999999999999999884
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=296.49 Aligned_cols=256 Identities=28% Similarity=0.386 Sum_probs=203.9
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
+..+.|+..+.||+|++|.||+|..+ +++.||+|++... ....+.+.+|++++++++|+|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~------------------~~~~~~~~~e~~~l~~l~~~~i 77 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR------------------KQNKELIINEILIMKDCKHPNI 77 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecC------------------chhHHHHHHHHHHHHHCCCCCe
Confidence 34567888899999999999999976 7899999988311 0135678899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++..+...++|+||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~ 153 (286)
T cd06614 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDG 153 (286)
T ss_pred eEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCC
Confidence 999999999999999999999999999998743 46899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
.++|+|||.+........ ......++..|+|||++.+..++.++|||||||++|||++|+.||... +......
T Consensus 154 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-----~~~~~~~ 226 (286)
T cd06614 154 SVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-----PPLRALF 226 (286)
T ss_pred CEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-----CHHHHHH
Confidence 999999999865543221 112335788999999998888999999999999999999999998422 1111111
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
....... . .. ......+..+.+++.+|++.+|.+||++.+++++--
T Consensus 227 ~~~~~~~--~-----~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 227 LITTKGI--P-----PL-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred HHHhcCC--C-----CC-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 1111100 0 00 011123456889999999999999999999986443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=298.42 Aligned_cols=266 Identities=21% Similarity=0.222 Sum_probs=194.3
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~ 706 (947)
++|+..+.||+|+||.||+|... +++.||||++.... ........+.+|+.+++++. ||||++
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~~~~~i~~ 65 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM---------------DEEGIPPTALREISLLQMLSESIYIVR 65 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc---------------cccCCchHHHHHHHHHHHccCCCCccc
Confidence 36888899999999999999965 68999999873211 11123456788999999995 699999
Q ss_pred EEEEEecCCc-----cEEEEeccCCCChHHHhhhcC---CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 707 LYCSITSEDS-----NLLVYEYLPNGSLWDRLHTCH---KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 707 l~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++++...+. .|+||||+++ +|.+++.... ...+++.....++.||+.||+||| +.+|+||||+|+||
T Consensus 66 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~ni 141 (295)
T cd07837 66 LLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNL 141 (295)
T ss_pred eeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHE
Confidence 9999887665 7999999975 8988886542 246799999999999999999999 89999999999999
Q ss_pred EecC-CCCeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 002250 779 LLDL-EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856 (947)
Q Consensus 779 ll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 856 (947)
+++. ++.+||+|||++........ ......+++.|+|||++.+ ..++.++||||||+++|||++|..||..... .
T Consensus 142 l~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-~ 218 (295)
T cd07837 142 LVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-L 218 (295)
T ss_pred EEecCCCeEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-H
Confidence 9998 89999999999875533211 1112356889999998865 4578999999999999999999999853211 1
Q ss_pred ccHHHHHHhhccccc-cccccc------------cCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 857 KDIVNWVYSKMDSRD-SMLTVV------------DPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~-~~~~~~------------d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
............... ...... ...+..........+.+++.+|++.||.+||++.|++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 219 QQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 111111100000000 000000 000011112345668899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=291.68 Aligned_cols=244 Identities=22% Similarity=0.312 Sum_probs=189.7
Q ss_pred HhhccCCcccc--cccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccc
Q 002250 627 IIDAVKPENLI--GKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHV 702 (947)
Q Consensus 627 ~~~~~~~~~~i--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 702 (947)
..+.|++.+.+ |+|+||.||++..+ +++.+|+|.+.+.. ... .|+.....+ +||
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--------------------~~~--~e~~~~~~~~~h~ 69 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKN--------------------FNA--IEPMVHQLMKDNP 69 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhh--------------------cch--hhHHHHHHhhcCC
Confidence 34667776666 99999999999954 68889999873211 001 122222222 799
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
||+++++++..++..++||||+++++|.+++.... .+++.....++.|+++|++||| +.+++||||||+||+++.
T Consensus 70 ~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~ 144 (267)
T PHA03390 70 NFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDR 144 (267)
T ss_pred CEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeC
Confidence 99999999999999999999999999999998743 7899999999999999999999 889999999999999999
Q ss_pred CC-CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 783 EW-KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 783 ~~-~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
++ .++|+|||++....... ...++..|+|||++.+..++.++||||+|+++|||++|+.||........+...
T Consensus 145 ~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~ 218 (267)
T PHA03390 145 AKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES 218 (267)
T ss_pred CCCeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHH
Confidence 98 99999999987654322 235789999999999888999999999999999999999999643322222222
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-MRVVVQ 915 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~~ 915 (947)
+.... .. ...........+.+++.+|++.+|.+||+ +.|+++
T Consensus 219 ~~~~~-~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 219 LLKRQ-QK-----------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHhh-cc-----------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 22111 11 01122245567888999999999999996 588874
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=300.20 Aligned_cols=265 Identities=25% Similarity=0.288 Sum_probs=195.2
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ........+.+|+.++++++|+||++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~i~~ 70 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN---------------ERDGIPISSLREITLLLNLRHPNIVE 70 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEecc---------------CCCCCcchhhHHHHHHHhCCCCCCcc
Confidence 467899999999999999999965 68999999884221 11122234567999999999999999
Q ss_pred EEEEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 707 LYCSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 707 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++... +..++||||++ ++|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~ 145 (309)
T cd07845 71 LKEVVVGKHLDSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKG 145 (309)
T ss_pred eEEEEecCCCCeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCC
Confidence 99998765 45799999996 5888888763 356899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
.+||+|||.+......... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.... .......+
T Consensus 146 ~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--~~~~~~~~ 221 (309)
T cd07845 146 CLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--EIEQLDLI 221 (309)
T ss_pred CEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHH
Confidence 9999999999876543211 112245788999999865 457899999999999999999999985321 11111111
Q ss_pred Hhhccc-ccccc---------cc--cc-CC---CCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 864 YSKMDS-RDSML---------TV--VD-PN---ISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 864 ~~~~~~-~~~~~---------~~--~d-~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...... ..... .. .. .. +..........+.+++.+|++.||++|||+.|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 222 IQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 110000 00000 00 00 00 000011134567889999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=297.78 Aligned_cols=270 Identities=17% Similarity=0.190 Sum_probs=186.5
Q ss_pred hccCCcccccccCceeEEEEEeCC----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|++.+.||+|+||+||+|...+ +..+|+|+...... .. ..+..............+...+..+.|+++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~----~~--~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TI--VMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCC----ch--hhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 579999999999999999999664 45667765421110 00 000000011111223345556667799999
Q ss_pred ceEEEEEecCC----ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 705 VKLYCSITSED----SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 705 v~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
+++++++.... ..++++|++. .++.+.+... ...++.....++.|++.||+||| +.+|+||||||+|||+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill 159 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMV 159 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 99998766543 2367888773 4666666542 23567788899999999999999 8999999999999999
Q ss_pred cCCCCeEEeccccceecccCCCC-----cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAG-----DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
+.++.++|+|||+|+........ .......||+.|+|||+..+..++.++|||||||++|||++|+.||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 99999999999999866432211 1122346999999999999999999999999999999999999999643211
Q ss_pred cccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 856 SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
........... ...+..+.. .....+..+.+++..|++.+|++||++.++++.++
T Consensus 240 -~~~~~~~~~~~-----~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 -GNLIHAAKCDF-----IKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred -hHHHHHhHHHH-----HHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111110000 000000111 01123566889999999999999999999998763
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=295.49 Aligned_cols=250 Identities=26% Similarity=0.291 Sum_probs=200.4
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||.|+||.||+|... +++.||+|++.... .........+.+|++++++++||||++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 66 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK--------------CVEKGSVRNVLNERRILQELNHPFLVNLW 66 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhh--------------hcchhHHHHHHHHHHHHHhCCCCChHHHH
Confidence 4778899999999999999966 68999999983211 11113456788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+.+..+...++|+||+++++|.+++... .++++.....++.|+++|++||| +.+++|+||+|+||++++++.++|
T Consensus 67 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l 141 (258)
T cd05578 67 YSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHI 141 (258)
T ss_pred HhhcCCCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEE
Confidence 9999999999999999999999999864 46889999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||.+........ .....|+..|+|||++....++.++|+||+|+++|+|++|..||...... ..........
T Consensus 142 ~d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~ 215 (258)
T cd05578 142 TDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQE 215 (258)
T ss_pred eecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhc
Confidence 99999876544321 22345788999999998888999999999999999999999998543221 1111111111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM--RVVV 914 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~ev~ 914 (947)
. .....+...+..+.+++.+||+.||.+||++ +|+.
T Consensus 216 ~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 216 T----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred c----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1 1112223344678899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=301.14 Aligned_cols=262 Identities=22% Similarity=0.278 Sum_probs=191.7
Q ss_pred cccccc--CceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEE
Q 002250 635 NLIGKG--GSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSI 711 (947)
Q Consensus 635 ~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 711 (947)
..||+| +||+||+|+.. +|+.||||++..... .....+.+.+|+.+++.++||||++++++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~---------------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~ 68 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC---------------TEEHLKALQNEVVLSHFFRHPNIMTSWTVF 68 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC---------------CHHHHHHHHHHHHHHHhCCCCCcceEeeeE
Confidence 356666 99999999964 799999999842110 112346788999999999999999999999
Q ss_pred ecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecc
Q 002250 712 TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791 (947)
Q Consensus 712 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 791 (947)
..++..++||||++++++.+++.......+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||
T Consensus 69 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~ 145 (328)
T cd08226 69 TTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGL 145 (328)
T ss_pred ecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEech
Confidence 99999999999999999999998765556899999999999999999999 899999999999999999999999999
Q ss_pred ccceecccCCCC-----cceecccccccccCccccccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 792 GLAKIVQTGEAG-----DLTHVIAGTHGYIAPEYAYTC--KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 792 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
+.+......... .......++..|+|||++.+. .++.++|||||||++|||++|+.||...... ........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~ 224 (328)
T cd08226 146 SHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT-QMLLQKLK 224 (328)
T ss_pred HHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHhc
Confidence 865432221110 001112345679999998764 4788999999999999999999998543211 11111000
Q ss_pred hhcc-----------------cc---------cccc-----ccccCCC-CccCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 002250 865 SKMD-----------------SR---------DSML-----TVVDPNI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRV 912 (947)
Q Consensus 865 ~~~~-----------------~~---------~~~~-----~~~d~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 912 (947)
.... .. .... .+.+..+ ..........+.+++.+|++.||++|||+.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e 304 (328)
T cd08226 225 GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASS 304 (328)
T ss_pred CCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHH
Confidence 0000 00 0000 0000111 1122345567899999999999999999999
Q ss_pred HHH
Q 002250 913 VVQ 915 (947)
Q Consensus 913 v~~ 915 (947)
+++
T Consensus 305 ~l~ 307 (328)
T cd08226 305 LLS 307 (328)
T ss_pred Hhh
Confidence 985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.00 Aligned_cols=262 Identities=22% Similarity=0.290 Sum_probs=195.6
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccceEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVKLY 708 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~ 708 (947)
|++.+.||+|++|+||+|... +++.||||++.... .........+|+..+++++ ||||++++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~~e~~~l~~~~~h~~i~~~~ 64 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----------------YSWEECMNLREVKSLRKLNEHPNIVKLK 64 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhc----------------cchhHHHHHHHHHHHHhccCCCCchhHH
Confidence 567789999999999999976 58899999873211 1112233457999999998 99999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+ +|+|.+++.......+++..+..++.|++.+|+||| +.+++|+||+|+||++++++.++|
T Consensus 65 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l 140 (283)
T cd07830 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKI 140 (283)
T ss_pred HHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEE
Confidence 9999999999999999 889999998755457899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH------
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN------ 861 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~------ 861 (947)
+|||.+......... ....++..|+|||++.. ..++.++|+||||+++|||++|+.||..... ......
T Consensus 141 ~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~ 216 (283)
T cd07830 141 ADFGLAREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE-IDQLYKICSVLG 216 (283)
T ss_pred eecccceeccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh-HHHHHHHHHhcC
Confidence 999999865443221 22357889999998754 4578999999999999999999999843311 000000
Q ss_pred ------HHHhhc---cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 862 ------WVYSKM---DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 862 ------~~~~~~---~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
|..... .............+.+........+.+++.+|++.+|++|||+.|++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 217 TPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred CCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 0000000000011111111224678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=307.64 Aligned_cols=269 Identities=21% Similarity=0.321 Sum_probs=197.2
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|... +|+.||||++.+.. .......+.+|+.++++++||||++
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~niv~ 67 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----------------HQTFCQRTLREIKILRRFKHENIIG 67 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc----------------cchhHHHHHHHHHHHHhCCCCCcCc
Confidence 468999999999999999999854 78999999883211 1123456778999999999999999
Q ss_pred EEEEEecCC-----ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 707 LYCSITSED-----SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 707 l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
+++++.... ..++|+||++ +++.+++.. ..+++.....++.|++.||+||| +.+|+||||||+||+++
T Consensus 68 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~ 140 (336)
T cd07849 68 ILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLN 140 (336)
T ss_pred hhheeecccccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEC
Confidence 998876543 4689999996 588877764 45899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCCCc-ceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
.++.++|+|||++.......... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||.... ....
T Consensus 141 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~--~~~~ 218 (336)
T cd07849 141 TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD--YLHQ 218 (336)
T ss_pred CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHH
Confidence 99999999999997654332211 1123468899999998754 458899999999999999999999984321 1111
Q ss_pred HHHHHhhcccc--cccccccc-------------CCC--CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhcc
Q 002250 860 VNWVYSKMDSR--DSMLTVVD-------------PNI--SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEA 920 (947)
Q Consensus 860 ~~~~~~~~~~~--~~~~~~~d-------------~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~ 920 (947)
........... .....+.+ +.. ..........+.+++.+|++.+|++|||+.|++++ ++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 219 LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 11110000000 00000000 000 01112234568899999999999999999999987 5544
Q ss_pred C
Q 002250 921 E 921 (947)
Q Consensus 921 ~ 921 (947)
.
T Consensus 299 ~ 299 (336)
T cd07849 299 H 299 (336)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=290.79 Aligned_cols=249 Identities=29% Similarity=0.415 Sum_probs=200.9
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
|...+.||+|++|.||+|... +++.+++|++.... ......+.+|++++++++|+|++++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----------------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 64 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES-----------------KEKKEKIINEIQILKKCKHPNIVKYYG 64 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc-----------------hhHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 677889999999999999976 78999999984211 124567889999999999999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
++..+...++++||+++++|.+++.... ..+++..+..++.|++.|++||| ..+++||||+|+||++++++.++|+
T Consensus 65 ~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~ 140 (253)
T cd05122 65 SYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLI 140 (253)
T ss_pred EEecCCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEe
Confidence 9999999999999999999999998742 46899999999999999999999 8999999999999999999999999
Q ss_pred ccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccc
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS 869 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 869 (947)
|||.+........ .....++..|+|||++....++.++||||||+++|||++|+.||.... ..+.......
T Consensus 141 d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~- 211 (253)
T cd05122 141 DFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-----PMKALFKIAT- 211 (253)
T ss_pred ecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc-----hHHHHHHHHh-
Confidence 9999976654432 224468899999999988889999999999999999999999984321 1111111111
Q ss_pred cccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 870 RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 870 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... ... ........+.+++.+|++.||++|||+.|++++
T Consensus 212 -~~~~-----~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 212 -NGPP-----GLR-NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -cCCC-----CcC-cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 000 011124568899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.18 Aligned_cols=252 Identities=28% Similarity=0.395 Sum_probs=203.8
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|+||.||+|... +++.||+|++.... ........+.+|+++++.++|||++++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~~~~~~ 65 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN---------------MSEKEREDALNEVKILKKLNHPNIIKYY 65 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc---------------CChHHHHHHHHHHHHHHhcCCCChhheE
Confidence 4777889999999999999965 68999999983211 1123456688999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcC--CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCH--KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+.+..++..++|+||+++++|.+++.... ...+++.....++.+++.|++||| +.+++|+||+|+||++++++.+
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~ 142 (258)
T cd08215 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLV 142 (258)
T ss_pred EEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcE
Confidence 99999999999999999999999998743 467899999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
+|+|||.+........ ......|++.|+|||......++.++|+||+|+++|+|++|+.||... +..+.....
T Consensus 143 ~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-----~~~~~~~~~ 215 (258)
T cd08215 143 KLGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-----NLLELALKI 215 (258)
T ss_pred EECCccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-----cHHHHHHHH
Confidence 9999999986654431 222346889999999998888999999999999999999999998432 122222111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... .....+......+.+++.+|+..+|++|||+.|++++
T Consensus 216 ~~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 216 LKG----------QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred hcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 1111222344668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=277.30 Aligned_cols=207 Identities=27% Similarity=0.365 Sum_probs=170.4
Q ss_pred HHhhccCCcccccccCceeEEEEEeC---C--CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN---S--GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR 700 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 700 (947)
+....|+....||+|.||.||+|.-+ + .+.+|||++.... +...-.....+|+..++.++
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~k---------------d~tGiS~SAcREiaL~REl~ 85 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEK---------------DGTGISMSACREIALLRELK 85 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccC---------------CCCCcCHHHHHHHHHHHHhc
Confidence 44578999999999999999999633 2 2378999984221 12233456779999999999
Q ss_pred ccccceEEEEEec-CCccEEEEeccCCCChHHHhhhc---CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 002250 701 HVNVVKLYCSITS-EDSNLLVYEYLPNGSLWDRLHTC---HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776 (947)
Q Consensus 701 h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 776 (947)
|||++.+..++.. +..+++++||.+. +|++.++-. ....++...+..|..||+.|++||| ++=|+||||||.
T Consensus 86 h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPa 161 (438)
T KOG0666|consen 86 HPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPA 161 (438)
T ss_pred CCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcc
Confidence 9999999998877 7888999999965 888888643 2356888899999999999999999 788999999999
Q ss_pred CeEecCC----CCeEEeccccceecccCCC-CcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCC
Q 002250 777 NILLDLE----WKPRIADFGLAKIVQTGEA-GDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 777 NIll~~~----~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
|||+..+ |.|||+|||+|+.+...-. ....+.++-|.+|.|||.+.+.+ |+.+.||||.||++.||+|-++-|.
T Consensus 162 NIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 162 NILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred eEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 9999887 8999999999998765432 22334567799999999998875 8899999999999999999887775
Q ss_pred C
Q 002250 851 P 851 (947)
Q Consensus 851 ~ 851 (947)
.
T Consensus 242 g 242 (438)
T KOG0666|consen 242 G 242 (438)
T ss_pred c
Confidence 4
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=298.75 Aligned_cols=263 Identities=21% Similarity=0.222 Sum_probs=190.1
Q ss_pred cccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEec
Q 002250 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITS 713 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 713 (947)
.+.+|.|+++.||++.. +++.||||++.... ........+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~---------------~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~ 70 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDS---------------CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccc---------------cchhHHHHHHHHHHHHHhcCCcchhhhhheeec
Confidence 34444555555555444 68999999984211 112345678999999999999999999999999
Q ss_pred CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecccc
Q 002250 714 EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793 (947)
Q Consensus 714 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 793 (947)
++..+++|||+++|+|.+++.......+++.....++.|++.||+||| +.+|+||||||+||+++.++.++++|||.
T Consensus 71 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~ 147 (314)
T cd08216 71 DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRY 147 (314)
T ss_pred CCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCcc
Confidence 999999999999999999998755556888899999999999999999 89999999999999999999999999998
Q ss_pred ceecccCCC-----CcceecccccccccCccccccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 794 AKIVQTGEA-----GDLTHVIAGTHGYIAPEYAYTC--KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 794 a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
+........ ........++..|+|||++... .++.++|||||||++|||++|+.||...... ....+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-~~~~~~~~~~ 226 (314)
T cd08216 148 SVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKVRGT 226 (314)
T ss_pred ceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcc
Confidence 865432211 1112234577889999998653 4788999999999999999999999542111 1111111000
Q ss_pred cc----c------cccccc----cccCCC-----CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MD----S------RDSMLT----VVDPNI-----SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~----~------~~~~~~----~~d~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. . ...+.. ..++.. ..........+.+++.+||+.||++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 0 000000 000000 11122334578899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.61 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=202.6
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|+||.||+++.. +++.+|+|.+.... ........+.+|++++++++|+||+++.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS---------------MSQKEREDAVNEIRILASVNHPNIISYK 65 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh---------------ccHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 4678889999999999999855 78899999883211 1112345677899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++......++||||+++++|.+++... ....+++..++.++.|++.|++||| +.+++||||+|+||++++++.+
T Consensus 66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~ 142 (256)
T cd08530 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLV 142 (256)
T ss_pred hhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcE
Confidence 9999999999999999999999998763 2356899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|++|||++....... .....++..|+|||...+..++.++|+||+|+++|||++|+.||... +..+.....
T Consensus 143 kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-----~~~~~~~~~ 213 (256)
T cd08530 143 KIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-----SMQDLRYKV 213 (256)
T ss_pred EEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHH
Confidence 999999998765441 12345789999999999888999999999999999999999998432 111111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
. ....+.........+.+++.+|++.+|++||++.++++.
T Consensus 214 ~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 214 Q----------RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred h----------cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1 111222333556678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=305.92 Aligned_cols=265 Identities=22% Similarity=0.260 Sum_probs=196.3
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
.+.++|+..+.||+|+||.||+|... +++.||||++.... ........+.+|+.++++++||||
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~i 77 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---------------QNVTHAKRAYRELVLMKLVNHKNI 77 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc---------------cChhHHHHHHHHHHHHHhcCCCCC
Confidence 35688999999999999999999955 78999999873110 111223456789999999999999
Q ss_pred ceEEEEEecCC------ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 705 VKLYCSITSED------SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 705 v~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++++++.... ..|+||||++ ++|.+.+... ++......++.|++.||+||| +.+|+||||||+||
T Consensus 78 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Ni 149 (353)
T cd07850 78 IGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNI 149 (353)
T ss_pred cceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHE
Confidence 99999986543 4689999995 5888887652 788888999999999999999 89999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC---
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD--- 855 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~--- 855 (947)
+++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 150 l~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~ 226 (353)
T cd07850 150 VVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQW 226 (353)
T ss_pred EECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 999999999999999986543321 12335788999999999989999999999999999999999998533110
Q ss_pred ----------cccHHHHH----Hhhccccc-----cccccccCCC-----CccCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 002250 856 ----------SKDIVNWV----YSKMDSRD-----SMLTVVDPNI-----SEILKEDALKVLRIAIHCTNKLPAFRPSMR 911 (947)
Q Consensus 856 ----------~~~~~~~~----~~~~~~~~-----~~~~~~d~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 911 (947)
..++.+.. ........ .+........ .......+..+.+++.+|++.||++|||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 306 (353)
T cd07850 227 NKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306 (353)
T ss_pred HHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHH
Confidence 00000000 00000000 0000000000 000123455688999999999999999999
Q ss_pred HHHHH
Q 002250 912 VVVQM 916 (947)
Q Consensus 912 ev~~~ 916 (947)
|++++
T Consensus 307 eiL~~ 311 (353)
T cd07850 307 DALQH 311 (353)
T ss_pred HHhcC
Confidence 99964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=297.62 Aligned_cols=269 Identities=19% Similarity=0.227 Sum_probs=194.0
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
+..++|++.+.||+|+||.||+|... +++.||||.+.... ........+.+|++++++++||||
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i 73 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN---------------EKEGFPITALREIKILQLLKHENV 73 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccC---------------CcCCchhHHHHHHHHHHhCCCCCc
Confidence 44578999999999999999999965 68999999883211 011223345689999999999999
Q ss_pred ceEEEEEecCCc--------cEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 002250 705 VKLYCSITSEDS--------NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776 (947)
Q Consensus 705 v~l~~~~~~~~~--------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 776 (947)
+++++++...+. .++||||++ +++.+++... ...+++.....++.|++.||+||| +.+++|+||||+
T Consensus 74 v~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~ 148 (310)
T cd07865 74 VNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAA 148 (310)
T ss_pred cceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 999999876543 499999995 5888887653 346899999999999999999999 889999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCC--cceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCC
Q 002250 777 NILLDLEWKPRIADFGLAKIVQTGEAG--DLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEF 853 (947)
Q Consensus 777 NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~ 853 (947)
||+++.++.+||+|||.+......... .......++..|+|||++.+.. ++.++||||||+++|||++|+.||....
T Consensus 149 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 149 NILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred HEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999765433221 1112345788999999886644 6889999999999999999999985332
Q ss_pred CCcccHHHHHHhhccc-cccc-c-----ccccC-CCCcc-----C-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 854 GDSKDIVNWVYSKMDS-RDSM-L-----TVVDP-NISEI-----L-----KEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 854 ~~~~~~~~~~~~~~~~-~~~~-~-----~~~d~-~~~~~-----~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
. ............. ...+ . ...+. ..+.. . ......+.+++.+|++.||++|||+.|+++
T Consensus 229 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 229 E--QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred H--HHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 1 1111111110000 0000 0 00000 00000 0 001235678999999999999999999986
Q ss_pred H
Q 002250 916 M 916 (947)
Q Consensus 916 ~ 916 (947)
+
T Consensus 307 h 307 (310)
T cd07865 307 H 307 (310)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=297.16 Aligned_cols=268 Identities=25% Similarity=0.295 Sum_probs=197.5
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
...++|++.+.||+|+||.||+|..+ +++.||||++.... ........+.+|++++++++||||
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------------~~~~~~~~~~~e~~~~~~l~h~~i 68 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN---------------EKEGFPITAIREIKILRQLNHRNI 68 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecc---------------cccCchHHHHHHHHHHHhCCCCCe
Confidence 34678999999999999999999976 68999999984221 111233567789999999999999
Q ss_pred ceEEEEEecCC----------ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCC
Q 002250 705 VKLYCSITSED----------SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVK 774 (947)
Q Consensus 705 v~l~~~~~~~~----------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlk 774 (947)
+++++++.+.. ..++|+||+++ ++.+.+... ...+++..+..++.|++.||+||| +.+|+|||||
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~ 143 (302)
T cd07864 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIK 143 (302)
T ss_pred eeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 99999987655 68999999975 777777653 346899999999999999999999 8899999999
Q ss_pred CCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 002250 775 SSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEF 853 (947)
Q Consensus 775 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~ 853 (947)
|+||++++++.+||+|||.+......... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 144 p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 144 CSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred HHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999765443321 11223467889999988653 47889999999999999999999985321
Q ss_pred CCcccHHHHHHhhcccc-c-ccccc--------ccC------CCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 854 GDSKDIVNWVYSKMDSR-D-SMLTV--------VDP------NISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 854 ~~~~~~~~~~~~~~~~~-~-~~~~~--------~d~------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.......+....... . ....+ .++ .........+..+.+++.+|++.+|++||++.+++++
T Consensus 223 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 223 --ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred --hHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111111111000 0 00000 000 0001111235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=298.28 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=192.2
Q ss_pred hhccCCcccccccCceeEEEEEeCC-CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNS-GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
.++|++.+.||+|+||.||+|..++ ++.||||++.... .......+.+|+.++.+. .||||+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~----------------~~~~~~~~~~e~~~~~~~~~~~~i~ 77 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----------------NKEENKRILMDLDVVLKSHDCPYIV 77 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC----------------ChHHHHHHHHHHHHHHhccCCCchH
Confidence 3678889999999999999999774 8999999984211 112234556677777666 499999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..+...|+||||++ +++.++..... ..+++..+..++.|++.|++|||+ ..+|+||||+|+||++++++.
T Consensus 78 ~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~ 153 (296)
T cd06618 78 KCYGYFITDSDVFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGN 153 (296)
T ss_pred hhheeeecCCeEEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCC
Confidence 99999999999999999984 57777766532 368999999999999999999993 258999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCC----CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK----INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
++|+|||++......... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||..... ..+
T Consensus 154 ~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~ 226 (296)
T cd06618 154 VKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT----EFE 226 (296)
T ss_pred EEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh----HHH
Confidence 999999998765433221 1235788999999987553 78899999999999999999999843211 111
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.......... +..+ .......++.+++.+|++.||++||++.+++++
T Consensus 227 ~~~~~~~~~~-------~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 227 VLTKILQEEP-------PSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHhcCCC-------CCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111110 0011 011234568899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=292.34 Aligned_cols=249 Identities=28% Similarity=0.357 Sum_probs=195.4
Q ss_pred ccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecCC
Q 002250 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSED 715 (947)
Q Consensus 637 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 715 (947)
||+|+||.||+|+.. +|+.+|+|++..... ........+.+|++++++++||||+++++.+..+.
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 66 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--------------IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK 66 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh--------------hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc
Confidence 689999999999976 599999998842211 11234567889999999999999999999999999
Q ss_pred ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 716 SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 716 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
..|+||||+++++|.+++.+.. .+++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||++.
T Consensus 67 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~ 141 (265)
T cd05579 67 NLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSK 141 (265)
T ss_pred EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccch
Confidence 9999999999999999998743 6899999999999999999999 8999999999999999999999999999987
Q ss_pred ecccCCC------CcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccc
Q 002250 796 IVQTGEA------GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS 869 (947)
Q Consensus 796 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 869 (947)
....... ........++..|+|||.......+.++||||||+++||+++|+.||.... ...........
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~ 216 (265)
T cd05579 142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----PEEIFQNILNG 216 (265)
T ss_pred hcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcC
Confidence 5433311 011223457889999999988889999999999999999999999985321 11111111111
Q ss_pred cccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 870 RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 870 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
... .+.. ...+..+.+++.+|++.+|++|||+.++.+.|+
T Consensus 217 ~~~--------~~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 217 KIE--------WPED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CcC--------CCcc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 110 0110 012567889999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=289.48 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=201.1
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|++|.||+|... +++.||+|.+..... .......+.+|++++++++|||+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI---------------KEEALKSIMQEIDLLKNLKHPNIVKYI 65 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc---------------CHHHHHHHHHHHHHHHhCCCCCccEEE
Confidence 4778899999999999999865 688999999842211 113446789999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..+...++||||+++++|.+++... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|
T Consensus 66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l 140 (254)
T cd06627 66 GSIETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKL 140 (254)
T ss_pred EEEEeCCEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999999864 46899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||.+......... .....++..|+|||...+..++.++||||+|+++|||++|+.||.... .... ......
T Consensus 141 ~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~-~~~~~~ 213 (254)
T cd06627 141 ADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAA-LFRIVQ 213 (254)
T ss_pred eccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHH-HHHHhc
Confidence 999999876544321 223467899999999988788899999999999999999999985321 1111 111111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
. .....+......+.+++.+|++.+|++|||+.++++
T Consensus 214 ~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 214 D----------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred c----------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0 011122233456789999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=294.26 Aligned_cols=245 Identities=27% Similarity=0.375 Sum_probs=194.0
Q ss_pred cccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEe
Q 002250 634 ENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSIT 712 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 712 (947)
...||+|+||.||+|..+ +++.||||++... .......+.+|+.+++.++|+||+++++++.
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 87 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----------------KQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----------------chhHHHHHHHHHHHHHhcCCcchhheeeEEE
Confidence 467999999999999864 7899999987211 1123456889999999999999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
.++..++||||+++++|.+++.. ..+++.....++.|++.|++||| +.+++||||+|+||+++.++.++|+|||
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg 161 (292)
T cd06657 88 VGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG 161 (292)
T ss_pred eCCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccc
Confidence 99999999999999999998764 34788999999999999999999 8899999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
.+........ ......|++.|+|||+.....++.++|+||+|+++|||++|+.||.... ............
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--~~~~~~~~~~~~----- 232 (292)
T cd06657 162 FCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNL----- 232 (292)
T ss_pred cceecccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhC-----
Confidence 9875543221 1223468899999999988888999999999999999999999985321 111111111100
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.+.+. ........+.+++.+|++.+|.+||++.+++++
T Consensus 233 -----~~~~~-~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 233 -----PPKLK-NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred -----CcccC-CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 01111 112234567788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=293.17 Aligned_cols=262 Identities=20% Similarity=0.269 Sum_probs=199.2
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
|+..+.||+|++|.||+|... +++.+|+|++..... .......+.+|++++++++|+||+++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 65 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE---------------SEGIPKTALREIKLLKELNHPNIIKLLD 65 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc---------------cchhHHHHHHHHHHHHHhcCCCcchHHH
Confidence 567788999999999999965 789999998842211 1123457788999999999999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
++..++..++||||+++ ++.+++.... ..+++..+..++.|++.|++||| +.+|+|+||+|+||+++.++.++|+
T Consensus 66 ~~~~~~~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~ 140 (283)
T cd05118 66 VFRHKGDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLA 140 (283)
T ss_pred hhccCCCEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEe
Confidence 99999999999999965 8888887633 56899999999999999999999 8999999999999999999999999
Q ss_pred ccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
|||.+........ ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||..... .+..........
T Consensus 141 df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~ 216 (283)
T cd05118 141 DFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLG 216 (283)
T ss_pred eeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcC
Confidence 9999987654431 11234578899999998776 688999999999999999999999843211 111111100000
Q ss_pred c-cc---------------cccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 869 S-RD---------------SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 869 ~-~~---------------~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
. .. ......+....+........+.+++.+|++.||.+||++.+++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 217 TPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred CCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 00 000000011122233456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=287.30 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=195.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.+|++.+.||+|+||.||+|... +++.||+|.+...... .........+.+|++++++++||||+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~------------~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 69 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS------------QETSKEVNALECEIQLLKNLRHDRIVQY 69 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc------------chhhHHHHHHHHHHHHHHHcCCCCcceE
Confidence 36888999999999999999964 6899999987321100 0112334678899999999999999999
Q ss_pred EEEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 708 YCSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 708 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++... ...++|+||+++++|.+++.... .+++.....++.|++.|++||| +.+++||||||+||+++.++.
T Consensus 70 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~ 144 (264)
T cd06653 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGN 144 (264)
T ss_pred EEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCC
Confidence 9998764 45789999999999999997643 4788888899999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCC-CcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 786 PRIADFGLAKIVQTGEA-GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
++|+|||+++....... ........++..|+|||++.+..++.++|+|||||++|||++|+.||... ..... ..
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~-~~ 219 (264)
T cd06653 145 VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY----EAMAA-IF 219 (264)
T ss_pred EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc----CHHHH-HH
Confidence 99999999975432111 11112345889999999998888999999999999999999999998432 11111 11
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
..... +..+..+......+.+++.+|+. +|.+||++.+++.
T Consensus 220 ~~~~~---------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 220 KIATQ---------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHcC---------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11100 01122333444668888999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=291.48 Aligned_cols=263 Identities=25% Similarity=0.312 Sum_probs=196.8
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
|++.+.||+|+||.||+|... +++.+|+|++.... ........+.+|++++++++|||++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 65 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---------------EKEGFPITAIREIKLLQKLRHPNIVRLKE 65 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---------------ccccchHHHHHHHHHHHhccCCCeeehee
Confidence 567788999999999999966 58999999984221 11223456888999999999999999999
Q ss_pred EEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 710 SITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 710 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++... +..++||||+++ +|.+++.... ..+++..+..++.|++.|++||| ..+++|+||+|+||++++++.++
T Consensus 66 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~ 140 (287)
T cd07840 66 IVTSKGKGSIYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLK 140 (287)
T ss_pred eEecCCCCcEEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEE
Confidence 99988 789999999974 8888887632 46899999999999999999999 88999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||.+......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ..........
T Consensus 141 l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--~~~~~~~~~~ 217 (287)
T cd07840 141 LADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE--LEQLEKIFEL 217 (287)
T ss_pred EccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHH
Confidence 9999999866544321 1223356788999998765 3578999999999999999999999853321 1111111111
Q ss_pred cccc--cccccc--------------ccCCCCccCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSR--DSMLTV--------------VDPNISEILKE-DALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~--~~~~~~--------------~d~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... ..+... ....+.+.... ++..+.+++.+|++.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 218 CGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 000000 00000111112 25678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=288.68 Aligned_cols=245 Identities=24% Similarity=0.278 Sum_probs=185.7
Q ss_pred cccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHH---HHHhhccccccceEEEEE
Q 002250 636 LIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV---ATLSAVRHVNVVKLYCSI 711 (947)
Q Consensus 636 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~ 711 (947)
.||+|+||.||+|... +++.||+|.+....... ......+..|. +.++...||+|+++++++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 66 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--------------KQGETLALNERIMLSLVSTGDCPFIVCMSYAF 66 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeecccccc--------------chhHHHHHHHHHHHHHHHhCCCCcEeeeeeee
Confidence 4899999999999954 68999999984321100 01111233343 344455799999999999
Q ss_pred ecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecc
Q 002250 712 TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791 (947)
Q Consensus 712 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 791 (947)
..++..++||||+++|+|.+++... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+||
T Consensus 67 ~~~~~~~~v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~df 141 (278)
T cd05606 67 HTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDL 141 (278)
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccC
Confidence 9999999999999999999988753 45899999999999999999999 899999999999999999999999999
Q ss_pred ccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccc
Q 002250 792 GLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSR 870 (947)
Q Consensus 792 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 870 (947)
|++....... .....|+..|+|||++.++ .++.++||||+||++|||++|+.||........ .........
T Consensus 142 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~-- 213 (278)
T cd05606 142 GLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT-- 213 (278)
T ss_pred cCccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhhc--
Confidence 9987543322 1234689999999998754 588999999999999999999999964321111 111000000
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 871 DSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 871 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
.... .+......+.+++.+|+..+|.+|| ++.+++++
T Consensus 214 ------~~~~---~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 214 ------MAVE---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ------cCCC---CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0111 1222346788899999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=293.42 Aligned_cols=249 Identities=29% Similarity=0.377 Sum_probs=192.9
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|...+.||+|+||+||+|+.. +++.||+|++..... ........+.+|++++++++|||++++
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 86 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK--------------QTNEKWQDIIKEVKFLQQLKHPNTIEY 86 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc--------------CchHHHHHHHHHHHHHHhCCCCCCccE
Confidence 44667788999999999999964 688999998842210 011223567889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.++...|+||||+. |++.+++... ..++++..+..++.|++.|++||| +.+++||||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~k 161 (313)
T cd06633 87 KGCYLKEHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVK 161 (313)
T ss_pred EEEEEeCCEEEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEE
Confidence 999999999999999995 6788887653 346899999999999999999999 88999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY---TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
|+|||.+..... .....|+..|+|||++. .+.++.++|||||||++|||++|..||... +......
T Consensus 162 L~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~-----~~~~~~~ 230 (313)
T cd06633 162 LADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALY 230 (313)
T ss_pred EeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHH
Confidence 999999864322 12346889999999984 456888999999999999999999998432 1111111
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....... ... ........+.+++.+|++.+|.+||++.+++++
T Consensus 231 ~~~~~~~--~~~-------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 231 HIAQNDS--PTL-------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHhcCC--CCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111110 000 011123457889999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=302.04 Aligned_cols=268 Identities=20% Similarity=0.258 Sum_probs=199.0
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|... +++.||||.+.... ........+.+|+.+++.++||||++
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~ni~~ 68 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF---------------DNRIDAKRTLREIKLLRHLDHENVIA 68 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc---------------cccchhHHHHHHHHHHHhcCCCCccc
Confidence 467889999999999999999954 78999999884211 11123356678999999999999999
Q ss_pred EEEEEecC-----CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 707 LYCSITSE-----DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 707 l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
+++++... ...++||||+. ++|.+++... ..+++.....++.|++.||+||| +.+++||||||+||+++
T Consensus 69 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~ 142 (337)
T cd07858 69 IKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLN 142 (337)
T ss_pred hHHheecccccccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEc
Confidence 99988654 34799999995 7899888763 45889999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
.++.+||+|||++....... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||..... ....
T Consensus 143 ~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~ 218 (337)
T cd07858 143 ANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQL 218 (337)
T ss_pred CCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHH
Confidence 99999999999998654332 11223457889999998865 4588999999999999999999999853210 0000
Q ss_pred HHHHhhccc--ccc---------------ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhcc
Q 002250 861 NWVYSKMDS--RDS---------------MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEA 920 (947)
Q Consensus 861 ~~~~~~~~~--~~~---------------~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~ 920 (947)
......... ... .....++............+.+++.+|++.+|++|||+.|++++ ++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 219 KLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000 000 00000111111122345668899999999999999999999987 5554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=301.62 Aligned_cols=266 Identities=21% Similarity=0.268 Sum_probs=196.9
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ........+.+|+.++++++||||++
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~iv~ 68 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------------DVPTLAKRTLRELKILRHFKHDNIIA 68 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc---------------ccccchHHHHHHHHHHHhcCCCCccC
Confidence 367889999999999999999955 69999999984211 11123456778999999999999999
Q ss_pred EEEEEec----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 707 LYCSITS----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 707 l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
+++++.. ....++||||+. ++|.+++... ..+++.....++.|++.||+||| ..+|+||||||+||++++
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~ 142 (334)
T cd07855 69 IRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNE 142 (334)
T ss_pred HHHhccccCCCCceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcC
Confidence 9988764 345789999995 6899988753 34899999999999999999999 889999999999999999
Q ss_pred CCCeEEeccccceecccCCCC--cceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 783 EWKPRIADFGLAKIVQTGEAG--DLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
++.+||+|||++......... .......|+..|+|||.+.. ..++.++|||||||++|||++|+.||..... ...
T Consensus 143 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~--~~~ 220 (334)
T cd07855 143 DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY--VHQ 220 (334)
T ss_pred CCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh--HHH
Confidence 999999999999765433221 11123468899999998865 4588999999999999999999999954311 000
Q ss_pred HHHHHhhcc-c----------ccc--ccccc----cCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 860 VNWVYSKMD-S----------RDS--MLTVV----DPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 860 ~~~~~~~~~-~----------~~~--~~~~~----d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
......... . ... ..... ..............+.+++.+|++.+|++||++.+++.+
T Consensus 221 ~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 221 LKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000 0 000 00000 000111223346778999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=280.82 Aligned_cols=259 Identities=22% Similarity=0.264 Sum_probs=209.2
Q ss_pred hccCCcccccccCceeEEEEEeCC------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
.+++....+-+|.||.||.|.+.+ .+.|.||.++.. ..+.....+..|.-.+..+.||
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~----------------AS~iQv~~~L~es~lly~~sH~ 347 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH----------------ASQIQVNLLLQESMLLYGASHP 347 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc----------------ccHHHHHHHHHHHHHHhcCcCC
Confidence 445666778999999999997653 345666655211 1123345677888888889999
Q ss_pred ccceEEEEEec-CCccEEEEeccCCCChHHHhhhc------CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCC
Q 002250 703 NVVKLYCSITS-EDSNLLVYEYLPNGSLWDRLHTC------HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKS 775 (947)
Q Consensus 703 niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp 775 (947)
|+..+.+++.+ .+..+++|.++.-|+|..++..+ ..+.....+...++.|++.|++||| +++|||.||.+
T Consensus 348 nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAa 424 (563)
T KOG1024|consen 348 NLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAA 424 (563)
T ss_pred CccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhh
Confidence 99999998865 45678999999999999999844 3456777888899999999999999 89999999999
Q ss_pred CCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCC
Q 002250 776 SNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFG 854 (947)
Q Consensus 776 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~ 854 (947)
+|+++|+.-.+||+|-.+++...+.+++...+..-....||+||.+....|+.++|||||||++|||+| |+.|+...
T Consensus 425 RNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI-- 502 (563)
T KOG1024|consen 425 RNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI-- 502 (563)
T ss_pred hcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc--
Confidence 999999999999999999999988888776666667889999999999999999999999999999999 99998422
Q ss_pred CcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 855 DSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
+..++.. -+.|+..-..+.+++.+++.+|.-||..+|++||+++|++.-|.++-
T Consensus 503 ---DPfEm~~----------ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 503 ---DPFEMEH----------YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ---CHHHHHH----------HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 2222211 12233333455678889999999999999999999999999888753
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=292.99 Aligned_cols=257 Identities=28% Similarity=0.351 Sum_probs=198.2
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+..... .......++.+|+++++.++|+|++++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 80 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--------------QSNEKWQDIIKEVRFLQKLRHPNTIQY 80 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc--------------cChHHHHHHHHHHHHHHhCCCCCcccE
Confidence 45777888999999999999965 688999998732110 011223567789999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..+...++||||+. |++.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~k 155 (308)
T cd06634 81 RGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVK 155 (308)
T ss_pred EEEEEcCCeeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEE
Confidence 999999999999999996 6888877643 345788999999999999999999 88999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY---TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
++|||++...... ....++..|+|||++. .+.++.++|||||||++|||++|+.||.... -.....
T Consensus 156 l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~ 224 (308)
T cd06634 156 LGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALY 224 (308)
T ss_pred ECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-----HHHHHH
Confidence 9999998765432 2345788999999974 3567889999999999999999999984321 111111
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
....... +. .........+.+++.+||+.+|++||++.++++.-......+
T Consensus 225 ~~~~~~~-------~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 225 HIAQNES-------PA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred HHhhcCC-------CC--cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 1111100 00 011233456788999999999999999999998765555433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=297.59 Aligned_cols=253 Identities=26% Similarity=0.340 Sum_probs=202.1
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
-...|.+...||+|.|+.|..|+.. ++..||||.+..... .....+.+.+|++++..++|||||
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l---------------n~~~~~k~~rev~imk~l~HPnIv 118 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL---------------NPSKRQKLGREVDIMKSLNHPNIV 118 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc---------------ChHHHHHHHHHHHHHHhcCCccee
Confidence 3567889999999999999999955 799999999853221 112234478999999999999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
+++.+...+...|+||||+.+|.+.+++.+.++. .......++.|+.+|++|+| ++.|||||||++||+++.+.+
T Consensus 119 kl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~--~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mn 193 (596)
T KOG0586|consen 119 KLFSVIETEATLYLVMEYASGGELFDYLVKHGRM--KEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMN 193 (596)
T ss_pred eeeeeeeecceeEEEEEeccCchhHHHHHhcccc--hhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccc
Confidence 9999999999999999999999999999986653 33667778899999999999 999999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCC-CccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKIN-EKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
+||+|||++.++..... ....+|++.|.|||+..+..|+ +++|+||+|+++|-|+.|..||++. .+...-
T Consensus 194 ikIaDfgfS~~~~~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~-----~lk~Lr- 264 (596)
T KOG0586|consen 194 IKIADFGFSTFFDYGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ-----NLKELR- 264 (596)
T ss_pred eeeeccccceeeccccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc-----cccccc-
Confidence 99999999998875443 2346899999999999887764 7899999999999999999999532 111110
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
..++..++ .++.-...++.+++++++-.+|.+|++++++.+.-.
T Consensus 265 ---------~rvl~gk~-rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 265 ---------PRVLRGKY-RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred ---------chheeeee-cccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 11111111 011122234667778999999999999999986543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=287.58 Aligned_cols=246 Identities=26% Similarity=0.299 Sum_probs=186.3
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHH-hhccccccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL-SAVRHVNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~ 712 (947)
+.||+|+||.||+|... +++.||||++..... ........+..|..++ ...+|+|++++++++.
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~--------------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 67 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM--------------IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ 67 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh--------------hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE
Confidence 46899999999999964 689999998832110 0001122344454444 4558999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
.++..|+||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||
T Consensus 68 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg 142 (260)
T cd05611 68 SKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFG 142 (260)
T ss_pred cCCeEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecc
Confidence 9999999999999999999998643 4788888899999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccc
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 872 (947)
+++..... ....++..|+|||...+..++.++||||||+++|||++|..||.... ..............
T Consensus 143 ~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~ 211 (260)
T cd05611 143 LSRNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-----PDAVFDNILSRRIN 211 (260)
T ss_pred cceecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcccC
Confidence 98754331 23457889999999988888999999999999999999999985321 11111111111100
Q ss_pred ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 002250 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML 917 (947)
Q Consensus 873 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 917 (947)
. . .......+..+.+++.+|++.+|++||++.++.+.+
T Consensus 212 ~----~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 212 W----P---EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred C----C---CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0 0 111123456688999999999999999876555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=298.18 Aligned_cols=266 Identities=21% Similarity=0.270 Sum_probs=192.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|... +++.||||++.... ........+.+|++++++++||||++
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~~ 71 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN---------------EKDGFPITALREIKILKKLKHPNVVP 71 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEecc---------------CCCCcchhHHHHHHHHHhcCCCCccc
Confidence 578999999999999999999965 68999999884221 11122345678999999999999999
Q ss_pred EEEEEecCC--------ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 707 LYCSITSED--------SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 707 l~~~~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++++.... ..++||||+++ ++...+... ...+++..+..++.|+++||+||| +.+|+||||||+||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~ni 146 (311)
T cd07866 72 LIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANI 146 (311)
T ss_pred hhhheecccccccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHE
Confidence 998875543 35899999964 677777653 346899999999999999999999 89999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCCc---------ceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCC
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAGD---------LTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRP 848 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p 848 (947)
++++++.++|+|||+++......... ......+++.|+|||++.+. .++.++||||||+++|||++|+.|
T Consensus 147 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~ 226 (311)
T cd07866 147 LIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226 (311)
T ss_pred EECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCC
Confidence 99999999999999997554322111 11234568889999987654 478999999999999999999999
Q ss_pred CCCCCCCcccHHHHHHhhcccc--------ccccc----ccc----CCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 002250 849 IVPEFGDSKDIVNWVYSKMDSR--------DSMLT----VVD----PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRV 912 (947)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~----~~d----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 912 (947)
|..... ....+......... ..... ... +...+........+.+++.+|++.||++|||+.|
T Consensus 227 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~e 304 (311)
T cd07866 227 LQGKSD--IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304 (311)
T ss_pred CCCCCH--HHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHH
Confidence 853211 11111111000000 00000 000 0111111122356889999999999999999999
Q ss_pred HHH
Q 002250 913 VVQ 915 (947)
Q Consensus 913 v~~ 915 (947)
++.
T Consensus 305 ll~ 307 (311)
T cd07866 305 ALE 307 (311)
T ss_pred Hhc
Confidence 875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=292.06 Aligned_cols=258 Identities=23% Similarity=0.280 Sum_probs=198.6
Q ss_pred cCCcccccccCceeEEEEEeC----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 631 VKPENLIGKGGSGNVYKVVLN----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
|++.+.||+|++|.||+|+.. +++.||||++.... ..........+.+|++++.++ +||||+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~-------------~~~~~~~~~~~~~E~~~l~~~~~~~~i~ 68 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKAT-------------IVQKAKTAEHTRTERQVLEAVRRCPFLV 68 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHH-------------HHhhhhHHHHHHHHHHHHHhccCCcchh
Confidence 677889999999999998842 57889999883110 111223345688999999999 599999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++.+..+...++||||+++|+|.+++... ..+++.....++.|+++||+||| +.+++||||+|+||+++.++.
T Consensus 69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~ 143 (288)
T cd05583 69 TLHYAFQTDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGH 143 (288)
T ss_pred hhheeeecCCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCC
Confidence 9999999999999999999999999998763 35788889999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK--INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
++++|||+++........ ......|+..|+|||...+.. .+.++||||||+++|||++|..||..... .....+..
T Consensus 144 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~ 221 (288)
T cd05583 144 VVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEIS 221 (288)
T ss_pred EEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHH
Confidence 999999998765443221 122345889999999987655 77899999999999999999999853211 11111111
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
....... ...+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 222 ~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 222 RRILKSK-----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHccC-----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1111110 11122233567889999999999999999988887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=290.11 Aligned_cols=255 Identities=23% Similarity=0.290 Sum_probs=194.9
Q ss_pred ccCCcccccccCceeEEEEEe----CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccccc
Q 002250 630 AVKPENLIGKGGSGNVYKVVL----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNV 704 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 704 (947)
.|++.+.||+|+||.||+|.. .+|+.||+|++.... ........+.+.+|+.+++++ +|+||
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~-------------~~~~~~~~~~~~~e~~~l~~l~~~~~i 67 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKAT-------------IVQKAKTTEHTRTERQVLEHIRQSPFL 67 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhh-------------hhhcchHHHHHHHHHHHHHhcccCCCh
Confidence 367788999999999999985 368999999984211 011123346678899999999 59999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++..+...++||||+++++|.+++... ..+++.....++.|++.||+||| +.+++||||+|+||+++.++
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~ 142 (290)
T cd05613 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNG 142 (290)
T ss_pred hceeeEeecCCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCC
Confidence 99999999999999999999999999999864 35788888889999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC--KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
.++|+|||++......... ......|+..|+|||.+... .++.++||||||+++|||++|+.||.... .......+
T Consensus 143 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~ 220 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG-EKNSQAEI 220 (290)
T ss_pred CEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC-ccccHHHH
Confidence 9999999999765433221 12234588999999998753 46789999999999999999999985321 11122222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQ 915 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 915 (947)
........ .+.+......+.+++.+|++.||++|| ++.++.+
T Consensus 221 ~~~~~~~~-----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 221 SRRILKSE-----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHhhccC-----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 21111111 111223345678899999999999997 5566554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-33 Score=276.91 Aligned_cols=244 Identities=25% Similarity=0.314 Sum_probs=193.4
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|...+.+|+|.||.|-.++-+ +|+.+|+|+++......+ .+...-..|-++++..+||.+..
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak--------------dEVAHTlTE~RVL~~~~HPFLt~ 232 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK--------------DEVAHTLTENRVLQNCRHPFLTS 232 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh--------------HHhhhhhhHHHHHHhccCcHHHH
Confidence 467888999999999999999965 799999999854332111 22334457889999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+.-.|+..+..|+||||+.||.|.-++.+. ..+++....-.-..|+.||.||| +++||.||+|.+|.|+|.||.+
T Consensus 233 LKYsFQt~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHI 307 (516)
T KOG0690|consen 233 LKYSFQTQDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHI 307 (516)
T ss_pred hhhhhccCceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCce
Confidence 988999999999999999999998888764 44666666667788999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+++.--. ....+..++|||.|.|||++....|+.++|.|.+||++|||++|+.||... +...+.+.+.
T Consensus 308 KitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~--dh~kLFeLIl-- 381 (516)
T KOG0690|consen 308 KITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK--DHEKLFELIL-- 381 (516)
T ss_pred Eeeecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc--chhHHHHHHH--
Confidence 9999999974332 233455789999999999999999999999999999999999999999532 2222222211
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP 908 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 908 (947)
+.|-+ +++....+...+....+.+||.+|.
T Consensus 382 ---------~ed~k---FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 382 ---------MEDLK---FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---------hhhcc---CCccCCHHHHHHHHHHhhcChHhhc
Confidence 11112 2333334455666688999999995
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-34 Score=277.61 Aligned_cols=251 Identities=28% Similarity=0.365 Sum_probs=192.4
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLY 708 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 708 (947)
.+....||.|+||+|+|..++ .|+..|||+++... ...+.+++..|.++..+- +.||||++|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n----------------~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN----------------IEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc----------------chHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 344567999999999999865 79999999994221 134567788888887666 689999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhh---hcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLH---TCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
|.+-.++..|+.||.| ..++..+.+ ......+++...-.|+...+.||+||.+ ...|||||+||+|||++..|.
T Consensus 130 Ga~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCC
Confidence 9999999999999999 456655443 2234567888887888888999999996 679999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT--CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
+||||||++..+...- ..+.-+|-..|||||.+.. ..|+-+|||||+|+++||+.||..|+. ...+..+.+
T Consensus 207 vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr----~w~svfeql 279 (361)
T KOG1006|consen 207 VKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR----KWDSVFEQL 279 (361)
T ss_pred EeeecccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc----hHHHHHHHH
Confidence 9999999997654332 2334568889999999853 348999999999999999999999984 222233333
Q ss_pred HhhccccccccccccCCCCcc---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEI---LKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.....+ |+.+-.. ..+....+.+++--|+.+|-..||...++.+
T Consensus 280 ~~Vv~g--------dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 280 CQVVIG--------DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHcC--------CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 222222 2222111 2235567889999999999999999988765
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=287.77 Aligned_cols=254 Identities=22% Similarity=0.301 Sum_probs=197.2
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|.+.+.||+|+||.||+|... .+..+++|.+..... ..........+.+|+.++++++||||++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 68 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPV------------GELNPNETVQANQEAQLLSKLDHPAIVKFH 68 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccc------------cccCcchHHHHHHHHHHHHhCCCCcHHHHH
Confidence 4778899999999999999865 455677776632111 011112334577899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++.++...++||||+++++|.+++... ....+++..++.++.|++.|++||| +.+++|+||+|+||++++ +.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~ 144 (260)
T cd08222 69 ASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLL 144 (260)
T ss_pred HHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCE
Confidence 9999999999999999999999998753 3456899999999999999999999 899999999999999975 569
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
+|+|||.+........ ......|++.|+|||......++.++|+||||+++|+|++|..||... .........
T Consensus 145 ~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~~~ 217 (260)
T cd08222 145 KIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVLRI 217 (260)
T ss_pred eecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHH
Confidence 9999999976543322 122345788999999998888899999999999999999999998421 222222221
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. ...+..+......+.+++.+|++.+|++||++.|+++.
T Consensus 218 ~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 218 VE----------GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred Hc----------CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11 11122234455678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=291.68 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=200.4
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccceE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVKL 707 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l 707 (947)
+|.+.+.||+|+||.||+|... +++.||+|++.... .........+.+|++++++++ ||||+++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--------------~~~~~~~~~~~~e~~~~~~l~~~~~i~~~ 67 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ--------------LIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHh--------------ccchHHHHHHHHHHHHHHhcccCCCchhH
Confidence 6788899999999999999965 79999999884211 111233467889999999998 9999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||+++++|.+++.+.+ .+++.....++.|++.||+||| +.+++|+||+|+||+++.++.++
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~ 142 (280)
T cd05581 68 YYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIK 142 (280)
T ss_pred HHHhcCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEE
Confidence 999999999999999999999999998743 6899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCC------------------cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 002250 788 IADFGLAKIVQTGEAG------------------DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPI 849 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~ 849 (947)
++|||++......... .......++..|+|||+.....++.++||||+|++++|+++|..||
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 9999999765443211 1222345788999999998888999999999999999999999998
Q ss_pred CCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 002250 850 VPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM----RVVVQ 915 (947)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~ev~~ 915 (947)
.... ............ ...+...+..+.+++.+|++.+|++||++ .++++
T Consensus 223 ~~~~-----~~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 223 RGSN-----EYLTFQKILKLE-----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCcc-----HHHHHHHHHhcC-----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 5331 111111111111 11122235668899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=297.06 Aligned_cols=271 Identities=22% Similarity=0.263 Sum_probs=203.2
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+|++.+.||+|++|.||+|+.. +++.||||++.... ......+.+.+|+.+++.++||||++++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 65 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF---------------DDLIDAKRILREIKLLRHLRHENIIGLL 65 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc---------------ccchhhhhHHHHHHHHHhcCCcchhhhh
Confidence 4778899999999999999965 58999999884211 1123446788999999999999999999
Q ss_pred EEEecCC-----ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 709 CSITSED-----SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 709 ~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
+++.... ..|+||||++ ++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 66 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~ 139 (330)
T cd07834 66 DILRPPSPEDFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSN 139 (330)
T ss_pred hhhcccCcccccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCC
Confidence 9988775 7899999997 5898888763 37899999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCC-cceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
+.++|+|||++......... .......++..|+|||++.+. .++.++|+||||+++|||++|+.||..... .....
T Consensus 140 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~--~~~~~ 217 (330)
T cd07834 140 CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY--IDQLN 217 (330)
T ss_pred CCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH--HHHHH
Confidence 99999999999876544310 112234578899999999887 789999999999999999999999854321 01011
Q ss_pred HHHhhccccc----------ccccccc-------CCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhccCC
Q 002250 862 WVYSKMDSRD----------SMLTVVD-------PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEAEP 922 (947)
Q Consensus 862 ~~~~~~~~~~----------~~~~~~d-------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~~~ 922 (947)
.......... .....+. ..........+..+.+++.+||+.+|++|||+.+++++ +++...
T Consensus 218 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 218 LIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 1000000000 0000000 00011122245678899999999999999999999975 655554
Q ss_pred C
Q 002250 923 C 923 (947)
Q Consensus 923 ~ 923 (947)
.
T Consensus 298 ~ 298 (330)
T cd07834 298 P 298 (330)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=296.78 Aligned_cols=267 Identities=19% Similarity=0.234 Sum_probs=194.0
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|...+.||+|+||.||+|... +|+.||||++.... ........+.+|+.++++++||||++
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~niv~ 78 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---------------QSEIFAKRAYRELTLLKHMQHENVIG 78 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc---------------ccccchhHHHHHHHHHHhcCCCCccc
Confidence 367888999999999999999954 68999999884211 01122346788999999999999999
Q ss_pred EEEEEecCC------ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 707 LYCSITSED------SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 707 l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
+++++.... ..++|+||+. .++.++.. ..+++..+..++.|++.||+||| +.+++||||||+||++
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll 150 (342)
T cd07879 79 LLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAV 150 (342)
T ss_pred hhheecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEE
Confidence 999987543 3589999995 46766553 35788999999999999999999 8899999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
+.++.++|+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+
T Consensus 151 ~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-~~~~ 224 (342)
T cd07879 151 NEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQL 224 (342)
T ss_pred CCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHH
Confidence 999999999999987543221 23357889999999876 4588899999999999999999999953211 0001
Q ss_pred HHHHHhhccccccc----------------cccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhccC
Q 002250 860 VNWVYSKMDSRDSM----------------LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEAE 921 (947)
Q Consensus 860 ~~~~~~~~~~~~~~----------------~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~~ 921 (947)
.............+ .......+..........+.+++.+|++.||++||++.+++++ ++..+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 225 TQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000000000000 0000000011111234567899999999999999999999955 66655
Q ss_pred CC
Q 002250 922 PC 923 (947)
Q Consensus 922 ~~ 923 (947)
+.
T Consensus 305 ~~ 306 (342)
T cd07879 305 DA 306 (342)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=288.14 Aligned_cols=261 Identities=24% Similarity=0.298 Sum_probs=196.7
Q ss_pred cCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
|+..+.||+|++|.||+|+.. +++.||+|++.... ......+.+..|+.++++++|+|++++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~---------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 65 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---------------EEEGIPSTALREISLLKELKHPNIVKLLD 65 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc---------------ccccccHHHHHHHHHHHhcCCCCHHHHHh
Confidence 456788999999999999965 59999999984221 11233466788999999999999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
++...+..++||||++ ++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||+|+||++++++.++|+
T Consensus 66 ~~~~~~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~ 140 (282)
T cd07829 66 VIHTERKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLA 140 (282)
T ss_pred hhhcCCceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEe
Confidence 9999999999999997 58999998742 46899999999999999999999 8899999999999999999999999
Q ss_pred ccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
|||.++....... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ............
T Consensus 141 d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~ 216 (282)
T cd07829 141 DFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQILG 216 (282)
T ss_pred cCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHhC
Confidence 9999976543321 11223457789999998776 788999999999999999999999854321 001111100000
Q ss_pred -----------cc----ccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 869 -----------SR----DSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 869 -----------~~----~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.. .....................+.+++.+|+..+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 217 TPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred CCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 000000000000111122557899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=297.42 Aligned_cols=261 Identities=19% Similarity=0.256 Sum_probs=193.8
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|... +++.||||++.... ........+.+|+.++++++||||+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv 77 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---------------QSELFAKRAYRELRLLKHMKHENVI 77 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---------------cchHHHHHHHHHHHHHHhcCCCCcc
Confidence 4578999999999999999999854 79999999884211 0112234677899999999999999
Q ss_pred eEEEEEecCC------ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 706 KLYCSITSED------SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 706 ~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
++++++..+. ..++||||+ +++|.+++.. ..+++..+..++.|++.|++||| +.+|+||||||+||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nil 150 (343)
T cd07880 78 GLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLA 150 (343)
T ss_pred ceeeeecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 9999987654 348999999 7799888864 35889999999999999999999 899999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 780 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
++.++.++++|||++....... ....+++.|+|||++.+ ..++.++|+||+|+++|++++|+.||..... ...
T Consensus 151 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~ 224 (343)
T cd07880 151 VNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH-LDQ 224 (343)
T ss_pred EcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHH
Confidence 9999999999999997553321 23357889999999876 4578899999999999999999999853211 000
Q ss_pred HHHHHHhhcccccc----------------ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 859 IVNWVYSKMDSRDS----------------MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 859 ~~~~~~~~~~~~~~----------------~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.............. ........+..........+.+++.+|++.||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 225 LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00100000000000 0000000111112233456889999999999999999999993
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=294.39 Aligned_cols=277 Identities=20% Similarity=0.202 Sum_probs=196.5
Q ss_pred hhccCC-cccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 628 IDAVKP-ENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 628 ~~~~~~-~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
.++|.. .+.||+|+||+||+|... +++.||||++......... .. .............+.+|+++++.++||||+
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDV--TK-DRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeecccccccc--cc-chhhhcccccchhHHHHHHHHHhCCCccee
Confidence 356654 577999999999999965 6899999998432211100 00 000000011123577899999999999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..++..++||||++ |+|.+++... ..+++.....++.|++.||+||| +.+++||||+|+||+++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred eeeEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCC
Confidence 99999999999999999996 6899998753 45788899999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCC------------CcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCC
Q 002250 786 PRIADFGLAKIVQTGEA------------GDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
++|+|||.+........ ........++..|+|||++.+.. ++.++||||+||++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999976541110 01111234678899999987643 688999999999999999999998533
Q ss_pred CCCcccHHHHHHhhcccccc--cc------------ccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 853 FGDSKDIVNWVYSKMDSRDS--ML------------TVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~--~~------------~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.. .+....+......... +. ....+............+.+++.+|++.+|++|||+.|++.
T Consensus 238 ~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 238 NE--IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CH--HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 21 1111111111100000 00 00001111112223456889999999999999999999996
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=312.74 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=198.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|.+.+.||+|+||.|..++.+ +++.+|+|++... ... ...+..-|..|-.+|..-+.+=|+.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~------------eMl--Kr~~tA~F~EERDimv~~ns~Wiv~ 139 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKW------------EML--KRAETACFREERDIMVFGNSEWIVQ 139 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHH------------HHh--hchhHHHHHHHhHHHHcCCcHHHHH
Confidence 377999999999999999999976 6888999998321 111 2244567899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+.-.|+++.+.|+|||||+||+|...+.+....+.+|+.. ++..|+-||+-+| +.|+|||||||+|||+|..|.+
T Consensus 140 LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArF--Y~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHi 214 (1317)
T KOG0612|consen 140 LHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARF--YTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHI 214 (1317)
T ss_pred HHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHH--HHHHHHHHHHHHH---hccceeccCCcceeEecccCcE
Confidence 9999999999999999999999999999876545555544 6667889999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccc----c-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY----T-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
||+|||.+-.+..++. ......+|||-|++||++. + +.|+..+|.||+||++|||+.|..||+ .+.+++
T Consensus 215 kLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY-----adslve 288 (1317)
T KOG0612|consen 215 KLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY-----ADSLVE 288 (1317)
T ss_pred eeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch-----HHHHHH
Confidence 9999999876654443 3345678999999999985 2 679999999999999999999999994 456666
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS---MRVVVQ 915 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~ev~~ 915 (947)
.....+.....+...-+ .+..+...++|.+.+ -+|+.|.. +.++..
T Consensus 289 TY~KIm~hk~~l~FP~~-------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 289 TYGKIMNHKESLSFPDE-------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHHHHhchhhhcCCCcc-------cccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 65555544333211111 123344455555544 36778877 666654
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=294.50 Aligned_cols=263 Identities=20% Similarity=0.246 Sum_probs=193.3
Q ss_pred HHhhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
.+.++|.+.+.||+|+||.||+|.. .+++.||||++.... ........+.+|+.++++++||||
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~Ei~~l~~l~h~~i 78 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---------------QSIIHAKRTYRELRLLKHMKHENV 78 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc---------------hhhHHHHHHHHHHHHHHHcCCCcc
Confidence 4457899999999999999999985 478999999884211 011223567789999999999999
Q ss_pred ceEEEEEecC------CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 705 VKLYCSITSE------DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 705 v~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++++++... ...+++++++ +++|.+++.. ..+++..+..++.|+++|++||| +.+|+||||||+||
T Consensus 79 v~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NI 151 (345)
T cd07877 79 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNL 151 (345)
T ss_pred cceeeeeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHE
Confidence 9999988643 3367888887 8899888864 35889999999999999999999 89999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
+++.++.++|+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 152 ll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~ 225 (345)
T cd07877 152 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-ID 225 (345)
T ss_pred EEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HH
Confidence 9999999999999998754322 123457889999998866 4578899999999999999999999843211 11
Q ss_pred cHHHHHHhhcccccccc----------------ccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 858 DIVNWVYSKMDSRDSML----------------TVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 858 ~~~~~~~~~~~~~~~~~----------------~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.+.............+. ........+........+.+++.+|++.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 226 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 11111000000000000 000000111111234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=291.28 Aligned_cols=262 Identities=23% Similarity=0.268 Sum_probs=194.0
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+.+|++++++++||||+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~hpniv 72 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF---------------STPVLAKRTYRELKLLKHLRHENII 72 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc---------------cccchhHHHHHHHHHHHhcCCCCee
Confidence 4678999999999999999999855 79999999873211 1112345677899999999999999
Q ss_pred eEEEEEec-CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 706 KLYCSITS-EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 706 ~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
++++++.. ....++|+||+ +++|.++++. ..+++.....++.|+++||+||| +.+|+||||+|+||++++++
T Consensus 73 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~ 145 (328)
T cd07856 73 SLSDIFISPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENC 145 (328)
T ss_pred eEeeeEecCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCC
Confidence 99999876 55788999998 6689888864 34678888889999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH---
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV--- 860 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~--- 860 (947)
.++|+|||.+....... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .....
T Consensus 146 ~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~ 219 (328)
T cd07856 146 DLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIIT 219 (328)
T ss_pred CEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Confidence 99999999987543221 12356889999998766 4688999999999999999999999853211 00000
Q ss_pred --------HHHHhhccccc--cccccccC---CCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 --------NWVYSKMDSRD--SMLTVVDP---NISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 --------~~~~~~~~~~~--~~~~~~d~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
++......... ........ ...+........+.+++.+|++.+|++|||+.+++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 220 DLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 00000000 0011111234678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=285.40 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=194.2
Q ss_pred cccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEe
Q 002250 634 ENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSIT 712 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 712 (947)
.+.+|.|.||+||-|+.+ +|+.||||++.+ ..........+++|++|++++.||.||.+...|+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdK---------------lrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E 633 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDK---------------LRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE 633 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeec---------------ccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec
Confidence 578999999999999955 899999999931 1122244578899999999999999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC---CCeEEe
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE---WKPRIA 789 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~ 789 (947)
..+..++|||-+ .|+..+++-..+...+++..-.-+..||+.||.||| -++|||+||||+|||+... ..+|||
T Consensus 634 T~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 634 TPERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred CCceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeec
Confidence 999999999999 556666666556667888887888899999999999 8999999999999999754 569999
Q ss_pred ccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccc
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS 869 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 869 (947)
|||+|++.+.... ...++||+.|.|||+++...|...-|+||.||++|--++|..||. .++++.+.+. .
T Consensus 710 DFGfARiIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN----EdEdIndQIQ----N 778 (888)
T KOG4236|consen 710 DFGFARIIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN----EDEDINDQIQ----N 778 (888)
T ss_pred cccceeecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC----CccchhHHhh----c
Confidence 9999999876543 346789999999999999999999999999999999999999983 4455544332 1
Q ss_pred cccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 002250 870 RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVV 914 (947)
Q Consensus 870 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 914 (947)
...| . .++-..+.....++++...++..=.+|-+..+-+
T Consensus 779 AaFM---y---Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 779 AAFM---Y---PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cccc---c---CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1111 1 1222344455666777777777777777665543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=296.69 Aligned_cols=263 Identities=21% Similarity=0.242 Sum_probs=189.8
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
..+|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|++++++++||||++
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~-----------------~~~~~~~~~~Ei~~l~~l~h~~i~~ 66 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT-----------------DPQSVKHALREIKIIRRLDHDNIVK 66 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecC-----------------CCchHHHHHHHHHHHHhcCCCcchh
Confidence 367889999999999999999965 6899999988321 1133466888999999999999999
Q ss_pred EEEEEecC--------------CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecc
Q 002250 707 LYCSITSE--------------DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRD 772 (947)
Q Consensus 707 l~~~~~~~--------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~D 772 (947)
+++++... ...++||||++ ++|.+++.. ..+++.....++.|++.||+||| +.+|+|||
T Consensus 67 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~givH~d 139 (342)
T cd07854 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIH---SANVLHRD 139 (342)
T ss_pred hHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence 99776553 34689999996 588888864 35788999999999999999999 88999999
Q ss_pred CCCCCeEec-CCCCeEEeccccceecccCCCCc-ceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCC
Q 002250 773 VKSSNILLD-LEWKPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPI 849 (947)
Q Consensus 773 lkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~ 849 (947)
|||+||+++ +++.++++|||.++......... ......++..|+|||++.. ..++.++|||||||++|||++|+.||
T Consensus 140 ikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf 219 (342)
T cd07854 140 LKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219 (342)
T ss_pred CCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999997 45678999999997653321111 1122357889999998754 45788999999999999999999999
Q ss_pred CCCCCCcccHHHHHHhhcc-cc-----------cccc---ccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 002250 850 VPEFGDSKDIVNWVYSKMD-SR-----------DSML---TVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVV 914 (947)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~-~~-----------~~~~---~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 914 (947)
...... ............ .. .... .................+.+++.+|++.||++|||+.|++
T Consensus 220 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 220 AGAHEL-EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred CCCCHH-HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 533110 000000000000 00 0000 0000000111122345688999999999999999999998
Q ss_pred H
Q 002250 915 Q 915 (947)
Q Consensus 915 ~ 915 (947)
+
T Consensus 299 ~ 299 (342)
T cd07854 299 M 299 (342)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=297.55 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=195.4
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++.++|++.+.||+|++|.||+|+.. +++.||||++.... ........+.+|+.++++++|||+
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~i 76 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---------------QSAIHAKRTYRELRLLKHMDHENV 76 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc---------------chhhHHHHHHHHHHHHHhccCCCH
Confidence 34578999999999999999999965 68899999873211 011233557789999999999999
Q ss_pred ceEEEEEecCCc------cEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 705 VKLYCSITSEDS------NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 705 v~l~~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++.+++...+. .++|+||+ +++|.+++.. ..+++..+..++.|++.|++||| +.+|+||||+|+||
T Consensus 77 v~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Ni 149 (343)
T cd07851 77 IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNI 149 (343)
T ss_pred HHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHe
Confidence 999988876654 79999999 6799998875 45899999999999999999999 89999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
++++++.++|+|||++...... .....++..|+|||.+.+. .++.++||||+|+++|||++|+.||..... .
T Consensus 150 ll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~ 222 (343)
T cd07851 150 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--I 222 (343)
T ss_pred EECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--H
Confidence 9999999999999999765332 1233578899999988653 578899999999999999999999853211 1
Q ss_pred cHHHHHHhhccc-cccc----------------cccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 858 DIVNWVYSKMDS-RDSM----------------LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 858 ~~~~~~~~~~~~-~~~~----------------~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
............ ...+ .....+............+.+++.+|++.+|++|||+.|++++
T Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 223 DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 111110000000 0000 0000000011111225678899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=268.10 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=191.5
Q ss_pred hccCC-cccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 629 DAVKP-ENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 629 ~~~~~-~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
+-|+. .+.||+|+||.|--+. ..+|.++|||++... ..-...+.-+|++++... .|+||+
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-----------------~gHsR~RvfREVe~f~~Cqgh~nil 139 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-----------------PGHSRSRVFREVETFYQCQGHKNIL 139 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-----------------CchHHHHHHHHHHHHHHhcCCccHH
Confidence 44444 4679999999999888 778999999998311 112235677899999998 599999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC-
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW- 784 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~- 784 (947)
.++++|++++..|+|||-|.||+|..++++. .-+++...-++..+||.||.||| .++|.|||+||+|||-.+..
T Consensus 140 qLiefFEdd~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~ 214 (463)
T KOG0607|consen 140 QLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNK 214 (463)
T ss_pred HHHHHhcccceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCC
Confidence 9999999999999999999999999999874 45888888899999999999999 89999999999999997543
Q ss_pred --CeEEeccccceecccC-----CCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 002250 785 --KPRIADFGLAKIVQTG-----EAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 785 --~~kl~DfG~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
-+|||||.++.-.... .........+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||.+.
T Consensus 215 vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 215 VSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred cCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 4899999987532211 1111122346888999999873 234889999999999999999999999765
Q ss_pred CCC-----cccHHHHHHhhccccccccccccCCCCccC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 853 FGD-----SKDIVNWVYSKMDSRDSMLTVVDPNISEIL----KEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 853 ~~~-----~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.+. .....+...... .+.+-...-+++ .....+..+++...+..|+.+|.++.+++.
T Consensus 295 Cg~dCGWdrGe~Cr~CQ~~L------FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 295 CGADCGWDRGEVCRVCQNKL------FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCcCCccCCCccHHHHHHH------HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 421 112222111111 111111111222 223344566777788899999999998886
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=277.50 Aligned_cols=239 Identities=28% Similarity=0.334 Sum_probs=191.7
Q ss_pred ccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecCC
Q 002250 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSED 715 (947)
Q Consensus 637 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 715 (947)
||+|+||.||++... +++.+|+|++.... .........+..|+.++++++||||+++++.+..+.
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 66 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK--------------IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE 66 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhh--------------hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC
Confidence 699999999999965 58999999884221 111124567889999999999999999999999999
Q ss_pred ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 716 SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 716 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
..++||||+++++|.+++.... .+++.....++.|++.|+.|+| +.+++|+||+|+||+++.++.++|+|||.+.
T Consensus 67 ~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~ 141 (250)
T cd05123 67 KLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAK 141 (250)
T ss_pred eeEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcce
Confidence 9999999999999999998643 5789999999999999999999 8999999999999999999999999999997
Q ss_pred ecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccc
Q 002250 796 IVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLT 875 (947)
Q Consensus 796 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 875 (947)
...... .......++..|+|||...+...+.++|+||||+++||+++|+.||.... ............
T Consensus 142 ~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~----- 209 (250)
T cd05123 142 ELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED-----RKEIYEKILKDP----- 209 (250)
T ss_pred ecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHhcCC-----
Confidence 654432 11234567889999999988888899999999999999999999984321 112111111111
Q ss_pred cccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 002250 876 VVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRV 912 (947)
Q Consensus 876 ~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 912 (947)
...+...+..+.+++.+|+..||++||++.+
T Consensus 210 ------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 210 ------LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1122222566788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=314.42 Aligned_cols=149 Identities=30% Similarity=0.399 Sum_probs=129.9
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|.+.+.||+|+||+||+|... +++.||||++..... ........+.+|+.+++.++||||++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~--------------~~~~~~~~~~~E~~~l~~l~hp~Iv~ 68 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM--------------INKNMVHQVQAERDALALSKSPFIVH 68 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc--------------cCHHHHHHHHHHHHHHHhcCCCCcCe
Confidence 367889999999999999999966 789999999842110 01122356889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++......|+||||+++++|.+++.... .+++...+.++.||+.||+||| ..+|+||||||+|||++.++.+
T Consensus 69 ~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~v 143 (669)
T cd05610 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHI 143 (669)
T ss_pred EEEEEEECCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCE
Confidence 9999999999999999999999999997643 4788888999999999999999 8899999999999999999999
Q ss_pred EEeccccce
Q 002250 787 RIADFGLAK 795 (947)
Q Consensus 787 kl~DfG~a~ 795 (947)
||+|||+++
T Consensus 144 kL~DFGls~ 152 (669)
T cd05610 144 KLTDFGLSK 152 (669)
T ss_pred EEEeCCCCc
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=290.61 Aligned_cols=263 Identities=21% Similarity=0.223 Sum_probs=189.5
Q ss_pred ccCCcccccccCceeEEEEEeC-C--CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-S--GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
+|++.+.||+|+||.||+|... + +..||||++... .......+.+.+|+.+++++ +||||+
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~~h~~iv 65 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV---------------FSKKILAKRALRELKLLRHFRGHKNIT 65 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccc---------------cccchhHHHHHHHHHHHHHhcCCCChh
Confidence 3677889999999999999965 4 789999987311 01112245677899999999 599999
Q ss_pred eEEEEEecC----CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 706 KLYCSITSE----DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 706 ~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
++++.+... ...++++||+. ++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~ 139 (332)
T cd07857 66 CLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVN 139 (332)
T ss_pred eeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEc
Confidence 999875432 45688999985 6899988753 45889999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCCC--cceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 782 LEWKPRIADFGLAKIVQTGEAG--DLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
.++.++|+|||+++........ .......||..|+|||++.+ ..++.++||||+||++|||++|+.||..... .+
T Consensus 140 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~--~~ 217 (332)
T cd07857 140 ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY--VD 217 (332)
T ss_pred CCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH--HH
Confidence 9999999999999865433221 11223468999999998765 4588999999999999999999999853210 00
Q ss_pred HHHHHHhh------------ccccc-----cccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 859 IVNWVYSK------------MDSRD-----SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 859 ~~~~~~~~------------~~~~~-----~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
........ ..... .........+..........+.+++.+|++.||++|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 218 QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11000000 00000 00000000111111122456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=294.97 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=206.0
Q ss_pred hhccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
.+.|++.+.||.|.+|.||+++ .++|+.+|||+..++ ....++++.|..|++.. .|||++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~------------------~d~deEiE~eynil~~~~~hpnv~ 79 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT------------------EDEEEEIELEYNMLKKYSHHPNVA 79 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC------------------ccccHHHHHHHHHHHhccCCCCcc
Confidence 3678889999999999999999 557999999988533 24557788899999988 699999
Q ss_pred eEEEEEec-----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 706 KLYCSITS-----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 706 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
.++|+|.. ++..|+|||||.+|+..|+++......+.|..+.-|+..++.|+.+|| ...++|||||-.|||+
T Consensus 80 ~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLL 156 (953)
T KOG0587|consen 80 TFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLL 156 (953)
T ss_pred eEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEE
Confidence 99999854 567899999999999999999877788999999999999999999999 8999999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
+.++.+|++|||.+..+..... .....+||+.|||||++. ...|+.++|+||+|++..||..|.+|+.+..
T Consensus 157 T~e~~VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-- 232 (953)
T KOG0587|consen 157 TENAEVKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-- 232 (953)
T ss_pred eccCcEEEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc--
Confidence 9999999999999986654322 233467999999999984 3457889999999999999999999985432
Q ss_pred cccHHHHHHhhccccccccccccCCC-CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 856 SKDIVNWVYSKMDSRDSMLTVVDPNI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
-++.+....+ .|.. ..-+....+++.+++..|+.+|.++||++.++++
T Consensus 233 ---PmraLF~IpR---------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 233 ---PMRALFLIPR---------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---hhhhhccCCC---------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111111111 1111 2235677788999999999999999999998875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=291.40 Aligned_cols=240 Identities=24% Similarity=0.281 Sum_probs=190.2
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
.+.|.....+|.|+|+.|-.+... +++..|||++... ...-.+|+.++... +||||+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---------------------~~~~~~e~~~~~~~~~h~niv 379 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---------------------ADDNQDEIPISLLVRDHPNIV 379 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc---------------------ccccccccchhhhhcCCCcce
Confidence 467778888999999999998854 7899999998311 23345677777666 799999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe-cCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL-DLEW 784 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll-~~~~ 784 (947)
++.+.+.++...|+|||++.++-+.+.+..... ....+..|+.+++.|+.||| +++|||||+||+|||+ ++.+
T Consensus 380 ~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g 453 (612)
T KOG0603|consen 380 KSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAG 453 (612)
T ss_pred eecceecCCceeeeeehhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCC
Confidence 999999999999999999999999888876432 22556679999999999999 8999999999999999 5889
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
+++|+|||.++...... ...+-|..|.|||++....|++++|+||||+++|||++|+.||...-.+ .++.
T Consensus 454 ~lrltyFG~a~~~~~~~-----~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~---- 523 (612)
T KOG0603|consen 454 HLRLTYFGFWSELERSC-----DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIH---- 523 (612)
T ss_pred cEEEEEechhhhCchhh-----cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHH----
Confidence 99999999998766541 1224588999999999999999999999999999999999999643222 1111
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..+. .+... ........+++.+|++.||.+||+|.++..+
T Consensus 524 ~~i~---------~~~~s---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 524 TRIQ---------MPKFS---ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred Hhhc---------CCccc---cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1111 11222 3334456677779999999999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=239.65 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=197.3
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.|.-.++||+|.||+||||+.. +++.||+|+++-+. ..+.-.....+|+-+++.++|+|||+++
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldd---------------ddegvpssalreicllkelkhknivrl~ 67 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD---------------DDEGVPSSALREICLLKELKHKNIVRLH 67 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccC---------------CCCCCcHHHHHHHHHHHHhhhcceeehh
Confidence 3555678999999999999955 68899999985332 1223345677899999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+....+...-+|+||+ ..+|..+..... ..++......++.|+.+|+.|+| ++.+.|||+||.|.++..+|+.|+
T Consensus 68 dvlhsdkkltlvfe~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkl 142 (292)
T KOG0662|consen 68 DVLHSDKKLTLVFEFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKL 142 (292)
T ss_pred hhhccCceeEEeHHHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEe
Confidence 9999999999999999 457888887653 45888889999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||+|+-.+-.. ...+..+-|..|.+|.++.+.+ |+...|+||-||++.|+.....|..+...-.+.+.+..+...
T Consensus 143 adfglarafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg 220 (292)
T KOG0662|consen 143 ADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220 (292)
T ss_pred cccchhhhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhC
Confidence 9999998654332 2233345689999999999876 788999999999999999977776554443444444333222
Q ss_pred cc-ccccc---ccccCCC-C---------ccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DS-RDSML---TVVDPNI-S---------EILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~-~~~~~---~~~d~~~-~---------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. ++.+. ..-|-.. + .+.+.....=.++.+..+.-+|.+|.++.+.+++
T Consensus 221 ~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 221 TPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11 11111 1111111 1 1112222233466667777899999999988764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=273.94 Aligned_cols=220 Identities=25% Similarity=0.244 Sum_probs=174.5
Q ss_pred cCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecCCccE
Q 002250 640 GGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNL 718 (947)
Q Consensus 640 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 718 (947)
|.+|.||+++.+ +++.||+|++... ..+.+|...+....||||+++++++...+..+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~----------------------~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 61 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKS----------------------SEYSRERLTIIPHCVPNMVCLHKYIVSEDSVF 61 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecch----------------------hhhhhHHHHHHhcCCCceeehhhheecCCeEE
Confidence 899999999965 7899999998321 12334555555667999999999999999999
Q ss_pred EEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecc
Q 002250 719 LVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798 (947)
Q Consensus 719 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 798 (947)
+||||+++|+|.+++.+. ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.++++|||.+....
T Consensus 62 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 62 LVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred EEEecCCCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence 999999999999999764 34889999999999999999999 8999999999999999999999999999876543
Q ss_pred cCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccccccccccc
Q 002250 799 TGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVD 878 (947)
Q Consensus 799 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 878 (947)
... ....++..|+|||+.....++.++||||+|+++|||++|..|+..... .... ...
T Consensus 137 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~-----------~~~~------~~~ 194 (237)
T cd05576 137 DSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS-----------GINT------HTT 194 (237)
T ss_pred ccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch-----------hccc------ccc
Confidence 321 123457789999999888899999999999999999999988632100 0000 000
Q ss_pred CCCCccCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 002250 879 PNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911 (947)
Q Consensus 879 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 911 (947)
.. .+......+.+++.+|++.||++||++.
T Consensus 195 ~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 195 LN---IPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred cC---CcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 01 1222345678899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=271.16 Aligned_cols=263 Identities=20% Similarity=0.227 Sum_probs=203.1
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc--
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH-- 701 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-- 701 (947)
+.+..+|.+...+|+|.||.|-++... .+..||||+++.. ..-.++..-|+++++++.+
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------------------~kYreAa~iEi~vLqki~~~D 146 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------------------DKYREAALIEIEVLQKINESD 146 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------------------HHHhhHHHHHHHHHHHHHhcC
Confidence 445789999999999999999999854 5789999988311 1223455679999999942
Q ss_pred c----ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 702 V----NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 702 ~----niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
| -+|.+.+||...+..++|+|.+ |-|+.++++.+...+++..++..|+.|++++++||| +.+++|-||||+|
T Consensus 147 P~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPEN 222 (415)
T KOG0671|consen 147 PNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPEN 222 (415)
T ss_pred CCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChhe
Confidence 2 3678889999999999999999 779999999988899999999999999999999999 8999999999999
Q ss_pred eEecC--------------------CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHH
Q 002250 778 ILLDL--------------------EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGV 837 (947)
Q Consensus 778 Ill~~--------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv 837 (947)
|++-+ +..++++|||.|++..... ...+.|..|.|||++.+-.++.++||||+||
T Consensus 223 ILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGC 297 (415)
T KOG0671|consen 223 ILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGC 297 (415)
T ss_pred EEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeee
Confidence 99931 3458999999998765544 3567899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCcccHHHHHHhhccc------------------ccc---------ccccccCCC-----CccC
Q 002250 838 VLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS------------------RDS---------MLTVVDPNI-----SEIL 885 (947)
Q Consensus 838 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------------~~~---------~~~~~d~~~-----~~~~ 885 (947)
|++|+.||..-|.... +.+++ .++...... .-. ...+.++-. ....
T Consensus 298 IL~ElytG~~LFqtHe-n~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~ 375 (415)
T KOG0671|consen 298 ILVELYTGETLFQTHE-NLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD 375 (415)
T ss_pred EEEEeeccceecccCC-cHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC
Confidence 9999999999886443 11111 111111100 000 011111111 1112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 886 KEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 886 ~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..+...+++++.+++.+||.+|+|+.|++.+
T Consensus 376 d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 376 DLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred cHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 3456679999999999999999999999863
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=268.65 Aligned_cols=243 Identities=27% Similarity=0.293 Sum_probs=189.4
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 706 (947)
.+|.....||+|+||.|..|.-+ +.+.+|||+++.+..-++. +.+--..|-++++.. +-|.++.
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdD--------------Dvectm~EKrvLAL~~kppFL~q 414 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDD--------------DVECTMVEKRVLALPGKPPFLVQ 414 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecC--------------cccceehhhhheecCCCCchHHH
Confidence 56788899999999999999966 5678999999765543332 222234466677655 5789999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+..+|+.-+..|.||||+.||+|.-.++..++. .+....-.|..||-||-+|| +++|+.||||..|||+|.+|.+
T Consensus 415 lHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkF--KEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHi 489 (683)
T KOG0696|consen 415 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKF--KEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHI 489 (683)
T ss_pred HHHHhhhhhheeeEEEEecCchhhhHHHHhccc--CCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCce
Confidence 999999999999999999999999999886664 44445557788899999999 9999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+++.---+ ...+...+||+.|+|||++....|+..+|.|||||++|||+.|++||+++ +..+.....
T Consensus 490 Ki~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe-----DE~elF~aI 562 (683)
T KOG0696|consen 490 KIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-----DEDELFQAI 562 (683)
T ss_pred EeeecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHH
Confidence 99999999743322 22345679999999999999999999999999999999999999999543 222222222
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP 908 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 908 (947)
.+.... ++.....+...+....+.+.|.+|.
T Consensus 563 ~ehnvs-----------yPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 563 MEHNVS-----------YPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHccCc-----------CcccccHHHHHHHHHHhhcCCcccc
Confidence 222111 2333445566777788889999984
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=272.40 Aligned_cols=267 Identities=27% Similarity=0.332 Sum_probs=198.7
Q ss_pred HHHhhccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
..+.++|-..+.||+|+|++||||. +...+.||||+-+... .++.. +...-.+...+|..|.+.|.||.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK-~WrdE---------KKeNYhKHAcREyrIHKeLDHpR 528 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNK-NWRDE---------KKENYHKHACREYRIHKELDHPR 528 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhcc-chhhH---------hhhhHHHHHHHHHhhhhccCcce
Confidence 4556888899999999999999999 5568899999753222 22211 11122355678999999999999
Q ss_pred cceEEEEEecC-CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 704 VVKLYCSITSE-DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 704 iv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
||++|+||.-+ +..|-|+||++|.+|.-+++.. ...++.....|+.||+.||.||.+- +.+|||-||||.|||+-.
T Consensus 529 IVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~ 605 (775)
T KOG1151|consen 529 IVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVN 605 (775)
T ss_pred eeeeeeeeeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEec
Confidence 99999999764 5568999999999999999863 4578888999999999999999854 789999999999999953
Q ss_pred ---CCCeEEeccccceecccCCCC-----cceecccccccccCccccccC----CCCCccchHHHHHHHHHHHhCCCCCC
Q 002250 783 ---EWKPRIADFGLAKIVQTGEAG-----DLTHVIAGTHGYIAPEYAYTC----KINEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 783 ---~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
-|.+||+|||+++++..+.+. ..+....||++|++||.+.-+ +.+.|+||||.||++|+++.|+.||.
T Consensus 606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 488999999999988765443 234456799999999998543 46789999999999999999999994
Q ss_pred CCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 002250 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVV 914 (947)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 914 (947)
... ...++.+ +... ...-+-.++.- +-...+...++++|+.+.-++|....++.
T Consensus 686 hnq-sQQdILq-------eNTI-lkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 686 HNQ-SQQDILQ-------ENTI-LKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred Cch-hHHHHHh-------hhch-hcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 321 2222222 1111 11111111111 11233466788899999999988777664
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-31 Score=292.66 Aligned_cols=244 Identities=25% Similarity=0.421 Sum_probs=186.3
Q ss_pred CCcccccccCce-eEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEEE
Q 002250 632 KPENLIGKGGSG-NVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYC 709 (947)
Q Consensus 632 ~~~~~iG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 709 (947)
...+.+|.|+.| .||+|... |+.||||++.+ ......++||..++.- +|||||++++
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~--------------------e~~~~A~rEi~lL~eSD~H~NviRyyc 570 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE--------------------EFFDFAQREIQLLQESDEHPNVIRYYC 570 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC-CceehHHHHhh--------------------HhHHHHHHHHHHHHhccCCCceEEEEe
Confidence 345678999988 47999988 89999998831 2334567999999888 6999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC---C-
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL---E- 783 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~- 783 (947)
.-.++...||..|.| ..+|.|++... ......-...+.+..|+++|++||| +.+||||||||.|||++. +
T Consensus 571 ~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~ 646 (903)
T KOG1027|consen 571 SEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADG 646 (903)
T ss_pred eccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCc
Confidence 999999999999999 56999999874 1111111345678889999999999 899999999999999975 3
Q ss_pred -CCeEEeccccceecccCCCC-cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCCcccHH
Q 002250 784 -WKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTG-KRPIVPEFGDSKDIV 860 (947)
Q Consensus 784 -~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg-~~p~~~~~~~~~~~~ 860 (947)
..++|+|||+++....+... .......||.+|+|||++....-+.++||||+||++|+.++| .+||......+.++.
T Consensus 647 ~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl 726 (903)
T KOG1027|consen 647 TLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL 726 (903)
T ss_pred ceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh
Confidence 46899999999877655432 223455799999999999998888899999999999999995 899954432222222
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
. +...+.. +.... ++ ...++|.+|++.+|..||++.+|+.
T Consensus 727 ~-------~~~~L~~-----L~~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 727 T-------GNYTLVH-----LEPLP-DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred c-------Cccceee-----eccCc-hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1 1111111 11111 11 5678888999999999999999974
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-31 Score=275.13 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=202.1
Q ss_pred hccCCcccccccCceeEEEEEeCC-CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS-GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.+++.+..||-|+||.|-.+..+. ...+|+|+++.. ........+....|-.+|...+.|.||++
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~--------------hIVdtkQqeHv~sEr~Im~~~~s~fIvrL 485 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKK--------------HIVDTKQQEHVFSERNIMMECRSDFIVRL 485 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHh--------------hccchhHHHHHHhHHHHHHhcCchHHHHH
Confidence 456667789999999999998664 334888887421 11223445677889999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
|..|.++..+|+.||-|=||.++..++..+ .++.....-++..+.+|++||| +++||+|||||+|.+++.+|-+|
T Consensus 486 YrTfrd~kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~K 560 (732)
T KOG0614|consen 486 YRTFRDSKYVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLK 560 (732)
T ss_pred HHHhccchhhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceE
Confidence 999999999999999999999999999743 4666666778888999999999 99999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|.|||+|+....+.... .++||+.|.|||++.+...+.++|.||+|+++||+++|.+||.+. +-........
T Consensus 561 LVDFGFAKki~~g~KTw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~-----dpmktYn~IL 632 (732)
T KOG0614|consen 561 LVDFGFAKKIGSGRKTW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV-----DPMKTYNLIL 632 (732)
T ss_pred EeehhhHHHhccCCcee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC-----chHHHHHHHH
Confidence 99999999887765433 468999999999999999999999999999999999999999533 2222212222
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-----MRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~ 916 (947)
.+-+. .+++........+++.+..+.+|.+|.. ..+|-++
T Consensus 633 kGid~---------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 633 KGIDK---------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hhhhh---------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 22111 2345666677888899999999999975 5666544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=255.64 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=196.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 706 (947)
.+|...+.||+|+|+.|..++++ +.+.+|+|+++.... ....+....+.|-.+..+. +||.+|.
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~--------------nddedidwvqtek~vfe~asn~pflvg 315 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV--------------NDDEDIDWVQTEKHVFEQASNNPFLVG 315 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc--------------CCcccchhHHhhHHHHHhccCCCeEEe
Confidence 56888999999999999999955 688999999853221 2234556677888888776 7999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+..+|+.+...++|.||++||+|.-+++.+ ..+++....-....|.-||.||| +++|+.||+|..|||+|..|.+
T Consensus 316 lhscfqtesrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 316 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred hhhhhcccceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCce
Confidence 999999999999999999999998877764 34777777777788899999999 9999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC--CCcccHHHHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEF--GDSKDIVNWVY 864 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~--~~~~~~~~~~~ 864 (947)
|++|+|+++.--. ....++.++|||.|+|||++++..|...+|.||+||+++||+.|+.||+-.. +...+..+++.
T Consensus 391 kltdygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf 468 (593)
T KOG0695|consen 391 KLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF 468 (593)
T ss_pred eecccchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH
Confidence 9999999975322 2334567899999999999999999999999999999999999999996432 33333334443
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP 908 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 908 (947)
..+-+... .+++...-+...+...-+++||.+|.
T Consensus 469 qvilekqi----------riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 469 QVILEKQI----------RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HHHhhhcc----------cccceeehhhHHHHHHhhcCCcHHhc
Confidence 33322221 12333333455666788899999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=240.18 Aligned_cols=200 Identities=29% Similarity=0.369 Sum_probs=164.4
Q ss_pred hccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 706 (947)
+.......||+|++|.|-+.++ .+|+..|+|++... ...+...+..+|+.+..+. .+|.+|.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t----------------vn~q~q~r~L~dldi~~r~~~CPf~V~ 109 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT----------------VNSQEQKRLLMDLDIIMRTVDCPFTVH 109 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh----------------cChHHHHHHHHhhhhhccCCCCCeEEE
Confidence 4445567899999999999885 47999999998311 1224455667788877665 7999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+||.+..++..++.||.| ..||..+-++. .+...++...=+||..|.+||.|||+ ...++|||+||+|||++.+|
T Consensus 110 FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~G 186 (282)
T KOG0984|consen 110 FYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDG 186 (282)
T ss_pred eehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCC
Confidence 999999999999999999 55777765542 45678888999999999999999996 67899999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCcccccc----CCCCCccchHHHHHHHHHHHhCCCCCC
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT----CKINEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
.+|+||||++.++.+.-. .+...|-..|||||.+.. ..|+-|+||||+|+++.||.+++.||.
T Consensus 187 qVKiCDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 187 QVKICDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred cEEEcccccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 999999999987755432 223457788999998853 358899999999999999999999984
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=293.69 Aligned_cols=258 Identities=19% Similarity=0.209 Sum_probs=166.5
Q ss_pred hhccCCcccccccCceeEEEEEeC-C----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-S----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
.++|.+.+.||+|+||.||+|+.. + +..||||++... ...+....| .++...+.
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~-------------------~~~e~~~~e--~l~~~~~~ 189 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEY-------------------GAVEIWMNE--RVRRACPN 189 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEeccc-------------------chhHHHHHH--HHHhhchh
Confidence 468899999999999999999965 4 689999987311 000111111 11112222
Q ss_pred ccceEEEE------EecCCccEEEEeccCCCChHHHhhhcCCc------------------cCCHHHHHHHHHHHHHHHH
Q 002250 703 NVVKLYCS------ITSEDSNLLVYEYLPNGSLWDRLHTCHKI------------------EMDWVVRYAIAVGAAKGLE 758 (947)
Q Consensus 703 niv~l~~~------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~~ia~~l~ 758 (947)
+++.+... ...+...++||||+++++|.+++...... .........++.|++.||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~ 269 (566)
T PLN03225 190 SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALD 269 (566)
T ss_pred hHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHH
Confidence 22222211 24566789999999999999998753210 1122345578999999999
Q ss_pred HHhcCCCCCeEeccCCCCCeEecC-CCCeEEeccccceecccCCCCcceecccccccccCccccccC-------------
Q 002250 759 YLHHGFDRPVIHRDVKSSNILLDL-EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC------------- 824 (947)
Q Consensus 759 yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------- 824 (947)
||| +++|+||||||+|||++. ++.+||+|||+|+......... .....+|++|+|||.+...
T Consensus 270 yLH---~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~ 345 (566)
T PLN03225 270 GLH---STGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 345 (566)
T ss_pred HHH---HCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccc
Confidence 999 899999999999999986 5899999999998654332221 2245789999999965322
Q ss_pred ---------CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccc---cccccccCCCC-------ccC
Q 002250 825 ---------KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRD---SMLTVVDPNIS-------EIL 885 (947)
Q Consensus 825 ---------~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~~~~-------~~~ 885 (947)
.++.++|||||||++|||+++..|+.. +...+......... .+.....+... +..
T Consensus 346 ~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (566)
T PLN03225 346 ALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVL 419 (566)
T ss_pred cccchhccccCCCCcccHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhc
Confidence 234567999999999999997766421 11111111000000 00001111100 011
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 886 KEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 886 ~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
........+++.+|++.||++|||+.|++++
T Consensus 420 d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 420 DLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred cccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 1112345589999999999999999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-31 Score=255.61 Aligned_cols=269 Identities=20% Similarity=0.270 Sum_probs=191.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
..|.-..+||+|.||+||+|+.+ .|+.||+|++.-. .....-.....+|++++..++|+|++.+
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme---------------neKeGfpitalreikiL~~lkHenv~nl 81 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME---------------NEKEGFPITALREIKILQLLKHENVVNL 81 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh---------------ccccCCcHHHHHHHHHHHHhcchhHHHH
Confidence 45666788999999999999955 6888999876311 1122233456789999999999999999
Q ss_pred EEEEec--------CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 708 YCSITS--------EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 708 ~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
++.|.. ....|+||.+++. +|.-.+.. ....++...+.+++.++..||.|+| +..|+|||+||.|+|
T Consensus 82 iEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvL 156 (376)
T KOG0669|consen 82 IEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVL 156 (376)
T ss_pred HHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEE
Confidence 877744 2346899999965 77777765 3456888899999999999999999 899999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCC--cceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCC-
Q 002250 780 LDLEWKPRIADFGLAKIVQTGEAG--DLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGD- 855 (947)
Q Consensus 780 l~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~- 855 (947)
++.++.+||+|||+|+.+...+.. ...+..+-|..|.+||.+.+. .|+++.|||+-||++.||+||.+-+.+..+.
T Consensus 157 It~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq 236 (376)
T KOG0669|consen 157 ITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ 236 (376)
T ss_pred EcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH
Confidence 999999999999999765543322 223344569999999999875 5899999999999999999998776433211
Q ss_pred cccHHHHH--------HhhccccccccccccCCCCc----cCHHHHH------HHHHHHHhccCCCCCCCCCHHHHHHHh
Q 002250 856 SKDIVNWV--------YSKMDSRDSMLTVVDPNISE----ILKEDAL------KVLRIAIHCTNKLPAFRPSMRVVVQML 917 (947)
Q Consensus 856 ~~~~~~~~--------~~~~~~~~~~~~~~d~~~~~----~~~~~~~------~l~~l~~~cl~~dP~~RPt~~ev~~~L 917 (947)
.-.+.+.+ +..++.-..+..+.-+.+++ ..++... ...+++..++..||.+|+++.+++.+-
T Consensus 237 ql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 237 QLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred HHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 00111111 11111111111111111111 0111122 466788899999999999999998653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=281.70 Aligned_cols=272 Identities=20% Similarity=0.245 Sum_probs=183.8
Q ss_pred hhccCCcccccccCceeEEEEEe-----------------CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHH
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-----------------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (947)
.++|++.++||+|+||+||+|.. ..++.||||++.........++... ........+.+.
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e---~~~~~~~~e~~~ 220 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKT---GTLAKGSAETGM 220 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhh---hhhhhcccchhH
Confidence 46899999999999999999964 2356899999853322111110000 000112234566
Q ss_pred HHHHHHhhcccccc-----ceEEEEEec--------CCccEEEEeccCCCChHHHhhhcC--------------------
Q 002250 691 AEVATLSAVRHVNV-----VKLYCSITS--------EDSNLLVYEYLPNGSLWDRLHTCH-------------------- 737 (947)
Q Consensus 691 ~E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~-------------------- 737 (947)
.|+.++.+++|.++ ++++++|.. ++..++||||+++++|.++++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 78888888877654 677777753 356799999999999999987421
Q ss_pred --CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccc
Q 002250 738 --KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815 (947)
Q Consensus 738 --~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y 815 (947)
....+|..+..++.|++.||+|+| +.+|+||||||+||+++.++.+||+|||++.......... .....+|+.|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y 376 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRY 376 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcce
Confidence 123467788899999999999999 8899999999999999999999999999997654332211 1122357899
Q ss_pred cCccccccCCC----------------------CCccchHHHHHHHHHHHhCCC-CCCCCC--C-----CcccHHHHHHh
Q 002250 816 IAPEYAYTCKI----------------------NEKSDVYSFGVVLMELVTGKR-PIVPEF--G-----DSKDIVNWVYS 865 (947)
Q Consensus 816 ~aPE~~~~~~~----------------------~~~~Dv~slGv~l~elltg~~-p~~~~~--~-----~~~~~~~~~~~ 865 (947)
+|||.+..... ..+.||||+||++|||++|.. ||.... . ...+...|...
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~ 456 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY 456 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence 99998754321 124799999999999999875 663211 0 01111112110
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCC---CCCCCHHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLP---AFRPSMRVVVQM 916 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~ev~~~ 916 (947)
... ...+. ..........+++.+++..+| .+|+|+.|++++
T Consensus 457 --~~~-------~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 --KGQ-------KYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --ccc-------CCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000 00111 122334567788889998766 689999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=262.55 Aligned_cols=239 Identities=30% Similarity=0.402 Sum_probs=190.6
Q ss_pred CceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecCCccEE
Q 002250 641 GSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLL 719 (947)
Q Consensus 641 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 719 (947)
+||.||+|... +++.+|+|++..... ......+.+|++.+++++|+|++++++++......++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~----------------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 64 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKI----------------KKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYL 64 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccc----------------ccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEE
Confidence 58999999976 589999999842211 0115788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceeccc
Q 002250 720 VYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT 799 (947)
Q Consensus 720 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 799 (947)
++||+++++|.+++..... +++.....++.+++.+++||| ..+++|+||+|+||++++++.++++|||.+.....
T Consensus 65 ~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~ 139 (244)
T smart00220 65 VMEYCDGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDP 139 (244)
T ss_pred EEeCCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence 9999999999999986433 789999999999999999999 88999999999999999999999999999987655
Q ss_pred CCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccC
Q 002250 800 GEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDP 879 (947)
Q Consensus 800 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 879 (947)
.. ......++..|+|||......++.++||||+|+++||+++|..||... .......+... .....
T Consensus 140 ~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-~~~~~~~~~~~---~~~~~------- 205 (244)
T smart00220 140 GG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-DQLLELFKKIG---KPKPP------- 205 (244)
T ss_pred cc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHh---ccCCC-------
Confidence 42 122346788999999998888999999999999999999999998432 11111111111 11100
Q ss_pred CCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 880 NISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 880 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
........+..+.+++.+|+..+|++||++.++++
T Consensus 206 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 206 -FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred -CccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00011014457889999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=238.62 Aligned_cols=258 Identities=19% Similarity=0.282 Sum_probs=197.4
Q ss_pred hhccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv 705 (947)
.++|++.+++|+|-+++||.|. ..+.+.++||+++| ...+.+.+|+.|++.++ ||||+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------------------VkkkKIkREikIL~nL~gg~NIi 96 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------------------VKKKKIKREIKILQNLRGGPNII 96 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------------------HHHHHHHHHHHHHHhccCCCCee
Confidence 4688999999999999999999 56788999999843 34577899999999996 99999
Q ss_pred eEEEEEecCC--ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 706 KLYCSITSED--SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 706 ~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
++++...++. ...+|+||+++.+....... ++-..+.-...++++||.|+| +.||+|||+||.|+++|..
T Consensus 97 ~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~ 168 (338)
T KOG0668|consen 97 KLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHE 168 (338)
T ss_pred ehhhhhcCccccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechh
Confidence 9999998754 45799999999877666554 455556667889999999999 9999999999999999965
Q ss_pred -CCeEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 784 -WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 784 -~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
-..+|+|+|+|.++.++... ...+.+..|.-||.+..- .|+..-|+|||||++..|+..+.||+......+.++.
T Consensus 169 ~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk 245 (338)
T KOG0668|consen 169 LRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK 245 (338)
T ss_pred hceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence 56999999999988776542 344667788999998654 4888999999999999999999999766555555555
Q ss_pred HHHhhc-------------cccccccccccCCC----Ccc----CH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 862 WVYSKM-------------DSRDSMLTVVDPNI----SEI----LK-EDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 862 ~~~~~~-------------~~~~~~~~~~d~~~----~~~----~~-~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.+.... .-...+..++.... ..+ .. -..++.++++-..+.+|..+|||++|.+.+
T Consensus 246 IakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 246 IAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 432211 11111111111100 000 01 123567888889999999999999998753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=251.14 Aligned_cols=262 Identities=22% Similarity=0.229 Sum_probs=194.5
Q ss_pred hccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-----c-
Q 002250 629 DAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-----H- 701 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h- 701 (947)
.+|.+.++||.|.|++||.|. ..+.+.||+|+++.. +.-.+....||+++++++ |
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA------------------qhYtEaAlDEIklL~~v~~~Dp~~~ 139 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA------------------QHYTEAALDEIKLLQQVREGDPNDP 139 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh------------------hHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 789999999999999999999 457889999998311 112245678999999983 3
Q ss_pred --cccceEEEEEec----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCC
Q 002250 702 --VNVVKLYCSITS----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKS 775 (947)
Q Consensus 702 --~niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp 775 (947)
..||++++.|.. +.+++||+|++ |.+|..++.++..+.++...+.+|+.||+.||.|||. ..+|||-||||
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKP 216 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKP 216 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCc
Confidence 479999999976 45679999999 8899999999888889999999999999999999997 66999999999
Q ss_pred CCeEecCC-----------C------------------------------------------------------------
Q 002250 776 SNILLDLE-----------W------------------------------------------------------------ 784 (947)
Q Consensus 776 ~NIll~~~-----------~------------------------------------------------------------ 784 (947)
+|||+..+ +
T Consensus 217 ENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~ 296 (590)
T KOG1290|consen 217 ENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEE 296 (590)
T ss_pred ceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 99999110 0
Q ss_pred --------------------------------------------------------------------------------
Q 002250 785 -------------------------------------------------------------------------------- 784 (947)
Q Consensus 785 -------------------------------------------------------------------------------- 784 (947)
T Consensus 297 ~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~ 376 (590)
T KOG1290|consen 297 EPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIAS 376 (590)
T ss_pred cccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccc
Confidence
Q ss_pred ---------------CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 002250 785 ---------------KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPI 849 (947)
Q Consensus 785 ---------------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~ 849 (947)
.+||+|||-|......- +.-.-|..|.|||++.+..|++.+||||++|++||++||...|
T Consensus 377 n~~v~p~~~~~~~di~vKIaDlGNACW~~khF-----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLF 451 (590)
T KOG1290|consen 377 NPLVNPDIPLPECDIRVKIADLGNACWVHKHF-----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLF 451 (590)
T ss_pred ccccCCCCCCCccceeEEEeeccchhhhhhhh-----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceee
Confidence 02333333333221111 0112477899999999999999999999999999999999999
Q ss_pred CCCCC-----CcccHHHHHHhh-------ccccccccccccC--CC------------------CccCHHHHHHHHHHHH
Q 002250 850 VPEFG-----DSKDIVNWVYSK-------MDSRDSMLTVVDP--NI------------------SEILKEDALKVLRIAI 897 (947)
Q Consensus 850 ~~~~~-----~~~~~~~~~~~~-------~~~~~~~~~~~d~--~~------------------~~~~~~~~~~l~~l~~ 897 (947)
++..+ +.+++..++.-. ......-.+.++. .+ -++..+.+.++.++..
T Consensus 452 ePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~ 531 (590)
T KOG1290|consen 452 EPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLS 531 (590)
T ss_pred cCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHH
Confidence 87643 233333322111 1111110111110 00 2356788999999999
Q ss_pred hccCCCCCCCCCHHHHHHH
Q 002250 898 HCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 898 ~cl~~dP~~RPt~~ev~~~ 916 (947)
-|++.+|++||||.+.+++
T Consensus 532 PmLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 532 PMLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred HHHhcCccccccHHHHhcC
Confidence 9999999999999999854
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=261.95 Aligned_cols=205 Identities=27% Similarity=0.430 Sum_probs=167.0
Q ss_pred hccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
..|..++.||-|+||+|..++ ..+...+|+|.+... .+..+ ......++|-.||+....+=||++
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKa------------DVl~r--nQvaHVKAERDILAEADn~WVVrL 694 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKA------------DVLMR--NQVAHVKAERDILAEADNEWVVRL 694 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHH------------HHHhh--hhhhhhhhhhhhHhhcCCcceEEE
Confidence 346667889999999999998 445677899988421 12222 334567789999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
|-.|++++.+|+||+|++||++..+|-+.+ -+++....-++..+++|+++.| ..|+|||||||+|||||.+|.+|
T Consensus 695 yySFQDkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIK 769 (1034)
T KOG0608|consen 695 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIK 769 (1034)
T ss_pred EEEeccCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCcee
Confidence 999999999999999999999999988743 3566666667778999999999 89999999999999999999999
Q ss_pred Eeccccce---------ecccCCCCcc-------------------------------eecccccccccCccccccCCCC
Q 002250 788 IADFGLAK---------IVQTGEAGDL-------------------------------THVIAGTHGYIAPEYAYTCKIN 827 (947)
Q Consensus 788 l~DfG~a~---------~~~~~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~~ 827 (947)
|+|||++. ++..++.... ....+||+.|+|||++....|+
T Consensus 770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~ 849 (1034)
T KOG0608|consen 770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT 849 (1034)
T ss_pred eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence 99999984 2221111000 0134699999999999999999
Q ss_pred CccchHHHHHHHHHHHhCCCCCCCC
Q 002250 828 EKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 828 ~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
.-+|.||.|||+|||+.|+.||...
T Consensus 850 q~cdwws~gvil~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 850 QLCDWWSVGVILYEMLVGQPPFLAD 874 (1034)
T ss_pred ccchhhHhhHHHHHHhhCCCCccCC
Confidence 9999999999999999999999654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=244.33 Aligned_cols=266 Identities=22% Similarity=0.272 Sum_probs=190.3
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+.+..+.||.|+||.||.+..+ +|+.||.|++. .....-...+.+-+|++++..++|.|++..+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~p---------------nvfq~L~s~krvFre~kmLcfFkHdNVLSaL 118 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMP---------------NVFQNLASCKRVFREIKMLSSFRHDNVLSLL 118 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcc---------------hHHHHHHHHHHHHHHHHHHHhhccccHHHHH
Confidence 3445688999999999999865 89999999883 1122234456788999999999999999988
Q ss_pred EEEecCC-----ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 709 CSITSED-----SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 709 ~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
+..+... +.|+|+|.| ..+|...+-. .+.++...+.-+..||++||.||| +.+|.||||||.|.+++.+
T Consensus 119 DILQPph~dfFqEiYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSN 192 (449)
T KOG0664|consen 119 DILQPANPSFFQELYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSN 192 (449)
T ss_pred HhcCCCCchHHHHHHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccC
Confidence 8765542 457888988 4467666654 456788888889999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCC--cccHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGD--SKDIV 860 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~--~~~~~ 860 (947)
...||||||+|+....++... ++..+-|-.|.|||++++.+ |+.++||||.||++.|++..+--|.....- -+-+.
T Consensus 193 CvLKICDFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt 271 (449)
T KOG0664|consen 193 CILKICDFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII 271 (449)
T ss_pred ceEEecccccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH
Confidence 999999999999765544322 33445688999999998865 899999999999999999888777432110 00000
Q ss_pred --------HHHHhhcccccccccccc-----C---CCCcc--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 861 --------NWVYSKMDSRDSMLTVVD-----P---NISEI--LKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 861 --------~~~~~~~~~~~~~~~~~d-----~---~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
+-++-..++.. ..++. | .+-.. ......+...+...++..||++|.+..+.+...-.
T Consensus 272 dLLGTPs~EaMr~ACEGAk--~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 272 DLLGTPSQEAMKYACEGAK--NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HHhCCCcHHHHHHHhhhhH--HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 00000011100 01111 0 11111 11222345566778899999999999998876543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=232.16 Aligned_cols=260 Identities=19% Similarity=0.301 Sum_probs=196.3
Q ss_pred ccHHHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-
Q 002250 622 FSEKEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV- 699 (947)
Q Consensus 622 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 699 (947)
+..-++.+.|.+.+.+|+|.||.+-.++++ +.+.+++|-++. ......+|.+|...--.|
T Consensus 17 l~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------------------p~tt~~dF~rEfhY~~~Ls 78 (378)
T KOG1345|consen 17 LKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------------------PQTTQADFVREFHYSFFLS 78 (378)
T ss_pred ccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------------------chhhHHHHHHHhccceeec
Confidence 334456788999999999999999999976 678899997742 224457899998776666
Q ss_pred cccccceEEEE-EecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 700 RHVNVVKLYCS-ITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 700 ~h~niv~l~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
-|.||+..|+. |+..+.+++++||+|.|+|.+-+.. ..+.+....+++.|+++|+.||| +..+||||||.+||
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNi 152 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENI 152 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceE
Confidence 48999988865 6777788899999999999888765 34677888899999999999999 99999999999999
Q ss_pred Eec--CCCCeEEeccccceecccCCCCcceecccccccccCccccccC-----CCCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 779 LLD--LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-----KINEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 779 ll~--~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
|+- +...+|+||||..+..+... ....-+..|.|||..... ...+.+|||.||+++|.++||+.||..
T Consensus 153 Lif~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 153 LIFDADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred EEecCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 994 34579999999987443221 122346679999987432 245678999999999999999999986
Q ss_pred CCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 852 EFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
..-.+...++|.......... ++.....-.+++.++..+-+..+|++|--..++.++-+
T Consensus 228 a~~~d~~Y~~~~~w~~rk~~~--------~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 228 ASIMDKPYWEWEQWLKRKNPA--------LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred hhccCchHHHHHHHhcccCcc--------CchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 666666777776554433332 22222223345667777889999999955555554443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=253.07 Aligned_cols=201 Identities=25% Similarity=0.370 Sum_probs=168.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhccc---CChhhHHHHHHHHhhcc---c
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRS---SRSSEYDAEVATLSAVR---H 701 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~E~~~l~~l~---h 701 (947)
..|...+.+|+|+||.|+.|.++ +...|+||.+.+.. +..... ...-..-.||+||..++ |
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeR------------IL~DtWvrDrkLGtVp~EIqIla~l~~~sH 628 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKER------------ILVDTWVRDRKLGTVPSEIQILATLNKHSH 628 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhh------------hhhhhhhcccccCccchhHHHHHHhhhcCc
Confidence 35888899999999999999976 56789999984322 111111 11223457999999997 9
Q ss_pred cccceEEEEEecCCccEEEEecc-CCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYL-PNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
+||+|++++|++++.+|++||-. ++-+|.+++... ..+++.....|+.||+.|+++|| +++|||||||-+||.+
T Consensus 629 ~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenviv 703 (772)
T KOG1152|consen 629 ENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIV 703 (772)
T ss_pred cchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEE
Confidence 99999999999999999999986 356899999864 34788888889999999999999 9999999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCC-CccchHHHHHHHHHHHhCCCCCC
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKIN-EKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~ 850 (947)
+.+|-+||+|||.|.+...+. .+.++||..|.|||++.+.+|- ..-||||+|+++|.++....||+
T Consensus 704 d~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 704 DSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999998765543 3467899999999999988864 56899999999999999988874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-26 Score=232.75 Aligned_cols=212 Identities=38% Similarity=0.543 Sum_probs=182.2
Q ss_pred ccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecCC
Q 002250 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSED 715 (947)
Q Consensus 637 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 715 (947)
||+|++|.||++... +++.+++|++...... .....+.+|++.++.++|++++++++++....
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----------------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 64 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS----------------SLLEELLREIEILKKLNHPNIVKLYGVFEDEN 64 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch----------------hHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Confidence 689999999999976 4899999998422110 03467899999999999999999999999999
Q ss_pred ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC-CCCeEEeccccc
Q 002250 716 SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL-EWKPRIADFGLA 794 (947)
Q Consensus 716 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a 794 (947)
..++++||+++++|.+++.... ...++..+..++.+++++++||| +.+++|+||+|.||+++. ++.++|+|||.+
T Consensus 65 ~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~ 140 (215)
T cd00180 65 HLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLS 140 (215)
T ss_pred eEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCce
Confidence 9999999999999999998642 45889999999999999999999 889999999999999999 899999999999
Q ss_pred eecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccc
Q 002250 795 KIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSM 873 (947)
Q Consensus 795 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 873 (947)
........ ......+...|++||..... .++.++|+|++|+++++|
T Consensus 141 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------- 187 (215)
T cd00180 141 KLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------- 187 (215)
T ss_pred EEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------
Confidence 86654321 12234578899999999877 788999999999999999
Q ss_pred cccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 002250 874 LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQML 917 (947)
Q Consensus 874 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 917 (947)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4578889999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=231.00 Aligned_cols=258 Identities=23% Similarity=0.267 Sum_probs=191.2
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
..+|.....+|.|.- .|..|... .+++||+|++-.. ........+..+|..++..++|+||++
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p---------------f~n~~~akra~rel~l~~~v~~~nii~ 79 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP---------------FQNQTHAKRAYRELKLMKCVNHKNIIS 79 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc---------------cccCccchhhhhhhhhhhhhcccceee
Confidence 457777888999988 56666533 6899999987322 111234466788999999999999999
Q ss_pred EEEEEecCC------ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 707 LYCSITSED------SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 707 l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
++.+|.... ..|+||||| .++|...+.- .++-.+...+..|+..|+.||| +.+|+||||||+||++
T Consensus 80 l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv 151 (369)
T KOG0665|consen 80 LLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVV 151 (369)
T ss_pred eeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCccccee
Confidence 999986543 469999999 5688888872 4677788889999999999999 9999999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
..+..+||.|||+|+..... -..+-.+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+. ..+.
T Consensus 152 ~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~id 224 (369)
T KOG0665|consen 152 NSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHID 224 (369)
T ss_pred cchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHH
Confidence 99999999999999865443 1233446789999999999888999999999999999999999887432 2222
Q ss_pred HHHHh---------------------hccccccc-cccccCCC--------CccCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 861 NWVYS---------------------KMDSRDSM-LTVVDPNI--------SEILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 861 ~~~~~---------------------~~~~~~~~-~~~~d~~~--------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
+|... .....+.. ...+...+ .+...-......+++.+|+-.+|++|-++
T Consensus 225 Q~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv 304 (369)
T KOG0665|consen 225 QWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV 304 (369)
T ss_pred HHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH
Confidence 22111 11111100 01111111 11122233446678889999999999999
Q ss_pred HHHHHH
Q 002250 911 RVVVQM 916 (947)
Q Consensus 911 ~ev~~~ 916 (947)
++++++
T Consensus 305 ~daL~H 310 (369)
T KOG0665|consen 305 DDALRH 310 (369)
T ss_pred HHHhcC
Confidence 999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=239.82 Aligned_cols=265 Identities=24% Similarity=0.296 Sum_probs=198.7
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV- 699 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 699 (947)
..+.+.|..+++||+|+|++||+|... ..+.||+|.+. ......++..|++++..+
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~-------------------~ts~p~ri~~El~~L~~~g 92 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIY-------------------RTSSPSRILNELEMLYRLG 92 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecc-------------------cccCchHHHHHHHHHHHhc
Confidence 345578999999999999999999843 36789999883 224556789999999999
Q ss_pred cccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 700 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
.+.||+++.+++..++.+.+|+||++.....++... ++..........+..||+|+| .+|||||||||+|++
T Consensus 93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL 164 (418)
T KOG1167|consen 93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFL 164 (418)
T ss_pred cchhhhcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccc
Confidence 589999999999999999999999999888888876 567778888999999999999 899999999999999
Q ss_pred ecC-CCCeEEeccccceecccCC-------------CC------------------c-----------ceeccccccccc
Q 002250 780 LDL-EWKPRIADFGLAKIVQTGE-------------AG------------------D-----------LTHVIAGTHGYI 816 (947)
Q Consensus 780 l~~-~~~~kl~DfG~a~~~~~~~-------------~~------------------~-----------~~~~~~gt~~y~ 816 (947)
.+. .+.-.|.|||+|....... .. . ......||+||.
T Consensus 165 ~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfR 244 (418)
T KOG1167|consen 165 YNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFR 244 (418)
T ss_pred cccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCC
Confidence 985 4778999999996211000 00 0 001245999999
Q ss_pred CccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc----------cccccccc----------
Q 002250 817 APEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM----------DSRDSMLT---------- 875 (947)
Q Consensus 817 aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~---------- 875 (947)
|||++.... .++++||||.||++.-+++++.||.....+-..+.+.+.... .+...+.+
T Consensus 245 aPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~ 324 (418)
T KOG1167|consen 245 APEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPEL 324 (418)
T ss_pred chHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHH
Confidence 999997654 678999999999999999999999766555444444332211 01100000
Q ss_pred -----ccc-CCC----------CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 876 -----VVD-PNI----------SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 876 -----~~d-~~~----------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
-++ ..+ ....+..+..++++..+|++.||.+|.|+++.+++
T Consensus 325 ~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 325 RVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred HhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 000 000 01111223468899999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-27 Score=253.94 Aligned_cols=253 Identities=26% Similarity=0.317 Sum_probs=196.5
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|.....+|.|+||.||||+.. .++..|||+++-. ......-.+.|+-+++..+|||||.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe-----------------p~dd~~~iqqei~~~~dc~h~niva 76 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE-----------------PGDDFSGIQQEIGMLRDCRHPNIVA 76 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeecc-----------------CCccccccccceeeeecCCCcChHH
Confidence 478899999999999999999954 7899999998421 2244556778999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
++|.+...+..++.|||+.+|+|++.-+.. .++++.+.--++....+|++||| +++-+|||||-.||++++.|.+
T Consensus 77 y~gsylr~dklwicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDv 151 (829)
T KOG0576|consen 77 YFGSYLRRDKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDV 151 (829)
T ss_pred HHhhhhhhcCcEEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCce
Confidence 999999999999999999999999988763 35777777778889999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCcccc---ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYA---YTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
|++|||.+..+...- .....+.||+.|||||+. +.+.|...+|||+.|+...|+-.-++|.+.... .+-.
T Consensus 152 klaDfgvsaqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-----mr~l 224 (829)
T KOG0576|consen 152 KLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-----MRAL 224 (829)
T ss_pred eecccCchhhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-----HHHH
Confidence 999999986543322 123356899999999987 456689999999999999999988888532211 1110
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
+-.- ...+++...+-.....+.+-.++..|+.++|.+||++...+.
T Consensus 225 ~LmT------kS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 225 FLMT------KSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHhh------ccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0000 111122111122233455778888999999999999876543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-25 Score=229.03 Aligned_cols=199 Identities=32% Similarity=0.476 Sum_probs=169.5
Q ss_pred cCCcccccccCceeEEEEEeCC-CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLNS-GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
|+..+.||+|++|.||+|.... ++.+|+|.+...... .....+.+|++.+++++|+|++++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----------------~~~~~~~~e~~~~~~~~~~~i~~~~~ 64 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----------------KQREEFLREIRILKKLKHPNIVKLYG 64 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----------------HHHHHHHHHHHHHHhCCCCChhhhee
Confidence 4567889999999999999774 899999998422110 13567889999999999999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
++......++++||+++++|.+++..... .+++.....++.+++.++.||| ..+++|+|++|+||+++.++.++|+
T Consensus 65 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~ 140 (225)
T smart00221 65 VFEDPEPLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLA 140 (225)
T ss_pred eeecCCceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEe
Confidence 99999999999999999999999987432 2789999999999999999999 7899999999999999999999999
Q ss_pred ccccceecccCCCCcceecccccccccCcccc-ccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYA-YTCKINEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
|||.+......... ......++..|++||.. ....++.++|||+||++++||++|+.||.
T Consensus 141 d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 141 DFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred eCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 99999876554311 12234678899999998 56667889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-26 Score=241.69 Aligned_cols=201 Identities=23% Similarity=0.261 Sum_probs=167.8
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc---
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR--- 700 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--- 700 (947)
+.+-.+|.+....|+|-|++|.+|... -|+.||||+|.-.. ...+.=.+|+++|++|+
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE------------------~M~KtGl~EleiLkKL~~AD 489 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE------------------VMHKTGLKELEILKKLNDAD 489 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch------------------HHhhhhhHHHHHHHHhhccC
Confidence 445578999999999999999999954 58899999994221 12233357999999995
Q ss_pred ---ccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC-CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 002250 701 ---HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH-KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776 (947)
Q Consensus 701 ---h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 776 (947)
--|.++++..|....++|||+|-+ ..+|.+.+++.+ ...+....+..++.|+.-||..|. ..+|+|.||||.
T Consensus 490 ~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPD 565 (752)
T KOG0670|consen 490 PEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPD 565 (752)
T ss_pred chhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCcc
Confidence 248899999999999999999998 569999999875 356788889999999999999999 889999999999
Q ss_pred CeEecCC-CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 777 NILLDLE-WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 777 NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
|||+.+. ..+||||||.|......+.... .-+..|.|||++.+-.|+...|+||.||.+||+.||+..|.+
T Consensus 566 NiLVNE~k~iLKLCDfGSA~~~~eneitPY----LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 566 NILVNESKNILKLCDFGSASFASENEITPY----LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred ceEeccCcceeeeccCccccccccccccHH----HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 9999865 5689999999987665543221 235689999999999999999999999999999999988843
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=273.66 Aligned_cols=340 Identities=19% Similarity=0.230 Sum_probs=257.2
Q ss_pred CCccCCCCCCCCEEECcCcc------cccccCccccCCC-CCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCC
Q 002250 174 IPEGIGNLTQLQNLELSDNE------LFGEIPAGIVKLN-KLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDL 246 (947)
Q Consensus 174 ~p~~~~~l~~L~~L~Ls~N~------l~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 246 (947)
.+..|.++++|+.|.+..+. +...+|..|..++ +|+.|++.+|.++ .+|..| ...+|++|+|++|++...+
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L~ 627 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKLW 627 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccccc
Confidence 34567788888888886653 2234566666664 5888888888887 667666 4688888888888888777
Q ss_pred ccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCc
Q 002250 247 SELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGA 326 (947)
Q Consensus 247 ~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 326 (947)
..+..+++|+.|+|+++.....+| .++.+++|+.|+|++|.....+|..++.+++|+.|++++|.....+|..+ .+.+
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 777788888888888776444566 47778888888888877666888888888888888888876555677655 6778
Q ss_pred cceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcC-------CCCCCcccccccc
Q 002250 327 MTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFE-------GPVTDDIGNAKSL 399 (947)
Q Consensus 327 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-------~~~~~~~~~l~~L 399 (947)
|+.|.+.+|...+.+|.. ..+|+.|++++|.+. .+|..+ .+++|+.|++.++... ...+..+..+++|
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL 780 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL 780 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccc
Confidence 888888888777777754 357888899999987 566655 5788888888764422 1222233445789
Q ss_pred cEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCc
Q 002250 400 ALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479 (947)
Q Consensus 400 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 479 (947)
+.|+|++|...+.+|..++++++|+.|++++|...+.+|..+ ++++|+.|+|++|.....+|.. .++|+.|+|++|
T Consensus 781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n 856 (1153)
T PLN03210 781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRT 856 (1153)
T ss_pred hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCC
Confidence 999999998877899999999999999999876555778766 7889999999998655555543 367889999999
Q ss_pred eeeeecCCCCCccCcCcEEECCC-CccCCccCCcccccccceeeCCCCc
Q 002250 480 SLSGKIPDSLGSLPSLNSLNLSN-NKFSGEIPISLTYPKLSLLDLSNNQ 527 (947)
Q Consensus 480 ~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~~~L~~L~ls~N~ 527 (947)
.++ .+|..+..+++|+.|+|++ |++++.++....+++|+.++++++.
T Consensus 857 ~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 857 GIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 998 7888899999999999988 5676544444456888889988874
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-26 Score=237.12 Aligned_cols=275 Identities=21% Similarity=0.204 Sum_probs=192.6
Q ss_pred ccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCC-cccccccceeecCC-CCccCccCcccccccCCCceee
Q 002250 62 ALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNS-SGISGKFPWKSLENLTNLEFLS 139 (947)
Q Consensus 62 ~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~-l~~l~~L~~L~L~~-n~i~~~~~~~~l~~l~~L~~L~ 139 (947)
.-..++|..|+|+.+.+.+|+.+++|+.||||+|.|+.+.|+ |.+|++|..|-+.+ |+|+ .+|...|.+|..|+.|.
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLL 146 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHh
Confidence 456788889999888889999999999999999999887665 88888888777766 7887 56668899999999999
Q ss_pred CCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCccc------------ccccCccccCCCC
Q 002250 140 LGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNEL------------FGEIPAGIVKLNK 207 (947)
Q Consensus 140 Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l------------~~~~~~~l~~l~~ 207 (947)
+.-|++.-.. ...+..+++|..|.+..|.+..+--..|..+.+++.+.+..|.+ ....|..+++..-
T Consensus 147 lNan~i~Cir-~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc 225 (498)
T KOG4237|consen 147 LNANHINCIR-QDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARC 225 (498)
T ss_pred cChhhhcchh-HHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccccee
Confidence 9888886542 55677888888888888888844444888888888888888872 1223334444444
Q ss_pred CcEEEeecccccccCCccCCCC-CCcc-EEeccCCCCCCCC-ccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEc
Q 002250 208 LWQLELYNNSLSGRLPVGFSNL-TNLM-NFDVSQNRLEGDL-SELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSL 284 (947)
Q Consensus 208 L~~L~L~~n~l~~~~~~~~~~l-~~L~-~L~Ls~N~l~~~~-~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 284 (947)
..-..+.++++...-+..|... ..+. .+....+.....+ ..|..+++|+.|+|++|+|+.+-+.+|.++..+++|+|
T Consensus 226 ~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L 305 (498)
T KOG4237|consen 226 VSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL 305 (498)
T ss_pred cchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence 4444455555554434333221 1111 1111111111111 23677778888888888888777778888888888888
Q ss_pred cCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccC
Q 002250 285 YTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFN 338 (947)
Q Consensus 285 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~ 338 (947)
..|+|...--..|.++..|+.|+|.+|+|+..-|..|..+..+.+|.+.+|.+.
T Consensus 306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 888887666666777788888888888887777777777777777777776653
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=263.22 Aligned_cols=336 Identities=20% Similarity=0.236 Sum_probs=214.2
Q ss_pred hcccccCcEEEccCcc------ccccCCccCCCCC-CCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccC
Q 002250 154 VLKLEKLYWLYLTNCS------VTGQIPEGIGNLT-QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGF 226 (947)
Q Consensus 154 ~~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~ 226 (947)
|.++++|+.|.+.++. +...+|..|..++ +|+.|++.+|.+. .+|..| .+.+|++|+|.+|++. .++..+
T Consensus 554 F~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~ 630 (1153)
T PLN03210 554 FKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGV 630 (1153)
T ss_pred HhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccccc
Confidence 4455555555554332 2223444454443 4666666666553 445544 3455666666666665 445555
Q ss_pred CCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCccccccc
Q 002250 227 SNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYV 306 (947)
Q Consensus 227 ~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 306 (947)
..+++|+.|+|++|......+.+..+++|+.|+|++|.....+|..+..+++|+.|++++|..-..+|..+ ++++|+.|
T Consensus 631 ~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L 709 (1153)
T PLN03210 631 HSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRL 709 (1153)
T ss_pred ccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEE
Confidence 56666666666655433333345556666666666655444566666666666666666654333555544 55666666
Q ss_pred ccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEccccccc-------ccCCCCCCCCCCcceec
Q 002250 307 DVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLS-------GTIPPGIWSLPNLSIID 379 (947)
Q Consensus 307 ~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~-------~~~p~~~~~l~~L~~L~ 379 (947)
++++|.....+|.. ..+++.|.+.+|.+. .+|..+ .+++|..|.+.++... ...+..+...++|+.|+
T Consensus 710 ~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~ 784 (1153)
T PLN03210 710 NLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLF 784 (1153)
T ss_pred eCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchhee
Confidence 66666544444432 234556666666543 344433 4566666666653321 11122233356889999
Q ss_pred cccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCC
Q 002250 380 LSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSG 459 (947)
Q Consensus 380 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 459 (947)
|++|...+.+|..++++++|+.|++++|..-+.+|..+ ++++|+.|+|++|.....+|.. .++|+.|+|++|.++
T Consensus 785 Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~- 859 (1153)
T PLN03210 785 LSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE- 859 (1153)
T ss_pred CCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-
Confidence 99988777788888899999999998876555777766 7889999999987655556643 367889999999998
Q ss_pred CCCcccccccccceeeccC-ceeeeecCCCCCccCcCcEEECCCCc
Q 002250 460 PLPYSIGSCVSLTDINFAQ-NSLSGKIPDSLGSLPSLNSLNLSNNK 504 (947)
Q Consensus 460 ~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~ 504 (947)
.+|.++..+++|+.|+|++ |+|. .+|..+..+++|+.|++++|.
T Consensus 860 ~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 860 EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 6788899999999999998 4665 688888899999999999885
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-25 Score=268.52 Aligned_cols=197 Identities=19% Similarity=0.183 Sum_probs=140.9
Q ss_pred hccc-cccceEEEEE-------ecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 002250 698 AVRH-VNVVKLYCSI-------TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVI 769 (947)
Q Consensus 698 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iv 769 (947)
.++| +||++++++| ...+..+.++||+ +++|.+++... ...+++..+..++.||++||+||| +++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH---SQGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 4556 6888888887 2334567888988 66999999753 346899999999999999999999 89999
Q ss_pred eccCCCCCeEecC-------------------CCCeEEeccccceecccCCC--------------Ccceeccccccccc
Q 002250 770 HRDVKSSNILLDL-------------------EWKPRIADFGLAKIVQTGEA--------------GDLTHVIAGTHGYI 816 (947)
Q Consensus 770 H~Dlkp~NIll~~-------------------~~~~kl~DfG~a~~~~~~~~--------------~~~~~~~~gt~~y~ 816 (947)
||||||+|||++. ++.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566777777653211000 00011235788999
Q ss_pred CccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHH
Q 002250 817 APEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIA 896 (947)
Q Consensus 817 aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~ 896 (947)
|||++.+..++.++|||||||++|||++|..|+.... ..+...... ...+ ...........++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~----------~~~~----~~~~~~~~~~~~~ 245 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHR----------VLPP----QILLNWPKEASFC 245 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHh----------hcCh----hhhhcCHHHHHHH
Confidence 9999999999999999999999999999988863211 001111000 0011 1111223456788
Q ss_pred HhccCCCCCCCCCHHHHHHH
Q 002250 897 IHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 897 ~~cl~~dP~~RPt~~ev~~~ 916 (947)
.+|++.+|.+||+|.|++++
T Consensus 246 ~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHhCCCChhhCcChHHHhhc
Confidence 89999999999999999864
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=246.07 Aligned_cols=123 Identities=28% Similarity=0.377 Sum_probs=71.6
Q ss_pred CcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhcc
Q 002250 374 NLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLH 453 (947)
Q Consensus 374 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 453 (947)
+|+.|+|++|+|++. |.. ..+|+.|++++|+|+ .+|.. ..+|+.|++++|+|+ .+|.. .++|+.|+++
T Consensus 343 ~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS 410 (788)
T PRK15387 343 GLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVS 410 (788)
T ss_pred ccceEecCCCccCCC-CCC---Ccccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCc---ccCCCEEEcc
Confidence 455555555555532 221 234555555555555 34432 235666666666666 34432 2456666777
Q ss_pred ccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCcc
Q 002250 454 DNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL 513 (947)
Q Consensus 454 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 513 (947)
+|+|++ +|.. ..+|+.|+|++|+|+ .+|..++++++|+.|+|++|+|++.+|..+
T Consensus 411 ~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 411 GNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 776663 4432 235666777777776 677777777777777777777777665543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-26 Score=232.53 Aligned_cols=276 Identities=18% Similarity=0.216 Sum_probs=202.6
Q ss_pred cCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeec-ccccccCCccCCCCCCccEEec
Q 002250 159 KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYN-NSLSGRLPVGFSNLTNLMNFDV 237 (947)
Q Consensus 159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L 237 (947)
.-..++|..|+|+.+.|.+|+.+++|+.||||+|+|+.+.|++|.++++|.+|-+.+ |+|+......|.+|.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 345677777777766677788888888888888888777788888887776666655 7787666667888888888888
Q ss_pred cCCCCCCCCc-cccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccc------------cccCCcCccCccccc
Q 002250 238 SQNRLEGDLS-ELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRL------------TGTLPQKLGSWADFN 304 (947)
Q Consensus 238 s~N~l~~~~~-~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l------------~~~~p~~l~~l~~L~ 304 (947)
.-|++..... .|..+++|..|.|..|.+..+--..|..+..++.+.+..|.+ ....|..++...-..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 8887776553 577777888888888887743334777788888888887772 223444555555555
Q ss_pred ccccccccccCCCCCCcccC-CccceeeecccccCCcCC-ccccCCCCccEEEcccccccccCCCCCCCCCCcceecccc
Q 002250 305 YVDVSENLLTGPIPPDMCKT-GAMTDLLVLQNNFNGTVP-ETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLST 382 (947)
Q Consensus 305 ~L~Ls~N~l~~~~p~~~~~~-~~l~~L~l~~n~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~ 382 (947)
...+.++++..+-+..+... ..+..-.....+..+.-| ..|..+++|++|+|++|+|+.+.+.+|..+..++.|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 55666666654333333221 122222223333444555 6789999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCccc
Q 002250 383 NQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFS 434 (947)
Q Consensus 383 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 434 (947)
|+|..+-...|.++..|+.|+|.+|+|+..-|.+|..+..|.+|+|-.|.+.
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 9998887888999999999999999999888999999999999999888754
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=243.86 Aligned_cols=266 Identities=26% Similarity=0.339 Sum_probs=179.6
Q ss_pred cCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEecc
Q 002250 159 KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVS 238 (947)
Q Consensus 159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 238 (947)
+-..|+|++|.++ .+|..+. ++|+.|++++|+|+ .+|.. +++|++|+|++|+|+. +|.. .++|+.|+|+
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeecc
Confidence 3556777777776 4566554 36777777777776 34432 4567777777777773 4432 3566777777
Q ss_pred CCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCC
Q 002250 239 QNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIP 318 (947)
Q Consensus 239 ~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 318 (947)
+|.++.++.. +.+|+.|+|++|+++ .+|.. .++|+.|+|++|+++ .+|... .+|+.|++++|.+++ +|
T Consensus 271 ~N~L~~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~-~Lp~lp---~~L~~L~Ls~N~L~~-LP 338 (788)
T PRK15387 271 SNPLTHLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLA-SLPALP---SELCKLWAYNNQLTS-LP 338 (788)
T ss_pred CCchhhhhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCccc-cCCCCc---ccccccccccCcccc-cc
Confidence 7776654432 245667777777776 34432 356777777777776 344422 345666666666652 33
Q ss_pred CCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCccccccc
Q 002250 319 PDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKS 398 (947)
Q Consensus 319 ~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 398 (947)
. . ..+|+.|+|++|+|+ .+|.. .++|+.|++++|+|+. +|.. +.+
T Consensus 339 ~------------------------l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~ 383 (788)
T PRK15387 339 T------------------------L---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPAL---PSG 383 (788)
T ss_pred c------------------------c---ccccceEecCCCccC-CCCCC---Ccccceehhhcccccc-Cccc---ccc
Confidence 1 0 135777888888887 34543 2467778888888875 4432 356
Q ss_pred ccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccC
Q 002250 399 LALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQ 478 (947)
Q Consensus 399 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 478 (947)
|+.|++++|+|+ .+|.. .++|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus 384 L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 384 LKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred cceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 888899999888 46643 357889999999998 46753 356888999999998 6888999999999999999
Q ss_pred ceeeeecCCCCCc
Q 002250 479 NSLSGKIPDSLGS 491 (947)
Q Consensus 479 N~l~~~~p~~~~~ 491 (947)
|+|++..|..+..
T Consensus 455 N~Ls~~~~~~L~~ 467 (788)
T PRK15387 455 NPLSERTLQALRE 467 (788)
T ss_pred CCCCchHHHHHHH
Confidence 9999887776533
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=206.70 Aligned_cols=167 Identities=22% Similarity=0.211 Sum_probs=126.8
Q ss_pred CChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcce
Q 002250 727 GSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806 (947)
Q Consensus 727 gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 806 (947)
|+|.++++.. ...+++..+..++.|++.||+||| +.+ ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6899999863 346899999999999999999999 555 999999999999999 99998654422
Q ss_pred ecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCH
Q 002250 807 HVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILK 886 (947)
Q Consensus 807 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 886 (947)
..||+.|||||++.+..++.++|||||||++|||+||+.||.........+..+..... .. ++.-.....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~-------~~~~~~~~~ 133 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP-AD-------DPRDRSNLE 133 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc-cC-------CccccccHH
Confidence 25889999999999999999999999999999999999998543222222222111111 00 001011122
Q ss_pred HHHH--HHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 887 EDAL--KVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 887 ~~~~--~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.... .+.+++.+|++.+|++||++.|+++++...
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2222 689999999999999999999999988754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=210.32 Aligned_cols=253 Identities=20% Similarity=0.310 Sum_probs=190.1
Q ss_pred ccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
......+|.+...|+.|+|+++ |..+++|++.... -......+|..|.-.++.+.||||+.++|
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~---------------~t~risrdfneefp~lrifshpnilpvlg 254 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVRE---------------VTARISRDFNEEFPALRIFSHPNILPVLG 254 (448)
T ss_pred hhhhhhhhccCCCccccccccc-Ccchhhhhhhhhh---------------cchhhcchhhhhCcceeeecCCchhhhhh
Confidence 3445567889999999999998 6667778773211 11223467899999999999999999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
.|..+....++..||+.|+|...++.......+..+..+++.++|+|++|||+- ++-|----+.+..|++|++.+++|+
T Consensus 255 acnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 255 ACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred hccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence 999999999999999999999999998888888899999999999999999952 2334445689999999999888774
Q ss_pred ccccceecccCCCCcceecccccccccCccccccCCCC---CccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKIN---EKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
= +-+++.... ....-.+.||+||.+....-+ .++|+|||++++||+.|...||..-..
T Consensus 334 m-ad~kfsfqe------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp------------ 394 (448)
T KOG0195|consen 334 M-ADTKFSFQE------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP------------ 394 (448)
T ss_pred c-ccceeeeec------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc------------
Confidence 1 111111111 112336889999999776543 578999999999999999999953210
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
++.. +.-.+++....+++.....+.++|.-|++.||.+||.+..|+-.|++.
T Consensus 395 mecg--mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 395 MECG--MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred hhhh--hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 0000 011122222344555566788889999999999999999999988863
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=240.20 Aligned_cols=207 Identities=24% Similarity=0.383 Sum_probs=144.9
Q ss_pred CCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEE
Q 002250 85 TRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLY 164 (947)
Q Consensus 85 ~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~ 164 (947)
.+.+.|+|+++.++..+..+. ++|+.|+|++|+|+ .+|. .+ .++|++|+|++|.++. +|..+. +.|+.|+
T Consensus 178 ~~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~Lt-sLP~-~l--~~nL~~L~Ls~N~Lts--LP~~l~--~~L~~L~ 247 (754)
T PRK15370 178 NNKTELRLKILGLTTIPACIP--EQITTLILDNNELK-SLPE-NL--QGNIKTLYANSNQLTS--IPATLP--DTIQEME 247 (754)
T ss_pred cCceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCC-cCCh-hh--ccCCCEEECCCCcccc--CChhhh--ccccEEE
Confidence 456788888888876655443 46788888888887 3442 22 2578888888888765 344332 4688888
Q ss_pred ccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCC
Q 002250 165 LTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEG 244 (947)
Q Consensus 165 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 244 (947)
|++|.+. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+. +|..+. ++|+.|++++|+++.
T Consensus 248 Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 248 LSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA 318 (754)
T ss_pred CcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc
Confidence 8888887 5666554 47888888888886 4666554 478888888888884 454443 468888888888877
Q ss_pred CCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCC
Q 002250 245 DLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPP 319 (947)
Q Consensus 245 ~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 319 (947)
.+..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+++ .+|..+. ++|+.|+|++|.++ .+|.
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~ 384 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPE 384 (754)
T ss_pred CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCH
Confidence 655443 578888888888874 565553 67888888888887 5666553 57888888888877 3444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=218.39 Aligned_cols=172 Identities=18% Similarity=0.162 Sum_probs=129.5
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC--CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN--SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
..+.+.|.+.+.||+|+||+||+|..+ +++.||||++....... ........|.+|++++++++|+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~------------~~~~~~~~~~~E~~iL~~L~h~ 81 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWW------------SKPLARHLAAREIRALKTVRGI 81 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccc------------ccHHHHHHHHHHHHHHHhccCC
Confidence 344578999999999999999999865 57778999873111000 0112235689999999999999
Q ss_pred ccce-EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccC-CCCCeEe
Q 002250 703 NVVK-LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDV-KSSNILL 780 (947)
Q Consensus 703 niv~-l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl-kp~NIll 780 (947)
|+++ ++++ +..|+||||++|++|... .. .. ...++.++++||+||| +.+|+|||| ||+|||+
T Consensus 82 ~iv~~l~~~----~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv 145 (365)
T PRK09188 82 GVVPQLLAT----GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLM 145 (365)
T ss_pred CCCcEEEEc----CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEE
Confidence 9985 4432 457999999999999632 11 11 1356788999999999 899999999 9999999
Q ss_pred cCCCCeEEeccccceecccCCCCcc------eecccccccccCccccccC
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDL------THVIAGTHGYIAPEYAYTC 824 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 824 (947)
+.++.+||+|||+|+.......... -....+++.|+|||++...
T Consensus 146 ~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 146 GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999999999987654432111 1245688999999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-21 Score=208.61 Aligned_cols=261 Identities=23% Similarity=0.210 Sum_probs=193.3
Q ss_pred ccCCcccccccCceeEEEEEeCCC--cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc----cc
Q 002250 630 AVKPENLIGKGGSGNVYKVVLNSG--KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH----VN 703 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~n 703 (947)
+|++.+.||+|+||.||.|..... ..+|+|...... ......+..|+.++..+.. ++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~-----------------~~~~~~l~~E~~vl~~l~~~~~~~~ 81 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKEL-----------------GSKPSVLKIEIQVLKKLEKKNGPSH 81 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecc-----------------cCCCccchhHHHHHHHHhhhcCCCC
Confidence 799999999999999999996643 478888763111 1111267789999999873 68
Q ss_pred cceEEEEE-ecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 704 VVKLYCSI-TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 704 iv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
+.++++.. ..+...|+||+.+ |.+|.+.........++.....+++.|++.+|+++| +.+++||||||.|+++..
T Consensus 82 ~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~ 157 (322)
T KOG1164|consen 82 FPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQ 157 (322)
T ss_pred CCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecC
Confidence 99999999 5777889999999 889999887766678999999999999999999999 999999999999999986
Q ss_pred C-----CCeEEeccccceecc--cCCC----Cc-c-eecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 002250 783 E-----WKPRIADFGLAKIVQ--TGEA----GD-L-THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPI 849 (947)
Q Consensus 783 ~-----~~~kl~DfG~a~~~~--~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~ 849 (947)
. ..+.+.|||+|+... .... .. . .....||.+|+++....+...+.+.|+||++.++.|+..|..||
T Consensus 158 ~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 158 SSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred CCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 5 458999999998322 1111 01 1 22456999999999999999999999999999999999999998
Q ss_pred CCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 850 VPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
...... ........... ... ... .....+..+.++...+-..+...+|....+...+++...
T Consensus 238 ~~~~~~-~~~~~~~~~~~--~~~----~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 238 EALEMT-DLKSKFEKDPR--KLL----TDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred cccccc-chHHHHHHHhh--hhc----ccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 432211 11111110000 000 000 111223445555556666889999999999998876543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-21 Score=190.54 Aligned_cols=200 Identities=23% Similarity=0.322 Sum_probs=171.7
Q ss_pred hccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~ 706 (947)
..|+++++||+|+||+.+.|+ +-++++||||.= .+..+...+..|.+..+.|. .++|..
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-------------------PrkS~APQLrdEYr~YKlL~g~~GIP~ 88 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-------------------PRKSEAPQLRDEYRTYKLLGGTEGIPQ 88 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEec-------------------cccCCcchHHHHHHHHHHHcCCCCCCc
Confidence 368999999999999999999 557999999953 22345567888999999885 689999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC---
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE--- 783 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~--- 783 (947)
+|-+..++.+-.+|+|.+ |-+|+|++.-|++ .++..++..+|.|++.-++|+| ++..|.|||||+|+||..-
T Consensus 89 vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k 163 (449)
T KOG1165|consen 89 VYYFGQEGKYNILVIDLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTK 163 (449)
T ss_pred eeeeccccchhhhhhhhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCC
Confidence 988888888888999999 8899999988764 6899999999999999999999 8999999999999999743
Q ss_pred --CCeEEeccccceecccCCCCc-----ceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 002250 784 --WKPRIADFGLAKIVQTGEAGD-----LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 784 --~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
..+.++|||+|+.+.+..... ......||.+||+--...+.+-+.+.|+=|+|-|+++.+-|..||.+-
T Consensus 164 ~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 164 DANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred CCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 458999999999887654422 223456999999999999999999999999999999999999999643
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.9e-21 Score=226.21 Aligned_cols=267 Identities=24% Similarity=0.421 Sum_probs=122.1
Q ss_pred CCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccC
Q 002250 183 QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFE 262 (947)
Q Consensus 183 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~ 262 (947)
+|+.|+|++|+|+ .+|..+. .+|++|+|++|+|+ .+|..+. .+|+.|+|++|+++.++..+. .+|+.|+|++
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~~LP~~l~--s~L~~L~Ls~ 271 (754)
T PRK15370 200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRITELPERLP--SALQSLDLFH 271 (754)
T ss_pred CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccCcCChhHh--CCCCEEECcC
Confidence 4444444444444 2333322 24455555555544 2333222 245555555555544433332 3455566666
Q ss_pred ccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCC
Q 002250 263 NQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVP 342 (947)
Q Consensus 263 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p 342 (947)
|+|+ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|.++. +|..+.
T Consensus 272 N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~-------------------- 324 (754)
T PRK15370 272 NKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETLP-------------------- 324 (754)
T ss_pred CccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-CCcccc--------------------
Confidence 6555 3444332 35666666666665 3444332 356666666666652 232111
Q ss_pred ccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCc
Q 002250 343 ETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASS 422 (947)
Q Consensus 343 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 422 (947)
++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+. +|..+ .++|+.|++++|+|+ .+|..+. ..
T Consensus 325 ------~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~l--p~~L~~LdLs~N~Lt-~LP~~l~--~s 389 (754)
T PRK15370 325 ------PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETL--PPTITTLDVSRNALT-NLPENLP--AA 389 (754)
T ss_pred ------ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhh--cCCcCEEECCCCcCC-CCCHhHH--HH
Confidence 234444444444442 333332 345555555555542 22222 234555555555555 3444332 24
Q ss_pred ceEEEcccCcccCCCCcccc----cccccchhhccccccCCCCCcccccccccceeeccCceeee-ecCCCCCccCcCcE
Q 002250 423 LVSIQLSLNQFSGQIPLDIG----KLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSG-KIPDSLGSLPSLNS 497 (947)
Q Consensus 423 L~~L~Ls~N~l~~~~p~~~~----~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~ 497 (947)
|+.|++++|+|+ .+|..+. .++++..|+|.+|.++. ..+.+|+.| ++.+.+.| .++...+...+++.
T Consensus 390 L~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~ 461 (754)
T PRK15370 390 LQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRV 461 (754)
T ss_pred HHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCcccccccccccccc
Confidence 555566666655 3443322 23555666666666541 234444444 33344433 23333344444443
Q ss_pred EECCCCccCC
Q 002250 498 LNLSNNKFSG 507 (947)
Q Consensus 498 L~Ls~N~l~~ 507 (947)
...-.+.+.+
T Consensus 462 ~~~l~~a~~~ 471 (754)
T PRK15370 462 TRPLHQAVQG 471 (754)
T ss_pred cchHHHHHhc
Confidence 3333333433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-21 Score=226.18 Aligned_cols=269 Identities=19% Similarity=0.242 Sum_probs=197.1
Q ss_pred CCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEE
Q 002250 632 KPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710 (947)
Q Consensus 632 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 710 (947)
...+.+|.|++|.|+.+... ..+..+.|.+... .. .. .........+..|+-+-..+.|||++..+..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~---------~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~ 389 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PT---------ESERKYNYNITSEFCIGSSLSHPNIIETLDI 389 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC-Cc---------ccHHHHhhhhhhheeecccccCCchhhhHHH
Confidence 35678999999988877643 3444555543200 00 00 0000111226678888889999999888877
Q ss_pred EecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEec
Q 002250 711 ITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790 (947)
Q Consensus 711 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 790 (947)
+.+....+-+|||+++ +|..++... ..+....+..+..|+..|++|+| +.+|.|||+|++|+++..+|.+||+|
T Consensus 390 ~~~~~~~~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~D 463 (601)
T KOG0590|consen 390 VQEIDGILQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIID 463 (601)
T ss_pred HhhcccchhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEee
Confidence 7776666666999999 999999874 34677788889999999999999 89999999999999999999999999
Q ss_pred cccceecccCCCC--cceecccccccccCccccccCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 791 FGLAKIVQTGEAG--DLTHVIAGTHGYIAPEYAYTCKINEK-SDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 791 fG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
||.+....-+... ......+|...|+|||.+....|+++ .||||.|+++..|++|+.||...-.....+.
T Consensus 464 fg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------- 536 (601)
T KOG0590|consen 464 FGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------- 536 (601)
T ss_pred cCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-------
Confidence 9999766544332 34456789999999999999999875 7999999999999999999965433322220
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HhhccCCCC
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ--MLEEAEPCS 924 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~--~L~~~~~~~ 924 (947)
.........+...........+.+...++.++++.||.+|.|+.+|++ .+++++-|-
T Consensus 537 ~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~ 595 (601)
T KOG0590|consen 537 TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH 595 (601)
T ss_pred hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence 001111111222334456667778889999999999999999999984 566666664
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-19 Score=198.72 Aligned_cols=262 Identities=28% Similarity=0.364 Sum_probs=196.7
Q ss_pred cCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc-ccceEEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV-NVVKLYC 709 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~ 709 (947)
|...+.||.|+||.||++... ..+|+|.+..... ........+.+|+.+++.+.|+ +++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~--------------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~ 65 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLE--------------SKSKEVERFLREIQILASLNHPPNIVKLYD 65 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhc--------------cchhHHHHHHHHHHHHHHccCCcceeeEEE
Confidence 567788999999999999977 8899998842211 0012467789999999999988 7999999
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCC-ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC-CeE
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHK-IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW-KPR 787 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~k 787 (947)
.+......+++++|+.++++.+++..... ..........+..|++.+++|+| +.+++|||+||+||+++..+ .++
T Consensus 66 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~ 142 (384)
T COG0515 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVK 142 (384)
T ss_pred EEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEE
Confidence 99777778999999999999977765322 26788889999999999999999 88999999999999999988 799
Q ss_pred EeccccceecccCCCCc----ceecccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCC--ccc
Q 002250 788 IADFGLAKIVQTGEAGD----LTHVIAGTHGYIAPEYAYT---CKINEKSDVYSFGVVLMELVTGKRPIVPEFGD--SKD 858 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~--~~~ 858 (947)
++|||.++......... ......||..|+|||.+.. ..+....|+||+|++++++++|..||...... ...
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~ 222 (384)
T COG0515 143 LIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ 222 (384)
T ss_pred EeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHH
Confidence 99999998655443221 2345679999999999987 57888999999999999999999996433221 112
Q ss_pred HHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 859 IVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..+........ ....... ..........+.+++..|+..+|..|.++.+....
T Consensus 223 ~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 223 TLKIILELPTP--SLASPLS---PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHhcCCc--ccccccC---ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 22222111111 0000000 00002233567788889999999999999887764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.4e-21 Score=182.11 Aligned_cols=202 Identities=27% Similarity=0.340 Sum_probs=167.9
Q ss_pred HhhccCCcccccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc-ccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH-VNV 704 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni 704 (947)
....|+++++||.|+||.+|.|. ..+|.+||||+=. .......+..|.++.+.++| ..|
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es-------------------~~a~hpqL~yEskvY~iL~~g~Gi 73 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES-------------------SKAKHPQLLYESKVYRILQGGVGI 73 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeec-------------------ccCCCcchhHHHHHHHHhccCCCC
Confidence 35789999999999999999999 6789999999741 11334556779999999975 577
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC-
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE- 783 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~- 783 (947)
..+..+..+...-.+||+.. |-+|.+.+.-+.+ .++..+++-.|.|++.-++|+| .++++||||||+|+|..-+
T Consensus 74 P~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgr 148 (341)
T KOG1163|consen 74 PHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGR 148 (341)
T ss_pred chhhhhccccccceeeeecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeecccc
Confidence 77788888888899999999 8899999887643 5888899999999999999999 8999999999999999743
Q ss_pred --CCeEEeccccceecccCCCC-----cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 002250 784 --WKPRIADFGLAKIVQTGEAG-----DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 784 --~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
..+.++|||+|+.+.+.... .......||.+|.+--...+...+.+.|+=|+|.++.++--|..||.+.
T Consensus 149 h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 149 HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 56889999999876544321 1223456999999988877777888999999999999999999999654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-20 Score=187.90 Aligned_cols=183 Identities=14% Similarity=0.143 Sum_probs=136.5
Q ss_pred HHHHhhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 624 EKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 624 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
++-+..+|+..+.+|.|+||.||.+.. +++.+|||++++..... ......-.....+++|+..+.++.|++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~--------~~~~~~f~~g~~~e~Ea~~l~rL~~~G 96 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRT--------ERFLKSFVKGDYYENLIVQTDRVRSEG 96 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCch--------HHHHHhhhhhHHHHHHHHHHHHHHHCC
Confidence 355668899999999999999999766 57789999996443211 001011111344789999999999999
Q ss_pred cceEEEEEecC--------CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCC
Q 002250 704 VVKLYCSITSE--------DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKS 775 (947)
Q Consensus 704 iv~l~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp 775 (947)
|..+.+++... +..++||||++|.+|.++.. .+. ....+++.++..+| ..+++|||++|
T Consensus 97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp 163 (232)
T PRK10359 97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHK 163 (232)
T ss_pred CCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCCh
Confidence 99999886543 35789999999999988742 222 23558899999999 89999999999
Q ss_pred CCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHH
Q 002250 776 SNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELV 843 (947)
Q Consensus 776 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell 843 (947)
+||++++++ ++++|||............ .+.....+..++|+|+||+++....
T Consensus 164 ~Nili~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 164 GNFIVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HHEEEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 999999988 9999999886553222111 1233445667899999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=180.04 Aligned_cols=156 Identities=18% Similarity=0.155 Sum_probs=110.5
Q ss_pred cccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccch--hhh-------hhcccCChhhHHHHHHHHhhcccccc
Q 002250 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSS--TAI-------LSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
...||+|+||.||+|...+|++||||+++++........... ... .............|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999988899999999975432111100000 000 00000001233569999999988876
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEeccCCCCCeEecCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
.....+.. ...++||||++++++...... ...++......++.|++.+|+|+ | +.+|+||||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-C
Confidence 44333222 234899999998877654332 24578888999999999999999 6 78999999999999998 4
Q ss_pred CCeEEeccccceec
Q 002250 784 WKPRIADFGLAKIV 797 (947)
Q Consensus 784 ~~~kl~DfG~a~~~ 797 (947)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=197.97 Aligned_cols=219 Identities=26% Similarity=0.413 Sum_probs=167.4
Q ss_pred HhhccccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCC
Q 002250 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKS 775 (947)
Q Consensus 696 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp 775 (947)
|+.+.|.|+.+++|.+.++...++|.+|++.|+|.|.+.. ....++|.....+..+++.||+|+|+ ++-..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence 3567899999999999999999999999999999999987 56789999999999999999999994 33349999999
Q ss_pred CCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCC-------CCCccchHHHHHHHHHHHhCCCC
Q 002250 776 SNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-------INEKSDVYSFGVVLMELVTGKRP 848 (947)
Q Consensus 776 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~slGv~l~elltg~~p 848 (947)
+|++++..+.+|++|||+.................-..-|.|||.+.... .+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987764311111111112345699999987642 45679999999999999999999
Q ss_pred CCCCCCCc--ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 849 IVPEFGDS--KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 849 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
|....... .++...+.. .. ...+.|.+.... +....+..++..||..+|++||++.+|-..++......
T Consensus 158 ~~~~~~~~~~~eii~~~~~--~~----~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK--GG----SNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cccccccCChHHHHHHHHh--cC----CCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 97544322 233333222 01 112223332222 44447899999999999999999999999988776643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.1e-19 Score=176.36 Aligned_cols=157 Identities=22% Similarity=0.224 Sum_probs=112.9
Q ss_pred cccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchh--hhh-h------cccCChhhHHHHHHHHhhcccccc
Q 002250 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSST--AIL-S------KRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~--~~~-~------~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
...||+|+||.||+|...+|+.||||++.+............. ... . ........+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999778999999999765321110000000 000 0 000012334689999999999987
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHH-hhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCCeEecC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDR-LHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFD-RPVIHRDVKSSNILLDL 782 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~Dlkp~NIll~~ 782 (947)
.....+... ..++||||++++++... +.. ...+.....+++.|++.++.|+| . .+|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-
Confidence 544443332 24899999998865443 332 34677788899999999999999 6 8999999999999999
Q ss_pred CCCeEEeccccceeccc
Q 002250 783 EWKPRIADFGLAKIVQT 799 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~ 799 (947)
++.++|+|||+|.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=171.27 Aligned_cols=191 Identities=17% Similarity=0.122 Sum_probs=138.8
Q ss_pred CCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccceEEEE
Q 002250 632 KPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVKLYCS 710 (947)
Q Consensus 632 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 710 (947)
.+...|++|+||+||.+.- .+.+++.+.+..+... ....+...+.+|+++++++. |+++++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~-------------~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~ 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWW-------------LRGVAWWLARREALALRQLDGLPRTPRLLHW 70 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhh-------------hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE
Confidence 4567899999999997766 5778887766311100 00111235889999999995 5889999886
Q ss_pred EecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccC-CCCCeEecCCCCeEEe
Q 002250 711 ITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDV-KSSNILLDLEWKPRIA 789 (947)
Q Consensus 711 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~ 789 (947)
...+++|||++|.+|.+.... . ...+..|++.+++++| +.+|+|||| ||.||+++.++.++|+
T Consensus 71 ----~~~~lvmeyI~G~~L~~~~~~------~---~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LI 134 (218)
T PRK12274 71 ----DGRHLDRSYLAGAAMYQRPPR------G---DLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVI 134 (218)
T ss_pred ----cCEEEEEeeecCccHHhhhhh------h---hHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEE
Confidence 446999999999998754422 0 1246678899999999 899999999 7999999999999999
Q ss_pred ccccceecccCCCC----cc-------eecccccccccCccccccC-CCC-CccchHHHHHHHHHHHhCCCCCCCC
Q 002250 790 DFGLAKIVQTGEAG----DL-------THVIAGTHGYIAPEYAYTC-KIN-EKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 790 DfG~a~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
|||+|......... .. ......++.|++|+....- ..+ .+.+.++-|..+|.++|+..|...+
T Consensus 135 DFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 135 DFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred ECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 99999855433210 00 1122357778888755332 222 5679999999999999999887544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6e-19 Score=181.34 Aligned_cols=204 Identities=21% Similarity=0.228 Sum_probs=143.5
Q ss_pred cccccceEEEEEec---------------------------CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHH
Q 002250 700 RHVNVVKLYCSITS---------------------------EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVG 752 (947)
Q Consensus 700 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ 752 (947)
+|||||++.++|.+ +...|+||.-.+ .+|.+++-... .+.....-|..|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999877643 234589998884 58888887632 344455667789
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCCeEec--CCC--CeEEeccccceecccCC----CCcceecccccccccCccccccC
Q 002250 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLD--LEW--KPRIADFGLAKIVQTGE----AGDLTHVIAGTHGYIAPEYAYTC 824 (947)
Q Consensus 753 ia~~l~yLH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DfG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~ 824 (947)
+.+|+.||| .++|.|||+|++|||+. +|+ ..+++|||++--..... .....-...|...-||||+....
T Consensus 350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999 89999999999999994 343 46899999884222110 00001123477889999987543
Q ss_pred C------CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHh
Q 002250 825 K------INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIH 898 (947)
Q Consensus 825 ~------~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~ 898 (947)
. .-.|+|.|+.|.+.||+++...||+...+..-+... --...++..++.++..+.+++..
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~--------------Yqe~qLPalp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT--------------YQESQLPALPSRVPPVARQLVFD 492 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh--------------hhhhhCCCCcccCChHHHHHHHH
Confidence 2 225899999999999999999999642211111111 01123455667778889999999
Q ss_pred ccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 899 CTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 899 cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
.++.||++|++..-...+|.-.-..+
T Consensus 493 lL~r~pskRvsp~iAANvl~LsLw~~ 518 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVLNLSLWRM 518 (598)
T ss_pred HhcCCccccCCccHHHhHHHHHHhcC
Confidence 99999999999887777666544333
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.5e-21 Score=174.13 Aligned_cols=179 Identities=26% Similarity=0.460 Sum_probs=155.1
Q ss_pred CCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCcc
Q 002250 45 EQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKF 124 (947)
Q Consensus 45 ~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~ 124 (947)
+.+++.....+-+..+..++.|.|++|++ ..+|..+..+.+|+.|++++|+|+..+++++.+++|+.|++.-|++. ..
T Consensus 17 DrgiSsf~~~~gLf~~s~ITrLtLSHNKl-~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~l 94 (264)
T KOG0617|consen 17 DRGISSFEELPGLFNMSNITRLTLSHNKL-TVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-IL 94 (264)
T ss_pred ccccccHhhcccccchhhhhhhhcccCce-eecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cC
Confidence 34444433334466778899999999999 56677899999999999999999999999999999999999999986 56
Q ss_pred CcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccC
Q 002250 125 PWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVK 204 (947)
Q Consensus 125 ~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 204 (947)
| ..|+.++.|+.|||.+|.+....+|..|..++.|+-|+|+.|.+. .+|..++++++|+.|.+.+|.+- .+|..++.
T Consensus 95 p-rgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~ 171 (264)
T KOG0617|consen 95 P-RGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGD 171 (264)
T ss_pred c-cccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHH
Confidence 6 789999999999999999998889999999999999999999998 88889999999999999999986 78899999
Q ss_pred CCCCcEEEeecccccccCCccCCCC
Q 002250 205 LNKLWQLELYNNSLSGRLPVGFSNL 229 (947)
Q Consensus 205 l~~L~~L~L~~n~l~~~~~~~~~~l 229 (947)
+..|++|++.+|+++ .+|..++++
T Consensus 172 lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 172 LTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred HHHHHHHhcccceee-ecChhhhhh
Confidence 999999999999998 666665553
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-19 Score=205.42 Aligned_cols=252 Identities=20% Similarity=0.244 Sum_probs=178.2
Q ss_pred ccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHH--HhhccccccceE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT--LSAVRHVNVVKL 707 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l 707 (947)
.+...+.+|.+.|=+|.+|+.+.|. |+||++-.. ........|.++++- ...++|||.+++
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~----------------~p~~sL~~~~qrL~~ik~~l~~~pn~lPf 86 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQ----------------DPTISLRPFKQRLEEIKFALMKAPNCLPF 86 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEecc----------------CCCCCchHHHHHHHHHHHHhhcCCcccch
Confidence 6777889999999999999998776 999998321 112233344433333 445589999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
.-+...+...|||-+|+ ..+|.|++.. +.-+.......|+.|+..|+..+| ..+|+|||||.+|||++.=.=+.
T Consensus 87 qk~~~t~kAAylvRqyv-khnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~ 160 (1431)
T KOG1240|consen 87 QKVLVTDKAAYLVRQYV-KHNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLY 160 (1431)
T ss_pred HHHHHhhHHHHHHHHHH-hhhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhh
Confidence 88888888889999999 4599999986 334677778889999999999999 89999999999999999877789
Q ss_pred Eecccccee--cccCCCCcce---ecccccccccCccccccCC-----------CCCccchHHHHHHHHHHHh-CCCCCC
Q 002250 788 IADFGLAKI--VQTGEAGDLT---HVIAGTHGYIAPEYAYTCK-----------INEKSDVYSFGVVLMELVT-GKRPIV 850 (947)
Q Consensus 788 l~DfG~a~~--~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~slGv~l~ellt-g~~p~~ 850 (947)
|+||..-+. .+.+...... +....-.+|+|||.+.... .+++-||||.||++.|+++ |++||.
T Consensus 161 LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 161 LTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred hhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 999986643 2222222211 1112335799999875421 4567899999999999998 788873
Q ss_pred CCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
-..+..+ +.. +... .+ ..+.++.. ..+..++..|++.||++|.++.+.++.-++
T Consensus 241 -----LSQL~aY--r~~-~~~~-~e---~~Le~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 241 -----LSQLLAY--RSG-NADD-PE---QLLEKIED---VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred -----HHHHHhH--hcc-CccC-HH---HHHHhCcC---ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1111111 111 0100 00 00111111 146778889999999999999999988655
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.8e-19 Score=196.33 Aligned_cols=235 Identities=26% Similarity=0.324 Sum_probs=179.8
Q ss_pred ccccCceeEEEEE----eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccceEEEEE
Q 002250 637 IGKGGSGNVYKVV----LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVKLYCSI 711 (947)
Q Consensus 637 iG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 711 (947)
+|+|+||.|+.++ ...|+-+|+|+........+ .......|..++...+ ||.+|++.-.+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~---------------~~~~t~~er~il~~~~~~~f~v~lhyaf 66 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR---------------DRTHTKQERIILAFVHNTPFLVKLHYAF 66 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccc---------------cccccccHHHHHhhccCCCceeeeeeee
Confidence 6999999999865 23477899998854332221 1114456788888886 99999999999
Q ss_pred ecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecc
Q 002250 712 TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791 (947)
Q Consensus 712 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 791 (947)
+.+...+++++|..+|.+...+... ..++..........+|-+++++| +.+|+|||+|++||+++.+|.+++.||
T Consensus 67 qt~~kl~l~ld~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdf 141 (612)
T KOG0603|consen 67 QTDGKLYLILDFLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDF 141 (612)
T ss_pred ccccchhHhhhhcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCc
Confidence 9999999999999999998888764 33566666666677888999999 899999999999999999999999999
Q ss_pred ccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccc
Q 002250 792 GLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRD 871 (947)
Q Consensus 792 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 871 (947)
|.++..-..+. .+||..|||||++. .....+|.||||++++||+||..||.. +.... ....
T Consensus 142 glske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~---Il~~-- 202 (612)
T KOG0603|consen 142 GLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKR---ILKA-- 202 (612)
T ss_pred hhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHHH---Hhhh--
Confidence 99986544332 28999999999988 467889999999999999999999853 22221 1111
Q ss_pred cccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHHhhc
Q 002250 872 SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR-VVVQMLEE 919 (947)
Q Consensus 872 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~~L~~ 919 (947)
-..++.+......+++..+...+|..|.-.. +.+..+++
T Consensus 203 ---------~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 203 ---------ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred ---------ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 1234556666677788888889999986542 44444443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-20 Score=168.57 Aligned_cols=179 Identities=26% Similarity=0.432 Sum_probs=117.9
Q ss_pred CCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccc
Q 002250 369 IWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLS 448 (947)
Q Consensus 369 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 448 (947)
+.++.++..|.||+|+++ .+|..+..+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 344556666666666666 34445666666666677777666 66667777777777777777776 6677777777777
Q ss_pred hhhccccccCC-CCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCcc-cccccceeeCCCC
Q 002250 449 SLYLHDNMFSG-PLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL-TYPKLSLLDLSNN 526 (947)
Q Consensus 449 ~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~~~L~~L~ls~N 526 (947)
.|||++|++.. .+|..|..|+.|+.|+|+.|.+. .+|..++++++|+.|.+..|.+- .+|... .+.+|+.|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 77777777653 36777777777777777777776 67777777777777777777776 334433 3567777777777
Q ss_pred cCCCCCCCccccc----ccccccccCCCCC
Q 002250 527 QLAGPIPEPLNIK----AFIDSFTGNPGLC 552 (947)
Q Consensus 527 ~l~~~~p~~~~~~----~~~~~~~gN~~~c 552 (947)
+++..+|+..+.. ....-+..|||.-
T Consensus 184 rl~vlppel~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 184 RLTVLPPELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred eeeecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence 7776666654311 1122456787764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.9e-18 Score=177.13 Aligned_cols=235 Identities=19% Similarity=0.233 Sum_probs=148.9
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc--------
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-------- 700 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------- 700 (947)
.+...+.||.|+++.||.++.. +++++|||++.-... ......+.+++|.-....+.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~--------------~~~~~~~~~~~e~l~~~~~~~~~~p~~a 78 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD--------------ASANEYEQLKEEQLAITLFPGVKNPKEA 78 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST--------------THTTHHHHHHHHHHGGGGSTT--SHHHH
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccc--------------cchHHHHHHHHHHHHhhhhccCCCHHHH
Confidence 3445678999999999999976 589999999853321 11133455666665555432
Q ss_pred --ccccceEEEE---------EecC---C-----ccEEEEeccCCCChHHHhhh---cC--CccCCHHHHHHHHHHHHHH
Q 002250 701 --HVNVVKLYCS---------ITSE---D-----SNLLVYEYLPNGSLWDRLHT---CH--KIEMDWVVRYAIAVGAAKG 756 (947)
Q Consensus 701 --h~niv~l~~~---------~~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~--~~~~~~~~~~~i~~~ia~~ 756 (947)
|-.++.-++. +... . ..+++|+-+ .++|.+.+.. .. ........+..+..|+++.
T Consensus 79 ~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~l 157 (288)
T PF14531_consen 79 YRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRL 157 (288)
T ss_dssp HHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHH
T ss_pred HHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHH
Confidence 2112211111 1111 1 235677777 5688887652 11 2235566778888999999
Q ss_pred HHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCcccccc--------CCCCC
Q 002250 757 LEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT--------CKINE 828 (947)
Q Consensus 757 l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ 828 (947)
+++|| ..++||+||+|+|++++.+|.++|+||+.....+.... ....+..|.+||.... ..++.
T Consensus 158 vA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~ 229 (288)
T PF14531_consen 158 VANLH---SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTF 229 (288)
T ss_dssp HHHHH---HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-H
T ss_pred HHHHh---hcceEecccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeee
Confidence 99999 89999999999999999999999999998765433211 1234578999997643 24788
Q ss_pred ccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCC
Q 002250 829 KSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFR 907 (947)
Q Consensus 829 ~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 907 (947)
+.|.|++|+++|.|++|..||....... ..+..+..+. +.++.+..++..+++.+|.+|
T Consensus 230 ~~DaW~LG~~ly~lWC~~lPf~~~~~~~-------------------~~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 230 ATDAWQLGITLYSLWCGRLPFGLSSPEA-------------------DPEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHHHHHSS-STCCCGGGS-------------------TSGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCHHHHHHHHHHHHHccCCCCCCCccc-------------------cccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 8999999999999999999985321100 0001334455 778889999999999999987
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-20 Score=205.46 Aligned_cols=60 Identities=27% Similarity=0.401 Sum_probs=28.9
Q ss_pred ccccEEEccCcccc----ccCCCCCCCCCcceEEEcccCcccCC----CCcccccc-cccchhhccccc
Q 002250 397 KSLALLLLANNRFS----GELPSKISEASSLVSIQLSLNQFSGQ----IPLDIGKL-KKLSSLYLHDNM 456 (947)
Q Consensus 397 ~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~ 456 (947)
..|+.|++++|.++ ..+...+..+++|+.+++++|.++.. +...+... +.|+.|++.+|.
T Consensus 250 ~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 250 ISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred CCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 34445555555443 11223334445666666666666532 22222333 456666666654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.2e-17 Score=193.37 Aligned_cols=194 Identities=22% Similarity=0.267 Sum_probs=158.2
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc---ccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR---HVNVV 705 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv 705 (947)
+.|.+.+.||+|+||+||+|...+|+.||+|+=.|.+. ++|.-=.+++.+|+ -+-|+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--------------------WEfYI~~q~~~RLk~~~~~~~~ 757 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--------------------WEFYICLQVMERLKPQMLPSIM 757 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--------------------eeeeehHHHHHhhchhhhcchH
Confidence 56788899999999999999988899999998755442 23333344555555 23455
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec----
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD---- 781 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~---- 781 (947)
.+...+.-.+.-++|+||.+.|+|.+++.. ....+|...+.++.|+++.+++|| ..+|||+||||+|+||.
T Consensus 758 ~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~ 832 (974)
T KOG1166|consen 758 HISSAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREIC 832 (974)
T ss_pred HHHHHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccC
Confidence 555556667788999999999999999984 456899999999999999999999 89999999999999995
Q ss_pred ---CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCC
Q 002250 782 ---LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKR 847 (947)
Q Consensus 782 ---~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~ 847 (947)
+...++|+|||.+-.+..-........+++|-.+-.+|+..+..+++.+|-|.++.+++-|+.|++
T Consensus 833 ~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 833 ADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 235689999999965543333334446788999999999999999999999999999999999984
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-19 Score=200.53 Aligned_cols=279 Identities=22% Similarity=0.259 Sum_probs=128.5
Q ss_pred EEeCcCccCcCCC--CCcccccccceeecCCCCccCc----cCcccccccCCCceeeCCCCCCCC--CC---CChhhccc
Q 002250 89 VLDLGNNSFSGEV--PDLSMLHELSFLNLNSSGISGK----FPWKSLENLTNLEFLSLGDNPFDP--SP---FPMEVLKL 157 (947)
Q Consensus 89 ~L~Ls~n~i~~~~--~~l~~l~~L~~L~L~~n~i~~~----~~~~~l~~l~~L~~L~Ls~n~i~~--~~---~~~~~~~l 157 (947)
.|+|+.+.+++.- ..+..+++|+.|+++++.++.. ++ ..+...++|++|+++++.+.. .. ++..+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~-~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~ 80 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALA-SALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHH-HHHhhCCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence 4677777776422 2255666677777777777432 22 345556667777777776542 00 11223334
Q ss_pred ccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccc----cCCccCCCC-CCc
Q 002250 158 EKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSG----RLPVGFSNL-TNL 232 (947)
Q Consensus 158 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~----~~~~~~~~l-~~L 232 (947)
++|+.|++++|.+.+..+..+..+.+ . ++|++|++++|++++ .+...+..+ ++|
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~--------------------~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L 139 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLR--------------------S-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL 139 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhc--------------------c-CcccEEEeeCCccchHHHHHHHHHHHhCCCCc
Confidence 45555555555444333333333322 0 114444444444441 111223333 445
Q ss_pred cEEeccCCCCCCC-----CccccccCCCCEEEccCccCccc----CCCCccCCCcCcEEEccCcccccc----CCcCccC
Q 002250 233 MNFDVSQNRLEGD-----LSELRFLNQLSSLHLFENQFSGE----IPEEFGEFKHLTELSLYTNRLTGT----LPQKLGS 299 (947)
Q Consensus 233 ~~L~Ls~N~l~~~-----~~~l~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~ 299 (947)
+.|++++|.+++. ...+..+.+|+.|++++|.+++. ++..+..+++|++|++++|.+++. ++..+..
T Consensus 140 ~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~ 219 (319)
T cd00116 140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLAS 219 (319)
T ss_pred eEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcc
Confidence 5555555554421 11233344555555555555421 122233344556666655555422 2233444
Q ss_pred cccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccc----cCCCCCCCCCCc
Q 002250 300 WADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSG----TIPPGIWSLPNL 375 (947)
Q Consensus 300 l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L 375 (947)
+++|++|++++|.+++.....++.. .....+.|+.|++++|.++. .+...+..+++|
T Consensus 220 ~~~L~~L~ls~n~l~~~~~~~l~~~-------------------~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L 280 (319)
T cd00116 220 LKSLEVLNLGDNNLTDAGAAALASA-------------------LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESL 280 (319)
T ss_pred cCCCCEEecCCCcCchHHHHHHHHH-------------------HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCc
Confidence 5556666666665543111111000 00123455566666665541 112233344566
Q ss_pred ceeccccCCcCCC----CCCccccc-ccccEEEccCcc
Q 002250 376 SIIDLSTNQFEGP----VTDDIGNA-KSLALLLLANNR 408 (947)
Q Consensus 376 ~~L~Ls~N~l~~~----~~~~~~~l-~~L~~L~L~~N~ 408 (947)
+++++++|.+... ....+... ..|+.+++.+|.
T Consensus 281 ~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 281 LELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred cEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 6666666666533 22222222 455666665554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.8e-17 Score=163.47 Aligned_cols=136 Identities=18% Similarity=0.297 Sum_probs=103.1
Q ss_pred CCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-----cccccce
Q 002250 632 KPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-----RHVNVVK 706 (947)
Q Consensus 632 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~ 706 (947)
...+.||+|+||.||. .+.....+||++.... ......+.+|+.+++.+ .||||++
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-----------------~~~~~~~~rEi~~l~~L~~~~~~h~nIvr 65 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-----------------DGGDKEIRRELKYYAHLSRRLIDWSGIPR 65 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccc-----------------cchHHHHHHHHHHHHHhhccCCCCcccce
Confidence 3457899999999996 5433444799884221 12345689999999999 5799999
Q ss_pred EEEEEecCC---ccE-EEEec--cCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEeccCCCCCeE
Q 002250 707 LYCSITSED---SNL-LVYEY--LPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGL-EYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 707 l~~~~~~~~---~~~-lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l-~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
++|+++++. ..+ +|+|| .++|+|.+++... .+++. ..++.+++.++ +||| +.+|+||||||+||+
T Consensus 66 ~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NIL 137 (210)
T PRK10345 66 YYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNIL 137 (210)
T ss_pred eeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEE
Confidence 999998874 334 78999 5579999999762 24444 24566777777 9999 899999999999999
Q ss_pred ecC----CCCeEEec-cccc
Q 002250 780 LDL----EWKPRIAD-FGLA 794 (947)
Q Consensus 780 l~~----~~~~kl~D-fG~a 794 (947)
++. ++.++|+| ||..
T Consensus 138 l~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 138 CQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EeccCCCCCcEEEEECCCCc
Confidence 974 34799999 5543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=165.16 Aligned_cols=157 Identities=22% Similarity=0.207 Sum_probs=111.6
Q ss_pred cCCcccccccCceeEEEEE--eCCCcEEEEEEecCCCCCCCCC--cc-chhh----hhhcccCChhhHHHHHHHHhhccc
Q 002250 631 VKPENLIGKGGSGNVYKVV--LNSGKELAVKHIWPSNSGFRGD--YR-SSTA----ILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~~~~--~~-~~~~----~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
|++.+.||+|+||.||+|. ..+|+.||||++.......... .. .... ...........+++|++.++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6678899999999999998 5689999999996543211000 00 0000 000000112346789999999976
Q ss_pred c--ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEeccCCCCCe
Q 002250 702 V--NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRP-VIHRDVKSSNI 778 (947)
Q Consensus 702 ~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~-ivH~Dlkp~NI 778 (947)
. .+.+++++ ...++||||++++++..+.... ..........++.|++.+++||| ..+ |+||||||+||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI 180 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI 180 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence 3 34444443 2458999999998887765332 23455566789999999999999 888 99999999999
Q ss_pred EecCCCCeEEeccccceec
Q 002250 779 LLDLEWKPRIADFGLAKIV 797 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~ 797 (947)
+++ ++.++++|||.|...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 889999999998744
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=160.07 Aligned_cols=153 Identities=22% Similarity=0.151 Sum_probs=111.6
Q ss_pred cCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhh-----hcccCChhhHHHHHHHHhhcccc--c
Q 002250 631 VKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAIL-----SKRSSRSSEYDAEVATLSAVRHV--N 703 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~--n 703 (947)
|.+.+.||+|+||.||+|..++|+.||||+++.+............... .........+.+|+.++.++.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 6778899999999999999888999999998654322211110000000 00011223467899999999887 4
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
+++.++. ...++||||+++++|.+.... .....++.+++.++.++| ..+|+||||||+||+++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCC
Confidence 4444442 456899999999998765431 234567889999999999 8999999999999999999
Q ss_pred CCeEEeccccceecc
Q 002250 784 WKPRIADFGLAKIVQ 798 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~ 798 (947)
+.++|+|||.+....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.6e-16 Score=160.32 Aligned_cols=142 Identities=22% Similarity=0.297 Sum_probs=114.4
Q ss_pred ccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecC
Q 002250 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSE 714 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 714 (947)
+.||+|++|.||+|.. +|..|+||+..+...... ..........+.+|+.++..+.|+++.....++...
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 71 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHP---------ELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP 71 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcCh---------HHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC
Confidence 5789999999999988 578899998743211000 000011234678899999999999988777777777
Q ss_pred CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccc
Q 002250 715 DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA 794 (947)
Q Consensus 715 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 794 (947)
+..++||||++|++|.+++.... + .+..++.+++.++.++| ..+++|||++|.||+++ ++.++++|||.+
T Consensus 72 ~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 72 ENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred CCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcc
Confidence 88899999999999999987521 2 77889999999999999 89999999999999999 789999999988
Q ss_pred ee
Q 002250 795 KI 796 (947)
Q Consensus 795 ~~ 796 (947)
..
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 64
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.5e-16 Score=180.20 Aligned_cols=145 Identities=23% Similarity=0.294 Sum_probs=113.8
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
...|...+.||+|+||+||+|.+.. +.+++|+..+... +. .........+.+.+|++++++++|++++..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~--~~-------~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGY--RH-------PELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC-ccceeEEEecccc--cc-------hhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 3455678999999999999998764 4455554321110 00 000111234568899999999999999988
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
..++..+...++||||+++++|.+++. ....++.++++++.||| +.+++|||+||+||++ +++.++
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~ 467 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLY 467 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEE
Confidence 888887788899999999999999886 24568899999999999 8999999999999999 678999
Q ss_pred Eecccccee
Q 002250 788 IADFGLAKI 796 (947)
Q Consensus 788 l~DfG~a~~ 796 (947)
|+|||+++.
T Consensus 468 liDFGla~~ 476 (535)
T PRK09605 468 LIDFGLGKY 476 (535)
T ss_pred EEeCccccc
Confidence 999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.8e-16 Score=157.42 Aligned_cols=138 Identities=24% Similarity=0.302 Sum_probs=108.0
Q ss_pred cccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecCC
Q 002250 636 LIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSED 715 (947)
Q Consensus 636 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 715 (947)
.||+|+||.||+|.. +++.|++|+..+...... ..........+.+|++++..+.|+++.....++....
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 70 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHP---------ELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD 70 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCc---------hHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC
Confidence 489999999999985 478999998643211000 0001122356788999999999887665555556667
Q ss_pred ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 716 SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 716 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
..++||||++|++|.+++..... .++.+++.++.++| +.+++|||++|.||+++ ++.++++|||.+.
T Consensus 71 ~~~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 71 NKTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CCEEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 78999999999999998765211 68889999999999 89999999999999999 8899999999986
Q ss_pred e
Q 002250 796 I 796 (947)
Q Consensus 796 ~ 796 (947)
.
T Consensus 138 ~ 138 (199)
T TIGR03724 138 Y 138 (199)
T ss_pred C
Confidence 5
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=5e-17 Score=175.38 Aligned_cols=174 Identities=25% Similarity=0.312 Sum_probs=130.5
Q ss_pred ccEEEEeccCCCChHHHhhh-cCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccc
Q 002250 716 SNLLVYEYLPNGSLWDRLHT-CHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA 794 (947)
Q Consensus 716 ~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 794 (947)
..|+.|+++.-.+|.+|+.. ......++.....++.|++.|++| ++.+|||+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 46899999999999999974 345567889999999999999998 58999999999999999999999999999
Q ss_pred eecccCC----CCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhccc
Q 002250 795 KIVQTGE----AGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDS 869 (947)
Q Consensus 795 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 869 (947)
....... .....+..+||..||+||.+.+..|+.++||||+|++++|++. -..+|+. ..
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er--------~~-------- 467 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER--------IA-------- 467 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH--------HH--------
Confidence 7665544 1222345579999999999999999999999999999999997 2222210 00
Q ss_pred cccccccccCCCCc-cCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 002250 870 RDSMLTVVDPNISE-ILKEDALKVLRIAIHCTNKLPAFRPSMRVVV 914 (947)
Q Consensus 870 ~~~~~~~~d~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 914 (947)
.+..+-|..+++ +..+ .+.=+.+..++++..|.+||++.++.
T Consensus 468 --t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 468 --TLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred --hhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHh
Confidence 011122222321 2222 22234677899999999999555443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6e-16 Score=178.30 Aligned_cols=208 Identities=23% Similarity=0.323 Sum_probs=140.4
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.+|..++.|-.|+||.||.++++ ..+.+|+|+= ..+ .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~----------------------lilRn--ilt~a~npfvv-- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQN----------------------LILRN--ILTFAGNPFVV-- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccc-ccc----------------------hhhhc--cccccCCccee--
Confidence 57888899999999999999977 4678888532 000 00000 22222333332
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
|+-...++..+..+.+ ++.+++|+| +.+|+|||+||+|.+++.-|.+|
T Consensus 136 -------------------gDc~tllk~~g~lPvd----------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiK 183 (1205)
T KOG0606|consen 136 -------------------GDCATLLKNIGPLPVD----------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIK 183 (1205)
T ss_pred -------------------chhhhhcccCCCCcch----------hhHHhHhhc---cCCeecCCCCCCcceeeeccccc
Confidence 4444445543332222 167899999 89999999999999999999999
Q ss_pred EeccccceecccC------------CCCcc-eecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 002250 788 IADFGLAKIVQTG------------EAGDL-THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG 854 (947)
Q Consensus 788 l~DfG~a~~~~~~------------~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~ 854 (947)
++|||+++..... ..+.. ...++||+.|+|||++....|...+|+|++|+++||.+-|+.||+++-
T Consensus 184 lTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt- 262 (1205)
T KOG0606|consen 184 LTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT- 262 (1205)
T ss_pred ccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC-
Confidence 9999988633211 01111 224689999999999999999999999999999999999999996541
Q ss_pred CcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC
Q 002250 855 DSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP 908 (947)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 908 (947)
.+++.. ..+.... ..++..+..+.+..+++.+.++++|..|-
T Consensus 263 -peelfg---~visd~i--------~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 263 -PEELFG---QVISDDI--------EWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -HHHHHh---hhhhhhc--------cccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 111111 1111111 11222344456677888899999999995
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-14 Score=145.45 Aligned_cols=153 Identities=22% Similarity=0.215 Sum_probs=101.9
Q ss_pred cccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchh-hhhh-c-----ccCChhhHHHHHHHHhhccccc--c
Q 002250 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSST-AILS-K-----RSSRSSEYDAEVATLSAVRHVN--V 704 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~-~~~~-~-----~~~~~~~~~~E~~~l~~l~h~n--i 704 (947)
.+.||+|+||+||+|...+++.||||++.+............. .... . ..........|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998654332211111000 0000 0 0001112246777777775543 4
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHH-HhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCCeEecC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWD-RLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFD-RPVIHRDVKSSNILLDL 782 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~Dlkp~NIll~~ 782 (947)
.+.++. ...++||||++++.+.. .+.... .. .....++.+++.++.++| . .+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence 455543 24589999999854322 121111 11 456778899999999999 6 8999999999999999
Q ss_pred CCCeEEeccccceecc
Q 002250 783 EWKPRIADFGLAKIVQ 798 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~ 798 (947)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.4e-14 Score=135.12 Aligned_cols=135 Identities=23% Similarity=0.194 Sum_probs=112.2
Q ss_pred CcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc--cccceEEEE
Q 002250 633 PENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH--VNVVKLYCS 710 (947)
Q Consensus 633 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~ 710 (947)
+.+.||+|.++.||++...+ +.++||++.... . ...+.+|+.+++.++| ..+++++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~------------------~-~~~~~~e~~~~~~l~~~~~~~p~~~~~ 61 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSRE------------------K-GADREREVAILQLLARKGLPVPKVLAS 61 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCC------------------c-hhHHHHHHHHHHHHHHcCCCCCeEEEE
Confidence 35679999999999999864 789999873210 1 3568899999999987 599999999
Q ss_pred EecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEec
Q 002250 711 ITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790 (947)
Q Consensus 711 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 790 (947)
+..++..+++|||++++.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|
T Consensus 62 ~~~~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~D 132 (155)
T cd05120 62 GESDGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIID 132 (155)
T ss_pred cCCCCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEe
Confidence 9888889999999988776544 5566677889999999999953335799999999999999989999999
Q ss_pred ccccee
Q 002250 791 FGLAKI 796 (947)
Q Consensus 791 fG~a~~ 796 (947)
||.++.
T Consensus 133 f~~~~~ 138 (155)
T cd05120 133 WEYAGY 138 (155)
T ss_pred cccccC
Confidence 998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.5e-16 Score=165.93 Aligned_cols=189 Identities=31% Similarity=0.495 Sum_probs=166.1
Q ss_pred cccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCc
Q 002250 130 ENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLW 209 (947)
Q Consensus 130 ~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 209 (947)
..+..-...||+.|++.. +|..+..+-.|+.|.|..|.+. .+|..+.++..|++|||+.|+++ ..|..++.|+ |+
T Consensus 72 ~~ltdt~~aDlsrNR~~e--lp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lk 146 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFSE--LPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LK 146 (722)
T ss_pred ccccchhhhhcccccccc--CchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ce
Confidence 345555678888888865 5566677778888999999998 88999999999999999999996 8899999886 99
Q ss_pred EEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccc
Q 002250 210 QLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRL 289 (947)
Q Consensus 210 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 289 (947)
.|-+++|+++ .+|..++.+..|..||.+.|.+...++.+..+.+|+.|.+..|++. .+|+.++.|+ |..||++.|++
T Consensus 147 vli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNki 223 (722)
T KOG0532|consen 147 VLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKI 223 (722)
T ss_pred eEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCce
Confidence 9999999999 8899999999999999999999999999999999999999999998 7788888775 99999999999
Q ss_pred cccCCcCccCcccccccccccccccCCCCCCcccCCccc
Q 002250 290 TGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMT 328 (947)
Q Consensus 290 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~ 328 (947)
+ .+|-.|.+|..|++|-|.+|.++ ..|..+|....+.
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVH 260 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVH 260 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCC-CChHHHHhcccee
Confidence 9 99999999999999999999998 5677777665543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.1e-13 Score=141.76 Aligned_cols=149 Identities=17% Similarity=0.162 Sum_probs=108.1
Q ss_pred ccccc-ccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc--ceEEEE
Q 002250 634 ENLIG-KGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV--VKLYCS 710 (947)
Q Consensus 634 ~~~iG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~ 710 (947)
...|| .|+.|+||.+... +..++||.+.......+ .. .............+.+|++++.+++|++| ++.+++
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~k--v~--~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~ 110 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGK--LS--KDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAA 110 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHh--hh--hhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEee
Confidence 45688 8999999999886 78899998843221000 00 00000111344678899999999998875 677776
Q ss_pred EecCCc-c---EEEEeccCC-CChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 711 ITSEDS-N---LLVYEYLPN-GSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 711 ~~~~~~-~---~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
...+.. . ++||||+++ .+|.+++... .++.. ...+++.++.+|| ..+|+||||||.|||++.++.
T Consensus 111 ~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~ 180 (239)
T PRK01723 111 RVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGK 180 (239)
T ss_pred eeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCC
Confidence 544322 2 599999997 6898888652 33433 3567899999999 899999999999999999999
Q ss_pred eEEeccccceec
Q 002250 786 PRIADFGLAKIV 797 (947)
Q Consensus 786 ~kl~DfG~a~~~ 797 (947)
++|+|||.+...
T Consensus 181 v~LIDfg~~~~~ 192 (239)
T PRK01723 181 FWLIDFDRGELR 192 (239)
T ss_pred EEEEECCCcccC
Confidence 999999998753
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.7e-14 Score=167.02 Aligned_cols=116 Identities=38% Similarity=0.633 Sum_probs=64.6
Q ss_pred cchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc-ccccceeeCCC
Q 002250 447 LSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSN 525 (947)
Q Consensus 447 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~ 525 (947)
++.|+|++|.+.|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|..+. +++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 44455555555555555555555555555555555555555555555555555555555555555443 35555555555
Q ss_pred CcCCCCCCCcccc---cccccccccCCCCCCCCccccCccCC
Q 002250 526 NQLAGPIPEPLNI---KAFIDSFTGNPGLCSKTDEYFKSCSS 564 (947)
Q Consensus 526 N~l~~~~p~~~~~---~~~~~~~~gN~~~c~~~~~~~~~~~s 564 (947)
|+++|.+|..+.. ......+.+|+++|+.+. .+.|..
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~~ 539 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACGP 539 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCC--CCCCcc
Confidence 5555555544321 112346788999998754 246743
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.5e-15 Score=170.44 Aligned_cols=258 Identities=26% Similarity=0.253 Sum_probs=186.3
Q ss_pred hccCCcccccccCceeEEEEEeCC--CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS--GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVV 705 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv 705 (947)
..|.+.+.||+|+|+.|-.+.... ...+|+|.+.... ...........|..+-..+. |+|++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---------------~~~~~~~~i~~e~~~~~~~s~h~n~~ 84 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---------------KSEDSSEHIDTETDIQKKLSKHSNTV 84 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---------------CccchhhhcCcccccccccccccccc
Confidence 467788889999999998887643 3445666542111 11122233445677767776 99999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHh-hhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRL-HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
.+++.....+..+++.||.+++++.+-+ +... ...+....-....|+..++.|+|. ..+++|||+||+|.+++..+
T Consensus 85 ~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~ 161 (601)
T KOG0590|consen 85 HMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESG 161 (601)
T ss_pred ccCCccCCCcccccccCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCC
Confidence 9999999999999999999999999988 4422 123344445578889999999995 57899999999999999999
Q ss_pred -CeEEeccccceeccc-CCCCcceecccc-cccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 785 -KPRIADFGLAKIVQT-GEAGDLTHVIAG-THGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 785 -~~kl~DfG~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
..+++|||+|..+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+...........
T Consensus 162 ~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~ 241 (601)
T KOG0590|consen 162 SALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS 241 (601)
T ss_pred CcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce
Confidence 999999999987776 444445556678 9999999998874 456788999999999999999999865544333333
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.|........ ............++..+++..+|+.|.+..++..
T Consensus 242 ~~~~~~~~~~-----------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 242 SWKSNKGRFT-----------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred eecccccccc-----------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 3332210000 1111222334556666888889999998877654
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.5e-14 Score=159.00 Aligned_cols=180 Identities=33% Similarity=0.512 Sum_probs=93.7
Q ss_pred ccCCCceeeCCCCCCCCCCCChhhcccc-cCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCc
Q 002250 131 NLTNLEFLSLGDNPFDPSPFPMEVLKLE-KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLW 209 (947)
Q Consensus 131 ~l~~L~~L~Ls~n~i~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 209 (947)
.++.++.|++.+|.+.. ++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|++. .+|.....++.|+
T Consensus 114 ~~~~l~~L~l~~n~i~~--i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~ 189 (394)
T COG4886 114 ELTNLTSLDLDNNNITD--IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLN 189 (394)
T ss_pred cccceeEEecCCccccc--Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhh
Confidence 33444444444444443 222233332 4555555555555 33344555555555555555554 3444444555555
Q ss_pred EEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccc
Q 002250 210 QLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRL 289 (947)
Q Consensus 210 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 289 (947)
.|++++|+++ .+|.....+..|++|++++|++...+..+..+.++..|.+.+|++. ..+..++.+++++.|++++|.+
T Consensus 190 ~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i 267 (394)
T COG4886 190 NLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI 267 (394)
T ss_pred heeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhccccccceeccccccc
Confidence 5555555555 3444434444455556665554445555555555555556666655 3345555666666666666666
Q ss_pred cccCCcCccCcccccccccccccccCCCC
Q 002250 290 TGTLPQKLGSWADFNYVDVSENLLTGPIP 318 (947)
Q Consensus 290 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 318 (947)
+ .++. ++.+.+++.|++++|.+....|
T Consensus 268 ~-~i~~-~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 268 S-SISS-LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred c-cccc-ccccCccCEEeccCccccccch
Confidence 5 3333 5566666666666666654443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.5e-13 Score=152.45 Aligned_cols=159 Identities=22% Similarity=0.200 Sum_probs=106.6
Q ss_pred cccccccCceeEEEEEeCCCcEEEEEEecCCCCCC-CCCc----------------------cchhhhhhcccCChhhHH
Q 002250 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGF-RGDY----------------------RSSTAILSKRSSRSSEYD 690 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~----------------------~~~~~~~~~~~~~~~~~~ 690 (947)
.+.||.|++|.||+|++++|+.||||+.+|+.... ..+. ..............-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46799999999999999999999999997653110 0000 000000000011122577
Q ss_pred HHHHHHhhcc----ccccceEEEEEe-cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHH-HHHHHhcCC
Q 002250 691 AEVATLSAVR----HVNVVKLYCSIT-SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK-GLEYLHHGF 764 (947)
Q Consensus 691 ~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~-~l~yLH~~~ 764 (947)
+|++.+.+++ |.+-+.+-..+. ..+..++||||++|++|.++..... ...+ +.+++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~--- 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVL--- 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHH---
Confidence 7888887773 333333333332 2456799999999999988765321 1122 3456666655 467888
Q ss_pred CCCeEeccCCCCCeEecCCCCeEEeccccceeccc
Q 002250 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT 799 (947)
Q Consensus 765 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 799 (947)
..+++|+|++|.||++++++.++++|||++.....
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 88999999999999999999999999999976643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.1e-14 Score=156.96 Aligned_cols=179 Identities=27% Similarity=0.466 Sum_probs=140.5
Q ss_pred cCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCC
Q 002250 340 TVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISE 419 (947)
Q Consensus 340 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 419 (947)
.+|..+..+-.|+.+.|..|.+. .+|..++++..|.+|||+.|+++ ..|..+..++ |+.|.+++|+++ .+|..++.
T Consensus 89 elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~ 164 (722)
T KOG0532|consen 89 ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGL 164 (722)
T ss_pred cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCccccc
Confidence 33444444455555666666665 67777777777888888888877 3455555554 889999999998 88999998
Q ss_pred CCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEE
Q 002250 420 ASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLN 499 (947)
Q Consensus 420 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 499 (947)
+..|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|..+. .-.|..||+|.|+++ .+|-.|.+|+.|++|-
T Consensus 165 ~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~ 240 (722)
T KOG0532|consen 165 LPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQ 240 (722)
T ss_pred chhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeee
Confidence 899999999999999 78889999999999999999998 6777777 456899999999999 8999999999999999
Q ss_pred CCCCccCCccCCcccc-cc---cceeeCCCCc
Q 002250 500 LSNNKFSGEIPISLTY-PK---LSLLDLSNNQ 527 (947)
Q Consensus 500 Ls~N~l~~~~p~~~~~-~~---L~~L~ls~N~ 527 (947)
|.+|.|+ .+|..+.. .+ .++|+..-.+
T Consensus 241 LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 241 LENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred eccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 9999998 56665543 33 3456655553
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.3e-13 Score=154.49 Aligned_cols=196 Identities=35% Similarity=0.523 Sum_probs=86.9
Q ss_pred EEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCC-cCcEEEccCccccccCCcCccCccccccccccccc
Q 002250 234 NFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFK-HLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENL 312 (947)
Q Consensus 234 ~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 312 (947)
.|+++.|.+......+..++.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..++.+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 345555554444444444455555555555555 3444444442 5555555555555 444445555555555555555
Q ss_pred ccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCc
Q 002250 313 LTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDD 392 (947)
Q Consensus 313 l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 392 (947)
++ .+|. .....+.|+.|++++|++. .+|..+.....|++|++++|.+. ..+..
T Consensus 175 l~-~l~~------------------------~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~ 227 (394)
T COG4886 175 LS-DLPK------------------------LLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSS 227 (394)
T ss_pred hh-hhhh------------------------hhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchh
Confidence 54 1111 1113334444444444444 33333323333444444444321 12233
Q ss_pred ccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCC
Q 002250 393 IGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPL 461 (947)
Q Consensus 393 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 461 (947)
+..+..+..+.+.+|++. .++..+..+++++.|++++|+++ .++. ++.+.+|+.|++++|.+...+
T Consensus 228 ~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~ 293 (394)
T COG4886 228 LSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNAL 293 (394)
T ss_pred hhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccc
Confidence 334444444444444443 22334444444444444444444 2222 444444444444444444333
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.5e-12 Score=146.72 Aligned_cols=168 Identities=17% Similarity=0.165 Sum_probs=105.2
Q ss_pred HHHhhccCCcccccccCceeEEEEEeCC-CcEEEEEEecCCCCCC--------------------CCC-c--cchhhhhh
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLNS-GKELAVKHIWPSNSGF--------------------RGD-Y--RSSTAILS 680 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--------------------~~~-~--~~~~~~~~ 680 (947)
+++...|+. +.||.|++|.||+|++++ |+.||||+++|..... .+. + ........
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 344556766 789999999999999987 9999999997653110 000 0 00000111
Q ss_pred cccCChhhHHHHHHHHhhcc----ccccceEEEEEec-CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHH-
Q 002250 681 KRSSRSSEYDAEVATLSAVR----HVNVVKLYCSITS-EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA- 754 (947)
Q Consensus 681 ~~~~~~~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia- 754 (947)
..-...-+|.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.+...-. ....+.. .++...+
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d~~---~la~~~v~ 270 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTDMK---LLAERGVE 270 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCCHH---HHHHHHHH
Confidence 11112234667777777663 4445555555543 55678999999999998753211 1111211 1222111
Q ss_pred HHHHHHhcCCCCCeEeccCCCCCeEecCCC----CeEEeccccceecccC
Q 002250 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEW----KPRIADFGLAKIVQTG 800 (947)
Q Consensus 755 ~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG~a~~~~~~ 800 (947)
.-+..+. ..+++|+|+||.||+++.++ .+++.|||++......
T Consensus 271 ~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 271 VFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 1233334 67999999999999999888 9999999999876543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=1e-12 Score=155.71 Aligned_cols=126 Identities=37% Similarity=0.639 Sum_probs=97.3
Q ss_pred ccccCCCCCc----ccceeeeCC---CC--ceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCC
Q 002250 16 SSWTEANSVC----KFNGIVCDS---NG--LVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTR 86 (947)
Q Consensus 16 ~sw~~~~~~C----~w~gv~c~~---~~--~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~ 86 (947)
.+|. +..|| .|.||+|+. .+ +|+.|+|+++++.|.+| .+++.+++|+.|+|++|.+.|.+|..++.+++
T Consensus 390 ~~W~-g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip-~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~ 467 (623)
T PLN03150 390 FGWN-GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIP-NDISKLRHLQSINLSGNSIRGNIPPSLGSITS 467 (623)
T ss_pred CCCC-CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCC-HHHhCCCCCCEEECCCCcccCcCChHHhCCCC
Confidence 4896 54553 799999962 22 58888888888888887 57888888888888888888888888888888
Q ss_pred ccEEeCcCccCcCCCCC-cccccccceeecCCCCccCccCcccccc-cCCCceeeCCCCC
Q 002250 87 LQVLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLEN-LTNLEFLSLGDNP 144 (947)
Q Consensus 87 L~~L~Ls~n~i~~~~~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~-l~~L~~L~Ls~n~ 144 (947)
|+.|||++|++++.+|. ++.|++|++|+|++|++++.+| ..+.. +.++..+++++|.
T Consensus 468 L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP-AALGGRLLHRASFNFTDNA 526 (623)
T ss_pred CCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCC-hHHhhccccCceEEecCCc
Confidence 88888888888886665 7888888888888888887777 34443 2455566666664
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.5e-13 Score=144.32 Aligned_cols=226 Identities=19% Similarity=0.180 Sum_probs=129.4
Q ss_pred eeeccCccccCcCchhh----hcCCCccEEeCcCccCcCCCC--CcccccccceeecCCCCccCcc-CcccccccCCCce
Q 002250 65 KINLGTNFLYGTITEGL----KSCTRLQVLDLGNNSFSGEVP--DLSMLHELSFLNLNSSGISGKF-PWKSLENLTNLEF 137 (947)
Q Consensus 65 ~L~L~~n~i~~~~~~~l----~~l~~L~~L~Ls~n~i~~~~~--~l~~l~~L~~L~L~~n~i~~~~-~~~~l~~l~~L~~ 137 (947)
.+.+++-.+..+.-+.+ .++++|++..|.++.+..... ....|++++.||||.|-+..-. .......|++|+.
T Consensus 97 ~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~ 176 (505)
T KOG3207|consen 97 VLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLEN 176 (505)
T ss_pred HhhhcCceeEEecHHHHHHHhhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchh
Confidence 34444444443333222 345666666666666554332 3556666666666666554311 1123445667777
Q ss_pred eeCCCCCCCCCCCChhhcccccCcEEEccCcccccc-CCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecc
Q 002250 138 LSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQ-IPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNN 216 (947)
Q Consensus 138 L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n 216 (947)
|+|+.|++....-...-..++.|+.|.|+.|.++.. +-..+..+++|+.|+|..|...........-+..|++|||++|
T Consensus 177 LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N 256 (505)
T KOG3207|consen 177 LNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNN 256 (505)
T ss_pred cccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCC
Confidence 777777654321112223456677777777777632 1122345677777777777433343444455666777777777
Q ss_pred cccccCC-ccCCCCCCccEEeccCCCCCCCC--cc-----ccccCCCCEEEccCccCccc-CCCCccCCCcCcEEEccCc
Q 002250 217 SLSGRLP-VGFSNLTNLMNFDVSQNRLEGDL--SE-----LRFLNQLSSLHLFENQFSGE-IPEEFGEFKHLTELSLYTN 287 (947)
Q Consensus 217 ~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~--~~-----l~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N 287 (947)
++-.... ...+.++.|..|+++.+.++.+. +. ....++|+.|++..|+|..- .-..+..+++|++|.+..|
T Consensus 257 ~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n 336 (505)
T KOG3207|consen 257 NLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLN 336 (505)
T ss_pred cccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccc
Confidence 7763221 34566777777777777776532 11 34567788888888888521 1133555677888888888
Q ss_pred ccc
Q 002250 288 RLT 290 (947)
Q Consensus 288 ~l~ 290 (947)
.++
T Consensus 337 ~ln 339 (505)
T KOG3207|consen 337 YLN 339 (505)
T ss_pred ccc
Confidence 876
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.9e-13 Score=133.20 Aligned_cols=207 Identities=25% Similarity=0.223 Sum_probs=82.2
Q ss_pred cCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhc
Q 002250 76 TITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVL 155 (947)
Q Consensus 76 ~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~ 155 (947)
.+|-.+..+.+|..+.+|.|.-..+..-...-+.|+++...+..++.. | .+-....+..+.-+.-.....+......
T Consensus 205 ~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~-~--~l~pe~~~~D~~~~E~~t~~G~~~~~~d 281 (490)
T KOG1259|consen 205 RLSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDV-P--SLLPETILADPSGSEPSTSNGSALVSAD 281 (490)
T ss_pred ccccchHHhhhhheeeeeccchhheeceeecCchhheeeeeccccccc-c--cccchhhhcCccCCCCCccCCceEEecc
Confidence 344455556667777766664332111112224555665555554422 1 1222222211111111111111111111
Q ss_pred ccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEE
Q 002250 156 KLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNF 235 (947)
Q Consensus 156 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 235 (947)
....|++|+|++|.|+ .+.++..-++.++.|++|+|.|... ..+..+++|+.||||+|.++ .+..+-..+-+.++|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 2233444444444444 3333444444444444444444321 22444444444444444444 233333334444444
Q ss_pred eccCCCCCCCCccccccCCCCEEEccCccCccc-CCCCccCCCcCcEEEccCcccc
Q 002250 236 DVSQNRLEGDLSELRFLNQLSSLHLFENQFSGE-IPEEFGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 236 ~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~ 290 (947)
.|+.|.|+ ..+.+..+-+|..||+++|+|... --..++++|.|++|.|.+|++.
T Consensus 358 ~La~N~iE-~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 358 KLAQNKIE-TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred ehhhhhHh-hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 44444443 223333344444444444444311 1123444444444444444444
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.2e-13 Score=149.59 Aligned_cols=243 Identities=26% Similarity=0.280 Sum_probs=135.2
Q ss_pred CCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCcee
Q 002250 59 GLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFL 138 (947)
Q Consensus 59 ~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L 138 (947)
.+..++.++++.|.|.. +-..+..+++|+.|+|.+|+|......+..+++|++|+|++|.|+... .+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~---~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLE---GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheecccccccccc---chhhccchhhh
Confidence 45556666666666633 334456666777777777766644333666667777777777766442 35566666677
Q ss_pred eCCCCCCCCCCCChhhcccccCcEEEccCccccccCC-ccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeeccc
Q 002250 139 SLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIP-EGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNS 217 (947)
Q Consensus 139 ~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~ 217 (947)
++++|.|.... .+..++.|+.+++++|++...-+ . ...+.+|+.+++.+|.+. ....+..+..+..+++..|.
T Consensus 146 ~l~~N~i~~~~---~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 146 NLSGNLISDIS---GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred eeccCcchhcc---CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhccccc
Confidence 77777665432 23346666666666666664322 1 355666666666666664 22344444555555666666
Q ss_pred ccccCCccCCCCCC--ccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccccc---
Q 002250 218 LSGRLPVGFSNLTN--LMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGT--- 292 (947)
Q Consensus 218 l~~~~~~~~~~l~~--L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~--- 292 (947)
++..-+ +..+.. |+.+++++|++......+..+..+..|++.+|++... ..+...+.+..+.+..|++...
T Consensus 220 i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (414)
T KOG0531|consen 220 ISKLEG--LNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAI 295 (414)
T ss_pred ceeccC--cccchhHHHHHHhcccCccccccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhh
Confidence 653211 222222 6666666666664445555566666666666666532 2234445555666666655411
Q ss_pred CCcC-ccCcccccccccccccccC
Q 002250 293 LPQK-LGSWADFNYVDVSENLLTG 315 (947)
Q Consensus 293 ~p~~-l~~l~~L~~L~Ls~N~l~~ 315 (947)
.... ....+.++.+.+..|.+..
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 296 SQEYITSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred hccccccccccccccccccCcccc
Confidence 1111 3444555566666665554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.5e-11 Score=136.36 Aligned_cols=251 Identities=19% Similarity=0.205 Sum_probs=174.2
Q ss_pred hccCCcccccc--cCceeEEEEEe--C-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccc
Q 002250 629 DAVKPENLIGK--GGSGNVYKVVL--N-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 702 (947)
..+.....+|. |.+|.||.+.. . ++..+|+|+-+.... .......=.+|+...+++ .|+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s---------------~p~~~~~k~~~~~s~~~i~~~~ 178 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS---------------PPLDSKRKLREFLSHHKIDSHE 178 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC---------------CccccccccchhhcccccCccc
Confidence 34566788999 99999999986 3 688899997421111 111222234577777777 599
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEeccCCCCCe
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK----GLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~----~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+.++.+..+...+..++-+|++ +.++.++.+.... .++....+....+..+ |+.++| +..++|-|+||.||
T Consensus 179 ~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i 253 (524)
T KOG0601|consen 179 NPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANI 253 (524)
T ss_pred cccccCcccccCCcceeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhhe
Confidence 9999999999999999999999 5788888776322 2344445555555556 999999 99999999999999
Q ss_pred EecCC-CCeEEeccccceecccCCCCcce---ecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 002250 779 LLDLE-WKPRIADFGLAKIVQTGEAGDLT---HVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG 854 (947)
Q Consensus 779 ll~~~-~~~kl~DfG~a~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~ 854 (947)
+...+ ...+++|||+............. ....|...|++||...+ .++..+|+|++|.++.|..++..+......
T Consensus 254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 99999 88999999999877665432221 11257788999997654 688899999999999999998776532210
Q ss_pred CcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 855 DSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
..|. ..+..... .++.+.-..++...+..+++.+|-.|++.+.+..
T Consensus 333 -----~~W~--~~r~~~ip--------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 333 -----SSWS--QLRQGYIP--------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----CCcc--ccccccCc--------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0111 01111100 1111112223444777899999999999887764
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.7e-13 Score=137.06 Aligned_cols=242 Identities=22% Similarity=0.252 Sum_probs=147.7
Q ss_pred cccCCcccceeeccCccccCc----CchhhhcCCCccEEeCcCc---cCcCCCCCcccccccceeecCCCCccCccCccc
Q 002250 56 SICGLQALQKINLGTNFLYGT----ITEGLKSCTRLQVLDLGNN---SFSGEVPDLSMLHELSFLNLNSSGISGKFPWKS 128 (947)
Q Consensus 56 ~~~~l~~L~~L~L~~n~i~~~----~~~~l~~l~~L~~L~Ls~n---~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~ 128 (947)
.+..+..+++|+|++|.+... +...+.+-++|+..++|+- +....+|+ .|..| .++
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e--~L~~l---------------~~a 87 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPE--ALKML---------------SKA 87 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHH--HHHHH---------------HHH
Confidence 355677888888888888432 4556677788888888764 22222221 00000 134
Q ss_pred ccccCCCceeeCCCCCCCCCCCCh---hhcccccCcEEEccCccccccCCc-------------cCCCCCCCCEEECcCc
Q 002250 129 LENLTNLEFLSLGDNPFDPSPFPM---EVLKLEKLYWLYLTNCSVTGQIPE-------------GIGNLTQLQNLELSDN 192 (947)
Q Consensus 129 l~~l~~L~~L~Ls~n~i~~~~~~~---~~~~l~~L~~L~L~~n~l~~~~p~-------------~~~~l~~L~~L~Ls~N 192 (947)
+...++|++||||+|.|....++. .+..+..|++|+|.||.+.-.-.. -.+.-+.|+++..+.|
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN 167 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence 445556666666666665433222 234456666666666666521111 2233467888888888
Q ss_pred cccccc----CccccCCCCCcEEEeecccccc----cCCccCCCCCCccEEeccCCCCCCC-----CccccccCCCCEEE
Q 002250 193 ELFGEI----PAGIVKLNKLWQLELYNNSLSG----RLPVGFSNLTNLMNFDVSQNRLEGD-----LSELRFLNQLSSLH 259 (947)
Q Consensus 193 ~l~~~~----~~~l~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~-----~~~l~~l~~L~~L~ 259 (947)
++.... ...|...+.|+.+.++.|.|.. .+..+|..+++|+.|||.+|-++.. ...++.+++|++|+
T Consensus 168 rlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~ 247 (382)
T KOG1909|consen 168 RLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELN 247 (382)
T ss_pred ccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeec
Confidence 775322 2345556778888888887753 2234567778888888888877642 23466677788888
Q ss_pred ccCccCcccCCCCcc-----CCCcCcEEEccCccccc----cCCcCccCccccccccccccccc
Q 002250 260 LFENQFSGEIPEEFG-----EFKHLTELSLYTNRLTG----TLPQKLGSWADFNYVDVSENLLT 314 (947)
Q Consensus 260 L~~N~i~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 314 (947)
+++|.+......+|. ..++|+.|.|.+|.++. .+...+...+.|..|+|++|.+.
T Consensus 248 l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 248 LGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 888887754443332 25778888888888772 23344556778888888888873
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-11 Score=124.20 Aligned_cols=211 Identities=20% Similarity=0.242 Sum_probs=140.8
Q ss_pred HHHHHHHHhhccccccceEEEEEecCC-----ccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHh
Q 002250 689 YDAEVATLSAVRHVNVVKLYCSITSED-----SNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLH 761 (947)
Q Consensus 689 ~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH 761 (947)
...-..-+-++-|-|||++..|+.+.. ...++.|||+.|++..++++. ....+....-.+++.||..||.|||
T Consensus 114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 333445556678999999999886643 357899999999999999864 2345666677789999999999999
Q ss_pred cCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCC--CcceecccccccccCccccccCCCCCccchHHHHHHH
Q 002250 762 HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA--GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839 (947)
Q Consensus 762 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l 839 (947)
. +.++|+|+++.-+-|++..++-+|+.--.-......... ........+-++|.|||+-.....+.++|||+||...
T Consensus 194 s-~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 194 S-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred c-cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 5 489999999999999999998888753221111111100 1112233467899999988777788899999999999
Q ss_pred HHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 840 MELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 840 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
.||.-+..-- ......-.++- ..........++.- ..++..|++..|..||+|.+.+.+.-
T Consensus 273 lemailEiq~--tnseS~~~~ee-----~ia~~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 273 LEMAILEIQS--TNSESKVEVEE-----NIANVIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HHHHHheecc--CCCcceeehhh-----hhhhheeeccCccc-----------cCcCcccccCCCCCCcchhhhhcCce
Confidence 9998875321 00000000000 00000001111111 23455899999999999999876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.8e-11 Score=117.11 Aligned_cols=127 Identities=20% Similarity=0.234 Sum_probs=94.0
Q ss_pred cccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc-eEEEEEe
Q 002250 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV-KLYCSIT 712 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~ 712 (947)
.+.++.|.++.||+++.. ++.+++|+..+.. .....+.+|+.+++.+.+.+++ +++.+..
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~------------------~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~ 63 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGT------------------ELLINRENEAENSKLAAEAGIGPKLYYFDP 63 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCc------------------ccccCHHHHHHHHHHHHHhCCCCceEEEeC
Confidence 356889999999999876 7889999863211 1123467899999998765544 4554433
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEeccCCCCCeEecCCCCeE
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRP-----VIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~-----ivH~Dlkp~NIll~~~~~~k 787 (947)
...++||||++|.++.+.- ......+.+++++++.|| ..+ ++|+|++|.||+++ ++.++
T Consensus 64 --~~~~lv~e~i~G~~l~~~~----------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~ 127 (170)
T cd05151 64 --ETGVLITEFIEGSELLTED----------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLW 127 (170)
T ss_pred --CCCeEEEEecCCCcccccc----------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEE
Confidence 3458999999998875430 011234568899999999 555 59999999999999 66899
Q ss_pred Eeccccce
Q 002250 788 IADFGLAK 795 (947)
Q Consensus 788 l~DfG~a~ 795 (947)
++|||.+.
T Consensus 128 liDf~~a~ 135 (170)
T cd05151 128 LIDWEYAG 135 (170)
T ss_pred EEeccccc
Confidence 99999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=2e-10 Score=113.71 Aligned_cols=153 Identities=13% Similarity=0.118 Sum_probs=104.6
Q ss_pred ccccccCceeEEEEEeCC-------CcEEEEEEecCCCCCCCCCccchhhhhhc-----ccCChh----hHHHHHHHHhh
Q 002250 635 NLIGKGGSGNVYKVVLNS-------GKELAVKHIWPSNSGFRGDYRSSTAILSK-----RSSRSS----EYDAEVATLSA 698 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~----~~~~E~~~l~~ 698 (947)
..||.|--+.||.|...+ +..+|||+.+.....++............ ...... ..++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 57999999986665554432211111000 011122 23489999999
Q ss_pred ccc--cccceEEEEEecCCccEEEEeccCCCChHH-HhhhcCCccCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEeccCC
Q 002250 699 VRH--VNVVKLYCSITSEDSNLLVYEYLPNGSLWD-RLHTCHKIEMDWVVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVK 774 (947)
Q Consensus 699 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~Dlk 774 (947)
+.. -++.+.+++ ...++||||+.++.+.. .++. ..++......+..+++.+|.++ | ..++||||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 953 466666654 56789999997654322 2222 2234445566778999999999 7 7899999999
Q ss_pred CCCeEecCCCCeEEeccccceecc
Q 002250 775 SSNILLDLEWKPRIADFGLAKIVQ 798 (947)
Q Consensus 775 p~NIll~~~~~~kl~DfG~a~~~~ 798 (947)
+.||+++ ++.+.++|||.|....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.7e-12 Score=126.99 Aligned_cols=203 Identities=24% Similarity=0.227 Sum_probs=142.8
Q ss_pred ccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCC-ccCccCcccccccC
Q 002250 55 DSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSG-ISGKFPWKSLENLT 133 (947)
Q Consensus 55 ~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~-i~~~~~~~~l~~l~ 133 (947)
-.+.-+++|.++.++++.-.. +.+.-..=+.|+.+...+.-++.. |.+--.+.+.-+.-+.-. ..|... .......
T Consensus 208 f~l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~~~-~~l~pe~~~~D~~~~E~~t~~G~~~-~~~dTWq 284 (490)
T KOG1259|consen 208 FNLNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQDV-PSLLPETILADPSGSEPSTSNGSAL-VSADTWQ 284 (490)
T ss_pred cchHHhhhhheeeeeccchhh-eeceeecCchhheeeeeccccccc-ccccchhhhcCccCCCCCccCCceE-EecchHh
Confidence 346677788888887765422 222222235677777776655532 222111222211111111 122211 3445567
Q ss_pred CCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEe
Q 002250 134 NLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLEL 213 (947)
Q Consensus 134 ~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 213 (947)
.|++||||+|.|+. +.....-+++++.|++++|.|+.+ +.+..+++|+.||||+|.++ .+..+-.++.+++.|.|
T Consensus 285 ~LtelDLS~N~I~~--iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 285 ELTELDLSGNLITQ--IDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhccccccchhh--hhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 79999999999976 455677789999999999999843 35889999999999999997 55566678899999999
Q ss_pred ecccccccCCccCCCCCCccEEeccCCCCCCCC--ccccccCCCCEEEccCccCcc
Q 002250 214 YNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDL--SELRFLNQLSSLHLFENQFSG 267 (947)
Q Consensus 214 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~l~~l~~L~~L~L~~N~i~~ 267 (947)
+.|.|... ..++.+-+|..||+++|+|.... ..+++++.|+.+.|.+|.+.+
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 99999854 56788899999999999998643 468999999999999999984
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.4e-12 Score=146.18 Aligned_cols=271 Identities=24% Similarity=0.254 Sum_probs=177.1
Q ss_pred cccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeC
Q 002250 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSL 140 (947)
Q Consensus 61 ~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~L 140 (947)
+.++.++...+.+....-. ...+..++.++|..|.|......+..+++|+.|++.+|+|..... .+..+++|++|+|
T Consensus 49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~--~l~~~~~L~~L~l 125 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIEN--LLSSLVNLQVLDL 125 (414)
T ss_pred chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhccc--chhhhhcchheec
Confidence 3455556555554222111 267788888889999998755668889999999999999985422 2788999999999
Q ss_pred CCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccC-ccccCCCCCcEEEeeccccc
Q 002250 141 GDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIP-AGIVKLNKLWQLELYNNSLS 219 (947)
Q Consensus 141 s~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~n~l~ 219 (947)
++|.|+... .+..++.|+.|++++|.|+.. ..+..+++|+.+++++|++....+ . ...+.+|+.+++.+|.+.
T Consensus 126 s~N~I~~i~---~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 126 SFNKITKLE---GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR 199 (414)
T ss_pred ccccccccc---chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence 999998754 466777799999999998843 466678889999999998874433 2 567778888888888887
Q ss_pred ccCCccCCCCCCccEEeccCCCCCCCCccccccC--CCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCc
Q 002250 220 GRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLN--QLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKL 297 (947)
Q Consensus 220 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~--~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l 297 (947)
.. ..+..+..+..+++..|.++... .+..+. .|+.+++++|.+. ..+..+..+..+..|++.+|++... ..+
T Consensus 200 ~i--~~~~~~~~l~~~~l~~n~i~~~~-~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~ 273 (414)
T KOG0531|consen 200 EI--EGLDLLKKLVLLSLLDNKISKLE-GLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGL 273 (414)
T ss_pred cc--cchHHHHHHHHhhcccccceecc-CcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccc
Confidence 33 33445555556677777766322 222222 2677777777776 3335556666677777777766521 123
Q ss_pred cCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCc-cccCCCCccEEEcccccccccCCC
Q 002250 298 GSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPE-TYANCKSLIRFRVNNNSLSGTIPP 367 (947)
Q Consensus 298 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~-~~~~l~~L~~L~L~~n~l~~~~p~ 367 (947)
.....+..+....|.+.... ..... .......++.+.+..|.+....+.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
T KOG0531|consen 274 ERLPKLSELWLNDNKLALSE---------------------AISQEYITSAAPTLVTLTLELNPIRKISSL 323 (414)
T ss_pred cccchHHHhccCcchhcchh---------------------hhhccccccccccccccccccCcccccccc
Confidence 34445555555555554210 01111 144556777777887777655443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.8e-12 Score=133.83 Aligned_cols=212 Identities=20% Similarity=0.144 Sum_probs=151.5
Q ss_pred cccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCC-CCChhhcccccCcEEEccCccccccCCccC-CCC
Q 002250 104 LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPS-PFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNL 181 (947)
Q Consensus 104 l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l 181 (947)
-+++++|+...|.+..+.....-.....|++++.||||+|-+... ++...+..|++|+.|+|+.|.+.-...... ..+
T Consensus 117 Qsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 117 QSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 467888999999888876322113667889999999999976432 233345678999999999998874333222 256
Q ss_pred CCCCEEECcCccccccc-CccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCC--ccccccCCCCEE
Q 002250 182 TQLQNLELSDNELFGEI-PAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDL--SELRFLNQLSSL 258 (947)
Q Consensus 182 ~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~l~~l~~L~~L 258 (947)
++|+.|.|+.|.++... ...+..+++|+.|+|..|..-........-+..|++|||++|++.... .....++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 78999999999886322 223456788999999999643344445566788999999999887655 457788889999
Q ss_pred EccCccCccc-CCCC-----ccCCCcCcEEEccCccccc-cCCcCccCcccccccccccccccC
Q 002250 259 HLFENQFSGE-IPEE-----FGEFKHLTELSLYTNRLTG-TLPQKLGSWADFNYVDVSENLLTG 315 (947)
Q Consensus 259 ~L~~N~i~~~-~~~~-----~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~ 315 (947)
+++.+.|..+ .|+. ...+++|++|++..|++.. ..-..+..+++|+.|.+..|.++.
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 9999988743 2333 3557889999999999852 112345667788888888888873
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.6e-11 Score=118.95 Aligned_cols=58 Identities=29% Similarity=0.458 Sum_probs=8.4
Q ss_pred CCCccEEeCcCccCcCCCCCcc-cccccceeecCCCCccCccCcccccccCCCceeeCCCCCC
Q 002250 84 CTRLQVLDLGNNSFSGEVPDLS-MLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF 145 (947)
Q Consensus 84 l~~L~~L~Ls~n~i~~~~~~l~-~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i 145 (947)
+.++++|+|++|.|+. +..++ .+.+|+.|+|++|.|+.. ..+..+++|++|++++|.|
T Consensus 18 ~~~~~~L~L~~n~I~~-Ie~L~~~l~~L~~L~Ls~N~I~~l---~~l~~L~~L~~L~L~~N~I 76 (175)
T PF14580_consen 18 PVKLRELNLRGNQIST-IENLGATLDKLEVLDLSNNQITKL---EGLPGLPRLKTLDLSNNRI 76 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S-----TT----TT--EEE--SS--
T ss_pred cccccccccccccccc-ccchhhhhcCCCEEECCCCCCccc---cCccChhhhhhcccCCCCC
Confidence 3345555555555552 22333 244444444444444421 1233344444444444444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.3e-11 Score=117.91 Aligned_cols=83 Identities=34% Similarity=0.462 Sum_probs=21.4
Q ss_pred CCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccC-CCCCCccEEeccCCCCCCC--CccccccCCCCE
Q 002250 181 LTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGF-SNLTNLMNFDVSQNRLEGD--LSELRFLNQLSS 257 (947)
Q Consensus 181 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~--~~~l~~l~~L~~ 257 (947)
+.+|+.|+|++|+|+.. +.+..+++|++|++++|+|+. +...+ ..+++|++|+|++|+|... ...+..+++|+.
T Consensus 41 l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~ 117 (175)
T PF14580_consen 41 LDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV 117 (175)
T ss_dssp -TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred hcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence 44555555555555422 234444455555555555542 22222 2344444444444444331 123334444444
Q ss_pred EEccCccCc
Q 002250 258 LHLFENQFS 266 (947)
Q Consensus 258 L~L~~N~i~ 266 (947)
|+|.+|.++
T Consensus 118 L~L~~NPv~ 126 (175)
T PF14580_consen 118 LSLEGNPVC 126 (175)
T ss_dssp EE-TT-GGG
T ss_pred eeccCCccc
Confidence 444444443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-09 Score=122.07 Aligned_cols=167 Identities=17% Similarity=0.165 Sum_probs=123.9
Q ss_pred eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecCCccEEEEeccCCCCh
Q 002250 650 LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSL 729 (947)
Q Consensus 650 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 729 (947)
..++.+|.|....... ........+-++.++.++||||+++++.++.++..|+|+|.+ -.|
T Consensus 34 k~~~~~vsVF~~~~~~-----------------~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl 94 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSN-----------------GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPL 94 (690)
T ss_pred eccCCceEEEEEeCCC-----------------chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccH
Confidence 4468888888763211 012344567788899999999999999999999999999998 467
Q ss_pred HHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecc
Q 002250 730 WDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809 (947)
Q Consensus 730 ~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 809 (947)
..+++..+ .......+.||+.||.|||+ ..+++|++|.-..|+++..|+.||++|-++........ .....
T Consensus 95 ~~~lk~l~-----~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~ 165 (690)
T KOG1243|consen 95 ETVLKELG-----KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSL 165 (690)
T ss_pred HHHHHHhH-----HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccc
Confidence 77887633 55566678899999999996 77999999999999999999999999998864332221 00111
Q ss_pred cccccccCccccccCCCCCccchHHHHHHHHHHHhCC
Q 002250 810 AGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGK 846 (947)
Q Consensus 810 ~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~ 846 (947)
.--..|..|+.+.... -..|.|-||++++|++.|.
T Consensus 166 ~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 166 YLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 1223466666443221 2359999999999999993
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1e-10 Score=129.83 Aligned_cols=249 Identities=20% Similarity=0.172 Sum_probs=173.5
Q ss_pred hhccCCcccccccCceeEEEEEeC--CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN--SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNV 704 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 704 (947)
..+|..+..||.|.|+.|++...+ ++..+++|.+........ ....-..|+.+...+ .|.++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~---------------~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA---------------SDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH---------------hhhcchhhhhHhhHhhccccc
Confidence 356778889999999999998744 578899997743322111 111123466666666 58899
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC-
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE- 783 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~- 783 (947)
++.+..+......|+--||+++++....... ..-++...++++..|++.++.++| ++.++|+|+||+||++..+
T Consensus 329 ~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 329 VGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDG 403 (524)
T ss_pred CCCCCCccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccch
Confidence 9988888887888899999999988777632 344677788889999999999999 8999999999999999886
Q ss_pred CCeEEeccccceecccCCCCcceeccccccccc--CccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYI--APEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
+..+++|||++..+.-.. ....++-+++ +|+......+..+.|+||||.-+.|.++|..-- .....
T Consensus 404 ~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls-------~~~~~ 471 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS-------ESGVQ 471 (524)
T ss_pred hhhhccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccC-------ccccc
Confidence 888999999986422111 1122333444 555556667888999999999999999986431 11111
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
| ..+....++.....- ..+..+...+...++..||.+.+...+.+..
T Consensus 472 ~-----------~~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 472 S-----------LTIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred c-----------eeeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1 111111122222222 4566667778889999999998887665443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.2e-11 Score=124.95 Aligned_cols=233 Identities=23% Similarity=0.308 Sum_probs=130.9
Q ss_pred CceeEeccCCCcccc----ccCcccccCCcccceeeccCccc---cCcCch-------hhhcCCCccEEeCcCccCcCCC
Q 002250 36 GLVAEINLPEQQLLG----VVPFDSICGLQALQKINLGTNFL---YGTITE-------GLKSCTRLQVLDLGNNSFSGEV 101 (947)
Q Consensus 36 ~~v~~l~l~~~~~~~----~~~~~~~~~l~~L~~L~L~~n~i---~~~~~~-------~l~~l~~L~~L~Ls~n~i~~~~ 101 (947)
.-++.++|+++.+-. .+. ..+...++|+..++++-.. ...+|+ ++..+++|++||||.|-|....
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~-~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g 108 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIA-KVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG 108 (382)
T ss_pred CceEEEeccCCchhHHHHHHHH-HHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence 579999999987632 122 4466778899999986332 233444 4566789999999999886432
Q ss_pred C-C----cccccccceeecCCCCccCccC------------cccccccCCCceeeCCCCCCCCCCC---ChhhcccccCc
Q 002250 102 P-D----LSMLHELSFLNLNSSGISGKFP------------WKSLENLTNLEFLSLGDNPFDPSPF---PMEVLKLEKLY 161 (947)
Q Consensus 102 ~-~----l~~l~~L~~L~L~~n~i~~~~~------------~~~l~~l~~L~~L~Ls~n~i~~~~~---~~~~~~l~~L~ 161 (947)
+ . +.+++.|++|.|.+|.+.-.-. .+....-++|+++..+.|.+...+. ...+...+.|+
T Consensus 109 ~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~le 188 (382)
T KOG1909|consen 109 IRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLE 188 (382)
T ss_pred hHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccc
Confidence 2 1 6778999999999998852111 0112334556666666666654321 12333445555
Q ss_pred EEEccCcccccc----CCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEec
Q 002250 162 WLYLTNCSVTGQ----IPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDV 237 (947)
Q Consensus 162 ~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 237 (947)
.+.++.|.|... +...|..+++|+.|||.+|-++..... .+...++.+++|++|++
T Consensus 189 evr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~--------------------~LakaL~s~~~L~El~l 248 (382)
T KOG1909|consen 189 EVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV--------------------ALAKALSSWPHLRELNL 248 (382)
T ss_pred eEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH--------------------HHHHHhcccchheeecc
Confidence 555555554311 112334445555555555544321111 12233444555555555
Q ss_pred cCCCCCCC-----Cccc-cccCCCCEEEccCccCcc----cCCCCccCCCcCcEEEccCccc
Q 002250 238 SQNRLEGD-----LSEL-RFLNQLSSLHLFENQFSG----EIPEEFGEFKHLTELSLYTNRL 289 (947)
Q Consensus 238 s~N~l~~~-----~~~l-~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l 289 (947)
++|.++.- ...+ ...++|+.|.+.+|.|+. .+...+...+.|..|+|++|.+
T Consensus 249 ~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 249 GDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 55555431 1111 224566777777776652 2222345567788888888877
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.9e-09 Score=109.61 Aligned_cols=142 Identities=23% Similarity=0.256 Sum_probs=107.3
Q ss_pred ccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc--cccceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH--VNVVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~ 712 (947)
+.+|.|.++.||++...+|+.+++|....... ......+..|+++++.+.+ ..+.+++.+..
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~----------------~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~ 67 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGAL----------------LPSAHDVAREYRVLRALAGTGVPVPKVLALCE 67 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCccc----------------CcccccHHHHHHHHHHhhCCCCCCCCEEEECC
Confidence 56899999999999987778999998632110 0123467889999999976 34677787776
Q ss_pred cCC---ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcC--------------------------
Q 002250 713 SED---SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG-------------------------- 763 (947)
Q Consensus 713 ~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-------------------------- 763 (947)
... ..++||||++|.++.+.+.. ..++...+..++.++++++.+||+.
T Consensus 68 ~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (223)
T cd05154 68 DPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRR 144 (223)
T ss_pred CCCccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHH
Confidence 643 56899999999888776532 2356667777888888888888831
Q ss_pred ---------------------------CCCCeEeccCCCCCeEecC--CCCeEEeccccce
Q 002250 764 ---------------------------FDRPVIHRDVKSSNILLDL--EWKPRIADFGLAK 795 (947)
Q Consensus 764 ---------------------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~ 795 (947)
....++|+|++|.||+++. ++.+.++||+.+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 145 QYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 0245799999999999998 5668999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.4e-09 Score=99.21 Aligned_cols=139 Identities=25% Similarity=0.324 Sum_probs=99.6
Q ss_pred ccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEecC
Q 002250 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSE 714 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 714 (947)
..+++|+-+.+|.+.+. |.++.+|.=.+. .|+.+. -.......+-.+|+.++++++--.|..-.=+..++
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K--~YR~p~-------LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~ 71 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPK--RYRHPE-------LDEKLRRERTRREARILAKAREAGVPVPIVYDVDP 71 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCc--ccCChH-------HHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC
Confidence 35789999999999876 445666653221 122110 01112234567899999998655544444456677
Q ss_pred CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccc
Q 002250 715 DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA 794 (947)
Q Consensus 715 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 794 (947)
+...|+|||++|..|.+.+... +..++..|-.-+.-|| ..+|||+|+.++||++..+. +.++|||++
T Consensus 72 ~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 72 DNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcc
Confidence 7788999999999999888763 2345556666677899 89999999999999998765 999999998
Q ss_pred ee
Q 002250 795 KI 796 (947)
Q Consensus 795 ~~ 796 (947)
.+
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 74
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=4e-10 Score=136.28 Aligned_cols=87 Identities=28% Similarity=0.370 Sum_probs=50.5
Q ss_pred hcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCcc
Q 002250 154 VLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLM 233 (947)
Q Consensus 154 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 233 (947)
|..++.|..|||++|.=-+.+|..++.|-+|++|+|++..+. .+|..+.+++.|.+|++..+.-...+|.....|.+|+
T Consensus 567 f~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr 645 (889)
T KOG4658|consen 567 FRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLR 645 (889)
T ss_pred HhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhccccc
Confidence 344555555555554444456666666666666666666664 5666666666666666666554444455555566666
Q ss_pred EEeccCCC
Q 002250 234 NFDVSQNR 241 (947)
Q Consensus 234 ~L~Ls~N~ 241 (947)
+|.+....
T Consensus 646 ~L~l~~s~ 653 (889)
T KOG4658|consen 646 VLRLPRSA 653 (889)
T ss_pred EEEeeccc
Confidence 66665544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-08 Score=96.36 Aligned_cols=151 Identities=20% Similarity=0.264 Sum_probs=106.7
Q ss_pred CcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEe
Q 002250 633 PENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSIT 712 (947)
Q Consensus 633 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 712 (947)
....+-+|+-+.|+++.++ |+...||.-.+ ..|+.+.- .......+-.+|++.+.++.--.|.--.-++.
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~--K~YRHP~L-------D~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~ 80 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFS--KRYRHPAL-------DQKLTRKRTKQEARLLAKCRALGIPAPRLIFI 80 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeeccc--ccccchHH-------HHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE
Confidence 4567889999999999988 78878885422 22332211 11122355678999999886544443344566
Q ss_pred cCCccEEEEeccCC-CChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC---CeEE
Q 002250 713 SEDSNLLVYEYLPN-GSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW---KPRI 788 (947)
Q Consensus 713 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 788 (947)
+...-.++|||++| .++.+++......+.........+..|-+.+.-|| ...|+|+||..+||++..++ .+.+
T Consensus 81 D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 81 DTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred ecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEE
Confidence 66667899999976 47888887653333333333667888888899999 89999999999999997554 4589
Q ss_pred ecccccee
Q 002250 789 ADFGLAKI 796 (947)
Q Consensus 789 ~DfG~a~~ 796 (947)
+|||++..
T Consensus 158 Idfgls~~ 165 (229)
T KOG3087|consen 158 IDFGLSSV 165 (229)
T ss_pred Eeecchhc
Confidence 99999854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.2e-10 Score=130.88 Aligned_cols=252 Identities=23% Similarity=0.268 Sum_probs=163.7
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.+.+.+.+.+-+|+++.++-++-. .|...++|+...... ....+.+....+-.++-...||.++.
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~--------------i~~~~~~s~r~~s~~~i~p~~P~v~~ 868 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPK--------------IRTNDYESIRSKSNILITPRSPAVVR 868 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchh--------------hccccccccCCccCccccCCCCceec
Confidence 355666778889999999887633 354455554321110 01111222222322332334566665
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
..-.+......++|++|..+++|...++..+. .+..........+..+.+||| ...+.|||++|.|.+...++..
T Consensus 869 ~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~ 943 (1205)
T KOG0606|consen 869 SFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHR 943 (1205)
T ss_pred ccCCCCCCCCcchhhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCc
Confidence 55445556778999999999999999987542 333333344455678899999 7779999999999999999999
Q ss_pred EEeccccceecccC---------------------------CC--CcceecccccccccCccccccCCCCCccchHHHHH
Q 002250 787 RIADFGLAKIVQTG---------------------------EA--GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGV 837 (947)
Q Consensus 787 kl~DfG~a~~~~~~---------------------------~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv 837 (947)
+++|||........ .. ........||+.|.|||...+......+|.|+.|+
T Consensus 944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen 944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGV 1023 (1205)
T ss_pred ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhh
Confidence 99999843211100 00 01122456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 002250 838 VLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911 (947)
Q Consensus 838 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 911 (947)
+++|.++|..||...... .+ ...+-.+ +...+..+.+...+..+++...+..+|.+|-.|.
T Consensus 1024 ~l~e~l~g~pp~na~tpq--~~----f~ni~~~-------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAETPQ--QI----FENILNR-------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhcCCCCCCCcchh--hh----hhccccC-------CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999999998543211 11 1111111 1122334445555667777788888899987766
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.8e-09 Score=102.53 Aligned_cols=143 Identities=24% Similarity=0.213 Sum_probs=84.3
Q ss_pred eEEEEEeCCCcEEEEEEecCCCCCCCCCccchhh---------hhhcccCChhhHHHHHHHHhhcccc--ccceEEEEEe
Q 002250 644 NVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTA---------ILSKRSSRSSEYDAEVATLSAVRHV--NVVKLYCSIT 712 (947)
Q Consensus 644 ~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 712 (947)
.||.|...+|..+|||+.+....+++........ ............++|++.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999999999999997655444321000000 0011111235577899999999755 566666552
Q ss_pred cCCccEEEEeccC--CCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 713 SEDSNLLVYEYLP--NGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEY-LHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 713 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~y-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
..++||||++ |..+..+... . ++......+..+++..+.. +| ..+++|+|+.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-D---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-G---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhc-c---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence 4579999998 5444333322 1 1122234455566664554 57 8899999999999999988 99999
Q ss_pred ccccceecc
Q 002250 790 DFGLAKIVQ 798 (947)
Q Consensus 790 DfG~a~~~~ 798 (947)
|||.|....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.6e-09 Score=131.12 Aligned_cols=129 Identities=25% Similarity=0.219 Sum_probs=79.3
Q ss_pred ccCcEEEccCccccccCCccCCCCCCCCEEECcCcc--cccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEE
Q 002250 158 EKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNE--LFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNF 235 (947)
Q Consensus 158 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 235 (947)
...+...+-+|.+. .++.... .++|++|-+..|. +.....+.|..++.|+.|||++|.=-+.+|..++++-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 45555666666655 3333332 2356666666664 433333445666677777777666555667777777777777
Q ss_pred eccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcc
Q 002250 236 DVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNR 288 (947)
Q Consensus 236 ~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 288 (947)
+|++..++.+|..+.++..|.+|++..+.....+|.....+++|++|.+..-.
T Consensus 601 ~L~~t~I~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 601 DLSDTGISHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccCCCccccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 77777776666677777777777777666544555666667777777665544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.3e-09 Score=84.46 Aligned_cols=60 Identities=33% Similarity=0.526 Sum_probs=39.9
Q ss_pred ccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCcc
Q 002250 446 KLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKF 505 (947)
Q Consensus 446 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 505 (947)
+|++|++++|+++...+..|..+++|++|++++|+++...|+.|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 456666666666655556666666777777777777666666667777777777777664
|
... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.4e-08 Score=115.28 Aligned_cols=158 Identities=23% Similarity=0.228 Sum_probs=105.3
Q ss_pred ccccccCceeEEEEEeCCCcEEEEEEecCCCCC-----------------------CCCCccchhhhhhcccCChhhHHH
Q 002250 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSG-----------------------FRGDYRSSTAILSKRSSRSSEYDA 691 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~ 691 (947)
+.|+.++-|.||+|++++|+.||||+.+|+... .+-..........+.-...-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999999999999999886521 111111122222223333445778
Q ss_pred HHHHHhhcc----ccccceEEEEE-ecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHH-HHHHhcCCC
Q 002250 692 EVATLSAVR----HVNVVKLYCSI-TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKG-LEYLHHGFD 765 (947)
Q Consensus 692 E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~-l~yLH~~~~ 765 (947)
|+.-+.+++ ...-+++-..| +..+...++|||++|-.+.+...-.. ...+ +..++..++++ +..+- .
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~---~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLL---R 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHH---h
Confidence 888887773 22233343444 33567799999999998888743221 2234 22233333322 33333 5
Q ss_pred CCeEeccCCCCCeEecCCCCeEEeccccceeccc
Q 002250 766 RPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT 799 (947)
Q Consensus 766 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 799 (947)
.+++|.|.+|.||+++.+|.+.+.|||+.....+
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 7999999999999999999999999999876544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.2e-07 Score=99.70 Aligned_cols=152 Identities=18% Similarity=0.121 Sum_probs=102.5
Q ss_pred ccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc--cceEEEEEe
Q 002250 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN--VVKLYCSIT 712 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~ 712 (947)
+.+-+.....|+++.+. |+.+.||+....... ...............+.+|...+.++...+ .++.+++..
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~------~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e 100 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWG------EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGE 100 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHH------HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEE
Confidence 34444444557777664 789999977322100 000000001122235789999999885333 334455554
Q ss_pred c-----CCccEEEEeccCCC-ChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC----
Q 002250 713 S-----EDSNLLVYEYLPNG-SLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL---- 782 (947)
Q Consensus 713 ~-----~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~---- 782 (947)
. ...-++|+|++++. +|.+++......+.+...+..++.+++..+.-|| ..+|+|+|++++|||++.
T Consensus 101 ~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~ 177 (268)
T PRK15123 101 RGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPG 177 (268)
T ss_pred ecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccC
Confidence 3 22468999999886 8999886432334566677789999999999999 899999999999999975
Q ss_pred ---CCCeEEecccccee
Q 002250 783 ---EWKPRIADFGLAKI 796 (947)
Q Consensus 783 ---~~~~kl~DfG~a~~ 796 (947)
++.+.++||+.+..
T Consensus 178 ~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 178 REEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCceEEEEECCcccc
Confidence 46799999998864
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.5e-09 Score=82.41 Aligned_cols=59 Identities=41% Similarity=0.544 Sum_probs=28.3
Q ss_pred CCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCC
Q 002250 183 QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNR 241 (947)
Q Consensus 183 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 241 (947)
+|++|+|++|+|+...+..|.++++|++|++++|.++...+..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333444444444555555444444444445555555555555444
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=6.4e-08 Score=97.63 Aligned_cols=152 Identities=20% Similarity=0.190 Sum_probs=98.2
Q ss_pred cCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcc-----cCChhhHHHHHHHHhhcccc--c
Q 002250 631 VKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKR-----SSRSSEYDAEVATLSAVRHV--N 703 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~--n 703 (947)
..+.+.||.|--+.||.|..+.|.++|||.=+.....++...+......... .......++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3467899999999999999999999999964333222221111111100000 01123467899999999544 5
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
+.+.+++ +...+||||++|-.|...-- +....-.++..|..-+.-+- ..||||+|+.+-||++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecC
Confidence 5555544 45689999998866543221 11112223334444444444 4789999999999999999
Q ss_pred CCeEEecccccee
Q 002250 784 WKPRIADFGLAKI 796 (947)
Q Consensus 784 ~~~kl~DfG~a~~ 796 (947)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999987653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2e-10 Score=127.60 Aligned_cols=175 Identities=29% Similarity=0.282 Sum_probs=91.6
Q ss_pred chhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCC-------------CccCccCcccccccCCCceeeCCCCC
Q 002250 78 TEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSS-------------GISGKFPWKSLENLTNLEFLSLGDNP 144 (947)
Q Consensus 78 ~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n-------------~i~~~~~~~~l~~l~~L~~L~Ls~n~ 144 (947)
|-.|..+.+|++|.|.++.|.....-..--.+|++|...+. .|+...+ .-.|...+.++|.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~------Wn~L~~a~fsyN~ 175 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTAKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPV------WNKLATASFSYNR 175 (1096)
T ss_pred CceeccccceeeEEecCcchhhhhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchh------hhhHhhhhcchhh
Confidence 44566677788888877777642111111123444433222 1111111 1235555566665
Q ss_pred CCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCc-cccCCCCCcEEEeecccccccCC
Q 002250 145 FDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPA-GIVKLNKLWQLELYNNSLSGRLP 223 (947)
Q Consensus 145 i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~L~~n~l~~~~~ 223 (947)
+.. +...+.-++.|+.|+|++|+++.. +.+..|++|++|||++|++. .+|. ...++ +|..|.|++|.++..
T Consensus 176 L~~--mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~tL-- 247 (1096)
T KOG1859|consen 176 LVL--MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALTTL-- 247 (1096)
T ss_pred HHh--HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeeecccHHHhh--
Confidence 543 233444555666666666666643 25666666666666666665 3332 22222 266666666666633
Q ss_pred ccCCCCCCccEEeccCCCCCCC--CccccccCCCCEEEccCccCc
Q 002250 224 VGFSNLTNLMNFDVSQNRLEGD--LSELRFLNQLSSLHLFENQFS 266 (947)
Q Consensus 224 ~~~~~l~~L~~L~Ls~N~l~~~--~~~l~~l~~L~~L~L~~N~i~ 266 (947)
..+.+|++|+.|||++|-|.+. ...++.+..|+.|+|.+|.+-
T Consensus 248 ~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 248 RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 3455666666666666666542 234555556666666666653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.8e-07 Score=99.13 Aligned_cols=169 Identities=21% Similarity=0.314 Sum_probs=128.1
Q ss_pred CceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEec----CC
Q 002250 641 GSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITS----ED 715 (947)
Q Consensus 641 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~ 715 (947)
--.+.||+..+ ||..|.+|+++...... ...-..-+++++++.|+|+|++-++|.. +.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-----------------~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~ 350 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS-----------------TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDL 350 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC-----------------cccchHHHHHHHHhccCceeehhhhhhhhccCcc
Confidence 44688999954 89999999996432211 1122345788999999999999988863 44
Q ss_pred ccEEEEeccCC-CChHHHhhhc-------------CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 716 SNLLVYEYLPN-GSLWDRLHTC-------------HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 716 ~~~lv~e~~~~-gsL~~~l~~~-------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
..++||+|.|+ ++|.+.-... .+...++...|.++.|++.||.++| +.|..-+-|.+++|+++
T Consensus 351 SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~ 427 (655)
T KOG3741|consen 351 SLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVT 427 (655)
T ss_pred eEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEee
Confidence 56899999986 6777755322 1234677889999999999999999 88999999999999999
Q ss_pred CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCC
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p 848 (947)
.+.+++|+..|+......+.. |.+.+ -.+-|.=.||.+++-+.||..-
T Consensus 428 G~~RIriS~C~i~Dvl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 428 GKMRIRISGCGIMDVLQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CcceEEEecccceeeecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 999999999998876654431 11111 1346888999999999999643
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.66 E-value=7.2e-09 Score=104.01 Aligned_cols=205 Identities=21% Similarity=0.181 Sum_probs=114.6
Q ss_pred CcccceeeccCccccCcCc-hhh-hcCCCccEEeCcCccCcC--CCCC-cccccccceeecCCCCccCccCcccc-cccC
Q 002250 60 LQALQKINLGTNFLYGTIT-EGL-KSCTRLQVLDLGNNSFSG--EVPD-LSMLHELSFLNLNSSGISGKFPWKSL-ENLT 133 (947)
Q Consensus 60 l~~L~~L~L~~n~i~~~~~-~~l-~~l~~L~~L~Ls~n~i~~--~~~~-l~~l~~L~~L~L~~n~i~~~~~~~~l-~~l~ 133 (947)
+..++.|.+.++.|-...- ..| ..++.+++|||.+|.|+. ++.. +.+|+.|++|+|+.|.+...+. .+ ..+.
T Consensus 44 ~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~--~lp~p~~ 121 (418)
T KOG2982|consen 44 LRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIK--SLPLPLK 121 (418)
T ss_pred ccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccc--cCccccc
Confidence 3345566666666633221 222 357889999999998875 3333 6888999999999998876554 34 4677
Q ss_pred CCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccC--CccCCCC-CCCCEEECcCccccc--ccCccccCCCCC
Q 002250 134 NLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQI--PEGIGNL-TQLQNLELSDNELFG--EIPAGIVKLNKL 208 (947)
Q Consensus 134 ~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~--p~~~~~l-~~L~~L~Ls~N~l~~--~~~~~l~~l~~L 208 (947)
+|+.|-|.+..+........+..+++++.|+++.|.+.... .+..... +.+++|.+..|.... ....--.-++++
T Consensus 122 nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv 201 (418)
T KOG2982|consen 122 NLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNV 201 (418)
T ss_pred ceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccc
Confidence 88888888887766556666777888888888888544211 1111111 233344433332210 000001123455
Q ss_pred cEEEeecccccccC-CccCCCCCCccEEeccCCCCCCC--CccccccCCCCEEEccCccCc
Q 002250 209 WQLELYNNSLSGRL-PVGFSNLTNLMNFDVSQNRLEGD--LSELRFLNQLSSLHLFENQFS 266 (947)
Q Consensus 209 ~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~--~~~l~~l~~L~~L~L~~N~i~ 266 (947)
..+.+..|.|+... ...+..++.+.-|+|+.|+|... ...+..+++|..|.+++|.+.
T Consensus 202 ~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 202 NSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred hheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 55556666554321 22344455555555555555432 233445555555555555544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=7.8e-07 Score=94.13 Aligned_cols=257 Identities=17% Similarity=0.184 Sum_probs=155.5
Q ss_pred CCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEEEE
Q 002250 632 KPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCS 710 (947)
Q Consensus 632 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 710 (947)
...+.+|+|+-+.+|-.--- ...+.|+.+..... .-...++.|.+. .||-+-.=+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa--------------------~~aqk~a~la~~p~~p~~~~rvaW 71 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPA--------------------AQAQKVAELAATPDAPLLNYRVAW 71 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCch--------------------HHHHHHHHhccCCCCcchhhhhcc
Confidence 34678999999999964311 12344666432211 011123333333 45533321222
Q ss_pred E------ec-CCccEEEEeccCCC-ChHHHhhh----cCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 711 I------TS-EDSNLLVYEYLPNG-SLWDRLHT----CHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 711 ~------~~-~~~~~lv~e~~~~g-sL~~~l~~----~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
= -+ +....+.|..+++. .+.++... +.....+|...++++..+|.+.+.|| ..|.+-+|+.++|+
T Consensus 72 Pqa~L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~ 148 (637)
T COG4248 72 PQATLHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSF 148 (637)
T ss_pred cHHHhhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccce
Confidence 1 11 22245778877764 22333321 12234799999999999999999999 88999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhC-CCCCCCC
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTG-KRPIVPE 852 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg-~~p~~~~ 852 (947)
|+++++.+.+.|-+.-.....+. ....-+|...|.+||.-. +...+...|.|.+||++++++.| ++||.+.
T Consensus 149 lVsd~~~V~LVdsDsfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 149 LVSDDSKVVLVDSDSFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eeecCceEEEEcccceeeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 99999999999865444332222 222346889999999754 22345678999999999999986 8999654
Q ss_pred CC--C-----cccHHHH--HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCC--CCCCCCHHHHHHHhhcc
Q 002250 853 FG--D-----SKDIVNW--VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKL--PAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 853 ~~--~-----~~~~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~d--P~~RPt~~ev~~~L~~~ 920 (947)
.. + ..++... .+...+.... .-+....-.+-.+..+..+..+|+... +.-|||++..+..|.++
T Consensus 226 ~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~----~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 226 PLISDAPNPLETDIAHGRFAYASDQRRGL----KPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred cccCCCCCcchhhhhcceeeechhccCCC----CCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 21 1 1112111 1111111000 001111112334566778888898765 56799999999888763
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.3e-09 Score=118.15 Aligned_cols=187 Identities=27% Similarity=0.288 Sum_probs=118.7
Q ss_pred cCCCccccccCcccccCCcccceeeccCccccCcCchhhhcC-CCccEEeCcCccCcC-------CCCCccc---ccccc
Q 002250 43 LPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSC-TRLQVLDLGNNSFSG-------EVPDLSM---LHELS 111 (947)
Q Consensus 43 l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l-~~L~~L~Ls~n~i~~-------~~~~l~~---l~~L~ 111 (947)
.+..+-++ | -+|..+..|+.|-|.++.|.. ...+..+ ..|+.|.-++ .++. -..++.+ -..|.
T Consensus 94 ~pa~~pt~--p-i~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~~Wn~L~ 167 (1096)
T KOG1859|consen 94 SPARDPTE--P-ISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSPVWNKLA 167 (1096)
T ss_pred cCCCCCCC--C-ceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccchhhhhHh
Confidence 34455555 3 468889999999999999854 2222222 3455554332 2211 1112211 23567
Q ss_pred eeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCcc-CCCCCCCCEEECc
Q 002250 112 FLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEG-IGNLTQLQNLELS 190 (947)
Q Consensus 112 ~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~Ls 190 (947)
+.+.++|.+.- .. .++.-++.|+.|||++|++.... .+..+++|++|||++|.++ .+|.. ...+ +|+.|.|+
T Consensus 168 ~a~fsyN~L~~-mD-~SLqll~ale~LnLshNk~~~v~---~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 168 TASFSYNRLVL-MD-ESLQLLPALESLNLSHNKFTKVD---NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred hhhcchhhHHh-HH-HHHHHHHHhhhhccchhhhhhhH---HHHhcccccccccccchhc-cccccchhhh-hheeeeec
Confidence 77778887752 22 56777888888888888887643 5677888888888888887 44432 2222 48888888
Q ss_pred CcccccccCccccCCCCCcEEEeecccccccCC-ccCCCCCCccEEeccCCCCCC
Q 002250 191 DNELFGEIPAGIVKLNKLWQLELYNNSLSGRLP-VGFSNLTNLMNFDVSQNRLEG 244 (947)
Q Consensus 191 ~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~ 244 (947)
+|.++.. ..+.+|++|+.|||++|-|.+.-. ..+..|..|..|+|.+|.+-.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 8887643 456778888888888888875321 124456777888888887754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=5.3e-08 Score=109.74 Aligned_cols=151 Identities=18% Similarity=0.314 Sum_probs=102.2
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcc-------eecccccccccCccccccC
Q 002250 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL-------THVIAGTHGYIAPEYAYTC 824 (947)
Q Consensus 752 ~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 824 (947)
+++.|+.|+|. +.++||+.|.|++|.++..+..||+.|+.+........... .........|.|||++...
T Consensus 107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 45689999996 78999999999999999999999999998864433111111 1112245679999999998
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCC
Q 002250 825 KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLP 904 (947)
Q Consensus 825 ~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP 904 (947)
..+.++|+||+||++|.+..|..+.....+. ........ ...+-.......+.+.++.+-+.+.+..++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~----------~~~~~~~~~~s~~~p~el~~~l~k~l~~~~ 253 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSR----------NLLNAGAFGYSNNLPSELRESLKKLLNGDS 253 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhh----------cccccccccccccCcHHHHHHHHHHhcCCc
Confidence 8899999999999999999655543222111 00000000 001111112224455567777788899999
Q ss_pred CCCCCHHHHHH
Q 002250 905 AFRPSMRVVVQ 915 (947)
Q Consensus 905 ~~RPt~~ev~~ 915 (947)
..||++.++..
T Consensus 254 ~~rp~~~~l~~ 264 (700)
T KOG2137|consen 254 AVRPTLDLLLS 264 (700)
T ss_pred ccCcchhhhhc
Confidence 99998877654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.8e-06 Score=84.26 Aligned_cols=144 Identities=22% Similarity=0.121 Sum_probs=104.2
Q ss_pred ccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc--ccceEEEEEe--
Q 002250 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV--NVVKLYCSIT-- 712 (947)
Q Consensus 637 iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~-- 712 (947)
-|+||-+.|++.... |+.+-+|+.. +.- ++. -........|.+|+..+.++..- .+.+.. ++.
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~--nhl-~~s--------~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~ 92 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMT--HHL-FHS--------VRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAV 92 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEecc--Ccc-ccc--------ccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeee
Confidence 367899999998776 4578899762 000 000 01123557899999999999532 244444 332
Q ss_pred -cCC--ccEEEEeccCC-CChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC--e
Q 002250 713 -SED--SNLLVYEYLPN-GSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK--P 786 (947)
Q Consensus 713 -~~~--~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~ 786 (947)
.+. ..+||+|-+++ -+|.+++....-.+.+...+..+..+++..+.-|| ..++.|+|+.+.||+++.++. +
T Consensus 93 k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v 169 (216)
T PRK09902 93 KIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEA 169 (216)
T ss_pred ccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeE
Confidence 111 24799998764 58999987644445677888899999999999999 899999999999999986666 9
Q ss_pred EEecccccee
Q 002250 787 RIADFGLAKI 796 (947)
Q Consensus 787 kl~DfG~a~~ 796 (947)
+++||--++.
T Consensus 170 ~lIDlEk~r~ 179 (216)
T PRK09902 170 GFLDLEKSRR 179 (216)
T ss_pred EEEEhhccch
Confidence 9999987764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.8e-06 Score=97.86 Aligned_cols=158 Identities=18% Similarity=0.209 Sum_probs=95.9
Q ss_pred cccccccCceeEEEEEeCCCcEEEEEEecCCCCCC--------------------CCCccchhhhhhcccCChhhHHHHH
Q 002250 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGF--------------------RGDYRSSTAILSKRSSRSSEYDAEV 693 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~E~ 693 (947)
.+.||..+.|.||+|++++|+.||||+-+|+-... +.++.-......+.--..-+|..|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46799999999999999999999999998765211 0000000000111111223456666
Q ss_pred HHHhhc----cccc---cceEEEEE-ecCCccEEEEeccCCCChHHH--hhhcCCccCCHHHHHHHHHHHHHHHHHHhcC
Q 002250 694 ATLSAV----RHVN---VVKLYCSI-TSEDSNLLVYEYLPNGSLWDR--LHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG 763 (947)
Q Consensus 694 ~~l~~l----~h~n---iv~l~~~~-~~~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~ 763 (947)
+-..+. +|-+ =|++-.++ .-.....++||||+|..+.|. +.+. .++... ++..+.++ |++.-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~---i~~~l~~~--~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHD---ILNKLVEA--YLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc---CCCHHH---HHHHHHHH--HHHHH
Confidence 665555 3545 12222333 234567899999999877765 3332 233332 22222222 22221
Q ss_pred CCCCeEeccCCCCCeEecC----CCCeEEeccccceeccc
Q 002250 764 FDRPVIHRDVKSSNILLDL----EWKPRIADFGLAKIVQT 799 (947)
Q Consensus 764 ~~~~ivH~Dlkp~NIll~~----~~~~kl~DfG~a~~~~~ 799 (947)
...|++|+|-+|.||+++. ++++.+.|||+......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2568999999999999984 67899999999875543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.7e-06 Score=84.27 Aligned_cols=110 Identities=24% Similarity=0.263 Sum_probs=86.0
Q ss_pred CChhhHHHHHHHHhhcccc--ccceEEEEEecCC----ccEEEEeccCCC-ChHHHhhhcCCccCCHHHHHHHHHHHHHH
Q 002250 684 SRSSEYDAEVATLSAVRHV--NVVKLYCSITSED----SNLLVYEYLPNG-SLWDRLHTCHKIEMDWVVRYAIAVGAAKG 756 (947)
Q Consensus 684 ~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~ia~~ 756 (947)
.......+|...+.++... .+.+.+++.+... ..++|+|++++. +|.+++..... .+......++.+++..
T Consensus 53 ~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 53 LRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARL 130 (206)
T ss_pred ccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHH
Confidence 3455788899988888533 3456666665532 247999999884 79998886333 5566677899999999
Q ss_pred HHHHhcCCCCCeEeccCCCCCeEecCCC---CeEEeccccceecc
Q 002250 757 LEYLHHGFDRPVIHRDVKSSNILLDLEW---KPRIADFGLAKIVQ 798 (947)
Q Consensus 757 l~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~a~~~~ 798 (947)
++-|| ..+|+|+|+++.|||++.+. .+.++||+-++...
T Consensus 131 i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999 89999999999999999887 89999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 947 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-44 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-44 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-39 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-39 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-32 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-29 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-09 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 1e-09 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 7e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-09 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-09 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-08 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 5e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-07 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 2e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 8e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 3e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 4e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-06 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 5e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 8e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-05 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 5e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 423 bits (1089), Expect = e-135
Identities = 160/538 (29%), Positives = 256/538 (47%), Gaps = 39/538 (7%)
Query: 10 SDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLG 69
D + W+ + C F+G+ C + V I+L +
Sbjct: 25 PDKNLLPDWSSNKNPCTFDGVTCR-DDKVTSIDLS----------------------SKP 61
Query: 70 TNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFP-WKS 128
N + ++ L S T L+ L L N+ +G V L+ L+L+ + +SG S
Sbjct: 62 LNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 129 LENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI---GNLTQLQ 185
L + + L+FL++ N D LKL L L L+ S++G G +L+
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181
Query: 186 NLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGD 245
+L +S N++ G++ + L L++ +N+ S +P + + L + D+S N+L GD
Sbjct: 182 HLAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD 238
Query: 246 L-SELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKL-GSWADF 303
+ +L L++ NQF G IP K L LSL N+ TG +P L G+
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTL 296
Query: 304 NYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVP-ETYANCKSLIRFRVNNNSLS 362
+D+S N G +PP + L + NNF+G +P +T + L ++ N S
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356
Query: 363 GTIPPGIWSL-PNLSIIDLSTNQFEGPVTDDIGN--AKSLALLLLANNRFSGELPSKISE 419
G +P + +L +L +DLS+N F GP+ ++ +L L L NN F+G++P +S
Sbjct: 357 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN 416
Query: 420 ASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479
S LVS+ LS N SG IP +G L KL L L NM G +P + +L + N
Sbjct: 417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476
Query: 480 SLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL-TYPKLSLLDLSNNQLAGPIPEPL 536
L+G+IP L + +LN ++LSNN+ +GEIP + L++L LSNN +G IP L
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 381 bits (980), Expect = e-119
Identities = 145/539 (26%), Positives = 230/539 (42%), Gaps = 41/539 (7%)
Query: 40 EINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLK-SCTRLQVLDLGNNSFS 98
+N+ Q +G +P L++LQ ++L N G I + L +C L LDL N F
Sbjct: 251 LLNISSNQFVGPIPPLP---LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307
Query: 99 GEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKL 157
G VP L L L+S+ SG+ P +L + L+ L L N F P + L
Sbjct: 308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS-GELPESLTNL 366
Query: 158 -EKLYWLYLTNCSVTGQIPEGIGN--LTQLQNLELSDNELFGEIPAGIVKLNKLWQLELY 214
L L L++ + +G I + LQ L L +N G+IP + ++L L L
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 215 NNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDL-SELRFLNQLSSLHLFENQFSGEIPEEF 273
N LSG +P +L+ L + + N LEG++ EL ++ L +L L N +GEIP
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486
Query: 274 GEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVL 333
+L +SL NRLTG +P+ +G + + +S N +G IP ++ ++ L +
Sbjct: 487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN 546
Query: 334 QNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTN--QFEGPVTD 391
N FNGT+P I N ++G I + + N +F+G ++
Sbjct: 547 TNLFNGTIPAAMFKQSGKIA----ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE 602
Query: 392 DIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLY 451
+ + + + + G S++ + +S N SG IP +IG + L L
Sbjct: 603 QLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILN 662
Query: 452 LHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPI 511
L N SG +P +G L ++ + N L G+IP ++ +L L ++LSNN SG IP
Sbjct: 663 LGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP- 721
Query: 512 SLTYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGLCSKTDEYFKSCSSGSGRSH 570
Q F NPGLC C + +
Sbjct: 722 ------------EMGQFE-------TFPP--AKFLNNPGLCG---YPLPRCDPSNADGY 756
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-12
Identities = 23/72 (31%), Positives = 36/72 (50%), Gaps = 3/72 (4%)
Query: 470 SLTDINFAQNSLS---GKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNN 526
+T I+ + L+ + SL SL L SL LSN+ +G + L+ LDLS N
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN 110
Query: 527 QLAGPIPEPLNI 538
L+GP+ ++
Sbjct: 111 SLSGPVTTLTSL 122
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-103
Identities = 108/312 (34%), Positives = 167/312 (53%), Gaps = 37/312 (11%)
Query: 621 SFSEKEIIDAVK---PENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTA 677
FS +E+ A +N++G+GG G VYK L G +AVK + +G
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL--KEERTQGGEL---- 72
Query: 678 ILSKRSSRSSEYDAEVATLSAVRHVNVVKL--YCSITSEDSNLLVYEYLPNGSLWDRLH- 734
++ EV +S H N+++L +C + LLVY Y+ NGS+ L
Sbjct: 73 ----------QFQTEVEMISMAVHRNLLRLRGFC--MTPTERLLVYPYMANGSVASCLRE 120
Query: 735 -TCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793
+ +DW R IA+G+A+GL YLH D +IHRDVK++NILLD E++ + DFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 794 AKIVQTGEAGDLTHV---IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPI- 849
AK++ + THV + GT G+IAPEY T K +EK+DV+ +GV+L+EL+TG+R
Sbjct: 181 AKLMDYKD----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236
Query: 850 --VPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNI-SEILKEDALKVLRIAIHCTNKLPAF 906
D +++WV + + +VD ++ E+ +++++A+ CT P
Sbjct: 237 LARLANDDDVMLLDWVK-GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPME 295
Query: 907 RPSMRVVVQMLE 918
RP M VV+MLE
Sbjct: 296 RPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = 2e-98
Identities = 109/323 (33%), Positives = 159/323 (49%), Gaps = 38/323 (11%)
Query: 610 NSWDMKSFRVLSFSEKEIIDAVK---PENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNS 666
+S + F ++ +A + LIG G G VYK VL G ++A+K +
Sbjct: 17 SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR--TPE 74
Query: 667 GFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL--YCSITSEDSNLLVYEYL 724
+G E++ E+ TLS RH ++V L +C + +L+Y+Y+
Sbjct: 75 SSQGI---------------EEFETEIETLSFCRHPHLVSLIGFC--DERNEMILIYKYM 117
Query: 725 PNGSLWDRLH--TCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782
NG+L L+ + M W R I +GAA+GL YLH +IHRDVKS NILLD
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174
Query: 783 EWKPRIADFGLAKIVQTGEAGDLTHV---IAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839
+ P+I DFG++K G D TH+ + GT GYI PEY ++ EKSDVYSFGVVL
Sbjct: 175 NFVPKITDFGISK---KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVL 231
Query: 840 MELVTGKRPIVPEF-GDSKDIVNWVYSKMDSRDSMLTVVDPNI-SEILKEDALKVLRIAI 897
E++ + IV + ++ W ++ + +VDPN+ +I E K A+
Sbjct: 232 FEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ-LEQIVDPNLADKIRPESLRKFGDTAV 290
Query: 898 HCTNKLPAFRPSMRVVVQMLEEA 920
C RPSM V+ LE A
Sbjct: 291 KCLALSSEDRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = 5e-97
Identities = 98/331 (29%), Positives = 157/331 (47%), Gaps = 49/331 (14%)
Query: 609 QNSWDMKSFRVLSFSEKEIIDA---------VKPENLIGKGGSGNVYKVVLNSGKELAVK 659
S ++ R SFS E+ + N +G+GG G VYK +N +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVK 60
Query: 660 HIWPSNSGFRGDYRSSTAILSKRSSRSS-----EYDAEVATLSAVRHVNVVKL--YCSIT 712
L+ ++ ++D E+ ++ +H N+V+L + +
Sbjct: 61 ------------------KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS--S 100
Query: 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIE-MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHR 771
D LVY Y+PNGSL DRL + W +R IA GAA G+ +LH + IHR
Sbjct: 101 DGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHR 157
Query: 772 DVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV---IAGTHGYIAPEYAYTCKINE 828
D+KS+NILLD + +I+DFGLA+ E T + I GT Y+APE +I
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARA---SEKFAQTVMTSRIVGTTAYMAPEA-LRGEITP 213
Query: 829 KSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKED 888
KSD+YSFGVVL+E++TG + + +++ D ++ +D +++
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS 272
Query: 889 ALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
+ +A C ++ RP ++ V Q+L+E
Sbjct: 273 VEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = 2e-92
Identities = 100/567 (17%), Positives = 189/567 (33%), Gaps = 63/567 (11%)
Query: 16 SSWTEANSVCKFN---GIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNF 72
++W + + G+ +SNG V ++L G VP D+I L L+ + LG++
Sbjct: 58 ANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVP-DAIGQLTELEVLALGSHG 116
Query: 73 LYG----TITEGLKSCTRLQVLDLGNNSFSGEVPD---LSMLHELSFLNLNSSGISGKFP 125
+G+ + + + D +L +NS
Sbjct: 117 EKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176
Query: 126 WKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQ 185
KS + N + V++L KL Y+ N + +
Sbjct: 177 -KSSRITLKDTQIGQLSNNI--TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE 233
Query: 186 NLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEG- 244
+ + L L +E+YN +LP L + +V+ NR
Sbjct: 234 Y-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288
Query: 245 --------DLSELRFLNQLSSLHLFENQF-SGEIPEEFGEFKHLTELSLYTNRLTGTLPQ 295
L++ ++ +++ N + + + K L L N+L G LP
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA 348
Query: 296 KLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL--LVLQNNFNGTVPETYA--NCKSL 351
GS ++++ N +T IP + C G + L +N +P + + +
Sbjct: 349 -FGSEIKLASLNLAYNQITE-IPANFC--GFTEQVENLSFAHNKLKYIPNIFDAKSVSVM 404
Query: 352 IRFRVNNNSLSG-------TIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLL 404
+ N + + P + N+S I+LS NQ + L+ + L
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464
Query: 405 ANNRFSG-------ELPSKISEASSLVSIQLSLNQFSGQIPLDI--GKLKKLSSLYLHDN 455
N + + L SI L N+ + + D L L + L N
Sbjct: 465 MGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYN 523
Query: 456 MFSGPLPYSIGSCVSLTDI------NFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEI 509
FS P + +L + N + P+ + PSL L + +N ++
Sbjct: 524 SFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KV 581
Query: 510 PISLTYPKLSLLDLSNNQLAGPIPEPL 536
+ P +S+LD+ +N +
Sbjct: 582 NEKI-TPNISVLDIKDNPNISIDLSYV 607
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 3e-66
Identities = 63/404 (15%), Positives = 129/404 (31%), Gaps = 32/404 (7%)
Query: 159 KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFG----EIPAGIVKLNKLWQLELY 214
++ L L +G++P+ IG LT+L+ L L + P GI Q +
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 215 NNSLSGRLP--VGFSNLTNLMNFDVSQNRLEGDLSELRFLN-QLSSLHLFENQFSGEIPE 271
+ ++L+ ++ + + + + + + + + N + + +
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSK 200
Query: 272 EFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLL 331
L + + + + + Y +TD+
Sbjct: 201 AVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTDVE 255
Query: 332 VLQNNFNGTVPETYANCKSLIRFRVNNNSL--------SGTIPPGIWSLPNLSIIDLSTN 383
V +P + V N + II + N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 384 QF-EGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIG 442
PV + K L +L N+ G+LP+ L S+ L+ NQ + G
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCG 374
Query: 443 KLKKLSSLYLHDNMFSG-PLPYSIGSCVSLTDINFAQNSLSG-------KIPDSLGSLPS 494
+++ +L N P + S ++ I+F+ N + + + +
Sbjct: 375 FTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434
Query: 495 LNSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQLAGPIPEPLN 537
++S+NLSNN+ S + LS ++L N L L
Sbjct: 435 VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-61
Identities = 75/487 (15%), Positives = 163/487 (33%), Gaps = 73/487 (14%)
Query: 42 NLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEV 101
+ + S +I +N + +++ + T+L+ +GN+ F E
Sbjct: 165 CINSDPQQKSIK-KSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAEN 222
Query: 102 P--------------------DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLG 141
L +L+ + + + K P L+ L ++ +++
Sbjct: 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP-TFLKALPEMQLINVA 281
Query: 142 DNPFDPSP-------FPMEVLKLEKLYWLYLTNCS-VTGQIPEGIGNLTQLQNLELSDNE 193
N + EK+ +Y+ + T + + + +L LE N+
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQ 341
Query: 194 LFGEIPAGIVKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEG--DLSELR 250
L G++PA KL L L N ++ +P + N + N+L+ ++ + +
Sbjct: 342 LEGKLPA-FGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399
Query: 251 FLNQLSSLHLFENQFSG-------EIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADF 303
++ +S++ N+ + + +++ ++L N+++ + + +
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL 459
Query: 304 NYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSG 363
+ +++ N+LT + N E + N L + N L+
Sbjct: 460 SSINLMGNMLTE-----------------IPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
Query: 364 TIPPGI--WSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALL------LLANNRFSGELPS 415
+ +LP L IDLS N F N+ +L NR E P
Sbjct: 503 -LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
Query: 416 KISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDIN 475
I+ SL +Q+ N + I +S L + DN + +
Sbjct: 561 GITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYM 617
Query: 476 FAQNSLS 482
+
Sbjct: 618 LFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-45
Identities = 47/319 (14%), Positives = 104/319 (32%), Gaps = 27/319 (8%)
Query: 40 EINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSG 99
I + L S+ ++ L + N L G + S +L L+L N +
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITE 367
Query: 100 EVPDL-SMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF------DPSPFPM 152
+ ++ L+ + + ++++ + + N + P
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427
Query: 153 EVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNEL-------FGEIPAGIVKL 205
K + + L+N ++ E + L ++ L N L +
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487
Query: 206 NKLWQLELYNNSLSGRLP--VGFSNLTNLMNFDVSQNRLE------GDLSELRFLNQLSS 257
L ++L N L+ L + L L+ D+S N + S L+ +
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQ 546
Query: 258 LHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPI 317
N+ E PE LT+L + +N + + +K+ + + +D+ +N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITP--NISVLDIKDNPNISID 603
Query: 318 PPDMCKTGAMTDLLVLQNN 336
+C ++ +
Sbjct: 604 LSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-29
Identities = 25/214 (11%), Positives = 60/214 (28%), Gaps = 13/214 (6%)
Query: 335 NNFNGTVPETYANCKSLIRFRVNNNSLSG----TIPPGIWSLPNLSIIDLSTNQFEGPVT 390
+G VP+ L + ++ P GI + + ++
Sbjct: 91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150
Query: 391 DDIGNAKSLAL--LLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLS 448
D L + ++ + I N + + + +L KL
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLR 209
Query: 449 SLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGE 508
Y+ ++ F + +L L + + N +
Sbjct: 210 QFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 509 IPISLTY-PKLSLLDLSNNQLAGPIPEPLNIKAF 541
+P L P++ L++++ N+ + +A
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 1e-75
Identities = 96/533 (18%), Positives = 166/533 (31%), Gaps = 45/533 (8%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP-DLSML 107
+ + + + L ++L N L T LQ L L NN +L +
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168
Query: 108 H--ELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPM--EVLKLEKLYWL 163
L L L+S+ I P + L L L + PS L + L
Sbjct: 169 ANSSLKKLELSSNQIKEFSP-GCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNL 227
Query: 164 YLTNCSVTGQIPEGIGNL--TQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGR 221
L+N ++ L T L L+LS N L L +L L N++
Sbjct: 228 SLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL 287
Query: 222 LPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTE 281
L N+ ++ ++ + +S F K L
Sbjct: 288 FSHSLHGLFNVRYLNLKRSFTKQSIS--------------LASLPKIDDFSFQWLKCLEH 333
Query: 282 LSLYTNRLTGTLPQKLGSWADFNYVDVSENLLT-GPIPPDMCKTGAMTDLLVL---QNNF 337
L++ N + G + Y+ +S + + + + + A + L +L +N
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393
Query: 338 NGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWS-LPNLSIIDLSTNQFEGPVTDDIGNA 396
+ + ++ L + N + + W L N+ I LS N++ +
Sbjct: 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV 453
Query: 397 KSLALLLLANNRFSG--ELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHD 454
SL L+L PS +L + LS N + + L+KL L L
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQH 513
Query: 455 NMFS--------GPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFS 506
N + G Y + L +N N + L L ++L N +
Sbjct: 514 NNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN 573
Query: 507 GEIPISLTY-PKLSLLDLSNNQLAGPIPEPL-----NIKAFIDSFTGNPGLCS 553
L L+L N + + N+ NP C+
Sbjct: 574 TLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL--DMRFNPFDCT 624
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 1e-69
Identities = 106/498 (21%), Positives = 171/498 (34%), Gaps = 36/498 (7%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSML 107
L +P + L +++G N + E + L+VL+L +N S +
Sbjct: 37 LRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96
Query: 108 HELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTN 167
L+ L+L S+ I NL L L N S ++LE L L L+N
Sbjct: 97 TNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLS-STKLGTQVQLENLQELLLSN 154
Query: 168 CSVTGQIPE--GIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVG 225
+ E I + L+ LELS N++ P + +L+ L L N L L
Sbjct: 155 NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214
Query: 226 FS---NLTNLMNFDVSQNRLEGDLSELRFLN----QLSSLHLFENQFSGEIPEEFGEFKH 278
T++ N +S ++L S FL L+ L L N + + F
Sbjct: 215 LCLELANTSIRNLSLSNSQLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ 273
Query: 279 LTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFN 338
L L N + L + Y+++ + I +
Sbjct: 274 LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS---------------LASLP 318
Query: 339 GTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEG----PVTDDIG 394
++ K L + +N + G L NL + LS + T
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 395 NAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLD-IGKLKKLSSLYLH 453
L +L L N+ S S L + L LN+ ++ L+ + +YL
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 454 DNMFSGPLPYSIGSCVSLTDINFAQNSLSG--KIPDSLGSLPSLNSLNLSNNKFSGEIPI 511
N + S SL + + +L P L +L L+LSNN +
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
Query: 512 SLTY-PKLSLLDLSNNQL 528
L KL +LDL +N L
Sbjct: 499 MLEGLEKLEILDLQHNNL 516
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 1e-65
Identities = 93/495 (18%), Positives = 157/495 (31%), Gaps = 67/495 (13%)
Query: 84 CT-RLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGD 142
CT +V D + + +VPD + ++ LNL + + P + + L L +G
Sbjct: 2 CTVSHEVADCSHLKLT-QVPD-DLPTNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGF 58
Query: 143 NPF---DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIP 199
N +P KL L L L + ++ + T L L L N +
Sbjct: 59 NTISKLEPELC----QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
Query: 200 AGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEG---DLSELRFLNQLS 256
VK L L+L +N LS L NL +S N+++ + ++ + L
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174
Query: 257 SLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGP 316
L L NQ P F L L L + L
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLFL------------------------NNVQLGPS 210
Query: 317 IPPDMCKTGAMTDLLVLQ---NNFNGTVPETYANCK--SLIRFRVNNNSLSGTIPPGIWS 371
+ +C A T + L + + T T+ K +L ++ N+L+
Sbjct: 211 LTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAW 270
Query: 372 LPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGEL---------PSKISEASS 422
LP L L N + + + ++ L L + +
Sbjct: 271 LPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKC 330
Query: 423 LVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIG----SCVSLTDINFAQ 478
L + + N G L L L L ++ S + + L +N +
Sbjct: 331 LEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTK 390
Query: 479 NSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL--TYPKLSLLDLSNNQLAGPIPEPL 536
N +S D+ L L L+L N+ E+ + + LS N+
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR--- 447
Query: 537 NIKAFIDSFTGNPGL 551
+SF P L
Sbjct: 448 ------NSFALVPSL 456
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-27
Identities = 44/231 (19%), Positives = 76/231 (32%), Gaps = 12/231 (5%)
Query: 40 EINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSG 99
++L ++ + GL+ + +I L N LQ L L +
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
Query: 100 --EVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF-------DPSP 149
P L L+ L+L+++ I+ LE L LE L L N +P
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIAN-INDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527
Query: 150 FPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLW 209
+ L L+ L L + E +L +L+ ++L N L + L
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK 587
Query: 210 QLELYNNSLSGRLPVGFS-NLTNLMNFDVSQNRLEGDLSELRFLNQLSSLH 259
L L N ++ F NL D+ N + + + +
Sbjct: 588 SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINET 638
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 4e-75
Identities = 94/509 (18%), Positives = 167/509 (32%), Gaps = 31/509 (6%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSML 107
L + S LQ ++L + +S + L L L N S L
Sbjct: 40 LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99
Query: 108 HELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTN 167
L L + ++ + +L L+ L++ N P L L L L++
Sbjct: 100 SSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 168 CSVTGQIPEGIGNLTQLQN----LELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLP 223
+ + L Q+ L+LS N + I G K +L +L L NN S +
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVM 217
Query: 224 -VGFSNLTNLMNFDVSQNRLEGDLSELRF----LNQLSSLHLFENQFS------GEIPEE 272
L L + + + +F L L +L + E + + +I +
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 273 FGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLV 332
F +++ SL + + + ++++ P K+ + L
Sbjct: 278 FNCLTNVSSFSLVSVTIERVKDFSYNF--GWQHLELVNCKFGQ-FPTLKLKS--LKRLTF 332
Query: 333 LQNNFNGTVPETYANCKSL--IRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVT 390
N E + SL + N S G + +L +DLS N ++
Sbjct: 333 TSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MS 389
Query: 391 DDIGNAKSLALLLLANNRFSGELPSKI-SEASSLVSIQLSLNQFSGQIPLDIGKLKKLSS 449
+ + L L ++ + +L+ + +S L L
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449
Query: 450 LYLHDNMFSGPL-PYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGE 508
L + N F P +LT ++ +Q L P + SL SL LN+S+N F
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509
Query: 509 IPISLTY-PKLSLLDLSNNQLAGPIPEPL 536
L +LD S N + + L
Sbjct: 510 DTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-62
Identities = 100/553 (18%), Positives = 170/553 (30%), Gaps = 76/553 (13%)
Query: 40 EINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSG 99
++L ++ + + L L + L N + + LQ L + +
Sbjct: 56 VLDLSRCEIQTIED-GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 100 EVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF---DPSPF----- 150
+ L L LN+ + I + NLTNLE L L N +
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 151 ------------------PMEVLKLEKLYWLYLTNCSVTGQIPEG-IGNLTQLQNLELSD 191
K +L+ L L N + + + I L L+ L
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 192 NELFGEIPAGIV---KLNKLWQLELYNNSLS------GRLPVGFSNLTNLMNFDVSQNRL 242
E E L L L + L+ + F+ LTN+ +F + +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294
Query: 243 EGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWAD 302
E + + + L L +F + K LT S +
Sbjct: 295 ER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS----- 348
Query: 303 FNYVDVSENLLT--GPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNS 360
++D+S N L+ G T ++ L L N T+ + + L +++
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD-LSFNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 361 LSGTIPPGIW-SLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGEL-PSKIS 418
L ++ SL NL +D+S SL +L +A N F P +
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 419 EASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQ 478
E +L + LS Q P L L L + N F + SL ++++
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 479 NSLSGKIPDSLGSLP-SLNSLNLSNNKFSG--------------------------EIPI 511
N + L P SL LNL+ N F+ P
Sbjct: 528 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 587
Query: 512 SLTYPKLSLLDLS 524
+ L+++
Sbjct: 588 DKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-55
Identities = 67/424 (15%), Positives = 118/424 (27%), Gaps = 30/424 (7%)
Query: 133 TNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDN 192
+ + L L NP +L L L+ C + +L+ L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLG-SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 193 ELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEG--DLSELR 250
+ L+ L +L +L+ +L L +V+ N ++
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 251 FLNQLSSLHLFENQFSGEIPEEFGEFKHLT----ELSLYTNRLTGTLPQKLGSWADFNYV 306
L L L L N+ + + L L N + P + +
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKL 205
Query: 307 DVSENLLTGPIPPDMCKTGAMTDLLVLQNN----FNGTVPETYANCKSLIRFRVNNNSLS 362
+ N + + + A ++ L + + L + L+
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 363 ------GTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSK 416
I L N+S L + E D L L N +F
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQ----- 318
Query: 417 ISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNM--FSGPLPYSIGSCVSLTDI 474
+L+ G L L L L N F G S SL +
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 475 NFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTY--PKLSLLDLSNNQLAGPI 532
+ + N + + + L L L+ ++ S+ L LD+S+
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 533 PEPL 536
Sbjct: 438 NGIF 441
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-09
Identities = 15/69 (21%), Positives = 25/69 (36%), Gaps = 1/69 (1%)
Query: 470 SLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQL 528
S +++ + N L S S P L L+LS + + LS L L+ N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 529 AGPIPEPLN 537
+
Sbjct: 89 QSLALGAFS 97
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 9e-75
Identities = 97/581 (16%), Positives = 196/581 (33%), Gaps = 57/581 (9%)
Query: 12 TGVFSSWTEANSVCKFN---GIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINL 68
T +W + + G+ D+NG V ++L G VP D+I L L+ ++
Sbjct: 296 TIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP-DAIGQLTELKVLSF 354
Query: 69 GTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKFPW 126
GT+ + + + + L L+ +L I+
Sbjct: 355 GTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM 414
Query: 127 KSLENLT--NLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQL 184
K ++ + +L+ +G+ + + +L KL +Y N T
Sbjct: 415 KPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDW 469
Query: 185 QNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEG 244
++ + + L L +ELYN +LP +L L + +++ NR
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
Query: 245 DL----------SELRFLNQLSSLHLFENQFSGEIPEE--FGEFKHLTELSLYTNRLTGT 292
+ ++ ++ N E P + L L N++
Sbjct: 530 AAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-H 587
Query: 293 LPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYA--NCKS 350
L G+ + + N + IP D C + L +N +P + +
Sbjct: 588 LE-AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYV 645
Query: 351 LIRFRVNNNSLSG-----TIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLA 405
+ + N + + + N S + LS N+ + T+ ++ ++L+
Sbjct: 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILS 705
Query: 406 NNRFS-------GELPSKISEASSLVSIQLSLNQFSGQIPLDI--GKLKKLSSLYLHDNM 456
NN + L +I L N+ + + D L LS++ + N
Sbjct: 706 NNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNC 764
Query: 457 FSGPLPYSIGSCVSLTDIN------FAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIP 510
FS P + L N + + P + + PSL L + +N ++
Sbjct: 765 FSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVD 822
Query: 511 ISLTYPKLSLLDLSNNQL-AGPIPE-PLNIKAFIDSFTGNP 549
LT P+L +LD+++N + + I+A + +
Sbjct: 823 EKLT-PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-38
Identities = 45/312 (14%), Positives = 99/312 (31%), Gaps = 29/312 (9%)
Query: 47 QLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--L 104
L S+ + L ++ N + E + +L L L N E+P+
Sbjct: 559 NLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFC 615
Query: 105 SMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF----DPSPFPMEVLKLEKL 160
+ ++ L + + + + +++ + + N M+ K
Sbjct: 616 AFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675
Query: 161 YWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNEL-------FGEIPAGIVKLNKLWQLEL 213
+ L+ + E + + + LS+N + L ++L
Sbjct: 676 STVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDL 735
Query: 214 YNNSLSGRLP--VGFSNLTNLMNFDVSQNRLE------GDLSELRFLNQLSSLHLFENQF 265
N L+ L + L L N DVS N + S+L+ N+
Sbjct: 736 RFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRI 794
Query: 266 SGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSEN-LLTGPIPPDMCKT 324
+ P L +L + +N + + +KL +D+++N ++ +
Sbjct: 795 LRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTP--QLYILDIADNPNISIDVTSVCPYI 851
Query: 325 GAMTDLLVLQNN 336
A +L+
Sbjct: 852 EAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-29
Identities = 55/369 (14%), Positives = 105/369 (28%), Gaps = 61/369 (16%)
Query: 181 LTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQN 240
LT+ N+ + E I L+ N + N NF+ +
Sbjct: 251 LTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLN-WNFNKELD 309
Query: 241 RLEGDLS-ELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGS 299
+L +++ L L G +P+ G+ L LS T+ T +
Sbjct: 310 MWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 300 WADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNN 359
+ + ++ + + N L++ +N N
Sbjct: 370 ELTPDMSEERKHRIRMHYKK------------------MFLDYDQRLNLSDLLQDAINRN 411
Query: 360 SLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISE 419
I + I TN+ ++ I L ++ AN+ F+ +
Sbjct: 412 PEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY-----DNI 465
Query: 420 ASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479
A + L LK L+ + L++
Sbjct: 466 AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC------------------------ 501
Query: 480 SLSGKIPDSLGSLPSLNSLNLSNNKFSG---------EIPISLTY-PKLSLLDLSNNQLA 529
++PD L LP L SLN++ N+ + PK+ + + N L
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561
Query: 530 GPIPEPLNI 538
P ++
Sbjct: 562 E-FPASASL 569
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-26
Identities = 39/263 (14%), Positives = 81/263 (30%), Gaps = 26/263 (9%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYG-TITEGLKSCTRLQVLDLGNNSFSGEVPDLSML 107
+ +P D ++ + N L KS + +D N E ++S
Sbjct: 607 IEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666
Query: 108 HE------LSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDN------PFDPSPFPMEVL 155
+ S + L+ + I FP + + + + L +N P
Sbjct: 667 MDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725
Query: 156 KLEKLYWLYLTNCSVTGQIPEGI--GNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLEL 213
L + L +T + + L L N+++S N P + ++L +
Sbjct: 726 NTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGI 783
Query: 214 ------YNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSG 267
N + + P G + +L+ + N + +L QL L + +N
Sbjct: 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKL--TPQLYILDIADNPNIS 841
Query: 268 EIPEEFGEFKHLTELSLYTNRLT 290
+ L ++
Sbjct: 842 IDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 3e-13
Identities = 29/282 (10%), Positives = 80/282 (28%), Gaps = 18/282 (6%)
Query: 250 RFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVS 309
R +L + + + S E ++ + + G++ Y S
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVA--TCDSAVWLPAGTYQVVAYTTYS 225
Query: 310 ENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGI 369
++ + G ++ + + VP + + I
Sbjct: 226 QSGIKRSELETQSVRGESFTVIDNKLTKDANVP-------------IQLKETAEYIKDYK 272
Query: 370 WSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLS 429
+D ++ ++ ++ + + + + + + + L+
Sbjct: 273 ALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNK-ELDMWGDQPGVDLDNNGRVTGLSLA 331
Query: 430 LNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKI-PDS 488
G++P IG+L +L L + + ++ ++ +
Sbjct: 332 GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMF 391
Query: 489 LGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAG 530
L LN +L + + P K S + L + Q+
Sbjct: 392 LDYDQRLNLSDLLQDAIN-RNPEMKPIKKDSRISLKDTQIGN 432
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 240 bits (616), Expect = 2e-72
Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 37/315 (11%)
Query: 256 SSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315
+ + G + + + + L L L
Sbjct: 29 PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP----------------------Y 66
Query: 316 PIPPDMCKTGAMTDLLVL----QNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWS 371
PIP + + L L NN G +P A L + + ++SG IP +
Sbjct: 67 PIPSSLAN---LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 372 LPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLV-SIQLSL 430
+ L +D S N G + I + +L + NR SG +P S L S+ +S
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 431 NQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLG 490
N+ +G+IP L L+ + L NM G GS + I+ A+NSL+ + +G
Sbjct: 184 NRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVG 241
Query: 491 SLPSLNSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQLAGPIPEPLNIKAF-IDSFTGN 548
+LN L+L NN+ G +P LT L L++S N L G IP+ N++ F + ++ N
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301
Query: 549 PGLCSKTDEYFKSCS 563
LC +C+
Sbjct: 302 KCLCGS---PLPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 5e-67
Identities = 77/371 (20%), Positives = 130/371 (35%), Gaps = 83/371 (22%)
Query: 173 QIPEGIGNLTQLQN----LELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGR--LPVGF 226
QI + +GN T L + + + G + + ++ L+L +L +P
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 227 SNLTNLMNFDVS-QNRLEGDL-SELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSL 284
+NL L + N L G + + L QL L++ SG IP+ + K L L
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 285 YTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPET 344
N L+GTLP +
Sbjct: 133 SYNALSGTLPPSIS---------------------------------------------- 146
Query: 345 YANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLL 404
+ +L+ + N +SG IP S L + +
Sbjct: 147 --SLPNLVGITFDGNRISGAIPDSYGSFSKLFTS-----------------------MTI 181
Query: 405 ANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYS 464
+ NR +G++P + +L + LS N G + G K ++L N + L
Sbjct: 182 SRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-K 239
Query: 465 IGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLS 524
+G +L ++ N + G +P L L L+SLN+S N GEIP + + +
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA 299
Query: 525 NNQL--AGPIP 533
NN+ P+P
Sbjct: 300 NNKCLCGSPLP 310
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-64
Identities = 84/330 (25%), Positives = 142/330 (43%), Gaps = 41/330 (12%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSVC--KFNGIVCDSNGL---VAEINLPEQQLLGVVPF- 54
+ +K + + SSW C + G++CD++ V ++L L P
Sbjct: 12 LQIKKDL--GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP 69
Query: 55 DSICGLQALQKINL-GTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSF 112
S+ L L + + G N L G I + T+L L + + + SG +PD LS + L
Sbjct: 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129
Query: 113 LNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTG 172
L+ + + +SG P S+ +L NL ++ N +G
Sbjct: 130 LDFSYNALSGTLP-PSISSLPNLVGITFDGNRI-------------------------SG 163
Query: 173 QIPEGIGNLTQL-QNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTN 231
IP+ G+ ++L ++ +S N L G+IP LN L ++L N L G V F + N
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKN 222
Query: 232 LMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTG 291
+++N L DL ++ L+ L L N+ G +P+ + K L L++ N L G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 292 TLPQKLGSWADFNYVDVSEN--LLTGPIPP 319
+PQ G+ F+ + N L P+P
Sbjct: 283 EIPQ-GGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 2e-69
Identities = 73/314 (23%), Positives = 118/314 (37%), Gaps = 45/314 (14%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE 688
++ + +G G V+K L + +AVK I + +S +
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVK------------------IFPIQDKQSWQ 64
Query: 689 YDAEVATLSAVRHVNVVKLY-CSITSEDSN---LLVYEYLPNGSLWDRLHTCHKIEMDWV 744
+ EV +L ++H N+++ + L+ + GSL D L + W
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWN 121
Query: 745 VRYAIAVGAAKGLEYLHH-------GFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
IA A+GL YLH G + HRD+KS N+LL IADFGLA
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 798 QTGEAGDLTHVIAGTHGYIAPEYA-----YTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
+ G++ TH GT Y+APE + + D+Y+ G+VL EL +
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 853 FGDSKDIVNWVYSKMDSRDSMLTVV-----DPNI-SEILKEDALKVL-RIAIHCTNKLPA 905
+ + S + M VV P + K + +L C +
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 906 FRPSMRVVVQMLEE 919
R S V + + +
Sbjct: 302 ARLSAGCVGERITQ 315
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 9e-60
Identities = 110/506 (21%), Positives = 179/506 (35%), Gaps = 21/506 (4%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSML 107
L + + L L ++L +Y + +S RL L L N LS
Sbjct: 45 LPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104
Query: 108 HELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTN 167
L L +GIS L N LE L LG N P EKL L N
Sbjct: 105 KALKHLFFIQTGISSIDF-IPLHNQKTLESLYLGSNHISSIKLPKG-FPTEKLKVLDFQN 162
Query: 168 CSVTGQIPEGIGNLTQLQNLEL--SDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVG 225
++ E + +L Q NL L + N++ I G L + G
Sbjct: 163 NAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKG 221
Query: 226 --FSNLTNLMNFDVSQNRLEGDLSELRF----LNQLSSLHLFENQFSGEIPEEFGEFKHL 279
S + +L E D+S F + S++L ++ F F F L
Sbjct: 222 LKNSTIQSLWLGTFEDMDDE-DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGL 280
Query: 280 TELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNG 339
EL L L+ LP L + + +S N ++T L + N
Sbjct: 281 QELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339
Query: 340 TV-PETYANCKSLIRFRVNNNSL--SGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNA 396
+ N ++L ++++ + S + +L +L ++LS N+ T+
Sbjct: 340 ELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC 399
Query: 397 KSLALLLLANNRFSG-ELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDN 455
L LL LA R + S L + LS + L L L L N
Sbjct: 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN 459
Query: 456 MFSG---PLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPIS 512
F S+ + L + + LS + SL +N ++LS+N+ + +
Sbjct: 460 HFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519
Query: 513 LTYPKLSLLDLSNNQLAGPIPEPLNI 538
L++ K L+L++N ++ +P L I
Sbjct: 520 LSHLKGIYLNLASNHISIILPSLLPI 545
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 6e-57
Identities = 87/468 (18%), Positives = 148/468 (31%), Gaps = 28/468 (5%)
Query: 88 QVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF-- 145
+ + N + E+P ++ + L + + + + L NL FL L
Sbjct: 15 KTYNCENLGLN-EIPG-TLPNSTECLEFSFNVLPTIQN-TTFSRLINLTFLDLTRCQIYW 71
Query: 146 -DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVK 204
F +L L LT + + L++L + +
Sbjct: 72 IHEDTF----QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN 127
Query: 205 LNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRL----EGDLSELRFLNQLSSLHL 260
L L L +N +S L D N + + D+S L+ SL+L
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA-TNLSLNL 186
Query: 261 FENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFN--YVDVSENLLTGPIP 318
N + I + L+ + + + L + + + I
Sbjct: 187 NGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED-IS 244
Query: 319 PDMCKTGAMTDLLVL---QNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNL 375
P + + + + ++ F T+ L + LS +P G+ L L
Sbjct: 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTL 303
Query: 376 SIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSK-ISEASSLVSIQLSLNQ-- 432
+ LS N+FE N SL L + N EL + + +L + LS +
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
Query: 433 FSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDS-LGS 491
S L + L L SL L N + C L ++ A L K S +
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
Query: 492 LPSLNSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQLAGPIPEPLNI 538
L L LNLS++ P L L+L N + N
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-26
Identities = 55/240 (22%), Positives = 90/240 (37%), Gaps = 9/240 (3%)
Query: 55 DSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSF 112
+ L LQ +NL N TE K C +L++LDL + LH L
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
Query: 113 LNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLK-LEKLYWLYLTNCSV 170
LNL+ S + + + L L+ L+L N F + L+ L +L L L+ C +
Sbjct: 430 LNLSHSLLDI-SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
Query: 171 TGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLT 230
+ +L + +++LS N L + L + L L +N +S LP L+
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILS 547
Query: 231 NLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290
++ QN L+ S + FL + L + L L+
Sbjct: 548 QQRTINLRQNPLDCTCSNIYFLEWYKENM---QKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-57
Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 43/300 (14%)
Query: 623 SEKEI-IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSK 681
S I ++ E ++G+G G V K K++A+K I +
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQI-------------------E 40
Query: 682 RSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK-IE 740
S + E+ LS V H N+VKLY + + LV EY GSL++ LH
Sbjct: 41 SESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPY 98
Query: 741 MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK-PRIADFGLAKIVQT 799
+ + ++G+ YLH + +IHRD+K N+LL +I DFG A +QT
Sbjct: 99 YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158
Query: 800 GEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859
+ G+ ++APE +EK DV+S+G++L E++T ++P E G
Sbjct: 159 HMTNN-----KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF-DEIGGPAFR 212
Query: 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
+ W +R ++ + I ++ C +K P+ RPSM +V+++
Sbjct: 213 IMWAVHN-GTRPPLIKNLPKPIESLMTR-----------CWSKDPSQRPSMEEIVKIMTH 260
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-57
Identities = 80/303 (26%), Positives = 141/303 (46%), Gaps = 37/303 (12%)
Query: 620 LSFSEKEI-IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI 678
+ + +I + + IG G G V++ + G ++AVK + +
Sbjct: 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDF------------ 73
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH- 737
+ R +E+ EVA + +RH N+V ++T + +V EYL GSL+ LH
Sbjct: 74 ---HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 738 KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
+ ++D R ++A AKG+ YLH+ + P++HR++KS N+L+D ++ ++ DFGL+++
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189
Query: 798 QTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857
+ + AGT ++APE NEKSDVYSFGV+L EL T ++P
Sbjct: 190 ASTFLSSKS--AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP--------- 238
Query: 858 DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIH-CTNKLPAFRPSMRVVVQM 916
+ ++ + V + + + I C P RPS ++ +
Sbjct: 239 ------WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292
Query: 917 LEE 919
L
Sbjct: 293 LRP 295
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 6e-57
Identities = 85/478 (17%), Positives = 157/478 (32%), Gaps = 31/478 (6%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSM 106
+ S GL +L+ + L + + L+ L++ +N S
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 107 LHELSFLNLNSSGISGKFPWKSLENLTNLEF----LSLGDNPFDPSPFPMEVLKLEKLYW 162
L L ++L+ + I L+ L L + NP + + KL+
Sbjct: 152 LTNLVHVDLSYNYIQT-ITVNDLQFLRENPQVNLSLDMSLNPI--DFIQDQAFQGIKLHE 208
Query: 163 LYLTNCSVTGQIPEG-IGNLTQLQNLELSDNELFG---------EIPAGIVKLNKLWQLE 212
L L + I + + NL L L E I G+ + +
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID-EFR 267
Query: 213 LYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEE 272
L + V F L N+ ++ ++ L ++ + SL + Q + P
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLK-QFP-- 323
Query: 273 FGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLV 332
+ L L+L N+ + + + +Y+D+S N L+ L
Sbjct: 324 TLDLPFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRNALSF-SGCCSYSDLGTNSLRH 380
Query: 333 LQNNFNG--TVPETYANCKSLIRFRVNNNSLSGTIPPGIW-SLPNLSIIDLSTNQFEGPV 389
L +FNG + + + L +++L + SL L +D+S +
Sbjct: 381 LDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF 440
Query: 390 TDDIGNAKSLALLLLANNRFSGELPSKI-SEASSLVSIQLSLNQFSGQIPLDIGKLKKLS 448
SL L +A N F S + + ++L + LS Q L +L
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500
Query: 449 SLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFS 506
L + N SL+ ++ + N + SL NL+NN +
Sbjct: 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-55
Identities = 86/513 (16%), Positives = 160/513 (31%), Gaps = 36/513 (7%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSML 107
L ++ S LQ ++L + + L L L N P S L
Sbjct: 44 LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL 103
Query: 108 HELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTN 167
L L + ++ + L L+ L++ N P L L + L+
Sbjct: 104 TSLENLVAVETKLAS-LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 168 CSVTGQIPEGIGNLTQLQN----LELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLP 223
+ + L + L++S N + I + KL +L L N S +
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIM 221
Query: 224 VG-FSNLTNLMNFDVSQNRLEG-------DLSELRFLNQLS--SLHLFENQFSGEIPEEF 273
NL L + + + S + L ++ L + +F
Sbjct: 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF 281
Query: 274 GEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL--L 331
+++ +SL + + + + + + L P + L L
Sbjct: 282 HCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ-FPT-----LDLPFLKSL 333
Query: 332 VLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWS---LPNLSIIDLSTNQFEGP 388
L N G++ SL ++ N+LS +S +L +DLS N
Sbjct: 334 TLTMN-KGSISFKKVALPSLSYLDLSRNALS-FSGCCSYSDLGTNSLRHLDLSFNGAIIM 391
Query: 389 VTDDIGNAKSLALLLLANNRFSGELP-SKISEASSLVSIQLSLNQFSGQIPLDIGKLKKL 447
+ + + L L ++ S L+ + +S L L
Sbjct: 392 -SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450
Query: 448 SSLYLHDNMFSG-PLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFS 506
++L + N F L + +LT ++ ++ L +L L LN+S+N
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL 510
Query: 507 GEIPISLTY-PKLSLLDLSNNQLAGPIPEPLNI 538
LS LD S N++ +
Sbjct: 511 FLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-48
Identities = 95/489 (19%), Positives = 166/489 (33%), Gaps = 49/489 (10%)
Query: 89 VLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPS 148
+ S +VPD + ++L+ + + S N + L++L L +
Sbjct: 15 TYQCMDQKLS-KVPD-DIPSSTKNIDLSFNPLKI-LKSYSFSNFSELQWLDLSRCEIETI 71
Query: 149 PFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKL 208
L L L LT + P LT L+NL + +L I +L L
Sbjct: 72 E-DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 209 WQLELYNNSLSG-RLPVGFSNLTNLMNFDVSQNRL----EGDLSELRFL-NQLSSLHLFE 262
+L + +N + +LP FSNLTNL++ D+S N + DL LR SL +
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 263 NQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQK-LGSWADFNYVDVSENLLTGPIPPDM 321
N I ++ + L EL+L N + + + L + A + + ++
Sbjct: 191 NPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249
Query: 322 CKTGAMTDLLVLQ--------NNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIW--- 370
+ M L + N + ++ + S+ +
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFK 308
Query: 371 -----------------SLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFS--G 411
LP L + L+ N+ SL+ L L+ N S G
Sbjct: 309 WQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSIS--FKKVALPSLSYLDLSRNALSFSG 366
Query: 412 ELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYS-IGSCVS 470
+SL + LS N + + L++L L + +S S
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
Query: 471 LTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTY--PKLSLLDLSNNQL 528
L ++ + + L SLN+L ++ N F ++ L+ LDLS QL
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL 485
Query: 529 AGPIPEPLN 537
+
Sbjct: 486 EQISWGVFD 494
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-24
Identities = 38/204 (18%), Positives = 73/204 (35%), Gaps = 4/204 (1%)
Query: 59 GLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSG--EVPDLSMLHELSFLNLN 116
G +L+ ++L N ++ LQ LD +++ E L +L +L+++
Sbjct: 374 GTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 117 SSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPE 176
+ LT+L L + N F + L +L L+ C +
Sbjct: 433 YTNTKI-DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
Query: 177 GIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFD 236
L +LQ L +S N L + +L L L+ N + + +L F+
Sbjct: 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFN 551
Query: 237 VSQNRLEGDLSELRFLNQLSSLHL 260
++ N + +FL +
Sbjct: 552 LTNNSVACICEHQKFLQWVKEQKQ 575
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-18
Identities = 41/176 (23%), Positives = 67/176 (38%), Gaps = 6/176 (3%)
Query: 363 GTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASS 422
G++ P I +PN++ + V DDI + S + L+ N S S
Sbjct: 2 GSLNPCIEVVPNITY-QCMDQKLSK-VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 423 LVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLS 482
L + LS + L LS+L L N P S SL ++ + L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 483 GKIPDSLGSLPSLNSLNLSNNKFSG-EIPISLTY-PKLSLLDLSNNQLAGPIPEPL 536
+G L +L LN+++N ++P + L +DLS N + L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL 173
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 9e-56
Identities = 64/305 (20%), Positives = 124/305 (40%), Gaps = 48/305 (15%)
Query: 623 SEKEI-IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSK 681
I + + + SG ++K G ++ VK + + S
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRD-------------WST 48
Query: 682 RSSRSSEYDAEVATLSAVRHVNVVKLY-CSITSEDSNL-LVYEYLPNGSLWDRLHTCHKI 739
R SR +++ E L H NV+ + + + L+ ++P GSL++ LH
Sbjct: 49 RKSR--DFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF 106
Query: 740 EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT 799
+D A+ A+G+ +LH + + + S ++++D + RI+ + Q+
Sbjct: 107 VVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165
Query: 800 GEAGDLTHVIAGTHGYIAPE---YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD- 855
++APE +D++SF V+L ELVT + P F D
Sbjct: 166 PGR-------MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP----FADL 214
Query: 856 -SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVV 914
+ +I V + R ++ + P++S+++K C N+ PA RP ++V
Sbjct: 215 SNMEIGMKVALE-GLRPTIPPGISPHVSKLMKI-----------CMNEDPAKRPKFDMIV 262
Query: 915 QMLEE 919
+LE+
Sbjct: 263 PILEK 267
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-55
Identities = 80/362 (22%), Positives = 140/362 (38%), Gaps = 67/362 (18%)
Query: 620 LSFSEKEI-IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI 678
+ SE + +D +K LIG+G G VYK L+ + +AVK +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVK------------------V 43
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLY--CSITSEDSN---LLVYEYLPNGSLWDRL 733
S + ++ + + + + H N+ + + D LLV EY PNGSL L
Sbjct: 44 FSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL 103
Query: 734 HTCHKIEMDWVVRYAIAVGAAKGLEYLH------HGFDRPVIHRDVKSSNILLDLEWKPR 787
DWV +A +GL YLH + + HRD+ S N+L+ +
Sbjct: 104 S---LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160
Query: 788 IADFGLAKI------VQTGEAGDLTHVIAGTHGYIAPEYA-------YTCKINEKSDVYS 834
I+DFGL+ V+ GE + GT Y+APE ++ D+Y+
Sbjct: 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA 220
Query: 835 FGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM----DSRDSMLTVVD-----PNISEIL 885
G++ E+ + P G+S + + + M +V P E
Sbjct: 221 LGLIYWEIFMRCTDLFP--GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW 278
Query: 886 KEDAL---KVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKVGESSPSFSR 942
KE++L + C ++ R + + + + E ++ ++ SP+
Sbjct: 279 KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM------MIWERNKSVSPTAHH 332
Query: 943 HY 944
H+
Sbjct: 333 HH 334
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-54
Identities = 81/326 (24%), Positives = 143/326 (43%), Gaps = 53/326 (16%)
Query: 606 SLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNS-GKELAVKHIWPS 664
++ + + L+ +E E E IGKGG G V+K L +A+K +
Sbjct: 2 AMGGSEFPKSRLPTLADNEIEY------EKQIGKGGFGLVHKGRLVKDKSVVAIKSL--- 52
Query: 665 NSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYL 724
GD T ++ K E+ EV +S + H N+VKLY + + +V E++
Sbjct: 53 ---ILGDSEGETEMIEKFQ----EFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFV 103
Query: 725 PNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784
P G L+ RL + W V+ + + A G+EY+ + + P++HRD++S NI L
Sbjct: 104 PCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLD 161
Query: 785 KPR-----IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE--YAYTCKINEKSDVYSFGV 837
+ +ADFGL++ ++ + G ++APE A EK+D YSF +
Sbjct: 162 ENAPVCAKVADFGLSQQ----SVHSVSGL-LGNFQWMAPETIGAEEESYTEKADTYSFAM 216
Query: 838 VLMELVTGKRPIVPEFGDSK----DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVL 893
+L ++TG+ P F + +N + + R ++ P + +++
Sbjct: 217 ILYTILTGEGP----FDEYSYGKIKFINMIREE-GLRPTIPEDCPPRLRNVIEL------ 265
Query: 894 RIAIHCTNKLPAFRPSMRVVVQMLEE 919
C + P RP +V+ L E
Sbjct: 266 -----CWSGDPKKRPHFSYIVKELSE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-54
Identities = 76/295 (25%), Positives = 114/295 (38%), Gaps = 45/295 (15%)
Query: 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
E +IG GG G VY+ G E+AVK S E
Sbjct: 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPD-------------EDISQTIENVRQEA 57
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
+ ++H N++ L E + LV E+ G L L + + AV
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQI 114
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR--------IADFGLAKIVQTGEAGDL 805
A+G+ YLH P+IHRD+KSSNIL+ + + I DFGLA+
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---- 170
Query: 806 THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865
AG + ++APE ++ SDV+S+GV+L EL+TG+ P +
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP---------------FR 215
Query: 866 KMDSRDSMLTVVDPNIS-EILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
+D V ++ I ++ C N P RPS ++ L
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 6e-54
Identities = 78/292 (26%), Positives = 132/292 (45%), Gaps = 47/292 (16%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL 696
IG G G VYK + ++AVK + + + + EV L
Sbjct: 32 IGSGSFGTVYKGKWH--GDVAVKMLNVTA---------------PTPQQLQAFKNEVGVL 74
Query: 697 SAVRHVNVVKLYCSITSEDSNL-LVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
RHVN++ T+ L +V ++ SL+ LH + + + IA A+
Sbjct: 75 RKTRHVNILLFMGYSTAP--QLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTAR 131
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
G++YLH + +IHRD+KS+NI L + +I DFGLA ++G+ +
Sbjct: 132 GMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 816 IAPE---YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS 872
+APE + + +SDVY+FG+VL EL+TG+ P YS +++RD
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP---------------YSNINNRDQ 233
Query: 873 MLTVVD-----PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
++ +V P++S++ ++ R+ C K RPS ++ +EE
Sbjct: 234 IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-52
Identities = 112/482 (23%), Positives = 192/482 (39%), Gaps = 37/482 (7%)
Query: 56 SICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNL 115
+ L K LG + T++ ++ L + + L+ L+ +N
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINF 75
Query: 116 NSSGISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLKLEKLYWLYLTNCSVTGQI 174
+++ ++ P L+NLT L + + +N D +P L L L L N +T
Sbjct: 76 SNNQLTDITP---LKNLTKLVDILMNNNQIADITPLA----NLTNLTGLTLFNNQITDID 128
Query: 175 PEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMN 234
P + NLT L LELS N + + + L L QL N +NLT L
Sbjct: 129 P--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFGNQVTD---LKPLANLTTLER 181
Query: 235 FDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLP 294
D+S N++ D+S L L L SL NQ S P G +L ELSL N+L
Sbjct: 182 LDISSNKVS-DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--I 236
Query: 295 QKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRF 354
L S + +D++ N ++ P +T+L + N + P A +L
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAPLSGLT--KLTELKLGANQISNISP--LAGLTALTNL 292
Query: 355 RVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELP 414
+N N L P I +L NL+ + L N + + L L NN+ S
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSD--V 346
Query: 415 SKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDI 474
S ++ +++ + NQ S P + L +++ L L+D ++ P + + VS+ +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNT 403
Query: 475 NFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPE 534
P ++ S +++ N S +S T+ + + +G + +
Sbjct: 404 VKNVTGAL-IAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQ 462
Query: 535 PL 536
PL
Sbjct: 463 PL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 6e-50
Identities = 99/474 (20%), Positives = 169/474 (35%), Gaps = 82/474 (17%)
Query: 79 EGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFL 138
+ LG + + V + L +++ L + GI +E L NL +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI---DGVEYLNNLTQI 73
Query: 139 SLGDNPF-DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGE 197
+ +N D +P L KL + + N + P + NLT L L L +N++
Sbjct: 74 NFSNNQLTDITPLK----NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI 127
Query: 198 IPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSS 257
P + L L +LEL +N++S S LT+L DL L L L
Sbjct: 128 DP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVT--DLKPLANLTTLER 181
Query: 258 LHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPI 317
L + N+ S + +L L N+++ I
Sbjct: 182 LDISSNKVSD--ISVLAKLTNLESLIATNNQISD-------------------------I 214
Query: 318 PPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSI 377
P +L +N N L + SL NL+
Sbjct: 215 TPL-------------------------GILTNLDELSLNGNQLKD--IGTLASLTNLTD 247
Query: 378 IDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQI 437
+DL+ NQ + L L L N+ S S ++ ++L +++L+ NQ
Sbjct: 248 LDLANNQISNL--APLSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDIS 303
Query: 438 PLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNS 497
P I LK L+ L L+ N S P + S L + F N +S SL +L ++N
Sbjct: 304 P--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINW 357
Query: 498 LNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGL 551
L+ +N+ S P++ +++ L L++ + ++ G
Sbjct: 358 LSAGHNQISDLTPLA-NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-49
Identities = 96/444 (21%), Positives = 172/444 (38%), Gaps = 41/444 (9%)
Query: 92 LGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFP 151
+ + ++ + L E L + ++ L+ +T L+ LG D
Sbjct: 9 TQDTPIN-QIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG---- 63
Query: 152 MEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQL 211
V L L + +N +T P + NLT+L ++ +++N++ P + L L L
Sbjct: 64 --VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117
Query: 212 ELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPE 271
L+NN ++ P NLTNL ++S N + D+S L L L L NQ + P
Sbjct: 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTIS-DISALSGLTSLQQLSF-GNQVTDLKP- 172
Query: 272 EFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL- 330
L L + +N+++ L + + + N ++ P G +T+L
Sbjct: 173 -LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPL-----GILTNLD 224
Query: 331 -LVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPV 389
L L N T A+ +L + NN +S P + L L+ + L NQ
Sbjct: 225 ELSLNGN-QLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-- 279
Query: 390 TDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSS 449
+ +L L L N+ S IS +L + L N S P+ L KL
Sbjct: 280 ISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQR 335
Query: 450 LYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEI 509
L+ ++N S + + ++ ++ N +S P L +L + L L++ ++
Sbjct: 336 LFFYNNKVSDVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAP 391
Query: 510 PISLTYPKLSLLDLSNNQLAGPIP 533
+S+ + N I
Sbjct: 392 VNYKA--NVSIPNTVKNVTGALIA 413
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-27
Identities = 67/323 (20%), Positives = 125/323 (38%), Gaps = 42/323 (13%)
Query: 232 LMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIP--------------------E 271
L + ++Q+ + L + L + + + +
Sbjct: 3 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSID 62
Query: 272 EFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLL 331
+LT+++ N+LT P L + + ++ N + P +T+L
Sbjct: 63 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-----LANLTNLT 115
Query: 332 VLQNNFNG-TVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVT 390
L N T + N +L R +++N++S + L +L + +
Sbjct: 116 GLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---L 170
Query: 391 DDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSL 450
+ N +L L +++N+ S S +++ ++L S+ + NQ S PL G L L L
Sbjct: 171 KPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPL--GILTNLDEL 226
Query: 451 YLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIP 510
L+ N + S +LTD++ A N +S P L L L L L N+ S P
Sbjct: 227 SLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 282
Query: 511 ISLTYPKLSLLDLSNNQLAGPIP 533
++ L+ L+L+ NQL P
Sbjct: 283 LA-GLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-21
Identities = 47/219 (21%), Positives = 86/219 (39%), Gaps = 17/219 (7%)
Query: 54 FDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFL 113
+ GL L ++ LG N + + L T L L+L N + +S L L++L
Sbjct: 258 LAPLSGLTKLTELKLGANQI--SNISPLAGLTALTNLELNENQLED-ISPISNLKNLTYL 314
Query: 114 NLNSSGISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLKLEKLYWLYLTNCSVTG 172
L + IS P + +LT L+ L +N D S L + WL + ++
Sbjct: 315 TLYFNNISDISP---VSSLTKLQRLFFYNNKVSDVSSLA----NLTNINWLSAGHNQISD 367
Query: 173 QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNL 232
P + NLT++ L L+D ++ ++ +L P S+ +
Sbjct: 368 LTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSY 423
Query: 233 MNFDVSQNRLEGDLSELRF-LNQLSSLHLFENQFSGEIP 270
D++ N +E+ + +Q ++ FSG +
Sbjct: 424 TEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 8e-51
Identities = 69/331 (20%), Positives = 118/331 (35%), Gaps = 52/331 (15%)
Query: 604 KHSLKQNSWDMKSFRVLSFSEKEIIDA--VKPENLIGKGGSGNVYKVVLNSGKELAVKHI 661
L S+ K+ + F ++ I ++ LIGKG G VY + E+A++ I
Sbjct: 6 LSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLI 63
Query: 662 WPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVY 721
+ + EV RH NVV + S ++
Sbjct: 64 DIERDN---------------EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108
Query: 722 EYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781
+L+ + KI +D IA KG+ YLH + ++H+D+KS N+ D
Sbjct: 109 SLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD 164
Query: 782 LEWKPRIADFGLAKIVQTGEAGDLTHVI---AGTHGYIAPE---------YAYTCKINEK 829
K I DFGL I +AG + G ++APE ++
Sbjct: 165 -NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH 223
Query: 830 SDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDA 889
SDV++ G + EL + P + + + + + +
Sbjct: 224 SDVFALGTIWYELHAREWP---------------FKTQPAEAIIWQMGTGMKPNLSQIGM 268
Query: 890 LKVLR-IAIHCTNKLPAFRPSMRVVVQMLEE 919
K + I + C RP+ ++ MLE+
Sbjct: 269 GKEISDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-50
Identities = 67/339 (19%), Positives = 117/339 (34%), Gaps = 49/339 (14%)
Query: 621 SFSEKEI-IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAI 678
S + + ++GKG G KV +G+ + +K + + + +
Sbjct: 1 SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---- 56
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK 738
EV + + H NV+K + + + EY+ G+L + +
Sbjct: 57 -------------EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-MD 102
Query: 739 IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798
+ W R + A A G+ YLH +IHRD+ S N L+ +ADFGLA+++
Sbjct: 103 SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159
Query: 799 TGEAGDLTHV------------IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGK 846
+ + G ++APE +EK DV+SFG+VL E++
Sbjct: 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219
Query: 847 RPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAF 906
+ D L V I + C + P
Sbjct: 220 NA-------------DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEK 266
Query: 907 RPSMRVVVQMLEE-AEPCSVTNIVVKKVGESSPSFSRHY 944
RPS + LE + + ++ + F Y
Sbjct: 267 RPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETY 305
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-49
Identities = 73/311 (23%), Positives = 119/311 (38%), Gaps = 45/311 (14%)
Query: 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
+GKG G V++ G+ +AVK I S R +S + E+
Sbjct: 13 LECVGKGRYGEVWRGSWQ-GENVAVK------------------IFSSRDEKSWFRETEL 53
Query: 694 ATLSAVRHVNVVKLYCSITSEDSN----LLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
+RH N++ S + + L+ Y GSL+D L +D V I
Sbjct: 54 YNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRI 110
Query: 750 AVGAAKGLEYLH-----HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV-QTGEAG 803
+ A GL +LH + HRD+KS NIL+ + IAD GLA + Q+
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL 170
Query: 804 DLT-HVIAGTHGYIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
D+ + GT Y+APE ++ D+++FG+VL E+
Sbjct: 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
Query: 857 KDIVNWVYSKMDSRDSMLTVVD----PNI-SEILKEDALKVLRIAIH-CTNKLPAFRPSM 910
+ V + D V PNI + + L L + C + P+ R +
Sbjct: 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290
Query: 911 RVVVQMLEEAE 921
+ + L + +
Sbjct: 291 LRIKKTLTKID 301
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 5e-49
Identities = 74/345 (21%), Positives = 123/345 (35%), Gaps = 47/345 (13%)
Query: 599 KQNNLKHSLKQNSWDMKSFRVLSFSEKEII-DAVKPENLIGKGGSGNVYKVVLNSGKELA 657
+L+ ++Q+ S L + I ++ IGKG G V+ G+++A
Sbjct: 7 PGESLRDLIEQSQ-SSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVA 64
Query: 658 VKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSN 717
VK + S + E+ +RH N++ + +
Sbjct: 65 VK------------------VFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106
Query: 718 ----LLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLH-----HGFDRPV 768
L+ +Y NGSL+D L +D +A + GL +LH +
Sbjct: 107 WTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163
Query: 769 IHRDVKSSNILLDLEWKPRIADFGLAKIVQ--TGEAGDLTHVIAGTHGYIAPE------Y 820
HRD+KS NIL+ IAD GLA T E + GT Y+ PE
Sbjct: 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN 223
Query: 821 AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVD-- 878
+ +D+YSFG++L E+ + V S D V
Sbjct: 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK 283
Query: 879 --PNI-SEILKEDALKVLRIAIH-CTNKLPAFRPSMRVVVQMLEE 919
P+ + ++ L+ + + C PA R + V + L +
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-46
Identities = 75/324 (23%), Positives = 124/324 (38%), Gaps = 46/324 (14%)
Query: 620 LSFSEKEIIDA-VKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI 678
L + I + + IGKG G V++ G+E+AVK I
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVK------------------I 72
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSN----LLVYEYLPNGSLWDRLH 734
S R RS +AE+ +RH N++ + ++ LV +Y +GSL+D L+
Sbjct: 73 FSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 132
Query: 735 TCHKIEMDWVVRYAIAVGAAKGLEYLH-----HGFDRPVIHRDVKSSNILLDLEWKPRIA 789
+ + +A+ A GL +LH + HRD+KS NIL+ IA
Sbjct: 133 ---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189
Query: 790 DFGLAKIVQTGEAGDLTHVI--AGTHGYIAPE------YAYTCKINEKSDVYSFGVVLME 841
D GLA + GT Y+APE + +++D+Y+ G+V E
Sbjct: 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249
Query: 842 LVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVD----PNI-SEILKEDALKVLRIA 896
+ + V S + V + PNI + +AL+V+
Sbjct: 250 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 309
Query: 897 IH-CTNKLPAFRPSMRVVVQMLEE 919
+ C A R + + + L +
Sbjct: 310 MRECWYANGAARLTALRIKKTLSQ 333
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-46
Identities = 84/420 (20%), Positives = 145/420 (34%), Gaps = 77/420 (18%)
Query: 110 LSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLKLEKLYWLYLTNC 168
+ L + I+ FP +L L D +LE + L +
Sbjct: 2 AATLATLPAPINQIFP---DADLAEGIRAVLQKASVTDVVTQE----ELESITKLVVAGE 54
Query: 169 SVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSN 228
V +GI LT L+ L L+ N++ P + L KL L + N ++ N
Sbjct: 55 KVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQN 108
Query: 229 LTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNR 288
LTNL ++++ + D+S L L ++ SL+L N L L++ ++
Sbjct: 109 LTNLRELYLNEDNIS-DISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESK 166
Query: 289 LTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANC 348
+ + P AN
Sbjct: 167 VKD-------------------------VTP-------------------------IANL 176
Query: 349 KSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNR 408
L +N N + P + SL +L NQ + N L L + NN+
Sbjct: 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI--TPVANMTRLNSLKIGNNK 232
Query: 409 FSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSC 468
+ S ++ S L +++ NQ S I + L KL L + N S + +
Sbjct: 233 ITD--LSPLANLSQLTWLEIGTNQISD-IN-AVKDLTKLKMLNVGSNQISDISV--LNNL 286
Query: 469 VSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQL 528
L + N L + + +G L +L +L LS N + P++ + K+ D +N +
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA-SLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-45
Identities = 87/398 (21%), Positives = 145/398 (36%), Gaps = 56/398 (14%)
Query: 59 GLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSS 118
G L + N + L S + V L ++ L +
Sbjct: 1 GAATLATLPAPINQI-----FPDADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGE 54
Query: 119 GISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEG 177
++ + +E LTNLE+L+L N D SP L KL LY+ +T
Sbjct: 55 KVASI---QGIEYLTNLEYLNLNGNQITDISPL----SNLVKLTNLYIGTNKIT--DISA 105
Query: 178 IGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDV 237
+ NLT L+ L L+++ + P + L K++ L L N SN+T L V
Sbjct: 106 LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTV 162
Query: 238 SQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKL 297
++++++ D++ + L L SL L NQ P L + Y N++T P +
Sbjct: 163 TESKVK-DVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--V 217
Query: 298 GSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVN 357
+ N + + N +T P AN L +
Sbjct: 218 ANMTRLNSLKIGNNKITDLSP--------------------------LANLSQLTWLEIG 251
Query: 358 NNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKI 417
N +S + L L ++++ +NQ + N L L L NN+ E I
Sbjct: 252 TNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI 307
Query: 418 SEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDN 455
++L ++ LS N + PL L K+ S +
Sbjct: 308 GGLTNLTTLFLSQNHITDIRPL--ASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-43
Identities = 76/421 (18%), Positives = 146/421 (34%), Gaps = 77/421 (18%)
Query: 87 LQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF- 145
L + ++ + L E L + ++ + E L ++ L +
Sbjct: 2 AATLATLPAPIN-QIFPDADLAEGIRAVLQKASVTDV---VTQEELESITKLVVAGEKVA 57
Query: 146 DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKL 205
L L +L L +T P + NL +L NL + N++ + + L
Sbjct: 58 SIQGI----EYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNL 109
Query: 206 NKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQF 265
L +L L +++S P +NLT + + ++ N DLS L + L+ L + E++
Sbjct: 110 TNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167
Query: 266 SGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTG 325
L LSL N++
Sbjct: 168 KD--VTPIANLTDLYSLSLNYNQI------------------------------------ 189
Query: 326 AMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQF 385
A+ SL F N ++ P + ++ L+ + + N+
Sbjct: 190 --------------EDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI 233
Query: 386 EGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLK 445
+ N L L + N+ S + + + + L + + NQ S + L
Sbjct: 234 TD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISV--LNNLS 287
Query: 446 KLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKF 505
+L+SL+L++N IG +LT + +QN ++ P L SL ++S + +N
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
Query: 506 S 506
Sbjct: 346 K 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-42
Identities = 73/353 (20%), Positives = 135/353 (38%), Gaps = 29/353 (8%)
Query: 184 LQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLE 243
L + P L + + L S++ V L ++ V+ ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 244 GDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADF 303
+ + +L L L+L NQ + P LT L + TN++T L + +
Sbjct: 58 -SIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNL 112
Query: 304 NYVDVSENLLTGPIPPDMCKTGAMTDL--LVLQNNFNGTVPETYANCKSLIRFRVNNNSL 361
+ ++E+ ++ P +T + L L N N + +N L V + +
Sbjct: 113 RELYLNEDNISDISP-----LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167
Query: 362 SGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEAS 421
P I +L +L + L+ NQ E + + SL N+ + + ++ +
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITD--ITPVANMT 221
Query: 422 SLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSL 481
L S+++ N+ + PL L +L+ L + N S ++ L +N N +
Sbjct: 222 RLNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQI 277
Query: 482 SGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQLAGPIP 533
S L +L LNSL L+NN+ E + L+ L LS N + P
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-35
Identities = 71/262 (27%), Positives = 123/262 (46%), Gaps = 19/262 (7%)
Query: 54 FDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFL 113
++ L L+++ L + + + L + T++ L+LG N ++ LS + L++L
Sbjct: 103 ISALQNLTNLRELYLNEDNI--SDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYL 160
Query: 114 NLNSSGISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLKLEKLYWLYLTNCSVTG 172
+ S + P + NLT+L LSL N D SP L L++ +T
Sbjct: 161 TVTESKVKDVTP---IANLTDLYSLSLNYNQIEDISPLA----SLTSLHYFTAYVNQITD 213
Query: 173 QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNL 232
P + N+T+L +L++ +N++ P + L++L LE+ N +S +LT L
Sbjct: 214 ITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKL 267
Query: 233 MNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGT 292
+V N++ D+S L L+QL+SL L NQ E E G +LT L L N +T
Sbjct: 268 KMLNVGSNQIS-DISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326
Query: 293 LPQKLGSWADFNYVDVSENLLT 314
P L S + + D + ++
Sbjct: 327 RP--LASLSKMDSADFANQVIK 346
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-45
Identities = 96/501 (19%), Positives = 158/501 (31%), Gaps = 55/501 (10%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSML 107
L + S LQ ++L + +S + L L L N S L
Sbjct: 40 LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99
Query: 108 HELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTN 167
L L + ++ + +L L+ L++ N P L L L L++
Sbjct: 100 SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 168 CSVTGQIPEGIGNLTQLQN----LELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLP 223
+ + L Q+ L+LS N + I G K +L +L L NN S +
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVM 217
Query: 224 VG-FSNLTNL------MNFDVSQNRLEG-DLSELRFLNQLSSLHLFENQ---FSGEIPEE 272
L L + ++ LE D S L L L+ + +I +
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 273 FGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLV 332
F +++ SL + + + G L +
Sbjct: 278 FNCLTNVSSFSLVSVTIER-------------------------VKDFSYNFG-WQHLEL 311
Query: 333 LQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQ--FEGPVT 390
+ F KSL R +N + LP+L +DLS N F+G +
Sbjct: 312 VNCKFGQF---PTLKLKSLKRLTFTSNKGG-NAFSEV-DLPSLEFLDLSRNGLSFKGCCS 366
Query: 391 DDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDI-GKLKKLSS 449
SL L L+ N + S L + + + L+ L
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 450 LYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKI-PDSLGSLPSLNSLNLSNNKFSGE 508
L + SL + A NS PD L +L L+LS +
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 509 IPISLTY-PKLSLLDLSNNQL 528
P + L +L++++NQL
Sbjct: 486 SPTAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 9e-38
Identities = 78/471 (16%), Positives = 148/471 (31%), Gaps = 56/471 (11%)
Query: 85 TRLQVLDLGNNSFSG-EVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDN 143
+ LDL N EL L+L+ I + ++L++L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 144 PFDPSPFPMEVL-KLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNEL-FGEIPAG 201
P + L L L ++ IG+L L+ L ++ N + ++P
Sbjct: 87 PI--QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 202 IVKLNKLWQLELYNNSLSGRLPVGFSNLTNL----MNFDVSQNRLEG-DLSELRFLNQLS 256
L L L+L +N + L + ++ D+S N + + + L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LH 203
Query: 257 SLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315
L L N S + + L L + N ++ L G
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN----------EGNLEKFDKSALEG 253
Query: 316 PIPPDMCKTGAMTDLLVLQNNFNG------TVPETYANCKSLIRFRVNNNSLSGTIPPGI 369
+ +L + + + + + ++ F + + ++ +
Sbjct: 254 -----------LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFS 301
Query: 370 --WSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQ 427
+ +L +++ QF KSL L +N+ S++ SL +
Sbjct: 302 YNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLD 353
Query: 428 LSLNQ--FSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKI 485
LS N F G L L L N + + L ++F ++L
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMS 412
Query: 486 PDS-LGSLPSLNSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQLAGPIPE 534
S SL +L L++S+ L +L ++ N
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 44/200 (22%), Positives = 74/200 (37%), Gaps = 10/200 (5%)
Query: 59 GLQALQKINLGTNFLY--GTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLN 116
L +L+ ++L N L G ++ T L+ LDL N + L +L L+
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQ 404
Query: 117 SSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVL-KLEKLYWLYLTNCSVTGQIP 175
S + + +L NL +L + + L L L + S
Sbjct: 405 HSNLKQMSEFSVFLSLRNLIYLDISHTHT--RVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 176 EGI-GNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNL 232
I L L L+LS +L ++ L+ L L + +N L +P G F LT+L
Sbjct: 463 PDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSL 520
Query: 233 MNFDVSQNRLEGDLSELRFL 252
+ N + + +L
Sbjct: 521 QKIWLHTNPWDCSCPRIDYL 540
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 8e-22
Identities = 64/263 (24%), Positives = 100/263 (38%), Gaps = 17/263 (6%)
Query: 38 VAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSF 97
V+ +L + V F G Q L+ +N L+ L +N
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF------PTLKLKSLKRLTFTSNKG 337
Query: 98 SGEVPDLSMLHELSFLNLNSSGISGK-FPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLK 156
L L FL+L+ +G+S K +S T+L++L L N L
Sbjct: 338 G-NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV--ITMSSNFLG 394
Query: 157 LEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELY 214
LE+L L + ++ + +L L L++S GI L+ L L++
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMA 453
Query: 215 NNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPE 271
NS F+ L NL D+SQ +LE LS F L+ L L++ NQ
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMASNQLKSVPDG 512
Query: 272 EFGEFKHLTELSLYTNRLTGTLP 294
F L ++ L+TN + P
Sbjct: 513 IFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 20/103 (19%), Positives = 36/103 (34%), Gaps = 3/103 (2%)
Query: 436 QIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSL 495
+IP ++ +L L N YS S L ++ ++ + + SL L
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 496 NSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQLAGPIPEPLN 537
++L L+ N + + L L LA P+
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-42
Identities = 105/552 (19%), Positives = 197/552 (35%), Gaps = 56/552 (10%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEG-LKSCTRLQVLDLGNNSFSGEVPD--LS 105
+ V S L+ LQ + LG+ + TI + ++ L++LDLG++ +
Sbjct: 36 IRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQ 94
Query: 106 MLHELSFLNLNSSGISGKF-PWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLY 164
L L L L G+S NL L L L N KL L +
Sbjct: 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154
Query: 165 LTNCSVTGQIPEGIGNLTQ--LQNLELSDNELFGEIPAGIVKLNKLWQ------LELYNN 216
++ + + L L L+ N L+ + K ++ L++ N
Sbjct: 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214
Query: 217 SLSGRLPVGFSN------------LTNLMNFDVSQNRLEGDLSELRFLN----QLSSLHL 260
+ + FSN ++M + ++ D + F + L L
Sbjct: 215 GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDL 273
Query: 261 FENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPD 320
F K L L+L N++ + + +++S NLL +
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE-LYSS 332
Query: 321 MCKTGAMTDLLVL---QNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSI 377
+ + + +N+ +T+ + L + +N+L+ I +P++
Sbjct: 333 NFYG--LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPD 385
Query: 378 IDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSG-ELPSKISEASSLVSIQLSLNQFSGQ 436
I LS N+ ++ + L+ L+ NR ++ + L + L+ N+FS
Sbjct: 386 IFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSS- 440
Query: 437 IPLD--IGKLKKLSSLYLHDNMFSGPLPYSIGSCV-----SLTDINFAQNSLSGKIPDSL 489
D + L L+L +NM + V L + N L+ P
Sbjct: 441 CSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVF 500
Query: 490 GSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNP 549
L +L L+L++N+ + + + L +LD+S NQL P P+ + +D T N
Sbjct: 501 SHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLD-ITHNK 558
Query: 550 GLCSKTDEYFKS 561
+C F +
Sbjct: 559 FICECELSTFIN 570
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-38
Identities = 95/511 (18%), Positives = 172/511 (33%), Gaps = 57/511 (11%)
Query: 59 GLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLN 116
L +++ L N++ +LQ+L+LG+ + L L L+L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 117 SSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLK-LEKLYWLYLTNCSVTG-QI 174
SS I + + L +L L L + + L+ L L L+ + +
Sbjct: 82 SSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140
Query: 175 PEGIGNLTQLQNLELSDNELFGEIPAGI---VKLNKLWQLELYNNSLSGRLPVGFSNLTN 231
G L L++++ S N++F + ++ L L NSL R+ V + N
Sbjct: 141 HPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 232 ------LMNFDVSQNRLEGDLS-------------ELRFLNQLSSLHLFENQFSGEIPEE 272
L DVS N D++ L + + +
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 273 FGEFKH--LTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL 330
F + L L + + + D ++++ N + I + + +L
Sbjct: 260 FAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK-IADEAFYG--LDNL 316
Query: 331 --LVLQNNFNGTVP-ETYANCKSLIRFRVNNNSLSGTIPPGIWS-LPNLSIIDLSTNQFE 386
L L N G + + + + N ++ I + L L +DL N
Sbjct: 317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT 375
Query: 387 GPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSG-QIPLDIGKLK 445
I S+ + L+ N+ LP + I LS N+ I + ++
Sbjct: 376 -----TIHFIPSIPDIFLSGNKLV-TLP---KINLTANLIHLSENRLENLDILYFLLRVP 426
Query: 446 KLSSLYLHDNMFSG-PLPYSIGSCVSLTDINFAQNSLSGKI-----PDSLGSLPSLNSLN 499
L L L+ N FS + SL + +N L D L L L
Sbjct: 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLY 486
Query: 500 LSNNKFSGEIP--ISLTYPKLSLLDLSNNQL 528
L++N + +P + L L L++N+L
Sbjct: 487 LNHNYLN-SLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-13
Identities = 46/255 (18%), Positives = 88/255 (34%), Gaps = 46/255 (18%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLH 108
LG + + GL + I+L N + + K +LQ LDL +N+ + + + +
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHFIPSIP 384
Query: 109 ELSF-----------------LNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFP 151
++ ++L+ + + L + +L+ L L N F
Sbjct: 385 DIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGD 444
Query: 152 MEVLKLEKLYWLYLTNCSVTGQIPEGI-----GNLTQLQNLELSDNELFGEIPAGIVK-L 205
+ L L+L + + L+ LQ L L+ N L +P G+ L
Sbjct: 445 QTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHL 503
Query: 206 NKLWQLELYNNSLSGRLPVGF--------------------SNLTNLMNFDVSQNRLEGD 245
L L L +N L+ L +L D++ N+ +
Sbjct: 504 TALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICE 562
Query: 246 LSELRFLNQLSSLHL 260
F+N L+ ++
Sbjct: 563 CELSTFINWLNHTNV 577
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 9e-42
Identities = 78/457 (17%), Positives = 151/457 (33%), Gaps = 27/457 (5%)
Query: 83 SCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGD 142
SC V D + SF+ +P + + L+L+ + I+ L NL+ L L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPS-GLTAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKS 59
Query: 143 NPF---DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFG-EI 198
+ + F L L L L++ ++ G L+ L+ L L N +
Sbjct: 60 SRINTIEGDAF----YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGV 115
Query: 199 PAGIVKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEG-DLSELRFLNQLS 256
+ L L L + N + F+ LT+L ++ L L+ + +
Sbjct: 116 TSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIH 175
Query: 257 SLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGP 316
L L ++ + + + L L L ++ +VS +
Sbjct: 176 HLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF------QFSPLPVDEVSSPMKKLA 229
Query: 317 IPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLS 376
+ + +LL L + +C N + G +
Sbjct: 230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289
Query: 377 IIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQ 436
+ + ++ + + + + N++ S SL + LS N +
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEE 349
Query: 437 I---PLDIGKLKKLSSLYLHDNMFS--GPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGS 491
G L +L L N + + +LT ++ ++N+ +PDS
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408
Query: 492 LPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQL 528
+ LNLS+ + + L +LD+SNN L
Sbjct: 409 PEKMRFLNLSSTGIR-VVKTCIP-QTLEVLDVSNNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-36
Identities = 97/491 (19%), Positives = 179/491 (36%), Gaps = 54/491 (10%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEG-LKSCTRLQVLDLGNNSFSGEVPD--LS 105
+ + + LQ + L ++ + TI S L+ LDL +N S +
Sbjct: 38 ITYIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFG 95
Query: 106 MLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYL 165
L L +LNL + NLTNL+ L +G+ ++ L L L +
Sbjct: 96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEI 155
Query: 166 TNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVG 225
S+ + + ++ + +L L +E + L+ + LEL + +L+
Sbjct: 156 KALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA------ 209
Query: 226 FSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLY 285
F S ++ S ++ L L + F+ E+ + L+E+
Sbjct: 210 --------RFQFSPLPVDEVSSPMKKLA-FRGSVLTDESFN-ELLKLLRYILELSEVEFD 259
Query: 286 TNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETY 345
L G + + DV L +T + L + Q + Y
Sbjct: 260 DCTLNGLG------DFNPSESDVVSELGKV-------ETVTIRRLHIPQFYLFYDLSTVY 306
Query: 346 ANCKSLIRFRVNNNSLSGTIPPGIWS-LPNLSIIDLSTNQFEGPVTDD---IGNAKSLAL 401
+ + + R V N+ + +P L +L +DLS N + G SL
Sbjct: 307 SLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365
Query: 402 LLLANNRFS--GELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSG 459
L+L+ N + + +L S+ +S N F +P +K+ L L
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR- 423
Query: 460 PLPYSIGSCV--SLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPK 517
+ +C+ +L ++ + N+L LP L L +S NK +P + +P
Sbjct: 424 ----VVKTCIPQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDASLFPV 474
Query: 518 LSLLDLSNNQL 528
L ++ +S NQL
Sbjct: 475 LLVMKISRNQL 485
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-17
Identities = 45/230 (19%), Positives = 82/230 (35%), Gaps = 30/230 (13%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD----L 104
L L+ +++I + + ++ + L+ LDL N E
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 105 SMLHELSFLNLNSSGISG-KFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWL 163
L L L+ + + + + L L NL L + N F P P EK+ +L
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF--HPMPDSCQWPEKMRFL 415
Query: 164 YLTNCSVTGQIPEGI------------------GNLTQLQNLELSDNELFGEIPAGIVKL 205
L++ + + I L +LQ L +S N+L +P
Sbjct: 416 NLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKL-KTLPDA-SLF 472
Query: 206 NKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRFLNQ 254
L +++ N L +P G F LT+L + N + + +L++
Sbjct: 473 PVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 521
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 29/134 (21%), Positives = 54/134 (40%), Gaps = 7/134 (5%)
Query: 404 LANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPY 463
+ F+ +PS ++ +++ S+ LS N+ + D+ L L L + +
Sbjct: 12 GRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68
Query: 464 SIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTY---PKLSL 520
+ S SL ++ + N LS G L SL LNL N + + ++ + L
Sbjct: 69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQT 127
Query: 521 LDLSNNQLAGPIPE 534
L + N + I
Sbjct: 128 LRIGNVETFSEIRR 141
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-40
Identities = 88/488 (18%), Positives = 171/488 (35%), Gaps = 77/488 (15%)
Query: 55 DSICGLQALQKINLGTNFLYGTITEG-----------LKSC--TRLQVLDLGNNSFSGEV 101
+++ + + G L+ C + L+L N S +
Sbjct: 28 VEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SL 86
Query: 102 PDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLY 161
P+L L L + + ++ + P + ++L +L + P L
Sbjct: 87 PEL--PPHLESLVASCNSLT-ELP-ELPQSLKSLLVDNNNLKALSDLP--------PLLE 134
Query: 162 WLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGR 221
+L ++N + ++PE + N + L+ +++ +N L ++P L + NN L
Sbjct: 135 YLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSL-KKLPDLPPSLEFIA---AGNNQLE-E 187
Query: 222 LPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTE 281
LP NL L N L+ L +L L S+ N E LT
Sbjct: 188 LPE-LQNLPFLTAIYADNNSLK-KLPDL--PLSLESIVAGNNILE--ELPELQNLPFLTT 241
Query: 282 LSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTV 341
+ N L TLP S ++V +N LT +P +T L V +N F+ +
Sbjct: 242 IYADNNLLK-TLPDLPPSL---EALNVRDNYLTD-LPELPQS---LTFLDVSENIFS-GL 292
Query: 342 PETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLAL 401
E +L ++N + ++ P+L +++S N+ + L
Sbjct: 293 SEL---PPNLYYLNASSNEIR-SLCD---LPPSLEELNVSNNKLIE-LPALPPR---LER 341
Query: 402 LLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPL 461
L+ + N + E+P +L + + N + P ++ L N +
Sbjct: 342 LIASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEV 391
Query: 462 PYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL-TYPKLSL 520
P + L ++ N L + PD S+ L +++ + + T KL
Sbjct: 392 PELPQN---LKQLHVETNPLR-EFPDIPESV---EDLRMNSERVVDPYEFAHETTDKLED 444
Query: 521 LDLSNNQL 528
++
Sbjct: 445 DVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 88/422 (20%), Positives = 134/422 (31%), Gaps = 83/422 (19%)
Query: 131 NLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNL--------- 181
+ T L+ + + P+E ++ Y P G G
Sbjct: 9 SNTFLQEPLRHSSNL--TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
Query: 182 ----TQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDV 237
Q LEL++ L +P L L NSL+ LP +L +L+ +
Sbjct: 67 DCLDRQAHELELNNLGL-SSLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNN 121
Query: 238 SQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKL 297
+ L L L + NQ ++PE L + + N L LP
Sbjct: 122 NLKALSD------LPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLP 172
Query: 298 GSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVN 357
S ++ N L P++ N L +
Sbjct: 173 PS---LEFIAAGNNQLE--ELPELQ------------------------NLPFLTAIYAD 203
Query: 358 NNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKI 417
NNSL +P +L I N E ++ N L + NN LP
Sbjct: 204 NNSLK-KLPD---LPLSLESIVAGNNILEEL--PELQNLPFLTTIYADNNLLK-TLPDLP 256
Query: 418 SEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFA 477
SL ++ + N + +P L L + L + L +N +
Sbjct: 257 P---SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSG----LSELPPN---LYYLNAS 305
Query: 478 QNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLN 537
N + + D PSL LN+SNNK E+P P+L L S N LA P N
Sbjct: 306 SNEIR-SLCDLP---PSLEELNVSNNKLI-ELPALP--PRLERLIASFNHLAEVPELPQN 358
Query: 538 IK 539
+K
Sbjct: 359 LK 360
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-34
Identities = 80/366 (21%), Positives = 126/366 (34%), Gaps = 48/366 (13%)
Query: 174 IPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLM 233
I + T LQ + L E+P + + + P G +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 234 NFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTL 293
+ Q L L S +PE HL L N LT L
Sbjct: 62 VSRLRDCL----------DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-EL 106
Query: 294 PQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIR 353
P+ S + + L+ +PP + L + NN +PE N L
Sbjct: 107 PELPQSLKSLLVDNNNLKALSD-LPPLLEY-------LGVSNNQLEKLPE-LQNSSFLKI 157
Query: 354 FRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGEL 413
V+NNSL +P P+L I NQ E ++ N L + NN +L
Sbjct: 158 IDVDNNSLK-KLPD---LPPSLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLK-KL 210
Query: 414 PSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTD 473
P SL SI N ++P ++ L L+++Y +N+ LP SL
Sbjct: 211 PDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDLPP---SLEA 261
Query: 474 INFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIP 533
+N N L+ +P+ SL L+ + S P L L+ S+N++
Sbjct: 262 LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELP------PNLYYLNASSNEIRSLCD 314
Query: 534 EPLNIK 539
P +++
Sbjct: 315 LPPSLE 320
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-22
Identities = 58/302 (19%), Positives = 105/302 (34%), Gaps = 58/302 (19%)
Query: 54 FDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFL 113
+ L L I N L + + S L+ + GNN E+P+L L L+ +
Sbjct: 188 LPELQNLPFLTAIYADNNSL-KKLPDLPLS---LESIVAGNNILE-ELPELQNLPFLTTI 242
Query: 114 NLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTG- 172
+++ + P + +LE L++ DN + P L L ++
Sbjct: 243 YADNNLLK-TLP----DLPPSLEALNVRDNYL--TDLPELPQSLTFLDVSENIFSGLSEL 295
Query: 173 ------------QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSG 220
+I L+ L +S+N+L E+PA +L +L N L+
Sbjct: 296 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLERLI---ASFNHLA- 350
Query: 221 RLPVGFSNLTNLMNFDVSQNRLE------GDLSELRFLNQLSSLHLFENQFSGEIPEEFG 274
+P NL L V N L + +LR + L+ + PE
Sbjct: 351 EVPELPQNLKQL---HVEYNPLREFPDIPESVEDLRMNSHLAEV-----------PELPQ 396
Query: 275 EFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQ 334
+L +L + TN L P S + ++ + +T + V +
Sbjct: 397 ---NLKQLHVETNPLR-EFPDIPES---VEDLRMNSERVV-DPYEFAHETTDKLEDDVFE 448
Query: 335 NN 336
++
Sbjct: 449 HH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 32/174 (18%), Positives = 58/174 (33%), Gaps = 36/174 (20%)
Query: 63 LQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISG 122
L +N +N I L+ L++ NN E+P L L L + + ++
Sbjct: 299 LYYLNASSN----EIRSLCDLPPSLEELNVSNNKLI-ELPAL--PPRLERLIASFNHLA- 350
Query: 123 KFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLT 182
+ P E NL+ L + NP FP +E L N + ++PE NL
Sbjct: 351 EVP----ELPQNLKQLHVEYNPL--REFPDIPESVEDLR----MNSHLA-EVPELPQNLK 399
Query: 183 -----------------QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLS 219
+++L ++ + +KL ++
Sbjct: 400 QLHVETNPLREFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 48/342 (14%), Positives = 97/342 (28%), Gaps = 28/342 (8%)
Query: 157 LEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNN 216
LY + + + + N + + N
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGR 66
Query: 217 SLSGRLPVGFSNLT--NLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFG 274
+L + T + ++ L + L+ L + + E+P+
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ 124
Query: 275 EFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQ 334
+F L L+L N L LP + S + + +P +
Sbjct: 125 QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA------------ 171
Query: 335 NNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIG 394
+ + +L R+ + ++P I +L NL + + + + I
Sbjct: 172 ---STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIH 226
Query: 395 NAKSLALLLLANNRFSGELPSKISEASSLVSIQLS-LNQFSGQIPLDIGKLKKLSSLYLH 453
+ L L L P + L + L + +PLDI +L +L L L
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLR 285
Query: 454 DNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSL 495
+ LP I + I + + + P+
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 54/322 (16%), Positives = 97/322 (30%), Gaps = 23/322 (7%)
Query: 75 GTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLT 133
G+ + + L ++ D LS + N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRN-----RWHSAWRQANSN 56
Query: 134 NLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNE 193
N + + + +E L L + + Q P+ L+ LQ++ +
Sbjct: 57 NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 194 LFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVS-QNRLE--------- 243
L E+P + + L L L N L LP ++L L + L
Sbjct: 116 L-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 244 GDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADF 303
E + L L SL L +P ++L L + + L+ L +
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231
Query: 304 NYVDVSE-NLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLS 362
+D+ L PP + L++ + T+P L + +
Sbjct: 232 EELDLRGCTALRN-YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290
Query: 363 GTIPPGIWSLPNLSIIDLSTNQ 384
+P I LP II + +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-39
Identities = 51/360 (14%), Positives = 101/360 (28%), Gaps = 51/360 (14%)
Query: 172 GQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTN 231
G + + +NL + + + + + + + R N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 232 LMNFDVSQNRLEGDLSELRFLNQ--LSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRL 289
+ L+ L Q +L L + P++ HL +++ L
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116
Query: 290 TGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCK 349
LP + +A + ++ N L +P + A+
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLR-------------------------ALPASIASLN 150
Query: 350 SLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRF 409
L + +P + S + +L L L
Sbjct: 151 RLRELSIRACPELTELPEPLASTDAS---------------GEHQGLVNLQSLRLEWTGI 195
Query: 410 SGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCV 469
LP+ I+ +L S+++ + S + I L KL L L P G
Sbjct: 196 R-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253
Query: 470 SLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQL 528
L + S +P + L L L+L +P + P ++ + +
Sbjct: 254 PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 43/254 (16%), Positives = 81/254 (31%), Gaps = 37/254 (14%)
Query: 55 DSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFL 113
D L LQ + + L + + ++ L+ L L N +P ++ L+ L L
Sbjct: 98 DQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155
Query: 114 NLNS--------SGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYL 165
++ + ++ + L NL+ L L P + L+ L L +
Sbjct: 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI--RSLPASIANLQNLKSLKI 213
Query: 166 TNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVG 225
N ++ + I +L +L+ L+L P L +L L + S LP+
Sbjct: 214 RNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD 272
Query: 226 FSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLY 285
LT L D+ LS L P + + +
Sbjct: 273 IHRLTQLEKLDLRGC------------VNLSRL-----------PSLIAQLPANCIILVP 309
Query: 286 TNRLTGTLPQKLGS 299
+ + +
Sbjct: 310 PHLQAQLDQHRPVA 323
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 64/286 (22%), Positives = 114/286 (39%), Gaps = 46/286 (16%)
Query: 632 KPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
K + IG+G VYK + + E+A + L+K + +
Sbjct: 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCEL-------------QDRKLTKSERQRFK-- 73
Query: 691 AEVATLSAVRHVNVVKLYCS---ITSEDSNLLVY-EYLPNGSLWDRLHTCHKIEMDWVVR 746
E L ++H N+V+ Y S +++ E + +G+L L +++ +
Sbjct: 74 EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS 133
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD-LEWKPRIADFGLAKIVQTGEAGDL 805
+ + KGL++LH P+IHRD+K NI + +I D GLA + +
Sbjct: 134 WCRQI--LKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASF 186
Query: 806 THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865
+ GT ++APE Y K +E DVY+FG+ ++E+ T + P YS
Sbjct: 187 AKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP---------------YS 230
Query: 866 KMDS-RDSMLTVVDPNISEILKEDALKVLR-IAIHCTNKLPAFRPS 909
+ + V + A+ ++ I C + R S
Sbjct: 231 ECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-37
Identities = 76/486 (15%), Positives = 142/486 (29%), Gaps = 35/486 (7%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLH 108
L +++++L N L L T+L++L+L +N E DL L
Sbjct: 22 LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDLESLS 80
Query: 109 ELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNC 168
L L+LN++ + L ++E L +N + +YL N
Sbjct: 81 TLRTLDLNNNYVQ------ELLVGPSIETLHAANNNISRVSCSR----GQGKKNIYLANN 130
Query: 169 SVTGQIPEGIGNLTQLQNLELSDNELFG-EIPAGIVKLNKLWQLELYNNSLSGRLPVGFS 227
+T G +++Q L+L NE+ + L L L N + +
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-V 188
Query: 228 NLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTN 287
L D+S N+L E + ++ + L N+ I + ++L L N
Sbjct: 189 VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
Query: 288 RL-TGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYA 346
GTL V + + + L +P +A
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKK---LTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304
Query: 347 -NCKSLIRFRVNNNSLSG----TIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLAL 401
+L R S G + + ID Q+ + ++
Sbjct: 305 DRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKIT 364
Query: 402 LLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPL 461
L ++ + + L ++ + L L +
Sbjct: 365 LEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYE--- 420
Query: 462 PYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLL 521
+ QN+ L N K +GE ++L +L
Sbjct: 421 -------EMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQ 473
Query: 522 DLSNNQ 527
+L +
Sbjct: 474 ELVVRE 479
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-36
Identities = 62/382 (16%), Positives = 127/382 (33%), Gaps = 26/382 (6%)
Query: 157 LEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNN 216
+ +T+ S+ + + ++ L+LS N L A + KL L L +N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 217 SLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEF 276
L L +L+ L D++ N + EL + +LH N S +
Sbjct: 69 VLYETLD--LESLSTLRTLDLNNNY----VQELLVGPSIETLHAANNNIS-RVSCSR--G 119
Query: 277 KHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL--LVLQ 334
+ + L N++T G + Y+D+ N + ++ + L L LQ
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL--AASSDTLEHLNLQ 177
Query: 335 NNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIG 394
NF V L +++N L+ + P S ++ I L N+ + +
Sbjct: 178 YNFIYDVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALR 234
Query: 395 NAKSLALLLLANNRFS-GELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLH 453
+++L L N F G L S+ + + ++ + + + +
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT--VAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 454 DNMFSGPLPYSIGSCVSLTDINFAQNSLSG----KIPDSLGSLPSLNSLNLSNNKFSGEI 509
++L A S G ++ + ++ ++ +
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TV 351
Query: 510 PISLTYPKLSL--LDLSNNQLA 529
+T K + L+ L
Sbjct: 352 IDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-36
Identities = 60/480 (12%), Positives = 126/480 (26%), Gaps = 84/480 (17%)
Query: 77 ITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNL 135
I E ++ R ++ + ++S + + L+L+ + +S L T L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-ISAADLAPFTKL 60
Query: 136 EFLSLGDNPF-DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNEL 194
E L+L N + L L L L N V + ++ L ++N +
Sbjct: 61 ELLNLSSNVLYETLDLE----SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 195 FGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEG--DLSELRFL 252
+ + L NN ++ + + + D+ N ++
Sbjct: 112 -SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 253 NQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENL 312
+ L L+L N ++ + F L L L +N+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA---------------------- 204
Query: 313 LTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSL 372
+ + + + + NN L I +
Sbjct: 205 ---------------------------FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236
Query: 373 PNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQ 432
NL DL N F D +K+ + +A E +
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295
Query: 433 FSGQIPLDIGKLKKLSSLYLHDNMF-------SGPLPYSIGSCVSLTDINFAQNSLSGKI 485
L +L +L ++ + L + +I+ + I
Sbjct: 296 CE---DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352
Query: 486 PDSLGSLPSLNSLNLSNNKFSGEIPISLTY----PKLSLLDLSNNQLAGPIPEPLNIKAF 541
+ +L ++ + +L E ++
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLL 412
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 60/293 (20%), Positives = 115/293 (39%), Gaps = 54/293 (18%)
Query: 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA--- 691
IG GGS V++V+ + A+K ++ + + D+
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIK------------------YVNLEEADNQTLDSYRN 75
Query: 692 EVATLSAVRH--VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
E+A L+ ++ +++LY ++ +V E N L L I+ Y
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK 134
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
+ + + +H ++H D+K +N L+ + ++ DFG+A +Q +
Sbjct: 135 NM--LEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 810 AGTHGYIAPE-----------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858
GT Y+ PE KI+ KSDV+S G +L + GK P F +
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIIN 244
Query: 859 IVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
++ +++ +D + +I ++D VL+ C + P R S+
Sbjct: 245 QISKLHAIIDPN------HEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIP 288
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 63/292 (21%), Positives = 120/292 (41%), Gaps = 52/292 (17%)
Query: 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE-YDAEV 693
IG GGS V++V+ + A+K++ L + +++ + Y E+
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYV----------------NLEEADNQTLDSYRNEI 58
Query: 694 ATLSAVRH--VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
A L+ ++ +++LY ++ +V E N L L I+ Y +
Sbjct: 59 AYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM 117
Query: 752 GAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ + +H HG ++H D+K +N L+ + ++ DFG+A +Q +
Sbjct: 118 --LEAVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 811 GTHGYIAPE-----------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859
GT Y+ PE KI+ KSDV+S G +L + GK P F +
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQ 226
Query: 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
++ +++ +D + +I ++D VL+ C + P R S+
Sbjct: 227 ISKLHAIIDPN------HEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIP 269
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 71/295 (24%), Positives = 117/295 (39%), Gaps = 63/295 (21%)
Query: 631 VKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEY 689
+G+GG V V L+ G A+K I + ++ R E
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI----------------LCHEQQDRE-EA 73
Query: 690 DAEVATLSAVRHVNVVKLYCSITSEDSN----LLVYEYLPNGSLWDRLHTCHK----IEM 741
E H N+++L E L+ + G+LW+ + +
Sbjct: 74 QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133
Query: 742 DWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG- 800
D ++ + +G +GLE +H + HRD+K +NILL E +P + D G
Sbjct: 134 DQILW--LLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188
Query: 801 ----EAGDLTHVIA--GTHGYIAPE----YAYTCKINEKSDVYSFGVVLMELVTGKRP-- 848
+A L A T Y APE ++ C I+E++DV+S G VL ++ G+ P
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSH-CVIDERTDVWSLGCVLYAMMFGEGPYD 247
Query: 849 IVPEFGDSKDIV---------NWVYSKMDSRD---SMLTVVDP----NISEILKE 887
+V + GDS + + +S SM+T VDP +I +L +
Sbjct: 248 MVFQKGDSVALAVQNQLSIPQSPRHSS-ALWQLLNSMMT-VDPHQRPHIPLLLSQ 300
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-35
Identities = 60/291 (20%), Positives = 117/291 (40%), Gaps = 50/291 (17%)
Query: 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE-YDAEV 693
IG GGS V++V+ + A+K++ L + +++ + Y E+
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYV----------------NLEEADNQTLDSYRNEI 105
Query: 694 ATLSAVRH--VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
A L+ ++ +++LY ++ +V E N L L I+ Y +
Sbjct: 106 AYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM 164
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
+ + +H ++H D+K +N L+ + ++ DFG+A +Q + G
Sbjct: 165 --LEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 812 THGYIAPE-----------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860
Y+ PE KI+ KSDV+S G +L + GK P F + +
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQI 274
Query: 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
+ +++ +D + +I ++D VL+ C + P R S+
Sbjct: 275 SKLHAIIDPN------HEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIP 316
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-35
Identities = 71/372 (19%), Positives = 126/372 (33%), Gaps = 46/372 (12%)
Query: 84 CTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDN 143
VL++G + + +PD + ++ L + + ++ P L L + N
Sbjct: 39 NNGNAVLNVGESGLT-TLPD-CLPAHITTLVIPDNNLT-SLP----ALPPELRTLEVSGN 91
Query: 144 PFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIV 203
+ P+ L +L + + L L + N+L +P
Sbjct: 92 QL--TSLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQL-TSLPVLPP 141
Query: 204 KLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFEN 263
L +L + +N L+ LP S L L N+L L L + L L + +N
Sbjct: 142 GLQELS---VSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPML--PSGLQELSVSDN 191
Query: 264 QFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCK 323
Q + +P L +L Y NRLT +LP + VS N LT +P
Sbjct: 192 QLA-SLPTLPS---ELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLTS-LPVLP-- 240
Query: 324 TGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTN 383
+ +L ++ N ++P + SL V N L+ +P + L + + ++L N
Sbjct: 241 -SELKEL-MVSGNRLTSLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 384 QFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGK 443
+ S RF S E +L + + +
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL--HLAAADWLVPAREGEPAP 352
Query: 444 LKKLSSLYLHDN 455
+ DN
Sbjct: 353 ADRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-34
Identities = 71/348 (20%), Positives = 126/348 (36%), Gaps = 69/348 (19%)
Query: 181 LTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQN 240
L + ++ L +P + + L + +N+L+ LP L L
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTL-------- 86
Query: 241 RLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSW 300
++S NQL+SL P L+ S L LP L
Sbjct: 87 ----EVSG----NQLTSL-----------PVLPPGLLELSIFSNPLTHLP-ALPSGLCK- 125
Query: 301 ADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNS 360
+ + N LT +P + +L V N ++P + L NN
Sbjct: 126 -----LWIFGNQLTS-LPVLP---PGLQELSVSDNQLA-SLPALPSELCKL---WAYNNQ 172
Query: 361 LSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEA 420
L+ ++P L + +S NQ + L NNR + LP+ S
Sbjct: 173 LT-SLPM---LPSGLQELSVSDNQLAS-LPTLPSELYKLWAY---NNRLT-SLPALPS-- 221
Query: 421 SSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNS 480
L + +S N+ + +P+ +LK+L + N + LP +SL + +N
Sbjct: 222 -GLKELIVSGNRLT-SLPVLPSELKEL---MVSGNRLTS-LPMLPSGLLSL---SVYRNQ 272
Query: 481 LSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQL 528
L+ ++P+SL L S ++NL N S E + +++ + +
Sbjct: 273 LT-RLPESLIHLSSETTVNLEGNPLS-ERTLQA-LREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-32
Identities = 79/400 (19%), Positives = 131/400 (32%), Gaps = 68/400 (17%)
Query: 152 MEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQL 211
M L + +T +P+ + + L + DN L +PA +L L
Sbjct: 34 MRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNL-TSLPALPPELRTL--- 86
Query: 212 ELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPE 271
E+ N L+ LPV L L F L S L L +F NQ + +P
Sbjct: 87 EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLC------KLWIFGNQLT-SLPV 138
Query: 272 EFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLL 331
L ELS+ N+L +LP + L
Sbjct: 139 LPP---GLQELSVSDNQLA-SLPALPSE---------------------------LCKLW 167
Query: 332 VLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTD 391
N ++P + + L V++N L+ ++P L L N+ +
Sbjct: 168 AYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLPA 218
Query: 392 DIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLY 451
L L+++ NR + LP S L + +S N+ + +P+ L SL
Sbjct: 219 LPSG---LKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLT-SLPMLPSGLL---SLS 267
Query: 452 LHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPI 511
++ N + LP S+ S T +N N LS + +L + S + +F
Sbjct: 268 VYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGA- 325
Query: 512 SLTYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGL 551
S +L + + L F
Sbjct: 326 SAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 6e-26
Identities = 69/324 (21%), Positives = 110/324 (33%), Gaps = 39/324 (12%)
Query: 60 LQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSG 119
L+ + + N L ++ L + L L + L S
Sbjct: 80 PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLW-IFGNQLTS-- 135
Query: 120 ISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIG 179
P L+ LS+ DN + P +L K L+ N +T +P
Sbjct: 136 ----LP----VLPPGLQELSVSDNQL--ASLPALPSELCK---LWAYNNQLT-SLPMLPS 181
Query: 180 NLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQ 239
L + L +SDN+L +P +L KLW YNN L+ LP S L L VS
Sbjct: 182 GLQE---LSVSDNQL-ASLPTLPSELYKLW---AYNNRLT-SLPALPSGLKEL---IVSG 230
Query: 240 NRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGS 299
NRL L L ++L L + N+ + +P L LS+Y N+LT LP+ L
Sbjct: 231 NRLT-SLPVL--PSELKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIH 282
Query: 300 WADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNN 359
+ V++ N L+ + + + F+ ++L +
Sbjct: 283 LSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH--LAAAD 340
Query: 360 SLSGTIPPGIWSLPNLSIIDLSTN 383
L + N
Sbjct: 341 WLVPAREGEPAPADRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 38/233 (16%), Positives = 72/233 (30%), Gaps = 34/233 (14%)
Query: 60 LQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSG 119
LQ++++ N L ++ +L + S L L +S L S
Sbjct: 180 PSGLQELSVSDNQL-ASLPTLPSELYKLWAYNNRLTSLPALPSGLKELI-VSGNRLTS-- 235
Query: 120 ISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIG 179
P + L+ L + N + PM L L + +T ++PE +
Sbjct: 236 ----LP----VLPSELKELMVSGNRL--TSLPML---PSGLLSLSVYRNQLT-RLPESLI 281
Query: 180 NLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQ 239
+L+ + L N L E + ++ Y+ + G S ++
Sbjct: 282 HLSSETTVNLEGNPL-SERTLQAL--REITSAPGYSGPIIRFDMAGASAPRETRALHLAA 338
Query: 240 NRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGT 292
E H+F + + SL+ +RL+ T
Sbjct: 339 ADWLVPAREGE-PAPADRWHMFGQE------------DNADAFSLFLDRLSET 378
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 67/279 (24%), Positives = 108/279 (38%), Gaps = 52/279 (18%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
IG G G K+ + GK L K + +++ + +EV
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKEL-------------DYGSMTEAEKQMLV--SEVN 57
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLL--VYEYLPNGSLWDRLHTCHK----IEMDWVVRYA 748
L ++H N+V+ Y I + L V EY G L + K ++ ++V+R
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 749 IAVGAAKGLEYLH--HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
+ L+ H V+HRD+K +N+ LD + ++ DFGLA+I+
Sbjct: 118 TQL--TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFA 173
Query: 807 HVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEF-GDS-----KDIV 860
GT Y++PE NEKSD++S G +L EL P F S I
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELAGKIR 229
Query: 861 NWVYSKMDSR---------DSMLTVVDPN----ISEILK 886
+ ++ R ML + + EIL+
Sbjct: 230 EGKFRRIPYRYSDELNEIITRMLN-LKDYHRPSVEEILE 267
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 68/309 (22%), Positives = 129/309 (41%), Gaps = 50/309 (16%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
IG+G G V G++ +K I + + +S + S EVA
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEI-------------NISRMSSKEREESR--REVA 75
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK--IEMDWVVRYAIAVG 752
L+ ++H N+V+ S S +V +Y G L+ R++ + D ++ + + +
Sbjct: 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI- 134
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGT 812
L+++H DR ++HRD+KS NI L + ++ DFG+A+++ + +L GT
Sbjct: 135 -CLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--ELARACIGT 188
Query: 813 HGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS------KDIVNWVYSK 866
Y++PE N KSD+++ G VL EL T K F I++ +
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA----FEAGSMKNLVLKIISGSFPP 244
Query: 867 MDSR---------DSMLTVVDPN----ISEILKEDALKVLRIAIHCTNKLPAFRPSMRVV 913
+ + +P ++ IL++ + RI + +L A ++
Sbjct: 245 VSLHYSYDLRSLVSQLFK-RNPRDRPSVNSILEKGFIA-KRIEKFLSPQLIAEEFCLKTF 302
Query: 914 VQMLEEAEP 922
+ + P
Sbjct: 303 SKFGSQPIP 311
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-34
Identities = 77/407 (18%), Positives = 148/407 (36%), Gaps = 55/407 (13%)
Query: 128 SLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQN 186
+L+ + + D F E + L + N ++ ++P + + Q++
Sbjct: 16 NLQYDCVFYDVHIDMQTQD-VYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVEL 73
Query: 187 LELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEG 244
L L+D ++ EI + + +L + N++ LP F N+ L + +N L
Sbjct: 74 LNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 245 DLSE--LRFLNQLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSWA 301
L +L++L + N I ++ F L L L +NRLT + L
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 186
Query: 302 DFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSL 361
+ +VS NLL+ P + L +N V L ++ +N+L
Sbjct: 187 SLFHANVSYNLLSTLAIPIAVEE------LDASHNSINVVRG--PVNVELTILKLQHNNL 238
Query: 362 SGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEAS 421
T + + P L +DLS N+ E + + L L ++NNR L
Sbjct: 239 --TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 422 SLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSL 481
+L + LS N + + + +L +LYL N S+ +
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN--------------SIVTLKL----- 335
Query: 482 SGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQL 528
+ +L +L LS+N + + + ++ + +
Sbjct: 336 --------STHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQ 373
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 78/412 (18%), Positives = 133/412 (32%), Gaps = 76/412 (18%)
Query: 60 LQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNS 117
L + + + + L S ++++L+L + E+ + H + L +
Sbjct: 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 102
Query: 118 SGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEG 177
+ I P +N+ L L L N +P G
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS--------------------------SLPRG 135
Query: 178 I-GNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNF 235
I N +L L +S+N L I L L+L +N L+ V S + +L +
Sbjct: 136 IFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHA 191
Query: 236 DVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQ 295
+VS N LS L + L N + + LT L L N LT
Sbjct: 192 NVSYNL----LSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW 243
Query: 296 KLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFR 355
L ++ VD+S N L I + + L R
Sbjct: 244 -LLNYPGLVEVDLSYNELEK-IMYH-----------------------PFVKMQRLERLY 278
Query: 356 VNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPS 415
++NN L + +P L ++DLS N V + L L L +N L
Sbjct: 279 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKL 335
Query: 416 KISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGS 467
+L ++ LS N + + + ++ + D + Y +
Sbjct: 336 STH--HTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 52/335 (15%), Positives = 117/335 (34%), Gaps = 21/335 (6%)
Query: 198 IPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEG-DLSELRFLNQLS 256
I + + + + + + L N + + + L Q+
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 257 SLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315
L+L + Q EI F + +L + N + P + + + N L+
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 316 PIPPDM-CKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPN 374
+P + T +T L + NN +T+ SL ++++N L+ + + +P+
Sbjct: 132 -LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPS 187
Query: 375 LSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFS 434
L ++S N + ++ L ++N + + ++ L ++L N +
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT 239
Query: 435 GQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPS 494
+ L + L N + + L + + N L + +P+
Sbjct: 240 -DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 296
Query: 495 LNSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQL 528
L L+LS+N + + +L L L +N +
Sbjct: 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 330
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 48/300 (16%), Positives = 106/300 (35%), Gaps = 46/300 (15%)
Query: 234 NFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTL 293
N Q + S L++ +H+ E + ++ + +
Sbjct: 2 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR--- 58
Query: 294 PQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL--LVLQNNFNGTVP-ETYANCKS 350
+ LL + L L + + +A +
Sbjct: 59 -------------KLPAALLDS-----------FRQVELLNLNDLQIEEIDTYAFAYAHT 94
Query: 351 LIRFRVNNNSLSGTIPPGI-WSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRF 409
+ + + N++ +PP + ++P L+++ L N N L L ++NN
Sbjct: 95 IQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL 153
Query: 410 SGELPSKI-SEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSC 468
+ +SL ++QLS N+ + +D+ + L + N+ S ++
Sbjct: 154 E-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIP 204
Query: 469 VSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQL 528
+++ +++ + NS++ + L L L +N + + L YP L +DLS N+L
Sbjct: 205 IAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNEL 260
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 28/140 (20%), Positives = 47/140 (33%), Gaps = 30/140 (21%)
Query: 55 DSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLN 114
+ L +++L N L + RL+ L + NN L LN
Sbjct: 242 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN-------------RLVALN 288
Query: 115 LNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQI 174
L + + L+ L L N + ++L LYL + S+ +
Sbjct: 289 L------------YGQPIPTLKVLDLSHNHL--LHVERNQPQFDRLENLYLDHNSIV-TL 333
Query: 175 PEGIGNLTQLQNLELSDNEL 194
+ L+NL LS N+
Sbjct: 334 K--LSTHHTLKNLTLSHNDW 351
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 63/283 (22%), Positives = 110/283 (38%), Gaps = 53/283 (18%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
LIG GG G V+K GK +K + + + EV
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVK----------------YNNEKAER-----EV 55
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNL----------------LVYEYLPNGSLWDRLHTCH 737
L+ + HVN+V D + + E+ G+L +
Sbjct: 56 KALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 115
Query: 738 KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
++D V+ + KG++Y+H + +I+RD+K SNI L + +I DFGL +
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
Query: 798 QTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857
+ G T GT Y++PE + ++ D+Y+ G++L EL+
Sbjct: 173 KND--GKRTRSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT 229
Query: 858 DIVNWVYSKMDSRD------SMLTVVD---PNISEILKEDALK 891
D+ + + S + + +L+ PN SEIL+ +
Sbjct: 230 DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 65/302 (21%), Positives = 117/302 (38%), Gaps = 46/302 (15%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
IG+G VY+ L G +A+K + ++ E+
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKV---------QIFDLMDAKARADCIK-----EID 84
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEM----DWVVRYAIA 750
L + H NV+K Y S ++ +V E G L + K + V +Y +
Sbjct: 85 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ LE++H R V+HRD+K +N+ + ++ D GL + + H +
Sbjct: 145 L--CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLV 197
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD----IVNWVYSK 866
GT Y++PE + N KSD++S G +L E+ + P + + I Y
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 257
Query: 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVT 926
+ S + SE L++ + C N P RP + V + + C+ +
Sbjct: 258 LPS---------DHYSEELRQ-------LVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301
Query: 927 NI 928
++
Sbjct: 302 SL 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 57/298 (19%), Positives = 110/298 (36%), Gaps = 67/298 (22%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
+G+GG G V++ A+K I L R + EV
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRI----------------RLPNRELAREKVMREVK 55
Query: 695 TLSAVRHVNVVKLYCSITSEDS---------NLLVY---EYLPNGSLWDRLHT-CHKIEM 741
L+ + H +V+ + + +++ + +Y + +L D ++ C E
Sbjct: 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 742 DWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGE 801
+ V I + A+ +E+LH + ++HRD+K SNI ++ ++ DFGL + E
Sbjct: 116 ERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 802 AGDLTHVIA----------GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
GT Y++PE + + K D++S G++L EL + P
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL------LYP 226
Query: 852 EFGDS------KDIVNWVYSKMDSRDS---------MLTVVD---PNISEILKEDALK 891
D+ N + + ++ ML+ P I++ +
Sbjct: 227 FSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 68/302 (22%), Positives = 111/302 (36%), Gaps = 65/302 (21%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++G+G G V K + A+K I + S +EV
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKI------------------RHTEEKLSTILSEVM 54
Query: 695 TLSAVRHVNVVKLYCSITSEDSNL-------------LVYEYLPNGSLWDRLHTC-HKIE 740
L+++ H VV+ Y + + + + EY NG+L+D +H+ +
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 741 MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG 800
D R + + L Y+H + +IHRD+K NI +D +I DFGLAK V
Sbjct: 115 RDEYWRLFRQI--LEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 801 EA------------GDLTHVIAGTHGYIAPE-YAYTCKINEKSDVYSFGVVLMELVTGKR 847
D GT Y+A E T NEK D+YS G++ E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-- 227
Query: 848 PIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFR 907
G + + K+ S P+ + + K++R + P R
Sbjct: 228 ---FSTGMERVN---ILKKLRSVSIEF---PPDFDDNKMKVEKKIIR---LLIDHDPNKR 275
Query: 908 PS 909
P
Sbjct: 276 PG 277
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 60/327 (18%), Positives = 115/327 (35%), Gaps = 63/327 (19%)
Query: 597 KLKQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKE 655
KL++ + + + + + + +E + + + +G+G G V+++ +G +
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 656 LAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSED 715
AVK + L E+ + + +V LY ++
Sbjct: 86 CAVKKV----------------RLEVFRVE------ELVACAGLSSPRIVPLYGAVREGP 123
Query: 716 SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKS 775
+ E L GSL + + D + Y +GLEYLH R ++H DVK+
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA--LEGLEYLH---TRRILHGDVKA 178
Query: 776 SNILLDLE-WKPRIADFGLAKIVQTGEAGDLT---HVIAGTHGYIAPE----YAYTCKIN 827
N+LL + + + DFG A +Q G I GT ++APE
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA--- 235
Query: 828 EKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVD-----PNIS 882
K D++S +++ ++ G P +++ L + I
Sbjct: 236 -KVDIWSSCCMMLHMLNGCHP---------------WTQYFRGPLCLKIASEPPPIREIP 279
Query: 883 EILKEDALKVLRIAIHCTNKLPAFRPS 909
+ ++ K P R S
Sbjct: 280 PSCAPLTAQAIQ---EGLRKEPVHRAS 303
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 72/281 (25%), Positives = 125/281 (44%), Gaps = 46/281 (16%)
Query: 636 LIGKGGSGNVYK---VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSK--RSSRSSEYD 690
+G GG VY +LN ++A+K I R L + R +
Sbjct: 18 KLGGGGMSTVYLAEDTILN--IKVAIKAI-------FIPPREKEETLKRFEREVHN---- 64
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
+ LS H N+V + +D LV EY+ +L + + + + +D + +
Sbjct: 65 --SSQLS---HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQ 119
Query: 751 VGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
+ +++ H ++HRD+K NIL+D +I DFG+AK + + + T+ +
Sbjct: 120 ILDG--IKHAHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHV 172
Query: 810 AGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEF-GDSKDIVNWVYSKM- 867
GT Y +PE A +E +D+YS G+VL E++ G+ P F G++ V+ +
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGETA--VSIAIKHIQ 226
Query: 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP 908
DS ++ T V +I + L + +LR T K A R
Sbjct: 227 DSVPNVTTDVRKDIPQSL--SNV-ILR----ATEKDKANRY 260
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 57/276 (20%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA--- 691
+GKGG +++ ++ + A K I+ K
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGK------------------IVPKSLLLKPHQREKMS 63
Query: 692 -EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
E++ ++ H +VV + D +V E SL + + + RY
Sbjct: 64 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT-EPEARY-YL 121
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
G +YLH VIHRD+K N+ L+ + + +I DFGLA V+ G+ V+
Sbjct: 122 RQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLC 176
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM--- 867
GT YIAPE + + DV+S G ++ L+ GK P F ++ + Y ++
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP----F-ETSCLKE-TYLRIKKN 230
Query: 868 ----------DSRD---SMLTVVDPN----ISEILK 886
+ ML DP I+E+L
Sbjct: 231 EYSIPKHINPVAASLIQKML-QTDPTARPTINELLN 265
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-33
Identities = 46/233 (19%), Positives = 93/233 (39%), Gaps = 19/233 (8%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL 696
+ +G + K A+K S + D+ S S+ ++ E+ +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 697 SAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA--- 753
+ +++ + IT+ D ++YEY+ N S+ ++ ++ I V
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 754 ---AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
Y+H+ ++ + HRDVK SNIL+D + +++DFG ++ +
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSR 211
Query: 811 GTHGYIAPE--YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861
GT+ ++ PE + K D++S G+ L + P F +V
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVE 260
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-32
Identities = 81/447 (18%), Positives = 151/447 (33%), Gaps = 72/447 (16%)
Query: 88 QVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDP 147
+ + + L L+ L+ ++S I+ +E LT L L N
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM---TGIEKLTGLTKLICTSNNITT 78
Query: 148 SPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNK 207
+ L +L + +T + + LT+L L N+L ++ +
Sbjct: 79 LDL----SQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL-TKLDVS--QNPL 128
Query: 208 LWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSG 267
L L N+L+ + S+ T L D N+ ++ QL++L N+ +
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCSFNKIT- 183
Query: 268 EIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAM 327
E+ + K L L+ TN +T L L ++D S N LT
Sbjct: 184 ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT------------- 225
Query: 328 TDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEG 387
+ T L F + N L+ + + +L L+ +
Sbjct: 226 ------------EIDVT--PLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL- 267
Query: 388 PVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKL 447
D+ + L R EL ++ + L + + LD+ + KL
Sbjct: 268 --EIDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKL 320
Query: 448 SSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSG 507
LYL++ + L + L ++ + S+G +P+LN+ + +
Sbjct: 321 VYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTIT 375
Query: 508 EIPISLTYPKLS------LLDLSNNQL 528
+LT L+ LLD N +
Sbjct: 376 MPKETLTNNSLTIAVSPDLLDQFGNPM 402
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-30
Identities = 80/486 (16%), Positives = 155/486 (31%), Gaps = 69/486 (14%)
Query: 56 SICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNL 115
S L L ++ + + T G++ T L L +N+ + DLS L++L
Sbjct: 37 SEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNITT--LDLSQNTNLTYLAC 92
Query: 116 NSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIP 175
+S+ ++ + LT L +L+ N + L +L ++T +I
Sbjct: 93 DSNKLTN----LDVTPLTKLTYLNCDTNKLTKLDV----SQNPLLTYLNCARNTLT-EID 143
Query: 176 EGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNF 235
+ + TQL L+ N+ ++ + +L L+ N ++ + S L
Sbjct: 144 --VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRL 196
Query: 236 DVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQ 295
+ N + L +L QL+ L N+ + EI LT N LT L
Sbjct: 197 NCDTNNIT-KL-DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD- 249
Query: 296 KLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFR 355
+ + + + + L + T + LI F+
Sbjct: 250 -VSTLSKLTTLHCIQTDLL-------------------------EIDLT--HNTQLIYFQ 281
Query: 356 VNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPS 415
+ + L ++D D+ L L L N + EL
Sbjct: 282 AEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD- 334
Query: 416 KISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDIN 475
+S + L S+ +GK+ L++ + + +P + SLT
Sbjct: 335 -VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTIT-MPKETLTNNSLT--I 388
Query: 476 FAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLL-DLSNNQLAGPIPE 534
L + + + P + +S P ++ N + G +
Sbjct: 389 AVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTT 448
Query: 535 PLNIKA 540
P
Sbjct: 449 PFEAPQ 454
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 72/321 (22%), Positives = 121/321 (37%), Gaps = 63/321 (19%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA--- 691
+GKGG +++ ++ + A K I+ K
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGK------------------IVPKSLLLKPHQREKMS 89
Query: 692 -EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
E++ ++ H +VV + D +V E SL + + + RY
Sbjct: 90 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT-EPEARY-YL 147
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
G +YLH VIHRD+K N+ L+ + + +I DFGLA V+ G+ V+
Sbjct: 148 RQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLC 202
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM--- 867
GT YIAPE + + DV+S G ++ L+ GK P F ++ + Y ++
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP----F-ETSCLKE-TYLRIKKN 256
Query: 868 ----------DSRD---SMLTVVDPN----ISEILKEDALKV----LRIAIHCTNKLPAF 906
+ ML DP I+E+L ++ R+ I C P F
Sbjct: 257 EYSIPKHINPVAASLIQKML-QTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRF 315
Query: 907 RPSMRVVVQMLEEAEPCSVTN 927
+ + +P +V N
Sbjct: 316 SIAPSSLDP--SNRKPLTVLN 334
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-32
Identities = 74/407 (18%), Positives = 144/407 (35%), Gaps = 77/407 (18%)
Query: 128 SLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQN 186
+L+ + + D F E + L + N ++ ++P + + Q++
Sbjct: 22 NLQYDCVFYDVHIDMQTQD-VYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVEL 79
Query: 187 LELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEG 244
L L+D ++ EI + + +L + N++ LP F N+ L + +N L
Sbjct: 80 LNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 136
Query: 245 DLSELRF--LNQLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSWA 301
L F +L++L + N I ++ F L L L +NRLT + L
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 192
Query: 302 DFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSL 361
+ +VS NLL+ T A ++ ++NS+
Sbjct: 193 SLFHANVSYNLLS-----------------------------TLAIPIAVEELDASHNSI 223
Query: 362 SGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEAS 421
+ + + L+I+ L N + N L + L+ N
Sbjct: 224 N-VVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE----------- 267
Query: 422 SLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSL 481
++ + F +++L LY+ +N L +L ++ + N L
Sbjct: 268 -----KIMYHPFVK--------MQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL 313
Query: 482 SGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQL 528
+ + L +L L +N + +S T+ L L LS+N
Sbjct: 314 L-HVERNQPQFDRLENLYLDHNSIV-TLKLS-THHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-27
Identities = 80/473 (16%), Positives = 147/473 (31%), Gaps = 78/473 (16%)
Query: 60 LQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNS 117
L + + + + L S ++++L+L + E+ + H + L +
Sbjct: 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 108
Query: 118 SGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVL-KLEKLYWLYLTNCSVTGQIPE 176
+ I P +N+ L L L N S P + KL L ++N ++ +I +
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDL--SSLPRGIFHNTPKLTTLSMSNNNLE-RIED 164
Query: 177 GI-GNLTQLQNLELSDNELFGEIPAG-----------------IVKLNKLWQLELYNNSL 218
T LQNL+LS N L + + + +L+ +NS+
Sbjct: 165 DTFQATTSLQNLQLSSNRL-THVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSI 223
Query: 219 SGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEE-FGEFK 277
+ LT L + N L D + L L + L N+ +I F + +
Sbjct: 224 NVVRGPVNVELTIL---KLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQ 278
Query: 278 HLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNF 337
L L + NRL L +D+S N L
Sbjct: 279 RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL----------------------- 314
Query: 338 NGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAK 397
V L +++NS+ T+ + L + LS N ++
Sbjct: 315 --HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWD----------- 358
Query: 398 SLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMF 457
+L L N + ++ L P L+ ++ + +
Sbjct: 359 CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEK-- 416
Query: 458 SGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIP 510
+ + G C + IN Q+ L L N+ E+
Sbjct: 417 ---VQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ 466
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 55/352 (15%), Positives = 118/352 (33%), Gaps = 26/352 (7%)
Query: 183 QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRL 242
Q N++ E I + + + + + + L N + +
Sbjct: 5 QRYNVKPRQPEYK-CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63
Query: 243 EG-DLSELRFLNQLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSW 300
+ L Q+ L+L + Q EI F + +L + N + LP +
Sbjct: 64 RKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN 121
Query: 301 ADF-NYVDVSENLLTGPIPPDMCKTGAMTDLLVL---QNNFNGTVPETYANCKSLIRFRV 356
+ + N L+ +P + L L NN +T+ SL ++
Sbjct: 122 VPLLTVLVLERNDLSS-LPRGIF--HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL 178
Query: 357 NNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSK 416
++N L+ + +P+L ++S N + ++ L ++N + +
Sbjct: 179 SSNRLT-HVDLS--LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGP 229
Query: 417 ISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINF 476
++ L ++L N + + L + L N + + L +
Sbjct: 230 VN--VELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 285
Query: 477 AQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQL 528
+ N L + +P+L L+LS+N + +L L L +N +
Sbjct: 286 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 336
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 15/112 (13%), Positives = 34/112 (30%), Gaps = 8/112 (7%)
Query: 424 VSIQLSLNQFSGQ-----IPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQ 478
V Q N Q I ++ +++ + + + + F
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 479 NSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL--TYPKLSLLDLSNNQL 528
+++ L S + LNL++ + EI + L + N +
Sbjct: 61 STMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAI 111
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 50/340 (14%), Positives = 105/340 (30%), Gaps = 47/340 (13%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLH 108
L +++++L N L L T+L++L+L +N E DL L
Sbjct: 22 LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDLESLS 80
Query: 109 ELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNC 168
L L+LN++ + L ++E L +N
Sbjct: 81 TLRTLDLNNNYVQ------ELLVGPSIETLHAANNNI----------------------- 111
Query: 169 SVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSG-RLPVGFS 227
++ +N+ L++N++ +++ L+L N + +
Sbjct: 112 ---SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
Query: 228 NLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTN 287
+ L + ++ N + D+ +L +L L N+ + + EF +T +SL N
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224
Query: 288 RLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPE-TYA 346
+L + + L + + D+ N D + + +
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNEE 281
Query: 347 NCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFE 386
C P +I L +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFA-----DRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 57/374 (15%), Positives = 113/374 (30%), Gaps = 67/374 (17%)
Query: 157 LEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNN 216
+ +T+ S+ + + ++ L+LS N L A + KL L L +N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 217 SLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEF 276
L L +L+ L D++ N + EL + +LH N S +
Sbjct: 69 VLYETLD--LESLSTLRTLDLNNNY----VQELLVGPSIETLHAANNNIS-RVSCSR--G 119
Query: 277 KHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNN 336
+ + L N++T G + Y+D+ N + +
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNF----------------- 161
Query: 337 FNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNA 396
E A+ +L + N + + + L +DLS+N+ + + +A
Sbjct: 162 -----AELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSA 213
Query: 397 KSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNM 456
+ + L NN+ I + + L L N
Sbjct: 214 AGVTWISLRNNKLV-------------------------LIEKALRFSQNLEHFDLRGNG 248
Query: 457 FS-GPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTY 515
F G L + + K+ ++ +L ++P
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFA- 304
Query: 516 PKLSLLDLSNNQLA 529
L+ L ++
Sbjct: 305 --DRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 53/331 (16%), Positives = 109/331 (32%), Gaps = 28/331 (8%)
Query: 130 ENLTNLEFLSLGDNPF---DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQN 186
+N + + D+ S + L L+ ++ + T+L+
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQ----SAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 187 LELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDL 246
L LS N L E + L+ L L+L NN + ++ + N + +
Sbjct: 63 LNLSSNVL-YETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RV 114
Query: 247 SELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTG-TLPQKLGSWADFNY 305
S R +++L N+ + + G + L L N + + S +
Sbjct: 115 SCSRGQG-KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173
Query: 306 VDVSENLLTGPIPPDMCKTGAMTDL--LVLQNNFNGTVPETYANCKSLIRFRVNNNSLSG 363
+++ N + + + L L L +N + + + + + NN L
Sbjct: 174 LNLQYNFIYD-VKGQVV----FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV- 227
Query: 364 TIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSL 423
I + NL DL N F T +K+ + +A +L + E ++
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTV 285
Query: 424 VSIQLSLNQFSGQIPLDIG-KLKKLSSLYLH 453
++ +P +L L + H
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 40/206 (19%), Positives = 74/206 (35%), Gaps = 24/206 (11%)
Query: 342 PETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLAL 401
E N +V ++SL + S N+ +DLS N D+ L L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 402 LLLANNRFSGELP------------------SKISEASSLVSIQLSLNQFSGQIPLDIGK 443
L L++N E ++ S+ ++ + N S ++
Sbjct: 63 LNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSR-- 118
Query: 444 LKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSG-KIPDSLGSLPSLNSLNLSN 502
+ ++YL +N + G + ++ N + + S +L LNL
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 503 NKFSGEIPISLTYPKLSLLDLSNNQL 528
N ++ + + KL LDLS+N+L
Sbjct: 179 NFIY-DVKGQVVFAKLKTLDLSSNKL 203
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 22/116 (18%), Positives = 43/116 (37%), Gaps = 6/116 (5%)
Query: 413 LPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLT 472
+ + +++ + + + L L N S + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 473 DINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQL 528
+N + N L + D L SL +L +L+L+NN E+ + P + L +NN +
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLVG---PSIETLHAANNNI 111
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 30/148 (20%), Positives = 58/148 (39%), Gaps = 5/148 (3%)
Query: 40 EINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSG 99
++L ++ V + L+ +NL NF+ +G +L+ LDL +N +
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI--YDVKGQVVFAKLKTLDLSSNKLAF 205
Query: 100 EVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEK 159
P+ +++++L ++ + K+L NLE L N F K ++
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIE-KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 160 LYWLYL-TNCSVTGQIPEGIGNLTQLQN 186
+ + T +TGQ E T
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHY 291
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 17/65 (26%), Positives = 26/65 (40%), Gaps = 1/65 (1%)
Query: 470 SLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQL 528
+SL + S ++ L+LS N S L + KL LL+LS+N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 529 AGPIP 533
+
Sbjct: 71 YETLD 75
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA--- 691
L+GKG VY+ +++G E+A+K ++ K++ +
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIK------------------MIDKKAMYKAGMVQRVQ 59
Query: 692 -EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
EV ++H ++++LY + LV E NG + L K + R+ +
Sbjct: 60 NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
G+ YLH ++HRD+ SN+LL +IADFGLA Q + + +
Sbjct: 120 -QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLC 173
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT YI+PE A +SDV+S G + L+ G+ P
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 51/286 (17%)
Query: 636 LIGKGGSGNVYK---VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSK--RSSRSSEYD 690
++G GG V+ + + +++AVK + R D + + R +++
Sbjct: 19 ILGFGGMSEVHLARDLRDH--RDVAVKVL-------RADLARDPSFYLRFRREAQN---- 65
Query: 691 AEVATLSAVRHVNVVKLY----CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
A L+ H +V +Y + +V EY+ +L D +HT + +
Sbjct: 66 --AAALN---HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120
Query: 747 YAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
A L + H +G +IHRDVK +NI++ ++ DFG+A+ + +
Sbjct: 121 VIADACQA--LNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SV 173
Query: 806 TH--VIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEF-GDSKDIVNW 862
T + GT Y++PE A ++ +SDVYS G VL E++TG+ P F GDS V+
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSP--VSV 227
Query: 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP 908
Y + + +S L DA+ VL+ K P R
Sbjct: 228 AYQHVREDPIPPSARHEGLSADL--DAV-VLK----ALAKNPENRY 266
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 62/219 (28%), Positives = 90/219 (41%), Gaps = 32/219 (14%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA-- 691
+GKG GNVY S LA+K +L K + +
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALK------------------VLFKAQLEKAGVEHQL 56
Query: 692 --EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
EV S +RH N+++LY L+ EY P G+++ L K + Y
Sbjct: 57 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 116
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
+ A L Y H + VIHRD+K N+LL + +IADFG + +
Sbjct: 117 EL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDL 167
Query: 810 AGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT Y+ PE +EK D++S GV+ E + GK P
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 9e-31
Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 32/218 (14%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA--- 691
+GKG GNVY + +A+K +L K +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALK------------------VLFKSQLEKEGVEHQLR 62
Query: 692 -EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
E+ S +RH N++++Y L+ E+ P G L+ L + + +
Sbjct: 63 REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ A L Y H R VIHRD+K N+L+ + + +IADFG + +
Sbjct: 123 L--ADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRTMC 173
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT Y+ PE +EK D++ GV+ E + G P
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 59/282 (20%), Positives = 91/282 (32%), Gaps = 55/282 (19%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
+G G G V+KV G+ AVK +R K AEV
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRS-------MSPFRGPKDRARKL--------AEVG 108
Query: 695 TLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
+ V +H V+L + L E SL + V
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWG-YLRDT 166
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
L +LH + ++H DVK +NI L + ++ DFGL + T V G
Sbjct: 167 LLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---AGAGEVQEGDP 220
Query: 814 GYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS-KDIVNWVYSKM 867
Y+APE Y +DV+S G+ ++E+ P G+ + +
Sbjct: 221 RYMAPELLQGSY------GTAADVFSLGLTILEVACNMEL--PHGGEGWQQLRQGYLP-- 270
Query: 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS 909
P + L + VL + P R +
Sbjct: 271 -----------PEFTAGLSSELRSVLVM---MLEPDPKLRAT 298
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-30
Identities = 68/298 (22%), Positives = 114/298 (38%), Gaps = 48/298 (16%)
Query: 621 SFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAIL 679
+ + + +G GG G V + + ++G+++A+K + +
Sbjct: 6 PSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC----------RQELSPKN 55
Query: 680 SKRSSRSSEYDAEVATLSAVRHVNVVKLY------CSITSEDSNLLVYEYLPNGSLWDRL 733
+R E+ + + H NVV + D LL EY G L L
Sbjct: 56 RERWCL------EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL 109
Query: 734 H---TCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR--- 787
+ C ++ + + +A L YLH + +IHRD+K NI+L +
Sbjct: 110 NQFENCCGLKEGPIRTLLSDISSA--LRYLH---ENRIIHRDLKPENIVLQPGPQRLIHK 164
Query: 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKR 847
I D G AK + GE L GT Y+APE K D +SFG + E +TG R
Sbjct: 165 IIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
Query: 848 PIVPEF-----------GDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLR 894
P +P + ++ IV + + S + ++S IL + L+
Sbjct: 222 PFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ 279
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-30
Identities = 34/316 (10%), Positives = 82/316 (25%), Gaps = 39/316 (12%)
Query: 615 KSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYR 673
V S + +K + G V+ V + ++ A+K R +
Sbjct: 49 AETTVDSLLSQGERK-LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELE 107
Query: 674 S-------STAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDS----NLLVYE 722
+ +L + + + + AV + +D N L+
Sbjct: 108 RLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLM 167
Query: 723 YLPNGSLWDRLHTCHKIE-----MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777
+ L T + + + + + L + ++H N
Sbjct: 168 PAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDN 224
Query: 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEY--AYTCKINEKSDVYSF 835
+ + + + + D + G + Y E+ A T + +
Sbjct: 225 LFIMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQL 279
Query: 836 GVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRI 895
G+ + + P FG + + + R + L + ++
Sbjct: 280 GLSIYRVWCLFLP----FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG- 334
Query: 896 AIHCTNKLPAFRPSMR 911
+ F R
Sbjct: 335 ------RFLNFDRRRR 344
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++GKG G VY L++ +A+K I R S E+A
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI---------PERDSRYS--------QPLHEEIA 71
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL-HTCHKIEMDWVVRYAIAVGA 753
++H N+V+ S + + E +P GSL L ++ +
Sbjct: 72 LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLD-LEWKPRIADFGLAKIVQTGEAGDLTHVIAGT 812
+GL+YLH D ++HRD+K N+L++ +I+DFG +K + T GT
Sbjct: 132 LEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGT 186
Query: 813 HGYIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
Y+APE Y +D++S G ++E+ TGK P
Sbjct: 187 LQYMAPEIIDKGPRGYGK----AADIWSLGCTIIEMATGKPP 224
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 65/319 (20%), Positives = 126/319 (39%), Gaps = 39/319 (12%)
Query: 597 KLKQNNL--KHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLN-SG 653
KL++ L + + ++ + +V + + + +G G G V+KV SG
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEK----ISELGAGNGGVVFKVSHKPSG 58
Query: 654 KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITS 713
+A K I L + + ++ E+ L +V Y + S
Sbjct: 59 LVMARKLIH----------------LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102
Query: 714 EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDV 773
+ + E++ GSL L +I + + +++ KGL YL ++HRDV
Sbjct: 103 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--VSIAVIKGLTYLRE--KHKIMHRDV 158
Query: 774 KSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA----GTHGYIAPEYAYTCKINEK 829
K SNIL++ + ++ DFG+ +G L +A GT Y++PE + +
Sbjct: 159 KPSNILVNSRGEIKLCDFGV--------SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 210
Query: 830 SDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDA 889
SD++S G+ L+E+ G+ PI P +++ + D+ ++ P
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 890 LKVLRIAIHCTNKLPAFRP 908
+ + + P
Sbjct: 271 SRPPMAIFELLDYIVNEPP 289
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 78/316 (24%), Positives = 128/316 (40%), Gaps = 62/316 (19%)
Query: 629 DAVKPENLIGKGGSGNVYKVVL-----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS 683
+K +G+G G V N+G+++AVK L S
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK------------------SLKPES 62
Query: 684 SRSSEYD--AEVATLSAVRHVNVVKLY--CSITSEDSNLLVYEYLPNGSLWDRLHTC-HK 738
+ D E+ L + H N+VK C+ + L+ E+LP+GSL + L +K
Sbjct: 63 GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK 122
Query: 739 IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798
I + ++YA+ + KG++YL R +HRD+ + N+L++ E + +I DFGL K ++
Sbjct: 123 INLKQQLKYAVQI--CKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
Query: 799 TGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPE 852
T + + APE K SDV+SFGV L EL+T P
Sbjct: 178 TDK----EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233
Query: 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDA---------LKVLRIAIHCTNKL 903
K I + +M + LKE +V ++ C
Sbjct: 234 ALFLKMIGPT-HGQMTVTRLV---------NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQ 283
Query: 904 PAFRPSMRVVVQMLEE 919
P+ R S + +++ E
Sbjct: 284 PSNRTSFQNLIEGFEA 299
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 65/285 (22%), Positives = 107/285 (37%), Gaps = 52/285 (18%)
Query: 634 ENLIGKGGSGNVYK---VVLNSGKELAVKHIWP---SNSGFRGDYRSSTAILSKRSSRSS 687
L+G+GG G+VY+ V + +A+K + S+ FR + R +R+
Sbjct: 39 RRLVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQ--------REART- 87
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
L +VV ++ + + + L L + V
Sbjct: 88 -----AGRLQ---EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAI 139
Query: 748 AIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
+G+A L+ H G HRDVK NIL+ + + DFG+A + LT
Sbjct: 140 VRQIGSA--LDAAHAAG----ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEK-LT 190
Query: 807 H--VIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEF-GDSKDIVNWV 863
GT Y+APE ++D+Y+ VL E +TG P + GD + +
Sbjct: 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGDQLSV---M 243
Query: 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP 908
+ ++ + V P I DA+ + R K P R
Sbjct: 244 GAHINQAIPRPSTVRPGIPVAF--DAV-IAR----GMAKNPEDRY 281
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 51/226 (22%), Positives = 85/226 (37%), Gaps = 50/226 (22%)
Query: 636 LIGKGGSGNVYK---VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEY--- 689
I GG G +Y +N G+ + +K L S +E
Sbjct: 87 CIAHGGLGWIYLALDRNVN-GRPVVLK------------------GL--VHSGDAEAQAM 125
Query: 690 -DAEVATLSAVRHVNVVKLYCSITSEDSNL-----LVYEYLPNGSLWDRLHTCHKIEMDW 743
AE L+ V H ++V+++ + D + +V EY+ SL K+ +
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAE 183
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK-IVQTGEA 802
+ Y + + A L YLH +++ D+K NI+L E + ++ D G I G
Sbjct: 184 AIAYLLEILPA--LSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG-- 235
Query: 803 GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+ GT G+ APE +D+Y+ G L L
Sbjct: 236 -----YLYGTPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 79/323 (24%), Positives = 118/323 (36%), Gaps = 77/323 (23%)
Query: 629 DAVKPENLIGKGGSGNVYKVVL-----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS 683
+K + +GKG G+V N+G +AVK + + S
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-------------------QHS 63
Query: 684 SRSSEYD--AEVATLSAVRHVNVVKLY--CSITSEDSNLLVYEYLPNGSLWDRLHTCHKI 739
+ D E+ L A+ +VK S LV EYLP+G L D L H+
Sbjct: 64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRA 122
Query: 740 EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT 799
+D + KG+EYL R +HRD+ + NIL++ E +IADFGLAK++
Sbjct: 123 RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179
Query: 800 GEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEF 853
+ + + G APE + +SDV+SFGVVL EL T +
Sbjct: 180 DK----DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS----- 230
Query: 854 GDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLR------------IAIH--- 898
S M+ + L++L +H
Sbjct: 231 ----------CSPSAEFLRMMGCERDVPA---LSRLLELLEEGQRLPAPPACPAEVHELM 277
Query: 899 --CTNKLPAFRPSMRVVVQMLEE 919
C P RPS + L+
Sbjct: 278 KLCWAPSPQDRPSFSALGPQLDM 300
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 83/323 (25%), Positives = 130/323 (40%), Gaps = 62/323 (19%)
Query: 623 SEKEIIDA--VKPENLIGKGGSGNVYKVVL-----NSGKELAVKHIWPSNSGFRGDYRSS 675
S+ + +K +GKG G+V N+G+ +AVK + + S
Sbjct: 2 SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-----------QHS 50
Query: 676 TAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY--CSITSEDSNLLVYEYLPNGSLWDRL 733
T +++ E+ L +++H N+VK C + L+ EYLP GSL D L
Sbjct: 51 T------EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
Query: 734 HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793
HK +D + KG+EYL + IHRD+ + NIL++ E + +I DFGL
Sbjct: 105 QK-HKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 160
Query: 794 AKIVQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKR 847
K++ + G APE K + SDV+SFGVVL EL T ++
Sbjct: 161 TKVLPQDK----EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216
Query: 848 PIVPEFGDSKDIVNWVYSKMDSRDSMLTVVD-----------PNISEILKEDALKVLRIA 896
P + I N +M + + + I I+ E
Sbjct: 217 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE--------- 267
Query: 897 IHCTNKLPAFRPSMRVVVQMLEE 919
C N RPS R + +++
Sbjct: 268 --CWNNNVNQRPSFRDLALRVDQ 288
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 72/433 (16%), Positives = 127/433 (29%), Gaps = 67/433 (15%)
Query: 85 TRLQVLDLGNNSFSG-EVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDN 143
+ +DL NS + S L +L FL + + L++L L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 144 PFDPSPFPMEVL-KLEKLYWLYLTNCSVTG-QIPEGI-GNLTQLQNLELSDNELFGEIPA 200
F L L L LT C++ G + LT L+ L L DN + PA
Sbjct: 90 QF--LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147
Query: 201 GI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELR-FLNQLSS 257
+ + + L+L N + + N + LR L
Sbjct: 148 SFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGK------------HFTLLRLSSITLQD 194
Query: 258 LHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPI 317
++ E E + +T L L N ++ ++ + + I
Sbjct: 195 MN--EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF-----------FDAIAGTKI 241
Query: 318 PPDMCKTGAMTDLLVLQNNFNGTVPETYANCK--SLIRFRVNNNSLSGTIPPGIWS-LPN 374
+ NF T+ + + ++ + + + ++S +
Sbjct: 242 QSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTD 300
Query: 375 LSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKI-SEASSLVSIQLSLNQF 433
L + L+ N+ + L L L+ N + S++ L + LS N
Sbjct: 301 LEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI 359
Query: 434 SGQIPLDI-GKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSL 492
+ L L L L N L + L
Sbjct: 360 R-ALGDQSFLGLPNLKELALDTN--------------QLKSVP----------DGIFDRL 394
Query: 493 PSLNSLNLSNNKF 505
SL + L N +
Sbjct: 395 TSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-28
Identities = 79/412 (19%), Positives = 139/412 (33%), Gaps = 74/412 (17%)
Query: 133 TNLEFLSLGDNPF---DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLE 188
++ ++ L N + + F +L+ L +L + + I L+ L L+
Sbjct: 30 AHVNYVDLSLNSIAELNETSFS----RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85
Query: 189 LSDNELFGEIPAGI-VKLNKLWQLELYNNSL-SGRLPVG-FSNLTNLMNFDVSQNRLEGD 245
L N+ ++ G L L L L +L L F LT+L + N ++
Sbjct: 86 LDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI 144
Query: 246 LSELRF--LNQLSSLHLFENQFSGEIPEEFGEF--KHLTELSLYTNRLTGTLPQKLGSWA 301
F + + L L N+ E+ F KH T L L + L
Sbjct: 145 QPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ----------- 193
Query: 302 DFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSL 361
D++E L + K ++T L + N F ++ + + + + + + S
Sbjct: 194 -----DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248
Query: 362 SGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKI-SEA 420
S + S + + D F+G A + L+ ++ L + S
Sbjct: 249 SYNM---GSSFGHTNFKDPDNFTFKGL------EASGVKTCDLSKSKIF-ALLKSVFSHF 298
Query: 421 SSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNS 480
+ L + L+ N+ + + DN F G L +N +QN
Sbjct: 299 TDLEQLTLAQNEIN----------------KIDDNAFWG--------LTHLLKLNLSQNF 334
Query: 481 LSGKIPDSLGSLPSLNSLNLSNNKFSGEIPI----SLTYPKLSLLDLSNNQL 528
L +L L L+LS N + L L L L NQL
Sbjct: 335 LGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLP--NLKELALDTNQL 383
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-21
Identities = 63/376 (16%), Positives = 122/376 (32%), Gaps = 56/376 (14%)
Query: 40 EINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEG-LKSCTRLQVLDLGNNSF- 97
+ + +Q V+ ++ GL +L + L N + G L+VL L +
Sbjct: 58 FLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLD 116
Query: 98 SGEVPD--LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVL 155
+ L L L L + I P N+ L L N ++L
Sbjct: 117 GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC-EEDLL 175
Query: 156 KLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYN 215
+ ++ L L+ + ++++ L E K + L+L
Sbjct: 176 NFQGKHFTLL--------------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSG 221
Query: 216 NSLSGRLPVGFSNLTNLMNF-------------DVSQNRLEGDLSELRF----LNQLSSL 258
N + F + + D F + + +
Sbjct: 222 NGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK-DPDNFTFKGLEASGVKTC 280
Query: 259 HLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLP----QKLGSWADFNYVDVSENLL 313
L +++ + + F F L +L+L N + + L +++S+N L
Sbjct: 281 DLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTH---LLKLNLSQNFL 335
Query: 314 TGPIPPDMCKTGAMTDL--LVLQNNFNGTVPE-TYANCKSLIRFRVNNNSLSGTIPPGI- 369
I M + + L L L N + + ++ +L ++ N L ++P GI
Sbjct: 336 GS-IDSRMFE--NLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIF 391
Query: 370 WSLPNLSIIDLSTNQF 385
L +L I L TN +
Sbjct: 392 DRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 57/337 (16%), Positives = 105/337 (31%), Gaps = 79/337 (23%)
Query: 197 EIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRF--LNQ 254
E+PA + ++ L NS++ FS L +L V Q + F L+
Sbjct: 27 ELPAHVNYVD------LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 255 LSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLL 313
L L L NQF ++ F +L L+L L G
Sbjct: 81 LIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGA--------------------- 118
Query: 314 TGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIW-SL 372
+ + F SL + +N++ P + ++
Sbjct: 119 --VLSGNF---------------FK--------PLTSLEMLVLRDNNIKKIQPASFFLNM 153
Query: 373 PNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQ 432
++DL+ N+ + +D+ N + LL + S+ ++
Sbjct: 154 RRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS--------------SITLQDMNEYW 199
Query: 433 FSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSL 492
+ + K +++L L N F + ++ T I S S + S
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS---YNMGSSF 256
Query: 493 PSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLA 529
N + N F G L + DLS +++
Sbjct: 257 GHTNFKDPDNFTFKG-----LEASGVKTCDLSKSKIF 288
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 33/195 (16%), Positives = 67/195 (34%), Gaps = 19/195 (9%)
Query: 357 NNNSLSGTIPPG-IWSLPNLSIIDLSTNQFEGPVTDDI-GNAKSLALLLLANNRFSGELP 414
+ NS++ + L +L + + + ++ SL +L L N+F +L
Sbjct: 38 SLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLE 95
Query: 415 SKI-SEASSLVSIQLSLNQF-SGQIPLDI-GKLKKLSSLYLHDNMFSGPLPYSI-GSCVS 470
+ + ++L + L+ + + L L L L DN P S +
Sbjct: 96 TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRR 155
Query: 471 LTDINFAQNSLSGKIPDSLGSLPSLN--SLNLSNNKFSGEIPISLTYPK---------LS 519
++ N + + L + + L LS+ L + K ++
Sbjct: 156 FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215
Query: 520 LLDLSNNQLAGPIPE 534
LDLS N + +
Sbjct: 216 TLDLSGNGFKESMAK 230
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 59 GLQALQKINLGTNFLYGTITEGL-KSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNL 115
GL L K+NL NFL G+I + ++ +L+VLDL N + D L L L L
Sbjct: 321 GLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELAL 378
Query: 116 NSSGISGKFPWKSLENLTNLEFLSLGDNPFD 146
+++ + P + LT+L+ + L NP+D
Sbjct: 379 DTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 50/256 (19%), Positives = 94/256 (36%), Gaps = 46/256 (17%)
Query: 623 SEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSK 681
S+ +++G+G + NV++ +G A+K + +
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIK------------------VFNN 44
Query: 682 RSSRSSEY--DAEVATLSAVRHVNVVKLYCSITSEDSNL--LVYEYLPNGSLWDRLH--- 734
S E L + H N+VKL+ + L+ E+ P GSL+ L
Sbjct: 45 ISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS 104
Query: 735 TCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR----IAD 790
+ + + V G+ +L + ++HR++K NI+ + + + D
Sbjct: 105 NAYGLPESEFLIVLRDV--VGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159
Query: 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPE--------YAYTCKINEKSDVYSFGVVLMEL 842
FG A+ ++ E + GT Y+ P+ + K D++S GV
Sbjct: 160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216
Query: 843 VTGKRPIVPEFGDSKD 858
TG P P G ++
Sbjct: 217 ATGSLPFRPFEGPRRN 232
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 74/317 (23%), Positives = 114/317 (35%), Gaps = 66/317 (20%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKEL-----AVKHIWPSNSGFRGDYRSSTAILSKRS 683
+K +G+G G V + + AVK L +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK------------------ALKADA 72
Query: 684 SRSSEYD--AEVATLSAVRHVNVVKLY--CSITSEDSNLLVYEYLPNGSLWDRLHTCHKI 739
E+ L + H +++K C S LV EY+P GSL D L H I
Sbjct: 73 GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSI 131
Query: 740 EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQT 799
+ ++ +A + +G+ YLH + IHRD+ + N+LLD + +I DFGLAK V
Sbjct: 132 GLAQLLLFAQQI--CEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186
Query: 800 GEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEF 853
G + G APE K SDV+SFGV L EL+T P
Sbjct: 187 GH----EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242
Query: 854 GDSKDIVNWVYSKMDSRDSMLTVVD-----------PNISEILKEDALKVLRIAIHCTNK 902
+ I +M + + ++K C
Sbjct: 243 KFLELIGI-AQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKN-----------CWET 290
Query: 903 LPAFRPSMRVVVQMLEE 919
+FRP+ ++ +L+
Sbjct: 291 EASFRPTFENLIPILKT 307
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-29
Identities = 78/423 (18%), Positives = 154/423 (36%), Gaps = 37/423 (8%)
Query: 133 TNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSD 191
L++ N ++L L KL L +++ + + + +L+ L+LS
Sbjct: 21 QKTTILNISQNYISELW-TSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSH 78
Query: 192 NELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVG--FSNLTNLMNFDVSQNRL-EGDLSE 248
N+L +I L L+L N+ LP+ F N++ L +S L + +
Sbjct: 79 NKL-VKISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLP 134
Query: 249 LRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDV 308
+ LN L + + E+ + SL+ T + + ++
Sbjct: 135 IAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192
Query: 309 SENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPE---------------TYANCKSLIR 353
+ + + + C ++ L LQ N + ++
Sbjct: 193 ELSNIKCVLEDNKCSY-FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
Query: 354 FRVNNNSLSGTIPPGIW-----SLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNR 408
F ++N L G + + SL LSI + ++ F P + ++ + +
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311
Query: 409 FSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFS--GPLPYSIG 466
S+ S + + S N + + + G L +L +L L N +
Sbjct: 312 TRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTT 371
Query: 467 SCVSLTDINFAQNSLSGKIPDSL-GSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSN 525
SL ++ +QNS+S SL SLN+S+N + I L P++ +LDL +
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-PRIKVLDLHS 430
Query: 526 NQL 528
N++
Sbjct: 431 NKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 8e-28
Identities = 75/459 (16%), Positives = 147/459 (32%), Gaps = 38/459 (8%)
Query: 85 TRLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDN 143
+ +L++ N S D+ L +L L ++ + I + LE+L L N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHN 79
Query: 144 PFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEG--IGNLTQLQNLELSDNELFGEIPAG 201
L L L+ + +P GN++QL+ L LS L
Sbjct: 80 KLVKISCH----PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLP 134
Query: 202 IVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLE-GDLSELRFLNQLSSLHL 260
I LN L + + L + + + + ++ + +L
Sbjct: 135 IAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192
Query: 261 FENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPD 320
+ + + + L TN L N ++ + N
Sbjct: 193 ELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL--------TLNNIETTWNSFIRI--LQ 242
Query: 321 MCKTGAMTDLLVLQNNFNGTVPETYANC-----KSLIRFRVNNNSLSGTIPPGIW-SLPN 374
+ + + G + + K+L +V ++ I+ N
Sbjct: 243 LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIFSN 301
Query: 375 LSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFS 434
++I + + + L +NN + + + L ++ L +NQ
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 435 GQIPLDIG---KLKKLSSLYLHDNMFSGPLPYSI-GSCVSLTDINFAQNSLSGKIPDSLG 490
++ ++K L L + N S SL +N + N L+ I L
Sbjct: 362 -ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL- 419
Query: 491 SLPSLNSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQL 528
P + L+L +NK IP + L L++++NQL
Sbjct: 420 -PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 85/468 (18%), Positives = 166/468 (35%), Gaps = 35/468 (7%)
Query: 63 LQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGI 120
+N+ N++ T + S ++L++L + +N + EL +L+L+ + +
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKL 81
Query: 121 SGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGN 180
K NL+ L L N FD P E + +L +L L+ + I +
Sbjct: 82 V-KISCHPT---VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 181 LTQLQNLELSDNELFGEIPAG---IVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDV 237
L + L + + L + N L V + NL ++
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 238 SQNR-------LEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEF---KHLTELSLYTN 287
L++L+ +LS+L L + + + + S+
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257
Query: 288 RLTGTLPQKLGSWAD-----FNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVP 342
+L G L + ++ + V ++ P + + + ++ + V
Sbjct: 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFP-QSYIYEIFSNMNIKNFTVSGTRMVH 316
Query: 343 E-TYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFE--GPVTDDIGNAKSL 399
+ + +NN L+ T+ L L + L NQ + + + KSL
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSL 376
Query: 400 ALLLLANNRFSGELPSKI-SEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFS 458
L ++ N S + S SL+S+ +S N + I + ++ L LH N
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK 434
Query: 459 GPLPYSIGSCVSLTDINFAQNSLSGKIPD-SLGSLPSLNSLNLSNNKF 505
+P + +L ++N A N L +PD L SL + L N +
Sbjct: 435 S-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 38/200 (19%), Positives = 76/200 (38%), Gaps = 9/200 (4%)
Query: 59 GLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSM-LHELSFLNLNS 117
+ N + + LD NN + V + L EL L L
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 118 SGISGKFPWKS--LENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIP 175
+ + + + + +L+ L + N + + L L +++ +T I
Sbjct: 358 NQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416
Query: 176 EGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMN 234
+ +++ L+L N++ IP +VKL L +L + +N L +P G F LT+L
Sbjct: 417 RCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQK 472
Query: 235 FDVSQNRLEGDLSELRFLNQ 254
+ N + + +L++
Sbjct: 473 IWLHTNPWDCSCPRIDYLSR 492
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 26/140 (18%), Positives = 54/140 (38%), Gaps = 6/140 (4%)
Query: 402 LLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHDNMFSGP 460
L ++ N S S I S L + +S N+ + + + ++L L L N
Sbjct: 26 LNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVK- 83
Query: 461 LPYSIGSCVSLTDINFAQNSL-SGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLS 519
+ V+L ++ + N+ + I G++ L L LS + + + +S
Sbjct: 84 IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS 141
Query: 520 LLDLSNNQLAGPIPEPLNIK 539
+ L + G +P ++
Sbjct: 142 KVLLVLGETYGEKEDPEGLQ 161
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 26/100 (26%), Positives = 44/100 (44%), Gaps = 3/100 (3%)
Query: 47 QLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSM 106
+ ++L +N+ +N L TI L R++VLDL +N +
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIKSIPKQVVK 442
Query: 107 LHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFD 146
L L LN+ S+ + P + LT+L+ + L NP+D
Sbjct: 443 LEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 61/309 (19%), Positives = 110/309 (35%), Gaps = 69/309 (22%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGK-ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSS 687
+ + IG+G G V+ L + +AVK + +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP----------------PDLKA 157
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
++ E L H N+V+L T + +V E + G L T +
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLL 216
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
+ AA G+EYL + IHRD+ + N L+ + +I+DFG+++ G +
Sbjct: 217 QMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-----Y 268
Query: 808 VIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVN 861
+G + APE + + +SDV+SFG++L E + G P
Sbjct: 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP------------- 315
Query: 862 WVYSKMDSRDSMLTVVD-----------PNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910
Y + ++ + V + ++++ C P RPS
Sbjct: 316 --YPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQ-----------CWAYEPGQRPSF 362
Query: 911 RVVVQMLEE 919
+ Q L+
Sbjct: 363 STIYQELQS 371
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 83/313 (26%), Positives = 130/313 (41%), Gaps = 56/313 (17%)
Query: 629 DAVKPENLIGKGGSGNVYKVVL-----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS 683
+K +GKG G+V N+G+ +AVK + + ST
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-----------QHST------E 83
Query: 684 SRSSEYDAEVATLSAVRHVNVVKLY--CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEM 741
+++ E+ L +++H N+VK C + L+ EYLP GSL D L HK +
Sbjct: 84 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERI 142
Query: 742 DWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGE 801
D + KG+EYL + IHRD+ + NIL++ E + +I DFGL K++ +
Sbjct: 143 DHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
Query: 802 AGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGD 855
+ G APE K + SDV+SFGVVL EL T ++ P
Sbjct: 200 ----EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 255
Query: 856 SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDA---------LKVLRIAIHCTNKLPAF 906
+ I N +M + E+LK + ++ I C N
Sbjct: 256 MRMIGNDKQGQMIVFH---------LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 306
Query: 907 RPSMRVVVQMLEE 919
RPS R + +++
Sbjct: 307 RPSFRDLALRVDQ 319
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IGKG G V+K + + K +A+K I L + + E+
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKII----------------DLEEAEDEIEDIQQEITV 73
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAK 755
LS V K Y S + ++ EYL GS D L ++ + I K
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIA--TILREILK 130
Query: 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGY 815
GL+YLH IHRD+K++N+LL + ++ADFG+A Q + + GT +
Sbjct: 131 GLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFW 185
Query: 816 IAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+APE + K+D++S G+ +EL G+ P
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 67/257 (26%), Positives = 107/257 (41%), Gaps = 53/257 (20%)
Query: 614 MKSFRVLSFSEKEIIDAVKPENL-----IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSG 667
++S L S ++ D E+L IG+G G+V K+V SG+ +AVK I
Sbjct: 3 IESSGKLKISPEQHWD-FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI------ 55
Query: 668 FRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNG 727
ST ++ + D + + +V+ Y ++ E + E + +
Sbjct: 56 ------RSTVDEKEQKQLLMDLDV---VMRSSDCPYIVQFYGALFREGDCWICMELM-ST 105
Query: 728 SLWDRLHTCHKIEMDWV---VRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784
S + + D + + I + K L +L + +IHRD+K SNILLD
Sbjct: 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSG 163
Query: 785 KPRIADFGLAKIVQTGEAGDLTHVIA-----GTHGYIAPE--------YAYTCKINEKSD 831
++ DFG+ +G L IA G Y+APE Y +SD
Sbjct: 164 NIKLCDFGI--------SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDV----RSD 211
Query: 832 VYSFGVVLMELVTGKRP 848
V+S G+ L EL TG+ P
Sbjct: 212 VWSLGITLYELATGRFP 228
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 49/243 (20%), Positives = 91/243 (37%), Gaps = 46/243 (18%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEY--DAE 692
++G+G + NV++ +G A+K + + S E
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIK------------------VFNNISFLRPVDVQMRE 57
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNL--LVYEYLPNGSLWDRLH---TCHKIEMDWVVRY 747
L + H N+VKL+ + L+ E+ P GSL+ L + + +
Sbjct: 58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR----IADFGLAKIVQTGEAG 803
V G+ +L + ++HR++K NI+ + + + DFG A+ ++ E
Sbjct: 118 LRDV--VGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-- 170
Query: 804 DLTHVIAGTHGYIAPE--------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855
+ GT Y+ P+ + K D++S GV TG P P G
Sbjct: 171 -QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 856 SKD 858
++
Sbjct: 230 RRN 232
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 57/296 (19%), Positives = 105/296 (35%), Gaps = 49/296 (16%)
Query: 631 VKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
P++++G G G + + +++AVK + ++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVK------------------RILPECFSFAD-- 65
Query: 691 AEVATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
EV L H NV++ +C+ + E +L + + + +
Sbjct: 66 REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPIT-L 123
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILL-----DLEWKPRIADFGLAKIVQTGE-AG 803
GL +LH ++HRD+K NIL+ + K I+DFGL K + G +
Sbjct: 124 LQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180
Query: 804 DLTHVIAGTHGYIAPEY---AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD-I 859
+ GT G+IAPE D++S G V +++ P FG S
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--P-FGKSLQRQ 237
Query: 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
N + + + + A +++ P RPS + V++
Sbjct: 238 ANILLGACS-------LDCLHPEKHEDVIARELIE---KMIAMDPQKRPSAKHVLK 283
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 61/307 (19%), Positives = 108/307 (35%), Gaps = 84/307 (27%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA--E 692
IG G G+V+K V G A+K S E +A E
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRS----------------KKPLAGSVD-EQNALRE 60
Query: 693 VATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEM----DWVVRY 747
V + + +H +VV+ + + +D L+ EY GSL D + ++I +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP-------------------RI 788
+ V +GL Y+H ++H D+K SNI + P +I
Sbjct: 121 LLQV--GRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175
Query: 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELV 843
D G + V G ++A E Y + K+D+++ + ++
Sbjct: 176 GDLGHVTRI------SSPQVEEGDSRFLANEVLQENYTH----LPKADIFALALTVVCAA 225
Query: 844 TGKRPIVPEFGDS-KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNK 902
+ P GD +I P I ++L ++ ++L++ +
Sbjct: 226 GAEPL--PRNGDQWHEIRQGRL--------------PRIPQVLSQEFTELLKV---MIHP 266
Query: 903 LPAFRPS 909
P RPS
Sbjct: 267 DPERRPS 273
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-28
Identities = 23/237 (9%), Positives = 59/237 (24%), Gaps = 29/237 (12%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDY--------RSSTAILSKRSSRS 686
++G+ + +G+ V + + R K ++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 687 SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYL----PNGSLWDRLHTCHKI--- 739
+ + V+ K+ E ++ + +L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 740 --EMDWVVRYAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
+ R + + + L LH +G ++H ++ +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 797 VQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRP 848
A + D ++ G+ + + P
Sbjct: 261 DGASAV-SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 66/228 (28%), Positives = 95/228 (41%), Gaps = 40/228 (17%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG G + V +++A+K I L K + E E+
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRI----------------NLEKCQTSMDELLKEIQA 66
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY---AIAV- 751
+S H N+V Y S +D LV + L GS+ D + IA
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 752 --GAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGL-AKIVQTGEAGDLT- 806
+GLEYLH +G IHRDVK+ NILL + +IADFG+ A + G+
Sbjct: 127 LREVLEGLEYLHKNG----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 807 -HVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT ++APE Y + K+D++SFG+ +EL TG P
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAP 226
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 77/335 (22%), Positives = 136/335 (40%), Gaps = 60/335 (17%)
Query: 597 KLKQNNLKHSLKQNSWDMKSFRVLSFSEKEI-IDAVKPENLIGKGGSGNVYKVVLNSGKE 655
K + L L K + EI +++K E +G G G V+ N +
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK 214
Query: 656 LAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSED 715
+AVK + + S A L+ E + ++H +VKL+ ++ +++
Sbjct: 215 VAVKTM-------KPGSMSVEAFLA-----------EANVMKTLQHDKLVKLH-AVVTKE 255
Query: 716 SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKS 775
++ E++ GSL D L + + + A+G+ ++ R IHRD+++
Sbjct: 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRA 312
Query: 776 SNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYI---APEYAYTCKINEKSDV 832
+NIL+ +IADFGLA++++ + G I APE KSDV
Sbjct: 313 ANILVSASLVCKIADFGLARVIE----DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 833 YSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVD-------PNISEI 884
+SFG++LME+VT G+ P Y M + + + + N E
Sbjct: 369 WSFGILLMEIVTYGRIP---------------YPGMSNPEVIRALERGYRMPRPENCPEE 413
Query: 885 LKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
L I + C P RP+ + +L++
Sbjct: 414 LYN-------IMMRCWKNRPEERPTFEYIQSVLDD 441
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 48/226 (21%), Positives = 88/226 (38%), Gaps = 36/226 (15%)
Query: 637 IGKGGS--GNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
IGKG V +G+ + V+ I + + + + + E+
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRI---------NLEACS------NEMVTFLQGEL 77
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
H N+V + +++ +V ++ GS D + T M+ + I G
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 137
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG-LAKIVQTGE----AGDLTHV 808
K L+Y+HH +HR VK+S+IL+ ++ K ++ ++ G+ D
Sbjct: 138 LKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 809 IAGTHGYIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+++PE Y + KSD+YS G+ EL G P
Sbjct: 195 SVKVLPWLSPEVLQQNLQGY----DAKSDIYSVGITACELANGHVP 236
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 40/235 (17%)
Query: 625 KEIIDAVKPENL------IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTA 677
E +PE + +G+G G+VYK + +G+ +A+K +
Sbjct: 19 DEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---------------- 62
Query: 678 ILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH 737
S E E++ + +VVK Y S +V EY GS+ D + +
Sbjct: 63 ---PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN 119
Query: 738 KI----EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793
K E+ +++ + KGLEYLH IHRD+K+ NILL+ E ++ADFG+
Sbjct: 120 KTLTEDEIATILQSTL-----KGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGV 171
Query: 794 AKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
A Q + + + GT ++APE N +D++S G+ +E+ GK P
Sbjct: 172 AG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 6e-27
Identities = 68/326 (20%), Positives = 128/326 (39%), Gaps = 62/326 (19%)
Query: 618 RVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTA 677
+ E+ + + V E ++G G SG V G+ +AVK
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVK------------------ 45
Query: 678 ILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC 736
+ E+ L+ H NV++ YCS T++ + E N +L D + +
Sbjct: 46 RMLI--DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESK 102
Query: 737 HKIEMDWVVRY-----AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR---- 787
+ + + ++ ++ A G+ +LH +IHRD+K NIL+ +
Sbjct: 103 NVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQ 159
Query: 788 ---------IADFGLAKIVQTGEAGDLTHV--IAGTHGYIAPE-------YAYTCKINEK 829
I+DFGL K + +G++ T++ +GT G+ APE ++
Sbjct: 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219
Query: 830 SDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDA 889
D++S G V +++ + P FGD + + + S D M + D ++ D
Sbjct: 220 IDIFSMGCVFYYILSKGKH--P-FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEAT-DL 275
Query: 890 LKVLRIAIHCTNKLPAFRPSMRVVVQ 915
+ + P RP+ V++
Sbjct: 276 IS------QMIDHDPLKRPTAMKVLR 295
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 70/346 (20%), Positives = 129/346 (37%), Gaps = 75/346 (21%)
Query: 631 VKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEY 689
++ ++ +GG VY+ + SG+E A+K + + +R+
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRL---------------LSNEEEKNRAII- 73
Query: 690 DAEVATLSAVR-HVNVVKLYCSITSEDSN-------LLVYEYLPNGSLWD---RLHTCHK 738
EV + + H N+V+ + + L+ L G L + ++ +
Sbjct: 74 -QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 739 IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798
+ D V++ I + ++++H P+IHRD+K N+LL + ++ DFG A +
Sbjct: 133 LSCDTVLK--IFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189
Query: 799 TGEAGDLTHVIA----------GTHGYIAPE----YAYTCKINEKSDVYSFGVVLMELVT 844
+ T Y PE Y+ I EK D+++ G +L L
Sbjct: 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN-FPIGEKQDIWALGCILYLLCF 248
Query: 845 GKRPIVPEFGDS--KDIVNWVYS--KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCT 900
+ P F D IVN YS D++ ++ + I +L+ +
Sbjct: 249 RQHP----FEDGAKLRIVNGKYSIPPHDTQYTVFHSL---IRAMLQVN------------ 289
Query: 901 NKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKVGESSPSFSRHYNS 946
P R S+ VV L+E + N+ K + Y S
Sbjct: 290 ---PEERLSIAEVVHQLQEI--AAARNVNPKSPITELLEQNGGYGS 330
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-27
Identities = 65/291 (22%), Positives = 98/291 (33%), Gaps = 40/291 (13%)
Query: 132 LTNLEFLSLGDNPFD------PSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQ 185
L SL N F + + K EK + E + + Q
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFS 62
Query: 186 NLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGD 245
L+L+ L +P + ++ LE+ N+L LP ++L L D NRL
Sbjct: 63 ELQLNRLNL-SSLPDNL--PPQITVLEITQNALI-SLPELPASLEYL---DACDNRLS-T 114
Query: 246 LSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNY 305
L EL L L + NQ + +PE L ++ N+LT LP+ S
Sbjct: 115 LPEL--PASLKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTSL---EV 164
Query: 306 VDVSENLLTGPIPPDMCKTGAMTDL--LVLQNNFNGTVPETYANCKSL----IRFRVNNN 359
+ V N LT +P L L + N ++P I FR N
Sbjct: 165 LSVRNNQLTF-LPE------LPESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCREN 217
Query: 360 SLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFS 410
++ IP I SL I L N + + + + FS
Sbjct: 218 RIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 69/416 (16%), Positives = 118/416 (28%), Gaps = 43/416 (10%)
Query: 30 IVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSC--TRL 87
I+ N + + D +K L LK C +
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGE-NRNEAVSLLKECLINQF 61
Query: 88 QVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDP 147
L L + S +PD ++ +++ L + + + P E +LE+L DN
Sbjct: 62 SELQLNRLNLS-SLPD-NLPPQITVLEITQNALI-SLP----ELPASLEYLDACDNRL-- 112
Query: 148 SPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNK 207
S P L L + N +T +PE L+ + +N+L +P L
Sbjct: 113 STLPEL---PASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQL-TMLPELPTSLEV 164
Query: 208 LWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLE------GDLSELRFLNQLSSLHLF 261
L + NN L+ LP +L L DVS N LE
Sbjct: 165 LS---VRNNQLT-FLPELPESLEAL---DVSTNLLESLPAVPVRNHHSEET--EIFFRCR 215
Query: 262 ENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDM 321
EN+ + IPE + L N L+ + + L D + +
Sbjct: 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT--AQPDYHGPRIYFSMSDGQ 272
Query: 322 CKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLS 381
T + F + + N+ S + +
Sbjct: 273 QNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGF 331
Query: 382 TNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQI 437
Q V + + A L + + + + +L L Q
Sbjct: 332 REQ----VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQA 383
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 69/345 (20%), Positives = 109/345 (31%), Gaps = 57/345 (16%)
Query: 198 IPAGIVKLNKLWQLELYNN--SLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQL 255
I I L Q YN + ++N L E +NQ
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC-LINQF 61
Query: 256 SSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315
S L L S +P+ +T L + N L +LP+ S Y+D +N L+
Sbjct: 62 SELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS- 113
Query: 316 PIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNL 375
T+PE A+ K L V+NN L+ +P L
Sbjct: 114 ------------------------TLPELPASLKHL---DVDNNQLT-MLPELP---ALL 142
Query: 376 SIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSG 435
I+ NQ + + + L +L + NN+ + LP SL ++ +S N
Sbjct: 143 EYINADNNQLTM-LPELPTS---LEVLSVRNNQLT-FLPELPE---SLEALDVSTNLLE- 193
Query: 436 QIPLDIGKLKKLSS----LYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGS 491
+P + +N + +P +I S I N LS +I +SL
Sbjct: 194 SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
Query: 492 LPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPL 536
+ + FS T L D +
Sbjct: 253 QTAQPDYHGPRIYFSMSDGQQNTLH-RPLADAVTAWFPENKQSDV 296
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 5e-17
Identities = 53/384 (13%), Positives = 118/384 (30%), Gaps = 46/384 (11%)
Query: 58 CGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNS 117
C + ++ L L ++ + L ++ VL++ N+ +P+L L +L+
Sbjct: 56 CLINQFSELQLNRLNL-SSLPDNL--PPQITVLEITQNALI-SLPEL--PASLEYLDACD 109
Query: 118 SGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLY---------------- 161
+ +S P E +L+ L + +N + P LE +
Sbjct: 110 NRLS-TLP----ELPASLKHLDVDNNQL--TMLPELPALLEYINADNNQLTMLPELPTSL 162
Query: 162 -WLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQ----LELYNN 216
L + N +T +PE +L L ++S N L +PA V+ + + N
Sbjct: 163 EVLSVRNNQLT-FLPELPESLEAL---DVSTNLL-ESLPAVPVRNHHSEETEIFFRCREN 217
Query: 217 SLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEF 276
++ +P +L + N L + E + + +
Sbjct: 218 RIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTL 276
Query: 277 KHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNN 336
++ W F + + + + T + + +
Sbjct: 277 HRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSA--FLDRLSDTVSARNTSGFREQ 334
Query: 337 FNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNA 396
V + R + +++ L+ +L ++ + +
Sbjct: 335 ----VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDN 390
Query: 397 KSLALLLLANNRFSGELPSKISEA 420
+ ALL L F E+ I+
Sbjct: 391 DTGALLSLGREMFRLEILEDIARD 414
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 58/231 (25%), Positives = 102/231 (44%), Gaps = 32/231 (13%)
Query: 625 KEIIDAVKPENL------IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTA 677
+ I+ P+ IG+G SG VY + + +G+E+A++ + + +
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---------NLQQQP- 59
Query: 678 ILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH 737
+ E+ + ++ N+V S D +V EYL GSL D + T
Sbjct: 60 -------KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTET 111
Query: 738 KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
++ + A+ + LE+LH VIHRD+KS NILL ++ ++ DFG
Sbjct: 112 CMDEGQIA--AVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-- 164
Query: 798 QTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
Q + GT ++APE K D++S G++ +E++ G+ P
Sbjct: 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 60/230 (26%), Positives = 96/230 (41%), Gaps = 50/230 (21%)
Query: 637 IGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+G+G G V K+ SG+ +AVK I +T ++ + D +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRI------------RATVNSQEQKRLLMDLDI---S 59
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK----IEMDWVVRYAIAV 751
+ V V Y ++ E + E + + SL I D + + IAV
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAV 116
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA- 810
K LE+LH VIHRDVK SN+L++ + ++ DFG+ +G L +A
Sbjct: 117 SIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGI--------SGYLVDDVAK 166
Query: 811 ----GTHGYIAPE--------YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
G Y+APE Y+ KSD++S G+ ++EL + P
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP 212
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 67/284 (23%), Positives = 106/284 (37%), Gaps = 69/284 (24%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA--E 692
+G+G G V V + + +AVK I+ + + + E
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVK------------------IVDMKRAVDCPENIKKE 55
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY---AI 749
+ + H NVVK Y + L EY G L+DR+ + R+ +
Sbjct: 56 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM 115
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
A G+ YLH + HRD+K N+LLD +I+DFGLA + + L + +
Sbjct: 116 A-----GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 810 AGTHGYIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN-- 861
GT Y+APE + E DV+S G+VL ++ G+ P + D
Sbjct: 168 CGTLPYVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELP----WDQPSDSCQEY 218
Query: 862 ------------WVYSKMDSRD---SMLTVVDPN----ISEILK 886
W +L V +P+ I +I K
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLALLHKIL-VENPSARITIPDIKK 261
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 55/251 (21%), Positives = 96/251 (38%), Gaps = 43/251 (17%)
Query: 613 DMKSFRVLSFSEKEI---IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGF 668
K L+ + I+ ++ +G G G V+K+ +G +AVK +
Sbjct: 6 SGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM------- 58
Query: 669 RGDYRSSTAILSKRSSRSSEYDAEVATL-SAVRHVNVVKLYCSITSEDSNLLVYEYLPNG 727
S + ++ + + +V+ + + + + E +
Sbjct: 59 ---------RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC 109
Query: 728 SLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787
+ + I + + + V K L YL VIHRDVK SNILLD + +
Sbjct: 110 AEKLKKRMQGPIPERILGK--MTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIK 165
Query: 788 IADFGLAKIVQTGEAGDLTHVIA-----GTHGYIAPE-----YAYTCKINEKSDVYSFGV 837
+ DFG+ +G L A G Y+APE + ++DV+S G+
Sbjct: 166 LCDFGI--------SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217
Query: 838 VLMELVTGKRP 848
L+EL TG+ P
Sbjct: 218 SLVELATGQFP 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 57/243 (23%), Positives = 99/243 (40%), Gaps = 47/243 (19%)
Query: 623 SEKEIID--AVKPENLIGKGGSGNVYKVVLNSGKE-----LAVKHIWPSNSGFRGDYRSS 675
+ I+ K ++G G G VYK + E +A+K
Sbjct: 7 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---------------- 50
Query: 676 TAILSKRSSRSSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL 733
L + +S + + E +++V + +V +L I + L+ + +P G L D +
Sbjct: 51 --ELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV 107
Query: 734 HT-CHKIEMDWVVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791
I +++ + V AKG+ YL +HRD+ + N+L+ +I DF
Sbjct: 108 REHKDNIGSQYLLNWC--VQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDF 161
Query: 792 GLAKIVQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-G 845
GLAK++ E G + A E +SDV+S+GV + EL+T G
Sbjct: 162 GLAKLLGAEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 846 KRP 848
+P
Sbjct: 217 SKP 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 51/304 (16%), Positives = 106/304 (34%), Gaps = 53/304 (17%)
Query: 634 ENLIGKGGSGNVYKVV------LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSS 687
+L+G+G VY+ + ++ +K P+N ++ T ++ +
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMER------ 120
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLH-----TCHKIEMD 742
L +K Y + ++ ++LV E G+L + ++ +
Sbjct: 121 --------LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172
Query: 743 WVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP-----------RIADF 791
V+ +A+ + +E +H D +IH D+K N +L + + D
Sbjct: 173 LVISFAMRM--LYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227
Query: 792 GLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
G + ++ G + T G+ E N + D + + ++ G V
Sbjct: 228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287
Query: 852 EFGDSKDIVNWVYSKMDSRDSMLTVVDP--NISEILKEDALKVLRIAI------HCTNKL 903
G ++ ++ D NI + +L +LR + H TNK+
Sbjct: 288 NEGGECKPEG-LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI 346
Query: 904 PAFR 907
A R
Sbjct: 347 RALR 350
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 71/389 (18%), Positives = 124/389 (31%), Gaps = 76/389 (19%)
Query: 83 SCT-RLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLG 141
C+ + + + F VP+ + E L+L + I + +LE L L
Sbjct: 8 ECSAQDRAVLCHRKRFV-AVPE-GIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELN 64
Query: 142 DNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPA 200
+N + G NL L+ L L N L IP
Sbjct: 65 ENIVS--------------------------AVEPGAFNNLFNLRTLGLRSNRL-KLIPL 97
Query: 201 GI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLS 256
G+ L+ L +L++ N + L F +L NL + +V N L +S F LN L
Sbjct: 98 GVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLE 155
Query: 257 SLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315
L L + + IP E L L L + + +
Sbjct: 156 QLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN----------------AIRDYSFKR 198
Query: 316 PIPPDMCKTGAMTDLLVL---QNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWS- 371
+ L VL + T+ +L + + +L+ +P
Sbjct: 199 -----------LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRH 246
Query: 372 LPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKI-SEASSLVSIQLSL 430
L L ++LS N + L + L + + + + L + +S
Sbjct: 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSG 305
Query: 431 NQFSGQIPLDI-GKLKKLSSLYLHDNMFS 458
NQ + + + + L +L L N +
Sbjct: 306 NQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-26
Identities = 63/336 (18%), Positives = 110/336 (32%), Gaps = 50/336 (14%)
Query: 63 LQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGI 120
+ ++LG N + + S L+ L+L N S V + L L L L S+ +
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRL 92
Query: 121 SGKFPWKSLENLTNLEFLSLGDNP---FDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEG 177
P L+NL L + +N F L L L + + + I
Sbjct: 93 K-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQ----DLYNLKSLEVGDNDLV-YISHR 146
Query: 178 I-GNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNF 235
L L+ L L L IP L+ L L L + +++ F L L
Sbjct: 147 AFSGLNSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVL 205
Query: 236 DVSQNRLEGDLSELRFLN-QLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTL 293
++S ++ L+SL + + +P +L L+L N ++
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS--- 261
Query: 294 PQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL--LVLQNNFNGTVPE-TYANCKS 350
+ ++L + L + L V +
Sbjct: 262 -------------TIEGSMLHE-----------LLRLQEIQLVGGQLAVVEPYAFRGLNY 297
Query: 351 LIRFRVNNNSLSGTIPPGI-WSLPNLSIIDLSTNQF 385
L V+ N L+ T+ + S+ NL + L +N
Sbjct: 298 LRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-26
Identities = 73/376 (19%), Positives = 132/376 (35%), Gaps = 90/376 (23%)
Query: 163 LYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGR 221
L L + + + L+ LEL++N + + G L L L L +N L
Sbjct: 37 LDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSNRLK-L 94
Query: 222 LPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEE-FGEFK 277
+P+G F+ L+NL D+S+N++ L + F L L SL + +N I F
Sbjct: 95 IPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLN 152
Query: 278 HLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNF 337
L +L+L LT ++P
Sbjct: 153 SLEQLTLEKCNLT-SIP------------------------------------------- 168
Query: 338 NGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWS-LPNLSIIDLSTNQFEGPVTDDIGNA 396
E ++ LI R+ + +++ I + L L ++++S + +T +
Sbjct: 169 ----TEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223
Query: 397 KSLALLLLANNRFSGELPSK-ISEASSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHD 454
+L L + + + +P + L + LS N S I + +L +L + L
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVG 281
Query: 455 NMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL- 513
L + P + L L LN+S N+ + + S+
Sbjct: 282 G--------------QLAVVE----------PYAFRGLNYLRVLNVSGNQLT-TLEESVF 316
Query: 514 -TYPKLSLLDLSNNQL 528
+ L L L +N L
Sbjct: 317 HSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-26
Identities = 73/352 (20%), Positives = 136/352 (38%), Gaps = 47/352 (13%)
Query: 167 NCSVTG--QIPEGIGNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLP 223
C +PEGI T+ + L+L N + + L +LEL N +S +
Sbjct: 17 LCHRKRFVAVPEGI--PTETRLLDLGKNRI-KTLNQDEFASFPHLEELELNENIVS-AVE 72
Query: 224 VG-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEEFGEFKHLT 280
G F+NL NL + NRL+ + F L+ L+ L + EN+ + F + +L
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK 131
Query: 281 ELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL--LVLQNNFN 338
L + N L +S +G + L L L+
Sbjct: 132 SLEVGDNDLV----------------YISHRAFSG-----------LNSLEQLTLEKCNL 164
Query: 339 GTVP-ETYANCKSLIRFRVNNNSLSGTIPPGIWS-LPNLSIIDLSTNQFEGPVTDDIGNA 396
++P E ++ LI R+ + +++ I + L L ++++S + +T +
Sbjct: 165 TSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223
Query: 397 KSLALLLLANNRFSGELPSK-ISEASSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHD 454
+L L + + + +P + L + LS N S I + +L +L + L
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVG 281
Query: 455 NMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFS 506
+ PY+ L +N + N L+ S+ +L +L L +N +
Sbjct: 282 GQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 52/257 (20%), Positives = 98/257 (38%), Gaps = 17/257 (6%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSM 106
+ V + L L+ + L +N L + L LD+ N + D
Sbjct: 68 VSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQD 126
Query: 107 LHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLK-LEKLYWLYL 165
L+ L L + + + ++ L +LE L+L + P E L L L L L
Sbjct: 127 LYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNL--TSIPTEALSHLHGLIVLRL 183
Query: 166 TNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPV 224
+ ++ I + L +L+ LE+S + + L L + + +L+ +P
Sbjct: 184 RHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY 241
Query: 225 G-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEE-FGEFKHLT 280
+L L ++S N + + L +L + L Q + + F +L
Sbjct: 242 LAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLR 299
Query: 281 ELSLYTNRLTGTLPQKL 297
L++ N+LT TL + +
Sbjct: 300 VLNVSGNQLT-TLEESV 315
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 51/325 (15%), Positives = 104/325 (32%), Gaps = 68/325 (20%)
Query: 632 KPENLIGKGGSGNVYKVV-LNSGKELAVKHI----------------------------- 661
+P +G+GG G V++ A+K I
Sbjct: 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 68
Query: 662 ----------WPSNSGFRGDYRSSTAILSKRSSRSSEYDA--EVATLSAVRHVNVVKLYC 709
+ + SS S ++ + N V
Sbjct: 69 YFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQ 128
Query: 710 SITSEDSNLLVYEYLPNGSLWDRL-HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPV 768
+ + + + +L D + C + + V I + A+ +E+LH + +
Sbjct: 129 PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGL 185
Query: 769 IHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA----------GTHGYIAP 818
+HRD+K SNI ++ ++ DFGL + E GT Y++P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 819 EYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDS------ 872
E + + K D++S G++L EL+ + D+ N + + ++
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMM 305
Query: 873 --MLTVVDPN----ISEILKEDALK 891
+ P ++I++ +
Sbjct: 306 VQDMLSPSPTERPEATDIIENAIFE 330
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 36/233 (15%)
Query: 625 KEIIDAVKPENL------IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTA 677
+ ++D P L IG+G +G V +SG+++AVK + D R
Sbjct: 35 RMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---------DLRKQQ- 84
Query: 678 ILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH 737
R EV + +H NVV++Y S + ++ E+L G+L D +
Sbjct: 85 -------RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR 137
Query: 738 KIE--MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795
E + V + + L YLH + VIHRD+KS +ILL L+ + +++DFG
Sbjct: 138 LNEEQIATVCEAVL-----QALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 189
Query: 796 IVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
Q + + GT ++APE + D++S G++++E+V G+ P
Sbjct: 190 --QISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 637 IGKGGSGNVYKVVLNSGKEL---AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
+G G G V K K + AVK + + + + E AE
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKIL-------KNEANDP--------ALKDELLAEA 69
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
+ + + +V++ +E S +LV E G L L ++ ++
Sbjct: 70 NVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV--HQV 126
Query: 754 AKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGT 812
+ G++YL F +HRD+ + N+LL + +I+DFGL+K ++ E + A T
Sbjct: 127 SMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADE----NYYKAQT 178
Query: 813 HGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
HG APE K + KSDV+SFGV++ E + G++P
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 62/289 (21%), Positives = 114/289 (39%), Gaps = 32/289 (11%)
Query: 25 CKFNGIVCDSNGLVAEI--NLPE--QQL------LGVVPFDSICGLQALQKINLGTNFLY 74
C + C GL ++ +LP L + + L+ L + L N +
Sbjct: 31 CHLRVVQCSDLGL-EKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI- 88
Query: 75 GTITEG-LKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLT 133
I+ G +L+ L L N E+P+ M L L ++ + I+ K L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPE-KMPKTLQELRVHENEIT-KVRKSVFNGLN 145
Query: 134 NLEFLSLGDNPFDPSPFPMEVLK-LEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDN 192
+ + LG NP S + ++KL ++ + + ++T IP+G+ L L L N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 202
Query: 193 ELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELR 250
++ ++ A LN L +L L NS+S + G +N +L ++ N+L L
Sbjct: 203 KI-TKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLA 260
Query: 251 FLNQLSSLHLFENQFSGEIPEE-------FGEFKHLTELSLYTNRLTGT 292
+ ++L N S I + + +SL++N +
Sbjct: 261 DHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 308
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 71/336 (21%), Positives = 130/336 (38%), Gaps = 51/336 (15%)
Query: 183 QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRL 242
L+ ++ SD L ++P + L+L NN ++ F NL NL + N++
Sbjct: 32 HLRVVQCSDLGL-EKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 243 EGDLSELRF--LNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSW 300
+S F L +L L+L +NQ E+PE+ K L EL ++ N +T + + +
Sbjct: 89 S-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRK--SVF 141
Query: 301 ADFN---YVDVSENLLT-GPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRV 356
N V++ N L I + K L R+
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENG-----------------------AFQGMKKLSYIRI 178
Query: 357 NNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSK 416
+ +++ TIP G+ P+L+ + L N+ + +LA L L+ N S
Sbjct: 179 ADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 235
Query: 417 ISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSG------PLPYSIGSCVS 470
++ L + L+ N+ ++P + K + +YLH+N S P S
Sbjct: 236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 294
Query: 471 LTDINFAQNSLSGKI--PDSLGSLPSLNSLNLSNNK 504
+ ++ N + P + + ++ L N K
Sbjct: 295 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 29/143 (20%), Positives = 53/143 (37%), Gaps = 14/143 (9%)
Query: 60 LQALQKINLGTNFLYGTITEG-LKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLN 116
+L +++L N + + LK L L L NS S V + L+ L L+LN
Sbjct: 191 PPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLN 248
Query: 117 SSGISGKFPWKSLENLTNLEFLSLGDNP---FDPSPF--PMEVLKLEKLYWLYLT-NCSV 170
++ + K P L + ++ + L +N + F P K + L N
Sbjct: 249 NNKLV-KVP-GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
Query: 171 TGQIPEGI-GNLTQLQNLELSDN 192
+I + ++L +
Sbjct: 307 YWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 23/107 (21%), Positives = 41/107 (38%), Gaps = 5/107 (4%)
Query: 422 SLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSL 481
L +Q S ++P D+ + L L +N + + +L + N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 482 SGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQL 528
S P + L L L LS N+ E+P + L L + N++
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM-PKTLQELRVHENEI 133
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 19/103 (18%), Positives = 39/103 (37%), Gaps = 9/103 (8%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFS-------GEV 101
+ V S+ L++++L N L + GL +QV+ L NN+ S
Sbjct: 228 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 286
Query: 102 PDLSMLHELSFLNLNSSGIS-GKFPWKSLENLTNLEFLSLGDN 143
+ S ++L S+ + + + + + LG+
Sbjct: 287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 57/290 (19%), Positives = 96/290 (33%), Gaps = 62/290 (21%)
Query: 605 HSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWP 663
H +S ++ S E+ + IG+G G V + + A+K +
Sbjct: 2 HHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIM-- 59
Query: 664 SNSGFRGDYRSSTAILSKRSSRSSE-YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYE 722
+ + + + + E EV + + H N+ +LY E LV E
Sbjct: 60 -----------NKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVME 108
Query: 723 YLPNGSLWDRLHTCHKIEMDWVVRYAIAVG------------------------------ 752
G L D+L+ +
Sbjct: 109 LCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREK 168
Query: 753 -AAK-------GLEYLHHGFDRPVIHRDVKSSNILL--DLEWKPRIADFGLAKIVQTGEA 802
+ L YLH ++ + HRD+K N L + ++ ++ DFGL+K
Sbjct: 169 LISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225
Query: 803 GD--LTHVIAGTHGYIAPE--YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
G+ AGT ++APE K D +S GV+L L+ G P
Sbjct: 226 GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 77/343 (22%), Positives = 139/343 (40%), Gaps = 67/343 (19%)
Query: 596 VKLKQNNLKHSLKQNSWDMKSFRVLSFSEKEII-DAVKPENLIGKGGSGNVYKVVLNSGK 654
+ K + + ++++ SF +EI + E +IG G SG V L
Sbjct: 16 FQGKLPEPQFYAEPHTYEEPGRAGRSF-TREIEASRIHIEKIIGSGDSGEVCYGRLRVPG 74
Query: 655 EL----AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710
+ A+K + + + ++ +E + + H N+++L
Sbjct: 75 QRDVPVAIKALKAGYT----------------ERQRRDFLSEASIMGQFDHPNIIRLEGV 118
Query: 711 ITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYL-HHGFDRPVI 769
+T ++V EY+ NGSL L T H + + + G G+ YL G+ +
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLGY----V 173
Query: 770 HRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYI-----APEYAYTC 824
HRD+ + N+L+D +++DFGL+++++ D T G I APE
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLE----DDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 825 KINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVD----- 878
+ SDV+SFGVV+ E++ G+RP Y M +RD + +V +
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERP---------------YWNMTNRDVISSVEEGYRLP 274
Query: 879 --PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
L + + + C +K A RP +V +L+
Sbjct: 275 APMGCPHALHQ-------LMLDCWHKDRAQRPRFSQIVSVLDA 310
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 78/320 (24%), Positives = 127/320 (39%), Gaps = 59/320 (18%)
Query: 623 SEKEIID--AVKPENLIGKGGSGNVYKVVLN--SGKEL--AVKHIWPSNSGFRGDYRSST 676
S +I ++ +G G G V + + SGK + AVK + + D S
Sbjct: 10 SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-------KPDVLSQ- 61
Query: 677 AILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT- 735
++ EV + ++ H N+++LY + +V E P GSL DRL
Sbjct: 62 ------PEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKH 114
Query: 736 CHKIEMDWVVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA 794
+ + RYA V A+G+ YL F IHRD+ + N+LL +I DFGL
Sbjct: 115 QGHFLLGTLSRYA--VQVAEGMGYLESKRF----IHRDLAARNLLLATRDLVKIGDFGLM 168
Query: 795 KIVQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ + + H + H + APE T + SD + FGV L E+ T G+ P
Sbjct: 169 RALPQND----DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
Query: 849 IVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILK--EDALKVL-RIAIHCTNKLPA 905
+ ++ + + E L ED + + + + C P
Sbjct: 225 ---------------WIGLNGSQILHKIDKEG--ERLPRPEDCPQDIYNVMVQCWAHKPE 267
Query: 906 FRPSMRVVVQMLEEAEPCSV 925
RP+ + L EA+P +
Sbjct: 268 DRPTFVALRDFLLEAQPTDM 287
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-26
Identities = 62/286 (21%), Positives = 110/286 (38%), Gaps = 31/286 (10%)
Query: 25 CKFNGIVCDSNGLVAEI--NLPE--QQL------LGVVPFDSICGLQALQKINLGTNFLY 74
C + C GL + + L + + D GLQ L + L N +
Sbjct: 33 CHLRVVQCSDLGL-KAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI- 90
Query: 75 GTITEG-LKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLT 133
I E +LQ L + N E+P ++ L L ++ + I K P L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPP-NLPSSLVELRIHDNRIR-KVPKGVFSGLR 147
Query: 134 NLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNE 193
N+ + +G NP + S F KL +L ++ +T IP+ + L L L N+
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNK 204
Query: 194 LFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF 251
+ I ++ +KL++L L +N + + G S L L + N+L + L
Sbjct: 205 I-QAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSRVPAGLPD 262
Query: 252 LNQLSSLHLFENQFSGEIPEE-------FGEFKHLTELSLYTNRLT 290
L L ++L N + ++ + + +SL+ N +
Sbjct: 263 LKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 69/380 (18%), Positives = 121/380 (31%), Gaps = 110/380 (28%)
Query: 133 TNLEFLSLGDNPF---DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLE 188
+ L L +N F L+ LY L L N ++ +I E L +LQ L
Sbjct: 54 PDTTLLDLQNNDISELRKDDFK----GLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLY 108
Query: 189 LSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRL-EGDL 246
+S N L EIP + + L +L +++N + ++P G FS L N+ ++ N L
Sbjct: 109 ISKNHL-VEIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGF 164
Query: 247 SELRFLN-QLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNY 305
F +L+ L + E + + IP+ + L EL L N++
Sbjct: 165 EPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQA-------------- 207
Query: 306 VDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTI 365
I + L R + +N + I
Sbjct: 208 -----------IELE-----------------------DLLRYSKLYRLGLGHNQIR-MI 232
Query: 366 PPGI-WSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLV 424
G LP L + L N+ V + + K L ++ L N +
Sbjct: 233 ENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-------------- 277
Query: 425 SIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGK 484
++ +N F K + + L +N V ++
Sbjct: 278 --KVGVNDFCPVGFGV--KRAYYNGISLFNNP------------VPYWEVQ--------- 312
Query: 485 IPDSLGSLPSLNSLNLSNNK 504
P + + ++ N K
Sbjct: 313 -PATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 63/358 (17%), Positives = 119/358 (33%), Gaps = 95/358 (26%)
Query: 183 QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRL 242
L+ ++ SD L +P I L+L NN +S F L +L + N
Sbjct: 34 HLRVVQCSDLGL-KAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN-- 88
Query: 243 EGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWAD 302
++S +H + F + L +L + N L
Sbjct: 89 -----------KISKIH----------EKAFSPLRKLQKLYISKNHLVE----------- 116
Query: 303 FNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLS 362
IPP++ SL+ R+++N +
Sbjct: 117 --------------IPPNL---------------P-----------SSLVELRIHDNRIR 136
Query: 363 GTIPPGIWS-LPNLSIIDLSTNQF-EGPVTDDIGNAKSLALLLLANNRFSGELPSKISEA 420
+P G++S L N++ I++ N + L L ++ + + +P +
Sbjct: 137 -KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--P 192
Query: 421 SSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479
+L + L N+ I L+ + KL L L N S+ +L +++ N
Sbjct: 193 ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNN 251
Query: 480 SLSGKIPDSLGSLPSLNSLNLSNNKFSGEIP--------ISLTYPKLSLLDLSNNQLA 529
LS ++P L L L + L N + ++ + + + L NN +
Sbjct: 252 KLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 17/104 (16%), Positives = 41/104 (39%), Gaps = 11/104 (10%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNN--------SFSGE 100
+ ++ S+ L L++++L N L + GL LQV+ L N F
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV 287
Query: 101 VPDLSMLHELSFLNLNSSGIS-GKFPWKSLENLTNLEFLSLGDN 143
+ + + ++L ++ + + + +T+ + G+
Sbjct: 288 GFGVKRAY-YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 70/304 (23%), Positives = 117/304 (38%), Gaps = 71/304 (23%)
Query: 634 ENLIGKGGSGNVYKVVLNSGK-ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
++ +G G G VY+ V +AVK L + + E+ E
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVK------------------TLKEDTMEVEEFLKE 59
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVG 752
A + ++H N+V+L T E ++ E++ G+L D L C++ E+ VV +A
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGT 812
+ +EYL + IHRD+ + N L+ ++ADFGL++++ A
Sbjct: 120 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT------YTAHA 170
Query: 813 HGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866
APE K + KSDV++FGV+L E+ T G P Y
Sbjct: 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---------------YPG 215
Query: 867 MDSRDSMLTVVD-----------PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
+D + + E+++ C P+ RPS + Q
Sbjct: 216 IDLSQVYELLEKDYRMERPEGCPEKVYELMRA-----------CWQWNPSDRPSFAEIHQ 264
Query: 916 MLEE 919
E
Sbjct: 265 AFET 268
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 67/284 (23%), Positives = 106/284 (37%), Gaps = 69/284 (24%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA--E 692
+G+G G V V + + +AVK I+ + + + E
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVK------------------IVDMKRAVDCPENIKKE 55
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY---AI 749
+ + H NVVK Y + L EY G L+DR+ + R+ +
Sbjct: 56 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM 115
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
A G+ YLH + HRD+K N+LLD +I+DFGLA + + L + +
Sbjct: 116 A-----GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 810 AGTHGYIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN-- 861
GT Y+APE + E DV+S G+VL ++ G+ P + D
Sbjct: 168 CGTLPYVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELP----WDQPSDSCQEY 218
Query: 862 ------------WVYSKMDSRD---SMLTVVDPN----ISEILK 886
W +L V +P+ I +I K
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLALLHKIL-VENPSARITIPDIKK 261
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 72/292 (24%), Positives = 109/292 (37%), Gaps = 60/292 (20%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVK-----HIWPSNSGFRGDYRSSTAILSKRSSRSSEY 689
IGKG G V N A+K + R T +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 690 DA----EVATLSAVRHVNVVKLYCSI-TSEDSNL-LVYEYLPNGSLWDRLHTCHKIEMDW 743
E+A L + H NVVKL + + +L +V+E + G + + T + D
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQ 138
Query: 744 VVRYA---IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG 800
Y I G+EYLH+ + +IHRD+K SN+L+ + +IADFG++ +
Sbjct: 139 ARFYFQDLIK-----GIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 801 EAGDLTHVIAGTHGYIAPEYAYTCKINEK------SDVYSFGVVLMELVTGKRPIVPEFG 854
+A L GT ++APE + K DV++ GV L V G+ P F
Sbjct: 191 DA--LLSNTVGTPAFMAPE---SLSETRKIFSGKALDVWAMGVTLYCFVFGQCP----FM 241
Query: 855 DS------KDIVN-------WVYSKMDSRD---SMLTVVDPN----ISEILK 886
D I + D +D ML +P + EI
Sbjct: 242 DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRML-DKNPESRIVVPEIKL 292
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 33/315 (10%), Positives = 82/315 (26%), Gaps = 58/315 (18%)
Query: 615 KSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDY- 672
+ FRV S + V+ ++G+ + +G+ V + +
Sbjct: 60 QPFRVESELGERPRTLVRGT-VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 673 --RSSTAILSKRSSRSSEYDA--------EVATLSAVRHVNVVKLYCSITSEDS-NLLVY 721
+ L ++ A + + ++++ +
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 722 EYLPNGSLWDRL-----HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776
+L H+ + R + + + L LHH ++H ++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPV 235
Query: 777 NILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEY-----------AYTCK 825
+I+LD + F V + + G+ PE
Sbjct: 236 DIVLDQRGGVFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTL 289
Query: 826 INEKSDVYSFGVVLMELVTGKRPIVPEFGDS--KDIVNWVYSKMDS-----RD---SMLT 875
+ D ++ G+V+ + P W++ + R L
Sbjct: 290 MTFSFDAWALGLVIYWIWCADLP----ITKDAALGGSEWIFRSCKNIPQPVRALLEGFLR 345
Query: 876 VVDPN----ISEILK 886
+ ++
Sbjct: 346 -YPKEDRLLPLQAME 359
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 85/462 (18%), Positives = 143/462 (30%), Gaps = 46/462 (9%)
Query: 85 TRLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDN 143
R + L L NS S D+S L EL L L+ + I + +LE+L + N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN 110
Query: 144 -----PFDPSPFPMEVLKLEKLYWLYL-TNCSVTGQIPEGIGNLTQLQNLELSDNELFGE 197
P + L L L N + + GNLT+L L LS +
Sbjct: 111 RLQNISCCP---------MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL 161
Query: 198 IPAGIVKLNKLW-QLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLS 256
+ L+ L+L + + G + V + +N L
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221
Query: 257 SLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGP 316
L L + + E + F +T +++ +
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT------------LQHIETTWKCSVKL 269
Query: 317 IPPDMCKTGAMTDLLVLQNNFNGTVPETYANC-----KSLIRFRVNNNSLSGTIPPGIWS 371
+ L + + KSL+ V N +
Sbjct: 270 FQFF--WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSV 327
Query: 372 LPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLN 431
++I LS + + S L N F+ + S L ++ L N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 432 QFSGQIPLDIGKLKKLSSLYLHDNMF----SGPLPYSIGSCVSLTDINFAQNSLSGKIPD 487
K +SSL D S + S+ +N + N L+G +
Sbjct: 388 GLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR 446
Query: 488 SLGSLPSLNSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQL 528
L P + L+L NN+ IP +T+ L L++++NQL
Sbjct: 447 CL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 85/473 (17%), Positives = 168/473 (35%), Gaps = 56/473 (11%)
Query: 54 FDSICGLQALQKINLGTNFLYGTITEGL-KSCTRLQVLDLGNNSFSGEVPDLSMLHELSF 112
L L+ + L N + ++ + L+ LD+ +N L +S
Sbjct: 72 ISF---LSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNR----------LQNISC 117
Query: 113 LNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTG 172
+ +L L L N FD P E L KL +L L+
Sbjct: 118 -----------------CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160
Query: 173 QIPEGIGNLTQLQN-LELSDNELFGEIPAGIVKLN--KLWQLELYNNSLSGRLPVGFSNL 229
+ +L L+L + G + N L + N+ S ++ + + L
Sbjct: 161 LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL 220
Query: 230 TNLMNFDV-----SQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEF---KHLTE 281
+L ++ + RL LSEL L ++ L + + + + +F + +
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY 280
Query: 282 LSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGP----IPPDMCKTGAMTDLLVLQNNF 337
L++Y +T + ++ ++++ + + + A ++ +L +
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340
Query: 338 NGTVPET-YANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFE--GPVTDDIG 394
+ + S N + ++ G +L L + L N + V
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400
Query: 395 NAKSLALLLLANNRF-SGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLH 453
N SL L ++ N S + A S++ + LS N +G + + K+ L LH
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLH 458
Query: 454 DNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPD-SLGSLPSLNSLNLSNNKF 505
+N +P + +L ++N A N L +PD L SL + L +N +
Sbjct: 459 NNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 8e-20
Identities = 67/388 (17%), Positives = 123/388 (31%), Gaps = 35/388 (9%)
Query: 167 NCSVTG--QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPV 224
+ S +P+ + + + L LS N + I L++L L L +N + L
Sbjct: 37 DYSNRNLTHVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93
Query: 225 G-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQF-SGEIPEEFGEFKHLT 280
F +L DVS NRL + + L L L N F + +EFG LT
Sbjct: 94 HVFLFNQDLEYLDVSHNRL----QNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLT 149
Query: 281 ELSLYTNRLTGTLPQKLGS-WADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNG 339
L L + + +D+ + G + LV N
Sbjct: 150 FLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLF 209
Query: 340 TVPE----TYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGN 395
+V L ++N+ + + ++++++ E +
Sbjct: 210 SVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL 269
Query: 396 AKSLAL-----LLLANNRFSGELPSKISEAS-----SLVSIQLSLNQFSGQIPLDIGKLK 445
+ L + N + + + S SL+ + F
Sbjct: 270 FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFA 329
Query: 446 KLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKF 505
+++ L + S S T +NF QN + + +L L +L L N
Sbjct: 330 EMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
Query: 506 S-----GEIPISLTYPKLSLLDLSNNQL 528
+ +++ L LD+S N L
Sbjct: 390 KNFFKVALMTKNMSS--LETLDVSLNSL 415
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 38/156 (24%), Positives = 63/156 (40%), Gaps = 24/156 (15%)
Query: 6 KIEKSDTGVFSSWTEANSVCKFNGIVCDSNGL-----VAEINLPEQQL---------LGV 51
S S+ ++ + NGL VA + L L
Sbjct: 364 VFTDSVFQGCSTLKRLQTL------ILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS 417
Query: 52 VPFDSICGLQA-LQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHEL 110
+D C + +NL +N L G++ L +++VLDL NN D++ L L
Sbjct: 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIMSIPKDVTHLQAL 475
Query: 111 SFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFD 146
LN+ S+ + P + LT+L+++ L DNP+D
Sbjct: 476 QELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 34/190 (17%), Positives = 58/190 (30%), Gaps = 39/190 (20%)
Query: 343 ETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALL 402
E+ + +N +L+ +P + P + LS N DI L +L
Sbjct: 33 ESMVDY--------SNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVL 81
Query: 403 LLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLP 462
L++NR L + F + L L + N +
Sbjct: 82 RLSHNRIR-SLDFHV---------------FL--------FNQDLEYLDVSHNRLQN-IS 116
Query: 463 YSIGSCVSLTDINFAQNSL-SGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLL 521
SL ++ + N + G+L L L LS KF + + + LS +
Sbjct: 117 --CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCI 174
Query: 522 DLSNNQLAGP 531
L
Sbjct: 175 LLDLVSYHIK 184
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 30/219 (13%)
Query: 636 LIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS---SRSSEY-D 690
++G+G V + +E A+K IL KR Y
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIK------------------ILEKRHIIKENKVPYVT 78
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR-YAI 749
E +S + H VKLY + ++ Y NG L + + R Y
Sbjct: 79 RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-CTRFYTA 137
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
+ +A LEYLH + +IHRD+K NILL+ + +I DFG AK++ +
Sbjct: 138 EIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 810 AGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT Y++PE + SD+++ G ++ +LV G P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 59/236 (25%), Positives = 107/236 (45%), Gaps = 34/236 (14%)
Query: 624 EKEII-DAVKPENLIGKGGSGNVYKVVLNSGKEL-----AVKHIWPSNSGFRGDYRSSTA 677
EI V + +IG G G VYK +L + A+K + +
Sbjct: 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT----------- 86
Query: 678 ILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH 737
+ ++ E + H N+++L I+ +++ EY+ NG+L L
Sbjct: 87 -----EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-K 140
Query: 738 KIEMDWVVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
E + + G A G++YL + + +HRD+ + NIL++ +++DFGL+++
Sbjct: 141 DGEFSVLQLVGMLRGIAAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRV 196
Query: 797 VQTGEAGDLTHVIAGTHGYI---APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
++ + T+ +G I APE K SDV+SFG+V+ E++T G+RP
Sbjct: 197 LEDDP--EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 66/259 (25%), Positives = 104/259 (40%), Gaps = 36/259 (13%)
Query: 598 LKQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKEL 656
+ ++ Q ++ + + + + +G G G V + E
Sbjct: 6 HHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVER 65
Query: 657 AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA---EVATLSAVRHVNVVKLYCSITS 713
A+K I+ K S +S EVA L + H N++KLY
Sbjct: 66 AIK------------------IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107
Query: 714 EDSNLLVYEYLPNGSLWDRLHTCHKI-EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRD 772
+ + LV E G L+D + K E+D V G+ YLH ++HRD
Sbjct: 108 KRNYYLVMECYKGGELFDEIIHRMKFNEVD-AAVIIKQV--LSGVTYLH---KHNIVHRD 161
Query: 773 VKSSNILL---DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEK 829
+K N+LL + + +I DFGL+ + + + GT YIAPE K +EK
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEK 217
Query: 830 SDVYSFGVVLMELVTGKRP 848
DV+S GV+L L+ G P
Sbjct: 218 CDVWSIGVILFILLAGYPP 236
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 66/255 (25%), Positives = 104/255 (40%), Gaps = 19/255 (7%)
Query: 599 KQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELA 657
++ + +L + + E +I ++ +G G G V N E A
Sbjct: 6 HHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKA 65
Query: 658 VKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSN 717
+K I S F S ++ E++ L ++ H N++KL+ +
Sbjct: 66 IKVI--KKSQFDKGRYSDDNKNIEKFHEEIY--NEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 718 LLVYEYLPNGSLWDRLHTCHKI-EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776
LV E+ G L++++ HK E D + G+ YLH ++HRD+K
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDECD-AANIMKQI--LSGICYLH---KHNIVHRDIKPE 175
Query: 777 NILL---DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVY 833
NILL + +I DFGL+ GT YIAPE K NEK DV+
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPE-VLKKKYNEKCDVW 231
Query: 834 SFGVVLMELVTGKRP 848
S GV++ L+ G P
Sbjct: 232 SCGVIMYILLCGYPP 246
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 61/273 (22%), Positives = 110/273 (40%), Gaps = 51/273 (18%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
L+G GG G+VY + ++ +A+KH+ G+ + T + EV
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV--PM---------EVV 98
Query: 695 TLSAVRHV--NVVKLYCSITSEDSNLLVYEY-LPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
L V V++L DS +L+ E P L+D + ++ + + V
Sbjct: 99 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE-WKPRIADFGLAKIVQTGEAGDLTHVIA 810
A + + H + V+HRD+K NIL+DL + ++ DFG +++ +
Sbjct: 159 LEA--VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFD 209
Query: 811 GTHGYIAPEY----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY-- 864
GT Y PE+ Y + + V+S G++L ++V G P F ++I+
Sbjct: 210 GTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFF 262
Query: 865 ----SKMDSRD---SMLTVVDPN----ISEILK 886
S + + L + P+ EI
Sbjct: 263 RQRVSS-ECQHLIRWCL-ALRPSDRPTFEEIQN 293
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 70/288 (24%), Positives = 107/288 (37%), Gaps = 73/288 (25%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA--- 691
L+G+G G V +V+ + AVK IL K+ R
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVK------------------ILKKKKLRRIPNGEANV 53
Query: 692 --EVATLSAVRHVNVVKLYCSITSEDSN--LLVYEYLPNGSLWDRLHTCHKIEM-DWVVR 746
E+ L +RH NV++L + +E+ +V EY G EM D V
Sbjct: 54 KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQ----------EMLDSVPE 103
Query: 747 YAIAVGAAK--------GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798
V A GLEYLH + ++H+D+K N+LL +I+ G+A+ +
Sbjct: 104 KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
Query: 799 TGEAGDLTHVIAGTHGYIAPEYAYTCKINE--KSDVYSFGVVLMELVTGKRPIVPEFGDS 856
A D G+ + PE A K D++S GV L + TG P F
Sbjct: 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP----FEGD 216
Query: 857 ------KDIVNWVYS-----KMDSRD---SMLTVVDP----NISEILK 886
++I Y+ D ML +P +I +I +
Sbjct: 217 NIYKLFENIGKGSYAIPGDCGPPLSDLLKGML-EYEPAKRFSIRQIRQ 263
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 51/227 (22%), Positives = 98/227 (43%), Gaps = 40/227 (17%)
Query: 634 ENLIGKGGSGNVYKVVLNSGKEL---AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+ +G G G+V + V K+ A+K +L + + ++ +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIK------------------VLKQGTEKADTEE 56
Query: 691 --AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA 748
E + + + +V+L +E + +LV E G L L + E+
Sbjct: 57 MMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAE 114
Query: 749 IAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
+ + G++YL F +HRD+ + N+LL +I+DFGL+K + ++ +
Sbjct: 115 LLHQVSMGMKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDS----Y 166
Query: 808 VIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
A + G APE K + +SDV+S+GV + E ++ G++P
Sbjct: 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 55/237 (23%), Positives = 107/237 (45%), Gaps = 37/237 (15%)
Query: 625 KEIIDAVKPENL------IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTA 677
+ + + P + +G G G VYK +G A K I + +S
Sbjct: 9 EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---------ETKSEEE 59
Query: 678 ILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH 737
+ +Y E+ L+ H +VKL + + ++ E+ P G++ +
Sbjct: 60 L--------EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD 111
Query: 738 KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL-AKI 796
+ + ++ + + L +LH + +IHRD+K+ N+L+ LE R+ADFG+ AK
Sbjct: 112 RGLTEPQIQV-VCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167
Query: 797 VQTGEAGDLTHVIAGTHGYIAPEYAYTCKI-----NEKSDVYSFGVVLMELVTGKRP 848
++T + D + + GT ++APE + + K+D++S G+ L+E+ + P
Sbjct: 168 LKTLQKRD-SFI--GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 60/262 (22%), Positives = 104/262 (39%), Gaps = 54/262 (20%)
Query: 603 LKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHI 661
+ H +S + + + I +G G G+V+ V +SG E +K
Sbjct: 1 MHHHHHHSSGRENLYFQGTIDDLFIFKRK-----LGSGAFGDVHLVEERSSGLERVIK-- 53
Query: 662 WPSNSGFRGDYRSSTAILSKRSSRSSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLL 719
++K S+ AE+ L ++ H N++K++ + +
Sbjct: 54 ----------------TINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97
Query: 720 VYEYLPNGSLWDRLHTCHKI-----EMD--WVVRYAIAVGAAKGLEYLHHGFDRPVIHRD 772
V E G L +R+ + E +++ + L Y H + V+H+D
Sbjct: 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA-----LAYFH---SQHVVHKD 149
Query: 773 VKSSNILL---DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE---YAYTCKI 826
+K NIL +I DFGLA++ ++ E + AGT Y+APE
Sbjct: 150 LKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFKRDV---- 202
Query: 827 NEKSDVYSFGVVLMELVTGKRP 848
K D++S GVV+ L+TG P
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLP 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 50/234 (21%), Positives = 95/234 (40%), Gaps = 45/234 (19%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKEL----AVKHIWPSNSGFRGDYRSSTAILSKRSS 684
+ V ++G+G G VY+ V + K AVK K +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK------------------TCKKDCT 53
Query: 685 RSSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT-CHKIEM 741
++ +E + + H ++VKL I E+ ++ E P G L L + +++
Sbjct: 54 LDNKEKFMSEAVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKV 112
Query: 742 DWVVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG 800
+V Y++ K + YL +HRD+ NIL+ ++ DFGL++ ++
Sbjct: 113 LTLVLYSL--QICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166
Query: 801 EAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ + + +PE + SDV+ F V + E+++ GK+P
Sbjct: 167 DY------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 72/333 (21%), Positives = 125/333 (37%), Gaps = 64/333 (19%)
Query: 602 NLKHSLKQNSWDMKSFRVLSFSEKEI-IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVK 659
L + + + ++ + E+ + ++ +G G G VY+ V +AVK
Sbjct: 192 TLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK 251
Query: 660 HIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLL 719
+ + D L E A + ++H N+V+L T E +
Sbjct: 252 TL-------KEDTMEVEEFLK-----------EAAVMKEIKHPNLVQLLGVCTREPPFYI 293
Query: 720 VYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779
+ E++ G+L D L C++ E+ VV +A + +EYL + IHR++ + N L
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCL 350
Query: 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYS 834
+ ++ADFGL++++ A APE K + KSDV++
Sbjct: 351 VGENHLVKVADFGLSRLMTGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404
Query: 835 FGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVD-------PNISEILK 886
FGV+L E+ T G P Y +D + E +
Sbjct: 405 FGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRMERPEGCPEKVY 449
Query: 887 EDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
E + C P+ RPS + Q E
Sbjct: 450 E-------LMRACWQWNPSDRPSFAEIHQAFET 475
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 57/320 (17%), Positives = 119/320 (37%), Gaps = 76/320 (23%)
Query: 620 LSFSEKEI-IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI 678
L + EI + +G G G V ++A+K +
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIK------------------M 55
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC-H 737
+ + S E+ E + + H +V+LY T + ++ EY+ NG L + L H
Sbjct: 56 IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH 115
Query: 738 KIEMDWVVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
+ + ++ + + +EYL F +HRD+ + N L++ + +++DFGL++
Sbjct: 116 RFQTQQLLE--MCKDVCEAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRY 169
Query: 797 VQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIV 850
V E + PE K + KSD+++FGV++ E+ + GK P
Sbjct: 170 VLDDE------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-- 221
Query: 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVD-----------PNISEILKEDALKVLRIAIHC 899
Y + + ++ + + I+ C
Sbjct: 222 -------------YERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS-----------C 257
Query: 900 TNKLPAFRPSMRVVVQMLEE 919
++ RP+ ++++ + +
Sbjct: 258 WHEKADERPTFKILLSNILD 277
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-25
Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 69/305 (22%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE 688
+K IGKG G+V G ++AVK I K + +
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI-------------------KNDATAQA 232
Query: 689 YDAEVATLSAVRHVNVVKLYCSITSEDSNL-LVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
+ AE + ++ +RH N+V+L I E L +V EY+ GSL D L + + +
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 292
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL-- 805
++ + +EYL +HRD+ + N+L+ + +++DFGL K + +
Sbjct: 293 KFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 349
Query: 806 ---THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVN 861
T APE K + KSDV+SFG++L E+ + G+ P
Sbjct: 350 VKWT----------APEALREKKFSTKSDVWSFGILLWEIYSFGRVP------------- 386
Query: 862 WVYSKMDSRDSMLTVVD-------PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVV 914
Y ++ +D + V + + + +C + A RP+ +
Sbjct: 387 --YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYD-------VMKNCWHLDAATRPTFLQLR 437
Query: 915 QMLEE 919
+ LE
Sbjct: 438 EQLEH 442
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 40/227 (17%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE 688
+K IGKG G+V G ++AVK I K + +
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI-------------------KNDATAQA 60
Query: 689 YDAEVATLSAVRHVNVVKLYCSITSEDSNL-LVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
+ AE + ++ +RH N+V+L I E L +V EY+ GSL D L + + +
Sbjct: 61 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 120
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
++ + +EYL +HRD+ + N+L+ + +++DFGL K + +
Sbjct: 121 KFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---- 173
Query: 808 VIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
G + APE K + KSDV+SFG++L E+ + G+ P
Sbjct: 174 ------GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-25
Identities = 80/316 (25%), Positives = 132/316 (41%), Gaps = 68/316 (21%)
Query: 620 LSFSEKEI-IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI 678
L+ EI ++++ E +G+G G V+ N +A+K + + S A
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-------KPGTMSPEAF 226
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWD--RLHTC 736
L E + +RH +V+LY ++ SE+ +V EY+ GSL D + T
Sbjct: 227 LQ-----------EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETG 274
Query: 737 HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
+ + +V A A G+ Y+ +HRD++++NIL+ ++ADFGLA++
Sbjct: 275 KYLRLPQLVDMAA--QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 797 VQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIV 850
++ E A APE A + KSDV+SFG++L EL T G+ P
Sbjct: 330 IEDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-- 381
Query: 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVD-------PNISEILKEDALKVLRIAIHCTNKL 903
Y M +R+ + V P E L + + C K
Sbjct: 382 -------------YPGMVNREVLDQVERGYRMPCPPECPESLHD-------LMCQCWRKE 421
Query: 904 PAFRPSMRVVVQMLEE 919
P RP+ + LE+
Sbjct: 422 PEERPTFEYLQAFLED 437
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 43/234 (18%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKEL-----AVKHIWPSNSGFRGDYRSSTAILSKRS 683
++ ++G G G V+K V E +K ++ +S
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK------------------VIEDKS 54
Query: 684 SRSSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEM 741
R S + + ++ H ++V+L + S LV +YLP GSL D + H+ +
Sbjct: 55 GRQSFQAVTDHMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQ-HRGAL 112
Query: 742 DWVVRYAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG 800
+ V AKG+ YL HG +HR++ + N+LL + ++ADFG+A ++
Sbjct: 113 GPQLLLNWGVQIAKGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168
Query: 801 EAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ + + A E + K +SDV+S+GV + EL+T G P
Sbjct: 169 D-----KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 56/308 (18%), Positives = 113/308 (36%), Gaps = 75/308 (24%)
Query: 631 VKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+ IG G G V+ + ++A+K + + + ++
Sbjct: 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIK------------------TIREGAMSEEDFI 51
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC-HKIEMDWVVRYAI 749
E + + H +V+LY + LV E++ +G L D L T + ++ +
Sbjct: 52 EEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG--M 109
Query: 750 AVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+ +G+ YL IHRD+ + N L+ +++DFG+ + V +
Sbjct: 110 CLDVCEGMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ------Y 159
Query: 809 IAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862
+ T +PE + + KSDV+SFGV++ E+ + GK P
Sbjct: 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP-------------- 205
Query: 863 VYSKMDSRDSMLTVVD-----------PNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
Y + + + + ++ +I+ C + P RP+
Sbjct: 206 -YENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH-----------CWRERPEDRPAFS 253
Query: 912 VVVQMLEE 919
+++ L E
Sbjct: 254 RLLRQLAE 261
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 74/304 (24%), Positives = 129/304 (42%), Gaps = 63/304 (20%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE 688
+ +K +G G G V+ N ++AVK L + S
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVK------------------SLKQGSMSPDA 54
Query: 689 YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA 748
+ AE + ++H +V+LY ++ +++ ++ EY+ NGSL D L T I++
Sbjct: 55 FLAEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+A A+G+ ++ +R IHRD++++NIL+ +IADFGLA++++ E
Sbjct: 114 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE------Y 164
Query: 809 IAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862
A APE KSDV+SFG++L E+VT G+ P
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-------------- 210
Query: 863 VYSKMDSRDSMLTVVD-------PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
Y M + + + + N E L + + C + P RP+ +
Sbjct: 211 -YPGMTNPEVIQNLERGYRMVRPDNCPEELYQ-------LMRLCWKERPEDRPTFDYLRS 262
Query: 916 MLEE 919
+LE+
Sbjct: 263 VLED 266
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 64/257 (24%), Positives = 107/257 (41%), Gaps = 50/257 (19%)
Query: 605 HSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWP 663
H +S ++ + + ++GKG G V K + +E AVK
Sbjct: 2 HHHHHHSSGRENLY----FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK---- 53
Query: 664 SNSGFRGDYRSSTAILSKRSSRSSEYDA---EVATLSAVRHVNVVKLYCSITSEDSNLLV 720
+++K S+++ + EV L + H N++KL+ + S +V
Sbjct: 54 --------------VINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99
Query: 721 YEYLPNGSLWDRLHTCHKI-EMD--WVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777
E G L+D + + E D +++ + + Y+H ++HRD+K N
Sbjct: 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG-----ITYMH---KHNIVHRDLKPEN 151
Query: 778 ILL---DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE---YAYTCKINEKSD 831
ILL + + +I DFGL+ Q GT YIAPE Y +EK D
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRGTY----DEKCD 204
Query: 832 VYSFGVVLMELVTGKRP 848
V+S GV+L L++G P
Sbjct: 205 VWSAGVILYILLSGTPP 221
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 79/314 (25%), Positives = 129/314 (41%), Gaps = 64/314 (20%)
Query: 620 LSFSEKEI-IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI 678
L+ EI ++++ E +G+G G V+ N +A+K + + S A
Sbjct: 257 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-------KPGTMSPEAF 309
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK 738
L E + +RH +V+LY ++ SE+ +V EY+ GSL D L
Sbjct: 310 LQ-----------EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETG 357
Query: 739 IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798
+ +A A G+ Y+ +HRD++++NIL+ ++ADFGLA++++
Sbjct: 358 KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414
Query: 799 TGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPE 852
E A APE A + KSDV+SFG++L EL T G+ P
Sbjct: 415 DNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP---- 464
Query: 853 FGDSKDIVNWVYSKMDSRDSMLTVVD-------PNISEILKEDALKVLRIAIHCTNKLPA 905
Y M +R+ + V P E L + + C K P
Sbjct: 465 -----------YPGMVNREVLDQVERGYRMPCPPECPESLHD-------LMCQCWRKEPE 506
Query: 906 FRPSMRVVVQMLEE 919
RP+ + LE+
Sbjct: 507 ERPTFEYLQAFLED 520
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 56/237 (23%), Positives = 103/237 (43%), Gaps = 37/237 (15%)
Query: 624 EKEII-DAVKPENLIGKGGSGNVYKVVLNSGKEL----AVKHIWPSNSGFRGDYRSSTAI 678
KE+ + + ++G G G V L + A+K + +
Sbjct: 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT------------ 86
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK 738
+ ++ E + + H N+++L +T ++V EY+ NGSL L H
Sbjct: 87 ----EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HD 141
Query: 739 IEMDWVVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
+ + + G A G++YL G+ +HRD+ + NIL++ +++DFGL +++
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVL 197
Query: 798 QTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ D G I +PE K SDV+S+G+VL E+++ G+RP
Sbjct: 198 E----DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 61/258 (23%), Positives = 101/258 (39%), Gaps = 49/258 (18%)
Query: 614 MKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDY 672
M+ F+ + I +G G V K ++G E A K
Sbjct: 2 MEPFKQQKVEDFYDIGEE-----LGSGQFAIVKKCREKSTGLEYAAK------------- 43
Query: 673 RSSTAILSKRSSRSSEYDA-------EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLP 725
+ KR SR+S EV+ L V H NV+ L+ + +L+ E +
Sbjct: 44 -----FIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 726 NGSLWDRLHTCHKI-EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784
G L+D L + E + + + G+ YLH + + H D+K NI+L +
Sbjct: 99 GGELFDFLAQKESLSEEE-ATSFIKQI--LDGVNYLH---TKKIAHFDLKPENIMLLDKN 152
Query: 785 KP----RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLM 840
P ++ DFGLA ++ G I GT ++APE + ++D++S GV+
Sbjct: 153 IPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 841 ELVTGKRPIVPEFGDSKD 858
L++G F
Sbjct: 210 ILLSG----ASPFLGDTK 223
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 68/249 (27%), Positives = 102/249 (40%), Gaps = 37/249 (14%)
Query: 609 QNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSG 667
+ + S D K + ++GKG G V +G+E AVK
Sbjct: 6 MDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVK-------- 57
Query: 668 FRGDYRSSTAILSKRSSRSSEYDA----EVATLSAVRHVNVVKLYCSITSEDSNLLVYEY 723
++SKR + EV L + H N++KLY + LV E
Sbjct: 58 ----------VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107
Query: 724 LPNGSLWDRLHTCHKI-EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL-- 780
G L+D + + + E+D R V G+ Y+H ++HRD+K N+LL
Sbjct: 108 YTGGELFDEIISRKRFSEVD-AARIIRQV--LSGITYMH---KNKIVHRDLKPENLLLES 161
Query: 781 -DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839
+ RI DFGL+ + + GT YIAPE +EK DV+S GV+L
Sbjct: 162 KSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217
Query: 840 MELVTGKRP 848
L++G P
Sbjct: 218 YILLSGCPP 226
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 55/270 (20%), Positives = 102/270 (37%), Gaps = 18/270 (6%)
Query: 79 EGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFL 138
+ +L S + + + L+ + + N+S I + ++ L N+ L
Sbjct: 15 FPDDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIK-SV--QGIQYLPNVTKL 70
Query: 139 SLGDNP-FDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGE 197
L N D P L+ L WL+L + + + +L +L++L L N + +
Sbjct: 71 FLNGNKLTDIKPLT----NLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGI-SD 123
Query: 198 IPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSS 257
I G+V L +L L L NN ++ S LT L + N++ D+ L L +L +
Sbjct: 124 IN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQN 179
Query: 258 LHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPI 317
L+L +N S ++ K+L L L++ + N V ++ L P
Sbjct: 180 LYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPE 237
Query: 318 PPDMCKTGAMTDLLVLQNNFNGTVPETYAN 347
++ F V +
Sbjct: 238 IISDDGDYEKPNVKWHLPEFTNEVSFIFYQ 267
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 94.8 bits (235), Expect = 3e-20
Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 18/232 (7%)
Query: 59 GLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSS 118
K NL + T + + N+ V + L ++ L LN +
Sbjct: 19 AFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGN 75
Query: 119 GISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEG 177
++ P +L+NL L L +N D S L+KL L L + ++ I G
Sbjct: 76 KLTDIKPLTNLKNLGW---LFLDENKIKDLSSLK----DLKKLKSLSLEHNGIS-DI-NG 126
Query: 178 IGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDV 237
+ +L QL++L L +N++ + +L KL L L +N +S + + LT L N +
Sbjct: 127 LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYL 182
Query: 238 SQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRL 289
S+N + DL L L L L LF + + + L
Sbjct: 183 SKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.1 bits (202), Expect = 3e-16
Identities = 47/188 (25%), Positives = 73/188 (38%), Gaps = 15/188 (7%)
Query: 57 ICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLN 116
+ L+ L + L N + LK +L+ L L +N S ++ L L +L L L
Sbjct: 83 LTNLKNLGWLFLDENKI--KDLSSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLG 139
Query: 117 SSGISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLKLEKLYWLYLTNCSVTGQIP 175
++ I+ L LT L+ LSL DN D P L KL LYL+ ++
Sbjct: 140 NNKITD---ITVLSRLTKLDTLSLEDNQISDIVPLA----GLTKLQNLYLSKNHIS--DL 190
Query: 176 EGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNF 235
+ L L LEL E + L ++ + SL P S+ +
Sbjct: 191 RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKP 248
Query: 236 DVSQNRLE 243
+V + E
Sbjct: 249 NVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 6e-16
Identities = 52/320 (16%), Positives = 97/320 (30%), Gaps = 71/320 (22%)
Query: 113 LNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLKLEKLYWLYLTNCSVT 171
S+ I FP + +L D +L + + N +
Sbjct: 4 TITVSTPIKQIFP---DDAFAETIKDNLKKKSVTDAVTQN----ELNSIDQIIANNSDIK 56
Query: 172 GQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTN 231
+ +GI L + L L+ N+L +I + L L L L N + L +L
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKL-TDIK-PLTNLKNLGWLFLDENKIK-DLS-SLKDLKK 110
Query: 232 LMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTG 291
L + + N + D++ L L QL SL+L N+ + L LSL N++
Sbjct: 111 LKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI-- 165
Query: 292 TLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSL 351
+D++ L L
Sbjct: 166 ------------------------------------SDIVPLA------------GLTKL 177
Query: 352 IRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSG 411
++ N +S + + L NL +++L + + + N + +
Sbjct: 178 QNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 235
Query: 412 ELPSKISEASSLVSIQLSLN 431
P IS+ + +
Sbjct: 236 --PEIISDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 1e-12
Identities = 51/315 (16%), Positives = 102/315 (32%), Gaps = 41/315 (13%)
Query: 225 GFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSL 284
+ ++ + + D LN + + + + + ++T+L L
Sbjct: 16 PDDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72
Query: 285 YTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPET 344
N+LT P L + + ++ + EN + DL L
Sbjct: 73 NGNKLTDIKP--LTNLKNLGWLFLDENKIK--------------DLSSL----------- 105
Query: 345 YANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLL 404
+ K L + +N +S I + LP L + L N+ + L L L
Sbjct: 106 -KDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 160
Query: 405 ANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYS 464
+N+ S ++ ++ + L ++ LS N S L LK L L L
Sbjct: 161 EDNQIS-DIVP-LAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINH 216
Query: 465 IGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLS 524
+ V + SL P+ + N+ + +S + + + +
Sbjct: 217 QSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKA 274
Query: 525 NNQLAGPIPEPLNIK 539
+ G + +PL
Sbjct: 275 KARFHGRVTQPLKEV 289
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 67/276 (24%), Positives = 112/276 (40%), Gaps = 60/276 (21%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA---E 692
IGKG V + +G+E+A+K I+ K + E
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIK------------------IIDKTQLNPTSLQKLFRE 64
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVG 752
V + + H N+VKL+ I +E + L+ EY G ++D L +++ +
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGT 812
+A ++Y H + ++HRD+K+ N+LLD + +IADFG + G G
Sbjct: 125 SA--VQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGA 176
Query: 813 HGYIAPEY----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS------KDIVNW 862
Y APE Y + DV+S GV+L LV+G P F + ++
Sbjct: 177 PPYAAPELFQGKKYDGP---EVDVWSLGVILYTLVSGSLP----FDGQNLKELRERVLRG 229
Query: 863 VYSK-----MDSRD---SMLTVVDPN----ISEILK 886
Y D + L V++P + +I+K
Sbjct: 230 KYRIPFYMSTDCENLLKRFL-VLNPIKRGTLEQIMK 264
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 59/251 (23%), Positives = 102/251 (40%), Gaps = 44/251 (17%)
Query: 621 SFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAIL 679
+F ++++ D +G G V K ++G E A K +
Sbjct: 4 TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK------------------FI 45
Query: 680 SKRSSRSSEYDA-------EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDR 732
KR SR+S EV+ L V H N++ L+ + +L+ E + G L+D
Sbjct: 46 KKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDF 105
Query: 733 LHTCHKI-EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP----R 787
L + E + + + G+ YLH + + H D+K NI+L + P +
Sbjct: 106 LAQKESLSEEE-ATSFIKQI--LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKR 847
+ DFGLA ++ G I GT ++APE + ++D++S GV+ L++G
Sbjct: 160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-- 214
Query: 848 PIVPEFGDSKD 858
F
Sbjct: 215 --ASPFLGDTK 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 66/252 (26%), Positives = 106/252 (42%), Gaps = 40/252 (15%)
Query: 605 HSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWP 663
H +S ++ + + + ++GKG G V K + +E AVK
Sbjct: 2 HHHHHHSSGRENL----YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK---- 53
Query: 664 SNSGFRGDYRSSTAILSKRSSRSSEYDA---EVATLSAVRHVNVVKLYCSITSEDSNLLV 720
+++K S+++ + EV L + H N++KL+ + S +V
Sbjct: 54 --------------VINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99
Query: 721 YEYLPNGSLWDRLHTCHKI-EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779
E G L+D + + E D R V G+ Y+H ++HRD+K NIL
Sbjct: 100 GELYTGGELFDEIIKRKRFSEHD-AARIIKQV--FSGITYMH---KHNIVHRDLKPENIL 153
Query: 780 L---DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFG 836
L + + +I DFGL+ Q GT YIAPE +EK DV+S G
Sbjct: 154 LESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAG 209
Query: 837 VVLMELVTGKRP 848
V+L L++G P
Sbjct: 210 VILYILLSGTPP 221
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 59/247 (23%), Positives = 102/247 (41%), Gaps = 65/247 (26%)
Query: 625 KEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS 683
+ D + +GKG V + V +G E A K I++ +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK------------------IINTKK 43
Query: 684 SRSSEYDA---EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL------- 733
+ ++ E ++H N+V+L+ SI E + LV++ + G L++ +
Sbjct: 44 LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS 103
Query: 734 -----HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP-- 786
H +I + + Y H ++HR++K N+LL + K
Sbjct: 104 EADASHCIQQI--------------LESIAYCH---SNGIVHRNLKPENLLLASKAKGAA 146
Query: 787 -RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE----YAYTCKINEKSDVYSFGVVLME 841
++ADFGLA V EA H AGT GY++PE Y ++ D+++ GV+L
Sbjct: 147 VKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGVILYI 199
Query: 842 LVTGKRP 848
L+ G P
Sbjct: 200 LLVGYPP 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 56/249 (22%), Positives = 94/249 (37%), Gaps = 54/249 (21%)
Query: 623 SEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSK 681
S + +P+ ++G+G S V + + + KE AVK I + S
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKII----------DVTGGGSFSA 60
Query: 682 RSSRSSEYDA--EVATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK 738
+ EV L V H N+++L + + LV++ + G L+D L
Sbjct: 61 EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----- 115
Query: 739 IEMDWVVRYAIAVG------AAK-------GLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785
K + LH ++HRD+K NILLD +
Sbjct: 116 ----------TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMN 162
Query: 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE------YAYTCKINEKSDVYSFGVVL 839
++ DFG + + GE + GT Y+APE ++ D++S GV++
Sbjct: 163 IKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
Query: 840 MELVTGKRP 848
L+ G P
Sbjct: 220 YTLLAGSPP 228
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 64/280 (22%), Positives = 102/280 (36%), Gaps = 69/280 (24%)
Query: 599 KQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELA 657
Q +L S + + KE P+++IG+G S V + V +G E A
Sbjct: 64 AQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123
Query: 658 VKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA---------EVATLSAVR-HVNVVKL 707
VK I+ + R S E L V H +++ L
Sbjct: 124 VK------------------IMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165
Query: 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVG------AAK------ 755
S S LV++ + G L+D L
Sbjct: 166 IDSYESSSFMFLVFDLMRKGELFDYL---------------TEKVALSEKETRSIMRSLL 210
Query: 756 -GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
+ +LH ++HRD+K NILLD + R++DFG + ++ GE + GT G
Sbjct: 211 EAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPG 264
Query: 815 YIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
Y+APE ++ D+++ GV+L L+ G P
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 45/242 (18%)
Query: 623 SEKEIID--AVKPENLIGKGGSGNVYKVVLNSGKE-----LAVKHIWPSNSGFRGDYRSS 675
+ I+ K ++G G G VYK + E +A+K
Sbjct: 7 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---------------- 50
Query: 676 TAILSKRSSRSSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL 733
L + +S + + E +++V + +V +L I + L+ + +P G L D +
Sbjct: 51 --ELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV 107
Query: 734 HTCHKIEMDWVVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792
HK + V AKG+ YL +HRD+ + N+L+ +I DFG
Sbjct: 108 RE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFG 162
Query: 793 LAKIVQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GK 846
LAK++ E G + A E +SDV+S+GV + EL+T G
Sbjct: 163 LAKLLGAEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 847 RP 848
+P
Sbjct: 218 KP 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 69/357 (19%), Positives = 120/357 (33%), Gaps = 92/357 (25%)
Query: 620 LSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAI 678
+S K + D +G G G V + K++A+K I + A+
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNL-LVYEYLPNGSLWDRLHTCH 737
+ E+ L + H ++K+ + + +V E + G L+D++
Sbjct: 61 NVET---------EIEILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKV---- 105
Query: 738 KIEMDWVVRYAIAVG------AAK-------GLEYLHHGFDRPVIHRDVKSSNILLDLEW 784
+ ++YLH + +IHRD+K N+LL +
Sbjct: 106 -----------VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQE 151
Query: 785 KP---RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE---YAYTCKINEKSDVYSFGVV 838
+ +I DFG +KI+ L + GT Y+APE T N D +S GV+
Sbjct: 152 EDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
Query: 839 LMELVTGKRPIVPEFGDSKD-------IVNWVYSKMDSR-------------DSMLTVVD 878
L ++G P F + + I + Y+ +L VVD
Sbjct: 209 LFICLSG----YPPFSEHRTQVSLKDQITSGKYN-FIPEVWAEVSEKALDLVKKLL-VVD 262
Query: 879 PN----ISEILK---------EDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922
P E L+ + + L + + LP + E E
Sbjct: 263 PKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEA 319
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-24
Identities = 54/258 (20%), Positives = 98/258 (37%), Gaps = 55/258 (21%)
Query: 621 SFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAIL 679
S K + D +G G G V + K++A++ I + A+
Sbjct: 127 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALN 186
Query: 680 SKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNL-LVYEYLPNGSLWDRL----- 733
+ E+ L + H ++K+ + + +V E + G L+D++
Sbjct: 187 VET---------EIEILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKR 235
Query: 734 -------HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786
+++ ++YLH + +IHRD+K N+LL + +
Sbjct: 236 LKEATCKLYFYQM--------------LLAVQYLH---ENGIIHRDLKPENVLLSSQEED 278
Query: 787 ---RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE---YAYTCKINEKSDVYSFGVVLM 840
+I DFG +KI+ L + GT Y+APE T N D +S GV+L
Sbjct: 279 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335
Query: 841 ELVTGKRPIVPEFGDSKD 858
++G P F + +
Sbjct: 336 ICLSG----YPPFSEHRT 349
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-24
Identities = 50/232 (21%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKEL---AVKHIWPSNSGFRGDYRSSTAILSKRSSR 685
+ + + +G G G+V + V K+ A+K +L + + +
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK------------------VLKQGTEK 377
Query: 686 SSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW 743
+ + E + + + +V+L +E + +LV E G L L + E+
Sbjct: 378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVG-KREEIPV 435
Query: 744 VVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA 802
+ + G++YL F +HR++ + N+LL +I+DFGL+K + ++
Sbjct: 436 SNVAELLHQVSMGMKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491
Query: 803 GDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ A + G APE K + +SDV+S+GV + E ++ G++P
Sbjct: 492 ----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 64/305 (20%), Positives = 121/305 (39%), Gaps = 65/305 (21%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE 688
+ + +G G G V ++AVK ++ + S E
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVK------------------MIKEGSMSEDE 49
Query: 689 YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA 748
+ E T+ + H +VK Y + E +V EY+ NG L + L + H ++
Sbjct: 50 FFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLE 108
Query: 749 IAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
+ +G+ +L H F IHRD+ + N L+D + +++DFG+ + V +
Sbjct: 109 MCYDVCEGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY----- 159
Query: 808 VIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVN 861
++ APE + K + KSDV++FG+++ E+ + GK P
Sbjct: 160 -VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP------------- 205
Query: 862 WVYSKMDSRDSMLTVVD-------PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVV 914
Y + + +L V S+ + + I C ++LP RP+ + ++
Sbjct: 206 --YDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ-------IMYSCWHELPEKRPTFQQLL 256
Query: 915 QMLEE 919
+E
Sbjct: 257 SSIEP 261
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 67/275 (24%), Positives = 105/275 (38%), Gaps = 53/275 (19%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
L+GKGG G V+ L ++A+K I + S EVA
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC--PL---------EVA 86
Query: 695 TLSAVR----HVNVVKLYCSITSEDSNLLVYEY-LPNGSLWDRLHTCHKIEMDWVVRYAI 749
L V H V++L +++ +LV E LP L+D + + +
Sbjct: 87 LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW-KPRIADFGLAKIVQTGEAGDLTHV 808
V AA +++ H R V+HRD+K NIL+DL ++ DFG ++
Sbjct: 147 QVVAA--IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTD 197
Query: 809 IAGTHGYIAPEY----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864
GT Y PE+ Y + V+S G++L ++V G P F ++I+
Sbjct: 198 FDGTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIP----FERDQEILEAEL 250
Query: 865 ------SKMDSRD---SMLTVVDPN----ISEILK 886
S D L P+ + EIL
Sbjct: 251 HFPAHVSP-DCCALIRRCL-APKPSSRPSLEEILL 283
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 42/233 (18%)
Query: 631 VKPENLIGKGGSGNVYKVVLNSGKEL----AVKHIWPSNSGFRGDYRSSTAILSKRSSRS 686
+ +IGKG G VY + A+K LS+ +
Sbjct: 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK------------------SLSRITEMQ 64
Query: 687 SEYD--AEVATLSAVRHVNVVKLY-CSITSEDSNLLVYEYLPNGSLWDRLHTC-HKIEMD 742
E + + H NV+ L + E ++ Y+ +G L + + +
Sbjct: 65 QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK 124
Query: 743 WVVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGE 801
++ + + V A+G+EYL F +HRD+ + N +LD + ++ADFGLA+ +
Sbjct: 125 DLISFGLQV--ARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDI---L 175
Query: 802 AGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ V H + A E T + KSDV+SFGV+L EL+T G P
Sbjct: 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 63/250 (25%), Positives = 98/250 (39%), Gaps = 50/250 (20%)
Query: 618 RVLSFSEKEIIDAVKPEN---------LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSG 667
R S + ++ + ++ IG G G VY + + + +A+K +
Sbjct: 34 RAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM------ 87
Query: 668 FRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNG 727
Y + + + + EV L +RH N ++ E + LV EY G
Sbjct: 88 ---SYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 138
Query: 728 SLWDRLHTCHKI----EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783
S D L K E+ V A+ +GL YLH +IHRDVK+ NILL
Sbjct: 139 SASDLLEVHKKPLQEVEIAAVTHGAL-----QGLAYLH---SHNMIHRDVKAGNILLSEP 190
Query: 784 WKPRIADFGLAKIVQTGEAGDLT--HVIAGTHGYIAPEYAYTCKI---NEKSDVYSFGVV 838
++ DFG A + + GT ++APE + K DV+S G+
Sbjct: 191 GLVKLGDFGS--------ASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 242
Query: 839 LMELVTGKRP 848
+EL K P
Sbjct: 243 CIELAERKPP 252
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 65/350 (18%), Positives = 122/350 (34%), Gaps = 46/350 (13%)
Query: 616 SFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRS 674
L+ E E + +G G G V+ V KE+ VK I
Sbjct: 11 ELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIED 70
Query: 675 STAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGS-LWDRL 733
E+A LS V H N++K+ ++ LV E +G L+ +
Sbjct: 71 PKLGKVTL---------EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121
Query: 734 HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793
+++ + + YL + +IHRD+K NI++ ++ ++ DFG
Sbjct: 122 DRHPRLDEPLASYIFRQL--VSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176
Query: 794 AKIVQTGEAGDLTHVIAGTHGYIAPEY----AYTCKINEKSDVYSFGVVLMELVTGKRPI 849
A ++ G+ L + GT Y APE Y + +++S GV L LV + P
Sbjct: 177 AAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENP- 229
Query: 850 VPEFGDSKDIVNWVYSK-----MDSRD---SMLTVVDPN----ISEILKEDALK--VLRI 895
F + ++ V + +L P + +++ + + V
Sbjct: 230 ---FCELEETVEAAIHPPYLVSKELMSLVSGLL-QPVPERRTTLEKLVTDPWVTQPVNLA 285
Query: 896 AIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKVGESSPSFSRHYN 945
+P V+ E S++++ + H++
Sbjct: 286 DYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQ-ELCGGEGHHHHH 334
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 60/319 (18%), Positives = 114/319 (35%), Gaps = 82/319 (25%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI--LSKRSSRS 686
+ + +G+G ++K G + + + + + L ++ R+
Sbjct: 8 EDLIFNESLGQGTFTKIFK-----G-------VRREVGDYGQLHETEVLLKVL-DKAHRN 54
Query: 687 SEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC-HKIEMDW 743
+ +S + H ++V Y D N+LV E++ GSL L + I + W
Sbjct: 55 YSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW 114
Query: 744 VVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPR--------IADFGLA 794
+ +A A + +L + IH +V + NILL E + ++D G++
Sbjct: 115 KLE--VAKQLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
Query: 795 KIVQTGEAGDLTHVIAGTHGY------IAPEYAYTCKI-NEKSDVYSFGVVLMELVT-GK 846
V + + PE K N +D +SFG L E+ + G
Sbjct: 169 ITVLPKD------------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD 216
Query: 847 RPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVD------PNISEILKEDALKVLRIAIHCT 900
+P S +DS+ + D P +E+ + +C
Sbjct: 217 KP---------------LSALDSQRKLQFYEDRHQLPAPKAAEL--------ANLINNCM 253
Query: 901 NKLPAFRPSMRVVVQMLEE 919
+ P RPS R +++ L
Sbjct: 254 DYEPDHRPSFRAIIRDLNS 272
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 74/283 (26%), Positives = 114/283 (40%), Gaps = 71/283 (25%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA--- 691
+G G G V +G ++AVK IL+++ RS +
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVK------------------ILNRQKIRSLDVVGKIK 59
Query: 692 -EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY--- 747
E+ L RH +++KLY I++ +V EY+ G L+D + ++E R
Sbjct: 60 REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ 119
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
++ ++Y H V+HRD+K N+LLD +IADFGL+ ++ GE
Sbjct: 120 ILS-----AVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLR 168
Query: 808 VIAGTHGYIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS----- 856
G+ Y APE YA + D++S GV+L L+ G P F D
Sbjct: 169 TSCGSPNYAAPEVISGRLYA-----GPEVDIWSCGVILYALLCGTLP----FDDEHVPTL 219
Query: 857 -KDIVNWVYSK-----MDSRD---SMLTVVDPN----ISEILK 886
K I V+ ML VDP I +I +
Sbjct: 220 FKKIRGGVFYIPEYLNRSVATLLMHML-QVDPLKRATIKDIRE 261
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 52/273 (19%), Positives = 113/273 (41%), Gaps = 22/273 (8%)
Query: 76 TITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNL 135
+ + + G ++ + V + L ++ L+ +G++ + ++ L NL
Sbjct: 10 NVIFPDPALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTT---IEGVQYLNNL 65
Query: 136 EFLSLGDNPF-DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNEL 194
L L DN D +P L K+ L L+ + I L ++ L+L+ ++
Sbjct: 66 IGLELKDNQITDLAPLK----NLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI 119
Query: 195 FGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQ 254
++ + L+ L L L N ++ + + LTNL + ++ DL+ L L++
Sbjct: 120 -TDVT-PLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS-DLTPLANLSK 174
Query: 255 LSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLT 314
L++L +N+ S +I +L E+ L N+++ P L + ++ V ++ +T
Sbjct: 175 LTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230
Query: 315 GPIPPDMCKTGAMTDLLVLQNNFNGTVPETYAN 347
P + +V + P T ++
Sbjct: 231 N--QPVFYNNNLVVPNVVKGPSGAPIAPATISD 261
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 46/252 (18%), Positives = 98/252 (38%), Gaps = 21/252 (8%)
Query: 40 EINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSG 99
+I + + V L + ++ + T EG++ L L+L +N +
Sbjct: 23 KIAAGKSNVTDTVTQA---DLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQIT- 76
Query: 100 EVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLKLE 158
++ L L +++ L L+ + + L+++ L+ L D +P L
Sbjct: 77 DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLD---LTSTQITDVTPLA----GLS 129
Query: 159 KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSL 218
L LYL +T I + LT LQ L + + ++ ++ + L+KL L+ +N +
Sbjct: 130 NLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQV-SDLT-PLANLSKLTTLKADDNKI 185
Query: 219 SGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKH 278
S + ++L NL+ + N++ D+S L + L + L + +
Sbjct: 186 SD-IS-PLASLPNLIEVHLKNNQIS-DVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVV 242
Query: 279 LTELSLYTNRLT 290
+ +
Sbjct: 243 PNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 65/319 (20%), Positives = 121/319 (37%), Gaps = 49/319 (15%)
Query: 115 LNSSGISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLKLEKLYWLYLTNCSVTGQ 173
+ I+ FP L N ++ G + D L+ + L VT
Sbjct: 4 TQPTAINVIFP---DPALANAIKIAAGKSNVTDTVTQA----DLDGITTLSAFGTGVT-T 55
Query: 174 IPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLM 233
I EG+ L L LEL DN++ ++ + L K+ +LEL N L + L ++
Sbjct: 56 I-EGVQYLNNLIGLELKDNQI-TDLA-PLKNLTKITELELSGNPLKN--VSAIAGLQSIK 110
Query: 234 NFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTL 293
D++ ++ D++ L L+ L L+L NQ + I +L LS+ +++
Sbjct: 111 TLDLTSTQIT-DVTPLAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSDLT 167
Query: 294 PQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIR 353
P L + + + +N + +D+ L A+ +LI
Sbjct: 168 P--LANLSKLTTLKADDNKI--------------SDISPL------------ASLPNLIE 199
Query: 354 FRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGEL 413
+ NN +S + P + + NL I+ L+ N + ++ +
Sbjct: 200 VHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQ--PVFYNNNLVVPNVVKGPSGAPIA 255
Query: 414 PSKISEASSLVSIQLSLNQ 432
P+ IS+ + S L+ N
Sbjct: 256 PATISDNGTYASPNLTWNL 274
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 55/312 (17%), Positives = 105/312 (33%), Gaps = 68/312 (21%)
Query: 227 SNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYT 286
L N + ++ + D L+ +++L F + I E +L L L
Sbjct: 16 PALANAIKIAAGKSNVT-DTVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKD 72
Query: 287 NRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYA 346
N++T DL L
Sbjct: 73 NQIT--------------------------------------DLAPL------------K 82
Query: 347 NCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLAN 406
N + ++ N L + I L ++ +DL++ Q + +L +L L
Sbjct: 83 NLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDL 138
Query: 407 NRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIG 466
N+ + + ++ ++L + + Q S PL L KL++L DN S P +
Sbjct: 139 NQIT-NISP-LAGLTNLQYLSIGNAQVSDLTPL--ANLSKLTTLKADDNKISDISP--LA 192
Query: 467 SCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNN 526
S +L +++ N +S P L + +L + L+N + + L + ++
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN--NLVVPNVVKG 248
Query: 527 QLAGPIPEPLNI 538
PI P I
Sbjct: 249 PSGAPIA-PATI 259
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 59/257 (22%), Positives = 105/257 (40%), Gaps = 65/257 (25%)
Query: 615 KSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYR 673
+ + + + D + +GKG V + V +G E A K
Sbjct: 15 RGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-------------- 60
Query: 674 SSTAILSKRSSRSSEYDA---EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLW 730
I++ + + ++ E ++H N+V+L+ SI E + LV++ + G L+
Sbjct: 61 ----IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 116
Query: 731 DRL------------HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778
+ + H +I + + Y H ++HR++K N+
Sbjct: 117 EDIVAREFYSEADASHCIQQI--------------LESIAYCH---SNGIVHRNLKPENL 159
Query: 779 LLDLEWKP---RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE----YAYTCKINEKSD 831
LL + K ++ADFGLA V EA H AGT GY++PE Y ++ D
Sbjct: 160 LLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPY----SKPVD 212
Query: 832 VYSFGVVLMELVTGKRP 848
+++ GV+L L+ G P
Sbjct: 213 IWACGVILYILLVGYPP 229
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 49/232 (21%), Positives = 95/232 (40%), Gaps = 41/232 (17%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKEL----AVKHIWPSNSGFRGDYRSSTAILSKRSS 684
+ ++ IG+G G+V++ + S + A+K S S
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS----------------DS 58
Query: 685 RSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHT-CHKIEMDW 743
++ E T+ H ++VKL + +E+ ++ E G L L + +++
Sbjct: 59 VREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLAS 117
Query: 744 VVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA 802
++ YA + L YL F +HRD+ + N+L+ ++ DFGL++ ++
Sbjct: 118 LILYAY--QLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST- 170
Query: 803 GDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ G + APE + SDV+ FGV + E++ G +P
Sbjct: 171 -----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 59/262 (22%), Positives = 102/262 (38%), Gaps = 57/262 (21%)
Query: 614 MKSFRVLSFSEKEIIDAVK-PENL------IGKGGSGNVYKVV-LNSGKELAVKHIWPSN 665
M S ++ + A++ P + +G G G VYK + +G+ A+K +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVT 60
Query: 666 SGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS-----ITSEDSNL-L 719
+ + +L K S H N+ Y + D L L
Sbjct: 61 GDEEEEIKQEINMLKKYS----------------HHRNIATYYGAFIKKNPPGMDDQLWL 104
Query: 720 VYEYLPNGSLWD--RLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777
V E+ GS+ D + + ++ +W+ I +GL +LH VIHRD+K N
Sbjct: 105 VMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH---QHKVIHRDIKGQN 159
Query: 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA------GTHGYIAPE-----YAYTCKI 826
+LL + ++ DFG+ + L + GT ++APE
Sbjct: 160 VLLTENAEVKLVDFGV--------SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY 211
Query: 827 NEKSDVYSFGVVLMELVTGKRP 848
+ KSD++S G+ +E+ G P
Sbjct: 212 DFKSDLWSLGITAIEMAEGAPP 233
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 34/221 (15%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
IGKG G V V N K++ A+K++ + + + R+ E+
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYM------------NKQKCVERNEVRNVF--KELQ 67
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA 754
+ + H +V L+ S E+ +V + L G L L + + V + + A
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
L+YL ++ +IHRD+K NILLD I DF +A ++ +AGT
Sbjct: 128 --LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTKP 179
Query: 815 YIAPE-------YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
Y+APE Y+ + D +S GV EL+ G+RP
Sbjct: 180 YMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 54/239 (22%), Positives = 97/239 (40%), Gaps = 18/239 (7%)
Query: 79 EGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFL 138
+ +L S + + + L+ + + N+S I + ++ L N+ L
Sbjct: 18 FSDDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKS---VQGIQYLPNVTKL 73
Query: 139 SLGDNP-FDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGE 197
L N D P L+ L WL+L V + + +L +L++L L N + +
Sbjct: 74 FLNGNKLTDIKPLA----NLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI-SD 126
Query: 198 IPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSS 257
I G+V L +L L L NN ++ S LT L + N++ D+ L L +L +
Sbjct: 127 IN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQN 182
Query: 258 LHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGP 316
L+L +N S ++ K+L L L++ + N V ++ L P
Sbjct: 183 LYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 55/275 (20%), Positives = 106/275 (38%), Gaps = 43/275 (15%)
Query: 40 EINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSG 99
+ NL ++ + V + L ++ +I + + +G++ + L L N +
Sbjct: 28 KDNLKKKSVTDAVTQN---ELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGNKLT- 81
Query: 100 EVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEK 159
++ L+ L L +L L+ + + SL++L L+ LSL N +
Sbjct: 82 DIKPLANLKNLGWLFLDENKVKD---LSSLKDLKKLKSLSLEHN------------GISD 126
Query: 160 LYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLS 219
+ G+ +L QL++L L +N++ + +L KL L L +N +S
Sbjct: 127 I---------------NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS 169
Query: 220 GRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHL 279
+ + LT L N +S+N + DL L L L L LF + +
Sbjct: 170 -DIV-PLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVP 226
Query: 280 TELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLT 314
+ L P+ + D+ +V +L
Sbjct: 227 NTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 48/304 (15%), Positives = 92/304 (30%), Gaps = 68/304 (22%)
Query: 129 LENLTNLEFLSLGDNPF-DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNL 187
+ +L D +L + + N + + +GI L + L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN----ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73
Query: 188 ELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLS 247
L+ N+L +I + L L L L N + L +L L + + N + D++
Sbjct: 74 FLNGNKL-TDIK-PLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DIN 128
Query: 248 ELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVD 307
L L QL SL+L N+ + L LSL N++
Sbjct: 129 GLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI------------------ 168
Query: 308 VSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPP 367
+D++ L L ++ N +S +
Sbjct: 169 --------------------SDIVPLA------------GLTKLQNLYLSKNHIS-DLRA 195
Query: 368 GIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQ 427
+ L NL +++L + + + N + + P IS+
Sbjct: 196 -LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPN 252
Query: 428 LSLN 431
+ +
Sbjct: 253 VKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 51/329 (15%), Positives = 97/329 (29%), Gaps = 70/329 (21%)
Query: 225 GFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSL 284
+ ++ + + D LN + + + + + ++T+L L
Sbjct: 19 SDDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 285 YTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNG-TVPE 343
N+LT D+ + +L L + N
Sbjct: 76 NGNKLT-----------------------------DIKPLANLKNLGWLFLDENKVKDLS 106
Query: 344 TYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLL 403
+ + K L + +N +S I + LP L + L N+ + L L
Sbjct: 107 SLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLS 162
Query: 404 LANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPY 463
L +N +IS+ L L KL +LYL N S
Sbjct: 163 LEDN--------QISDIVPL------------------AGLTKLQNLYLSKNHISDLRA- 195
Query: 464 SIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPIS----LTYPKLS 519
+ +L + K + +L N++ ++ IS P +
Sbjct: 196 -LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVK 254
Query: 520 L-LDLSNNQLAGPIPEPLNIKAFIDSFTG 547
L N+++ +P+ I F G
Sbjct: 255 WHLPEFTNEVSFIFYQPVTIGKAKARFHG 283
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 72/310 (23%), Positives = 115/310 (37%), Gaps = 69/310 (22%)
Query: 631 VKPENLIGKGGSGNVYKVVLNSGKEL----AVKHIWPSNSGFRGDYRSSTAILSKRSSRS 686
V +IG+G G VY L AVK L++ +
Sbjct: 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------------------SLNRITDIG 68
Query: 687 SEYD--AEVATLSAVRHVNVVKLY-CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW 743
E + H NV+ L + SE S L+V Y+ +G L + +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV 127
Query: 744 VVRYAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA 802
+ AKG++YL F +HRD+ + N +LD ++ ++ADFGLA+ +
Sbjct: 128 KDLIGFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDK-- 181
Query: 803 GDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDS 856
+ V T + A E T K KSDV+SFGV+L EL+T G P
Sbjct: 182 -EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-------- 232
Query: 857 KDIVNWVYSKMDSRDSMLTVVD-------PNISEILKEDALKVLRIAIHCTNKLPAFRPS 909
Y +++ D + ++ + L E + + C + RPS
Sbjct: 233 -------YPDVNTFDITVYLLQGRRLLQPEYCPDPLYE-------VMLKCWHPKAEMRPS 278
Query: 910 MRVVVQMLEE 919
+V +
Sbjct: 279 FSELVSRISA 288
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 55/309 (17%), Positives = 101/309 (32%), Gaps = 34/309 (11%)
Query: 83 SCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGD 142
SC R + + S + +P + + L+L+++ I+ L+ NL+ L L
Sbjct: 29 SCDRNGICKGSSGSLN-SIPS-GLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTS 85
Query: 143 NPFDPSPFPMEVL-KLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPA 200
N + + L L L L+ ++ + L+ L L L N
Sbjct: 86 NGI--NTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGET 142
Query: 201 GI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLS 256
+ L KL L + N ++ F+ LT L ++ + L+ + +S
Sbjct: 143 SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVS 201
Query: 257 SLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315
L L Q + E + L L L +L +
Sbjct: 202 HLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELST---------------- 244
Query: 316 PIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIW-SLPN 374
+ + + + V + L+ + N L ++P GI+ L +
Sbjct: 245 -GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTS 302
Query: 375 LSIIDLSTN 383
L I L TN
Sbjct: 303 LQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-22
Identities = 47/247 (19%), Positives = 96/247 (38%), Gaps = 20/247 (8%)
Query: 63 LQKINLGTNFLYGTITEG-LKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSG 119
++ ++L N + I+ L+ C LQ L L +N + + + S L L L+L+ +
Sbjct: 54 VKSLDLSNNRI-TYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 120 ISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI- 178
+S + L++L FL+L NP+ L KL L + N +I
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 179 GNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDV 237
LT L+ LE+ ++L + + L L+ L + +++ ++
Sbjct: 171 AGLTFLEELEIDASDL-QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229
Query: 238 SQNRLE---------GDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNR 288
L+ G+ + L ++ + + ++ + + L EL N+
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQ 288
Query: 289 LTGTLPQ 295
L ++P
Sbjct: 289 LK-SVPD 294
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 43/285 (15%), Positives = 88/285 (30%), Gaps = 60/285 (21%)
Query: 255 LSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLT 314
+ SL L N+ + + +L L L +N +
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT----------------------- 90
Query: 315 GPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGI-WSLP 373
I D F+ SL ++ N LS + L
Sbjct: 91 --IEEDS---------------FSSLG--------SLEHLDLSYNYLS-NLSSSWFKPLS 124
Query: 374 NLSIIDLSTNQFEG-PVTDDIGNAKSLALLLLANNRFSGELPSKI-SEASSLVSIQLSLN 431
+L+ ++L N ++ T + L +L + N ++ K + + L +++ +
Sbjct: 125 SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184
Query: 432 QFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN--------SLSG 483
P + ++ +S L LH L + S+ + LS
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244
Query: 484 KIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQL 528
+SL + ++ +++ + + L L+ S NQL
Sbjct: 245 GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQL 289
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 44/207 (21%), Positives = 86/207 (41%), Gaps = 18/207 (8%)
Query: 59 GLQALQKINLGTNFLYGTITEG--LKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLN 114
L +L +NL N T+ E T+LQ+L +GN ++ + L L L
Sbjct: 122 PLSSLTFLNLLGNPY-KTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180
Query: 115 LNSSGISGKFPWKSLENLTNLEFLSLGDNP--------FDPSPFPMEVLKLEKLYWLYLT 166
+++S + + KSL+++ N+ L L D + +E L+L
Sbjct: 181 IDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS-SVECLELRDTDLDTFH 238
Query: 167 NCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVG- 225
++ + +N++++D LF ++ + +++ L +LE N L +P G
Sbjct: 239 FSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGI 296
Query: 226 FSNLTNLMNFDVSQNRLEGDLSELRFL 252
F LT+L + N + + +L
Sbjct: 297 FDRLTSLQKIWLHTNPWDCSCPRIDYL 323
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 43/216 (19%), Positives = 74/216 (34%), Gaps = 12/216 (5%)
Query: 318 PPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSI 377
P + + ++ L + + +C + ++ SL+ +IP G+ +
Sbjct: 2 PHTLWMVWVLGVIISLS--KEESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKS 56
Query: 378 IDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKI-SEASSLVSIQLSLNQFSGQ 436
+DLS N+ D+ +L L+L +N + + S SL + LS N S
Sbjct: 57 LDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-N 114
Query: 437 IPLDI-GKLKKLSSLYLHDNMFSGPLPYSI-GSCVSLTDINFAQNSLSGKIPD-SLGSLP 493
+ L L+ L L N + S+ L + KI L
Sbjct: 115 LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174
Query: 494 SLNSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQL 528
L L + + P SL +S L L Q
Sbjct: 175 FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 25/163 (15%), Positives = 52/163 (31%), Gaps = 16/163 (9%)
Query: 41 INLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEG-LKSCTRLQVLDLGNNSFSG 99
+ + + GL L+++ + + L + LKS + L L
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL-QSYEPKSLKSIQNVSHLILHMKQHI- 211
Query: 100 EVPDLSM--LHELSFLNLNSSGISG-------KFPWKSLENLTNLEFLSLGDNPFDPSPF 150
+ ++ + + L L + + SL + + D
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL--FQV 269
Query: 151 PMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDN 192
+ ++ L L + + +P+GI LT LQ + L N
Sbjct: 270 MKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 58/254 (22%), Positives = 106/254 (41%), Gaps = 45/254 (17%)
Query: 620 LSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAI 678
++ + D + +IGKG V + + +G++ AVK + A
Sbjct: 15 MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIV-------------DVAK 61
Query: 679 LSKRSSRSSEY-DAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH 737
+ S+E E + ++H ++V+L + +S+ +V+E++ L +
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK-- 119
Query: 738 KIEMDWVVRYAIAVGAA------KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP---RI 788
D Y+ AV + + L Y H D +IHRDVK +LL + ++
Sbjct: 120 --RADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKL 174
Query: 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE----YAYTCKINEKSDVYSFGVVLMELVT 844
FG+A + E+G + GT ++APE Y + DV+ GV+L L++
Sbjct: 175 GGFGVAIQLG--ESGLVAGGRVGTPHFMAPEVVKREPY----GKPVDVWGCGVILFILLS 228
Query: 845 GKRPIVPEFGDSKD 858
G P F +K+
Sbjct: 229 GCLP----FYGTKE 238
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 40/225 (17%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA---- 691
+G G V K +GKE A K I KR SS
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFI------------------KKRRLSSSRRGVSREE 54
Query: 692 ---EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKI-EMDWVVRY 747
EV L +RH N++ L+ ++ +L+ E + G L+D L + E + ++
Sbjct: 55 IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE-ATQF 113
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP----RIADFGLAKIVQTGEAG 803
+ G+ YLH + + H D+K NI+L + P ++ DFG+A ++ G
Sbjct: 114 LKQI--LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE- 167
Query: 804 DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
I GT ++APE + ++D++S GV+ L++G P
Sbjct: 168 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-22
Identities = 45/218 (20%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+G+G G V++ V +S K K + + + E++
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV------------------KVKGTDQVLVKKEISI 54
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL--HTCHKIEMDWVVRYAIAVGA 753
L+ RH N++ L+ S S + ++++E++ +++R+ E + +V Y V
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE-IVSYVHQV-- 111
Query: 754 AKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKP--RIADFGLAKIVQTGEAGDLTHVIA 810
+ L++LH H + H D++ NI+ +I +FG A+ ++ G+ ++
Sbjct: 112 CEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLF 164
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
Y APE ++ +D++S G ++ L++G P
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 62/245 (25%), Positives = 95/245 (38%), Gaps = 48/245 (19%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
IG G G + + + +AVK+I A + + R E+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYI------------ERGAAIDENVQR------EII 68
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY---AIAV 751
++RH N+V+ I + ++ EY G L++R+ + D + ++
Sbjct: 69 NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS- 127
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR--IADFGLAKIVQTGEAGDLTHVI 809
G+ Y H + HRD+K N LLD PR I DFG +K
Sbjct: 128 ----GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKST 177
Query: 810 AGTHGYIAPE----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865
GT YIAPE Y K +DV+S GV L ++ G P F D ++ + Y
Sbjct: 178 VGTPAYIAPEVLLRQEYDGK---IADVWSCGVTLYVMLVGAYP----FEDPEEPRD--YR 228
Query: 866 KMDSR 870
K R
Sbjct: 229 KTIQR 233
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 40/225 (17%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA---- 691
+G G V K ++G + A K I KR ++SS
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFI------------------KKRRTKSSRRGVSRED 60
Query: 692 ---EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL-HTCHKIEMDWVVRY 747
EV+ L ++H NV+ L+ ++ +L+ E + G L+D L E + +
Sbjct: 61 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE-ATEF 119
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP----RIADFGLAKIVQTGEAG 803
+ G+ YLH + H D+K NI+L P +I DFGLA + G
Sbjct: 120 LKQI--LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-- 172
Query: 804 DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
I GT ++APE + ++D++S GV+ L++G P
Sbjct: 173 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-22
Identities = 62/232 (26%), Positives = 94/232 (40%), Gaps = 40/232 (17%)
Query: 631 VKPENLIGKGGSGNVYKVVLNSGKEL----AVKHIWPSNSGFRGDYRSSTAILSKRSSRS 686
V +IG+G G VY L AVK L++ +
Sbjct: 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------------------SLNRITDIG 132
Query: 687 SEYD--AEVATLSAVRHVNVVKLY-CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW 743
E + H NV+ L + SE S L+V Y+ +G L + +
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV 191
Query: 744 VVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA 802
+ AKG+++L F +HRD+ + N +LD ++ ++ADFGLA+ +
Sbjct: 192 KDLIGFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDK-- 245
Query: 803 GDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ V T + A E T K KSDV+SFGV+L EL+T G P
Sbjct: 246 -EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 53/251 (21%), Positives = 100/251 (39%), Gaps = 33/251 (13%)
Query: 604 KHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIW 662
+ + W + + ++D +G G G V++V +G A K +
Sbjct: 132 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV- 190
Query: 663 PSNSGFRGDYRSSTAILSKRSSRSSEY-DAEVATLSAVRHVNVVKLYCSITSEDSNLLVY 721
E E+ T+S +RH +V L+ + ++ +++Y
Sbjct: 191 -----------------MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233
Query: 722 EYLPNGSLWDRL--HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779
E++ G L++++ E + V Y V KGL ++H + +H D+K NI+
Sbjct: 234 EFMSGGELFEKVADEHNKMSEDE-AVEYMRQV--CKGLCHMH---ENNYVHLDLKPENIM 287
Query: 780 LDLEWKPRI--ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGV 837
+ + DFGL + + V GT + APE A + +D++S GV
Sbjct: 288 FTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 838 VLMELVTGKRP 848
+ L++G P
Sbjct: 345 LSYILLSGLSP 355
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 55/241 (22%), Positives = 85/241 (35%), Gaps = 58/241 (24%)
Query: 617 FRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSS 675
+ L + + D + + IG G + + + E AVK
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---------------- 53
Query: 676 TAILSKRSSRSSEYDAEVATL-SAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL- 733
I+ K +E E+ L +H N++ L +V E + G L D++
Sbjct: 54 --IIDKSKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL 108
Query: 734 -----------HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782
I K +EYLH + V+HRD+K SNIL
Sbjct: 109 RQKFFSEREASAVLFTI--------------TKTVEYLH---AQGVVHRDLKPSNILYVD 151
Query: 783 EWKP----RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVV 838
E RI DFG AK ++ L T ++APE + D++S GV+
Sbjct: 152 ESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209
Query: 839 L 839
L
Sbjct: 210 L 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-22
Identities = 63/271 (23%), Positives = 103/271 (38%), Gaps = 62/271 (22%)
Query: 592 SYFVVKLKQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKV-VL 650
YF+ L+ L+ F ++G+GG G V+ +
Sbjct: 166 LYFLRFLQWKWLE----AQPMGEDWFLDFR--------------VLGRGGFGEVFACQMK 207
Query: 651 NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS-SRSSEYD---AEVATLSAVRHVNVVK 706
+GK A K L+K+ + Y E L+ V +V
Sbjct: 208 ATGKLYACK------------------KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIE----MDWVVRYAIAVGAAKGLEYLHH 762
L + ++ LV + G + ++ + + Y + GLE+LH
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGLEHLH- 306
Query: 763 GFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE--- 819
R +I+RD+K N+LLD + RI+D GLA ++ G T AGT G++APE
Sbjct: 307 --QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYAGTPGFMAPELLL 362
Query: 820 -YAYTCKINEKS-DVYSFGVVLMELVTGKRP 848
Y S D ++ GV L E++ + P
Sbjct: 363 GEEYD-----FSVDYFALGVTLYEMIAARGP 388
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 58/262 (22%), Positives = 97/262 (37%), Gaps = 25/262 (9%)
Query: 24 VCKFNGIVCDSNGLVA-EINLPE--QQL------LGVVPFDSICGLQALQKINLGTNFLY 74
C I C+S GL + +P +L L +P L L K++L +N L
Sbjct: 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 75 --GTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENL 132
G ++ T L+ LDL N + L +L L+ S + + +L
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 133 TNLEFLSLGDNPFDPSPFPMEVLK-LEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELS 190
NL +L + + L L L + S I L L L+LS
Sbjct: 126 RNLIYLDISHTHT--RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 191 DNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRL----EG 244
+L ++ L+ L L + +N+ L + L +L D S N + +
Sbjct: 184 QCQL-EQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241
Query: 245 DLSELRFLNQLSSLHLFENQFS 266
+L + L+ L+L +N F+
Sbjct: 242 ELQHF--PSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 18/221 (8%)
Query: 85 TRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKF-PWKSLENLTNLEFLSLG 141
+ L+L +N +P L +L+ L+L+S+G+S K +S T+L++L L
Sbjct: 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86
Query: 142 DNPFD--PSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEI 198
N S F L LE+L L + ++ + +L L L++S
Sbjct: 87 FNGVITMSSNF----LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT-RVA 141
Query: 199 PAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSE--LRFLNQ 254
GI L+ L L++ NS F+ L NL D+SQ +LE LS L+
Sbjct: 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSS 200
Query: 255 LSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQ 295
L L++ N F + L L N + T +
Sbjct: 201 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKK 240
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 58/280 (20%), Positives = 93/280 (33%), Gaps = 53/280 (18%)
Query: 255 LSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLT 314
+ L L N+ F + LT+LSL +N L+ + S +DF +L
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS---FKGCCSQSDFGTT----SLKY 82
Query: 315 GPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGI-WSLP 373
L L N T+ + + L +++L + SL
Sbjct: 83 ----------------LDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 374 NLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQF 433
NL +D+S + N F+G L S L ++++ N F
Sbjct: 127 NLIYLDISHTH----------------TRVAFNGIFNG-LSS-------LEVLKMAGNSF 162
Query: 434 SGQIPLDI-GKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSL 492
DI +L+ L+ L L P + S SL +N + N+ L
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 222
Query: 493 PSLNSLNLSNNKFSGEIPISLTYP---KLSLLDLSNNQLA 529
SL L+ S N L+ L+L+ N A
Sbjct: 223 NSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 37/177 (20%), Positives = 68/177 (38%), Gaps = 9/177 (5%)
Query: 357 NNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFS-GELPS 415
N+ L+ ++P GI + + ++L +N+ + L L L++N S S
Sbjct: 15 NSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71
Query: 416 KISEA-SSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSI-GSCVSLTD 473
+ +SL + LS N + + L++L L + +S+ S +L
Sbjct: 72 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130
Query: 474 INFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTY--PKLSLLDLSNNQL 528
++ + L SL L ++ N F + L+ LDLS QL
Sbjct: 131 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 6e-22
Identities = 49/249 (19%), Positives = 100/249 (40%), Gaps = 33/249 (13%)
Query: 606 SLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPS 664
++ W + + + + D +G G G V++ V +G+ K I
Sbjct: 28 KFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI--- 84
Query: 665 NSGFRGDYRSSTAILSKRSSRSSE-YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEY 723
+ E++ ++ + H ++ L+ + + +L+ E+
Sbjct: 85 ---------------NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129
Query: 724 LPNGSLWDRL--HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781
L G L+DR+ E + V+ Y +GL+++H + ++H D+K NI+ +
Sbjct: 130 LSGGELFDRIAAEDYKMSEAE-VINYMRQA--CEGLKHMH---EHSIVHLDIKPENIMCE 183
Query: 782 LEWKPR--IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839
+ I DFGLA + E + V T + APE + +D+++ GV+
Sbjct: 184 TKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
Query: 840 MELVTGKRP 848
L++G P
Sbjct: 241 YVLLSGLSP 249
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 7e-22
Identities = 47/226 (20%), Positives = 83/226 (36%), Gaps = 44/226 (19%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA---E 692
+G+G V + + ++G+E A K + KR E
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFL------------------KKRRRGQDCRAEILHE 78
Query: 693 VATLSAVRHV-NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY--AI 749
+A L + V+ L+ + +L+ EY G ++ +
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL------CLPELAEMVSEND 132
Query: 750 AVGAAK----GLEYLHHGFDRPVIHRDVKSSNILL---DLEWKPRIADFGLAKIVQTGEA 802
+ K G+ YLH ++H D+K NILL +I DFG+++ +
Sbjct: 133 VIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189
Query: 803 GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
I GT Y+APE I +D+++ G++ L+T P
Sbjct: 190 ---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 48/225 (21%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEY-DAEVA 694
IG+G G V V + A K + K + E+
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAK------------------KIPKYFVEDVDRFKQEIE 58
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKI-EMD--WVVRYAIAV 751
+ ++ H N+++LY + LV E G L++R+ E D +++ ++
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILL---DLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+ Y H V HRD+K N L + ++ DFGLA + G+ +
Sbjct: 119 -----VAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRT 167
Query: 809 IAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT Y++P+ Y + D +S GV++ L+ G P
Sbjct: 168 KVGTPYYVSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPP 206
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-22
Identities = 53/253 (20%), Positives = 100/253 (39%), Gaps = 68/253 (26%)
Query: 621 SFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAIL 679
+ + + + +GKG V + V + +G+E A I+
Sbjct: 3 TITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAM------------------II 44
Query: 680 SKRSSRSSEYDA---EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL--- 733
+ + + ++ E ++H N+V+L+ SI+ E + L+++ + G L++ +
Sbjct: 45 NTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR 104
Query: 734 ---------HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL---- 780
H +I + + + H V+HR++K N+LL
Sbjct: 105 EYYSEADASHCIQQI--------------LEAVLHCH---QMGVVHRNLKPENLLLASKL 147
Query: 781 -DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE----YAYTCKINEKSDVYSF 835
K +ADFGLA V+ AGT GY++PE Y + D+++
Sbjct: 148 KGAAVK--LADFGLAIEVEGE--QQAWFGFAGTPGYLSPEVLRKDPY----GKPVDLWAC 199
Query: 836 GVVLMELVTGKRP 848
GV+L L+ G P
Sbjct: 200 GVILYILLVGYPP 212
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-21
Identities = 52/237 (21%), Positives = 94/237 (39%), Gaps = 40/237 (16%)
Query: 624 EKEII-DAVKPENLIGKGGSGNVYKVVLNSGKEL----AVKHIWPSNSGFRGDYRSSTAI 678
+ EI + ++ IG+G G+V++ + S + A+K S
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS------------ 431
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK 738
S ++ E T+ H ++VKL + +E+ ++ E G L L K
Sbjct: 432 ----DSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQV-RK 485
Query: 739 IEMDWVVRYAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
+D A + L YL F +HRD+ + N+L+ ++ DFGL++ +
Sbjct: 486 FSLDLASLILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM 541
Query: 798 QTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ + G + APE + SDV+ FGV + E++ G +P
Sbjct: 542 EDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-21
Identities = 68/274 (24%), Positives = 103/274 (37%), Gaps = 63/274 (22%)
Query: 589 LLASYFVVKLKQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKV 648
+ + F + N++ M F V +IG+GG G VY
Sbjct: 166 IESDKFTRFCQWKNVE---LNIHLTMNDFSVHR--------------IIGRGGFGEVYGC 208
Query: 649 -VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS-SRSSEYD---AEVATLSAVRHVN 703
++GK A+K L K+ E LS V +
Sbjct: 209 RKADTGKMYAMK------------------CLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 704 ---VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYL 760
+V + + + D + + + G L L + YA + GLE++
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI--ILGLEHM 308
Query: 761 HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE- 819
H +R V++RD+K +NILLD RI+D GLA + H GTHGY+APE
Sbjct: 309 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEV 361
Query: 820 ----YAYTCKINEKS-DVYSFGVVLMELVTGKRP 848
AY S D +S G +L +L+ G P
Sbjct: 362 LQKGVAYD-----SSADWFSLGCMLFKLLRGHSP 390
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-21
Identities = 64/312 (20%), Positives = 111/312 (35%), Gaps = 69/312 (22%)
Query: 83 SCT-RLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLG 141
SC+ + + S EVP + +LNL + I + +L +LE L LG
Sbjct: 51 SCSNQFSKVVCTRRGLS-EVPQ-GIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLG 107
Query: 142 DNP---FDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGE 197
N + F L L L L + +T IP G L++L+ L L +N +
Sbjct: 108 RNSIRQIEVGAF----NGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ES 161
Query: 198 IPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRFLNQL 255
IP+ ++ L +L+L + G F L NL ++ ++ D+ L L L
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGL 220
Query: 256 SSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLT 314
L + N F EI F L +L + ++++
Sbjct: 221 EELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSL----------------------- 256
Query: 315 GPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIW-SLP 373
I + + SL+ + +N+LS ++P ++ L
Sbjct: 257 --IERN-----------------------AFDGLASLVELNLAHNNLS-SLPHDLFTPLR 290
Query: 374 NLSIIDLSTNQF 385
L + L N +
Sbjct: 291 YLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-20
Identities = 62/274 (22%), Positives = 101/274 (36%), Gaps = 52/274 (18%)
Query: 32 CDSNGLVA-EINLPE--QQL------LGVVPFDSICGLQALQKINLGTNFLYGTITEG-L 81
C GL +P + L + ++ D+ L L+ + LG N + I G
Sbjct: 61 CTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAF 119
Query: 82 KSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLG 141
L L+L +N L+++ +F E L+ L L L
Sbjct: 120 NGLASLNTLELFDNW-------LTVIPSGAF-----------------EYLSKLRELWLR 155
Query: 142 DNPF---DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGE 197
+NP F ++ L L L I EG L L+ L L + +
Sbjct: 156 NNPIESIPSYAF----NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-D 210
Query: 198 IPAGIVKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQ 254
+P + L L +LE+ N + G F L++L V +++ + F L
Sbjct: 211 MPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLAS 267
Query: 255 LSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTN 287
L L+L N S +P + F ++L EL L+ N
Sbjct: 268 LVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 57/286 (19%), Positives = 97/286 (33%), Gaps = 47/286 (16%)
Query: 253 NQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENL 312
NQ S + S E+P+ + L+L N + + + N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 313 LTGPIPPDMCKTGAMTDL-----LVLQNNFNGTVP-ETYANCKSLIRFRVNNNSLSGTIP 366
+ I GA L L L +N+ +P + L + NN + +IP
Sbjct: 111 IRQ-IEV-----GAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIP 163
Query: 367 PGIWS-LPNLSIIDLS-TNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLV 424
++ +P+L +DL + L ++ F G +L
Sbjct: 164 SYAFNRVPSLMRLDLGELKK----------------LEYISEGAFEG--------LFNLK 199
Query: 425 SIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGK 484
+ L + +P ++ L L L + N F P S SL + + +S
Sbjct: 200 YLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI 257
Query: 485 IPDSLGSLPSLNSLNLSNNKFSGEIPISL--TYPKLSLLDLSNNQL 528
++ L SL LNL++N S +P L L L L +N
Sbjct: 258 ERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 9e-12
Identities = 56/257 (21%), Positives = 92/257 (35%), Gaps = 50/257 (19%)
Query: 302 DFNYVDVSENLLT---GPIPPDMCKTGAMTDLLVLQNNFNGTVPE-TYANCKSLIRFRVN 357
F+ V + L+ IP + T L L N + T+ + L ++
Sbjct: 55 QFSKVVCTRRGLSEVPQGIPSN-------TRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107
Query: 358 NNSLSGTIPPGI-WSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSK 416
NS+ I G L +L+ ++L N + L L L NN +PS
Sbjct: 108 RNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165
Query: 417 ISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINF 476
+ + S+ LD+G+LKKL + + F G +L +N
Sbjct: 166 AF--NRVPSLMR----------LDLGELKKLEYI--SEGAFEG--------LFNLKYLNL 203
Query: 477 AQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL--TYPKLSLLDLSNNQLAGPIPE 534
++ +P+ L L L L +S N F EI L L + N+Q++ I
Sbjct: 204 GMCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSL-IER 259
Query: 535 PLNIKAFIDSFTGNPGL 551
++F G L
Sbjct: 260 --------NAFDGLASL 268
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 22/91 (24%), Positives = 35/91 (38%), Gaps = 6/91 (6%)
Query: 59 GLQALQKINLGTNFLYGTITEG-LKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNL 115
L L+++ + N I G + L+ L + N+ S + L L LNL
Sbjct: 216 PLVGLEELEMSGNHF-PEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNL 273
Query: 116 NSSGISGKFPWKSLENLTNLEFLSLGDNPFD 146
+ +S P L L L L NP++
Sbjct: 274 AHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-21
Identities = 73/283 (25%), Positives = 116/283 (40%), Gaps = 71/283 (25%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA--- 691
+G G G V +G ++AVK IL+++ RS +
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVK------------------ILNRQKIRSLDVVGKIR 64
Query: 692 -EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY--- 747
E+ L RH +++KLY I++ +V EY+ G L+D + +++ R
Sbjct: 65 REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ 124
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
++ G++Y H V+HRD+K N+LLD +IADFGL+ ++ GE
Sbjct: 125 ILS-----GVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLR 173
Query: 808 VIAGTHGYIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS----- 856
G+ Y APE YA + D++S GV+L L+ G P F D
Sbjct: 174 TSCGSPNYAAPEVISGRLYA-----GPEVDIWSSGVILYALLCGTLP----FDDDHVPTL 224
Query: 857 -KDIVNWVYS-----KMDSRD---SMLTVVDPN----ISEILK 886
K I + ++ ML VDP I +I +
Sbjct: 225 FKKICDGIFYTPQYLNPSVISLLKHML-QVDPMKRATIKDIRE 266
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 39/227 (17%)
Query: 631 VKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEY 689
V ++G G G V+K +G +LA K I R + E
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKII------------------KTRGMKDKEE 132
Query: 690 -DAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL--HTCHKIEMDWVVR 746
E++ ++ + H N+++LY + S++ +LV EY+ G L+DR+ + + E+D +
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD-TIL 191
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI--ADFGLAKIVQTGEAGD 804
+ + +G+ ++H ++H D+K NIL +I DFGLA+ + E
Sbjct: 192 FMKQI--CEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244
Query: 805 LTHVIAGTHGYIAPE---YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
V GT ++APE Y + ++ +D++S GV+ L++G P
Sbjct: 245 -LKVNFGTPEFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 51/225 (22%), Positives = 85/225 (37%), Gaps = 60/225 (26%)
Query: 634 ENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE-YDA 691
++G G V+ V +GK A+K + K + +
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALK------------------CIKKSPAFRDSSLEN 55
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL------------HTCHKI 739
E+A L ++H N+V L S LV + + G L+DR+ ++
Sbjct: 56 EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV 115
Query: 740 EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL-----DLEWKPRIADFGLA 794
++YLH + ++HRD+K N+L + + I DFGL+
Sbjct: 116 --------------LSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIM--ITDFGLS 156
Query: 795 KIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839
K+ Q G GT GY+APE ++ D +S GV+
Sbjct: 157 KMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-21
Identities = 64/225 (28%), Positives = 90/225 (40%), Gaps = 43/225 (19%)
Query: 636 LIGKGGSGNVYKV-VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS-SRSSEYD--- 690
++GKGG G V V +GK A K L K+ +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACK------------------KLEKKRIKKRKGEAMAL 232
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKI--EMDWVVRYA 748
E L V VV L + ++D+ LV + G L ++ + V YA
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+ GLE LH +++RD+K NILLD RI+D GLA V G
Sbjct: 293 AEI--CCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKG 344
Query: 809 IAGTHGYIAPE----YAYTCKINEKS-DVYSFGVVLMELVTGKRP 848
GT GY+APE YT S D ++ G +L E++ G+ P
Sbjct: 345 RVGTVGYMAPEVVKNERYT-----FSPDWWALGCLLYEMIAGQSP 384
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-21
Identities = 65/257 (25%), Positives = 100/257 (38%), Gaps = 67/257 (26%)
Query: 623 SEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKR 682
+ ++ A +IG G G V++ L E+A+K + D +
Sbjct: 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-------LQD--------KRF 78
Query: 683 SSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNL------LVYEYLPNGSLWDRLHTC 736
+R E+ + V+H NVV L S LV EY+P T
Sbjct: 79 KNR------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP--------ETV 124
Query: 737 HKIEMDWVVRYAIAVGAA----------KGLEYLH-HGFDRPVIHRDVKSSNILLDLE-W 784
++ + + + L Y+H G + HRD+K N+LLD
Sbjct: 125 YRA-SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG----ICHRDIKPQNLLLDPPSG 179
Query: 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVL 839
++ DFG AKI+ GE I + Y APE YT I D++S G V+
Sbjct: 180 VLKLIDFGSAKILIAGEP--NVSYIC-SRYYRAPELIFGATNYTTNI----DIWSTGCVM 232
Query: 840 MELVTGKRPIVPEFGDS 856
EL+ G+ P+ P G+S
Sbjct: 233 AELMQGQ-PLFP--GES 246
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-21
Identities = 67/258 (25%), Positives = 102/258 (39%), Gaps = 68/258 (26%)
Query: 623 SEKEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSK 681
++ + +IG G G VY+ L SG+ +A+K + D +
Sbjct: 48 PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQD--------KR 92
Query: 682 RSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNL------LVYEYLPNGSLWDRLHT 735
+R E+ + + H N+V+L S LV +Y+P T
Sbjct: 93 FKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--------ET 138
Query: 736 CHKIEMDWVVRYAIAVGAA----------KGLEYLH-HGFDRPVIHRDVKSSNILLDLE- 783
+++ R + + L Y+H G + HRD+K N+LLD +
Sbjct: 139 VYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDT 193
Query: 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVV 838
++ DFG AK + GE I + Y APE YT I DV+S G V
Sbjct: 194 AVLKLCDFGSAKQLVRGEP--NVSYIC-SRYYRAPELIFGATDYTSSI----DVWSAGCV 246
Query: 839 LMELVTGKRPIVPEFGDS 856
L EL+ G +PI P GDS
Sbjct: 247 LAELLLG-QPIFP--GDS 261
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 29/165 (17%), Positives = 65/165 (39%), Gaps = 10/165 (6%)
Query: 105 SMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLKLEKLYWL 163
+ ++ L+++ L + ++ +E N++ L++ + + +P L L L
Sbjct: 41 AQMNSLTYITLANINVTD---LTGIEYAHNIKDLTINNIHATNYNPIS----GLSNLERL 93
Query: 164 YLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLP 223
+ VT + LT L L++S + I I L K+ ++L N +
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153
Query: 224 VGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGE 268
L L + ++ + + D + +L+ L+ F G+
Sbjct: 154 -PLKTLPELKSLNIQFDGVH-DYRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 29/186 (15%), Positives = 68/186 (36%), Gaps = 13/186 (6%)
Query: 107 LHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLKLEKLYWLYL 165
L S + + + +L +++L + D + + L +
Sbjct: 22 FKAYLNGLLGQSSTANI----TEAQMNSLTYITLANINVTDLTGIE----YAHNIKDLTI 73
Query: 166 TNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVG 225
N T I L+ L+ L + ++ + + L L L++ +++ +
Sbjct: 74 NNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
Query: 226 FSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLY 285
+ L + + D+S N D+ L+ L +L SL++ + +F L +L +
Sbjct: 132 INTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189
Query: 286 TNRLTG 291
+ + G
Sbjct: 190 SQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 37/187 (19%), Positives = 74/187 (39%), Gaps = 13/187 (6%)
Query: 346 ANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTD--DIGNAKSLALLL 403
+ K+ + + +S + I + +L+ I L+ VTD I A ++ L
Sbjct: 20 STFKAYLNGLLGQSSTA-NITEA--QMNSLTYITLANIN----VTDLTGIEYAHNIKDLT 72
Query: 404 LANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPY 463
+ N + + IS S+L +++ + ++ L L+ L + + +
Sbjct: 73 INNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 464 SIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDL 523
I + + I+ + N I L +LP L SLN+ + I +PKL+ L
Sbjct: 131 KINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIE-DFPKLNQLYA 188
Query: 524 SNNQLAG 530
+ + G
Sbjct: 189 FSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 31/179 (17%), Positives = 62/179 (34%), Gaps = 7/179 (3%)
Query: 330 LLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPV 389
L + T T A SL + N +++ GI N+ + ++
Sbjct: 25 YLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATN-- 80
Query: 390 TDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSS 449
+ I +L L + + + +S +SL + +S + I I L K++S
Sbjct: 81 YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS 140
Query: 450 LYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGE 508
+ L N + + + L +N + + + P LN L + G+
Sbjct: 141 IDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 23/207 (11%), Positives = 56/207 (27%), Gaps = 37/207 (17%)
Query: 180 NLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQ 239
N L + ++N L + L N +++ L G N+ + ++
Sbjct: 21 TFKAYLNGLLGQSST---ANITEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINN 75
Query: 240 NRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGS 299
+ + + L+ L L + + + LT L + + ++ K+ +
Sbjct: 76 IHAT-NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 300 WADFNYVDVSENLLTGPIPPDMCKTGAMTDL--LVLQNNFNGTVPETYANCKSLIRFRVN 357
+ + + L N T L +
Sbjct: 135 ---------------------------LPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQ 167
Query: 358 NNSLSGTIPPGIWSLPNLSIIDLSTNQ 384
+ + I P L+ + +
Sbjct: 168 FDGVHDYRG--IEDFPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 7e-10
Identities = 17/91 (18%), Positives = 38/91 (41%), Gaps = 3/91 (3%)
Query: 54 FDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFL 113
++ GL +L +++ + +I + + ++ +DL N ++ L L EL L
Sbjct: 105 IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSL 164
Query: 114 NLNSSGISGKFPWKSLENLTNLEFLSLGDNP 144
N+ G+ ++ +E+ L L
Sbjct: 165 NIQFDGVHD---YRGIEDFPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 22/140 (15%), Positives = 45/140 (32%), Gaps = 28/140 (20%)
Query: 55 DSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLN 114
+ I GL L+++ + + L T L +LD+ ++
Sbjct: 82 NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS------------------A 123
Query: 115 LNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQI 174
+ S ++ + L + + L N P++ L +L L + V
Sbjct: 124 HDDSILTK------INTLPKVNSIDLSYNGAITDIMPLK--TLPELKSLNIQFDGVHDY- 174
Query: 175 PEGIGNLTQLQNLELSDNEL 194
GI + +L L +
Sbjct: 175 -RGIEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 19/113 (16%), Positives = 43/113 (38%), Gaps = 6/113 (5%)
Query: 426 IQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKI 485
+ L Q S + ++ L+ + L + + I ++ D+ +
Sbjct: 26 LNGLLGQSSTA-NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYN 82
Query: 486 PDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQLAGPIPEPLN 537
P + L +L L + + + +L+ L+LLD+S++ I +N
Sbjct: 83 P--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 4e-21
Identities = 62/307 (20%), Positives = 104/307 (33%), Gaps = 89/307 (28%)
Query: 85 TRLQVLDLGNNSFSGEVP--DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGD 142
T ++L+L N + L L L L+ + I + L NL L L D
Sbjct: 64 TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFD 121
Query: 143 NPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPAG 201
N LT IP G L++L+ L L +N + IP+
Sbjct: 122 NR--------------------LT------TIPNGAFVYLSKLKELWLRNNPI-ESIPSY 154
Query: 202 I-VKLNKLWQLELY-NNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSL 258
++ L +L+L LS + G F L+NL +++ L ++ L L +L L
Sbjct: 155 AFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDEL 212
Query: 259 HLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPI 317
L N S I F HL +L + +++ +
Sbjct: 213 DLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIE----------------------- 247
Query: 318 PPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIW-SLPNLS 376
+ N +SL+ + +N+L+ +P ++ L +L
Sbjct: 248 ------------------------RNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLE 282
Query: 377 IIDLSTN 383
I L N
Sbjct: 283 RIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-20
Identities = 62/274 (22%), Positives = 104/274 (37%), Gaps = 48/274 (17%)
Query: 30 IVCDSNGLVA-EINLPE--QQL------LGVVPFDSICGLQALQKINLGTNFLYGTITEG 80
++C L + + L + ++ +S L+ L+ + L N + TI G
Sbjct: 48 VICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIG 106
Query: 81 -LKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLS 139
L L+L +N L+ + +F L+ L+ L
Sbjct: 107 AFNGLANLNTLELFDNR-------LTTIPNGAF-----------------VYLSKLKELW 142
Query: 140 LGDNPFDPSPFPMEVLK-LEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGE 197
L +NP P + L L L I EG L+ L+ L L+ L E
Sbjct: 143 LRNNPI--ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL-RE 199
Query: 198 IPAGIVKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQ 254
IP + L KL +L+L N LS + G F L +L + Q++++ + F L
Sbjct: 200 IPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQS 256
Query: 255 LSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTN 287
L ++L N + +P + F HL + L+ N
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 64/331 (19%), Positives = 111/331 (33%), Gaps = 90/331 (27%)
Query: 206 NKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFE 262
N+ ++ +L +P G +N L ++ +N+++ + F L L L L
Sbjct: 43 NQFSKVICVRKNLR-EVPDGISTNTRLL---NLHENQIQ-IIKVNSFKHLRHLEILQLSR 97
Query: 263 NQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDM 321
N I F +L L L+ NRLT IP
Sbjct: 98 NHIR-TIEIGAFNGLANLNTLELFDNRLTT-------------------------IPNGA 131
Query: 322 CKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWS-LPNLSIIDL 380
F L + NN + +IP ++ +P+L +DL
Sbjct: 132 ---------------FVYL--------SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDL 167
Query: 381 S-TNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPL 439
+ L ++ F G S+L + L++ +IP
Sbjct: 168 GELKR----------------LSYISEGAFEG--------LSNLRYLNLAMCNLR-EIP- 201
Query: 440 DIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLN 499
++ L KL L L N S P S + L + Q+ + ++ +L SL +N
Sbjct: 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261
Query: 500 LSNNKFSGEIPISL--TYPKLSLLDLSNNQL 528
L++N + +P L L + L +N
Sbjct: 262 LAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 21/91 (23%), Positives = 36/91 (39%), Gaps = 6/91 (6%)
Query: 59 GLQALQKINLGTNFLYGTITEG-LKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNL 115
L L +++L N L I G + LQ L + + + L L +NL
Sbjct: 205 PLIKLDELDLSGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINL 262
Query: 116 NSSGISGKFPWKSLENLTNLEFLSLGDNPFD 146
+ ++ P L +LE + L NP++
Sbjct: 263 AHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 80/333 (24%), Positives = 137/333 (41%), Gaps = 88/333 (26%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA--- 691
+G+G G V + +++A+K +S++ + S+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALK------------------FISRQLLKKSDMHMRVE 57
Query: 692 -EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY--- 747
E++ L +RH +++KLY IT+ ++V EY G L+D + ++ D R+
Sbjct: 58 REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQ 116
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
I +EY H ++HRD+K N+LLD +IADFGL+ I+ G
Sbjct: 117 IIC-----AIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLK 165
Query: 808 VIAGTHGYIAPE------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS----- 856
G+ Y APE YA + DV+S G+VL ++ G+ P F D
Sbjct: 166 TSCGSPNYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGRLP----FDDEFIPNL 216
Query: 857 -KDIVNWVYS-----KMDSRD---SMLTVVDPN----ISEILKEDALKVLRIAIHCTNKL 903
K + + VY ++ M+ V DP I EI +
Sbjct: 217 FKKVNSCVYVMPDFLSPGAQSLIRRMI-VADPMQRITIQEIRR-----------D----- 259
Query: 904 PAFRPSMRVVVQMLEEAEPCSVTNIVVKKVGES 936
P F ++ ++ +EE + + +V K+GE+
Sbjct: 260 PWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEA 292
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 5e-21
Identities = 62/318 (19%), Positives = 104/318 (32%), Gaps = 35/318 (11%)
Query: 19 TEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTIT 78
E + C F+ D + + + +L G L++++ + T
Sbjct: 9 DEESCSCNFSDPKPDWSSAFNCLGAADVELYG----GGRSLEYLLKRVDTEADLG--QFT 62
Query: 79 EGLKSCTRLQVLDLGNNSFSGEVP-------DLSMLHELSFLNLNSSGISGKFPWKSLEN 131
+ +KS L+ L + + +S L EL+ NL +G + P
Sbjct: 63 DIIKS-LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTA--PPPLLEAT 119
Query: 132 LTNLEFLSLGDN---PFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLE 188
+L L+L + D ++ L L + E + L L+
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 189 LSDNELFGEIP----AGIVKLNKLWQLELYNN---SLSGRLPVGFSNLTNLMNFDVSQNR 241
LSDN GE +K L L L N + SG + L D+S N
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 242 LEGDLSELRF--LNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGT-LPQKLG 298
L +QL+SL+L ++P+ L+ L L NRL P +L
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRNPSPDELP 296
Query: 299 SWADFNYVDVSENLLTGP 316
+ + N
Sbjct: 297 Q---VGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 6e-21
Identities = 43/244 (17%), Positives = 71/244 (29%), Gaps = 21/244 (8%)
Query: 305 YVDVSENLLTGPIPPDMCKTGAMTDLLVL---QNNFNGTVPETYANC--KSLIRFRVNNN 359
+ V + I + ++ L L GT P L + N
Sbjct: 72 RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 360 SLSGTIPP----GIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGEL-- 413
S + W P L ++ ++ + + +L+ L L++N GE
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191
Query: 414 -----PSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGS- 467
P K L + SG +L L L N
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251
Query: 468 CVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQ 527
L +N + L ++P L L+ L+LS N+ P P++ L L N
Sbjct: 252 PSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNP 307
Query: 528 LAGP 531
Sbjct: 308 FLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 37/217 (17%), Positives = 62/217 (28%), Gaps = 18/217 (8%)
Query: 330 LLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPG---IWSLPNLSIIDLSTNQFE 386
L + + SL R V + I G + + L + L +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 387 GPVTDDIGNAKSLAL--LLLANNRFSGELPS----KISEASSLVSIQLSLNQFSGQIPLD 440
G + A L L L N ++ + L + ++
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 441 IGKLKKLSSLYLHDNMFSGPLPYSIGSCV----SLTDINFAQN---SLSGKIPDSLGSLP 493
+ LS+L L DN G C +L + + SG +
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228
Query: 494 SLNSLNLSNNKFSGEIPISLTY--PKLSLLDLSNNQL 528
L L+LS+N +L+ L+LS L
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 38/209 (18%), Positives = 70/209 (33%), Gaps = 27/209 (12%)
Query: 336 NFNGTVPETY--ANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDI 393
NF+ P+ NC + S L +D + + DI
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLE--------YLLKRVDTEADLGQFT---DI 64
Query: 394 GNAKSLALLLLANNRFSGELPSKISEA---SSLVSIQLSLNQFSGQIPLDIGKL--KKLS 448
+ SL L + R + S L + L + +G P + + L+
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124
Query: 449 SLYLHDNMFSGPLPY----SIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNK 504
L L + ++ + L ++ AQ + + P+L++L+LS+N
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 505 FSGEIPISLT-----YPKLSLLDLSNNQL 528
GE + +P L +L L N +
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGM 213
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 66/323 (20%), Positives = 107/323 (33%), Gaps = 74/323 (22%)
Query: 624 EKEI-IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSST-AI--L 679
KE+ + +G G G VY+ ++ G D A+ L
Sbjct: 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVS---------------GMPNDPSPLQVAVKTL 68
Query: 680 SKRSSRSSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWD-----R 732
+ S E D E +S H N+V+ ++ E + G L R
Sbjct: 69 PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR 128
Query: 733 LHTCHKIEMDWVVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPR---I 788
+ + +A A G +YL + F IHRD+ + N LL R I
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKI 184
Query: 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELV 843
DFG+A+ + + G + PE K+D +SFGV+L E+
Sbjct: 185 GDFGMARDIYRAS-----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
Query: 844 T-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVD-------PNISEILKEDALKVLRI 895
+ G P Y +++ + V N V RI
Sbjct: 240 SLGYMP---------------YPSKSNQEVLEFVTSGGRMDPPKNCPG-------PVYRI 277
Query: 896 AIHCTNKLPAFRPSMRVVVQMLE 918
C P RP+ ++++ +E
Sbjct: 278 MTQCWQHQPEDRPNFAIILERIE 300
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-21
Identities = 72/328 (21%), Positives = 118/328 (35%), Gaps = 92/328 (28%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKEL---AVKHIWPSNSGFRGDYRSSTAILSKRSSR 685
+ +K +++IG+G G V K + A+K + + +S+
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK------------------RMKEYASK 66
Query: 686 SSEYD--AEVATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMD 742
D E+ L + H N++ L + L EY P+G+L D L +E D
Sbjct: 67 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 126
Query: 743 WVVRYA--------------IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788
A A A+G++YL + IHRD+ + NIL+ + +I
Sbjct: 127 PAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI 183
Query: 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYI-----APE----YAYTCKINEKSDVYSFGVVL 839
ADFGL++ + T G + A E YT SDV+S+GV+L
Sbjct: 184 ADFGLSR--------GQEVYVKKTMGRLPVRWMAIESLNYSVYT----TNSDVWSYGVLL 231
Query: 840 MELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVD-------PNISEILKEDALK 891
E+V+ G P Y M + + N + +
Sbjct: 232 WEIVSLGGTP---------------YCGMTCAELYEKLPQGYRLEKPLNCDD-------E 269
Query: 892 VLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
V + C + P RPS ++ L
Sbjct: 270 VYDLMRQCWREKPYERPSFAQILVSLNR 297
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 51/249 (20%), Positives = 90/249 (36%), Gaps = 56/249 (22%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKEL------AVKHIWPSNSGFRGDYRSSTAILSKR 682
AV+ +G+ G VYK L A+K L +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK------------------TLKDK 50
Query: 683 SSRSSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIE 740
+ + E + ++H NVV L +T + +++ Y +G L + L
Sbjct: 51 AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHS 110
Query: 741 MDWVVRYA--------------IAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWK 785
+ A G+EYL H +H+D+ + N+L+ +
Sbjct: 111 DVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLN 166
Query: 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLM 840
+I+D GL + V + + + APE K + SD++S+GVVL
Sbjct: 167 VKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 221
Query: 841 ELVT-GKRP 848
E+ + G +P
Sbjct: 222 EVFSYGLQP 230
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 59/218 (27%), Positives = 83/218 (38%), Gaps = 29/218 (13%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRS-SRSSEYD--- 690
L+GKG G V V + A+K IL K E
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMK------------------ILKKEVIVAKDEVAHTL 196
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
E L RH + L S + D V EY G L+ L D Y
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ L+YLH + V++RD+K N++LD + +I DFGL K + + G
Sbjct: 257 I--VSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFC 310
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT Y+APE D + GVV+ E++ G+ P
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 60/262 (22%), Positives = 108/262 (41%), Gaps = 47/262 (17%)
Query: 681 KRSSRSSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK 738
K + ++ D E L+ ++H ++VK Y D ++V+EY+ +G L L
Sbjct: 54 KDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGP 113
Query: 739 IEMDWVVRYA--------------IAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLE 783
M V IA A G+ YL F +HRD+ + N L+
Sbjct: 114 DAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGAN 169
Query: 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVV 838
+I DFG+++ V + D V G H + PE K +SDV+SFGV+
Sbjct: 170 LLVKIGDFGMSRDV---YSTDYYRV--GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 224
Query: 839 LMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAI 897
L E+ T GK+P + ++ + + + + + E + +V + +
Sbjct: 225 LWEIFTYGKQP---------------WFQLSNTEVIECITQGRVLERPRVCPKEVYDVML 269
Query: 898 HCTNKLPAFRPSMRVVVQMLEE 919
C + P R +++ + ++L
Sbjct: 270 GCWQREPQQRLNIKEIYKILHA 291
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 66/323 (20%), Positives = 107/323 (33%), Gaps = 74/323 (22%)
Query: 624 EKEI-IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSST-AI--L 679
KE+ + +G G G VY+ ++ G D A+ L
Sbjct: 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVS---------------GMPNDPSPLQVAVKTL 109
Query: 680 SKRSSRSSEYD--AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWD-----R 732
+ S E D E +S H N+V+ ++ E + G L R
Sbjct: 110 PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 169
Query: 733 LHTCHKIEMDWVVRYAIAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPR---I 788
+ + +A A G +YL + F IHRD+ + N LL R I
Sbjct: 170 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKI 225
Query: 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELV 843
DFG+A+ + + G + PE K+D +SFGV+L E+
Sbjct: 226 GDFGMARDIYRAG-----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
Query: 844 T-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVD-------PNISEILKEDALKVLRI 895
+ G P Y +++ + V N V RI
Sbjct: 281 SLGYMP---------------YPSKSNQEVLEFVTSGGRMDPPKNCPG-------PVYRI 318
Query: 896 AIHCTNKLPAFRPSMRVVVQMLE 918
C P RP+ ++++ +E
Sbjct: 319 MTQCWQHQPEDRPNFAIILERIE 341
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 62/243 (25%), Positives = 106/243 (43%), Gaps = 41/243 (16%)
Query: 620 LSFSEKEIIDAVKPEN-----LIGKGGSGNVY----KVVLNSGKELAVKHIWPSNSGFRG 670
++ KE + P ++G+G G V+ ++ + A+K
Sbjct: 10 ITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK----------- 58
Query: 671 DYRSSTAILSKRS--SRSS-EYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNG 727
+L K + R E L V H +VKL+ + +E L+ ++L G
Sbjct: 59 -------VLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG 111
Query: 728 SLWDRLHTCHKIEMDWVVRYA--IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785
L+ RL + V Y +A+ L++LH +I+RD+K NILLD E
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLAELAL----ALDHLH---SLGIIYRDLKPENILLDEEGH 164
Query: 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTG 845
++ DFGL+K ++ + + GT Y+APE + +D +SFGV++ E++TG
Sbjct: 165 IKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
Query: 846 KRP 848
P
Sbjct: 223 TLP 225
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 48/234 (20%), Positives = 91/234 (38%), Gaps = 48/234 (20%)
Query: 637 IGKGGSGNVYKVVLNSGKEL------AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+G+G G VY+ V + A+K +++ +S +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIK------------------TVNEAASMRERIE 74
Query: 691 --AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA 748
E + + +VV+L ++ L++ E + G L L + + V
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 749 --------IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG 800
+A A G+ YL+ +HRD+ + N ++ ++ +I DFG+ + +
Sbjct: 135 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191
Query: 801 EAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ + G G + +PE SDV+SFGVVL E+ T ++P
Sbjct: 192 D-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 57/256 (22%), Positives = 107/256 (41%), Gaps = 53/256 (20%)
Query: 612 WDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRG 670
WD +S V E D + +G+G V++ + + + +++ VK + P
Sbjct: 23 WDYESHVV----EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------- 71
Query: 671 DYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVKLYCSITSEDSN--LLVYEYLPNG 727
+ K+ R E+ L +R N++ L + S LV+E++ N
Sbjct: 72 -------VKKKKIKR------EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 118
Query: 728 SLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKP 786
D ++ D+ +R+ + K L+Y H G ++HRDVK N+++D E +
Sbjct: 119 ---D-FKQLYQTLTDYDIRFYM-YEILKALDYCHSMG----IMHRDVKPHNVMIDHEHRK 169
Query: 787 -RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLM 840
R+ D+GLA+ G+ + +A + + PE Y + D++S G +L
Sbjct: 170 LRLIDWGLAEFYHPGQ--EYNVRVA-SRYFKGPELLVDYQMYDYSL----DMWSLGCMLA 222
Query: 841 ELVTGKRPIVPEFGDS 856
++ K P G
Sbjct: 223 SMIFRKEPFFH--GHD 236
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 65/247 (26%), Positives = 101/247 (40%), Gaps = 49/247 (19%)
Query: 615 KSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYR 673
+ + + + D + E+ +G+G + VY+ + K A+K +
Sbjct: 39 PDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL------------ 86
Query: 674 SSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL 733
K + E+ L + H N++KL + LV E + G L+DR+
Sbjct: 87 ------KKTVDKKIVRT-EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI 139
Query: 734 HTCHK---IEMDWVVRYAIAVGAAK----GLEYLHHGFDRPVIHRDVKSSNILL-----D 781
K E D A A K + YLH + ++HRD+K N+L D
Sbjct: 140 --VEKGYYSERD-------AADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPD 187
Query: 782 LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLME 841
K IADFGL+KIV E L + GT GY APE C + D++S G++
Sbjct: 188 APLK--IADFGLSKIV---EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYI 242
Query: 842 LVTGKRP 848
L+ G P
Sbjct: 243 LLCGFEP 249
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 45/225 (20%)
Query: 634 ENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEY-DA 691
E+++G+G V + L + +E AVK I+ K+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVK------------------IIEKQPGHIRSRVFR 59
Query: 692 EVATLSAVR-HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC-HKIEMD--WVVRY 747
EV L + H NV++L ED LV+E + GS+ +H H E++ VV+
Sbjct: 60 EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ- 118
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP---RIADFGLAKIVQTGE--- 801
+ A L++LH ++ + HRD+K NIL + + +I DF L ++
Sbjct: 119 DV----ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 802 --AGDLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVL 839
+ G+ Y+APE +++ D++S GV+L
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 57/249 (22%), Positives = 94/249 (37%), Gaps = 66/249 (26%)
Query: 621 SFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAIL 679
F + +D +G+G K V S + AVK I+
Sbjct: 5 PFYQHYDLDLKDKP--LGEGSFSICRKCVHKKSNQAFAVK------------------II 44
Query: 680 SKRSSRSSEYDAEVATLSAVR-HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRL----- 733
SKR +++ E+ L H N+VKL+ + LV E L G L++R+
Sbjct: 45 SKRMEANTQ--KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH 102
Query: 734 -------HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL---DLE 783
+ K+ + ++H D V+HRD+K N+L +
Sbjct: 103 FSETEASYIMRKL--------------VSAVSHMH---DVGVVHRDLKPENLLFTDENDN 145
Query: 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE----YAYTCKINEKSDVYSFGVVL 839
+ +I DFG A++ T Y APE Y +E D++S GV+L
Sbjct: 146 LEIKIIDFGFARLKP--PDNQPLKTPCFTLHYAAPELLNQNGY----DESCDLWSLGVIL 199
Query: 840 MELVTGKRP 848
+++G+ P
Sbjct: 200 YTMLSGQVP 208
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 56/261 (21%), Positives = 94/261 (36%), Gaps = 70/261 (26%)
Query: 624 EKEIIDAVKPENLIGKGGSGNVYK-VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKR 682
++ +D + E + G+G G V ++G +A+K + D R L
Sbjct: 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-------IQDPRFRNRELQ-- 68
Query: 683 SSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSN-------LLVYEYLPNGSLWDRLHT 735
+ L+ + H N+V+L + +V EY+P T
Sbjct: 69 ---------IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--------DT 111
Query: 736 CHKIEMDWVVRYAIAVGAA--------------KGLEYLHHGFDRPVIHRDVKSSNILLD 781
H+ R A + + LH V HRD+K N+L++
Sbjct: 112 LHR-----CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVN 165
Query: 782 LE-WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSF 835
++ DFG AK + E I + Y APE YT + D++S
Sbjct: 166 EADGTLKLCDFGSAKKLSPSEP--NVAYIC-SRYYRAPELIFGNQHYTTAV----DIWSV 218
Query: 836 GVVLMELVTGKRPIVPEFGDS 856
G + E++ G+ PI GD+
Sbjct: 219 GCIFAEMMLGE-PIFR--GDN 236
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 35/291 (12%), Positives = 81/291 (27%), Gaps = 67/291 (23%)
Query: 636 LIGKGGSGNVYK---VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
G ++ L +++A+ + P + + +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQ--------GVLPDDVLQETLS------R 81
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVG 752
LS + V ++ + + L+V E++ GSL + T +R ++
Sbjct: 82 TLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLA 139
Query: 753 AAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
AA + H G V S + ++ G +
Sbjct: 140 AA--ADAAHRAG----VALSIDHPSRVR--------VSIDGDVVL--------------A 171
Query: 812 THGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRD 871
+ N + D+ G L L+ + P+ S + +
Sbjct: 172 YPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRS--GLAPAERDTAGQP 222
Query: 872 SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922
+D +I + A+ R R + ++ ++++A
Sbjct: 223 IEPADIDRDIPFQI--SAV-AAR----SVQGDGGIRSAS-TLLNLMQQATA 265
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-20
Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 45/233 (19%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNS--GFRGDYRSSTAILSKRSSRSSEYDAEV 693
+G+G G VYK + + + +A+K I + G TAI R EV
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV-----PGTAI------R------EV 84
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
+ L ++H N+++L I L++EY N L + + M + + +
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL-- 141
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR-----IADFGLAKIVQTGEAGDLTHV 808
G+ + H R +HRD+K N+LL + I DFGLA+ TH
Sbjct: 142 INGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHE 197
Query: 809 IAGTHGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
I T Y PE Y+ + D++S + E++ P+ P GDS
Sbjct: 198 II-TLWYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT-PLFP--GDS 242
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 7e-20
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 48/229 (20%)
Query: 636 LIGKGGSGNVYKVVLNSGKE----LAVKHIWPSNSGFRGDYRSSTAILSKRS--SRSSEY 689
++GKGG G V++V +G A+K +L K + +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMK------------------VLKKAMIVRNAKDT 65
Query: 690 D---AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
AE L V+H +V L + + L+ EYL G L+ +L D
Sbjct: 66 AHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF 125
Query: 747 YA--IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGD 804
Y I++ L +LH + +I+RD+K NI+L+ + ++ DFGL K ++ G
Sbjct: 126 YLAEISMA----LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGT 176
Query: 805 LTHVIAGTHGYIAPEYAYTCKINEKS-----DVYSFGVVLMELVTGKRP 848
+TH GT Y+APE + D +S G ++ +++TG P
Sbjct: 177 VTHTFCGTIEYMAPEI-----LMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-20
Identities = 53/237 (22%), Positives = 99/237 (41%), Gaps = 45/237 (18%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI--LSKRSSRSSEYD--AE 692
+G+G G V + + + + A+ L ++ D +E
Sbjct: 77 LGEGAFGQVVL-----AE-------AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 693 VATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA--- 748
+ + + +H N++ L + T + ++ EY G+L + L +++ +
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 749 -----------IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
A A+G+EYL + IHRD+ + N+L+ + +IADFGLA+ +
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 798 QTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ + T+G + APE + +SDV+SFGV+L E+ T G P
Sbjct: 242 HHID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 65/310 (20%), Positives = 110/310 (35%), Gaps = 72/310 (23%)
Query: 637 IGKGGSGNVYKVVLNSGKEL----AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
+GKG G+V + L AVK + SS E+ E
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA---------------SSDIEEFLRE 75
Query: 693 VATLSAVRHVNVVKLY--CS----ITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
A + H +V KL +++ ++ +G L L E + +
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 747 YA----IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEA 802
V A G+EYL R IHRD+ + N +L + +ADFGL++ + +G+
Sbjct: 136 LQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD- 191
Query: 803 GDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDS 856
+ G + A E SDV++FGV + E++T G+ P
Sbjct: 192 ----YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP-------- 239
Query: 857 KDIVNWVYSKMDSRDSMLTVVD-------PNISEILKEDALKVLRIAIHCTNKLPAFRPS 909
Y+ +++ + ++ P E +V + C + P RPS
Sbjct: 240 -------YAGIENAEIYNYLIGGNRLKQPPECME-------EVYDLMYQCWSADPKQRPS 285
Query: 910 MRVVVQMLEE 919
+ LE
Sbjct: 286 FTCLRMELEN 295
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 9e-20
Identities = 60/315 (19%), Positives = 119/315 (37%), Gaps = 74/315 (23%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI--LSKRSSRSSEYD--AE 692
+G+G G V + + + A+ L ++ D +E
Sbjct: 89 LGEGCFGQVVM-----AE-------AVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 693 VATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA--- 748
+ + + +H N++ L + T + ++ EY G+L + L M++
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 749 -----------IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
A+G+EYL + IHRD+ + N+L+ +IADFGLA+ +
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 798 QTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVP 851
+ + T+G + APE + +SDV+SFGV++ E+ T G P
Sbjct: 254 NNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--- 305
Query: 852 EFGDSKDIVNWVYSKMDSRDSMLTVVD-------PNISEILKEDALKVLRIAIHCTNKLP 904
Y + + + + N + ++ + C + +P
Sbjct: 306 ------------YPGIPVEELFKLLKEGHRMDKPANCTN-------ELYMMMRDCWHAVP 346
Query: 905 AFRPSMRVVVQMLEE 919
+ RP+ + +V+ L+
Sbjct: 347 SQRPTFKQLVEDLDR 361
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 56/188 (29%), Positives = 79/188 (42%), Gaps = 27/188 (14%)
Query: 113 LNLNSSGISGKFPWKSLENLTNLEFLSLGDNP--------FDPSPFPMEVLKLEKLYWLY 164
L+L S+ +S P K+ LT L L L DN F +L+ L L+
Sbjct: 42 LDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFK---------ELKNLETLW 91
Query: 165 LTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRL 222
+T+ + +P G+ L L L L N+L +P + L KL L L N L L
Sbjct: 92 VTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SL 148
Query: 223 PVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEEFGEFKHL 279
P G F LT+L + N+L+ + E F L +L +L L NQ F + L
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKL 207
Query: 280 TELSLYTN 287
L L N
Sbjct: 208 KMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 51/167 (30%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 133 TNLEFLSLGDNPF---DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLE 188
+ + L L N F +L KL LYL + + +P GI L L+ L
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFH----RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLW 91
Query: 189 LSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDL 246
++DN+L +P G+ +L L +L L N L LP F +LT L + N L+ L
Sbjct: 92 VTDNKL-QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SL 148
Query: 247 SELRF--LNQLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLT 290
+ F L L L L+ NQ +PE F + L L L N+L
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 54/215 (25%), Positives = 81/215 (37%), Gaps = 33/215 (15%)
Query: 304 NYVDVSENLLT---GPIPPDMCKTGAMTDLLVLQNN-FNGTVPETYANCKSLIRFRVNNN 359
N VD S LT IP D T L LQ+N + + + L +N+N
Sbjct: 19 NSVDCSSKKLTAIPSNIPAD-------TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDN 71
Query: 360 SLSGTIPPGIW-SLPNLSIIDLSTNQ--------FEGPVTDDIGNAKSLALLLLANNRFS 410
L T+P GI+ L NL + ++ N+ F+ V +LA L L N+
Sbjct: 72 KLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLV--------NLAELRLDRNQLK 122
Query: 411 GELPSKI-SEASSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHDNMFSGPLPYSIGSC 468
LP ++ + L + L N+ +P + KL L L L++N +
Sbjct: 123 -SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKL 180
Query: 469 VSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNN 503
L + N L + SL L L L N
Sbjct: 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 49/180 (27%), Positives = 79/180 (43%), Gaps = 18/180 (10%)
Query: 357 NNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSK 416
++ L+ IP I + +DL +N+ + L LL L +N+ LP+
Sbjct: 24 SSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAG 79
Query: 417 I-SEASSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHDNMFSGPLPYSI-GSCVSLTD 473
I E +L ++ ++ N+ +P+ + +L L+ L L N LP + S LT
Sbjct: 80 IFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTY 137
Query: 474 INFAQNSLSGKIPDSL-GSLPSLNSLNLSNNKFSGEIPI----SLTYPKLSLLDLSNNQL 528
++ N L +P + L SL L L NN+ +P LT +L L L NNQL
Sbjct: 138 LSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLT--ELKTLKLDNNQL 193
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 61/223 (27%), Positives = 87/223 (39%), Gaps = 40/223 (17%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRS-SRSSEYD--- 690
L+GKG G V V + A+K IL K E
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMK------------------ILRKEVIIAKDEVAHTV 53
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
E L RH + L + + D V EY G L+ L + Y
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ +A LEYLH R V++RD+K N++LD + +I DFGL K + G
Sbjct: 114 IVSA--LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 166
Query: 811 GTHGYIAPE----YAYTCKINEKS-DVYSFGVVLMELVTGKRP 848
GT Y+APE Y ++ D + GVV+ E++ G+ P
Sbjct: 167 GTPEYLAPEVLEDNDYG-----RAVDWWGLGVVMYEMMCGRLP 204
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 30/171 (17%)
Query: 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA----------- 748
H+N+V L + T L++ EY G L + L + A
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 749 -----IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG 803
+ AKG+ +L + IHRD+ + NILL +I DFGLA+ ++
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN- 200
Query: 804 DLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ + + APE + C +SDV+S+G+ L EL + G P
Sbjct: 201 ----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 47/190 (24%), Positives = 82/190 (43%), Gaps = 30/190 (15%)
Query: 681 KRSSRSSEYDA---EVATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC 736
K ++ + E +A E+ +S + +H N+V L + T L++ EY G L + L
Sbjct: 85 KSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRK 144
Query: 737 HKIEMDWVVRYA------------IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784
++ + A+G+ +L + IHRDV + N+LL
Sbjct: 145 SRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGH 201
Query: 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVL 839
+I DFGLA+ + I + + APE + C +SDV+S+G++L
Sbjct: 202 VAKIGDFGLARDIMNDSN-----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
Query: 840 MELVT-GKRP 848
E+ + G P
Sbjct: 257 WEIFSLGLNP 266
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 59/244 (24%), Positives = 93/244 (38%), Gaps = 39/244 (15%)
Query: 610 NSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGF 668
W+ S + + I +G G G V V SG A+K
Sbjct: 28 KKWETPSQNTAQLDQFDRIK------TLGTGSFGRVMLVKHKESGNHYAMK--------- 72
Query: 669 RGDYRSSTAILSKRS-SRSSEYD---AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYL 724
IL K+ + + + E L AV +VKL S + +V EY+
Sbjct: 73 ---------ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 725 PNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784
G ++ L + YA + EYLH +I+RD+K N+L+D +
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLH---SLDLIYRDLKPENLLIDQQG 178
Query: 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
++ DFG AK T + GT +APE + N+ D ++ GV++ E+
Sbjct: 179 YIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 845 GKRP 848
G P
Sbjct: 234 GYPP 237
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 71/229 (31%), Positives = 104/229 (45%), Gaps = 42/229 (18%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNS--GFRGDYRSSTAILSKRSSRSSEYDAEVA 694
IG+G G VYK N G+ A+K I G ST I R E++
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI-----PSTTI------R------EIS 52
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPN--GSLWDRLHTCHKIEMDWVVRYAIAVG 752
L ++H N+VKLY I ++ +LV+E+L L D +E + + +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQL- 109
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGT 812
G+ Y H R V+HRD+K N+L++ E + +IADFGLA+ TH I T
Sbjct: 110 -LNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-T 163
Query: 813 HGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
Y AP+ Y+ I D++S G + E+V G P+ P G S
Sbjct: 164 LWYRAPDVLMGSKKYSTTI----DIWSVGCIFAEMVNG-TPLFP--GVS 205
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 51/263 (19%), Positives = 97/263 (36%), Gaps = 52/263 (19%)
Query: 603 LKHSLKQNSWDMKS-FRVLSFSEKEIIDAVK-PENLIGKGGSGNVYKVV-LNSGKELAVK 659
+ H +S ++ F+ + + D + + ++G G +G V + +G++ A+K
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60
Query: 660 HIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL-SAVRHVNVVKL---YCSITSED 715
+L E V A ++V + Y ++
Sbjct: 61 ------------------LLYDSPKARQE----VDHHWQASGGPHIVCILDVYENMHHGK 98
Query: 716 SNL-LVYEYLPNGSLWDRLHTCHKIEMDWVVRY------AIAVGAAKGLEYLHHGFDRPV 768
L ++ E + G L+ R I+ + I +++LH +
Sbjct: 99 RCLLIIMECMEGGELFSR------IQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNI 149
Query: 769 IHRDVKSSNILL---DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK 825
HRDVK N+L + + ++ DFG AK T Y+APE K
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYTPYYVAPEVLGPEK 205
Query: 826 INEKSDVYSFGVVLMELVTGKRP 848
++ D++S GV++ L+ G P
Sbjct: 206 YDKSCDMWSLGVIMYILLCGFPP 228
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 52/242 (21%), Positives = 91/242 (37%), Gaps = 48/242 (19%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKEL----AVKHIWPSNSGFRGDYRSSTAILSKRSS 684
+ + ++G+G G+V + L AVK + +S
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK------------------TMKLDNS 75
Query: 685 RSSEYD---AEVATLSAVRHVNVVKLYCSITSEDSN-----LLVYEYLPNGSLWD--RLH 734
E + +E A + H NV++L S +++ ++ G L
Sbjct: 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 735 TCHKIEMDWVVR--YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792
++ V A G+EYL +R +HRD+ + N +L + +ADFG
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFG 192
Query: 793 LAKIVQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GK 846
L+K + +G+ + G + A E KSDV++FGV + E+ T G
Sbjct: 193 LSKKIYSGD-----YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM 247
Query: 847 RP 848
P
Sbjct: 248 TP 249
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 66/258 (25%), Positives = 100/258 (38%), Gaps = 60/258 (23%)
Query: 637 IGKGGSGNVYKVV---LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
+G+G G+VYK K+ A+K I G S +A E+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI-------EGTGISMSAC------------REI 69
Query: 694 ATLSAVRHVNVVKLY--CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
A L ++H NV+ L ++ L+++Y + LW + H+ +
Sbjct: 70 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKF-HRASKANKKPVQLPR 127
Query: 752 GAAK--------GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR----IADFGLAKIVQT 799
G K G+ YLH V+HRD+K +NIL+ E R IAD G A++ +
Sbjct: 128 GMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 800 GEAGDLTH----VIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRPIV 850
L V+ T Y APE YT I D+++ G + EL+T PI
Sbjct: 185 -PLKPLADLDPVVV--TFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT-SEPIF 236
Query: 851 PEFGDSKDIVNWVYSKMD 868
+DI D
Sbjct: 237 H--CRQEDIKTSNPYHHD 252
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 72/274 (26%), Positives = 113/274 (41%), Gaps = 54/274 (19%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSK----RSSRSSEYD 690
+IG+G G V V S +++ A+K +LSK + S S+ +
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMK------------------LLSKFEMIKRSDSAFFW 117
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
E ++ VV+L+ + + +V EY+P G L + + + + W Y
Sbjct: 118 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAE 176
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
V A L+ +H IHRDVK N+LLD ++ADFG + E
Sbjct: 177 VVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAV 230
Query: 811 GTHGYIAPE----------YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860
GT YI+PE Y C D +S GV L E++ G P F D +
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGREC------DWWSVGVFLYEMLVGDTP----FYA--DSL 278
Query: 861 NWVYSK-MDSRDSMLTVVDPNISEILKEDALKVL 893
YSK M+ ++S+ D +IS+ K + +
Sbjct: 279 VGTYSKIMNHKNSLTFPDDNDISKEAK-NLICAF 311
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 57/235 (24%), Positives = 85/235 (36%), Gaps = 39/235 (16%)
Query: 632 KPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA 691
+ I G G V V + G +A+K ++ + S R S + L KR R
Sbjct: 25 TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR------ 78
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNL-----LVYEYLP---------NGSLWDRLHTCH 737
E+ L+ H N++ L + LV E + + H +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY 138
Query: 738 KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
+ Y I GL LH V+HRD+ NILL I DF LA+
Sbjct: 139 FM-------YHIL----LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR-- 182
Query: 798 QTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKS-DVYSFGVVLMELVTGKRPIVP 851
+ + TH + Y APE K K D++S G V+ E+ K +
Sbjct: 183 EDTADANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFR 235
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 56/248 (22%), Positives = 99/248 (39%), Gaps = 44/248 (17%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA--- 748
E L+ ++H ++V+ + T L+V+EY+ +G L L +
Sbjct: 93 EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 749 ----------IAVGAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
+A A G+ YL F +HRD+ + N L+ +I DFG+++ +
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDI 208
Query: 798 QTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVP 851
+ D V G + PE K +SDV+SFGVVL E+ T GK+P
Sbjct: 209 YS---TDYYRV--GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--- 260
Query: 852 EFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
+ ++ + +++ + E + +V I C + P R S++
Sbjct: 261 ------------WYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIK 308
Query: 912 VVVQMLEE 919
V L+
Sbjct: 309 DVHARLQA 316
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 60/315 (19%), Positives = 119/315 (37%), Gaps = 74/315 (23%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI--LSKRSSRSSEYD--AE 692
+G+G G V + + + A+ L ++ D +E
Sbjct: 43 LGEGAFGQVVM-----AE-------AVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 693 VATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA--- 748
+ + + +H N++ L + T + ++ EY G+L + L M++
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 749 -----------IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
A+G+EYL + IHRD+ + N+L+ +IADFGLA+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 798 QTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVP 851
+ + T+G + APE + +SDV+SFGV++ E+ T G P
Sbjct: 208 NNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--- 259
Query: 852 EFGDSKDIVNWVYSKMDSRDSMLTVVD-------PNISEILKEDALKVLRIAIHCTNKLP 904
Y + + + + N + ++ + C + +P
Sbjct: 260 ------------YPGIPVEELFKLLKEGHRMDKPANCTN-------ELYMMMRDCWHAVP 300
Query: 905 AFRPSMRVVVQMLEE 919
+ RP+ + +V+ L+
Sbjct: 301 SQRPTFKQLVEDLDR 315
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 42/230 (18%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNS--GFRGDYRSSTAILSKRSSRSSEYDAEV 693
IG+G G V+K + + +A+K + + G S+A+ R E+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-----PSSAL------R------EI 52
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPN--GSLWDRLHTCHKIEMDWVVRYAIAV 751
L ++H N+V+L+ + S+ LV+E+ +D + ++ + V + +
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQL 110
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
KGL + H R V+HRD+K N+L++ + ++A+FGLA+ + +
Sbjct: 111 --LKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV- 163
Query: 812 THGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
T Y P+ Y+ I D++S G + EL RP+ P G+
Sbjct: 164 TLWYRPPDVLFGAKLYSTSI----DMWSAGCIFAELANAGRPLFP--GND 207
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 46/179 (25%), Positives = 68/179 (37%), Gaps = 13/179 (7%)
Query: 113 LNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTG 172
L+L+ + + F +L T L L+L L L L L++ +
Sbjct: 36 LHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTKLQ---VDGTLPVLGTLDLSHNQLQ- 90
Query: 173 QIPEGIGNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLT 230
+P L L L++S N L +P G L +L +L L N L LP G +
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148
Query: 231 NLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTN 287
L ++ N L +L L L +L L EN IP+ F L L+ N
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 43/177 (24%), Positives = 66/177 (37%), Gaps = 15/177 (8%)
Query: 357 NNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSK 416
+ +L+ +PP + + +I+ LS N + L L L + +L
Sbjct: 18 DKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD 73
Query: 417 ISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSI-GSCVSLTDIN 475
L ++ LS NQ +PL L L+ L + N + LP L ++
Sbjct: 74 -GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELY 130
Query: 476 FAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPI----SLTYPKLSLLDLSNNQL 528
N L P L P L L+L+NN + E+P L L L L N L
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLE--NLDTLLLQENSL 184
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 47/207 (22%), Positives = 72/207 (34%), Gaps = 40/207 (19%)
Query: 255 LSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLT 314
+ LHL EN + LT+L+L LT L G+ +D+S N L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ 90
Query: 315 GPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGI-WSLP 373
++P +L V+ N L+ ++P G L
Sbjct: 91 -------------------------SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124
Query: 374 NLSIIDLSTNQF----EGPVTDDIGNAKSLALLLLANNRFSGELPSKI-SEASSLVSIQL 428
L + L N+ G + L L LANN + ELP+ + + +L ++ L
Sbjct: 125 ELQELYLKGNELKTLPPG-LLTPTPK---LEKLSLANNNLT-ELPAGLLNGLENLDTLLL 179
Query: 429 SLNQFSGQIPLDIGKLKKLSSLYLHDN 455
N IP L +LH N
Sbjct: 180 QENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 45/235 (19%), Positives = 72/235 (30%), Gaps = 51/235 (21%)
Query: 279 LTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFN 338
E++ LT LP L D + +SENLL L L
Sbjct: 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAEL 67
Query: 339 GTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQ--------FEGPVT 390
+ L +++N L ++P +LP L+++D+S N+ G
Sbjct: 68 TKLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG- 124
Query: 391 DDIGNAKSLALLLLANNRFSGELPSKI-SEASSLVSIQLSLNQFSGQIPLDI-GKLKKLS 448
L L L N LP + + L + L+ N + ++P + L+ L
Sbjct: 125 -------ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD 175
Query: 449 SLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNN 503
+L L +N IP L L N
Sbjct: 176 TLLLQENSLYT-------------------------IPKGFFGSHLLPFAFLHGN 205
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 42/229 (18%)
Query: 637 IGKGGSGNVYKVVLNSGKELAVKHIWPSNS--GFRGDYRSSTAILSKRSSRSSEYDAEVA 694
+G+G G VYK + G+ +A+K I G STAI R E++
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI-----PSTAI------R------EIS 71
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPN--GSLWDRLHTCHKIEMDWVVRYAIAVG 752
L + H N+V L I SE LV+E++ + D T ++ + Y +
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKT--GLQDSQIKIYLYQL- 128
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGT 812
+G+ + H ++HRD+K N+L++ + ++ADFGLA+ TH + T
Sbjct: 129 -LRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-T 182
Query: 813 HGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
Y AP+ Y+ + D++S G + E++TGK P+ P G +
Sbjct: 183 LWYRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGK-PLFP--GVT 224
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 7e-19
Identities = 64/227 (28%), Positives = 93/227 (40%), Gaps = 47/227 (20%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++GKG G V EL AVK IL K D +V
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVK------------------ILKKDVVIQ---DDDVE 386
Query: 695 -TLS-------AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
T+ + + +L+ + D V EY+ G L + + + V
Sbjct: 387 CTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 446
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
YA + A GL +L + +I+RD+K N++LD E +IADFG+ K G T
Sbjct: 447 YAAEI--AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTT 499
Query: 807 HVIAGTHGYIAPE----YAYTCKINEKS-DVYSFGVVLMELVTGKRP 848
GT YIAPE Y KS D ++FGV+L E++ G+ P
Sbjct: 500 KTFCGTPDYIAPEIIAYQPYG-----KSVDWWAFGVLLYEMLAGQAP 541
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 52/263 (19%), Positives = 81/263 (30%), Gaps = 67/263 (25%)
Query: 133 TNLEFLSLGDNPF---DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLE 188
+ + L N + F L L+L + + +I L L+ L+
Sbjct: 32 AASQRIFLHGNRISHVPAASFR----ACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLD 86
Query: 189 LSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDL 246
LSDN + L +L L L L L G F L L + N L+ L
Sbjct: 87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-AL 144
Query: 247 SELRF--LNQLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSWADF 303
+ F L L+ L L N+ S +PE F L L L+ NR+
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH------------ 191
Query: 304 NYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSG 363
+ P + + L+ + N+LS
Sbjct: 192 -------------VHPH-----------------------AFRDLGRLMTLYLFANNLS- 214
Query: 364 TIPPGIW-SLPNLSIIDLSTNQF 385
+P L L + L+ N +
Sbjct: 215 ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 55/225 (24%), Positives = 85/225 (37%), Gaps = 23/225 (10%)
Query: 32 CDSNGLVA-EINLPE--QQL------LGVVPFDSICGLQALQKINLGTNFLYGTITEG-L 81
C GL A + +P Q++ + VP S + L + L +N L I
Sbjct: 18 CPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAF 76
Query: 82 KSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLS 139
L+ LDL +N+ V L L L+L+ G+ + L L++L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLY 135
Query: 140 LGDNPFDPSPFPMEVL-KLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGE 197
L DN P + L L L+L ++ +PE L L L L N +
Sbjct: 136 LQDNAL--QALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRV-AH 191
Query: 198 IPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQN 240
+ L +L L L+ N+LS LP + L L ++ N
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 52/235 (22%), Positives = 80/235 (34%), Gaps = 21/235 (8%)
Query: 304 NYVDVSENLLT---GPIPPDMCKTGAMTDLLVLQNNFNGTVPE-TYANCKSLIRFRVNNN 359
+ L IP + + L N VP ++ C++L +++N
Sbjct: 14 VTTSCPQQGLQAVPVGIPAA-------SQRIFLHGNRISHVPAASFRACRNLTILWLHSN 66
Query: 360 SLSGTIPPGI-WSLPNLSIIDLSTNQFEGPVTDDI-GNAKSLALLLLANNRFSGELPSKI 417
L+ I L L +DLS N V L L L EL +
Sbjct: 67 VLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL 124
Query: 418 -SEASSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDIN 475
++L + L N +P D L L+ L+LH N S + SL +
Sbjct: 125 FRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183
Query: 476 FAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL--TYPKLSLLDLSNNQL 528
QN ++ P + L L +L L N S +P L L L++N
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 27/101 (26%), Positives = 43/101 (42%), Gaps = 6/101 (5%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEG-LKSCTRLQVLDLGNNSFSGEVPD--LS 105
L +P D+ L L + L N + ++ E + L L L N + V
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR 198
Query: 106 MLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFD 146
L L L L ++ +S P ++L L L++L L DNP+
Sbjct: 199 DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 59/242 (24%), Positives = 106/242 (43%), Gaps = 55/242 (22%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNS--GFRGDYRSSTAILSKRSSRSSEYDAEV 693
IG+G G V+K +G+++A+K + N GF TA+ R E+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-----ITAL------R------EI 67
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNL--------LVYEYLPN--GSLWDRLHTCHKIEMDW 743
L ++H NVV L ++ S LV+++ + L + K +
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSE 125
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK---IVQTG 800
+ R + GL Y+H ++HRD+K++N+L+ + ++ADFGLA+ + +
Sbjct: 126 IKRVMQML--LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 801 EAGDLTH-VIAGTHGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG 854
+ T+ V+ T Y PE Y I D++ G ++ E+ T PI+ G
Sbjct: 181 QPNRYTNRVV--TLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS-PIMQ--G 231
Query: 855 DS 856
++
Sbjct: 232 NT 233
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 37/226 (16%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSK----RSSRSSEYD 690
+IG+G V V + ++ A+K I++K + S +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMK------------------IMNKWDMLKRGEVSCFR 109
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC-HKIEMDWVVRYAI 749
E L + +L+ + E+ LV EY G L L +I + Y
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA 169
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
+ A ++ +H +HRD+K NILLD R+ADFG ++ + V
Sbjct: 170 EIVMA--IDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVA 223
Query: 810 AGTHGYIAPEYAYTCKINEKSDVY-------SFGVVLMELVTGKRP 848
GT Y++PE + Y + GV E+ G+ P
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 59/232 (25%), Positives = 93/232 (40%), Gaps = 50/232 (21%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL----AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD- 690
++G G G V+ V SG + A+K +L K +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMK------------------VLKKATIVQKAKTT 102
Query: 691 ----AEVATLSAVRHVN-VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVV 745
E L +R +V L+ + +E L+ +Y+ G L+ L + V
Sbjct: 103 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ 162
Query: 746 RYA--IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG 803
Y I + LE+LH +I+RD+K NILLD + DFGL+K E
Sbjct: 163 IYVGEIVLA----LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-T 214
Query: 804 DLTHVIAGTHGYIAPE------YAYTCKINEKS-DVYSFGVVLMELVTGKRP 848
+ + GT Y+AP+ + K+ D +S GV++ EL+TG P
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHD-----KAVDWWSLGVLMYELLTGASP 261
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 2e-18
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 43/223 (19%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRS-SRSSEYD--- 690
+G G G V+ + A+K +L K R + +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMK------------------VLKKEIVVRLKQVEHTN 54
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
E LS V H +++++ + ++ +Y+ G L+ L + YA
Sbjct: 55 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE 114
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
V A LEYLH + +I+RD+K NILLD +I DFG AK D+T+ +
Sbjct: 115 VCLA--LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLC 164
Query: 811 GTHGYIAPEYAYTCKINEKS-----DVYSFGVVLMELVTGKRP 848
GT YIAPE ++ K D +SFG+++ E++ G P
Sbjct: 165 GTPDYIAPEV-----VSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 50/255 (19%), Positives = 90/255 (35%), Gaps = 65/255 (25%)
Query: 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA----------- 748
H N+V L + T L++EY G L + L + + + + Y
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 749 ----------IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798
A AKG+E+L + +HRD+ + N+L+ +I DFGLA+ +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 799 TGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPE 852
+ + + + + APE + KSDV+S+G++L E+ + G P
Sbjct: 224 SDS-----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP---- 274
Query: 853 FGDSKDIVNWVYSKMDSRDSMLTVVD--------PNISEILKEDALKVLRIAIHCTNKLP 904
Y + + ++ +E ++ I C
Sbjct: 275 -----------YPGIPVDANFYKLIQNGFKMDQPFYATE-------EIYIIMQSCWAFDS 316
Query: 905 AFRPSMRVVVQMLEE 919
RPS + L
Sbjct: 317 RKRPSFPNLTSFLGC 331
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 36/228 (15%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+G+G VYK N+ + +A+K I + D + TA+ R E+
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL------R------EIKL 65
Query: 696 LSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH-KIEMDWVVRYAIAVGAA 754
L + H N++ L + + + LV++++ L + + + Y +
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT--L 122
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH-VIAGTH 813
+GLEYLH ++HRD+K +N+LLD ++ADFGLAK + TH V+ T
Sbjct: 123 QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVV--TR 176
Query: 814 GYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
Y APE Y + D+++ G +L EL+ P +P GDS
Sbjct: 177 WYRAPELLFGARMYGVGV----DMWAVGCILAELLLRV-PFLP--GDS 217
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 47/227 (20%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++GKG G V+ + A+K L K D +V
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIK------------------ALKKDVVLM---DDDVE 62
Query: 695 -TLS-------AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
T+ A H + ++C+ ++++ V EYL G L + +CHK ++
Sbjct: 63 CTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF 122
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
YA + GL++LH + +++RD+K NILLD + +IADFG+ K G T
Sbjct: 123 YAAEI--ILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKT 175
Query: 807 HVIAGTHGYIAPE----YAYTCKINEKS-DVYSFGVVLMELVTGKRP 848
+ GT YIAPE Y S D +SFGV+L E++ G+ P
Sbjct: 176 NTFCGTPDYIAPEILLGQKYN-----HSVDWWSFGVLLYEMLIGQSP 217
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 53/230 (23%), Positives = 92/230 (40%), Gaps = 47/230 (20%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSK----RSSRSSEYD 690
+IG+G G V V L + ++ A+K IL+K + + ++ +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMK------------------ILNKWEMLKRAETACFR 122
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC-HKIEMDWVVRYAI 749
E L + L+ + +++ LV +Y G L L ++ + Y
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA 182
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
+ A ++ +H +HRD+K NIL+D+ R+ADFG + + V
Sbjct: 183 EMVIA--IDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVA 236
Query: 810 AGTHGYIAPE-----------YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
GT YI+PE Y C D +S GV + E++ G+ P
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPEC------DWWSLGVCMYEMLYGETP 280
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 39/228 (17%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSN--SGFRGDYRSSTAILSKRSSRSSEYDAEV 693
IG+G G V+K ++G+ +A+K S + A+ R E+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-----KIAL------R------EI 53
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
L ++H N+V L + LV+EY + ++ L + + +V+ I
Sbjct: 54 RMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKS-ITWQT 111
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
+ + + H IHRDVK NIL+ ++ DFG A+++ TG + +A T
Sbjct: 112 LQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TR 166
Query: 814 GYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
Y +PE Y + DV++ G V EL++G P+ P G S
Sbjct: 167 WYRSPELLVGDTQYGPPV----DVWAIGCVFAELLSG-VPLWP--GKS 207
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++GKG G V + +L AVK +L K D +V
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVK------------------VLKKDVILQ---DDDVE 68
Query: 695 -TLS-------AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
T++ A H + +L+C + D V E++ G L + + +
Sbjct: 69 CTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF 128
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
YA + +A L +LH D+ +I+RD+K N+LLD E ++ADFG+ K + G T
Sbjct: 129 YAAEIISA--LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTT 181
Query: 807 HVIAGTHGYIAPE----YAYTCKINEKS-DVYSFGVVLMELVTGKRP 848
GT YIAPE Y + D ++ GV+L E++ G P
Sbjct: 182 ATFCGTPDYIAPEILQEMLYG-----PAVDWWAMGVLLYEMLCGHAP 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 42/229 (18%)
Query: 637 IGKGGSGNVYKV-VLNSGKELAVKHIWPSNS-GFRGDYRSSTAILSKRSSRSSEYDAEVA 694
+G+G VYK + +A+K I + G TAI R EV+
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-----PCTAI------R------EVS 52
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK-IEMDWVVRYAIAVGA 753
L ++H N+V L+ I +E S LV+EYL L L C I M V + +
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL-- 109
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH-VIAGT 812
+GL Y H + V+HRD+K N+L++ + ++ADFGLA+ + V+ T
Sbjct: 110 LRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV--T 163
Query: 813 HGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
Y P+ Y+ +I D++ G + E+ TG RP+ P G +
Sbjct: 164 LWYRPPDILLGSTDYSTQI----DMWGVGCIFYEMATG-RPLFP--GST 205
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 62/227 (27%), Positives = 92/227 (40%), Gaps = 47/227 (20%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
++GKG G V EL AVK IL K D +V
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVK------------------ILKKDVVIQ---DDDVE 65
Query: 695 -TLS-------AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
T+ + + +L+ + D V EY+ G L + + + V
Sbjct: 66 CTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 125
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
YA + L +L + +I+RD+K N++LD E +IADFG+ K + G T
Sbjct: 126 YAAEIAIG--LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTT 178
Query: 807 HVIAGTHGYIAPE----YAYTCKINEKS-DVYSFGVVLMELVTGKRP 848
GT YIAPE Y KS D ++FGV+L E++ G+ P
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYG-----KSVDWWAFGVLLYEMLAGQAP 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 5e-18
Identities = 68/288 (23%), Positives = 111/288 (38%), Gaps = 62/288 (21%)
Query: 629 DAVKPEN-----LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKR 682
D + ++ +IG+G V V L + A+K ++ K
Sbjct: 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMK------------------VVKKE 45
Query: 683 SSRSSEYDAEVA-TLS-------AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLH 734
D ++ + A H +V L+ +E V EY+ G L +
Sbjct: 46 LVND---DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ 102
Query: 735 TCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLA 794
K+ + Y+ + A L YLH +R +I+RD+K N+LLD E ++ D+G+
Sbjct: 103 RQRKLPEEHARFYSAEISLA--LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
Query: 795 KIVQTGEAGDLTHVIAGTHGYIAPE----YAYTCKINEKS-DVYSFGVVLMELVTGKRPI 849
K + GD T GT YIAPE Y S D ++ GV++ E++ G+ P
Sbjct: 158 K--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG-----FSVDWWALGVLMFEMMAGRSP- 209
Query: 850 VPEFGDSKDIVNWVYSKMDSRDSMLTVV---DPNISEILKEDALKVLR 894
F N ++ D + V+ I L A VL+
Sbjct: 210 ---FDIVGSSDN---PDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 251
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 51/185 (27%), Positives = 82/185 (44%), Gaps = 36/185 (19%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA--- 748
E L V H +V+KLY + + + LL+ EY GSL L K+ ++
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 749 -------------------IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789
A ++G++YL + ++HRD+ + NIL+ K +I+
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKIS 192
Query: 790 DFGLAKIVQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT 844
DFGL++ V + + + G I A E + +SDV+SFGV+L E+VT
Sbjct: 193 DFGLSRDVYEED-----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 845 -GKRP 848
G P
Sbjct: 248 LGGNP 252
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 44/170 (25%), Positives = 70/170 (41%), Gaps = 29/170 (17%)
Query: 700 RHVNVVKLY-CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA---------- 748
H+NVV L +++ E+ G+L L + + + V
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 749 ----IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGD 804
+ AKG+E+L R IHRD+ + NILL + +I DFGLA+ +
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP--- 202
Query: 805 LTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848
+ + APE + +SDV+SFGV+L E+ + G P
Sbjct: 203 --DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-18
Identities = 60/229 (26%), Positives = 89/229 (38%), Gaps = 51/229 (22%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
+IGKG G V + + AVK +L K++ E
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVK------------------VLQKKAILK---KKEEK 83
Query: 695 -TLS-------AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
+S V+H +V L+ S + D V +Y+ G L+ L
Sbjct: 84 HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF 143
Query: 747 YA--IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGD 804
YA IA L YLH +++RD+K NILLD + + DFGL K + E
Sbjct: 144 YAAEIASA----LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNS 194
Query: 805 LTHVIAGTHGYIAPEYAYTCKINEKS-----DVYSFGVVLMELVTGKRP 848
T GT Y+APE ++++ D + G VL E++ G P
Sbjct: 195 TTSTFCGTPEYLAPEV-----LHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 60/256 (23%), Positives = 105/256 (41%), Gaps = 51/256 (19%)
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA--- 748
E A ++ + N+VKL L++EY+ G L + L + + +
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 749 -------------------IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789
IA A G+ YL +R +HRD+ + N L+ +IA
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 216
Query: 790 DFGLAKIVQTGEAGDLTHVIAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT 844
DFGL++ + + + + A + I PE + + +SDV+++GVVL E+ +
Sbjct: 217 DFGLSRNIYSAD-----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
Query: 845 -GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKL 903
G +P Y M + + V D NI + L++ + C +KL
Sbjct: 272 YGLQP---------------YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKL 316
Query: 904 PAFRPSMRVVVQMLEE 919
PA RPS + ++L+
Sbjct: 317 PADRPSFCSIHRILQR 332
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 64/276 (23%), Positives = 107/276 (38%), Gaps = 57/276 (20%)
Query: 636 LIGKGGSGNVYKVVLNSGKEL-AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
+IG+G V V L + A++ ++ K D ++
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMR------------------VVKKELVND---DEDID 97
Query: 695 -TLS-------AVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
+ A H +V L+ +E V EY+ G L + K+ +
Sbjct: 98 WVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF 157
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
Y+ + A L YLH +R +I+RD+K N+LLD E ++ D+G+ K + GD T
Sbjct: 158 YSAEISLA--LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTT 210
Query: 807 HVIAGTHGYIAPEYAYTCKINEKS-----DVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861
GT YIAPE + + D ++ GV++ E++ G+ P F N
Sbjct: 211 STFCGTPNYIAPEI-----LRGEDYGFSVDWWALGVLMFEMMAGRSP----FDIVGSSDN 261
Query: 862 WVYSKMDSRDSMLTVV---DPNISEILKEDALKVLR 894
++ D + V+ I L A VL+
Sbjct: 262 ---PDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 294
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 39/230 (16%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNS-GFRGDYRSSTAILSKRSSRSSEYDAEVA 694
+G G VYK + +G +A+K + + G STAI R E++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-----PSTAI------R------EIS 55
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPN---GSLWDRLHTCHKIEMDWVVRYAIAV 751
+ ++H N+V+LY I +E+ LV+E++ N + R ++ +
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG 811
+GL + H ++HRD+K N+L++ + ++ DFGLA+ + +
Sbjct: 116 QLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV- 170
Query: 812 THGYIAPEY-----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
T Y AP+ Y+ I D++S G +L E++TGK P+ P G +
Sbjct: 171 TLWYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGK-PLFP--GTN 213
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 47/230 (20%), Positives = 83/230 (36%), Gaps = 49/230 (21%)
Query: 634 ENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
++G G +G V ++ + ++ A+K +L E
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALK------------------MLQDCPKARRE---- 104
Query: 693 VATLSAV-RHVNVVKLYC----SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRY 747
V + ++V++ L+V E L G L+ R I+ +
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR------IQDRGDQAF 158
Query: 748 ------AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL---DLEWKPRIADFGLAKIVQ 798
I + ++YLH + HRDVK N+L ++ DFG AK
Sbjct: 159 TEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 799 TGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+ + T Y+APE K ++ D++S GV++ L+ G P
Sbjct: 216 SHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 4e-17
Identities = 57/256 (22%), Positives = 104/256 (40%), Gaps = 35/256 (13%)
Query: 604 KHSLKQNSWDMKSFRVLSFSEK-EIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHI 661
+++ ++ D + + V ++ + IG G G V + +A+K +
Sbjct: 36 HYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL 95
Query: 662 WPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNL--- 718
+ F+ +KR+ R E+ + V H N++ L T + +
Sbjct: 96 ---SRPFQ------NQTHAKRAYR------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140
Query: 719 ---LVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKS 775
LV E + +L + E + Y + G+++LH +IHRD+K
Sbjct: 141 DVYLVMELMDA-NLCQVIQMELDHERMSYLLYQM----LCGIKHLH---SAGIIHRDLKP 192
Query: 776 SNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSF 835
SNI++ + +I DFGLA+ T +T + T Y APE E D++S
Sbjct: 193 SNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVV-TRYYRAPEVILGMGYKENVDIWSV 249
Query: 836 GVVLMELVTGKRPIVP 851
G ++ E+V K + P
Sbjct: 250 GCIMGEMVRHK-ILFP 264
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG G G V + +A+K + + F+ +KR+ R E+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKL---SRPFQ------NQTHAKRAYR------ELVL 77
Query: 696 LSAVRHVNVVKLYCSITSEDSNL------LVYEYLPNGSLWDRLHTCHKIEM-DWVVRYA 748
+ V H N++ L T + S +V E + + L ++E+ + Y
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----N-LCQVIQMELDHERMSY- 131
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+ G+++LH +IHRD+K SNI++ + +I DFGLA+ G + +T
Sbjct: 132 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 186
Query: 809 IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
+ T Y APE E D++S G ++ E++ G + P
Sbjct: 187 VV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-VLFP 227
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 43/234 (18%), Positives = 80/234 (34%), Gaps = 39/234 (16%)
Query: 57 ICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLN 116
GL K NLG + T K + +Q + N++ + + L L+L+
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLS 71
Query: 117 SSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPE 176
+ IS L++LT LE LS+ N + + L L+L N + +
Sbjct: 72 HNQISD---LSPLKDLTKLEELSVNRNRLKN----LNGIPSACLSRLFLDNNELRD--TD 122
Query: 177 GIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFD 236
+ +L L+ L + +N+L S+ L+ L D
Sbjct: 123 SLIHLKNLEILSIRNNKL---------------------KSIVM-----LGFLSKLEVLD 156
Query: 237 VSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290
+ N + + L L +++ + L + E + E + R
Sbjct: 157 LHGNEIT-NTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 39/212 (18%), Positives = 70/212 (33%), Gaps = 39/212 (18%)
Query: 79 EGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFL 138
+LG S + ++ L + N ++S I + NL L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQSLAGMQFFTNLKE---L 68
Query: 139 SLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEI 198
L N ++ L + +LT+L+ L ++ N L +
Sbjct: 69 HLSHN------------QISDL---------------SPLKDLTKLEELSVNRNRL-KNL 100
Query: 199 PAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSL 258
+ L +L L NN L +L NL + N+L+ + L FL++L L
Sbjct: 101 NG--IPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVL 155
Query: 259 HLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290
L N+ + K + + L +
Sbjct: 156 DLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 42/216 (19%), Positives = 83/216 (38%), Gaps = 20/216 (9%)
Query: 55 DSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLN 114
+ L++++L N + + LK T+L+ L + N + + LS L
Sbjct: 57 AGMQFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLK-NLNGIPSAC-LSRLF 112
Query: 115 LNSSGISGKFPWKSLENLTNLEFLSLGDNPF-DPSPFPMEVLKLEKLYWLYLTNCSVTGQ 173
L+++ + SL +L NLE LS+ +N L KL L L +T
Sbjct: 113 LDNNELRD---TDSLIHLKNLEILSIRNNKLKSIVMLG----FLSKLEVLDLHGNEITN- 164
Query: 174 IPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQL-ELYNNSLSGRLPVGFSNLTNL 232
G+ L ++ ++L+ + E + +L+ + + P SN +
Sbjct: 165 -TGGLTRLKKVNWIDLTGQKCVNEP---VKYQPELYITNTVKDPDGRWISPYYISNGGSY 220
Query: 233 MNFDVSQNRLEGDLSELRF-LNQLSSLHLFENQFSG 267
++ V L E+ + ++ ++ E F G
Sbjct: 221 VDGCVLWE-LPVYTDEVSYKFSEYINVGETEAIFDG 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 34/183 (18%), Positives = 63/183 (34%), Gaps = 36/183 (19%)
Query: 346 ANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLA 405
+ ++ + S++ + L + + + + + +L L L+
Sbjct: 16 PGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHLS 71
Query: 406 NNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSI 465
+N +IS+ S L L KL L ++ N +
Sbjct: 72 HN--------QISDLSPL------------------KDLTKLEELSVNRNRLKN---LNG 102
Query: 466 GSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSN 525
L+ + N L DSL L +L L++ NNK I + KL +LDL
Sbjct: 103 IPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHG 159
Query: 526 NQL 528
N++
Sbjct: 160 NEI 162
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 35/197 (17%), Positives = 68/197 (34%), Gaps = 24/197 (12%)
Query: 346 ANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLA 405
+ F +N+++ ++ G+ NL + LS NQ + + L L +
Sbjct: 38 KELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS--DLSPLKDLTKLEELSVN 93
Query: 406 NNRFSGELPSKIS--EASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPY 463
NR ++ ++ L + L N+ L LK L L + +N +
Sbjct: 94 RNRLK-----NLNGIPSACLSRLFLDNNELRDTDSLI--HLKNLEILSIRNNKLKSIVM- 145
Query: 464 SIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDL 523
+G L ++ N ++ L L +N ++L+ K + L +
Sbjct: 146 -LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV-----NEPVKYQPELYI 197
Query: 524 SNN--QLAGPIPEPLNI 538
+N G P I
Sbjct: 198 TNTVKDPDGRWISPYYI 214
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 38/255 (14%), Positives = 73/255 (28%), Gaps = 90/255 (35%)
Query: 276 FKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQN 335
+ + +L +T + QK
Sbjct: 18 LANAVKQNLGKQSVTDLVSQK--------------------------------------- 38
Query: 336 NFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGN 395
+ F +N+++ ++ G+ NL + LS NQ + +
Sbjct: 39 -----------ELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQIS--DLSPLKD 83
Query: 396 AKSLALLLLANNRFSGELPSKIS--EASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLH 453
L L + NR ++ ++ L + L N+ L LK L L +
Sbjct: 84 LTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRDTDSLI--HLKNLEILSIR 136
Query: 454 DNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL 513
+N L I LG L L L+L N+ + ++
Sbjct: 137 NN--------------KLKSI------------VMLGFLSKLEVLDLHGNEITNTGGLT- 169
Query: 514 TYPKLSLLDLSNNQL 528
K++ +DL+ +
Sbjct: 170 RLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 28/169 (16%), Positives = 58/169 (34%), Gaps = 15/169 (8%)
Query: 346 ANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLAL--LL 403
+L +++N +S + P + L L + ++ N+ + ++ S L L
Sbjct: 60 QFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLF 112
Query: 404 LANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPY 463
L NN + +L + + N+ + L L KL L LH N +
Sbjct: 113 LDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVMLG--FLSKLEVLDLHGNEITNTGG- 167
Query: 464 SIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPIS 512
+ + I+ + L N++ + ++ IS
Sbjct: 168 -LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYIS 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 15/88 (17%), Positives = 32/88 (36%), Gaps = 5/88 (5%)
Query: 441 IGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNL 500
L L + + + + N +++ + + +L L+L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHL 70
Query: 501 SNNKFSGEIPISLTYPKLSLLDLSNNQL 528
S+N+ S P+ KL L ++ N+L
Sbjct: 71 SHNQISDLSPLK-DLTKLEELSVNRNRL 97
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSN--SGFRGDYRSSTAILSKRSSRSSEYDA 691
L+G+G G V K ++G+ +A+K S+ + A+ R
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-----KIAM------R------ 73
Query: 692 EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC-HKIEMDWVVRYAIA 750
E+ L +RH N+V L + LV+E++ + ++ D L + ++ V +Y
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
+ G+ + H +IHRD+K NIL+ ++ DFG A+ + +A
Sbjct: 133 I--INGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA 186
Query: 811 GTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
T Y APE Y + DV++ G ++ E+ G P+ P GDS
Sbjct: 187 -TRWYRAPELLVGDVKYGKAV----DVWAIGCLVTEMFMG-EPLFP--GDS 229
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 55/260 (21%), Positives = 90/260 (34%), Gaps = 62/260 (23%)
Query: 133 TNLEFLSLGDNPF---DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLE 188
+ + L L NP F +L L L+ C + I +G +L+ L L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSF----FSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82
Query: 189 LSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDL 246
L+ N + + G L+ L +L +L+ L +L L +V+ N ++
Sbjct: 83 LTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 247 SELRF--LNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFN 304
F L L L L N+ I + + L ++ L L
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQ-SIYC--TDLRVLHQMPLLNLSL--------------- 182
Query: 305 YVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGT 364
D+S N + I P GA ++ L ++ N L +
Sbjct: 183 --DLSLNPMNF-IQP-----GAFKEI-------------------RLKELALDTNQLK-S 214
Query: 365 IPPGIW-SLPNLSIIDLSTN 383
+P GI+ L +L I L TN
Sbjct: 215 VPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 54/236 (22%), Positives = 84/236 (35%), Gaps = 28/236 (11%)
Query: 25 CKFNGIVCDSNGLVAEI--NLPE--QQL------LGVVPFDSICGLQALQKINLGTNFLY 74
C +I NLP + L L + S LQ ++L +
Sbjct: 7 VPNITYQCMELNF-YKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI- 64
Query: 75 GTITEGL-KSCTRLQVLDLGNN---SFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLE 130
TI +G +S + L L L N S + L L L + ++ +
Sbjct: 65 QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS--GLSSLQKLVAVETNLA-SLENFPIG 121
Query: 131 NLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQ---- 185
+L L+ L++ N P L L L L++ + I L Q+
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL 180
Query: 186 NLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQN 240
+L+LS N + I G K +L +L L N L +P G F LT+L + N
Sbjct: 181 SLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 44/188 (23%), Positives = 70/188 (37%), Gaps = 27/188 (14%)
Query: 357 NNNSLSGTIPPGI-WSLPNLSIIDLSTNQ--------FEGPVTDDIGNAKSLALLLLANN 407
+ N L + +S P L ++DLS + ++ L+ L+L N
Sbjct: 36 SFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS--------HLSTLILTGN 86
Query: 408 RFSGELPSKISEA-SSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHDN-MFSGPLPYS 464
L SSL + + + G LK L L + N + S LP
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 465 IGSCVSLTDINFAQN---SLSGKIPDSLGSLPSLN-SLNLSNNKFSGEIPISLTYPKLSL 520
+ +L ++ + N S+ L +P LN SL+LS N + P + +L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKE 204
Query: 521 LDLSNNQL 528
L L NQL
Sbjct: 205 LALDTNQL 212
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 41/182 (22%), Positives = 69/182 (37%), Gaps = 17/182 (9%)
Query: 357 NNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSK 416
+ IP + + +DLS N + + L +L L+ +
Sbjct: 15 MELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70
Query: 417 I-SEASSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDI 474
S L ++ L+ N + L L L L + + + IG +L ++
Sbjct: 71 AYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 475 NFAQNSL-SGKIPDSLGSLPSLNSLNLSNNKFSGEIP-------ISLTYPKLSLLDLSNN 526
N A N + S K+P+ +L +L L+LS+NK I + LS LDLS N
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS-LDLSLN 187
Query: 527 QL 528
+
Sbjct: 188 PM 189
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 9e-08
Identities = 35/253 (13%), Positives = 70/253 (27%), Gaps = 56/253 (22%)
Query: 257 SLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLP----QKLGSWADFNYVDVSENL 312
+L L N F F L L L + T+ Q L + + ++ N
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH---LSTLILTGNP 87
Query: 313 LTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWS- 371
+ + ++ SL + +L+ ++
Sbjct: 88 IQS-LALG-----------------------AFSGLSSLQKLVAVETNLA-SLENFPIGH 122
Query: 372 LPNLSIIDLSTNQF-EGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSL 430
L L ++++ N + + N +L L L++N+ +
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ----------------SIYC 166
Query: 431 NQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLG 490
+ + L L L N + + + L ++ N L
Sbjct: 167 TDLRVLHQMPLLNLS----LDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFD 221
Query: 491 SLPSLNSLNLSNN 503
L SL + L N
Sbjct: 222 RLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 40/231 (17%), Positives = 67/231 (29%), Gaps = 43/231 (18%)
Query: 317 IPPDMCKTGAMTDLLVLQNNFNGTVPETY-ANCKSLIRFRVNNNSLSGTIPPGI-WSLPN 374
+P T L L N + + L ++ + TI G SL +
Sbjct: 26 LPFS-------TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 375 LSIIDLSTNQ--------FEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSI 426
LS + L+ N F G SL L+ + L + L ++
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLS--------SLQKLVAVETNLA-SLENFP--IGHLKTL 126
Query: 427 Q---LSLNQFSGQIPLD--IGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINF----A 477
+ ++ N L L L L L N + + +N +
Sbjct: 127 KELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 478 QNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL--TYPKLSLLDLSNN 526
N ++ I L L L N+ +P + L + L N
Sbjct: 186 LNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 52/272 (19%), Positives = 89/272 (32%), Gaps = 82/272 (30%)
Query: 632 KPENLIGKGGSGNVYK-VVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+G G G V + + SGK A+K + + +R
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD---------------PRYKNR----- 49
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW------- 743
E+ + + HVN++KL + P+
Sbjct: 50 -ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108
Query: 744 ------------------VVRYAIAVGAA--------------KGLEYLH-HGFDRPVIH 770
V++ I G + + + ++H G + H
Sbjct: 109 QNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG----ICH 164
Query: 771 RDVKSSNILLDLE-WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPE-----YAYTC 824
RD+K N+L++ + ++ DFG AK + E I + Y APE YT
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYIC-SRFYRAPELMLGATEYTP 221
Query: 825 KINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
I D++S G V EL+ GK P+ G++
Sbjct: 222 SI----DLWSIGCVFGELILGK-PLFS--GET 246
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 47/233 (20%)
Query: 632 KPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+G G G+V + SG+++A+K + + F+ + I +KR+ R
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL---SRPFQ------SEIFAKRAYR----- 72
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNL------LVYEYLPNGSLWDRLHTCHKIEM-DW 743
E+ L ++H NV+ L T S LV ++ D L ++ +
Sbjct: 73 -ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT----D-LQKIMGLKFSEE 126
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG 803
++Y + KGL+Y+H V+HRD+K N+ ++ + + +I DFGLA+
Sbjct: 127 KIQY-LVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA---- 178
Query: 804 DLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
++T + T Y APE Y + D++S G ++ E++TGK +
Sbjct: 179 EMTGYVV-TRWYRAPEVILSWMHYNQTV----DIWSVGCIMAEMLTGK-TLFK 225
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 40/216 (18%), Positives = 79/216 (36%), Gaps = 22/216 (10%)
Query: 85 TRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGD 142
Q L L +P S L +S + ++ + S NL+ + + + +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 143 NPF----DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEG--IGNLTQLQNLELSDNELFG 196
DP +L L +L + N + P+ + + LE++DN
Sbjct: 90 TRNLTYIDPDAL----KELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMT 144
Query: 197 EIPAGIVK--LNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRF--- 251
IP + N+ L+LYNN + + N T L +++N+ + + F
Sbjct: 145 SIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV 203
Query: 252 LNQLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYT 286
+ S L + + + +P + K L + +T
Sbjct: 204 YSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 35/243 (14%), Positives = 74/243 (30%), Gaps = 46/243 (18%)
Query: 32 CDSNGLVA---------EINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGL- 81
+ + L E L +P + L + +I + + +
Sbjct: 18 VTCKDIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSF 76
Query: 82 KSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLG 141
+ +++ +++ N +L+ + + + L L+FL +
Sbjct: 77 YNLSKVTHIEIRNT------RNLTYIDPDAL-----------------KELPLLKFLGIF 113
Query: 142 DNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLT-QLQNLELSDNELFGEIP 199
+ P +V + + L +T+ IP L + L+L +N +
Sbjct: 114 NTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQ 172
Query: 200 AGIVKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNF-DVSQNRLE-------GDLSELR 250
KL + L N + F + + + DVSQ + L EL
Sbjct: 173 GYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELI 232
Query: 251 FLN 253
N
Sbjct: 233 ARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 42/197 (21%), Positives = 68/197 (34%), Gaps = 29/197 (14%)
Query: 208 LWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQ 264
L+L L +P FSNL N+ VS + L F L++++ + + +
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 265 FSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQ--KLGSWADFNYVDVSENLLTGPIPPDM 321
I + E L L ++ L P K+ S F +++++N IP +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 322 -CKTGAMTDLLVLQNN---------FNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWS 371
T L L NN FNGT L +N N I +
Sbjct: 151 FQGLCNETLTLKLYNNGFTSVQGYAFNGT---------KLDAVYLNKNKYLTVIDKDAFG 201
Query: 372 --LPNLSIIDLSTNQFE 386
S++D+S
Sbjct: 202 GVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 32/186 (17%), Positives = 63/186 (33%), Gaps = 11/186 (5%)
Query: 348 CKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANN 407
C FRV + P + P+ + L + N +++ + ++ +
Sbjct: 10 CHQEEDFRVTCKDI--QRIPSL--PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID 65
Query: 408 RFSGELPSKI-SEASSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHDNMFSG-PLPYS 464
+L S S + I++ + I D +L L L + + P
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTK 125
Query: 465 IGSCVSLTDINFAQNSLSGKIP-DSLGSLPS-LNSLNLSNNKFSGEIPIS-LTYPKLSLL 521
+ S + N IP ++ L + +L L NN F+ + KL +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 522 DLSNNQ 527
L+ N+
Sbjct: 185 YLNKNK 190
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 26/152 (17%), Positives = 57/152 (37%), Gaps = 8/152 (5%)
Query: 357 NNNSLSGTIPPGI-WSLPNLSIIDLSTNQFEG-PVTDDIGNAKSLALLLLANNRFSGELP 414
N +L+ I P LP L + + + P + + +L + +N + +P
Sbjct: 89 NTRNLT-YIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 415 SKI--SEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSI--GSCVS 470
+ ++++L N F+ + KL ++YL+ N + + G
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 471 LTDINFAQNSLSGKIPDSLGSLPSLNSLNLSN 502
+ ++ +Q S++ L L L + N
Sbjct: 207 PSLLDVSQTSVTALPSKGLEHLKELIARNTWT 238
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 63/241 (26%), Positives = 99/241 (41%), Gaps = 58/241 (24%)
Query: 632 KPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+ IG+G G V + +A+K I P F +R+ R
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----FE------HQTYCQRTLR----- 74
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNL-----LVYEYLP--------NGSLWDRLHTCH 737
E+ L RH N++ + I + +V + + L + H C+
Sbjct: 75 -EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-HICY 132
Query: 738 KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
+ Y I +GL+Y+H V+HRD+K SN+LL+ +I DFGLA++
Sbjct: 133 FL-------YQIL----RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
Query: 798 --QTGEAGDLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRPIV 850
G LT +A T Y APE YT I D++S G +L E+++ + PI
Sbjct: 179 DPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNR-PIF 232
Query: 851 P 851
P
Sbjct: 233 P 233
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 65/235 (27%), Positives = 98/235 (41%), Gaps = 39/235 (16%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
IG G G VYK +SG +A+K + N G G + + R EV
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV------R------EV 62
Query: 694 ATL---SAVRHVNVVKLYCSITSEDSNL-----LVYEYLPNGSLWDRLHTCHKIEMDWVV 745
A L A H NVV+L + ++ LV+E++ L L +
Sbjct: 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAET 121
Query: 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
+ +GL++LH ++HRD+K NIL+ ++ADFGLA+I L
Sbjct: 122 IKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMAL 176
Query: 806 THVIAGTHGYIAPEY----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
T V+ T Y APE Y + D++S G + E+ K P+ G+S
Sbjct: 177 TPVVV-TLWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRK-PLFC--GNS 223
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 51/240 (21%)
Query: 635 NLIGKGGSGNVYKV--VLNSGKELAVKHIWPSNS--GFRGDYRSSTAILSKRSSRSSEYD 690
IG+G G V+K + N G+ +A+K + G + I R
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----PLSTI------R----- 60
Query: 691 AEVATL---SAVRHVNVVKLY----CSITSEDSNL-LVYEYLPN--GSLWDRLHTCHKIE 740
EVA L H NVV+L+ S T ++ L LV+E++ + D++ +
Sbjct: 61 -EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VP 118
Query: 741 MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG 800
+ + + +GL++LH V+HRD+K NIL+ + ++ADFGLA+I
Sbjct: 119 TETIKDMMFQL--LRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY--S 171
Query: 801 EAGDLTHVIAGTHGYIAPEY----AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
LT V+ T Y APE +Y + D++S G + E+ K P+ G S
Sbjct: 172 FQMALTSVVV-TLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK-PLFR--GSS 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 58/251 (23%), Positives = 101/251 (40%), Gaps = 69/251 (27%)
Query: 632 KPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+G GG+G V+ V + K +A+K I ++ K + R
Sbjct: 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-----------PQSVKHALR----- 57
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNL--------------LVYEYLP--------NGS 728
E+ + + H N+VK++ + S L +V EY+ G
Sbjct: 58 -EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP 116
Query: 729 LWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW-KPR 787
L + H + Y + +GL+Y+H V+HRD+K +N+ ++ E +
Sbjct: 117 LLEE-HARLFM-------YQLL----RGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161
Query: 788 IADFGLAKIV--QTGEAGDLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLM 840
I DFGLA+I+ G L+ + T Y +P YT I D+++ G +
Sbjct: 162 IGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAI----DMWAAGCIFA 216
Query: 841 ELVTGKRPIVP 851
E++TGK +
Sbjct: 217 EMLTGK-TLFA 226
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 51/252 (20%), Positives = 90/252 (35%), Gaps = 28/252 (11%)
Query: 25 CKFNGIVCDSNGLVAEI--NLPE--QQL------LGVVPFDSICGLQALQKINLGTNFLY 74
C +C + + EI +LP +L L V+ + G L+KI + N +
Sbjct: 9 CSNRVFLCQESKV-TEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67
Query: 75 GTITEG-LKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKFPWKSLEN 131
I + +L + + + + L L +L ++++GI P +
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIH 126
Query: 132 LTNLEFLSLGDNP----FDPSPFPMEVLKL-EKLYWLYLTNCSVTGQIPEGIGNLTQLQN 186
L + DN + + F + L + L+L + +I N TQL
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSF----VGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDE 181
Query: 187 LELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEG 244
L LSDN E+P + + L++ + LP NL L +
Sbjct: 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLP 240
Query: 245 DLSELRFLNQLS 256
L +L L + S
Sbjct: 241 TLEKLVALMEAS 252
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 40/222 (18%), Positives = 70/222 (31%), Gaps = 22/222 (9%)
Query: 85 TRLQVLDLGNNSFSGEVP--DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGD 142
L + S +L + ++ + + NL L + +
Sbjct: 30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 143 NP----FDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGE 197
+P F L L +L ++N + +P+ + Q L++ DN
Sbjct: 89 ANNLLYINPEAF----QNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHT 143
Query: 198 IPAG-IVKLNKLWQ-LELYNNSLSGRLPVGFSNLTNLMNFDVSQ-NRLEGDLSELRF--L 252
I V L+ L L N + + N T L ++S N LE +L F
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGA 201
Query: 253 NQLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTL 293
+ L + + +P K L S Y + TL
Sbjct: 202 SGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLPTL 242
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 39/258 (15%), Positives = 78/258 (30%), Gaps = 47/258 (18%)
Query: 163 LYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELYN-NSLS 219
L + I +G L+ +E+S N++ I A + L KL ++ + N+L
Sbjct: 35 LRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL 93
Query: 220 GRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRFLN--QLSSLHLFENQFSGEIPEEFGEF 276
+ F NL NL +S ++ L ++ ++ Q L + +N I F
Sbjct: 94 -YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER--NSF 149
Query: 277 KHLT----ELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLV 332
L+ L L N + I + +L +
Sbjct: 150 VGLSFESVILWLNKNGIQE-------------------------IHNSAFNGTQLDELNL 184
Query: 333 LQNN-FNGTVPETYANCKSLIRFRVNNNSLSGTIPPGI-WSLPNLSIIDLSTNQFEGPVT 390
NN + + + ++ + ++P +L L + +
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLPTLE 243
Query: 391 DDIGNAKSLALLLLANNR 408
+L L
Sbjct: 244 ----KLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 40/271 (14%), Positives = 82/271 (30%), Gaps = 49/271 (18%)
Query: 268 EIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFN------YVDVSENLLTGPIPPDM 321
EIP + ++ EL +L + + F+ +++S+N + I D
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLR-VIQKG-----AFSGFGDLEKIEISQNDVLEVIEAD- 73
Query: 322 CKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRV-NNNSLSGTIPPGI-WSLPNLSIID 379
++N L R+ N+L I P +LPNL +
Sbjct: 74 ----------------------VFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLL 110
Query: 380 LSTNQFEG-PVTDDIGNAKSLALLLLANNRFSGELPSKISE--ASSLVSIQLSLNQFSGQ 436
+S + P I + + + L + N + + V + L+ N +
Sbjct: 111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQ-E 168
Query: 437 IPLDI-GKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSL 495
I + +N ++ ++ + L +L L
Sbjct: 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL 228
Query: 496 NSLNLSNNKFSGEIPISLTYPKLSLLDLSNN 526
+ + N K ++P L L+
Sbjct: 229 RARSTYNLK---KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 34/189 (17%), Positives = 70/189 (37%), Gaps = 13/189 (6%)
Query: 349 KSLIRFRVNNNSLSGTIPPGIWS-LPNLSIIDLSTNQFEGPVTDDI--GNAKSLALLLLA 405
++ I R L I G +S +L I++S N + D+ K + +
Sbjct: 30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 406 NNRFSGELPSKI-SEASSLVSIQLSLNQFSGQIP-LDIGKLKKLSSLYLHDNMFSGPLPY 463
N + + +L + +S +P + + L + DN+ +
Sbjct: 89 ANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 464 SI--GSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL--TYPKLS 519
+ G + +N + +I +S + L+ LNLS+N E+P +
Sbjct: 147 NSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205
Query: 520 LLDLSNNQL 528
+LD+S ++
Sbjct: 206 ILDISRTRI 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 22/122 (18%), Positives = 47/122 (38%), Gaps = 8/122 (6%)
Query: 412 ELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSI-GSCVS 470
E+PS + + + ++ L + L + + N + + +
Sbjct: 23 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 471 LTDINFAQ-NSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIP--ISLTYPKLSLLDLS-NN 526
L +I + N+L P++ +LP+L L +SN +P + + LLD+ N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
Query: 527 QL 528
+
Sbjct: 140 NI 141
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 57/236 (24%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 626 EIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSS 684
E+ + +G G G V V +G ++A+K + F+ + + +KR+
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL---YRPFQ------SELFAKRAY 72
Query: 685 RSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNL------LVYEYLPNGSLWDRLHTCHK 738
R E+ L +RH NV+ L T +++ LV ++ D L K
Sbjct: 73 R------ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----D-LGKLMK 121
Query: 739 IEM--DWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
E + +++ + KGL Y+H +IHRD+K N+ ++ + + +I DFGLA+
Sbjct: 122 HEKLGEDRIQF-LVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 177
Query: 797 VQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKS-DVYSFGVVLMELVTGKRPIVP 851
+ ++T + T Y APE ++ D++S G ++ E++TGK +
Sbjct: 178 ADS----EMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TLFK 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 59/248 (23%), Positives = 101/248 (40%), Gaps = 65/248 (26%)
Query: 632 KPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+ ++L+G+G G V +G+ +A+K I P F + + R+ R
Sbjct: 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FD------KPLFALRTLR----- 58
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNL-----LVYEYLP--------NGSLWDRLHTCH 737
E+ L +H N++ ++ + ++ E + L D H +
Sbjct: 59 -EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD-DHIQY 116
Query: 738 KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797
I Y + ++ LH VIHRD+K SN+L++ ++ DFGLA+I+
Sbjct: 117 FI-------YQTL----RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 798 ---------QTGEAGDLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELV 843
TG+ + +A T Y APE Y+ + DV+S G +L EL
Sbjct: 163 DESAADNSEPTGQQSGMVEFVA-TRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELF 217
Query: 844 TGKRPIVP 851
+ PI P
Sbjct: 218 LRR-PIFP 224
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 13/162 (8%)
Query: 85 TRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGD 142
+ +LDL +N+ S + + L L L L+ + ++ ++ + NL +L L
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 143 NPFDPSPFPMEVL-KLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPA 200
N + L+ L L L N + + ++ QLQ L LS N++ P
Sbjct: 98 NHL--HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 201 GI----VKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVS 238
+ KL KL L+L +N L L + +
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 18/183 (9%)
Query: 357 NNNSLSGTIPPGIWSLPNLSIIDLSTNQFEG-PVTDDIGNAKSLALLLLANNRFSGELPS 415
+ L +P + +++DLS N +L LLL++N + + S
Sbjct: 26 SKQQLP-NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISS 81
Query: 416 KI-SEASSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTD 473
+ +L + LS N + + L+ L L L++N + L
Sbjct: 82 EAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQK 140
Query: 474 INFAQNSLSGKIP----DSLGSLPSLNSLNLSNNKFSGEIPI----SLTYPKLSLLDLSN 525
+ +QN +S + P LP L L+LS+NK ++P+ L + L L N
Sbjct: 141 LYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHN 198
Query: 526 NQL 528
N L
Sbjct: 199 NPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 34/183 (18%), Positives = 60/183 (32%), Gaps = 38/183 (20%)
Query: 258 LHLFENQFSGEIPEE--FGEFKHLTELSLYTNRLTGTLPQKLGSWADF---NYVDVSENL 312
L L N S + E +L L L N L + ++ Y+D+S N
Sbjct: 44 LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISS--EAFVPVPNLRYLDLSSNH 99
Query: 313 LTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWS- 371
L + + F+ +L + NN + + +
Sbjct: 100 LHT-LDEFL---------------FSDLQ--------ALEVLLLYNNHIV-VVDRNAFED 134
Query: 372 LPNLSIIDLSTNQ---FEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQL 428
+ L + LS NQ F + D L LL L++N+ + + + + V L
Sbjct: 135 MAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 429 SLN 431
L+
Sbjct: 195 YLH 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 30/150 (20%), Positives = 53/150 (35%), Gaps = 32/150 (21%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEG-LKSCTRLQVLDLGNNSFSGEVPDLSML 107
L + ++ + L+ ++L +N L T+ E L+VL L NN + ++
Sbjct: 76 LNFISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNN-------HIVVV 127
Query: 108 HELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNP---FDPSPFPMEVLKLEKLYWLY 164
+F E++ L+ L L N F + KL KL L
Sbjct: 128 DRNAF-----------------EDMAQLQKLYLSQNQISRFPVELI-KDGNKLPKLMLLD 169
Query: 165 LTNCSVTGQIPEGIGNLTQL--QNLELSDN 192
L++ + + L L L +N
Sbjct: 170 LSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 40/225 (17%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
+G G G+V +G +AVK + F+ + I +KR+ R E+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQ------SIIHAKRTYR------ELRL 81
Query: 696 LSAVRHVNVVKLYCSITSEDSNL------LVYEYLPNGSLWDRLHTCHKIEM--DWVVRY 747
L ++H NV+ L T S LV + D L+ K + D V++
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----D-LNNIVKCQKLTDDHVQF 136
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTH 807
+ +GL+Y+H +IHRD+K SN+ ++ + + +I DFGLA+ A ++T
Sbjct: 137 -LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTG 188
Query: 808 VIAGTHGYIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRPIVP 851
+A T Y APE N+ D++S G ++ EL+TG+ + P
Sbjct: 189 YVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFP 231
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 89/498 (17%), Positives = 152/498 (30%), Gaps = 119/498 (23%)
Query: 87 LQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKFPWKS----LENLTNLEFLSL 140
+Q LD+ S L +L + + L+ G++ K L L L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEAR-CKDISSALRVNPALAELNL 63
Query: 141 GDNPFDPSPFPM--EVLKLE--KLYWLYLTNCSVTGQ----IPEGIGNLTQLQNLELSDN 192
N + L+ K+ L L NC +TG + + L LQ L LSDN
Sbjct: 64 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123
Query: 193 ELFGE----IPAGIVKLN-KLWQLELYNNSLSGR----LPVGFSNLTNLMNFDVSQNRLE 243
L + G++ +L +L+L SLS L + VS N +
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
Query: 244 GD----LSE-LRFLN-QLSSLHLFENQFSGEIPEEFGEF----KHLTELSLYTNRLTGTL 293
L + L+ QL +L L + + + L EL+L +N+L
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD-- 241
Query: 294 PQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIR 353
G L + L
Sbjct: 242 ------------------------------VGMAELCPGLLH-----------PSSRLRT 260
Query: 354 FRVNNNSLS----GTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNA-----KSLALLLL 404
+ ++ G + + + +L + L+ N+ + L L +
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320
Query: 405 ANNRFSGELPSKISEA----SSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGP 460
+ F+ S S L+ +Q+S N+ D G +++L
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE-----DAG-VRELCQGLGQPGS---- 370
Query: 461 LPYSIGSCVSLTDINFAQNSLSGK----IPDSLGSLPSLNSLNLSNNKFSGE----IPIS 512
L + A +S + +L + SL L+LSNN + S
Sbjct: 371 ---------VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 421
Query: 513 LTYPKLSL--LDLSNNQL 528
+ P L L L +
Sbjct: 422 VRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-13
Identities = 55/268 (20%), Positives = 101/268 (37%), Gaps = 40/268 (14%)
Query: 63 LQKINLGTNFL----YGTITEGLKSCTRLQVLDLGNNSFSGE-VPDLS--MLHE---LSF 112
+QK++L L G ++ L++ LQ L L +N + L +L L
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146
Query: 113 LNLNSSGIS---GKFPWKSLENLTNLEFLSLGDNPFDPSPFPM--EVLK--LEKLYWLYL 165
L L +S + L + + L++ +N + + + + LK +L L L
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKL 206
Query: 166 TNCSVTGQ----IPEGIGNLTQLQNLELSDNELFGE----IPAGIVKLN-KLWQLELYNN 216
+C VT + + + L+ L L N+L + G++ + +L L ++
Sbjct: 207 ESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWEC 266
Query: 217 SLSGR----LPVGFSNLTNLMNFDVSQNRLEGD----LSE-LRFLN-QLSSLHLFENQFS 266
++ + L +L ++ N L + L E L QL SL + F+
Sbjct: 267 GITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326
Query: 267 GEIPEEFGEF----KHLTELSLYTNRLT 290
F + L EL + NRL
Sbjct: 327 AACCSHFSSVLAQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-12
Identities = 85/504 (16%), Positives = 148/504 (29%), Gaps = 131/504 (25%)
Query: 59 GLQALQKINLGTNFLYGT----ITEGLKSCTRLQVLDLGNNSFSGE-VPDLS-MLHE--- 109
LQ Q + L L I+ L+ L L+L +N V + L
Sbjct: 26 LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSC 85
Query: 110 -LSFLNLNSSGISG---KFPWKSLENLTNLEFLSLGDNPFDPSPFPM--EVLKLE--KLY 161
+ L+L + ++G +L L L+ L L DN + + E L +L
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145
Query: 162 WLYLTNCSVTGQ----IPEGIGNLTQLQNLELSDNELFGEIPAGIVKL--------NKLW 209
L L CS++ + + + L +S+N++ AG+ L +L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI---NEAGVRVLCQGLKDSPCQLE 202
Query: 210 QLELYNNSLSGR----LPVGFSNLTNLMNFDVSQNRLEGD----LSE--LRFLNQLSSLH 259
L+L + ++ L ++ +L + N+L L L ++L +L
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262
Query: 260 LFENQFSGE----IPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315
++E + + + + L ELSL N L
Sbjct: 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD------------------------ 298
Query: 316 PIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGT----IPPGIWS 371
GA L L V + S + +
Sbjct: 299 --------EGARLLCETLLE-----------PGCQLESLWVKSCSFTAACCSHFSSVLAQ 339
Query: 372 LPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLN 431
L + +S N+ E D G + L L S L + L+
Sbjct: 340 NRFLLELQISNNRLE-----DAG-VRELCQGLGQPG-------------SVLRVLWLADC 380
Query: 432 QFSGQIPLDIGKL----KKLSSLYLHDN--------MFSGPLPYSIGSCVSLTDINFAQN 479
S + L L L +N + L +
Sbjct: 381 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ---PGCLLEQLVLYDI 437
Query: 480 SLSGKIPDSLGSL----PSLNSLN 499
S ++ D L +L PSL ++
Sbjct: 438 YWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 61/394 (15%), Positives = 122/394 (30%), Gaps = 90/394 (22%)
Query: 182 TQLQNLELSDNELFGEIPAGIVKLNK-LWQLELYNNSLSGR----LPVGFSNLTNLMNFD 236
+Q+L++ EL A ++ L + + L + L+ + L +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 237 VSQNRLEGD----LSE-LRFLN-QLSSLHLFENQFSGE----IPEEFGEFKHLTELSLYT 286
+ N L + + L+ + ++ L L +G + L EL L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 287 NRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYA 346
N L G L +
Sbjct: 123 NLLGD--------------------------------AGLQLLCEGLLDP---------- 140
Query: 347 NCKSLIRFRVNNNSLSGT----IPPGIWSLPNLSIIDLSTNQFEGPVTDDIG-----NAK 397
C+ L + ++ SLS + + + P+ + +S N + +
Sbjct: 141 QCR-LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPC 199
Query: 398 SLALLLLANNRFSGELPSKISEA----SSLVSIQLSLNQF--SGQIPLDIGKLK---KLS 448
L L L + + + + +SL + L N+ G L G L +L
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259
Query: 449 SLYLHDNMFSGP----LPYSIGSCVSLTDINFAQNSLSGK----IPDSLGS-LPSLNSLN 499
+L++ + + L + + SL +++ A N L + + ++L L SL
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW 319
Query: 500 LSNNKFSGEIPISL-----TYPKLSLLDLSNNQL 528
+ + F+ L L +SNN+L
Sbjct: 320 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL 353
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 41/191 (21%), Positives = 67/191 (35%), Gaps = 32/191 (16%)
Query: 58 CGLQALQKINLGTNFL----YGTITEGLKSCTRLQVLDLGNNSFSGE-VPDLS-MLHE-- 109
L+ + + + G + L++ L+ L L N E L L E
Sbjct: 253 HPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG 312
Query: 110 --LSFLNLNSSGISGKFPW---KSLENLTNLEFLSLGDNPFDPSPFPM--EVLK--LEKL 160
L L + S + L L L + +N + + + L L
Sbjct: 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 372
Query: 161 YWLYLTNCSVTGQ----IPEGIGNLTQLQNLELSDNELFGEIPAGIVKL--------NKL 208
L+L +C V+ + + L+ L+LS+N L G AGI++L L
Sbjct: 373 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL-G--DAGILQLVESVRQPGCLL 429
Query: 209 WQLELYNNSLS 219
QL LY+ S
Sbjct: 430 EQLVLYDIYWS 440
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 5e-14
Identities = 44/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+ AKG+E+L R IHRD+ + NILL + +I DFGLA+ +
Sbjct: 198 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----DY 249
Query: 809 IAGTHGYI-----APEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862
+ + APE + +SDV+SFGV+L E+ + G P P ++
Sbjct: 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRR 308
Query: 863 VYS--KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
+ +M + D P + + + + C + P+ RP+ +V+ L
Sbjct: 309 LKEGTRMRAPDYT----TPEMYQTMLD-----------CWHGEPSQRPTFSELVEHLGN 352
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-14
Identities = 58/296 (19%), Positives = 106/296 (35%), Gaps = 77/296 (26%)
Query: 603 LKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHI 661
+ H +S + + D ++LIG+G G VY N+ K +A+K +
Sbjct: 1 MHHHHHHSSGRENLYFQ-GIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV 59
Query: 662 WPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNL--- 718
N F I KR R E+ L+ ++ +++LY I +D
Sbjct: 60 ---NRMFE------DLIDCKRILR------EITILNRLKSDYIIRLYDLIIPDDLLKFDE 104
Query: 719 --LVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA----------KGLEYLHHGFDR 766
+V E D L + + I + G ++H
Sbjct: 105 LYIVLEIAD----SD-LKK--------LFKTPIFLTEEHIKTILYNLLLGENFIHES--- 148
Query: 767 PVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG------------ 814
+IHRD+K +N LL+ + ++ DFGLA+ + + + ++ + +
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208
Query: 815 --------YIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857
Y APE YT I D++S G + EL+ + + + +
Sbjct: 209 TSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFAELLNMLQSHINDPTNRF 260
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 67/303 (22%), Positives = 109/303 (35%), Gaps = 78/303 (25%)
Query: 599 KQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELA 657
+Q + +S S S+ +I D + +LIG G G+V + + +A
Sbjct: 24 QQEGQQRKQHHSSKPTASMPR-PHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVA 82
Query: 658 VKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSN 717
+K I F I KR R E+A L+ + H +VVK+ + +D
Sbjct: 83 IKKI---LRVFE------DLIDCKRILR------EIAILNRLNHDHVVKVLDIVIPKDVE 127
Query: 718 L-----LVYEYLPNGSLWDRLH----TCHKIEMDWV--VRYAIAVGAAKGLEYLH-HGFD 765
+V E D T + + + Y + G++Y+H G
Sbjct: 128 KFDELYVVLEIAD----SD-FKKLFRTPVYLTELHIKTLLYNLL----VGVKYVHSAG-- 176
Query: 766 RPVIHRDVKSSNILLDLEWKPRIADFGLAKIV--------------------------QT 799
++HRD+K +N L++ + ++ DFGLA+ V
Sbjct: 177 --ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 800 GEAGDLTHVIAGTHGYIAPE-----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG 854
LT + T Y APE YT I DV+S G + EL+ + V
Sbjct: 235 NLKRQLTGHVV-TRWYRAPELILLQENYTEAI----DVWSIGCIFAELLNMIKENVAYHA 289
Query: 855 DSK 857
D
Sbjct: 290 DRG 292
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 32 CDSNGLVA----------EINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGL 81
+ + NL ++ + V + L ++ +I + + +G+
Sbjct: 5 VSTPIKQIFPDDAFAETIKANLKKKSVTDAVTQN---ELNSIDQIIANNSDI--KSVQGI 59
Query: 82 KSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLG 141
+ ++ L LG N ++ L L L++L L + + P + LTNL+ L L
Sbjct: 60 QYLPNVRYLALGGNKLH-DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLV 117
Query: 142 DNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGN-LTQLQNLELSDNELFGEIPA 200
+N +L+ L P+G+ + LT L L L+ N+L +P
Sbjct: 118 EN------------QLQSL--------------PDGVFDKLTNLTYLNLAHNQL-QSLPK 150
Query: 201 GIV-KLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRL 242
G+ KL L +L+L N L LP G F LT L + + QN+L
Sbjct: 151 GVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 52/208 (25%), Positives = 79/208 (37%), Gaps = 41/208 (19%)
Query: 32 CDSNGL-----------VAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEG 80
+ + +I + V L ++ + LG N L
Sbjct: 26 LKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQY---LPNVRYLALGGNKL--HDISA 80
Query: 81 LKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFL 138
LK T L L L N +P+ L L L L + + P + LTNL +L
Sbjct: 81 LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYL 138
Query: 139 SLGDN-----P---FDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLEL 189
+L N P FD KL L L L+ + +PEG+ LTQL++L L
Sbjct: 139 NLAHNQLQSLPKGVFD---------KLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRL 188
Query: 190 SDNELFGEIPAGIV-KLNKLWQLELYNN 216
N+L +P G+ +L L + L++N
Sbjct: 189 YQNQL-KSVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 45/142 (31%), Positives = 67/142 (47%), Gaps = 10/142 (7%)
Query: 156 KLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYN 215
+L + + N + +GI L ++ L L N+L +I A + +L L L L
Sbjct: 39 ELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKL-HDISA-LKELTNLTYLILTG 94
Query: 216 NSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEE 272
N L LP G F LTNL + +N+L+ L + F L L+ L+L NQ
Sbjct: 95 NQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGV 152
Query: 273 FGEFKHLTELSLYTNRLTGTLP 294
F + +LTEL L N+L +LP
Sbjct: 153 FDKLTNLTELDLSYNQLQ-SLP 173
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 49/208 (23%), Positives = 76/208 (36%), Gaps = 42/208 (20%)
Query: 328 TDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEG 387
T L+ T S+ + NN+ + GI LPN+ + L N+
Sbjct: 21 TIKANLKKKSVTDAV-TQNELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLHD 77
Query: 388 -PVTDDIGNAKSLALLLLANNRFSGELPSKISEA-SSLVSIQLSLNQFSGQIPLDI-GKL 444
++ N L L+L N+ LP+ + + ++L + L NQ +P + KL
Sbjct: 78 ISALKELTN---LTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKL 132
Query: 445 KKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNK 504
L+ L L N SL + D L +L L+LS N+
Sbjct: 133 TNLTYLNLAHNQLQ---------------------SLPKGVFDKLTNL---TELDLSYNQ 168
Query: 505 FSGEIPI----SLTYPKLSLLDLSNNQL 528
+P LT +L L L NQL
Sbjct: 169 LQ-SLPEGVFDKLT--QLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 53/299 (17%), Positives = 92/299 (30%), Gaps = 97/299 (32%)
Query: 167 NCSVTG--QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPV 224
S P+ + L + + +LN + Q+ N+ + +
Sbjct: 4 TVSTPIKQIFPDDA--FAETIKANLKKKSV-TDAVTQN-ELNSIDQIIANNSDIK-SVQ- 57
Query: 225 GFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSL 284
G L N+ + N +L + + +LT L L
Sbjct: 58 GIQYLPNVRYLALGGN-------------KLHDISALKE------------LTNLTYLIL 92
Query: 285 YTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPET 344
N+L +LP G F+
Sbjct: 93 TGNQLQ-SLP-----------------------------NGV----------FDKLTNLK 112
Query: 345 YANCKSLIRFRVNNNSLSGTIPPGIW-SLPNLSIIDLSTNQF---EGPVTDDIGNAKSLA 400
N L ++P G++ L NL+ ++L+ NQ V D + N L
Sbjct: 113 ELVL--------VENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTN---LT 160
Query: 401 LLLLANNRFSGELPSKISEA-SSLVSIQLSLNQFSGQIP---LDIGKLKKLSSLYLHDN 455
L L+ N+ LP + + + L ++L NQ +P D +L L ++LHDN
Sbjct: 161 ELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFD--RLTSLQYIWLHDN 215
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 9e-13
Identities = 31/159 (19%), Positives = 55/159 (34%), Gaps = 31/159 (19%)
Query: 133 TNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSD 191
L L +N F KL +L + +N +T I EG + + + L+
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90
Query: 192 NELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSEL 249
N L + + L L L L +N ++ + F L+++
Sbjct: 91 NRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSV----------------- 131
Query: 250 RFLNQLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTN 287
L L++NQ + + F L+ L+L N
Sbjct: 132 ------RLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 28/158 (17%), Positives = 58/158 (36%), Gaps = 34/158 (21%)
Query: 113 LNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTG 172
L LN++ + + L L ++ +N K+ +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNN------------KITDI------------ 72
Query: 173 QIPEGI-GNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNL 229
EG + + + L+ N L + + L L L L +N ++ + F L
Sbjct: 73 --EEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGL 128
Query: 230 TNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQF 265
+++ + N++ ++ F L+ LS+L+L N F
Sbjct: 129 SSVRLLSLYDNQITT-VAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 34/172 (19%), Positives = 61/172 (35%), Gaps = 38/172 (22%)
Query: 364 TIPPGIWSLPNLSIIDLSTNQFEG-PVTDDIGNAKSLALLLLANNRFSGELPSKI-SEAS 421
IP I + + L+ N+F T L + +NN+ + ++ AS
Sbjct: 25 KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 422 SLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNS 480
+ I L+ N+ + + L+ L +L L N +T +
Sbjct: 82 GVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSN--------------RITCVG----- 121
Query: 481 LSGKIPDSLGSLPSLNSLNLSNNKFSGEIP----ISLTYPKLSLLDLSNNQL 528
DS L S+ L+L +N+ + + +L LS L+L N
Sbjct: 122 -----NDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLH--SLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 23/96 (23%), Positives = 42/96 (43%), Gaps = 9/96 (9%)
Query: 54 FDSICGLQALQKINLGTNFLYGTITEGL-KSCTRLQVLDLGNNSFSGEVPD--LSMLHEL 110
F+ G + +I L +N L + + K L+ L L +N + V + L +
Sbjct: 77 FE---GASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSV 131
Query: 111 SFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFD 146
L+L + I+ + + L +L L+L NPF+
Sbjct: 132 RLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 33/198 (16%), Positives = 62/198 (31%), Gaps = 66/198 (33%)
Query: 197 EIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRFLNQ 254
+IP I +L L NN + G F L L + S N +
Sbjct: 25 KIPEHIPQYTAELR---LNNNEFTVLEATGIFKKLPQLRKINFSNN-------------K 68
Query: 255 LSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFN------YVDV 308
++ + F + E+ L +NRL + F + +
Sbjct: 69 ITDIE----------EGAFEGASGVNEILLTSNRLE-NVQ-----HKMFKGLESLKTLML 112
Query: 309 SENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPG 368
N +T + + L ++ + +N ++ T+ PG
Sbjct: 113 RSNRITC-VGN-----DSFIGLSSVR------------------LLSLYDNQIT-TVAPG 147
Query: 369 IW-SLPNLSIIDLSTNQF 385
+ +L +LS ++L N F
Sbjct: 148 AFDTLHSLSTLNLLANPF 165
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.4 bits (174), Expect = 1e-12
Identities = 102/643 (15%), Positives = 185/643 (28%), Gaps = 212/643 (32%)
Query: 7 IEKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSIC-----GLQ 61
++ + S E + I+ + L + F ++ +Q
Sbjct: 38 VQDMPKSILSK-EE------IDHIIMSKD--------AVSGTLRL--FWTLLSKQEEMVQ 80
Query: 62 ALQKINLGTNFLYGTITEGLKSCTR------------LQVLDLGNNSFS-GEVPDLSMLH 108
+ L N Y + +K+ R L N F+ V L
Sbjct: 81 KFVEEVLRIN--YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL 138
Query: 109 EL--SFLNLNSSGI--------SGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLE 158
+L + L L + SGK W +L+ + + ++
Sbjct: 139 KLRQALLELRPAKNVLIDGVLGSGK-TWVALDVCLSYKVQCK---------MDFKI---- 184
Query: 159 KLYWLYLTNCSVTGQIPEGIGNLTQLQNL---------ELSDNELFGEIPAGIVK--LNK 207
+WL L NC PE + L LQ L SD+ ++ ++ L +
Sbjct: 185 --FWLNLKNC----NSPETV--LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 208 LWQLELYNNSLSGRLPVGFSNLTNLMN------FDVS-----QNRLEGDLSELRFLNQLS 256
L + + Y N L L V L N+ N F++S R FL+ +
Sbjct: 237 LLKSKPYENCL---L-V----LLNVQNAKAWNAFNLSCKILLTTR---FKQVTDFLSAAT 285
Query: 257 SLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLP-------------------QKL 297
+ H+ + + + L Y + LP L
Sbjct: 286 TTHISLD----HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGL 341
Query: 298 GSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANC-KSLIRFRV 356
+W ++ +V+ + LT I + L VL+ P Y L F
Sbjct: 342 ATWDNWKHVNCDK--LTTII--ESS-------LNVLE-------PAEYRKMFDRLSVFPP 383
Query: 357 NNNSLSGTIPPG----IWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLA------------ 400
+ + IP IW S + + N+ SL
Sbjct: 384 SAH-----IPTILLSLIWFDVIKSDVMVVVNKLH---------KYSLVEKQPKESTISIP 429
Query: 401 ---LLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLD------IG--------- 442
L L L I + ++ + LD IG
Sbjct: 430 SIYLELKVKLENEYALHRSIVDHYNIPK-TFDSDDLI-PPYLDQYFYSHIGHHLKNIEHP 487
Query: 443 -KLKKLSSLYLHDNMF-------SGPLPYSIGSCVS-LTDINF-------AQNSLSGKIP 486
++ ++L D F + GS ++ L + F +
Sbjct: 488 ERMTLFRMVFL-DFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVN 546
Query: 487 DSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLA 529
L LP + NL +K++ + I+L ++ + ++ Q+
Sbjct: 547 AILDFLPKIEE-NLICSKYTDLLRIALMAEDEAIFEEAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 2e-08
Identities = 97/695 (13%), Positives = 198/695 (28%), Gaps = 242/695 (34%)
Query: 233 MNFDVSQNRLE-GDLSELRFLNQLSSLHLFENQFSG-----EIPEEF------GEFKHLT 280
M+F+ +++ + D+ L +FE+ F ++ + E H+
Sbjct: 7 MDFETGEHQYQYKDI-----------LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHII 55
Query: 281 ELS---LYTNRLTGTLPQK--------LGSWADFNYVDVSENLLTGPIPPDMCKTGAMTD 329
T RL TL K + NY + + T P M
Sbjct: 56 MSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSM-------- 107
Query: 330 LLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQF---E 386
+ + Y + + ++ V + L ++++L + +
Sbjct: 108 ---MTRMYIEQRDRLYNDNQVFAKYNV-------SRLQPYLKLRQ-ALLELRPAKNVLID 156
Query: 387 GPVTDDIGNAKS-LALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLK 445
G +G+ K+ +AL + + + ++ KI F
Sbjct: 157 G----VLGSGKTWVALDVCLSYKVQCKMDFKI---------------F------------ 185
Query: 446 KLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKF 505
+L ++ +C S + L +I + S +S N+
Sbjct: 186 -----WL-----------NLKNCNSPETVLEMLQKLLYQIDPNWTSRSD-HSSNIKLRIH 228
Query: 506 SGEIPISL-----TYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGLC-------- 552
S + + Y LL L N + ++F + C
Sbjct: 229 SIQAELRRLLKSKPYEN-CLLVLLN----------VQNAKAWNAFNLS---CKILLTTRF 274
Query: 553 -SKTDEYFKSCSSGSGRSHHVSTFVWCLIAITMVL-----LVLLASYFVVKLKQNNLKHS 606
TD + + H+S L +M L LL Y + + +L
Sbjct: 275 KQVTD------FLSAATTTHIS-----LDHHSMTLTPDEVKSLLLKY--LDCRPQDLPRE 321
Query: 607 LKQNSWDMKSFRVLS-FSEKEIIDAVKPENLIGKGGSGNVYKVV----LNSGKELAVKHI 661
+ + R LS +E +N +K V L + E ++ +
Sbjct: 322 VLTT-----NPRRLSIIAESIRDGLATWDN----------WKHVNCDKLTTIIESSLNVL 366
Query: 662 WPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV--ATLSAVRHVNVVKLYCSITSEDSNLL 719
P+ +R + ++ A + LS ++ + D ++
Sbjct: 367 EPAE--YRKMFD-RLSVFPP--------SAHIPTILLS--------LIWFDVIKSDVMVV 407
Query: 720 VYEYLPNGSLWDR--------LHTCH---KIEMD--------WVVRYAIAVGAAKG---- 756
V + L SL ++ + + + K++++ V Y I
Sbjct: 408 VNK-LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIP 466
Query: 757 -------LEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
++ HH + R + LD + + KI A + +
Sbjct: 467 PYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF---LE----QKIRHDSTAWNASGS 519
Query: 809 IAGT-------HGYIAP-EYAYTCKINEKSDVYSF 835
I T YI + Y +N + F
Sbjct: 520 ILNTLQQLKFYKPYICDNDPKYERLVN---AILDF 551
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 2e-07
Identities = 58/427 (13%), Positives = 135/427 (31%), Gaps = 112/427 (26%)
Query: 585 VLLVLLASYFVVKLKQNNLKHSLKQNSWDMKSFRVLSFSE-KEIIDAVKPENLIGKGGSG 643
+L V + FV +++ K +LS E II + + G+
Sbjct: 21 ILSVFEDA-FVDNFDCKDVQDMPKS---------ILSKEEIDHIIMSKDAVS-----GTL 65
Query: 644 NVYKVVLNSGKELAVKHIWPSNSGFRGDYR---SSTAILSK-RSSRSSEYDAEVATLSAV 699
++ +L+ +E+ K + R +Y+ S + S + Y + L
Sbjct: 66 RLFWTLLSKQEEMVQKFV---EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 700 ------RHVNVVKLYCSITS------EDSNLLVY---------------------EYLPN 726
+V+ ++ Y + N+L+ +
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDF 182
Query: 727 GSLW-------------DRLHT-CHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRD 772
W + L ++I+ +W R + + + R + +
Sbjct: 183 KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP 242
Query: 773 VKSSNILLDLEWKPRIAD-FGL-AKI-VQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEK 829
++ ++L + + F L KI + T + A T +I+ ++
Sbjct: 243 YENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS--------LDHH 294
Query: 830 SDVYSF--GVVLMELVTGKRP---------IVPE----FGDS-KDIVN-WVYSKMDSRDS 872
S + L+ RP P +S +D + W K + D
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK 354
Query: 873 MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRV---VVQML----EEAEPCSV 925
+ T+++ ++ +L+ + ++L F PS + ++ ++ +++ V
Sbjct: 355 LTTIIESSL-NVLEPAEYR------KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVV 407
Query: 926 TNIVVKK 932
N + K
Sbjct: 408 VNKLHKY 414
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 62/255 (24%), Positives = 109/255 (42%), Gaps = 69/255 (27%)
Query: 632 KPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+ +GKG G V+K + +G+ +AVK I F+ + ++R+ R
Sbjct: 12 ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI---FDAFQ------NSTDAQRTFR----- 57
Query: 691 AEVATLSAVR-HVNVVKLYCSITSEDSN--LLVYEYLP-------NGSLWDRLHTCHKIE 740
E+ L+ + H N+V L + +++ LV++Y+ ++ + +H + +
Sbjct: 58 -EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVV- 115
Query: 741 MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG 800
Y + K ++YLH G ++HRD+K SNILL+ E ++ADFGL++
Sbjct: 116 ------YQLI----KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
Query: 801 EAGDLTHVIAGTHG-------------------YIAPE-----YAYTCKINEKSDVYSFG 836
++ Y APE YT I D++S G
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLG 218
Query: 837 VVLMELVTGKRPIVP 851
+L E++ GK PI P
Sbjct: 219 CILGEILCGK-PIFP 232
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 40/168 (23%), Positives = 61/168 (36%), Gaps = 35/168 (20%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG G G + L + + +A+K L SR+ + E
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK-------------------LEPMKSRAPQLHLEYRF 57
Query: 696 LSAVRH-VNVVKLYCSITSEDSNLLVYEYLPNG-SLWDRLHTC-HKIEMDWVVRYAIAVG 752
+ + ++Y N +V E L G SL D C + V+ IA+
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLM--IAIQ 113
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR-----IADFGLAK 795
+EY+H + +I+RDVK N L+ I DF LAK
Sbjct: 114 LISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 41/188 (21%), Positives = 66/188 (35%), Gaps = 45/188 (23%)
Query: 127 KSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQN 186
+L L + L+L N +EK+ + + L+
Sbjct: 42 ATLSTLKACKHLALSTN------------NIEKI---------------SSLSGMENLRI 74
Query: 187 LELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLE--G 244
L L N + +I + L +L + N ++ L G L NL +S N++ G
Sbjct: 75 LSLGRNLI-KKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWG 131
Query: 245 DLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQ--KLGSWAD 302
++ +L L++L L L N + E S Y + LP KL D
Sbjct: 132 EIDKLAALDKLEDLLLAGNPLYNDYKEN-------NATSEYRIEVVKRLPNLKKL----D 180
Query: 303 FNYVDVSE 310
VDV E
Sbjct: 181 GMPVDVDE 188
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 32/143 (22%), Positives = 57/143 (39%), Gaps = 35/143 (24%)
Query: 77 ITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTN-L 135
+ L + + L L N+ ++ LS + L L+L + I ++L+ + + L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKK---IENLDAVADTL 95
Query: 136 EFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNEL- 194
E L + N ++ L GI L L+ L +S+N++
Sbjct: 96 EELWISYN------------QIASL---------------SGIEKLVNLRVLYMSNNKIT 128
Query: 195 -FGEIPAGIVKLNKLWQLELYNN 216
+GEI + L+KL L L N
Sbjct: 129 NWGEI-DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 31/144 (21%), Positives = 58/144 (40%), Gaps = 19/144 (13%)
Query: 56 SICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDL-SMLHELSFLN 114
++ L+A + + L TN + L L++L LG N ++ +L ++ L L
Sbjct: 43 TLSTLKACKHLALSTNNI--EKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99
Query: 115 LNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLK-LEKLYWLYLTNCSVTGQ 173
++ + I+ +E L NL L + +N + ++ L L+KL L L +
Sbjct: 100 ISYNQIA-SL--SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYND 155
Query: 174 IPEG----------IGNLTQLQNL 187
E + L L+ L
Sbjct: 156 YKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 29/139 (20%), Positives = 53/139 (38%), Gaps = 8/139 (5%)
Query: 402 LLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPL 461
L ++ + +S + + LS N +I + ++ L L L N+ +
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKK-I 85
Query: 462 PYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFS--GEIPISLTYPKLS 519
+L ++ + N ++ + + L +L L +SNNK + GEI KL
Sbjct: 86 ENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143
Query: 520 LLDLSNNQLAGPIPEPLNI 538
L L+ N L E
Sbjct: 144 DLLLAGNPLYNDYKENNAT 162
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 30/152 (19%), Positives = 56/152 (36%), Gaps = 28/152 (18%)
Query: 365 IPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLV 424
+ + +L + LSTN E + ++L +L L N ++ + + A +L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE--KISSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 425 SIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGK 484
+ +S NQ + + I KL L LY+ +N + + +I
Sbjct: 97 ELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT-----------NWGEI---------- 133
Query: 485 IPDSLGSLPSLNSLNLSNNKFSGEIPISLTYP 516
D L +L L L L+ N + +
Sbjct: 134 --DKLAALDKLEDLLLAGNPLYNDYKENNATS 163
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 34/127 (26%), Positives = 58/127 (45%), Gaps = 12/127 (9%)
Query: 174 IPEGIGNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTN 231
IP + + + L N + IP G KL +++L NN +S L F L +
Sbjct: 26 IPTNL--PETITEIRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 232 LMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNR 288
L + + N++ +L + F L L L L N+ + + + F + +L LSLY N+
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139
Query: 289 LTGTLPQ 295
L T+ +
Sbjct: 140 LQ-TIAK 145
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 31/130 (23%), Positives = 57/130 (43%), Gaps = 9/130 (6%)
Query: 163 LYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSG 220
+ L ++ IP G +L+ ++LS+N++ E+ L L L LY N ++
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 221 RLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEEFGEFK 277
LP F L +L ++ N++ L F L+ L+ L L++N+ F +
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 278 HLTELSLYTN 287
+ + L N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 33/158 (20%), Positives = 59/158 (37%), Gaps = 35/158 (22%)
Query: 113 LNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTG 172
+ L + I P + L + L +N ++ +L
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNN------------QISEL------------ 71
Query: 173 QIPEGI-GNLTQLQNLELSDNELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNL 229
L L +L L N++ E+P + L L L L N ++ L V F +L
Sbjct: 72 --APDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDL 127
Query: 230 TNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQF 265
NL + N+L+ +++ F L + ++HL +N F
Sbjct: 128 HNLNLLSLYDNKLQT-IAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 32/136 (23%), Positives = 48/136 (35%), Gaps = 33/136 (24%)
Query: 85 TRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGD 142
+L+ +DL NN S E+ L L+ L L + I+ + P E L +L+ L L
Sbjct: 56 KKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNA 113
Query: 143 NPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPAG 201
N K+ + +L L L L DN+L I G
Sbjct: 114 N------------KIN--------------CLRVDAFQDLHNLNLLSLYDNKL-QTIAKG 146
Query: 202 IV-KLNKLWQLELYNN 216
L + + L N
Sbjct: 147 TFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 41/196 (20%), Positives = 69/196 (35%), Gaps = 61/196 (31%)
Query: 197 EIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--L 252
EIP + + ++ L N++ +P G FS L D+S N++ +L+ F L
Sbjct: 25 EIPTNLPETITEIR---LEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGL 79
Query: 253 NQLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSEN 311
L+SL L+ N+ + E+P+ F L L L N++
Sbjct: 80 RSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-------------------- 118
Query: 312 LLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIW- 370
+ A DL +L + +N L TI G +
Sbjct: 119 -----LRV-----DAFQDL------------------HNLNLLSLYDNKLQ-TIAKGTFS 149
Query: 371 SLPNLSIIDLSTNQFE 386
L + + L+ N F
Sbjct: 150 PLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 34/129 (26%), Positives = 55/129 (42%), Gaps = 7/129 (5%)
Query: 402 LLLANNRFSGELPSKI-SEASSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHDNMFSG 459
+ L N +P S L I LS NQ S ++ D L+ L+SL L+ N +
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 460 PLPYSI-GSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTY-PK 517
LP S+ SL + N ++ D+ L +LN L+L +NK + +
Sbjct: 95 -LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 518 LSLLDLSNN 526
+ + L+ N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 37/136 (27%), Positives = 59/136 (43%), Gaps = 22/136 (16%)
Query: 355 RVNNNSLSGTIPPGI-WSLPNLSIIDLSTNQ--------FEGPVTDDIGNAKSLALLLLA 405
R+ N++ IPPG L IDLS NQ F+G +SL L+L
Sbjct: 38 RLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQG--------LRSLNSLVLY 88
Query: 406 NNRFSGELPSKI-SEASSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHDNMFSGPLPY 463
N+ + ELP + SL + L+ N+ + + +D L L+ L L+DN
Sbjct: 89 GNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146
Query: 464 SIGSCVSLTDINFAQN 479
+ ++ ++ AQN
Sbjct: 147 TFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 26/83 (31%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 450 LYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEI 509
+ L N P + L I+ + N +S PD+ L SLNSL L NK + E+
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95
Query: 510 PI----SLTYPKLSLLDLSNNQL 528
P L L LL L+ N++
Sbjct: 96 PKSLFEGLF--SLQLLLLNANKI 116
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 22/96 (22%), Positives = 40/96 (41%), Gaps = 9/96 (9%)
Query: 54 FDSICGLQALQKINLGTNFLYGTITEGL-KSCTRLQVLDLGNNSFSGEVPD--LSMLHEL 110
F GL++L + L N + + + L + LQ+L L N + + LH L
Sbjct: 76 FQ---GLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNL 130
Query: 111 SFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFD 146
+ L+L + + + L ++ + L NPF
Sbjct: 131 NLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 61/234 (26%), Positives = 90/234 (38%), Gaps = 58/234 (24%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG G G++Y + +G+E+A+K L ++ + E
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIK-------------------LECVKTKHPQLHIESKI 57
Query: 696 LSAVRH-VNVVKLYCSITSEDSNLLVYEYLPNG-SLWDRLHTC-HKIEMDWVVRYAIAVG 752
++ V + + D N++V E L G SL D + C K + V+ +A
Sbjct: 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLL--LADQ 113
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP---RIADFGLAKIVQTGEAGDLTHV- 808
+EY+H + IHRDVK N L+ L K I DFGLAK + H+
Sbjct: 114 MISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH--QHIP 168
Query: 809 ------IAGTHGYIAPEYAYTCKIN-----EKS---DVYSFGVVLMELVTGKRP 848
+ GT Y IN E+S D+ S G VLM G P
Sbjct: 169 YRENKNLTGTARY--------ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 49/236 (20%), Positives = 86/236 (36%), Gaps = 60/236 (25%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG+G G +++ L + +++A+K R S + + E T
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIK-------------------FEPRRSDAPQLRDEYRT 58
Query: 696 LSAVRH-VNVVKLYCSITSEDSNLLVYEYLPNG-SLWDRLHTC-HKIEMDWVVRYAIAVG 752
+ + +Y N+LV + L G SL D L C K + V A
Sbjct: 59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAM--AAKQ 114
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR-----IADFGLAKIVQTGEAGDLTH 807
++ +H ++ +++RD+K N L+ + DFG+ K + H
Sbjct: 115 MLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK--FYRDPVTKQH 169
Query: 808 V-------IAGTHGYIAPEYAYTCKIN-----EKS---DVYSFGVVLMELVTGKRP 848
+ ++GT Y IN E+S D+ + G V M + G P
Sbjct: 170 IPYREKKNLSGTARY--------MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 48/246 (19%), Positives = 89/246 (36%), Gaps = 69/246 (28%)
Query: 618 RVLSFSEKEIIDAVK-PENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSS 675
L + IID K ++G G +G V ++ + ++ A+K
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---------------- 49
Query: 676 TAILSKRSSRSSEYDAEVATLSAV-RHVNVVKL---YCSITSEDSNL-LVYEYLPNGSLW 730
+L E V + ++V++ Y ++ + L +V E L G L+
Sbjct: 50 --MLQDCPKARRE----VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 103
Query: 731 DR-LHTCHKI--EMD--WVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL---DL 782
R + E + +++ +I + ++YLH + HRDVK N+L
Sbjct: 104 SRIQDRGDQAFTEREASEIMK-SIG----EAIQYLH---SINIAHRDVKPENLLYTSKRP 155
Query: 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMEL 842
++ DFG AK Y ++ D++S GV++ L
Sbjct: 156 NAILKLTDFGFAKETTGE-------------KY-----------DKSCDMWSLGVIMYIL 191
Query: 843 VTGKRP 848
+ G P
Sbjct: 192 LCGYPP 197
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-11
Identities = 33/111 (29%), Positives = 51/111 (45%), Gaps = 5/111 (4%)
Query: 156 KLEKLYWLYLTNCSVT-GQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELY 214
+ L L N G++ +L+ L + L I A + KLNKL +LEL
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSI-ANLPKLNKLKKLELS 72
Query: 215 NNSLSGRLPVGFSNLTNLMNFDVSQNRLE--GDLSELRFLNQLSSLHLFEN 263
+N +SG L V NL + ++S N+++ + L+ L L SL LF
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-08
Identities = 22/86 (25%), Positives = 39/86 (45%), Gaps = 3/86 (3%)
Query: 60 LQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLS-MLHELSFLNLNSS 118
+ L+ ++ L T L +L+ L+L +N SG + L+ L+ LNL+ +
Sbjct: 41 FEELEFLSTINVGL--TSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98
Query: 119 GISGKFPWKSLENLTNLEFLSLGDNP 144
I + L+ L NL+ L L +
Sbjct: 99 KIKDLSTIEPLKKLENLKSLDLFNCE 124
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 25/116 (21%), Positives = 44/116 (37%), Gaps = 9/116 (7%)
Query: 419 EASSLVSIQLSLNQFS-GQIPLDIGKLKKLSSLYLHDNMFS--GPLPYSIGSCVSLTDIN 475
S + + L ++ + G++ + ++L L + + LP L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70
Query: 476 FAQNSLSGKIPDSLGSLPSLNSLNLSNNKFS--GEIPISLTYPKLSLLDLSNNQLA 529
+ N +SG + P+L LNLS NK I L LDL N ++
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 29/98 (29%), Positives = 41/98 (41%), Gaps = 4/98 (4%)
Query: 75 GTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTN 134
G + L+ L N + + +L L++L L L+ + +SG E N
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDNRVSGGLEV-LAEKCPN 89
Query: 135 LEFLSLGDNPFDPSPFPMEVLK-LEKLYWLYLTNCSVT 171
L L+L N +E LK LE L L L NC VT
Sbjct: 90 LTHLNLSGNKIK-DLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 21/88 (23%), Positives = 38/88 (43%), Gaps = 2/88 (2%)
Query: 204 KLNKLWQLELYNNSLS-GRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFE 262
+ + +L L N+ + G+L L L ++ L LN+L L L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSD 73
Query: 263 NQFSGEIPEEFGEFKHLTELSLYTNRLT 290
N+ SG + + +LT L+L N++
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 27/118 (22%), Positives = 51/118 (43%), Gaps = 7/118 (5%)
Query: 80 GLKSCTRLQVLDLGNNSFS-GEVPDL-SMLHELSFLNLNSSGISGKFPWKSLENLTNLEF 137
++ + ++ L L N+ + G++ L EL FL+ + G++ +L L L+
Sbjct: 12 RNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---IANLPKLNKLKK 68
Query: 138 LSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTG-QIPEGIGNLTQLQNLELSDNEL 194
L L DN + K L L L+ + E + L L++L+L + E+
Sbjct: 69 LELSDNRVS-GGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-11
Identities = 35/115 (30%), Positives = 51/115 (44%), Gaps = 5/115 (4%)
Query: 152 MEVLKLEKLYWLYLTNC-SVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQ 210
+ + L L NC S G+I L+ L L + L + + KL KL +
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKK 75
Query: 211 LELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLE--GDLSELRFLNQLSSLHLFEN 263
LEL N + G L + L NL + ++S N+L+ L L+ L L SL LF
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 6e-07
Identities = 20/86 (23%), Positives = 36/86 (41%), Gaps = 3/86 (3%)
Query: 60 LQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLS-MLHELSFLNLNSS 118
L+ ++L L L +L+ L+L N G + L+ L L+ LNL+ +
Sbjct: 48 FVNLEFLSLINVGL--ISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN 105
Query: 119 GISGKFPWKSLENLTNLEFLSLGDNP 144
+ + L+ L L+ L L +
Sbjct: 106 KLKDISTLEPLKKLECLKSLDLFNCE 131
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 25/116 (21%), Positives = 43/116 (37%), Gaps = 9/116 (7%)
Query: 419 EASSLVSIQLSLNQFS-GQIPLDIGKLKKLSSLYLHDNMFS--GPLPYSIGSCVSLTDIN 475
+++ + L + + G+I + L L L + LP L +
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLE 77
Query: 476 FAQNSLSGKIPDSLGSLPSLNSLNLSNNKFS--GEIPISLTYPKLSLLDLSNNQLA 529
++N + G + LP+L LNLS NK + L LDL N ++
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 39/123 (31%), Positives = 47/123 (38%), Gaps = 7/123 (5%)
Query: 75 GTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTN 134
G I L+ L L N V +L L +L L L+ + I G E L N
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRIFGGLDM-LAEKLPN 96
Query: 135 LEFLSLGDNPFDPSPFPMEVLK-LEKLYWLYLTNCSVTGQI---PEGIGNLTQLQNLELS 190
L L+L N +E LK LE L L L NC VT L QL L+
Sbjct: 97 LTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGY 155
Query: 191 DNE 193
D E
Sbjct: 156 DRE 158
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 16/129 (12%)
Query: 167 NCSVTG--QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPV 224
CS G +P+GI L L N+ +P + L ++L NN +S L
Sbjct: 16 RCSNKGLKVLPKGIPRDVT--ELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSN 71
Query: 225 G-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEEFGEFKHLTE 281
FSN+T L+ +S NRL + F L L L L N S +PE G F L+
Sbjct: 72 QSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPE--GAFNDLSA 127
Query: 282 LS---LYTN 287
LS + N
Sbjct: 128 LSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 31/103 (30%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 133 TNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSD 191
++ L L N F + P E+ + L + L+N ++ + N+TQL L LS
Sbjct: 31 RDVTELYLDGNQF--TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSY 87
Query: 192 NELFGEIPAGIV-KLNKLWQLELYNNSLSGRLPVG-FSNLTNL 232
N L IP L L L L+ N +S +P G F++L+ L
Sbjct: 88 NRL-RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSAL 128
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 30/131 (22%), Positives = 48/131 (36%), Gaps = 30/131 (22%)
Query: 88 QVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDP 147
L L N F+ +LS L+ ++L+++ IS +S N+T L L L N
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN---- 88
Query: 148 SPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPAGIV-KL 205
+L + P L L+ L L N++ +P G L
Sbjct: 89 --------RLRCI--------------PPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDL 125
Query: 206 NKLWQLELYNN 216
+ L L + N
Sbjct: 126 SALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 25/84 (29%), Positives = 37/84 (44%), Gaps = 8/84 (9%)
Query: 449 SLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGE 508
LYL N F+ +P + + LT I+ + N +S S ++ L +L LS N+
Sbjct: 35 ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 509 IPI----SLTYPKLSLLDLSNNQL 528
IP L L LL L N +
Sbjct: 93 IPPRTFDGLK--SLRLLSLHGNDI 114
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 39/130 (30%), Positives = 57/130 (43%), Gaps = 23/130 (17%)
Query: 113 LNLNSSGISGKFPWKSLENLTNLEFLSLGDNP--------FDPSPFPMEVLKLEKLYWLY 164
L L+ + I+ K ++L NL+ L LG N FD L +L L
Sbjct: 45 LYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLGALPVGVFD---------SLTQLTVLD 94
Query: 165 LTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLP 223
L +T +P + L L+ L + N+L E+P GI +L L L L N L +P
Sbjct: 95 LGTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIP 151
Query: 224 VG-FSNLTNL 232
G F L++L
Sbjct: 152 HGAFDRLSSL 161
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 42/128 (32%), Positives = 57/128 (44%), Gaps = 10/128 (7%)
Query: 167 NCSVTG--QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPV 224
+C +P GI Q L L DN++ P L L +L L +N L LPV
Sbjct: 25 DCRSKRHASVPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPV 81
Query: 225 G-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEEFGEFKHLTE 281
G F +LT L D+ N+L L F L L L + N+ + E+P HLT
Sbjct: 82 GVFDSLTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTH 139
Query: 282 LSLYTNRL 289
L+L N+L
Sbjct: 140 LALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 43/157 (27%), Positives = 61/157 (38%), Gaps = 29/157 (18%)
Query: 133 TNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSD 191
TN + L L DN P L L LYL + + +P G+ +LTQL L+L
Sbjct: 40 TNAQILYLHDNQITKLE-PGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGT 97
Query: 192 NELFGEIPAGIV-KLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELR 250
N+L +P+ + +L L +L + N L+ LP G LT
Sbjct: 98 NQL-TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLT-------------------- 135
Query: 251 FLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTN 287
L+ L L +NQ F LT L+ N
Sbjct: 136 ---HLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 35/135 (25%), Positives = 58/135 (42%), Gaps = 10/135 (7%)
Query: 326 AMTDLLVLQNNFNGTVPET-YANCKSLIRFRVNNNSLSGTIPPGIW-SLPNLSIIDLSTN 383
+L L +N + + + +L + +N L +P G++ SL L+++DL TN
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 384 QFEG-P--VTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLD 440
Q P V D + + L L + N+ + ELP I + L + L NQ
Sbjct: 99 QLTVLPSAVFDRLVH---LKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGA 154
Query: 441 IGKLKKLSSLYLHDN 455
+L L+ YL N
Sbjct: 155 FDRLSSLTHAYLFGN 169
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 29/115 (25%), Positives = 44/115 (38%), Gaps = 7/115 (6%)
Query: 152 MEVLKLEKLYWLYLTNCSVTGQIPEGIG-NLTQLQNLELSDNELFGEIPAGIVKLNKLWQ 210
+ + L L + I E +G L Q ++ SDNE+ G L +L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VI-ENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 68
Query: 211 LELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLE--GDLSELRFLNQLSSLHLFEN 263
L + NN + L +L ++ N L GDL L L L+ L + N
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 21/114 (18%), Positives = 46/114 (40%), Gaps = 7/114 (6%)
Query: 60 LQALQKINLGTNFLYGTITEGL-KSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSS 118
++++L + + E L + + +D +N ++ +L L L +N++
Sbjct: 18 AVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNN 74
Query: 119 GISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLK-LEKLYWLYLTNCSVT 171
I + + L +L L L +N ++ L L+ L +L + VT
Sbjct: 75 RIC-RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 23/128 (17%), Positives = 44/128 (34%), Gaps = 10/128 (7%)
Query: 408 RFSGELPSKISEASSLVSIQ-LSL-NQFSGQIPLDIGKLKKLSSLYLHDNMFS--GPLPY 463
+ + EL + ++ ++ V + L L I L + ++ DN P
Sbjct: 3 KLTAELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP- 61
Query: 464 SIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFS--GEIPISLTYPKLSLL 521
L + N + +LP L L L+NN G++ + L+ L
Sbjct: 62 ---LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 118
Query: 522 DLSNNQLA 529
+ N +
Sbjct: 119 CILRNPVT 126
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 29/193 (15%), Positives = 66/193 (34%), Gaps = 32/193 (16%)
Query: 622 FSEKEII-DAVKP----ENLIGKGGSGNVYKVV---------LNSGKELAVKHIWPSNSG 667
++ D ++ + G +Y+ ++ ++K + +
Sbjct: 30 LPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGR 88
Query: 668 FRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDS-NLLVYEYLPN 726
+ +R+++ + + L + + + +D LV L
Sbjct: 89 LFNEQN-----FFQRAAKPLQVNKW-KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-- 140
Query: 727 G-SLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEW 784
G SL L K + +A LE+LH + + +H +V + NI +D E
Sbjct: 141 GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEY----VHGNVTAENIFVDPED 196
Query: 785 KPRI--ADFGLAK 795
+ ++ A +G A
Sbjct: 197 QSQVTLAGYGFAF 209
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 3e-10
Identities = 54/325 (16%), Positives = 101/325 (31%), Gaps = 18/325 (5%)
Query: 228 NLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFS-----GEIPEEFGEFKHLTEL 282
++ ++ + L S + L + P+ H+
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLC 302
Query: 283 SLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKT-GAMTDLLVLQNNFN--G 339
L L LPQ E +L P C+ L + +
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST 362
Query: 340 TVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSL 399
+ +CK L N TI I + L + + T +
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419
Query: 400 ALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSG 459
A L ++F E E + + + L+ + + + +L ++ L L N
Sbjct: 420 AYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA 477
Query: 460 PLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSG--EIPISLTYPK 517
LP ++ + L + + N+L + + +LP L L L NN+ I ++ P+
Sbjct: 478 -LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534
Query: 518 LSLLDLSNNQLAGPIPEPLNIKAFI 542
L LL+L N L + +
Sbjct: 535 LVLLNLQGNSLCQEEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 3e-10
Identities = 34/232 (14%), Positives = 75/232 (32%), Gaps = 15/232 (6%)
Query: 331 LVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVT 390
VL + A + L R ++ + + + S L ++ +
Sbjct: 331 CVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKW---CLL 386
Query: 391 DDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSL 450
I ++L LL K + + ++F + + + + L
Sbjct: 387 TIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVL 446
Query: 451 YLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIP 510
+L + + + + +T ++ + N L +P +L +L L L S+N +
Sbjct: 447 HLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD 502
Query: 511 ISLTYPKLSLLDLSNNQLAGPIPEPLNIKAFID----SFTGNPGLCSKTDEY 558
P+L L L NN+L + + + GN + +
Sbjct: 503 GVANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVLLNLQGNS--LCQEEGI 551
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 3e-08
Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 2/92 (2%)
Query: 54 FDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFL 113
+ L + ++L N L + L + L+VL +N+ V ++ L L L
Sbjct: 456 LCHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQEL 513
Query: 114 NLNSSGISGKFPWKSLENLTNLEFLSLGDNPF 145
L ++ + + L + L L+L N
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 5e-08
Identities = 38/236 (16%), Positives = 73/236 (30%), Gaps = 27/236 (11%)
Query: 78 TEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSL-ENLTNLE 136
+G + + + DL S + ++P + + + + K + + E
Sbjct: 290 PDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDE 349
Query: 137 FL-SLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQI-------------PEGIGNLT 182
L + + E+ ++L L N I E + +
Sbjct: 350 QLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS 409
Query: 183 QLQNLE--------LSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMN 234
L+ ++ ++ E ++ + L L + L+ L L + +
Sbjct: 410 TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTH 467
Query: 235 FDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290
D+S NRL L L L L +N + L EL L NRL
Sbjct: 468 LDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 58/388 (14%), Positives = 120/388 (30%), Gaps = 101/388 (26%)
Query: 63 LQKINLGTNFLYG----TITEGLKSCTRLQVLDLGNNSFS-------GEVPDLSMLHELS 111
++ +L + + ++ L ++ + L N+ E ++ +L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN--IASKKDLE 63
Query: 112 FLNLNSSGISGKFPW---------KSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYW 162
+ ++L L + L DN F P+ L
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT----AQEPLI---- 115
Query: 163 LYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRL 222
+ + T L++L L +N L G P K+ + L +++ +
Sbjct: 116 -------------DFLSKHTPLEHLYLHNNGL-G--PQAGAKIARA----LQELAVNKKA 155
Query: 223 PVGFSNLTNLMNFDVSQNRLEGD----LSE-LRFLNQLSSLHLFENQFSGE-----IPEE 272
N L + +NRLE ++ + L ++ + +N E + E
Sbjct: 156 ----KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211
Query: 273 FGEFKHLTELSLYTNRLTGT----LPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMT 328
+ L L L N T L L SW + + +++ LL+ GA
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA--------RGAAA 263
Query: 329 DLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSL--------PNLSIIDL 380
+ N L R+ N + + +L P+L ++L
Sbjct: 264 VVDAFSKLEN----------IGLQTLRLQYNEIE---LDAVRTLKTVIDEKMPDLLFLEL 310
Query: 381 STNQFEGPVTDDIGNAKSLALLLLANNR 408
+ N+F +++ + + R
Sbjct: 311 NGNRF----SEEDDVVDEIREVFSTRGR 334
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 53/395 (13%), Positives = 123/395 (31%), Gaps = 94/395 (23%)
Query: 178 IGNLTQLQNLELSDNELFGE----IPAGIVKLNKLWQLELYNNSLSGR----LPVGFSNL 229
+ + ++ L + + E + A +++ + + ++ L N++ L ++
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 230 TNLMNFDVSQNRLEGDLSE-----------LRFLNQLSSLHLFENQFSGEIPEEFGEF-- 276
+L + S E L +L ++ L +N F E +F
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 277 --KHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQ 334
L L L+ N L ++ L + + ++ +
Sbjct: 120 KHTPLEHLYLHNNGLG-----------PQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 335 NNF--NGTVP--ETYANCKSLIRFRVNNNSL-----SGTIPPGIWSLPNLSIIDLSTNQF 385
N +T+ + + L ++ N + + G+ L ++DL N F
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
Query: 386 EGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLK 445
+G + +LA+ L + +L + L+ S G
Sbjct: 229 -----THLG-SSALAIALKSW--------------PNLRELGLNDCLLS-----ARGAAA 263
Query: 446 KLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGK----IPDSLGS-LPSLNSLNL 500
+ + +N+ L + N + + + +P L L L
Sbjct: 264 VVDAFSKLENI-------------GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 310
Query: 501 SNNKFS--GEIPISL-----TYPKLSLLDLSNNQL 528
+ N+FS ++ + T + L +L + +
Sbjct: 311 NGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEE 345
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 53/279 (18%), Positives = 94/279 (33%), Gaps = 56/279 (20%)
Query: 61 QALQKINLGTNFL----------YGTITEGLKSCTRLQVLDLGNNSFSGE-----VPDLS 105
+ L+ F + + L C +L + L +N+F + LS
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 106 MLHELSFLNLNSSGISGK------------FPWKSLENLTNLEFLSLGDNPFDPS--PFP 151
L L L+++G+ + K +N L + G N +
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179
Query: 152 MEVLKL-EKLYWLYLTNCSVTGQ-----IPEGIGNLTQLQNLELSDNELFGE-----IPA 200
+ + L+ + + + + + EG+ +L+ L+L DN F +
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT-FTHLGSSALAI 238
Query: 201 GIVKLNKLWQLELYNNSLSGR----LPVGFSNLTN--LMNFDVSQNRLEGD----LSELR 250
+ L +L L + LS R + FS L N L + N +E D L +
Sbjct: 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 298
Query: 251 FLN--QLSSLHLFENQFS--GEIPEEFGE-FKHLTELSL 284
L L L N+FS ++ +E E F L
Sbjct: 299 DEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGEL 337
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 54/234 (23%), Positives = 89/234 (38%), Gaps = 58/234 (24%)
Query: 637 IGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695
IG G G +Y + + +E+A+K L ++ + E
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIK-------------------LENVKTKHPQLLYESKI 55
Query: 696 LSAVR-HVNVVKLYCSITSEDSNLLVYEYLPNG-SLWDRLHTC-HKIEMDWVVRYAIAVG 752
++ + + D N+LV + L G SL D + C K+ + V+ +A
Sbjct: 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLM--LADQ 111
Query: 753 AAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR---IADFGLAKIVQTGEAGDLTHV- 808
+E++H + +HRD+K N L+ L + I DFGLAK + H+
Sbjct: 112 MINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIP 166
Query: 809 ------IAGTHGYIAPEYAYTCKIN-----EKS---DVYSFGVVLMELVTGKRP 848
+ GT Y +N E+S D+ S G VLM + G P
Sbjct: 167 YRENKNLTGTARY--------ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 44/132 (33%), Positives = 55/132 (41%), Gaps = 15/132 (11%)
Query: 167 NCSVTG--QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPV 224
+C +P GI T+ L+L L A L KL L L N L L
Sbjct: 20 DCQGKSLDSVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSA 76
Query: 225 G-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEEFGEFKHLT- 280
G F +LT L ++ N+L L F L QL L+L NQ +P G F LT
Sbjct: 77 GVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPS--GVFDRLTK 132
Query: 281 --ELSLYTNRLT 290
EL L TN+L
Sbjct: 133 LKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 48/165 (29%), Positives = 70/165 (42%), Gaps = 25/165 (15%)
Query: 64 QKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGIS 121
+K++L + L + T+L L+L N + L EL L L ++ ++
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 122 GKFPWKSLENLTNLEFLSLGDN-----P---FDPSPFPMEVLKLEKLYWLYLTNCSVTGQ 173
P ++LT L+ L LG N P FD +L KL L L +
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFD---------RLTKLKELRLNTNQLQ-S 145
Query: 174 IPEGI-GNLTQLQNLELSDNELFGEIPAGIV-KLNKLWQLELYNN 216
IP G LT LQ L LS N+L +P G +L KL + L+ N
Sbjct: 146 IPAGAFDKLTNLQTLSLSTNQL-QSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 45/174 (25%), Positives = 71/174 (40%), Gaps = 25/174 (14%)
Query: 198 IPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRF--LNQL 255
+P+GI + +L+L + L+ F LT L ++ N+L+ LS F L +L
Sbjct: 29 VPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTEL 85
Query: 256 SSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQ----KLGSWADFNYVDVSEN 311
+L L NQ + F L +L L N+L +LP +L + ++ N
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRL---TKLKELRLNTN 141
Query: 312 LLTGPIPPDMCKTGA---MTDL--LVLQNNFNGTVPE-TYANCKSLIRFRVNNN 359
L IP GA +T+L L L N +VP + L + N
Sbjct: 142 QLQS-IPA-----GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 29/110 (26%), Positives = 38/110 (34%), Gaps = 15/110 (13%)
Query: 427 QLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSI-GSCVSLTDINFAQN---SLS 482
L + L KL+ L L N L + L + A N SL
Sbjct: 41 DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLASLP 99
Query: 483 GKIPDSLGSLPSLNSLNLSNNKFSGEIPI----SLTYPKLSLLDLSNNQL 528
+ D L L+ L L N+ +P LT KL L L+ NQL
Sbjct: 100 LGVFD---HLTQLDKLYLGGNQLK-SLPSGVFDRLT--KLKELRLNTNQL 143
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 33/134 (24%), Positives = 50/134 (37%), Gaps = 13/134 (9%)
Query: 402 LLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDI-GKLKKLSSLYLHDNMFSGP 460
L L + + + + L + L NQ + + L +L +L L +N +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS- 97
Query: 461 LPYSI-GSCVSLTDINFAQNSLSGKIPDSL-GSLPSLNSLNLSNNKFSGEIPI----SLT 514
LP + L + N L +P + L L L L+ N+ IP LT
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155
Query: 515 YPKLSLLDLSNNQL 528
L L LS NQL
Sbjct: 156 --NLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 21/83 (25%), Positives = 30/83 (36%), Gaps = 5/83 (6%)
Query: 449 SLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFS-- 506
L L + + LT +N N L L L +L L+NN+ +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASL 98
Query: 507 -GEIPISLTYPKLSLLDLSNNQL 528
+ LT +L L L NQL
Sbjct: 99 PLGVFDHLT--QLDKLYLGGNQL 119
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 43/204 (21%), Positives = 66/204 (32%), Gaps = 58/204 (28%)
Query: 257 SLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGP 316
L L + F LT L+L N+L TL
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLS---------------------- 75
Query: 317 IPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIW-SLPNL 375
G DL L + NN L+ ++P G++ L L
Sbjct: 76 -------AGVFDDL------------------TELGTLGLANNQLA-SLPLGVFDHLTQL 109
Query: 376 SIIDLSTNQFEG-P--VTDDIGNAKSLALLLLANNRFSGELPSKISEA-SSLVSIQLSLN 431
+ L NQ + P V D + L L L N+ +P+ + ++L ++ LS N
Sbjct: 110 DKLYLGGNQLKSLPSGVFDRLTK---LKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTN 165
Query: 432 QFSGQIPLDIGKLKKLSSLYLHDN 455
Q +L KL ++ L N
Sbjct: 166 QLQSVPHGAFDRLGKLQTITLFGN 189
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 45/229 (19%), Positives = 91/229 (39%), Gaps = 40/229 (17%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSK-RSSRSSEYDAEV 693
+G G V+ + + +A+K I + + +L + + +++ D+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM- 83
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNL----LVYEYLPNGSLWD--RLHTCHKIEMDWVVRY 747
+++KL + N +V+E L +L + + I + +V +
Sbjct: 84 ------GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI 136
Query: 748 AIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP------RIADFGLAKIVQTGE 801
+ + GL+Y+H +IH D+K N+L+++ P +IAD G A
Sbjct: 137 SKQL--LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWY 188
Query: 802 AGDLTHVIAGTHGYIAPE----YAYTCKINEKSDVYSFGVVLMELVTGK 846
T+ I Y +PE + C D++S ++ EL+TG
Sbjct: 189 DEHYTNSIQTRE-YRSPEVLLGAPWGCGA----DIWSTACLIFELITGD 232
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 42/130 (32%), Positives = 57/130 (43%), Gaps = 9/130 (6%)
Query: 163 LYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIV-KLNKLWQLELYNNSLSGR 221
L L S+ LT L L L N+L +P G+ KL L L L N L
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 222 LPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEE-FGEFK 277
LP G F LT L ++ N+L+ L + F L QL L L++NQ +P+ F
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLT 148
Query: 278 HLTELSLYTN 287
L + L+ N
Sbjct: 149 SLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 44/129 (34%), Positives = 58/129 (44%), Gaps = 11/129 (8%)
Query: 167 NCSVTG--QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPV 224
C G +P GI T L+L N L +L L QL L N L LP
Sbjct: 13 ECYSQGRTSVPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPN 69
Query: 225 G-FSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEE-FGEFKHLT 280
G F+ LT+L ++S N+L+ L F L QL L L NQ +P+ F + L
Sbjct: 70 GVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLK 127
Query: 281 ELSLYTNRL 289
+L LY N+L
Sbjct: 128 DLRLYQNQL 136
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 40/193 (20%), Positives = 80/193 (41%), Gaps = 32/193 (16%)
Query: 622 FSEKEIIDAV-----KPENLIGKGGSGNVYKVVLNSGKELAVKH-----IWPSNSGFRGD 671
F+ EII + K IG+GG G +Y +NS + + + PS++G
Sbjct: 23 FAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---- 78
Query: 672 YRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS----ITSEDSNLLVYEYLPNG 727
T + + + E + ++++ V K + S + ++ + G
Sbjct: 79 -PLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--G 135
Query: 728 -SLWDRLHTC-HKIEMDWVVRYAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLEW 784
L + V++ +++ LEY+H H + +H D+K+SN+LL+ +
Sbjct: 136 SDLQKIYEANAKRFSRKTVLQ--LSLRILDILEYIHEHEY----VHGDIKASNLLLNYKN 189
Query: 785 KPRI--ADFGLAK 795
++ D+GLA
Sbjct: 190 PDQVYLVDYGLAY 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 37/194 (19%), Positives = 78/194 (40%), Gaps = 35/194 (18%)
Query: 621 SFSEKEIIDAV-----KPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRS 674
F E +++D + IG GG G +Y N ++ A + + +Y+
Sbjct: 24 PFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV-------KVEYQE 76
Query: 675 STAILS-----KRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSE----DSNLLVYEYLP 725
+ + S +R ++ + + ++ + Y S +E +V E L
Sbjct: 77 NGPLFSELKFYQRVAKKDCIKKWI-ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL- 134
Query: 726 NG-SLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLH-HGFDRPVIHRDVKSSNILLDLE 783
G L + V++ + + LEY+H + + +H D+K++N+LL +
Sbjct: 135 -GIDLQKISGQNGTFKKSTVLQ--LGIRMLDVLEYIHENEY----VHGDIKAANLLLGYK 187
Query: 784 WKPRI--ADFGLAK 795
++ AD+GL+
Sbjct: 188 NPDQVYLADYGLSY 201
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 28/103 (27%), Positives = 46/103 (44%), Gaps = 6/103 (5%)
Query: 133 TNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-GNLTQLQNLELSD 191
+ L L DN +L L L L +TG I + +Q L+L +
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGE 87
Query: 192 NELFGEIPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNL 232
N++ EI + + L++L L LY+N +S + G F +L +L
Sbjct: 88 NKI-KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSL 128
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 28/128 (21%), Positives = 50/128 (39%), Gaps = 30/128 (23%)
Query: 167 NCSVTG--QIPEGIGNLTQLQNLELSDNELFGEIPAGIV-KLNKLWQLELYNNSLSGRLP 223
+C+ G +IP I T L L+DNEL G+ +L L +LEL N L+ +
Sbjct: 14 DCTGRGLKEIPRDIPLHTT--ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIE 70
Query: 224 VG-FSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTEL 282
F +++ + +N ++ + + F L L
Sbjct: 71 PNAFEGASHIQELQLGEN-------------KIKEIS----------NKMFLGLHQLKTL 107
Query: 283 SLYTNRLT 290
+LY N+++
Sbjct: 108 NLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 26/114 (22%), Positives = 39/114 (34%), Gaps = 21/114 (18%)
Query: 113 LNLNSSGISGKFPWKSLENLTNLEFLSLGDN-----P---FDPSPFPMEVLKLEKLYWLY 164
L LN + + L +L L L N F+ + L
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFE---------GASHIQELQ 84
Query: 165 LTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPAGIV-KLNKLWQLELYNN 216
L + +I + L QL+ L L DN++ + G LN L L L +N
Sbjct: 85 LGENKIK-EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 21/86 (24%), Positives = 32/86 (37%), Gaps = 10/86 (11%)
Query: 449 SLYLHDNMFSGPLPYSI-GSCVSLTDINFAQNSLSGKIPDSL-GSLPSLNSLNLSNNKFS 506
L L+DN + G L + +N L+ I + + L L NK
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 507 GEIPI----SLTYPKLSLLDLSNNQL 528
EI L +L L+L +NQ+
Sbjct: 92 -EISNKMFLGLH--QLKTLNLYDNQI 114
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 9e-08
Identities = 33/248 (13%), Positives = 59/248 (23%), Gaps = 47/248 (18%)
Query: 618 RVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTA 677
+ FS + ++ IG+G G V++ + +A+K I T
Sbjct: 9 GPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 678 ILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC---------------------------- 709
S+ + ++ R + L
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 710 --SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRP 767
+D +V E+ G L +I L
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLR-- 182
Query: 768 VIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKIN 827
HRD+ N+LL ++ K + G YT
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRL 231
Query: 828 EKSDVYSF 835
E+ + F
Sbjct: 232 ERDGIVVF 239
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 56/243 (23%), Positives = 92/243 (37%), Gaps = 59/243 (24%)
Query: 626 EIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSS 684
E++ +IGKG G V K + +A+K + + F IL
Sbjct: 100 EVLK------VIGKGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAAEEIRILEHLR- 151
Query: 685 RSSEYDAEVATLSAVRHVNVVKLYCS--------ITSE--DSNLLVYEYLPNGSLWDRLH 734
+ D + NV+ + + +T E NL YE +
Sbjct: 152 ---KQDKDNTM-------NVIHMLENFTFRNHICMTFELLSMNL--YELIKKNKF----- 194
Query: 735 TCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP--RIADFG 792
+ V ++A ++ + L+ LH +IH D+K NILL + + ++ DFG
Sbjct: 195 --QGFSLPLVRKFAHSI--LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
Query: 793 LAKIVQTGEAGDLTHVIAGTHGYIAPE----YAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+ E + I Y APE Y I D++S G +L EL+TG P
Sbjct: 248 SS----CYEHQRVYTYIQSRF-YRAPEVILGARYGMPI----DMWSLGCILAELLTGY-P 297
Query: 849 IVP 851
++P
Sbjct: 298 LLP 300
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 18/95 (18%), Positives = 31/95 (32%), Gaps = 5/95 (5%)
Query: 174 IPEGIGNLTQLQNLELSDNELFGEIPAGIVK-LNKLWQLELYNNSLSGRLPVG-FSNLTN 231
+ L L + + + + ++ L +L L + + L + F
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 232 LMNFDVSQNRLEGDLSELRFLN-QLSSLHLFENQF 265
L ++S N LE LS L L L N
Sbjct: 82 LSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 3e-06
Identities = 20/115 (17%), Positives = 34/115 (29%), Gaps = 8/115 (6%)
Query: 83 SCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGD 142
L + + L L+ L + + + L L L L++
Sbjct: 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 143 NPF---DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNEL 194
+ P F +L L L+ ++ + LQ L LS N L
Sbjct: 66 SGLRFVAPDAF----HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 21/93 (22%), Positives = 35/93 (37%), Gaps = 1/93 (1%)
Query: 437 IPLDIGKLKKLSSLYLHDNMFSGPLP-YSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSL 495
+ + L+ LY+ + L + L ++ ++ L PD+ P L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 496 NSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQL 528
+ LNLS N ++ L L LS N L
Sbjct: 83 SRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 19/96 (19%), Positives = 37/96 (38%), Gaps = 6/96 (6%)
Query: 54 FDSICGLQALQKINLGTNFLYGTITEG-LKSCTRLQVLDLGNNSFSGEVPD--LSMLHEL 110
+ G + L ++ + + L+ L+ L + + V L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRL 82
Query: 111 SFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFD 146
S LNL+ + + WK+++ L +L+ L L NP
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 16/103 (15%), Positives = 29/103 (28%), Gaps = 27/103 (26%)
Query: 197 EIPAGIVKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRFLNQL 255
+ + L +L + N L + L L N + ++ L
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR------------ 69
Query: 256 SSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKL 297
+ + F L+ L+L N L +L K
Sbjct: 70 ------------FVAPDAFHFTPRLSRLNLSFNALE-SLSWKT 99
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 5e-07
Identities = 41/350 (11%), Positives = 101/350 (28%), Gaps = 49/350 (14%)
Query: 206 NKLWQLELYNNSLS---GRL-------PVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQL 255
K W +++ + G+L FS+ + + L ++
Sbjct: 13 QKFWSIDVRGTDVIVNYGKLGTDGQTQVKNFSSAGEAEKAAGKLIAEKTKKGYVETLEEV 72
Query: 256 SSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLG--SWADFNYVDVSENLL 313
+ E + +E E +L + L +L +G + + D+++ ++
Sbjct: 73 AKEMKVEAKKYALSYDEAEEGVNLMDKILKDKKLPSLKQITIGXWGYEGEDCSDIADGIV 132
Query: 314 TGPIPPDMCKTGAMTDLLVLQNNF----NGTVPETYANCKSLIRFRVNNNSLSGTIPPGI 369
+ D+ + + L ++ + + G
Sbjct: 133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTN---NLSIGK 189
Query: 370 WSLPNLSIIDLSTNQFEGPVTDDIGNA-----KSLALLLLANNRFSGELPSKISEASSLV 424
PNL +++ + V +DI + + L L + + +
Sbjct: 190 KPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL---- 245
Query: 425 SIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCV---SLTDINFAQNSL 481
+ L L + D + L ++ + L
Sbjct: 246 --------------FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291
Query: 482 SGK----IPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQ 527
+ + + D + + L +N+ N S E+ L +D+S++Q
Sbjct: 292 TDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 7e-05
Identities = 30/193 (15%), Positives = 59/193 (30%), Gaps = 21/193 (10%)
Query: 75 GTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFP----WKSLE 130
++ L + L L + + L L + S G+ L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN--NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLP 219
Query: 131 NLTNLE-FLSLGDNPFDPSPFPMEVL----KLEKLYWLYLTNCSVTGQIPEGIGN---LT 182
NL L ++ + D FD L + L WL + + + E L
Sbjct: 220 NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279
Query: 183 QLQNLELSDNEL----FGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVS 238
QL+ +++S L + + K+ L + + N LS L + +
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS---DEMKKELQKSLPMKID 336
Query: 239 QNRLEGDLSELRF 251
+ + + +
Sbjct: 337 VSDSQEYDDDYSY 349
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 38/114 (33%), Positives = 51/114 (44%), Gaps = 22/114 (19%)
Query: 113 LNLNSSGISGKFPWKSLENLTNLEFLSLGDN-----P---FDPSPFPMEVLKLEKLYWLY 164
L L S+ + P + LT L LSL N P FD KL KL LY
Sbjct: 33 LELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFD---------KLTKLTILY 82
Query: 165 LTNCSVTGQIPEGI-GNLTQLQNLELSDNELFGEIPAGIV-KLNKLWQLELYNN 216
L + +P G+ LTQL+ L L N+L +P GI +L L ++ L+ N
Sbjct: 83 LHENKLQ-SLPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 11/97 (11%)
Query: 198 IPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LN 253
+P GI +L L +N L LP G F LT L +SQN+++ L + F L
Sbjct: 22 VPTGIPSSATRLE---LESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLT 76
Query: 254 QLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRL 289
+L+ L+L EN+ +P F + L EL+L TN+L
Sbjct: 77 KLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL 112
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 28/103 (27%), Positives = 44/103 (42%), Gaps = 17/103 (16%)
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP--RIADFGLAKIVQTGEAGDLTHVIAGT 812
L +L + +IH D+K NILL + +I DFG + + I
Sbjct: 168 TALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSR 222
Query: 813 HGYIAPE----YAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
Y +PE Y I D++S G +L+E+ TG+ P+
Sbjct: 223 F-YRSPEVLLGMPYDLAI----DMWSLGCILVEMHTGE-PLFS 259
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 39/257 (15%), Positives = 75/257 (29%), Gaps = 43/257 (16%)
Query: 63 LQKINLGTNFLYGT----ITEGLKSC-TRLQVLDLGNNSFSGE-VPDLS-MLHE----LS 111
+ ++LG N + + + L+L N + +L +L ++
Sbjct: 111 ITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVN 170
Query: 112 FLNLNSSGIS---GKFPWKSLENL-TNLEFLSLGDNPFDPSPFPM--EVLKL--EKLYWL 163
LNL + ++ K L ++ ++ L L N + + + L
Sbjct: 171 SLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSL 230
Query: 164 YLTNCSVTGQ----IPEGIGNLTQLQNLELSDNELFGEIPAGIVKL-------NKLWQLE 212
L + G + +L LQ + L + + L K+ ++
Sbjct: 231 NLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVD 290
Query: 213 LYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEE 272
+ P ++NL+ L G LNQ L Q E+
Sbjct: 291 KNGKEIH---PSHSIPISNLIR------ELSGKADVPSLLNQC----LIFAQKHQTNIED 337
Query: 273 FGEFKHLTELSLYTNRL 289
L E L
Sbjct: 338 LNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 44/260 (16%), Positives = 83/260 (31%), Gaps = 53/260 (20%)
Query: 77 ITEGLKSCTRLQVLDLGNNSFSGE-VPDLS-MLHE----LSFLNLNSSGISGKFPWKSL- 129
+ E + LDL N+ +L ++ LNL+ + + K L
Sbjct: 14 VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK-NSDELV 72
Query: 130 ----ENLTNLEFLSLGDNPFDPSPFP--MEVLKLEK--LYWLYLTNCSVTGQIPEGIGNL 181
N+ L+L N ++ L + L L + +
Sbjct: 73 QILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS---SKSSSEF 129
Query: 182 --------TQLQNLELSDNELFGE----IPAGIVKLN-KLWQLELYNNSLSGR------- 221
+ +L L N+L + + + + + L L N+L+ +
Sbjct: 130 KQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAK 189
Query: 222 -LPVGFSNLTNLMNFDVSQNRLEGD----LSE-LRFLN-QLSSLHLFENQFSGEIPEEFG 274
L +++T+L D+S N L L+ + + SL+L N G E
Sbjct: 190 FLASIPASVTSL---DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLK 246
Query: 275 EF----KHLTELSLYTNRLT 290
KHL + L + +
Sbjct: 247 LLKDSLKHLQTVYLDYDIVK 266
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 39/184 (21%), Positives = 59/184 (32%), Gaps = 51/184 (27%)
Query: 719 LVYEYL-PNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777
+V+E L + W + + V + V +GL+YLH +IH D+K N
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQV--LQGLDYLHT--KCRIIHTDIKPEN 177
Query: 778 ILLDLE-----------------------------------------WKPRIADFGLAKI 796
ILL + +P+ A+ KI
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237
Query: 797 VQTGEA----GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
G A T I T Y + E N +D++S + EL TG P
Sbjct: 238 ADLGNACWVHKHFTEDI-QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296
Query: 853 FGDS 856
G+
Sbjct: 297 SGEE 300
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 32/187 (17%), Positives = 66/187 (35%), Gaps = 22/187 (11%)
Query: 621 SFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILS 680
+DA+ L+G+G V+ E VK ++ F+ +
Sbjct: 84 RLVRSGKVDAI--GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFK-KVKEKRDYGD 140
Query: 681 KRSSRSSEYDA--EVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK 738
S + A E L ++ + V K+Y + N ++ E + + R+ +
Sbjct: 141 LHFSVLAIRSARNEFRALQKLQGLAVPKVYAW----EGNAVLMELI-DAKELYRVRVENP 195
Query: 739 IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798
E+ ++ +A +G+ +H D+ N+L+ E I DF + V
Sbjct: 196 DEVLDMILEEVAKFYHRGI-----------VHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 243
Query: 799 TGEAGDL 805
++
Sbjct: 244 EEGWREI 250
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 50/266 (18%), Positives = 87/266 (32%), Gaps = 33/266 (12%)
Query: 60 LQALQKINLGTNFLYG----TITEGLKSCT-RLQVLDLGNNSFSGE--VPDLSMLHELSF 112
L +L+++NL + + L S L ++L + L +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 113 LNLNSSGIS---GKFPWKSL-ENLTNLEFLSLGDNPFDPS--PFPMEVLKL-EKLYWLYL 165
L L + + K L + + L L +NP + ME L + L L
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSL 190
Query: 166 TNCSVTGQ----IPEGIGNLTQLQNLELSDNELFGEIPAGIVKL-------NKLWQLELY 214
+ + + + + QLQ L ++ N + L L L LY
Sbjct: 191 LHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA---GDTAALALARAAREHPSLELLHLY 247
Query: 215 NNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFG 274
N LS G L +L R+ L+E +++ S+ L E Q + +
Sbjct: 248 FNELS---SEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRAR 304
Query: 275 EFKH--LTELSLYTNRLTGTLPQKLG 298
+H L L +R P +
Sbjct: 305 VQRHLELLLRDLEDSRGATLNPWRKA 330
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 35/234 (14%), Positives = 73/234 (31%), Gaps = 31/234 (13%)
Query: 60 LQALQKINLGTNFL----YGTITEGLKS-CTRLQVLDLGNNSFSGE-VPDLS-MLHE--- 109
+K+ L N L + + L ++ L L NN + V L L
Sbjct: 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS 184
Query: 110 LSFLNLNSSGIS---GKFPWKSLENLTNLEFLSLGDNPFDPS--PFPMEVLKL-EKLYWL 163
++ L+L +G+ + L+ L+ L++ N + + L L
Sbjct: 185 VTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELL 244
Query: 164 YLTNCSVT----GQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLS 219
+L ++ + + G + +S E V L++ ++ NS
Sbjct: 245 HLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSE---VQRNLNSW- 300
Query: 220 GRLPVGFSNLTNLMNFDVSQNRLEGD----LSE-LRFLNQLSSLHLFENQFSGE 268
L+ D+ +R ++ LR ++ +L
Sbjct: 301 --DRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSGSP 352
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 33/95 (34%), Positives = 44/95 (46%), Gaps = 11/95 (11%)
Query: 198 IPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LN 253
+P GI L+ LY+N ++ +L G F LT L D+ N+L L F L
Sbjct: 24 VPTGIPTTTQVLY---LYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLT 78
Query: 254 QLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTN 287
QL+ L L +NQ IP F K LT + L N
Sbjct: 79 QLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 90/549 (16%), Positives = 149/549 (27%), Gaps = 95/549 (17%)
Query: 81 LKSCTRLQVLDLGNNSFSGEVPD-----LSMLHELSFLNLNSSGISGKFPWKSLENLTNL 135
LK +L + + G V S L + L ++ ++ N
Sbjct: 73 LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNF 132
Query: 136 EFLSLGDNP-FDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIG----NLTQLQNLELS 190
+ L L F L L L V + T L +L +S
Sbjct: 133 KVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNIS 192
Query: 191 DNELFGEI-PAGIVKL----NKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGD 245
L E+ + + +L L L+L +L L E
Sbjct: 193 C--LASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVR 250
Query: 246 -------LSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSL-YTNRLTGTLPQKL 297
L +L L F + +P + LT L+L Y + L + L
Sbjct: 251 PDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLL 310
Query: 298 GSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVN 357
C + L VL + + + CK L RV
Sbjct: 311 CQ----------------------CP--KLQRLWVLDYIEDAGLEVLASTCKDLRELRVF 346
Query: 358 N-NSLSGTIPPGI---------WSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANN 407
+ P L + Q +T+ AL+ +A N
Sbjct: 347 PSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQ----MTNA-------ALITIARN 395
Query: 408 RFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIG------KLKKLSSLYLHDNMFSGPL 461
R L I+ + PLDIG K L L L +
Sbjct: 396 R-------PNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVF 448
Query: 462 PYSIGSCVSLTDINFAQNSLSGK-IPDSLGSLPSLNSLNLSNNKFS--GEIPISLTYPKL 518
Y + ++ A S + L SL L + + F + + +
Sbjct: 449 EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETM 508
Query: 519 SLLDLSNNQ--------LAGPIPEPLNIKAFIDSFTGNPGLCSKTDEYFKSCSSGSGRSH 570
L +S+ L +P+ LN++ + + S E + +G
Sbjct: 509 RSLWMSSCSVSFGACKLLGQKMPK-LNVEVIDERGAPDSRPESCPVERVFIYRTVAGPRF 567
Query: 571 HVSTFVWCL 579
+ FVW +
Sbjct: 568 DMPGFVWNM 576
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 33/95 (34%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 198 IPAGI-VKLNKLWQLELYNNSLSGRLPVG-FSNLTNLMNFDVSQNRLEGDLSELRF--LN 253
+PAGI +LW L NN ++ +L G F +L NL + N+L + F L
Sbjct: 27 VPAGIPTDKQRLW---LNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLT 81
Query: 254 QLSSLHLFENQFSGEIPE-EFGEFKHLTELSLYTN 287
QL+ L L +N IP F K LT + LY N
Sbjct: 82 QLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 947 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.58 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.34 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.33 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.32 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.31 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.19 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.07 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.98 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.93 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.88 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.44 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.38 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.37 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.35 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.3 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.27 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.17 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.06 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.94 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.89 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.8 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.76 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.39 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.35 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.26 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.24 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.14 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.11 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.04 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.96 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.81 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.61 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.59 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.47 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.36 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.26 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.73 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.34 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.26 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.52 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.42 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 86.35 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-76 Score=722.19 Aligned_cols=555 Identities=31% Similarity=0.511 Sum_probs=428.2
Q ss_pred CCcccccccCCccccccccCCCCCcccceeeeCCCCceeEeccCCCccccc---cCc----------------------c
Q 002250 1 MNLKSKIEKSDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGV---VPF----------------------D 55 (947)
Q Consensus 1 ~~~k~~~~~~~~~~~~sw~~~~~~C~w~gv~c~~~~~v~~l~l~~~~~~~~---~~~----------------------~ 55 (947)
|.||++++ |+. +++||+.++|||.|.||+|+ +|+|++++|++.++.|. ++. .
T Consensus 18 l~~k~~~~-~~~-~l~~W~~~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~~l~~ 94 (768)
T 3rgz_A 18 ISFKDVLP-DKN-LLPDWSSNKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS 94 (768)
T ss_dssp HHHHTTCS-CTT-SSTTCCTTSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEEECCC
T ss_pred HHHHhhCC-Ccc-cccCCCCCCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcCCCch
Confidence 46999996 666 99999989999999999999 79999999999988876 432 4
Q ss_pred cccCCcccceeeccCccccCcCch--hhhcCCCccEEeCcCccCcCCCCC-c-ccccccceeecCCCCccC---------
Q 002250 56 SICGLQALQKINLGTNFLYGTITE--GLKSCTRLQVLDLGNNSFSGEVPD-L-SMLHELSFLNLNSSGISG--------- 122 (947)
Q Consensus 56 ~~~~l~~L~~L~L~~n~i~~~~~~--~l~~l~~L~~L~Ls~n~i~~~~~~-l-~~l~~L~~L~L~~n~i~~--------- 122 (947)
.++.+++|++|+|++|.+.+.+|. .++.+++|++|||++|.+++..+. + ..+++|++|+|++|++++
T Consensus 95 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~ 174 (768)
T 3rgz_A 95 GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS 174 (768)
T ss_dssp CCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHT
T ss_pred hhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhh
Confidence 688899999999999999998888 899999999999999988765543 2 445555555555544433
Q ss_pred ----------------------------------------ccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcE
Q 002250 123 ----------------------------------------KFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYW 162 (947)
Q Consensus 123 ----------------------------------------~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~ 162 (947)
.+| .+.++++|++|+|++|.+... +|..+..+++|++
T Consensus 175 ~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~l~~l~~L~~L~Ls~n~l~~~-~~~~l~~l~~L~~ 251 (768)
T 3rgz_A 175 DGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIP--FLGDCSALQHLDISGNKLSGD-FSRAISTCTELKL 251 (768)
T ss_dssp TCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCC--BCTTCCSCCEEECCSSCCCSC-HHHHTTTCSSCCE
T ss_pred ccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCc--ccccCCCCCEEECcCCcCCCc-ccHHHhcCCCCCE
Confidence 222 144444444444444444321 2333444444444
Q ss_pred EEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCC-CCCcEEEeecccccccCCccCCCCCCccEEeccCCC
Q 002250 163 LYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKL-NKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNR 241 (947)
Q Consensus 163 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 241 (947)
|++++|.+++.+|.. .+++|++|+|++|++++.+|..+... ++|++|+|++|.+++.+|..|..+++|++|+|++|+
T Consensus 252 L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 329 (768)
T 3rgz_A 252 LNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329 (768)
T ss_dssp EECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSE
T ss_pred EECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCc
Confidence 444444444333221 23333333333333333444444443 555666666666555555555555555555555555
Q ss_pred CCC-CCcc-ccccC-------------------------CCCEEEccCccCcccCCCCccC--CCcCcEEEccCcccccc
Q 002250 242 LEG-DLSE-LRFLN-------------------------QLSSLHLFENQFSGEIPEEFGE--FKHLTELSLYTNRLTGT 292 (947)
Q Consensus 242 l~~-~~~~-l~~l~-------------------------~L~~L~L~~N~i~~~~~~~~~~--l~~L~~L~L~~N~l~~~ 292 (947)
+++ .+.. +..++ +|+.|+|++|++++.+|..+.. +++|++|++++|++++.
T Consensus 330 l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~ 409 (768)
T 3rgz_A 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409 (768)
T ss_dssp EEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEE
T ss_pred ccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccc
Confidence 542 2222 44444 4555555555555545555544 66788888888888888
Q ss_pred CCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCC
Q 002250 293 LPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSL 372 (947)
Q Consensus 293 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l 372 (947)
+|..++.+++|++|++++|.+++.+|..+..+.+|+.|.+.+|.+.+.+|..+..+++|+.|++++|++++.+|..+..+
T Consensus 410 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 489 (768)
T 3rgz_A 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred cCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcC
Confidence 88899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCccc-----------
Q 002250 373 PNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDI----------- 441 (947)
Q Consensus 373 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----------- 441 (947)
++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.+|..+
T Consensus 490 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~ 569 (768)
T 3rgz_A 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF 569 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCST
T ss_pred CCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhc
Confidence 999999999999999999999999999999999999999999999999999999999999998777644
Q ss_pred -----------------------------------------------------------ccccccchhhccccccCCCCC
Q 002250 442 -----------------------------------------------------------GKLKKLSSLYLHDNMFSGPLP 462 (947)
Q Consensus 442 -----------------------------------------------------------~~l~~L~~L~Ls~N~l~~~~p 462 (947)
+.+++|+.|+|++|+++|.+|
T Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip 649 (768)
T 3rgz_A 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649 (768)
T ss_dssp TCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCC
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCC
Confidence 335778999999999999999
Q ss_pred cccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc-ccccceeeCCCCcCCCCCCCcccc-cc
Q 002250 463 YSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQLAGPIPEPLNI-KA 540 (947)
Q Consensus 463 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N~l~~~~p~~~~~-~~ 540 (947)
..|+.+++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+. +++|++|||++|+|+|.||+..++ .+
T Consensus 650 ~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~ 729 (768)
T 3rgz_A 650 KEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGS
T ss_pred HHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccC
Confidence 9999999999999999999999999999999999999999999999999886 599999999999999999987664 44
Q ss_pred cccccccCCCCCCCCccccCccCCCC
Q 002250 541 FIDSFTGNPGLCSKTDEYFKSCSSGS 566 (947)
Q Consensus 541 ~~~~~~gN~~~c~~~~~~~~~~~s~~ 566 (947)
...+|.|||++||.+.. .|.+..
T Consensus 730 ~~~~~~gN~~Lcg~~l~---~C~~~~ 752 (768)
T 3rgz_A 730 PPAKFLNNPGLCGYPLP---RCDPSN 752 (768)
T ss_dssp CGGGGCSCTEEESTTSC---CCCSCC
T ss_pred CHHHhcCCchhcCCCCc---CCCCCc
Confidence 56689999999998854 687643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-60 Score=585.36 Aligned_cols=488 Identities=32% Similarity=0.537 Sum_probs=386.4
Q ss_pred CceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCC-cccccccceee
Q 002250 36 GLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLN 114 (947)
Q Consensus 36 ~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~-l~~l~~L~~L~ 114 (947)
...+.++++++.+.+..+ +..+++|+.|+|++|.+.+.+|. ++.+++|++|+|++|.+++..+. +..+++|++|+
T Consensus 178 ~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~ 253 (768)
T 3rgz_A 178 GELKHLAISGNKISGDVD---VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLN 253 (768)
T ss_dssp TTCCEEECCSSEEESCCB---CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEE
T ss_pred CCCCEEECCCCcccccCC---cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEE
Confidence 457777787777777655 36777788888888888777766 77788888888888887765553 77778888888
Q ss_pred cCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhccc-ccCcEEEccCccccccCCccCCCCCCCCEEECcCcc
Q 002250 115 LNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKL-EKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNE 193 (947)
Q Consensus 115 L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 193 (947)
|++|.+.+.+|. . .+++|++|+|++|.+... +|..+..+ ++|++|+|++|.+++.+|..|+++++|++|+|++|+
T Consensus 254 Ls~n~l~~~~~~--~-~l~~L~~L~L~~n~l~~~-ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 329 (768)
T 3rgz_A 254 ISSNQFVGPIPP--L-PLKSLQYLSLAENKFTGE-IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329 (768)
T ss_dssp CCSSCCEESCCC--C-CCTTCCEEECCSSEEEES-CCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSE
T ss_pred CCCCcccCccCc--c-ccCCCCEEECcCCccCCc-cCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCc
Confidence 888877766652 1 677788888888877532 45555553 778888888888877777777778888888888887
Q ss_pred cccccCcc-ccCCCCCcEEEeecccccccCCccCCCCC-CccEEeccCCCCCC-CCccccc--cCCCCEEEccCccCccc
Q 002250 194 LFGEIPAG-IVKLNKLWQLELYNNSLSGRLPVGFSNLT-NLMNFDVSQNRLEG-DLSELRF--LNQLSSLHLFENQFSGE 268 (947)
Q Consensus 194 l~~~~~~~-l~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~-~~~~l~~--l~~L~~L~L~~N~i~~~ 268 (947)
+++.+|.. +.++++|++|+|++|.+++.+|..+.+++ +|++|++++|++++ .+..+.. +++|++|+|++|++++.
T Consensus 330 l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~ 409 (768)
T 3rgz_A 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409 (768)
T ss_dssp EEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEE
T ss_pred ccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccc
Confidence 77667655 77777788888888887777777777776 77888888777765 2334444 66777777777777777
Q ss_pred CCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCC
Q 002250 269 IPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANC 348 (947)
Q Consensus 269 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l 348 (947)
+|..+..+++|++|+|++|++++.+|..++.+++|+.|++++|.+++.+|..+..+..|+.|++.+|++.+.+|..+.++
T Consensus 410 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 489 (768)
T 3rgz_A 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred cCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcC
Confidence 77777777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCC-------------
Q 002250 349 KSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPS------------- 415 (947)
Q Consensus 349 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~------------- 415 (947)
++|+.|++++|++++.+|.+++.+++|++|+|++|++.+.+|..++.+++|++|++++|+++|.+|.
T Consensus 490 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~ 569 (768)
T 3rgz_A 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF 569 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCST
T ss_pred CCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhc
Confidence 7777777777777777777777777777777777777777777777777777777777777766554
Q ss_pred ---------------------------------------------------------CCCCCCcceEEEcccCcccCCCC
Q 002250 416 ---------------------------------------------------------KISEASSLVSIQLSLNQFSGQIP 438 (947)
Q Consensus 416 ---------------------------------------------------------~~~~l~~L~~L~Ls~N~l~~~~p 438 (947)
.+..+++|+.|||++|+++|.+|
T Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip 649 (768)
T 3rgz_A 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649 (768)
T ss_dssp TCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCC
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCC
Confidence 44556789999999999999999
Q ss_pred cccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccccccc
Q 002250 439 LDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKL 518 (947)
Q Consensus 439 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L 518 (947)
..|+++++|+.|+|++|+++|.+|..|+.+++|+.|||++|+++|.+|..+.++++|++|||++|+++|.+|....+..+
T Consensus 650 ~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~ 729 (768)
T 3rgz_A 650 KEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGS
T ss_pred HHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987777777
Q ss_pred ceeeCCCCc-CCCC
Q 002250 519 SLLDLSNNQ-LAGP 531 (947)
Q Consensus 519 ~~L~ls~N~-l~~~ 531 (947)
....+.+|+ |+|.
T Consensus 730 ~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 730 PPAKFLNNPGLCGY 743 (768)
T ss_dssp CGGGGCSCTEEEST
T ss_pred CHHHhcCCchhcCC
Confidence 778888886 6663
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=553.30 Aligned_cols=524 Identities=20% Similarity=0.188 Sum_probs=410.7
Q ss_pred CceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCC-cccccccceee
Q 002250 36 GLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLN 114 (947)
Q Consensus 36 ~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~-l~~l~~L~~L~ 114 (947)
.+++.++|+++++.+.. ...|.++++|+.|+|++|.+.+..|..|..+++|++|+|++|.+++.++. ++.+++|++|+
T Consensus 25 ~~l~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLP-AANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCCCCC-GGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEECCCCCCCCcC-HHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 47899999999887654 46799999999999999999999999999999999999999999987774 99999999999
Q ss_pred cCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCC--CCCCCCEEECcCc
Q 002250 115 LNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIG--NLTQLQNLELSDN 192 (947)
Q Consensus 115 L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~Ls~N 192 (947)
|++|++++..+ ..|.++++|++|+|++|.+... .+..+.++++|++|++++|.+++..+..+. .+++|++|+|++|
T Consensus 104 L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n 181 (680)
T 1ziw_A 104 LMSNSIQKIKN-NPFVKQKNLITLDLSHNGLSST-KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181 (680)
T ss_dssp CCSSCCCCCCS-CTTTTCTTCCEEECCSSCCSCC-CCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTC
T ss_pred CCCCccCccCh-hHccccCCCCEEECCCCccccc-CchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCC
Confidence 99999986544 7899999999999999999765 356678899999999999999977776654 5588999999999
Q ss_pred ccccccCccccCC---------------------------CCCcEEEeecccccccCCccCCCCCC--ccEEeccCCCCC
Q 002250 193 ELFGEIPAGIVKL---------------------------NKLWQLELYNNSLSGRLPVGFSNLTN--LMNFDVSQNRLE 243 (947)
Q Consensus 193 ~l~~~~~~~l~~l---------------------------~~L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~Ls~N~l~ 243 (947)
++++..|..+..+ ++|++|++++|.+++..|..|..++. |++|+|++|+++
T Consensus 182 ~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~ 261 (680)
T 1ziw_A 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN 261 (680)
T ss_dssp CCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCC
T ss_pred cccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcC
Confidence 8887777666543 45667777777777777777777654 788888887777
Q ss_pred CCC-ccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccc-----cCCc----CccCcccccccccccccc
Q 002250 244 GDL-SELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTG-----TLPQ----KLGSWADFNYVDVSENLL 313 (947)
Q Consensus 244 ~~~-~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-----~~p~----~l~~l~~L~~L~Ls~N~l 313 (947)
+.+ ..+..+++|++|+|++|++++..|..|..+++|++|++++|...+ .+|. .|..+++|++|++++|.+
T Consensus 262 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l 341 (680)
T 1ziw_A 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDI 341 (680)
T ss_dssp EECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCB
T ss_pred ccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCcc
Confidence 654 346777777778887777777666666666666666665544332 1221 445555555555555555
Q ss_pred cCCCCCCcccCC----------------------------ccceeeecccccCCcCCccccCCCCccEEEcccccccccC
Q 002250 314 TGPIPPDMCKTG----------------------------AMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTI 365 (947)
Q Consensus 314 ~~~~p~~~~~~~----------------------------~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 365 (947)
++..+..+..+. .++.|++.+|++.+..|..|..+++|+.|++++|.+++.+
T Consensus 342 ~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 421 (680)
T 1ziw_A 342 PGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421 (680)
T ss_dssp CCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEEC
T ss_pred CCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCcccc
Confidence 554444444444 4555555666666677777888888888888888887666
Q ss_pred C-CCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCcccc--ccCCCCCCCCCcceEEEcccCcccCCCCcccc
Q 002250 366 P-PGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFS--GELPSKISEASSLVSIQLSLNQFSGQIPLDIG 442 (947)
Q Consensus 366 p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 442 (947)
| ..+..+++|++|++++|++.+..+..|..+++|+.|++++|.++ +.+|..+..+++|+.|+|++|++++..|..|.
T Consensus 422 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~ 501 (680)
T 1ziw_A 422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501 (680)
T ss_dssp CSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhc
Confidence 5 46777888888888888888777788888888888888888876 56788899999999999999999988788899
Q ss_pred cccccchhhccccccCCCCC--------cccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc
Q 002250 443 KLKKLSSLYLHDNMFSGPLP--------YSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT 514 (947)
Q Consensus 443 ~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 514 (947)
++++|++|+|++|++++..+ ..|..+++|+.|+|++|+++...+..|.++++|+.|+|++|++++.++..+.
T Consensus 502 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~ 581 (680)
T 1ziw_A 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581 (680)
T ss_dssp TCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred cccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhC
Confidence 99999999999999986522 2478899999999999999955455799999999999999999987777664
Q ss_pred -ccccceeeCCCCcCCCCCCCccc---ccccccccccCCCCCCCCc-cccCcc
Q 002250 515 -YPKLSLLDLSNNQLAGPIPEPLN---IKAFIDSFTGNPGLCSKTD-EYFKSC 562 (947)
Q Consensus 515 -~~~L~~L~ls~N~l~~~~p~~~~---~~~~~~~~~gN~~~c~~~~-~~~~~~ 562 (947)
+++|+.|+|++|+|++.+|..+. .......+.||||.|+|.. .|+...
T Consensus 582 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~ 634 (680)
T 1ziw_A 582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNW 634 (680)
T ss_dssp TCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEECC
T ss_pred CCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHHHH
Confidence 69999999999999998876442 2334557889999999986 776443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-57 Score=540.49 Aligned_cols=492 Identities=18% Similarity=0.179 Sum_probs=403.6
Q ss_pred ccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCC-cccccccceeecCCCCccCccCcccccccCCCceeeC
Q 002250 62 ALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSL 140 (947)
Q Consensus 62 ~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~L 140 (947)
.++.|+|++|.|++..|..|..+++|++|+|++|++++..|. +..+++|++|+|++|++++..| ..|.++++|++|+|
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAE-TALSGPKALKHLFF 112 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECT-TTTSSCTTCCEEEC
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccCh-hhhcccccccEeec
Confidence 567777777777777777777777777777777777766543 7777777777777777775545 56777777777777
Q ss_pred CCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCc--EEEeecccc
Q 002250 141 GDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLW--QLELYNNSL 218 (947)
Q Consensus 141 s~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~--~L~L~~n~l 218 (947)
++|.++..+ +..+..+++|++|++++|.+++..+..+..+++|++|+|++|.+++..|..+..+++|+ .|++++|.+
T Consensus 113 ~~n~i~~l~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l 191 (606)
T 3t6q_A 113 IQTGISSID-FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191 (606)
T ss_dssp TTSCCSCGG-GSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred cccCcccCC-cchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence 777776532 34466777777777777777764434444577777777777777766677777777777 777777777
Q ss_pred cccCCccCCCCCCccEEeccCCCC---------------------CC-----C-CccccccC--CCCEEEccCccCcccC
Q 002250 219 SGRLPVGFSNLTNLMNFDVSQNRL---------------------EG-----D-LSELRFLN--QLSSLHLFENQFSGEI 269 (947)
Q Consensus 219 ~~~~~~~~~~l~~L~~L~Ls~N~l---------------------~~-----~-~~~l~~l~--~L~~L~L~~N~i~~~~ 269 (947)
++..|..|.. .+|++|++++|.. .. . ...+..+. +|+.|++++|.+++..
T Consensus 192 ~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~ 270 (606)
T 3t6q_A 192 AGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270 (606)
T ss_dssp CEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCC
T ss_pred CccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccC
Confidence 7666665544 5677777776641 10 0 11122222 7899999999999888
Q ss_pred CCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCc-cccCC
Q 002250 270 PEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPE-TYANC 348 (947)
Q Consensus 270 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~-~~~~l 348 (947)
+..|..+++|++|++++|+++ .+|..++.+++|++|++++|.+++..|..+..++.|+.|.+.+|.+.+.+|. .+..+
T Consensus 271 ~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l 349 (606)
T 3t6q_A 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL 349 (606)
T ss_dssp TTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTC
T ss_pred HHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhcc
Confidence 888999999999999999999 8899999999999999999999988888999999999999999999877764 58999
Q ss_pred CCccEEEcccccccccC--CCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCC-CCCCCcceE
Q 002250 349 KSLIRFRVNNNSLSGTI--PPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSK-ISEASSLVS 425 (947)
Q Consensus 349 ~~L~~L~L~~n~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~ 425 (947)
++|+.|++++|.+++.. +..+..+++|+.|++++|++.+..+..|..+++|++|++++|++++..|.. +..+++|+.
T Consensus 350 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 429 (606)
T 3t6q_A 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429 (606)
T ss_dssp TTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCE
T ss_pred CcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCE
Confidence 99999999999999776 788999999999999999999999999999999999999999999776654 899999999
Q ss_pred EEcccCcccCCCCcccccccccchhhccccccCCC---CCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCC
Q 002250 426 IQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGP---LPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSN 502 (947)
Q Consensus 426 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 502 (947)
|++++|.+++..|..++.+++|+.|+|++|++++. .+..+..+++|+.|+|++|++++..|..|.++++|+.|+|++
T Consensus 430 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 509 (606)
T 3t6q_A 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509 (606)
T ss_dssp EECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCC
Confidence 99999999998999999999999999999999873 346799999999999999999999999999999999999999
Q ss_pred CccCCccCCccc-ccccceeeCCCCcCCCCCCCccc--ccccccccccCCCCCCCCccc
Q 002250 503 NKFSGEIPISLT-YPKLSLLDLSNNQLAGPIPEPLN--IKAFIDSFTGNPGLCSKTDEY 558 (947)
Q Consensus 503 N~l~~~~p~~~~-~~~L~~L~ls~N~l~~~~p~~~~--~~~~~~~~~gN~~~c~~~~~~ 558 (947)
|++++.+|..+. ++.| .|++++|++++.+|+.+. .......+.||||.|+|+..|
T Consensus 510 N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~ 567 (606)
T 3t6q_A 510 NRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIY 567 (606)
T ss_dssp SCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHH
T ss_pred CccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHH
Confidence 999999988776 5889 999999999998887654 233455789999999988654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-56 Score=551.22 Aligned_cols=521 Identities=20% Similarity=0.202 Sum_probs=432.5
Q ss_pred cccceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccCcC-chhhhcCCCccEEeCcCccCcCCCC-
Q 002250 25 CKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTI-TEGLKSCTRLQVLDLGNNSFSGEVP- 102 (947)
Q Consensus 25 C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~l~~l~~L~~L~Ls~n~i~~~~~- 102 (947)
|.|.+|.+ --..++.|+|+++.+.+..+ .+|.++++|+.|+|++|.+.+.+ |..|..+++|++|+|++|.|++..|
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~-~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTA-SSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECS-SSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccCh-hHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 56777776 44678888888888776555 67888888999999888655554 7888888899999999888888755
Q ss_pred CcccccccceeecCCCCccCccC-cccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCC
Q 002250 103 DLSMLHELSFLNLNSSGISGKFP-WKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNL 181 (947)
Q Consensus 103 ~l~~l~~L~~L~L~~n~i~~~~~-~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l 181 (947)
.+..+++|++|+|++|.+++.++ ...+.++++|++|+|++|.+.....+..+.++++|++|+|++|.+++..+..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 48888889999999888887544 23488888899999998888876666678888889999999888888888888877
Q ss_pred --CCCCEEECcCcccccccCccccCCCC------CcEEEeecccccccCCccCCCC---CCccEEeccCCCCC-------
Q 002250 182 --TQLQNLELSDNELFGEIPAGIVKLNK------LWQLELYNNSLSGRLPVGFSNL---TNLMNFDVSQNRLE------- 243 (947)
Q Consensus 182 --~~L~~L~Ls~N~l~~~~~~~l~~l~~------L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~Ls~N~l~------- 243 (947)
++|+.|+|++|.+.+..|..+..+.+ |++|+|++|.+++..+..+... ++++.|.++.+.+.
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 88888899988888877777766655 8888998888887777666543 56778887744332
Q ss_pred --CCC-ccccc--cCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCC
Q 002250 244 --GDL-SELRF--LNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIP 318 (947)
Q Consensus 244 --~~~-~~l~~--l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 318 (947)
... ..+.. .++|+.|+|++|.+.+..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|.+++..|
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 331 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS 331 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCS
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCH
Confidence 111 12333 3689999999999999999999999999999999999998889999999999999999999998889
Q ss_pred CCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCccccccc
Q 002250 319 PDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKS 398 (947)
Q Consensus 319 ~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 398 (947)
..+..+..|+.|++.+|++.+..+..|.++++|+.|+|++|.+++. ..+++|+.|++++|+++.. |.. ..+
T Consensus 332 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~~l-~~~---~~~ 402 (844)
T 3j0a_A 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLVTL-PKI---NLT 402 (844)
T ss_dssp CSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCCCC-CCC---CTT
T ss_pred HHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcccc-ccc---ccc
Confidence 9999999999999999999988889999999999999999999842 3388999999999999854 332 467
Q ss_pred ccEEEccCccccccCC-CCCCCCCcceEEEcccCcccCCCCc-ccccccccchhhccccccC-----CCCCccccccccc
Q 002250 399 LALLLLANNRFSGELP-SKISEASSLVSIQLSLNQFSGQIPL-DIGKLKKLSSLYLHDNMFS-----GPLPYSIGSCVSL 471 (947)
Q Consensus 399 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L 471 (947)
++.|++++|++++... ..+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|..+++|
T Consensus 403 l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L 482 (844)
T 3j0a_A 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHL 482 (844)
T ss_dssp CCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCE
T ss_pred cceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccc
Confidence 9999999999985322 2356899999999999999965443 4567899999999999997 4556778999999
Q ss_pred ceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCcccccccceeeCCCCcCCCCCCCcccccccccccccCCCC
Q 002250 472 TDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGL 551 (947)
Q Consensus 472 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~gN~~~ 551 (947)
+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|..+. ++|+.|||++|+|++.+|+.+. ......+.||||.
T Consensus 483 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~~~-~L~~l~l~~Np~~ 560 (844)
T 3j0a_A 483 QVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDVFV-SLSVLDITHNKFI 560 (844)
T ss_dssp ECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCCCS-SCCEEEEEEECCC
T ss_pred cEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhHhC-CcCEEEecCCCcc
Confidence 9999999999999999999999999999999999988887766 8999999999999999998764 4445678999999
Q ss_pred CCCCccc
Q 002250 552 CSKTDEY 558 (947)
Q Consensus 552 c~~~~~~ 558 (947)
|+|+..+
T Consensus 561 C~c~~~~ 567 (844)
T 3j0a_A 561 CECELST 567 (844)
T ss_dssp CSSSCCS
T ss_pred cccccHH
Confidence 9998754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-57 Score=543.99 Aligned_cols=474 Identities=21% Similarity=0.321 Sum_probs=321.8
Q ss_pred cccccCCCCCccc---ceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccc------cC------cCch
Q 002250 15 FSSWTEANSVCKF---NGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFL------YG------TITE 79 (947)
Q Consensus 15 ~~sw~~~~~~C~w---~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i------~~------~~~~ 79 (947)
.++|+.++|||.| .||+|+..|||++|+|+++++.|.+| .+++.|++|+.|+|++|.+ .+ .+|.
T Consensus 57 ~~~W~~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp-~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~ 135 (636)
T 4eco_A 57 GANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVP-DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135 (636)
T ss_dssp -CCCCCSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEEC-GGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCH
T ss_pred CCCCCCCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCC-hHHhcCccceEEECcCCccccCCccccccccccCchH
Confidence 4589999999999 99999988999999999999999988 6888999999999988876 23 3343
Q ss_pred hhhcCCCccEEeCcCccCcCCCCC-cc-cccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhccc
Q 002250 80 GLKSCTRLQVLDLGNNSFSGEVPD-LS-MLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKL 157 (947)
Q Consensus 80 ~l~~l~~L~~L~Ls~n~i~~~~~~-l~-~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l 157 (947)
.+ +..|+ +++++|.+.+.++. +. .+..+..+++....+.. .....++.+.+.
T Consensus 136 ~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~-------~~~~~l~~l~l~---------------- 189 (636)
T 4eco_A 136 EQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK-------SSRITLKDTQIG---------------- 189 (636)
T ss_dssp HH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC-------CCCCCCCTTTTT----------------
T ss_pred HH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc-------ccccchhhhhhc----------------
Confidence 33 45566 66666666654443 22 12333333443332221 011111111111
Q ss_pred ccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccc-----------------cCcccc--CCCCCcEEEeecccc
Q 002250 158 EKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGE-----------------IPAGIV--KLNKLWQLELYNNSL 218 (947)
Q Consensus 158 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~~~~l~--~l~~L~~L~L~~n~l 218 (947)
..+|++++ +|..|+++++|++|+|++|++++. +|..+. ++++|++|+|++|.+
T Consensus 190 -------~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l 261 (636)
T 4eco_A 190 -------QLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261 (636)
T ss_dssp -------CCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred -------cccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence 12345554 555555555555555555555543 555555 555555555555555
Q ss_pred cccCCccCCCCCCccEEeccCCC-CCC--CCcccccc------CCCCEEEccCccCcccCCC--CccCCCcCcEEEccCc
Q 002250 219 SGRLPVGFSNLTNLMNFDVSQNR-LEG--DLSELRFL------NQLSSLHLFENQFSGEIPE--EFGEFKHLTELSLYTN 287 (947)
Q Consensus 219 ~~~~~~~~~~l~~L~~L~Ls~N~-l~~--~~~~l~~l------~~L~~L~L~~N~i~~~~~~--~~~~l~~L~~L~L~~N 287 (947)
.+.+|..|.++++|++|+|++|+ +++ .+..+..+ ++|++|+|++|+++ .+|. .++.+++|++|++++|
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N 340 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYN 340 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSC
T ss_pred CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCC
Confidence 55555555555555556655555 554 33334433 55666666666665 5555 5566666666666666
Q ss_pred cccccCCcCccCcccccccccccccccCCCCCCcccCCc-cceeeecccccCCcCCccccCCC--CccEEEccccccccc
Q 002250 288 RLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGA-MTDLLVLQNNFNGTVPETYANCK--SLIRFRVNNNSLSGT 364 (947)
Q Consensus 288 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~-l~~L~l~~n~~~~~~p~~~~~l~--~L~~L~L~~n~l~~~ 364 (947)
+++|.+| .++.+++|++|++++|.++ .+|..+..+.. |+.|++.+|.+. .+|..+..++ +|+.|++++|.+++.
T Consensus 341 ~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~ 417 (636)
T 4eco_A 341 QLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSV 417 (636)
T ss_dssp CCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTT
T ss_pred cCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCc
Confidence 6665555 5556666666666666665 55555555555 666666666655 5566665544 788888888888887
Q ss_pred CCCCCC-------CCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCC-C-------CcceEEEcc
Q 002250 365 IPPGIW-------SLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISE-A-------SSLVSIQLS 429 (947)
Q Consensus 365 ~p~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l-------~~L~~L~Ls 429 (947)
.|..+. .+++|+.|+|++|+++..++..+..+++|++|+|++|+++ .+|..+.. . ++|+.|+|+
T Consensus 418 ~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls 496 (636)
T 4eco_A 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLR 496 (636)
T ss_dssp TTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECC
T ss_pred chhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECc
Confidence 777777 7778888888888888655555666888888888888888 56654433 2 288888888
Q ss_pred cCcccCCCCcccc--cccccchhhccccccCCCCCcccccccccceeec------cCceeeeecCCCCCccCcCcEEECC
Q 002250 430 LNQFSGQIPLDIG--KLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINF------AQNSLSGKIPDSLGSLPSLNSLNLS 501 (947)
Q Consensus 430 ~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~Ls 501 (947)
+|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+.++++|+.|+|+
T Consensus 497 ~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls 574 (636)
T 4eco_A 497 FNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574 (636)
T ss_dssp SSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECC
T ss_pred CCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECC
Confidence 88888 6777776 88888899999998887 7888888888999988 5688889999999999999999999
Q ss_pred CCccCCccCCcccccccceeeCCCCcCCCCC
Q 002250 502 NNKFSGEIPISLTYPKLSLLDLSNNQLAGPI 532 (947)
Q Consensus 502 ~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~ 532 (947)
+|++ +.+|..+. ++|+.|||++|++....
T Consensus 575 ~N~l-~~ip~~~~-~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 575 SNDI-RKVNEKIT-PNISVLDIKDNPNISID 603 (636)
T ss_dssp SSCC-CBCCSCCC-TTCCEEECCSCTTCEEE
T ss_pred CCcC-CccCHhHh-CcCCEEECcCCCCcccc
Confidence 9999 57777655 89999999999887533
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-55 Score=522.84 Aligned_cols=510 Identities=18% Similarity=0.152 Sum_probs=392.3
Q ss_pred ceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCC-Ccccccccceeec
Q 002250 37 LVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP-DLSMLHELSFLNL 115 (947)
Q Consensus 37 ~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~-~l~~l~~L~~L~L 115 (947)
.++.++++++.+.+..+ .+|.++++|+.|+|++|.+.+..|..|..+++|++|+|++|++++.+| .++.+++|++|+|
T Consensus 33 ~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 33 STKNIDLSFNPLKILKS-YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CcCEEECCCCCcCEeCh-hhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 56677777776655443 567777777777777777777777777777777777777777776644 3777777777777
Q ss_pred CCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCC----EEECcC
Q 002250 116 NSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQ----NLELSD 191 (947)
Q Consensus 116 ~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~----~L~Ls~ 191 (947)
++|.+.+..+ ..+.++++|++|+|++|.+....+|..+.++++|++|++++|++++..|..++.+++|+ +|++++
T Consensus 112 ~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~ 190 (606)
T 3vq2_A 112 VETKLASLES-FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190 (606)
T ss_dssp TTSCCCCSSS-SCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred cCCccccccc-cccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence 7777765443 45777777777777777776655677777777777777777777776666666655544 677777
Q ss_pred cccccccCccccCCCCCcEEEeeccccc-ccCCccCCCCCCccEEeccCCCCCCC------C-ccccccC--CCCEEEc-
Q 002250 192 NELFGEIPAGIVKLNKLWQLELYNNSLS-GRLPVGFSNLTNLMNFDVSQNRLEGD------L-SELRFLN--QLSSLHL- 260 (947)
Q Consensus 192 N~l~~~~~~~l~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~------~-~~l~~l~--~L~~L~L- 260 (947)
|.+++..+..+... +|++|++++|.++ +..|..+.++++|+.+++..+.+... . ..+..+. +++.+++
T Consensus 191 n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 269 (606)
T 3vq2_A 191 NPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269 (606)
T ss_dssp CCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEEC
T ss_pred CCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecc
Confidence 77765544444433 6777777777765 35556667777777776654443321 0 1111111 3556666
Q ss_pred cCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCc
Q 002250 261 FENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGT 340 (947)
Q Consensus 261 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~ 340 (947)
..|.+.+.+|. +..+++|+.|++++|.++ .+| .+..+++|+.|++++|.+ +.+| .+ .+..|+.|.+.+|...+.
T Consensus 270 ~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~ 343 (606)
T 3vq2_A 270 YTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSIS 343 (606)
T ss_dssp CCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEE
T ss_pred ccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccc
Confidence 77788877777 888999999999999997 566 788899999999999999 5777 45 889999999999976654
Q ss_pred CCccccCCCCccEEEccccccccc--CCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCC-CCC
Q 002250 341 VPETYANCKSLIRFRVNNNSLSGT--IPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELP-SKI 417 (947)
Q Consensus 341 ~p~~~~~l~~L~~L~L~~n~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~ 417 (947)
. .+..+++|+.|++++|.+++. .|..+..+++|+.|++++|.+.+ ++..+..+++|+.|++++|++.+..| ..+
T Consensus 344 ~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 420 (606)
T 3vq2_A 344 F--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAF 420 (606)
T ss_dssp C--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTT
T ss_pred h--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhh
Confidence 4 677899999999999999866 37778889999999999999986 44788899999999999999998777 688
Q ss_pred CCCCcceEEEcccCcccCCCCcccccccccchhhccccccCC-CCCcccccccccceeeccCceeeeecCCCCCccCcCc
Q 002250 418 SEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSG-PLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLN 496 (947)
Q Consensus 418 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 496 (947)
..+++|+.|++++|++++..|..++++++|+.|+|++|.+++ .+|..|+.+++|+.|+|++|++++..|..|.++++|+
T Consensus 421 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 500 (606)
T 3vq2_A 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500 (606)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCC
Confidence 999999999999999998889999999999999999999987 4788899999999999999999998899999999999
Q ss_pred EEECCCCccCCccCCccc-ccccceeeCCCCcCCCCCCCccc-c--cccccccccCCCCCCCCcccc
Q 002250 497 SLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQLAGPIPEPLN-I--KAFIDSFTGNPGLCSKTDEYF 559 (947)
Q Consensus 497 ~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N~l~~~~p~~~~-~--~~~~~~~~gN~~~c~~~~~~~ 559 (947)
.|+|++|++++.+|..+. +++|+.|||++|+++. +|..+. . ......+.+|||.|+|+..|+
T Consensus 501 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~ 566 (606)
T 3vq2_A 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICEHQKF 566 (606)
T ss_dssp EEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSSTTHHH
T ss_pred EEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCccHHH
Confidence 999999999998887775 5899999999999985 444343 2 134457889999999988764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-55 Score=524.03 Aligned_cols=478 Identities=20% Similarity=0.165 Sum_probs=416.8
Q ss_pred cccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCC-cccccccceeecCCCCccCccCcccccccCCCceee
Q 002250 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLS 139 (947)
Q Consensus 61 ~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~ 139 (947)
++|+.|+|++|.+.+..+..|..+++|++|+|++|.+++..+. +..+++|++|+|++|.+++..| ..|.++++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP-GSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCT-TSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccCh-hhcCCcccCCEEE
Confidence 7899999999999999999999999999999999999987664 8999999999999999997666 7899999999999
Q ss_pred CCCCCCCCCCCChhhcccccCcEEEccCccccc-cCCccCCCCCCCCEEECcCcccccccCccccCCCCCc----EEEee
Q 002250 140 LGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTG-QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLW----QLELY 214 (947)
Q Consensus 140 Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~----~L~L~ 214 (947)
|++|.+...+ +..+.++++|++|++++|.+++ .+|..|+++++|++|+|++|++++..+..+..+.+|+ +|+++
T Consensus 111 L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~ 189 (606)
T 3vq2_A 111 AVETKLASLE-SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189 (606)
T ss_dssp CTTSCCCCSS-SSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECT
T ss_pred ccCCcccccc-ccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeecc
Confidence 9999998754 3568999999999999999986 5699999999999999999999988888888776655 89999
Q ss_pred cccccccCCccCCCCCCccEEeccCCCCCC--CCccccccCCCCEEEccCccCccc---------CCCCccCCCcCcEEE
Q 002250 215 NNSLSGRLPVGFSNLTNLMNFDVSQNRLEG--DLSELRFLNQLSSLHLFENQFSGE---------IPEEFGEFKHLTELS 283 (947)
Q Consensus 215 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~l~~l~~L~~L~L~~N~i~~~---------~~~~~~~l~~L~~L~ 283 (947)
+|.+++..+..+... +|++|++++|.+.+ .+..+..++.|+.+++..+.+.+. .+..+..+ .++.++
T Consensus 190 ~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l-~l~~l~ 267 (606)
T 3vq2_A 190 LNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV-TIDEFR 267 (606)
T ss_dssp TCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGS-EEEEEE
T ss_pred CCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhc-cHhhee
Confidence 999997777777665 99999999999874 344678899999998876655421 11222333 477788
Q ss_pred c-cCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEccccccc
Q 002250 284 L-YTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLS 362 (947)
Q Consensus 284 L-~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~ 362 (947)
+ ..|.+++.+|. +..+++|+.|++++|.+. .+| .+..+..++.|.+.+|.+ +.+| .+ .+++|+.|++++|...
T Consensus 268 l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~ 341 (606)
T 3vq2_A 268 LTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGS 341 (606)
T ss_dssp ECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSC
T ss_pred ccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCc
Confidence 8 88889988887 999999999999999997 566 888999999999999999 7888 45 9999999999999765
Q ss_pred ccCCCCCCCCCCcceeccccCCcCCC--CCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCC-c
Q 002250 363 GTIPPGIWSLPNLSIIDLSTNQFEGP--VTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIP-L 439 (947)
Q Consensus 363 ~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~ 439 (947)
+.. .+..+++|+.|++++|++++. .+..+..+++|++|++++|.++ .+|..+..+++|+.|++++|++.+..| .
T Consensus 342 ~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 418 (606)
T 3vq2_A 342 ISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFS 418 (606)
T ss_dssp EEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTT
T ss_pred cch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChh
Confidence 444 677899999999999999876 3778899999999999999998 577899999999999999999998877 6
Q ss_pred ccccccccchhhccccccCCCCCcccccccccceeeccCceeee-ecCCCCCccCcCcEEECCCCccCCccCCccc-ccc
Q 002250 440 DIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSG-KIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPK 517 (947)
Q Consensus 440 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~ 517 (947)
.+.++++|+.|++++|.+++..|..|+.+++|++|++++|++++ .+|..+..+++|+.|+|++|++++.+|..+. +++
T Consensus 419 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 498 (606)
T 3vq2_A 419 AFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498 (606)
T ss_dssp TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred hhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhccccc
Confidence 89999999999999999999999999999999999999999998 5899999999999999999999999888775 699
Q ss_pred cceeeCCCCcCCCCCCCccc--ccccccccccCCCC
Q 002250 518 LSLLDLSNNQLAGPIPEPLN--IKAFIDSFTGNPGL 551 (947)
Q Consensus 518 L~~L~ls~N~l~~~~p~~~~--~~~~~~~~~gN~~~ 551 (947)
|+.|+|++|++++.+|..+. .......+.+|...
T Consensus 499 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 534 (606)
T 3vq2_A 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534 (606)
T ss_dssp CCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred CCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence 99999999999998887664 22334456677643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=515.46 Aligned_cols=495 Identities=18% Similarity=0.177 Sum_probs=381.1
Q ss_pred CceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCC-cccccccceee
Q 002250 36 GLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLN 114 (947)
Q Consensus 36 ~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~-l~~l~~L~~L~ 114 (947)
.+++.++++++.+.+..| ..++++++|+.|+|++|.+.+..+..|..+++|++|+|++|++++.++. ++.+++|++|+
T Consensus 49 ~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 127 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEP-ELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127 (680)
T ss_dssp TTCSEEECCSSCCCCCCT-THHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEE
T ss_pred CcCcEEECCCCccCccCH-HHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEE
Confidence 357778888877766555 6778888888888888888766666788888888888888888776653 77888888888
Q ss_pred cCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhh--cccccCcEEEccCccccccCCccC--------------
Q 002250 115 LNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEV--LKLEKLYWLYLTNCSVTGQIPEGI-------------- 178 (947)
Q Consensus 115 L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~--~~l~~L~~L~L~~n~l~~~~p~~~-------------- 178 (947)
|++|.+++..+ ..+.++++|++|+|++|.++... +..+ ..+++|++|++++|.+++..|..+
T Consensus 128 Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~ 205 (680)
T 1ziw_A 128 LSHNGLSSTKL-GTQVQLENLQELLLSNNKIQALK-SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205 (680)
T ss_dssp CCSSCCSCCCC-CSSSCCTTCCEEECCSSCCCCBC-HHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTC
T ss_pred CCCCcccccCc-hhhcccccCCEEEccCCcccccC-HHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhcccc
Confidence 88888876554 56777888888888888776532 2222 234566666666666665555443
Q ss_pred -------------------------------------CCCC--CCCEEECcCcccccccCccccCCCCCcEEEeeccccc
Q 002250 179 -------------------------------------GNLT--QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLS 219 (947)
Q Consensus 179 -------------------------------------~~l~--~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~ 219 (947)
..++ +|++|+|++|++++..|..|..+++|++|+|++|.++
T Consensus 206 ~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 285 (680)
T 1ziw_A 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285 (680)
T ss_dssp CCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBS
T ss_pred ccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccC
Confidence 3332 2555555555555555555555555555555555555
Q ss_pred ccCCccCCCCCCccEEeccCCCCCC------CCc----cccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccc
Q 002250 220 GRLPVGFSNLTNLMNFDVSQNRLEG------DLS----ELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRL 289 (947)
Q Consensus 220 ~~~~~~~~~l~~L~~L~Ls~N~l~~------~~~----~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 289 (947)
+..|..|..+++|++|++++|...+ .+. .+..+++|++|++++|++++..+..|..+++|++|++++|.+
T Consensus 286 ~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~ 365 (680)
T 1ziw_A 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365 (680)
T ss_dssp EECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBS
T ss_pred ccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCch
Confidence 5555555555555555555543332 111 355667777777778877777777777788888888887765
Q ss_pred cc--cCCcCccCc--ccccccccccccccCCCCCCcccCCccceeeecccccCCcCC-ccccCCCCccEEEccccccccc
Q 002250 290 TG--TLPQKLGSW--ADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVP-ETYANCKSLIRFRVNNNSLSGT 364 (947)
Q Consensus 290 ~~--~~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~ 364 (947)
+. ..+..+..+ ++|+.|++++|++++..|..+..+.+|+.|++.+|.+.+.+| ..|.++++|+.|++++|++.+.
T Consensus 366 ~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 445 (680)
T 1ziw_A 366 SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445 (680)
T ss_dssp CCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEEC
T ss_pred hhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCccee
Confidence 42 122233332 478888888899988888899999999999999999998776 7899999999999999999988
Q ss_pred CCCCCCCCCCcceeccccCCcC--CCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCC----
Q 002250 365 IPPGIWSLPNLSIIDLSTNQFE--GPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIP---- 438 (947)
Q Consensus 365 ~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---- 438 (947)
.+..|..+++|+.|++++|.+. +..|..|..+++|+.|++++|++++..|..|..+++|+.|+|++|++++..+
T Consensus 446 ~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 525 (680)
T 1ziw_A 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANP 525 (680)
T ss_dssp CTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTST
T ss_pred ChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhcc
Confidence 8999999999999999999997 5678899999999999999999998888889999999999999999986422
Q ss_pred ----cccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc
Q 002250 439 ----LDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT 514 (947)
Q Consensus 439 ----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 514 (947)
..|+++++|+.|+|++|+++...+..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++.+|..+.
T Consensus 526 ~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 605 (680)
T 1ziw_A 526 GGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFG 605 (680)
T ss_dssp TSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHH
T ss_pred CCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhc
Confidence 2478999999999999999976667899999999999999999977777889999999999999999998887664
Q ss_pred --ccccceeeCCCCcCCCCCC
Q 002250 515 --YPKLSLLDLSNNQLAGPIP 533 (947)
Q Consensus 515 --~~~L~~L~ls~N~l~~~~p 533 (947)
+++|+.|++++|++.+..+
T Consensus 606 ~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 606 PAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp HHHTTCSEEECTTCCCCBCCC
T ss_pred ccccccCEEEccCCCcccCCc
Confidence 6899999999999998765
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-54 Score=521.73 Aligned_cols=506 Identities=20% Similarity=0.254 Sum_probs=298.1
Q ss_pred CcccccccCCccccccccCCC-----CC--ccc------------ceeeeCCCCceeEeccCCCccccccCcccccCCcc
Q 002250 2 NLKSKIEKSDTGVFSSWTEAN-----SV--CKF------------NGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQA 62 (947)
Q Consensus 2 ~~k~~~~~~~~~~~~sw~~~~-----~~--C~w------------~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~ 62 (947)
.||.++ +++ +|+.+. +| |.| .||+|+.+|+|+.|+|+++++.|.+| +++++|++
T Consensus 276 ~~k~~l--~~~----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip-~~l~~L~~ 348 (876)
T 4ecn_A 276 AIWEAL--DGK----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP-DAIGQLTE 348 (876)
T ss_dssp HHHHHT--TGG----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEEC-GGGGGCTT
T ss_pred HHHHHc--CCC----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCc-hHHhcccc
Confidence 466666 333 897554 55 999 99999988999999999999999998 78999999
Q ss_pred cceeec-cCccccCcCchhhhcC----CCcc--EEeC----------cCccCcCC------------CCCccccccccee
Q 002250 63 LQKINL-GTNFLYGTITEGLKSC----TRLQ--VLDL----------GNNSFSGE------------VPDLSMLHELSFL 113 (947)
Q Consensus 63 L~~L~L-~~n~i~~~~~~~l~~l----~~L~--~L~L----------s~n~i~~~------------~~~l~~l~~L~~L 113 (947)
|+.|+| ++|.+.|..|-..... ..++ .+.. ....+.+. .........++.+
T Consensus 349 L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l 428 (876)
T 4ecn_A 349 LKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428 (876)
T ss_dssp CCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTT
T ss_pred ceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccchhhc
Confidence 999999 8888877744221111 0000 0000 00000000 0001112233333
Q ss_pred ecCC--CCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCC--CCCCCCEEEC
Q 002250 114 NLNS--SGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIG--NLTQLQNLEL 189 (947)
Q Consensus 114 ~L~~--n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~L 189 (947)
.+.. |++++ +| ..+.++++|++|+|++|.++...++... +..+.|.+.+.+|..++ ++++|++|+|
T Consensus 429 ~l~~~~N~L~~-IP-~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~--------~~~s~n~~~g~iP~~l~f~~L~~L~~L~L 498 (876)
T 4ecn_A 429 QIGNLTNRITF-IS-KAIQRLTKLQIIYFANSPFTYDNIAVDW--------EDANSDYAKQYENEELSWSNLKDLTDVEL 498 (876)
T ss_dssp TTTCCSCEEEE-EC-GGGGGCTTCCEEEEESCCCCGGGBSSSC--------SCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred eeccccCcccc-hh-HHHhcCCCCCEEECcCCcCCCCcccccc--------cccccccccccCChhhhhccCCCCCEEEC
Confidence 3333 55555 45 4566666666666666666541111100 11112333334666655 6666666666
Q ss_pred cCcccccccCccccCCCCCcEEEeeccc-ccc-cCCccCCCC-------CCccEEeccCCCCCCCCc--cccccCCCCEE
Q 002250 190 SDNELFGEIPAGIVKLNKLWQLELYNNS-LSG-RLPVGFSNL-------TNLMNFDVSQNRLEGDLS--ELRFLNQLSSL 258 (947)
Q Consensus 190 s~N~l~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~~~~~~~l-------~~L~~L~Ls~N~l~~~~~--~l~~l~~L~~L 258 (947)
++|.+.+.+|..|.++++|++|+|++|+ +++ .+|..+..+ ++|++|+|++|+++.++. .+..+++|+.|
T Consensus 499 s~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L 578 (876)
T 4ecn_A 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLL 578 (876)
T ss_dssp ESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEE
T ss_pred cCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEE
Confidence 6666666666666666666666666666 665 555544333 366666666666665554 46666666666
Q ss_pred EccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCccc-ccccccccccccCCCCCCcccCCccceeeeccccc
Q 002250 259 HLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWAD-FNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNF 337 (947)
Q Consensus 259 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~ 337 (947)
+|++|+++ .+| .|+.+++|++|+|++|+++ .+|..+..+++ |+.|+|++|.++ .+|..+.....
T Consensus 579 ~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~----------- 643 (876)
T 4ecn_A 579 DCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSV----------- 643 (876)
T ss_dssp ECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCS-----------
T ss_pred ECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhcccc-----------
Confidence 66666666 555 5666666666666666666 56666666666 666666666665 34433322211
Q ss_pred CCcCCccccCCCCccEEEcccccccccCCCCC---C--CCCCcceeccccCCcCCCCCCcccccccccEEEccCcccccc
Q 002250 338 NGTVPETYANCKSLIRFRVNNNSLSGTIPPGI---W--SLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGE 412 (947)
Q Consensus 338 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~---~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 412 (947)
++|+.|++++|.+.+.+|... . .+++|+.|+|++|+++..++..+..+++|+.|+|++|+|+ .
T Consensus 644 -----------~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ 711 (876)
T 4ecn_A 644 -----------YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-S 711 (876)
T ss_dssp -----------SCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-C
T ss_pred -----------CCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-c
Confidence 225555555555554433211 1 2235666666666666433333445566666666666665 4
Q ss_pred CCCCCCCC--------CcceEEEcccCcccCCCCcccc--cccccchhhccccccCCCCCcccccccccceeeccC----
Q 002250 413 LPSKISEA--------SSLVSIQLSLNQFSGQIPLDIG--KLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQ---- 478 (947)
Q Consensus 413 ~p~~~~~l--------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~---- 478 (947)
+|..+... ++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..++.+++|+.|+|++
T Consensus 712 ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~l 789 (876)
T 4ecn_A 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDA 789 (876)
T ss_dssp CCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCT
T ss_pred cChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCc
Confidence 44433322 26666666666666 5566665 66666666666666665 566666666666666654
Q ss_pred --ceeeeecCCCCCccCcCcEEECCCCccCCccCCcccccccceeeCCCCcCCCCCCCccc--ccccccccccCCCCC--
Q 002250 479 --NSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLN--IKAFIDSFTGNPGLC-- 552 (947)
Q Consensus 479 --N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~p~~~~--~~~~~~~~~gN~~~c-- 552 (947)
|++.+.+|..|.++++|+.|+|++|++ +.+|..+. ++|+.|||++|++....+..+. .......+.+|++.|
T Consensus 790 s~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~-~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~ 867 (876)
T 4ecn_A 790 EGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT-PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIR 867 (876)
T ss_dssp TCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEE
T ss_pred ccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc-CCCCEEECCCCCCCccChHHccccccchheeecCCCccccC
Confidence 778888888888888888888888888 57776644 6888888888888765544332 112233455666554
Q ss_pred CCC
Q 002250 553 SKT 555 (947)
Q Consensus 553 ~~~ 555 (947)
+|+
T Consensus 868 gC~ 870 (876)
T 4ecn_A 868 GCD 870 (876)
T ss_dssp SCG
T ss_pred CCC
Confidence 665
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=496.75 Aligned_cols=463 Identities=19% Similarity=0.186 Sum_probs=408.2
Q ss_pred CccEEeCcCccCcCCCC-CcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEE
Q 002250 86 RLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLY 164 (947)
Q Consensus 86 ~L~~L~Ls~n~i~~~~~-~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~ 164 (947)
++++|||++|.|++.++ .+..+++|++|+|++|++.+..| .+|.++++|++|+|++|.+... .|..+.++++|++|+
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~ 111 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHE-DTFQSQHRLDTLVLTANPLIFM-AETALSGPKALKHLF 111 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECT-TTTTTCTTCCEEECTTCCCSEE-CTTTTSSCTTCCEEE
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeCh-hhccCccccCeeeCCCCccccc-ChhhhcccccccEee
Confidence 78999999999998766 59999999999999999987666 7899999999999999999764 367899999999999
Q ss_pred ccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCcc--EEeccCCCC
Q 002250 165 LTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLM--NFDVSQNRL 242 (947)
Q Consensus 165 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L~Ls~N~l 242 (947)
+++|.+++..|..++++++|++|+|++|++++..+..+..+++|++|+|++|.+++..+..|..+++|+ .|++++|.+
T Consensus 112 L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l 191 (606)
T 3t6q_A 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191 (606)
T ss_dssp CTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred ccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence 999999987788999999999999999999875555666699999999999999988888999999999 999999999
Q ss_pred CCCCccccccCCCCEEEccCccCc--------------------------ccCCCCccCCC--cCcEEEccCccccccCC
Q 002250 243 EGDLSELRFLNQLSSLHLFENQFS--------------------------GEIPEEFGEFK--HLTELSLYTNRLTGTLP 294 (947)
Q Consensus 243 ~~~~~~l~~l~~L~~L~L~~N~i~--------------------------~~~~~~~~~l~--~L~~L~L~~N~l~~~~p 294 (947)
++.++......+|+.|++++|... ...+..|..+. +|++|++++|.+++..+
T Consensus 192 ~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~ 271 (606)
T 3t6q_A 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271 (606)
T ss_dssp CEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT
T ss_pred CccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH
Confidence 987776666678999999887511 11122233332 79999999999998888
Q ss_pred cCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCC-CCCCCC
Q 002250 295 QKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPP-GIWSLP 373 (947)
Q Consensus 295 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~ 373 (947)
..|+.+++|++|++++|.++ .+|..+..+..|+.|++.+|.+.+..|..+..+++|+.|++++|.+.+.+|. .+..++
T Consensus 272 ~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 350 (606)
T 3t6q_A 272 NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350 (606)
T ss_dssp TTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT
T ss_pred HHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccC
Confidence 88999999999999999999 7899999999999999999999999999999999999999999999877765 488999
Q ss_pred CcceeccccCCcCCCC--CCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcc-cccccccchh
Q 002250 374 NLSIIDLSTNQFEGPV--TDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLD-IGKLKKLSSL 450 (947)
Q Consensus 374 ~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L 450 (947)
+|++|++++|++++.. +..+..+++|++|++++|++++..|..+..+++|+.|++++|++++..|.. +..+++|+.|
T Consensus 351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 430 (606)
T 3t6q_A 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430 (606)
T ss_dssp TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEE
T ss_pred cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEE
Confidence 9999999999999776 778999999999999999999899999999999999999999999876654 8999999999
Q ss_pred hccccccCCCCCcccccccccceeeccCceeeee---cCCCCCccCcCcEEECCCCccCCccCCccc-ccccceeeCCCC
Q 002250 451 YLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGK---IPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNN 526 (947)
Q Consensus 451 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N 526 (947)
+|++|.+++..|..|+.+++|++|+|++|++++. .+..+..+++|+.|+|++|++++.+|..+. +++|+.|+|++|
T Consensus 431 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 510 (606)
T 3t6q_A 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510 (606)
T ss_dssp ECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred ECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCC
Confidence 9999999999999999999999999999999862 336789999999999999999999888775 699999999999
Q ss_pred cCCCCCCCcccc-cccccccccCCCC
Q 002250 527 QLAGPIPEPLNI-KAFIDSFTGNPGL 551 (947)
Q Consensus 527 ~l~~~~p~~~~~-~~~~~~~~gN~~~ 551 (947)
++++.+|+.+.. ......+.+|...
T Consensus 511 ~l~~~~~~~l~~l~~L~L~L~~N~l~ 536 (606)
T 3t6q_A 511 RLTSSSIEALSHLKGIYLNLASNHIS 536 (606)
T ss_dssp CCCGGGGGGGTTCCSCEEECCSSCCC
T ss_pred ccCcCChhHhCcccccEEECcCCccc
Confidence 999988876641 1113445666543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=454.22 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=213.8
Q ss_pred hccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
..+++.+.||+|+||+||+|++. +++.||||++.... .....++|.+|+.++++++||
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~----------------~~~~~~~f~~E~~il~~l~Hp 89 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA----------------EGPLREEFRHEAMLRARLQHP 89 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C----------------CC-CHHHHHHHHHHHHHCCCT
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc----------------ChHHHHHHHHHHHHHHhCCCC
Confidence 45667889999999999999863 46789999984221 123457899999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPV 768 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~i 768 (947)
|||+++|+|.+++..++||||+++|+|.+++.... ...++|..+..++.|||+||+||| +++|
T Consensus 90 NIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~i 166 (308)
T 4gt4_A 90 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHV 166 (308)
T ss_dssp TBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred CCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCC
Confidence 99999999999999999999999999999997532 245899999999999999999999 8999
Q ss_pred EeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCC
Q 002250 769 IHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKR 847 (947)
Q Consensus 769 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~ 847 (947)
|||||||+|||+++++.+||+|||+|+...............||++|||||++.++.|+.++|||||||++|||+| |+.
T Consensus 167 iHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~ 246 (308)
T 4gt4_A 167 VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 246 (308)
T ss_dssp CCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987665544444445679999999999999999999999999999999999 899
Q ss_pred CCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 848 PIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 848 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
||... ...++...+. +....+.+.+++..+.+++.+||+.||++||||.||+++|+++.
T Consensus 247 Pf~~~--~~~~~~~~i~-------------~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 247 PYCGY--SNQDVVEMIR-------------NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp TTTTC--CHHHHHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCC--CHHHHHHHHH-------------cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 98532 1222222221 11122334456677999999999999999999999999999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=457.25 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=207.0
Q ss_pred hccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
++|.+.+.||+|+||+||+|+++ +++.||||++... .....++|.+|++++++++||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----------------~~~~~~~f~~E~~il~~l~Hp 103 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----------------SESARQDFQREAELLTMLQHQ 103 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-----------------SHHHHHHHHHHHHHHTTCCCT
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-----------------CHHHHHHHHHHHHHHHhCCCC
Confidence 45667789999999999999864 4788999998421 112346799999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcC-------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH-------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVI 769 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~iv 769 (947)
|||+++|+|.+++..|+||||+++|+|.++++... ..+++|..++.++.|||+||+||| +++||
T Consensus 104 nIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~ii 180 (329)
T 4aoj_A 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFV 180 (329)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCee
Confidence 99999999999999999999999999999997642 246899999999999999999999 89999
Q ss_pred eccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCC
Q 002250 770 HRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRP 848 (947)
Q Consensus 770 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p 848 (947)
||||||+|||+++++.+||+|||+|+...............||++|||||++.+..|+.++|||||||++|||+| |+.|
T Consensus 181 HRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~P 260 (329)
T 4aoj_A 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260 (329)
T ss_dssp CSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCC
Confidence 999999999999999999999999987655544444445679999999999999999999999999999999999 8999
Q ss_pred CCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCcce
Q 002250 849 IVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTN 927 (947)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 927 (947)
|... ...++...+ .... ..+.+..++..+.+++.+||+.||++||||.||+++|+.+...|+..
T Consensus 261 f~~~--~~~~~~~~i---~~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~~ 324 (329)
T 4aoj_A 261 WYQL--SNTEAIDCI---TQGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVY 324 (329)
T ss_dssp TCSS--CHHHHHHHH---HHTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC--
T ss_pred CCCC--CHHHHHHHH---HcCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCccc
Confidence 9532 122222221 1111 11223345567899999999999999999999999999987666543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=454.05 Aligned_cols=258 Identities=22% Similarity=0.375 Sum_probs=211.3
Q ss_pred hccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
++|.+.+.||+|+||+||+|++. +++.||||++... .....++|.+|++++++++||
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----------------~~~~~~~f~~E~~il~~l~Hp 75 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----------------SDNARKDFHREAELLTNLQHE 75 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----------------CHHHHHHHHHHHHHHTTCCCT
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----------------ChHHHHHHHHHHHHHHhCCCC
Confidence 56778899999999999999864 4778999998421 112346799999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcC-----------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH-----------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHR 771 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~ 771 (947)
|||+++|+|.+++..|+||||+++|+|.++++..+ ...++|..+..++.|||+||+||| +++||||
T Consensus 76 nIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHR 152 (299)
T 4asz_A 76 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHR 152 (299)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 99999999999999999999999999999998642 356899999999999999999999 8999999
Q ss_pred cCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 002250 772 DVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIV 850 (947)
Q Consensus 772 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~ 850 (947)
||||+|||+++++.+||+|||+|+...............||++|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 153 DlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~ 232 (299)
T 4asz_A 153 DLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 232 (299)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999987655443333334569999999999999999999999999999999999 899995
Q ss_pred CCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
.. ...++...+ .. ....+.+..++..+.+++.+||+.||++||||.||.+.|+++.
T Consensus 233 ~~--~~~~~~~~i---~~----------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 233 QL--SNNEVIECI---TQ----------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp TS--CHHHHHHHH---HH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC--CHHHHHHHH---Hc----------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 32 122222221 11 1112233445667899999999999999999999999998764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=496.74 Aligned_cols=484 Identities=21% Similarity=0.220 Sum_probs=423.1
Q ss_pred CceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCC-C--cccccccce
Q 002250 36 GLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP-D--LSMLHELSF 112 (947)
Q Consensus 36 ~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~-~--l~~l~~L~~ 112 (947)
.+...|+|++++..+.+++.+|.++++|+.|+|++|.|.+..|+.|..+++|++|+|++|.+++..+ . +..+++|++
T Consensus 48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~ 127 (844)
T 3j0a_A 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127 (844)
T ss_dssp CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence 4688999999988888877899999999999999999999999999999999999999999998544 3 899999999
Q ss_pred eecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhccc--ccCcEEEccCccccccCCccCCCCCC------C
Q 002250 113 LNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKL--EKLYWLYLTNCSVTGQIPEGIGNLTQ------L 184 (947)
Q Consensus 113 L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~------L 184 (947)
|+|++|.+.+..+...|.++++|++|+|++|.+... .+..+..+ ++|+.|++++|.+.+..|..++.+++ |
T Consensus 128 L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~-~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L 206 (844)
T 3j0a_A 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV-CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206 (844)
T ss_dssp EEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC-CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCB
T ss_pred EECCCCcccccccchhHhhCCCCCEEECCCCcCCee-CHHHcccccCCccceEECCCCccccccccchhhcCCccccCce
Confidence 999999998776656899999999999999999765 36667777 89999999999999988888877766 9
Q ss_pred CEEECcCcccccccCccccCC---CCCcEEEeecc---------cccccCCccCCCC--CCccEEeccCCCCCCCC-ccc
Q 002250 185 QNLELSDNELFGEIPAGIVKL---NKLWQLELYNN---------SLSGRLPVGFSNL--TNLMNFDVSQNRLEGDL-SEL 249 (947)
Q Consensus 185 ~~L~Ls~N~l~~~~~~~l~~l---~~L~~L~L~~n---------~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~-~~l 249 (947)
++|+|++|.+++..+..+... .+++.|.++++ .+.+..+..|..+ ++|+.|+|++|.+.+.. ..+
T Consensus 207 ~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~ 286 (844)
T 3j0a_A 207 EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF 286 (844)
T ss_dssp SEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCS
T ss_pred eEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhh
Confidence 999999999988888877654 57888988743 3444444556655 78999999999998754 458
Q ss_pred cccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccce
Q 002250 250 RFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTD 329 (947)
Q Consensus 250 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~ 329 (947)
..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|++++|.+++..+..+..+.+|+.
T Consensus 287 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 366 (844)
T 3j0a_A 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366 (844)
T ss_dssp SSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCE
T ss_pred hcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCE
Confidence 88999999999999999999999999999999999999999888999999999999999999999888888999999999
Q ss_pred eeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCC-CcccccccccEEEccCcc
Q 002250 330 LLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVT-DDIGNAKSLALLLLANNR 408 (947)
Q Consensus 330 L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~ 408 (947)
|++.+|.+.+. ..+++|+.|++++|+++ .+|.. ..+++.|++++|++++... ..+..+++|+.|+|++|+
T Consensus 367 L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~ 437 (844)
T 3j0a_A 367 LDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNR 437 (844)
T ss_dssp EEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCC
T ss_pred EECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCc
Confidence 99999998753 33789999999999998 55554 4679999999999997533 235688999999999999
Q ss_pred ccccCCC-CCCCCCcceEEEcccCccc-----CCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceee
Q 002250 409 FSGELPS-KISEASSLVSIQLSLNQFS-----GQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLS 482 (947)
Q Consensus 409 l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 482 (947)
+++..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|+
T Consensus 438 l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 517 (844)
T 3j0a_A 438 FSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517 (844)
T ss_dssp CCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCS
T ss_pred ccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCC
Confidence 9965443 4667899999999999997 445567899999999999999999999999999999999999999999
Q ss_pred eecCCCCCccCcCcEEECCCCccCCccCCcccccccceeeCCCCcCCCCCC
Q 002250 483 GKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIP 533 (947)
Q Consensus 483 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~p 533 (947)
+..|..+. ++|+.|+|++|+|++.+|..+ .+|+.|++++|++.+..+
T Consensus 518 ~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~--~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 518 VLSHNDLP--ANLEILDISRNQLLAPNPDVF--VSLSVLDITHNKFICECE 564 (844)
T ss_dssp SCCCCCCC--SCCCEEEEEEECCCCCCSCCC--SSCCEEEEEEECCCCSSS
T ss_pred ccChhhhh--ccccEEECCCCcCCCCChhHh--CCcCEEEecCCCcccccc
Confidence 87777666 899999999999999999765 489999999999988665
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=443.13 Aligned_cols=261 Identities=29% Similarity=0.440 Sum_probs=204.5
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
+++++.+.||+|+||+||+|+++ ..||||+++... ......+.|.+|+.++++++|||||+++
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~---------------~~~~~~~~f~~E~~il~~l~HpNIV~l~ 98 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVD---------------PTPEQFQAFRNEVAVLRKTRHVNILLFM 98 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSS---------------CCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecC---------------CCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 56778899999999999999976 369999984211 1113346799999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
|++.+ +..++||||+++|+|.++++.. ...++|..+..++.|||+||+||| +++||||||||+|||+++++.+||
T Consensus 99 g~~~~-~~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki 173 (307)
T 3omv_A 99 GYMTK-DNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKI 173 (307)
T ss_dssp EEECS-SSCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEE
T ss_pred EEEEC-CeEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEE
Confidence 99865 5689999999999999999863 346999999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT---CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+|||+|+..............+||+.|||||++.. +.|+.++|||||||++|||+||+.||.... ....+...+.
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-~~~~~~~~~~- 251 (307)
T 3omv_A 174 GDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-NRDQIIFMVG- 251 (307)
T ss_dssp CCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHH-
T ss_pred eeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-hHHHHHHHHh-
Confidence 99999987655443333445689999999999864 458999999999999999999999995321 1111111111
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
.. ...+.+...+.+++..+.+++.+||+.||++||||.||+++|+.++
T Consensus 252 ---~~-----~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 252 ---RG-----YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp ---TT-----CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred ---cC-----CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11 1123334444556678899999999999999999999999998764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=482.14 Aligned_cols=463 Identities=20% Similarity=0.191 Sum_probs=346.0
Q ss_pred ccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCC-cccccccceeecCCCCccCccCcccccccCCCceeeC
Q 002250 62 ALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSL 140 (947)
Q Consensus 62 ~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~L 140 (947)
+++.|+|++|.+.+..+..|..+++|++|||++|++++.++. +..+++|++|+|++|++++..+ ..|.++++|++|++
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L 107 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL-GAFSGLSSLQKLVA 107 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECT-TTTTTCTTCCEEEC
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCH-hhhcCccccccccc
Confidence 456666666666655555666666666666666666654443 5566666666666666654333 45666666666666
Q ss_pred CCCCCCCCCCChhhcccccCcEEEccCccccc-cCCccCCCCCCCCEEECcCcccccccCccccCCCCC----cEEEeec
Q 002250 141 GDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTG-QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKL----WQLELYN 215 (947)
Q Consensus 141 s~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L----~~L~L~~ 215 (947)
++|.++..+ +..+.++++|++|++++|.+++ .+|..|+++++|++|++++|++++..+..+..+++| +.|++++
T Consensus 108 ~~n~l~~l~-~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 108 VETNLASLE-NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp TTSCCCCST-TCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred cccccccCC-CccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 666665432 1235566666666666666654 245666666666666666666665555555555555 5666666
Q ss_pred ccccccCCccCCCCCCccEEeccCCCCCC-------------------------------CC-ccccccC--CCCEEEcc
Q 002250 216 NSLSGRLPVGFSNLTNLMNFDVSQNRLEG-------------------------------DL-SELRFLN--QLSSLHLF 261 (947)
Q Consensus 216 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-------------------------------~~-~~l~~l~--~L~~L~L~ 261 (947)
|.+++..|..|..+ +|++|++++|.... .. ..+..+. .++.++++
T Consensus 187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp CCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred CCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 66665555555544 56666666553211 00 1122222 35667777
Q ss_pred Cc-cCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCc
Q 002250 262 EN-QFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGT 340 (947)
Q Consensus 262 ~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~ 340 (947)
+| .+.+..|..+..+++|++|++++|.++ .+|..+..+ +|+.|++++|.+. .+|. ..+..++.|.+.+|.+.+.
T Consensus 266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~ 340 (570)
T 2z63_A 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNA 340 (570)
T ss_dssp ETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCB
T ss_pred cchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCccccc
Confidence 77 777788889999999999999999998 688888888 9999999999998 6665 4678899999999998877
Q ss_pred CCccccCCCCccEEEcccccccccC--CCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCC-CCC
Q 002250 341 VPETYANCKSLIRFRVNNNSLSGTI--PPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELP-SKI 417 (947)
Q Consensus 341 ~p~~~~~l~~L~~L~L~~n~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~ 417 (947)
.+. ..+++|+.|++++|.+++.. |..+..+++|+.|++++|++.+..+. +..+++|+.|++++|++++..| ..+
T Consensus 341 ~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~ 417 (570)
T 2z63_A 341 FSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVF 417 (570)
T ss_dssp CCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTT
T ss_pred ccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhh
Confidence 765 78899999999999998654 66788899999999999999876555 8899999999999999987766 578
Q ss_pred CCCCcceEEEcccCcccCCCCcccccccccchhhccccccC-CCCCcccccccccceeeccCceeeeecCCCCCccCcCc
Q 002250 418 SEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFS-GPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLN 496 (947)
Q Consensus 418 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 496 (947)
..+++|+.|++++|++.+..|..+.++++|+.|+|++|.++ +.+|..|+.+++|+.|+|++|++++..|..|..+++|+
T Consensus 418 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 497 (570)
T 2z63_A 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497 (570)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCC
Confidence 89999999999999999888999999999999999999997 57889999999999999999999988899999999999
Q ss_pred EEECCCCccCCccCCccc-ccccceeeCCCCcCCCCCCCc
Q 002250 497 SLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQLAGPIPEP 535 (947)
Q Consensus 497 ~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N~l~~~~p~~ 535 (947)
.|+|++|++++.+|..+. +++|+.|++++|++++..|..
T Consensus 498 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred EEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 999999999988887664 689999999999999988853
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=484.42 Aligned_cols=484 Identities=18% Similarity=0.206 Sum_probs=372.5
Q ss_pred CcccceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCC
Q 002250 24 VCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD 103 (947)
Q Consensus 24 ~C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~ 103 (947)
.|.|.|+ ||..+ +++ ..+|. .+ .++|+.|+|++|.+.+..|..|..+++|++|+|++|++++.++.
T Consensus 3 ~C~~~~~-c~~~~---------~~l-~~ip~-~~--~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~ 68 (549)
T 2z81_A 3 SCDASGV-CDGRS---------RSF-TSIPS-GL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68 (549)
T ss_dssp EECTTSE-EECTT---------SCC-SSCCS-CC--CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred cCCCCce-EECCC---------Ccc-ccccc-cC--CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence 4999999 98532 222 23442 22 27899999999999999999999999999999999999987764
Q ss_pred -cccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCcc-ccccCCccCCCC
Q 002250 104 -LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCS-VTGQIPEGIGNL 181 (947)
Q Consensus 104 -l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l 181 (947)
+..+++|++|+|++|++++..+ ..|.++++|++|+|++|.++..+.|..+.++++|++|++++|. +....+..|.++
T Consensus 69 ~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l 147 (549)
T 2z81_A 69 AFYSLGSLEHLDLSDNHLSSLSS-SWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147 (549)
T ss_dssp TTTTCTTCCEEECTTSCCCSCCH-HHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred hccccccCCEEECCCCccCccCH-HHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence 8999999999999999986655 6799999999999999999877677788999999999999998 454445789999
Q ss_pred CCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCC----ccccccCCCCE
Q 002250 182 TQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDL----SELRFLNQLSS 257 (947)
Q Consensus 182 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~l~~l~~L~~ 257 (947)
++|++|+|++|++++..|..+..+++|++|++++|.+.......+..+++|++|++++|++++.. .....+++|+.
T Consensus 148 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~ 227 (549)
T 2z81_A 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227 (549)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCE
T ss_pred cccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccc
Confidence 99999999999999999999999999999999999987443333567899999999999998742 23456789999
Q ss_pred EEccCccCcccCC----CCccCCCcCcEEEccCccccccC------CcCccCcccccccccccccccCC-----CCCCcc
Q 002250 258 LHLFENQFSGEIP----EEFGEFKHLTELSLYTNRLTGTL------PQKLGSWADFNYVDVSENLLTGP-----IPPDMC 322 (947)
Q Consensus 258 L~L~~N~i~~~~~----~~~~~l~~L~~L~L~~N~l~~~~------p~~l~~l~~L~~L~Ls~N~l~~~-----~p~~~~ 322 (947)
|++++|.+++..+ ..+..+++|+.+++++|.+.+.. ...+..+.+|+.|++.++.+... ++..+.
T Consensus 228 L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~ 307 (549)
T 2z81_A 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307 (549)
T ss_dssp EEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHH
T ss_pred eeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhh
Confidence 9999999886444 34466789999999999987531 23456678888888888876531 111122
Q ss_pred cCCccceeeecccccCCcCCccc-cCCCCccEEEcccccccccCC---CCCCCCCCcceeccccCCcCCCCC--Cccccc
Q 002250 323 KTGAMTDLLVLQNNFNGTVPETY-ANCKSLIRFRVNNNSLSGTIP---PGIWSLPNLSIIDLSTNQFEGPVT--DDIGNA 396 (947)
Q Consensus 323 ~~~~l~~L~l~~n~~~~~~p~~~-~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l 396 (947)
....++.|.+.+|.+. .+|..+ ..+++|+.|++++|.+++..| ..+..+++|+.|+|++|++++..+ ..+..+
T Consensus 308 ~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l 386 (549)
T 2z81_A 308 LLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386 (549)
T ss_dssp HSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC
T ss_pred hcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcC
Confidence 3456777888777765 555544 567888888888888876553 346777888888888888876543 457777
Q ss_pred ccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeec
Q 002250 397 KSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINF 476 (947)
Q Consensus 397 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 476 (947)
++|++|++++|+++ .+|..+..+++|+.|++++|+++ .+|..+. ++|++|+|++|++++.+ ..+++|++|+|
T Consensus 387 ~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~L 458 (549)
T 2z81_A 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYI 458 (549)
T ss_dssp TTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEEC
T ss_pred CCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEEC
Confidence 88888888888887 67777777788888888888877 4444332 57788888888777643 46777888888
Q ss_pred cCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc-ccccceeeCCCCcCCCCCC
Q 002250 477 AQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQLAGPIP 533 (947)
Q Consensus 477 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N~l~~~~p 533 (947)
++|+|+ .+|. ...+++|+.|+|++|++++.+|..+. +++|+.|++++|++++..|
T Consensus 459 s~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 459 SRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 888877 6665 45677788888888888877776554 5777888887777776655
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=471.68 Aligned_cols=464 Identities=19% Similarity=0.162 Sum_probs=401.8
Q ss_pred CCccEEeCcCccCcCCCC-CcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEE
Q 002250 85 TRLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWL 163 (947)
Q Consensus 85 ~~L~~L~Ls~n~i~~~~~-~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L 163 (947)
++++.|||++|.+++..+ .+..+++|++|+|++|++++..+ ..|.++++|++|+|++|.+...+ |..+.++++|++|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~-~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L 105 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED-GAYQSLSHLSTLILTGNPIQSLA-LGAFSGLSSLQKL 105 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECT-TTTTTCTTCCEEECTTCCCCEEC-TTTTTTCTTCCEE
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCc-ccccCchhCCEEeCcCCcCCccC-HhhhcCccccccc
Confidence 589999999999998766 59999999999999999986544 78999999999999999997653 5678999999999
Q ss_pred EccCccccccCCccCCCCCCCCEEECcCccccc-ccCccccCCCCCcEEEeecccccccCCccCCCCCCc----cEEecc
Q 002250 164 YLTNCSVTGQIPEGIGNLTQLQNLELSDNELFG-EIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNL----MNFDVS 238 (947)
Q Consensus 164 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~Ls 238 (947)
++++|.+++..+..++++++|++|+|++|.+++ .+|..|.++++|++|++++|++++..+..|..+++| +.|+++
T Consensus 106 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~ 185 (570)
T 2z63_A 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185 (570)
T ss_dssp ECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECT
T ss_pred cccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccC
Confidence 999999997766689999999999999999987 469999999999999999999998888889988888 899999
Q ss_pred CCCCCCCCccccccCCCCEEEccCccCc-------------------------------ccCCCCccCCC--cCcEEEcc
Q 002250 239 QNRLEGDLSELRFLNQLSSLHLFENQFS-------------------------------GEIPEEFGEFK--HLTELSLY 285 (947)
Q Consensus 239 ~N~l~~~~~~l~~l~~L~~L~L~~N~i~-------------------------------~~~~~~~~~l~--~L~~L~L~ 285 (947)
+|.+++..+......+|+.|++++|... ......+..++ .++.++++
T Consensus 186 ~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 186 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp TCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred CCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 9999886654444447999999988422 11122233332 35677777
Q ss_pred Cc-cccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEccccccccc
Q 002250 286 TN-RLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGT 364 (947)
Q Consensus 286 ~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~ 364 (947)
+| .+.+..|..+..+++|+.|++++|.++ .+|..+..+ .++.|.+.+|.+. .+|. ..+++|+.|++++|.+.+.
T Consensus 266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~ 340 (570)
T 2z63_A 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNA 340 (570)
T ss_dssp ETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCB
T ss_pred cchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCccccc
Confidence 77 777889999999999999999999998 688888888 9999999999988 5554 5788999999999999877
Q ss_pred CCCCCCCCCCcceeccccCCcCCCC--CCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCC-ccc
Q 002250 365 IPPGIWSLPNLSIIDLSTNQFEGPV--TDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIP-LDI 441 (947)
Q Consensus 365 ~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~ 441 (947)
.+. ..+++|+.|++++|++++.. +..+..+++|++|++++|.+++..+ .+..+++|+.|++++|++.+..| ..+
T Consensus 341 ~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~ 417 (570)
T 2z63_A 341 FSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVF 417 (570)
T ss_dssp CCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTT
T ss_pred ccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhh
Confidence 665 78999999999999998654 6778899999999999999995544 49999999999999999997766 578
Q ss_pred ccccccchhhccccccCCCCCcccccccccceeeccCceee-eecCCCCCccCcCcEEECCCCccCCccCCccc-ccccc
Q 002250 442 GKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLS-GKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLS 519 (947)
Q Consensus 442 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~ 519 (947)
.++++|++|+|++|.+.+..|..|..+++|+.|+|++|+++ +.+|..+..+++|+.|+|++|++++.+|..+. +++|+
T Consensus 418 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 497 (570)
T 2z63_A 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497 (570)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCC
Confidence 99999999999999999999999999999999999999998 68999999999999999999999999887775 69999
Q ss_pred eeeCCCCcCCCCCCCccc--ccccccccccCCCCCCCCccc
Q 002250 520 LLDLSNNQLAGPIPEPLN--IKAFIDSFTGNPGLCSKTDEY 558 (947)
Q Consensus 520 ~L~ls~N~l~~~~p~~~~--~~~~~~~~~gN~~~c~~~~~~ 558 (947)
.|++++|++++.+|..+. .......+.+||+.|+|+..+
T Consensus 498 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred EEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence 999999999998887654 233455789999999988643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=441.12 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=204.7
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+.+|++++++++|||||+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---------------~~~~~~~~~~E~~il~~l~HpnIV~ 87 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM---------------SSKEREESRREVAVLANMKHPNIVQ 87 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS---------------CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC---------------CHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 368999999999999999999965 799999999953211 1123467899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..|+||||++||+|.+++...+...+++.....++.||+.||+||| +++||||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~v 164 (350)
T 4b9d_A 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTV 164 (350)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCE
T ss_pred EEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCE
Confidence 9999999999999999999999999998766677899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+|+...... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||... +..+.....
T Consensus 165 Kl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~~i 237 (350)
T 4b9d_A 165 QLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-----SMKNLVLKI 237 (350)
T ss_dssp EECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHH
T ss_pred EEcccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHH
Confidence 999999998654321 1223467999999999999999999999999999999999999999532 233333222
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.... .++.....+..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~----------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 238 ISGS----------FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HcCC----------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2221 11222334456889999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=426.27 Aligned_cols=251 Identities=21% Similarity=0.271 Sum_probs=209.4
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +|+.||||++... ........+.+.+|++++++++|||||++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~--------------~~~~~~~~~~~~~E~~il~~l~HpnIv~l 97 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--------------HIIKENKVPYVTRERDVMSRLDHPFFVKL 97 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHH--------------HCCCHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 57999999999999999999965 7999999998311 11123455789999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++|++++..|+||||++||+|.+++.+. ..+++.....++.||+.||+||| +++|+||||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vK 172 (311)
T 4aw0_A 98 YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQ 172 (311)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEE
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEE
Confidence 99999999999999999999999999874 35889999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||+|+..............+||+.|||||++.+..|+.++||||+||++|||+||+.||... +..+......
T Consensus 173 l~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~~i~ 247 (311)
T 4aw0_A 173 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEGLIFAKII 247 (311)
T ss_dssp ECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHH
T ss_pred EEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHH
Confidence 99999999876554444445678999999999999999999999999999999999999999532 2222222222
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVV 914 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 914 (947)
..... ++.....++.+++.+|++.||++|||+.|+.
T Consensus 248 ~~~~~-----------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 248 KLEYD-----------FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HTCCC-----------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred cCCCC-----------CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 22211 1122334678899999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=432.13 Aligned_cols=253 Identities=24% Similarity=0.288 Sum_probs=204.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.+.|+..++||+|+||+||+|+.+ +|+.||||++... ....+|+.++++++|||||+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~----------------------~~~~~E~~il~~l~HpnIV~ 114 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE----------------------VFRVEELVACAGLSSPRIVP 114 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT----------------------TCCTHHHHTTTTCCCTTBCC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHH----------------------HhHHHHHHHHHhCCCCCCCc
Confidence 456788889999999999999965 6999999998421 11246999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC-C
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW-K 785 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-~ 785 (947)
+++++.+++..|+||||++||+|.++++.. ..+++.....++.||+.||+||| +++||||||||+|||++.++ .
T Consensus 115 l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~ 189 (336)
T 4g3f_A 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSR 189 (336)
T ss_dssp EEEEEEETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCC
T ss_pred EEEEEEECCEEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCE
Confidence 999999999999999999999999999874 35899999999999999999999 89999999999999999987 5
Q ss_pred eEEeccccceecccCCCCc---ceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 786 PRIADFGLAKIVQTGEAGD---LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
+||+|||+|+......... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||...... .-....
T Consensus 190 vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i 268 (336)
T 4g3f_A 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-PLCLKI 268 (336)
T ss_dssp EEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS-CCHHHH
T ss_pred EEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHH
Confidence 9999999998775443211 223457999999999999999999999999999999999999999654321 111111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
. ... +...+.+...+..+.+++.+||+.||++|||+.|++++|..+
T Consensus 269 ~----~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 269 A----SEP--------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp H----HSC--------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----cCC--------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 111 111223344556788999999999999999999999887753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=426.75 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=206.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|+..+.||+|+||+||+|+.+ +|+.||||++.. ......+.+.+|+.++++++|||||++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~-----------------~~~~~~~~~~~Ei~il~~l~HpnIV~l 136 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDL-----------------RKQQRRELLFNEVVIMRDYQHENVVEM 136 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEG-----------------GGCSSGGGGHHHHHHHHHCCCTTBCCE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEec-----------------CchhHHHHHHHHHHHHHhCCCCCCCcE
Confidence 56888899999999999999975 799999999831 122345678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++|.+++..|+||||+++|+|.+++.. ..+++.....++.||+.||+||| +++||||||||+|||++.++.+|
T Consensus 137 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vK 210 (346)
T 4fih_A 137 YNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVK 210 (346)
T ss_dssp EEEEEETTEEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEE
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEE
Confidence 9999999999999999999999999976 35899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||+|+....... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..+......
T Consensus 211 l~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~~i~ 283 (346)
T 4fih_A 211 LSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPLKAMKMIR 283 (346)
T ss_dssp ECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHH
T ss_pred EecCcCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHHH
Confidence 999999987654332 233568999999999999999999999999999999999999999532 2222222111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... +.+ +........+.+++.+||..||++|||+.|++++
T Consensus 284 ~~~~-------~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 284 DNLP-------PRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HSSC-------CCC-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCC-------CCC-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1110 111 1122334568889999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=426.63 Aligned_cols=270 Identities=25% Similarity=0.279 Sum_probs=203.3
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.++|.+.+.||+|+||+||+|+++ |+.||||++.. .......+++|+..+.+++|||||++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~------------------~~~~~~~~e~Ei~~~~~l~HpNIv~l 62 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS------------------REERSWFREAEIYQTVMLRHENILGF 62 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECG------------------GGHHHHHHHHHHHTSTTCCCTTBCCE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECc------------------cchhhHHHHHHHHHHhcCCCCCCCcE
Confidence 356778899999999999999985 89999999831 01112234567777788999999999
Q ss_pred EEEEecCC----ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEeccCCCCCe
Q 002250 708 YCSITSED----SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG-----FDRPVIHRDVKSSNI 778 (947)
Q Consensus 708 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-----~~~~ivH~Dlkp~NI 778 (947)
+|++.+++ ..|+||||+++|+|.++++. ..++|..+.+++.|+|+||+|||+. +.++||||||||+||
T Consensus 63 ~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NI 139 (303)
T 3hmm_A 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139 (303)
T ss_dssp EEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGE
T ss_pred EEEEEecCCCceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccE
Confidence 99998764 46899999999999999986 3589999999999999999999932 134999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCC--cceecccccccccCccccccC------CCCCccchHHHHHHHHHHHhCCCCCC
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAG--DLTHVIAGTHGYIAPEYAYTC------KINEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
|++.++.+||+|||+|+........ ......+||++|||||++.+. .++.++|||||||++|||+||+.||.
T Consensus 140 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred EECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 9999999999999999876554321 122345799999999998754 36779999999999999999988764
Q ss_pred CCCC----------CcccHHHHHHhhccccccccccccCCCCcc--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 851 PEFG----------DSKDIVNWVYSKMDSRDSMLTVVDPNISEI--LKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 851 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
.... .............. ...++.++.. ..+.+..+.+++.+||+.||++||||.||+++|+
T Consensus 220 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~------~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 220 IHEDYQLPYYDLVPSDPSVEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTT------SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred ccccccccchhcccccchHHHHHHHHhc------ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 3211 11111121111111 1122333222 2356678999999999999999999999999999
Q ss_pred ccCCCCc
Q 002250 919 EAEPCSV 925 (947)
Q Consensus 919 ~~~~~~~ 925 (947)
++....+
T Consensus 294 ~l~~~~~ 300 (303)
T 3hmm_A 294 QLSQQEG 300 (303)
T ss_dssp HHHHC--
T ss_pred HHHHHcC
Confidence 8765543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=438.01 Aligned_cols=260 Identities=24% Similarity=0.307 Sum_probs=211.2
Q ss_pred hhccCCcccccccCceeEEEEEeCC------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNS------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.++|++.+.||+|+||+||+|++.. ++.||||++.... .....+.|.+|++++++++|
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~----------------~~~~~~~~~~E~~il~~l~h 126 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----------------THSEHRALMSELKILIHIGH 126 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHHHCC
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----------------ChHHHHHHHHHHHHHHHcCC
Confidence 3678999999999999999998542 3679999984221 11234678999999999976
Q ss_pred -cccceEEEEEecC-CccEEEEeccCCCChHHHhhhcC--------------CccCCHHHHHHHHHHHHHHHHHHhcCCC
Q 002250 702 -VNVVKLYCSITSE-DSNLLVYEYLPNGSLWDRLHTCH--------------KIEMDWVVRYAIAVGAAKGLEYLHHGFD 765 (947)
Q Consensus 702 -~niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~ 765 (947)
||||+++|+|.++ +..++||||+++|+|.++++... ...++|..+..++.|||+||+||| +
T Consensus 127 hpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~ 203 (353)
T 4ase_A 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---S 203 (353)
T ss_dssp CTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---h
Confidence 8999999999764 56899999999999999997642 235899999999999999999999 8
Q ss_pred CCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-
Q 002250 766 RPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT- 844 (947)
Q Consensus 766 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt- 844 (947)
++||||||||+|||+++++.+||+|||+|+...............||++|||||++.+..|+.++|||||||++|||+|
T Consensus 204 ~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~ 283 (353)
T 4ase_A 204 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 283 (353)
T ss_dssp TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred CCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhC
Confidence 9999999999999999999999999999997765544444445679999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 845 GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 845 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
|+.||.... ....+...+... . ..+.+..++.++.+++.+||+.||++||||.|++++|+++
T Consensus 284 G~~Pf~~~~-~~~~~~~~i~~g----~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 284 GASPYPGVK-IDEEFCRRLKEG----T---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp SCCSSTTCC-CSHHHHHHHHHT----C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCC-HHHHHHHHHHcC----C---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 899985432 122222222111 1 1122333456788999999999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=415.98 Aligned_cols=247 Identities=27% Similarity=0.378 Sum_probs=194.8
Q ss_pred CCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEE
Q 002250 632 KPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710 (947)
Q Consensus 632 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 710 (947)
++.+.||+|+||+||+|... +++.||||++.... ......+.|.+|++++++++|||||+++++
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---------------~~~~~~~~~~~E~~il~~l~HpnIV~~~~~ 93 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---------------LTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---------------SCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---------------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 56678999999999999965 68999999984211 111234679999999999999999999999
Q ss_pred Eec----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEeccCCCCCeEec-CC
Q 002250 711 ITS----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRP--VIHRDVKSSNILLD-LE 783 (947)
Q Consensus 711 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dlkp~NIll~-~~ 783 (947)
|.. +...|+||||+++|+|.+++++. ..+++.....++.||+.||+||| +++ ||||||||+|||++ .+
T Consensus 94 ~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~ 168 (290)
T 3fpq_A 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPT 168 (290)
T ss_dssp EEEEETTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTT
T ss_pred EeeccCCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCC
Confidence 865 34579999999999999999874 45899999999999999999999 666 99999999999998 47
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
+.+||+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||... .......
T Consensus 169 g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~----~~~~~~~ 239 (290)
T 3fpq_A 169 GSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC----QNAAQIY 239 (290)
T ss_dssp SCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHHHHH
T ss_pred CCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC----CcHHHHH
Confidence 99999999999754322 2335689999999998864 6999999999999999999999999532 1222221
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
. .+..... . ...+...++++.+++.+||+.||++|||+.|++++
T Consensus 240 ~-~i~~~~~-~-------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 240 R-RVTSGVK-P-------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp H-HHTTTCC-C-------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred H-HHHcCCC-C-------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1111110 0 11112223457889999999999999999999863
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=460.28 Aligned_cols=475 Identities=22% Similarity=0.225 Sum_probs=394.2
Q ss_pred eeccCccccCcCchhhhcCCCccEEeCcCccCcCCCC-CcccccccceeecCCCCccCccCcccccccCCCceeeCCCCC
Q 002250 66 INLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNP 144 (947)
Q Consensus 66 L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~-~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~ 144 (947)
.+.++++++ .+|..+. ++|++|+|++|++++.++ .+..+++|++|+|++|++++..+ ..|.++++|++|+|++|.
T Consensus 10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~ 85 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG-DAFYSLGSLEHLDLSDNH 85 (549)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTSC
T ss_pred EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccCh-hhccccccCCEEECCCCc
Confidence 466778884 4555443 799999999999998765 59999999999999999996655 789999999999999999
Q ss_pred CCCCCCChhhcccccCcEEEccCcccccc-CCccCCCCCCCCEEECcCccccccc-CccccCCCCCcEEEeecccccccC
Q 002250 145 FDPSPFPMEVLKLEKLYWLYLTNCSVTGQ-IPEGIGNLTQLQNLELSDNELFGEI-PAGIVKLNKLWQLELYNNSLSGRL 222 (947)
Q Consensus 145 i~~~~~~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~ 222 (947)
+...+ +..+.++++|++|++++|.+++. .|..++++++|++|+|++|++.+.+ +..|.++++|++|++++|.+++..
T Consensus 86 l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 164 (549)
T 2z81_A 86 LSSLS-SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164 (549)
T ss_dssp CCSCC-HHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEEC
T ss_pred cCccC-HHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccC
Confidence 98643 45589999999999999999963 5778999999999999999844444 468999999999999999999999
Q ss_pred CccCCCCCCccEEeccCCCCCCCCccc-cccCCCCEEEccCccCcccC--C-CCccCCCcCcEEEccCccccccCC----
Q 002250 223 PVGFSNLTNLMNFDVSQNRLEGDLSEL-RFLNQLSSLHLFENQFSGEI--P-EEFGEFKHLTELSLYTNRLTGTLP---- 294 (947)
Q Consensus 223 ~~~~~~l~~L~~L~Ls~N~l~~~~~~l-~~l~~L~~L~L~~N~i~~~~--~-~~~~~l~~L~~L~L~~N~l~~~~p---- 294 (947)
|..+..+++|++|+++.|.+...+..+ ..+++|+.|++++|++++.. | .....+++|+.|++++|.+++..+
T Consensus 165 ~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~ 244 (549)
T 2z81_A 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL 244 (549)
T ss_dssp TTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHH
T ss_pred hhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHH
Confidence 999999999999999999987655543 56899999999999998642 2 233457899999999999986544
Q ss_pred cCccCcccccccccccccccCCC------CCCcccCCccceeeecccccCCc-----CCccccCCCCccEEEcccccccc
Q 002250 295 QKLGSWADFNYVDVSENLLTGPI------PPDMCKTGAMTDLLVLQNNFNGT-----VPETYANCKSLIRFRVNNNSLSG 363 (947)
Q Consensus 295 ~~l~~l~~L~~L~Ls~N~l~~~~------p~~~~~~~~l~~L~l~~n~~~~~-----~p~~~~~l~~L~~L~L~~n~l~~ 363 (947)
..+..+++|+.+++++|.+.+.. ...+..+..++.|.+.++.+... ++..+....+|+.|++++|.+.
T Consensus 245 ~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~- 323 (549)
T 2z81_A 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF- 323 (549)
T ss_dssp GGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-
T ss_pred HHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-
Confidence 44567889999999999987632 12345677888999888876532 2233445678999999999998
Q ss_pred cCCCCC-CCCCCcceeccccCCcCCCCC---CcccccccccEEEccCccccccCC--CCCCCCCcceEEEcccCcccCCC
Q 002250 364 TIPPGI-WSLPNLSIIDLSTNQFEGPVT---DDIGNAKSLALLLLANNRFSGELP--SKISEASSLVSIQLSLNQFSGQI 437 (947)
Q Consensus 364 ~~p~~~-~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~ 437 (947)
.+|..+ ..+++|++|+|++|++.+..+ ..++.+++|++|++++|++++..+ ..+..+++|+.|++++|+++ .+
T Consensus 324 ~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l 402 (549)
T 2z81_A 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PM 402 (549)
T ss_dssp CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CC
T ss_pred cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cC
Confidence 677666 479999999999999997653 447889999999999999985432 45889999999999999999 78
Q ss_pred CcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCcccccc
Q 002250 438 PLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPK 517 (947)
Q Consensus 438 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 517 (947)
|..++.+++|++|+|++|++++ +|..+ .++|+.|+|++|+|++.+ ..+++|+.|+|++|+|+ .+|....+++
T Consensus 403 p~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~~~~l~~ 474 (549)
T 2z81_A 403 PDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPDASLFPV 474 (549)
T ss_dssp CSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCCGGGCTT
T ss_pred ChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCCcccCcc
Confidence 8899999999999999999984 44443 268999999999999643 57899999999999999 6676556799
Q ss_pred cceeeCCCCcCCCCCCCccc--ccccccccccCCCCCCCC
Q 002250 518 LSLLDLSNNQLAGPIPEPLN--IKAFIDSFTGNPGLCSKT 555 (947)
Q Consensus 518 L~~L~ls~N~l~~~~p~~~~--~~~~~~~~~gN~~~c~~~ 555 (947)
|+.|||++|++++.+|+.+. .......+.+|||.|+|+
T Consensus 475 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 99999999999999887654 233455789999999987
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=470.10 Aligned_cols=452 Identities=19% Similarity=0.256 Sum_probs=373.3
Q ss_pred cccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCc-----------ccccccceeecCCCCccCccCcccc
Q 002250 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDL-----------SMLHELSFLNLNSSGISGKFPWKSL 129 (947)
Q Consensus 61 ~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l-----------~~l~~L~~L~L~~n~i~~~~~~~~l 129 (947)
.+++.|+|++|++.|.+|..|+.+++|++|||++|.+......+ ..+..|+ +++++|.+.+.++...-
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~-l~l~~~~l~~~~~~~~~ 159 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR-MHYQKTFVDYDPREDFS 159 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHH-THHHHHHTCCCGGGGSC
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHH-hhHHHhhhccCchhhHH
Confidence 47889999999999999999999999999999999873211111 1134455 55655555544431111
Q ss_pred cccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEEC--cCcccccccCccccCCCC
Q 002250 130 ENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLEL--SDNELFGEIPAGIVKLNK 207 (947)
Q Consensus 130 ~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L--s~N~l~~~~~~~l~~l~~ 207 (947)
..+..+..+++... .+.. .....++.+++ .+|++++ +|..+.++++
T Consensus 160 ~~~~~l~~~~l~~~-------------------------~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~ 207 (636)
T 4eco_A 160 DLIKDCINSDPQQK-------------------------SIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTK 207 (636)
T ss_dssp HHHHHHHHHCTTSC-------------------------CCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTT
T ss_pred HHHHHHhhcCcccc-------------------------cccc------ccccchhhhhhccccCCCcc-CCHHHhcccC
Confidence 12223333333322 2211 11223333334 3689998 8999999999
Q ss_pred CcEEEeeccccccc-----------------CCccCC--CCCCccEEeccCCCCCCC-CccccccCCCCEEEccCcc-Cc
Q 002250 208 LWQLELYNNSLSGR-----------------LPVGFS--NLTNLMNFDVSQNRLEGD-LSELRFLNQLSSLHLFENQ-FS 266 (947)
Q Consensus 208 L~~L~L~~n~l~~~-----------------~~~~~~--~l~~L~~L~Ls~N~l~~~-~~~l~~l~~L~~L~L~~N~-i~ 266 (947)
|++|+|++|.+++. +|..++ ++++|++|+|++|++.+. +..+..+++|++|+|++|+ ++
T Consensus 208 L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~ 287 (636)
T 4eco_A 208 LRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287 (636)
T ss_dssp CCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSC
T ss_pred CCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCc
Confidence 99999999999985 999999 999999999999998774 5579999999999999999 99
Q ss_pred c-cCCCCccCC------CcCcEEEccCccccccCCc--CccCcccccccccccccccCCCCCCcccCCccceeeeccccc
Q 002250 267 G-EIPEEFGEF------KHLTELSLYTNRLTGTLPQ--KLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNF 337 (947)
Q Consensus 267 ~-~~~~~~~~l------~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~ 337 (947)
+ .+|..++.+ ++|++|+|++|+++ .+|. .++.+++|++|++++|.++|.+| .+..+.+|+.|++.+|++
T Consensus 288 ~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l 365 (636)
T 4eco_A 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI 365 (636)
T ss_dssp HHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEE
T ss_pred cccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCcc
Confidence 8 889888876 99999999999999 8999 99999999999999999999999 999999999999999999
Q ss_pred CCcCCccccCCCC-ccEEEcccccccccCCCCCCCCC--CcceeccccCCcCCCCCCccc-------ccccccEEEccCc
Q 002250 338 NGTVPETYANCKS-LIRFRVNNNSLSGTIPPGIWSLP--NLSIIDLSTNQFEGPVTDDIG-------NAKSLALLLLANN 407 (947)
Q Consensus 338 ~~~~p~~~~~l~~-L~~L~L~~n~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~-------~l~~L~~L~L~~N 407 (947)
. .+|..+..+++ |+.|++++|.++ .+|..+..++ +|+.|++++|++.+..|..+. .+.+|++|+|++|
T Consensus 366 ~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N 443 (636)
T 4eco_A 366 T-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNN 443 (636)
T ss_dssp E-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSS
T ss_pred c-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCC
Confidence 8 88999999999 999999999999 7888887755 999999999999999999888 8889999999999
Q ss_pred cccccCCCC-CCCCCcceEEEcccCcccCCCCccccc-c-------cccchhhccccccCCCCCcccc--cccccceeec
Q 002250 408 RFSGELPSK-ISEASSLVSIQLSLNQFSGQIPLDIGK-L-------KKLSSLYLHDNMFSGPLPYSIG--SCVSLTDINF 476 (947)
Q Consensus 408 ~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L 476 (947)
+++ .+|.. +..+++|+.|+|++|+++ .+|..+.. + ++|+.|+|++|+++ .+|..+. .+++|+.|+|
T Consensus 444 ~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~L 520 (636)
T 4eco_A 444 QIS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDL 520 (636)
T ss_dssp CCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEEC
T ss_pred ccC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEEC
Confidence 999 56655 556899999999999999 66654433 2 39999999999999 7888887 9999999999
Q ss_pred cCceeeeecCCCCCccCcCcEEEC------CCCccCCccCCccc-ccccceeeCCCCcCCCCCCCcccccccccccccCC
Q 002250 477 AQNSLSGKIPDSLGSLPSLNSLNL------SNNKFSGEIPISLT-YPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNP 549 (947)
Q Consensus 477 s~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~-~~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~gN~ 549 (947)
++|++++ +|..+.++++|+.|+| ++|++.+.+|..+. +++|+.|+|++|++ +.+|..+........+.+||
T Consensus 521 s~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~ 598 (636)
T 4eco_A 521 SYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNP 598 (636)
T ss_dssp CSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCT
T ss_pred CCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHhCcCCEEECcCCC
Confidence 9999997 9999999999999999 56889999998775 69999999999999 67787665444556788999
Q ss_pred CCCCC
Q 002250 550 GLCSK 554 (947)
Q Consensus 550 ~~c~~ 554 (947)
+.|-.
T Consensus 599 l~~~~ 603 (636)
T 4eco_A 599 NISID 603 (636)
T ss_dssp TCEEE
T ss_pred Ccccc
Confidence 88743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=410.44 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=191.7
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ........+.+|++++++++|||||+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--------------~~~~~~~~~~~Ei~il~~l~HpnIv~ 77 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL--------------AKSDMQGRIEREISYLRLLRHPHIIK 77 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc--------------CCHHHHHHHHHHHHHHHHCCCCCCCe
Confidence 478999999999999999999965 799999999953221 11234567899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..|+||||+ +|+|.+++.+. ..+++.....++.||+.||+||| +++|+||||||+|||+++++.+
T Consensus 78 ~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~v 151 (275)
T 3hyh_A 78 LYDVIKSKDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNV 151 (275)
T ss_dssp EEEEEECSSEEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCE
T ss_pred EEEEEEECCEEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCE
Confidence 999999999999999999 78999999874 45899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||+|+....... ....+||+.|||||++.+..+ +.++||||+||++|||+||+.||... +.......
T Consensus 152 kl~DFGla~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~~~~~ 223 (275)
T 3hyh_A 152 KIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPVLFKN 223 (275)
T ss_dssp EECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred EEeecCCCeecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHH
Confidence 9999999986654322 234689999999999988776 57999999999999999999999532 22222222
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....... ++......+.+++.+|++.||++|||+.|++++
T Consensus 224 i~~~~~~-----------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 224 ISNGVYT-----------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHTCCC-----------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHcCCCC-----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2222111 112234567889999999999999999999873
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=427.72 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=206.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|+..+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.++++++|||||++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-----------------~~~~~~~~~~Ei~il~~l~HpnIV~l 213 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-----------------KQQRRELLFNEVVIMRDYQHENVVEM 213 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST-----------------TCSSGGGHHHHHHHHHHCCCTTBCCE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc-----------------chhHHHHHHHHHHHHHhCCCCCCCce
Confidence 56889999999999999999965 7999999998421 12344678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++|.+++..||||||++||+|.++++. ..+++.....++.||+.||+||| +++||||||||+|||++.++.+|
T Consensus 214 ~~~~~~~~~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vK 287 (423)
T 4fie_A 214 YNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVK 287 (423)
T ss_dssp EEEEEETTEEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEE
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEE
Confidence 9999999999999999999999999975 34899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||+|+....... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..+......
T Consensus 288 l~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~~i~ 360 (423)
T 4fie_A 288 LSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPLKAMKMIR 360 (423)
T ss_dssp ECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHH
T ss_pred EecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHHH
Confidence 999999987654332 233568999999999999999999999999999999999999999532 2222222111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... +.+ .........+.+++.+||..||++|||+.|++++
T Consensus 361 ~~~~-------~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 361 DNLP-------PRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HSCC-------CCC-SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCC-------CCC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1110 111 1112234567889999999999999999999875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=455.66 Aligned_cols=454 Identities=19% Similarity=0.219 Sum_probs=301.7
Q ss_pred eEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCC-CcccccccceeecCC
Q 002250 39 AEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNS 117 (947)
Q Consensus 39 ~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~-~l~~l~~L~~L~L~~ 117 (947)
+.+|+++++++ .+|. .+. ++|+.|+|++|.+.+..|..|..+++|++|+|++|+|++..| .+..+++|++|+|++
T Consensus 3 ~~l~ls~n~l~-~ip~-~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 78 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPK-DLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH 78 (520)
T ss_dssp CEEECTTSCCS-SCCC-SCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCS
T ss_pred ceEecCCCCcc-cccc-ccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCC
Confidence 35777777776 3552 333 788888888888888777888888888888888888887654 478888888888888
Q ss_pred CCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCC--CEEECcCccc-
Q 002250 118 SGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQL--QNLELSDNEL- 194 (947)
Q Consensus 118 n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~Ls~N~l- 194 (947)
|+|+ .+|.. .+++|++|+|++|.+...++|..+.++++|++|++++|.+++ ..+..+++| ++|+|++|.+
T Consensus 79 N~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~ 151 (520)
T 2z7x_B 79 NKLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETY 151 (520)
T ss_dssp SCCC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTT
T ss_pred Ccee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccc
Confidence 8887 44422 678888888888888766667777777888888888877775 355666666 7777777777
Q ss_pred -ccccCccccCCC-CCcEEEeecccccccCCc-cCCCCCCccEEeccCCC-------CCCCCccccccCCCCEEEccCcc
Q 002250 195 -FGEIPAGIVKLN-KLWQLELYNNSLSGRLPV-GFSNLTNLMNFDVSQNR-------LEGDLSELRFLNQLSSLHLFENQ 264 (947)
Q Consensus 195 -~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~-------l~~~~~~l~~l~~L~~L~L~~N~ 264 (947)
.+..|..+..+. +...+++++|.+.+.++. .+..+++|+.|++++|. +.+..+.+..+++|+.|++++|.
T Consensus 152 ~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~ 231 (520)
T 2z7x_B 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE 231 (520)
T ss_dssp TSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEE
T ss_pred ccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccc
Confidence 666666666655 234566677776654443 46667777777777775 44444456666667777776666
Q ss_pred CcccCCCCcc---CCCcCcEEEccCccccccCCcCc-----cCcccccccccccccccCCCCCCcccCCccceeeecccc
Q 002250 265 FSGEIPEEFG---EFKHLTELSLYTNRLTGTLPQKL-----GSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNN 336 (947)
Q Consensus 265 i~~~~~~~~~---~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~ 336 (947)
+++..+..+. ..++|++|++++|++++.+|..+ +.+++|+.+++++|.+ .+|.
T Consensus 232 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~----------------- 292 (520)
T 2z7x_B 232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQ----------------- 292 (520)
T ss_dssp EEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCT-----------------
T ss_pred cCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecch-----------------
Confidence 6542221111 12466666666666666666666 5666666666666655 2331
Q ss_pred cCCcCCccccCC---CCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccc--
Q 002250 337 FNGTVPETYANC---KSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSG-- 411 (947)
Q Consensus 337 ~~~~~p~~~~~l---~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-- 411 (947)
..+..+ .+|+.|++++|.+.+.. .+..+++|++|++++|++++..|..+..+++|++|++++|++++
T Consensus 293 ------~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 364 (520)
T 2z7x_B 293 ------SYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364 (520)
T ss_dssp ------HHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHH
T ss_pred ------hhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccc
Confidence 222222 45666777777665321 12456677777777777776666667777777777777777764
Q ss_pred cCCCCCCCCCcceEEEcccCcccCCCCc-ccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCC
Q 002250 412 ELPSKISEASSLVSIQLSLNQFSGQIPL-DIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLG 490 (947)
Q Consensus 412 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 490 (947)
.+|..+..+++|+.|++++|++++.+|. .+..+++|+.|+|++|++++..|..+. ++|+.|+|++|+++ .+|..+.
T Consensus 365 ~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~ 441 (520)
T 2z7x_B 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV 441 (520)
T ss_dssp HHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGG
T ss_pred cchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhh
Confidence 4455666777777777777777764454 366677777777777777766665554 57777777777777 6677666
Q ss_pred ccCcCcEEECCCCccCCccCCcc-cccccceeeCCCCcCCCCCC
Q 002250 491 SLPSLNSLNLSNNKFSGEIPISL-TYPKLSLLDLSNNQLAGPIP 533 (947)
Q Consensus 491 ~l~~L~~L~Ls~N~l~~~~p~~~-~~~~L~~L~ls~N~l~~~~p 533 (947)
.+++|+.|+|++|++++.++..+ .+++|+.|++++|++++..+
T Consensus 442 ~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 442 KLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp GCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 77777777777777774443323 35777777777777766444
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=453.33 Aligned_cols=434 Identities=19% Similarity=0.226 Sum_probs=370.5
Q ss_pred CceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeec
Q 002250 36 GLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNL 115 (947)
Q Consensus 36 ~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L 115 (947)
.+++.++++++.+.+..| .+|.++++|++|+|++|.|.+..|+.|..+++|++|||++|+|++.++. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWT-SDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCH-HHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccCh-hhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEec
Confidence 689999999999877654 6899999999999999999999999999999999999999999965555 8999999999
Q ss_pred CCCCccCc-cCcccccccCCCceeeCCCCCCCCCCCChhhcccccC--cEEEccCccc--cccCCccCCCCC-CCCEEEC
Q 002250 116 NSSGISGK-FPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKL--YWLYLTNCSV--TGQIPEGIGNLT-QLQNLEL 189 (947)
Q Consensus 116 ~~n~i~~~-~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~p~~~~~l~-~L~~L~L 189 (947)
++|.+++. +| ..+.++++|++|+|++|.+.. ..+..+++| +.|++++|.+ .+..|..+..+. +...|++
T Consensus 98 ~~N~l~~~~~p-~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l 172 (520)
T 2z7x_B 98 SFNAFDALPIC-KEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF 172 (520)
T ss_dssp CSSCCSSCCCC-GGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEEC
T ss_pred cCCccccccch-hhhccCCcceEEEecCcccch----hhccccccceeeEEEeecccccccccccccccccccceEEEEe
Confidence 99999873 45 689999999999999999975 357778888 9999999999 888888888776 3456789
Q ss_pred cCcccccccCc-cccCCCCCcEEEeeccc-------ccccCCccCCCCCCccEEeccCCCCCCCC-cc---ccccCCCCE
Q 002250 190 SDNELFGEIPA-GIVKLNKLWQLELYNNS-------LSGRLPVGFSNLTNLMNFDVSQNRLEGDL-SE---LRFLNQLSS 257 (947)
Q Consensus 190 s~N~l~~~~~~-~l~~l~~L~~L~L~~n~-------l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~---l~~l~~L~~ 257 (947)
++|.+.+.++. .+.++++|+.|++++|. +.+.+| .+..+++|+.|++++|.+++.. .. ....++|++
T Consensus 173 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~ 251 (520)
T 2z7x_B 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251 (520)
T ss_dssp CSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSE
T ss_pred ccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccE
Confidence 99998776554 67889999999999998 776666 7899999999999999887521 11 122469999
Q ss_pred EEccCccCcccCCCCc-----cCCCcCcEEEccCccccccCC-cCccCc---ccccccccccccccCCCCCCcccCCccc
Q 002250 258 LHLFENQFSGEIPEEF-----GEFKHLTELSLYTNRLTGTLP-QKLGSW---ADFNYVDVSENLLTGPIPPDMCKTGAMT 328 (947)
Q Consensus 258 L~L~~N~i~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p-~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~~~~l~ 328 (947)
|++++|++++.+|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+....
T Consensus 252 L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~----------- 318 (520)
T 2z7x_B 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML----------- 318 (520)
T ss_dssp EEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC-----------
T ss_pred EEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc-----------
Confidence 9999999999999998 8999999999999999 556 455554 67999999999876311
Q ss_pred eeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCC--CCCCcccccccccEEEccC
Q 002250 329 DLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEG--PVTDDIGNAKSLALLLLAN 406 (947)
Q Consensus 329 ~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~ 406 (947)
.+..+++|++|++++|.+++..|..+..+++|+.|+|++|++++ ..|..+..+++|++|++++
T Consensus 319 ---------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~ 383 (520)
T 2z7x_B 319 ---------------CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQ 383 (520)
T ss_dssp ---------------CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCS
T ss_pred ---------------chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCC
Confidence 12467788999999999998888889999999999999999986 4456788899999999999
Q ss_pred ccccccCCC-CCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeec
Q 002250 407 NRFSGELPS-KISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKI 485 (947)
Q Consensus 407 N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 485 (947)
|++++.+|. .+..+++|+.|++++|++++.+|..+. ++|+.|+|++|+++ .+|..+..+++|++|+|++|+|+ .+
T Consensus 384 N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l 459 (520)
T 2z7x_B 384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SV 459 (520)
T ss_dssp SCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CC
T ss_pred CcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-cc
Confidence 999975665 488899999999999999888877665 79999999999999 78888889999999999999999 56
Q ss_pred CCC-CCccCcCcEEECCCCccCCccC
Q 002250 486 PDS-LGSLPSLNSLNLSNNKFSGEIP 510 (947)
Q Consensus 486 p~~-~~~l~~L~~L~Ls~N~l~~~~p 510 (947)
|.. +..+++|+.|+|++|++++..+
T Consensus 460 ~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 460 PDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CHHHhccCCcccEEECcCCCCcccCC
Confidence 665 9999999999999999997654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=417.79 Aligned_cols=244 Identities=25% Similarity=0.298 Sum_probs=193.1
Q ss_pred hccCCcccccccCceeEEEEEeC----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|++.+.||+|+||+||+|+.. +++.||||++.... ........+.+|++++++++||||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---------------~~~~~~~~~~~E~~il~~l~HpnI 88 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT---------------LKVRDRVRTKMERDILVEVNHPFI 88 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEE---------------EEEEECC------CCCCCCCCTTE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHH---------------cChHHHHHHHHHHHHHHHCCCCCC
Confidence 57999999999999999999852 47889999984221 111223467889999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
|++++++.+++..|+||||++||+|.+++.+. ..+++.....++.||+.||+||| +++|+||||||+|||++.++
T Consensus 89 v~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g 163 (304)
T 3ubd_A 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEG 163 (304)
T ss_dssp ECEEEEEEETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTS
T ss_pred CeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCC
Confidence 99999999999999999999999999999874 35899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
.+||+|||+|+....... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||... +..+...
T Consensus 164 ~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~ 236 (304)
T 3ubd_A 164 HIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-----DRKETMT 236 (304)
T ss_dssp CEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHH
T ss_pred CEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-----CHHHHHH
Confidence 999999999986543322 223468999999999999999999999999999999999999999532 2223222
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
........ ++...+.++.+++.+||+.||++|||+
T Consensus 237 ~i~~~~~~-----------~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 237 MILKAKLG-----------MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp HHHHCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred HHHcCCCC-----------CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 22222111 122234568889999999999999985
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=453.29 Aligned_cols=530 Identities=19% Similarity=0.175 Sum_probs=351.5
Q ss_pred CCccccccccCCCCCcccceeeeCCCCceeEeccCCCccccccCcccccCC-cccceeeccCccccCcCchhhhcCCCcc
Q 002250 10 SDTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGL-QALQKINLGTNFLYGTITEGLKSCTRLQ 88 (947)
Q Consensus 10 ~~~~~~~sw~~~~~~C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l-~~L~~L~L~~n~i~~~~~~~l~~l~~L~ 88 (947)
|+...+++|..+... .|....|...+. ..+-++.+++. +|. ++ ++++.|+|++|.|++..+..|..+++|+
T Consensus 8 ~~~~~~~~~~~~~p~-~~~~c~~~~~~~--~~~c~~~~l~~-vP~----~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~ 79 (635)
T 4g8a_A 8 DDDDKLAAANSSIPE-SWEPCVEVVPNI--TYQCMELNFYK-IPD----NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQ 79 (635)
T ss_dssp ------------------CCSEEEETTT--EEECTTSCCSS-CCS----SSCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCcchhhcccCCCCC-CCCCccccCCCC--EEECCCCCcCc-cCC----CCCcCCCEEEeeCCCCCCCCHHHHhCCCCCC
Confidence 566778888754432 244433332221 12333333332 221 12 2566666666666666666666666666
Q ss_pred EEeCcCccCcCCCCC-cccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccC
Q 002250 89 VLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTN 167 (947)
Q Consensus 89 ~L~Ls~n~i~~~~~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~ 167 (947)
+|||++|+|++.++. |.+|++|++|+|++|+|++ +|...|.++++|++|+|++|+++..+ +..+.++++|++|+|++
T Consensus 80 ~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~-l~~~~f~~L~~L~~L~Ls~N~l~~l~-~~~~~~L~~L~~L~Ls~ 157 (635)
T 4g8a_A 80 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLE-NFPIGHLKTLKELNVAH 157 (635)
T ss_dssp EEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE-ECGGGGTTCTTCCEEECTTSCCCCST-TCCCTTCTTCCEEECCS
T ss_pred EEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC-CCHHHhcCCCCCCEEECCCCcCCCCC-hhhhhcCcccCeecccc
Confidence 666666666665543 6666666666666666653 33355666666666666666665432 33456666666666666
Q ss_pred cccccc-CCccCCCCCCCCEEECcCcccccccCccccCCCCC----cEEEeecccccccCCccCCCCCCccEEeccCCCC
Q 002250 168 CSVTGQ-IPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKL----WQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRL 242 (947)
Q Consensus 168 n~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L----~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 242 (947)
|.+++. +|..++.+++|++|+|++|+|++..+..+..+.++ ..++++.|.++...+..+. ...++.|++++|..
T Consensus 158 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~-~~~~~~l~l~~n~~ 236 (635)
T 4g8a_A 158 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLHKLTLRNNFD 236 (635)
T ss_dssp SCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTT-TCEEEEEEEESCCS
T ss_pred CccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCccccc-chhhhhhhhhcccc
Confidence 666542 45566666666666666666666555555544332 3566666666644333332 23445555555533
Q ss_pred CC--------------------------------CCccccccCCCCEEEccCccCc---ccCCCCccCCCcCcEEEccCc
Q 002250 243 EG--------------------------------DLSELRFLNQLSSLHLFENQFS---GEIPEEFGEFKHLTELSLYTN 287 (947)
Q Consensus 243 ~~--------------------------------~~~~l~~l~~L~~L~L~~N~i~---~~~~~~~~~l~~L~~L~L~~N 287 (947)
.. ....+..+..+..+.+..+... ...+..+..+.+++.+++.+|
T Consensus 237 ~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~ 316 (635)
T 4g8a_A 237 SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSV 316 (635)
T ss_dssp SHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESC
T ss_pred cccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccc
Confidence 21 0112233334444444433322 123445566778888888888
Q ss_pred cccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccc--cC
Q 002250 288 RLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSG--TI 365 (947)
Q Consensus 288 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~--~~ 365 (947)
.+... ..+.....|+.|++++|.+.+..+. .+..+..+.+..|..... .....+++|+.|++++|.+.. ..
T Consensus 317 ~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~ 389 (635)
T 4g8a_A 317 TIERV--KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCC 389 (635)
T ss_dssp EEEEC--GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEEC
T ss_pred ccccc--cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhcccccccccc
Confidence 87633 2355667888999999988754443 345677777877776543 335578899999999999864 34
Q ss_pred CCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCC-CCCCCCCcceEEEcccCcccCCCCcccccc
Q 002250 366 PPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELP-SKISEASSLVSIQLSLNQFSGQIPLDIGKL 444 (947)
Q Consensus 366 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 444 (947)
+..+..+.+|+.++++.|.+.. .+..+..+++|+.+++++|+.....+ ..+..+++++.++++.|.+.+..+..+..+
T Consensus 390 ~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~ 468 (635)
T 4g8a_A 390 SQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 468 (635)
T ss_dssp CHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTC
T ss_pred ccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccc
Confidence 4556678899999999999875 45568889999999999988876554 468899999999999999999999999999
Q ss_pred cccchhhcccccc-CCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc-ccccceee
Q 002250 445 KKLSSLYLHDNMF-SGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLD 522 (947)
Q Consensus 445 ~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ 522 (947)
+.|+.|+|++|.+ .+..|..|..+++|++|+|++|+|++.+|..|.++++|+.|+|++|+|++.+|..+. +++|++||
T Consensus 469 ~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 548 (635)
T 4g8a_A 469 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 548 (635)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEE
T ss_pred hhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEE
Confidence 9999999999984 456788999999999999999999999999999999999999999999998887775 69999999
Q ss_pred CCCCcCCCCCCCcccc---cccccccccCCCCCCCCccc
Q 002250 523 LSNNQLAGPIPEPLNI---KAFIDSFTGNPGLCSKTDEY 558 (947)
Q Consensus 523 ls~N~l~~~~p~~~~~---~~~~~~~~gN~~~c~~~~~~ 558 (947)
|++|+|++.+|+.+.. ......+.+|||.|+|...|
T Consensus 549 Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~ 587 (635)
T 4g8a_A 549 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQS 587 (635)
T ss_dssp CTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHH
T ss_pred CCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHH
Confidence 9999999999987642 23345788999999998766
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=411.06 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=191.0
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
..+|++.+.||+|+||+||+|+.+ +|+.||||++... ......+.+.+|++++++++|||||+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----------------~~~~~~~~~~~E~~il~~l~HpnIV~ 67 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP----------------NRELAREKVMREVKALAKLEHPGIVR 67 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC----------------SSHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc----------------CCHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 456899999999999999999965 7999999998421 11123457889999999999999999
Q ss_pred EEEEEecCCc------------cEEEEeccCCCChHHHhhhcCC-ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccC
Q 002250 707 LYCSITSEDS------------NLLVYEYLPNGSLWDRLHTCHK-IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDV 773 (947)
Q Consensus 707 l~~~~~~~~~------------~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl 773 (947)
++++|.+.+. .|+||||+++|+|.+++..... ...++.....++.||+.||+||| +++||||||
T Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDl 144 (299)
T 4g31_A 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDL 144 (299)
T ss_dssp EEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCC
T ss_pred EEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccC
Confidence 9999876543 5899999999999999987543 34567778899999999999999 899999999
Q ss_pred CCCCeEecCCCCeEEeccccceecccCCCCc----------ceecccccccccCccccccCCCCCccchHHHHHHHHHHH
Q 002250 774 KSSNILLDLEWKPRIADFGLAKIVQTGEAGD----------LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELV 843 (947)
Q Consensus 774 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell 843 (947)
||+|||++.++.+||+|||+|+......... .....+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 145 Kp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell 224 (299)
T 4g31_A 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224 (299)
T ss_dssp CGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred cHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHc
Confidence 9999999999999999999998765432211 123457999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 844 TGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 844 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
+ ||.. ..+....... +.+...++...+..+...+++.+||+.||++|||+.|+++
T Consensus 225 ~---Pf~~----~~~~~~~~~~----------~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 225 Y---PFST----QMERVRTLTD----------VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp S---CCSS----HHHHHHHHHH----------HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c---CCCC----ccHHHHHHHH----------HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 6 7632 1111111111 1112223334445556778999999999999999999987
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=434.98 Aligned_cols=453 Identities=18% Similarity=0.199 Sum_probs=317.7
Q ss_pred eEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCC-cccccccceeecCC
Q 002250 39 AEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNS 117 (947)
Q Consensus 39 ~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~-l~~l~~L~~L~L~~ 117 (947)
..++++++++++ +|. .+. ++|+.|+|++|.|.+..+..|..+++|++|+|++|+|++..+. +..+++|++|+|++
T Consensus 34 ~~l~ls~~~L~~-ip~-~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPK-DLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CEEECTTSCCCS-CCT-TSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred cEEEcCCCCCcc-CCC-CCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 678888888775 553 232 7889999999999888888899999999999999999887554 88888899999999
Q ss_pred CCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCC--CEEECcCccc-
Q 002250 118 SGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQL--QNLELSDNEL- 194 (947)
Q Consensus 118 n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~Ls~N~l- 194 (947)
|+|+ .+|.. .+++|++|+|++|++...+.|..+.++++|++|++++|.+++. .+..+++| ++|+|++|++
T Consensus 110 N~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~ 182 (562)
T 3a79_B 110 NRLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYH 182 (562)
T ss_dssp SCCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCC
T ss_pred CcCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccc
Confidence 9887 45523 7888888888888888766677788888888888888888753 34444555 8888888887
Q ss_pred -ccccCccccCCC-CCcEEEeecccccccCCc-cCCCCCCccEEeccCCCC-----CCCCccccccCCCCEEEccCccCc
Q 002250 195 -FGEIPAGIVKLN-KLWQLELYNNSLSGRLPV-GFSNLTNLMNFDVSQNRL-----EGDLSELRFLNQLSSLHLFENQFS 266 (947)
Q Consensus 195 -~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l-----~~~~~~l~~l~~L~~L~L~~N~i~ 266 (947)
++..|..+..+. ..-.+++++|.+.+.++. .+..+++|+.|++++|+. .+....+..+++|+.|+|+++.+.
T Consensus 183 ~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~ 262 (562)
T 3a79_B 183 IKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262 (562)
T ss_dssp CCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEEC
T ss_pred ccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCc
Confidence 777777777654 122457777777664443 356677777777777742 222334555666666666666554
Q ss_pred ccC----CCCccCCCcCcEEEccCccccccCCcCc-----cCcccccccccccccccCCCCCCcccCCccceeeeccccc
Q 002250 267 GEI----PEEFGEFKHLTELSLYTNRLTGTLPQKL-----GSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNF 337 (947)
Q Consensus 267 ~~~----~~~~~~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~ 337 (947)
+.. +..+ ..++|++|++++|.+++.+|..+ ..++.|+.++++.|.+ .+|.
T Consensus 263 ~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~------------------ 321 (562)
T 3a79_B 263 WKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSK------------------ 321 (562)
T ss_dssp HHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCH------------------
T ss_pred HHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecCh------------------
Confidence 311 1111 12356666666666665566555 4444444444444443 1221
Q ss_pred CCcCCcccc---CCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccc--c
Q 002250 338 NGTVPETYA---NCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSG--E 412 (947)
Q Consensus 338 ~~~~p~~~~---~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~ 412 (947)
..+. ...+|+.|++++|.+.... ....+++|++|++++|++++..|..+..+++|++|++++|++++ .
T Consensus 322 -----~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 394 (562)
T 3a79_B 322 -----EALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFK 394 (562)
T ss_dssp -----HHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTH
T ss_pred -----hhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCccc
Confidence 1111 1246778888888775322 12567788888888888888777888888888888888888875 2
Q ss_pred CCCCCCCCCcceEEEcccCcccCCCCc-ccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCc
Q 002250 413 LPSKISEASSLVSIQLSLNQFSGQIPL-DIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGS 491 (947)
Q Consensus 413 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 491 (947)
+|..+..+++|+.|++++|++++.+|. .+..+++|+.|+|++|++++..|..+. ++|+.|+|++|+|+ .+|..+..
T Consensus 395 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~ 471 (562)
T 3a79_B 395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTH 471 (562)
T ss_dssp HHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTS
T ss_pred chhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcC
Confidence 346678888888888888888874554 477788888888888888877766554 68888888888888 67777778
Q ss_pred cCcCcEEECCCCccCCccCCcc-cccccceeeCCCCcCCCCCC
Q 002250 492 LPSLNSLNLSNNKFSGEIPISL-TYPKLSLLDLSNNQLAGPIP 533 (947)
Q Consensus 492 l~~L~~L~Ls~N~l~~~~p~~~-~~~~L~~L~ls~N~l~~~~p 533 (947)
+++|+.|+|++|+|++.++..+ .+++|+.|++++|++++..|
T Consensus 472 l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 472 LQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp SCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 8888888888888885444424 35888888888888877655
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=439.19 Aligned_cols=397 Identities=21% Similarity=0.260 Sum_probs=277.0
Q ss_pred cceeeccC--ccccCcCchhhhcCCCccEEeCcCccCcC------------------CCCCcc--cccccceeecCCCCc
Q 002250 63 LQKINLGT--NFLYGTITEGLKSCTRLQVLDLGNNSFSG------------------EVPDLS--MLHELSFLNLNSSGI 120 (947)
Q Consensus 63 L~~L~L~~--n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~------------------~~~~l~--~l~~L~~L~L~~n~i 120 (947)
++.+.+.. |++.+ +|..|+++++|++|+|++|+|++ .++.++ ++++|++|+|++|.+
T Consensus 425 l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l 503 (876)
T 4ecn_A 425 LKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPN 503 (876)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTT
T ss_pred hhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCC
Confidence 34444433 77777 78888888888888888888888 555566 788888888888887
Q ss_pred cCccCcccccccCCCceeeCCCCC-CCCCCCChhhcccc-------cCcEEEccCccccccCCc--cCCCCCCCCEEECc
Q 002250 121 SGKFPWKSLENLTNLEFLSLGDNP-FDPSPFPMEVLKLE-------KLYWLYLTNCSVTGQIPE--GIGNLTQLQNLELS 190 (947)
Q Consensus 121 ~~~~~~~~l~~l~~L~~L~Ls~n~-i~~~~~~~~~~~l~-------~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls 190 (947)
.+.+| ..|.++++|++|+|++|+ ++...+|..+..++ +|+.|+|++|.++ .+|. .|+++++|++|+|+
T Consensus 504 ~~~iP-~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls 581 (876)
T 4ecn_A 504 MTQLP-DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCV 581 (876)
T ss_dssp CCSCC-GGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECT
T ss_pred CccCh-HHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECC
Confidence 77777 677888888888888887 54313555555554 7777777777777 6676 77777777777777
Q ss_pred CcccccccCccccCCCCCcEEEeecccccccCCccCCCCCC-ccEEeccCCCCCCCCccccccC--CCCEEEccCccCcc
Q 002250 191 DNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTN-LMNFDVSQNRLEGDLSELRFLN--QLSSLHLFENQFSG 267 (947)
Q Consensus 191 ~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~l~~l~--~L~~L~L~~N~i~~ 267 (947)
+|+++ .+| .|..+++|++|+|++|+++ .+|..+..+++ |++|+|++|+++..+..+..++ +|+.|+|++|++.+
T Consensus 582 ~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~~~~~~~~~~L~~L~Ls~N~l~g 658 (876)
T 4ecn_A 582 HNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS 658 (876)
T ss_dssp TSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCSCCCTTCSSCEEEEECCSSCTTT
T ss_pred CCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCchhhhccccCCCCEEECcCCcCCC
Confidence 77776 666 7777777777777777777 66777777777 7777777777776655555543 37777777777776
Q ss_pred cCCCCc---c--CCCcCcEEEccCccccccCCcCc-cCcccccccccccccccCCCCCCcccCCccceeeecccccCCcC
Q 002250 268 EIPEEF---G--EFKHLTELSLYTNRLTGTLPQKL-GSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTV 341 (947)
Q Consensus 268 ~~~~~~---~--~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~ 341 (947)
.+|... . .+++|+.|+|++|+++ .+|..+ ..+++|+.|+|++|.++ .+|..++...
T Consensus 659 ~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~---------------- 720 (876)
T 4ecn_A 659 EGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPK---------------- 720 (876)
T ss_dssp TSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCT----------------
T ss_pred ccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccc----------------
Confidence 554322 2 2346777777777777 555544 36677777777777776 5554433211
Q ss_pred CccccCCCCccEEEcccccccccCCCCCC--CCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCC
Q 002250 342 PETYANCKSLIRFRVNNNSLSGTIPPGIW--SLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISE 419 (947)
Q Consensus 342 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 419 (947)
+..+.++++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+
T Consensus 721 ~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~----------- 787 (876)
T 4ecn_A 721 DGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR----------- 787 (876)
T ss_dssp TSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB-----------
T ss_pred cccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC-----------
Confidence 112345568899999999988 6777776 88899999999999987 67778888888888888765
Q ss_pred CCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEE
Q 002250 420 ASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLN 499 (947)
Q Consensus 420 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 499 (947)
++++|++.+.+|..|+++++|+.|+|++|++ +.+|..+. ++|+.|||++|++....+..+.....+..+.
T Consensus 788 -------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~ 857 (876)
T 4ecn_A 788 -------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYV 857 (876)
T ss_dssp -------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCE
T ss_pred -------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchhee
Confidence 4556666666666666666666666666666 45565554 4677777777766655556665555566666
Q ss_pred CCCCccC
Q 002250 500 LSNNKFS 506 (947)
Q Consensus 500 Ls~N~l~ 506 (947)
|.+|++.
T Consensus 858 L~~n~~~ 864 (876)
T 4ecn_A 858 LLYDKTQ 864 (876)
T ss_dssp EECCTTS
T ss_pred ecCCCcc
Confidence 6666654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=425.90 Aligned_cols=461 Identities=20% Similarity=0.172 Sum_probs=348.8
Q ss_pred CCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCC-CcccccccceeecCCCCccCccCcccccccCCCce
Q 002250 59 GLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEF 137 (947)
Q Consensus 59 ~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~-~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~ 137 (947)
.....+.+++++|++++ +|..+. ++|++|+|++|.|++.++ .+..+++|++|+|++|+|++..| ..|.++++|++
T Consensus 29 ~~~~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~ 104 (562)
T 3a79_B 29 SNELESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDF-HVFLFNQDLEY 104 (562)
T ss_dssp ----CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECT-TTTTTCTTCCE
T ss_pred ccCCCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCH-HHhCCCCCCCE
Confidence 34445889999999975 565554 899999999999998775 58999999999999999986655 78999999999
Q ss_pred eeCCCCCCCCCCCChhhcccccCcEEEccCcccccc-CCccCCCCCCCCEEECcCcccccccCccccCCCCC--cEEEee
Q 002250 138 LSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQ-IPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKL--WQLELY 214 (947)
Q Consensus 138 L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L--~~L~L~ 214 (947)
|+|++|.++. +|.. .+++|++|+|++|++++. +|..|+++++|++|+|++|++++. .+..+++| ++|+|+
T Consensus 105 L~Ls~N~l~~--lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~ 177 (562)
T 3a79_B 105 LDVSHNRLQN--ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLD 177 (562)
T ss_dssp EECTTSCCCE--ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEE
T ss_pred EECCCCcCCc--cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEee
Confidence 9999999975 4444 789999999999999863 467899999999999999998754 34445555 999999
Q ss_pred cccc--cccCCccCCCCC--CccEEeccCCCCCCCCc--cccccCCCCEEEccCcc-----CcccCCCCccCCCcCcEEE
Q 002250 215 NNSL--SGRLPVGFSNLT--NLMNFDVSQNRLEGDLS--ELRFLNQLSSLHLFENQ-----FSGEIPEEFGEFKHLTELS 283 (947)
Q Consensus 215 ~n~l--~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~--~l~~l~~L~~L~L~~N~-----i~~~~~~~~~~l~~L~~L~ 283 (947)
+|.+ ++..|..|..+. .| .++++.|.+.+... .+..+++|+.|++++|+ +.+ ....+..+++|+.|+
T Consensus 178 ~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~ 255 (562)
T 3a79_B 178 LVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVT 255 (562)
T ss_dssp ESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEE
T ss_pred cccccccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEE
Confidence 9998 777787777665 33 56778888776443 35567778888888874 222 123466677777777
Q ss_pred ccCccccccC----CcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccc
Q 002250 284 LYTNRLTGTL----PQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNN 359 (947)
Q Consensus 284 L~~N~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n 359 (947)
++++.+++.. +..+ ..++|++|++++|.+++.+|..+... ....++.|+.+++..|
T Consensus 256 L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~-------------------~~~~L~~L~~~~~~~~ 315 (562)
T 3a79_B 256 LQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTY-------------------SETALKSLMIEHVKNQ 315 (562)
T ss_dssp EEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCC-------------------CSCSCCEEEEEEEEEC
T ss_pred ecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhc-------------------ccccchheehhhcccc
Confidence 7777665321 1111 12366666666666665555443211 0156677777777777
Q ss_pred cccccCC-CCCCC---CCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccC
Q 002250 360 SLSGTIP-PGIWS---LPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSG 435 (947)
Q Consensus 360 ~l~~~~p-~~~~~---l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 435 (947)
.+ .+| ..+.. ..+|+.|++++|.+.... ....+++|++|++++|++++.+|..+..+++|+.|+|++|++++
T Consensus 316 ~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 391 (562)
T 3a79_B 316 VF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN 391 (562)
T ss_dssp CC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCB
T ss_pred ee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCC
Confidence 77 334 22222 267999999999987433 23688999999999999999899999999999999999999996
Q ss_pred --CCCcccccccccchhhccccccCCCCC-cccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCc
Q 002250 436 --QIPLDIGKLKKLSSLYLHDNMFSGPLP-YSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPIS 512 (947)
Q Consensus 436 --~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 512 (947)
.+|..++++++|+.|+|++|++++.+| ..+..+++|++|+|++|++++.+|..+. ++|+.|+|++|+++..++..
T Consensus 392 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~ 469 (562)
T 3a79_B 392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDV 469 (562)
T ss_dssp TTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTT
T ss_pred cccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhh
Confidence 335679999999999999999998555 4588999999999999999988888765 79999999999999555555
Q ss_pred ccccccceeeCCCCcCCCCCCCccc--ccccccccccCCCCCCCCccc
Q 002250 513 LTYPKLSLLDLSNNQLAGPIPEPLN--IKAFIDSFTGNPGLCSKTDEY 558 (947)
Q Consensus 513 ~~~~~L~~L~ls~N~l~~~~p~~~~--~~~~~~~~~gN~~~c~~~~~~ 558 (947)
..+++|+.|+|++|+|++.++..+. .......+.+|||.|+|+..|
T Consensus 470 ~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~ 517 (562)
T 3a79_B 470 THLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIR 517 (562)
T ss_dssp TSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHH
T ss_pred cCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchHH
Confidence 5679999999999999965544243 223345788999999987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=398.04 Aligned_cols=265 Identities=20% Similarity=0.277 Sum_probs=198.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ......+.+.+|++++++++|||||++
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~---------------~~~~~~~~~~~Ei~il~~l~HpnIv~l 118 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF---------------DVVTNAKRTLRELKILKHFKHDNIIAI 118 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT---------------SSHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc---------------cchHHHHHHHHHHHHHHhcCCCCcceE
Confidence 57999999999999999999965 79999999984211 111233567899999999999999999
Q ss_pred EEEEec------CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 708 YCSITS------EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 708 ~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
++++.. .+..|+||||++ |+|.+++... ..+++.....++.||+.||+||| +++||||||||+|||++
T Consensus 119 ~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~ 192 (398)
T 4b99_A 119 KDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVN 192 (398)
T ss_dssp EEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEEC
T ss_pred eeeeecccccccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccC
Confidence 999764 356799999995 6899999863 46899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCC--CcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 782 LEWKPRIADFGLAKIVQTGEA--GDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
.++.+||+|||+|+....... .......+||+.|||||++.+.. ++.++||||+||++|||++|+.||.+.. ..+
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--~~~ 270 (398)
T 4b99_A 193 ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--YVH 270 (398)
T ss_dssp TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHH
T ss_pred CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--HHH
Confidence 999999999999986643321 22233568999999999988754 6899999999999999999999995431 111
Q ss_pred HHHHHHhhc-ccccccccc------------ccCCC----CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 859 IVNWVYSKM-DSRDSMLTV------------VDPNI----SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 859 ~~~~~~~~~-~~~~~~~~~------------~d~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....+.... ......... +.+.. ..........+.+++.+|+..||++|||+.|++++
T Consensus 271 ~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 271 QLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111111110 000000000 00000 01111223567889999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=392.57 Aligned_cols=200 Identities=28% Similarity=0.441 Sum_probs=170.3
Q ss_pred HHhhccCCcccccccCceeEEEEEeC----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-c
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-R 700 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 700 (947)
.+.++|++.+.||+|+||+||+|+.+ +++.||||++.+ ......+.+|+++++.+ +
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~-------------------~~~~~~~~~E~~~l~~~~~ 78 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIP-------------------TSHPIRIAAELQCLTVAGG 78 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECT-------------------TSCHHHHHHHHHHHHHTCS
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcc-------------------ccCHHHHHHHHHHHHHhcC
Confidence 34578999999999999999999853 467899998832 12345678999999998 6
Q ss_pred ccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 701 HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 701 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
|||||+++++|.+++..|+||||+++|+|.+++.. +++.....++.|++.||+||| +++|+||||||+|||+
T Consensus 79 h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl 150 (361)
T 4f9c_A 79 QDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLY 150 (361)
T ss_dssp BTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEE
Confidence 99999999999999999999999999999999954 788899999999999999999 8999999999999999
Q ss_pred cCC-CCeEEeccccceecccCCCC--------------------------cceecccccccccCccccccC-CCCCccch
Q 002250 781 DLE-WKPRIADFGLAKIVQTGEAG--------------------------DLTHVIAGTHGYIAPEYAYTC-KINEKSDV 832 (947)
Q Consensus 781 ~~~-~~~kl~DfG~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv 832 (947)
+.+ +.+||+|||+|+........ ......+||+.|||||++.+. .|+.++||
T Consensus 151 ~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~Di 230 (361)
T 4f9c_A 151 NRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDM 230 (361)
T ss_dssp ETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHH
T ss_pred eCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccch
Confidence 877 79999999999865433211 112235799999999999875 48999999
Q ss_pred HHHHHHHHHHHhCCCCCCCC
Q 002250 833 YSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 833 ~slGv~l~elltg~~p~~~~ 852 (947)
||+||++|||++|+.||.+.
T Consensus 231 WSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 231 WSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp HHHHHHHHHHHHTCSSSSCC
T ss_pred hhhHHHHHHHHHCCCCCCCC
Confidence 99999999999999999654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=405.80 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=198.9
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHH---HHHHHHhhccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD---AEVATLSAVRHVN 703 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~n 703 (947)
.++|++.+.||+|+||+||+|+.+ +|+.||||++... .+. .......+. .++.+++.++|||
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~------------~i~--~~~~~~~~~~E~~~l~ll~~~~HP~ 253 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK------------RIK--MKQGETLALNERIMLSLVSTGDCPF 253 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH------------HHH--HTTCHHHHHHHHHHHHHHSSSCCTT
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHH------------Hcc--hhhhHHHHHHHHHHHHHHhhCCCCC
Confidence 367999999999999999999966 6999999998311 011 112223333 3466677789999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
||+++++|.+++..|+||||++||+|.+++... ..+++.....++.||+.||+||| +++||||||||+|||++.+
T Consensus 254 IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~ 328 (689)
T 3v5w_A 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEH 328 (689)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTT
T ss_pred EeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCC
Confidence 999999999999999999999999999999874 35889999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
|.+||+|||+|+...... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||...... +....
T Consensus 329 G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--~~~~i 402 (689)
T 3v5w_A 329 GHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEI 402 (689)
T ss_dssp SCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--CHHHH
T ss_pred CCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHH
Confidence 999999999998765443 234689999999999975 46999999999999999999999999643221 12222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-----MRVVVQ 915 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 915 (947)
......... .++......+.+++.+|++.||.+|++ +.||.+
T Consensus 403 ~~~i~~~~~-----------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 403 DRMTLTMAV-----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHhhcCCCC-----------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111111111 112223456788999999999999998 577654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=394.84 Aligned_cols=404 Identities=23% Similarity=0.241 Sum_probs=173.4
Q ss_pred CCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCC-CcccccccceeecCCCCccCccCcccccccCCCce
Q 002250 59 GLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEF 137 (947)
Q Consensus 59 ~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~-~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~ 137 (947)
..++|+.|++++|.+ +.+|..++++++|++|+|++|++++..| .++.+++|+.+++..|.. .+|++
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~------------~~l~~ 75 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD------------RQAHE 75 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH------------HTCSE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc------------cCCCE
Confidence 457888888888888 8888888888888888888888887555 477777764444333321 22344
Q ss_pred eeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeeccc
Q 002250 138 LSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNS 217 (947)
Q Consensus 138 L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~ 217 (947)
|++++|.++.. |. -.++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|+
T Consensus 76 L~l~~~~l~~l--p~---~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~ 142 (454)
T 1jl5_A 76 LELNNLGLSSL--PE---LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQ 142 (454)
T ss_dssp EECTTSCCSCC--CS---CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSC
T ss_pred EEecCCccccC--CC---CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCC
Confidence 44444444331 11 12344444444444443 3322 1344444444444432 1111 1344444444444
Q ss_pred ccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCc
Q 002250 218 LSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKL 297 (947)
Q Consensus 218 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l 297 (947)
+++ +| .|.++++|++|++++|++++.+..+ .+|++|++++|++++ +| .++.+++|++|++++|++++ +|...
T Consensus 143 l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~ 214 (454)
T 1jl5_A 143 LEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP 214 (454)
T ss_dssp CSS-CC-CCTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC
T ss_pred CCC-Cc-ccCCCCCCCEEECCCCcCcccCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc
Confidence 443 33 3444444444444444444432221 244444444444443 23 34444444444444444442 23221
Q ss_pred cCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcce
Q 002250 298 GSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSI 377 (947)
Q Consensus 298 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 377 (947)
++|++|++++|.++ .+| .+..+..++.|++.+|++.+ +|.. .++|+.|++++|.+++ +|.. +++|+.
T Consensus 215 ---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~ 281 (454)
T 1jl5_A 215 ---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTF 281 (454)
T ss_dssp ---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCE
T ss_pred ---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCE
Confidence 24444444444444 333 24444444444444444433 2221 2456666666666664 3432 256666
Q ss_pred eccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhcccccc
Q 002250 378 IDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMF 457 (947)
Q Consensus 378 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 457 (947)
|++++|++++.. . ..++|++|++++|++++ ++.. .++|+.|++++|++++ +|.. +++|+.|+|++|++
T Consensus 282 L~ls~N~l~~l~-~---~~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l 349 (454)
T 1jl5_A 282 LDVSENIFSGLS-E---LPPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHL 349 (454)
T ss_dssp EECCSSCCSEES-C---CCTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCC
T ss_pred EECcCCccCccc-C---cCCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcc
Confidence 666666666521 1 11466666677666663 2211 1366677777777664 4433 45666777777776
Q ss_pred CCCCCcccccccccceeeccCceeee--ecCCCCCccCcCcEEECCCCccCCccCCcccccccceeeCCCCcCCC--CCC
Q 002250 458 SGPLPYSIGSCVSLTDINFAQNSLSG--KIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAG--PIP 533 (947)
Q Consensus 458 ~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ls~N~l~~--~~p 533 (947)
++ +|. .+++|++|++++|++++ .+|..+..+ +.|++.|.+|.. .++|+.||+++|++++ .+|
T Consensus 350 ~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~--~~~L~~L~ls~N~l~~~~~iP 415 (454)
T 1jl5_A 350 AE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL--PQNLKQLHVETNPLREFPDIP 415 (454)
T ss_dssp SC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC-------------------------------
T ss_pred cc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc--cCcCCEEECCCCcCCccccch
Confidence 63 444 35667777777777766 555554432 234555555542 2556666666666665 555
Q ss_pred Cc
Q 002250 534 EP 535 (947)
Q Consensus 534 ~~ 535 (947)
..
T Consensus 416 ~s 417 (454)
T 1jl5_A 416 ES 417 (454)
T ss_dssp --
T ss_pred hh
Confidence 44
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=376.81 Aligned_cols=278 Identities=38% Similarity=0.610 Sum_probs=230.4
Q ss_pred HHHhhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
+...++|+..+.||+|+||+||+|+.++++.||||++... .....+.+.+|+.++++++||||
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~~i 97 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-----------------SSQGIEEFETEIETLSFCRHPHL 97 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-----------------CSSHHHHHHHHHHGGGSCCCTTB
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-----------------ChHHHHHHHHHHHHHHhCCCCCE
Confidence 3456889999999999999999999888999999987422 11335678999999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcC--CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
+++++++..++..++||||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 98 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~ 174 (321)
T 2qkw_B 98 VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDE 174 (321)
T ss_dssp CCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECT
T ss_pred eeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECC
Confidence 999999999999999999999999999997643 345899999999999999999999 899999999999999999
Q ss_pred CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC-CCcccHHH
Q 002250 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEF-GDSKDIVN 861 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~-~~~~~~~~ 861 (947)
++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||.... ........
T Consensus 175 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~ 254 (321)
T 2qkw_B 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254 (321)
T ss_dssp TCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH
T ss_pred CCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH
Confidence 99999999999987554333333334568999999999999999999999999999999999999997543 23334555
Q ss_pred HHHhhccccccccccccCCC-CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 862 WVYSKMDSRDSMLTVVDPNI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
|....... ..+...+++.+ .....+.+..+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 255 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 255 WAVESHNN-GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HTHHHHTT-TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred Hhhhcccc-ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 54333222 22344555554 445678889999999999999999999999999999976543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=405.41 Aligned_cols=256 Identities=21% Similarity=0.302 Sum_probs=208.5
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.+.++|++.+.||+|+||+||+|+.+ +|+.||||++... .....+.+.+|+.+|+.++|||
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-----------------~~~~~~~~~~Ei~il~~l~hpn 215 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----------------HESDKETVRKEIQTMSVLRHPT 215 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------SHHHHHHHHHHHHHHHHTCCTT
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-----------------chhhHHHHHHHHHHHHhCCCCC
Confidence 445688999999999999999999965 7999999998421 1123456889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
||+++++|.+++..|+||||++||+|.+++... ...+++.....++.||+.||+||| +++|+||||||+|||++.+
T Consensus 216 Iv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~ 291 (573)
T 3uto_A 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTK 291 (573)
T ss_dssp BCCEEEEEECSSEEEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSS
T ss_pred CCeEEEEEEECCEEEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCC
Confidence 999999999999999999999999999999753 346899999999999999999999 8999999999999999854
Q ss_pred --CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 784 --WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 784 --~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
+.+||+|||+|+...... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..+
T Consensus 292 ~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~-----~~~~ 363 (573)
T 3uto_A 292 RSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDE 363 (573)
T ss_dssp SCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHH
T ss_pred CCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHH
Confidence 899999999999775443 233568999999999999999999999999999999999999999532 2222
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...........+. ..........+.+++.+||+.||.+|||+.|++++
T Consensus 364 ~~~~i~~~~~~~~-------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 364 TLRNVKSCDWNMD-------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHHTTCCCCC-------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhCCCCCC-------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222222111111 11112233457789999999999999999999874
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=388.26 Aligned_cols=363 Identities=19% Similarity=0.190 Sum_probs=239.1
Q ss_pred ccCcEEEccCccccccCCccCCCCCCCCEEECcCccccccc-CccccCCCCCcEEEeecccccccCCccCCCCCCccEEe
Q 002250 158 EKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEI-PAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFD 236 (947)
Q Consensus 158 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 236 (947)
++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 34555555555555555555555555555555555554322 34455555555555555555555555555555555555
Q ss_pred ccCCCCCCC-Ccc--ccccCCCCEEEccCccCcccCCCC-ccCCCcCcEEEccCccccccCCcCccCc--cccccccccc
Q 002250 237 VSQNRLEGD-LSE--LRFLNQLSSLHLFENQFSGEIPEE-FGEFKHLTELSLYTNRLTGTLPQKLGSW--ADFNYVDVSE 310 (947)
Q Consensus 237 Ls~N~l~~~-~~~--l~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~Ls~ 310 (947)
|++|++++. +.. +..+++|++|+|++|++++..|.. +..+++|++|++++|++++..|..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 555555542 111 455555666666666655554544 5556666666666666655555555544 4555666666
Q ss_pred ccccCCCCCC--------cccCCccceeeecccccCCcCCccccCC---CCccEEEcccccccccCCCCCCCCCCcceec
Q 002250 311 NLLTGPIPPD--------MCKTGAMTDLLVLQNNFNGTVPETYANC---KSLIRFRVNNNSLSGTIPPGIWSLPNLSIID 379 (947)
Q Consensus 311 N~l~~~~p~~--------~~~~~~l~~L~l~~n~~~~~~p~~~~~l---~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 379 (947)
|.+.+..+.. +..+.+|+.|++.+|++.+..|..+... ++|+.|++++|.+.+...
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~------------- 256 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF------------- 256 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT-------------
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc-------------
Confidence 6655433222 1223344444444444444444444322 566666666665543211
Q ss_pred cccCCcCCCCCCccccc--ccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhcccccc
Q 002250 380 LSTNQFEGPVTDDIGNA--KSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMF 457 (947)
Q Consensus 380 Ls~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 457 (947)
..+.+....+..+..+ ++|+.|++++|++++..|..+..+++|+.|+|++|++++..|..|+++++|+.|+|++|++
T Consensus 257 -~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 335 (455)
T 3v47_A 257 -GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335 (455)
T ss_dssp -TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred -chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCcc
Confidence 1122222223333333 5899999999999988899999999999999999999988888999999999999999999
Q ss_pred CCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc-ccccceeeCCCCcCCCCCCC
Q 002250 458 SGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQLAGPIPE 534 (947)
Q Consensus 458 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N~l~~~~p~ 534 (947)
++..|..|+.+++|++|+|++|++++..|..|..+++|++|+|++|++++.++..+. +++|+.|++++|++++.+|.
T Consensus 336 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 336 GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 988889999999999999999999988899999999999999999999987776654 68999999999999998884
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=375.48 Aligned_cols=286 Identities=36% Similarity=0.604 Sum_probs=231.3
Q ss_pred ccccccH-HHHhhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHH
Q 002250 618 RVLSFSE-KEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL 696 (947)
Q Consensus 618 ~~~~~~~-~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 696 (947)
..+++.+ +...++|++.+.||+|+||.||+|+..+++.||||++.... .......+.+|++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~e~~~l 81 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER----------------TQGGELQFQTEVEMI 81 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------------------CCCHHHHHHHGG
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEecccc----------------CchHHHHHHHHHHHH
Confidence 3344444 44568899999999999999999998889999999984221 112234689999999
Q ss_pred hhccccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCC
Q 002250 697 SAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVK 774 (947)
Q Consensus 697 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlk 774 (947)
++++||||+++++++..++..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||..+..+|+|||||
T Consensus 82 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk 161 (326)
T 3uim_A 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK 161 (326)
T ss_dssp GTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCS
T ss_pred HhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCc
Confidence 99999999999999999999999999999999999998653 3458999999999999999999994322399999999
Q ss_pred CCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC--
Q 002250 775 SSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE-- 852 (947)
Q Consensus 775 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~-- 852 (947)
|+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 162 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (326)
T 3uim_A 162 AANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240 (326)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHH
T ss_pred hhhEEECCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccc
Confidence 99999999999999999999876544322 233456999999999999888999999999999999999999999521
Q ss_pred -CCCcccHHHHHHhhccccccccccccCCC-CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 853 -FGDSKDIVNWVYSKMDSRDSMLTVVDPNI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 853 -~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
........+|+........ .....+... .....+.+..+.+++.+|++.||++|||+.|++++|++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 241 ANDDDVMLLDWVKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTTSCSBHHHHHTTTTSSCC-STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred ccccchhHHHHHHHHhhchh-hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 2334455566544433332 244444444 4567788899999999999999999999999999999744
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=391.79 Aligned_cols=385 Identities=20% Similarity=0.179 Sum_probs=247.4
Q ss_pred eeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCC-CcccccccceeecCCCCccCccCcccccccCCCceeeCCCC
Q 002250 65 KINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDN 143 (947)
Q Consensus 65 ~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~-~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n 143 (947)
.++.++++++ .+|. + .++|++|||++|.|++..+ .+..+++|++|+|++|.+.+.++...|.++++|++|+|++|
T Consensus 14 ~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n 89 (455)
T 3v47_A 14 NAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89 (455)
T ss_dssp EEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred ccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence 4566666663 3343 2 2677777777777776544 36777777777777777765555456666666666666666
Q ss_pred CCCCCCCChhhcccccCcEEEccCccccccCCcc--CCCCCCCCEEECcCcccccccCcc-ccCCCCCcEEEeecccccc
Q 002250 144 PFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEG--IGNLTQLQNLELSDNELFGEIPAG-IVKLNKLWQLELYNNSLSG 220 (947)
Q Consensus 144 ~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~~~~-l~~l~~L~~L~L~~n~l~~ 220 (947)
.+... .|..+.++++|++|+|++|.+++.+|.. |..+++|++|+|++|++++..|.. +.++++|++|+|++|.+++
T Consensus 90 ~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 168 (455)
T 3v47_A 90 QFLQL-ETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168 (455)
T ss_dssp TTCEE-CTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred ccCcc-ChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence 66432 2444555555555555555555433332 555555555555555555444443 4555555555555555555
Q ss_pred cCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCC--------ccCCCcCcEEEccCcccccc
Q 002250 221 RLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEE--------FGEFKHLTELSLYTNRLTGT 292 (947)
Q Consensus 221 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~--------~~~l~~L~~L~L~~N~l~~~ 292 (947)
..+..+..+. ..+|+.|++++|.+.+..+.. +..+++|++|++++|++++.
T Consensus 169 ~~~~~l~~l~---------------------~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~ 227 (455)
T 3v47_A 169 ICEEDLLNFQ---------------------GKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES 227 (455)
T ss_dssp CCTTTSGGGT---------------------TCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHH
T ss_pred cChhhhhccc---------------------cccccccccccCcccccchhhccccccccccccceeeeEecCCCccccc
Confidence 4444444330 033444444444444332222 33556777777777777766
Q ss_pred CCcCccCc---ccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCC
Q 002250 293 LPQKLGSW---ADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGI 369 (947)
Q Consensus 293 ~p~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~ 369 (947)
.|..+... .+|+.|++++|.+.+... ..+.+....+..+..+
T Consensus 228 ~~~~~~~~~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~--------------------- 272 (455)
T 3v47_A 228 MAKRFFDAIAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFTFKGL--------------------- 272 (455)
T ss_dssp HHHHHHHHTTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTTTGGG---------------------
T ss_pred chhhhhccccccceeeEeecccccccccc--------------chhhhccCcccccccc---------------------
Confidence 66655444 667777777776553211 0111111111111111
Q ss_pred CCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccch
Q 002250 370 WSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSS 449 (947)
Q Consensus 370 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 449 (947)
..++|+.|++++|++.+..+..+..+++|++|++++|++++..|..|..+++|+.|+|++|++++..|..|+++++|+.
T Consensus 273 -~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 351 (455)
T 3v47_A 273 -EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEV 351 (455)
T ss_dssp -TTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCE
T ss_pred -cccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCE
Confidence 1246667777777776666666777777777777777777677777888888888888888888777888888889999
Q ss_pred hhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCC
Q 002250 450 LYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPI 511 (947)
Q Consensus 450 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 511 (947)
|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..|.
T Consensus 352 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 352 LDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred EECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 99999999888888999999999999999999977777789999999999999999998884
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=383.69 Aligned_cols=409 Identities=22% Similarity=0.257 Sum_probs=240.5
Q ss_pred CceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCc-------------cEEeCcCccCcCCCC
Q 002250 36 GLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRL-------------QVLDLGNNSFSGEVP 102 (947)
Q Consensus 36 ~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L-------------~~L~Ls~n~i~~~~~ 102 (947)
.++..++++++++ |.+| .+++++++|++|++++|.+.+.+|..++.+++| ++|++++|.+++.+.
T Consensus 11 ~~L~~L~l~~n~l-~~iP-~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMP-VEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE 88 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS
T ss_pred ccchhhhcccCch-hhCC-hhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC
Confidence 4678899999888 8888 679999999999999999999999999998876 788888888776444
Q ss_pred CcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCC
Q 002250 103 DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLT 182 (947)
Q Consensus 103 ~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 182 (947)
. .++|++|++++|.+++ +| . .+++|++|++++|++...+ .. .++|++|++++|++++ +| .|++++
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp-~---~~~~L~~L~l~~n~l~~l~--~~---~~~L~~L~L~~n~l~~-lp-~~~~l~ 153 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LP-E---LPQSLKSLLVDNNNLKALS--DL---PPLLEYLGVSNNQLEK-LP-ELQNSS 153 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CC-C---CCTTCCEEECCSSCCSCCC--SC---CTTCCEEECCSSCCSS-CC-CCTTCT
T ss_pred C---cCCCCEEEccCCcCCc-cc-c---ccCCCcEEECCCCccCccc--CC---CCCCCEEECcCCCCCC-Cc-ccCCCC
Confidence 2 3677888888888775 44 1 2367888888888776532 11 1577788888887775 56 477777
Q ss_pred CCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccC
Q 002250 183 QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFE 262 (947)
Q Consensus 183 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~ 262 (947)
+|++|++++|++++ +|..+ .+|++|++++|++++ +| .|.++++|++|++++|++++.+... .+|++|++++
T Consensus 154 ~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~ 224 (454)
T 1jl5_A 154 FLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDLP---LSLESIVAGN 224 (454)
T ss_dssp TCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCCC---TTCCEEECCS
T ss_pred CCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCCc---CcccEEECcC
Confidence 88888888887764 45433 467777777777775 44 5777777777777777777644322 4677777777
Q ss_pred ccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCC
Q 002250 263 NQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVP 342 (947)
Q Consensus 263 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p 342 (947)
|+++ .+| .++.+++|++|++++|++++ +|.. +++|+.|++++|.+++ +|
T Consensus 225 n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~------------------------ 273 (454)
T 1jl5_A 225 NILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LP------------------------ 273 (454)
T ss_dssp SCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CC------------------------
T ss_pred CcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cC------------------------
Confidence 7777 555 37777777777777777763 4442 3567777777777663 22
Q ss_pred ccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCc
Q 002250 343 ETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASS 422 (947)
Q Consensus 343 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 422 (947)
.. .++|+.|++++|.+++. |.. .++|+.|++++|++++.. . ..++|++|++++|++++ +|.. +++
T Consensus 274 ~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i~-~---~~~~L~~L~Ls~N~l~~-lp~~---~~~ 338 (454)
T 1jl5_A 274 EL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSLC-D---LPPSLEELNVSNNKLIE-LPAL---PPR 338 (454)
T ss_dssp CC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEEC-C---CCTTCCEEECCSSCCSC-CCCC---CTT
T ss_pred cc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCccc-C---CcCcCCEEECCCCcccc-cccc---CCc
Confidence 21 25778888888888752 221 257888888888887532 1 12578889999998885 6654 578
Q ss_pred ceEEEcccCcccCCCCcccccccccchhhccccccCC--CCCcccccccccceeeccCceeeeecCCCCCccCcCcEEEC
Q 002250 423 LVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSG--PLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNL 500 (947)
Q Consensus 423 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 500 (947)
|+.|++++|+++ .+|. .+++|++|+|++|++++ .+|.+++. |+.|.+.+.+|.. +++|+.|++
T Consensus 339 L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~l 403 (454)
T 1jl5_A 339 LERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHV 403 (454)
T ss_dssp CCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC--------------------
T ss_pred CCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEEC
Confidence 899999999998 5665 47889999999999988 66766653 3457788888874 578999999
Q ss_pred CCCccCC--ccCCcccccccceeeCCCCcCCCCCCCcc
Q 002250 501 SNNKFSG--EIPISLTYPKLSLLDLSNNQLAGPIPEPL 536 (947)
Q Consensus 501 s~N~l~~--~~p~~~~~~~L~~L~ls~N~l~~~~p~~~ 536 (947)
++|++++ .+|. .++.|.+.+|.+.+++|...
T Consensus 404 s~N~l~~~~~iP~-----sl~~L~~~~~~~~~~~~~~~ 436 (454)
T 1jl5_A 404 ETNPLREFPDIPE-----SVEDLRMNSERVVDPYEFAH 436 (454)
T ss_dssp --------------------------------------
T ss_pred CCCcCCccccchh-----hHhheeCcCcccCCccccCH
Confidence 9999997 5553 56778889999988777543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=378.66 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=211.4
Q ss_pred hhccCCcccccccCceeEEEEEeC--------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN--------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV 699 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 699 (947)
.++|++.+.||+|+||.||+|+.. ++..||||++... ........+.+|+++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----------------~~~~~~~~~~~E~~~l~~l 143 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----------------ATEKDLSDLVSEMEMMKMI 143 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----------------CBHHHHHHHHHHHHHHHHS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----------------cCHHHHHHHHHHHHHHHHh
Confidence 367889999999999999999852 3567999998421 1112346789999999999
Q ss_pred -cccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC--------------ccCCHHHHHHHHHHHHHHHHHHhcCC
Q 002250 700 -RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK--------------IEMDWVVRYAIAVGAAKGLEYLHHGF 764 (947)
Q Consensus 700 -~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~ia~~l~yLH~~~ 764 (947)
+||||+++++++..++..|+||||+++|+|.+++..... ..+++..+..++.||+.||+|||
T Consensus 144 ~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--- 220 (370)
T 2psq_A 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--- 220 (370)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred cCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---
Confidence 899999999999999999999999999999999986432 35789999999999999999999
Q ss_pred CCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh
Q 002250 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844 (947)
Q Consensus 765 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt 844 (947)
+.+|+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++
T Consensus 221 ~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 300 (370)
T 2psq_A 221 SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300 (370)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHT
T ss_pred hCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHc
Confidence 89999999999999999999999999999987655443333334467889999999999999999999999999999999
Q ss_pred -CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 845 -GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 845 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
|+.||... ....+...+... ...+.+..++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 301 ~g~~p~~~~--~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 301 LGGSPYPGI--PVEELFKLLKEG-------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp TSCCSSTTC--CGGGHHHHHHTT-------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCC--CHHHHHHHHhcC-------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99998542 222222222111 111222334567889999999999999999999999998753
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=378.66 Aligned_cols=371 Identities=19% Similarity=0.211 Sum_probs=296.3
Q ss_pred ccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCC
Q 002250 55 DSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTN 134 (947)
Q Consensus 55 ~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~ 134 (947)
.+++.+++|+.|++++|.+.+. | .+..+++|++|+|++|+|++.+ ++.+++|++|+|++|++++. + +.++++
T Consensus 36 ~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~--~~~l~~L~~L~Ls~N~l~~~-~---~~~l~~ 107 (457)
T 3bz5_A 36 ISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLTNL-D---VTPLTK 107 (457)
T ss_dssp EEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCC-C---CTTCTT
T ss_pred cChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeEc--cccCCCCCEEECcCCCCcee-e---cCCCCc
Confidence 4678889999999999999775 4 6889999999999999998763 88899999999999998863 2 788999
Q ss_pred CceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEee
Q 002250 135 LEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELY 214 (947)
Q Consensus 135 L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 214 (947)
|++|+|++|+++.. + +..+++|++|++++|++++. .++++++|++|++++|+..+.+ .+..+++|++|+++
T Consensus 108 L~~L~L~~N~l~~l--~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls 178 (457)
T 3bz5_A 108 LTYLNCDTNKLTKL--D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCS 178 (457)
T ss_dssp CCEEECCSSCCSCC--C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECC
T ss_pred CCEEECCCCcCCee--c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECC
Confidence 99999999998764 3 77889999999999999864 3788899999999999654454 57888899999999
Q ss_pred cccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCC
Q 002250 215 NNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLP 294 (947)
Q Consensus 215 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 294 (947)
+|++++ +| +..+++|+.|++++|++++. .+..+++|+.|+|++|++++ +| ++.+++|++|++++|++++..
T Consensus 179 ~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~- 249 (457)
T 3bz5_A 179 FNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD- 249 (457)
T ss_dssp SSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC-
T ss_pred CCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC-
Confidence 999986 44 78889999999999998876 47788899999999999986 55 788889999999999998643
Q ss_pred cCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCC
Q 002250 295 QKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPN 374 (947)
Q Consensus 295 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 374 (947)
++.+++|+.|++++|.++ .+++.+|.+.+.+| ++.+++|+.|++++|...+.+|. ..++
T Consensus 250 --~~~l~~L~~L~l~~n~L~--------------~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~ 308 (457)
T 3bz5_A 250 --VSTLSKLTTLHCIQTDLL--------------EIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAG 308 (457)
T ss_dssp --CTTCTTCCEEECTTCCCS--------------CCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCC
T ss_pred --HHHCCCCCEEeccCCCCC--------------EEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCc
Confidence 456778888888777543 56677777777777 56788888888888888777774 3466
Q ss_pred cceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccc
Q 002250 375 LSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHD 454 (947)
Q Consensus 375 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (947)
|+.|++++| ++|++|++++|++++ ++ +..+++|+.|++++|+|++ ++.|..|++++
T Consensus 309 L~~L~l~~~-------------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~ 364 (457)
T 3bz5_A 309 ITELDLSQN-------------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALN 364 (457)
T ss_dssp CSCCCCTTC-------------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGG
T ss_pred ceEechhhc-------------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccC
Confidence 777776665 578889999999986 33 8888899999999999885 25677788888
Q ss_pred cccCCCCCcccccccccceeeccCceeeeecCCCCCcc-CcCcEEECC
Q 002250 455 NMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSL-PSLNSLNLS 501 (947)
Q Consensus 455 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls 501 (947)
|.+.|. +.+..|..+++++|+++|.+|..+... .++....-+
T Consensus 365 n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~~~~~~~~~~~~ 407 (457)
T 3bz5_A 365 NNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPG 407 (457)
T ss_dssp TSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBCTTSCCCEEEES
T ss_pred CcEEec-----ceeeecCccccccCcEEEEcChhHhcccCceeeccCC
Confidence 888875 366778888999999998888765432 334334433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=360.37 Aligned_cols=279 Identities=33% Similarity=0.527 Sum_probs=224.7
Q ss_pred HHHhhccCCc------ccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhh
Q 002250 625 KEIIDAVKPE------NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSA 698 (947)
Q Consensus 625 ~~~~~~~~~~------~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 698 (947)
..+++.|... +.||+|+||.||+|... ++.||||++..... .......+.+.+|+.++++
T Consensus 21 ~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~~~~~E~~~l~~ 86 (307)
T 2nru_A 21 KNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVD-------------ITTEELKQQFDQEIKVMAK 86 (307)
T ss_dssp HHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTT-------------SCTTTHHHHHHHHHHHHHH
T ss_pred HHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccC-------------cchHHHHHHHHHHHHHHHh
Confidence 4555555554 89999999999999874 88999999843211 0112335678999999999
Q ss_pred ccccccceEEEEEecCCccEEEEeccCCCChHHHhhhc-CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 699 VRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC-HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 699 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
++||||+++++++..++..++||||+++++|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|
T Consensus 87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~N 163 (307)
T 2nru_A 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSAN 163 (307)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGG
T ss_pred cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHH
Confidence 99999999999999999999999999999999999754 2356899999999999999999999 8899999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 778 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
|+++.++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|||++|+.||..... ..
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~ 241 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE-PQ 241 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS-SS
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc-hH
Confidence 9999999999999999987655433333334578999999998764 588999999999999999999999965432 12
Q ss_pred cHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 858 DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
....+..........+...+++.+.......+..+.+++.+||+.||.+|||+.+++++|+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp BTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 22233222233333344555666677788888999999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=370.85 Aligned_cols=262 Identities=25% Similarity=0.319 Sum_probs=207.7
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|+.. ++.||||++.. .......+.+|+.++++++||||++++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~------------------~~~~~~~~~~E~~~l~~l~hpniv~~~ 84 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPI------------------QDKQSWQNEYEVYSLPGMKHENILQFI 84 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECG------------------GGHHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeec------------------CchHHHHHHHHHHHHhcCCCCCchhhc
Confidence 67899999999999999999987 79999999831 112234566799999999999999999
Q ss_pred EEEecCCc----cEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeEeccCC
Q 002250 709 CSITSEDS----NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDR----------PVIHRDVK 774 (947)
Q Consensus 709 ~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~----------~ivH~Dlk 774 (947)
+++..+.. .++||||+++|+|.++++. ..+++..+..++.|++.||+||| +. +|+|||||
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlk 158 (322)
T 3soc_A 85 GAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIK 158 (322)
T ss_dssp EEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCS
T ss_pred ceeccCCCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCC
Confidence 99988654 5999999999999999986 34899999999999999999999 77 99999999
Q ss_pred CCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccC-----CCCCccchHHHHHHHHHHHhCCCCC
Q 002250 775 SSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-----KINEKSDVYSFGVVLMELVTGKRPI 849 (947)
Q Consensus 775 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slGv~l~elltg~~p~ 849 (947)
|+||+++.++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||+||+.||
T Consensus 159 p~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf 238 (322)
T 3soc_A 159 SKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238 (322)
T ss_dssp GGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTS
T ss_pred hHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999877655443333446799999999999763 4566889999999999999999999
Q ss_pred CCCCCCcc-----------cHHHHHHhhccccccccccccCCCCc--cCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 850 VPEFGDSK-----------DIVNWVYSKMDSRDSMLTVVDPNISE--ILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 850 ~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
........ ....+....... ...+.+.. .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHK------KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp SSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS------CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcchhccchhhhhccCCchhhhhhhhhcc------cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 65432111 111111111111 11112211 123456779999999999999999999999999
Q ss_pred hhccC
Q 002250 917 LEEAE 921 (947)
Q Consensus 917 L~~~~ 921 (947)
|+++.
T Consensus 313 L~~l~ 317 (322)
T 3soc_A 313 ITQMQ 317 (322)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=394.21 Aligned_cols=492 Identities=18% Similarity=0.160 Sum_probs=406.7
Q ss_pred eeeeCCCC----------ceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCc
Q 002250 29 GIVCDSNG----------LVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFS 98 (947)
Q Consensus 29 gv~c~~~~----------~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~ 98 (947)
.|.|...| .++.|||+++++++ ++..+|.++++|+.|+|++|+|.++.+++|..+++|++|+|++|+|+
T Consensus 35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~-l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~ 113 (635)
T 4g8a_A 35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 113 (635)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred EEECCCCCcCccCCCCCcCCCEEEeeCCCCCC-CCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence 47787532 68899999998775 45578999999999999999999999999999999999999999999
Q ss_pred CCCCC-cccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCcc
Q 002250 99 GEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEG 177 (947)
Q Consensus 99 ~~~~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~ 177 (947)
+.++. |.+|++|++|+|++|++++..+ ..|.++++|++|+|++|.+.....|..+..+++|++|+|++|++++..|..
T Consensus 114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~-~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 192 (635)
T 4g8a_A 114 SLALGAFSGLSSLQKLVAVETNLASLEN-FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 192 (635)
T ss_dssp EECGGGGTTCTTCCEEECTTSCCCCSTT-CCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CCCHHHhcCCCCCCEEECCCCcCCCCCh-hhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence 88775 8999999999999999986544 789999999999999999998888999999999999999999999988888
Q ss_pred CCCCCCC----CEEECcCcccccccCccccCCCCCcEEEeeccccccc-CCccCCC------------------------
Q 002250 178 IGNLTQL----QNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGR-LPVGFSN------------------------ 228 (947)
Q Consensus 178 ~~~l~~L----~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~------------------------ 228 (947)
|..+.++ ..++++.|.+....+..+ ....++.|++.+|..... .+..+..
T Consensus 193 l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~ 271 (635)
T 4g8a_A 193 LRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 271 (635)
T ss_dssp GHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCC
T ss_pred ccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccc
Confidence 8766554 478999999975544443 444567788877754321 1122222
Q ss_pred ------CCCccEEeccCCCCC----CCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCcc
Q 002250 229 ------LTNLMNFDVSQNRLE----GDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLG 298 (947)
Q Consensus 229 ------l~~L~~L~Ls~N~l~----~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 298 (947)
+..+..+++..+... +....+..+.+++.+.+.+|.+.... .+.....|+.|++.+|.+.+..+.
T Consensus 272 ~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~--- 346 (635)
T 4g8a_A 272 KSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL--- 346 (635)
T ss_dssp TTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC---
T ss_pred ccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcc---
Confidence 333333333333222 23344667788999999999987433 466678899999999998854433
Q ss_pred CcccccccccccccccCCCCCCcccCCccceeeecccccCC--cCCccccCCCCccEEEcccccccccCCCCCCCCCCcc
Q 002250 299 SWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNG--TVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLS 376 (947)
Q Consensus 299 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~--~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 376 (947)
.+..|+.++++.|.+... .....++.++.+.+..|.+.. ..+..+..+.+|+.+++..|.+. ..+..+..+++|+
T Consensus 347 ~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~ 423 (635)
T 4g8a_A 347 KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLE 423 (635)
T ss_dssp BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCC
T ss_pred cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-ccccccccccccc
Confidence 467888999999987643 345578889999999998753 45667778899999999999998 4566788899999
Q ss_pred eeccccCCcCCCCC-CcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCccc-CCCCcccccccccchhhccc
Q 002250 377 IIDLSTNQFEGPVT-DDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFS-GQIPLDIGKLKKLSSLYLHD 454 (947)
Q Consensus 377 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~ 454 (947)
.+++++|......+ ..|..+.+++.++++.|.+.+..|..+..++.|+.|+|++|++. +.+|..|..+++|++|+|++
T Consensus 424 ~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~ 503 (635)
T 4g8a_A 424 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 503 (635)
T ss_dssp EEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred chhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCC
Confidence 99999888766544 56889999999999999999999999999999999999999854 46788999999999999999
Q ss_pred cccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc-c-cccceeeCCCCcCCCC
Q 002250 455 NMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-Y-PKLSLLDLSNNQLAGP 531 (947)
Q Consensus 455 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~-~~L~~L~ls~N~l~~~ 531 (947)
|+|++..|..|+.+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.+|..+. + ++|+.|+|++|++++.
T Consensus 504 N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 504 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp SCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred CccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 999999999999999999999999999988899999999999999999999999998875 4 6899999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.05 Aligned_cols=261 Identities=31% Similarity=0.445 Sum_probs=201.5
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.++|++.+.||+|+||+||+|+.. |+.||||++..... .......+.+|++++++++||||+++
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~---------------~~~~~~~~~~E~~~l~~l~hp~iv~~ 99 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDF---------------HAERVNEFLREVAIMKRLRHPNIVLF 99 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCC---------------SHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCC---------------CHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 367889999999999999999875 88999999842211 11234578899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcC-CccCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEeccCCCCCeEecCCC
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCH-KIEMDWVVRYAIAVGAAKGLEYLHHGFDRP--VIHRDVKSSNILLDLEW 784 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dlkp~NIll~~~~ 784 (947)
++++..++..++||||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+ |+||||||+||+++.++
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~ 176 (309)
T 3p86_A 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKY 176 (309)
T ss_dssp EEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTC
T ss_pred EEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCC
Confidence 999999999999999999999999998643 234899999999999999999999 788 99999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...+...
T Consensus 177 ~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~-----~~~~~~~ 249 (309)
T 3p86_A 177 TVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-----NPAQVVA 249 (309)
T ss_dssp CEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS-----CHHHHHH
T ss_pred cEEECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHH
Confidence 999999999975443321 123457899999999999999999999999999999999999998532 1111111
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
...... ...+.+...+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 250 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 250 AVGFKC---------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHSC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111000 01112233445688999999999999999999999999976543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=357.00 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=205.7
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|.. .+++.||||++.. ......+.+.+|+.++++++||||++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------------~~~~~~~~~~~E~~~l~~l~hp~iv~ 81 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----------------QQQPKKELIINEILVMRENKNPNIVN 81 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEG-----------------GGCSCHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeec-----------------ccccHHHHHHHHHHHHhcCCCCCCCe
Confidence 47899999999999999999995 4799999999831 12234567889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||+++|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~ 155 (297)
T 3fxz_A 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSV 155 (297)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCE
T ss_pred EeEEEEECCEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCE
Confidence 999999999999999999999999999863 5889999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... +........
T Consensus 156 kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~~ 228 (297)
T 3fxz_A 156 KLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-----NPLRALYLI 228 (297)
T ss_dssp EECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHH
T ss_pred EEeeCCCceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHH
Confidence 99999999876544322 23457999999999999999999999999999999999999999532 111111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...... . ...+......+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~-------~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 229 ATNGTP-------E-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHCSC-------C-CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HhCCCC-------C-CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111100 0 01122334568889999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=364.41 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=207.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|.+.+.||+|+||+||+|... +++.||+|++... .......+.+|++++++++||||+++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-----------------~~~~~~~~~~E~~~l~~l~hp~iv~~ 72 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----------------DEETQRTFLKEVKVMRCLEHPNVLKF 72 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-----------------CHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-----------------CHHHHHHHHHHHHHHHhCCCcCcccE
Confidence 67888999999999999999965 6899999987311 12344678999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.+++..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~k 148 (310)
T 3s95_A 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVV 148 (310)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEE
T ss_pred EEEEecCCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEE
Confidence 99999999999999999999999999873 346899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcc------------eecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 788 IADFGLAKIVQTGEAGDL------------THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
|+|||+++.......... .....||+.|+|||++.+..++.++||||||+++|||++|..||......
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~ 228 (310)
T 3s95_A 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 228 (310)
T ss_dssp ECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred EeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhh
Confidence 999999987644322110 11356999999999999999999999999999999999999998543211
Q ss_pred c----ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 856 S----KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 856 ~----~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
. ........ . ..+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 229 ~~~~~~~~~~~~~--------------~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 229 TMDFGLNVRGFLD--------------R---YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp CTTSSBCHHHHHH--------------H---TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhhhhcccc--------------c---cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 11111110 0 011223346888999999999999999999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=379.29 Aligned_cols=258 Identities=24% Similarity=0.309 Sum_probs=207.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +++.||||++.... .......|.+|++++++++||||+++
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~hpniv~~ 177 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL----------------PPDLKAKFLQEARILKQYSHPNIVRL 177 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS----------------CHHHHTTTTHHHHHHTTCCCTTBCCE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC----------------CHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 67888999999999999999976 78999999984211 11223468899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 178 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~k 253 (377)
T 3cbl_A 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLK 253 (377)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred EEEEecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEE
Confidence 99999999999999999999999999863 345899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||... ......+.+.
T Consensus 254 l~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~--~~~~~~~~~~-- 329 (377)
T 3cbl_A 254 ISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL--SNQQTREFVE-- 329 (377)
T ss_dssp ECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS--CHHHHHHHHH--
T ss_pred ECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHH--
Confidence 999999986543321111112235778999999998899999999999999999999 99998532 1111222111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
... ..+.+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 330 --~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 330 --KGG---------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp --TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111 11122234557889999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=354.92 Aligned_cols=257 Identities=23% Similarity=0.314 Sum_probs=210.1
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|+.+++..||||++... ......+.+|++++++++||||++++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~h~~i~~~~ 69 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG------------------SMSEDEFFQEAQTMMKLSHPKLVKFY 69 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT------------------TBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccC------------------CCcHHHHHHHHHHHHhCCCCCEeeEE
Confidence 678899999999999999999998889999998421 12346789999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l 145 (268)
T 3sxs_A 70 GVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKV 145 (268)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEE
T ss_pred EEEccCCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEE
Confidence 9999999999999999999999999864 345899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.+......... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||... ...+......
T Consensus 146 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~~ 219 (268)
T 3sxs_A 146 SDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-----TNSEVVLKVS 219 (268)
T ss_dssp CCTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHHHH
T ss_pred ccCccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc-----ChHHHHHHHH
Confidence 999999876544321 1223346778999999998889999999999999999999 99998432 1111111111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
.... ...+...+..+.+++.+|++.||++|||+.|+++.|+++...
T Consensus 220 ~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 220 QGHR----------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TTCC----------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred cCCC----------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1111 011112234688899999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=363.85 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=205.3
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.. +++.||||++.... .....+.+.+|+.+++.++||||++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~hpnIv~ 69 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----------------AVDCPENIKKEICINKMLNHENVVK 69 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------------CHHHHHHHHHHCCCTTBCC
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc----------------ccchHHHHHHHHHHHHhCCCCCCCe
Confidence 578999999999999999999966 78999999984211 1122356889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~ 144 (323)
T 3tki_A 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNL 144 (323)
T ss_dssp EEEEEECSSEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred EEEEEecCCeEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCE
Confidence 999999999999999999999999999763 45899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||+++...............||+.|+|||++.+..+ +.++|||||||++|||++|+.||............+...
T Consensus 145 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 224 (323)
T 3tki_A 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224 (323)
T ss_dssp EECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT
T ss_pred EEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc
Confidence 9999999987654433333335679999999999987775 678999999999999999999996543333333222211
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
. .. ..........+.+++.+|++.||++|||+.|++++
T Consensus 225 ~----~~---------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 K----TY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp C----TT---------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c----cc---------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 00 00112234557789999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=362.57 Aligned_cols=250 Identities=25% Similarity=0.339 Sum_probs=204.9
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ......+.+.+|+++++.++||||++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~hpnIv~ 78 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ---------------LNPTSLQKLFREVRIMKILNHPNIVK 78 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---------------SCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc---------------CCHHHHHHHHHHHHHHHhCCCCCEee
Confidence 57899999999999999999996 579999999983211 11123456889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 79 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~ 153 (328)
T 3fe3_A 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNI 153 (328)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCE
T ss_pred EEEEEEECCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCE
Confidence 999999999999999999999999999764 35889999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCC-CccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKIN-EKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||+++...... .....+||+.|+|||++.+..++ .++||||+||++|||++|+.||... +.......
T Consensus 154 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~ 225 (328)
T 3fe3_A 154 KIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-----NLKELRER 225 (328)
T ss_dssp EECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred EEeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-----CHHHHHHH
Confidence 999999997654432 22345799999999999888765 7899999999999999999999532 22222222
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....... .+......+.+++.+|++.||.+|||+.|++++
T Consensus 226 i~~~~~~-----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 226 VLRGKYR-----------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHCCCC-----------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHhCCCC-----------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2221111 111234567889999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=365.69 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=207.5
Q ss_pred hhccCCcccccccCceeEEEEEeC----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
.++|++.+.||+|+||+||+|+.. .+..||||++.... .....+.+.+|+.++++++|||
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~ 111 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----------------TERQRRDFLSEASIMGQFDHPN 111 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC----------------CHHHHHHHHHHHHHHTTCCCTT
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 467889999999999999999974 34569999984211 1123467889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++..++..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 187 (325)
T 3kul_A 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSN 187 (325)
T ss_dssp BCCEEEEECGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTT
T ss_pred CCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCC
Confidence 999999999999999999999999999999763 346899999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCCc-ceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~ 861 (947)
+.+||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||... ...+...
T Consensus 188 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~ 265 (325)
T 3kul_A 188 LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM--TNRDVIS 265 (325)
T ss_dssp CCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS--CHHHHHH
T ss_pred CCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC--CHHHHHH
Confidence 999999999998765433221 1223346788999999998899999999999999999999 99998532 1111221
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
.+ .... ....+...+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 266 ~~---~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 266 SV---EEGY----------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HH---HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HH---HcCC----------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 11 1110 1112223456788999999999999999999999999987544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=358.52 Aligned_cols=283 Identities=28% Similarity=0.505 Sum_probs=231.3
Q ss_pred CcccccccCCccccccccCCCCCcc--cceeeeCCC---CceeEeccCCCcccc--ccCcccccCCcccceeeccC-ccc
Q 002250 2 NLKSKIEKSDTGVFSSWTEANSVCK--FNGIVCDSN---GLVAEINLPEQQLLG--VVPFDSICGLQALQKINLGT-NFL 73 (947)
Q Consensus 2 ~~k~~~~~~~~~~~~sw~~~~~~C~--w~gv~c~~~---~~v~~l~l~~~~~~~--~~~~~~~~~l~~L~~L~L~~-n~i 73 (947)
.||.++ +++..+++|..++|||. |.||+|+.. ++|+.++|+++++.+ .+| ..+.++++|+.|+|++ |.+
T Consensus 13 ~~k~~~--~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~-~~l~~l~~L~~L~L~~~n~l 89 (313)
T 1ogq_A 13 QIKKDL--GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP-SSLANLPYLNFLYIGGINNL 89 (313)
T ss_dssp HHHHHT--TCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECC-GGGGGCTTCSEEEEEEETTE
T ss_pred HHHHhc--CCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccC-hhHhCCCCCCeeeCCCCCcc
Confidence 578777 34458999998899999 999999964 789999888888887 666 5788888888888884 778
Q ss_pred cCcCchhhhcCCCccEEeCcCccCcCCCCC-cccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCCh
Q 002250 74 YGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPM 152 (947)
Q Consensus 74 ~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~ 152 (947)
.+.+|..|..+++|++|+|++|++++..|. +..+++|++|+|++|.+++.+ |.
T Consensus 90 ~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--------------------------p~ 143 (313)
T 1ogq_A 90 VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL--------------------------PP 143 (313)
T ss_dssp ESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCC--------------------------CG
T ss_pred cccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcC--------------------------Ch
Confidence 778888888888888888888877754443 555555555555555555433 44
Q ss_pred hhcccccCcEEEccCccccccCCccCCCCC-CCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCC
Q 002250 153 EVLKLEKLYWLYLTNCSVTGQIPEGIGNLT-QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTN 231 (947)
Q Consensus 153 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 231 (947)
.+..+++|++|+|++|.+++.+|..+..++ +|++|+|++|++++.+|..+..++ |++|+|++|.+++..|..|..+++
T Consensus 144 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~ 222 (313)
T 1ogq_A 144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKN 222 (313)
T ss_dssp GGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSC
T ss_pred HHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCC
Confidence 555666666666666677777888888887 889999999998888888888887 999999999998888888999999
Q ss_pred ccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccc
Q 002250 232 LMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSEN 311 (947)
Q Consensus 232 L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 311 (947)
|++|+|++|++++.++.+..+++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|.. +.+++|+.|++++|
T Consensus 223 L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N 301 (313)
T 1ogq_A 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301 (313)
T ss_dssp CSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSS
T ss_pred CCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCC
Confidence 99999999999887777888999999999999999999999999999999999999999999987 89999999999999
Q ss_pred c-ccC
Q 002250 312 L-LTG 315 (947)
Q Consensus 312 ~-l~~ 315 (947)
+ +.|
T Consensus 302 ~~lc~ 306 (313)
T 1ogq_A 302 KCLCG 306 (313)
T ss_dssp SEEES
T ss_pred CCccC
Confidence 8 443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=356.22 Aligned_cols=256 Identities=23% Similarity=0.313 Sum_probs=208.6
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|...+++.||||++... ....+.+.+|++++++++||||++++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~h~~i~~~~ 71 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG------------------AMSEEDFIEEAEVMMKLSHPKLVQLY 71 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT------------------SBCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc------------------ccCHHHHHHHHHHHHhCCCCCEeeEE
Confidence 578889999999999999999988999999998421 12346789999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++.+++..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl 147 (269)
T 4hcu_A 72 GVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKV 147 (269)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEE
T ss_pred EEEecCCceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEe
Confidence 9999999999999999999999999763 346899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||+++........ ......+|+.|+|||++....++.++||||+|+++|||++ |+.||... ...+......
T Consensus 148 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~-----~~~~~~~~~~ 221 (269)
T 4hcu_A 148 SDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDIS 221 (269)
T ss_dssp CCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHH
T ss_pred ccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHh
Confidence 999999765432211 1123356788999999998899999999999999999999 89998432 1112211111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
.... ...+...+..+.+++.+|++.||++|||+.|++++|+++..
T Consensus 222 ~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 222 TGFR----------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcc----------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 1110 11112234568899999999999999999999999998653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.15 Aligned_cols=260 Identities=23% Similarity=0.293 Sum_probs=208.4
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
..+.+.|++.+.||+|+||+||+|+.+ +|+.||||++....... .......+.+.+|+.++++++|||
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~-----------~~~~~~~~~~~~E~~il~~l~hpn 76 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA-----------SRRGVCREEIEREVSILRQVLHPN 76 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTT-----------CSSSBCHHHHHHHHHHHTTCCCTT
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccc-----------ccchhHHHHHHHHHHHHHhCCCcC
Confidence 445678999999999999999999976 68999999995432211 111123567899999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++..+...++||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.+
T Consensus 77 Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~ 151 (361)
T 2yab_A 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDK 151 (361)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCT
T ss_pred CCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCC
Confidence 999999999999999999999999999999763 46899999999999999999999 8999999999999999887
Q ss_pred C----CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 784 W----KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 784 ~----~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
+ .+||+|||++........ .....||+.|+|||++.+..++.++||||+||++|||++|..||... ..
T Consensus 152 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~-----~~ 223 (361)
T 2yab_A 152 NIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TK 223 (361)
T ss_dssp TSSSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SH
T ss_pred CCCccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-----CH
Confidence 6 799999999987654332 23457999999999999889999999999999999999999999532 12
Q ss_pred HHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.+...........+ + .+........+.+++.+|+..||++|||+.|+++
T Consensus 224 ~~~~~~i~~~~~~~----~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 224 QETLANITAVSYDF----D---EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHHTTCCCC----C---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcCCCC----C---chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22222211111110 0 0111123456788999999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=365.52 Aligned_cols=263 Identities=24% Similarity=0.312 Sum_probs=204.9
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcE----EEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKE----LAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
++|++.+.||+|+||+||+|+.. +++. ||+|.+... ........+.+|+.++++++|||
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~~ 78 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------------TSPKANKEILDEAYVMASVDNPH 78 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------------------CHHHHHHHHHHHHHCCBTT
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc----------------cCHHHHHHHHHHHHHHHhCCCCC
Confidence 67889999999999999999954 4444 578876311 12244577999999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++..+. .++|+||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 79 iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~ 153 (327)
T 3poz_A 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTP 153 (327)
T ss_dssp BCCEEEEEESSS-EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEET
T ss_pred EeEEEEEEecCC-eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCC
Confidence 999999998754 78999999999999999874 346899999999999999999999 8899999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||+|+...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ....+...
T Consensus 154 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~ 231 (327)
T 3poz_A 154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSI 231 (327)
T ss_dssp TEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHH
T ss_pred CCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC--CHHHHHHH
Confidence 9999999999987655444333334567889999999999999999999999999999999 99998543 22223222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCcce
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTN 927 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 927 (947)
+.... ....+...+..+.+++.+||+.||++|||+.|++++|+.+...+...
T Consensus 232 ~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~ 283 (327)
T 3poz_A 232 LEKGE-------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 283 (327)
T ss_dssp HHTTC-------------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHHHH
T ss_pred HHcCC-------------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhhhh
Confidence 21111 01112233456889999999999999999999999999877655433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=353.77 Aligned_cols=270 Identities=18% Similarity=0.256 Sum_probs=212.2
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +++.||||++.. .......+.+.+|++++++++||||+++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 72 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN----------------ISFLRPVDVQMREFEVLKKLNHKNIVKL 72 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECG----------------GGGGSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecc----------------ccccchHHHHHHHHHHHHhcCCCCcceE
Confidence 67899999999999999999976 589999999831 1112345678899999999999999999
Q ss_pred EEEEecCC--ccEEEEeccCCCChHHHhhhcCC-ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe----
Q 002250 708 YCSITSED--SNLLVYEYLPNGSLWDRLHTCHK-IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL---- 780 (947)
Q Consensus 708 ~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll---- 780 (947)
++++.... ..++||||+++++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~ 149 (319)
T 4euu_A 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGE 149 (319)
T ss_dssp EEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECT
T ss_pred EEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccC
Confidence 99998765 66999999999999999986432 34899999999999999999999 8999999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcceecccccccccCccccc--------cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY--------TCKINEKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
+.++.+||+|||+++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 150 ~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 150 DGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp TSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred CCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 7788899999999987654432 22346899999999986 467899999999999999999999999643
Q ss_pred CCCcccHHHHHHhhccccc--cccc---------cccCCC---CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 853 FGDSKDIVNWVYSKMDSRD--SMLT---------VVDPNI---SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~--~~~~---------~~d~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
..... ..+.+........ .+.. ...+.+ ..........+.+++.+|++.||++|||+.|++++..
T Consensus 227 ~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 227 EGPRR-NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp TCGGG-CHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred Cccch-hHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 32211 1122222211110 0000 000111 2345677888999999999999999999999999988
Q ss_pred ccC
Q 002250 919 EAE 921 (947)
Q Consensus 919 ~~~ 921 (947)
+..
T Consensus 306 d~~ 308 (319)
T 4euu_A 306 DIL 308 (319)
T ss_dssp HHT
T ss_pred HHh
Confidence 654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.73 Aligned_cols=263 Identities=25% Similarity=0.366 Sum_probs=211.3
Q ss_pred hhccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .......+.+|+.++++++|
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h 109 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----------------SADMQADFQREAALMAEFDN 109 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----------------CHHHHHHHHHHHHHHHTCCC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc----------------CHHHHHHHHHHHHHHHhCCC
Confidence 468899999999999999999964 34889999984211 11234678999999999999
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcC----------------------CccCCHHHHHHHHHHHHHHHHH
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH----------------------KIEMDWVVRYAIAVGAAKGLEY 759 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~ia~~l~y 759 (947)
|||+++++++..++..++||||+++|+|.+++.... ...+++..++.++.|++.||+|
T Consensus 110 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~ 189 (343)
T 1luf_A 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAY 189 (343)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred CCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999998642 1568999999999999999999
Q ss_pred HhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHH
Q 002250 760 LHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839 (947)
Q Consensus 760 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l 839 (947)
|| +.+|+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++
T Consensus 190 LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 266 (343)
T 1luf_A 190 LS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266 (343)
T ss_dssp HH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HH---hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHH
Confidence 99 889999999999999999999999999999866543332333345688999999999988999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 840 MELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 840 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
|||++ |..||... ...+........ .....+...+..+.+++.+||+.||++|||+.+++++|+
T Consensus 267 ~el~t~g~~p~~~~-----~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 267 WEIFSYGLQPYYGM-----AHEEVIYYVRDG----------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp HHHHTTTCCTTTTS-----CHHHHHHHHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcCCCcCCCC-----ChHHHHHHHhCC----------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 99999 99998532 111221111111 111222334567889999999999999999999999999
Q ss_pred ccCCCC
Q 002250 919 EAEPCS 924 (947)
Q Consensus 919 ~~~~~~ 924 (947)
++....
T Consensus 332 ~~~~~~ 337 (343)
T 1luf_A 332 RMCERA 337 (343)
T ss_dssp HTTC--
T ss_pred HHHhhh
Confidence 987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=373.37 Aligned_cols=261 Identities=23% Similarity=0.366 Sum_probs=198.5
Q ss_pred hhccCCcccccccCceeEEEEEeC----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
.++|++.+.||+|+||.||+|+.. ++..||||++.... .....+.|.+|+.++++++|||
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~n 107 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----------------TEKQRRDFLGEASIMGQFDHPN 107 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC----------------CHHHHHHHHHHHHHHTTCCCTT
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 468999999999999999999864 57789999984211 1123467899999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++..++..++||||+++|+|.++++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~ 183 (373)
T 2qol_A 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSN 183 (373)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred CCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCC
Confidence 999999999999999999999999999999863 346899999999999999999999 8899999999999999999
Q ss_pred CCeEEeccccceecccCCCCc-ceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~ 861 (947)
+.+||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||... .......
T Consensus 184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~--~~~~~~~ 261 (373)
T 2qol_A 184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM--SNQDVIK 261 (373)
T ss_dssp CCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC--CHHHHHH
T ss_pred CCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC--CHHHHHH
Confidence 999999999998765432211 1112245778999999999999999999999999999998 99998532 1122222
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
.+... .. .+.+...+..+.+++.+||+.||++||++.|++++|+++...
T Consensus 262 ~i~~~----~~---------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 262 AVDEG----YR---------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHTT----EE---------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHcC----CC---------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11111 00 111223456788999999999999999999999999987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=354.61 Aligned_cols=265 Identities=24% Similarity=0.335 Sum_probs=207.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ......+.+.+|+.++++++||||++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~~~~e~~~l~~l~hp~iv~ 75 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR--------------EKEETLKRFEREVHNSSQLSHQNIVS 75 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS--------------CCHHHHHHHHHHHHHHTTCCBTTBCC
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc--------------ccHHHHHHHHHHHHHHhcCCCCCCce
Confidence 468999999999999999999965 689999999843211 11123467889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 76 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~ 150 (294)
T 4eqm_A 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTL 150 (294)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred EEEeeeeCCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCE
Confidence 999999999999999999999999999874 35899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+++........ ......||+.|+|||++.+..++.++||||+|+++|||++|+.||... .........
T Consensus 151 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-----~~~~~~~~~ 224 (294)
T 4eqm_A 151 KIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE-----TAVSIAIKH 224 (294)
T ss_dssp EECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS-----CHHHHHHHH
T ss_pred EEEeCCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHH
Confidence 99999999765433221 223456999999999999999999999999999999999999999532 122221122
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhccCCC
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-SMRVVVQMLEEAEPC 923 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~~~~~ 923 (947)
...... ..........+..+.+++.+|++.||++|| ++.++.+.|+.+...
T Consensus 225 ~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 225 IQDSVP------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HSSCCC------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred hhccCC------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 111110 000112233456788999999999999998 999999999986544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=372.69 Aligned_cols=263 Identities=22% Similarity=0.308 Sum_probs=210.6
Q ss_pred hhccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.++|++.+.||+|+||+||+|+.. +++.||||++.... .......+.+|+.++++++|
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h 133 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----------------SEQDELDFLMEALIISKFNH 133 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC----------------CHHHHHHHHHHHHHHHHCCC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc----------------ChhhHHHHHHHHHHHHhCCC
Confidence 367889999999999999999943 46789999983211 11234568899999999999
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC-----ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK-----IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 776 (947)
|||+++++++..+...++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+
T Consensus 134 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~ 210 (367)
T 3l9p_A 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAAR 210 (367)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGG
T ss_pred CCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChh
Confidence 9999999999999999999999999999999986432 45899999999999999999999 899999999999
Q ss_pred CeEecCCC---CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 002250 777 NILLDLEW---KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPE 852 (947)
Q Consensus 777 NIll~~~~---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~ 852 (947)
|||++.++ .+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 211 NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 211 NCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp GEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999554 599999999986544333333345568999999999999999999999999999999998 99998432
Q ss_pred CCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
....+...+ .... ....+...+..+.+++.+||+.||++|||+.+++++|+.+...+
T Consensus 291 --~~~~~~~~i---~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 291 --SNQEVLEFV---TSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp --CHHHHHHHH---HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred --CHHHHHHHH---HcCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 112222211 1111 11112233456889999999999999999999999999876554
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=382.24 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=209.9
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|..++++.||||++.+. ....+.|.+|+.++++++||||++++
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~h~~iv~l~ 249 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------------------SMSVEAFLAEANVMKTLQHDKLVKLH 249 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT------------------SBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC------------------CccHHHHHHHHHHHhhCCCCCEeeEE
Confidence 678889999999999999999988899999998421 13457899999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++. .+..++||||+++|+|.++++......+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||
T Consensus 250 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl 325 (454)
T 1qcf_A 250 AVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKI 325 (454)
T ss_dssp EEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEE
T ss_pred EEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEE
Confidence 9987 567899999999999999998655556889999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||+++........ ......+|+.|+|||++..+.++.++|||||||++|||+| |+.||... ...+....+..
T Consensus 326 ~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~-- 400 (454)
T 1qcf_A 326 ADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRALER-- 400 (454)
T ss_dssp CSTTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHH--
T ss_pred eeCCCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHc--
Confidence 999999865432111 1122346789999999998999999999999999999999 99998532 11222221111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
. . ..+.+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 401 -~-~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 401 -G-Y---------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -T-C---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -C-C---------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1 0 0111233456788999999999999999999999999987643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=353.66 Aligned_cols=264 Identities=24% Similarity=0.332 Sum_probs=205.1
Q ss_pred HhhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhh--cccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSA--VRHVNV 704 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~ni 704 (947)
+.++|++.+.||+|+||+||+|+. +++.||||++.. .....+.+|.+++.. ++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--------------------~~~~~~~~e~~~~~~~~l~h~ni 64 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS--------------------RDEKSWFRETELYNTVMLRHENI 64 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG--------------------GGHHHHHHHHHHHHHTCCCCTTB
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc--------------------ccchhhHHHHHHHHHhhccCcCe
Confidence 357899999999999999999998 489999999831 223455667777666 799999
Q ss_pred ceEEEEEec----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEeccCCC
Q 002250 705 VKLYCSITS----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGF-----DRPVIHRDVKS 775 (947)
Q Consensus 705 v~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~-----~~~ivH~Dlkp 775 (947)
+++++++.. ....++||||+++|+|.++++. ..+++..+..++.|++.||+|||... +.+|+||||||
T Consensus 65 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp 141 (301)
T 3q4u_A 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKS 141 (301)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCG
T ss_pred eeEEEeeccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCCh
Confidence 999998654 3457899999999999999965 46899999999999999999999321 57899999999
Q ss_pred CCeEecCCCCeEEeccccceecccCCCCc--ceecccccccccCccccccC------CCCCccchHHHHHHHHHHHhC--
Q 002250 776 SNILLDLEWKPRIADFGLAKIVQTGEAGD--LTHVIAGTHGYIAPEYAYTC------KINEKSDVYSFGVVLMELVTG-- 845 (947)
Q Consensus 776 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slGv~l~elltg-- 845 (947)
+||+++.++.+||+|||+|+......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 142 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~ 221 (301)
T 3q4u_A 142 KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221 (301)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhc
Confidence 99999999999999999998765443211 12234799999999999876 445789999999999999999
Q ss_pred --------CCCCCCCCCCcccHHHHHHhhccccccccccccCCCC--ccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 846 --------KRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNIS--EILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 846 --------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
+.||...................... .+.++ ......+..+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 222 SNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ------RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC------CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CccccccccccccccCCCCcchhhhhHHHhccCC------CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 88886544333333332221111111 11111 123456788999999999999999999999999
Q ss_pred Hhhcc
Q 002250 916 MLEEA 920 (947)
Q Consensus 916 ~L~~~ 920 (947)
.|+++
T Consensus 296 ~L~~i 300 (301)
T 3q4u_A 296 TLTKI 300 (301)
T ss_dssp HHHHH
T ss_pred HHhcc
Confidence 99875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=358.63 Aligned_cols=253 Identities=20% Similarity=0.311 Sum_probs=205.7
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||+||+|... +++.||+|++... ......+.+|+.+++.++||||+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------------------~~~~~~~~~E~~~l~~l~hpnIv 64 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------------------GTDQVLVKKEISILNIARHRNIL 64 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------------------THHHHHHHHHHHHHHHSCCTTBC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------------------cccHHHHHHHHHHHHhCCCCCCC
Confidence 4578999999999999999999966 6889999988311 12345688999999999999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC--C
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL--E 783 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~--~ 783 (947)
++++++.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++. +
T Consensus 65 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~ 140 (321)
T 1tki_A 65 HLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRS 140 (321)
T ss_dssp CEEEEEEETTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSC
T ss_pred eEeEEEecCCEEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCC
Confidence 9999999999999999999999999999763 346899999999999999999999 899999999999999987 7
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
+.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|..||... ...+..
T Consensus 141 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~ 212 (321)
T 1tki_A 141 STIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-----TNQQII 212 (321)
T ss_dssp CCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHH
T ss_pred CCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC-----CHHHHH
Confidence 899999999998765433 233457899999999999888999999999999999999999999532 112222
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
........... .+.....+..+.+++.+|++.||++|||+.|++++
T Consensus 213 ~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 213 ENIMNAEYTFD-------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHTCCCCC-------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHcCCCCCC-------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22211111100 00111234568899999999999999999999973
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=355.91 Aligned_cols=252 Identities=24% Similarity=0.291 Sum_probs=205.0
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.+ +|+.||||++... ..........+.+|+.+++.++||||++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 69 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE--------------VIIAKDEVAHTVTESRVLQNTRHPFLTA 69 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHHSCCCTTBCC
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHH--------------HhhhhhHHHHHHHHHHHHHhCCCCcCcc
Confidence 367899999999999999999966 6999999998311 1112245567889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++...+..|+||||+++|+|.+++... ..+++.....++.||+.||+||| +.+|+||||||+||+++.++.+
T Consensus 70 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~v 144 (337)
T 1o6l_A 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHI 144 (337)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred eEEEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCE
Confidence 999999999999999999999999999864 35889999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+++....... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+.....
T Consensus 145 kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i 217 (337)
T 1o6l_A 145 KITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHERLFELI 217 (337)
T ss_dssp EECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHH
T ss_pred EEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC-----CHHHHHHHH
Confidence 9999999975432221 223457999999999999999999999999999999999999999532 122222211
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
..... . ++......+.+++.+|++.||++|| ++.|++++
T Consensus 218 ~~~~~--------~---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 218 LMEEI--------R---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHCCC--------C---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HcCCC--------C---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11111 1 1222345678899999999999999 89998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=363.32 Aligned_cols=265 Identities=22% Similarity=0.307 Sum_probs=207.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcE----EEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKE----LAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
++|++.+.||+|+||+||+|+.. +++. ||+|++.... .......+.+|+.++++++|||
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~ 76 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS----------------GRQSFQAVTDHMLAIGSLDHAH 76 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT----------------SCSCBCSCCHHHHHHHTCCCTT
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc----------------cHHHHHHHHHHHHHHhcCCCCC
Confidence 57888999999999999999965 4554 7788763211 1133456778999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++. ++..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 77 iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~ 151 (325)
T 3kex_A 77 IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSP 151 (325)
T ss_dssp BCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSS
T ss_pred cCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCC
Confidence 999999986 46688999999999999999863 346888899999999999999999 8899999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||+++...............||..|+|||++.+..++.++||||||+++|||++ |+.||.... .......
T Consensus 152 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~ 229 (325)
T 3kex_A 152 SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--LAEVPDL 229 (325)
T ss_dssp SCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--TTHHHHH
T ss_pred CeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC--HHHHHHH
Confidence 9999999999987765544434445668889999999999999999999999999999999 999985432 2222222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCcceee
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIV 929 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 929 (947)
+.... . ...+...+..+.+++.+||+.||.+|||+.|++++|+++...+.....
T Consensus 230 ~~~~~----~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~~~~ 283 (325)
T 3kex_A 230 LEKGE----R---------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLV 283 (325)
T ss_dssp HHTTC----B---------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHHHBC
T ss_pred HHcCC----C---------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhc
Confidence 21110 0 111112233577899999999999999999999999998776644443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=370.42 Aligned_cols=260 Identities=23% Similarity=0.343 Sum_probs=210.6
Q ss_pred hhccCCcccccccCceeEEEEEeC--------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN--------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV 699 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 699 (947)
.++|.+.+.||+|+||+||+|+.. .+..||||++.... .......+.+|+++++++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l 131 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----------------TEKDLSDLISEMEMMKMI 131 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHHH
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc----------------CHHHHHHHHHHHHHHHHh
Confidence 368889999999999999999852 24579999984211 112346788999999999
Q ss_pred -cccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------------CccCCHHHHHHHHHHHHHHHHHHhcCC
Q 002250 700 -RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------------KIEMDWVVRYAIAVGAAKGLEYLHHGF 764 (947)
Q Consensus 700 -~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~ia~~l~yLH~~~ 764 (947)
+||||+++++++..++..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||
T Consensus 132 ~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--- 208 (382)
T 3tt0_A 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--- 208 (382)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred cCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---
Confidence 99999999999999999999999999999999998753 235899999999999999999999
Q ss_pred CCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh
Q 002250 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844 (947)
Q Consensus 765 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt 844 (947)
+.+|+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++
T Consensus 209 ~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 288 (382)
T 3tt0_A 209 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288 (382)
T ss_dssp HTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred hCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHh
Confidence 88999999999999999999999999999987655443333334567899999999999999999999999999999999
Q ss_pred -CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 845 -GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 845 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
|+.||... ....+...+. .... ...+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 289 ~g~~p~~~~--~~~~~~~~~~---~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 289 LGGSPYPGV--PVEELFKLLK---EGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp TSCCSSTTC--CHHHHHHHHH---TTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCC--CHHHHHHHHH---cCCC----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99998432 1122222111 1111 1112233456889999999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=375.02 Aligned_cols=251 Identities=27% Similarity=0.370 Sum_probs=207.0
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||.||+|... ++.||||++... ...+.|.+|+.++++++||||++++
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~-------------------~~~~~~~~E~~~l~~l~h~niv~~~ 252 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------------------ATAQAFLAEASVMTQLRHSNLVQLL 252 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC-------------------TTSHHHHHHHHHHHTCCCTTBCCEE
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc-------------------hHHHHHHHHHHHHHhccCCCEEEEE
Confidence 67888999999999999999987 789999998421 2346789999999999999999999
Q ss_pred EEEecCC-ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 709 CSITSED-SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 709 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+++.... ..++||||+++|+|.+++...+...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 253 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~k 329 (450)
T 1k9a_A 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 329 (450)
T ss_dssp EEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEE
T ss_pred EEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEE
Confidence 9987765 6899999999999999999866556799999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||+++...... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+....+...
T Consensus 330 l~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i~~~ 402 (450)
T 1k9a_A 330 VSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKG 402 (450)
T ss_dssp ECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC--TTTHHHHHHTT
T ss_pred EeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcC
Confidence 99999998543221 12357889999999999999999999999999999999 999985432 22222222111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
...+.+..++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 403 -------------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 403 -------------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp -------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1112233445678899999999999999999999999987643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=381.09 Aligned_cols=258 Identities=26% Similarity=0.363 Sum_probs=213.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|..+ ++..||||++... ....+.|.+|+.++++++||||+++
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~hpniv~l 281 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------------TMEVEEFLKEAAVMKEIKHPNLVQL 281 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS------------------SSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc------------------ccchHHHHHHHHHHHhcCCCCEeeE
Confidence 56888999999999999999977 4889999998421 1345779999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||+++|+|.+++.......+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 282 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~k 358 (495)
T 1opk_A 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVK 358 (495)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEE
Confidence 999999999999999999999999998866677999999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||+++....... .......+++.|+|||++....++.++|||||||++|||++ |..||... ....+.+.+...
T Consensus 359 l~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~ 435 (495)
T 1opk_A 359 VADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKD 435 (495)
T ss_dssp ECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTT
T ss_pred EeecccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcC
Confidence 999999987643321 11223346789999999998899999999999999999999 88998543 222233222111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
. ..+.+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 436 ~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 436 Y-------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp C-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred C-------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 1 0112233456788999999999999999999999999987544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=371.80 Aligned_cols=261 Identities=24% Similarity=0.305 Sum_probs=207.8
Q ss_pred hhccCCcccccccCceeEEEEEe------CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-c
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-R 700 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 700 (947)
.++|++.+.||+|+||.||+|++ .+++.||||++.... .....+.+.+|+++++++ +
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~ 84 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----------------THSEHRALMSELKILIHIGH 84 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHHHCC
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC----------------CHHHHHHHHHHHHHHHhhcC
Confidence 47899999999999999999983 246789999984211 112345789999999999 7
Q ss_pred ccccceEEEEEecCCc-cEEEEeccCCCChHHHhhhcCC-----------------------------------------
Q 002250 701 HVNVVKLYCSITSEDS-NLLVYEYLPNGSLWDRLHTCHK----------------------------------------- 738 (947)
Q Consensus 701 h~niv~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~----------------------------------------- 738 (947)
||||+++++++..++. .++||||+++|+|.+++.....
T Consensus 85 hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (359)
T 3vhe_A 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164 (359)
T ss_dssp CTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------
T ss_pred CcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccc
Confidence 8999999999988655 8999999999999999986432
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 739 -----------------------IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 739 -----------------------~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 241 (359)
T 3vhe_A 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR 241 (359)
T ss_dssp -------------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred cccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEecccee
Confidence 12889999999999999999999 8899999999999999999999999999998
Q ss_pred ecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcccccccc
Q 002250 796 IVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSML 874 (947)
Q Consensus 796 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 874 (947)
...............||+.|+|||++.+..++.++||||||+++|||++ |+.||..... ........... .
T Consensus 242 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~~----~--- 313 (359)
T 3vhe_A 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRLKEG----T--- 313 (359)
T ss_dssp CTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHHHHHHHHT----C---
T ss_pred eecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch-hHHHHHHHHcC----C---
Confidence 7655443333445568999999999999999999999999999999999 9999854321 11222211111 0
Q ss_pred ccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 875 TVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 875 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
....+......+.+++.+||+.||++|||+.|++++|+++.
T Consensus 314 ------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 314 ------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 01112223456889999999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=364.48 Aligned_cols=282 Identities=23% Similarity=0.299 Sum_probs=195.6
Q ss_pred hccCCcccccccCceeEEEEEeCC-Cc---EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS-GK---ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|++.+.||+|+||+||+|+... ++ .||||++.... ......+.+.+|++++++++||||
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~i 87 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI---------------IASSDIEEFLREAACMKEFDHPHV 87 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------------------CHHHHHHHHHHHHHTTCCCTTB
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccc---------------cCHHHHHHHHHHHHHHHHCCCCce
Confidence 678999999999999999999653 32 79999984221 112335678999999999999999
Q ss_pred ceEEEEEecCCcc------EEEEeccCCCChHHHhhhcC----CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCC
Q 002250 705 VKLYCSITSEDSN------LLVYEYLPNGSLWDRLHTCH----KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVK 774 (947)
Q Consensus 705 v~l~~~~~~~~~~------~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlk 774 (947)
+++++++...... ++||||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+|+|||||
T Consensus 88 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dik 164 (323)
T 3qup_A 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLA 164 (323)
T ss_dssp CCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred ehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCC
Confidence 9999999887665 99999999999999997532 225899999999999999999999 8899999999
Q ss_pred CCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 002250 775 SSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEF 853 (947)
Q Consensus 775 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~ 853 (947)
|+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 165 p~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~- 243 (323)
T 3qup_A 165 ARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI- 243 (323)
T ss_dssp GGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-
T ss_pred cceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-
Confidence 9999999999999999999987655443333334457889999999999999999999999999999999 89998543
Q ss_pred CCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCcceeeecc-
Q 002250 854 GDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKK- 932 (947)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~- 932 (947)
............ .....+...+..+.+++.+|++.||++|||+.++++.|+++...+...-....
T Consensus 244 -~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p 309 (323)
T 3qup_A 244 -ENAEIYNYLIGG-------------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309 (323)
T ss_dssp -CGGGHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred -ChHHHHHHHhcC-------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 122222221111 11112223445688999999999999999999999999987655533222222
Q ss_pred -cccCCCCcCCC
Q 002250 933 -VGESSPSFSRH 943 (947)
Q Consensus 933 -~~~~~~~~~~~ 943 (947)
....+++++||
T Consensus 310 l~~~~~~~~~~~ 321 (323)
T 3qup_A 310 LYINIERAHHHH 321 (323)
T ss_dssp ------------
T ss_pred CCCCCCcCCccC
Confidence 24455555554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=360.25 Aligned_cols=260 Identities=26% Similarity=0.336 Sum_probs=210.8
Q ss_pred hhccCCcccccccCceeEEEEEe------CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++|
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h 85 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----------------SPSELRDLLSEFNVLKQVNH 85 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC----------------CHHHHHHHHHHHHHHTTCCC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC----------------CHHHHHHHHHHHHHHhhCCC
Confidence 36788999999999999999985 245789999984211 11234678899999999999
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC----------------------ccCCHHHHHHHHHHHHHHHHH
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK----------------------IEMDWVVRYAIAVGAAKGLEY 759 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~~ia~~l~y 759 (947)
|||+++++++..++..++||||+++|+|.+++..... ..+++..+..++.|++.||+|
T Consensus 86 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 165 (314)
T 2ivs_A 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQY 165 (314)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHH
T ss_pred CceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999986432 348899999999999999999
Q ss_pred HhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHH
Q 002250 760 LHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839 (947)
Q Consensus 760 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l 839 (947)
|| +.+|+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++
T Consensus 166 lH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 242 (314)
T 2ivs_A 166 LA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242 (314)
T ss_dssp HH---HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred HH---HCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHH
Confidence 99 889999999999999999999999999999876554332223344578899999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 840 MELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 840 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
|||++ |+.||... ....+...+.... ....+...+..+.+++.+|++.||++|||+.|++++|+
T Consensus 243 ~el~t~g~~p~~~~--~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 243 WEIVTLGGNPYPGI--PPERLFNLLKTGH-------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp HHHHTTSCCSSTTC--CGGGHHHHHHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCCCCCCCC--CHHHHHHHhhcCC-------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99999 99998533 2222322221111 11122234467889999999999999999999999998
Q ss_pred ccC
Q 002250 919 EAE 921 (947)
Q Consensus 919 ~~~ 921 (947)
++.
T Consensus 308 ~~~ 310 (314)
T 2ivs_A 308 KMM 310 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=370.73 Aligned_cols=259 Identities=19% Similarity=0.257 Sum_probs=205.0
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.+ +++.||||++... ..........+.+|+.++..++||||++
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~--------------~~~~~~~~~~~~~E~~il~~~~hp~Iv~ 138 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--------------EMLKRAETACFREERDVLVNGDSKWITT 138 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHH--------------HHHHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHH--------------HhhhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 478999999999999999999976 5789999998311 1112233456889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
++++|.+++..|+||||+++|+|.+++... ...+++.....++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~v 214 (437)
T 4aw2_A 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHI 214 (437)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEEeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCE
Confidence 999999999999999999999999999863 346899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
||+|||+|+........ .....+||+.|+|||++. .+.++.++|||||||++|||++|+.||... +..+
T Consensus 215 kL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~-----~~~~ 288 (437)
T 4aw2_A 215 RLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVE 288 (437)
T ss_dssp EECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHH
T ss_pred EEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC-----ChhH
Confidence 99999999866543322 223457999999999987 556899999999999999999999999532 2222
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAF--RPSMRVVVQM 916 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~ 916 (947)
........... ..++.........+.+++.+|+..+|++ ||++.|++++
T Consensus 289 ~~~~i~~~~~~------~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 289 TYGKIMNHKER------FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHHHHTHHHH------CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred HHHhhhhcccc------ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 22221111100 0111111223456788899999988888 9999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=352.77 Aligned_cols=261 Identities=23% Similarity=0.285 Sum_probs=208.5
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.+.+.|++.+.||+|+||.||+|... +|+.||||++....... .......+.+.+|+.++++++|||
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~hp~ 75 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKS-----------SRRGVSREDIEREVSILKEIQHPN 75 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTT-----------CSSSBCHHHHHHHHHHHHHCCCTT
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccc-----------ccchhhHHHHHHHHHHHHhCCCCC
Confidence 445688999999999999999999976 68999999985432111 111224567899999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++..+...++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 76 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~ 150 (326)
T 2y0a_A 76 VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDR 150 (326)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCS
T ss_pred CCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecC
Confidence 999999999999999999999999999999763 46899999999999999999999 8999999999999999988
Q ss_pred C----CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 784 W----KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 784 ~----~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
+ .+||+|||+++....... .....||+.|+|||++....++.++|||||||++|||++|+.||... ..
T Consensus 151 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~ 222 (326)
T 2y0a_A 151 NVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TK 222 (326)
T ss_dssp SSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SH
T ss_pred CCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-----CH
Confidence 7 799999999987654332 22457999999999999889999999999999999999999998532 11
Q ss_pred HHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.+............. .......+..+.+++.+|++.||++|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 223 QETLANVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHHHHTCCCCC-------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHhcCCCcC-------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111111111000 01111234567889999999999999999999974
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=354.24 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=205.2
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.++|++.+.||+|+||+||+|...++..||||++... ....+.+.+|++++++++||||+++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~h~~i~~~ 84 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------------------SMSEDEFIEEAKVMMNLSHEKLVQL 84 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT------------------SBCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC------------------CCCHHHHHHHHHHHhcCCCCCEeeE
Confidence 3678899999999999999999998889999998421 1234678999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~k 160 (283)
T 3gen_A 85 YGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVK 160 (283)
T ss_dssp EEEECSSSSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEE
Confidence 99999999999999999999999999763 345899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||+++........ ......+|+.|+|||++....++.++||||+|+++|||++ |+.||... ...+.....
T Consensus 161 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~-----~~~~~~~~~ 234 (283)
T 3gen_A 161 VSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-----TNSETAEHI 234 (283)
T ss_dssp ECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHHH
T ss_pred Eccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-----ChhHHHHHH
Confidence 9999999765432211 1112346788999999998899999999999999999998 99998532 111111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
..... ...+...+..+.+++.+||+.||++|||+.|++++|+++.
T Consensus 235 ~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 235 AQGLR----------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcccC----------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 11111 1111122356889999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=362.51 Aligned_cols=268 Identities=21% Similarity=0.282 Sum_probs=210.6
Q ss_pred hhccCCcccccccCceeEEEEEe------CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-c
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-R 700 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 700 (947)
.++|++.+.||+|+||.||+|+. .+++.||||++.... .......+.+|+.+++++ +
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~ 107 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----------------DSSEREALMSELKMMTQLGS 107 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------------------CHHHHHHHHHHHHHCC
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----------------CHHHHHHHHHHHHHHHhhcC
Confidence 46889999999999999999995 245689999984211 123446789999999999 8
Q ss_pred ccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC---------------------ccCCHHHHHHHHHHHHHHHHH
Q 002250 701 HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK---------------------IEMDWVVRYAIAVGAAKGLEY 759 (947)
Q Consensus 701 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~ia~~l~y 759 (947)
||||+++++++..++..++||||+++|+|.+++..... ..+++..+..++.|++.||+|
T Consensus 108 hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 187 (344)
T 1rjb_A 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187 (344)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHH
T ss_pred CCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999986432 237899999999999999999
Q ss_pred HhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHH
Q 002250 760 LHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839 (947)
Q Consensus 760 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l 839 (947)
|| +.+|+||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++
T Consensus 188 LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 264 (344)
T 1rjb_A 188 LE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264 (344)
T ss_dssp HH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HH---hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHH
Confidence 99 899999999999999999999999999999876655443334445678899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 840 MELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 840 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
|||+| |..||..... ...+........ . ...+...+..+.+++.+||+.||.+|||+.|++++|+
T Consensus 265 ~el~t~g~~p~~~~~~-~~~~~~~~~~~~----~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 265 WEIFSLGVNPYPGIPV-DANFYKLIQNGF----K---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HHHTTTSCCSSTTCCC-SHHHHHHHHTTC----C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHcCCCCCcccCCc-HHHHHHHHhcCC----C---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 99998 9999854321 222222221110 0 1112223456889999999999999999999999999
Q ss_pred ccCCCCccee
Q 002250 919 EAEPCSVTNI 928 (947)
Q Consensus 919 ~~~~~~~~~~ 928 (947)
.+........
T Consensus 331 ~~~~~~~~~~ 340 (344)
T 1rjb_A 331 CQLADAEEAM 340 (344)
T ss_dssp HHC-------
T ss_pred HHHHHHHHHH
Confidence 8776554433
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=353.96 Aligned_cols=268 Identities=22% Similarity=0.250 Sum_probs=204.8
Q ss_pred HHHhhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
+.+.++|++.+.||+|+||+||+|+..+|+.||||++.... ........+.+|++++++++||||
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~hp~i 81 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---------------EDEGIPSTAIREISLLKELHHPNI 81 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------------------CHHHHHHHHHHHHHHCCCTTB
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc---------------ccchhhHHHHHHHHHHHHcCCCCE
Confidence 44568999999999999999999999889999999984221 112234678899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++..++..++||||++ |+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~ 156 (311)
T 3niz_A 82 VSLIDVIHSERCLTLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDG 156 (311)
T ss_dssp CCEEEEECCSSCEEEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTC
T ss_pred eeeeeEEccCCEEEEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCC
Confidence 999999999999999999997 5888888763 345899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
.+||+|||+++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+....
T Consensus 157 ~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~ 233 (311)
T 3niz_A 157 ALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD-DDQLPKIF 233 (311)
T ss_dssp CEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST-TTHHHHHH
T ss_pred CEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHH
Confidence 999999999987643322 2224568999999999876 4689999999999999999999999964422 22222221
Q ss_pred Hhhccccc-cccc-------------cccC-CCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 864 YSKMDSRD-SMLT-------------VVDP-NISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 864 ~~~~~~~~-~~~~-------------~~d~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
........ .+.. ..+. ...........++.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 234 SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111000 0000 0000 001112223456889999999999999999999997
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.00 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=203.1
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|.. .+++.||||++.. ...........+.+|+.+++.++||||++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~--------------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 73 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISR--------------QLLKKSDMHMRVEREISYLKLLRHPHIIK 73 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEH--------------HHHHHTTCSHHHHHHHHHHTTCCCTTBCC
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeh--------------HHccchhHHHHHHHHHHHHHhCCCCCCCe
Confidence 47899999999999999999996 4789999999831 11112234567899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||+ +|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+
T Consensus 74 l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~ 147 (336)
T 3h4j_B 74 LYDVITTPTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNV 147 (336)
T ss_dssp EEEEEECSSEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCE
T ss_pred EEEEEEeCCEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCE
Confidence 999999999999999999 78999998764 35899999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||++........ ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.......
T Consensus 148 kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------- 215 (336)
T 3h4j_B 148 KIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--------- 215 (336)
T ss_dssp EECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---------
T ss_pred EEEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---------
Confidence 9999999986654332 224579999999999988776 689999999999999999999995432110
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....+.......+...+..+.+++.+|++.||.+|||+.|++++
T Consensus 216 -------~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 216 -------LFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -------CBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -------HHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01111111112223344568899999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=377.21 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=204.9
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|..+++..||||++... ....+.|.+|++++++++||||++++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~hp~iv~~~ 245 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG------------------TMSPEAFLQEAQVMKKLRHEKLVQLY 245 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT------------------SSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccC------------------CCCHHHHHHHHHHHHhCCCCCEeeEE
Confidence 578889999999999999999988888999998421 12346789999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++.+ +..++||||+++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 246 ~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl 321 (452)
T 1fmk_A 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKV 321 (452)
T ss_dssp EEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEE
Confidence 99876 67899999999999999998654456899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||+++........ ......+|+.|+|||++..+.++.++||||||+++|||++ |+.||... ...+....+.
T Consensus 322 ~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~--- 395 (452)
T 1fmk_A 322 ADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVE--- 395 (452)
T ss_dssp CCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHH---
T ss_pred CCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHH---
Confidence 999999876543221 1223456789999999999999999999999999999999 89998432 1112221111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
.. . ..+.+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 396 ~~-~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 396 RG-Y---------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TT-C---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cC-C---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 11 0 1112234456788999999999999999999999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.65 Aligned_cols=264 Identities=28% Similarity=0.355 Sum_probs=203.4
Q ss_pred hhccCCcccccccCceeEEEEEe-----CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
.++|++.+.||+|+||+||+|++ .+++.||||++... .....+.+.+|++++++++||
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~ 71 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----------------TEEHLRDFEREIEILKSLQHD 71 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----------------CHHHHHHHHHHHHHHHTCCCT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----------------CHHHHHHHHHHHHHHHhCCCC
Confidence 36889999999999999999984 26889999998421 112346788999999999999
Q ss_pred ccceEEEEEec--CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 703 NVVKLYCSITS--EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 703 niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
||+++++++.. ....++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 72 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~ 147 (295)
T 3ugc_A 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILV 147 (295)
T ss_dssp TBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEE
Confidence 99999999865 35589999999999999999874 345899999999999999999999 8999999999999999
Q ss_pred cCCCCeEEeccccceecccCCCC-cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-----
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG----- 854 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~----- 854 (947)
+.++.+||+|||+++........ .......+|..|+|||++.+..++.++||||||+++|||++|..|+.....
T Consensus 148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~ 227 (295)
T 3ugc_A 148 ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227 (295)
T ss_dssp EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHH
T ss_pred cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhh
Confidence 99999999999999876543221 122234577889999999999999999999999999999999999743210
Q ss_pred -----CcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 855 -----DSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 855 -----~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
............. ......+.+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 228 IGNDKQGQMIVFHLIELL---------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HCTTCCTHHHHHHHHHHH---------HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCccccchhHHHHHHHH---------hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0000000001111 011112223345567899999999999999999999999998864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.57 Aligned_cols=259 Identities=20% Similarity=0.269 Sum_probs=205.0
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.+.|++.+.||+|+||+||+|... +++.||||++... ..........+.+.+|+.+++.++||||+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 89 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA------------KFTSSPGLSTEDLKREASICHMLKHPHIV 89 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH------------HHHTSSSCCHHHHHHHHHHHHHCCCTTBC
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhh------------hccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 4578999999999999999999965 6899999998311 01111123457799999999999999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
++++++..++..|+||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~ 166 (351)
T 3c0i_A 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASK 166 (351)
T ss_dssp CEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSS
T ss_pred cEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecC
Confidence 9999999999999999999999999888653 2345899999999999999999999 8999999999999999866
Q ss_pred CC---eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 784 WK---PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 784 ~~---~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+. +||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... .....
T Consensus 167 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~ 241 (351)
T 3c0i_A 167 ENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT---KERLF 241 (351)
T ss_dssp STTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS---HHHHH
T ss_pred CCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc---HHHHH
Confidence 54 99999999987654332 123457999999999999989999999999999999999999999542 11111
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
. ......... . .......+..+.+++.+|++.||++|||+.|+++
T Consensus 242 ~---~i~~~~~~~----~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 242 E---GIIKGKYKM----N---PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp H---HHHHTCCCC----C---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H---HHHcCCCCC----C---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 111111110 0 0011123456889999999999999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=349.38 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=204.1
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.. +|+.||||++... ........+.+.+|+.+++.++||||++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~E~~~l~~l~hp~Iv~ 70 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE--------------IVVRLKQVEHTNDERLMLSIVTHPFIIR 70 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHHSCCBTTBCC
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--------------HhhhhhHHHHHHHHHHHHhhCCCCCCce
Confidence 367899999999999999999965 7999999998311 1112245567889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+....|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 71 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~ 145 (318)
T 1fot_A 71 MWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHI 145 (318)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCE
T ss_pred EeEEEEeCCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCE
Confidence 999999999999999999999999999874 35889999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+++..... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||... +........
T Consensus 146 kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i 215 (318)
T 1fot_A 146 KITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NTMKTYEKI 215 (318)
T ss_dssp EECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHH
T ss_pred EEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHH
Confidence 99999999865432 22457999999999999999999999999999999999999999532 222222222
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQ 915 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 915 (947)
...... ++......+.+++.+|++.||++|| ++.|+++
T Consensus 216 ~~~~~~-----------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 216 LNAELR-----------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHCCCC-----------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HhCCCC-----------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 211111 1122335678899999999999999 8888874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=357.74 Aligned_cols=254 Identities=21% Similarity=0.332 Sum_probs=201.5
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|+.. +|+.||||++.... .....+.+.+|++++++++||||+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~hpniv 67 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----------------RELAREKVMREVKALAKLEHPGIV 67 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS----------------TTTHHHHHHHHHHHHTSCCCTTBC
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC----------------chhHHHHHHHHHHHHHhCCCCCEe
Confidence 4678999999999999999999976 79999999984211 123446789999999999999999
Q ss_pred eEEEEEecCCc---------------------------------------------------------cEEEEeccCCCC
Q 002250 706 KLYCSITSEDS---------------------------------------------------------NLLVYEYLPNGS 728 (947)
Q Consensus 706 ~l~~~~~~~~~---------------------------------------------------------~~lv~e~~~~gs 728 (947)
++++++.+... .++||||+++|+
T Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 147 (332)
T 3qd2_B 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKEN 147 (332)
T ss_dssp CEEEEEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSC
T ss_pred eEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCC
Confidence 99999865432 789999999999
Q ss_pred hHHHhhhcCC-ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCC----
Q 002250 729 LWDRLHTCHK-IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG---- 803 (947)
Q Consensus 729 L~~~l~~~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~---- 803 (947)
|.+++..... ...++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 148 L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~ 224 (332)
T 3qd2_B 148 LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224 (332)
T ss_dssp HHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------
T ss_pred HHHHHhcccCccchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccc
Confidence 9999987532 44677788999999999999999 899999999999999999999999999999876554221
Q ss_pred ------cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccc
Q 002250 804 ------DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVV 877 (947)
Q Consensus 804 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (947)
.......||+.|+|||++.+..++.++||||||+++|||++|..|+. +....... ..
T Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-------~~~~~~~~----------~~ 287 (332)
T 3qd2_B 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-------ERVRIITD----------VR 287 (332)
T ss_dssp -------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-------HHHHHHHH----------HH
T ss_pred ccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-------HHHHHHHH----------hh
Confidence 11223469999999999999999999999999999999999887741 11111111 11
Q ss_pred cCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 878 DPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 878 d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....+.........+.+++.+|++.||++|||+.|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 288 NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 112233344555678899999999999999999999873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=346.02 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=205.8
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.++|++.+.||+|+||+||+|+.. ++.||||++..... .....+.+.+|+.++++++||||+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~iv~~ 72 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDW---------------STRKSRDFNEECPRLRIFSHPNVLPV 72 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTC---------------CHHHHHHHHHHGGGGCCCSCTTEECE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEeccccc---------------CHHHHHHHHHHHHHHHhcCCCchhhe
Confidence 367889999999999999999987 89999999842211 11234578999999999999999999
Q ss_pred EEEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEeccCCCCCeEecCC
Q 002250 708 YCSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRP--VIHRDVKSSNILLDLE 783 (947)
Q Consensus 708 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dlkp~NIll~~~ 783 (947)
++++..+ ...++||||+++|+|.+++.......+++..+..++.|++.||+||| +.+ |+||||||+||+++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~ 149 (271)
T 3kmu_A 73 LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDED 149 (271)
T ss_dssp EEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTT
T ss_pred EEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCC
Confidence 9999887 77899999999999999999866667999999999999999999999 777 9999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCC---ccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINE---KSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+.++++|||++..... ....||+.|+|||++.+..++. ++||||||+++|||++|+.||... ...
T Consensus 150 ~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~ 217 (271)
T 3kmu_A 150 MTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-----SNM 217 (271)
T ss_dssp SCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS-----CHH
T ss_pred cceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc-----ChH
Confidence 9999999998754222 1346899999999998765554 799999999999999999998532 111
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
+.......... ....+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 218 ~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 218 EIGMKVALEGL---------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHSCC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11111111111 111222344568899999999999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=356.14 Aligned_cols=259 Identities=19% Similarity=0.196 Sum_probs=207.2
Q ss_pred hccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 706 (947)
++|++.+.||+|+||+||+|+. .+++.||||++... .....+.+|+.+++++ +||||++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------------~~~~~~~~E~~~l~~l~~h~~i~~ 69 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-------------------SRAPQLHLEYRFYKQLGSGDGIPQ 69 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT-------------------CSSCCHHHHHHHHHHHCSCTTSCC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc-------------------cchHHHHHHHHHHHHhhCCCCCCE
Confidence 6788999999999999999996 47899999988321 2234688999999999 9999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC-
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK- 785 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~- 785 (947)
+++++..++..++||||+ +++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~ 144 (330)
T 2izr_A 70 VYYFGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNK 144 (330)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGT
T ss_pred EEEEEecCCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCC
Confidence 999999999999999999 99999999874 356899999999999999999999 889999999999999998887
Q ss_pred ----eEEeccccceecccCCCCc-----ceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 002250 786 ----PRIADFGLAKIVQTGEAGD-----LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856 (947)
Q Consensus 786 ----~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 856 (947)
+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .
T Consensus 145 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~--~ 222 (330)
T 2izr_A 145 TQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK--A 222 (330)
T ss_dssp CTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--C
T ss_pred CCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc--c
Confidence 9999999998765433211 1235579999999999999999999999999999999999999996532 2
Q ss_pred ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.+..+............ .........+ .+.+++..|++.||.+||++.++.+.|+++
T Consensus 223 ~~~~~~~~~i~~~~~~~------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 223 DTLKERYQKIGDTKRAT------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SSHHHHHHHHHHHHHHS------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ccHHHHHHHHHhhhccC------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 22222221111110000 0000111123 789999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=357.16 Aligned_cols=257 Identities=23% Similarity=0.292 Sum_probs=205.8
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
..+.++|++.+.||+|+||.||+|..+ +|+.||||++..... .....+.+.+|+.++++++|||
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------------~~~~~~~~~~E~~il~~l~hpn 89 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---------------SARDFQKLEREARICRKLQHPN 89 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------------CHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC---------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 345688999999999999999999965 689999999842211 1123467889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++.+++..|+||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.+
T Consensus 90 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~ 164 (362)
T 2bdw_A 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASK 164 (362)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCS
T ss_pred CCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecC
Confidence 999999999999999999999999999999763 45899999999999999999999 8899999999999999865
Q ss_pred ---CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 784 ---WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 784 ---~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||... +..
T Consensus 165 ~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~-----~~~ 236 (362)
T 2bdw_A 165 AKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----DQH 236 (362)
T ss_dssp STTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHH
T ss_pred CCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-----CHH
Confidence 4599999999986654322 22457999999999999989999999999999999999999998532 112
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+............. .......+..+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~i~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 237 RLYAQIKAGAYDYP-------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHHTCCCCC-------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHhCCCCCC-------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 22111111111100 11112234568889999999999999999998864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.14 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=202.9
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||++++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~niv~~~ 108 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-----------------KQQRRELLFNEVVIMRDYQHFNVVEMY 108 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-----------------TCCSHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc-----------------chhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3666778999999999999976 7999999998422 123456788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 109 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl 182 (321)
T 2c30_A 109 KSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKL 182 (321)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEE
T ss_pred EEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEE
Confidence 999999999999999999999999875 35899999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||... ...+.......
T Consensus 183 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~-----~~~~~~~~~~~ 255 (321)
T 2c30_A 183 SDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD-----SPVQAMKRLRD 255 (321)
T ss_dssp CCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHH
T ss_pred eeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhc
Confidence 999999876543221 23457999999999999989999999999999999999999998532 11111111111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... +.+ ......+..+.+++.+|++.||++|||+.|++++
T Consensus 256 ~~~-------~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 256 SPP-------PKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp SSC-------CCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCC-------CCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 011 0111234568889999999999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=351.97 Aligned_cols=269 Identities=24% Similarity=0.318 Sum_probs=206.6
Q ss_pred HHHhhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc--ccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV--RHV 702 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~ 702 (947)
..+.++|++.+.||+|+||.||+|+.. ++.||||++.. .....+.+|.+++... +||
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--------------------~~~~~~~~e~~~~~~~~~~h~ 91 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT--------------------TEEASWFRETEIYQTVLMRHE 91 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG--------------------GGHHHHHHHHHHHTSTTCCCT
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec--------------------cccchhhhHHHHHHHHhhcCC
Confidence 556789999999999999999999987 89999998831 1223445566666554 999
Q ss_pred ccceEEEEEecC----CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeEe
Q 002250 703 NVVKLYCSITSE----DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDR--------PVIH 770 (947)
Q Consensus 703 niv~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~--------~ivH 770 (947)
||+++++++... ...++||||+++|+|.++++. ..+++..+..++.|++.||+||| +. +|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH 165 (337)
T 3mdy_A 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAH 165 (337)
T ss_dssp TBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEEC
T ss_pred CeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEe
Confidence 999999999887 678999999999999999976 35899999999999999999999 66 9999
Q ss_pred ccCCCCCeEecCCCCeEEeccccceecccCCCCc--ceecccccccccCccccccCCCCCc------cchHHHHHHHHHH
Q 002250 771 RDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGD--LTHVIAGTHGYIAPEYAYTCKINEK------SDVYSFGVVLMEL 842 (947)
Q Consensus 771 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slGv~l~el 842 (947)
|||||+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.+ +|||||||++|||
T Consensus 166 ~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el 245 (337)
T 3mdy_A 166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245 (337)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHH
T ss_pred cccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHH
Confidence 9999999999999999999999997664433211 1124479999999999987766665 9999999999999
Q ss_pred HhC----------CCCCCCCCCCcccHHHHHHhhccccccccccccCCCCc--cCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 843 VTG----------KRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISE--ILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 843 ltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
++| +.||................... ....+..+. ...+++..+.+++.+||+.||++|||+
T Consensus 246 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (337)
T 3mdy_A 246 ARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCI------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319 (337)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred HhccCcccccccccccHhhhcCCCCchhhhHHHHhh------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH
Confidence 999 56664433322222222111111 011111111 123677889999999999999999999
Q ss_pred HHHHHHhhccCCCCcc
Q 002250 911 RVVVQMLEEAEPCSVT 926 (947)
Q Consensus 911 ~ev~~~L~~~~~~~~~ 926 (947)
.|++++|+++....+.
T Consensus 320 ~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 320 LRVKKTLAKMSESQDI 335 (337)
T ss_dssp HHHHHHHHHHHHTTTC
T ss_pred HHHHHHHHHHHhhccc
Confidence 9999999987765543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=363.71 Aligned_cols=258 Identities=21% Similarity=0.259 Sum_probs=205.1
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
..+.++|++.+.||+|+||+||+|... +|+.||+|++..... .....+.+.+|+.++++++|||
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~---------------~~~~~~~~~~E~~il~~l~hpn 71 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL---------------SARDHQKLEREARICRLLKHPN 71 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC---------------HHHHHHHHHHHHHHHHHCCBTT
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC---------------CHHHHHHHHHHHHHHHhCCCcC
Confidence 355688999999999999999999965 789999999842210 1123456889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec--
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD-- 781 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~-- 781 (947)
|+++++++.+++..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++
T Consensus 72 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~ 146 (444)
T 3soa_A 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASK 146 (444)
T ss_dssp BCCEEEEEECSSEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBS
T ss_pred CCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecc
Confidence 999999999999999999999999999999874 45899999999999999999999 89999999999999998
Q ss_pred -CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 782 -LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 782 -~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|..||... +..
T Consensus 147 ~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~-----~~~ 219 (444)
T 3soa_A 147 LKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE-----DQH 219 (444)
T ss_dssp STTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHH
T ss_pred CCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc-----cHH
Confidence 468899999999976654322 122457999999999999989999999999999999999999999532 122
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+............ ..+. ....+..+.+++.+|++.||++|||+.|++++
T Consensus 220 ~~~~~i~~~~~~~---~~~~----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 220 RLYQQIKAGAYDF---PSPE----WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHHHTCCCC---CTTT----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhCCCCC---Cccc----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2222111111110 0111 11234568889999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.21 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=203.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +++.||||++........ .......+.+.+|++++++++||||+++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE----------TEMIEKFQEFQREVFIMSNLNHPNIVKL 88 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCC----------HHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccc----------hhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence 67889999999999999999965 789999999853321110 0111233678999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEeccCCCCCeEecCCCC
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRP--VIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dlkp~NIll~~~~~ 785 (947)
++++.+.. ++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCT
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCC
Confidence 99997654 7999999999999988763 346899999999999999999999 788 999999999999988776
Q ss_pred -----eEEeccccceecccCCCCcceecccccccccCccccc--cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 786 -----PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY--TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 786 -----~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
+||+|||+++.... ......||+.|+|||++. ...++.++||||+|+++|||++|+.||.........
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 237 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237 (287)
T ss_dssp TCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH
T ss_pred CCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH
Confidence 99999999974332 223457899999999983 455788999999999999999999999643322221
Q ss_pred HHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 859 IVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
....... ... ....+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 238 ~~~~~~~---~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 238 FINMIRE---EGL---------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHH---SCC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHhc---cCC---------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1221111 110 0112233456788999999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=354.38 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=211.1
Q ss_pred hhccCCcccccccCceeEEEEEe------CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-c
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-R 700 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 700 (947)
.++|++.+.||+|+||.||+|+. .+++.||||++.... .....+.+.+|+.+++++ +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~ 85 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----------------HLTEREALMSELKVLSYLGN 85 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHHHCC
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch----------------hHHHHHHHHHHHHHHhhccc
Confidence 36889999999999999999984 246789999984221 112346788999999999 9
Q ss_pred ccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC----------------ccCCHHHHHHHHHHHHHHHHHHhcCC
Q 002250 701 HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK----------------IEMDWVVRYAIAVGAAKGLEYLHHGF 764 (947)
Q Consensus 701 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~~ia~~l~yLH~~~ 764 (947)
||||+++++++..++..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||
T Consensus 86 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--- 162 (313)
T 1t46_A 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--- 162 (313)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred CCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---
Confidence 99999999999999999999999999999999986532 24899999999999999999999
Q ss_pred CCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh
Q 002250 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844 (947)
Q Consensus 765 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt 844 (947)
+.+|+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++
T Consensus 163 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 242 (313)
T 1t46_A 163 SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242 (313)
T ss_dssp HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 88999999999999999999999999999987665543333334457889999999999999999999999999999999
Q ss_pred -CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 845 -GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 845 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
|+.||..... ............. ...+...+..+.+++.+|++.||.+|||+.|++++|+++.
T Consensus 243 ~g~~p~~~~~~-~~~~~~~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 243 LGSSPYPGMPV-DSKFYKMIKEGFR-------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp TTCCSSTTCCS-SHHHHHHHHHTCC-------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCcccc-hhHHHHHhccCCC-------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 9999854321 1122222111110 0111223456889999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=360.03 Aligned_cols=263 Identities=20% Similarity=0.286 Sum_probs=210.4
Q ss_pred hhccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.++|++.+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++|
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h 87 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----------------SMRERIEFLNEASVMKEFNC 87 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----------------CHHHHHHHHHHHHHGGGCCC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc----------------CHHHHHHHHHHHHHHHhcCC
Confidence 478999999999999999999854 36789999984211 11233568899999999999
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccC
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDV 773 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl 773 (947)
|||+++++++..++..++||||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||
T Consensus 88 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~di 164 (322)
T 1p4o_A 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDL 164 (322)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCC
T ss_pred CCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCC
Confidence 999999999999999999999999999999997632 135689999999999999999999 889999999
Q ss_pred CCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 002250 774 KSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPE 852 (947)
Q Consensus 774 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~ 852 (947)
||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 165 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 165 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp SGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 99999999999999999999986544332222223457889999999998899999999999999999999 88888432
Q ss_pred CCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
...+........ .....+...+..+.+++.+|++.||++|||+.|+++.|++.....
T Consensus 245 -----~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 245 -----SNEQVLRFVMEG----------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp -----CHHHHHHHHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred -----CHHHHHHHHHcC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 111111111111 111222334556889999999999999999999999999876543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=362.91 Aligned_cols=346 Identities=27% Similarity=0.381 Sum_probs=169.3
Q ss_pred CCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEE
Q 002250 84 CTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWL 163 (947)
Q Consensus 84 l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L 163 (947)
+++|+.|++++|.++. .+.+..+++|++|+|++|.+.+..+ +.++++|++|++++|.+... +. +..+++|++|
T Consensus 45 l~~l~~L~l~~~~i~~-l~~~~~l~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~--~~-~~~l~~L~~L 117 (466)
T 1o6v_A 45 LDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQIADI--TP-LANLTNLTGL 117 (466)
T ss_dssp HHTCCEEECCSSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCC--GG-GTTCTTCCEE
T ss_pred hccccEEecCCCCCcc-CcchhhhcCCCEEECCCCccCCchh---hhccccCCEEECCCCccccC--hh-hcCCCCCCEE
Confidence 4455555555555543 2234444555555555555443221 44455555555555544432 11 4444455555
Q ss_pred EccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCC
Q 002250 164 YLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLE 243 (947)
Q Consensus 164 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 243 (947)
++++|.+++..+ +.++++|++|+|++|.+.+. + .+.++++|++|+++ |.+.+.. .+.++++|++|++++|.++
T Consensus 118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~ 190 (466)
T 1o6v_A 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS 190 (466)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCC
Confidence 555555443221 55555555555555555432 2 35555555555554 3333221 2555555555555555554
Q ss_pred CCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCccc
Q 002250 244 GDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCK 323 (947)
Q Consensus 244 ~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 323 (947)
+. +.+..+++|++|++++|.+++..| ++.+++|++|++++|++++ + ..+..+++|+.|++++|.+
T Consensus 191 ~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l---------- 255 (466)
T 1o6v_A 191 DI-SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQI---------- 255 (466)
T ss_dssp CC-GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCC----------
T ss_pred CC-hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCcc----------
Confidence 32 234445555555555555543332 4445555555555555542 1 2233444444444444443
Q ss_pred CCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEE
Q 002250 324 TGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLL 403 (947)
Q Consensus 324 ~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 403 (947)
++..+ +..+++|+.|++++|++++..+ +..+++|+.|+
T Consensus 256 --------------------------------------~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 293 (466)
T 1o6v_A 256 --------------------------------------SNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293 (466)
T ss_dssp --------------------------------------CCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred --------------------------------------ccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEE
Confidence 32222 3334444444444444443222 34444444444
Q ss_pred ccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeee
Q 002250 404 LANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSG 483 (947)
Q Consensus 404 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 483 (947)
+++|++++..| +..+++|+.|+|++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~ 367 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISD 367 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCB
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCc
Confidence 44444443222 4455555555555555554433 45556666666666665543 345566666666666666665
Q ss_pred ecCCCCCccCcCcEEECCCCccCCc
Q 002250 484 KIPDSLGSLPSLNSLNLSNNKFSGE 508 (947)
Q Consensus 484 ~~p~~~~~l~~L~~L~Ls~N~l~~~ 508 (947)
..| +..+++|+.|++++|++++.
T Consensus 368 ~~~--~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 368 LTP--LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp CGG--GTTCTTCCEEECCCEEEECC
T ss_pred cch--hhcCCCCCEEeccCCcccCC
Confidence 555 56666666666666666653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=358.89 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=199.4
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
.++|++.+.||+|+||+||+|+.+ +++.||||++... ..........+.+|+.+++.+ +||||+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~--------------~~~~~~~~~~~~~E~~il~~~~~hp~Iv 87 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD--------------VILQDDDVECTMTEKRILSLARNHPFLT 87 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--------------HHHHHTTHHHHHHHHHHHHHTTTCTTBC
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHH--------------HhcchhHHHHHHHHHHHHHhccCCCcee
Confidence 478999999999999999999966 6899999998311 111224456788999999988 799999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..++..|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 88 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ 162 (353)
T 3txo_A 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGH 162 (353)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSC
T ss_pred eEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCC
Confidence 9999999999999999999999999999874 35899999999999999999999 889999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+||+|||+|+...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....
T Consensus 163 ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~~~~~~~ 235 (353)
T 3txo_A 163 CKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-----NEDDLFEA 235 (353)
T ss_dssp EEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred EEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC-----CHHHHHHH
Confidence 9999999997533222 1233457999999999999888999999999999999999999999532 22222222
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM------RVVVQ 915 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~ev~~ 915 (947)
....... ++......+.+++.+|++.||++||++ .|+++
T Consensus 236 i~~~~~~-----------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 236 ILNDEVV-----------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHcCCCC-----------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 2221111 112233457889999999999999998 66654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.62 Aligned_cols=256 Identities=21% Similarity=0.303 Sum_probs=195.2
Q ss_pred hhccCCcccccccCceeEEEEEeCC----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNS----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
.++|++.+.||+|+||.||+|.... +..||||++... ......+.+.+|+.++++++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~ 77 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----------------TSDSVREKFLQEALTMRQFDHPH 77 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----------------TSHHHHHHHHHHHHHHHTCCCTT
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc----------------CCHHHHHHHHHHHHHHHhCCCCc
Confidence 3688999999999999999999642 457999987321 11123467889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++. ++..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 78 iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 152 (281)
T 1mp8_A 78 IVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSN 152 (281)
T ss_dssp BCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEET
T ss_pred cceEEEEEc-cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCC
Confidence 999999985 46789999999999999999863 346899999999999999999999 8899999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||+++......... .....+|+.|+|||++....++.++||||||+++|||++ |..||.... ..+....
T Consensus 153 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~--~~~~~~~ 229 (281)
T 1mp8_A 153 DCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGR 229 (281)
T ss_dssp TEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHH
T ss_pred CCEEECccccccccCcccccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC--HHHHHHH
Confidence 999999999998765433221 223356789999999998899999999999999999997 899985431 2222222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
+... .....+...+..+.+++.+|++.||++|||+.|+++.|+++
T Consensus 230 i~~~-------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 230 IENG-------------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp HHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcC-------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2111 11112233456788999999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=362.45 Aligned_cols=276 Identities=18% Similarity=0.234 Sum_probs=207.2
Q ss_pred hhccCCccccccc--CceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 628 IDAVKPENLIGKG--GSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 628 ~~~~~~~~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
.++|++.+.||+| +||+||+|+.. +++.||||++.... ........+.+|+.++++++||||
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~ni 88 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA---------------CSNEMVTFLQGELHVSKLFNHPNI 88 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG---------------SCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc---------------cChHHHHHHHHHHHHHHhCCCCCC
Confidence 3689999999999 99999999976 79999999984211 111234678889999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
|++++++..++..++||||+++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~ 165 (389)
T 3gni_B 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDG 165 (389)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred CcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence 999999999999999999999999999998765567999999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCC-----CcceecccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 785 KPRIADFGLAKIVQTGEA-----GDLTHVIAGTHGYIAPEYAYT--CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
.+||+|||.+........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~ 244 (389)
T 3gni_B 166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT-Q 244 (389)
T ss_dssp CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST-T
T ss_pred CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH-H
Confidence 999999999865432211 111223478999999999987 57899999999999999999999999643211 1
Q ss_pred cHHHHHHhhccc----cc---------------------------cccccccCCCCccCHHHHHHHHHHHHhccCCCCCC
Q 002250 858 DIVNWVYSKMDS----RD---------------------------SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAF 906 (947)
Q Consensus 858 ~~~~~~~~~~~~----~~---------------------------~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 906 (947)
............ .. ......+....+........+.+++.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 324 (389)
T 3gni_B 245 MLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324 (389)
T ss_dssp HHHHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTT
T ss_pred HHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCccc
Confidence 111100000000 00 00000000001122334567899999999999999
Q ss_pred CCCHHHHHHH--hhccCC
Q 002250 907 RPSMRVVVQM--LEEAEP 922 (947)
Q Consensus 907 RPt~~ev~~~--L~~~~~ 922 (947)
|||+.|++++ ++++..
T Consensus 325 Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 325 RPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp SCCHHHHTTSGGGGGC--
T ss_pred CCCHHHHhcCHHHHHHhh
Confidence 9999999965 555543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=360.67 Aligned_cols=252 Identities=22% Similarity=0.302 Sum_probs=198.7
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
.++|++.+.||+|+||+||+|+.+ +++.||||++.... .........+.+|..+++++ +||||+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~--------------~~~~~~~~~~~~E~~il~~~~~hp~Iv 116 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKEL--------------VNDDEDIDWVQTEKHVFEQASNHPFLV 116 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGG--------------TC----CCHHHHHHHHHHHHTTCTTBC
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh--------------ccCHHHHHHHHHHHHHHHhcCCCCCcC
Confidence 467999999999999999999976 68899999984221 11123345678899999887 899999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..++..|+||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 117 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ 191 (396)
T 4dc2_A 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGH 191 (396)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSC
T ss_pred eeEEEEEECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCC
Confidence 9999999999999999999999999999874 35899999999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC---cccHHHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD---SKDIVNW 862 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~---~~~~~~~ 862 (947)
+||+|||+|+...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.
T Consensus 192 ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~ 269 (396)
T 4dc2_A 192 IKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 269 (396)
T ss_dssp EEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH
T ss_pred EEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH
Confidence 9999999998533222 1233567999999999999999999999999999999999999999643211 1111111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
....+.... ..++......+.+++.+|++.||++||++
T Consensus 270 ~~~~i~~~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 270 LFQVILEKQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHCC----------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHhccc----------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 111111111 11222334567889999999999999996
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=347.60 Aligned_cols=261 Identities=17% Similarity=0.192 Sum_probs=209.6
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+|+.+++++ +|+|++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------------~~~~~~~~e~~~~~~l~~~~~i~ 69 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-------------------SDAPQLRDEYRTYKLLAGCTGIP 69 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-------------------TTSCCHHHHHHHHHHTTTCTTCC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-------------------CccHHHHHHHHHHHHHhcCCCCC
Confidence 46799999999999999999995 57999999988321 2334688999999999 799999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..+...++||||+ +++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 70 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~ 144 (298)
T 1csn_A 70 NVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNS 144 (298)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSS
T ss_pred eEEeecCCCceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCC
Confidence 9999999999999999999 99999999874 345899999999999999999999 899999999999999987776
Q ss_pred -----eEEeccccceecccCCCC-----cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 786 -----PRIADFGLAKIVQTGEAG-----DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 786 -----~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 145 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 224 (298)
T 1csn_A 145 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224 (298)
T ss_dssp TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence 999999999876554322 1223457999999999999989999999999999999999999999653211
Q ss_pred -cccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 856 -SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 856 -~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
............. ...........+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 225 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 225 TNKQKYERIGEKKQ---------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp CHHHHHHHHHHHHH---------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ccHHHHHHHHhhcc---------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 1111111111000 00111122234567889999999999999999999999999764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=344.26 Aligned_cols=254 Identities=30% Similarity=0.397 Sum_probs=194.7
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||.||+|... ++.||||++..... .......+.+.+|+++++.++||||++++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 72 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPD-------------EDISQTIENVRQEAKLFAMLKHPNIIALR 72 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC-----------------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCc-------------ccHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 57888999999999999999986 89999999842211 11123456789999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCC---eEeccCCCCCeEecC---
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRP---VIHRDVKSSNILLDL--- 782 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~---ivH~Dlkp~NIll~~--- 782 (947)
+++..++..++||||+++++|.+++.. ..+++..+..++.|++.||+||| +.+ |+||||||+||+++.
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~ 146 (271)
T 3dtc_A 73 GVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVE 146 (271)
T ss_dssp EEECCC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCS
T ss_pred EEEecCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccc
Confidence 999999999999999999999999864 46899999999999999999999 666 999999999999986
Q ss_pred -----CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 783 -----EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 783 -----~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
++.+||+|||.++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 147 ~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----- 217 (271)
T 3dtc_A 147 NGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI----- 217 (271)
T ss_dssp SSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS-----
T ss_pred cccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----
Confidence 67899999999976543322 2346899999999999988999999999999999999999998532
Q ss_pred cHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 858 DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
+............. ....+...+..+.+++.+|++.||++|||+.|++++|+++
T Consensus 218 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 218 DGLAVAYGVAMNKL---------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CHHHHHHHHHTSCC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CHHHHHHhhhcCCC---------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11111111111110 0112233445788999999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=349.90 Aligned_cols=253 Identities=29% Similarity=0.443 Sum_probs=197.6
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|+.. ++.||||++.. ....+.+.+|++++++++||||++++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-------------------~~~~~~~~~E~~~l~~l~hp~iv~~~ 67 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES-------------------ESERKAFIVELRQLSRVNHPNIVKLY 67 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS-------------------TTHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC-------------------hhHHHHHHHHHHHHhcCCCCCcCeEE
Confidence 57888999999999999999986 78999998831 12346789999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCC-ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC-e
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHK-IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK-P 786 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~ 786 (947)
+++.+ ..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +
T Consensus 68 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~ 145 (307)
T 2eva_A 68 GACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVL 145 (307)
T ss_dssp EBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEE
T ss_pred EEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEE
Confidence 98874 58999999999999999986543 24788999999999999999999332289999999999999998887 7
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......
T Consensus 146 kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~ 217 (307)
T 2eva_A 146 KICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA---FRIMWAV 217 (307)
T ss_dssp EECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH---HHHHHHH
T ss_pred EEccccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH---HHHHHHH
Confidence 999999997543321 23468999999999999899999999999999999999999985432211 1111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
.... ........+..+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 218 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 218 HNGT----------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp HTTC----------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred hcCC----------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1111 11122233456889999999999999999999999998765
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=360.75 Aligned_cols=355 Identities=17% Similarity=0.177 Sum_probs=295.5
Q ss_pred CceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeec
Q 002250 36 GLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNL 115 (947)
Q Consensus 36 ~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L 115 (947)
.+++.++++++++.+. | .++.+++|+.|+|++|.+.+. | ++.+++|++|+|++|+|++. .++.+++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~~-~--~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~--~~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T--GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL--DVTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T--TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC--CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h--hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee--ecCCCCcCCEEEC
Confidence 5789999999998875 4 699999999999999999875 3 89999999999999999986 3899999999999
Q ss_pred CCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccc
Q 002250 116 NSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELF 195 (947)
Q Consensus 116 ~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 195 (947)
++|++++ ++ +..+++|++|++++|+++..+ +..+++|++|++++|...+.+ .+..+++|++|+|++|+++
T Consensus 114 ~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l~----l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~ 183 (457)
T 3bz5_A 114 DTNKLTK-LD---VSQNPLLTYLNCARNTLTEID----VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT 183 (457)
T ss_dssp CSSCCSC-CC---CTTCTTCCEEECTTSCCSCCC----CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCC
T ss_pred CCCcCCe-ec---CCCCCcCCEEECCCCccceec----cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccc
Confidence 9999986 33 889999999999999998753 778999999999999665555 5889999999999999998
Q ss_pred cccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccC
Q 002250 196 GEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGE 275 (947)
Q Consensus 196 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~ 275 (947)
+ +| +..+++|++|++++|++++. .+..+++|++|++++|++++.+ +..+++|+.|++++|++++.. ++.
T Consensus 184 ~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~~---~~~ 252 (457)
T 3bz5_A 184 E-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELD---VST 252 (457)
T ss_dssp C-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCC---CTT
T ss_pred e-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCcC---HHH
Confidence 6 44 88999999999999999975 4889999999999999999865 888999999999999999754 456
Q ss_pred CCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEE
Q 002250 276 FKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFR 355 (947)
Q Consensus 276 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~ 355 (947)
+++|+.|++++|+ |+.|++++|.+.+.+| +..+..|+.|++.+|...+.+|.. ..+|+.|+
T Consensus 253 l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~---~~~L~~L~ 313 (457)
T 3bz5_A 253 LSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQ---AAGITELD 313 (457)
T ss_dssp CTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECT---TCCCSCCC
T ss_pred CCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccC---CCcceEec
Confidence 7788888887764 4567888888777666 355677888888888877777743 33444444
Q ss_pred cccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccC
Q 002250 356 VNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSG 435 (947)
Q Consensus 356 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 435 (947)
+++ +++|+.|++++|++++. .++.+++|+.|++++|++++ ++.|..|++++|.+.|
T Consensus 314 l~~-------------~~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g 369 (457)
T 3bz5_A 314 LSQ-------------NPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEA 369 (457)
T ss_dssp CTT-------------CTTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEE
T ss_pred hhh-------------cccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEEe
Confidence 444 36888889999998874 27888889999999998885 2456667888999886
Q ss_pred CCCcccccccccchhhccccccCCCCCccccc
Q 002250 436 QIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGS 467 (947)
Q Consensus 436 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 467 (947)
. +.+..|+.++|++|+++|.+|..+..
T Consensus 370 ~-----~~~~~l~~l~l~~N~l~g~ip~~~~~ 396 (457)
T 3bz5_A 370 E-----GQTITMPKETLTNNSLTIAVSPDLLD 396 (457)
T ss_dssp E-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred c-----ceeeecCccccccCcEEEEcChhHhc
Confidence 5 46778889999999999998876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=358.61 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=209.0
Q ss_pred hhccCCcccccccCceeEEEEEeC--------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN--------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV 699 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 699 (947)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .......+.+|+++++++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l 97 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----------------TEKDLSDLVSEMEMMKMI 97 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC----------------CHHHHHHHHHHHHHHHHH
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC----------------cHHHHHHHHHHHHHHHHh
Confidence 368899999999999999999863 46789999984211 112346788999999999
Q ss_pred -cccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC--------------ccCCHHHHHHHHHHHHHHHHHHhcCC
Q 002250 700 -RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK--------------IEMDWVVRYAIAVGAAKGLEYLHHGF 764 (947)
Q Consensus 700 -~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~ia~~l~yLH~~~ 764 (947)
+||||+++++++..++..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||
T Consensus 98 ~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--- 174 (334)
T 2pvf_A 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--- 174 (334)
T ss_dssp CCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---
T ss_pred hcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---
Confidence 899999999999999999999999999999999986432 34899999999999999999999
Q ss_pred CCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh
Q 002250 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844 (947)
Q Consensus 765 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt 844 (947)
+.+|+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++
T Consensus 175 ~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 254 (334)
T 2pvf_A 175 SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254 (334)
T ss_dssp HTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred hCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHh
Confidence 88999999999999999999999999999987655433222334457889999999998889999999999999999999
Q ss_pred -CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 845 -GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 845 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
|+.||... ....+...+.. .. ....+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 255 ~g~~p~~~~--~~~~~~~~~~~---~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 255 LGGSPYPGI--PVEELFKLLKE---GH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp TSCCSSTTC--CHHHHHHHHHH---TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCcC--CHHHHHHHHhc---CC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99998532 11122221111 11 011122334568899999999999999999999999998643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=347.11 Aligned_cols=266 Identities=21% Similarity=0.294 Sum_probs=202.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +++.||||++.... ........+.+|+.++++++||||+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 66 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---------------DDEGVPSSALREICLLKELKHKNIVRL 66 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---------------SSTTHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC---------------CcCCcchHHHHHHHHHhcCCCCCEeeE
Confidence 57889999999999999999975 68999999984321 111233667899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||+++ ++.+.+... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 67 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~k 141 (292)
T 3o0g_A 67 HDVLHSDKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp EEEEEETTEEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEE
T ss_pred EeEEEeCCEEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 9999999999999999975 666666542 346899999999999999999999 88999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||+++....... ......||+.|+|||++.+.. ++.++||||+||++|||++|..||.........+.......
T Consensus 142 l~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~ 219 (292)
T 3o0g_A 142 LANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp ECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred EeecccceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 999999987643322 223457899999999998766 79999999999999999999998754332222222221111
Q ss_pred cccccc-cccc-------------ccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDS-MLTV-------------VDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~-~~~~-------------~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...... +... ...............+.+++.+|++.||++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 110000 0000 0001112223345668899999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=349.77 Aligned_cols=263 Identities=28% Similarity=0.428 Sum_probs=196.8
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.++|++.+.||+|+||+||+|+.. ..||||++.... ......+.+.+|+.++++++||||+++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA---------------PTPQQLQAFKNEVGVLRKTRHVNILLF 85 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSS---------------CCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccC---------------CCHHHHHHHHHHHHHHHhCCCCcEEEE
Confidence 367999999999999999999865 359999984221 111234678999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++ .....++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 86 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~k 160 (289)
T 3og7_A 86 MGYS-TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVK 160 (289)
T ss_dssp EEEE-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEE
T ss_pred Eeec-cCCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEE
Confidence 9965 456689999999999999999763 356899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY---TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
|+|||+++...............||+.|+|||++. ...++.++||||||+++|||++|+.||.... ....+.+...
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~ 239 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVG 239 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC-CHHHHHHHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc-hHHHHHHHhc
Confidence 99999998655433322333457899999999986 5668889999999999999999999985432 1122222221
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
... ..+.........+..+.+++.+|++.||++|||+.|+++.|+++..
T Consensus 240 ~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 240 RGS---------LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HTS---------CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccc---------cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111 1122222333455678999999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=354.97 Aligned_cols=253 Identities=24% Similarity=0.297 Sum_probs=203.5
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +++.||||++... ..........+.+|+.+++.++||||++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~--------------~~~~~~~~~~~~~E~~il~~l~hp~Iv~ 79 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ--------------KCVERNEVRNVFKELQIMQGLEHPFLVN 79 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehh--------------hcccHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 478999999999999999999966 6889999998311 1112344577889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 80 l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~v 154 (384)
T 4fr4_A 80 LWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHV 154 (384)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEEEeCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCE
Confidence 999999999999999999999999999863 45899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT---CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
||+|||+|+....... ....+||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ......
T Consensus 155 kL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~ 229 (384)
T 4fr4_A 155 HITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIV 229 (384)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHH
T ss_pred EEeccceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHH
Confidence 9999999987654322 234579999999999864 45889999999999999999999999643221 122211
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-MRVVVQ 915 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~~ 915 (947)
....... ...+......+.+++.+|++.||++||+ +.++.+
T Consensus 230 ~~~~~~~-----------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 230 HTFETTV-----------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHCC-----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHhhcc-----------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1111111 1122233456889999999999999998 666553
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.82 Aligned_cols=248 Identities=22% Similarity=0.265 Sum_probs=204.5
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +|+.||||++... ..........+.+|+.+++.++||||++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 105 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--------------KVVKLKQIEHTLNEKRILQAVNFPFLVK 105 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHTTCCCTTBCC
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhH--------------HhccHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 468999999999999999999976 6999999998311 1112244567889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 106 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~ 180 (350)
T 1rdq_E 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180 (350)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCE
Confidence 999999999999999999999999999874 34889999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+++...... ...+||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+.....
T Consensus 181 kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i 250 (350)
T 1rdq_E 181 QVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QPIQIYEKI 250 (350)
T ss_dssp EECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHH
T ss_pred EEcccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC-----CHHHHHHHH
Confidence 999999998764332 2457999999999999999999999999999999999999999532 222222222
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-----MRVVVQ 915 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 915 (947)
...... ++......+.+++.+|++.||++||+ +.|+.+
T Consensus 251 ~~~~~~-----------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 251 VSGKVR-----------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHCCCC-----------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HcCCCC-----------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 211111 12223456889999999999999998 788775
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=347.94 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=207.2
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||.||+|...+++.||||++... ....+.+.+|++++++++||||++++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG------------------SMSPDAFLAEANLMKQLQHQRLVRLY 74 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT------------------SSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC------------------cccHHHHHHHHHHHHhCCCcCcceEE
Confidence 678999999999999999999988889999998421 12346789999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++.. +..++||||+++++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||
T Consensus 75 ~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl 150 (279)
T 1qpc_A 75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKI 150 (279)
T ss_dssp EEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred EEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEE
Confidence 99874 56899999999999999998654456899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.+......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||... ......... .
T Consensus 151 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~---~ 224 (279)
T 1qpc_A 151 ADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNL---E 224 (279)
T ss_dssp CCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHH---H
T ss_pred CCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc--CHHHHHHHH---h
Confidence 999999876543221 1123356789999999998889999999999999999999 89998432 111111111 1
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
.... ...+...+..+.+++.+|++.||++|||+.++++.|+++.
T Consensus 225 ~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 225 RGYR----------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccC----------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 1100 1112233457889999999999999999999999999754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.48 Aligned_cols=256 Identities=23% Similarity=0.305 Sum_probs=208.0
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||.||+|...+++.||||++... ....+.+.+|++++++++||||++++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~ 69 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG------------------AMSEEDFIEEAEVMMKLSHPKLVQLY 69 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT------------------TBCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEcccc------------------CCCHHHHHHHHHHHHhCCCCCEeeEE
Confidence 578889999999999999999988899999998421 12346789999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl 145 (267)
T 3t9t_A 70 GVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKV 145 (267)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEE
T ss_pred EEEccCCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEE
Confidence 9999999999999999999999999864 346899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.+........ .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||... ...+......
T Consensus 146 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~i~ 219 (267)
T 3t9t_A 146 SDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDIS 219 (267)
T ss_dssp CCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHH
T ss_pred cccccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC-----CHHHHHHHHh
Confidence 99999976533211 11123356788999999998889999999999999999999 89998532 1122211111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
.... ...+...+..+.+++.+|++.||++|||+.+++++|+++..
T Consensus 220 ~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 220 TGFR----------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCc----------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1110 01111234568889999999999999999999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=346.45 Aligned_cols=265 Identities=26% Similarity=0.339 Sum_probs=199.9
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|+..+++.||||++.... ........+.+|++++++++||||++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 66 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---------------EDEGIPSTTIREISILKELKHSNIVKLY 66 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS---------------GGGCCCHHHHHHHHGGGGCCCTTBCCEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccc---------------cccccchhHHHHHHHHHhcCCCCEeeee
Confidence 5788899999999999999999889999999984221 1123346788999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+++ +|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 67 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl 141 (288)
T 1ob3_A 67 DVIHTKKRLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKI 141 (288)
T ss_dssp EEEECSSCEEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred eEEccCCeEEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEE
Confidence 999999999999999975 999988764 345889999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||+++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ....+........
T Consensus 142 ~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~ 218 (288)
T 1ob3_A 142 ADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-EADQLMRIFRILG 218 (288)
T ss_dssp CCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHC
T ss_pred eECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHHC
Confidence 99999976543221 12234689999999998764 58999999999999999999999985431 1111111111100
Q ss_pred ccc-cccc-----ccccCCC--------CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSR-DSML-----TVVDPNI--------SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~-~~~~-----~~~d~~~--------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... ..+. ...++.. ..........+.+++.+|++.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0000 0011111 11222345668899999999999999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=357.55 Aligned_cols=256 Identities=21% Similarity=0.288 Sum_probs=203.4
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.+ +++.||||++... ..........+.+|+.+++.++||||++
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~--------------~~~~~~~~~~~~~E~~il~~l~hp~Iv~ 133 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--------------EMIKRSDSAFFWEERDIMAFANSPWVVQ 133 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--------------HHHHTCCCSTHHHHHHHHHHCCCTTBCC
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehh--------------hhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 468999999999999999999976 6889999998311 1112234456889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..|+||||+++|+|.++++. ..+++.....++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 134 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~i 207 (410)
T 3v8s_A 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL 207 (410)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEEEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCE
Confidence 99999999999999999999999999976 35788999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCC----CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK----INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
||+|||+|+........ .....+||+.|+|||++.... ++.++|||||||++|||++|+.||... +....
T Consensus 208 kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~ 281 (410)
T 3v8s_A 208 KLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----SLVGT 281 (410)
T ss_dssp EECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHH
T ss_pred EEeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC-----ChhhH
Confidence 99999999876543221 122457999999999997655 788999999999999999999999532 22222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAF--RPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~ 916 (947)
........... ..+. .......+.+++.+|+..+|.+ ||++.||+++
T Consensus 282 ~~~i~~~~~~~------~~p~-~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 282 YSKIMNHKNSL------TFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHHTHHHHC------CCCT-TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHHHHhccccc------cCCC-cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 22221111100 0000 0112345788899999999998 9999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=350.32 Aligned_cols=257 Identities=27% Similarity=0.369 Sum_probs=212.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|... +++.||||++... ....+.+.+|++++++++||||++
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------~~~~~~~~~E~~~l~~l~h~~i~~ 73 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------------TMEVEEFLKEAAVMKEIKHPNLVQ 73 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC------------------STHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC------------------HHHHHHHHHHHHHHHhCCCCCEee
Confidence 467889999999999999999976 5889999998421 133467889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||+++++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~ 150 (288)
T 3kfa_A 74 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 150 (288)
T ss_dssp EEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCE
Confidence 9999999999999999999999999998877777999999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||.+........ .......+|+.|+|||++.+..++.++||||||+++|||++ |..||... ......+....
T Consensus 151 ~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~--~~~~~~~~~~~ 227 (288)
T 3kfa_A 151 KVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEK 227 (288)
T ss_dssp EECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHT
T ss_pred EEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhc
Confidence 9999999986654322 22223457889999999998899999999999999999999 88898532 22222222211
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
.. ....+...+..+.+++.+|++.||++|||+.|+++.|+++.
T Consensus 228 ~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 228 DY-------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp TC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cC-------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 11 01112233457889999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=356.24 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=190.4
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
.+.+.|++.+.||+|+||+||+|+.. +++.||||++... ...+.+.+|++++++++||||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------------------~~~~~~~~E~~~l~~l~h~ni 110 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-------------------VDKKIVRTEIGVLLRLSHPNI 110 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------------------CHHHHHCCCTTB
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------------------hhHHHHHHHHHHHHhCCCCCC
Confidence 34578999999999999999999976 5889999998421 123567889999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC--
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL-- 782 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~-- 782 (947)
+++++++..++..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 111 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~ 185 (349)
T 2w4o_A 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPA 185 (349)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSS
T ss_pred cceeeeEecCCeEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCC
Confidence 99999999999999999999999999999863 45899999999999999999999 889999999999999975
Q ss_pred -CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 783 -EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 783 -~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 186 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~- 260 (349)
T 2w4o_A 186 PDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-FMF- 260 (349)
T ss_dssp TTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-HHH-
T ss_pred CCCCEEEccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-HHH-
Confidence 88999999999986543321 234578999999999999899999999999999999999999985432211 111
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
......... . ..+...+.+..+.+++.+|++.||++|||+.|++++
T Consensus 261 --~~i~~~~~~---~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 261 --RRILNCEYY---F----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --HHHHTTCCC---C----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --HHHHhCCCc---c----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111111 0 111122344568899999999999999999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=357.99 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=206.4
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
..+.+.|++.+.||+|+||+||+|... +|+.||+|++.... ......+.+|+.++++++|||
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----------------~~~~~~~~~E~~il~~l~hpn 109 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----------------PLDKYTVKNEISIMNQLHHPK 109 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----------------HHHHHHHHHHHHHHTTCCSTT
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----------------hhhHHHHHHHHHHHHhCCCcC
Confidence 345678999999999999999999965 68999999983210 122356889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC-
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL- 782 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~- 782 (947)
|+++++++.++...++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 110 Iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~ 185 (387)
T 1kob_A 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETK 185 (387)
T ss_dssp BCCEEEEEECSSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESST
T ss_pred CCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecC
Confidence 999999999999999999999999999999763 346899999999999999999999 899999999999999974
Q ss_pred -CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 783 -EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 783 -~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+
T Consensus 186 ~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~~ 257 (387)
T 1kob_A 186 KASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDLE 257 (387)
T ss_dssp TCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHH
T ss_pred CCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC-----CHHH
Confidence 57799999999987654332 23457999999999999989999999999999999999999999532 1122
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
........... .+ .......+..+.+++.+|++.||++|||+.|++++
T Consensus 258 ~~~~i~~~~~~----~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 258 TLQNVKRCDWE----FD---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHHCCCC----CC---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhCCCC----CC---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 22111111111 01 11112334568899999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=360.35 Aligned_cols=277 Identities=17% Similarity=0.187 Sum_probs=206.1
Q ss_pred hhccCCcccccccCceeEEEEEeCC------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNS------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.++|++.+.||+|+||+||+|.... ++.||||++..... ....+...........+..|+..++.++|
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~e~~~~~~~~~~~~~~e~~~~~~l~h 107 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG------PLFTELKFYQRAAKPEQIQKWIRTRKLKY 107 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH------HHHHHHHHHHHHCCHHHHHHHHHHTTCSC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch------hHHHHHHHHHhhhhhHHHHHHHHHhhccC
Confidence 4589999999999999999999764 47899999843210 00111111112233455667788888899
Q ss_pred cccceEEEEEecC----CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 702 VNVVKLYCSITSE----DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 702 ~niv~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
|||+++++++... ...++||||+ +++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|
T Consensus 108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~N 182 (364)
T 3op5_A 108 LGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASN 182 (364)
T ss_dssp CCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGG
T ss_pred CCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHH
Confidence 9999999998775 3479999999 99999999873 356899999999999999999999 8899999999999
Q ss_pred eEec--CCCCeEEeccccceecccCCCCc-----ceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 002250 778 ILLD--LEWKPRIADFGLAKIVQTGEAGD-----LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 778 Ill~--~~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
||++ .++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999 88999999999998765432211 1123459999999999999899999999999999999999999996
Q ss_pred CCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 851 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
...... .......... ...+....++.+. ....+..+.+++..||+.||++||++.++++.|+++
T Consensus 263 ~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 263 DNLKDP-KYVRDSKIRY--RENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp GGTTCH-HHHHHHHHHH--HHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccccCH-HHHHHHHHHh--hhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 433221 1221111111 1111111111110 012245788999999999999999999999998864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=356.71 Aligned_cols=262 Identities=26% Similarity=0.369 Sum_probs=206.0
Q ss_pred hccCCcccccccCceeEEEEEe-----CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.|++.+.||+|+||.||+|++ .+++.||||++.... .......+.+|++++++++|||
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~ 84 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----------------GGNHIADLKKEIEILRNLYHEN 84 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------------------CCHHHHHHHHHHHHTCCCTT
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc----------------cchhHHHHHHHHHHHHhCCCCC
Confidence 5688899999999999999983 368899999984221 1234577899999999999999
Q ss_pred cceEEEEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 704 VVKLYCSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 704 iv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
|+++++++..+ ...++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 85 i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~ 160 (302)
T 4e5w_A 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVE 160 (302)
T ss_dssp BCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEE
T ss_pred eeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEc
Confidence 99999999876 6679999999999999999653 345899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCCC-cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC-------
Q 002250 782 LEWKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEF------- 853 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~------- 853 (947)
.++.+||+|||++......... .......||..|+|||++.+..++.++||||+|+++|||++|+.|+....
T Consensus 161 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 240 (302)
T 4e5w_A 161 SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240 (302)
T ss_dssp ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH
T ss_pred CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhcc
Confidence 9999999999999876544321 12223467888999999999889999999999999999999999863211
Q ss_pred ---CCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 854 ---GDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 854 ---~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.......... ... ........+...+..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 241 ~~~~~~~~~~~~~-~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 241 GPTHGQMTVTRLV-NTL---------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp CSCCGGGHHHHHH-HHH---------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccccCHHHHH-HHH---------hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 0000111111 111 01111222334456788999999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=356.30 Aligned_cols=280 Identities=24% Similarity=0.372 Sum_probs=204.1
Q ss_pred hccCCcccccccCceeEEEEEeCC-----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS-----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
++|+..+.||+|+||+||+|.... +..||||++.... .......+.+|+.++++++|||
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~ 107 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----------------TEKQRVDFLGEAGIMGQFSHHN 107 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHTCCCTT
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 567778999999999999998652 2359999984211 1123456889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++...+..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~ 183 (333)
T 1mqb_A 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSN 183 (333)
T ss_dssp BCCEEEEECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred CCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCC
Confidence 999999999999999999999999999999863 346899999999999999999999 8899999999999999999
Q ss_pred CCeEEeccccceecccCCCCc-ceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~ 861 (947)
+.+||+|||+++......... ......+|+.|+|||++....++.++||||||+++|||++ |+.||... ....+..
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--~~~~~~~ 261 (333)
T 1mqb_A 184 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMK 261 (333)
T ss_dssp CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHH
T ss_pred CcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC--CHHHHHH
Confidence 999999999998765432211 1222346789999999998899999999999999999999 99998532 1111221
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCcceeeecccccCCCCcC
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIVVKKVGESSPSFS 941 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~ 941 (947)
.+ .... ....+...+..+.+++.+||+.||++||++.+++++|+++...+... ...+...|..+
T Consensus 262 ~~---~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~---~~~~~~~p~~~ 325 (333)
T 1mqb_A 262 AI---NDGF----------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL---KTLADFDPRVS 325 (333)
T ss_dssp HH---HTTC----------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG---GSBCCC-----
T ss_pred HH---HCCC----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh---hhhcCCCccch
Confidence 11 1110 01112234456889999999999999999999999999876544221 22344445555
Q ss_pred CCCCC
Q 002250 942 RHYNS 946 (947)
Q Consensus 942 ~~~~~ 946 (947)
.+++|
T Consensus 326 ~~~p~ 330 (333)
T 1mqb_A 326 IRLPS 330 (333)
T ss_dssp -----
T ss_pred hhCCC
Confidence 55544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=354.02 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=202.1
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
.++|++.+.||+|+||.||+|+.+ +|+.||||++... ..........+..|..+++.+ +||||+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~~~E~~il~~~~~hp~iv 81 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD--------------VVLMDDDVECTMVEKRVLSLAWEHPFLT 81 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHHHHTTCTTBC
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhH--------------HhhhhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 478999999999999999999976 6899999998311 011123456778899999987 999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++.+++..|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 82 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~ 156 (345)
T 1xjd_A 82 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGH 156 (345)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSC
T ss_pred cEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCC
Confidence 9999999999999999999999999999864 35889999999999999999999 889999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+||+|||+++....... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....
T Consensus 157 vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~ 229 (345)
T 1xjd_A 157 IKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEEELFHS 229 (345)
T ss_dssp EEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred EEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Confidence 99999999975433221 233467999999999999989999999999999999999999999532 12222211
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR-VVV 914 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~ 914 (947)
...... .+ +......+.+++.+|++.||++||++. ++.
T Consensus 230 i~~~~~--------~~---p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 230 IRMDNP--------FY---PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHCCC--------CC---CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHhCCC--------CC---CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111111 11 122345678899999999999999997 554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.55 Aligned_cols=265 Identities=21% Similarity=0.326 Sum_probs=189.2
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|... +|+.||||++.... .......+.+|++++++++||||++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~hp~iv~ 67 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS----------------EEGTPSTAIREISLMKELKHENIVR 67 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS----------------TTCSCHHHHHHHHHHTTCCBTTBCC
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc----------------ccccHHHHHHHHHHHHhcCCCCcce
Confidence 367899999999999999999965 68999999984221 1233467889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcC----CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCH----KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
+++++..++..++||||++ |+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 68 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~ 143 (317)
T 2pmi_A 68 LYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINK 143 (317)
T ss_dssp EEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECT
T ss_pred EEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcC
Confidence 9999999999999999997 69999987532 245889999999999999999999 889999999999999999
Q ss_pred CCCeEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ..+...
T Consensus 144 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~ 219 (317)
T 2pmi_A 144 RGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN--DEEQLK 219 (317)
T ss_dssp TCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHH
T ss_pred CCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHH
Confidence 99999999999987643321 12234689999999998764 58999999999999999999999995431 111112
Q ss_pred HHHhhccc-ccccc-c-----cccCCC----C---------ccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 862 WVYSKMDS-RDSML-T-----VVDPNI----S---------EILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 862 ~~~~~~~~-~~~~~-~-----~~d~~~----~---------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.+...... ..... . ...+.+ . .........+.+++.+|++.||++|||+.|++++
T Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 220 LIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp HHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 11111110 00000 0 000000 0 0011234568899999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.64 Aligned_cols=266 Identities=24% Similarity=0.288 Sum_probs=196.1
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccc---------hhhhhhcccCChhhHHHHHHHHh
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRS---------STAILSKRSSRSSEYDAEVATLS 697 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~E~~~l~ 697 (947)
.++|++.+.||+|+||.||+|+.. +++.||||++............. ............+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999965 68999999996543211100000 00000011223467899999999
Q ss_pred hccccccceEEEEEec--CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCC
Q 002250 698 AVRHVNVVKLYCSITS--EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKS 775 (947)
Q Consensus 698 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp 775 (947)
+++||||+++++++.. ++..++||||+++++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence 9999999999999987 5678999999999999887543 46899999999999999999999 88999999999
Q ss_pred CCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCC---CCCccchHHHHHHHHHHHhCCCCCCCC
Q 002250 776 SNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK---INEKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 776 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999987654322 223457999999999997665 367899999999999999999998532
Q ss_pred CCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
....+.......... .+... ..+..+.+++.+|++.||++|||+.|+++
T Consensus 244 -----~~~~~~~~~~~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 -----RIMCLHSKIKSQALE-----FPDQP----DIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -----SHHHHHHHHHHCCCC-----CCSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----cHHHHHHHHhcccCC-----CCCcc----ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 222221111111110 01111 23346889999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=357.94 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=208.6
Q ss_pred hhccCCcccccccCceeEEEEEeCC-C-----cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-c
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNS-G-----KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-R 700 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 700 (947)
.++|++.+.||+|+||.||+|.... + ..||||++.... .....+.+.+|+.+++++ +
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~ 108 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----------------HADEKEALMSELKIMSHLGQ 108 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC----------------CHHHHHHHHHHHHHHHHHCC
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc----------------ChHHHHHHHHHHHHHHhhcC
Confidence 4678899999999999999999652 3 479999984211 112346788999999999 8
Q ss_pred ccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 002250 701 HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPV 768 (947)
Q Consensus 701 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~i 768 (947)
||||+++++++..++..++||||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+|
T Consensus 109 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i 185 (333)
T 2i1m_A 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNC 185 (333)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred CCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCc
Confidence 9999999999999999999999999999999997542 235799999999999999999999 8899
Q ss_pred EeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCC
Q 002250 769 IHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKR 847 (947)
Q Consensus 769 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~ 847 (947)
+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |..
T Consensus 186 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 265 (333)
T 2i1m_A 186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265 (333)
T ss_dssp ECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999987655443333334457889999999999899999999999999999999 888
Q ss_pred CCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 848 PIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 848 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
||..... ............. ...+...+..+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 266 p~~~~~~-~~~~~~~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 266 PYPGILV-NSKFYKLVKDGYQ-------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp SSTTCCS-SHHHHHHHHHTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcccch-hHHHHHHHhcCCC-------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 9854321 1222222211110 0111122456889999999999999999999999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=356.78 Aligned_cols=265 Identities=24% Similarity=0.311 Sum_probs=203.4
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcE----EEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKE----LAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
++|++.+.||+|+||+||+|+.. +++. ||+|.+... ........+.+|+.++++++|||
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~----------------~~~~~~~~~~~E~~~l~~l~hp~ 78 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------------TSPKANKEILDEAYVMASVDNPH 78 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC----------------SSCCCHHHHHHHHHHHTTCCBTT
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc----------------cCHHHHHHHHHHHHHHHhCCCCC
Confidence 67889999999999999999954 4554 467766311 12245577899999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++..+. .++|+||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 79 iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~ 153 (327)
T 3lzb_A 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTP 153 (327)
T ss_dssp BCCCCEEEESSS-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEET
T ss_pred eeEEEEEEecCC-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCC
Confidence 999999998764 78999999999999999874 346899999999999999999999 8899999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||... ....+...
T Consensus 154 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~ 231 (327)
T 3lzb_A 154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSI 231 (327)
T ss_dssp TEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHH
T ss_pred CCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHH
Confidence 9999999999987654443333334457889999999999999999999999999999999 99998543 22223222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCcceee
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSVTNIV 929 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 929 (947)
+.... ....+...+..+.+++.+||+.||.+|||+.|+++.|+++...+...++
T Consensus 232 ~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 285 (327)
T 3lzb_A 232 LEKGE-------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 285 (327)
T ss_dssp HHTTC-------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHHBC
T ss_pred HHcCC-------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCceEE
Confidence 21111 0111222345688999999999999999999999999998766544443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.77 Aligned_cols=269 Identities=24% Similarity=0.269 Sum_probs=202.8
Q ss_pred HhhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc---cc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR---HV 702 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~ 702 (947)
+.++|++.+.||+|+||+||+|+. .+++.||||++....... ........+.+|+.++++++ ||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~~~~e~~~l~~l~~~~h~ 74 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG------------GGGGLPISTVREVALLRRLEAFEHP 74 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCT------------TSSCCCHHHHHHHHHHHHHHHHCCT
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccc------------cccccchhHHHHHHHHHHHhhcCCC
Confidence 457899999999999999999995 478999999985322110 11122356778888888775 99
Q ss_pred ccceEEEEEecCC-----ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 703 NVVKLYCSITSED-----SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 703 niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
||+++++++.... ..++||||++ ++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|
T Consensus 75 niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~N 150 (308)
T 3g33_A 75 NVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPEN 150 (308)
T ss_dssp TBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTT
T ss_pred CeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHH
Confidence 9999999998765 3689999996 69999998866666999999999999999999999 8899999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 778 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
|+++.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..
T Consensus 151 il~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~ 225 (308)
T 3g33_A 151 ILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EA 225 (308)
T ss_dssp EEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS--HH
T ss_pred EEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HH
Confidence 9999999999999999976543322 234578999999999999999999999999999999999999995431 11
Q ss_pred cHHHHHHhhccc--cccccc-------ccc----CCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 858 DIVNWVYSKMDS--RDSMLT-------VVD----PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 858 ~~~~~~~~~~~~--~~~~~~-------~~d----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+........... ...+.. .+. ........+....+.+++.+|++.||++|||+.|++++
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 226 DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 111111111100 000000 000 00011122344578899999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.72 Aligned_cols=256 Identities=25% Similarity=0.343 Sum_probs=206.8
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|... +++.||||++... ......+.+.+|+.+++.++||||+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~i~ 68 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----------------RAVDCPENIKKEICINKMLNHENVV 68 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGG----------------GCTTHHHHHHHHHHHHHTCCCTTBC
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeec----------------cchhhhHHHHHHHHHHHhcCCCCce
Confidence 4678999999999999999999976 7899999998311 1123346788999999999999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~ 143 (276)
T 2yex_A 69 KFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDN 143 (276)
T ss_dssp CEEEEEEETTEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCC
T ss_pred eeeeEEEcCCEEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCC
Confidence 9999999999999999999999999999753 45899999999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
+||+|||.+................||+.|+|||++.+..+ +.++||||||+++|||++|+.||............+..
T Consensus 144 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 223 (276)
T 2yex_A 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223 (276)
T ss_dssp EEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT
T ss_pred EEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh
Confidence 99999999987654332222334578999999999987665 67899999999999999999999654333322222221
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
. ... ..........+.+++.+|++.||++|||+.|++++
T Consensus 224 ~----~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 224 K----KTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp T----CTT---------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c----ccc---------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 1 000 00111234567889999999999999999999863
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=361.03 Aligned_cols=348 Identities=25% Similarity=0.357 Sum_probs=240.4
Q ss_pred cccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCC
Q 002250 106 MLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQ 185 (947)
Q Consensus 106 ~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 185 (947)
.+++|+.|++++|.+.. ++ .+..+++|++|+|++|.+... +. +..+++|++|++++|.+++..+ ++++++|+
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~--~~~~l~~L~~L~Ls~n~l~~~--~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~ 115 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDI--TP-LKNLTKLVDILMNNNQIADITP--LANLTNLT 115 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CT--TGGGCTTCCEEECCSSCCCCC--GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCC
T ss_pred HhccccEEecCCCCCcc-Cc--chhhhcCCCEEECCCCccCCc--hh-hhccccCCEEECCCCccccChh--hcCCCCCC
Confidence 35566666666666653 33 355666666666666666543 22 5556666666666666654332 55566666
Q ss_pred EEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccC
Q 002250 186 NLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQF 265 (947)
Q Consensus 186 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i 265 (947)
+|+|++|++++..+ +.++++|++|++++|.+++. + .+..+++|++|+++ |.+.+.. .
T Consensus 116 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~-~----------------- 172 (466)
T 1o6v_A 116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK-P----------------- 172 (466)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG-G-----------------
T ss_pred EEECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch-h-----------------
Confidence 66666666553322 55555566666666655532 1 24555555555553 2222211 1
Q ss_pred cccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccc
Q 002250 266 SGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETY 345 (947)
Q Consensus 266 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~ 345 (947)
+..+++|++|++++|++++. ..+..+++|++|++++|.+++.. | +
T Consensus 173 -------~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~------------------------~--~ 217 (466)
T 1o6v_A 173 -------LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDIT------------------------P--L 217 (466)
T ss_dssp -------GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG------------------------G--G
T ss_pred -------hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccccc------------------------c--c
Confidence 44455555555555555421 22445555555555555554211 1 3
Q ss_pred cCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceE
Q 002250 346 ANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVS 425 (947)
Q Consensus 346 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 425 (947)
+.+++|+.|++++|.+++. +.+..+++|+.|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.
T Consensus 218 ~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 291 (466)
T 1o6v_A 218 GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN 291 (466)
T ss_dssp GGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred cccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCe
Confidence 4456677777777777643 356778999999999999998665 8899999999999999996544 889999999
Q ss_pred EEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCcc
Q 002250 426 IQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKF 505 (947)
Q Consensus 426 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 505 (947)
|++++|++++..+ ++.+++|+.|+|++|++++..| ++.+++|+.|++++|++++. ..+.++++|+.|++++|++
T Consensus 292 L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l 365 (466)
T 1o6v_A 292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQI 365 (466)
T ss_dssp EECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred EEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCcc
Confidence 9999999996544 8899999999999999998776 78999999999999999965 4689999999999999999
Q ss_pred CCccCCcccccccceeeCCCCcCCCCC
Q 002250 506 SGEIPISLTYPKLSLLDLSNNQLAGPI 532 (947)
Q Consensus 506 ~~~~p~~~~~~~L~~L~ls~N~l~~~~ 532 (947)
++.+| ...+++|+.|++++|++++.+
T Consensus 366 ~~~~~-~~~l~~L~~L~l~~n~~~~~p 391 (466)
T 1o6v_A 366 SDLTP-LANLTRITQLGLNDQAWTNAP 391 (466)
T ss_dssp CBCGG-GTTCTTCCEEECCCEEEECCC
T ss_pred Cccch-hhcCCCCCEEeccCCcccCCc
Confidence 99888 556799999999999999853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=358.82 Aligned_cols=273 Identities=19% Similarity=0.259 Sum_probs=213.3
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +|+.||||++.. .......+.+.+|++++++++||||+++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~----------------~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 72 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN----------------ISFLRPVDVQMREFEVLKKLNHKNIVKL 72 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECG----------------GGGGSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecc----------------ccccchHHHHHHHHHHHHhcCCCCCCeE
Confidence 67899999999999999999976 589999999831 1112345677899999999999999999
Q ss_pred EEEEecCC--ccEEEEeccCCCChHHHhhhcC-CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe----
Q 002250 708 YCSITSED--SNLLVYEYLPNGSLWDRLHTCH-KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL---- 780 (947)
Q Consensus 708 ~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll---- 780 (947)
++++...+ ..++||||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~ 149 (396)
T 4eut_A 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGE 149 (396)
T ss_dssp EEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECT
T ss_pred EEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecC
Confidence 99998765 6699999999999999998643 234899999999999999999999 8999999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcceecccccccccCcccccc--------CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT--------CKINEKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
+.++.+||+|||+++....... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||.+.
T Consensus 150 ~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 150 DGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp TSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred CCceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 7778899999999987654332 223569999999999865 45778999999999999999999999654
Q ss_pred CCCcccHHHHHHhhcccccc--cc---cc------cc---CCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 853 FGDSKDIVNWVYSKMDSRDS--ML---TV------VD---PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~--~~---~~------~d---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
...... .+.+......... +. .. .. +............+.+++.+|++.||++||++.|+++.++
T Consensus 227 ~~~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~ 305 (396)
T 4eut_A 227 EGPRRN-KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (396)
T ss_dssp TCTTTC-HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred Ccccch-HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence 322221 1222222211110 00 00 00 1112345677888999999999999999999999999998
Q ss_pred ccCCCC
Q 002250 919 EAEPCS 924 (947)
Q Consensus 919 ~~~~~~ 924 (947)
++....
T Consensus 306 ~il~~~ 311 (396)
T 4eut_A 306 DILHRM 311 (396)
T ss_dssp HHHTCE
T ss_pred HHhhce
Confidence 865543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=344.19 Aligned_cols=261 Identities=23% Similarity=0.292 Sum_probs=209.1
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.+.+.|++.+.||+|+||.||+|+.. +|+.||||++....... .......+.+.+|+.++++++|||
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~h~~ 76 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA-----------SRRGVSREEIEREVSILRQVLHHN 76 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSS-----------CSSSBCHHHHHHHHHHHHHCCCTT
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccc-----------cccchhHHHHHHHHHHHHhCCCCC
Confidence 456688999999999999999999966 68999999985432211 111224567899999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 77 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~ 151 (321)
T 2a2a_A 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDK 151 (321)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCT
T ss_pred cceEEEEEecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecC
Confidence 999999999999999999999999999999863 45889999999999999999999 8899999999999999988
Q ss_pred C----CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 784 W----KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 784 ~----~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
+ .+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||... ..
T Consensus 152 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~ 223 (321)
T 2a2a_A 152 NIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TK 223 (321)
T ss_dssp TSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SH
T ss_pred CCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC-----CH
Confidence 7 799999999987654332 22346899999999999889999999999999999999999998532 11
Q ss_pred HHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.+............ + .......+..+.+++.+|++.||++|||+.|++++
T Consensus 224 ~~~~~~i~~~~~~~----~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 224 QETLANITSVSYDF----D---EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHHHTTCCCC----C---HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccccc----C---hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 22221111111110 0 11111234568899999999999999999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=359.15 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=194.7
Q ss_pred HHHhhccCCc-ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhh-ccc
Q 002250 625 KEIIDAVKPE-NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSA-VRH 701 (947)
Q Consensus 625 ~~~~~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h 701 (947)
..+.++|.+. +.||+|+||+||+|... +++.||||++. ....+.+|+.++.+ .+|
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~----------------------~~~~~~~E~~~~~~~~~h 114 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----------------------DCPKARREVELHWRASQC 114 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE----------------------CSHHHHHHHHHHHHHTTS
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeC----------------------cchhHHHHHHHHHHhcCC
Confidence 3445677776 78999999999999965 68999999982 23457789998754 489
Q ss_pred cccceEEEEEec----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 702 VNVVKLYCSITS----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 702 ~niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
|||+++++++.. ....|+||||+++|+|.+++.......+++..+..++.||+.||+||| +.+|+||||||+|
T Consensus 115 p~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~N 191 (400)
T 1nxk_A 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 191 (400)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGG
T ss_pred CCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcce
Confidence 999999999875 566899999999999999998765567999999999999999999999 8999999999999
Q ss_pred eEecC---CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 002250 778 ILLDL---EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG 854 (947)
Q Consensus 778 Ill~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~ 854 (947)
|+++. ++.+||+|||+++....... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 192 ill~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 192 LLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp EEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred EEEecCCCCccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 99997 78999999999986543321 2345789999999999999999999999999999999999999965432
Q ss_pred Cc--ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 855 DS--KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 855 ~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. ......+.. .... ...+ ........+.+++.+||+.||++|||+.|++++
T Consensus 269 ~~~~~~~~~~i~~---~~~~---~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 269 LAISPGMKTRIRM---GQYE---FPNP----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CSSCCSHHHHHHH---TCCC---CCTT----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccHHHHHHHHc---Cccc---CCCc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 112211111 1000 0001 112234568899999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=356.84 Aligned_cols=255 Identities=22% Similarity=0.233 Sum_probs=194.5
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHH-Hhhccccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT-LSAVRHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv 705 (947)
.++|++.+.||+|+||.||+|+.+ +++.||||++..... ........+.+|..+ ++.++||||+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~--------------~~~~~~~~~~~e~~~ll~~~~hp~Iv 102 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAI--------------LKKKEEKHIMSERNVLLKNVKHPFLV 102 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGB--------------C-------------CCBCCCCCTTBC
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHh--------------hhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 467999999999999999999976 688999999842211 111233455667776 5678999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..++..|+||||+++|+|.+++... ..+++.....++.||+.||+||| +.+|+||||||+||+++.++.
T Consensus 103 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ 177 (373)
T 2r5t_A 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGH 177 (373)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSC
T ss_pred CEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCC
Confidence 9999999999999999999999999999864 35788888999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+....
T Consensus 178 ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~~~~~~~ 250 (373)
T 2r5t_A 178 IVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----NTAEMYDN 250 (373)
T ss_dssp EEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-----BHHHHHHH
T ss_pred EEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHH
Confidence 99999999975433221 233567999999999999999999999999999999999999999532 22222222
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
....... ++......+.+++.+|++.||.+||++.+.++.+.+
T Consensus 251 i~~~~~~-----------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~ 293 (373)
T 2r5t_A 251 ILNKPLQ-----------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293 (373)
T ss_dssp HHHSCCC-----------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred HHhcccC-----------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence 2211111 111233467889999999999999998655544444
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=351.22 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=198.8
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
.++|++.+.||+|+||.||+|+.+ +++.||||++..... ........+.+|+.+++++ +||||+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--------------~~~~~~~~~~~E~~~l~~~~~hp~iv 73 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV--------------NDDEDIDWVQTEKHVFEQASNHPFLV 73 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS--------------CSHHHHHHHHHHHHHHHHTTTCTTBC
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh--------------cchHHHHHHHHHHHHHHhcCCCCccC
Confidence 367889999999999999999976 689999999842110 1112345678899999988 899999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..++..|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 74 ~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~ 148 (345)
T 3a8x_A 74 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGH 148 (345)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSC
T ss_pred eEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCC
Confidence 9999999999999999999999999999864 35899999999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc---ccHHHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS---KDIVNW 862 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~---~~~~~~ 862 (947)
+||+|||+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ......
T Consensus 149 ~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 226 (345)
T 3a8x_A 149 IKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226 (345)
T ss_dssp EEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHH
T ss_pred EEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHH
Confidence 9999999998543222 12334579999999999999899999999999999999999999996422110 011111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
....+.... ..++......+.+++.+|++.||++||++
T Consensus 227 ~~~~i~~~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 227 LFQVILEKQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHCC----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHcCC----------CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111111111 11122334568889999999999999996
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=342.22 Aligned_cols=263 Identities=24% Similarity=0.307 Sum_probs=204.5
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|... +++.||||++... ...........+.+|++++++++||||+
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~-------------~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 69 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKK-------------KLRRIPNGEANVKKEIQLLRRLRHKNVI 69 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHH-------------HHHHSTTHHHHHHHHHHHHTTCCCTTBC
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccc-------------cccccchhHHHHHHHHHHHHhcCCCCee
Confidence 4578999999999999999999965 6899999998311 1111123457789999999999999999
Q ss_pred eEEEEEe--cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 706 KLYCSIT--SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 706 ~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
++++++. +....++||||++++ +.+++.......+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 70 ~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~ 145 (305)
T 2wtk_C 70 QLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTG 145 (305)
T ss_dssp CEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTT
T ss_pred EEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCC
Confidence 9999984 456789999999876 888887766677999999999999999999999 8899999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK--INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
+.+||+|||.+................||+.|+|||++.+.. ++.++||||||+++|||++|+.||... +..+
T Consensus 146 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~ 220 (305)
T 2wtk_C 146 GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-----NIYK 220 (305)
T ss_dssp CCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHH
T ss_pred CcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc-----hHHH
Confidence 999999999998765443333334557899999999987644 377999999999999999999998532 2222
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhccCC
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEAEP 922 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~~~ 922 (947)
.......... ..+......+.+++.+|++.||++|||+.|++++ +++..+
T Consensus 221 ~~~~i~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 221 LFENIGKGSY-----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHCCC-----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHhcCCC-----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 2221111111 1112234567889999999999999999999964 444433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=359.74 Aligned_cols=258 Identities=20% Similarity=0.213 Sum_probs=202.7
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.+ +|+.||||++... ..........+.+|+.++..++||||++
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~--------------~~~~~~~~~~~~~E~~il~~~~hp~Iv~ 125 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW--------------DMLKRGEVSCFREERDVLVNGDRRWITQ 125 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--------------HHHHHGGGCCHHHHHHHHHHSCTTTBCC
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH--------------HhhhHHHHHHHHHHHHHHHhcCCCCeee
Confidence 478999999999999999999975 7999999998310 0111233456889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..|+||||+++|+|.+++.+.+ ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 126 l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~v 201 (412)
T 2vd5_A 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHI 201 (412)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCE
Confidence 9999999999999999999999999998643 36899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccc-------cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-------TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
||+|||+++........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||... +.
T Consensus 202 kL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~ 275 (412)
T 2vd5_A 202 RLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD-----ST 275 (412)
T ss_dssp EECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS-----SH
T ss_pred EEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC-----CH
Confidence 99999999876543321 122457999999999997 356899999999999999999999999532 12
Q ss_pred HHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCC---CCHHHHHHH
Q 002250 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFR---PSMRVVVQM 916 (947)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~ev~~~ 916 (947)
.+........... ..++......+..+.+++.+|+. +|.+| |++.|++++
T Consensus 276 ~~~~~~i~~~~~~------~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 276 AETYGKIVHYKEH------LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHHHHHTHHHH------CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHHHHHhcccC------cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 2221111111100 01111122334568889999999 99998 689998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=340.08 Aligned_cols=254 Identities=25% Similarity=0.329 Sum_probs=198.8
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++.++|.+.+.||+|+||+||+|+.. +++.||+|++... ......+.+.+|++++++++||||
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~hp~i 82 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD----------------RSQVPMEQIEAEIEVLKSLDHPNI 82 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGG----------------GCCSCHHHHHHHHHHHHTCCCTTB
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecc----------------ccchhHHHHHHHHHHHHhCCCchH
Confidence 45688999999999999999999965 6899999998321 122445788999999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe--
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL-- 780 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll-- 780 (947)
+++++++...+..++||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 83 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~ 159 (285)
T 3is5_A 83 IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQD 159 (285)
T ss_dssp CCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESS
T ss_pred HhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEec
Confidence 99999999999999999999999999998653 2356899999999999999999999 8999999999999999
Q ss_pred -cCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 781 -DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 781 -~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
+.++.+||+|||++........ .....||+.|+|||++. +.++.++||||||+++|||++|+.||... ..
T Consensus 160 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~-----~~ 230 (285)
T 3is5_A 160 TSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT-----SL 230 (285)
T ss_dssp SSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SH
T ss_pred CCCCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC-----CH
Confidence 4568899999999976544322 23456899999999875 56889999999999999999999998532 12
Q ss_pred HHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.+........... ...........+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 231 EEVQQKATYKEPN--------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHHHCCCC--------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHhhhccCCcc--------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111111110 00000112346788999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=348.74 Aligned_cols=253 Identities=24% Similarity=0.318 Sum_probs=193.8
Q ss_pred hhccCCcccccccCceeEEEEEe----CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .........+.+|+.++++++|||
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hp~ 82 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI-------------VRNAKDTAHTKAERNILEEVKHPF 82 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------------------HHHHHHHCCCTT
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHh-------------hhhhhHHHHHHHHHHHHHhCCCCC
Confidence 46899999999999999999996 4789999999853211 011223456788999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++..++..|+||||+++|+|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 83 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQ 157 (327)
T ss_dssp BCCEEEEEECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTT
T ss_pred ccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCC
Confidence 999999999999999999999999999999864 35788899999999999999999 8899999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
+.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... +.....
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~ 230 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE-----NRKKTI 230 (327)
T ss_dssp SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHH
T ss_pred CcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC-----CHHHHH
Confidence 9999999999975433221 123457999999999999989999999999999999999999999532 112222
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
........ ..+......+.+++.+|++.||++|| ++.|++++
T Consensus 231 ~~i~~~~~-----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 231 DKILKCKL-----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHTCC-----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHhCCC-----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11111111 11122345688899999999999999 77787753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=353.47 Aligned_cols=253 Identities=23% Similarity=0.258 Sum_probs=194.4
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.. +++.||||++... ......+.+|+.++++++||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~hpniv~ 80 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG------------------AAIDENVQREIINHRSLRHPNIVR 80 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS------------------TTSCHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC------------------ccccHHHHHHHHHHHhCCCCCCCc
Confidence 468999999999999999999976 7899999998421 123356889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC-
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK- 785 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~- 785 (947)
+++++..++..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~ 155 (361)
T 3uc3_A 81 FKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAP 155 (361)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSC
T ss_pred EEEEEeeCCEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCc
Confidence 999999999999999999999999999764 35899999999999999999999 899999999999999987765
Q ss_pred -eEEeccccceecccCCCCcceecccccccccCccccccCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 786 -PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEK-SDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 786 -~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
+||+|||+++...... ......||+.|+|||++.+..++.+ +||||+||++|||++|+.||..... ........
T Consensus 156 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~ 231 (361)
T 3uc3_A 156 RLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PRDYRKTI 231 (361)
T ss_dssp CEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-----CCCHHHHH
T ss_pred eEEEeecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc-HHHHHHHH
Confidence 9999999997433222 1234579999999999988887665 8999999999999999999964322 22222222
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.......... +. .......+.+++.+|++.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~--------~~-~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 232 QRILSVKYSI--------PD-DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHTTCCCC--------CT-TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhcCCCCC--------CC-cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 2222111110 00 01123567889999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.13 Aligned_cols=250 Identities=20% Similarity=0.234 Sum_probs=194.8
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVN 703 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 703 (947)
.+.++|++.+.||+|+||+||+|+.. +++.||||++..... .......+..|+..+.++ +|||
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~~~~e~~~~~~~~~h~~ 118 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR---------------GPKDRARKLAEVGSHEKVGQHPC 118 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC---------------SHHHHHHHHHHHHHHHHHCCCTT
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc---------------ChHHHHHHHHHHHHHHHhcCCCc
Confidence 44578999999999999999999976 799999998742210 111223445566666555 8999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++.+++..++||||+ +++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 119 iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~ 193 (311)
T 3p1a_A 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPR 193 (311)
T ss_dssp BCCEEEEEEETTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGG
T ss_pred EEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCC
Confidence 999999999999999999999 77999988764 346899999999999999999999 7899999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
+.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|||++|..|+... .....
T Consensus 194 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~~~~- 263 (311)
T 3p1a_A 194 GRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EGWQQ- 263 (311)
T ss_dssp GCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HHHHH-
T ss_pred CCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHH-
Confidence 9999999999987654322 234569999999998875 7999999999999999999998776321 11111
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...... . .+........+.+++.+|++.||++|||+.|++++
T Consensus 264 ---~~~~~~-----~---~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 264 ---LRQGYL-----P---PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---HTTTCC-----C---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HhccCC-----C---cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111000 0 11122334678899999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=359.38 Aligned_cols=266 Identities=27% Similarity=0.316 Sum_probs=206.7
Q ss_pred hccCCcccccccCceeEEEEEe-----CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++|||
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~~ 85 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----------------GPDQQRDFQREIQILKALHSDF 85 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----------------CHHHHHHHHHHHHHHHTCCCTT
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----------------CHHHHHHHHHHHHHHHhcCCCc
Confidence 6788999999999999999984 36889999998421 1123356899999999999999
Q ss_pred cceEEEEEec--CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 704 VVKLYCSITS--EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 704 iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
|+++++++.. ....++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 86 i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~ 161 (327)
T 3lxl_A 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVE 161 (327)
T ss_dssp BCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEE
T ss_pred eeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEEC
Confidence 9999999874 455789999999999999998632 35899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCCCc-ceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC-----
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD----- 855 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~----- 855 (947)
.++.+||+|||+++......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 162 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~ 241 (327)
T 3lxl_A 162 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241 (327)
T ss_dssp ETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC
T ss_pred CCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc
Confidence 99999999999998765433211 122345788899999999888999999999999999999999998432100
Q ss_pred ----cccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 856 ----SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 856 ----~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
............ ........+...+..+.+++.+|++.||++|||+.|++++|+.+....
T Consensus 242 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 242 GCERDVPALSRLLELL---------EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp C----CCHHHHHHHHH---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ccccccccHHHHHHHh---------hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 000000000000 011112223344567889999999999999999999999999876554
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=356.08 Aligned_cols=277 Identities=16% Similarity=0.171 Sum_probs=204.4
Q ss_pred hccCCcccccccCceeEEEEEeC----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|++.+.||+|+||+||+|+.. ++..||||++..... ....+...........+.+|+..++.++||||
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG------PLFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-C------HHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCc------chHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 67999999999999999999975 578899999853211 00011111122234567889999999999999
Q ss_pred ceEEEEEec----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 705 VKLYCSITS----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 705 v~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
+++++++.. +...++||||+ +++|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 184 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLL 184 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEE
Confidence 999999987 67789999999 999999998744 6899999999999999999999 8899999999999999
Q ss_pred cCCC--CeEEeccccceecccCCCC-----cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 002250 781 DLEW--KPRIADFGLAKIVQTGEAG-----DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEF 853 (947)
Q Consensus 781 ~~~~--~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~ 853 (947)
+.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9887 9999999999876443211 11134579999999999999889999999999999999999999995433
Q ss_pred CCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 854 GDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
................. ......... ....+..+.+++.+||+.||++|||+.++++.|++...
T Consensus 265 ~~~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 KDPVAVQTAKTNLLDEL---PQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TCHHHHHHHHHHHHHTT---THHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccHHHHHHHHhhcccc---cHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 22222222111111000 000000000 00234578899999999999999999999999998664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=349.64 Aligned_cols=251 Identities=25% Similarity=0.283 Sum_probs=202.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
.++|++.+.||+|+||+||+|+.+ +++.||||++... ..........+.+|..+++.+ +||||+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~--------------~~~~~~~~~~~~~E~~~l~~~~~hp~iv 84 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD--------------VVIQDDDVECTMVEKRVLALPGKPPFLT 84 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHTCTTCCTTBC
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--------------HhhcchHHHHHHHHHHHHHhcCCCCEEe
Confidence 478999999999999999999976 5889999998311 111224456788999999988 899999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++...+..|+||||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 85 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ 159 (353)
T 2i0e_A 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGH 159 (353)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSC
T ss_pred eEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCc
Confidence 99999999999999999999999999998643 5889999999999999999999 889999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+....
T Consensus 160 vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~~~~~~~ 232 (353)
T 2i0e_A 160 IKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-----DEDELFQS 232 (353)
T ss_dssp EEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred EEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC-----CHHHHHHH
Confidence 99999999975432221 233457999999999999999999999999999999999999999532 22222222
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-----MRVVVQ 915 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 915 (947)
....... ++......+.+++.+|++.||++||+ +.++.+
T Consensus 233 i~~~~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 233 IMEHNVA-----------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHCCCC-----------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHhCCCC-----------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 2211111 12233456888999999999999995 466654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=356.07 Aligned_cols=262 Identities=26% Similarity=0.350 Sum_probs=204.7
Q ss_pred hcc-CCcccccccCceeEEEEEeC-----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAV-KPENLIGKGGSGNVYKVVLN-----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~-~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
++| ++.+.||+|+||+||++.+. +++.||||++.... .......+.+|++++++++||
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~ 93 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA----------------GPQHRSGWKQEIDILRTLYHE 93 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHHCCCT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc----------------ChHHHHHHHHHHHHHHhCCCc
Confidence 455 88999999999999988643 58899999984211 112346688999999999999
Q ss_pred ccceEEEEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 703 NVVKLYCSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 703 niv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
||+++++++... ...++||||+++|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 94 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~ 167 (318)
T 3lxp_A 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLL 167 (318)
T ss_dssp TBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred chhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEE
Confidence 999999999874 5678999999999999999863 4899999999999999999999 8899999999999999
Q ss_pred cCCCCeEEeccccceecccCCCC-cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC----
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD---- 855 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~---- 855 (947)
+.++.+||+|||++......... .......+|..|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 168 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~ 247 (318)
T 3lxp_A 168 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247 (318)
T ss_dssp CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH
T ss_pred cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh
Confidence 99999999999999877554321 1122345788999999999988999999999999999999999998432100
Q ss_pred ---cccHHH--HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 856 ---SKDIVN--WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 856 ---~~~~~~--~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
...... ....... .......+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 248 IGIAQGQMTVLRLTELLE---------RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HCSCCHHHHHHHHHHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcccccchhHHHHHHHHh---------cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 000000 0000000 11112223344567899999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=353.75 Aligned_cols=261 Identities=24% Similarity=0.307 Sum_probs=208.1
Q ss_pred hhccCCcccccccCceeEEEEEe------CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-c
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-R 700 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 700 (947)
.++|++.+.||+|+||+||+|+. .+++.||||++.... .......+.+|+.+++++ +
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~ 89 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----------------THSEHRALMSELKILIHIGH 89 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHHHCC
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC----------------CcHHHHHHHHHHHHHHhccc
Confidence 47899999999999999999984 246899999984211 112345788999999999 7
Q ss_pred ccccceEEEEEecCC-ccEEEEeccCCCChHHHhhhcCC--------------ccCCHHHHHHHHHHHHHHHHHHhcCCC
Q 002250 701 HVNVVKLYCSITSED-SNLLVYEYLPNGSLWDRLHTCHK--------------IEMDWVVRYAIAVGAAKGLEYLHHGFD 765 (947)
Q Consensus 701 h~niv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~ia~~l~yLH~~~~ 765 (947)
||||+++++++..++ ..++||||+++|+|.+++..... ..+++..+..++.|++.||+||| +
T Consensus 90 hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~ 166 (316)
T 2xir_A 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---S 166 (316)
T ss_dssp CTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---H
T ss_pred CCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---h
Confidence 999999999988755 48999999999999999987532 12789999999999999999999 8
Q ss_pred CCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-
Q 002250 766 RPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT- 844 (947)
Q Consensus 766 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt- 844 (947)
.+|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++
T Consensus 167 ~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 167 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence 8999999999999999999999999999987655443333334567899999999999999999999999999999998
Q ss_pred CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 845 GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 845 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
|+.||..... ............ . ...+...+..+.+++.+||+.||++|||+.|++++|+++.
T Consensus 247 g~~p~~~~~~-~~~~~~~~~~~~---~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 247 GASPYPGVKI-DEEFCRRLKEGT---R----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp SCCSSTTCCC-SHHHHHHHHHTC---C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcccch-hHHHHHHhccCc---c----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999854321 112222111110 0 1111223456889999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=379.47 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=208.3
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|.+.++..||||++... ....+.|.+|++++++++||||++++
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~hpniv~~~ 328 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG------------------TMSPEAFLQEAQVMKKLRHEKLVQLY 328 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTT------------------SSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCC------------------CCCHHHHHHHHHHHHhCCCCCEeeEE
Confidence 678889999999999999999988889999998421 12346789999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++.+ +..++||||+++|+|.+++.......+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||
T Consensus 329 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl 404 (535)
T 2h8h_A 329 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKV 404 (535)
T ss_dssp EEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEE
Confidence 99876 67899999999999999998654456899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++ |+.||... ...++.+.+.
T Consensus 405 ~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~--~~~~~~~~i~--- 478 (535)
T 2h8h_A 405 ADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVE--- 478 (535)
T ss_dssp CCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC--CHHHHHHHHH---
T ss_pred cccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHH---
Confidence 99999976543211 11112346789999999999999999999999999999999 89998532 1112222111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
... ....+..++..+.+++.+||+.||++|||+.++++.|+++-.
T Consensus 479 -~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 479 -RGY---------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp -TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred -cCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 111 011223345678899999999999999999999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=351.18 Aligned_cols=249 Identities=17% Similarity=0.196 Sum_probs=202.8
Q ss_pred hccCCcccccccCceeEEEEE------eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc--
Q 002250 629 DAVKPENLIGKGGSGNVYKVV------LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-- 700 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-- 700 (947)
++|.+.+.||+|+||+||+|. ..+++.||||++.. ....++.+|++++++++
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--------------------~~~~~~~~e~~~~~~l~~~ 124 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--------------------ANPWEFYIGTQLMERLKPS 124 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS--------------------CCHHHHHHHHHHHHHSCGG
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC--------------------CChhHHHHHHHHHHHhhhh
Confidence 678899999999999999994 44689999999831 23456788888888886
Q ss_pred -ccccceEEEEEecCCccEEEEeccCCCChHHHhhhc---CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 002250 701 -HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC---HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776 (947)
Q Consensus 701 -h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 776 (947)
|+||+++++++..++..++||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+
T Consensus 125 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~ 201 (365)
T 3e7e_A 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPD 201 (365)
T ss_dssp GGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGG
T ss_pred hhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHH
Confidence 999999999999999999999999999999999753 3456999999999999999999999 899999999999
Q ss_pred CeEecC-----------CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhC
Q 002250 777 NILLDL-----------EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTG 845 (947)
Q Consensus 777 NIll~~-----------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg 845 (947)
|||++. ++.+||+|||+|+..............+||+.|+|||++.+..++.++|||||||++|||+||
T Consensus 202 NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 281 (365)
T 3e7e_A 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281 (365)
T ss_dssp GEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred HEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 999998 899999999999876544333344456799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHhhcc
Q 002250 846 KRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFR-PSMRVVVQMLEEA 920 (947)
Q Consensus 846 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~ev~~~L~~~ 920 (947)
+.||....... . .....+.... ....+.+++..|++.+|.+| |+++++.+.|+++
T Consensus 282 ~~pf~~~~~~~--------------~----~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 282 TYMKVKNEGGE--------------C----KPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp SCCCEEEETTE--------------E----EECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred CCccccCCCCc--------------e----eechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 99984322110 0 0111111111 13456678889999999998 6888888888764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=362.34 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=204.5
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|.+.+.||+|+||.||+|+.. +|+.||||++... ..........+.+|+.+++.++||||++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~--------------~~~~~~~~~~~~~Ei~~l~~l~HpnIv~ 80 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQ--------------KIRSLDVVGKIRREIQNLKLFRHPHIIK 80 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHH--------------HHHHTTTHHHHHHHHHHHTTCCCTTBCC
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhh--------------hccCHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 467899999999999999999976 7999999998311 1111234567899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 81 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~v 155 (476)
T 2y94_A 81 LYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNA 155 (476)
T ss_dssp EEEEEECSSEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCE
T ss_pred EEEEEEECCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCe
Confidence 999999999999999999999999999863 45899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||+++....... ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .......
T Consensus 156 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~~~~~~ 227 (476)
T 2y94_A 156 KIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----VPTLFKK 227 (476)
T ss_dssp EECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----SHHHHHH
T ss_pred EEEeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----HHHHHHH
Confidence 9999999987654332 224579999999999988765 689999999999999999999995321 1122111
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
...... ..+......+.+++.+|++.||++|||+.|+++
T Consensus 228 i~~~~~-----------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 228 ICDGIF-----------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHTTCC-----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhcCCc-----------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 111111 111122346788999999999999999999996
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=340.76 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=207.8
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.+..+|++.+.||+|+||.||+|+.. +++.||||++.. ....+.+|++++++++|||
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---------------------~~~~~~~e~~~l~~l~h~~ 65 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY---------------------NNEKAEREVKALAKLDHVN 65 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEEC---------------------CSGGGHHHHHHHHHCCCTT
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecc---------------------ccHHHHHHHHHHHhCCCCC
Confidence 455688999999999999999999976 799999999831 1246788999999999999
Q ss_pred cceEEEEEec----------------CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 002250 704 VVKLYCSITS----------------EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRP 767 (947)
Q Consensus 704 iv~l~~~~~~----------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ 767 (947)
|+++++++.. ....++||||+++++|.+++.......+++..+..++.|++.||+||| +.+
T Consensus 66 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ 142 (284)
T 2a19_B 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKK 142 (284)
T ss_dssp BCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred EEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 9999998864 345789999999999999998765567999999999999999999999 889
Q ss_pred eEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCC
Q 002250 768 VIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKR 847 (947)
Q Consensus 768 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~ 847 (947)
|+||||||+||+++.++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|..
T Consensus 143 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~ 219 (284)
T 2a19_B 143 LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219 (284)
T ss_dssp EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCS
T ss_pred eeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999987654432 223468999999999999889999999999999999999998
Q ss_pred CCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCCc
Q 002250 848 PIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCSV 925 (947)
Q Consensus 848 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 925 (947)
|+.. ....... .. +..++. ..+..+.+++.+|++.||++|||+.|++++|+.++..+.
T Consensus 220 ~~~~-------~~~~~~~-~~---------~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 220 TAFE-------TSKFFTD-LR---------DGIISD---IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp SHHH-------HHHHHHH-HH---------TTCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred cchh-------HHHHHHH-hh---------cccccc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 8621 1111111 10 011111 123457789999999999999999999999999876653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=360.42 Aligned_cols=259 Identities=26% Similarity=0.335 Sum_probs=193.2
Q ss_pred ccCCcccccccCceeEEEEEeC--CC--cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN--SG--KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
.|++.+.||+|+||+||+|+.. ++ ..||||.+... ......+.+.+|+.++++++||||+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----------------~~~~~~~~~~~E~~il~~l~hpnIv 153 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------------TDIGEVSQFLTEGIIMKDFSHPNVL 153 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC----------------SCSHHHHHHHHHHTTSTTCCCTTBC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC----------------CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 4667789999999999999854 22 36899987321 1113346789999999999999999
Q ss_pred eEEEEEec-CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 706 KLYCSITS-EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 706 ~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
++++++.. ++..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 154 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~ 229 (373)
T 3c1x_A 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKF 229 (373)
T ss_dssp CCCEEECCCSSCCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTC
T ss_pred eEEEEEEcCCCCeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCC
Confidence 99998754 56789999999999999999763 346789999999999999999999 88999999999999999999
Q ss_pred CeEEeccccceecccCCCCc--ceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGD--LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~ 861 (947)
.+||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||.... ..+...
T Consensus 230 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~--~~~~~~ 307 (373)
T 3c1x_A 230 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITV 307 (373)
T ss_dssp CEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--SSCHHH
T ss_pred CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC--HHHHHH
Confidence 99999999998654332211 1223457889999999999999999999999999999999 566664321 222222
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
.... ... ...+...+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 308 ~~~~---~~~----------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 308 YLLQ---GRR----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp HHHT---TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHc---CCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 2211 111 111223345688999999999999999999999999986543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=353.62 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=194.9
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc--cccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH--VNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~ 706 (947)
++|++.+.||+|+||.||+|...+++.||||++.... ........+.+|+.++++++| |||++
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~~~~~~iv~ 73 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---------------ADNQTLDSYRNEIAYLNKLQQHSDKIIR 73 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT---------------CCHHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc---------------cchHHHHHHHHHHHHHHhhhhcCCceEE
Confidence 5688999999999999999998889999999984221 111234678899999999987 99999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..+...++|||+ .+++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++ ++.+
T Consensus 74 ~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~ 146 (343)
T 3dbq_A 74 LYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGML 146 (343)
T ss_dssp EEEEEECSSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEE
T ss_pred EeeeEeeCCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcE
Confidence 99999999999999995 588999999874 45889999999999999999999 88999999999999997 5789
Q ss_pred EEeccccceecccCCCCcceecccccccccCcccccc-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-----------CKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~- 225 (343)
T 3dbq_A 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN- 225 (343)
T ss_dssp EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-
T ss_pred EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-
Confidence 9999999987655443333345679999999999865 6688999999999999999999999954321
Q ss_pred cccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 856 SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.............. ...+......+.+++.+||+.||.+|||+.|++++
T Consensus 226 ---~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 226 ---QISKLHAIIDPNHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---HHHHHHHHHCTTSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHHHhcCCcc---------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111111111110 11111223467889999999999999999999865
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=349.09 Aligned_cols=265 Identities=23% Similarity=0.241 Sum_probs=202.4
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
.++.++|++.+.||+|+||+||+|... +++.||||++... ..........+.+.+|++++++++|||
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~~~E~~~l~~l~hpn 89 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN------------KIRQINPKDVERIKTEVRLMKKLHHPN 89 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH------------HHHC---CHHHHHHHHHHHHHHCCCTT
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhh------------hhcccCHHHHHHHHHHHHHHHhCCCCC
Confidence 567899999999999999999999965 6889999998311 011112344577899999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhc--------------------------------------CCccCCHHH
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC--------------------------------------HKIEMDWVV 745 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------------------------------~~~~~~~~~ 745 (947)
|+++++++.+++..++||||+++|+|.+++... ....+++..
T Consensus 90 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (345)
T 3hko_A 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKL 169 (345)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHH
T ss_pred cceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHH
Confidence 999999999999999999999999999998521 012346777
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC--CeEEeccccceecccCCCCc--ceecccccccccCcccc
Q 002250 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW--KPRIADFGLAKIVQTGEAGD--LTHVIAGTHGYIAPEYA 821 (947)
Q Consensus 746 ~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~ 821 (947)
+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++......... ......||+.|+|||++
T Consensus 170 ~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 246 (345)
T 3hko_A 170 ISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246 (345)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence 8889999999999999 88999999999999998776 89999999998764432211 22345799999999998
Q ss_pred cc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhc
Q 002250 822 YT--CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHC 899 (947)
Q Consensus 822 ~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~c 899 (947)
.+ ..++.++||||||+++|||++|+.||.... ..+............ . .+........+.+++.+|
T Consensus 247 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~---~----~~~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN-----DADTISQVLNKKLCF---E----NPNYNVLSPLARDLLSNL 314 (345)
T ss_dssp TCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCT---T----SGGGGGSCHHHHHHHHHH
T ss_pred ccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----hHHHHHHHHhccccc---C----CcccccCCHHHHHHHHHH
Confidence 65 678899999999999999999999985321 112212211111110 0 111112345688999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 002250 900 TNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 900 l~~dP~~RPt~~ev~~~ 916 (947)
++.||.+|||+.|++++
T Consensus 315 l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 315 LNRNVDERFDAMRALQH 331 (345)
T ss_dssp SCSCTTTSCCHHHHHHS
T ss_pred cCCChhHCCCHHHHhcC
Confidence 99999999999999873
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=352.19 Aligned_cols=246 Identities=24% Similarity=0.343 Sum_probs=193.8
Q ss_pred cccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEe
Q 002250 634 ENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSIT 712 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 712 (947)
.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-----------------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 156 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-----------------MKDKEEVKNEISVMNQLDHANLIQLYDAFE 156 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS-----------------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-----------------cccHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 568999999999999965 68999999984211 123467899999999999999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe--cCCCCeEEec
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL--DLEWKPRIAD 790 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~D 790 (947)
.++..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|
T Consensus 157 ~~~~~~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~D 232 (373)
T 2x4f_A 157 SKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIID 232 (373)
T ss_dssp CSSEEEEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEe
Confidence 999999999999999999998763 346899999999999999999999 8999999999999999 5678899999
Q ss_pred cccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccc
Q 002250 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSR 870 (947)
Q Consensus 791 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 870 (947)
||+++....... .....||+.|+|||++....++.++|||||||++|||++|+.||... +..+.........
T Consensus 233 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-----~~~~~~~~i~~~~ 304 (373)
T 2x4f_A 233 FGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-----NDAETLNNILACR 304 (373)
T ss_dssp CSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTC
T ss_pred CCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcc
Confidence 999987654432 22346999999999999888999999999999999999999999532 1122222111111
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 871 DSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 871 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
... . .+........+.+++.+|++.||.+|||+.|+++
T Consensus 305 ~~~---~----~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 305 WDL---E----DEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CCS---C----SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCC---C----hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 110 0 1111223456889999999999999999999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=350.63 Aligned_cols=255 Identities=24% Similarity=0.268 Sum_probs=201.3
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHV 702 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 702 (947)
..+.++|++.+.||+|+||+||+|+.+ +++.||||++... .....+|++++.++ +||
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~---------------------~~~~~~E~~~l~~~~~hp 76 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS---------------------KRDPTEEIEILLRYGQHP 76 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETT---------------------TCCCHHHHHHHHHHTTST
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcc---------------------cCChHHHHHHHHHhcCCC
Confidence 345688999999999999999999976 6899999998421 12345788999888 799
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
||+++++++.+++..|+||||+++|+|.+++... ..+++.....++.||+.||+||| +.+|+||||||+||++.+
T Consensus 77 ~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~ 151 (342)
T 2qr7_A 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVD 151 (342)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESS
T ss_pred CcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEec
Confidence 9999999999999999999999999999999864 45899999999999999999999 889999999999999854
Q ss_pred C----CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 783 E----WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 783 ~----~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
+ +.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 152 ~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~ 227 (342)
T 2qr7_A 152 ESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DT 227 (342)
T ss_dssp SSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SC
T ss_pred CCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CC
Confidence 3 3499999999987654322 12245789999999999888899999999999999999999999964321 12
Q ss_pred HHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 859 IVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..+............ . ..........+.+++.+|++.||++|||+.|++++
T Consensus 228 ~~~~~~~i~~~~~~~----~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 228 PEEILARIGSGKFSL----S---GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHHHHCCCCC----C---STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHccCCccc----C---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 222222221111110 0 11122334567889999999999999999999853
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=348.94 Aligned_cols=253 Identities=22% Similarity=0.284 Sum_probs=204.7
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
.++.++|++.+.||+|+||+||+|+.. +++.||||++......... .........+.+|+.++++++|||
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~~ 90 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC---------WIEDPKLGKVTLEIAILSRVEHAN 90 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTS---------EEEETTTEEEEHHHHHHTTCCCTT
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhccccc---------ccchHHHHHHHHHHHHHHhCCCCC
Confidence 356789999999999999999999954 7899999999543221110 001123456788999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCC-ChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNG-SLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
|+++++++..++..++||||+.+| +|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 91 Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~ 165 (335)
T 3dls_A 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAE 165 (335)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred EeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcC
Confidence 999999999999999999999777 999999864 35899999999999999999999 889999999999999999
Q ss_pred CCCeEEeccccceecccCCCCcceecccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
++.+||+|||+++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 166 ~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------- 235 (335)
T 3dls_A 166 DFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------- 235 (335)
T ss_dssp TSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------
T ss_pred CCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------
Confidence 99999999999987654432 224579999999999988776 7899999999999999999999843100
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... .. ..+......+.+++.+|++.||++|||+.|++++
T Consensus 236 ----~~~~------~~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ----TVEA------AI-----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----GTTT------CC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----HHhh------cc-----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00 0111133568899999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=338.32 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=200.9
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|... +++.||||++... ..........+.+|+.++++++||||++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 73 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--------------QLEKAGVEHQLRREVEIQSHLRHPNILR 73 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--------------HHHHHTCHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecc--------------ccchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 478999999999999999999966 6789999998311 1112234567889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~ 148 (279)
T 3fdn_A 74 LYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGEL 148 (279)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCE
T ss_pred hhheEecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCE
Confidence 999999999999999999999999999864 35889999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
+|+|||++....... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||... .........
T Consensus 149 ~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~ 219 (279)
T 3fdn_A 149 KIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRI 219 (279)
T ss_dssp EECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHH
T ss_pred EEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC-----cHHHHHHHH
Confidence 999999986543322 22456899999999999988999999999999999999999998532 122211111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..... ..+...+..+.+++.+|++.||++|||+.|++++
T Consensus 220 ~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 220 SRVEF-----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHTCC-----------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HhCCC-----------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111 1112234567889999999999999999999964
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=347.23 Aligned_cols=254 Identities=23% Similarity=0.271 Sum_probs=183.4
Q ss_pred hccCC---cccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccc
Q 002250 629 DAVKP---ENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVN 703 (947)
Q Consensus 629 ~~~~~---~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n 703 (947)
++|++ .+.||+|+||+||+|... +++.||||++.. .....+.+|+.+++++. |||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--------------------~~~~~~~~e~~~l~~l~~h~n 67 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--------------------RMEANTQKEITALKLCEGHPN 67 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG--------------------GGHHHHHHHHHHHHHTTTCTT
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh--------------------hhhhhHHHHHHHHHHhcCCCC
Confidence 44544 378999999999999975 689999999831 23456788999999997 999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++.++...|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 68 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~ 142 (325)
T 3kn6_A 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDE 142 (325)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC-
T ss_pred eeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecC
Confidence 999999999999999999999999999999874 45899999999999999999999 8999999999999999876
Q ss_pred C---CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC--Cccc
Q 002250 784 W---KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG--DSKD 858 (947)
Q Consensus 784 ~---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~--~~~~ 858 (947)
+ .+||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....
T Consensus 143 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 220 (325)
T 3kn6_A 143 NDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220 (325)
T ss_dssp ---CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC
T ss_pred CCcccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc
Confidence 5 799999999986654322 12244689999999999999999999999999999999999999964321 1112
Q ss_pred HHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 859 IVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..+............ ..+........+.+++.+|++.||++|||+.|++++
T Consensus 221 ~~~~~~~i~~~~~~~-------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 221 AVEIMKKIKKGDFSF-------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHHTTTCCCC-------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHHHcCCCCC-------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 222222221111110 011122345678899999999999999999999854
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=347.87 Aligned_cols=270 Identities=24% Similarity=0.304 Sum_probs=213.0
Q ss_pred HHHhhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhh--cccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSA--VRHV 702 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~ 702 (947)
+.+.++|++.+.||+|+||.||+|+.. ++.||||++.. .....+.+|++++.. ++||
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~--------------------~~~~~~~~e~~~~~~~~l~h~ 96 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS--------------------REERSWFREAEIYQTVMLRHE 96 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG--------------------GGHHHHHHHHHHHHHSCCCCT
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc--------------------hhHHHHHHHHHHHHHhhcCCC
Confidence 566789999999999999999999985 89999999831 223567788888887 7999
Q ss_pred ccceEEEEEecCC----ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEeccC
Q 002250 703 NVVKLYCSITSED----SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG-----FDRPVIHRDV 773 (947)
Q Consensus 703 niv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-----~~~~ivH~Dl 773 (947)
||+++++++.... ..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||.. .+.+|+||||
T Consensus 97 ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl 173 (342)
T 1b6c_B 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173 (342)
T ss_dssp TBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred cEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCC
Confidence 9999999998876 78999999999999999976 3589999999999999999999932 1468999999
Q ss_pred CCCCeEecCCCCeEEeccccceecccCCCCc--ceecccccccccCccccccCC------CCCccchHHHHHHHHHHHhC
Q 002250 774 KSSNILLDLEWKPRIADFGLAKIVQTGEAGD--LTHVIAGTHGYIAPEYAYTCK------INEKSDVYSFGVVLMELVTG 845 (947)
Q Consensus 774 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slGv~l~elltg 845 (947)
||+||+++.++.+||+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 9999999999999999999998765443211 123446899999999987652 33689999999999999999
Q ss_pred ----------CCCCCCCCCCcccHHHHHHhhccccccccccccCCCCc--cCHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 002250 846 ----------KRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISE--ILKEDALKVLRIAIHCTNKLPAFRPSMRVV 913 (947)
Q Consensus 846 ----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 913 (947)
..||............+....... ...+.++. ...+.+..+.+++.+||+.||++|||+.|+
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCcCCcccccccCccccCcCcccHHHHHHHHHHH------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 678765443333333333222111 11122221 234667789999999999999999999999
Q ss_pred HHHhhccCCCC
Q 002250 914 VQMLEEAEPCS 924 (947)
Q Consensus 914 ~~~L~~~~~~~ 924 (947)
+++|+++....
T Consensus 328 ~~~L~~i~~~~ 338 (342)
T 1b6c_B 328 KKTLSQLSQQE 338 (342)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHHh
Confidence 99999876443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=351.43 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=197.0
Q ss_pred HhhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|+. .+++.||||++..... ........+.+|+.++++++||||+
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~~~~E~~~l~~l~hp~iv 75 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA--------------RDPSFYLRFRREAQNAAALNHPAIV 75 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT--------------TSHHHHHHHHHHHTTCCCCCCTTBC
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc--------------CCHHHHHHHHHHHHHHHcCCCCCcc
Confidence 457899999999999999999996 5789999999843211 1112235688999999999999999
Q ss_pred eEEEEEecCCcc----EEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 706 KLYCSITSEDSN----LLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 706 ~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
++++++...... |+||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~ 150 (311)
T 3ork_A 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMIS 150 (311)
T ss_dssp CEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE
T ss_pred eEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEc
Confidence 999999876654 9999999999999999864 35899999999999999999999 88999999999999999
Q ss_pred CCCCeEEeccccceecccCCCC-cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 782 LEWKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...
T Consensus 151 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-----~~~ 225 (311)
T 3ork_A 151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-----SPV 225 (311)
T ss_dssp TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHH
T ss_pred CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-----ChH
Confidence 9999999999999866543221 1223456899999999999999999999999999999999999999532 222
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHH-HHhhc
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVV-QMLEE 919 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~-~~L~~ 919 (947)
.............. .......+..+.+++.+|++.||++||++.+++ +.+.+
T Consensus 226 ~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 226 SVAYQHVREDPIPP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHHHHHHCCCCCH-------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCc-------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 22222221111100 011122345688999999999999999766655 44444
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=361.03 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=195.8
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc--ccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR--HVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~ 706 (947)
+.|++.+.||+|+||+||+|...+++.||||++.... ........+.+|+.++++++ ||||++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~Ei~~l~~l~~~~~~iv~ 120 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---------------ADNQTLDSYRNEIAYLNKLQQHSDKIIR 120 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTT---------------CCHHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc---------------ccHHHHHHHHHHHHHHHHcccCCCeEEE
Confidence 4589999999999999999998889999999984221 11123467899999999997 599999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..|+||| +.+++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++ ++.+
T Consensus 121 ~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~ 193 (390)
T 2zmd_A 121 LYDYEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGML 193 (390)
T ss_dssp EEEEEECSSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCE
T ss_pred EEEEEecCCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeE
Confidence 9999999999999999 5688999999874 36788889999999999999999 89999999999999995 5899
Q ss_pred EEeccccceecccCCCCcceecccccccccCcccccc-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-----------CKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
||+|||+++..............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~- 272 (390)
T 2zmd_A 194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN- 272 (390)
T ss_dssp EECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-
T ss_pred EEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-
Confidence 9999999987654433222334579999999999865 3688899999999999999999999953321
Q ss_pred cccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 856 SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.............. ...+... ...+.+++.+||+.||++|||+.|++++
T Consensus 273 ---~~~~~~~~~~~~~~------~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 273 ---QISKLHAIIDPNHE------IEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---HHHHHHHHHCTTSC------CCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHHHhCcccc------CCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111111111111 1111111 3467889999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=366.38 Aligned_cols=256 Identities=25% Similarity=0.279 Sum_probs=207.8
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|+.. +|+.||||++... ..........+.+|+.++++++||||+++
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~--------------~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l 249 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK--------------RIKKRKGEAMALNEKQILEKVNSRFVVSL 249 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhH--------------hhhhhHHHHHHHHHHHHHHHcCCCCEeeE
Confidence 67888999999999999999975 7999999998311 11122345678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.+++..|+||||+++|+|.+++...+...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 250 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEE
T ss_pred EEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeE
Confidence 999999999999999999999999998766666999999999999999999999 88999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||+|+....... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 327 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~~i~ 402 (576)
T 2acx_A 327 ISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERLVK 402 (576)
T ss_dssp ECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHHHHH
T ss_pred EEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHHHhh
Confidence 999999987654332 234579999999999999889999999999999999999999996543211 1111111111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
.... .++......+.+++.+|++.||++|| ++.|++++
T Consensus 403 ~~~~-----------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 403 EVPE-----------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HCCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cccc-----------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1111 11222345688899999999999999 77888754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=344.07 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=199.8
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.++|++.+.||+|+||+||+|+.. |+.||||++.. ....+.+.+|++++++++||||+++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-------------------~~~~~~~~~E~~~l~~l~h~~iv~~ 79 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN-------------------DATAQAFLAEASVMTQLRHSNLVQL 79 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC-------------------CC--HHHHHTHHHHTTCCCTTBCCE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecc-------------------hhHHHHHHHHHHHHHhCCCCCEeeE
Confidence 368999999999999999999886 88999999831 1234678899999999999999999
Q ss_pred EEEEecC-CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 708 YCSITSE-DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 708 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
++++... +..++||||+++++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 156 (278)
T 1byg_A 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVA 156 (278)
T ss_dssp EEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCE
T ss_pred EEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcE
Confidence 9997654 57899999999999999998755445889999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||++....... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||... ...+....+.
T Consensus 157 ~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~~~~~~~~~~- 228 (278)
T 1byg_A 157 KVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVE- 228 (278)
T ss_dssp EECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHT-
T ss_pred EEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHh-
Confidence 999999997554322 12357889999999998899999999999999999998 99998532 1222222111
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
.. .....+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 229 ---~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 229 ---KG---------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp ---TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cC---------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 10 0111223345678899999999999999999999999998643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.28 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=196.4
Q ss_pred hccCCcccccccCceeEEEEEeC----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|++.+.||+|+||.||+|... .++.||||++.... ......+.+.+|+.++++++||||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i 98 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN---------------SSQREIEEFLSEAACMKDFSHPNV 98 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C---------------CCHHHHHHHHHHHHHHHTCCCTTB
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc---------------cchhHHHHHHHHHHHHhcCCCCCe
Confidence 67889999999999999999854 34589999984221 111234668899999999999999
Q ss_pred ceEEEEEecCCc-----cEEEEeccCCCChHHHhhhc----CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCC
Q 002250 705 VKLYCSITSEDS-----NLLVYEYLPNGSLWDRLHTC----HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKS 775 (947)
Q Consensus 705 v~l~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp 775 (947)
+++++++...+. .++||||+++|+|.+++... ....+++..++.++.|++.||+||| +.+|+||||||
T Consensus 99 v~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp 175 (313)
T 3brb_A 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAA 175 (313)
T ss_dssp CCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSG
T ss_pred eeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCc
Confidence 999999987654 49999999999999998532 3456899999999999999999999 89999999999
Q ss_pred CCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCC
Q 002250 776 SNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFG 854 (947)
Q Consensus 776 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~ 854 (947)
+||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 176 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-- 253 (313)
T 3brb_A 176 RNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-- 253 (313)
T ss_dssp GGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--
T ss_pred ceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC--
Confidence 999999999999999999987654433333334567889999999999999999999999999999999 88888532
Q ss_pred CcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 855 DSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
............ .....+...+..+.+++.+|++.||++|||+.+++++|+++.
T Consensus 254 ~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 254 QNHEMYDYLLHG-------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp CGGGHHHHHHTT-------------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHcC-------------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 122222221111 111122334457889999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.86 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=204.7
Q ss_pred hccCCcc-cccccCceeEEEEEeC---CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPEN-LIGKGGSGNVYKVVLN---SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~-~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|.+.+ .||+|+||.||+|... +++.||||++.... .....+.+.+|++++++++||||
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~i 72 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----------------EKADTEEMMREAQIMHQLDNPYI 72 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----------------CHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc----------------chhHHHHHHHHHHHHHhCCCCCE
Confidence 4566665 8999999999999854 57889999984221 11234678899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++ ..+..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 73 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~ 147 (287)
T 1u59_A 73 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRH 147 (287)
T ss_dssp CCEEEEE-ESSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETT
T ss_pred eEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCC
Confidence 9999999 456789999999999999999753 446899999999999999999999 88999999999999999999
Q ss_pred CeEEeccccceecccCCCC-cceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
.+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... .......
T Consensus 148 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~ 225 (287)
T 1u59_A 148 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAF 225 (287)
T ss_dssp EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHH
T ss_pred CEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HHHHHHH
Confidence 9999999999876543321 11223356889999999988889999999999999999999 999985431 2222222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
+.. . .....+...+..+.+++.+||+.||++||++.+++++|+++
T Consensus 226 i~~---~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 226 IEQ---G----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp HHT---T----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hhc---C----------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1 11122234456788999999999999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.96 Aligned_cols=252 Identities=21% Similarity=0.262 Sum_probs=203.3
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
.+.++|++.+.||+|+||+||+|... ++..||+|++.. ......+.+.+|++++++++||||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~-----------------~~~~~~~~~~~E~~~l~~l~h~~i 68 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-----------------YFVEDVDRFKQEIEIMKSLDHPNI 68 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEG-----------------GGCSCHHHHHHHHHHHHTCCCTTB
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehh-----------------hccchHHHHHHHHHHHHhCCCCCE
Confidence 45688999999999999999999966 578999999832 112345778999999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe---c
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL---D 781 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll---~ 781 (947)
+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||++ +
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~ 143 (277)
T 3f3z_A 69 IRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDS 143 (277)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSS
T ss_pred eeEEEEEecCCeEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCC
Confidence 99999999999999999999999999999864 35899999999999999999999 8999999999999999 7
Q ss_pred CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|||++|+.||.... ..+
T Consensus 144 ~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~ 214 (277)
T 3f3z_A 144 PDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT-----DSE 214 (277)
T ss_dssp TTCCEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHH
T ss_pred CCCcEEEEecccceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC-----HHH
Confidence 889999999999987654432 224468999999998865 48999999999999999999999985321 111
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
............. .......+..+.+++.+|++.||++|||+.|+++
T Consensus 215 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 215 VMLKIREGTFTFP-------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHHCCCCCC-------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhCCCCCC-------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111111100 0000123456889999999999999999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.52 Aligned_cols=255 Identities=24% Similarity=0.298 Sum_probs=203.8
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|... +++.||+|++.... ........+.+|+.++++++||||+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~ 68 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK---------------LSARDFQKLEREARICRKLQHPNIV 68 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---------------CCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc---------------CCHHHHHHHHHHHHHHHHcCCCCcC
Confidence 3578999999999999999999965 68999999984211 1112346788999999999999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~ 143 (284)
T 3kk8_A 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAK 143 (284)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSST
T ss_pred eEEEEEEcCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCC
Confidence 9999999999999999999999999998764 45899999999999999999999 889999999999999986655
Q ss_pred ---eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 786 ---PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 786 ---~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
+||+|||.+........ .....||+.|+|||++.+..++.++||||+|+++|||++|+.||... ...+.
T Consensus 144 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-----~~~~~ 215 (284)
T 3kk8_A 144 GAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----DQHRL 215 (284)
T ss_dssp TCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHH
T ss_pred CCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC-----chhHH
Confidence 99999999986654332 22356899999999999999999999999999999999999998532 11111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
........... . .......+..+.+++.+|++.||++|||+.|++++
T Consensus 216 ~~~~~~~~~~~---~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 216 YAQIKAGAYDY---P----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHTCCCC---C----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHhccccC---C----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11111111110 0 01112234568899999999999999999999873
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=365.04 Aligned_cols=251 Identities=23% Similarity=0.283 Sum_probs=203.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|+..+.||+|+||.||+|+.+ +|+.||||++... ..........+.+|+.++++++||||+++
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~--------------~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l 250 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKK--------------RLKKRKGYQGAMVEKKILAKVHSRFIVSL 250 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhH--------------HhhhhHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 67888899999999999999976 6999999998311 11122445678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcC--CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCH--KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++..++..|+||||+++|+|.+++.... ...+++.....++.||+.||+||| +.+|+||||||+||+++.++.
T Consensus 251 ~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~ 327 (543)
T 3c4z_A 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGN 327 (543)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSC
T ss_pred EEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCC
Confidence 999999999999999999999999997643 456899999999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+||+|||+++........ ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........
T Consensus 328 vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~ 404 (543)
T 3c4z_A 328 VRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQR 404 (543)
T ss_dssp EEECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHH
T ss_pred EEEeecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHH
Confidence 999999999876543321 22457999999999999989999999999999999999999999654221 112222221
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 910 (947)
...... .++...+..+.+++.+|++.||++||++
T Consensus 405 i~~~~~-----------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 405 VLEQAV-----------TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHCCC-----------CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred Hhhccc-----------CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 111111 1122334567889999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=356.07 Aligned_cols=262 Identities=17% Similarity=0.173 Sum_probs=206.3
Q ss_pred hccCCcccccccCceeEEEEEeCC---------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS---------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV 699 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 699 (947)
++|++.+.||+|+||.||+|+... ++.||||++. ....+.+|+++++++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~----------------------~~~~~~~E~~~l~~l 99 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA----------------------KDGRLFNEQNFFQRA 99 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEE----------------------TTSTHHHHHHHHHHH
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEec----------------------ccchHHHHHHHHHHh
Confidence 689999999999999999999763 7899999983 114688999999999
Q ss_pred cccccce---------------EEEEEec-CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcC
Q 002250 700 RHVNVVK---------------LYCSITS-EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG 763 (947)
Q Consensus 700 ~h~niv~---------------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~ 763 (947)
+||||++ +++++.. +...++||||+ +++|.+++.......+++..+..++.|++.||+|||
T Consensus 100 ~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-- 176 (352)
T 2jii_A 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH-- 176 (352)
T ss_dssp CCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred cccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 9999998 6677766 67789999999 999999999765567999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEecCCC--CeEEeccccceecccCCCC-----cceecccccccccCccccccCCCCCccchHHHH
Q 002250 764 FDRPVIHRDVKSSNILLDLEW--KPRIADFGLAKIVQTGEAG-----DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFG 836 (947)
Q Consensus 764 ~~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG 836 (947)
+.+|+||||||+||+++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++||||||
T Consensus 177 -~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 255 (352)
T 2jii_A 177 -ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLG 255 (352)
T ss_dssp -HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred -hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHH
Confidence 88999999999999999998 8999999999866543221 111234789999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 837 VVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 837 v~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+++|||++|+.||.........+............. ..+.... ....+..+.+++.+|++.||++|||+.++++.
T Consensus 256 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 256 YCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP---FVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp HHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCC---EECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhh---hhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 999999999999965433333333332222111111 1111100 01123568889999999999999999999999
Q ss_pred hhccC
Q 002250 917 LEEAE 921 (947)
Q Consensus 917 L~~~~ 921 (947)
|+++.
T Consensus 331 L~~~~ 335 (352)
T 2jii_A 331 LEALL 335 (352)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=353.27 Aligned_cols=207 Identities=26% Similarity=0.278 Sum_probs=178.8
Q ss_pred ccccccH-HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHH
Q 002250 618 RVLSFSE-KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695 (947)
Q Consensus 618 ~~~~~~~-~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 695 (947)
..+++.+ ..+.++|++.+.||+|+||+||+|+.. +++.||||++.. .......+..|+.+
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------------------~~~~~~~~~~e~~~ 84 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN------------------IKKYTRSAKIEADI 84 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------------------CHHHHHHHHHHHHH
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc------------------chhhhhhhHHHHHH
Confidence 3344444 445688999999999999999999964 789999999831 11233567789999
Q ss_pred Hhhcc-----ccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 002250 696 LSAVR-----HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIH 770 (947)
Q Consensus 696 l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 770 (947)
++.+. ||||+++++++...+..++||||+ +++|.+++.......+++..+..++.|++.||+||| +.+|+|
T Consensus 85 l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH 160 (360)
T 3llt_A 85 LKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTH 160 (360)
T ss_dssp HHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred HHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeee
Confidence 99996 999999999999999999999999 999999999866667999999999999999999999 899999
Q ss_pred ccCCCCCeEecC-------------------------CCCeEEeccccceecccCCCCcceecccccccccCccccccCC
Q 002250 771 RDVKSSNILLDL-------------------------EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK 825 (947)
Q Consensus 771 ~Dlkp~NIll~~-------------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 825 (947)
|||||+|||++. ++.+||+|||+|+...... ....||+.|+|||++.+..
T Consensus 161 rDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~ 235 (360)
T 3llt_A 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLG 235 (360)
T ss_dssp SCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCC
T ss_pred CCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCC
Confidence 999999999975 7899999999998654322 2457899999999999999
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 826 INEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 826 ~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
++.++|||||||++|||++|+.||..
T Consensus 236 ~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 236 WDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCccchHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999954
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.15 Aligned_cols=260 Identities=27% Similarity=0.328 Sum_probs=200.3
Q ss_pred hccCCcccccccCceeEEEEEeCC----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
..|++.+.||+|+||+||+|+..+ ...||||.+... ......+.+.+|+.++++++||||
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~~i 88 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------------TDIGEVSQFLTEGIIMKDFSHPNV 88 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC----------------CSHHHHHHHHHHHHHHHTCCCTTB
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC----------------CCHHHHHHHHHHHHHHHhCCCCCE
Confidence 468888999999999999999642 235899988321 111234678899999999999999
Q ss_pred ceEEEEEe-cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 705 VKLYCSIT-SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 705 v~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
+++++++. .++..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 89 v~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~ 164 (298)
T 3f66_A 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEK 164 (298)
T ss_dssp CCCCEEECCSSSCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTT
T ss_pred eeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCC
Confidence 99999864 566789999999999999999763 456789999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCC--cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAG--DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
+.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||+|+++|||++|..|+...... .+...
T Consensus 165 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~~~~~ 243 (298)
T 3f66_A 165 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITV 243 (298)
T ss_dssp CCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-TTHHH
T ss_pred CCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-HHHHH
Confidence 99999999999865433211 1222345788999999999999999999999999999999955544332221 12222
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
.... ... ...+...+..+.+++.+|++.||++|||+.|+++.|+++..
T Consensus 244 ~~~~---~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 244 YLLQ---GRR----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp HHHT---TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhc---CCC----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111 111 11112234568899999999999999999999999998643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=344.91 Aligned_cols=265 Identities=22% Similarity=0.340 Sum_probs=199.9
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... ........+.+|+.++++++||||++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~i~~ 96 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL--------------MDAKARADCIKEIDLLKQLNHPNVIK 96 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS--------------CCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc--------------cCHHHHHHHHHHHHHHHhCCCCCEee
Confidence 46899999999999999999996 4799999999842110 01123467889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++..++..++||||+++++|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~ 173 (310)
T 2wqm_A 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATG 173 (310)
T ss_dssp EEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTS
T ss_pred EEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCC
Confidence 999999999999999999999999999753 3456899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......
T Consensus 174 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~ 248 (310)
T 2wqm_A 174 VVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCK 248 (310)
T ss_dssp CEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHHH
T ss_pred CEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHHH
Confidence 999999999976543321 122346899999999999989999999999999999999999998643222 222221
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
........ .. .....+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 249 ~~~~~~~~-------~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 249 KIEQCDYP-------PL--PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp HHHTTCSC-------CC--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhhcccCC-------CC--cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11111100 00 0122345688999999999999999999999999987654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.00 Aligned_cols=257 Identities=21% Similarity=0.314 Sum_probs=202.0
Q ss_pred hhccCCcccccccCceeEEEEEeCC----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNS----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
.++|++.+.||+|+||+||+|+... +..||||++.... .....+.+.+|+.++++++|||
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~ 74 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC----------------TLDNKEKFMSEAVIMKNLDHPH 74 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS----------------CHHHHHHHHHHHHHHHHHCCTT
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc----------------CchHHHHHHHHHHHHHhCCCCC
Confidence 3678899999999999999998542 3369999984211 1123467889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++.+ +..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 75 i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 149 (281)
T 3cc6_A 75 IVKLIGIIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASP 149 (281)
T ss_dssp BCCEEEEECS-SSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEET
T ss_pred cceEEEEEcC-CCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCC
Confidence 9999999875 4568999999999999999763 345899999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||.+.......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||... ...+....
T Consensus 150 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~--~~~~~~~~ 226 (281)
T 3cc6_A 150 ECVKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL--ENKDVIGV 226 (281)
T ss_dssp TEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CGGGHHHH
T ss_pred CcEEeCccCCCcccccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC--ChHHHHHH
Confidence 999999999998665432211 223457889999999998899999999999999999998 99998533 22223222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
...... ...+...+..+.+++.+|++.||++|||+.|++++|+++.
T Consensus 227 ~~~~~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 227 LEKGDR-------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp HHHTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCCC-------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 211100 1111223456889999999999999999999999998753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=352.09 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=205.4
Q ss_pred hhccCCcccccccCceeEEEEEe------CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.++|++.+.||+|+||.||+|+. .+++.||||++.... .......+.+|+.++++++|
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h 92 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----------------SEQDELDFLMEALIISKFNH 92 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC----------------CHHHHHHHHHHHHHHHHCCC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc----------------chhhHHHHHHHHHHHhhCCC
Confidence 47899999999999999999984 257789999983211 11234578899999999999
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC-----ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK-----IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 776 (947)
|||+++++++..++..++||||+++++|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+
T Consensus 93 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~ 169 (327)
T 2yfx_A 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAAR 169 (327)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGG
T ss_pred CCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHh
Confidence 9999999999999999999999999999999987532 45889999999999999999999 889999999999
Q ss_pred CeEecC---CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 002250 777 NILLDL---EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPE 852 (947)
Q Consensus 777 NIll~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~ 852 (947)
||+++. +..+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 170 NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 170 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp GEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred HEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 999984 45699999999976544433333334568899999999998899999999999999999998 88998432
Q ss_pred CCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
........+.. .. ....+...+..+.+++.+||+.||.+|||+.+++++|+.+...+
T Consensus 250 --~~~~~~~~~~~---~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 250 --SNQEVLEFVTS---GG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp --CHHHHHHHHHT---TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred --CHHHHHHHHhc---CC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 11222222111 11 01112233456889999999999999999999999999876554
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.15 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=200.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CC-------cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SG-------KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR 700 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 700 (947)
++|++.+.||+|+||+||+|+.. ++ ..||+|++.. ......+.+.+|+.++++++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~-----------------~~~~~~~~~~~E~~~l~~l~ 70 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-----------------AHRNYSESFFEAASMMSKLS 70 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECG-----------------GGGGGHHHHHHHHHHHHTSC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccc-----------------ccHHHHHHHHHHHHHHHhCC
Confidence 67889999999999999999865 33 4799998831 11234567899999999999
Q ss_pred ccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 701 HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 701 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
||||+++++++..++..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 71 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll 146 (289)
T 4fvq_A 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILL 146 (289)
T ss_dssp CTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred CCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEE
Confidence 999999999999999999999999999999999873 345899999999999999999999 8999999999999999
Q ss_pred cCCCC--------eEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 781 DLEWK--------PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 781 ~~~~~--------~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
+.++. +||+|||.+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+..
T Consensus 147 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 147 IREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp EECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 98887 99999999864422 123468999999999987 6789999999999999999997665533
Q ss_pred CCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 852 EFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
.... ....... ...... +...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 221 ~~~~-~~~~~~~----~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 221 ALDS-QRKLQFY----EDRHQL-----------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TSCH-HHHHHHH----HTTCCC-----------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ccch-HHHHHHh----hccCCC-----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2211 1111111 111110 01112347789999999999999999999999998765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.70 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=203.3
Q ss_pred ccCCcccccccCceeEEEEEeC-CC---cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SG---KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
.|+..+.||+|+||+||+|... ++ ..||+|++... ......+.+.+|+.++++++||||+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~~iv 85 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----------------TEMQQVEAFLREGLLMRGLNHPNVL 85 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC----------------CSHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc----------------ccHHHHHHHHHHHHHHHhCCCCCee
Confidence 4566789999999999999853 23 37999988321 1112346788999999999999999
Q ss_pred eEEEEEecCCcc-EEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 706 KLYCSITSEDSN-LLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 706 ~l~~~~~~~~~~-~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
++++++..++.. ++||||+++|+|.+++.. ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~ 161 (298)
T 3pls_A 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESF 161 (298)
T ss_dssp CCCEEECCSSSCCEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTC
T ss_pred eEEEEEecCCCCcEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCC
Confidence 999999876665 999999999999999986 3456899999999999999999999 88999999999999999999
Q ss_pred CeEEeccccceecccCCC--CcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 785 KPRIADFGLAKIVQTGEA--GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+.... ...+....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~ 240 (298)
T 3pls_A 162 TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHF 240 (298)
T ss_dssp CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHH
T ss_pred cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHH
Confidence 999999999975543221 112224467899999999999999999999999999999999776654332 22223222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
..... ....+...+..+.+++.+|++.||.+|||+.++++.|+++..
T Consensus 241 ~~~~~-------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 241 LAQGR-------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp HHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCC-------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 21111 011122234568899999999999999999999999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=336.79 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=184.1
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+. .+|+.||||++... ........+.+.+|+.++++++||||++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 75 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKK--------------AMYKAGMVQRVQNEVKIHCQLKHPSILE 75 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHTTBCCTTBCC
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehh--------------hhhhhhHHHHHHHHHHHHHhCCCCCeEe
Confidence 46799999999999999999996 47999999998311 1112234577899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~ 151 (278)
T 3cok_A 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNI 151 (278)
T ss_dssp EEEEEECSSEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCE
T ss_pred EEEEEccCCeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCE
Confidence 999999999999999999999999999863 346899999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||.+......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. ....
T Consensus 152 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~---~~~~ 224 (278)
T 3cok_A 152 KIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--NT---LNKV 224 (278)
T ss_dssp EECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------C
T ss_pred EEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--HH---HHHH
Confidence 99999999876433221 12346899999999999888999999999999999999999998543211 00 0000
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. .+.. .+......+.+++.+|++.||++|||+.+++++
T Consensus 225 ~~--------~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 225 VL--------ADYE---MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CS--------SCCC---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hh--------cccC---CccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 00 0111 122234567889999999999999999999863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=344.76 Aligned_cols=265 Identities=20% Similarity=0.252 Sum_probs=207.2
Q ss_pred cccccH-HHHhhccCCc-ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHH
Q 002250 619 VLSFSE-KEIIDAVKPE-NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVAT 695 (947)
Q Consensus 619 ~~~~~~-~~~~~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 695 (947)
-+.|.. +.+.+.|.+. +.||+|+||+||+|+.. +++.||||++.... ........+.+|+.+
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~e~~~ 81 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR---------------RGQDCRAEILHEIAV 81 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEE---------------TTEECHHHHHHHHHH
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhh---------------cchHHHHHHHHHHHH
Confidence 344444 6667788887 89999999999999966 69999999984211 112335678899999
Q ss_pred Hhhcc-ccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCC
Q 002250 696 LSAVR-HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVK 774 (947)
Q Consensus 696 l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlk 774 (947)
++++. ||||+++++++..++..++||||+++|+|.+++.......+++..+..++.|++.||+||| +.+|+|||||
T Consensus 82 l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dik 158 (327)
T 3lm5_A 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLK 158 (327)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred HHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCC
Confidence 99994 6999999999999999999999999999999997665667999999999999999999999 8899999999
Q ss_pred CCCeEecC---CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 775 SSNILLDL---EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 775 p~NIll~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
|+||+++. ++.+||+|||+++....... .....||+.|+|||++....++.++||||||+++|||++|+.||..
T Consensus 159 p~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp GGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999997 78999999999987654322 2235799999999999999999999999999999999999999853
Q ss_pred CCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 852 EFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. ..+........... ...+........+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~-----~~~~~~~i~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 236 ED-----NQETYLNISQVNVD-------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp SS-----HHHHHHHHHHTCCC-------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred CC-----chHHHHHHHhcccc-------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 21 11111111111110 0111222334568889999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=351.11 Aligned_cols=253 Identities=28% Similarity=0.363 Sum_probs=201.1
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.+.|+..+.||+|+||+||+|+. .+++.||||++..... ......+.+.+|++++++++||||++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~~~~E~~~l~~l~hpniv~ 118 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--------------QSNEKWQDIIKEVRFLQKLRHPNTIQ 118 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS--------------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc--------------cchHHHHHHHHHHHHHHhCCCCCEee
Confidence 46688899999999999999996 5789999999842211 01122356889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||++ |++.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 119 ~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~ 193 (348)
T 1u5q_A 119 YRGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLV 193 (348)
T ss_dssp EEEEEEETTEEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEE
T ss_pred EEEEEEECCeEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCE
Confidence 9999999999999999996 6888888653 346899999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY---TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
||+|||+++..... ....||+.|+|||++. .+.++.++|||||||++|||++|+.||... ......
T Consensus 194 kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~-----~~~~~~ 262 (348)
T 1u5q_A 194 KLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSAL 262 (348)
T ss_dssp EECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHH
T ss_pred EEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----ChHHHH
Confidence 99999999765432 2347899999999984 567899999999999999999999998532 122222
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
......... .. .....+..+.+++.+||+.||++|||+.+++++---
T Consensus 263 ~~~~~~~~~-------~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 263 YHIAQNESP-------AL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp HHHHHSCCC-------CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHhcCCC-------CC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 222111110 00 011223457889999999999999999999875443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=339.31 Aligned_cols=262 Identities=21% Similarity=0.248 Sum_probs=202.5
Q ss_pred HHhhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
.+.++|++.+.||+|+||+||+|+. .+++.||||++... .....+.+|+++++.++|+++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------------~~~~~~~~e~~~l~~l~~~~~ 66 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-------------------TKHPQLHIESKIYKMMQGGVG 66 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------------------CCCHHHHHHHHHHHTTSTT
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc-------------------ccchHHHHHHHHHHHhcCCCC
Confidence 3457899999999999999999996 57899999986311 223458889999999998887
Q ss_pred ceEEEEE-ecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe---
Q 002250 705 VKLYCSI-TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL--- 780 (947)
Q Consensus 705 v~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll--- 780 (947)
+..++++ ..++..++||||+ +++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 67 i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~ 141 (296)
T 4hgt_A 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLG 141 (296)
T ss_dssp CCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCG
T ss_pred CCeeeeecCCCCceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeecc
Confidence 7776665 5667779999999 99999999853 345899999999999999999999 8999999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCc-----ceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGD-----LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG- 854 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~- 854 (947)
+.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 142 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 4hgt_A 142 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred CCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence 788999999999998765543311 12345789999999999999999999999999999999999999965321
Q ss_pred CcccHH-HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 855 DSKDIV-NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 855 ~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
...... ......... .........+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 222 TKRQKYERISEKKMST----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SSSSHHHHHHHHHHHS----------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhhhhhhhcccccc----------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 111111 111111100 001111223457889999999999999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=363.31 Aligned_cols=251 Identities=24% Similarity=0.281 Sum_probs=194.5
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +|+.||||++... ..........+.+|+.+++.++||||++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 212 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKE--------------VIVAKDEVAHTLTENRVLQNSRHPFLTA 212 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--------------HHC-------------CCCCCSCTTSCC
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhh--------------hhhhhHHHHHHHHHHHHHHhCCCCeEee
Confidence 467999999999999999999965 7899999998421 0112233456778999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCCeEecCCCC
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFD-RPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~Dlkp~NIll~~~~~ 785 (947)
+++++...+..++||||+++|+|.+++... ..+++..+..++.|++.||+||| + .+|+||||||+|||++.++.
T Consensus 213 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~ 287 (446)
T 4ejn_A 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGH 287 (446)
T ss_dssp EEEEEEETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSC
T ss_pred EEEEEeeCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCC
Confidence 999999999999999999999999999864 35899999999999999999999 6 89999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+||+|||+|+....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +.......
T Consensus 288 ~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~ 360 (446)
T 4ejn_A 288 IKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFEL 360 (446)
T ss_dssp EEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred EEEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC-----CHHHHHHH
Confidence 99999999975433221 223467999999999999999999999999999999999999999532 11222111
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQ 915 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 915 (947)
....... ++......+.+++.+|++.||.+|| ++.|+++
T Consensus 361 i~~~~~~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 361 ILMEEIR-----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHCCCC-----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHhCCCC-----------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1111111 1222345688999999999999999 9999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=350.57 Aligned_cols=264 Identities=24% Similarity=0.341 Sum_probs=195.2
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHH--HHHHhhccccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE--VATLSAVRHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E--~~~l~~l~h~niv 705 (947)
.++|++.+.||+|+||+||+|+.. ++.||||++.. .....+..| +..+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~--------------------~~~~~~~~e~~~~~~~~~~h~~i~ 70 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSF--------------------ANRQNFINEKNIYRVPLMEHDNIA 70 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEG--------------------GGHHHHHHHHHHHTSTTCCCTTBC
T ss_pred hHHhheeeecccCCCeEEEEEEEC-CeEEEEEEeec--------------------cchhhHHHHHHHHHHHhccCcchh
Confidence 468899999999999999999874 89999999831 112334444 4445568999999
Q ss_pred eEEEEEec-----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeEec
Q 002250 706 KLYCSITS-----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDR---------PVIHR 771 (947)
Q Consensus 706 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~---------~ivH~ 771 (947)
++++++.. ....++||||+++|+|.+++... ..++..+..++.|++.||+||| +. +|+||
T Consensus 71 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~ 144 (336)
T 3g2f_A 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHR 144 (336)
T ss_dssp CEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECS
T ss_pred hheecccccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeec
Confidence 99986543 23468999999999999999763 3588999999999999999999 77 99999
Q ss_pred cCCCCCeEecCCCCeEEeccccceecccCCC------CcceecccccccccCcccccc-------CCCCCccchHHHHHH
Q 002250 772 DVKSSNILLDLEWKPRIADFGLAKIVQTGEA------GDLTHVIAGTHGYIAPEYAYT-------CKINEKSDVYSFGVV 838 (947)
Q Consensus 772 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGv~ 838 (947)
||||+||+++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||+
T Consensus 145 Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~i 224 (336)
T 3g2f_A 145 DLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224 (336)
T ss_dssp SCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHH
T ss_pred ccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHH
Confidence 9999999999999999999999987654321 111224469999999999876 356678999999999
Q ss_pred HHHHHhCCCCCCCCCCCcc-------------cHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCC
Q 002250 839 LMELVTGKRPIVPEFGDSK-------------DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPA 905 (947)
Q Consensus 839 l~elltg~~p~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~ 905 (947)
+|||++|+.||........ ....+.. ....... ...+ +.........+..+.+++.+||+.||+
T Consensus 225 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~ 301 (336)
T 3g2f_A 225 YWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQV-LVSREKQ-RPKF-PEAWKENSLAVRSLKETIEDCWDQDAE 301 (336)
T ss_dssp HHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHH-HHTTSCC-CCCC-CTTCCCCSHHHHHHHHHHHHHSCSSGG
T ss_pred HHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHh-hhccccc-CCCC-CcccccccchHHHHHHHHHHHhcCChh
Confidence 9999999888754321110 0111100 0000000 0000 011112234667899999999999999
Q ss_pred CCCCHHHHHHHhhccC
Q 002250 906 FRPSMRVVVQMLEEAE 921 (947)
Q Consensus 906 ~RPt~~ev~~~L~~~~ 921 (947)
+|||+.|+++.|+++.
T Consensus 302 ~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 302 ARLTAQXAEERMAELM 317 (336)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred hCcchHHHHHHHHHHH
Confidence 9999999999999865
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=360.66 Aligned_cols=319 Identities=21% Similarity=0.206 Sum_probs=178.9
Q ss_pred cEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCC
Q 002250 161 YWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQN 240 (947)
Q Consensus 161 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 240 (947)
+.++.++++++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 45566666666 4555443 46777777777777666677777777777777777777766777777777777777777
Q ss_pred CCCCCCc-cccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCC
Q 002250 241 RLEGDLS-ELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPP 319 (947)
Q Consensus 241 ~l~~~~~-~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 319 (947)
+++..+. .+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+++..
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-- 168 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP-- 168 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC--
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC--
Confidence 7766554 3566777777777777777666777777777777777777777666666777777777777766665321
Q ss_pred CcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccc
Q 002250 320 DMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSL 399 (947)
Q Consensus 320 ~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 399 (947)
+..|.++++|+.|++++|.+.+..+..|..+++|+.|++++|.+.+.++.
T Consensus 169 ----------------------~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~-------- 218 (477)
T 2id5_A 169 ----------------------TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP-------- 218 (477)
T ss_dssp ----------------------HHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECT--------
T ss_pred ----------------------hhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCc--------
Confidence 22344455555555555555544444444455555555544444333322
Q ss_pred cEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCc
Q 002250 400 ALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479 (947)
Q Consensus 400 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 479 (947)
.+....+|+.|+|++|++++..+..+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|
T Consensus 219 ----------------~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 282 (477)
T 2id5_A 219 ----------------NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282 (477)
T ss_dssp ----------------TTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSS
T ss_pred ----------------ccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCC
Confidence 2222223444444444444222233444444444444444444444444444444444444444
Q ss_pred eeeeecCCCCCccCcCcEEECCCCccCCccCCccc-ccccceeeCCCCcCCC
Q 002250 480 SLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQLAG 530 (947)
Q Consensus 480 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N~l~~ 530 (947)
++++..|..|.++++|+.|+|++|++++.++..+. +++|+.|+|++|++++
T Consensus 283 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 283 QLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp CCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred ccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 44444444444444444444444444443333322 3444444444444443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=376.96 Aligned_cols=249 Identities=21% Similarity=0.289 Sum_probs=197.6
Q ss_pred cccccCceeEEEEEeC---CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEe
Q 002250 636 LIGKGGSGNVYKVVLN---SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSIT 712 (947)
Q Consensus 636 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 712 (947)
.||+|+||.||+|... ++..||||++.... .....+.+.+|++++++++|||||++++++.
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~----------------~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 406 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----------------EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC----------------SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC----------------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence 7999999999999864 46679999984221 1234578999999999999999999999998
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
. +..++||||+++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 407 ~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFG 481 (613)
T 2ozo_A 407 A-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFG 481 (613)
T ss_dssp S-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeecc
Confidence 6 5689999999999999999763 456899999999999999999999 8899999999999999999999999999
Q ss_pred cceecccCCCC-cceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcccc
Q 002250 793 LAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDSR 870 (947)
Q Consensus 793 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 870 (947)
+++........ .......+|+.|+|||++....++.++|||||||++|||++ |+.||.... ..++...+.. .
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i~~----~ 555 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQ----G 555 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--SHHHHHHHHT----T
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHc----C
Confidence 99865433221 11122345689999999999999999999999999999998 999985431 2222222211 1
Q ss_pred ccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 871 DSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 871 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
...+.+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus 556 ---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 556 ---------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11122334556789999999999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=338.62 Aligned_cols=266 Identities=19% Similarity=0.191 Sum_probs=200.2
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
...++|++.+.||+|+||.||+|+.. +++.||||++.... .........+.+|+.++++++||||
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~hp~i 96 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL--------------SSDPVFRTRMQREARTAGRLQEPHV 96 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGG--------------GGSHHHHHHHHHHHHHHTTCCCTTB
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc--------------ccCHHHHHHHHHHHHHHhhcCCCCe
Confidence 34578999999999999999999965 78999999983110 1111224678899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 97 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~ 171 (309)
T 2h34_A 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADD 171 (309)
T ss_dssp CCEEEEEEETTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTS
T ss_pred eEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCC
Confidence 99999999999999999999999999999864 35899999999999999999999 88999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... .. ....
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~-~~~~ 244 (309)
T 2h34_A 172 FAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-----QL-SVMG 244 (309)
T ss_dssp CEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC-----HH-HHHH
T ss_pred CEEEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc-----hH-HHHH
Confidence 9999999999765543221 122446899999999999989999999999999999999999998532 11 1111
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhccCCCC
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-SMRVVVQMLEEAEPCS 924 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~~~~~~ 924 (947)
........ .........+..+.+++.+||+.||++|| ++.++++.|+++....
T Consensus 245 ~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 245 AHINQAIP-------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHSCCC-------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHhccCCC-------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 11111111 11112233345688899999999999999 9999999999876554
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=334.36 Aligned_cols=257 Identities=23% Similarity=0.298 Sum_probs=203.3
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +++.||||++....... .......+.+.+|+.++++++||||++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~h~~i~~ 72 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSS-----------SRRGVSREEIEREVNILREIRHPNIIT 72 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTT-----------CSSSBCHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccc-----------cccchHHHHHHHHHHHHHhCCCCCeee
Confidence 468999999999999999999976 68999999985432211 111234577899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC--
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW-- 784 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-- 784 (947)
+++++..++..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 147 (283)
T 3bhy_A 73 LHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVP 147 (283)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSS
T ss_pred hhheecCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCC
Confidence 999999999999999999999999999763 45899999999999999999999 88999999999999998877
Q ss_pred --CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 785 --KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 785 --~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
.+||+|||.+........ .....||+.|+|||++....++.++||||||+++|||++|+.||.... ..+.
T Consensus 148 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~ 219 (283)
T 3bhy_A 148 NPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-----KQET 219 (283)
T ss_dssp SCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHH
T ss_pred CCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc-----hHHH
Confidence 899999999987644322 223468999999999998899999999999999999999999985321 1111
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
........... ..+.....+..+.+++.+|++.||++|||+.|+++
T Consensus 220 ~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 220 LTNISAVNYDF-------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHHHTTCCCC-------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhHhcccCC-------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 11111111100 01111223456889999999999999999999996
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.47 Aligned_cols=260 Identities=22% Similarity=0.251 Sum_probs=205.3
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+|+.+++.++|++++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------------~~~~~~~~e~~~l~~l~~~~~i~ 68 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-------------------TKHPQLHIESKIYKMMQGGVGIP 68 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESC-------------------SSCCHHHHHHHHHHHHTTSTTCC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCC-------------------cchhHHHHHHHHHHHhhcCCCCC
Confidence 47899999999999999999996 57999999987321 22346889999999999988776
Q ss_pred EEEEE-ecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe---cC
Q 002250 707 LYCSI-TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL---DL 782 (947)
Q Consensus 707 l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll---~~ 782 (947)
.++++ ..++..++||||+ +++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.
T Consensus 69 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~ 143 (296)
T 3uzp_A 69 TIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKK 143 (296)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGG
T ss_pred ccccccCCCCceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCC
Confidence 66655 5566779999999 99999999853 346899999999999999999999 8999999999999999 48
Q ss_pred CCCeEEeccccceecccCCCCc-----ceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-Cc
Q 002250 783 EWKPRIADFGLAKIVQTGEAGD-----LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG-DS 856 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~-~~ 856 (947)
++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 144 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 223 (296)
T 3uzp_A 144 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 223 (296)
T ss_dssp TTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS
T ss_pred CCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh
Confidence 8999999999998765543311 12345799999999999999999999999999999999999999965321 12
Q ss_pred ccHHHHH-HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 857 KDIVNWV-YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 857 ~~~~~~~-~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
....... ...... .........+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 224 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 224 RQKYERISEKKMST----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SSHHHHHHHHHHHS----------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhhhhcccccCC----------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 2222111 111110 001111223456889999999999999999999999999754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=345.66 Aligned_cols=263 Identities=23% Similarity=0.289 Sum_probs=204.1
Q ss_pred hccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~~iv~~ 91 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----------------EQQDREEAQREADMHRLFNHPNILRL 91 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----------------SHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----------------CHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 6799999999999999999996 57999999988321 11334678899999999999999999
Q ss_pred EEEEec----CCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 708 YCSITS----EDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 708 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
++++.. ....++||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~ 168 (317)
T 2buj_A 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLG 168 (317)
T ss_dssp CEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEC
T ss_pred EEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEc
Confidence 999873 44678999999999999999763 3456899999999999999999999 88999999999999999
Q ss_pred CCCCeEEeccccceecccCCCCc-------ceecccccccccCccccccCC---CCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGD-------LTHVIAGTHGYIAPEYAYTCK---INEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
.++.+||+|||.+.......... ......||+.|+|||++.... ++.++||||||+++|||++|+.||..
T Consensus 169 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 99999999999987543221110 011235799999999987543 68899999999999999999999843
Q ss_pred CCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 852 EFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
.............. ... .......+..+.+++.+||+.||.+|||+.++++.|+++.+.+
T Consensus 249 ~~~~~~~~~~~~~~----~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 249 VFQKGDSVALAVQN----QLS---------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp HHHTTSCHHHHHHC----C-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred hhcccchhhHHhhc----cCC---------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 21111122211111 000 0111223456889999999999999999999999999987654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=354.40 Aligned_cols=268 Identities=23% Similarity=0.342 Sum_probs=192.3
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-cc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HV 702 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ 702 (947)
+.+.++|++.+.||+|+||.||+|... +|+.||||++.... ........+.+|+.+++++. ||
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---------------~~~~~~~~~~~E~~~l~~l~~h~ 69 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---------------QNSTDAQRTFREIMILTELSGHE 69 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----------------CCHHHHHHHHHHHHHHHHTTTCT
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc---------------cChHHHHHHHHHHHHHHhccCCC
Confidence 456789999999999999999999965 78999999984211 11223456779999999997 99
Q ss_pred ccceEEEEEecCC--ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 703 NVVKLYCSITSED--SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 703 niv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
||+++++++..++ ..|+||||++ ++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 70 niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll 142 (388)
T 3oz6_A 70 NIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILL 142 (388)
T ss_dssp TBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred CCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEE
Confidence 9999999997644 6799999996 689999876 35889999999999999999999 8999999999999999
Q ss_pred cCCCCeEEeccccceecccCCC-------------------CcceecccccccccCcccccc-CCCCCccchHHHHHHHH
Q 002250 781 DLEWKPRIADFGLAKIVQTGEA-------------------GDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLM 840 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ 840 (947)
+.++.+||+|||+|+....... .......+||+.|+|||++.+ ..++.++||||+||++|
T Consensus 143 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 222 (388)
T 3oz6_A 143 NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222 (388)
T ss_dssp CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHH
Confidence 9999999999999986543110 111234579999999999976 57899999999999999
Q ss_pred HHHhCCCCCCCCCCCcccHHHHHHhhccccc--cccccc------------------cCCCCccC-------------HH
Q 002250 841 ELVTGKRPIVPEFGDSKDIVNWVYSKMDSRD--SMLTVV------------------DPNISEIL-------------KE 887 (947)
Q Consensus 841 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~------------------d~~~~~~~-------------~~ 887 (947)
||++|+.||.... ..+....+........ .+..+. ........ ..
T Consensus 223 ell~g~~pf~~~~--~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (388)
T 3oz6_A 223 EILCGKPIFPGSS--TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300 (388)
T ss_dssp HHHHSSCSCCCSS--HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCC
T ss_pred HHHhCCCCCCCCC--HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccccccc
Confidence 9999999995431 1111111111100000 000000 00000000 02
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 888 DALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 888 ~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....+.+++.+|++.||++|||+.|++++
T Consensus 301 ~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 301 CNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 24568899999999999999999999976
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=357.44 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=195.0
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.+.++|.+.+.||+|+||+||+|... +++.||||++........ ..........+.+|+.++++++|||
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpn 201 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG---------SAREADPALNVETEIEILKKLNHPC 201 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC-----------------CCHHHHHHHHHHCCCTT
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccc---------ccccchhHHHHHHHHHHHHhCCCCC
Confidence 566789999999999999999999965 689999999843211100 0111123346889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++.. +..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 202 iv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~ 275 (419)
T 3i6u_A 202 IIKIKNFFDA-EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQ 275 (419)
T ss_dssp BCCCCEEEES-SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSS
T ss_pred EeeEEEEEec-CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecC
Confidence 9999999865 4579999999999999998763 45899999999999999999999 8899999999999999754
Q ss_pred ---CCeEEeccccceecccCCCCcceecccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 784 ---WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT---CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 784 ---~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
+.+||+|||+|+...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ..
T Consensus 276 ~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~ 351 (419)
T 3i6u_A 276 EEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-QV 351 (419)
T ss_dssp SSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS-SC
T ss_pred CCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc-hH
Confidence 459999999998764432 2234579999999999863 5678899999999999999999999954322 22
Q ss_pred cHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 858 DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.+....... ... ..++.....+..+.+++.+|++.||++|||+.|++++
T Consensus 352 ~~~~~i~~~---~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 352 SLKDQITSG---KYN-------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CHHHHHHTT---CCC-------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhcC---CCC-------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 222221111 000 0111112234568899999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=347.90 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=203.4
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEE--EEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKEL--AVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 704 (947)
++|++.+.||+|+||.||+|+.. ++..+ |||++... ......+.+.+|+++++++ +||||
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~----------------~~~~~~~~~~~E~~~l~~l~~hp~i 88 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----------------ASKDDHRDFAGELEVLCKLGHHPNI 88 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------------------CHHHHHHHHHTTCCCCTTB
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc----------------cchHHHHHHHHHHHHHHhccCCCch
Confidence 68899999999999999999965 56644 99988421 1123346788999999999 89999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIH 770 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 770 (947)
+++++++..++..++||||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+|
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH 165 (327)
T 1fvr_A 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIH 165 (327)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred hhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccC
Confidence 999999999999999999999999999998643 246899999999999999999999 899999
Q ss_pred ccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCC
Q 002250 771 RDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPI 849 (947)
Q Consensus 771 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~ 849 (947)
|||||+||+++.++.+||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||
T Consensus 166 ~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf 242 (327)
T 1fvr_A 166 RDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242 (327)
T ss_dssp SCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999997433221 1123356889999999988889999999999999999998 99998
Q ss_pred CCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 850 VPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
... ...+........ . ....+...+..+.+++.+|++.||++|||+.|+++.|+++...
T Consensus 243 ~~~-----~~~~~~~~~~~~-~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 243 CGM-----TCAELYEKLPQG-Y---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp TTC-----CHHHHHHHGGGT-C---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCC-----cHHHHHHHhhcC-C---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 432 222222111111 0 0111223345688999999999999999999999999875443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=340.70 Aligned_cols=249 Identities=20% Similarity=0.255 Sum_probs=199.5
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVN 703 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 703 (947)
.+.++|++.+.||+|+||+||+|+.. +++.||||++..... .......+.+|+.++.++ +|||
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~~~~e~~~~~~l~~h~~ 72 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA---------------GSVDEQNALREVYAHAVLGQHSH 72 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT---------------TSHHHHHHHHHHHHHHHSCSCTT
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc---------------ccHHHHHHHHHHHHHHHhCCCCC
Confidence 34678999999999999999999976 799999999843211 112346778899999999 9999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCC--ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK--IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
|+++++++.+++..++||||+++++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 73 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~ 149 (289)
T 1x8b_A 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFIS 149 (289)
T ss_dssp BCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred eeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEc
Confidence 99999999999999999999999999999986422 56899999999999999999999 89999999999999998
Q ss_pred CC-------------------CCeEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHH
Q 002250 782 LE-------------------WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLME 841 (947)
Q Consensus 782 ~~-------------------~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~e 841 (947)
.+ ..+||+|||.+....... ...||+.|+|||++.+. .++.++||||||+++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 223 (289)
T 1x8b_A 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223 (289)
T ss_dssp --------------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHH
T ss_pred CCCCCcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHH
Confidence 44 479999999998765432 23589999999999766 56689999999999999
Q ss_pred HHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 842 LVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 842 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
|++|.+|+.. .+....... ...+..+...+..+.+++.+|++.||++|||+.|++++
T Consensus 224 l~~~~~~~~~-----~~~~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 224 AAGAEPLPRN-----GDQWHEIRQ-------------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HTTCCCCCSS-----SHHHHHHHT-------------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HhcCCCCCcc-----hhHHHHHHc-------------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 9999877532 111111110 11112222334568899999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=348.48 Aligned_cols=260 Identities=23% Similarity=0.280 Sum_probs=204.1
Q ss_pred hhccCCcccccccCceeEEEEEe----CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHV 702 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 702 (947)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ..........+.+|+++++++ .||
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~~~~E~~~l~~l~~h~ 119 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT-------------IVQKAKTTEHTRTERQVLEHIRQSP 119 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEE-------------EEEEESSGGGCCCHHHHHHHHHTCT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHH-------------hhhhhhHHHHHHHHHHHHHHccCCC
Confidence 46899999999999999999997 368999999984211 011123345677899999999 699
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
||+++++++..++..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 120 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 194 (355)
T 1vzo_A 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDS 194 (355)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred ceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECC
Confidence 9999999999999999999999999999999864 35889999999999999999999 889999999999999999
Q ss_pred CCCeEEeccccceecccCCCCcceecccccccccCccccccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC--KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
++.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ....
T Consensus 195 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~ 272 (355)
T 1vzo_A 195 NGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQA 272 (355)
T ss_dssp TSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHH
T ss_pred CCcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-chHH
Confidence 999999999999865433222 12245799999999999853 4788999999999999999999999643221 1222
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQMLE 918 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~L~ 918 (947)
.......... ...+.+....+.+++.+||+.||.+|| ++.|++++.-
T Consensus 273 ~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 273 EISRRILKSE-----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp HHHHHHHHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred HHHHHHhccC-----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 2222111111 112223345678899999999999999 9999987643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=341.41 Aligned_cols=256 Identities=22% Similarity=0.266 Sum_probs=202.2
Q ss_pred hccCCcc-cccccCceeEEEEEe---CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPEN-LIGKGGSGNVYKVVL---NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~-~iG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|++.+ .||+|+||+||+|.. .+++.||||++.... ......+.+.+|+.++++++||||
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i 80 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------------NDPALKDELLAEANVMQQLDNPYI 80 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------------------CHHHHHHHHHHHHHHTCCCTTB
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc---------------cCHHHHHHHHHHHHHHHhCCCCCE
Confidence 5677777 999999999999964 247889999984221 111234678999999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++ ..+..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 81 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~ 154 (291)
T 1xbb_A 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQH 154 (291)
T ss_dssp CCEEEEE-ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETT
T ss_pred EEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCC
Confidence 9999999 566789999999999999999874 35889999999999999999999 88999999999999999999
Q ss_pred CeEEeccccceecccCCCCc-ceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
.+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||... ........
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~ 232 (291)
T 1xbb_A 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAM 232 (291)
T ss_dssp EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHH
T ss_pred cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHH
Confidence 99999999998765443211 1222346789999999988889999999999999999999 99998532 11122221
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
+. ... ....+...+..+.+++.+||+.||++||++.++++.|+++
T Consensus 233 ~~----~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 233 LE----KGE---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HH----TTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HH----cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 111 1112233456788999999999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.02 Aligned_cols=265 Identities=20% Similarity=0.269 Sum_probs=197.8
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ........+.+|++++++++||||++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~i~~ 66 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---------------DDPVIKKIALREIRMLKQLKHPNLVN 66 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC---------------C-HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc---------------cchHHHHHHHHHHHHHHhCCCCCccc
Confidence 467899999999999999999976 58999999884221 01122356789999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 67 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~ 141 (311)
T 4agu_A 67 LLEVFRRKRRLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVI 141 (311)
T ss_dssp EEEEEEETTEEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred hhheeecCCeEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCE
Confidence 999999999999999999999999988753 45899999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||.+........ ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.... ..+.......
T Consensus 142 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~ 217 (311)
T 4agu_A 142 KLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS--DVDQLYLIRK 217 (311)
T ss_dssp EECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHH
T ss_pred EEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHH
Confidence 9999999987653322 1224468999999999876 568999999999999999999999985432 1111111111
Q ss_pred hccc-----------ccccc--ccccCCC----CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 866 KMDS-----------RDSML--TVVDPNI----SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 866 ~~~~-----------~~~~~--~~~d~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... ..... ...++.. .......+..+.+++.+|++.||++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 218 TLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred HhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 1000 00000 0000000 00112344568899999999999999999999964
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=332.04 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=203.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +++.||||++... ..........+.+|++++++++||||++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 78 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS--------------QLEKEGVEHQLRREIEIQSHLRHPNILR 78 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccc--------------ccchHHHHHHHHHHHHHHhcCCCCCEee
Confidence 367999999999999999999966 6889999998311 1112234567899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 79 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 153 (284)
T 2vgo_A 79 MYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGEL 153 (284)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCE
T ss_pred EEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCE
Confidence 9999999999999999999999999998743 5889999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||... ...+.....
T Consensus 154 kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~~ 224 (284)
T 2vgo_A 154 KIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-----SHTETHRRI 224 (284)
T ss_dssp EECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHH
T ss_pred EEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC-----CHhHHHHHH
Confidence 999999997654322 22456899999999999989999999999999999999999998532 111111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.... .. .+......+.+++.+|++.||.+|||+.|+++
T Consensus 225 ~~~~--------~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 225 VNVD--------LK---FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HTTC--------CC---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccc--------cC---CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1111 11 11223456788999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=358.56 Aligned_cols=263 Identities=23% Similarity=0.256 Sum_probs=194.3
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||+||+|+.. +++.||||++... .........+.+|+.+++.++||||+
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~hpnIv 124 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---------------FQNQTHAKRAYRELVLMKCVNHKNII 124 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG---------------GGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc---------------ccChHHHHHHHHHHHHHHhCCCCCCC
Confidence 3578999999999999999999965 6899999998421 11123346788999999999999999
Q ss_pred eEEEEEecCC------ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 706 KLYCSITSED------SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 706 ~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
++++++.... ..|+||||+++ ++.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||
T Consensus 125 ~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIl 196 (464)
T 3ttj_A 125 SLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIV 196 (464)
T ss_dssp CCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred cEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEE
Confidence 9999997654 45999999965 56666653 3889999999999999999999 889999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 780 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
++.++.+||+|||+|+...... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ...+
T Consensus 197 l~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-~~~~ 272 (464)
T 3ttj_A 197 VKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQW 272 (464)
T ss_dssp ECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH
T ss_pred EeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHH
Confidence 9999999999999998665432 22345799999999999999999999999999999999999999954310 0000
Q ss_pred HHHHHh------------------hccccccc-----ccccc----CCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 002250 860 VNWVYS------------------KMDSRDSM-----LTVVD----PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRV 912 (947)
Q Consensus 860 ~~~~~~------------------~~~~~~~~-----~~~~d----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 912 (947)
...+.. ........ ...+. +...+........+.+++.+|++.||++|||+.|
T Consensus 273 ~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 352 (464)
T 3ttj_A 273 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352 (464)
T ss_dssp HHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHH
Confidence 010000 00000000 00000 0001112223567899999999999999999999
Q ss_pred HHHH
Q 002250 913 VVQM 916 (947)
Q Consensus 913 v~~~ 916 (947)
++++
T Consensus 353 ~L~H 356 (464)
T 3ttj_A 353 ALQH 356 (464)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=358.74 Aligned_cols=260 Identities=25% Similarity=0.329 Sum_probs=206.5
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
..+.++|++.+.||+|+||+||+|+.. +++.||||++.. ..........+.+|++++++++|||
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---------------~~~~~~~~~~~~~E~~~l~~l~hpn 82 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINK---------------ASAKNKDTSTILREVELLKKLDHPN 82 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEH---------------HHHBCSCHHHHHHHHHHHHHCCCTT
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEec---------------ccccchHHHHHHHHHHHHHhCCCCC
Confidence 456789999999999999999999975 789999999831 1122345677899999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec--
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD-- 781 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~-- 781 (947)
|+++++++..+...++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 83 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~ 157 (486)
T 3mwu_A 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESK 157 (486)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSS
T ss_pred cCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecC
Confidence 999999999999999999999999999999764 35899999999999999999999 89999999999999995
Q ss_pred -CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 782 -LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 782 -~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
.++.+||+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||... ...
T Consensus 158 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~ 228 (486)
T 3mwu_A 158 EKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK-----NEY 228 (486)
T ss_dssp STTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHH
T ss_pred CCCCCEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHH
Confidence 556799999999976544322 234579999999999875 5999999999999999999999999532 122
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhcc
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEA 920 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~ 920 (947)
+............ . .+.....+..+.+++.+|++.||++|||+.|++++ +++.
T Consensus 229 ~~~~~i~~~~~~~------~-~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 229 DILKRVETGKYAF------D-LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HHHHHHHHTCCCS------C-SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HHHHHHHhCCCCC------C-CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 2222111111110 0 11112234568899999999999999999999975 4443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=346.48 Aligned_cols=262 Identities=20% Similarity=0.269 Sum_probs=194.2
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +++.||||++..... ......+.+|++++++++||||+++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~~iv~~ 65 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE----------------EGAPCTAIREVSLLKDLKHANIVTL 65 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------------------CCCCCCCHHHHSCCCCTTBCCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc----------------cccchhHHHHHHHHHhcCCCCCCee
Confidence 57889999999999999999976 789999999842211 1112234569999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||++ |+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 66 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~k 140 (324)
T 3mtl_A 66 HDIIHTEKSLTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELK 140 (324)
T ss_dssp EEEEECSSCEEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEE
T ss_pred eeEEeeCCEEEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEE
Confidence 999999999999999996 5999998874 346899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||+++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+...
T Consensus 141 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~ 216 (324)
T 3mtl_A 141 LADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--VEEQLHFIFRI 216 (324)
T ss_dssp ECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHH
T ss_pred EccCcccccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHH
Confidence 999999986543321 1223468999999999876 568999999999999999999999995431 11122222111
Q ss_pred cccc--cccccccc--------------CCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 867 MDSR--DSMLTVVD--------------PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 867 ~~~~--~~~~~~~d--------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.... ..+..... .............+.+++.+|++.||++|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 217 LGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1100 00000000 0001111223456789999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=340.09 Aligned_cols=250 Identities=27% Similarity=0.388 Sum_probs=204.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.+.|+..+.||+|+||.||+|+.. +++.||||++.... .......+.+|+.++++++||||++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~ 84 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----------------AEDEIEDIQQEITVLSQCDSPYVTK 84 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT----------------CSTTHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc----------------cHHHHHHHHHHHHHHHhCCCCCEeE
Confidence 367889999999999999999965 68999999984221 1234577899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..+...++||||+++++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 158 (303)
T 3a7i_A 85 YYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEV 158 (303)
T ss_dssp EEEEEEETTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEEecCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCE
Confidence 99999999999999999999999999975 46899999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||... .........
T Consensus 159 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~ 231 (303)
T 3a7i_A 159 KLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-----HPMKVLFLI 231 (303)
T ss_dssp EECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHH
T ss_pred EEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc-----CHHHHHHHh
Confidence 9999999987654332 122456899999999999989999999999999999999999998532 111111111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... ........+..+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 232 PKNN----------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHSC----------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred hcCC----------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111 011122234568899999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.75 Aligned_cols=261 Identities=25% Similarity=0.333 Sum_probs=204.8
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+.++++++||||++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~i~~ 69 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---------------TEAEKQMLVSEVNLLRELKHPNIVR 69 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC---------------CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC---------------CHHHHHHHHHHHHHHHhcCCCCCCe
Confidence 468899999999999999999975 789999999843211 1123467889999999999999999
Q ss_pred EEEEEe--cCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEeccCCCCC
Q 002250 707 LYCSIT--SEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRP-----VIHRDVKSSN 777 (947)
Q Consensus 707 l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~-----ivH~Dlkp~N 777 (947)
+++++. .+...++||||+++++|.+++... ....+++..++.++.|++.||+||| +.+ |+||||||+|
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~N 146 (279)
T 2w5a_A 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPAN 146 (279)
T ss_dssp EEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGG
T ss_pred EEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhh
Confidence 999874 456789999999999999999764 2345899999999999999999999 666 9999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 778 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
|+++.++.+||+|||.++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..
T Consensus 147 Il~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~ 222 (279)
T 2w5a_A 147 VFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QK 222 (279)
T ss_dssp EEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--HH
T ss_pred EEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--HH
Confidence 9999999999999999976543221 1223468999999999998889999999999999999999999985331 11
Q ss_pred cHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 858 DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
.+...+ ... .....+...+..+.+++.+||+.||++|||+.|+++.+....+-
T Consensus 223 ~~~~~i---~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 223 ELAGKI---REG----------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHHHHH---HHT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHHHHH---hhc----------ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 111111 111 11122223446788999999999999999999999987665543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=343.64 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=195.8
Q ss_pred hhccCCc-ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccccc
Q 002250 628 IDAVKPE-NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNV 704 (947)
Q Consensus 628 ~~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 704 (947)
.+.|++. +.||+|+||+||+|+.. +++.||||++... .......+.+|++++.++ +||||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~~~~h~~i 73 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ-----------------PGHIRSRVFREVEMLYQCQGHRNV 73 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC-----------------SSCCHHHHHHHHHHHHHTCCCTTB
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC-----------------cchhHHHHHHHHHHHHHhcCCCCe
Confidence 4677774 78999999999999954 7999999998421 123456788999999985 79999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++..++..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~ 148 (316)
T 2ac3_A 74 LELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPN 148 (316)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSS
T ss_pred eeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCC
Confidence 99999999999999999999999999999874 35889999999999999999999 88999999999999999877
Q ss_pred C---eEEeccccceecccCCC-----CcceecccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 785 K---PRIADFGLAKIVQTGEA-----GDLTHVIAGTHGYIAPEYAYT-----CKINEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 785 ~---~kl~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
. +||+|||++........ ........||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 149 QVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp SSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 6 99999999976542211 111123458999999999875 5588999999999999999999999965
Q ss_pred CCCCccc---------HHHHHHhhccccccccccccCCCCc-cCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 852 EFGDSKD---------IVNWVYSKMDSRDSMLTVVDPNISE-ILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 852 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....... ........+..... .++. .....+..+.+++.+|++.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 229 RCGSDCGWDRGEACPACQNMLFESIQEGKY-------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCCSCSCC----CCHHHHHHHHHHHHHCCC-------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccccccccccchhHHHHHHHHHhccCc-------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 4321100 00001111110000 0000 001234568899999999999999999999984
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=339.62 Aligned_cols=257 Identities=20% Similarity=0.274 Sum_probs=199.9
Q ss_pred hccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~ 706 (947)
++|++.+.||+|+||+||+|+. .+++.||||++.. .....+.+|+.++++++ ||||++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--------------------~~~~~~~~E~~~l~~l~~~~~i~~ 95 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------------------VKKKKIKREIKILENLRGGPNIIT 95 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--------------------CCHHHHHHHHHHHHHHTTSTTBCC
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--------------------cchHHHHHHHHHHHHcCCCCCEEE
Confidence 6899999999999999999995 4789999999831 23467899999999997 999999
Q ss_pred EEEEEec--CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 707 LYCSITS--EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 707 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++.. ....++||||+++++|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 96 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~ 167 (330)
T 3nsz_A 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEH 167 (330)
T ss_dssp EEEEEECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTT
T ss_pred eeeeeccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCC
Confidence 9999988 5667999999999999999864 788899999999999999999 89999999999999999776
Q ss_pred -CeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 785 -KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 785 -~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+...
T Consensus 168 ~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~ 244 (330)
T 3nsz_A 168 RKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 244 (330)
T ss_dssp TEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred CEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHH
Confidence 899999999987654432 224478999999999877 668999999999999999999999996543222222211
Q ss_pred HHhhcc-------------ccccccccc--------cCCC-CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMD-------------SRDSMLTVV--------DPNI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~-------------~~~~~~~~~--------d~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...... ......... .... ..........+.+++.+|++.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 245 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 110000 000000000 0000 11111235678899999999999999999999873
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=341.15 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=205.4
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHV 702 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 702 (947)
..+.++|++.+.||+|+||.||+|+.. +|+.||||++.+...... ........+.+.+|+.+++++ +||
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~~hp 160 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS---------PEQLEEVREATRRETHILRQVAGHP 160 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCC---------HHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccC---------HHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 455678999999999999999999976 799999999854321100 000112235678999999999 799
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
||+++++++......++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 161 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~ 235 (365)
T 2y7j_A 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDD 235 (365)
T ss_dssp TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence 9999999999999999999999999999999863 45899999999999999999999 889999999999999999
Q ss_pred CCCeEEeccccceecccCCCCcceecccccccccCcccccc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 002250 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT------CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 856 (947)
++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 236 ~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~---- 308 (365)
T 2y7j_A 236 NMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR---- 308 (365)
T ss_dssp TCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS----
T ss_pred CCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC----
Confidence 99999999999987654332 234579999999999863 35888999999999999999999998532
Q ss_pred ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
................. .+.....+..+.+++.+|++.||++|||+.|++++
T Consensus 309 -~~~~~~~~i~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 309 -RQILMLRMIMEGQYQFS-------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -SHHHHHHHHHHTCCCCC-------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CHHHHHHHHHhCCCCCC-------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111111111111000 00001223568899999999999999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.02 Aligned_cols=263 Identities=29% Similarity=0.368 Sum_probs=205.1
Q ss_pred hccCCcccccccCceeEEEEEe-----CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++|||
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~~ 103 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----------------TEEHLRDFEREIEILKSLQHDN 103 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-----------------CSHHHHHHHHHHHHHHTCCCTT
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 5688999999999999999984 36889999998421 1123467899999999999999
Q ss_pred cceEEEEEecCC--ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 704 VVKLYCSITSED--SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 704 iv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
|+++++++...+ ..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 104 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~ 179 (326)
T 2w1i_A 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVE 179 (326)
T ss_dssp BCCEEEEECC----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEE
T ss_pred eeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEc
Confidence 999999987654 679999999999999999874 345899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCCCc-ceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC-------
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEF------- 853 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~------- 853 (947)
.++.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++|..||....
T Consensus 180 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~ 259 (326)
T 2w1i_A 180 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259 (326)
T ss_dssp ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHH
T ss_pred CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhh
Confidence 99999999999998765443211 1122356788999999998889999999999999999999999874220
Q ss_pred CC--c-ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 854 GD--S-KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 854 ~~--~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
.. . ............. ....+.+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 260 GNDKQGQMIVFHLIELLKN---------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp CTTCCTHHHHHHHHHHHHT---------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccchhhhHHHHHHHhhc---------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 0 0000000011100 0111223334567889999999999999999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=334.33 Aligned_cols=254 Identities=26% Similarity=0.332 Sum_probs=202.8
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
..+.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++|||
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~~~~~e~~~l~~l~h~~ 67 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-----------------AFRDSSLENEIAVLKKIKHEN 67 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------------------HHHHHHHHHHHCCCTT
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-----------------ccchHHHHHHHHHHHhCCCCC
Confidence 345688999999999999999999965 79999999984211 122356889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe---
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL--- 780 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll--- 780 (947)
|+++++++..++..++||||+++++|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||++
T Consensus 68 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~ 142 (304)
T 2jam_A 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTP 142 (304)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSS
T ss_pred eeehhhhcccCCEEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecC
Confidence 999999999999999999999999999999764 35889999999999999999999 8899999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+.++.+||+|||++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.... ..
T Consensus 143 ~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~ 213 (304)
T 2jam_A 143 EENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET-----ES 213 (304)
T ss_dssp STTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC-----HH
T ss_pred CCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HH
Confidence 78899999999999754332 1223468999999999999899999999999999999999999985321 11
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
............. ........+..+.+++.+|++.||++|||+.|++++
T Consensus 214 ~~~~~i~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 214 KLFEKIKEGYYEF-------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHHHCCCCC-------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCCCC-------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111111110 011122334568899999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.04 Aligned_cols=263 Identities=25% Similarity=0.367 Sum_probs=198.3
Q ss_pred hccCCcccccccCceeEEEEEeC--CCc--EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN--SGK--ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|++.+.||+|+||+||+|++. +++ .||||++.+... ......+.+.+|+.++++++||||
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i 83 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--------------SQPEAMDDFIREVNAMHSLDHRNL 83 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------------------CHHHHHHHHHHHHHHHCCCTTB
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc--------------CCHHHHHHHHHHHHHHHhCCCCCc
Confidence 67899999999999999999853 333 689998843211 112345678899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++..+. .++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 84 ~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 84 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRD 158 (291)
T ss_dssp CCEEEEECSSS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETT
T ss_pred ccEEEEEccCC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCC
Confidence 99999998765 88999999999999999864 345899999999999999999999 88999999999999999999
Q ss_pred CeEEeccccceecccCCCCc-ceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
.+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||... ...+.
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~ 233 (291)
T 1u46_A 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQI 233 (291)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHH
T ss_pred CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC-----CHHHH
Confidence 99999999998765433211 1223457889999999988889999999999999999999 99998532 11222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
.......... .......+..+.+++.+|++.||++|||+.++++.|+++.+..
T Consensus 234 ~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 234 LHKIDKEGER---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp HHHHHTSCCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHHHccCCC---------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 2221111111 1112234467889999999999999999999999999887643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=372.92 Aligned_cols=250 Identities=22% Similarity=0.270 Sum_probs=196.4
Q ss_pred ccccccCceeEEEEEeC---CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEE
Q 002250 635 NLIGKGGSGNVYKVVLN---SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSI 711 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 711 (947)
+.||+|+||+||+|.+. .++.||||++... .......+.+.+|++++++++|||||++++++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---------------~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 439 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---------------ANDPALKDELLAEANVMQQLDNPYIVRMIGIC 439 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGG---------------GGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccc---------------cCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 47999999999999653 4678999998421 11123356799999999999999999999999
Q ss_pred ecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecc
Q 002250 712 TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791 (947)
Q Consensus 712 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 791 (947)
.. +..++||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 440 ~~-~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DF 513 (635)
T 4fl3_A 440 EA-ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDF 513 (635)
T ss_dssp ES-SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCT
T ss_pred ec-CCEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEc
Confidence 75 5688999999999999999763 45899999999999999999999 889999999999999999999999999
Q ss_pred ccceecccCCC-CcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhccc
Q 002250 792 GLAKIVQTGEA-GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDS 869 (947)
Q Consensus 792 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 869 (947)
|+|+....... ........+|+.|+|||++....++.++|||||||++|||++ |+.||.... ...+...+. .
T Consensus 514 Gla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i~----~ 587 (635)
T 4fl3_A 514 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLE----K 587 (635)
T ss_dssp THHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH----T
T ss_pred CCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH----c
Confidence 99987654332 112223456789999999999999999999999999999999 999985321 112222111 1
Q ss_pred cccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 870 RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 870 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.. ....+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 588 ~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 588 GE---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC---------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 1122334456789999999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=347.02 Aligned_cols=262 Identities=19% Similarity=0.268 Sum_probs=195.6
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+.+|+++++.++||||+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~hpnIv 87 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---------------QSELFAKRAYRELRLLKHMRHENVI 87 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---------------SSHHHHHHHHHHHHHHHHCCBTTBC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---------------cCHHHHHHHHHHHHHHHhCCCcCCC
Confidence 3578999999999999999999965 79999999984211 1112345688999999999999999
Q ss_pred eEEEEEecCC------ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 706 KLYCSITSED------SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 706 ~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
++++++..++ ..|+||||+ +++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 88 ~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIl 160 (367)
T 1cm8_A 88 GLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLA 160 (367)
T ss_dssp CCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred CceeeEecCCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEE
Confidence 9999998764 459999999 8899999986 35889999999999999999999 899999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 780 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...
T Consensus 161 l~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~ 234 (367)
T 1cm8_A 161 VNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQ 234 (367)
T ss_dssp ECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHH
T ss_pred EcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-HHH
Confidence 999999999999999875432 223568999999999887 6799999999999999999999999954311 000
Q ss_pred HHHHHHhhccccc----------------cccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 859 IVNWVYSKMDSRD----------------SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 859 ~~~~~~~~~~~~~----------------~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+............ .+.......+..........+.+++.+|+..||++|||+.|++++
T Consensus 235 l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 1111000000000 000001111222233445678899999999999999999999984
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.63 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=204.4
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|.+.+.||+|+||.||+|... +++.||+|++.... .......+.+.+|+.++++++||||++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~iv~ 79 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--------------LLKPHQREKMSMEISIHRSLAHQHVVG 79 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--------------CCSHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhh--------------ccCHHHHHHHHHHHHHHHhCCCCCEee
Confidence 468999999999999999999976 58899999984211 011123467889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 154 (294)
T 2rku_A 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEV 154 (294)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCE
T ss_pred eeeeeccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCE
Confidence 999999999999999999999999998763 35889999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||.+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...+.....
T Consensus 155 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~ 227 (294)
T 2rku_A 155 KIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-----CLKETYLRI 227 (294)
T ss_dssp EECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHH
T ss_pred EEEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHH
Confidence 9999999987643322 122456899999999999888999999999999999999999998532 112211111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..... ..+......+.+++.+|++.||++|||+.|++++
T Consensus 228 ~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 228 KKNEY-----------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HTTCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhccC-----------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111 1111233567889999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=355.76 Aligned_cols=256 Identities=26% Similarity=0.325 Sum_probs=200.6
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
..+.+.|++.+.||+|+||+||+|+.. +++.||||++.... ........+.+|+.+++.++|||
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~hpn 97 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS---------------VSTSSNSKLLEEVAVLKLLDHPN 97 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------------------CTTHHHHHHHHHHTTCCCTT
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccc---------------cCchHHHHHHHHHHHHHhCCCCC
Confidence 456688999999999999999999976 78999999984321 11233567889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC-
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL- 782 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~- 782 (947)
|+++++++..+...|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~ 172 (494)
T 3lij_A 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESK 172 (494)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCS
T ss_pred CCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCC
Confidence 999999999999999999999999999998764 45889999999999999999999 889999999999999976
Q ss_pred --CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 783 --EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 783 --~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
++.+||+|||+++....... .....||+.|+|||++. +.++.++||||+||++|||++|+.||... ...
T Consensus 173 ~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~ 243 (494)
T 3lij_A 173 EKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ-----TDQ 243 (494)
T ss_dssp STTCCEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHH
T ss_pred CCCCcEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHH
Confidence 45599999999987654432 23457999999999876 56999999999999999999999999532 112
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+............. .+.....+..+.+++.+|++.||.+|||+.|++++
T Consensus 244 ~~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 244 EILRKVEKGKYTFD-------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHHHHTCCCCC-------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHhCCCCCC-------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 22222111111100 11112234568889999999999999999999853
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=332.18 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=196.1
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|++.+.||+|+||+||+|... ++..||+|++... .......+.+.+|+.++++++||||+++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~---------------~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 90 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR---------------KLTKSERQRFKEEAEMLKGLQHPNIVRF 90 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---------------GSCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecch---------------hhCHHHHHHHHHHHHHHHhCCCCCeeee
Confidence 45778889999999999999965 6889999998421 1112234678899999999999999999
Q ss_pred EEEEec----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEeccCCCCCeEec
Q 002250 708 YCSITS----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRP--VIHRDVKSSNILLD 781 (947)
Q Consensus 708 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dlkp~NIll~ 781 (947)
++++.. ....++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+ |+||||||+||+++
T Consensus 91 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~ 165 (290)
T 1t4h_A 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFIT 165 (290)
T ss_dssp EEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEES
T ss_pred eeeeccccCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEE
Confidence 999865 34578999999999999999864 45889999999999999999999 777 99999999999998
Q ss_pred -CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 782 -LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 782 -~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
.++.+||+|||++....... .....||+.|+|||++. +.++.++||||+|+++|||++|+.||... ....
T Consensus 166 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~ 236 (290)
T 1t4h_A 166 GPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC----QNAA 236 (290)
T ss_dssp STTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHH
T ss_pred CCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc----CcHH
Confidence 78999999999997543322 23456899999999876 46899999999999999999999998532 1222
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
............ ..........+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 237 QIYRRVTSGVKP---------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHTTTCCC---------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCCc---------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 221111111110 11111223468899999999999999999999863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=343.29 Aligned_cols=271 Identities=20% Similarity=0.255 Sum_probs=197.5
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
...++|++.+.||+|+||.||+|+.. +|+.||||++...... .........+.+|++++++++||||
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~~~~E~~~l~~l~h~~i 74 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS------------EAKDGINRTALREIKLLQELSHPNI 74 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------------------CTHHHHHHHHHHHCCCTTB
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcc------------hhhhhhhHHHHHHHHHHhhCCCCCC
Confidence 34578999999999999999999965 6899999998432110 0111223568899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++..++..++||||+++ +|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 75 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~ 149 (346)
T 1ua2_A 75 IGLLDAFGHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENG 149 (346)
T ss_dssp CCEEEEECCTTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred CeEEEEEeeCCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCC
Confidence 9999999999999999999975 898888763 345788889999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.... ....+....
T Consensus 150 ~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-~~~~~~~i~ 226 (346)
T 1ua2_A 150 VLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIF 226 (346)
T ss_dssp CEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHH
T ss_pred CEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHH
Confidence 999999999986543322 22245789999999998764 48899999999999999999999885331 111111111
Q ss_pred Hhhccc-cccccccc---c----CCCCc-----cCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 864 YSKMDS-RDSMLTVV---D----PNISE-----ILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 864 ~~~~~~-~~~~~~~~---d----~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...... ...+.... + ...+. ........+.+++.+|++.||++|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 227 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 111110 00000000 0 00111 112334678999999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.54 Aligned_cols=267 Identities=19% Similarity=0.228 Sum_probs=192.6
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
....++|++.+.||+|+||+||+|+.. +++.||||++.... ........+.+|+.++++++|||
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~ 94 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---------------EEEGVPGTAIREVSLLKELQHRN 94 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------------------CHHHHHHGGGCCCTT
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc---------------cccccchhHHHHHHHHHHcCCCC
Confidence 344688999999999999999999955 78999999984221 11123456778999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec--
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD-- 781 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~-- 781 (947)
|+++++++..++..++||||++ |+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 95 iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~ 168 (329)
T 3gbz_A 95 IIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVS 168 (329)
T ss_dssp BCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-
T ss_pred cceEEEEEecCCEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecC
Confidence 9999999999999999999997 59999998743 4889999999999999999999 88999999999999994
Q ss_pred ---CCCCeEEeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 782 ---LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 782 ---~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ..
T Consensus 169 ~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~ 245 (329)
T 3gbz_A 169 DASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-ID 245 (329)
T ss_dssp ----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HH
T ss_pred CCCccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-HH
Confidence 445699999999986543321 122446899999999998754 89999999999999999999999854311 11
Q ss_pred cHHHHHHhhccccc-ccccc-----ccCCCCc---------cCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 858 DIVNWVYSKMDSRD-SMLTV-----VDPNISE---------ILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 858 ~~~~~~~~~~~~~~-~~~~~-----~d~~~~~---------~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.+............ .+... .....+. ........+.+++.+|++.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 246 QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 11111111100000 00000 0000000 01113356789999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=359.41 Aligned_cols=255 Identities=27% Similarity=0.351 Sum_probs=205.5
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
.+.++|++.+.||+|+||+||+|+.. +++.||||++..... ........+.+|+.++++++||||
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------------~~~~~~~~~~~E~~~l~~l~hpni 88 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV--------------KQKTDKESLLREVQLLKQLDHPNI 88 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------------CBSSCHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhc--------------ccchHHHHHHHHHHHHHhCCCCCC
Confidence 45678999999999999999999976 799999999843211 112445778999999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe---c
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL---D 781 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll---~ 781 (947)
+++++++...+..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||++ +
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~ 163 (484)
T 3nyv_A 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKS 163 (484)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSS
T ss_pred CcEEEEEEeCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCC
Confidence 99999999999999999999999999999864 45899999999999999999999 8899999999999999 5
Q ss_pred CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
.++.+||+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||... ...+
T Consensus 164 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~ 234 (484)
T 3nyv_A 164 KDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA-----NEYD 234 (484)
T ss_dssp TTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHH
T ss_pred CCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC-----CHHH
Confidence 678999999999986654332 234579999999998865 6999999999999999999999999532 1222
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
............ . .+.....+..+.+++.+|++.||.+|||+.|+++
T Consensus 235 ~~~~i~~~~~~~------~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 235 ILKKVEKGKYTF------E-LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHHCCCCC------C-SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCCC------C-CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 222111111110 0 1111233456889999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=330.14 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=195.9
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|... +|+.||||++... ..........+.+|+.++++++||||++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 75 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ--------------KIRSLDVVGKIKREIQNLKLFRHPHIIK 75 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccc--------------cccchhHHHHHHHHHHHHhcCCCCCEeE
Confidence 367899999999999999999976 7999999998311 1112234567899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 150 (276)
T 2h6d_A 76 LYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNA 150 (276)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCE
T ss_pred EEEEEecCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCE
Confidence 999999999999999999999999999864 35889999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||++........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||... ........
T Consensus 151 ~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~ 222 (276)
T 2h6d_A 151 KIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE-----HVPTLFKK 222 (276)
T ss_dssp EECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred EEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHH
Confidence 9999999976544322 223468999999999987765 58999999999999999999998532 12221111
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...... ..+......+.+++.+|++.||++|||+.|++++
T Consensus 223 ~~~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 223 IRGGVF-----------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHCCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhcCcc-----------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111110 1112234567889999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=350.24 Aligned_cols=201 Identities=22% Similarity=0.300 Sum_probs=173.9
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc----
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV---- 699 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---- 699 (947)
+.+..+|++.+.||+|+||+||+|... +++.||||++... ......+.+|+++++.+
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------------------~~~~~~~~~E~~~l~~l~~~~ 154 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------------------KRFHRQAAEEIRILEHLRKQD 154 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------------------HHHHHHHHHHHHHHHHHHTTC
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------------------cchHHHHHHHHHHHHHHhhcc
Confidence 445678999999999999999999865 6899999998311 12235677888888887
Q ss_pred --cccccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 700 --RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 700 --~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
+|+||+++++++......++||||++ ++|.+++.......+++..+..++.||+.||+||| +.+|+||||||+|
T Consensus 155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~N 230 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPEN 230 (429)
T ss_dssp TTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGG
T ss_pred ccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHH
Confidence 56799999999999999999999995 69999998866667999999999999999999999 7899999999999
Q ss_pred eEecCCCC--eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 002250 778 ILLDLEWK--PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 778 Ill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
||++.++. +||+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 231 ILl~~~~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 231 ILLKQQGRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEccCCCcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99999887 9999999997654322 2347899999999999999999999999999999999999998543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=340.84 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=204.3
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... .......+.+.+|+.++++++||||++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~iv~ 105 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--------------LLKPHQREKMSMEISIHRSLAHQHVVG 105 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--------------CCSHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhh--------------hcCHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 468999999999999999999976 58899999983211 011123467889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 180 (335)
T 2owb_A 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEV 180 (335)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCE
T ss_pred EEEEEecCCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCE
Confidence 999999999999999999999999998763 45899999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...+.....
T Consensus 181 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~~ 253 (335)
T 2owb_A 181 KIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-----CLKETYLRI 253 (335)
T ss_dssp EECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHH
T ss_pred EEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC-----CHHHHHHHH
Confidence 9999999987643322 123456899999999999888999999999999999999999998532 112211111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...... .+......+.+++.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 254 KKNEYS-----------IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHTCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hcCCCC-----------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111 111223467889999999999999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=355.35 Aligned_cols=198 Identities=26% Similarity=0.350 Sum_probs=154.3
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+.+|++++++++||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---------------~~~~~~~~~~~E~~~l~~l~h~niv 115 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---------------EDLIDCKRILREIAILNRLNHDHVV 115 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT---------------SSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh---------------cCHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3478999999999999999999965 78999999984211 1112346788999999999999999
Q ss_pred eEEEEEecC-----CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 706 KLYCSITSE-----DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 706 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
++++++... ...|+||||+ +++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||+
T Consensus 116 ~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl 189 (458)
T 3rp9_A 116 KVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLV 189 (458)
T ss_dssp CEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEE
T ss_pred ceEEEEecCCcccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEE
Confidence 999999543 5679999998 57999998763 45899999999999999999999 8899999999999999
Q ss_pred cCCCCeEEeccccceecccCCCC-------------------------cceecccccccccCcccc-ccCCCCCccchHH
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAG-------------------------DLTHVIAGTHGYIAPEYA-YTCKINEKSDVYS 834 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s 834 (947)
+.++.+||+|||+|+........ ......+||+.|+|||++ ....++.++||||
T Consensus 190 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwS 269 (458)
T 3rp9_A 190 NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWS 269 (458)
T ss_dssp CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHH
T ss_pred CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHH
Confidence 99999999999999876432211 112345789999999986 4566999999999
Q ss_pred HHHHHHHHHhC
Q 002250 835 FGVVLMELVTG 845 (947)
Q Consensus 835 lGv~l~elltg 845 (947)
|||++|||++|
T Consensus 270 lG~il~elltg 280 (458)
T 3rp9_A 270 IGCIFAELLNM 280 (458)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHHh
Confidence 99999999994
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=348.09 Aligned_cols=260 Identities=20% Similarity=0.265 Sum_probs=194.2
Q ss_pred HhhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
..++|++.+.||+|+||+||+|+. .+|+.||||++... .....+|+++++.++||||+
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---------------------~~~~~~E~~il~~l~hpnIv 63 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD---------------------PRYKNRELDIMKVLDHVNII 63 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC---------------------TTSCCHHHHHHTTCCCTTBC
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC---------------------cchHHHHHHHHHHcCCCCcc
Confidence 346899999999999999999996 47999999998421 12234799999999999999
Q ss_pred eEEEEEecC--------------------------------------CccEEEEeccCCCChHHHhhhc--CCccCCHHH
Q 002250 706 KLYCSITSE--------------------------------------DSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVV 745 (947)
Q Consensus 706 ~l~~~~~~~--------------------------------------~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~ 745 (947)
++++++... ...++||||++ |+|.+.+... ....+++..
T Consensus 64 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~ 142 (383)
T 3eb0_A 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNL 142 (383)
T ss_dssp CEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHH
T ss_pred chhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHH
Confidence 999998543 33789999997 5888877642 345789999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec-CCCCeEEeccccceecccCCCCcceecccccccccCccccccC
Q 002250 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD-LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC 824 (947)
Q Consensus 746 ~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 824 (947)
+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||+|+....... .....||+.|+|||++.+.
T Consensus 143 ~~~i~~qi~~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~ 216 (383)
T 3eb0_A 143 ISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGA 216 (383)
T ss_dssp HHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCC
Confidence 9999999999999999 89999999999999998 688999999999987654432 2234689999999998775
Q ss_pred C-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcccc--------ccccccccCCC------CccCHHHH
Q 002250 825 K-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSR--------DSMLTVVDPNI------SEILKEDA 889 (947)
Q Consensus 825 ~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~d~~~------~~~~~~~~ 889 (947)
. ++.++||||+||++|||++|+.||.... ....+...+....... .......-+.. ..++...+
T Consensus 217 ~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (383)
T 3eb0_A 217 TEYTPSIDLWSIGCVFGELILGKPLFSGET-SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295 (383)
T ss_dssp SSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCC
T ss_pred CCCCcchhhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCC
Confidence 4 8999999999999999999999995431 1111111111100000 00000000000 11222345
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 890 LKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 890 ~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
..+.+++.+|++.||++|||+.|+++
T Consensus 296 ~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 296 SLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 56889999999999999999999984
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=338.08 Aligned_cols=273 Identities=23% Similarity=0.289 Sum_probs=207.5
Q ss_pred hhccCCcccccccCceeEEEEEe--CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc---ccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL--NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV---RHV 702 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~ 702 (947)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .......+.+|+.+++.+ +||
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~h~ 74 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---------------EEGMPLSTIREVAVLRHLETFEHP 74 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC---------------TTSCBCTHHHHHHHHHHHHHTCCT
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc---------------cccCCchhhHHHHHHHhhhccCCC
Confidence 46899999999999999999997 3688999999842211 112234567888888777 799
Q ss_pred ccceEEEEEe-----cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 703 NVVKLYCSIT-----SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 703 niv~l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
||+++++++. .....++||||++ |+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|
T Consensus 75 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~N 150 (326)
T 1blx_A 75 NVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQN 150 (326)
T ss_dssp TBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGG
T ss_pred CeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHH
Confidence 9999999987 5567799999997 69999998766666899999999999999999999 8899999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 778 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
|+++.++.+||+|||.++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..
T Consensus 151 ili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~ 225 (326)
T 1blx_A 151 ILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DV 225 (326)
T ss_dssp EEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HH
T ss_pred eEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--HH
Confidence 999999999999999997654322 1224568999999999999899999999999999999999999985431 11
Q ss_pred cHHHHHHhhccc--cccc-----------cccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhccCC
Q 002250 858 DIVNWVYSKMDS--RDSM-----------LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEAEP 922 (947)
Q Consensus 858 ~~~~~~~~~~~~--~~~~-----------~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~~~ 922 (947)
+....+...... ...+ .......+.......+..+.+++.+|++.||++|||+.|++++ +++...
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 226 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 111111111000 0000 0000011122233445678899999999999999999999953 666665
Q ss_pred CC
Q 002250 923 CS 924 (947)
Q Consensus 923 ~~ 924 (947)
+.
T Consensus 306 ~~ 307 (326)
T 1blx_A 306 CK 307 (326)
T ss_dssp CC
T ss_pred hh
Confidence 54
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=351.95 Aligned_cols=260 Identities=20% Similarity=0.257 Sum_probs=204.7
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc-cccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH-VNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv 705 (947)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+|+++++.++| +++.
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------------------~~~~~~~~E~~il~~L~~~~~i~ 66 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------------------TKHPQLLYESKIYRILQGGTGIP 66 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETT-------------------CSSCCHHHHHHHHHHTTTSTTCC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------------------cccHHHHHHHHHHHHhcCCCCCC
Confidence 47899999999999999999996 47999999987311 223458899999999987 5566
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe---cC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL---DL 782 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll---~~ 782 (947)
.+..++...+..++||||+ +++|.+++... ...+++..++.++.||+.||+||| +.+|+||||||+|||+ +.
T Consensus 67 ~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~ 141 (483)
T 3sv0_A 67 NVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRR 141 (483)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGG
T ss_pred eEEEEEeeCCEEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCC
Confidence 6666777788889999999 99999999863 346899999999999999999999 8899999999999999 58
Q ss_pred CCCeEEeccccceecccCCCCc-----ceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc-
Q 002250 783 EWKPRIADFGLAKIVQTGEAGD-----LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS- 856 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~- 856 (947)
++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~ 221 (483)
T 3sv0_A 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (483)
T ss_dssp TTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH
T ss_pred CCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH
Confidence 8999999999998766543321 1224579999999999999999999999999999999999999996532211
Q ss_pred ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
........... ....+.......+.++.+++..||+.+|++||++.++++.|+++
T Consensus 222 ~~~~~~i~~~~---------~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 222 KQKYEKISEKK---------VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHHHHHHHH---------HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHhhcc---------ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111111000 00111111122345789999999999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=338.71 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=199.5
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
..+.++|++.+.||+|+||.||+|+.. +++.||||++........ ..........+.+|++++++++|||
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~h~~ 76 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIG---------SAREADPALNVETEIEILKKLNHPC 76 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC------------------------CHHHHHHHHHHCCCTT
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhc---------ccccchhhhhHHHHHHHHHhCCCCC
Confidence 556789999999999999999999965 689999999853321100 0111123456889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++..+. .++||||+++++|.+++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 77 i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~ 150 (322)
T 2ycf_A 77 IIKIKNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQ 150 (322)
T ss_dssp BCCEEEEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSS
T ss_pred CceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecC
Confidence 999999997665 89999999999999999763 46899999999999999999999 8999999999999999876
Q ss_pred CC---eEEeccccceecccCCCCcceecccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 784 WK---PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY---TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 784 ~~---~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
+. +||+|||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~ 226 (322)
T 2ycf_A 151 EEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-QV 226 (322)
T ss_dssp SSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC-SS
T ss_pred CCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-HH
Confidence 54 9999999998764322 122446899999999974 45688999999999999999999999964322 12
Q ss_pred cHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 858 DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.+....... ... ..++.....+..+.+++.+|++.||++|||+.|+++
T Consensus 227 ~~~~~~~~~---~~~-------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 227 SLKDQITSG---KYN-------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CHHHHHHHT---CCC-------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhC---ccc-------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 222222111 000 011111223456889999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=365.99 Aligned_cols=251 Identities=25% Similarity=0.283 Sum_probs=204.3
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 705 (947)
.++|++.+.||+|+||.||+|+.. +++.||||++... ........+.+..|..++..+ +||+|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~--------------~~~~~~~~~~~~~E~~~l~~~~~~~~i~ 405 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD--------------VVIQDDDVECTMVEKRVLALPGKPPFLT 405 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHH--------------HHHHTTTTHHHHHHHHHHTCTTCCTTBC
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecc--------------ccccHHHHHHHHHHHHHHHhccCCCeEE
Confidence 467899999999999999999966 6889999998311 111234456788899999988 799999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++.+.+..|+||||+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 406 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ 480 (674)
T 3pfq_A 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGH 480 (674)
T ss_dssp CEEEECBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSC
T ss_pred EEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCc
Confidence 99999999999999999999999999998743 5899999999999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+||+|||+|+....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+....
T Consensus 481 ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-----~~~~~~~~ 553 (674)
T 3pfq_A 481 IKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-----DEDELFQS 553 (674)
T ss_dssp EEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred EEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC-----CHHHHHHH
Confidence 99999999986433222 233567999999999999999999999999999999999999999532 22222222
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM-----RVVVQ 915 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~ 915 (947)
...... .++......+.+++.+|++.||++||++ .||.+
T Consensus 554 i~~~~~-----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 554 IMEHNV-----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHSSCC-----------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHhCCC-----------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 222211 1222344568889999999999999997 66653
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=354.37 Aligned_cols=325 Identities=18% Similarity=0.185 Sum_probs=237.2
Q ss_pred CEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCcc
Q 002250 185 QNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQ 264 (947)
Q Consensus 185 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~ 264 (947)
+.++.++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~----------------------- 67 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI----------------------- 67 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSC-----------------------
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCc-----------------------
Confidence 34555555554 3343332 345555555555554444444444444444444333
Q ss_pred CcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCcc
Q 002250 265 FSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPET 344 (947)
Q Consensus 265 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~ 344 (947)
+++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|.++ +..|..
T Consensus 68 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~------------------------~~~~~~ 123 (477)
T 2id5_A 68 VSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV------------------------ILLDYM 123 (477)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCC------------------------EECTTT
T ss_pred cCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccc------------------------cCChhH
Confidence 33333444444444444444444444333333444444444444444443 334455
Q ss_pred ccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcce
Q 002250 345 YANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLV 424 (947)
Q Consensus 345 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 424 (947)
|..+++|+.|++++|.+++..+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|.+.+..+..|..+++|+
T Consensus 124 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~ 203 (477)
T 2id5_A 124 FQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203 (477)
T ss_dssp TTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCC
T ss_pred ccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccc
Confidence 66677777888888888777777888888899999999998887777888999999999999999988888999999999
Q ss_pred EEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCc
Q 002250 425 SIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNK 504 (947)
Q Consensus 425 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 504 (947)
.|++++|.+.+.+|..+....+|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|+
T Consensus 204 ~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 283 (477)
T 2id5_A 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQ 283 (477)
T ss_dssp EEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSC
T ss_pred eeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCc
Confidence 99999999888888887778899999999999997666789999999999999999998888999999999999999999
Q ss_pred cCCccCCccc-ccccceeeCCCCcCCCCCCCccc--ccccccccccCCCCCCCCcccc
Q 002250 505 FSGEIPISLT-YPKLSLLDLSNNQLAGPIPEPLN--IKAFIDSFTGNPGLCSKTDEYF 559 (947)
Q Consensus 505 l~~~~p~~~~-~~~L~~L~ls~N~l~~~~p~~~~--~~~~~~~~~gN~~~c~~~~~~~ 559 (947)
+++..|..+. +++|+.|+|++|+|++.++..+. .......+.+|||.|+|...|+
T Consensus 284 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~ 341 (477)
T 2id5_A 284 LAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWV 341 (477)
T ss_dssp CSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHH
T ss_pred cceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhH
Confidence 9999887775 69999999999999987776553 2334557899999999998775
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.29 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=198.7
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
...+.|++.+.||+|+||.||+|... +|+.||||++.. ......+.+|+.++++++||||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-------------------~~~~~~~~~e~~~l~~l~h~~i 86 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-------------------ESDLQEIIKEISIMQQCDSPHV 86 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEET-------------------TSCCHHHHHHHHHHHTCCCTTB
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCc-------------------hHHHHHHHHHHHHHHhCCCCCC
Confidence 34577999999999999999999976 689999999832 1234678899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++++..++..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~ 162 (314)
T 3com_A 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEG 162 (314)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred ccEEEEEEeCCEEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCC
Confidence 99999999999999999999999999999742 346899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 864 (947)
.+||+|||.+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ......
T Consensus 163 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~ 235 (314)
T 3com_A 163 HAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-----PMRAIF 235 (314)
T ss_dssp CEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHH
T ss_pred CEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----hHHHHH
Confidence 999999999987654322 1224468999999999999899999999999999999999999985321 111111
Q ss_pred hhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 865 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
....... +.. ..+...+..+.+++.+|++.||.+|||+.++++
T Consensus 236 ~~~~~~~-------~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 236 MIPTNPP-------PTF-RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHSCC-------CCC-SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHhcCCC-------ccc-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111110 000 111223456889999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=340.01 Aligned_cols=267 Identities=19% Similarity=0.240 Sum_probs=200.1
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ........+.+|++++++++||||++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv~ 80 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---------------EKEGFPITALREIKILQLLKHENVVN 80 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSS---------------CSSSSCHHHHHHHHHHHHCCCTTBCC
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccc---------------ccccchHHHHHHHHHHHhccCCCccc
Confidence 478999999999999999999974 79999999984321 11233456789999999999999999
Q ss_pred EEEEEecC--------CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 707 LYCSITSE--------DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 707 l~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++++... +..++||||+++ ++.+.+... ...+++..+..++.|++.||+||| +.+|+||||||+||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NI 155 (351)
T 3mi9_A 81 LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANV 155 (351)
T ss_dssp EEEEEEEC--------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred HhheeeccccccccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHE
Confidence 99999874 457899999974 777777653 345899999999999999999999 88999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCC--cceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAG--DLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
+++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 156 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-- 233 (351)
T 3mi9_A 156 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-- 233 (351)
T ss_dssp EECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred EEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC--
Confidence 9999999999999999876533221 12234568999999999876 457999999999999999999999985431
Q ss_pred cccHHHHHHhhcc-ccccccccc------------cCCCCccCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 856 SKDIVNWVYSKMD-SRDSMLTVV------------DPNISEILKE-----DALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 856 ~~~~~~~~~~~~~-~~~~~~~~~------------d~~~~~~~~~-----~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.......+..... ......... .......... ....+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 234 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1111111111110 000000000 0000001111 13458899999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=346.65 Aligned_cols=261 Identities=24% Similarity=0.358 Sum_probs=200.4
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|... +++.||+|++.... .......+.+|+.++++++||||++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~ 95 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----------------KPAIRNQIIRELQVLHECNSPYIVG 95 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC----------------CHHHHHHHHHHHGGGGGCCCTTBCC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc----------------CHHHHHHHHHHHHHHHHCCCCCEEE
Confidence 367899999999999999999976 78999999984221 1123467889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEeccCCCCCeEecCCCC
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDR-PVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~Dlkp~NIll~~~~~ 785 (947)
+++++..++..++||||+++++|.+++.... .+++..+..++.|++.||+||| +. +|+||||||+||+++.++.
T Consensus 96 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~ 170 (360)
T 3eqc_A 96 FYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGE 170 (360)
T ss_dssp EEEEEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCC
T ss_pred EeEEEEECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCC
Confidence 9999999999999999999999999998743 5889999999999999999999 64 8999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+||+|||++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .........
T Consensus 171 ~kl~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~ 244 (360)
T 3eqc_A 171 IKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA--KELELMFGC 244 (360)
T ss_dssp EEECCCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH--HHHHHHHC-
T ss_pred EEEEECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcc
Confidence 9999999997553322 2234789999999999999999999999999999999999999954311 111000000
Q ss_pred hccc-------------------------cccc----cccccCCCCcc-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 866 KMDS-------------------------RDSM----LTVVDPNISEI-LKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 866 ~~~~-------------------------~~~~----~~~~d~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.... .... ..+........ .......+.+++.+|++.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 245 QVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000 0000 00000000011 1113456889999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=331.83 Aligned_cols=252 Identities=25% Similarity=0.311 Sum_probs=196.9
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|.....||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~iv~~ 84 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-----------------DSRYSQPLHEEIALHKHLKHKNIVQY 84 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-----------------CC---HHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-----------------chHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 34555668999999999999964 6889999998422 11334678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhc-CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC-CCC
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTC-HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL-EWK 785 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~-~~~ 785 (947)
++++...+..++||||+++++|.+++... .....++..+..++.|++.||+||| +.+|+||||||+||+++. ++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 161 (295)
T 2clq_A 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGV 161 (295)
T ss_dssp EEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCC
T ss_pred eeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCC
Confidence 99999999999999999999999999864 2345678899999999999999999 889999999999999987 899
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK--INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
+||+|||.+........ ......||+.|+|||++.... ++.++||||||+++|||++|+.||........ ...
T Consensus 162 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~ 236 (295)
T 2clq_A 162 LKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMF 236 (295)
T ss_dssp EEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHH
T ss_pred EEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHH
Confidence 99999999987643321 122446899999999997654 78899999999999999999999853211111 111
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
..... ...+..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 237 KVGMF----------KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHH----------CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred hhccc----------cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 10000 0011122334456888999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=336.08 Aligned_cols=253 Identities=24% Similarity=0.297 Sum_probs=186.3
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ........+.++...++.++||||++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~~~~~~~~~~h~~iv~ 70 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---------------NSQEQKRLLMDLDISMRTVDCPFTVT 70 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------------------CHHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc---------------CcHHHHHHHHHHHHHHHhCCCCeEEE
Confidence 368899999999999999999964 78999999984211 01112233455556688889999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEeccCCCCCeEecCC
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDR-PVIHRDVKSSNILLDLE 783 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~Dlkp~NIll~~~ 783 (947)
+++++..++..++||||++ |+|.+++... ....+++..+..++.|++.||+||| +. +|+||||||+||+++.+
T Consensus 71 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~ 146 (290)
T 3fme_A 71 FYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINAL 146 (290)
T ss_dssp EEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTT
T ss_pred EeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCC
Confidence 9999999999999999996 5888887642 3457899999999999999999999 76 99999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCcccc----ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYA----YTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
+.+||+|||+++....... .....||+.|+|||++ ....++.++||||+|+++|||++|+.||.........+
T Consensus 147 ~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 223 (290)
T 3fme_A 147 GQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223 (290)
T ss_dssp CCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH
T ss_pred CCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH
Confidence 9999999999986644322 2234689999999996 55668899999999999999999999985321111111
Q ss_pred HHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
......... .......+..+.+++.+|++.||++|||+.|+++
T Consensus 224 ----~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 224 ----KQVVEEPSP---------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----HHHHHSCCC---------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----HHHhccCCC---------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111110 0011123456889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.06 Aligned_cols=263 Identities=28% Similarity=0.395 Sum_probs=185.7
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~ 77 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK----------------CQTSMDELLKEIQAMSQCHHPNIVS 77 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------------------CCCCCCCTTBCC
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh----------------cchhHHHHHHHHHHHhhcCCCCEee
Confidence 367899999999999999999954 78999999873211 1123456788999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhc------CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTC------HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
+++++..++..++||||+++++|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 78 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~ 154 (303)
T 2vwi_A 78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILL 154 (303)
T ss_dssp EEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEE
T ss_pred EEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEE
Confidence 999999999999999999999999998742 2345899999999999999999999 8899999999999999
Q ss_pred cCCCCeEEeccccceecccCCC---CcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 002250 781 DLEWKPRIADFGLAKIVQTGEA---GDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 856 (947)
+.++.+||+|||.+........ ........||+.|+|||++.. ..++.++||||||+++|||++|+.||.....
T Consensus 155 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-- 232 (303)
T 2vwi_A 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-- 232 (303)
T ss_dssp CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG--
T ss_pred cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch--
Confidence 9999999999999976543321 111224468999999999876 5689999999999999999999999854321
Q ss_pred ccHHHHHHhhcccccccc-ccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 857 KDIVNWVYSKMDSRDSML-TVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~-~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
........ ........ ...+ .+.....+..+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 233 MKVLMLTL--QNDPPSLETGVQD---KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp GGHHHHHH--TSSCCCTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhHHHHHh--ccCCCcccccccc---chhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11111111 11111000 0111 11122234568889999999999999999999873
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=338.58 Aligned_cols=347 Identities=21% Similarity=0.209 Sum_probs=213.4
Q ss_pred ccccccCCCCCcc----cceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccE
Q 002250 14 VFSSWTEANSVCK----FNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQV 89 (947)
Q Consensus 14 ~~~sw~~~~~~C~----w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~ 89 (947)
.+++|..+.+||. |.++.|+. ++ +-........ ..-..+++++.|++++|.+....+..+..+++|++
T Consensus 2 ~~~~~~~~~~C~~~~~~~~c~~~~~--~i---~~~~~~~~~~---~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~ 73 (390)
T 3o6n_A 2 NVKPRQPEYKCIDSNLQYDCVFYDV--HI---DMQTQDVYFG---FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 73 (390)
T ss_dssp -----CCEECBCC------EEEESC--EE---CSSCCCCEES---CSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSE
T ss_pred CcCCCCCccceehhhhhhccceeee--ee---eccccccccc---ccccccCCceEEEecCCchhhCChhHhcccccCcE
Confidence 3789999999986 55555542 11 1111111111 11235688999999999997777777899999999
Q ss_pred EeCcCccCcCCCC-CcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCc
Q 002250 90 LDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNC 168 (947)
Q Consensus 90 L~Ls~n~i~~~~~-~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n 168 (947)
|+|++|.+++.++ .+..+++|++|+|++|.+++..+ ..+.++++|++|+|++|.++..+ +..+..+++|++|++++|
T Consensus 74 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~l~-~~~~~~l~~L~~L~L~~n 151 (390)
T 3o6n_A 74 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP-HVFQNVPLLTVLVLERNDLSSLP-RGIFHNTPKLTTLSMSNN 151 (390)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCC-TTTTTTCTTCCEEECCSS
T ss_pred EECCCCcccccChhhccCCCCcCEEECCCCCCCcCCH-HHhcCCCCCCEEECCCCccCcCC-HHHhcCCCCCcEEECCCC
Confidence 9999999988766 58888888888888888876544 66778888888888888776432 222456677777777777
Q ss_pred cccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCcc
Q 002250 169 SVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSE 248 (947)
Q Consensus 169 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 248 (947)
.+++..|..+..+++|++|+|++|++++. .+..+++|++|++++|.+++. ...++|++|++++|.++..+..
T Consensus 152 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~~~~ 223 (390)
T 3o6n_A 152 NLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGP 223 (390)
T ss_dssp CCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEEECC
T ss_pred ccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeecccc
Confidence 77766666677777777777777766543 244556666666666666532 2233455555555555433221
Q ss_pred ccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccc
Q 002250 249 LRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMT 328 (947)
Q Consensus 249 l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~ 328 (947)
.. ++|++|++++|++++. ..++.+++|++|++++|.+++
T Consensus 224 --~~------------------------~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~------------- 262 (390)
T 3o6n_A 224 --VN------------------------VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEK------------- 262 (390)
T ss_dssp --CC------------------------SSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCE-------------
T ss_pred --cc------------------------ccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCC-------------
Confidence 12 3455555555555421 344445555555555554442
Q ss_pred eeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCcc
Q 002250 329 DLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNR 408 (947)
Q Consensus 329 ~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 408 (947)
..|..|..+++|+.|++++|++++ +|..+..+++|+.|+|++|++++ +|..+..+++|++|++++|+
T Consensus 263 -----------~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~ 329 (390)
T 3o6n_A 263 -----------IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNS 329 (390)
T ss_dssp -----------EESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSC
T ss_pred -----------cChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCc
Confidence 123334445555555555555553 34445566777777777777764 44456667777777777777
Q ss_pred ccccCCCCCCCCCcceEEEcccCcccC
Q 002250 409 FSGELPSKISEASSLVSIQLSLNQFSG 435 (947)
Q Consensus 409 l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 435 (947)
++. +| +..+++|+.|++++|++..
T Consensus 330 i~~-~~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 330 IVT-LK--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp CCC-CC--CCTTCCCSEEECCSSCEEH
T ss_pred cce-eC--chhhccCCEEEcCCCCccc
Confidence 763 33 5667788888888888774
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=349.91 Aligned_cols=244 Identities=12% Similarity=0.103 Sum_probs=189.5
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHH---HHhhccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA---TLSAVRHVN 703 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~n 703 (947)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... ......+.+.+|+. ++++++|||
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--------------~~~~~~~~~~~E~~~l~~l~~l~hpn 137 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--------------PPSNAIKQMKEEVLRLRLLRGIKNQK 137 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC---------------CCTTHHHHHHHHHHGGGGSTTCCSHH
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc--------------cchHHHHHHHHHHHHHHhccccCCHH
Confidence 36788899999999999999995 5799999999842211 11234467889994 555568999
Q ss_pred cceEE-------EEEecCCc-----------------cEEEEeccCCCChHHHhhhcCC-----ccCCHHHHHHHHHHHH
Q 002250 704 VVKLY-------CSITSEDS-----------------NLLVYEYLPNGSLWDRLHTCHK-----IEMDWVVRYAIAVGAA 754 (947)
Q Consensus 704 iv~l~-------~~~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~ia 754 (947)
||+++ +++..++. .|+||||+ +|+|.+++..... ..+++..+..++.||+
T Consensus 138 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~ 216 (377)
T 3byv_A 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVI 216 (377)
T ss_dssp HHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHH
T ss_pred HHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHH
Confidence 99998 66666543 78999999 6899999986422 2344688889999999
Q ss_pred HHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccC----------
Q 002250 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC---------- 824 (947)
Q Consensus 755 ~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------- 824 (947)
.||+||| +.+|+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+.
T Consensus 217 ~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~ 287 (377)
T 3byv_A 217 RLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRR 287 (377)
T ss_dssp HHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCE
T ss_pred HHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhccccccccccccc
Confidence 9999999 88999999999999999999999999999985322 2334567 999999999887
Q ss_pred -CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCC
Q 002250 825 -KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKL 903 (947)
Q Consensus 825 -~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~d 903 (947)
.++.++|||||||++|||++|+.||...... .....+. .... ..+..+.+++.+||+.|
T Consensus 288 ~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~---------------~~~~~~~-~~~~----~~~~~~~~li~~~L~~d 347 (377)
T 3byv_A 288 TLMTFSFDAWALGLVIYWIWCADLPITKDAAL---------------GGSEWIF-RSCK----NIPQPVRALLEGFLRYP 347 (377)
T ss_dssp EECCHHHHHHHHHHHHHHHHHSSCCC---------------------CCSGGGG-SSCC----CCCHHHHHHHHHHTCSS
T ss_pred ccCChhhhHHHHHHHHHHHHHCCCCCcccccc---------------cchhhhh-hhcc----CCCHHHHHHHHHHcCCC
Confidence 7999999999999999999999998432110 0000111 1111 22356888999999999
Q ss_pred CCCCCCHHHHHH
Q 002250 904 PAFRPSMRVVVQ 915 (947)
Q Consensus 904 P~~RPt~~ev~~ 915 (947)
|++|||+.|+++
T Consensus 348 p~~Rpt~~e~l~ 359 (377)
T 3byv_A 348 KEDRLLPLQAME 359 (377)
T ss_dssp GGGCCCHHHHHT
T ss_pred chhCCCHHHHhh
Confidence 999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.75 Aligned_cols=266 Identities=22% Similarity=0.293 Sum_probs=198.4
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ........+.+|+.++++++||||++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv~ 88 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---------------DDKMVKKIAMREIKLLKQLRHENLVN 88 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS---------------SCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC---------------CchHHHHHHHHHHHHHhhCCCCCEee
Confidence 478999999999999999999976 58999999984221 01122355789999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||||+++++|.++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~ 163 (331)
T 4aaa_A 89 LLEVCKKKKRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVV 163 (331)
T ss_dssp EEEEEEETTEEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred EEEEeecCCEEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcE
Confidence 999999999999999999999998887653 35899999999999999999999 8899999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||+++....... ......||+.|+|||++.+. .++.++||||+|+++|||++|+.||..... ..........
T Consensus 164 kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~ 240 (331)
T 4aaa_A 164 KLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD-IDQLYHIMMC 240 (331)
T ss_dssp EECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHH
T ss_pred EEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHH
Confidence 9999999976543322 12234689999999999775 688999999999999999999999854321 1111111100
Q ss_pred hc----------cccccccccccCCC------CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 866 KM----------DSRDSMLTVVDPNI------SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 866 ~~----------~~~~~~~~~~d~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. ...........+.. .......+..+.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00000000001111 11122345678999999999999999999998863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=343.91 Aligned_cols=277 Identities=19% Similarity=0.217 Sum_probs=206.4
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.++|++.+.||+|+||.||+|.. +++.||||++...........................+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 89999999984221110000000000000000112789999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHH------hhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCCeEe
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDR------LHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFD-RPVIHRDVKSSNILL 780 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~Dlkp~NIll 780 (947)
++++..++..++||||+++|+|.++ +.......+++..+..++.|++.||+||| + .+|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence 9999999999999999999999999 66544677999999999999999999999 6 899999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcceecccccccccCccccccC-CCCC-ccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINE-KSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
+.++.+||+|||.+...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||...... ..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VE 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HH
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HH
Confidence 99999999999999876443 22345689999999999877 5666 999999999999999999999643221 22
Q ss_pred HHHHHHhhccccccccc----cccCC----CCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 859 IVNWVYSKMDSRDSMLT----VVDPN----ISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 859 ~~~~~~~~~~~~~~~~~----~~d~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.... .......... ...+. ........+..+.+++.+|++.||++|||+.|++++
T Consensus 261 ~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LFNN---IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHH---HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHH---HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2221 1111111110 00000 001113345678899999999999999999999873
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=353.48 Aligned_cols=267 Identities=24% Similarity=0.253 Sum_probs=202.9
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
..+.++|++.+.||+|+||+||+|+.. +++.||||++......... +. ..........+.+.+|+.++++++|||
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~E~~~l~~l~hpn 107 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGR-YS---DDNKNIEKFHEEIYNEISLLKSLDHPN 107 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC--------------------CTHHHHHHHHHHHHTCCCTT
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhccccc-cc---ccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence 456788999999999999999999966 6889999999543221100 00 000111234567899999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++..+...++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENK 182 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESST
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecC
Confidence 999999999999999999999999999999764 45899999999999999999999 8899999999999999877
Q ss_pred C---CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 784 W---KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 784 ~---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+ .+||+|||+++....... .....||+.|+|||++. +.++.++||||+||++|||++|+.||... ...
T Consensus 183 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~ 253 (504)
T 3q5i_A 183 NSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ-----NDQ 253 (504)
T ss_dssp TCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHH
T ss_pred CCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC-----CHH
Confidence 5 699999999987654432 23457999999999886 46999999999999999999999999532 122
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+............. .+.....+..+.+++.+|++.||.+|||+.|++++
T Consensus 254 ~~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 254 DIIKKVEKGKYYFD-------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHHHHCCCCCC-------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCCCCC-------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 22221111111100 00011234568899999999999999999999853
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=341.64 Aligned_cols=259 Identities=22% Similarity=0.259 Sum_probs=192.0
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|... +++.||||++.... ........+.+|+.+++.++||||+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~hpniv 87 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---------------QNQTHAKRAYRELVLMKCVNHKNII 87 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT---------------SSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc---------------CChHHHHHHHHHHHHHHhcCCCCcc
Confidence 3578999999999999999999965 68999999984211 1112345678999999999999999
Q ss_pred eEEEEEecCC------ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 706 KLYCSITSED------SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 706 ~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
++++++...+ ..++||||++ |+|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl 159 (371)
T 2xrw_A 88 GLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIV 159 (371)
T ss_dssp CEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred ceEEeeccccccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEE
Confidence 9999998765 5799999996 578888863 4889999999999999999999 889999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 780 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .
T Consensus 160 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~ 231 (371)
T 2xrw_A 160 VKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-----H 231 (371)
T ss_dssp ECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----H
T ss_pred EcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----H
Confidence 9999999999999998654332 1224578999999999999899999999999999999999999995431 1
Q ss_pred HHHHHhhccc----------------------cccc---------cccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC
Q 002250 860 VNWVYSKMDS----------------------RDSM---------LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP 908 (947)
Q Consensus 860 ~~~~~~~~~~----------------------~~~~---------~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 908 (947)
.......... .... .....+...+........+.+++.+|++.||++||
T Consensus 232 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 311 (371)
T 2xrw_A 232 IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311 (371)
T ss_dssp HHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCC
Confidence 1111111000 0000 00000111112233467799999999999999999
Q ss_pred CHHHHHHH
Q 002250 909 SMRVVVQM 916 (947)
Q Consensus 909 t~~ev~~~ 916 (947)
|+.|++++
T Consensus 312 t~~e~l~h 319 (371)
T 2xrw_A 312 SVDEALQH 319 (371)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhCC
Confidence 99999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=350.80 Aligned_cols=204 Identities=24% Similarity=0.334 Sum_probs=167.4
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
.+.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+.+|++++++++||||
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~nI 87 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---------------EDLIDCKRILREITILNRLKSDYI 87 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---------------TSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---------------cChHHHHHHHHHHHHHHHcCCCCc
Confidence 34578999999999999999999965 68899999984211 111234678899999999999999
Q ss_pred ceEEEEEecC-----CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 705 VKLYCSITSE-----DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 705 v~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
+++++++... ...|+||||++ |+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+||+
T Consensus 88 v~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NIL 161 (432)
T 3n9x_A 88 IRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCL 161 (432)
T ss_dssp CCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred ceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeE
Confidence 9999999776 56899999995 699999986 345899999999999999999999 889999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCC--------------------cceecccccccccCcccc-ccCCCCCccchHHHHHH
Q 002250 780 LDLEWKPRIADFGLAKIVQTGEAG--------------------DLTHVIAGTHGYIAPEYA-YTCKINEKSDVYSFGVV 838 (947)
Q Consensus 780 l~~~~~~kl~DfG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slGv~ 838 (947)
++.++.+||+|||+|+........ ......+||+.|+|||++ ....++.++||||+||+
T Consensus 162 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~i 241 (432)
T 3n9x_A 162 LNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI 241 (432)
T ss_dssp ECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred ECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHH
Confidence 999999999999999876543221 112456799999999986 45569999999999999
Q ss_pred HHHHHhCCCCCC
Q 002250 839 LMELVTGKRPIV 850 (947)
Q Consensus 839 l~elltg~~p~~ 850 (947)
+|||++|..||.
T Consensus 242 l~ell~g~~p~~ 253 (432)
T 3n9x_A 242 FAELLNMLQSHI 253 (432)
T ss_dssp HHHHHTTCTTTC
T ss_pred HHHHHhcccccc
Confidence 999998766553
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=346.35 Aligned_cols=263 Identities=21% Similarity=0.230 Sum_probs=203.5
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-----
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR----- 700 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----- 700 (947)
+.++|++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~~~~~~ 96 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------------------EHYTETALDEIRLLKSVRNSDPN 96 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------------------HHHHHHHHHHHHHHHHHHHSCTT
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------------------CcchHHHHHHHHHHHHHhhcCCC
Confidence 3478999999999999999999954 6889999998311 123456889999999996
Q ss_pred ---ccccceEEEEEe----cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecc
Q 002250 701 ---HVNVVKLYCSIT----SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDR-PVIHRD 772 (947)
Q Consensus 701 ---h~niv~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~D 772 (947)
|+||+++++++. .....++||||+ ++++.+++.......+++..+..++.||+.||+||| ++ +|+|||
T Consensus 97 ~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrD 172 (397)
T 1wak_A 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTD 172 (397)
T ss_dssp CGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCC
T ss_pred CCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCC
Confidence 788999999987 556789999999 677878777655567999999999999999999999 77 999999
Q ss_pred CCCCCeEecCCC-------------------------------------------------CeEEeccccceecccCCCC
Q 002250 773 VKSSNILLDLEW-------------------------------------------------KPRIADFGLAKIVQTGEAG 803 (947)
Q Consensus 773 lkp~NIll~~~~-------------------------------------------------~~kl~DfG~a~~~~~~~~~ 803 (947)
|||+|||++.++ .+||+|||.++......
T Consensus 173 ikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-- 250 (397)
T 1wak_A 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-- 250 (397)
T ss_dssp CSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS--
T ss_pred CCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC--
Confidence 999999999775 79999999998765432
Q ss_pred cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc----cHHHHHHhhcccc---------
Q 002250 804 DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK----DIVNWVYSKMDSR--------- 870 (947)
Q Consensus 804 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~--------- 870 (947)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ +............
T Consensus 251 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 327 (397)
T 1wak_A 251 ---TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327 (397)
T ss_dssp ---CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred ---ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccc
Confidence 234689999999999999999999999999999999999999965432211 1111111110000
Q ss_pred ---------ccccccccC----------CCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 871 ---------DSMLTVVDP----------NISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 871 ---------~~~~~~~d~----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.......+. ...+...+....+.+++.+||+.||++|||+.|++++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000000000 0012356777889999999999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=336.86 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=195.5
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNV 704 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 704 (947)
..++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|+.+++++ +||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------------------~~~~~~~~~e~~~l~~l~~h~~i 83 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------------GDEEEEIKQEINMLKKYSHHRNI 83 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------------SSTTHHHHHHHHHHHHHCCSTTB
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC------------------cccHHHHHHHHHHHHhccCCCCe
Confidence 4578999999999999999999964 7899999998421 13346788999999999 89999
Q ss_pred ceEEEEEec------CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 705 VKLYCSITS------EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 705 v~l~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++++++.. .+..++||||+++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NI 160 (326)
T 2x7f_A 84 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNV 160 (326)
T ss_dssp CCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGE
T ss_pred eeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHE
Confidence 999999977 457899999999999999998765567899999999999999999999 88999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRPIVPEF 853 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~ 853 (947)
+++.++.+||+|||++........ ......||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 161 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 161 LLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp EECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999976543221 122346899999999987 5668899999999999999999999984321
Q ss_pred CCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 854 GDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
............. +.. .....+..+.+++.+||+.||++|||+.++++
T Consensus 239 -----~~~~~~~~~~~~~-------~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 239 -----PMRALFLIPRNPA-------PRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -----HHHHHHHHHHSCC-------CCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHHhhcCcc-------ccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111111100 000 01122356888999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=350.22 Aligned_cols=259 Identities=22% Similarity=0.306 Sum_probs=192.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
..|+..+.||+|+||+||+|+.. +|+.||||++... .....+|++++++++||||+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---------------------~~~~~~E~~il~~l~hpniv~l 112 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---------------------KRFKNRELQIMRKLDHCNIVRL 112 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------------------TTSCCHHHHHHHTCCCTTBCCE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc---------------------chhHHHHHHHHHHcCCCCccce
Confidence 46888999999999999999975 6999999998421 1123479999999999999999
Q ss_pred EEEEecCC------ccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 708 YCSITSED------SNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 708 ~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
+++|...+ ..++||||+++ ++.+.+... ....+++..+..++.||++||+||| +.+|+||||||+|||
T Consensus 113 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIL 188 (420)
T 1j1b_A 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLL 188 (420)
T ss_dssp EEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEE
T ss_pred eeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEE
Confidence 99985421 25699999975 676666532 3457899999999999999999999 899999999999999
Q ss_pred ecCC-CCeEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 780 LDLE-WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 780 l~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
++.+ +.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...
T Consensus 189 l~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-~~~ 264 (420)
T 1j1b_A 189 LDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-GVD 264 (420)
T ss_dssp EETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHH
T ss_pred EeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-HHH
Confidence 9965 5689999999987654332 2234789999999998765 68999999999999999999999995432 111
Q ss_pred cHHHHHHhhccc--------cccccccccCCCCc------cCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 858 DIVNWVYSKMDS--------RDSMLTVVDPNISE------ILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 858 ~~~~~~~~~~~~--------~~~~~~~~d~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.+...+...... .........+.+.. +.......+.+++.+|++.||++|||+.|++++
T Consensus 265 ~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 265 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 122222111000 00000000011100 122334678899999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=349.00 Aligned_cols=255 Identities=11% Similarity=-0.004 Sum_probs=181.0
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc--cccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV--RHVNVV 705 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv 705 (947)
..|+..+.||+|+||+||+|+.. +++.||||++..... ........+.+|+.+++.+ +||||+
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~~~~E~~~~~~l~~~hp~iv 127 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE--------------NSRSELERLHEATFAAARLLGESPEEA 127 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST--------------THHHHHHHHHHHHHHHHHHHC------
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc--------------ccccHHHHHHHHHHHHHHhcccChhhh
Confidence 45888999999999999999965 789999999953211 0112345677886666555 599988
Q ss_pred eEE-------EEEecCC-----------------ccEEEEeccCCCChHHHhhhcCCccCCHHHH------HHHHHHHHH
Q 002250 706 KLY-------CSITSED-----------------SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR------YAIAVGAAK 755 (947)
Q Consensus 706 ~l~-------~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~~ia~ 755 (947)
+++ +++..++ ..|+||||++ |+|.+++..... .+++..+ ..++.||+.
T Consensus 128 ~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~ 205 (371)
T 3q60_A 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIR 205 (371)
T ss_dssp ----CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHH
T ss_pred hhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHH
Confidence 865 4444332 3699999998 899999987422 3355555 778899999
Q ss_pred HHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCcccccc--CCCCCccchH
Q 002250 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT--CKINEKSDVY 833 (947)
Q Consensus 756 ~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~ 833 (947)
||+||| +.+|+||||||+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+ ..++.++|||
T Consensus 206 aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~Diw 277 (371)
T 3q60_A 206 LAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAW 277 (371)
T ss_dssp HHHHHH---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHH
T ss_pred HHHHHH---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHH
Confidence 999999 899999999999999999999999999999865322 214467799999999987 6799999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCC-CccCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 002250 834 SFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRV 912 (947)
Q Consensus 834 slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 912 (947)
||||++|||++|+.||.......... .. ............ .......+..+.+++.+||+.||++|||+.|
T Consensus 278 SlG~il~elltg~~Pf~~~~~~~~~~-------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 349 (371)
T 3q60_A 278 QLGLSIYRVWCLFLPFGLVTPGIKGS-------WK-RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349 (371)
T ss_dssp HHHHHHHHHHHSSCSTTBCCTTCTTC-------CC-BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHH
T ss_pred HHHHHHHHHHhCCCCCCCcCcccccc-------hh-hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 99999999999999996543211100 00 000000000010 1111234567889999999999999999999
Q ss_pred HHH
Q 002250 913 VVQ 915 (947)
Q Consensus 913 v~~ 915 (947)
+++
T Consensus 350 ~l~ 352 (371)
T 3q60_A 350 AME 352 (371)
T ss_dssp HTT
T ss_pred Hhc
Confidence 974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=340.80 Aligned_cols=202 Identities=25% Similarity=0.283 Sum_probs=172.1
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-cc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HV 702 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ 702 (947)
+.+.++|++.+.||+|+||+||+|+.. +++.||||++... ......+.+|+.+++.++ |+
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------~~~~~~~~~e~~~l~~l~~~~ 111 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------------------KAFLNQAQIEVRLLELMNKHD 111 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------------------HHHHHHHHHHHHHHHHHHHCS
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------------------HHHHHHHHHHHHHHHHHHhcc
Confidence 445689999999999999999999965 6889999998311 122356778999988885 44
Q ss_pred -----ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 703 -----NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 703 -----niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
+|+++++++..++..++||||++ |+|.+++.......+++..+..++.|++.||+|||.. ..+|+||||||+|
T Consensus 112 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~N 189 (382)
T 2vx3_A 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPEN 189 (382)
T ss_dssp SGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGG
T ss_pred cccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCccc
Confidence 49999999999999999999995 5999999886556789999999999999999999931 4689999999999
Q ss_pred eEec--CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 778 ILLD--LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 778 Ill~--~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
||++ .++.+||+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 190 Ill~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 190 ILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp EEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9995 47889999999998764322 245789999999999999999999999999999999999999964
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=355.97 Aligned_cols=349 Identities=21% Similarity=0.203 Sum_probs=224.7
Q ss_pred ccccccccCCCCCcc----cceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCc
Q 002250 12 TGVFSSWTEANSVCK----FNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRL 87 (947)
Q Consensus 12 ~~~~~sw~~~~~~C~----w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L 87 (947)
...+++|.++.+||. |.++.|+. .++.........++ -..+.+++.|++++|.+....+..+..+++|
T Consensus 6 ~~~l~~~~~~~~C~~~~~~~~c~~~~~-----~i~~~~~~~~~~~~---~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L 77 (597)
T 3oja_B 6 RYNVKPRQPEYKCIDSNLQYDCVFYDV-----HIDMQTQDVYFGFE---DITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77 (597)
T ss_dssp -----CCCSEECCCCC--CCSEEECSC-----EECSSCCCCEESCS---SGGGCCCSEEEESSCEESEECTHHHHHCCCC
T ss_pred cccccCCCCCCcCcccCcCceeEecCc-----eecccccccccCcc---cccCCCceEEEeeCCCCCCcCHHHHccCCCC
Confidence 456889999999985 77666652 12222222221111 2346788999999999988777888999999
Q ss_pred cEEeCcCccCcCCCC-CcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEcc
Q 002250 88 QVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLT 166 (947)
Q Consensus 88 ~~L~Ls~n~i~~~~~-~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~ 166 (947)
++|+|++|.|++.++ .++.+++|++|+|++|.+++..+ ..|.++++|++|+|++|.++..+ +..+..+++|++|+|+
T Consensus 78 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~l~-~~~~~~l~~L~~L~Ls 155 (597)
T 3oja_B 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP-HVFQNVPLLTVLVLERNDLSSLP-RGIFHNTPKLTTLSMS 155 (597)
T ss_dssp SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCC-TTTTTTCTTCCEEECC
T ss_pred cEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCH-HHHcCCCCCCEEEeeCCCCCCCC-HHHhccCCCCCEEEee
Confidence 999999999998776 58888888889988888886554 67788888888888888776532 2234667777777777
Q ss_pred CccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCC
Q 002250 167 NCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDL 246 (947)
Q Consensus 167 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 246 (947)
+|.+++..|..|+.+++|++|+|++|.+++. .+..+++|+.|++++|.+++. ...++|+.|++++|.++..+
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~ 227 (597)
T 3oja_B 156 NNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVR 227 (597)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEE
T ss_pred CCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccccc-----cCCchhheeeccCCcccccc
Confidence 7777766666677777777777777776643 244456666666666666532 22344555555555554332
Q ss_pred ccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCc
Q 002250 247 SELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGA 326 (947)
Q Consensus 247 ~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 326 (947)
..+ . ++|+.|+|++|.+++ +..++.+++|+.|+|++|.+++
T Consensus 228 ~~~--~------------------------~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~----------- 268 (597)
T 3oja_B 228 GPV--N------------------------VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEK----------- 268 (597)
T ss_dssp CSC--C------------------------SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCE-----------
T ss_pred ccc--C------------------------CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCC-----------
Confidence 221 1 345555555555543 2344455555555555554442
Q ss_pred cceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccC
Q 002250 327 MTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLAN 406 (947)
Q Consensus 327 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 406 (947)
..|..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.+.. +|..+..+++|++|+|++
T Consensus 269 -------------~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L~~ 333 (597)
T 3oja_B 269 -------------IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDH 333 (597)
T ss_dssp -------------EESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCS
T ss_pred -------------CCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEECCC
Confidence 223344455555566666666553 35555667777777777777773 555677778888888888
Q ss_pred ccccccCCCCCCCCCcceEEEcccCcccC
Q 002250 407 NRFSGELPSKISEASSLVSIQLSLNQFSG 435 (947)
Q Consensus 407 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 435 (947)
|++++. | +..+++|+.|+|++|.+.+
T Consensus 334 N~l~~~-~--~~~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 334 NSIVTL-K--LSTHHTLKNLTLSHNDWDC 359 (597)
T ss_dssp SCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred CCCCCc-C--hhhcCCCCEEEeeCCCCCC
Confidence 888743 3 6677888899999998874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=340.94 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=183.8
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~ 706 (947)
.+|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.+++++. ||||++
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~e~~~l~~l~~h~~iv~ 90 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----------------EEEKNRAIIQEVCFMKKLSGHPNIVQ 90 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----------------SHHHHHHHHHHHHHHHHHTTSTTBCC
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----------------chHHHHHHHHHHHHHHHhccCCChhh
Confidence 57899999999999999999965 7899999988321 1123456889999999996 999999
Q ss_pred EEEEEe--------cCCccEEEEeccCCCChHHHhhhc-CCccCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEeccCCC
Q 002250 707 LYCSIT--------SEDSNLLVYEYLPNGSLWDRLHTC-HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRP--VIHRDVKS 775 (947)
Q Consensus 707 l~~~~~--------~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dlkp 775 (947)
+++++. .....++||||++ |+|.+++... ....+++..+..++.|++.||+||| +.+ |+||||||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp 166 (337)
T 3ll6_A 91 FCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKV 166 (337)
T ss_dssp EEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCG
T ss_pred ccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCc
Confidence 999984 3344689999995 7999988753 3456999999999999999999999 777 99999999
Q ss_pred CCeEecCCCCeEEeccccceecccCCCCc----------ceecccccccccCcccc---ccCCCCCccchHHHHHHHHHH
Q 002250 776 SNILLDLEWKPRIADFGLAKIVQTGEAGD----------LTHVIAGTHGYIAPEYA---YTCKINEKSDVYSFGVVLMEL 842 (947)
Q Consensus 776 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slGv~l~el 842 (947)
+||+++.++.+||+|||+++......... ......||+.|+|||++ .+..++.++||||||+++|||
T Consensus 167 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el 246 (337)
T 3ll6_A 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246 (337)
T ss_dssp GGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHH
T ss_pred ccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHH
Confidence 99999999999999999998765432211 11134589999999998 566788999999999999999
Q ss_pred HhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 843 VTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 843 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
++|+.||..... ......... .. ........+.+++.+||+.||++|||+.|++++|+++.
T Consensus 247 ~~g~~p~~~~~~-----~~~~~~~~~----------~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 247 CFRQHPFEDGAK-----LRIVNGKYS----------IP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp HHSSCCC-----------------CC----------CC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhCCCCCcchhH-----HHhhcCccc----------CC---cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999843211 111110000 00 00111233678999999999999999999999998764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=338.53 Aligned_cols=261 Identities=25% Similarity=0.355 Sum_probs=198.0
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.++|++.+.||+|+||.||+|+... .||||++..... .....+.+.+|+.++++++||||+++
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~~ 94 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERD---------------NEDQLKAFKREVMAYRQTRHENVVLF 94 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSC---------------CCCCCCCCCTTGGGGTTCCCTTBCCC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCC---------------CHHHHHHHHHHHHHHhcCCCCCEeEE
Confidence 3678999999999999999999863 599999853211 12233557789999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..++..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++ ++.+|
T Consensus 95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~ 169 (319)
T 2y4i_B 95 MGACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVV 169 (319)
T ss_dssp CEEEECSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCE
T ss_pred EEEEecCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEE
Confidence 99999999999999999999999999863 346889999999999999999999 88999999999999998 67999
Q ss_pred EeccccceecccCCC---CcceecccccccccCcccccc---------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 788 IADFGLAKIVQTGEA---GDLTHVIAGTHGYIAPEYAYT---------CKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 788 l~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
|+|||+++....... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--- 246 (319)
T 2y4i_B 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--- 246 (319)
T ss_dssp ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC---
T ss_pred EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC---
Confidence 999999875432211 112223468999999999864 34788999999999999999999998532
Q ss_pred cccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 856 SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
.............. +... ....+..+.+++.+||+.||++|||+.+++++|+++....
T Consensus 247 --~~~~~~~~~~~~~~-------~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 247 --PAEAIIWQMGTGMK-------PNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp --CHHHHHHHHHTTCC-------CCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred --CHHHHHHHhccCCC-------CCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111111111111 1110 0012345788999999999999999999999999987653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=333.53 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=198.2
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
..+.|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.++++++||||+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~i~ 79 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-----------------SEEELEDYIVEIEILATCDHPYIV 79 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------------------CCHHHHHHHHHHHHHCCCTTBC
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-----------------CHHHHHHHHHHHHHHhcCCCCCEe
Confidence 3478999999999999999999976 6899999998321 123457788999999999999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..++..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 155 (302)
T 2j7t_A 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGD 155 (302)
T ss_dssp CEEEEEECC-CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSC
T ss_pred eeeeeeeeCCeEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCC
Confidence 9999999999999999999999999998763 345899999999999999999999 889999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+||+|||++........ ......||+.|+|||++. ...++.++||||||+++|||++|+.||... +..
T Consensus 156 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~ 228 (302)
T 2j7t_A 156 IRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPM 228 (302)
T ss_dssp EEECCCHHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS-----CHH
T ss_pred EEEEECCCCcccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC-----CHH
Confidence 99999998754321110 112346899999999983 567889999999999999999999998532 111
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+........... ....+...+..+.+++.+|++.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 229 RVLLKIAKSDPP--------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHHSCCC--------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHhccCCc--------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111111111110 001112234568899999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=328.97 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=204.2
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVN 703 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n 703 (947)
.+.++|++.+.||+|+||.||+|... +++.||||++........ . ........+.+.+|+++++++. |||
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~-----~~~~~~~~~~~~~e~~~l~~l~~h~~ 85 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF---S-----AEEVQELREATLKEVDILRKVSGHPN 85 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTC---C-----HHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEeccccccc---C-----HHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 34578999999999999999999975 689999999853321100 0 0011122456789999999995 999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDD 160 (298)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTT
T ss_pred EeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCC
Confidence 999999999999999999999999999999863 45899999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccc------cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY------TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
+.+||+|||.+........ .....||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----- 232 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR----- 232 (298)
T ss_dssp CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----
T ss_pred CcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc-----
Confidence 9999999999987654332 22346899999999885 456888999999999999999999998532
Q ss_pred cHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 858 DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
................ . .+.....+..+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~---~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 233 KQMLMLRMIMSGNYQF---G----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SHHHHHHHHHHTCCCC---C----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cHHHHHHHHhcCCccc---C----cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111111111111110 0 0111233456889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=343.15 Aligned_cols=276 Identities=20% Similarity=0.195 Sum_probs=197.1
Q ss_pred HHHhhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
..+.++|++.+.||+|+||.||+|...+|+.||||++.......... .........+.+.+|+.++++++||||
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV------NILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCE------EGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchh------hhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 45568899999999999999999998889999999985332211100 000111223678999999999999999
Q ss_pred ceEEEEEec-----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 705 VKLYCSITS-----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 705 v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
+++++++.. ....++||||++ |+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEE
Confidence 999999854 335699999997 6888888753 446899999999999999999999 889999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 780 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
++.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~ 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST--FYN 241 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHH
T ss_pred EcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC--HHH
Confidence 99999999999999975443322 224568999999999877 678999999999999999999999995431 111
Q ss_pred HHHHHHhhcccc------------------ccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 859 IVNWVYSKMDSR------------------DSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 859 ~~~~~~~~~~~~------------------~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
............ .....................+.+++.+|++.||++|||+.|++++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111110000000 0000000011112222335568899999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=368.47 Aligned_cols=256 Identities=21% Similarity=0.315 Sum_probs=201.4
Q ss_pred hhccCCcccccccCceeEEEEEeCC----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNS----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
.++|++.+.||+|+||+||+|.... +..||||++.... .....+.+.+|+.++++++|||
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~Hpn 452 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT----------------SDSVREKFLQEALTMRQFDHPH 452 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT----------------CHHHHHHHHHHHHHHHHCCCTT
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 3678889999999999999999642 4579999873211 1123367889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|+++++++. ++..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 453 Iv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~ 527 (656)
T 2j0j_A 453 IVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSN 527 (656)
T ss_dssp BCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEET
T ss_pred CCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCC
Confidence 999999985 45689999999999999999863 346899999999999999999999 8899999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||+++......... .....+|+.|+|||++....++.++||||||+++|||++ |..||... ...+....
T Consensus 528 ~~vkL~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~--~~~~~~~~ 604 (656)
T 2j0j_A 528 DCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGR 604 (656)
T ss_dssp TEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHH
T ss_pred CCEEEEecCCCeecCCCccee-ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC--CHHHHHHH
Confidence 999999999998764433221 223457789999999998899999999999999999997 99998532 11122211
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
+. ... ....+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 605 i~---~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 605 IE---NGE----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp HH---HTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---cCC----------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 111 1112233456788999999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=334.29 Aligned_cols=261 Identities=19% Similarity=0.241 Sum_probs=204.2
Q ss_pred HhhccCCcccccccCceeEEEEEe-C-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc-
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVL-N-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN- 703 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n- 703 (947)
+.++|++.+.||+|+||+||+|.. . +++.||||++.. .....+.+.+|+++++.++|++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------------------~~~~~~~~~~e~~~l~~l~~~~~ 73 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN------------------VDRYCEAARSEIQVLEHLNTTDP 73 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------------------SHHHHHHHHHHHHHHHHHHHHCT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec------------------CCchhHHHHHHHHHHHHhhhcCC
Confidence 347899999999999999999986 3 688999999831 1123466889999999998775
Q ss_pred -----cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 704 -----VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 704 -----iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
++++++++..++..++||||+ +++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||
T Consensus 74 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Ni 149 (339)
T 1z57_A 74 NSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENI 149 (339)
T ss_dssp TCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred CCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHE
Confidence 999999999999999999999 899999998866667899999999999999999999 88999999999999
Q ss_pred EecC-------------------CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHH
Q 002250 779 LLDL-------------------EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839 (947)
Q Consensus 779 ll~~-------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l 839 (947)
+++. ++.+||+|||.++...... ....||+.|+|||++.+..++.++|||||||++
T Consensus 150 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 224 (339)
T 1z57_A 150 LFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCIL 224 (339)
T ss_dssp EESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHH
T ss_pred EEeccccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHH
Confidence 9987 6789999999998654322 234789999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCCCCcccHHHHHHhhccccc-cc------ccc---------------------cc--CCCCccCHHHH
Q 002250 840 MELVTGKRPIVPEFGDSKDIVNWVYSKMDSRD-SM------LTV---------------------VD--PNISEILKEDA 889 (947)
Q Consensus 840 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~------~~~---------------------~d--~~~~~~~~~~~ 889 (947)
|||++|+.||.... ..+....+........ .+ ... .. ...........
T Consensus 225 ~el~~g~~pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (339)
T 1z57_A 225 IEYYLGFTVFPTHD--SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302 (339)
T ss_dssp HHHHHSSCSCCCSC--HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHH
T ss_pred HHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhH
Confidence 99999999995431 1111111111110000 00 000 00 00011233456
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 890 LKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 890 ~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..+.+++.+|++.||++|||+.|++++
T Consensus 303 ~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 303 ERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 789999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=346.34 Aligned_cols=268 Identities=21% Similarity=0.272 Sum_probs=184.0
Q ss_pred HHhhccCC-cccccccCceeEEEEEeC---CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 626 EIIDAVKP-ENLIGKGGSGNVYKVVLN---SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 626 ~~~~~~~~-~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.+.+.|++ .++||+|+||+||+|+.+ +++.||||++... .....+.+|+.++++++|
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-------------------~~~~~~~~E~~~l~~l~h 77 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-------------------GISMSACREIALLRELKH 77 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-------------------SCCHHHHHHHHHHHHCCC
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-------------------CCCHHHHHHHHHHHhcCC
Confidence 34466776 568999999999999965 5789999998311 223467899999999999
Q ss_pred cccceEEEEEec--CCccEEEEeccCCCChHHHhhhc-------CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecc
Q 002250 702 VNVVKLYCSITS--EDSNLLVYEYLPNGSLWDRLHTC-------HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRD 772 (947)
Q Consensus 702 ~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~D 772 (947)
|||+++++++.. +...++||||++ |+|.+++... ....+++..+..++.|++.||+||| +.+|+|||
T Consensus 78 pniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~D 153 (405)
T 3rgf_A 78 PNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRD 153 (405)
T ss_dssp TTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCC
T ss_pred CCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCC
Confidence 999999999954 667899999996 5888887632 1234899999999999999999999 88999999
Q ss_pred CCCCCeEe----cCCCCeEEeccccceecccCCC-CcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCC
Q 002250 773 VKSSNILL----DLEWKPRIADFGLAKIVQTGEA-GDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGK 846 (947)
Q Consensus 773 lkp~NIll----~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~ 846 (947)
|||+|||+ +.++.+||+|||+|+....... ........||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 154 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 233 (405)
T 3rgf_A 154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233 (405)
T ss_dssp CCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCC
Confidence 99999999 6778999999999987654321 1222345789999999999874 4899999999999999999999
Q ss_pred CCCCCCCCC--------cccHHHHHHhhcccccc-ccccc-------------cCCCCccC---------HHHHHHHHHH
Q 002250 847 RPIVPEFGD--------SKDIVNWVYSKMDSRDS-MLTVV-------------DPNISEIL---------KEDALKVLRI 895 (947)
Q Consensus 847 ~p~~~~~~~--------~~~~~~~~~~~~~~~~~-~~~~~-------------d~~~~~~~---------~~~~~~l~~l 895 (947)
.||...... ...+............. +..+. ........ ......+.++
T Consensus 234 ~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 313 (405)
T 3rgf_A 234 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313 (405)
T ss_dssp CTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHH
T ss_pred CCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHH
Confidence 999643221 01111111111000000 00000 00000000 0013467899
Q ss_pred HHhccCCCCCCCCCHHHHHHH
Q 002250 896 AIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 896 ~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+.+|++.||++|||+.|++++
T Consensus 314 l~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 314 LQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHccCCcccCCCHHHHhcC
Confidence 999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=345.03 Aligned_cols=264 Identities=24% Similarity=0.313 Sum_probs=195.1
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
..+|++.+.||+|+||+||+|+...+..||+|++... .....+|+++++.++||||+++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~---------------------~~~~~~E~~il~~l~h~niv~l 97 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD---------------------KRFKNRELQIMRIVKHPNVVDL 97 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECC---------------------TTSCCHHHHHHHTCCCTTBCCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecC---------------------cchHHHHHHHHHhCCCCCcceE
Confidence 4679999999999999999999887777999988321 1122369999999999999999
Q ss_pred EEEEecCCc------cEEEEeccCCCChHHHhhh--cCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 708 YCSITSEDS------NLLVYEYLPNGSLWDRLHT--CHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 708 ~~~~~~~~~------~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
++++...+. .++||||++++ +.+.+.. .....+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 98 ~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nil 173 (394)
T 4e7w_A 98 KAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLL 173 (394)
T ss_dssp EEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred EEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEE
Confidence 999965443 68999999765 4443332 13456899999999999999999999 899999999999999
Q ss_pred ec-CCCCeEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 780 LD-LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 780 l~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
++ .++.+||+|||+|+........ ....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ..
T Consensus 174 l~~~~~~~kL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~ 249 (394)
T 4e7w_A 174 LDPPSGVLKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-ID 249 (394)
T ss_dssp EETTTTEEEECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HH
T ss_pred EcCCCCcEEEeeCCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HH
Confidence 99 7899999999999876544322 234689999999998765 589999999999999999999999954321 11
Q ss_pred cHHHHHHhhcccc--------ccccccccCCC------CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhcc
Q 002250 858 DIVNWVYSKMDSR--------DSMLTVVDPNI------SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEA 920 (947)
Q Consensus 858 ~~~~~~~~~~~~~--------~~~~~~~d~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~ 920 (947)
.+........... .......-+.. ..+.......+.+++.+|++.||++|||+.|++++ ++++
T Consensus 250 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 250 QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 1111111100000 00000000000 01122245678999999999999999999999975 4443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=323.07 Aligned_cols=256 Identities=25% Similarity=0.341 Sum_probs=203.7
Q ss_pred HHHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 624 EKEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 624 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
...+.++|++.+.||+|+||.||+|+.. +++.||||++... .........+.+|+.++++++||
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~---------------~~~~~~~~~~~~e~~~l~~l~h~ 81 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA---------------SAKNKDTSTILREVELLKKLDHP 81 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG---------------GBSSSCHHHHHHHHHHHHTCCCT
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccc---------------ccchHHHHHHHHHHHHHHhccCC
Confidence 3566789999999999999999999976 7899999998421 11224457789999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 82 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~ 156 (287)
T 2wei_A 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLES 156 (287)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESC
T ss_pred CccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEec
Confidence 9999999999999999999999999999998764 35899999999999999999999 889999999999999975
Q ss_pred C---CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 783 E---WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 783 ~---~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
+ +.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|||++|+.||... ..
T Consensus 157 ~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~ 227 (287)
T 2wei_A 157 KEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK-----NE 227 (287)
T ss_dssp SSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SH
T ss_pred CCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC-----CH
Confidence 4 4799999999976544322 123458999999998865 5899999999999999999999998532 11
Q ss_pred HHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.+............ .. +.....+..+.+++.+|++.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~------~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 228 YDILKRVETGKYAF------DL-PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHHHHCCCCC------CS-GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCC------Cc-hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 12211111111100 00 011123456889999999999999999999997
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=339.27 Aligned_cols=264 Identities=21% Similarity=0.292 Sum_probs=199.7
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .......+.+|++++++++||||++
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~niv~ 89 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE----------------HQTYCQRTLREIKILLRFRHENIIG 89 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT----------------CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc----------------CcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 368999999999999999999965 68899999984211 1123367889999999999999999
Q ss_pred EEEEEecC-----CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 707 LYCSITSE-----DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 707 l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
+++++... ...++||||++ |+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 90 ~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~ 162 (364)
T 3qyz_A 90 INDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLN 162 (364)
T ss_dssp CCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEC
T ss_pred ceeEEecCCccccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEEC
Confidence 99999765 35799999996 599999876 35899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCCCc-ceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
.++.+||+|||+++......... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+.
T Consensus 163 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~ 240 (364)
T 3qyz_A 163 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--YLDQ 240 (364)
T ss_dssp TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS--GGGH
T ss_pred CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC--hHHH
Confidence 99999999999998765432211 12345799999999987654 48999999999999999999999995432 1111
Q ss_pred HHHHHhhccccc-c-cc------------ccccC---CCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 860 VNWVYSKMDSRD-S-ML------------TVVDP---NISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 860 ~~~~~~~~~~~~-~-~~------------~~~d~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
............ . +. ....+ ............+.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 241 LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111111100000 0 00 00000 0011122334568899999999999999999999964
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=339.76 Aligned_cols=261 Identities=20% Similarity=0.240 Sum_probs=200.7
Q ss_pred hccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-------
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR------- 700 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------- 700 (947)
++|++.+.||+|+||+||+|+. .+++.||||++... ......+.+|+.++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------~~~~~~~~~e~~~l~~l~~~~~~~~ 80 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------------------KVYTEAAEDEIKLLQRVNDADNTKE 80 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------------------HHHHHHHHHHHHHHHHHHHTCCSHH
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------------------ccchhhhhHHHHHHHHhhcccccch
Confidence 6799999999999999999996 47899999998311 123356788999999886
Q ss_pred ----ccccceEEEEEecCC----ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEec
Q 002250 701 ----HVNVVKLYCSITSED----SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDR-PVIHR 771 (947)
Q Consensus 701 ----h~niv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~ 771 (947)
||||+++++++...+ ..++||||+ +++|.+++.......+++..+..++.||+.||+||| +. +|+||
T Consensus 81 ~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~ 156 (373)
T 1q8y_A 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHT 156 (373)
T ss_dssp HHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECS
T ss_pred hccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEec
Confidence 899999999998654 678999999 999999998866667999999999999999999999 77 99999
Q ss_pred cCCCCCeEec------CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhC
Q 002250 772 DVKSSNILLD------LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTG 845 (947)
Q Consensus 772 Dlkp~NIll~------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg 845 (947)
||||+||+++ ..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 157 Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 231 (373)
T 1q8y_A 157 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231 (373)
T ss_dssp CCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhC
Confidence 9999999994 44579999999998764432 234689999999999999999999999999999999999
Q ss_pred CCCCCCCCCC-----cccHHHHHHhhc-----------------ccccccccccc----------CCCCccCHHHHHHHH
Q 002250 846 KRPIVPEFGD-----SKDIVNWVYSKM-----------------DSRDSMLTVVD----------PNISEILKEDALKVL 893 (947)
Q Consensus 846 ~~p~~~~~~~-----~~~~~~~~~~~~-----------------~~~~~~~~~~d----------~~~~~~~~~~~~~l~ 893 (947)
+.||...... ...+........ ........+.. .............+.
T Consensus 232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (373)
T 1q8y_A 232 DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311 (373)
T ss_dssp SCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHH
T ss_pred CCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHH
Confidence 9999644211 111111111000 00000000000 001234567788899
Q ss_pred HHHHhccCCCCCCCCCHHHHHHH
Q 002250 894 RIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 894 ~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+++.+|++.||++|||+.|++++
T Consensus 312 ~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 312 DFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHHHHhccCccccCCHHHHhhC
Confidence 99999999999999999999973
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.12 Aligned_cols=253 Identities=22% Similarity=0.304 Sum_probs=193.6
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc--cccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH--VNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~ 706 (947)
++|++.+.||+|+||.||+|...+++.||||++.... ........+.+|++++++++| |||++
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~~~~~~iv~ 92 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---------------ADNQTLDSYRNEIAYLNKLQQHSDKIIR 92 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS---------------CCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc---------------ccccchHHHHHHHHHHHhccccCCceEE
Confidence 5799999999999999999998889999999984221 011234678899999999974 99999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++..++..++||| +.+++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||++++ +.+
T Consensus 93 ~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~ 165 (313)
T 3cek_A 93 LYDYEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GML 165 (313)
T ss_dssp EEEEEECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEE
T ss_pred EEEEeecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeE
Confidence 9999999999999999 5588999999874 35889999999999999999999 889999999999999964 899
Q ss_pred EEeccccceecccCCCCcceecccccccccCcccccc-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-----------CKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
||+|||+++...............||+.|+|||++.. ..++.++||||||+++|||++|+.||.....
T Consensus 166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~- 244 (313)
T 3cek_A 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN- 244 (313)
T ss_dssp EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-
T ss_pred EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-
Confidence 9999999987654433222334568999999999865 4688899999999999999999999854321
Q ss_pred cccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 856 SKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.............. ...+. ..+..+.+++.+||+.||++|||+.|+++.
T Consensus 245 ---~~~~~~~~~~~~~~------~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 ---QISKLHAIIDPNHE------IEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ---HHHHHHHHHCTTSC------CCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHHHHhcccc------cCCcc---cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11111111111110 11111 123568889999999999999999999964
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.50 Aligned_cols=261 Identities=20% Similarity=0.260 Sum_probs=182.6
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|... +|+.||||++.... ........+.+|+.+++.++||||+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~hpnIv 91 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---------------QSIIHAKRTYRELRLLKHMKHENVI 91 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT---------------SSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc---------------cCHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3478999999999999999999954 78999999984211 1112345678999999999999999
Q ss_pred eEEEEEecC------CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 706 KLYCSITSE------DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 706 ~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
++++++... ...|+|+||+ +++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIl 164 (367)
T 2fst_X 92 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLA 164 (367)
T ss_dssp CCSEEECSCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred cEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEE
Confidence 999999764 5679999999 7899998875 45899999999999999999999 899999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 780 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+
T Consensus 165 l~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~ 237 (367)
T 2fst_X 165 VNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HID 237 (367)
T ss_dssp ECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHH
T ss_pred ECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHH
Confidence 999999999999999865432 224578999999999877 678999999999999999999999995431 111
Q ss_pred HHHHHHhhccc-ccc-cccc---------------ccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 859 IVNWVYSKMDS-RDS-MLTV---------------VDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 859 ~~~~~~~~~~~-~~~-~~~~---------------~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....+...... ... +..+ -...+..........+.+++.+|+..||++|||+.|++++
T Consensus 238 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 11111111000 000 0000 0000111112234568899999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.21 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=193.2
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|+.. +++.||||++.. .......+.+|+.++++++||||+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------------------~~~~~~~~~~E~~~l~~l~h~~i~ 65 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------------------TEEKLSTILSEVMLLASLNHQYVV 65 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------------------EHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------------------cHHHHHHHHHHHHHHHhcCchHHH
Confidence 4578999999999999999999965 799999998831 112346788999999999999999
Q ss_pred eEEEEEec-------------CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecc
Q 002250 706 KLYCSITS-------------EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRD 772 (947)
Q Consensus 706 ~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~D 772 (947)
++++++.+ ....++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+|||
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~d 141 (303)
T 1zy4_A 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRD 141 (303)
T ss_dssp CEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred HHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence 99998865 34578999999999999999863 356788899999999999999999 88999999
Q ss_pred CCCCCeEecCCCCeEEeccccceecccCCC------------CcceecccccccccCccccccC-CCCCccchHHHHHHH
Q 002250 773 VKSSNILLDLEWKPRIADFGLAKIVQTGEA------------GDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVL 839 (947)
Q Consensus 773 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l 839 (947)
|||+||+++.++.+||+|||.+........ ........||+.|+|||++.+. .++.++||||||+++
T Consensus 142 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 221 (303)
T 1zy4_A 142 LKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221 (303)
T ss_dssp CCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHH
T ss_pred CCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHH
Confidence 999999999999999999999976543210 1112244689999999998764 689999999999999
Q ss_pred HHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 840 MELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 840 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
|||++ ||.. ..+.............. .........+..+.+++.+|++.||++|||+.|++++
T Consensus 222 ~~l~~---p~~~----~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 222 FEMIY---PFST----GMERVNILKKLRSVSIE-------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHS---CCSS----HHHHHHHHHHHHSTTCC-------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHh---ccCC----chhHHHHHHhccccccc-------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 99998 5421 11111221111111111 0122233445568899999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=334.34 Aligned_cols=254 Identities=19% Similarity=0.268 Sum_probs=174.7
Q ss_pred HHhhccCCcc-cccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 626 EIIDAVKPEN-LIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 626 ~~~~~~~~~~-~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
.+.++|.+.+ .||+|+||+||+|+.. +++.||||++.. ......+....++.++|||
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---------------------~~~~~~e~~~~~~~~~h~~ 83 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD---------------------SPKARQEVDHHWQASGGPH 83 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEES---------------------SHHHHHHHHHHHHHTTSTT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecC---------------------cHHHHHHHHHHHHhcCCCC
Confidence 4567888854 6999999999999976 799999999831 1112222333456679999
Q ss_pred cceEEEEEec----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 704 VVKLYCSITS----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 704 iv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
|+++++++.. +...++||||+++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 84 i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIl 160 (336)
T 3fhr_A 84 IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLL 160 (336)
T ss_dssp BCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred hHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 9999999876 445789999999999999999866667999999999999999999999 889999999999999
Q ss_pred ecC---CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 002250 780 LDL---EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856 (947)
Q Consensus 780 l~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 856 (947)
++. ++.+||+|||+++...... .....||+.|+|||++....++.++||||||+++|||++|+.||.......
T Consensus 161 l~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (336)
T 3fhr_A 161 YTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA 236 (336)
T ss_dssp ESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred EEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh
Confidence 986 4559999999998654332 223468999999999988889999999999999999999999995432111
Q ss_pred ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
............. .. .........+..+.+++.+|++.||++|||+.|+++
T Consensus 237 --~~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 237 --ISPGMKRRIRLGQ--YG----FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------------------C----CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --hhhhHHHhhhccc--cc----cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000000000 00 001111234456889999999999999999999997
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=337.59 Aligned_cols=270 Identities=20% Similarity=0.290 Sum_probs=200.3
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|+.. +|+.||||++.+.. .......+.+|+.++++++||||+
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv 72 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD----------------KPLFALRTLREIKILKHFKHENII 72 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS----------------SHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc----------------cchHHHHHHHHHHHHHhCcCCCcC
Confidence 3478999999999999999999966 68999999983211 112345678999999999999999
Q ss_pred eEEEEEecC-----CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 706 KLYCSITSE-----DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 706 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
++++++..+ ...++||||++ ++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 73 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~ 145 (353)
T 2b9h_A 73 TIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLI 145 (353)
T ss_dssp CEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CeeeeecccccCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEE
Confidence 999998764 66799999996 689999876 35899999999999999999999 8899999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCc--------ceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCC
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGD--------LTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVP 851 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~ 851 (947)
+.++.+||+|||+++......... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 146 NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999998765332211 1123468999999998765 6789999999999999999999999954
Q ss_pred CCCCcccHHHHHHhhccccc---ccccc---------------ccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 002250 852 EFGDSKDIVNWVYSKMDSRD---SMLTV---------------VDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVV 913 (947)
Q Consensus 852 ~~~~~~~~~~~~~~~~~~~~---~~~~~---------------~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 913 (947)
.. ..+............. ..... ............+..+.+++.+|++.||++|||+.|+
T Consensus 226 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 303 (353)
T 2b9h_A 226 RD--YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303 (353)
T ss_dssp SS--HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CC--cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence 31 1111111111100000 00000 0000111122345678899999999999999999999
Q ss_pred HHH--hhccC
Q 002250 914 VQM--LEEAE 921 (947)
Q Consensus 914 ~~~--L~~~~ 921 (947)
+++ ++...
T Consensus 304 l~hp~~~~~~ 313 (353)
T 2b9h_A 304 LEHPYLQTYH 313 (353)
T ss_dssp HTSGGGTTTC
T ss_pred hcCccccccC
Confidence 973 44443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=334.95 Aligned_cols=268 Identities=19% Similarity=0.238 Sum_probs=188.5
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
....++|++.+.||+|+||+||+|+.. +++.||||++... ......+.+|++.++.++|||
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~~~~~l~~l~h~n 80 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------------------PRFRNRELQIMQDLAVLHHPN 80 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC------------------TTCCCHHHHHHHHHHHHCCTT
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC------------------ccccHHHHHHHHHHHhcCCCC
Confidence 455689999999999999999999975 6899999988321 122345667888889999999
Q ss_pred cceEEEEEecCCc-------cEEEEeccCCCChHHHhhh--cCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCC
Q 002250 704 VVKLYCSITSEDS-------NLLVYEYLPNGSLWDRLHT--CHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVK 774 (947)
Q Consensus 704 iv~l~~~~~~~~~-------~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlk 774 (947)
|+++++++...+. .++||||+++ ++.+.+.. .....+++..+..++.|++.|++|||. ++.+|+|||||
T Consensus 81 iv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlk 158 (360)
T 3e3p_A 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIK 158 (360)
T ss_dssp BCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCC
T ss_pred cccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCC
Confidence 9999999976443 6899999976 55554442 234568899999999999999999993 26899999999
Q ss_pred CCCeEecC-CCCeEEeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCC
Q 002250 775 SSNILLDL-EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPE 852 (947)
Q Consensus 775 p~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~ 852 (947)
|+||+++. ++.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 159 p~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 159 PHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp GGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 99999996 89999999999987654432 22446899999999987654 899999999999999999999999543
Q ss_pred CCCcccHHHHHHhhccccccc----------ccccc-------CCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 853 FGDSKDIVNWVYSKMDSRDSM----------LTVVD-------PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~----------~~~~d-------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
.. ...+.............. ....+ ..+..........+.+++.+|++.||.+|||+.|+++
T Consensus 236 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 236 NS-AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp SH-HHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Ch-HHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11 111111111100000000 00000 0011122234667999999999999999999999996
Q ss_pred H
Q 002250 916 M 916 (947)
Q Consensus 916 ~ 916 (947)
+
T Consensus 315 h 315 (360)
T 3e3p_A 315 H 315 (360)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=338.92 Aligned_cols=260 Identities=20% Similarity=0.261 Sum_probs=196.0
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|.+.+.||+|+||+||+|... +|+.||||++.... ........+.+|+.++++++||||+
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~niv 104 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---------------QSEIFAKRAYRELLLLKHMQHENVI 104 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT---------------SSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc---------------cchhHHHHHHHHHHHHHhcCCCCch
Confidence 3478999999999999999999965 68999999984221 0112246788999999999999999
Q ss_pred eEEEEEecCCcc------EEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 706 KLYCSITSEDSN------LLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 706 ~l~~~~~~~~~~------~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
++++++...+.. ++||||++ ++|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 105 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl 176 (371)
T 4exu_A 105 GLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLA 176 (371)
T ss_dssp CCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred hhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeE
Confidence 999999887765 99999996 688887753 4899999999999999999999 889999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 780 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+
T Consensus 177 l~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~ 249 (371)
T 4exu_A 177 VNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLD 249 (371)
T ss_dssp ECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHH
T ss_pred ECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--hHH
Confidence 999999999999999855432 224568999999999987 678999999999999999999999995431 111
Q ss_pred HHHHHHhhc-cccccc----------------cccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 859 IVNWVYSKM-DSRDSM----------------LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 859 ~~~~~~~~~-~~~~~~----------------~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
......... ...... ..................+.+++.+|++.||++|||+.|++++
T Consensus 250 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 250 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 111111000 000000 0000011111222345678999999999999999999999875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=333.39 Aligned_cols=309 Identities=19% Similarity=0.180 Sum_probs=185.4
Q ss_pred ccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEE
Q 002250 156 KLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNF 235 (947)
Q Consensus 156 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 235 (947)
.+++++.|++++|.++...+..+..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 34566666666666665444456667777777777777766666667777777777777777776666667777777777
Q ss_pred eccCCCCCCCCcc-ccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCccccccccccccccc
Q 002250 236 DVSQNRLEGDLSE-LRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLT 314 (947)
Q Consensus 236 ~Ls~N~l~~~~~~-l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 314 (947)
+|++|+++..+.. +..+++|++|+|++|++++..+..|..+++|++|++++|++++. .++.+++|+.|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 7777777665554 46677777777777777766666777777777777777777643 2455666677777766655
Q ss_pred CCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCccc
Q 002250 315 GPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIG 394 (947)
Q Consensus 315 ~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 394 (947)
+ +....+|+.|++++|.+... |... .++|+.|++++|++++. ..+.
T Consensus 200 ~-----------------------------~~~~~~L~~L~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~~~--~~l~ 245 (390)
T 3o6n_A 200 T-----------------------------LAIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT--AWLL 245 (390)
T ss_dssp E-----------------------------EECCSSCSEEECCSSCCCEE-ECCC--CSSCCEEECCSSCCCCC--GGGG
T ss_pred c-----------------------------cCCCCcceEEECCCCeeeec-cccc--cccccEEECCCCCCccc--HHHc
Confidence 2 11223566677777776633 3222 35666777777766643 3455
Q ss_pred ccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCccccccccccee
Q 002250 395 NAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDI 474 (947)
Q Consensus 395 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 474 (947)
.+++|++|++++|++++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..++.+++|+.|
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L 323 (390)
T 3o6n_A 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323 (390)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred CCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEE
Confidence 66666666666666665555556666666666666666652 3444444555555555555554 233344444444455
Q ss_pred eccCceeeeecCCCCCccCcCcEEECCCCccC
Q 002250 475 NFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFS 506 (947)
Q Consensus 475 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 506 (947)
+|++|++++. | +..+++|+.|+|++|+++
T Consensus 324 ~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 324 YLDHNSIVTL-K--LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp ECCSSCCCCC-C--CCTTCCCSEEECCSSCEE
T ss_pred ECCCCcccee-C--chhhccCCEEEcCCCCcc
Confidence 5555444421 1 333444444444444444
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=345.04 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=186.7
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 707 (947)
+.|...+.||+|+||+||.+...+|+.||||++.. ...+.+.+|+++++++ +||||+++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~--------------------~~~~~~~~E~~~l~~l~~HpnIv~~ 74 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--------------------DFCDIALMEIKLLTESDDHPNVIRY 74 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG--------------------GGHHHHHHHHHHHHHHTTSTTBCCE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH--------------------HHHHHHHHHHHHHHhccCCCCcCeE
Confidence 44556788999999999877767799999998831 1234578899999987 89999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccC-----CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEM-----DWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
++++..++..++||||++ |+|.+++........ ++..+..++.||+.||+||| +.+|+||||||+||+++.
T Consensus 75 ~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~ 150 (434)
T 2rio_A 75 YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVST 150 (434)
T ss_dssp EEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEC
T ss_pred EEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEec
Confidence 999999999999999995 699999986432211 23345679999999999999 899999999999999975
Q ss_pred C-------------CCeEEeccccceecccCCCCc--ceecccccccccCcccccc-------CCCCCccchHHHHHHHH
Q 002250 783 E-------------WKPRIADFGLAKIVQTGEAGD--LTHVIAGTHGYIAPEYAYT-------CKINEKSDVYSFGVVLM 840 (947)
Q Consensus 783 ~-------------~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~ 840 (947)
+ +.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 151 ~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ 230 (434)
T 2rio_A 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230 (434)
T ss_dssp CHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHH
T ss_pred CcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHH
Confidence 4 489999999998765443211 1224579999999999965 56889999999999999
Q ss_pred HHHh-CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 841 ELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 841 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
||++ |+.||....... ........ ... ..........+..+.+++.+|++.||++|||+.|+++
T Consensus 231 ellt~g~~Pf~~~~~~~---~~i~~~~~----~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 231 YILSKGKHPFGDKYSRE---SNIIRGIF----SLD----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHTTSCCTTCSTTTHH---HHHHHTCC----CCC----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhCCCCCCCCchhhH---HHHhcCCC----Ccc----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 9999 999985432211 11111111 000 0011123456678999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.65 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=175.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHH-HHhhccccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA-TLSAVRHVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~ 706 (947)
++|+..+.||+|+||.||+|... +|+.||||++.... .......+.+|+. +++.++||||++
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~~~~~~~h~niv~ 85 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV----------------DEKEQKQLLMDLDVVMRSSDCPYIVQ 85 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC----------------CHHHHHHHHHHHHHHHSSCCCTTBCC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc----------------CchHHHHHHHHHHHHHHcCCCCcEee
Confidence 67889999999999999999975 78999999984221 0112234555555 677789999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhh---cCCccCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEeccCCCCCeEecC
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHT---CHKIEMDWVVRYAIAVGAAKGLEYLHHGFDR-PVIHRDVKSSNILLDL 782 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~Dlkp~NIll~~ 782 (947)
+++++..++..++||||+++ +|.+++.. .....+++..+..++.|++.||+||| +. +|+||||||+||+++.
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~ 161 (327)
T 3aln_A 86 FYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDR 161 (327)
T ss_dssp EEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEET
T ss_pred eeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcC
Confidence 99999999999999999975 88887763 23456899999999999999999999 67 9999999999999999
Q ss_pred CCCeEEeccccceecccCCCCcceecccccccccCcccc----ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYA----YTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
++.+||+|||+++....... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.....
T Consensus 162 ~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---- 234 (327)
T 3aln_A 162 SGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS---- 234 (327)
T ss_dssp TTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------
T ss_pred CCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch----
Confidence 99999999999976543322 2233689999999998 456689999999999999999999999853211
Q ss_pred HHHHHHhhccccccccccccCCC-CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 859 IVNWVYSKMDSRDSMLTVVDPNI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
..+......... .+.+ ..........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 235 VFDQLTQVVKGD-------PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -----CCCCCSC-------CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhcCC-------CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111110010000 0111 1111223456889999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=330.59 Aligned_cols=260 Identities=20% Similarity=0.281 Sum_probs=190.6
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~iv 71 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----------------DPQSVKHALREIKIIRRLDHDNIV 71 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----------------SHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----------------ChHHHHHHHHHHHHHHhcCCCCee
Confidence 3578999999999999999999976 5899999988321 112346788999999999999999
Q ss_pred eEEEEEe--------------cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 002250 706 KLYCSIT--------------SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHR 771 (947)
Q Consensus 706 ~l~~~~~--------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~ 771 (947)
++++++. .....++||||++ |+|.+++.. ..+++..+..++.|++.||+||| +.+|+||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 144 (320)
T 2i6l_A 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH---SANVLHR 144 (320)
T ss_dssp CEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred EEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH---hCCEecC
Confidence 9999874 3456789999997 699999875 45889999999999999999999 8899999
Q ss_pred cCCCCCeEec-CCCCeEEeccccceecccCCC-CcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCC
Q 002250 772 DVKSSNILLD-LEWKPRIADFGLAKIVQTGEA-GDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRP 848 (947)
Q Consensus 772 Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p 848 (947)
||||+||+++ +++.+||+|||+++....... ........+|..|+|||.+.. ..++.++||||||+++|||++|+.|
T Consensus 145 dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (320)
T 2i6l_A 145 DLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224 (320)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCC
Confidence 9999999997 567999999999986543221 111223457999999998865 6789999999999999999999999
Q ss_pred CCCCCCCcccHHHHHHhhccccccc-----cc------------cccC--CCCccCHHHHHHHHHHHHhccCCCCCCCCC
Q 002250 849 IVPEFGDSKDIVNWVYSKMDSRDSM-----LT------------VVDP--NISEILKEDALKVLRIAIHCTNKLPAFRPS 909 (947)
Q Consensus 849 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~------------~~d~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 909 (947)
|.... ..+............ .+ ...+ .........+..+.+++.+|++.||++|||
T Consensus 225 f~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 225 FAGAH-----ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp SCCSS-----HHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred CCCCC-----HHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 95432 111111111000000 00 0000 011122234567889999999999999999
Q ss_pred HHHHHH
Q 002250 910 MRVVVQ 915 (947)
Q Consensus 910 ~~ev~~ 915 (947)
+.|+++
T Consensus 300 ~~ell~ 305 (320)
T 2i6l_A 300 AEEALS 305 (320)
T ss_dssp HHHHHT
T ss_pred HHHHhC
Confidence 999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=330.39 Aligned_cols=260 Identities=18% Similarity=0.218 Sum_probs=201.2
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CC-cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc-
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SG-KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN- 703 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n- 703 (947)
+.++|++.+.||+|+||+||+|... ++ +.||||++... ......+.+|+.++++++|++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~~~~~ 78 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------------------GKYREAARLEINVLKKIKEKDK 78 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------------------HHHHHHHHHHHHHHHHHHHHCT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------------------ccchhHHHHHHHHHHHHhhcCC
Confidence 4578999999999999999999965 44 68999998311 123456788999999998877
Q ss_pred -----cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 704 -----VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 704 -----iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
++.+++++...+..++||||+ ++++.+++.......+++..+..++.|++.||+||| +.+|+||||||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NI 154 (355)
T 2eu9_A 79 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENI 154 (355)
T ss_dssp TSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGE
T ss_pred CCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHE
Confidence 999999999999999999999 778888887765567999999999999999999999 89999999999999
Q ss_pred Ee-------------------cCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHH
Q 002250 779 LL-------------------DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839 (947)
Q Consensus 779 ll-------------------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l 839 (947)
++ +.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++
T Consensus 155 ll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 229 (355)
T 2eu9_A 155 LFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229 (355)
T ss_dssp EESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred EEecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHH
Confidence 99 567899999999998654322 235789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCcccHHHHHHhhccccc-cc-------cc------cccC----------------CCCccCHHHH
Q 002250 840 MELVTGKRPIVPEFGDSKDIVNWVYSKMDSRD-SM-------LT------VVDP----------------NISEILKEDA 889 (947)
Q Consensus 840 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~-------~~------~~d~----------------~~~~~~~~~~ 889 (947)
|||++|+.||.... ..+....+........ .+ .. ..+. ..........
T Consensus 230 ~el~~g~~pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (355)
T 2eu9_A 230 FEYYRGFTLFQTHE--NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 307 (355)
T ss_dssp HHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHH
T ss_pred HHHHhCCCCCCCCC--HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhH
Confidence 99999999995432 1111111111110000 00 00 0000 0001122345
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 890 LKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 890 ~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
..+.+++.+|++.||++|||+.|+++
T Consensus 308 ~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 308 VQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 67899999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=332.00 Aligned_cols=259 Identities=20% Similarity=0.258 Sum_probs=195.7
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ........+.+|+.++++++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv~ 87 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---------------QSEIFAKRAYRELLLLKHMQHENVIG 87 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT---------------SSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc---------------cchHHHHHHHHHHHHHHhcCCCCccc
Confidence 467889999999999999999965 68999999984211 01122456889999999999999999
Q ss_pred EEEEEecCCc------cEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 707 LYCSITSEDS------NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 707 l~~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
+++++..... .++||||++ ++|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 88 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~ 159 (353)
T 3coi_A 88 LLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAV 159 (353)
T ss_dssp CSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEE
T ss_pred HhheEecccccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeE
Confidence 9999987654 499999996 688887753 4899999999999999999999 8899999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
+.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ..+.
T Consensus 160 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~ 232 (353)
T 3coi_A 160 NEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQ 232 (353)
T ss_dssp CTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC--HHHH
T ss_pred CCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHH
Confidence 99999999999999764332 223468999999999877 678999999999999999999999995431 1111
Q ss_pred HHHHHhhc-cccc----------------cccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 860 VNWVYSKM-DSRD----------------SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 860 ~~~~~~~~-~~~~----------------~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
........ .... .+.......+..........+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 233 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11111000 0000 000000111222333445678999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=330.93 Aligned_cols=249 Identities=20% Similarity=0.292 Sum_probs=199.3
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc--cc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR--HV 702 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ 702 (947)
.+.++|++.+.||+|+||.||+|+.. +++.||||++....... .........+.+|+.++++++ ||
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~~~~~ 108 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD-----------WGELPNGTRVPMEVVLLKKVSSGFS 108 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCC-----------EEECTTCCEEEHHHHHHHHHCSSSC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchh-----------hhhhhhhhHHHHHHHHHHhhccCCC
Confidence 34578999999999999999999954 78999999985322110 000123356778999999996 59
Q ss_pred ccceEEEEEecCCccEEEEeccCC-CChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPN-GSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
||+++++++..++..++||||+.+ ++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 109 ~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILID 183 (320)
T ss_dssp SBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEE
T ss_pred CceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEe
Confidence 999999999999999999999976 8999999863 45889999999999999999999 89999999999999999
Q ss_pred -CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 782 -LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 782 -~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
+++.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------- 252 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------- 252 (320)
T ss_dssp TTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------
T ss_pred CCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-------
Confidence 78999999999998765432 223468999999999987765 67899999999999999999998421
Q ss_pred HHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..... .... .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 253 ~~~~~----~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 253 EEIIR----GQVF-----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HHHHH----CCCC-----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhc----cccc-----------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 0000 111223568889999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=327.81 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=191.4
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc----
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV---- 699 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---- 699 (947)
+.+.++|++.+.||+|+||.||+|+.. +++.||||++........ ........+.+|+.++.++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~~~~ 95 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW-----------SPLSDSVTCPLEVALLWKVGAGG 95 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-------------------CCCCHHHHHHHHHHSSC
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccc-----------ccchhhHHHHHHHHHHHhhcccC
Confidence 455688999999999999999999964 789999999853321100 0112334566799999999
Q ss_pred cccccceEEEEEecCCccEEEEec-cCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 700 RHVNVVKLYCSITSEDSNLLVYEY-LPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 700 ~h~niv~l~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+||||+++++++..++..++|||| +++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni 170 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENI 170 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGE
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhE
Confidence 899999999999999999999999 7899999999874 35899999999999999999999 88999999999999
Q ss_pred Eec-CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCC-CccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 002250 779 LLD-LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKIN-EKSDVYSFGVVLMELVTGKRPIVPEFGDS 856 (947)
Q Consensus 779 ll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~ 856 (947)
+++ .++.+||+|||+++...... .....||..|+|||++.+..+. .++||||||+++|||++|+.||...
T Consensus 171 l~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---- 242 (312)
T 2iwi_A 171 LIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---- 242 (312)
T ss_dssp EEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----
T ss_pred EEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----
Confidence 999 88999999999998765432 2244689999999999877664 5899999999999999999998421
Q ss_pred ccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.+... ... .........+.+++.+|++.||++|||+.|++++
T Consensus 243 ---~~~~~----~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 243 ---QEILE----AEL-----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---HHHHH----TCC-----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---HHHhh----hcc-----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 000 1112234567889999999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=338.89 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=184.3
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 707 (947)
.+|...+.||+|+||+||.....+++.||||++.+ .....+.+|+++++++ +|||||++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~--------------------~~~~~~~~E~~~l~~l~~HpnIv~l 83 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP--------------------ECFSFADREVQLLRESDEHPNVIRY 83 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECT--------------------TTEEECHHHHHHHHHSCCCTTBCCE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECH--------------------HHHHHHHHHHHHHHhccCCCCcCeE
Confidence 35788899999999997765566799999999832 1123457899999999 89999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC-----
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL----- 782 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~----- 782 (947)
++++.++...|+||||++ |+|.+++.... ....+.....++.||+.||+||| +.+|+||||||+||+++.
T Consensus 84 ~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~ 158 (432)
T 3p23_A 84 FCTEKDRQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHG 158 (432)
T ss_dssp EEEEEETTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTT
T ss_pred EEEEecCCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCC
Confidence 999999999999999995 69999998643 23444455689999999999999 889999999999999953
Q ss_pred CCCeEEeccccceecccCCC-CcceecccccccccCccccc---cCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 002250 783 EWKPRIADFGLAKIVQTGEA-GDLTHVIAGTHGYIAPEYAY---TCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSK 857 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~ 857 (947)
...+||+|||+|+....... ........||+.|+|||++. ...++.++|||||||++|||++ |..||.....
T Consensus 159 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--- 235 (432)
T 3p23_A 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--- 235 (432)
T ss_dssp BCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---
T ss_pred ceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---
Confidence 34588999999987654321 12233457999999999997 4567789999999999999999 8889843211
Q ss_pred cHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 858 DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
..... ... ... .............+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~---~~~-~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 236 RQANI---LLG-ACS------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHH---HTT-CCC------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHH---Hhc-cCC------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11111 110 000 0111112234456788999999999999999999984
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=349.42 Aligned_cols=336 Identities=18% Similarity=0.144 Sum_probs=194.7
Q ss_pred cccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEe
Q 002250 157 LEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFD 236 (947)
Q Consensus 157 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 236 (947)
+.+++.|++++|.++...+..+.++++|++|+|++|.|++..|..|..+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 44556666666666655555566666677777777766666666666666777777777777666666666677777777
Q ss_pred ccCCCCCCCCcc-ccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccC
Q 002250 237 VSQNRLEGDLSE-LRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315 (947)
Q Consensus 237 Ls~N~l~~~~~~-l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 315 (947)
|++|.+++.+.. +..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++. + ++.+++|+.|++++|.+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~--~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-C--GGGCTTCSEEECCSSCCSE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-C--hhhhhhhhhhhcccCcccc
Confidence 777766665544 46666677777777777766666777777777777777777643 2 4455666666666666542
Q ss_pred CCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccc
Q 002250 316 PIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGN 395 (947)
Q Consensus 316 ~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 395 (947)
+....+|+.|++++|.++...+ .+ .++|+.|+|++|.+++. ..+..
T Consensus 207 -----------------------------l~~~~~L~~L~ls~n~l~~~~~-~~--~~~L~~L~L~~n~l~~~--~~l~~ 252 (597)
T 3oja_B 207 -----------------------------LAIPIAVEELDASHNSINVVRG-PV--NVELTILKLQHNNLTDT--AWLLN 252 (597)
T ss_dssp -----------------------------EECCTTCSEEECCSSCCCEEEC-SC--CSCCCEEECCSSCCCCC--GGGGG
T ss_pred -----------------------------ccCCchhheeeccCCccccccc-cc--CCCCCEEECCCCCCCCC--hhhcc
Confidence 1122346666666666653322 22 14566666666666542 34555
Q ss_pred cccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceee
Q 002250 396 AKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDIN 475 (947)
Q Consensus 396 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 475 (947)
+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++ + |..+..+++|+.|+
T Consensus 253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l------------------------~~~~~~l~~L~~L~ 307 (597)
T 3oja_B 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-L------------------------NLYGQPIPTLKVLD 307 (597)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-E------------------------ECSSSCCTTCCEEE
T ss_pred CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-C------------------------CcccccCCCCcEEE
Confidence 5555555555555555555555555555555555555542 3 33344455555555
Q ss_pred ccCceeeeecCCCCCccCcCcEEECCCCccCCccCCcccccccceeeCCCCcCCCCCCCcccccccccccccCCCCCCCC
Q 002250 476 FAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGLCSKT 555 (947)
Q Consensus 476 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~gN~~~c~~~ 555 (947)
|++|.++ .+|..+..+++|+.|+|++|++++..+ ..+++|+.|+|++|++++..+..+-.......+.+|+..|+..
T Consensus 308 Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 308 LSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKL--STHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp CCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCC--CTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCTT
T ss_pred CCCCCCC-ccCcccccCCCCCEEECCCCCCCCcCh--hhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCcc
Confidence 5555555 445455555555566666665554321 1235566666666666543322221222334567888899875
Q ss_pred cc
Q 002250 556 DE 557 (947)
Q Consensus 556 ~~ 557 (947)
..
T Consensus 385 ~~ 386 (597)
T 3oja_B 385 YQ 386 (597)
T ss_dssp CE
T ss_pred hh
Confidence 43
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=326.94 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=178.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... .......+.++..+++.++||||++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~~~~~~~~~~~~~h~~i~~ 88 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---------------KEENKRILMDLDVVLKSHDCPYIVQ 88 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC---------------HHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc---------------chHHHHHHHHHHHHHHhcCCCceee
Confidence 478899999999999999999975 789999999842210 0111233445556788889999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEeccCCCCCeEecCCCC
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDR-PVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~Dlkp~NIll~~~~~ 785 (947)
+++++..++..++||||+ ++.+..+... ....+++..+..++.|++.||+||| +. +|+||||||+||+++.++.
T Consensus 89 ~~~~~~~~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~ 163 (318)
T 2dyl_A 89 CFGTFITNTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQ 163 (318)
T ss_dssp EEEEEECSSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSC
T ss_pred EEEEEecCCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCC
Confidence 999999999999999999 5555554443 3456899999999999999999999 64 9999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+||+|||++........ .....||+.|+|||++. ...++.++||||||+++|||++|+.||..... ..
T Consensus 164 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~ 236 (318)
T 2dyl_A 164 IKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT----DF 236 (318)
T ss_dssp EEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS----HH
T ss_pred EEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc----cH
Confidence 99999999976544322 22346899999999984 45688999999999999999999999853211 11
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
+........... .++ .....+..+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~-------~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 237 EVLTKVLQEEPP-------LLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHHHHHSCCC-------CCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHhccCCC-------CCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111111111111 010 01123356888999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=347.76 Aligned_cols=270 Identities=24% Similarity=0.323 Sum_probs=201.2
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
..++|++.+.||+|+||+||+|... +|+.||||++.... .......+.+|++++++++||||+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~----------------~~~~~~~~~~Ei~iL~~L~HpnIV 75 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL----------------SPKNRERWCLEIQIMKKLNHPNVV 75 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC----------------CHHHHHHHHHHHHHHHHCCBTTBC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC----------------CHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3588999999999999999999964 68999999884211 112346788999999999999999
Q ss_pred eEEEEEec------CCccEEEEeccCCCChHHHhhhcC-CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 706 KLYCSITS------EDSNLLVYEYLPNGSLWDRLHTCH-KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 706 ~l~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
++++++.. ++..++||||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||
T Consensus 76 ~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NI 152 (676)
T 3qa8_A 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENI 152 (676)
T ss_dssp CEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTE
T ss_pred ceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHe
Confidence 99999765 667799999999999999998743 235888889999999999999999 89999999999999
Q ss_pred EecCCCC---eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 779 LLDLEWK---PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 779 ll~~~~~---~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
+++.++. +||+|||.+........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||.+..
T Consensus 153 Ll~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-- 227 (676)
T 3qa8_A 153 VLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-- 227 (676)
T ss_dssp EEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC--
T ss_pred EeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc--
Confidence 9997765 99999999987654432 234578999999999999999999999999999999999999996431
Q ss_pred cccHHHHHHhhccccc---cccc------ccc---CCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHH-----HHHHhh
Q 002250 856 SKDIVNWVYSKMDSRD---SMLT------VVD---PNISEILKEDALKVLRIAIHCTNKLPAFRPSMRV-----VVQMLE 918 (947)
Q Consensus 856 ~~~~~~~~~~~~~~~~---~~~~------~~d---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e-----v~~~L~ 918 (947)
....|......... .... .+. +.........+..+.+++.+|++.||++|||+.| +.+.++
T Consensus 228 --~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 228 --QPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp --HHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred --chhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 11111110000000 0000 000 1112344456778999999999999999999987 445555
Q ss_pred ccCC
Q 002250 919 EAEP 922 (947)
Q Consensus 919 ~~~~ 922 (947)
.+..
T Consensus 306 ~iL~ 309 (676)
T 3qa8_A 306 SILS 309 (676)
T ss_dssp HHHC
T ss_pred HHHh
Confidence 5443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.31 Aligned_cols=235 Identities=14% Similarity=0.122 Sum_probs=184.0
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||.||+|+.. +++.||||++...... .......+.+|+.++++++||||+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~--------------~~~~~~~~~~e~~~l~~l~hp~iv 94 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL--------------PDDVLQETLSRTLRLSRIDKPGVA 94 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS--------------CHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc--------------CHHHHHHHHHHHHHHhcCCCCCcc
Confidence 3477999999999999999999976 5899999998532110 012336788999999999999999
Q ss_pred eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCC
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWK 785 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 785 (947)
++++++..++..|+||||+++++|.++++.. .......+++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 95 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~ 167 (286)
T 3uqc_A 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGD 167 (286)
T ss_dssp CEEEEEEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSC
T ss_pred eeeEEEEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCC
Confidence 9999999999999999999999999999652 344567889999999999999 899999999999999999999
Q ss_pred eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 786 PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 786 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+||+++| |++| ++.++|||||||++|||+||+.||........
T Consensus 168 ~kl~~~~----------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-------- 210 (286)
T 3uqc_A 168 VVLAYPA----------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-------- 210 (286)
T ss_dssp EEECSCC----------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC--------
T ss_pred EEEEecc----------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh--------
Confidence 9998543 3333 67899999999999999999999964321100
Q ss_pred hccccccccccccCCC---CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 866 KMDSRDSMLTVVDPNI---SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
. ........... .......+..+.+++.+||+.||++| |+.|+++.|+++....
T Consensus 211 -~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 211 -L---APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp -S---EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred -h---HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0 00000001111 12223345668899999999999999 9999999999977654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=317.16 Aligned_cols=152 Identities=25% Similarity=0.373 Sum_probs=84.4
Q ss_pred cccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCC
Q 002250 128 SLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNK 207 (947)
Q Consensus 128 ~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 207 (947)
.+..+++|++|++++|.+... + .+..+++|++|++++|.+++. +. +..+++|++|+|++|.+++ + ..+.++++
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~~--~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~ 111 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVASI--Q-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-I-SALQNLTN 111 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCCC--T-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTT
T ss_pred cchhcccccEEEEeCCccccc--h-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-c-hHHcCCCc
Confidence 355677777777777777553 2 255666666666666666643 22 6666666666666666653 2 24566666
Q ss_pred CcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCc
Q 002250 208 LWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTN 287 (947)
Q Consensus 208 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 287 (947)
|++|++++|.+++..+ +..+++|++|++++|.....+..+..+++|++|++++|.+.+..+ +..+++|++|++++|
T Consensus 112 L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp CSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CCEEECcCCcccCchh--hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 6666666666653322 555555555555555444344444555555555555555442222 444444444444444
Q ss_pred ccc
Q 002250 288 RLT 290 (947)
Q Consensus 288 ~l~ 290 (947)
+++
T Consensus 188 ~l~ 190 (347)
T 4fmz_A 188 QIE 190 (347)
T ss_dssp CCC
T ss_pred ccc
Confidence 444
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=315.84 Aligned_cols=194 Identities=25% Similarity=0.377 Sum_probs=102.4
Q ss_pred cccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCC
Q 002250 104 LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQ 183 (947)
Q Consensus 104 l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 183 (947)
+..+++|++|++++|.+.. ++ .+..+++|++|++++|.+... +. +..+++|++|++++|.+++ + +.+..+++
T Consensus 40 ~~~l~~L~~L~l~~~~i~~-~~--~~~~~~~L~~L~l~~n~i~~~--~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~ 111 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVAS-IQ--GIEYLTNLEYLNLNGNQITDI--SP-LSNLVKLTNLYIGTNKITD-I-SALQNLTN 111 (347)
T ss_dssp HHHHTTCSEEECCSSCCCC-CT--TGGGCTTCCEEECCSSCCCCC--GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTT
T ss_pred chhcccccEEEEeCCcccc-ch--hhhhcCCccEEEccCCccccc--hh-hhcCCcCCEEEccCCcccC-c-hHHcCCCc
Confidence 3455566666666666543 22 355566666666666655542 22 5556666666666666653 2 24556666
Q ss_pred CCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCc
Q 002250 184 LQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFEN 263 (947)
Q Consensus 184 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N 263 (947)
|++|+|++|++.+. +. +..+++|++|++++|..... +..+..+++|++|++++|.+.+... +..+++|++|++++|
T Consensus 112 L~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 112 LRELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYN 187 (347)
T ss_dssp CSEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECTTS
T ss_pred CCEEECcCCcccCc-hh-hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCCchh-hccCCCCCEEEccCC
Confidence 66666666665533 22 55566666666666644322 2235566666666666666554433 555566666666666
Q ss_pred cCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccc
Q 002250 264 QFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLL 313 (947)
Q Consensus 264 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 313 (947)
.+.+..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.+
T Consensus 188 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l 233 (347)
T 4fmz_A 188 QIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI 233 (347)
T ss_dssp CCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred ccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCcc
Confidence 6553222 5555555555555555542222 33344444444444433
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.48 Aligned_cols=232 Identities=23% Similarity=0.317 Sum_probs=183.0
Q ss_pred HHHHhhccCCc-ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHH-hhcc
Q 002250 624 EKEIIDAVKPE-NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATL-SAVR 700 (947)
Q Consensus 624 ~~~~~~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~ 700 (947)
...+.++|.+. +.||+|+||.||+|... +++.||||++. ....+.+|+.++ +..+
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~----------------------~~~~~~~e~~~~~~~~~ 69 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----------------------DCPKARREVELHWRASQ 69 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE----------------------CSHHHHHHHHHHHHHTT
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEec----------------------ccHHHHHHHHHHHHhcc
Confidence 34556778887 78999999999999964 78999999982 234677899988 5559
Q ss_pred ccccceEEEEEec----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 002250 701 HVNVVKLYCSITS----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776 (947)
Q Consensus 701 h~niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~ 776 (947)
||||+++++++.. +...++||||+++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+
T Consensus 70 h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~ 146 (299)
T 3m2w_A 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 146 (299)
T ss_dssp STTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGG
T ss_pred CCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHH
Confidence 9999999999876 667899999999999999999866667999999999999999999999 899999999999
Q ss_pred CeEecC---CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 002250 777 NILLDL---EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEF 853 (947)
Q Consensus 777 NIll~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~ 853 (947)
||+++. ++.+||+|||++.... +..++.++||||+||++|||++|+.||....
T Consensus 147 Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 147 NLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred HEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 999998 7889999999986432 1346778999999999999999999995331
Q ss_pred CCcccHHHHHHhhccccccccccccCCCCccC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 854 GDSKDIVNWVYSKMDSRDSMLTVVDPNISEIL----KEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
... . .... ...........+ ...+..+.+++.+|++.||++|||+.|++++
T Consensus 203 ~~~-----~-~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 203 GLA-----I-SPGM------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp -----------CCS------CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chh-----h-hHHH------HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 100 0 0000 000000001111 2235678899999999999999999999973
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=347.45 Aligned_cols=239 Identities=21% Similarity=0.268 Sum_probs=190.7
Q ss_pred hhccCCcccccccCceeEEEEEeC--CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN--SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
.++|++.+.||+|+||+||+|... +++.||||++.... .......+.+|+.++++++||||+
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~hp~iv 142 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG----------------DAEAQAMAMAERQFLAEVVHPSIV 142 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC----------------CHHHHHHHHHHHGGGGGCCCTTBC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC----------------CHHHHHHHHHHHHHHHhcCCCCcC
Confidence 478999999999999999999975 68999999884211 112345688999999999999999
Q ss_pred eEEEEEecCCc-----cEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 706 KLYCSITSEDS-----NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 706 ~l~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
++++++...+. .|+||||+++++|.+++.. .+++..+..++.||+.||+||| +.+|+||||||+||++
T Consensus 143 ~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll 215 (681)
T 2pzi_A 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIML 215 (681)
T ss_dssp CEEEEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred eEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEE
Confidence 99999988766 6999999999999987764 5899999999999999999999 8899999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 781 DLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 781 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+.+ .+||+|||+++..... ....||+.|+|||++.++ ++.++|||||||++|||++|..||.......
T Consensus 216 ~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---- 283 (681)
T 2pzi_A 216 TEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---- 283 (681)
T ss_dssp CSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----
T ss_pred eCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----
Confidence 986 9999999999876443 245699999999998765 4889999999999999999998874321100
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHhhc
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-MRVVVQMLEE 919 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~~~L~~ 919 (947)
.. . ..........+.+++.+|++.||++||+ +.++.+.|..
T Consensus 284 ------------~~----~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 ------------LP----E--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------------CC----T--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------------cc----c--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 0 0011223457889999999999999995 5556565554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=303.40 Aligned_cols=294 Identities=21% Similarity=0.281 Sum_probs=197.9
Q ss_pred cCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEecc
Q 002250 159 KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVS 238 (947)
Q Consensus 159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 238 (947)
+|+.+++++|.++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4566666666666 4555443 577778888777776666777777778888888888777777778888888888888
Q ss_pred CCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccc--ccCCcCccCcccccccccccccccCC
Q 002250 239 QNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT--GTLPQKLGSWADFNYVDVSENLLTGP 316 (947)
Q Consensus 239 ~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~~ 316 (947)
+|+++..+..+. ++|++|++++|++++..+..|..+++|++|++++|+++ +..|..+..+ +|++|++++|.+++
T Consensus 111 ~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~- 186 (332)
T 2ft3_A 111 KNHLVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG- 186 (332)
T ss_dssp SSCCCSCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred CCcCCccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence 887776665544 68888888888888666667888888999999999886 3667777777 88888888888773
Q ss_pred CCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCccccc
Q 002250 317 IPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNA 396 (947)
Q Consensus 317 ~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 396 (947)
+|..+ . ++|+.|++++|.+++..+..+..+++|+.|+|++|++++..+..+..+
T Consensus 187 l~~~~------------------------~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 240 (332)
T 2ft3_A 187 IPKDL------------------------P--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240 (332)
T ss_dssp CCSSS------------------------C--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGC
T ss_pred cCccc------------------------c--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCC
Confidence 33211 1 456667777777776666677777777777777777777666667777
Q ss_pred ccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeec
Q 002250 397 KSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINF 476 (947)
Q Consensus 397 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 476 (947)
++|++|++++|+++ .+|..+..+++|+.|++++|+|++..+..|..... -....+|+.|++
T Consensus 241 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~~~~l~~L~l 301 (332)
T 2ft3_A 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF------------------GVKRAYYNGISL 301 (332)
T ss_dssp TTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSC------------------CSSSCCBSEEEC
T ss_pred CCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccc------------------ccccccccceEe
Confidence 77777777777776 56666666666666666666666544444432200 001244555666
Q ss_pred cCceee--eecCCCCCccCcCcEEECCCCc
Q 002250 477 AQNSLS--GKIPDSLGSLPSLNSLNLSNNK 504 (947)
Q Consensus 477 s~N~l~--~~~p~~~~~l~~L~~L~Ls~N~ 504 (947)
++|.+. +..|..|..+++|+.|+|++|+
T Consensus 302 ~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 302 FNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ecCcccccccCcccccccchhhhhhccccc
Confidence 666554 4455556666666666666653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=322.22 Aligned_cols=242 Identities=13% Similarity=0.099 Sum_probs=177.2
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc-cccc-
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH-VNVV- 705 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv- 705 (947)
..|+..+.||+|+||+||+|+.. +|+.||||++..... ......+.+.+|+.+++.++| +|..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~--------------~~~~~~~~~~~E~~~~~~l~~~~~~~~ 143 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--------------PPSNAIKQMKEEVLRLRLLRGIKNQKQ 143 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------------------CCHHHHHHHHGGGGSTTCCSHHH
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC--------------ccHHHHHHHHHHHHHHHhhccCCCHHH
Confidence 45777889999999999999954 799999999842211 112345779999999999977 2211
Q ss_pred --------------------eEEEEEec-----CCccEEEEeccCCCChHHHhhh-----cCCccCCHHHHHHHHHHHHH
Q 002250 706 --------------------KLYCSITS-----EDSNLLVYEYLPNGSLWDRLHT-----CHKIEMDWVVRYAIAVGAAK 755 (947)
Q Consensus 706 --------------------~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~~i~~~ia~ 755 (947)
.+..++.. ....+++|+++ +++|.+++.. .....+++..++.++.|++.
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~ 222 (413)
T 3dzo_A 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222 (413)
T ss_dssp HHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHH
T ss_pred HHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHH
Confidence 11111111 12346777766 7899998852 23456788899999999999
Q ss_pred HHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCcccc----------ccCC
Q 002250 756 GLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYA----------YTCK 825 (947)
Q Consensus 756 ~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~ 825 (947)
||+||| +.+|+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ ....
T Consensus 223 aL~~LH---~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~ 293 (413)
T 3dzo_A 223 LLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTL 293 (413)
T ss_dssp HHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEE
T ss_pred HHHHHH---hCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcC
Confidence 999999 899999999999999999999999999999865432 234467 999999999 5556
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCC
Q 002250 826 INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPA 905 (947)
Q Consensus 826 ~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~ 905 (947)
++.++|||||||++|||++|+.||...... .....++. .... .+..+.+++.+||+.||+
T Consensus 294 ~~~~~DvwSlGvil~elltg~~Pf~~~~~~---------------~~~~~~~~-~~~~----~~~~~~~li~~~l~~dP~ 353 (413)
T 3dzo_A 294 MTFAFDTWTLGLAIYWIWCADLPNTDDAAL---------------GGSEWIFR-SCKN----IPQPVRALLEGFLRYPKE 353 (413)
T ss_dssp ECHHHHHHHHHHHHHHHHHSSCCCCTTGGG---------------SCSGGGGS-SCCC----CCHHHHHHHHHHTCSSGG
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCcchh---------------hhHHHHHh-hccc----CCHHHHHHHHHHccCChh
Confidence 888999999999999999999999532110 00011111 1112 235688999999999999
Q ss_pred CCCCHHHHH
Q 002250 906 FRPSMRVVV 914 (947)
Q Consensus 906 ~RPt~~ev~ 914 (947)
+|||+.|++
T Consensus 354 ~Rpt~~~~l 362 (413)
T 3dzo_A 354 DRLLPLQAM 362 (413)
T ss_dssp GSCCHHHHT
T ss_pred hCcCHHHHH
Confidence 999977664
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=310.23 Aligned_cols=248 Identities=27% Similarity=0.476 Sum_probs=149.8
Q ss_pred CCCEEEccCccCcc--cCCCCccCCCcCcEEEccC-ccccccCCcCccCcccccccccccccccCCCCCCcccCCcccee
Q 002250 254 QLSSLHLFENQFSG--EIPEEFGEFKHLTELSLYT-NRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL 330 (947)
Q Consensus 254 ~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L 330 (947)
+++.|+|++|.+++ .+|..|..+++|++|+|++ |.+.+.+|..|+.+++|++|++++|.+++
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~--------------- 115 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG--------------- 115 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEE---------------
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCC---------------
Confidence 45555555555555 5555555555555555553 55555555555555555555555555443
Q ss_pred eecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccc-cccEEEccCccc
Q 002250 331 LVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAK-SLALLLLANNRF 409 (947)
Q Consensus 331 ~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l 409 (947)
.+|..|.++++|++|++++|.+++.+|..+..+++|++|+|++|++++.+|..+..+. .|++|++++|++
T Consensus 116 ---------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l 186 (313)
T 1ogq_A 116 ---------AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp ---------ECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred ---------cCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCee
Confidence 4444555566666666666666666666666666666666666666655666666655 666666666666
Q ss_pred cccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCC
Q 002250 410 SGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSL 489 (947)
Q Consensus 410 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 489 (947)
++.+|..+..++ |+.|+|++|++++.+|..|..+++|+.|+|++|.+++.+|. +..+++|++|+|++|++++.+|..+
T Consensus 187 ~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp EEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred eccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHH
Confidence 666666666665 66666666666666666666666666666666666654444 5566666666666666666666666
Q ss_pred CccCcCcEEECCCCccCCccCCcccccccceeeCCCCc
Q 002250 490 GSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQ 527 (947)
Q Consensus 490 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ls~N~ 527 (947)
..+++|+.|+|++|+++|.+|....+++|+.|++++|+
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred hcCcCCCEEECcCCcccccCCCCccccccChHHhcCCC
Confidence 66666666666666666666655445556655555444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=301.30 Aligned_cols=295 Identities=20% Similarity=0.273 Sum_probs=174.1
Q ss_pred cCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEecc
Q 002250 159 KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVS 238 (947)
Q Consensus 159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 238 (947)
+|+.++++++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4555555555555 3444443 466677777777765555566667777777777777766666667777777777777
Q ss_pred CCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccc--cCCcCccCcccccccccccccccCC
Q 002250 239 QNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTG--TLPQKLGSWADFNYVDVSENLLTGP 316 (947)
Q Consensus 239 ~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~ 316 (947)
+|+++..+..+. ++|++|++++|++++..+..|..+++|++|++++|+++. ..+..+..+++|++|++++|.++.
T Consensus 109 ~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~- 185 (330)
T 1xku_A 109 KNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT- 185 (330)
T ss_dssp SSCCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-
T ss_pred CCcCCccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-
Confidence 777665544433 567777777777776666667777777777777777752 556666667777777777776652
Q ss_pred CCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCccccc
Q 002250 317 IPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNA 396 (947)
Q Consensus 317 ~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 396 (947)
+|..+ . ++|+.|++++|.+++..|..+..+++|+.|+|++|++++..+..+..+
T Consensus 186 l~~~~------------------------~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 239 (330)
T 1xku_A 186 IPQGL------------------------P--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 239 (330)
T ss_dssp CCSSC------------------------C--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred CCccc------------------------c--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCC
Confidence 22211 1 355566666666665555556666666666666666665555555555
Q ss_pred ccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeec
Q 002250 397 KSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINF 476 (947)
Q Consensus 397 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 476 (947)
++|++|++++|+++ .+|..+..+++|+.|++++|+|++..+..|.... ......+|+.|++
T Consensus 240 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~------------------~~~~~~~l~~l~l 300 (330)
T 1xku_A 240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG------------------YNTKKASYSGVSL 300 (330)
T ss_dssp TTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS------------------CCTTSCCCSEEEC
T ss_pred CCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcc------------------cccccccccceEe
Confidence 66666666666655 5555555556666666666666544433332210 0001244555555
Q ss_pred cCceeee--ecCCCCCccCcCcEEECCCCc
Q 002250 477 AQNSLSG--KIPDSLGSLPSLNSLNLSNNK 504 (947)
Q Consensus 477 s~N~l~~--~~p~~~~~l~~L~~L~Ls~N~ 504 (947)
++|.+.. ..|..|..+.+|+.++|++|+
T Consensus 301 ~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 301 FSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ecCcccccccCccccccccceeEEEecccC
Confidence 5555542 344555666666666666664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=314.60 Aligned_cols=251 Identities=16% Similarity=0.131 Sum_probs=186.4
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-------
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR------- 700 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------- 700 (947)
.++|++.+.||+|+||+||+|+. +|+.||||++........ ........+.+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~~l~~~~~ 88 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLV---------NGSHQKTFEEILPEIIISKELSLLSGEVC 88 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCB---------TTBCCBCHHHHHHHHHHHHHHHHGGGCSS
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCcccc---------ccccchhHHHHHHHHHHHHHHHHhhcccc
Confidence 47899999999999999999998 589999999954322100 0012234477889999999886
Q ss_pred --ccccceEEEEE-----------------ec-------------CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHH
Q 002250 701 --HVNVVKLYCSI-----------------TS-------------EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA 748 (947)
Q Consensus 701 --h~niv~l~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~ 748 (947)
||||+++.+.+ .. ++..|+||||+++|++.+.+.+ ..+++..+..
T Consensus 89 ~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~ 165 (336)
T 2vuw_A 89 NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKS 165 (336)
T ss_dssp SBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHH
T ss_pred ccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHH
Confidence 66666666553 32 6788999999999987777654 4579999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC--------------------CeEEeccccceecccCCCCcceec
Q 002250 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW--------------------KPRIADFGLAKIVQTGEAGDLTHV 808 (947)
Q Consensus 749 i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~ 808 (947)
++.||+.||+|||+ +.+|+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 166 i~~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~ 236 (336)
T 2vuw_A 166 ILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------I 236 (336)
T ss_dssp HHHHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------E
T ss_pred HHHHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------c
Confidence 99999999999993 37899999999999999887 8999999999876532 3
Q ss_pred ccccccccCccccccCCCCCccchHHHHHH-HHHHHhCCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHH
Q 002250 809 IAGTHGYIAPEYAYTCKINEKSDVYSFGVV-LMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKE 887 (947)
Q Consensus 809 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 887 (947)
.+||+.|+|||++.+.. +.++||||+|++ .+++++|..||.. ............... .............
T Consensus 237 ~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 307 (336)
T 2vuw_A 237 VVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----VLWLHYLTDKMLKQM---TFKTKCNTPAMKQ 307 (336)
T ss_dssp EECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----HHHHHHHHHHHHHTC---CCSSCCCSHHHHH
T ss_pred EEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----hhhhhHHHHhhhhhh---ccCcccchhhhhh
Confidence 47999999999998665 889999998777 7889999999721 000000111110000 0001112334556
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHH
Q 002250 888 DALKVLRIAIHCTNKLPAFRPSMRVVV 914 (947)
Q Consensus 888 ~~~~l~~l~~~cl~~dP~~RPt~~ev~ 914 (947)
....+.+++.+|++.| |+.|++
T Consensus 308 ~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 308 IKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred cCHHHHHHHHHHhccC-----CHHHHH
Confidence 7788999999999976 999988
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-31 Score=293.39 Aligned_cols=219 Identities=23% Similarity=0.266 Sum_probs=104.3
Q ss_pred ccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCC-CcccccccceeecCCCCccCccCcccccccCCCceeeC
Q 002250 62 ALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSL 140 (947)
Q Consensus 62 ~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~-~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~L 140 (947)
+++.++++++.+. .+|..+. ++|++|+|++|+|++.++ .+..+++|++|+|++|++++..| ..|.++++|++|+|
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP-GAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEEC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCH-HHhcCCCCCCEEEC
Confidence 4555666666653 2333322 456666666666665444 35555555555555555554333 44555555555555
Q ss_pred CCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccc
Q 002250 141 GDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSG 220 (947)
Q Consensus 141 s~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 220 (947)
++|.++. +|..+. ++|++|++++|++++..+..+.++++|++|++++|.++.
T Consensus 108 s~n~l~~--------------------------l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 159 (330)
T 1xku_A 108 SKNQLKE--------------------------LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 159 (330)
T ss_dssp CSSCCSB--------------------------CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG
T ss_pred CCCcCCc--------------------------cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc
Confidence 5555543 222221 344444444444443333344444444444444444432
Q ss_pred --cCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCcc
Q 002250 221 --RLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLG 298 (947)
Q Consensus 221 --~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 298 (947)
..+..|..+++|++|++++|+++..+..+. ++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+.
T Consensus 160 ~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 237 (330)
T 1xku_A 160 SGIENGAFQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237 (330)
T ss_dssp GGBCTTGGGGCTTCCEEECCSSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGG
T ss_pred cCcChhhccCCCCcCEEECCCCccccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhcc
Confidence 333444444444444444444443333222 4455555555555444444455555555555555555444444444
Q ss_pred Cccccccccccccccc
Q 002250 299 SWADFNYVDVSENLLT 314 (947)
Q Consensus 299 ~l~~L~~L~Ls~N~l~ 314 (947)
.+++|++|++++|.++
T Consensus 238 ~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 238 NTPHLRELHLNNNKLV 253 (330)
T ss_dssp GSTTCCEEECCSSCCS
T ss_pred CCCCCCEEECCCCcCc
Confidence 4444444444444443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-31 Score=295.16 Aligned_cols=287 Identities=19% Similarity=0.258 Sum_probs=200.0
Q ss_pred CccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCccccccccccc
Q 002250 231 NLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSE 310 (947)
Q Consensus 231 ~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 310 (947)
+|+.+++++|.++..+..+. ++|+.|+|++|.+++..|..|..+++|++|+|++|++++..|..|+.+++|++|++++
T Consensus 34 ~l~~l~~~~~~l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 34 HLRVVQCSDLGLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp ETTEEECCSSCCSSCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred cCCEEECCCCCccccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 34455555555544443332 4556666666666655555666666666666666666655566666666666666666
Q ss_pred ccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEccccccc--ccCCCCCCCCCCcceeccccCCcCCC
Q 002250 311 NLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLS--GTIPPGIWSLPNLSIIDLSTNQFEGP 388 (947)
Q Consensus 311 N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~ 388 (947)
|.++ .+|..+. ..|++|++.+|++.+..+..|.++++|+.|++++|.++ +..|..+..+ +|+.|++++|++++.
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l 187 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGI 187 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSC
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCcc
Confidence 6665 4444443 45666666666666555667888888888888888885 3667777777 888888888888864
Q ss_pred CCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccc
Q 002250 389 VTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSC 468 (947)
Q Consensus 389 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 468 (947)
+. .+. ++|++|++++|++++..|..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|..+..+
T Consensus 188 ~~-~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 263 (332)
T 2ft3_A 188 PK-DLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL 263 (332)
T ss_dssp CS-SSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGC
T ss_pred Cc-ccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcC
Confidence 33 332 67888888888888777778888888888888888888777777888888888888888887 677778888
Q ss_pred cccceeeccCceeeeecCCCCCcc------CcCcEEECCCCccC--CccCCccc-ccccceeeCCCCc
Q 002250 469 VSLTDINFAQNSLSGKIPDSLGSL------PSLNSLNLSNNKFS--GEIPISLT-YPKLSLLDLSNNQ 527 (947)
Q Consensus 469 ~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~--~~~p~~~~-~~~L~~L~ls~N~ 527 (947)
++|+.|++++|++++..+..|..+ .+|+.|++++|.+. +..|..+. +++|+.+++++|+
T Consensus 264 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 264 KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp TTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 888888888888887666666553 56888888888887 55555554 5788888888874
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=298.39 Aligned_cols=267 Identities=18% Similarity=0.203 Sum_probs=178.3
Q ss_pred CcccccccCCccccccc----cCCCCCcccceeeeCC---------CCceeEeccCCCccccccCcccccCCcccceeec
Q 002250 2 NLKSKIEKSDTGVFSSW----TEANSVCKFNGIVCDS---------NGLVAEINLPEQQLLGVVPFDSICGLQALQKINL 68 (947)
Q Consensus 2 ~~k~~~~~~~~~~~~sw----~~~~~~C~w~gv~c~~---------~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L 68 (947)
+||..+..|+.+++++| ..+.++|.|.|++|+. .++|+.|+|+++++. .+| ..++.+++|++|+|
T Consensus 34 ~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp-~~l~~l~~L~~L~L 111 (328)
T 4fcg_A 34 QWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFP-DQAFRLSHLQHMTI 111 (328)
T ss_dssp HHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCC-SCGGGGTTCSEEEE
T ss_pred HHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcC-hhhhhCCCCCEEEC
Confidence 57888877888899999 5677899999999963 245555555555544 333 23555555555555
Q ss_pred cCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCC
Q 002250 69 GTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPS 148 (947)
Q Consensus 69 ~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~ 148 (947)
++|.+. .+|..+..+++|++|+|++|.++..++.+..+++|++|+|++|++.+.+| ..+.. +
T Consensus 112 ~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p-~~~~~------~---------- 173 (328)
T 4fcg_A 112 DAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELP-EPLAS------T---------- 173 (328)
T ss_dssp ESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCC-SCSEE------E----------
T ss_pred CCCCcc-chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccC-hhHhh------c----------
Confidence 555554 45555555555555555555555433345555555555555555444444 12211 0
Q ss_pred CCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCC
Q 002250 149 PFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSN 228 (947)
Q Consensus 149 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~ 228 (947)
.++..+..+++|++|+|++|+++ .+|..++++++|++|+|++|+++ .+|..+..+++|++|+|++|.+.+.+|..|..
T Consensus 174 ~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~ 251 (328)
T 4fcg_A 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251 (328)
T ss_dssp C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTC
T ss_pred cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcC
Confidence 00112334777777777777777 66777777777777777777776 35556777777888888887777777777778
Q ss_pred CCCccEEeccCCCCCCC-CccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccc
Q 002250 229 LTNLMNFDVSQNRLEGD-LSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 229 l~~L~~L~Ls~N~l~~~-~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 290 (947)
+++|++|+|++|++.+. +..+..+++|+.|+|++|.+.+.+|..++.+++|+.+++..|.+.
T Consensus 252 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 252 RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 88888888888766553 446777888888888888888888888888888888888877665
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-36 Score=347.23 Aligned_cols=108 Identities=19% Similarity=0.134 Sum_probs=53.3
Q ss_pred cceEEEcccCcccCC----CCcccccccccchhhccccccCCCCCccccc-----ccccceeeccCceeee----ecCCC
Q 002250 422 SLVSIQLSLNQFSGQ----IPLDIGKLKKLSSLYLHDNMFSGPLPYSIGS-----CVSLTDINFAQNSLSG----KIPDS 488 (947)
Q Consensus 422 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~ 488 (947)
+|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++..+..+.. .++|+.|+|++|++++ .+|..
T Consensus 314 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 393 (461)
T 1z7x_W 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 393 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred cceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHH
Confidence 444444444444432 2333344455555555555544333332221 4466666666666664 55666
Q ss_pred CCccCcCcEEECCCCccCCccCCcc------cccccceeeCCCCcCC
Q 002250 489 LGSLPSLNSLNLSNNKFSGEIPISL------TYPKLSLLDLSNNQLA 529 (947)
Q Consensus 489 ~~~l~~L~~L~Ls~N~l~~~~p~~~------~~~~L~~L~ls~N~l~ 529 (947)
+..+++|++|+|++|++++.-...+ ...+|+.|++.++.+.
T Consensus 394 l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 394 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440 (461)
T ss_dssp HHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred HHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccC
Confidence 6666666666666666654311111 0124566666655554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-35 Score=339.93 Aligned_cols=356 Identities=17% Similarity=0.146 Sum_probs=225.1
Q ss_pred cccceeeccCccccCcCchh-hhcCCCccEEeCcCccCcCC-----CCCcccccccceeecCCCCccCccCcccccccC-
Q 002250 61 QALQKINLGTNFLYGTITEG-LKSCTRLQVLDLGNNSFSGE-----VPDLSMLHELSFLNLNSSGISGKFPWKSLENLT- 133 (947)
Q Consensus 61 ~~L~~L~L~~n~i~~~~~~~-l~~l~~L~~L~Ls~n~i~~~-----~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~- 133 (947)
++|+.|+|++|++.+..... +..+++|++|+|++|++++. +..+..+++|++|+|++|.+.+..+...+..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 45677777777775544333 66777777777777777642 223556677777777777776432212223344
Q ss_pred ---CCceeeCCCCCCCCC---CCChhhcccccCcEEEccCccccccCCccC-----CCCCCCCEEECcCccccccc----
Q 002250 134 ---NLEFLSLGDNPFDPS---PFPMEVLKLEKLYWLYLTNCSVTGQIPEGI-----GNLTQLQNLELSDNELFGEI---- 198 (947)
Q Consensus 134 ---~L~~L~Ls~n~i~~~---~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~---- 198 (947)
+|++|+|++|.++.. .++..+..+++|++|+|++|.+++..+..+ ...++|++|+|++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 577777777776542 235556677777777777777764433322 23457888888888776533
Q ss_pred CccccCCCCCcEEEeecccccccCCccCC-----CCCCccEEeccCCCCCCC-----CccccccCCCCEEEccCccCccc
Q 002250 199 PAGIVKLNKLWQLELYNNSLSGRLPVGFS-----NLTNLMNFDVSQNRLEGD-----LSELRFLNQLSSLHLFENQFSGE 268 (947)
Q Consensus 199 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~-----~~~l~~l~~L~~L~L~~N~i~~~ 268 (947)
+..+..+++|++|+|++|.+++..+..+. .+++|++|+|++|.++.. +..+..+++|++|+|++|++++.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 45556677888888888887754444433 256788888888877763 34466677888888888877643
Q ss_pred C-----CCCccCCCcCcEEEccCcccccc----CCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCC
Q 002250 269 I-----PEEFGEFKHLTELSLYTNRLTGT----LPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNG 339 (947)
Q Consensus 269 ~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~ 339 (947)
. +..+..+++|++|++++|++++. ++..+..+++|++|++++|.+++..+..+...
T Consensus 243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~--------------- 307 (461)
T 1z7x_W 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET--------------- 307 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH---------------
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHH---------------
Confidence 2 22233577888888888888743 56666777888888888887763322211110
Q ss_pred cCCccccCCCCccEEEccccccccc----CCCCCCCCCCcceeccccCCcCCCCCCcccc-----cccccEEEccCcccc
Q 002250 340 TVPETYANCKSLIRFRVNNNSLSGT----IPPGIWSLPNLSIIDLSTNQFEGPVTDDIGN-----AKSLALLLLANNRFS 410 (947)
Q Consensus 340 ~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~ 410 (947)
.....++|+.|++++|.+++. ++..+..+++|+.|+|++|++++..+..+.. .++|++|++++|+++
T Consensus 308 ----l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 308 ----LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp ----HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred ----hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 011224666777777766644 3444455667777777777766543333332 457777777777776
Q ss_pred c----cCCCCCCCCCcceEEEcccCcccC
Q 002250 411 G----ELPSKISEASSLVSIQLSLNQFSG 435 (947)
Q Consensus 411 ~----~~p~~~~~l~~L~~L~Ls~N~l~~ 435 (947)
+ .+|..+..+++|+.|+|++|++++
T Consensus 384 ~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 384 DSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp HHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred hhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 5 566667777777777777777764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-30 Score=281.10 Aligned_cols=281 Identities=22% Similarity=0.257 Sum_probs=225.5
Q ss_pred cccceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCC---C
Q 002250 25 CKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGE---V 101 (947)
Q Consensus 25 C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~---~ 101 (947)
|.|.+|.|+..+. ..+|. .+ .++|+.|+|++|.+....+..|..+++|++|+|++|.++.. +
T Consensus 7 C~~~~l~c~~~~l------------~~ip~-~~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 71 (306)
T 2z66_A 7 CSGTEIRCNSKGL------------TSVPT-GI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71 (306)
T ss_dssp EETTEEECCSSCC------------SSCCS-CC--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEE
T ss_pred eCCCEEEcCCCCc------------ccCCC-CC--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcc
Confidence 8999999986541 12331 11 25899999999999877777789999999999999999854 3
Q ss_pred CCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCC
Q 002250 102 PDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNL 181 (947)
Q Consensus 102 ~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l 181 (947)
..+..+++|++|+|++|.+.+ ++ ..+..+++|++|++++|.+...+....+..+++|++|++++|.+++..+..+..+
T Consensus 72 ~~~~~~~~L~~L~Ls~n~i~~-l~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 149 (306)
T 2z66_A 72 QSDFGTTSLKYLDLSFNGVIT-MS-SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 149 (306)
T ss_dssp HHHHSCSCCCEEECCSCSEEE-EE-EEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTC
T ss_pred cccccccccCEEECCCCcccc-Ch-hhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccC
Confidence 446778999999999999984 44 4688999999999999998876544578889999999999999998888889999
Q ss_pred CCCCEEECcCccccc-ccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCc-cccccCCCCEEE
Q 002250 182 TQLQNLELSDNELFG-EIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLS-ELRFLNQLSSLH 259 (947)
Q Consensus 182 ~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~ 259 (947)
++|++|+|++|.+++ ..|..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++.+. .+..+++|+.|+
T Consensus 150 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 229 (306)
T 2z66_A 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 229 (306)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEE
T ss_pred cCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeE
Confidence 999999999999976 578889999999999999999998888889999999999999999987655 577888999999
Q ss_pred ccCccCcccCCCCccCCC-cCcEEEccCccccccCC--cCccCcccccccccccccccCCCCCCcc
Q 002250 260 LFENQFSGEIPEEFGEFK-HLTELSLYTNRLTGTLP--QKLGSWADFNYVDVSENLLTGPIPPDMC 322 (947)
Q Consensus 260 L~~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 322 (947)
|++|++++..|..+..++ +|++|+|++|++++.-+ ....-+...+.+.+..+.+.+..|..+.
T Consensus 230 L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~ 295 (306)
T 2z66_A 230 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 295 (306)
T ss_dssp CTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGT
T ss_pred CCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhC
Confidence 999999888888888884 89999999998874321 1122234455566666666655555443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=290.59 Aligned_cols=286 Identities=20% Similarity=0.255 Sum_probs=221.8
Q ss_pred ccccCCCCCcccceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCc
Q 002250 16 SSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNN 95 (947)
Q Consensus 16 ~sw~~~~~~C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n 95 (947)
..|.....+|.|.|+ ||-. ++++ ..+|. .+ .++|+.|+|++|.+.+..+..|..+++|++|+|++|
T Consensus 21 ~~~~~~~~~C~~~~~-c~~~---------~~~l-~~iP~-~~--~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 86 (353)
T 2z80_A 21 ESSNQASLSCDRNGI-CKGS---------SGSL-NSIPS-GL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86 (353)
T ss_dssp ------CCEECTTSE-EECC---------STTC-SSCCT-TC--CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cCCCccCCCCCCCeE-eeCC---------CCCc-ccccc-cc--cccCcEEECCCCcCcccCHHHhccCCCCCEEECCCC
Confidence 356667778999998 8742 2222 23342 22 258999999999998888889999999999999999
Q ss_pred cCcCCCCC-cccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCc-ccccc
Q 002250 96 SFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNC-SVTGQ 173 (947)
Q Consensus 96 ~i~~~~~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n-~l~~~ 173 (947)
++++..+. +..+++|++|+|++|++++ ++...+.++++|++|+|++|+++..+....+..+++|++|++++| .+++.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~ 165 (353)
T 2z80_A 87 GINTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI 165 (353)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEE
T ss_pred ccCccCHhhcCCCCCCCEEECCCCcCCc-CCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccccc
Confidence 99987664 8999999999999999985 443568899999999999999986543246788999999999998 47777
Q ss_pred CCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCc----cc
Q 002250 174 IPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLS----EL 249 (947)
Q Consensus 174 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~----~l 249 (947)
.+..|.++++|++|++++|++++..|..+.++++|++|++++|.++...+..+..+++|++|++++|++++... ..
T Consensus 166 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 245 (353)
T 2z80_A 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245 (353)
T ss_dssp CTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-----
T ss_pred CHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccc
Confidence 77888899999999999999988888889999999999999999875444445668899999999998887432 23
Q ss_pred cccCCCCEEEccCccCcc----cCCCCccCCCcCcEEEccCccccccCCcC-ccCcccccccccccccccCCC
Q 002250 250 RFLNQLSSLHLFENQFSG----EIPEEFGEFKHLTELSLYTNRLTGTLPQK-LGSWADFNYVDVSENLLTGPI 317 (947)
Q Consensus 250 ~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~ 317 (947)
.....++.++|+++.+++ .+|..+..+++|++|+|++|+++ .+|.. |+.+++|++|++++|++++..
T Consensus 246 ~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 246 ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp -CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 346678888888888875 35667888888999999999888 55555 588888888888888887543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-33 Score=333.44 Aligned_cols=432 Identities=13% Similarity=0.044 Sum_probs=255.9
Q ss_pred CCCcccceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccc---cCcCc------------hhhhcCCC
Q 002250 22 NSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFL---YGTIT------------EGLKSCTR 86 (947)
Q Consensus 22 ~~~C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i---~~~~~------------~~l~~l~~ 86 (947)
.-|+.|.++.+....++. +.+. ....+...+..+++|+.|+|+++.. .+.+| .....+++
T Consensus 39 ~vck~W~~~~~~~~~~l~---~~~~--~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 113 (592)
T 3ogk_B 39 LVCRRWFKIDSETREHVT---MALC--YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQ 113 (592)
T ss_dssp TSCHHHHHHHHHHCCEEE---ESCG--GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTT
T ss_pred HHhHHHHHhhhccccEEE---Eeec--cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCC
Confidence 346689998654333222 2221 1222334566788899999976432 12222 22237899
Q ss_pred ccEEeCcCccCcCCCCC-ccc-c-cccceeecCCCC-ccCccCcccccccCCCceeeCCCCCCCCCC---CChhhccccc
Q 002250 87 LQVLDLGNNSFSGEVPD-LSM-L-HELSFLNLNSSG-ISGKFPWKSLENLTNLEFLSLGDNPFDPSP---FPMEVLKLEK 159 (947)
Q Consensus 87 L~~L~Ls~n~i~~~~~~-l~~-l-~~L~~L~L~~n~-i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~---~~~~~~~l~~ 159 (947)
|++|+|++|.+++.... +.. + ++|++|+|++|. ++.........++++|++|+|++|.+.... ++.....+++
T Consensus 114 L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~ 193 (592)
T 3ogk_B 114 LKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTS 193 (592)
T ss_dssp CCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCC
T ss_pred CCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCC
Confidence 99999999988764332 444 3 349999999887 221111123347899999999999876544 3334567889
Q ss_pred CcEEEccCcccc----ccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeeccccc---ccCCccCCCCCCc
Q 002250 160 LYWLYLTNCSVT----GQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLS---GRLPVGFSNLTNL 232 (947)
Q Consensus 160 L~~L~L~~n~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~---~~~~~~~~~l~~L 232 (947)
|++|++++|.++ +.++..+.++++|++|+|++|.+.+ ++..+.++++|++|+++++... ...+..+..+++|
T Consensus 194 L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L 272 (592)
T 3ogk_B 194 LEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKL 272 (592)
T ss_dssp CCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTC
T ss_pred ccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccc
Confidence 999999999887 3344455678899999999998874 6678888899999999864433 2344567778888
Q ss_pred cEEeccCCCCCCCCccccccCCCCEEEccCccCcccCC-CCccCCCcCcEEEccCcccc-ccCCcCccCccccccccccc
Q 002250 233 MNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIP-EEFGEFKHLTELSLYTNRLT-GTLPQKLGSWADFNYVDVSE 310 (947)
Q Consensus 233 ~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~ 310 (947)
+.|+++++.....+..+..+++|++|+|++|.+++... ..+..+++|++|+++ |.+. +.++..+..+++|++|++++
T Consensus 273 ~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~ 351 (592)
T 3ogk_B 273 CRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIER 351 (592)
T ss_dssp CEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEEC
T ss_pred cccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeec
Confidence 89988887666566667778889999999888765433 335778888998888 4443 33444446678888888883
Q ss_pred -----------ccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCC-CCCccee
Q 002250 311 -----------NLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWS-LPNLSII 378 (947)
Q Consensus 311 -----------N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L 378 (947)
|.+++... +..+..+++|++|+++.|.+++..+..+.. +++|+.|
T Consensus 352 g~~~~~~~~~~~~~~~~~~-----------------------~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L 408 (592)
T 3ogk_B 352 GADEQGMEDEEGLVSQRGL-----------------------IALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDF 408 (592)
T ss_dssp CCCSSTTSSTTCCCCHHHH-----------------------HHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEE
T ss_pred CccccccccccCccCHHHH-----------------------HHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEE
Confidence 44442111 111223445555555555544433333332 4455555
Q ss_pred ccc----cCCcCCC-----CCCcccccccccEEEccCc--cccccCCCCCC-CCCcceEEEcccCcccC-CCCccccccc
Q 002250 379 DLS----TNQFEGP-----VTDDIGNAKSLALLLLANN--RFSGELPSKIS-EASSLVSIQLSLNQFSG-QIPLDIGKLK 445 (947)
Q Consensus 379 ~Ls----~N~l~~~-----~~~~~~~l~~L~~L~L~~N--~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~ 445 (947)
+++ .|.+++. ++..+..+++|++|++++| .+++..+..+. .+++|+.|+|++|++++ .++..+.+++
T Consensus 409 ~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 488 (592)
T 3ogk_B 409 RLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCP 488 (592)
T ss_dssp EEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCT
T ss_pred EEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCc
Confidence 553 3444432 1112334455555555432 23332222222 24455555555555543 2233334455
Q ss_pred ccchhhccccccCCC-CCcccccccccceeeccCceeee
Q 002250 446 KLSSLYLHDNMFSGP-LPYSIGSCVSLTDINFAQNSLSG 483 (947)
Q Consensus 446 ~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~ 483 (947)
+|++|+|++|.+++. ++..+..+++|++|+|++|++++
T Consensus 489 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 489 NLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp TCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred ccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 555555555554432 22223345555555555555553
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=297.26 Aligned_cols=298 Identities=25% Similarity=0.306 Sum_probs=154.0
Q ss_pred CccccccccCCCCCcccceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEE
Q 002250 11 DTGVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVL 90 (947)
Q Consensus 11 ~~~~~~sw~~~~~~C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L 90 (947)
--..+++|..+.+||.|.|..|.-. ....|...+++.|++++|+++ .+|..+. ++|++|
T Consensus 8 ~~~~w~~W~~~~~~~~~~~r~~~~~------------------~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L 66 (622)
T 3g06_A 8 YDAVWSAWRRAAPAEESRGRAAVVQ------------------KMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTL 66 (622)
T ss_dssp --CHHHHHHHTCCGGGHHHHHHHHH------------------HHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEE
T ss_pred HHHHHHHHHhcCCcchhccccccCc------------------ccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEE
Confidence 3467889998899999987554210 011122234566666666664 4454443 567777
Q ss_pred eCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccc
Q 002250 91 DLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSV 170 (947)
Q Consensus 91 ~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l 170 (947)
+|++|.|++.++ .+++|++|+|++|+|++ +|. .+++|++|+|++|.++..+ . .+++|+.|++++|++
T Consensus 67 ~L~~N~l~~lp~---~l~~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~l~~l~--~---~l~~L~~L~L~~N~l 133 (622)
T 3g06_A 67 VIPDNNLTSLPA---LPPELRTLEVSGNQLTS-LPV----LPPGLLELSIFSNPLTHLP--A---LPSGLCKLWIFGNQL 133 (622)
T ss_dssp EECSCCCSCCCC---CCTTCCEEEECSCCCSC-CCC----CCTTCCEEEECSCCCCCCC--C---CCTTCCEEECCSSCC
T ss_pred EecCCCCCCCCC---cCCCCCEEEcCCCcCCc-CCC----CCCCCCEEECcCCcCCCCC--C---CCCCcCEEECCCCCC
Confidence 777777664433 45666666666666652 331 4566666666666665422 2 345566666666665
Q ss_pred cccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCcccc
Q 002250 171 TGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELR 250 (947)
Q Consensus 171 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~ 250 (947)
++ +|.. +++|++|+|++|++++ +|. .+.+|+.|++++|.|++ +| ..+++|+.|+|++|++++.+..
T Consensus 134 ~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~~-- 199 (622)
T 3g06_A 134 TS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPTL-- 199 (622)
T ss_dssp SC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCCC--
T ss_pred Cc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCCc--
Confidence 53 3332 2556666666666553 232 23445555566555553 33 2345555555555555443321
Q ss_pred ccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCcccee
Q 002250 251 FLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL 330 (947)
Q Consensus 251 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L 330 (947)
+++|+.|++++|.++ .+|.. +++|++|+|++|++++ +| ..+
T Consensus 200 -~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l------------------------------ 240 (622)
T 3g06_A 200 -PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLP------------------------------ 240 (622)
T ss_dssp -CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCC------------------------------
T ss_pred -cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCC------------------------------
Confidence 234444455554444 22221 2344444444444442 22 122
Q ss_pred eecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCcccc
Q 002250 331 LVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFS 410 (947)
Q Consensus 331 ~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 410 (947)
++|+.|++++|.|+ .+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.++
T Consensus 241 ------------------~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~ 297 (622)
T 3g06_A 241 ------------------SELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297 (622)
T ss_dssp ------------------TTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCC
T ss_pred ------------------CcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCC
Confidence 34444555555554 2333 3445555555555555 33445555566666666666665
Q ss_pred ccCCCCCC
Q 002250 411 GELPSKIS 418 (947)
Q Consensus 411 ~~~p~~~~ 418 (947)
+..|..+.
T Consensus 298 ~~~~~~l~ 305 (622)
T 3g06_A 298 ERTLQALR 305 (622)
T ss_dssp HHHHHHHH
T ss_pred CcCHHHHH
Confidence 55554443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-33 Score=331.83 Aligned_cols=407 Identities=18% Similarity=0.157 Sum_probs=233.2
Q ss_pred CcCchhhhcCCCccEEeCcCccCc---CCCC-Ccc------------cccccceeecCCCCccCccCcccccc-cC-CCc
Q 002250 75 GTITEGLKSCTRLQVLDLGNNSFS---GEVP-DLS------------MLHELSFLNLNSSGISGKFPWKSLEN-LT-NLE 136 (947)
Q Consensus 75 ~~~~~~l~~l~~L~~L~Ls~n~i~---~~~~-~l~------------~l~~L~~L~L~~n~i~~~~~~~~l~~-l~-~L~ 136 (947)
...+..+..+++|++|+|++|... +..| .++ .+++|++|+|++|.+++..+ ..+.. ++ +|+
T Consensus 63 ~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~-~~l~~~~~~~L~ 141 (592)
T 3ogk_B 63 ATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDL-DRLAKARADDLE 141 (592)
T ss_dssp SCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHH-HHHHHHHGGGCC
T ss_pred cChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHH-HHHHHhccccCc
Confidence 445566788999999999886431 1222 222 56677777777776654332 23333 23 377
Q ss_pred eeeCCCCC-CCCCCCChhhcccccCcEEEccCcccccc----CCccCCCCCCCCEEECcCcccc----cccCccccCCCC
Q 002250 137 FLSLGDNP-FDPSPFPMEVLKLEKLYWLYLTNCSVTGQ----IPEGIGNLTQLQNLELSDNELF----GEIPAGIVKLNK 207 (947)
Q Consensus 137 ~L~Ls~n~-i~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~----~~~~~~l~~l~~ 207 (947)
+|+|++|. +....++.....+++|++|+|++|.+++. ++..+..+++|++|+|++|.++ +.++..+.++++
T Consensus 142 ~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~ 221 (592)
T 3ogk_B 142 TLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRS 221 (592)
T ss_dssp EEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTT
T ss_pred EEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCC
Confidence 77776664 22111222233566666666666666544 2223345566666666666664 223333445666
Q ss_pred CcEEEeecccccccCCccCCCCCCccEEeccCCCCC----CCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEE
Q 002250 208 LWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLE----GDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELS 283 (947)
Q Consensus 208 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~----~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 283 (947)
|++|+|++|.+.+ ++..+..+++|++|+++.+... .....+..+++|+.|+++++... .+|..+..+++|++|+
T Consensus 222 L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~ 299 (592)
T 3ogk_B 222 LVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLD 299 (592)
T ss_dssp CCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEE
T ss_pred CcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEe
Confidence 6666666666663 4455666666666666542211 11223445555666655554332 3444555555566666
Q ss_pred ccCccccccCC-cCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEccc----
Q 002250 284 LYTNRLTGTLP-QKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNN---- 358 (947)
Q Consensus 284 L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~---- 358 (947)
|++|.+++... ..+..+++|+.|+++ |.+. .+.++..+..+++|++|++++
T Consensus 300 Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~-----------------------~~~l~~~~~~~~~L~~L~L~~g~~~ 355 (592)
T 3ogk_B 300 LLYALLETEDHCTLIQKCPNLEVLETR-NVIG-----------------------DRGLEVLAQYCKQLKRLRIERGADE 355 (592)
T ss_dssp ETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGH-----------------------HHHHHHHHHHCTTCCEEEEECCCCS
T ss_pred cCCCcCCHHHHHHHHHhCcCCCEEecc-CccC-----------------------HHHHHHHHHhCCCCCEEEeecCccc
Confidence 66555543222 223445555555554 2222 112333445677888888883
Q ss_pred -------ccccccCCC-CCCCCCCcceeccccCCcCCCCCCcccc-cccccEEEcc----Ccccccc-----CCCCCCCC
Q 002250 359 -------NSLSGTIPP-GIWSLPNLSIIDLSTNQFEGPVTDDIGN-AKSLALLLLA----NNRFSGE-----LPSKISEA 420 (947)
Q Consensus 359 -------n~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l 420 (947)
|.+++.... ....+++|+.|+++.|++++..+..+.. +++|+.|+++ .|.+++. ++..+..+
T Consensus 356 ~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~ 435 (592)
T 3ogk_B 356 QGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGC 435 (592)
T ss_dssp STTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHC
T ss_pred cccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhC
Confidence 555533222 2334778888888888887655555554 7778888885 5666642 22235567
Q ss_pred CcceEEEcccCc--ccCCCCccccc-ccccchhhccccccCCC-CCcccccccccceeeccCceeeee-cCCCCCccCcC
Q 002250 421 SSLVSIQLSLNQ--FSGQIPLDIGK-LKKLSSLYLHDNMFSGP-LPYSIGSCVSLTDINFAQNSLSGK-IPDSLGSLPSL 495 (947)
Q Consensus 421 ~~L~~L~Ls~N~--l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L 495 (947)
++|+.|+|++|. +++..+..++. +++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+++|
T Consensus 436 ~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L 515 (592)
T 3ogk_B 436 KKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSL 515 (592)
T ss_dssp TTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSC
T ss_pred CCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCcc
Confidence 778888886433 55444444443 67788888888877652 344456677788888888877644 33334567778
Q ss_pred cEEECCCCccCCc
Q 002250 496 NSLNLSNNKFSGE 508 (947)
Q Consensus 496 ~~L~Ls~N~l~~~ 508 (947)
+.|+|++|++++.
T Consensus 516 ~~L~ls~n~it~~ 528 (592)
T 3ogk_B 516 RYLWVQGYRASMT 528 (592)
T ss_dssp CEEEEESCBCCTT
T ss_pred CeeECcCCcCCHH
Confidence 8888888887754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-29 Score=270.44 Aligned_cols=262 Identities=19% Similarity=0.182 Sum_probs=154.0
Q ss_pred CCCEEECcCcccccccCccccCCCCCcEEEeeccccccc--CCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEc
Q 002250 183 QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGR--LPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHL 260 (947)
Q Consensus 183 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L 260 (947)
+|++|+|++|+++...+..|.++++|++|+|++|.++.. .+..+..+++|++|+|++|.++..+..+..+++|++|++
T Consensus 29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~l~~~~~~l~~L~~L~l 108 (306)
T 2z66_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDF 108 (306)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEEEEEEEETCTTCCEEEC
T ss_pred CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccccChhhcCCCCCCCEEEC
Confidence 445555555554433223344455555555555554421 133344455555555555555444444555555555555
Q ss_pred cCccCcccCC-CCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCC
Q 002250 261 FENQFSGEIP-EEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNG 339 (947)
Q Consensus 261 ~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~ 339 (947)
++|++++..+ ..+..+++|++|++++|++++..+..+..+++|++|++++|.+++.
T Consensus 109 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----------------------- 165 (306)
T 2z66_A 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN----------------------- 165 (306)
T ss_dssp TTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG-----------------------
T ss_pred CCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc-----------------------
Confidence 5555554333 3566666666666666666655556666666666666666655420
Q ss_pred cCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCC
Q 002250 340 TVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISE 419 (947)
Q Consensus 340 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 419 (947)
.+|..+..+++|+.|++++|.+++..|..+..+++|+.|+|++|++++..+..+..+++|++|++++|++++..|..+..
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence 23445666677777777777777666777777788888888888887766667777778888888888887777777777
Q ss_pred CC-cceEEEcccCcccCCCC--cccccccccchhhccccccCCCCCccccc
Q 002250 420 AS-SLVSIQLSLNQFSGQIP--LDIGKLKKLSSLYLHDNMFSGPLPYSIGS 467 (947)
Q Consensus 420 l~-~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 467 (947)
++ +|+.|+|++|.+++.-+ .....+..++.+....+.+....|..+.+
T Consensus 246 ~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g 296 (306)
T 2z66_A 246 FPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG 296 (306)
T ss_dssp CCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred hhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCC
Confidence 74 78888888888774321 11222334444444455554444444433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=278.67 Aligned_cols=275 Identities=16% Similarity=0.147 Sum_probs=178.9
Q ss_pred cEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCccccccccccccc
Q 002250 233 MNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENL 312 (947)
Q Consensus 233 ~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 312 (947)
...++++|.++..+..+. ++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|+.+++|++|++++|.
T Consensus 34 ~~c~~~~~~l~~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 111 (353)
T 2z80_A 34 GICKGSSGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111 (353)
T ss_dssp SEEECCSTTCSSCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred eEeeCCCCCccccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCc
Confidence 344555555555444333 356666666666665555566666666666666666665556666666666666666666
Q ss_pred ccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCC-CCCCCCCCcceeccccC-CcCCCCC
Q 002250 313 LTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIP-PGIWSLPNLSIIDLSTN-QFEGPVT 390 (947)
Q Consensus 313 l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~~ 390 (947)
+++ ..+..|.++++|++|++++|++++..+ ..+..+++|++|++++| .+....+
T Consensus 112 l~~------------------------~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 167 (353)
T 2z80_A 112 LSN------------------------LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167 (353)
T ss_dssp CSS------------------------CCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred CCc------------------------CCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCH
Confidence 652 112235556666666666666663333 35666777777777776 3555556
Q ss_pred CcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccc---c
Q 002250 391 DDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIG---S 467 (947)
Q Consensus 391 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~ 467 (947)
..|..+++|++|++++|++++..|..+..+++|+.|++++|+++...+..+..+++|+.|+|++|.+++..+..+. .
T Consensus 168 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~ 247 (353)
T 2z80_A 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247 (353)
T ss_dssp TTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------C
T ss_pred HHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccc
Confidence 6677777777777777777766777777777777777777777633333344577777777777777765554433 3
Q ss_pred ccccceeeccCceeee----ecCCCCCccCcCcEEECCCCccCCccCCcc-cccccceeeCCCCcCCCCCC
Q 002250 468 CVSLTDINFAQNSLSG----KIPDSLGSLPSLNSLNLSNNKFSGEIPISL-TYPKLSLLDLSNNQLAGPIP 533 (947)
Q Consensus 468 l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~~~L~~L~ls~N~l~~~~p 533 (947)
...++.++|++|.+++ .+|..+..+++|+.|+|++|+++..++..+ .+++|+.|+|++|++++..|
T Consensus 248 ~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 248 NSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 4556677777776665 467777888888888888888885444433 46888888888888887666
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=277.22 Aligned_cols=254 Identities=20% Similarity=0.212 Sum_probs=193.8
Q ss_pred CCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeec
Q 002250 254 QLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVL 333 (947)
Q Consensus 254 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~ 333 (947)
..+.++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~------------------ 102 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT------------------ 102 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCE------------------
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCc------------------
Confidence 3566777777777 5665554 567777777777776666777777777777777777653
Q ss_pred ccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCc-ccccc
Q 002250 334 QNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANN-RFSGE 412 (947)
Q Consensus 334 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~ 412 (947)
..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+++...+..|..+++|++|++++| .+...
T Consensus 103 ------i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i 176 (440)
T 3zyj_A 103 ------IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYI 176 (440)
T ss_dssp ------ECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEE
T ss_pred ------cChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCccee
Confidence 33456777888888888888888666667888888888888888888777778888888888888884 44433
Q ss_pred CCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCcc
Q 002250 413 LPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSL 492 (947)
Q Consensus 413 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 492 (947)
.+..|..+++|+.|+|++|+++ .+| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|.++
T Consensus 177 ~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 254 (440)
T 3zyj_A 177 SEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254 (440)
T ss_dssp CTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTC
T ss_pred CcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCC
Confidence 4446888888888888888888 555 47788888888888888888888888888888888888888888888888888
Q ss_pred CcCcEEECCCCccCCccCCccc-ccccceeeCCCCcCCCCCCCcccccccccccccCCCCCCCCccc
Q 002250 493 PSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGLCSKTDEY 558 (947)
Q Consensus 493 ~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~gN~~~c~~~~~~ 558 (947)
++|+.|+|++|+|++.++..+. +++|+.|+|+ +|||.|+|...|
T Consensus 255 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~----------------------~Np~~CdC~l~~ 299 (440)
T 3zyj_A 255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLH----------------------HNPWNCNCDILW 299 (440)
T ss_dssp TTCCEEECTTSCCCCCCTTTTSSCTTCCEEECC----------------------SSCEECSSTTHH
T ss_pred CCCCEEECCCCCCCccChhHhccccCCCEEEcC----------------------CCCccCCCCchH
Confidence 8888888888888877666554 4777777665 566678877655
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-29 Score=274.65 Aligned_cols=250 Identities=20% Similarity=0.242 Sum_probs=206.2
Q ss_pred ccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcC-CCCC-cc-------cccccceeecCCCCccCccC
Q 002250 55 DSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSG-EVPD-LS-------MLHELSFLNLNSSGISGKFP 125 (947)
Q Consensus 55 ~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~-~~~~-l~-------~l~~L~~L~L~~n~i~~~~~ 125 (947)
..+++.++|+.|++++|.+ .+|..+... |+.|+|++|+++. ..+. +. .+++|++|+|++|++++.+|
T Consensus 37 ~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 112 (312)
T 1wwl_A 37 ELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAP 112 (312)
T ss_dssp EEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCC
T ss_pred EEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhH
Confidence 3467788999999999999 778777766 9999999999954 3443 33 68999999999999998877
Q ss_pred cccc-cccCCCceeeCCCCCCCCCCCChhhccc-----ccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccc--
Q 002250 126 WKSL-ENLTNLEFLSLGDNPFDPSPFPMEVLKL-----EKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGE-- 197 (947)
Q Consensus 126 ~~~l-~~l~~L~~L~Ls~n~i~~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-- 197 (947)
...+ ..+++|++|+|++|+++.. |..+..+ ++|++|+|++|++++..|..|+++++|++|+|++|++.+.
T Consensus 113 ~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 190 (312)
T 1wwl_A 113 PPLLEATGPDLNILNLRNVSWATR--DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190 (312)
T ss_dssp CCSSSCCSCCCSEEEEESCBCSSS--SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHH
T ss_pred HHHHHhcCCCccEEEccCCCCcch--hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchH
Confidence 4332 8999999999999999875 6677777 8999999999999988889999999999999999998764
Q ss_pred cCccc--cCCCCCcEEEeecccccc---cCCccCCCCCCccEEeccCCCCCCCC--ccccccCCCCEEEccCccCcccCC
Q 002250 198 IPAGI--VKLNKLWQLELYNNSLSG---RLPVGFSNLTNLMNFDVSQNRLEGDL--SELRFLNQLSSLHLFENQFSGEIP 270 (947)
Q Consensus 198 ~~~~l--~~l~~L~~L~L~~n~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~l~~l~~L~~L~L~~N~i~~~~~ 270 (947)
.+..+ .++++|++|+|++|+|++ .....+..+++|++|+|++|++++.. ..+..+++|++|+|++|+|+ .+|
T Consensus 191 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip 269 (312)
T 1wwl_A 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVP 269 (312)
T ss_dssp HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCC
T ss_pred HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhh
Confidence 23444 788999999999999983 22244567899999999999998865 45667889999999999998 677
Q ss_pred CCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccC
Q 002250 271 EEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315 (947)
Q Consensus 271 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 315 (947)
..+. ++|++|+|++|++++. |. +..+++|++|++++|++++
T Consensus 270 ~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 270 KGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp SSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred hhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 7776 8899999999999855 66 8889999999999999875
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-29 Score=272.99 Aligned_cols=269 Identities=20% Similarity=0.177 Sum_probs=230.3
Q ss_pred ceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecC
Q 002250 37 LVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLN 116 (947)
Q Consensus 37 ~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~ 116 (947)
+....+++..++..... ..+..+++|+.|+|++|.+.+..|..|..+++|++|+|++|++++.++ +..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~-~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALA-SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHH-HHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHH-HHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECc
Confidence 45566777766654433 445677899999999999999999999999999999999999997665 8999999999999
Q ss_pred CCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCccccc
Q 002250 117 SSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFG 196 (947)
Q Consensus 117 ~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 196 (947)
+|++++ +...++|++|++++|.+...+ ...+++|++|++++|++++..+..+..+++|++|+|++|++++
T Consensus 89 ~n~l~~------l~~~~~L~~L~l~~n~l~~~~----~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 158 (317)
T 3o53_A 89 NNYVQE------LLVGPSIETLHAANNNISRVS----CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158 (317)
T ss_dssp SSEEEE------EEECTTCCEEECCSSCCSEEE----ECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCE
T ss_pred CCcccc------ccCCCCcCEEECCCCccCCcC----ccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCc
Confidence 999974 345599999999999997643 2347889999999999998888899999999999999999998
Q ss_pred ccCcccc-CCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccC
Q 002250 197 EIPAGIV-KLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGE 275 (947)
Q Consensus 197 ~~~~~l~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~ 275 (947)
..+..+. .+++|++|+|++|.+++.. ....+++|++|+|++|++++.+..+..+++|+.|+|++|+|+ .+|..+..
T Consensus 159 ~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~ 235 (317)
T 3o53_A 159 VNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235 (317)
T ss_dssp EEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCC
T ss_pred ccHHHHhhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhc
Confidence 8777774 7899999999999999663 334589999999999999988888999999999999999999 57888999
Q ss_pred CCcCcEEEccCcccc-ccCCcCccCccccccccccc-ccccCCCCCC
Q 002250 276 FKHLTELSLYTNRLT-GTLPQKLGSWADFNYVDVSE-NLLTGPIPPD 320 (947)
Q Consensus 276 l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~ 320 (947)
+++|++|++++|+++ +.+|..+..+++|+.|++++ +.+++..|..
T Consensus 236 l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp CTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred CCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 999999999999998 78888999999999999994 4466655543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=266.22 Aligned_cols=230 Identities=18% Similarity=0.220 Sum_probs=119.4
Q ss_pred CccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCccccccccccc
Q 002250 231 NLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSE 310 (947)
Q Consensus 231 ~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 310 (947)
.++.|+|++|.++..+..+..+++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++.+++|++|++++
T Consensus 82 ~l~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~ 159 (328)
T 4fcg_A 82 GRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA 159 (328)
T ss_dssp TCCEEEEESSCCSSCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEE
T ss_pred ceeEEEccCCCchhcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCC
Confidence 334444444444433334444445555555555555 45555555555555555555555 5555555555666666665
Q ss_pred ccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCC
Q 002250 311 NLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVT 390 (947)
Q Consensus 311 N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 390 (947)
|.+.+.+|..+... ..+..|.++++|+.|++++|.++ .+|..+..+++|+.|+|++|++++ +|
T Consensus 160 n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~ 222 (328)
T 4fcg_A 160 CPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LG 222 (328)
T ss_dssp ETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CC
T ss_pred CCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cc
Confidence 55555555443321 11233455666666666666666 555556666666666666666654 23
Q ss_pred CcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccc
Q 002250 391 DDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVS 470 (947)
Q Consensus 391 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 470 (947)
..+..+++|++|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..++++++|+.|+|++|.+.+.+|..++.+++
T Consensus 223 ~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~ 302 (328)
T 4fcg_A 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302 (328)
T ss_dssp GGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCT
T ss_pred hhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccC
Confidence 34555555555555555555555555555555555555555555444444444444444444444444444444444444
Q ss_pred cceeeccCc
Q 002250 471 LTDINFAQN 479 (947)
Q Consensus 471 L~~L~Ls~N 479 (947)
|+.+++..|
T Consensus 303 L~~l~l~~~ 311 (328)
T 4fcg_A 303 NCIILVPPH 311 (328)
T ss_dssp TCEEECCGG
T ss_pred ceEEeCCHH
Confidence 444444433
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-28 Score=258.61 Aligned_cols=254 Identities=20% Similarity=0.204 Sum_probs=137.5
Q ss_pred EEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCccccccccccccc-
Q 002250 234 NFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENL- 312 (947)
Q Consensus 234 ~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~- 312 (947)
.++.+++.++..+..+ .++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|..+++|++|++++|.
T Consensus 15 ~~~c~~~~l~~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~ 92 (285)
T 1ozn_A 15 TTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (285)
T ss_dssp EEECCSSCCSSCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEEcCcCCcccCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCC
Confidence 4444555444443322 2456666666666665555566666666666666666665556666666666666666665
Q ss_pred ccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCc
Q 002250 313 LTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDD 392 (947)
Q Consensus 313 l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 392 (947)
++...| ..|..+++|+.|++++|.+++..|..+..+++|++|++++|++++..+..
T Consensus 93 l~~~~~------------------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 148 (285)
T 1ozn_A 93 LRSVDP------------------------ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148 (285)
T ss_dssp CCCCCT------------------------TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred ccccCH------------------------HHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhH
Confidence 443222 33444445555555555555444445555555555555555555544444
Q ss_pred ccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccc
Q 002250 393 IGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLT 472 (947)
Q Consensus 393 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 472 (947)
|..+++|++|++++|++++..+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|.+++..+..+..+++|+
T Consensus 149 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 228 (285)
T 1ozn_A 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (285)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred hccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccC
Confidence 55555555555555555544444455555555555555555555555555555566666666665554445555566666
Q ss_pred eeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc
Q 002250 473 DINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT 514 (947)
Q Consensus 473 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 514 (947)
.|+|++|.+....+.. .-+..++.+..+.|.+....|..+.
T Consensus 229 ~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 229 YLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp EEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGT
T ss_pred EEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhC
Confidence 6666666665322211 1112344444555666655555443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-27 Score=268.56 Aligned_cols=247 Identities=21% Similarity=0.238 Sum_probs=166.4
Q ss_pred cCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEecc
Q 002250 159 KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVS 238 (947)
Q Consensus 159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 238 (947)
....++.+++.++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3456666777776 5565554 577778888888777777777777888888888888777766777777777777777
Q ss_pred CCCCCCCCc-cccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCc-cccccCCcCccCcccccccccccccccCC
Q 002250 239 QNRLEGDLS-ELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTN-RLTGTLPQKLGSWADFNYVDVSENLLTGP 316 (947)
Q Consensus 239 ~N~l~~~~~-~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 316 (947)
+|+++..+. .+..+++|++|+|++|+|+...+..|..+++|++|+|++| .+....+..|..+++|++|+|++|.++.
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~- 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE- 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-
Confidence 777776654 4667777777777777777666667777778888888774 4443334456677777777777776652
Q ss_pred CCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCccccc
Q 002250 317 IPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNA 396 (947)
Q Consensus 317 ~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 396 (947)
+| .+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|..+
T Consensus 200 ~~-------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 254 (440)
T 3zyj_A 200 IP-------------------------NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254 (440)
T ss_dssp CC-------------------------CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTC
T ss_pred cc-------------------------ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCC
Confidence 11 14455566666666666666666666666666666666666666666666666
Q ss_pred ccccEEEccCccccccCCCCCCCCCcceEEEcccCccc
Q 002250 397 KSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFS 434 (947)
Q Consensus 397 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 434 (947)
++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 255 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 66666666666666555555566666666666666654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-29 Score=272.58 Aligned_cols=247 Identities=19% Similarity=0.205 Sum_probs=152.8
Q ss_pred CCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEE
Q 002250 180 NLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLH 259 (947)
Q Consensus 180 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~ 259 (947)
.+++|++|+|++|++++..|..|.++++|++|+|++|.+++..+ |..+++|++|+|++|++++.+ ..++|++|+
T Consensus 32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~----~~~~L~~L~ 105 (317)
T 3o53_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL----VGPSIETLH 105 (317)
T ss_dssp TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE----ECTTCCEEE
T ss_pred cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc----CCCCcCEEE
Confidence 33444444444444444333444444444444444444443322 444444444444444443221 225566666
Q ss_pred ccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCC
Q 002250 260 LFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNG 339 (947)
Q Consensus 260 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~ 339 (947)
+++|++++..+.. +++|++|++++|++++..+..++.+++|++|++++|.+++.
T Consensus 106 l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----------------------- 159 (317)
T 3o53_A 106 AANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV----------------------- 159 (317)
T ss_dssp CCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEE-----------------------
T ss_pred CCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcc-----------------------
Confidence 6666665443332 45667777777777665566666666666666666666532
Q ss_pred cCCccc-cCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCC
Q 002250 340 TVPETY-ANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKIS 418 (947)
Q Consensus 340 ~~p~~~-~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 418 (947)
.|..+ ..+++|+.|++++|.+++. +. ...+++|+.|+|++|++++.++. +..+++|++|+|++|+++ .+|..+.
T Consensus 160 -~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~-~~~l~~L~~L~L~~N~l~-~l~~~~~ 234 (317)
T 3o53_A 160 -NFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLV-LIEKALR 234 (317)
T ss_dssp -EGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCC-EECTTCC
T ss_pred -cHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchhh-hcccCcccEEECcCCccc-chhhHhh
Confidence 12222 3566777777777777754 22 23478888888888888865444 788888888888888888 5777888
Q ss_pred CCCcceEEEcccCccc-CCCCcccccccccchhhcccc-ccCCCCCc
Q 002250 419 EASSLVSIQLSLNQFS-GQIPLDIGKLKKLSSLYLHDN-MFSGPLPY 463 (947)
Q Consensus 419 ~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~ 463 (947)
.+++|+.|++++|.+. +.+|..+..+++|+.|++++| .+++..|.
T Consensus 235 ~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp CCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred cCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 8888888888888888 677777888888888888844 45554443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-27 Score=276.34 Aligned_cols=264 Identities=28% Similarity=0.378 Sum_probs=149.7
Q ss_pred cCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEecc
Q 002250 159 KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVS 238 (947)
Q Consensus 159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 238 (947)
+++.|++++|.++ .+|..+. ++|++|+|++|.|+ .+|. .+++|++|+|++|+|++ +|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence 4677777777777 5565554 56777777777765 3443 45666666666666663 333 45566666666
Q ss_pred CCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCC
Q 002250 239 QNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIP 318 (947)
Q Consensus 239 ~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 318 (947)
+|++++.+. .+++|+.|+|++|+|++ +|.. +++|++|+|++|+++ .+|.. .
T Consensus 110 ~N~l~~l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~-~l~~~---~------------------ 160 (622)
T 3g06_A 110 SNPLTHLPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLA-SLPAL---P------------------ 160 (622)
T ss_dssp SCCCCCCCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCCC---C------------------
T ss_pred CCcCCCCCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCC-CcCCc---c------------------
Confidence 666555443 33455555555555552 3322 244455555555444 22221 1
Q ss_pred CCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCccccccc
Q 002250 319 PDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKS 398 (947)
Q Consensus 319 ~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 398 (947)
.+|+.|++++|.+++ +| ..+++|+.|+|++|++++.. . .+++
T Consensus 161 ------------------------------~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~-~---~~~~ 202 (622)
T 3g06_A 161 ------------------------------SELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLP-T---LPSE 202 (622)
T ss_dssp ------------------------------TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCC-C---CCTT
T ss_pred ------------------------------CCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCC-C---ccch
Confidence 234444444444442 23 22345555555555555422 1 1245
Q ss_pred ccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccC
Q 002250 399 LALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQ 478 (947)
Q Consensus 399 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 478 (947)
|+.|++++|.++ .+|.. +++|+.|+|++|+|++ +| ..+++|+.|+|++|+|++ +|. .+++|+.|+|++
T Consensus 203 L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~ 270 (622)
T 3g06_A 203 LYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYR 270 (622)
T ss_dssp CCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred hhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCC
Confidence 566666666665 34432 3566677777777663 44 344666777777777663 443 456677777777
Q ss_pred ceeeeecCCCCCccCcCcEEECCCCccCCccCCcc
Q 002250 479 NSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL 513 (947)
Q Consensus 479 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 513 (947)
|+|+ .+|..+.++++|+.|+|++|++++.+|..+
T Consensus 271 N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l 304 (622)
T 3g06_A 271 NQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 304 (622)
T ss_dssp SCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHH
T ss_pred CCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHH
Confidence 7777 667777777777777777777777666543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=269.61 Aligned_cols=179 Identities=21% Similarity=0.158 Sum_probs=116.8
Q ss_pred CceeeCCCCCCCCCCCChhhc-------ccccCcEEEccCccccccCCccC--CCCCCCCEEECcCcccccccCccccCC
Q 002250 135 LEFLSLGDNPFDPSPFPMEVL-------KLEKLYWLYLTNCSVTGQIPEGI--GNLTQLQNLELSDNELFGEIPAGIVKL 205 (947)
Q Consensus 135 L~~L~Ls~n~i~~~~~~~~~~-------~l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~~~~l~~l 205 (947)
|+.|+|++|.+....+|..+. ++++|++|+|++|.+++.+|..+ ..+++|++|+|++|++++. |..+..+
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l 143 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAEL 143 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHH
Confidence 555555555554444455444 57778888888888887777766 7888888888888888766 7777766
Q ss_pred -----CCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCC---Cccc--cccCCCCEEEccCccCcc---cCCCC
Q 002250 206 -----NKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGD---LSEL--RFLNQLSSLHLFENQFSG---EIPEE 272 (947)
Q Consensus 206 -----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~l--~~l~~L~~L~L~~N~i~~---~~~~~ 272 (947)
++|++|+|++|++++..|..|..+++|++|+|++|++.+. +..+ ..+++|++|+|++|+|++ .....
T Consensus 144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 223 (312)
T 1wwl_A 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223 (312)
T ss_dssp HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHH
T ss_pred HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHH
Confidence 7888888888888877777888888888888888876543 2222 556666666666666652 11122
Q ss_pred ccCCCcCcEEEccCccccccCC-cCccCccccccccccccccc
Q 002250 273 FGEFKHLTELSLYTNRLTGTLP-QKLGSWADFNYVDVSENLLT 314 (947)
Q Consensus 273 ~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~ 314 (947)
+..+++|++|+|++|++++..| ..+..+++|++|+|++|.++
T Consensus 224 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp HHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred HhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence 3455666666666666665443 23344455555555555554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-26 Score=266.64 Aligned_cols=244 Identities=20% Similarity=0.219 Sum_probs=156.7
Q ss_pred EEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCC
Q 002250 162 WLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNR 241 (947)
Q Consensus 162 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 241 (947)
.++.+++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++|+
T Consensus 58 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 58 KVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 3444444444 3444333 456666666666655555566666666666666666665555566666666666666666
Q ss_pred CCCCCcc-ccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccC-ccccccCCcCccCcccccccccccccccCCCCC
Q 002250 242 LEGDLSE-LRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYT-NRLTGTLPQKLGSWADFNYVDVSENLLTGPIPP 319 (947)
Q Consensus 242 l~~~~~~-l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 319 (947)
++..+.. +..+++|++|+|++|+|+...+..|..+++|++|+|++ |.+....+..|..+++|++|+|++|.+++. |
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~- 212 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P- 212 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-
Confidence 6554443 55566666666666666655556677777777777777 344433334567777777777777777632 2
Q ss_pred CcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccc
Q 002250 320 DMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSL 399 (947)
Q Consensus 320 ~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 399 (947)
.+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|..+++|
T Consensus 213 ------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 268 (452)
T 3zyi_A 213 ------------------------NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268 (452)
T ss_dssp ------------------------CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred ------------------------cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCC
Confidence 13455666777777777766666667777777777777777777667777777777
Q ss_pred cEEEccCccccccCCCCCCCCCcceEEEcccCccc
Q 002250 400 ALLLLANNRFSGELPSKISEASSLVSIQLSLNQFS 434 (947)
Q Consensus 400 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 434 (947)
+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 269 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp CEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 77777777777666666777788888888888776
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-27 Score=270.27 Aligned_cols=248 Identities=20% Similarity=0.243 Sum_probs=172.2
Q ss_pred CccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCccccccccccc
Q 002250 231 NLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSE 310 (947)
Q Consensus 231 ~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 310 (947)
....++.+++.++.++..+. ++|+.|+|++|.|++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCcEEEECCCCcCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 34567777777777666554 5778888888888877777788888888888888888776677777777777777777
Q ss_pred ccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceecccc-CCcCCCC
Q 002250 311 NLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLST-NQFEGPV 389 (947)
Q Consensus 311 N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~ 389 (947)
|.+++. .+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++ |.+....
T Consensus 133 n~l~~~------------------------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~ 188 (452)
T 3zyi_A 133 NWLTVI------------------------PSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYIS 188 (452)
T ss_dssp SCCSBC------------------------CTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC
T ss_pred CcCCcc------------------------ChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccC
Confidence 777632 233456666777777777777755555667777777777776 4444444
Q ss_pred CCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCccccccc
Q 002250 390 TDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCV 469 (947)
Q Consensus 390 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 469 (947)
+..|..+++|++|+|++|++++ +| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..++
T Consensus 189 ~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 266 (452)
T 3zyi_A 189 EGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLA 266 (452)
T ss_dssp TTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred hhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCC
Confidence 4456666777777777777763 33 366667777777777777766666677777777777777777766666777777
Q ss_pred ccceeeccCceeeeecCCCCCccCcCcEEECCCCccC
Q 002250 470 SLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFS 506 (947)
Q Consensus 470 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 506 (947)
+|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 267 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 267 SLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 7777777777777655666666777777777777665
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=256.41 Aligned_cols=254 Identities=17% Similarity=0.203 Sum_probs=180.5
Q ss_pred CEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeeccc
Q 002250 256 SSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQN 335 (947)
Q Consensus 256 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n 335 (947)
+.++.+++.++ .+|..+ .++|++|+|++|++++..+..|..+++|++|++++|.+++
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~-------------------- 70 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-------------------- 70 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE--------------------
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccce--------------------
Confidence 56777777776 445433 3567777777777776555667777777777777666653
Q ss_pred ccCCcCCccccCCCCccEEEccccc-ccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCC
Q 002250 336 NFNGTVPETYANCKSLIRFRVNNNS-LSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELP 414 (947)
Q Consensus 336 ~~~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 414 (947)
..|..|.++++|+.|++++|. ++...|..+..+++|++|++++|++++..+..|..+++|++|++++|++++..+
T Consensus 71 ----~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 146 (285)
T 1ozn_A 71 ----IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD 146 (285)
T ss_dssp ----ECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred ----eCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCH
Confidence 334556677778888888886 666667777888888888888888887777777778888888888888876666
Q ss_pred CCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCc
Q 002250 415 SKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPS 494 (947)
Q Consensus 415 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 494 (947)
..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..+..+++
T Consensus 147 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 226 (285)
T 1ozn_A 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred hHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcc
Confidence 66777788888888888877655556777777777777777777777777777777777777777777655566777777
Q ss_pred CcEEECCCCccCCccCCcccccccceeeCCCCcCCCCCCCcc
Q 002250 495 LNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPL 536 (947)
Q Consensus 495 L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~p~~~ 536 (947)
|+.|+|++|+++...+.......++.+..+.|.+.+..|+.+
T Consensus 227 L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 227 LQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp CCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGG
T ss_pred cCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCchHh
Confidence 777777777777554433223445556666677766666554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=274.90 Aligned_cols=238 Identities=21% Similarity=0.181 Sum_probs=210.7
Q ss_pred CCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCcee
Q 002250 59 GLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFL 138 (947)
Q Consensus 59 ~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L 138 (947)
.+++|+.|+|++|.+.+..|..|..+++|++|+|++|.+++.++ +..+++|++|+|++|.|++ +...++|++|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~------l~~~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQE------LLVGPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEE------EEECTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCC------CCCCCCcCEE
Confidence 44589999999999999999999999999999999999998766 9999999999999999974 3345899999
Q ss_pred eCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCcccc-CCCCCcEEEeeccc
Q 002250 139 SLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIV-KLNKLWQLELYNNS 217 (947)
Q Consensus 139 ~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-~l~~L~~L~L~~n~ 217 (947)
+|++|.+...+ ...+++|++|+|++|.+++..|..++++++|++|+|++|.+++..|..+. .+++|++|+|++|.
T Consensus 105 ~L~~N~l~~~~----~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 105 HAANNNISRVS----CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp ECCSSCCCCEE----ECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred ECcCCcCCCCC----ccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 99999997643 23568999999999999998898999999999999999999988888886 79999999999999
Q ss_pred ccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccc-ccCCcC
Q 002250 218 LSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT-GTLPQK 296 (947)
Q Consensus 218 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~ 296 (947)
|++..+ +..+++|++|+|++|++++.++.+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++. +.+|..
T Consensus 181 l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~ 257 (487)
T 3oja_A 181 IYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (487)
T ss_dssp CCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred cccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence 997633 446899999999999999988889999999999999999995 6778999999999999999998 777888
Q ss_pred ccCccccccccccc
Q 002250 297 LGSWADFNYVDVSE 310 (947)
Q Consensus 297 l~~l~~L~~L~Ls~ 310 (947)
+..++.|+.++++.
T Consensus 258 ~~~l~~L~~l~~~~ 271 (487)
T 3oja_A 258 FSKNQRVQTVAKQT 271 (487)
T ss_dssp HTTCHHHHHHHHHH
T ss_pred HHhCCCCcEEeccc
Confidence 88999999998873
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-28 Score=287.28 Aligned_cols=196 Identities=17% Similarity=0.091 Sum_probs=133.5
Q ss_pred cccccCceeEEEEE-eCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cccccceEEEEEec
Q 002250 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCSITS 713 (947)
Q Consensus 636 ~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 713 (947)
..+.|++|.+.+++ ...|+.+|||++........ ..........++|.+|+++|+++ .|+||+++++++++
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~-------~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed 313 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGI-------LTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN 313 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTC-------SCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC
T ss_pred ccccCCcccccccccccccceeEEEEEeccccccc-------chhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE
Confidence 45677888777766 34589999999954321111 01112223446799999999999 79999999999999
Q ss_pred CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecccc
Q 002250 714 EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793 (947)
Q Consensus 714 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 793 (947)
++..||||||++|++|.+++...+ +++.. +|+.||+.||+|+| +++||||||||+|||+++++.+||+|||+
T Consensus 314 ~~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGl 385 (569)
T 4azs_A 314 AQSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGS 385 (569)
T ss_dssp SSEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeeccc
Confidence 999999999999999999998743 35543 48899999999999 89999999999999999999999999999
Q ss_pred ceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 002250 794 AKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPI 849 (947)
Q Consensus 794 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~ 849 (947)
|+....... .....+||+.|||||++.+ .+..++|+||+|++++++.++..|+
T Consensus 386 Ar~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 386 IVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp EESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 987654332 2334679999999999865 5778899999999988887665443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-26 Score=243.76 Aligned_cols=215 Identities=25% Similarity=0.314 Sum_probs=125.5
Q ss_pred CCCcccceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCC
Q 002250 22 NSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEV 101 (947)
Q Consensus 22 ~~~C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~ 101 (947)
.++|.|.|+.|+-.+.++.+++++++++. +|. .+ .++|+.|+|++|.+.+..+..|..+++|++|+|++|++++.+
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~~-ip~-~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLTA-IPS-NI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCSS-CCS-CC--CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCCc-cCC-CC--CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 58999999999865667788888887764 442 22 256777788877777766667777777777777777777655
Q ss_pred CC-cccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCC
Q 002250 102 PD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGN 180 (947)
Q Consensus 102 ~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 180 (947)
+. +..+++|++|+|++|++++..+ ..|..+++|++|+|++|.++..+ +..+..+++|++|+|++|.+++..+..|..
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 155 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPI-GVFDQLVNLAELRLDRNQLKSLP-PRVFDSLTKLTYLSLGYNELQSLPKGVFDK 155 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCT-TTTTTCSSCCEEECCSSCCCCCC-TTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCH-hHcccccCCCEEECCCCccCeeC-HHHhCcCcCCCEEECCCCcCCccCHhHccC
Confidence 54 4566666666666666653322 45555666666666666554432 223444455555555555555443334444
Q ss_pred CCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCC
Q 002250 181 LTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRL 242 (947)
Q Consensus 181 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 242 (947)
+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+
T Consensus 156 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (270)
T 2o6q_A 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPW 217 (270)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred CcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCe
Confidence 55555555555555444334444444455555554444443333344444444444444444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.9e-31 Score=313.20 Aligned_cols=462 Identities=15% Similarity=0.095 Sum_probs=238.1
Q ss_pred CCcccceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccCc---C------------chhhhcCCCc
Q 002250 23 SVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGT---I------------TEGLKSCTRL 87 (947)
Q Consensus 23 ~~C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~---~------------~~~l~~l~~L 87 (947)
-|+.|.++.. .....+++.+.. ...+...+..+++|++|+|+++..... . +.....+++|
T Consensus 33 vck~W~~~~~---~~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 33 VCKSWYEIER---WCRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp SCHHHHHHHH---HHCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHHhhh---hhceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 4668998822 123344444332 223334567788899999887653211 1 2234567888
Q ss_pred cEEeCcCccCcCCCCC-cc-cccccceeecCCC-CccCccCcccccccCCCceeeCCCCCCCCCC---CChhhcccccCc
Q 002250 88 QVLDLGNNSFSGEVPD-LS-MLHELSFLNLNSS-GISGKFPWKSLENLTNLEFLSLGDNPFDPSP---FPMEVLKLEKLY 161 (947)
Q Consensus 88 ~~L~Ls~n~i~~~~~~-l~-~l~~L~~L~L~~n-~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~---~~~~~~~l~~L~ 161 (947)
++|+|++|.+++.... +. .+++|++|+|++| .+++......+.++++|++|+|++|.++... ++.....+++|+
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~ 187 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence 8888888887764332 43 5778888888888 4443211133447788888888888765433 122223556777
Q ss_pred EEEccCcc--ccc-cCCccCCCCCCCCEEECcCc-ccccccCccccCCCCCcEEEee-------cccccccCCccCCCCC
Q 002250 162 WLYLTNCS--VTG-QIPEGIGNLTQLQNLELSDN-ELFGEIPAGIVKLNKLWQLELY-------NNSLSGRLPVGFSNLT 230 (947)
Q Consensus 162 ~L~L~~n~--l~~-~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~-------~n~l~~~~~~~~~~l~ 230 (947)
+|++++|. ++. .++..+.++++|++|+|++| .+. .++..+..+++|++|+++ .|.+.+ ++..+.+++
T Consensus 188 ~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~ 265 (594)
T 2p1m_B 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCK 265 (594)
T ss_dssp EEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCT
T ss_pred EEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCC
Confidence 77777776 221 11112234577777777777 443 356666777777777743 333443 233566777
Q ss_pred CccEE-eccCCCCCCCCccccccCCCCEEEccCccCcccCCC-CccCCCcCcEEEccCcccccc-CCcCccCcccccccc
Q 002250 231 NLMNF-DVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPE-EFGEFKHLTELSLYTNRLTGT-LPQKLGSWADFNYVD 307 (947)
Q Consensus 231 ~L~~L-~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~ 307 (947)
+|+.| .+........+..+..+++|++|+|++|.+++.... .+..+++|++|++++| ++.. ++.....+++|+.|+
T Consensus 266 ~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~ 344 (594)
T 2p1m_B 266 ELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELR 344 (594)
T ss_dssp TCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEE
T ss_pred CcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEE
Confidence 77777 343332222223334566777777777776533222 2445667777777766 3322 222222356666666
Q ss_pred cccccccCCCCCCcccCCccceeeecccccCCcCCccc-cCCCCccEEEcccccccccCCCCCC-CCCCcceeccc--c-
Q 002250 308 VSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETY-ANCKSLIRFRVNNNSLSGTIPPGIW-SLPNLSIIDLS--T- 382 (947)
Q Consensus 308 Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~-~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls--~- 382 (947)
++++.-.| ....+.++......+ ..+++|+.|.+..|.+++..+..+. .+++|+.|+++ +
T Consensus 345 L~~~~~~g---------------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~ 409 (594)
T 2p1m_B 345 VFPSEPFV---------------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEP 409 (594)
T ss_dssp EECSCTTC---------------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESST
T ss_pred EecCcccc---------------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccC
Confidence 64432100 000111111111112 2355666666666666544333333 35566666665 2
Q ss_pred ---CCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCccccc-ccccchhhccccccC
Q 002250 383 ---NQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGK-LKKLSSLYLHDNMFS 458 (947)
Q Consensus 383 ---N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~ 458 (947)
|.++....+. .++..+..+++|+.|+|++ .+++..+..++. +++|+.|+|++|.++
T Consensus 410 ~~~~~l~~~~~~~-------------------~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~ 469 (594)
T 2p1m_B 410 KAPDYLTLEPLDI-------------------GFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDS 469 (594)
T ss_dssp TCCCTTTCCCTHH-------------------HHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSS
T ss_pred CCcccccCCchhh-------------------HHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCc
Confidence 3333211100 0011123344555555544 343333333333 555666666666554
Q ss_pred CCCCccc-ccccccceeeccCceeeeecCC-CCCccCcCcEEECCCCccCCccCCcc--cccccceeeCCCCc
Q 002250 459 GPLPYSI-GSCVSLTDINFAQNSLSGKIPD-SLGSLPSLNSLNLSNNKFSGEIPISL--TYPKLSLLDLSNNQ 527 (947)
Q Consensus 459 ~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~~L~~L~ls~N~ 527 (947)
+..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|+|++|+++..-...+ .++.|+...+..+.
T Consensus 470 ~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 470 DLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp HHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred HHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 4333333 4456666666666666543332 33446677777777776643222212 23555555555443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=269.17 Aligned_cols=235 Identities=19% Similarity=0.210 Sum_probs=146.0
Q ss_pred cCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEecc
Q 002250 159 KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVS 238 (947)
Q Consensus 159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 238 (947)
+|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| +..+++|++|+|++|.|++..
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~---------------- 96 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL---------------- 96 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE----------------
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC----------------
Confidence 56666666666655555555556666666666665554333 555555555555555555322
Q ss_pred CCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCC
Q 002250 239 QNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIP 318 (947)
Q Consensus 239 ~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 318 (947)
..++|+.|+|++|.|++..+. .+++|++|+|++|.+++..|..++.+++|++|+|++|.+++..
T Consensus 97 ------------~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~- 160 (487)
T 3oja_A 97 ------------VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN- 160 (487)
T ss_dssp ------------ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEE-
T ss_pred ------------CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcC-
Confidence 124455555555555543332 2345666666666666555555666666666666666555322
Q ss_pred CCcccCCccceeeecccccCCcCCcccc-CCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccc
Q 002250 319 PDMCKTGAMTDLLVLQNNFNGTVPETYA-NCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAK 397 (947)
Q Consensus 319 ~~~~~~~~l~~L~l~~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 397 (947)
|..+. .+++|+.|+|++|.+++..+ +..+++|+.|+|++|++++.++. +..++
T Consensus 161 -----------------------~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~ 214 (487)
T 3oja_A 161 -----------------------FAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPE-FQSAA 214 (487)
T ss_dssp -----------------------GGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGG-GGGGT
T ss_pred -----------------------hHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCHh-HcCCC
Confidence 22332 45666777777777765422 23477888888888888865554 77788
Q ss_pred cccEEEccCccccccCCCCCCCCCcceEEEcccCccc-CCCCcccccccccchhhccc
Q 002250 398 SLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFS-GQIPLDIGKLKKLSSLYLHD 454 (947)
Q Consensus 398 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~ 454 (947)
+|+.|+|++|.|+ .+|..+..+++|+.|++++|.+. +.+|..+..++.|+.|+++.
T Consensus 215 ~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~ 271 (487)
T 3oja_A 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271 (487)
T ss_dssp TCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHH
T ss_pred CccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccc
Confidence 8888888888887 46777888888888888888887 56677777777777777753
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-30 Score=308.49 Aligned_cols=419 Identities=14% Similarity=0.155 Sum_probs=230.2
Q ss_pred eeeccCccccCcCchhhhcCCCccEEeCcCccCcCC---CC-C------------cccccccceeecCCCCccCccCccc
Q 002250 65 KINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGE---VP-D------------LSMLHELSFLNLNSSGISGKFPWKS 128 (947)
Q Consensus 65 ~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~---~~-~------------l~~l~~L~~L~L~~n~i~~~~~~~~ 128 (947)
.++++.... ......+..+++|+.|+|++|..... .+ . ...+++|++|+|++|.+++..+ ..
T Consensus 47 ~l~~~~~~~-~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~-~~ 124 (594)
T 2p1m_B 47 KVFIGNCYA-VSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCL-EL 124 (594)
T ss_dssp EEEESSTTS-SCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHH-HH
T ss_pred EEeeccccc-cCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHH-HH
Confidence 445544322 22335677889999999999853211 11 1 1345667777777776654433 23
Q ss_pred cc-ccCCCceeeCCCC-CCCCCCCChhhcccccCcEEEccCccccccCCccCC----CCCCCCEEECcCcc--cccc-cC
Q 002250 129 LE-NLTNLEFLSLGDN-PFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIG----NLTQLQNLELSDNE--LFGE-IP 199 (947)
Q Consensus 129 l~-~l~~L~~L~Ls~n-~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~----~l~~L~~L~Ls~N~--l~~~-~~ 199 (947)
+. .+++|++|+|++| .++...++..+..+++|++|+|++|.+++..+..+. .+++|++|+|++|. +... ++
T Consensus 125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~ 204 (594)
T 2p1m_B 125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALE 204 (594)
T ss_dssp HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHH
T ss_pred HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHH
Confidence 33 5667777777766 333322333344566677777776666654433332 44566666666665 2111 11
Q ss_pred ccccCCCCCcEEEeecc-cccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCc
Q 002250 200 AGIVKLNKLWQLELYNN-SLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKH 278 (947)
Q Consensus 200 ~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 278 (947)
..+.++++|++|+|++| .+++ ++..+..+++|++|+++.+... +..|.+.+ ++..+.++++
T Consensus 205 ~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~----------------~~~~~~~~-l~~~l~~~~~ 266 (594)
T 2p1m_B 205 RLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAE----------------VRPDVYSG-LSVALSGCKE 266 (594)
T ss_dssp HHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCC----------------CCHHHHHH-HHHHHHTCTT
T ss_pred HHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCc----------------cchhhHHH-HHHHHhcCCC
Confidence 11233466666666666 3332 4555555666666664433210 22222332 2224445555
Q ss_pred CcEE-EccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcc
Q 002250 279 LTEL-SLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVN 357 (947)
Q Consensus 279 L~~L-~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~ 357 (947)
|+.| .+.+... +.++..+..+++|++|++++|.+++.. ++..+..+++|+.|+++
T Consensus 267 L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~-----------------------l~~~~~~~~~L~~L~l~ 322 (594)
T 2p1m_B 267 LRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYD-----------------------LVKLLCQCPKLQRLWVL 322 (594)
T ss_dssp CCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHH-----------------------HHHHHTTCTTCCEEEEE
T ss_pred cccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHH-----------------------HHHHHhcCCCcCEEeCc
Confidence 5555 2322222 133333344555555555555543110 01112233444444444
Q ss_pred ccccccc-CCCCCCCCCCcceecc---------ccCCcCCCCCCcc-cccccccEEEccCccccccCCCCCC-CCCcceE
Q 002250 358 NNSLSGT-IPPGIWSLPNLSIIDL---------STNQFEGPVTDDI-GNAKSLALLLLANNRFSGELPSKIS-EASSLVS 425 (947)
Q Consensus 358 ~n~l~~~-~p~~~~~l~~L~~L~L---------s~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~ 425 (947)
+| +... ++.....+++|+.|++ +.+.+++.....+ ..+++|+.|.++.|++++..+..+. .+++|+.
T Consensus 323 ~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~ 401 (594)
T 2p1m_B 323 DY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTR 401 (594)
T ss_dssp GG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCE
T ss_pred Cc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcce
Confidence 44 2211 1111112344444444 2233332111122 2356777777777777655444443 4678888
Q ss_pred EEcc--c----CcccCC-----CCcccccccccchhhccccccCCCCCccccc-ccccceeeccCceeeeecCCCC-Ccc
Q 002250 426 IQLS--L----NQFSGQ-----IPLDIGKLKKLSSLYLHDNMFSGPLPYSIGS-CVSLTDINFAQNSLSGKIPDSL-GSL 492 (947)
Q Consensus 426 L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l 492 (947)
|+|+ + |.+++. ++..+..+++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+
T Consensus 402 L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~ 480 (594)
T 2p1m_B 402 FRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGC 480 (594)
T ss_dssp EEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHC
T ss_pred eEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcC
Confidence 8888 4 555521 122266789999999987 666655556665 8999999999999987655555 668
Q ss_pred CcCcEEECCCCccCCccCCc-c-cccccceeeCCCCcCC
Q 002250 493 PSLNSLNLSNNKFSGEIPIS-L-TYPKLSLLDLSNNQLA 529 (947)
Q Consensus 493 ~~L~~L~Ls~N~l~~~~p~~-~-~~~~L~~L~ls~N~l~ 529 (947)
++|+.|+|++|++++..+.. . .+++|+.|++++|+++
T Consensus 481 ~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 481 DSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp TTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred CCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 99999999999997544432 2 3689999999999984
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.5e-25 Score=233.93 Aligned_cols=226 Identities=24% Similarity=0.270 Sum_probs=133.4
Q ss_pred cccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeC
Q 002250 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSL 140 (947)
Q Consensus 61 ~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~L 140 (947)
..+..+++..+.+.+.. .+..+++|+.|++++|.++. .+.+ ..+++|++|+|
T Consensus 19 ~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~~~l-------------------------~~l~~L~~L~l 70 (272)
T 3rfs_A 19 AETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQGI-------------------------QYLPNVRYLAL 70 (272)
T ss_dssp HHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-CTTG-------------------------GGCTTCCEEEC
T ss_pred HHHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-cccc-------------------------ccCCCCcEEEC
Confidence 34445555555553332 24455566666666665552 2234 44444444444
Q ss_pred CCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccc
Q 002250 141 GDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSG 220 (947)
Q Consensus 141 s~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 220 (947)
++|.+... ..+..+++|++|++++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++
T Consensus 71 ~~n~l~~~---~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 147 (272)
T 3rfs_A 71 GGNKLHDI---SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS 147 (272)
T ss_dssp TTSCCCCC---GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCc---hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCc
Confidence 44444331 134455555555555555555555556666666666666666665555556666666666666666665
Q ss_pred cCCccCCCCCCccEEeccCCCCCCCCcc-ccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccC
Q 002250 221 RLPVGFSNLTNLMNFDVSQNRLEGDLSE-LRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGS 299 (947)
Q Consensus 221 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 299 (947)
..+..|..+++|++|++++|++++.+.. +..+++|+.|+|++|++++..+..|..+++|++|+|++|++.+.
T Consensus 148 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~------- 220 (272)
T 3rfs_A 148 LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT------- 220 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------
T ss_pred cCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------
Confidence 5555566666666666666666655443 45666677777777777666666667777777777777766532
Q ss_pred cccccccccccccccCCCCCCcccC
Q 002250 300 WADFNYVDVSENLLTGPIPPDMCKT 324 (947)
Q Consensus 300 l~~L~~L~Ls~N~l~~~~p~~~~~~ 324 (947)
+++|+.|+++.|.++|.+|..++.+
T Consensus 221 ~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 221 CPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred CcHHHHHHHHHHhCCCcccCccccc
Confidence 4456777777777776666655544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=260.39 Aligned_cols=193 Identities=22% Similarity=0.241 Sum_probs=146.7
Q ss_pred CCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEE
Q 002250 632 KPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSI 711 (947)
Q Consensus 632 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 711 (947)
...+.||+|+||+||+|... ++.+|+|+....... . .........+.+.+|++++++++||||+++..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~------~---~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 408 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYR------D---ERLDENIRKSRTAREARYLALVKDFGIPAPYIFD 408 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTS------C---HHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEeccccc------c---hhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEE
Confidence 44678999999999999554 789999987431110 0 0001112245689999999999999999666666
Q ss_pred ecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecc
Q 002250 712 TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791 (947)
Q Consensus 712 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 791 (947)
..++..|+||||+++++|.+++.. +..++.|+++||+||| +++|+||||||+|||++. .+||+||
T Consensus 409 ~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DF 473 (540)
T 3en9_A 409 VDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDF 473 (540)
T ss_dssp EETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCC
T ss_pred EeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEEC
Confidence 677788999999999999999986 4578999999999999 899999999999999999 9999999
Q ss_pred ccceecccCCCCc-----ceecccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCC
Q 002250 792 GLAKIVQTGEAGD-----LTHVIAGTHGYIAPEYAYT--CKINEKSDVYSFGVVLMELVTGKRPI 849 (947)
Q Consensus 792 G~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~ 849 (947)
|+|+......... ......||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9998765432111 1235679999999999976 55778899999999999988887775
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=230.94 Aligned_cols=224 Identities=16% Similarity=0.169 Sum_probs=119.5
Q ss_pred EEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeeccccc
Q 002250 258 LHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNF 337 (947)
Q Consensus 258 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~ 337 (947)
.+..+..+. .+|..+. ++|++|++++|++++..+..|..+++|++|++++|.+++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---------------------- 66 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT---------------------- 66 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCE----------------------
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCc----------------------
Confidence 344444444 3444332 346666666666654444455555555555555555442
Q ss_pred CCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCC
Q 002250 338 NGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKI 417 (947)
Q Consensus 338 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 417 (947)
..+..|.++++|+.|++++|.+++..+..+..+++|++|++++|++.+..+..+
T Consensus 67 --~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~------------------------ 120 (276)
T 2z62_A 67 --IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI------------------------ 120 (276)
T ss_dssp --ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCC------------------------
T ss_pred --cCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhc------------------------
Confidence 122334444555555555555554444445555555555555555544444344
Q ss_pred CCCCcceEEEcccCcccCC-CCcccccccccchhhccccccCCCCCcccccccccc----eeeccCceeeeecCCCCCcc
Q 002250 418 SEASSLVSIQLSLNQFSGQ-IPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLT----DINFAQNSLSGKIPDSLGSL 492 (947)
Q Consensus 418 ~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l 492 (947)
..+++|+.|++++|++++. +|..++++++|+.|+|++|++++..+..|..+.+|+ .|++++|++++..+..+. .
T Consensus 121 ~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~ 199 (276)
T 2z62_A 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-E 199 (276)
T ss_dssp TTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-S
T ss_pred ccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-C
Confidence 4444444555555544432 344555555555555555555544444555444444 567777777654444443 3
Q ss_pred CcCcEEECCCCccCCccCCccc-ccccceeeCCCCcCCCCCC
Q 002250 493 PSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQLAGPIP 533 (947)
Q Consensus 493 ~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N~l~~~~p 533 (947)
.+|+.|+|++|++++.++..+. +++|+.|+|++|++++..|
T Consensus 200 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 200 IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 4677777777777766555443 5677777777777776655
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=229.84 Aligned_cols=207 Identities=22% Similarity=0.224 Sum_probs=184.4
Q ss_pred CCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEc
Q 002250 349 KSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQL 428 (947)
Q Consensus 349 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 428 (947)
++|++|++++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46888999999998777778889999999999999999888888999999999999999999888889999999999999
Q ss_pred ccCcccCCCCcccccccccchhhccccccCCC-CCcccccccccceeeccCceeeeecCCCCCccCcCc----EEECCCC
Q 002250 429 SLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGP-LPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLN----SLNLSNN 503 (947)
Q Consensus 429 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N 503 (947)
++|++++..+..++.+++|++|+|++|.+++. +|..|+.+++|++|+|++|++++..+..+..+++|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99999987777899999999999999999875 699999999999999999999988888888888888 9999999
Q ss_pred ccCCccCCcccccccceeeCCCCcCCCCCCCccc--ccccccccccCCCCCCCC
Q 002250 504 KFSGEIPISLTYPKLSLLDLSNNQLAGPIPEPLN--IKAFIDSFTGNPGLCSKT 555 (947)
Q Consensus 504 ~l~~~~p~~~~~~~L~~L~ls~N~l~~~~p~~~~--~~~~~~~~~gN~~~c~~~ 555 (947)
++++..+..+...+|+.|+|++|++++.++..+. .......+.+||+.|+|+
T Consensus 188 ~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 188 PMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 9998888877778999999999999987776543 233455789999999986
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=230.07 Aligned_cols=203 Identities=21% Similarity=0.266 Sum_probs=171.5
Q ss_pred cccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCC
Q 002250 106 MLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQ 185 (947)
Q Consensus 106 ~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 185 (947)
.+.++..+++..+.+.+.. .+..+++|+.|++++|.+...+ .+..+++|++|++++|.+++. ..+..+++|+
T Consensus 17 ~~~~l~~l~l~~~~~~~~~---~~~~l~~L~~L~l~~~~i~~~~---~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~ 88 (272)
T 3rfs_A 17 AFAETIKANLKKKSVTDAV---TQNELNSIDQIIANNSDIKSVQ---GIQYLPNVRYLALGGNKLHDI--SALKELTNLT 88 (272)
T ss_dssp HHHHHHHHHHTCSCTTSEE---CHHHHTTCCEEECTTSCCCCCT---TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCC
T ss_pred hHHHHHHHHhcCccccccc---ccccccceeeeeeCCCCccccc---ccccCCCCcEEECCCCCCCCc--hhhcCCCCCC
Confidence 3456667777777776543 4778899999999999887532 478899999999999999863 4788999999
Q ss_pred EEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCcc-ccccCCCCEEEccCcc
Q 002250 186 NLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSE-LRFLNQLSSLHLFENQ 264 (947)
Q Consensus 186 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~L~~N~ 264 (947)
+|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++.+.. +..+++|+.|+|++|+
T Consensus 89 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 168 (272)
T 3rfs_A 89 YLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQ 168 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCC
Confidence 999999999887777889999999999999999988777889999999999999999887654 6788999999999999
Q ss_pred CcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCC
Q 002250 265 FSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGP 316 (947)
Q Consensus 265 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 316 (947)
+++..+..|..+++|++|++++|++++..|..++.+++|++|++++|++.+.
T Consensus 169 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 169 LQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence 9977777788899999999999999987777788899999999999988743
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.4e-23 Score=223.92 Aligned_cols=202 Identities=22% Similarity=0.166 Sum_probs=114.0
Q ss_pred cccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCC-cccccccceeecCCCCccCccCcccccccCC
Q 002250 56 SICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTN 134 (947)
Q Consensus 56 ~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~ 134 (947)
.+.++++++.+++++|+++. +|..+. ++|+.|+|++|.|++..+. +..+++|++|+|++|.|++..+ ..
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~---~~---- 74 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV---DG---- 74 (290)
T ss_dssp EEECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC---CS----
T ss_pred cccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC---CC----
Confidence 34555556666666655533 232222 4555555555555544332 4445555555555555443211 13
Q ss_pred CceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEee
Q 002250 135 LEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELY 214 (947)
Q Consensus 135 L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 214 (947)
.+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 75 ---------------------~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~ 132 (290)
T 1p9a_G 75 ---------------------TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132 (290)
T ss_dssp ---------------------CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECT
T ss_pred ---------------------CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECC
Confidence 4444555555555554 345555556666666666666655555556666666666666
Q ss_pred cccccccCCccCCCCCCccEEeccCCCCCCCCcc-ccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccc
Q 002250 215 NNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSE-LRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 215 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 290 (947)
+|+|++..+..|..+++|+.|+|++|+++..+.. +..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 133 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 6666655555566666666666666666655543 455666666666667666 55666666667777777777765
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-23 Score=220.46 Aligned_cols=163 Identities=21% Similarity=0.223 Sum_probs=78.8
Q ss_pred cccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcc
Q 002250 344 TYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSL 423 (947)
Q Consensus 344 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 423 (947)
.|.++++|++|++++|.++...+..|..+++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..
T Consensus 56 ~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~---- 131 (270)
T 2o6q_A 56 AFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDS---- 131 (270)
T ss_dssp SSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTT----
T ss_pred HhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCc----
Confidence 3444455555555555554333333444555555555555555444444444444455555444444444444444
Q ss_pred eEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCC
Q 002250 424 VSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNN 503 (947)
Q Consensus 424 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 503 (947)
+++|++|+|++|.+++..+..|+.+++|+.|+|++|++++..+..|..+++|+.|+|++|
T Consensus 132 --------------------l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (270)
T 2o6q_A 132 --------------------LTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191 (270)
T ss_dssp --------------------CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred --------------------CcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC
Confidence 444444444444444444444444555555555555555444444455555555555555
Q ss_pred ccCCccCCccc-ccccceeeCCCCcCCC
Q 002250 504 KFSGEIPISLT-YPKLSLLDLSNNQLAG 530 (947)
Q Consensus 504 ~l~~~~p~~~~-~~~L~~L~ls~N~l~~ 530 (947)
++++.++..+. +++|+.|+|++|++.+
T Consensus 192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 192 QLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 55544443332 3455555555555543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-23 Score=222.38 Aligned_cols=203 Identities=20% Similarity=0.177 Sum_probs=162.0
Q ss_pred hhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccC
Q 002250 81 LKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKL 160 (947)
Q Consensus 81 l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L 160 (947)
+..+++|+++++++|.++..++.+. ++|+.|+|++|.+++..+ ..|. .+++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~-~~~~-------------------------~l~~L 57 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSL-ATLM-------------------------PYTRL 57 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEG-GGGT-------------------------TCTTC
T ss_pred ccccCCccEEECCCCCCCcCCCCCC--CCCCEEEcCCCcCCccCH-HHhh-------------------------cCCCC
Confidence 4556677777777777765554432 455566666665553322 3444 44555
Q ss_pred cEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCC
Q 002250 161 YWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQN 240 (947)
Q Consensus 161 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 240 (947)
++|+|++|.+++..+ .+.+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 58 ~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N 134 (290)
T 1p9a_G 58 TQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134 (290)
T ss_dssp CEEECTTSCCCEEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred CEEECCCCccCcccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence 555555555553322 278899999999999997 78889999999999999999999888889999999999999999
Q ss_pred CCCCCCcc-ccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccC
Q 002250 241 RLEGDLSE-LRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315 (947)
Q Consensus 241 ~l~~~~~~-l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 315 (947)
++++.+.. +..+++|+.|+|++|+|+...+..|..+++|++|+|++|+++ .+|..+..+.+|+.|+|++|++.+
T Consensus 135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 99987764 678999999999999999777777899999999999999999 889999999999999999999975
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=228.46 Aligned_cols=200 Identities=21% Similarity=0.215 Sum_probs=116.3
Q ss_pred ccceeecCCCCccCccCcccc--cccCCCceeeCCCCCCCCCCC---ChhhcccccCcEEEccCccccccCCccCCCCCC
Q 002250 109 ELSFLNLNSSGISGKFPWKSL--ENLTNLEFLSLGDNPFDPSPF---PMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQ 183 (947)
Q Consensus 109 ~L~~L~L~~n~i~~~~~~~~l--~~l~~L~~L~Ls~n~i~~~~~---~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 183 (947)
+|++|+|++|.+.+..| ..+ ..+++|++|+|++|.+..... ...+..+++|++|+|++|.+++..|..|+.+++
T Consensus 92 ~L~~L~l~~n~l~~~~~-~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 92 RLKELTLEDLKITGTMP-PLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp CCCEEEEESCCCBSCCC-CCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred ceeEEEeeCCEeccchh-hhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 34444444444444333 222 445555555555555443111 012234566666666666666666666666677
Q ss_pred CCEEECcCcccccc--c--CccccCCCCCcEEEeecccccccCCc----cCCCCCCccEEeccCCCCCCC-Ccccccc--
Q 002250 184 LQNLELSDNELFGE--I--PAGIVKLNKLWQLELYNNSLSGRLPV----GFSNLTNLMNFDVSQNRLEGD-LSELRFL-- 252 (947)
Q Consensus 184 L~~L~Ls~N~l~~~--~--~~~l~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~-~~~l~~l-- 252 (947)
|++|+|++|++.+. + +..+..+++|++|+|++|+++. ++. .+..+++|++|+|++|++++. +..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 77777777765431 1 1223556667777777777652 222 245666777777777777665 3334333
Q ss_pred -CCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccC
Q 002250 253 -NQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315 (947)
Q Consensus 253 -~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 315 (947)
++|++|+|++|+|+ .+|..+. ++|++|+|++|++++. |. +..+++|+.|+|++|+++.
T Consensus 250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 57777777777777 5566554 6777777777777743 33 5667777777777777763
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-25 Score=244.93 Aligned_cols=269 Identities=20% Similarity=0.243 Sum_probs=134.2
Q ss_pred CCCCcccceeeeCCCCceeEeccCCCccccccCcccccCC--cccceeeccCccccCcCchhhhcCCCccEEeCcCccCc
Q 002250 21 ANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGL--QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFS 98 (947)
Q Consensus 21 ~~~~C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l--~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~ 98 (947)
+..|..|.++.|+. ..++.++++++.+.. ..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.++
T Consensus 33 ~~vc~~W~~~~~~~-~~~~~l~l~~~~~~~----~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~ 106 (336)
T 2ast_B 33 SGVCKRWYRLASDE-SLWQTLDLTGKNLHP----DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIE 106 (336)
T ss_dssp TSSCHHHHHHHTCS-TTSSEEECTTCBCCH----HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEEC
T ss_pred HHHHHHHHHHhcCc-hhheeeccccccCCH----HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcC
Confidence 34677899999874 345566665544331 223333 4455555555555444333 234455555555555444
Q ss_pred CCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCc-ccccc-CCc
Q 002250 99 GEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNC-SVTGQ-IPE 176 (947)
Q Consensus 99 ~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~p~ 176 (947)
+. .++ ..+..+++|++|+|++|.+... .+..+..+++|++|++++| .+++. ++.
T Consensus 107 ~~----------------------~~~-~~~~~~~~L~~L~L~~~~l~~~-~~~~l~~~~~L~~L~L~~~~~l~~~~l~~ 162 (336)
T 2ast_B 107 VS----------------------TLH-GILSQCSKLQNLSLEGLRLSDP-IVNTLAKNSNLVRLNLSGCSGFSEFALQT 162 (336)
T ss_dssp HH----------------------HHH-HHHTTBCCCSEEECTTCBCCHH-HHHHHTTCTTCSEEECTTCBSCCHHHHHH
T ss_pred HH----------------------HHH-HHHhhCCCCCEEeCcCcccCHH-HHHHHhcCCCCCEEECCCCCCCCHHHHHH
Confidence 32 022 2344444555555555444321 2333444455555555555 34431 333
Q ss_pred cCCCCCCCCEEECcCc-ccccc-cCccccCCC-CCcEEEeecc--ccc-ccCCccCCCCCCccEEeccCCC-CCC-CCcc
Q 002250 177 GIGNLTQLQNLELSDN-ELFGE-IPAGIVKLN-KLWQLELYNN--SLS-GRLPVGFSNLTNLMNFDVSQNR-LEG-DLSE 248 (947)
Q Consensus 177 ~~~~l~~L~~L~Ls~N-~l~~~-~~~~l~~l~-~L~~L~L~~n--~l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~ 248 (947)
.+.++++|++|+|++| .+++. ++..+..++ +|++|+|++| .++ +.++..+..+++|++|++++|. +++ .+..
T Consensus 163 ~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~ 242 (336)
T 2ast_B 163 LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQE 242 (336)
T ss_dssp HHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGG
T ss_pred HHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHH
Confidence 4445555555555555 55432 344445555 5555555555 233 2334444555555555555555 332 2334
Q ss_pred ccccCCCCEEEccCcc-CcccCCCCccCCCcCcEEEccCccccccCCcCccCc-ccccccccccccccCCCCCCccc
Q 002250 249 LRFLNQLSSLHLFENQ-FSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSW-ADFNYVDVSENLLTGPIPPDMCK 323 (947)
Q Consensus 249 l~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~ 323 (947)
+..+++|++|+|++|. +.......+..+++|++|++++| ++ ...+..+ ..+..|++++|.+++..|+.+..
T Consensus 243 l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 243 FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp GGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred HhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 5555666666666663 22222224566667777777766 32 1223333 23666667777777766665543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=8.5e-23 Score=215.22 Aligned_cols=192 Identities=23% Similarity=0.284 Sum_probs=107.1
Q ss_pred CCcccceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCC
Q 002250 23 SVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP 102 (947)
Q Consensus 23 ~~C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~ 102 (947)
+||.|.|++|... .+.+++++.++.. +|. .+. ++++.|+|++|.+.+..+..|..+++|++|+|++|+|++.++
T Consensus 3 ~Cp~~~gC~C~~~--~~~l~~~~~~l~~-~p~-~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNEG--KKEVDCQGKSLDS-VPS-GIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEGG--GTEEECTTCCCSS-CCS-CCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCCC--CeEEecCCCCccc-cCC-CCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 6999999999632 2345666665543 331 121 456666666666666666566666666666666666655443
Q ss_pred CcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCC
Q 002250 103 DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLT 182 (947)
Q Consensus 103 ~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 182 (947)
. .|..+++|++|+|++|.++..+ +..+..+++|++|+|++|++++..+..|..++
T Consensus 77 ~------------------------~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 131 (251)
T 3m19_A 77 G------------------------VFDDLTELGTLGLANNQLASLP-LGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLT 131 (251)
T ss_dssp T------------------------TTTTCTTCCEEECTTSCCCCCC-TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred h------------------------HhccCCcCCEEECCCCcccccC-hhHhcccCCCCEEEcCCCcCCCcChhHhccCC
Confidence 3 3344444444444444443221 22233444444555555555544444556666
Q ss_pred CCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCC
Q 002250 183 QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGD 245 (947)
Q Consensus 183 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 245 (947)
+|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+...
T Consensus 132 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 132 KLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 666666666666655555566666666666666666655555566666666666666665543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.5e-23 Score=214.46 Aligned_cols=195 Identities=17% Similarity=0.147 Sum_probs=129.5
Q ss_pred ccceeeccCccccCcCchhhhcCCCccEEeCcCcc-CcCCCC-CcccccccceeecCC-CCccCccCcccccccCCCcee
Q 002250 62 ALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNS-FSGEVP-DLSMLHELSFLNLNS-SGISGKFPWKSLENLTNLEFL 138 (947)
Q Consensus 62 ~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~-i~~~~~-~l~~l~~L~~L~L~~-n~i~~~~~~~~l~~l~~L~~L 138 (947)
+|+.|+|++|+|.+..+..|..+++|++|+|++|+ +++.++ .+..+++|++|+|++ |++++ ++...|.++++|++|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~-i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY-IDPDALKELPLLKFL 110 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE-ECTTSEECCTTCCEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE-cCHHHhCCCCCCCEE
Confidence 78899999999988888888889999999999996 776665 477788888888887 77774 333567777777777
Q ss_pred eCCCCCCCCCCCChhhcccccCc---EEEccCc-cccccCCccCCCCCCCC-EEECcCcccccccCccccCCCCCcEEEe
Q 002250 139 SLGDNPFDPSPFPMEVLKLEKLY---WLYLTNC-SVTGQIPEGIGNLTQLQ-NLELSDNELFGEIPAGIVKLNKLWQLEL 213 (947)
Q Consensus 139 ~Ls~n~i~~~~~~~~~~~l~~L~---~L~L~~n-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 213 (947)
++++|.++. +|. +..+++|+ +|++++| .+++..+..|.++++|+ +|+|++|+++...+..+.. ++|++|+|
T Consensus 111 ~l~~n~l~~--lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L 186 (239)
T 2xwt_C 111 GIFNTGLKM--FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYL 186 (239)
T ss_dssp EEEEECCCS--CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEEC
T ss_pred eCCCCCCcc--ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEc
Confidence 777777765 333 55556665 6777777 66655555666666666 6777666665322223333 56666666
Q ss_pred eccc-ccccCCccCCCC-CCccEEeccCCCCCCCCccccccCCCCEEEccCc
Q 002250 214 YNNS-LSGRLPVGFSNL-TNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFEN 263 (947)
Q Consensus 214 ~~n~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N 263 (947)
++|+ +++..+..|..+ ++|++|++++|++++.+.. .+++|+.|+++++
T Consensus 187 ~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp TTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred CCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence 6663 665555556666 6666666666665544333 3444555554443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-24 Score=241.72 Aligned_cols=249 Identities=18% Similarity=0.136 Sum_probs=154.1
Q ss_pred eeccCccccCcCchhhhcCCCccEEeCcCccCcCCCC-----Cccccc-ccceeecCCCCccCccCccccccc-----CC
Q 002250 66 INLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP-----DLSMLH-ELSFLNLNSSGISGKFPWKSLENL-----TN 134 (947)
Q Consensus 66 L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~-----~l~~l~-~L~~L~L~~n~i~~~~~~~~l~~l-----~~ 134 (947)
+.|+.|.+++.+|..+...++|++|||++|.|++..+ .+..++ +|++|+|++|.+++..+ ..+..+ ++
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~-~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNS-DELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCH-HHHHHHHHTSCTT
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHH-HHHHHHHhccCCC
Confidence 4556666666666666655666666666666665543 245555 66666666666654333 344443 66
Q ss_pred CceeeCCCCCCCCCCCChh----hccc-ccCcEEEccCccccccCCccC----CC-CCCCCEEECcCcccccccC----c
Q 002250 135 LEFLSLGDNPFDPSPFPME----VLKL-EKLYWLYLTNCSVTGQIPEGI----GN-LTQLQNLELSDNELFGEIP----A 200 (947)
Q Consensus 135 L~~L~Ls~n~i~~~~~~~~----~~~l-~~L~~L~L~~n~l~~~~p~~~----~~-l~~L~~L~Ls~N~l~~~~~----~ 200 (947)
|++|+|++|.++... +.. +..+ ++|++|+|++|.+++..+..+ .. .++|++|+|++|++++..+ .
T Consensus 82 L~~L~Ls~n~l~~~~-~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 160 (362)
T 3goz_A 82 VTSLNLSGNFLSYKS-SDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160 (362)
T ss_dssp CCEEECCSSCGGGSC-HHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred ccEEECcCCcCChHH-HHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence 777777777665432 222 2233 677777777777765554443 23 2577777777777764333 3
Q ss_pred cccCCC-CCcEEEeecccccccCCccC----CCC-CCccEEeccCCCCCC-----CCccccc-cCCCCEEEccCccCccc
Q 002250 201 GIVKLN-KLWQLELYNNSLSGRLPVGF----SNL-TNLMNFDVSQNRLEG-----DLSELRF-LNQLSSLHLFENQFSGE 268 (947)
Q Consensus 201 ~l~~l~-~L~~L~L~~n~l~~~~~~~~----~~l-~~L~~L~Ls~N~l~~-----~~~~l~~-l~~L~~L~L~~N~i~~~ 268 (947)
.+..++ +|++|+|++|++++..+..+ ..+ ++|++|+|++|.++. .+..+.. .++|++|+|++|.|++.
T Consensus 161 ~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 240 (362)
T 3goz_A 161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240 (362)
T ss_dssp HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCC
T ss_pred HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcH
Confidence 334444 77777777777776555433 334 477888888887765 2333444 34788888888887754
Q ss_pred CC----CCccCCCcCcEEEccCccccc-------cCCcCccCcccccccccccccccCC
Q 002250 269 IP----EEFGEFKHLTELSLYTNRLTG-------TLPQKLGSWADFNYVDVSENLLTGP 316 (947)
Q Consensus 269 ~~----~~~~~l~~L~~L~L~~N~l~~-------~~p~~l~~l~~L~~L~Ls~N~l~~~ 316 (947)
.+ ..+..+++|++|+|++|.+.+ .++..+..+++|+.||+++|++.+.
T Consensus 241 ~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 241 SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp CHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 43 334567788888888887432 2344667778888888888887644
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=9e-23 Score=221.76 Aligned_cols=210 Identities=25% Similarity=0.308 Sum_probs=132.4
Q ss_pred cceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCC
Q 002250 63 LQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGD 142 (947)
Q Consensus 63 L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~ 142 (947)
+..+.+..+.+.+... +..+++|++|++++|.++.. +.+..+++|++|+|++|.+.+..+ +..+++|++|+|++
T Consensus 21 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~l-~~~~~l~~L~~L~L~~n~i~~~~~---~~~l~~L~~L~L~~ 94 (308)
T 1h6u_A 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLAP---LKNLTKITELELSG 94 (308)
T ss_dssp HHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG---GTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCceec--HHHcCCcCEEEeeCCCccCc-hhhhccCCCCEEEccCCcCCCChh---HccCCCCCEEEccC
Confidence 3344455555544322 34566777777777777643 356667777777777777664322 66677777777777
Q ss_pred CCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccC
Q 002250 143 NPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRL 222 (947)
Q Consensus 143 n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 222 (947)
|.++.. + .+..+++|++|++++|.+++. + .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++..
T Consensus 95 n~l~~~--~-~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~ 167 (308)
T 1h6u_A 95 NPLKNV--S-AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLT 167 (308)
T ss_dssp CCCSCC--G-GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG
T ss_pred CcCCCc--h-hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCCh
Confidence 776552 2 466666777777777776643 3 26677777777777777764432 666777777777777776433
Q ss_pred CccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccc
Q 002250 223 PVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 223 ~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 290 (947)
+ +..+++|++|+|++|++++.+. +..+++|++|+|++|++++.. .+..+++|++|+|++|+++
T Consensus 168 ~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 168 P--LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp G--GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred h--hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 2 6667777777777777665443 566666666777766666433 2666666666666666665
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.9e-25 Score=245.21 Aligned_cols=257 Identities=19% Similarity=0.172 Sum_probs=118.1
Q ss_pred EccCccccccCCccCCCCCCCCEEECcCcccccccC----ccccCCC-CCcEEEeecccccccCCccCCCC-----CCcc
Q 002250 164 YLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIP----AGIVKLN-KLWQLELYNNSLSGRLPVGFSNL-----TNLM 233 (947)
Q Consensus 164 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~----~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~L~ 233 (947)
++++|.+++.+|..+...++|++|+|++|.+++..+ ..+.+++ +|++|+|++|.+++..+..|..+ ++|+
T Consensus 4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~ 83 (362)
T 3goz_A 4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83 (362)
T ss_dssp ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence 334444444444433333344444444444443333 3344444 44444444444444333333332 4444
Q ss_pred EEeccCCCCCCCCcc-----cccc-CCCCEEEccCccCcccCCCCcc----C-CCcCcEEEccCccccccC----CcCcc
Q 002250 234 NFDVSQNRLEGDLSE-----LRFL-NQLSSLHLFENQFSGEIPEEFG----E-FKHLTELSLYTNRLTGTL----PQKLG 298 (947)
Q Consensus 234 ~L~Ls~N~l~~~~~~-----l~~l-~~L~~L~L~~N~i~~~~~~~~~----~-l~~L~~L~L~~N~l~~~~----p~~l~ 298 (947)
+|+|++|++++.... +..+ ++|++|+|++|++++..+..+. . .++|++|+|++|++++.. +..+.
T Consensus 84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~ 163 (362)
T 3goz_A 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA 163 (362)
T ss_dssp EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHh
Confidence 444444444432221 2222 4455555555555433332222 1 134555555555554322 22222
Q ss_pred Ccc-cccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCC-CCccEEEccccccccc----CCCCCCC-
Q 002250 299 SWA-DFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANC-KSLIRFRVNNNSLSGT----IPPGIWS- 371 (947)
Q Consensus 299 ~l~-~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l-~~L~~L~L~~n~l~~~----~p~~~~~- 371 (947)
.++ +|++|+|++|.+++..+..++ ..+..+ ++|+.|+|++|.+++. ++..+..
T Consensus 164 ~~~~~L~~L~Ls~n~l~~~~~~~l~--------------------~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~ 223 (362)
T 3goz_A 164 AIPANVNSLNLRGNNLASKNCAELA--------------------KFLASIPASVTSLDLSANLLGLKSYAELAYIFSSI 223 (362)
T ss_dssp TSCTTCCEEECTTSCGGGSCHHHHH--------------------HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHS
T ss_pred cCCccccEeeecCCCCchhhHHHHH--------------------HHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcC
Confidence 332 455555555555432221111 122223 3555555555555532 2223333
Q ss_pred CCCcceeccccCCcCCCCC----CcccccccccEEEccCccccc-------cCCCCCCCCCcceEEEcccCcccCCCCcc
Q 002250 372 LPNLSIIDLSTNQFEGPVT----DDIGNAKSLALLLLANNRFSG-------ELPSKISEASSLVSIQLSLNQFSGQIPLD 440 (947)
Q Consensus 372 l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~-------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 440 (947)
.++|+.|+|++|++++..+ ..+..+++|+.|+|++|.+.+ .++..+..+++|+.||+++|++.+..+..
T Consensus 224 ~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~ 303 (362)
T 3goz_A 224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIP 303 (362)
T ss_dssp CTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHH
T ss_pred CCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHH
Confidence 2366666666666665433 223445566666666666332 24456677778888888888877554433
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=213.52 Aligned_cols=159 Identities=19% Similarity=0.223 Sum_probs=98.0
Q ss_pred CccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcc
Q 002250 350 SLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLS 429 (947)
Q Consensus 350 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 429 (947)
.++.|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 55666666666665555556666666666666666666555556666666666666666665555555666666666666
Q ss_pred cCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCc
Q 002250 430 LNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGE 508 (947)
Q Consensus 430 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 508 (947)
+|+|++..+..|..+++|+.|+|++|++++..+..|+.+++|++|+|++|+|++..|..|..+++|+.|+|++|++++.
T Consensus 116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 6666654444456666666666666666655555566666666666666666655555566666666666666666554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=211.60 Aligned_cols=196 Identities=15% Similarity=0.201 Sum_probs=142.3
Q ss_pred ccceeeecccccCCcCCccccCCCCccEEEccccc-ccccCCCCCCCCCCcceecccc-CCcCCCCCCcccccccccEEE
Q 002250 326 AMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNS-LSGTIPPGIWSLPNLSIIDLST-NQFEGPVTDDIGNAKSLALLL 403 (947)
Q Consensus 326 ~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~ 403 (947)
.++.|++.+|++.+..+..|.++++|+.|++++|. +++..+..|..+++|++|++++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 44445555555554555567777788888888886 7755566777788888888887 788777777777888888888
Q ss_pred ccCccccccCCCCCCCCCcce---EEEcccC-cccCCCCcccccccccc-hhhccccccCCCCCcccccccccceeeccC
Q 002250 404 LANNRFSGELPSKISEASSLV---SIQLSLN-QFSGQIPLDIGKLKKLS-SLYLHDNMFSGPLPYSIGSCVSLTDINFAQ 478 (947)
Q Consensus 404 L~~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 478 (947)
+++|++++ +|. +..+++|+ .|++++| ++++..+..|.++++|+ .|+|++|+++...+..|.. ++|+.|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 88888874 565 77777776 8888888 78766666678888888 8888888887444444444 7888888888
Q ss_pred ce-eeeecCCCCCcc-CcCcEEECCCCccCCccCCcccccccceeeCCCC
Q 002250 479 NS-LSGKIPDSLGSL-PSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNN 526 (947)
Q Consensus 479 N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ls~N 526 (947)
|+ +++..+..|.++ ++|+.|+|++|++++.++. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence 84 886667778888 8888888888888855443 5567888887765
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-23 Score=231.66 Aligned_cols=254 Identities=17% Similarity=0.159 Sum_probs=204.6
Q ss_pred CccEEeCcCccCcCCCCCcccc--cccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEE
Q 002250 86 RLQVLDLGNNSFSGEVPDLSML--HELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWL 163 (947)
Q Consensus 86 ~L~~L~Ls~n~i~~~~~~l~~l--~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L 163 (947)
.++.|||++|.+. ...+..+ ++++.|++++|.+.+..+ .+..+++|++|+|++|.+....++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~--~~~~~~~~~~~l~~L~l~~n~l~~~~~--~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH--PDVTGRLLSQGVIAFRCPRSFMDQPLA--EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC--HHHHHHHHHTTCSEEECTTCEECSCCC--SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC--HHHHHhhhhccceEEEcCCccccccch--hhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4677777777765 2224455 677778888887776554 356789999999999988654467778899999999
Q ss_pred EccCccccccCCccCCCCCCCCEEECcCc-ccccc-cCccccCCCCCcEEEeecc-ccccc-CCccCCCCC-CccEEecc
Q 002250 164 YLTNCSVTGQIPEGIGNLTQLQNLELSDN-ELFGE-IPAGIVKLNKLWQLELYNN-SLSGR-LPVGFSNLT-NLMNFDVS 238 (947)
Q Consensus 164 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~-~L~~L~Ls 238 (947)
+|++|.+++..+..++.+++|++|+|++| .+++. ++..+.++++|++|+|++| .+++. ++..+..++ +|++|+|+
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999999888999999999999999999 67753 6677889999999999999 99864 567788899 99999999
Q ss_pred CCC--CC--CCCccccccCCCCEEEccCcc-CcccCCCCccCCCcCcEEEccCcc-ccccCCcCccCccccccccccccc
Q 002250 239 QNR--LE--GDLSELRFLNQLSSLHLFENQ-FSGEIPEEFGEFKHLTELSLYTNR-LTGTLPQKLGSWADFNYVDVSENL 312 (947)
Q Consensus 239 ~N~--l~--~~~~~l~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~ 312 (947)
+|. ++ +.+..+..+++|++|+|++|. +++..+..+..+++|++|++++|. +.......++.+++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 995 43 234456789999999999999 777788899999999999999995 43333346888999999999999
Q ss_pred ccCCCCCCcccC-CccceeeecccccCCcCCccccC
Q 002250 313 LTGPIPPDMCKT-GAMTDLLVLQNNFNGTVPETYAN 347 (947)
Q Consensus 313 l~~~~p~~~~~~-~~l~~L~l~~n~~~~~~p~~~~~ 347 (947)
++. ..+..+ ..+..|.+..|++.+..|..+++
T Consensus 283 i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 283 VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence 332 233444 34788889999999999988775
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-24 Score=243.32 Aligned_cols=187 Identities=22% Similarity=0.258 Sum_probs=93.9
Q ss_pred cccCCCceeeCCCCCCCCCC---CChhhcccccCcEEEccCccccccCCccCC----CC---------CCCCEEECcCcc
Q 002250 130 ENLTNLEFLSLGDNPFDPSP---FPMEVLKLEKLYWLYLTNCSVTGQIPEGIG----NL---------TQLQNLELSDNE 193 (947)
Q Consensus 130 ~~l~~L~~L~Ls~n~i~~~~---~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~----~l---------~~L~~L~Ls~N~ 193 (947)
..+++|++|+|++|.+.... ++..+..+++|++|+|++|.+++..+..+. .+ ++|++|+|++|+
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~ 170 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence 34455555555555444321 233344445555555555555432222222 22 555555555555
Q ss_pred cc-cccC---ccccCCCCCcEEEeecccccc-----cCCccCCCCCCccEEeccCCCCC-----CCCccccccCCCCEEE
Q 002250 194 LF-GEIP---AGIVKLNKLWQLELYNNSLSG-----RLPVGFSNLTNLMNFDVSQNRLE-----GDLSELRFLNQLSSLH 259 (947)
Q Consensus 194 l~-~~~~---~~l~~l~~L~~L~L~~n~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~-----~~~~~l~~l~~L~~L~ 259 (947)
++ +.++ ..+..+++|++|+|++|.|+. ..+..+..+++|++|+|++|.++ ..+..+..+++|+.|+
T Consensus 171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~ 250 (386)
T 2ca6_A 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 250 (386)
T ss_dssp CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence 54 2222 244455555666666655552 22334555556666666666552 1233455555666666
Q ss_pred ccCccCccc----CCCCc--cCCCcCcEEEccCccccc----cCCcCc-cCcccccccccccccccCC
Q 002250 260 LFENQFSGE----IPEEF--GEFKHLTELSLYTNRLTG----TLPQKL-GSWADFNYVDVSENLLTGP 316 (947)
Q Consensus 260 L~~N~i~~~----~~~~~--~~l~~L~~L~L~~N~l~~----~~p~~l-~~l~~L~~L~Ls~N~l~~~ 316 (947)
|++|.|++. ++..+ +.+++|++|+|++|++++ .+|..+ .++++|++|++++|++++.
T Consensus 251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~ 318 (386)
T 2ca6_A 251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318 (386)
T ss_dssp CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence 666666543 33344 225666666666666664 355555 4456666666666666543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=4.3e-22 Score=216.38 Aligned_cols=206 Identities=20% Similarity=0.299 Sum_probs=177.9
Q ss_pred cCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccC
Q 002250 43 LPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISG 122 (947)
Q Consensus 43 l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~ 122 (947)
+....+.+.+ .+.++++|+.|++++|.+... + .+..+++|++|+|++|.+++.++ +..+++|++|+|++|++++
T Consensus 26 l~~~~~~~~~---~~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~ 99 (308)
T 1h6u_A 26 AGKSNVTDTV---TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKN 99 (308)
T ss_dssp TTCSSTTSEE---CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSC
T ss_pred hCCCCcCcee---cHHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCC
Confidence 3444444433 356789999999999999654 4 68999999999999999998776 9999999999999999986
Q ss_pred ccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccc
Q 002250 123 KFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGI 202 (947)
Q Consensus 123 ~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l 202 (947)
. ..+..+++|++|+|++|.++.. + .+..+++|++|++++|.+++..+ +..+++|++|+|++|++++..+ +
T Consensus 100 ~---~~~~~l~~L~~L~l~~n~l~~~--~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l 169 (308)
T 1h6u_A 100 V---SAIAGLQSIKTLDLTSTQITDV--T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--L 169 (308)
T ss_dssp C---GGGTTCTTCCEEECTTSCCCCC--G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred c---hhhcCCCCCCEEECCCCCCCCc--h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--h
Confidence 3 3699999999999999999874 3 38899999999999999996543 8999999999999999986443 9
Q ss_pred cCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcc
Q 002250 203 VKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSG 267 (947)
Q Consensus 203 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~ 267 (947)
..+++|++|+|++|++++..+ +..+++|++|+|++|++++.+ .+..+++|+.|+|++|++++
T Consensus 170 ~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG-GGTTCTTCCEEEEEEEEEEC
T ss_pred cCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc-cccCCCCCCEEEccCCeeec
Confidence 999999999999999996543 889999999999999999776 48899999999999999984
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=220.49 Aligned_cols=226 Identities=19% Similarity=0.259 Sum_probs=157.1
Q ss_pred cCcEEEccCccccccCCc---CccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEE
Q 002250 278 HLTELSLYTNRLTGTLPQ---KLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRF 354 (947)
Q Consensus 278 ~L~~L~L~~N~l~~~~p~---~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L 354 (947)
.++.+.+.++.++..... .+..+++|++|++++|.+++..|..+.. ..+++|+.|
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~----------------------~~~~~L~~L 122 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLE----------------------ATGLALSSL 122 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSS----------------------CCCBCCSSC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhh----------------------ccCCCCCEE
Confidence 356666666665421100 1122455777777777777655544400 455566666
Q ss_pred EcccccccccCC----CCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCcccccc--C--CCCCCCCCcceEE
Q 002250 355 RVNNNSLSGTIP----PGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGE--L--PSKISEASSLVSI 426 (947)
Q Consensus 355 ~L~~n~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L 426 (947)
++++|.+++..+ ..++.+++|++|+|++|++.+..+..|+.+++|++|+|++|++.+. + +..+..+++|++|
T Consensus 123 ~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L 202 (310)
T 4glp_A 123 RLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNL 202 (310)
T ss_dssp EEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSC
T ss_pred EeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEE
Confidence 666666665433 2334567777777777777777777777777777777777776542 2 2334677888888
Q ss_pred EcccCcccCCCCc----ccccccccchhhccccccCCCCCcccccc---cccceeeccCceeeeecCCCCCccCcCcEEE
Q 002250 427 QLSLNQFSGQIPL----DIGKLKKLSSLYLHDNMFSGPLPYSIGSC---VSLTDINFAQNSLSGKIPDSLGSLPSLNSLN 499 (947)
Q Consensus 427 ~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 499 (947)
+|++|+++ .++. .++.+++|++|+|++|++++..|..++.+ ++|++|+|++|+|+ .+|..+. ++|+.|+
T Consensus 203 ~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~ 278 (310)
T 4glp_A 203 ALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLD 278 (310)
T ss_dssp BCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEE
T ss_pred ECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEE
Confidence 88888887 3333 25677899999999999998878877776 68999999999998 7788775 7999999
Q ss_pred CCCCccCCccCCcccccccceeeCCCCcCCC
Q 002250 500 LSNNKFSGEIPISLTYPKLSLLDLSNNQLAG 530 (947)
Q Consensus 500 Ls~N~l~~~~p~~~~~~~L~~L~ls~N~l~~ 530 (947)
|++|+|++. |....+++|+.|+|++|+++.
T Consensus 279 Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 279 LSSNRLNRA-PQPDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCSCCCCSC-CCTTSCCCCSCEECSSTTTSC
T ss_pred CCCCcCCCC-chhhhCCCccEEECcCCCCCC
Confidence 999999975 444456899999999999874
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-24 Score=245.87 Aligned_cols=40 Identities=20% Similarity=0.159 Sum_probs=19.5
Q ss_pred CCCCCccEEeccCCCCCC-----CCccccccCCCCEEEccCccCc
Q 002250 227 SNLTNLMNFDVSQNRLEG-----DLSELRFLNQLSSLHLFENQFS 266 (947)
Q Consensus 227 ~~l~~L~~L~Ls~N~l~~-----~~~~l~~l~~L~~L~L~~N~i~ 266 (947)
..+++|++|+|++|+++. .+..+..+++|++|+|++|.++
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 135 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 135 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCC
Confidence 444555555555555543 1223444455555555555554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.9e-22 Score=231.47 Aligned_cols=219 Identities=21% Similarity=0.298 Sum_probs=114.3
Q ss_pred cccccccCCCCCc-----cccee-eeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCC
Q 002250 13 GVFSSWTEANSVC-----KFNGI-VCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTR 86 (947)
Q Consensus 13 ~~~~sw~~~~~~C-----~w~gv-~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~ 86 (947)
..+.+|..+.+.| .|.|+ .|.. ++++.|+++++++.+ +| ..+ +++
T Consensus 31 ~~l~~W~~~~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp-------------------------~~l--~~~ 81 (571)
T 3cvr_A 31 SAWDKWEKQALPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LP-------------------------DNL--PPQ 81 (571)
T ss_dssp HHHHHHHTTCCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CC-------------------------SCC--CTT
T ss_pred HHHHHHhccCCccccccchhhhcccccc-CCccEEEeCCCCCCc-cC-------------------------HhH--cCC
Confidence 3577887777778 78888 6763 345555555544443 33 222 144
Q ss_pred ccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEcc
Q 002250 87 LQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLT 166 (947)
Q Consensus 87 L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~ 166 (947)
|++|+|++|+|+..+ ..+++|++|+|++|+|++ +|. +.. +|++|+|++|.++. +|. .+++|+.|+|+
T Consensus 82 L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~-ip~--l~~--~L~~L~Ls~N~l~~--lp~---~l~~L~~L~Ls 148 (571)
T 3cvr_A 82 ITVLEITQNALISLP---ELPASLEYLDACDNRLST-LPE--LPA--SLKHLDVDNNQLTM--LPE---LPALLEYINAD 148 (571)
T ss_dssp CSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC-CCC--CCT--TCCEEECCSSCCSC--CCC---CCTTCCEEECC
T ss_pred CCEEECcCCCCcccc---cccCCCCEEEccCCCCCC-cch--hhc--CCCEEECCCCcCCC--CCC---cCccccEEeCC
Confidence 555555555555322 234445555555555443 331 222 45555555555443 222 33444444444
Q ss_pred CccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCC
Q 002250 167 NCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDL 246 (947)
Q Consensus 167 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 246 (947)
+|.|++ +|. .+++|++|+|++|+|++ +|. |. ++|++|+|++|+|+ .+|. |.. +|
T Consensus 149 ~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L-------------- 202 (571)
T 3cvr_A 149 NNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RN-------------- 202 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC-------------------
T ss_pred CCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hh--------------
Confidence 444443 332 34455555555555543 333 33 44555555555554 2332 221 22
Q ss_pred ccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCccc
Q 002250 247 SELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWAD 302 (947)
Q Consensus 247 ~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 302 (947)
......|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+..
T Consensus 203 --~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 203 --HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp -------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred --hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 011122377777777777 56777777888888888888888777777666543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.7e-21 Score=213.27 Aligned_cols=220 Identities=15% Similarity=0.154 Sum_probs=98.0
Q ss_pred cCcEEEccCccccccCCcCccCcccccccccccccccCCCCC-CcccCCcccee-eecccccCCcCCccccCCCCccEEE
Q 002250 278 HLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPP-DMCKTGAMTDL-LVLQNNFNGTVPETYANCKSLIRFR 355 (947)
Q Consensus 278 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~~l~~L-~l~~n~~~~~~p~~~~~l~~L~~L~ 355 (947)
++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|. .|..+.++.++ .+..|++.+..|..|..+++|+.|+
T Consensus 31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~ 110 (350)
T 4ay9_X 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 110 (350)
T ss_dssp TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEE
T ss_pred CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccc
Confidence 344444444444422223344444444444444444332222 12222222221 1222333334445555666666666
Q ss_pred cccccccccCCCCCCCCCCcceecccc-CCcCCCCCCcccccc-cccEEEccCccccccCCCCCCCCCcceEEEccc-Cc
Q 002250 356 VNNNSLSGTIPPGIWSLPNLSIIDLST-NQFEGPVTDDIGNAK-SLALLLLANNRFSGELPSKISEASSLVSIQLSL-NQ 432 (947)
Q Consensus 356 L~~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~ 432 (947)
+++|++++..+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+ .+|.......+|+.|++++ |.
T Consensus 111 l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~ 189 (350)
T 4ay9_X 111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNN 189 (350)
T ss_dssp EEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTT
T ss_pred ccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCc
Confidence 666666544444444555555555533 344444444444432 3555555555555 3333333444555555543 34
Q ss_pred ccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCC
Q 002250 433 FSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSN 502 (947)
Q Consensus 433 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 502 (947)
++...+..|.++++|+.|+|++|+|+...+..|.++++|+.+++ +.++ .+|. +.++++|+.+++++
T Consensus 190 l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP~-l~~l~~L~~l~l~~ 255 (350)
T 4ay9_X 190 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT-LEKLVALMEASLTY 255 (350)
T ss_dssp CCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCCC-TTTCCSCCEEECSC
T ss_pred ccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCCC-chhCcChhhCcCCC
Confidence 44222234455555555555555555433333443333333332 1222 3342 44445555555543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=8.3e-22 Score=210.45 Aligned_cols=161 Identities=15% Similarity=0.096 Sum_probs=116.6
Q ss_pred cCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhh-hhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 631 VKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI-LSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
|++.+.||+|+||.||+|...+|+.||||++.......+......... ..-.......+.+|++++++++| +++.+
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~ 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPK 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCe
Confidence 556699999999999999997799999999854322111000000000 00000124568899999999994 55555
Q ss_pred EEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEe
Q 002250 710 SITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIA 789 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 789 (947)
++.. +..++||||+++|+|.+ +.. + ....++.|++.||+||| +.+|+||||||+|||++ ++.+||+
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~~------~--~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VRV------E--NPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CCC------S--CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred EEec-cceEEEEEecCCCcHHH-cch------h--hHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 5443 56799999999999988 432 1 13368999999999999 89999999999999999 9999999
Q ss_pred ccccceecccCCCCcceecccccccccCcccccc
Q 002250 790 DFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT 823 (947)
Q Consensus 790 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 823 (947)
|||+|+. +..|+|||++..
T Consensus 235 DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 235 DFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp CCTTCEE---------------TTSTTHHHHHHH
T ss_pred ECCCCeE---------------CCCCCHHHHHHH
Confidence 9999862 445788998743
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=208.05 Aligned_cols=239 Identities=15% Similarity=0.080 Sum_probs=146.0
Q ss_pred cEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCC-ccccCCCCccE-EEcc
Q 002250 280 TELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVP-ETYANCKSLIR-FRVN 357 (947)
Q Consensus 280 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p-~~~~~l~~L~~-L~L~ 357 (947)
++++.++++++ .+|..+ .+++++|+|++|+|+...+..|.++.+|+.|++.+|++.+.+| .+|.+++++.. +.+.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 67888888888 777765 3578888888888885444456677777777777777666554 45666666554 4555
Q ss_pred cccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccC-ccccccCCCCCCCCC-cceEEEcccCcccC
Q 002250 358 NNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLAN-NRFSGELPSKISEAS-SLVSIQLSLNQFSG 435 (947)
Q Consensus 358 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~ 435 (947)
.|++++..|..|..+++|++|++++|++....+..+.....+..|++.+ |++....+..|..+. .++.|+|++|+|+
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~- 167 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ- 167 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-
Confidence 6777766666677777777777777777766665666666666666644 455544444555553 4666777777776
Q ss_pred CCCcccccccccchhhccc-cccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc
Q 002250 436 QIPLDIGKLKKLSSLYLHD-NMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT 514 (947)
Q Consensus 436 ~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 514 (947)
.+|.......+|+.|++++ |.++.+.+..|..+++|+.|||++|+|+...+..| .+|+.|.+.+++--..+|..-.
T Consensus 168 ~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~---~~L~~L~~l~~~~l~~lP~l~~ 244 (350)
T 4ay9_X 168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL---ENLKKLRARSTYNLKKLPTLEK 244 (350)
T ss_dssp EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC---TTCCEEECTTCTTCCCCCCTTT
T ss_pred CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh---ccchHhhhccCCCcCcCCCchh
Confidence 3444444455666666654 44554444456666677777777776663323333 3344444333332224454444
Q ss_pred ccccceeeCCC
Q 002250 515 YPKLSLLDLSN 525 (947)
Q Consensus 515 ~~~L~~L~ls~ 525 (947)
+++|+.+++++
T Consensus 245 l~~L~~l~l~~ 255 (350)
T 4ay9_X 245 LVALMEASLTY 255 (350)
T ss_dssp CCSCCEEECSC
T ss_pred CcChhhCcCCC
Confidence 56666666554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=9e-21 Score=220.82 Aligned_cols=169 Identities=22% Similarity=0.272 Sum_probs=114.6
Q ss_pred CCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEE
Q 002250 133 TNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLE 212 (947)
Q Consensus 133 ~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 212 (947)
++|++|+|++|.|+. +| ..+++|++|+|++|+|++ +|. +.. +|++|+|++|+|++ +|. .+++|++|+
T Consensus 80 ~~L~~L~Ls~N~l~~--ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 146 (571)
T 3cvr_A 80 PQITVLEITQNALIS--LP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYIN 146 (571)
T ss_dssp TTCSEEECCSSCCSC--CC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred CCCCEEECcCCCCcc--cc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEe
Confidence 344455555554442 22 234555666666666654 444 443 67777777777664 444 466677777
Q ss_pred eecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcC-------cEEEcc
Q 002250 213 LYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHL-------TELSLY 285 (947)
Q Consensus 213 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L-------~~L~L~ 285 (947)
|++|.|++ +|. .+++|++|+|++|++++.+. +. ++|+.|+|++|+|+ .+|. |.. +| +.|+|+
T Consensus 147 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls 215 (571)
T 3cvr_A 147 ADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCR 215 (571)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECC
T ss_pred CCCCccCc-CCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecC
Confidence 77777764 443 45677777777777776555 44 77888888888887 5555 554 66 999999
Q ss_pred CccccccCCcCccCcccccccccccccccCCCCCCcccCCc
Q 002250 286 TNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGA 326 (947)
Q Consensus 286 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 326 (947)
+|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+..
T Consensus 216 ~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp SSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred CCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 99999 78999999999999999999999988887766543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.2e-20 Score=190.60 Aligned_cols=144 Identities=22% Similarity=0.285 Sum_probs=79.0
Q ss_pred cccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcc
Q 002250 344 TYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSL 423 (947)
Q Consensus 344 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 423 (947)
.|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|
T Consensus 47 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 126 (208)
T 2o6s_A 47 VFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQL 126 (208)
T ss_dssp TTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred hhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcC
Confidence 34455555556666665554444445555566666666666555555555555555555555555554444445555555
Q ss_pred eEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCc
Q 002250 424 VSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPS 494 (947)
Q Consensus 424 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 494 (947)
+.|+|++|++++..+..+..+++|+.|+|++|.+.+ .+++|+.|+++.|+++|.+|..++.++.
T Consensus 127 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 127 KDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred CEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 555555555554444445555555555555555443 2345555555555555555555554443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=221.43 Aligned_cols=191 Identities=26% Similarity=0.343 Sum_probs=106.8
Q ss_pred CcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceee
Q 002250 60 LQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLS 139 (947)
Q Consensus 60 l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~ 139 (947)
+..+..++++.+.+.+..+ +..+++|+.|+|++|.|+.. +.+..+++|+.|+|++|.|.+..+ +..+++|+.|+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP---LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-TTGGGCTTCCEEECTTSCCCCCGG---GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-hHHccCCCCCEEEeeCCCCCCChh---hccCCCCCEEE
Confidence 3345555666666654433 45666777777777776643 346666666666666666664332 66666666666
Q ss_pred CCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeeccccc
Q 002250 140 LGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLS 219 (947)
Q Consensus 140 Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~ 219 (947)
|++|.+... + .+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.|+
T Consensus 94 Ls~N~l~~l--~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~ 166 (605)
T 1m9s_A 94 LDENKIKDL--S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 166 (605)
T ss_dssp CCSSCCCCC--T-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred CcCCCCCCC--h-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence 666666542 2 355555555555555555532 2355555566666666555533 44555555555555555555
Q ss_pred ccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCc
Q 002250 220 GRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFS 266 (947)
Q Consensus 220 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~ 266 (947)
+..| +..+++|+.|+|++|+|++. +.+..+++|+.|+|++|++.
T Consensus 167 ~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 167 DIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEE
T ss_pred Cchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCc
Confidence 4333 55555555555555555443 33444555555555555554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-19 Score=184.99 Aligned_cols=160 Identities=23% Similarity=0.220 Sum_probs=107.0
Q ss_pred ccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEec
Q 002250 158 EKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDV 237 (947)
Q Consensus 158 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 237 (947)
++|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 45666666666666555555666677777777777776555555666777777777777776555555667777777777
Q ss_pred cCCCCCCCCcc-ccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCC
Q 002250 238 SQNRLEGDLSE-LRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGP 316 (947)
Q Consensus 238 s~N~l~~~~~~-l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 316 (947)
++|++++.+.. +..+++|+.|+|++|++++..+..|..+++|++|++++|.+.+ .+++|++|+++.|.++|.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ 180 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGV 180 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTT
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCce
Confidence 77777665543 5666777777777777776555567777777777777776653 345677777777777777
Q ss_pred CCCCcccC
Q 002250 317 IPPDMCKT 324 (947)
Q Consensus 317 ~p~~~~~~ 324 (947)
+|..++.+
T Consensus 181 ip~~~~~l 188 (208)
T 2o6s_A 181 VRNSAGSV 188 (208)
T ss_dssp BBCTTSSB
T ss_pred eeccCccc
Confidence 77665543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.8e-20 Score=199.11 Aligned_cols=171 Identities=22% Similarity=0.342 Sum_probs=91.3
Q ss_pred cccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCc
Q 002250 130 ENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLW 209 (947)
Q Consensus 130 ~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 209 (947)
..+++|++|++++|.+... + .+..+++|++|++++|++++..+ +..+++|++|+|++|++++ + ..+..+++|+
T Consensus 43 ~~l~~L~~L~l~~~~i~~~--~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~ 115 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV--Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-L-SSLKDLKKLK 115 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC--T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-G-GGGTTCTTCC
T ss_pred hhcCcccEEEccCCCcccC--h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-C-hhhccCCCCC
Confidence 3444444555554444432 1 24444555555555555553322 5555555555555555543 1 2355555555
Q ss_pred EEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccc
Q 002250 210 QLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRL 289 (947)
Q Consensus 210 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 289 (947)
+|+|++|++++. ..+..+++|++|++++|++++. +.+..+++|+.|+|++|++++..+ +..+++|++|+|++|++
T Consensus 116 ~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 555555555532 3455555566666666655544 445556666666666666654333 56666666666666666
Q ss_pred cccCCcCccCccccccccccccccc
Q 002250 290 TGTLPQKLGSWADFNYVDVSENLLT 314 (947)
Q Consensus 290 ~~~~p~~l~~l~~L~~L~Ls~N~l~ 314 (947)
++ ++ .+..+++|+.|++++|+++
T Consensus 191 ~~-l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 191 SD-LR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp CB-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred CC-Ch-hhccCCCCCEEECcCCccc
Confidence 53 33 2566666666666666665
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.6e-20 Score=200.47 Aligned_cols=189 Identities=24% Similarity=0.324 Sum_probs=94.7
Q ss_pred ccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCC
Q 002250 62 ALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLG 141 (947)
Q Consensus 62 ~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls 141 (947)
.+..+.+..+.+.+..+ +..+++|++|++++|.+++. +.+..+++|++|+|++|++++..+ +..+++|++|+|+
T Consensus 25 ~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~---l~~l~~L~~L~l~ 98 (291)
T 1h6t_A 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP---LANLKNLGWLFLD 98 (291)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECC
T ss_pred HHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc---cccCCCCCEEECC
Confidence 34444555555544322 34566666677766666643 345556666666666666654322 5555566666666
Q ss_pred CCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeeccccccc
Q 002250 142 DNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGR 221 (947)
Q Consensus 142 ~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 221 (947)
+|.++.. + .+..+++|++|++++|++++. ..+..+++|++|+|++|++++. ..+..+
T Consensus 99 ~n~l~~~--~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l---------------- 155 (291)
T 1h6t_A 99 ENKVKDL--S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRL---------------- 155 (291)
T ss_dssp SSCCCCG--G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGC----------------
T ss_pred CCcCCCC--h-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccC----------------
Confidence 6555431 1 244444444444444444432 2344444455555555444432 334444
Q ss_pred CCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccc
Q 002250 222 LPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 222 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 290 (947)
++|++|+|++|++++..+ +..+++|+.|+|++|+|++ ++ .+..+++|+.|++++|+++
T Consensus 156 --------~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 156 --------TKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp --------TTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred --------CCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCccc
Confidence 444444444444444333 4444455555555555543 22 2555555555555555555
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=6e-20 Score=216.49 Aligned_cols=191 Identities=24% Similarity=0.336 Sum_probs=110.7
Q ss_pred CCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEE
Q 002250 84 CTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWL 163 (947)
Q Consensus 84 l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L 163 (947)
+.++..++|+.+.+++.. .+..|++|+.|+|++|.|... + .+..+++|+.|+|++|.+... +. +..+++|+.|
T Consensus 20 l~~l~~l~l~~~~i~~~~-~~~~L~~L~~L~l~~n~i~~l-~--~l~~l~~L~~L~Ls~N~l~~~--~~-l~~l~~L~~L 92 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSV-Q--GIQYLPNVTKLFLNGNKLTDI--KP-LTNLKNLGWL 92 (605)
T ss_dssp HHHHHHHHTTCSCTTSEE-CHHHHTTCCCCBCTTCCCCCC-T--TGGGCTTCCEEECTTSCCCCC--GG-GGGCTTCCEE
T ss_pred HHHHHHHhccCCCccccc-chhcCCCCCEEECcCCCCCCC-h--HHccCCCCCEEEeeCCCCCCC--hh-hccCCCCCEE
Confidence 334555666666665432 245666677777777766532 2 466666777777777666543 22 5566666666
Q ss_pred EccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCC
Q 002250 164 YLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLE 243 (947)
Q Consensus 164 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 243 (947)
+|++|.+++ +| .+..+++|+.|+|++|+|.+. ..+..+++|+.|+|++|.|++. ..|..+++|+.|+|++|+++
T Consensus 93 ~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~ 166 (605)
T 1m9s_A 93 FLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 166 (605)
T ss_dssp ECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred ECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence 666666663 22 566666666666666666532 3455666666666666666543 44555666666666666655
Q ss_pred CCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccc
Q 002250 244 GDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 244 ~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 290 (947)
+.++ +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+++
T Consensus 167 ~~~~-l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 167 DIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp CCGG-GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred Cchh-hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence 5444 55555555555555555532 23555555555555555555
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.5e-19 Score=183.57 Aligned_cols=165 Identities=20% Similarity=0.199 Sum_probs=116.3
Q ss_pred cccccccCCCCCcccceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeC
Q 002250 13 GVFSSWTEANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDL 92 (947)
Q Consensus 13 ~~~~sw~~~~~~C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L 92 (947)
....-|..+++.|.|.+|.|+..+ .+.+|. .+ .++|+.|+|++|.|.+..|..|..+++|++|+|
T Consensus 7 ~~~~~~~~~~~~Cs~~~v~c~~~~------------l~~ip~-~~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 71 (229)
T 3e6j_A 7 HHHSAACPSQCSCSGTTVDCRSKR------------HASVPA-GI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYL 71 (229)
T ss_dssp ----CCCCTTCEEETTEEECTTSC------------CSSCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred chhhccCCCCCEEeCCEeEccCCC------------cCccCC-CC--CCCCCEEEcCCCccCccCHHHhhCccCCcEEEC
Confidence 444556678889999999998643 223332 12 278899999999998888888999999999999
Q ss_pred cCccCcCCCCC-cccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCcccc
Q 002250 93 GNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVT 171 (947)
Q Consensus 93 s~n~i~~~~~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~ 171 (947)
++|+|++.++. +..+++|++|+|++|+|++..+ ..|..+++|++|+|++|++.. +|..+..+++|++|+|++|+++
T Consensus 72 ~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~-~~~~~l~~L~~L~Ls~N~l~~--lp~~~~~l~~L~~L~L~~N~l~ 148 (229)
T 3e6j_A 72 GSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPS-AVFDRLVHLKELFMCCNKLTE--LPRGIERLTHLTHLALDQNQLK 148 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCS--CCTTGGGCTTCSEEECCSSCCC
T ss_pred CCCCCCCcChhhcccCCCcCEEECCCCcCCccCh-hHhCcchhhCeEeccCCcccc--cCcccccCCCCCEEECCCCcCC
Confidence 99998876655 6778888888888888874433 566777777777777777763 4555666666666666666666
Q ss_pred ccCCccCCCCCCCCEEECcCcccc
Q 002250 172 GQIPEGIGNLTQLQNLELSDNELF 195 (947)
Q Consensus 172 ~~~p~~~~~l~~L~~L~Ls~N~l~ 195 (947)
+..+..|..+++|+.|+|++|.+.
T Consensus 149 ~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 149 SIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCBC
T ss_pred ccCHHHHhCCCCCCEEEeeCCCcc
Confidence 555555666666666666666654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=2e-19 Score=184.85 Aligned_cols=156 Identities=21% Similarity=0.213 Sum_probs=114.6
Q ss_pred cEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCC-CcccccccccEEEccCccccccCCCCCCCCCcceEEEccc
Q 002250 352 IRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVT-DDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSL 430 (947)
Q Consensus 352 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 430 (947)
+.+++++|.++ .+|..+. +.++.|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 46777777776 4565543 345777888888776643 4567777778888888877766666777777888888888
Q ss_pred CcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccC
Q 002250 431 NQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIP 510 (947)
Q Consensus 431 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 510 (947)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.+++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 88776666667777777777777777777777777777777777777777777767777777777777777777775544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=202.15 Aligned_cols=179 Identities=22% Similarity=0.154 Sum_probs=111.6
Q ss_pred eeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCC-CCCcceEEEcccCcccCCCCcccccccccchhhcccc
Q 002250 377 IIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKIS-EASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDN 455 (947)
Q Consensus 377 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 455 (947)
.+++++|+++.+ |..+. ..++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~~i-P~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPNV-PQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSSC-CSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCcc-CccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 445555555432 22221 2355566666666555555555 6666666666666666555556666666666666666
Q ss_pred ccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCcc----cccccceeeCCCCcCCCC
Q 002250 456 MFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISL----TYPKLSLLDLSNNQLAGP 531 (947)
Q Consensus 456 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~~~L~~L~ls~N~l~~~ 531 (947)
+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++..+ .+++|+.|||++|+|++.
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 6666666667777777777777777776667777777777777777777776554443 257777777777777765
Q ss_pred CCCcccc-c---ccccccccCCCCCCCCccc
Q 002250 532 IPEPLNI-K---AFIDSFTGNPGLCSKTDEY 558 (947)
Q Consensus 532 ~p~~~~~-~---~~~~~~~gN~~~c~~~~~~ 558 (947)
++..+.. . .....+.+|||.|+|...+
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~C~C~l~~ 209 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLECDCKLYQ 209 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEECCHHHHH
T ss_pred CHHHhhhccHhhcceEEecCCCccCCcCcHH
Confidence 4433321 1 1234678999999987543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-21 Score=228.98 Aligned_cols=217 Identities=20% Similarity=0.175 Sum_probs=138.1
Q ss_pred cCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCce
Q 002250 58 CGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEF 137 (947)
Q Consensus 58 ~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~ 137 (947)
..+++|+.|+|++|.+ +.+|..++.|++|++|++++|......+ .+ +..+.+.+..| ..+..+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L-~~Lp~~i~~l~~L~~L~l~~n~~l~~l~---------~l-l~~~~~~~~~~-~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKS-TVLQSELESCKELQELEPENKWCLLTII---------LL-MRALDPLLYEK-ETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHH-HHHHHHHHHHHHHHHHCTTCHHHHHHHH---------HH-HHHHCTGGGHH-HHHHHHHHHHH
T ss_pred ccCccceeccCChhhH-HhhHHHHHHHHHHHHhccccchhhhhHH---------HH-HHhcccccCCH-HHHHHHHhccc
Confidence 3455555556665555 3455555555555555554443100000 00 00011333333 56777777887
Q ss_pred ee-CCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecc
Q 002250 138 LS-LGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNN 216 (947)
Q Consensus 138 L~-Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n 216 (947)
|+ ++.|. +..|+.+.+++|.++...+ ..|+.|+|++|+|++ +|. +..+++|++|+|++|
T Consensus 414 L~~l~~n~------------~~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N 473 (567)
T 1dce_A 414 VDPMRAAY------------LDDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHN 473 (567)
T ss_dssp HCGGGHHH------------HHHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSS
T ss_pred Ccchhhcc------------cchhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCcc
Confidence 77 55553 2355666677777764322 247788888888874 555 778888888888888
Q ss_pred cccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccC-CCCccCCCcCcEEEccCccccccCCc
Q 002250 217 SLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEI-PEEFGEFKHLTELSLYTNRLTGTLPQ 295 (947)
Q Consensus 217 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~ 295 (947)
.|+ .+|..|+.+++|+.|+|++|+|++++ .+..+++|+.|+|++|+|++.. |..|+.+++|+.|+|++|++++..|.
T Consensus 474 ~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 474 RLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred ccc-ccchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 888 67778888888888888888887755 7777888888888888887665 77888888888888888888754432
Q ss_pred C---ccCccccccccc
Q 002250 296 K---LGSWADFNYVDV 308 (947)
Q Consensus 296 ~---l~~l~~L~~L~L 308 (947)
. +..+++|+.|++
T Consensus 552 ~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 552 QERLAEMLPSVSSILT 567 (567)
T ss_dssp TTHHHHHCTTCSEEEC
T ss_pred HHHHHHHCcccCccCC
Confidence 2 223566666653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.8e-19 Score=182.08 Aligned_cols=153 Identities=20% Similarity=0.183 Sum_probs=112.0
Q ss_pred cEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccC
Q 002250 352 IRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLN 431 (947)
Q Consensus 352 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 431 (947)
+.++++++.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45677777776 4555443 56777777777777766667777777777777777777666777777777777777777
Q ss_pred cccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCC
Q 002250 432 QFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSG 507 (947)
Q Consensus 432 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 507 (947)
+|+...+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 7775555556777777777777777777777777777777777777777776666667777777777777777764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.3e-22 Score=233.44 Aligned_cols=216 Identities=20% Similarity=0.186 Sum_probs=166.8
Q ss_pred cCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccE
Q 002250 274 GEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIR 353 (947)
Q Consensus 274 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~ 353 (947)
..+++|+.|+|++|+++ .+|..++.+++|+.|++++|.....+| ..+..++..+..|..++.+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~-----------~ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII-----------LLMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHH-----------HHHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHH-----------HHHHhcccccCCHHHHHHHHhccc
Confidence 56778888888888887 788888888888888887665311111 112234455677788888888888
Q ss_pred EE-cccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCc
Q 002250 354 FR-VNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQ 432 (947)
Q Consensus 354 L~-L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 432 (947)
|+ ++.|.+. +|..+.+++|.++...+ ..|+.|+|++|+|++ +|. +..+++|+.|+|++|+
T Consensus 414 L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 414 VDPMRAAYLD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp HCGGGHHHHH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred Ccchhhcccc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence 87 6766553 67777888888765332 247888999998884 666 8888899999999999
Q ss_pred ccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeec-CCCCCccCcCcEEECCCCccCCccCC
Q 002250 433 FSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKI-PDSLGSLPSLNSLNLSNNKFSGEIPI 511 (947)
Q Consensus 433 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~ 511 (947)
|+ .+|..|+++++|+.|+|++|+|++ +| .|+.+++|+.|+|++|+|++.+ |..++.+++|+.|+|++|+|++.+|.
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 88 788888899999999999999986 56 7888999999999999998776 88899999999999999999888775
Q ss_pred ccc----ccccceeeC
Q 002250 512 SLT----YPKLSLLDL 523 (947)
Q Consensus 512 ~~~----~~~L~~L~l 523 (947)
... +++|+.||+
T Consensus 552 ~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 552 QERLAEMLPSVSSILT 567 (567)
T ss_dssp TTHHHHHCTTCSEEEC
T ss_pred HHHHHHHCcccCccCC
Confidence 432 478888864
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-18 Score=178.01 Aligned_cols=153 Identities=16% Similarity=0.183 Sum_probs=78.6
Q ss_pred EEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCc
Q 002250 89 VLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNC 168 (947)
Q Consensus 89 ~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n 168 (947)
.+++++|.++..+..+. ..+++|+|++|+|++..+...|..+++|++|+|++|+|+..+ +..+..+++|++|+|++|
T Consensus 15 ~l~~s~n~l~~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~-~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIE-EGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEEC-TTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcccCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEEC-HHHhCCCCCCCEEECCCC
Confidence 44444444443332221 123444444444443323233455555555555555544321 223444555555555555
Q ss_pred cccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCC
Q 002250 169 SVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEG 244 (947)
Q Consensus 169 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 244 (947)
.+++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+..
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 5554555555566666666666666665555566666666666666666665555556666666666666555543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-18 Score=176.56 Aligned_cols=151 Identities=21% Similarity=0.273 Sum_probs=91.3
Q ss_pred EEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCC
Q 002250 162 WLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNR 241 (947)
Q Consensus 162 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 241 (947)
.++++++.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3444455544 3343333 455666666666655555555566666666666666665555666666666666666666
Q ss_pred CCCCCcc-ccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccC
Q 002250 242 LEGDLSE-LRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315 (947)
Q Consensus 242 l~~~~~~-l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 315 (947)
|+..+.. +..+++|+.|+|++|+|++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++.+
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 6655443 4556666666666666666666666666677777777777765555566666677777777776653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.7e-19 Score=197.11 Aligned_cols=176 Identities=22% Similarity=0.221 Sum_probs=124.2
Q ss_pred cEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCccc-ccccccEEEccCccccccCCCCCCCCCcceEEEccc
Q 002250 352 IRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIG-NAKSLALLLLANNRFSGELPSKISEASSLVSIQLSL 430 (947)
Q Consensus 352 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 430 (947)
+.+++++|.++ .+|..+. +.++.|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 46677777776 4555443 3467777777777776666666 777777777777777766666777777777777777
Q ss_pred CcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCC---CccCcCcEEECCCCccCC
Q 002250 431 NQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSL---GSLPSLNSLNLSNNKFSG 507 (947)
Q Consensus 431 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~ 507 (947)
|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 77776666667777788888888888777777778788888888888888875433334 567788888888888886
Q ss_pred ccCCccc-ccc--cceeeCCCCcCCC
Q 002250 508 EIPISLT-YPK--LSLLDLSNNQLAG 530 (947)
Q Consensus 508 ~~p~~~~-~~~--L~~L~ls~N~l~~ 530 (947)
.++..+. ++. ++.|+|++|++.+
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred cCHHHhhhccHhhcceEEecCCCccC
Confidence 5544443 343 4778888888764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=184.03 Aligned_cols=171 Identities=21% Similarity=0.275 Sum_probs=110.4
Q ss_pred cccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCC
Q 002250 106 MLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQ 185 (947)
Q Consensus 106 ~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 185 (947)
.+.++..+++++|.+++.. .+..+++|++|++++|.++.. + .+..+++|++|+|++|++++..+ +..+++|+
T Consensus 17 ~l~~l~~l~l~~~~i~~~~---~~~~l~~L~~L~l~~n~i~~l--~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~ 88 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV---SQKELSGVQNFNGDNSNIQSL--A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLE 88 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE---CHHHHTTCSEEECTTSCCCCC--T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCC
T ss_pred HHHHHHHHHhcCCCccccc---chhhcCcCcEEECcCCCcccc--h-HHhhCCCCCEEECCCCccCCChh--hccCCCCC
Confidence 3455555666666655332 356666666666666666543 2 45666667777777777664433 67777777
Q ss_pred EEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccC
Q 002250 186 NLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQF 265 (947)
Q Consensus 186 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i 265 (947)
+|+|++|++++ +|. +.. ++|++|+|++|++++. ..+..+++|++|+|++|++++.+ .+..+++|+.|+|++|+|
T Consensus 89 ~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 89 ELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp EEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTSCC
T ss_pred EEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCCcC
Confidence 77777777764 332 222 6677777777777743 34677777777777777776653 566677777777777777
Q ss_pred cccCCCCccCCCcCcEEEccCcccccc
Q 002250 266 SGEIPEEFGEFKHLTELSLYTNRLTGT 292 (947)
Q Consensus 266 ~~~~~~~~~~l~~L~~L~L~~N~l~~~ 292 (947)
++. ..+..+++|+.|++++|++++.
T Consensus 163 ~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 163 TNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred cch--HHhccCCCCCEEeCCCCcccCC
Confidence 754 5677777777777777777643
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=5.4e-19 Score=187.01 Aligned_cols=171 Identities=22% Similarity=0.273 Sum_probs=147.9
Q ss_pred ccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcE
Q 002250 131 NLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQ 210 (947)
Q Consensus 131 ~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 210 (947)
.+.+++.+++++|.++... .+..+++|++|++++|.++. +| .+..+++|++|+|++|+|++..+ +.++++|++
T Consensus 17 ~l~~l~~l~l~~~~i~~~~---~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~ 89 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV---SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEE 89 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE---CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCE
T ss_pred HHHHHHHHHhcCCCccccc---chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCE
Confidence 6777889999999997643 57889999999999999994 55 78999999999999999986544 999999999
Q ss_pred EEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccc
Q 002250 211 LELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 211 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 290 (947)
|+|++|++++. |. +.. ++|++|+|++|++++. +.+..+++|+.|+|++|+|++. + .+..+++|++|+|++|+++
T Consensus 90 L~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~-~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 90 LSVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT-DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp EECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS-GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred EECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC-hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 99999999964 43 333 9999999999999875 4688999999999999999964 3 6889999999999999998
Q ss_pred ccCCcCccCcccccccccccccccCC
Q 002250 291 GTLPQKLGSWADFNYVDVSENLLTGP 316 (947)
Q Consensus 291 ~~~p~~l~~l~~L~~L~Ls~N~l~~~ 316 (947)
+. ..+..+++|+.|++++|++++.
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 65 7789999999999999999854
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=1e-17 Score=173.29 Aligned_cols=151 Identities=23% Similarity=0.219 Sum_probs=92.0
Q ss_pred ceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeec
Q 002250 136 EFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYN 215 (947)
Q Consensus 136 ~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 215 (947)
+.++.+++.+... |..+ .++|++|+|++|.+++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 22 ~~v~c~~~~l~~i--p~~~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 22 TTVDCRSKRHASV--PAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TEEECTTSCCSSC--CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEeEccCCCcCcc--CCCC--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 4455555555432 2222 25566666666666666666666666666666666666554445566666666666666
Q ss_pred ccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccc
Q 002250 216 NSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 216 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 290 (947)
|+|++..+..|..+++|++|+|++|+++.++..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred CcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 666655555566666666666666666655555666666666666666666554455666666666666666655
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.5e-18 Score=171.75 Aligned_cols=153 Identities=16% Similarity=0.252 Sum_probs=84.4
Q ss_pred cccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCc
Q 002250 130 ENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLW 209 (947)
Q Consensus 130 ~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 209 (947)
..+++|++|++++|.+.. +| .+..+++|++|++++|.++ .+..+..+++|++|+|++|++++..+..+.++++|+
T Consensus 41 ~~l~~L~~L~l~~n~i~~--l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTD--LT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHTCCEEEEESSCCSC--CT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhcCCccEEeccCCCccC--hH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 444555555555555543 22 3445555555555555444 123555566666666666666555555666666666
Q ss_pred EEEeecccccccCCccCCCCCCccEEeccCCC-CCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcc
Q 002250 210 QLELYNNSLSGRLPVGFSNLTNLMNFDVSQNR-LEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNR 288 (947)
Q Consensus 210 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 288 (947)
+|+|++|++++..+..+..+++|++|+|++|+ ++.. +.+..+++|+.|++++|++++ ++ .+..+++|++|++++|+
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-GGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-HhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 66666666665555556666666666666665 4333 345556666666666666653 22 45666666666666666
Q ss_pred cc
Q 002250 289 LT 290 (947)
Q Consensus 289 l~ 290 (947)
+.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=4.7e-18 Score=170.67 Aligned_cols=176 Identities=22% Similarity=0.244 Sum_probs=118.0
Q ss_pred ceeccccCCcCCCCCCcccccccccEEEccCccccccCCC-CCCCCCcceEEEcccCcccCCCCcccccccccchhhccc
Q 002250 376 SIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPS-KISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHD 454 (947)
Q Consensus 376 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (947)
+.+++++|+++. +|..+. .++++|++++|+|++..+. .|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCc-CccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 455666666643 233222 2566666666666644443 367777777777777777777677777778888888888
Q ss_pred cccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCcccccccceeeCCCCcCCCCCCC
Q 002250 455 NMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPE 534 (947)
Q Consensus 455 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~p~ 534 (947)
|+|++..|..|..+++|++|+|++|+|++.+|..|..+++|+.|+|++|++++..+...-...++...+..+...+..|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 88887777778888888888888888888888888888899999999999887765432223344445556666555565
Q ss_pred cccccccccccccCCCCCCCC
Q 002250 535 PLNIKAFIDSFTGNPGLCSKT 555 (947)
Q Consensus 535 ~~~~~~~~~~~~gN~~~c~~~ 555 (947)
.+.. .....+..+...|..+
T Consensus 168 ~l~~-~~l~~l~~~~~~C~~~ 187 (192)
T 1w8a_A 168 KVRD-VQIKDLPHSEFKCSSE 187 (192)
T ss_dssp TTTT-SBGGGSCTTTCCCCCC
T ss_pred HHcC-CChhhCcHhhcCcCCC
Confidence 5432 2223455566666544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.2e-19 Score=214.00 Aligned_cols=194 Identities=22% Similarity=0.221 Sum_probs=80.7
Q ss_pred ccc-CCCCCcccceeeeCCCCceeEeccCCCccccccCcccccCCcccceeeccCccccC---------cCchhhhcCCC
Q 002250 17 SWT-EANSVCKFNGIVCDSNGLVAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYG---------TITEGLKSCTR 86 (947)
Q Consensus 17 sw~-~~~~~C~w~gv~c~~~~~v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~---------~~~~~l~~l~~ 86 (947)
+|. ..+..+.|.+++++. ++++.++|..+++... + . ..|+.++|+.|.|.+ ..++.+..+++
T Consensus 154 ~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~-~-~-----~~l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~ 225 (727)
T 4b8c_D 154 QPTGDSTPSGTATNSAVST-PLTPKIELFANGKDEA-N-Q-----ALLQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQL 225 (727)
T ss_dssp ----------------------------------------------------------------------------CCCC
T ss_pred CCcCCCCccccCCCceecC-CccceEEeeCCCCCcc-h-h-----hHhhcCccCcccccCccccccceecChhhhccCCC
Confidence 453 345568899988886 7889999987776542 2 1 223444454444432 34566667777
Q ss_pred ccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEcc
Q 002250 87 LQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLT 166 (947)
Q Consensus 87 L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~ 166 (947)
|+.|+|++|.|...++.+..+++|++|+|++|.|+ .+| ..|.+|++|++|+|++|.|+. +|..+..+++|++|+|+
T Consensus 226 L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp-~~~~~l~~L~~L~Ls~N~l~~--lp~~~~~l~~L~~L~L~ 301 (727)
T 4b8c_D 226 WHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELP-AEIKNLSNLRVLDLSHNRLTS--LPAELGSCFQLKYFYFF 301 (727)
T ss_dssp CCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCC-GGGGGGTTCCEEECTTSCCSS--CCSSGGGGTTCSEEECC
T ss_pred CcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccC-hhhhCCCCCCEEeCcCCcCCc--cChhhcCCCCCCEEECC
Confidence 77777777777655555556666666666666666 444 456666666666666666652 45556666666666666
Q ss_pred CccccccCCccCCCCCCCCEEECcCcccccccCccccCCCC-CcEEEeecccccccCC
Q 002250 167 NCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNK-LWQLELYNNSLSGRLP 223 (947)
Q Consensus 167 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~-L~~L~L~~n~l~~~~~ 223 (947)
+|.|+ .+|..|+++++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|
T Consensus 302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p 358 (727)
T 4b8c_D 302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP 358 (727)
T ss_dssp SSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred CCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence 66665 45555666666666666666666555555543321 1224555555554444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.4e-18 Score=170.61 Aligned_cols=133 Identities=19% Similarity=0.228 Sum_probs=97.3
Q ss_pred ccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCC
Q 002250 129 LENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKL 208 (947)
Q Consensus 129 l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 208 (947)
+..+++|++|++++|.+.. +..+..+++|++|++++|.+++..|..++.+++|++|+|++|++++..|..+..+++|
T Consensus 62 l~~l~~L~~L~l~~n~~~~---~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L 138 (197)
T 4ezg_A 62 IEYAHNIKDLTINNIHATN---YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKV 138 (197)
T ss_dssp GGGCTTCSEEEEESCCCSC---CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSC
T ss_pred HhcCCCCCEEEccCCCCCc---chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCC
Confidence 4555556666666664433 2246667777777777777776677788888888888888888887777888888888
Q ss_pred cEEEeeccc-ccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcc
Q 002250 209 WQLELYNNS-LSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSG 267 (947)
Q Consensus 209 ~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~ 267 (947)
++|+|++|. ++ .+| .+..+++|++|++++|++++.. .+..+++|+.|++++|+|.+
T Consensus 139 ~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 139 NSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC----
T ss_pred CEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCcccCC
Confidence 888888887 66 344 6788888888888888888654 77888888888888888763
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.8e-18 Score=209.29 Aligned_cols=163 Identities=20% Similarity=0.228 Sum_probs=89.7
Q ss_pred EEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeeccccc
Q 002250 258 LHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNF 337 (947)
Q Consensus 258 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~ 337 (947)
+++..|.+. ..+..|..++.|+.|+|++|.+. .+|..+..+++|++|+|++|.|+
T Consensus 206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~----------------------- 260 (727)
T 4b8c_D 206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT----------------------- 260 (727)
T ss_dssp -----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-----------------------
T ss_pred cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-----------------------
Confidence 345556655 56667777777777777777776 56665556666666666666655
Q ss_pred CCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCC
Q 002250 338 NGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKI 417 (947)
Q Consensus 338 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 417 (947)
.+|..|+.+++|++|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|
T Consensus 261 --------------------------~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~ 312 (727)
T 4b8c_D 261 --------------------------ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEF 312 (727)
T ss_dssp --------------------------CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSST
T ss_pred --------------------------ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhh
Confidence 23333444445555555555555 34555556666666666666665 667777
Q ss_pred CCCCcceEEEcccCcccCCCCcccccccc-cchhhccccccCCCCCcccccccccceeeccCc
Q 002250 418 SEASSLVSIQLSLNQFSGQIPLDIGKLKK-LSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479 (947)
Q Consensus 418 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 479 (947)
..+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.. |+.|++++|
T Consensus 313 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 313 GNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp TSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred hcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 77888888888888888777777765532 335778888888777653 344556665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=176.07 Aligned_cols=154 Identities=19% Similarity=0.185 Sum_probs=107.7
Q ss_pred cCCcccccccCceeEEEEEe-CCCcE--EEEEEecCCCCCCCCCccc-------hhhhhhcccCChhhHHHHHHHHhhcc
Q 002250 631 VKPENLIGKGGSGNVYKVVL-NSGKE--LAVKHIWPSNSGFRGDYRS-------STAILSKRSSRSSEYDAEVATLSAVR 700 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~E~~~l~~l~ 700 (947)
|++.+.||+|+||.||+|.. .+|+. ||||+++......+..... ..............+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678999999999999997 67989 9999985443221110000 00000000111246889999999999
Q ss_pred cccc--ceEEEEEecCCccEEEEeccCC-C----ChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccC
Q 002250 701 HVNV--VKLYCSITSEDSNLLVYEYLPN-G----SLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDV 773 (947)
Q Consensus 701 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl 773 (947)
|+++ ..++++ ...++||||+.+ | +|.++... .++.....++.|++.||+|||. +.+|+||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence 8864 444443 367899999942 4 66665443 2234566789999999999994 479999999
Q ss_pred CCCCeEecCCCCeEEeccccceec
Q 002250 774 KSSNILLDLEWKPRIADFGLAKIV 797 (947)
Q Consensus 774 kp~NIll~~~~~~kl~DfG~a~~~ 797 (947)
||+|||+++ .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.5e-17 Score=180.74 Aligned_cols=289 Identities=12% Similarity=0.096 Sum_probs=180.0
Q ss_pred CCcccceeeccCccccCcCchhhhc-CCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccc------
Q 002250 59 GLQALQKINLGTNFLYGTITEGLKS-CTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLEN------ 131 (947)
Q Consensus 59 ~l~~L~~L~L~~n~i~~~~~~~l~~-l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~------ 131 (947)
.+.+++.|.++++ +.......+.. +++|+.|||++|+|......-+.++.+..+.+..|.| |..+|.+
T Consensus 23 ~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I----~~~aF~~~~~~~~ 97 (329)
T 3sb4_A 23 EANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFV----PAYAFSNVVNGVT 97 (329)
T ss_dssp HHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEE----CTTTTEEEETTEE
T ss_pred hhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccccccccccccccccc----CHHHhcccccccc
Confidence 4677888888764 32333344555 7889999999999882111112233356666666644 3367777
Q ss_pred --cCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCccc----ccccCccccCC
Q 002250 132 --LTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNEL----FGEIPAGIVKL 205 (947)
Q Consensus 132 --l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l----~~~~~~~l~~l 205 (947)
+++|+.|+|.+ .++.++ +..|.++++|+.|++++|.++.+.+..|.++.++..+.+..+.. .......|.++
T Consensus 98 ~g~~~L~~l~L~~-~i~~I~-~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~ 175 (329)
T 3sb4_A 98 KGKQTLEKVILSE-KIKNIE-DAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG 175 (329)
T ss_dssp EECTTCCC-CBCT-TCCEEC-TTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred cccCCCcEEECCc-cccchh-HHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccc
Confidence 88888888887 665543 44567777777777777777766677777776666666665322 22233445555
Q ss_pred CCCc-EEEeeccc-ccccCCccCCCCCCccEEeccCCCCCCCCcccc-ccCCCCEEEccCccCcccCCCCccCCCcCcEE
Q 002250 206 NKLW-QLELYNNS-LSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELR-FLNQLSSLHLFENQFSGEIPEEFGEFKHLTEL 282 (947)
Q Consensus 206 ~~L~-~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 282 (947)
..|+ .+.+.... +.......-....+++.+.+.++-.......+. .+++|+.|+|++|+++.+.+.+|.++++|++|
T Consensus 176 ~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l 255 (329)
T 3sb4_A 176 EPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKI 255 (329)
T ss_dssp CCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEE
T ss_pred cccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEE
Confidence 5555 44443221 111111111123455555555442111111121 26778888888887876666778888888888
Q ss_pred EccCccccccCCcCccCccccc-ccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccc
Q 002250 283 SLYTNRLTGTLPQKLGSWADFN-YVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSL 361 (947)
Q Consensus 283 ~L~~N~l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l 361 (947)
+|.+| ++...+.+|.++.+|+ .+++.+ .++ ...+.+|.+|++|+.+++++|.+
T Consensus 256 ~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~------------------------~I~~~aF~~c~~L~~l~l~~n~i 309 (329)
T 3sb4_A 256 KLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT------------------------AIEFGAFMGCDNLRYVLATGDKI 309 (329)
T ss_dssp ECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC------------------------EECTTTTTTCTTEEEEEECSSCC
T ss_pred ECCcc-cceehHHHhhCChhccEEEEEcc-cce------------------------EEchhhhhCCccCCEEEeCCCcc
Confidence 88777 6656666777777777 777765 443 23456788888888888888888
Q ss_pred cccCCCCCCCCCCcceecc
Q 002250 362 SGTIPPGIWSLPNLSIIDL 380 (947)
Q Consensus 362 ~~~~p~~~~~l~~L~~L~L 380 (947)
+.+.+..|.++++|+.++.
T Consensus 310 ~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 310 TTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CEECTTTTCTTCCCCEEEC
T ss_pred CccchhhhcCCcchhhhcc
Confidence 8777778888888888763
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-17 Score=182.95 Aligned_cols=225 Identities=11% Similarity=0.040 Sum_probs=119.2
Q ss_pred cCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceee
Q 002250 252 LNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLL 331 (947)
Q Consensus 252 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~ 331 (947)
+++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.++...+.+|....++..+.+..+....
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~---------------- 162 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYR---------------- 162 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHH----------------
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhh----------------
Confidence 56666666666 5555555666666667777766666665555566655555555444322100
Q ss_pred ecccccCCcCCccccCCCCcc-EEEccccc-ccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccc
Q 002250 332 VLQNNFNGTVPETYANCKSLI-RFRVNNNS-LSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRF 409 (947)
Q Consensus 332 l~~n~~~~~~p~~~~~l~~L~-~L~L~~n~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 409 (947)
........+|.++..|+ .+.+.... +.......-....++..+.+.++-...........+++|+.++|++|++
T Consensus 163 ----~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i 238 (329)
T 3sb4_A 163 ----FKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNA 238 (329)
T ss_dssp ----TSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCC
T ss_pred ----ccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCc
Confidence 00001112233333333 22222111 0000000001123344444433311100000011245666777776666
Q ss_pred cccCCCCCCCCCcceEEEcccCcccCCCCcccccccccc-hhhccccccCCCCCcccccccccceeeccCceeeeecCCC
Q 002250 410 SGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLS-SLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDS 488 (947)
Q Consensus 410 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 488 (947)
+...+.+|.++++|+.|+|++| ++...+.+|.++++|+ .|+|.+ .++.+.+.+|.+|++|+.|++++|+++...+.+
T Consensus 239 ~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~a 316 (329)
T 3sb4_A 239 TTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDEL 316 (329)
T ss_dssp CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTT
T ss_pred ceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhh
Confidence 6555556777777777777766 5545556677777777 777766 566566677777777777777777777666667
Q ss_pred CCccCcCcEEE
Q 002250 489 LGSLPSLNSLN 499 (947)
Q Consensus 489 ~~~l~~L~~L~ 499 (947)
|.++++|+.++
T Consensus 317 F~~~~~L~~ly 327 (329)
T 3sb4_A 317 FGNGVPSKLIY 327 (329)
T ss_dssp TCTTCCCCEEE
T ss_pred hcCCcchhhhc
Confidence 77777777765
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-16 Score=159.98 Aligned_cols=112 Identities=24% Similarity=0.326 Sum_probs=78.2
Q ss_pred CCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEe
Q 002250 134 NLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLEL 213 (947)
Q Consensus 134 ~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 213 (947)
+|++|+|++|.++..+....+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 45555555555544322223556666666666666666666777777888888888888887777777777888888888
Q ss_pred ecccccccCCccCCCCCCccEEeccCCCCCCC
Q 002250 214 YNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGD 245 (947)
Q Consensus 214 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 245 (947)
++|+|++..|..|..+++|++|+|++|.+.+.
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 88888877777777777777777777777654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.9e-16 Score=158.83 Aligned_cols=125 Identities=25% Similarity=0.312 Sum_probs=91.9
Q ss_pred cEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCc
Q 002250 400 ALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479 (947)
Q Consensus 400 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 479 (947)
+.+++++|+++ .+|..+. ++|+.|+|++|+|+ .+|..|.++++|+.|+|++|.|++..+..|..+++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45666666666 5555443 46777778888777 66677778888888888888888777777888888888888888
Q ss_pred eeeeecCCCCCccCcCcEEECCCCccCCccCCccc-ccccceeeCCCCcC
Q 002250 480 SLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQL 528 (947)
Q Consensus 480 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N~l 528 (947)
+|++..|..|.++++|+.|+|++|+|++.++..+. +++|+.|+|++|++
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 138 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL 138 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCe
Confidence 88877777788888888888888888866665554 57777777665444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.5e-16 Score=154.47 Aligned_cols=129 Identities=29% Similarity=0.347 Sum_probs=52.8
Q ss_pred CcEEEccCcccc-ccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEecc
Q 002250 160 LYWLYLTNCSVT-GQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVS 238 (947)
Q Consensus 160 L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 238 (947)
|++|++++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+|+
T Consensus 26 L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 103 (168)
T 2ell_A 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103 (168)
T ss_dssp CSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECB
T ss_pred CCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEecc
Confidence 333333333333 23333344444444444444444322 334444444444444444443333333334444444444
Q ss_pred CCCCCCCC--ccccccCCCCEEEccCccCcccCC---CCccCCCcCcEEEccCcccc
Q 002250 239 QNRLEGDL--SELRFLNQLSSLHLFENQFSGEIP---EEFGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 239 ~N~l~~~~--~~l~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~~N~l~ 290 (947)
+|++++.+ ..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 104 ~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 104 GNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp SSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred CCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 44444322 233344444444444444442222 13444444444444444443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.4e-16 Score=153.48 Aligned_cols=131 Identities=24% Similarity=0.216 Sum_probs=73.9
Q ss_pred CCccEEeCcCccCc-C-CCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcE
Q 002250 85 TRLQVLDLGNNSFS-G-EVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYW 162 (947)
Q Consensus 85 ~~L~~L~Ls~n~i~-~-~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~ 162 (947)
++|++|+|++|.++ + .+..+..+++|++|+|++|.+++. ..+..+++|++|+|++|.+... +|..+..+++|++
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~---~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~ 99 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV---SNLPKLPKLKKLELSENRIFGG-LDMLAEKLPNLTH 99 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC---SSCCCCSSCCEEEEESCCCCSC-CCHHHHHCTTCCE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh---hhhccCCCCCEEECcCCcCchH-HHHHHhhCCCCCE
Confidence 44555555555554 2 222234455555555555555432 2455555555555555555443 3444445666666
Q ss_pred EEccCccccccC-CccCCCCCCCCEEECcCcccccccC---ccccCCCCCcEEEeeccccc
Q 002250 163 LYLTNCSVTGQI-PEGIGNLTQLQNLELSDNELFGEIP---AGIVKLNKLWQLELYNNSLS 219 (947)
Q Consensus 163 L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~---~~l~~l~~L~~L~L~~n~l~ 219 (947)
|+|++|.+++.. +..+..+++|++|+|++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 666666665432 1566677777777777777764443 36677777777777777776
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=4.4e-16 Score=149.31 Aligned_cols=129 Identities=22% Similarity=0.234 Sum_probs=72.2
Q ss_pred CcccceeeccCcccc-CcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCcee
Q 002250 60 LQALQKINLGTNFLY-GTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFL 138 (947)
Q Consensus 60 l~~L~~L~L~~n~i~-~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L 138 (947)
.++|+.|++++|.+. +.+|..+..+++|++|+|++|.+++. +.+..+++|++|+|++|.+++.+| ..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLE-VLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTH-HHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHH-HHhhhCCCCCEE
Confidence 356666666666665 45666666666666666666666654 445555556666666665554333 334445555555
Q ss_pred eCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccC---ccccCCCCCcEEEee
Q 002250 139 SLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIP---AGIVKLNKLWQLELY 214 (947)
Q Consensus 139 ~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~---~~l~~l~~L~~L~L~ 214 (947)
++++|.++..+ .+..+..+++|++|++++|.+++..+ ..+..+++|++|+++
T Consensus 94 ~ls~N~i~~~~------------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLS------------------------TIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHH------------------------HHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChH------------------------HHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 55555544322 22455555566666666666554433 345556666666554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=3e-16 Score=171.01 Aligned_cols=149 Identities=17% Similarity=0.131 Sum_probs=101.1
Q ss_pred cCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCCh--------hhHHHHHHHHhhcccc
Q 002250 631 VKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS--------SEYDAEVATLSAVRHV 702 (947)
Q Consensus 631 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~E~~~l~~l~h~ 702 (947)
|++.+.||+|+||.||+|...+|+.||||+++.....++..... ... ...... ....+|...+.++.+.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~-r~~--~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKAN-RDY--LRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC---CEE--CTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHH-HHH--HHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 78899999999999999999999999999986543322211000 000 000011 1123566666666444
Q ss_pred ccc--eEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEe
Q 002250 703 NVV--KLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILL 780 (947)
Q Consensus 703 niv--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll 780 (947)
++. +.+++ ...++||||++|++|.++... .. ...++.|++.+|.||| ..+||||||||.|||+
T Consensus 174 gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-----~~---~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 174 GFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-----PD---PASLYADLIALILRLA---KHGLIHGDFNEFNILI 238 (397)
T ss_dssp TCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-----SC---HHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred CCCCCeeeec----cCceEEEEecCCccHhhhccc-----HH---HHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEE
Confidence 332 22221 234799999999888655432 11 2457789999999999 7899999999999999
Q ss_pred cCCCC----------eEEeccccceec
Q 002250 781 DLEWK----------PRIADFGLAKIV 797 (947)
Q Consensus 781 ~~~~~----------~kl~DfG~a~~~ 797 (947)
++++. +.|+||+-+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 87763 899999987643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=7e-16 Score=147.91 Aligned_cols=126 Identities=29% Similarity=0.335 Sum_probs=65.5
Q ss_pred ccCcEEEccCcccc-ccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEe
Q 002250 158 EKLYWLYLTNCSVT-GQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFD 236 (947)
Q Consensus 158 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 236 (947)
++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 44555555555555 45555556666666666666666543 4555555555555555555544454444555555555
Q ss_pred ccCCCCCCCC--ccccccCCCCEEEccCccCcccCC---CCccCCCcCcEEEcc
Q 002250 237 VSQNRLEGDL--SELRFLNQLSSLHLFENQFSGEIP---EEFGEFKHLTELSLY 285 (947)
Q Consensus 237 Ls~N~l~~~~--~~l~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~ 285 (947)
+++|++++.+ ..+..+++|++|++++|++++..+ ..+..+++|++|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 5555555432 334444455555555555543322 234444455554443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.7e-15 Score=148.41 Aligned_cols=131 Identities=19% Similarity=0.194 Sum_probs=72.8
Q ss_pred cEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCc
Q 002250 400 ALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479 (947)
Q Consensus 400 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 479 (947)
+.+++++|+++ .+|..+. ++|+.|++++|++++..+..|+++++|++|+|++|++++..+..|+.+++|+.|+|++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 34444444444 3332221 34555555555555444444555555666666666655555555566666666666666
Q ss_pred eeeeecCCCCCccCcCcEEECCCCccCCccCCccc-ccccceeeCCCCcCCCCCC
Q 002250 480 SLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQLAGPIP 533 (947)
Q Consensus 480 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N~l~~~~p 533 (947)
+|++..+..+..+++|+.|+|++|++++.++..+. +++|+.|+|++|++++..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 66655555556666666666666666655544433 4666666666666665544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.3e-15 Score=150.90 Aligned_cols=129 Identities=21% Similarity=0.281 Sum_probs=95.7
Q ss_pred ceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhcccc
Q 002250 376 SIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDN 455 (947)
Q Consensus 376 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 455 (947)
+.+++++|+++.+ |..+ ..+|++|+|++|+|+ .+|..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~~i-p~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKVL-PKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSSC-CSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCcC-CCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 3455556665533 2222 245667777777776 56667777777777777777777666677788888888888888
Q ss_pred ccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCc
Q 002250 456 MFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGE 508 (947)
Q Consensus 456 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 508 (947)
+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+...
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 88877777888888888888888888866666788899999999999988753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=3.2e-15 Score=147.87 Aligned_cols=133 Identities=23% Similarity=0.247 Sum_probs=99.6
Q ss_pred cceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccc
Q 002250 375 LSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHD 454 (947)
Q Consensus 375 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (947)
.+.+++++|+++..+.. + .++|+.|++++|++++..+..|..+++|+.|+|++|++++..+..|+.+++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~~~p~~-~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTSVPTG-I--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSSCCTT-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCccCCCC-C--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 34556666666543322 1 24667777777777655555667777778888888887766666677888888888888
Q ss_pred cccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccC
Q 002250 455 NMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIP 510 (947)
Q Consensus 455 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 510 (947)
|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 88887777778889999999999999986666667889999999999999998766
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3.7e-14 Score=158.79 Aligned_cols=250 Identities=10% Similarity=0.091 Sum_probs=135.0
Q ss_pred cCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCcccccc
Q 002250 173 QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFL 252 (947)
Q Consensus 173 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l 252 (947)
+...+|.++ +|+.+.|..| ++.+...+|.+. +|+.+.+.+ .++.+.+.+|.++++|+.++|+.|+++.+.......
T Consensus 127 I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~ 202 (401)
T 4fdw_A 127 IPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFVY 202 (401)
T ss_dssp ECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTTT
T ss_pred ehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEee
Confidence 334445543 4555555554 444444455552 455555554 444455555556666666666555555443332224
Q ss_pred CCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeee
Q 002250 253 NQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLV 332 (947)
Q Consensus 253 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l 332 (947)
.+|+.+.|..+ ++.+...+|.++++|+.+.+..| ++.....+|.+ .+|+.+++.
T Consensus 203 ~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp----------------------- 256 (401)
T 4fdw_A 203 AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP----------------------- 256 (401)
T ss_dssp CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-----------------------
T ss_pred cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-----------------------
Confidence 55555555533 44455555666666666666543 33233333433 444444442
Q ss_pred cccccCCcCCccccCCCCccEEEccccccc-----ccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCc
Q 002250 333 LQNNFNGTVPETYANCKSLIRFRVNNNSLS-----GTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANN 407 (947)
Q Consensus 333 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 407 (947)
+++....+.+|.+|++|+.+.+.+|.+. .+.+..|.++++|+.++|. +.++.+....|.++.+|+.+.+..|
T Consensus 257 --~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 257 --NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp --TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred --CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence 2222233345566666666666655543 3444556666666666666 3455555666666666777666444
Q ss_pred cccccCCCCCCCCCcceEEEcccCcccCCCCccccccc-ccchhhcccccc
Q 002250 408 RFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLK-KLSSLYLHDNMF 457 (947)
Q Consensus 408 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l 457 (947)
++..-+.+|.++ +|+.+++++|.+....+..|.+++ +++.|++..+.+
T Consensus 334 -l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 334 -VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp -CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred -ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 554555666666 677777777766655555566653 566666666654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.57 E-value=8.7e-14 Score=156.53 Aligned_cols=314 Identities=13% Similarity=0.055 Sum_probs=170.1
Q ss_pred cCcCchhhhcCCCccEEeCcCccCcCCCC-CcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCCh
Q 002250 74 YGTITEGLKSCTRLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPM 152 (947)
Q Consensus 74 ~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~-~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~ 152 (947)
+.+...+|..|++|+.+.|..+ ++.... .|.++++|+.++|..+ +. .++..+|.++++|+.+.+..+ +.... ..
T Consensus 60 tsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~-~~ 134 (394)
T 4fs7_A 60 VSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIG-VE 134 (394)
T ss_dssp EEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEEC-TT
T ss_pred eEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeec-ce
Confidence 3344455555555555555432 333222 2555555555555433 22 334456666666666665543 22111 12
Q ss_pred hhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCc
Q 002250 153 EVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNL 232 (947)
Q Consensus 153 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 232 (947)
.+.....+....... +......+|.++++|+.+.+.++. .......|.++.+|+.+.+..| ++.....+|.++..|
T Consensus 135 aF~~~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L 210 (394)
T 4fs7_A 135 AFKGCDFKEITIPEG--VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILL 210 (394)
T ss_dssp TTTTCCCSEEECCTT--CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred eeecccccccccCcc--ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhcccccc
Confidence 233333222222222 222344577788888888887654 3355667777888888888766 554666778888888
Q ss_pred cEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCccccccccccccc
Q 002250 233 MNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENL 312 (947)
Q Consensus 233 ~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 312 (947)
+.+.+..+... .........+|+.+.+..+ ++.+...+|..+..|+.+.+..+... .....|.....++.+....+.
T Consensus 211 ~~i~~~~~~~~-i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~ 287 (394)
T 4fs7_A 211 ENMEFPNSLYY-LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVI 287 (394)
T ss_dssp CBCCCCTTCCE-ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSE
T ss_pred ceeecCCCceE-eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCcee
Confidence 87777665432 1122333456777777544 33355566777777777777766544 445555555555555443332
Q ss_pred ccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCc
Q 002250 313 LTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDD 392 (947)
Q Consensus 313 l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 392 (947)
+. ..+|..+.+|+.+.+.++ ++.+...+|.++++|+.++|..+ ++.+...+
T Consensus 288 i~---------------------------~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a 338 (394)
T 4fs7_A 288 VP---------------------------EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRS 338 (394)
T ss_dssp EC---------------------------TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred ec---------------------------cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHh
Confidence 21 134555666666666543 44344455666666666666432 44444455
Q ss_pred ccccccccEEEccCccccccCCCCCCCCCcceEEEcc
Q 002250 393 IGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLS 429 (947)
Q Consensus 393 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 429 (947)
|.++.+|+.+.+..| ++..-..+|.++++|+.+++.
T Consensus 339 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 339 FRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp TTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred ccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 555555555555544 443344455555555555554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.56 E-value=4.1e-14 Score=158.41 Aligned_cols=262 Identities=10% Similarity=0.094 Sum_probs=128.1
Q ss_pred CCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCc-cccccCCCCEEEccCccCcccCCCCccCCCcCcEEE
Q 002250 205 LNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLS-ELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELS 283 (947)
Q Consensus 205 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 283 (947)
...++.+.+.+ .++.+...+|.++ +|+.+.+..| ++.+.. .|.. .+|+.+.+.. .++.+.+.+|.++++|+.++
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 35566666654 3444555666664 5666666554 333222 2333 2455555553 44444455555555555555
Q ss_pred ccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccc
Q 002250 284 LYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSG 363 (947)
Q Consensus 284 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~ 363 (947)
|.+|+++.....+|. ..+|+.+.+..+ ++ .....+|.++++|+.+.+.+| ++
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~------------------------~I~~~aF~~~~~L~~l~l~~~-l~- 238 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LK------------------------EIGSQAFLKTSQLKTIEIPEN-VS- 238 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCTT-CC------------------------EECTTTTTTCTTCCCEECCTT-CC-
T ss_pred cCCCcceEechhhEe-ecccCEEEeCCc-hh------------------------eehhhHhhCCCCCCEEecCCC-cc-
Confidence 555555522222232 234444433321 21 122234444445555544432 22
Q ss_pred cCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCccc-----CCCC
Q 002250 364 TIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFS-----GQIP 438 (947)
Q Consensus 364 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p 438 (947)
.+....|.+ .+|+.+.+ .+.++...+.+|.++++|+.+++.+|.+. ...+
T Consensus 239 -----------------------~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~ 293 (401)
T 4fdw_A 239 -----------------------TIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHP 293 (401)
T ss_dssp -----------------------EECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECT
T ss_pred -----------------------Ccccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECH
Confidence 223333333 33444444 22233233444445555555555444432 2334
Q ss_pred cccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCccc-c-c
Q 002250 439 LDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-Y-P 516 (947)
Q Consensus 439 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~-~ 516 (947)
..|.++++|+.++|. |.++.+....|.+|++|+.++|..| ++...+.+|.++ +|+.|++++|.+....+..+. + .
T Consensus 294 ~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~ 370 (401)
T 4fdw_A 294 YCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPD 370 (401)
T ss_dssp TTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCT
T ss_pred HHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCC
Confidence 455566666666666 3355455566666666666666444 554555666666 677777776666544444332 2 2
Q ss_pred ccceeeCCCCc
Q 002250 517 KLSLLDLSNNQ 527 (947)
Q Consensus 517 ~L~~L~ls~N~ 527 (947)
.+..|.+..|.
T Consensus 371 ~l~~l~vp~~~ 381 (401)
T 4fdw_A 371 DITVIRVPAES 381 (401)
T ss_dssp TCCEEEECGGG
T ss_pred CccEEEeCHHH
Confidence 45555554443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.56 E-value=9.3e-14 Score=156.30 Aligned_cols=313 Identities=11% Similarity=0.058 Sum_probs=131.3
Q ss_pred cCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCcccc
Q 002250 124 FPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIV 203 (947)
Q Consensus 124 ~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 203 (947)
++..+|.++++|+.+.|..+ ++.++ ..+|.++++|+.+++.++ ++.+....|.++++|+.+.+..+ +......+|.
T Consensus 62 Ig~~AF~~c~~L~~i~lp~~-i~~I~-~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~ 137 (394)
T 4fs7_A 62 IGYAAFQGCRKVTEIKIPST-VREIG-EFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFK 137 (394)
T ss_dssp ECTTTTTTCTTEEEEECCTT-CCEEC-TTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTT
T ss_pred hHHHHhhCCCCceEEEeCCC-ccCcc-hhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeee
Confidence 34467777777777777543 43322 233445555555555433 33333444555555555444433 2223333443
Q ss_pred CCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEE
Q 002250 204 KLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELS 283 (947)
Q Consensus 204 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 283 (947)
+...+...... .+......+|.++ .+|+.+.+.++... +...+|.++.+|+.+.
T Consensus 138 ~~~~~~~~~~~--~~~~i~~~aF~~c-----------------------~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~ 191 (394)
T 4fs7_A 138 GCDFKEITIPE--GVTVIGDEAFATC-----------------------ESLEYVSLPDSMET-LHNGLFSGCGKLKSIK 191 (394)
T ss_dssp TCCCSEEECCT--TCCEECTTTTTTC-----------------------TTCCEEECCTTCCE-ECTTTTTTCTTCCBCC
T ss_pred cccccccccCc--cccccchhhhccc-----------------------CCCcEEecCCccce-eccccccCCCCceEEE
Confidence 33322211111 1111222334444 44444444433222 3444555555555555
Q ss_pred ccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccc
Q 002250 284 LYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSG 363 (947)
Q Consensus 284 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~ 363 (947)
+..| ++.....+|.+...|+.+.+..+... +.........++.+.+. +........+|.++..|+.+.+..+...
T Consensus 192 l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip-~~~~~i~~~~f~~~~~l~~~~~~~~~~~- 266 (394)
T 4fs7_A 192 LPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIP-DSFTELGKSVFYGCTDLESISIQNNKLR- 266 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEEC-TTCCEECSSTTTTCSSCCEEEECCTTCE-
T ss_pred cCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEEC-CCceecccccccccccceeEEcCCCcce-
Confidence 5444 33233444555555555554443321 11111122223333221 1112222334555555555555554333
Q ss_pred cCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCccccc
Q 002250 364 TIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGK 443 (947)
Q Consensus 364 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 443 (947)
.....|..+..++.+....+.+. ...|..+.+|+.+.+..+ ++..-..+|.++++|+.++|..+ ++..-..+|.+
T Consensus 267 i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 341 (394)
T 4fs7_A 267 IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRG 341 (394)
T ss_dssp ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTT
T ss_pred eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccC
Confidence 34444555555555554443321 233444445555544433 33233334444444444444322 33222333444
Q ss_pred ccccchhhccccccCCCCCcccccccccceeecc
Q 002250 444 LKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFA 477 (947)
Q Consensus 444 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 477 (947)
+++|+.+++..| ++.+-..+|.+|.+|+.+++.
T Consensus 342 c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 342 CTSLSNINFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp CTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred CCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 444444444333 332333344444444444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=1e-14 Score=144.03 Aligned_cols=105 Identities=21% Similarity=0.194 Sum_probs=46.5
Q ss_pred CCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCc--cccccCCCCEEEc
Q 002250 183 QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLS--ELRFLNQLSSLHL 260 (947)
Q Consensus 183 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~l~~l~~L~~L~L 260 (947)
+|++|+|++|+|++. ..+..+++|++|+|++|.|++..+..|..+++|++|+|++|+++..+. .+..+++|+.|++
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l 120 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 120 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEEC
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEe
Confidence 444444444444322 334444444444444444443322333444444444444444433332 3444445555555
Q ss_pred cCccCcccCCCC----ccCCCcCcEEEccCcccc
Q 002250 261 FENQFSGEIPEE----FGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 261 ~~N~i~~~~~~~----~~~l~~L~~L~L~~N~l~ 290 (947)
++|.++ ..|.. +..+++|+.|++++|.+.
T Consensus 121 ~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 121 LRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred cCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 555554 23332 445555555555555443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1e-16 Score=161.88 Aligned_cols=132 Identities=17% Similarity=0.193 Sum_probs=89.9
Q ss_pred cCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCC
Q 002250 177 GIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLS 256 (947)
Q Consensus 177 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~ 256 (947)
.+..+++|++|+|++|++++ +| .+.++++|++|+|++|.++ .+|..+..+++|++|+|++|++++.+ .+..+++|+
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l~-~~~~l~~L~ 118 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLS-GIEKLVNLR 118 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCHH-HHHHHHHSS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcCC-ccccCCCCC
Confidence 66667777777777777764 45 6667777777777777776 45656666677777777777776643 566677777
Q ss_pred EEEccCccCcccCC-CCccCCCcCcEEEccCccccccCCcC----------ccCccccccccccccccc
Q 002250 257 SLHLFENQFSGEIP-EEFGEFKHLTELSLYTNRLTGTLPQK----------LGSWADFNYVDVSENLLT 314 (947)
Q Consensus 257 ~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~----------l~~l~~L~~L~Ls~N~l~ 314 (947)
.|+|++|++++..+ ..+..+++|++|++++|++++..|.. +..+++|+.|| +|.++
T Consensus 119 ~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred EEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 77777777764322 35677777888888888777655543 66777777776 56555
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.6e-16 Score=158.92 Aligned_cols=136 Identities=23% Similarity=0.250 Sum_probs=83.4
Q ss_pred ccCCcccceeeccCccccCcCch------hhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCccccc
Q 002250 57 ICGLQALQKINLGTNFLYGTITE------GLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLE 130 (947)
Q Consensus 57 ~~~l~~L~~L~L~~n~i~~~~~~------~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~ 130 (947)
+.....++.++++.+.+.+..|. .+..+++|++|+|++|++++.+ .+..+++|++|+|++|.++ .+| ..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~-~l~-~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIK-KIE-NLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEEC-SCS-SHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcc-ccc-chhh
Confidence 44556666777777777666665 7788888888888888877643 6666777777777777766 334 3455
Q ss_pred ccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCC-ccCCCCCCCCEEECcCccccccc
Q 002250 131 NLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIP-EGIGNLTQLQNLELSDNELFGEI 198 (947)
Q Consensus 131 ~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~ 198 (947)
.+++|++|+|++|+++. +| .+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.+..
T Consensus 91 ~~~~L~~L~L~~N~l~~--l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 156 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS--LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp HHHHCSEEEEEEEECCC--HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred cCCcCCEEECcCCcCCc--CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccc
Confidence 55666666666666654 22 35555566666666665553221 24555555555555555554443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=1.7e-14 Score=142.53 Aligned_cols=133 Identities=17% Similarity=0.107 Sum_probs=82.3
Q ss_pred cccccCCCceeeCCCCCCCCCCCChhhcccc-cCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCC
Q 002250 128 SLENLTNLEFLSLGDNPFDPSPFPMEVLKLE-KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLN 206 (947)
Q Consensus 128 ~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 206 (947)
.+.++++|++|+|++|.++.. +. +..+. +|++|++++|.+++. ..+..+++|++|+|++|+|++..+..+..++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i--~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI--EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC--CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred hcCCcCCceEEEeeCCCCchh--HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 345555666666666665532 32 33333 666666666666644 4566667777777777777654444446677
Q ss_pred CCcEEEeecccccccCCc--cCCCCCCccEEeccCCCCCCCCcc----ccccCCCCEEEccCccCc
Q 002250 207 KLWQLELYNNSLSGRLPV--GFSNLTNLMNFDVSQNRLEGDLSE----LRFLNQLSSLHLFENQFS 266 (947)
Q Consensus 207 ~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~----l~~l~~L~~L~L~~N~i~ 266 (947)
+|++|+|++|+|+ .+|. .+..+++|++|++++|.++..+.. +..+++|+.|++++|.+.
T Consensus 89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 7777777777775 3343 566677777777777777655543 666777777777777654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.45 E-value=1.4e-13 Score=134.85 Aligned_cols=108 Identities=19% Similarity=0.230 Sum_probs=67.7
Q ss_pred cEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCc
Q 002250 400 ALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479 (947)
Q Consensus 400 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 479 (947)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 45556666655 3454442 55666666666666555666666666666666666666555555666666777777777
Q ss_pred eeeeecCCCCCccCcCcEEECCCCccCCccC
Q 002250 480 SLSGKIPDSLGSLPSLNSLNLSNNKFSGEIP 510 (947)
Q Consensus 480 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 510 (947)
+|++..|..|..+++|+.|+|++|+++...+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 7665555556666777777777776665443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.9e-13 Score=133.02 Aligned_cols=106 Identities=24% Similarity=0.308 Sum_probs=65.2
Q ss_pred cEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCc
Q 002250 400 ALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQN 479 (947)
Q Consensus 400 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 479 (947)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45555555554 4554443 55666666666666555666666666666666666666555555566666666666666
Q ss_pred eeeeecCCCCCccCcCcEEECCCCccCCc
Q 002250 480 SLSGKIPDSLGSLPSLNSLNLSNNKFSGE 508 (947)
Q Consensus 480 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 508 (947)
+|++..+..|..+++|+.|+|++|++...
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 66654444566666677777776666644
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.41 E-value=7e-13 Score=129.77 Aligned_cols=107 Identities=25% Similarity=0.261 Sum_probs=60.9
Q ss_pred ceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeec
Q 002250 136 EFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYN 215 (947)
Q Consensus 136 ~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 215 (947)
+.|++++|.++.. |..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 12 ~~l~~s~n~l~~i--p~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 12 TTVDCSGKSLASV--PTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TEEECTTSCCSSC--CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCcc--CccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4455555555432 2222 24555566666666655556666666666666666666655555556666666666666
Q ss_pred ccccccCCccCCCCCCccEEeccCCCCCCCC
Q 002250 216 NSLSGRLPVGFSNLTNLMNFDVSQNRLEGDL 246 (947)
Q Consensus 216 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 246 (947)
|+|++..+..|..+++|++|+|++|.+....
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 6666555555666666666666666555443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.2e-12 Score=128.54 Aligned_cols=107 Identities=23% Similarity=0.273 Sum_probs=59.1
Q ss_pred ceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeec
Q 002250 136 EFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYN 215 (947)
Q Consensus 136 ~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 215 (947)
+.+++++|.++. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 15 ~~l~~~~n~l~~--iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLAS--VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCSS--CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCCc--cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 344555555433 222221 4555555555555555555666666666666666666554444455666666666666
Q ss_pred ccccccCCccCCCCCCccEEeccCCCCCCCC
Q 002250 216 NSLSGRLPVGFSNLTNLMNFDVSQNRLEGDL 246 (947)
Q Consensus 216 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 246 (947)
|+|++..+..|..+++|++|+|++|.+....
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 6666444444566666666666666555443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=2e-14 Score=159.42 Aligned_cols=117 Identities=21% Similarity=0.207 Sum_probs=60.4
Q ss_pred cccCcEEEccCccccccCCccC-----CCCCCCCEEECcCcccccc----cCccccCCCCCcEEEeecccccccC----C
Q 002250 157 LEKLYWLYLTNCSVTGQIPEGI-----GNLTQLQNLELSDNELFGE----IPAGIVKLNKLWQLELYNNSLSGRL----P 223 (947)
Q Consensus 157 l~~L~~L~L~~n~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~----~ 223 (947)
+++|+.|+|++|.++......+ ...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++.. +
T Consensus 125 L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~ 204 (372)
T 3un9_A 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA 204 (372)
T ss_dssp HHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHH
T ss_pred HHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHH
Confidence 3344444444444443222222 2345666666666666432 2233355666666666666665422 3
Q ss_pred ccCCCCCCccEEeccCCCCCCC-----CccccccCCCCEEEccCccCcccCCCCc
Q 002250 224 VGFSNLTNLMNFDVSQNRLEGD-----LSELRFLNQLSSLHLFENQFSGEIPEEF 273 (947)
Q Consensus 224 ~~~~~l~~L~~L~Ls~N~l~~~-----~~~l~~l~~L~~L~L~~N~i~~~~~~~~ 273 (947)
..+...++|++|+|++|.|+.. ...+...++|++|+|++|.|+......+
T Consensus 205 ~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 205 AQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred HHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 3445556666666666666531 1223445666666666666654433333
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.33 E-value=4.9e-11 Score=134.02 Aligned_cols=301 Identities=12% Similarity=0.124 Sum_probs=125.5
Q ss_pred cCcEEEccCccccccCCccCCCCCCCCEEECcCcc---cccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEE
Q 002250 159 KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNE---LFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNF 235 (947)
Q Consensus 159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 235 (947)
.|+.+.+-.+ ++.+...+|.++++|+.+.++.|. ++.+...+|.++.+|+.+.+..+ ++.....+|..+.+|+.+
T Consensus 65 ~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i 142 (394)
T 4gt6_A 65 VLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTV 142 (394)
T ss_dssp CCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEE
T ss_pred cCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccc
Confidence 3555555432 444445556666666666655542 44344445555555555554433 333444455555555555
Q ss_pred eccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccC
Q 002250 236 DVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315 (947)
Q Consensus 236 ~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 315 (947)
.+..+.-.-....+..+.+|+.+.+..+ ++.+...+|.. ..|+.+.+..+-.. ....+|.....+.......+...
T Consensus 143 ~lp~~~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~- 218 (394)
T 4gt6_A 143 TIPEGVTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYP- 218 (394)
T ss_dssp ECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSC-
T ss_pred cccceeeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceecccccccc-
Confidence 5543322111223444555555555443 22233344433 34555555443322 33344444444444443333222
Q ss_pred CCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccc
Q 002250 316 PIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGN 395 (947)
Q Consensus 316 ~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 395 (947)
.+...+..... ........+.....+..+.+. +.++......|.++.+|+.+.+..+... .....|.+
T Consensus 219 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~ 286 (394)
T 4gt6_A 219 AIDNVLYEKSA----------NGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMN 286 (394)
T ss_dssp BSSSCEEEECT----------TSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTT
T ss_pred cccceeecccc----------cccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCccccc
Confidence 00000000000 000000001112222333322 1222233344555555555555433222 33344555
Q ss_pred cccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceee
Q 002250 396 AKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDIN 475 (947)
Q Consensus 396 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 475 (947)
+..|+.+.+. +.++.....+|.++.+|+.++|..+ ++..-..+|.++.+|+.+.|..+ ++.+-..+|.+|++|+.++
T Consensus 287 c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~ 363 (394)
T 4gt6_A 287 CPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIE 363 (394)
T ss_dssp CTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEE
T ss_pred ccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEE
Confidence 5555555553 2333233344555555555555433 33223334444444444444332 3333334444445555554
Q ss_pred ccCce
Q 002250 476 FAQNS 480 (947)
Q Consensus 476 Ls~N~ 480 (947)
+.+|.
T Consensus 364 ~~~~~ 368 (394)
T 4gt6_A 364 YSGSR 368 (394)
T ss_dssp ESSCH
T ss_pred ECCce
Confidence 44443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.6e-14 Score=158.40 Aligned_cols=183 Identities=19% Similarity=0.110 Sum_probs=106.0
Q ss_pred CCCccEEeCcCccCcCCCCC-c----c-cccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCCh---hh
Q 002250 84 CTRLQVLDLGNNSFSGEVPD-L----S-MLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPM---EV 154 (947)
Q Consensus 84 l~~L~~L~Ls~n~i~~~~~~-l----~-~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~---~~ 154 (947)
+++|++|+|++|.|+..... + . ..++|++|+|++|.+++.........+++|++|+|++|.++...... .+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 35666777777766543221 1 1 22567777777777654322122334566777777777765432111 11
Q ss_pred -cccccCcEEEccCcccccc----CCccCCCCCCCCEEECcCccccccc----CccccCCCCCcEEEeeccccccc----
Q 002250 155 -LKLEKLYWLYLTNCSVTGQ----IPEGIGNLTQLQNLELSDNELFGEI----PAGIVKLNKLWQLELYNNSLSGR---- 221 (947)
Q Consensus 155 -~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~---- 221 (947)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++.. +..+...++|++|+|++|.|++.
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 1346677888888877642 3444566788888888888876433 45566777888888888888753
Q ss_pred CCccCCCCCCccEEeccCCCCCCCCc-cc---cccCC--CCEEE--ccCccCc
Q 002250 222 LPVGFSNLTNLMNFDVSQNRLEGDLS-EL---RFLNQ--LSSLH--LFENQFS 266 (947)
Q Consensus 222 ~~~~~~~l~~L~~L~Ls~N~l~~~~~-~l---~~l~~--L~~L~--L~~N~i~ 266 (947)
++..+...++|++|+|++|.|+.... .+ ..... |+.+. +..|.+.
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 23344556888888888888864211 12 22222 66666 6666665
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.31 E-value=4.4e-11 Score=134.35 Aligned_cols=333 Identities=11% Similarity=0.080 Sum_probs=231.2
Q ss_pred ccCcccccccC-CCceeeCCCCCCCCCCCChhhcccccCcEEEccCcc---ccccCCccCCCCCCCCEEECcCccccccc
Q 002250 123 KFPWKSLENLT-NLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCS---VTGQIPEGIGNLTQLQNLELSDNELFGEI 198 (947)
Q Consensus 123 ~~~~~~l~~l~-~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 198 (947)
.++..+|.++. .|+.+.+..+ ++.++ ..+|.++++|+.+.+..|. ++.+...+|.++.+|+.+.+..+ ++.+.
T Consensus 53 ~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig-~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~ 129 (394)
T 4gt6_A 53 KIGDRVFCNYKYVLTSVQIPDT-VTEIG-SNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEID 129 (394)
T ss_dssp EECTTTTTTCCSCCCEEEECTT-CCEEC-TTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEEC
T ss_pred EcCHhhccCCCCcCEEEEECCC-eeEEh-HHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceeh
Confidence 34457888884 6999999765 54443 5578899999999998874 66666788999999999988766 55566
Q ss_pred CccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCc-cccccCCCCEEEccCccCcccCCCCccCCC
Q 002250 199 PAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLS-ELRFLNQLSSLHLFENQFSGEIPEEFGEFK 277 (947)
Q Consensus 199 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~ 277 (947)
..+|.++.+|+.+.+..+- ......+|..+.+|+.+.+..+ ++.... .+. ..+|+.+.+..+-.. ....+|..+.
T Consensus 130 ~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~c~ 205 (394)
T 4gt6_A 130 SEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPAKVTR-IGTNAFSECF 205 (394)
T ss_dssp TTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECTTCCE-ECTTTTTTCT
T ss_pred hhhhhhhccccccccccee-eeecccceecccccccccccce-eeEecccccc-ccceeEEEECCcccc-cccchhhhcc
Confidence 7789999999999997654 4477788999999999999876 332222 343 467999999876554 7778899999
Q ss_pred cCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcc
Q 002250 278 HLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVN 357 (947)
Q Consensus 278 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~ 357 (947)
.|+......+... .+...+..........+.. +.....+..+.+ .+.+...-..+|.++..|+.+.+.
T Consensus 206 ~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~i-p~~v~~i~~~aF~~c~~L~~i~lp 273 (394)
T 4gt6_A 206 ALSTITSDSESYP-AIDNVLYEKSANGDYALIR----------YPSQREDPAFKI-PNGVARIETHAFDSCAYLASVKMP 273 (394)
T ss_dssp TCCEEEECCSSSC-BSSSCEEEECTTSCEEEEE----------CCTTCCCSEEEC-CTTEEEECTTTTTTCSSCCEEECC
T ss_pred ccceecccccccc-cccceeecccccccccccc----------cccccccceEEc-CCcceEcccceeeecccccEEecc
Confidence 9999988777665 2222221111110000000 000011111111 122333445678999999999998
Q ss_pred cccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCC
Q 002250 358 NNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQI 437 (947)
Q Consensus 358 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 437 (947)
++..+ .....|.++++|+.+.+. +.++.+....|.++.+|+.+.+..+ ++..-..+|.++.+|+.+.+..+ ++..-
T Consensus 274 ~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~ 349 (394)
T 4gt6_A 274 DSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIP 349 (394)
T ss_dssp TTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCC
T ss_pred cccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEh
Confidence 76554 667788899999999996 5666677788999999999999865 66566778999999999999765 66456
Q ss_pred CcccccccccchhhccccccCCCCCcccccccccceeeccCcee
Q 002250 438 PLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSL 481 (947)
Q Consensus 438 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 481 (947)
..+|.++++|+.+++.+|.... ..+..+.+|+.+.+..|.+
T Consensus 350 ~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 350 ESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp GGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred HhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 6789999999999999886542 4566777888887776654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.1e-11 Score=136.91 Aligned_cols=104 Identities=18% Similarity=0.177 Sum_probs=72.1
Q ss_pred EEEccCc-cccccCCCCCCCCCcceEEEccc-CcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccC
Q 002250 401 LLLLANN-RFSGELPSKISEASSLVSIQLSL-NQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQ 478 (947)
Q Consensus 401 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 478 (947)
.++++++ +|+ .+|. +..+++|+.|+|++ |+|++..+..|+++++|+.|+|++|+|++..|..|+.+++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4566776 676 4666 77777777777775 777766666677777777777777777777777777777777777777
Q ss_pred ceeeeecCCCCCccCcCcEEECCCCccCC
Q 002250 479 NSLSGKIPDSLGSLPSLNSLNLSNNKFSG 507 (947)
Q Consensus 479 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 507 (947)
|+|++..|..|..++ |+.|+|++|+|..
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 777755455555444 7777777777764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.19 E-value=1.7e-11 Score=135.31 Aligned_cols=103 Identities=19% Similarity=0.219 Sum_probs=59.6
Q ss_pred EEcccC-cccCCCCcccccccccchhhccc-cccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCC
Q 002250 426 IQLSLN-QFSGQIPLDIGKLKKLSSLYLHD-NMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNN 503 (947)
Q Consensus 426 L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 503 (947)
++++++ +|+ .+|. +..+++|+.|+|++ |+|++..+..|+.+++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455555 555 3555 55566666666664 6666555555666666666666666666555555666666666666666
Q ss_pred ccCCccCCcccccccceeeCCCCcCCC
Q 002250 504 KFSGEIPISLTYPKLSLLDLSNNQLAG 530 (947)
Q Consensus 504 ~l~~~~p~~~~~~~L~~L~ls~N~l~~ 530 (947)
+|++.++..+....|+.|+|++|+|..
T Consensus 91 ~l~~~~~~~~~~~~L~~l~l~~N~~~c 117 (347)
T 2ifg_A 91 ALESLSWKTVQGLSLQELVLSGNPLHC 117 (347)
T ss_dssp CCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred ccceeCHHHcccCCceEEEeeCCCccC
Confidence 666555544443336666666666554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=9.7e-11 Score=123.67 Aligned_cols=145 Identities=14% Similarity=0.063 Sum_probs=111.9
Q ss_pred HHhhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-cccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni 704 (947)
...+.|++....|.|+++.||++... ++.+++|+..... ......+.+|+++++.+. +..+
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~-----------------~~~~~~~~~E~~~l~~l~~~~~v 72 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRY-----------------KGTTYDVEREKDMMLWLEGKLPV 72 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGG-----------------TTSTTCHHHHHHHHHHHTTTSCC
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCccc-----------------CCCHHHHHHHHHHHHHHhcCCCC
Confidence 44567888888898999999999865 6899999873210 012345889999999994 6778
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcC---------------------
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG--------------------- 763 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~--------------------- 763 (947)
.++++++...+..|+||||++|.++.+.+... .....++.+++++++.||.-
T Consensus 73 P~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~ 145 (263)
T 3tm0_A 73 PKVLHFERHDGWSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL 145 (263)
T ss_dssp CCEEEEEEETTEEEEEEECCSSEEHHHHCCTT-------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHH
T ss_pred CeEEEEEecCCceEEEEEecCCeehhhccCCc-------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHH
Confidence 89999999888899999999999988764211 11235778889999999951
Q ss_pred -----------------------------------CCCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 764 -----------------------------------FDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 764 -----------------------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
....++|+|++|.||+++++..+.|+||+.+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876556799999875
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.07 E-value=9.9e-09 Score=114.51 Aligned_cols=127 Identities=7% Similarity=0.009 Sum_probs=70.9
Q ss_pred ccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEE
Q 002250 156 KLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNF 235 (947)
Q Consensus 156 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 235 (947)
...+|+.+.+.. .++.+...+|.++.+|+.++|..+ ++.+...+|.++ +|+.+.+..+ ++.....+|... +|+.+
T Consensus 44 ~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~~i 118 (379)
T 4h09_A 44 DRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLDDF 118 (379)
T ss_dssp GGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCSEE
T ss_pred cccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Ccccc
Confidence 334455554432 345455567777888888887654 555556667665 5777766543 444555566553 67777
Q ss_pred eccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccc
Q 002250 236 DVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRL 289 (947)
Q Consensus 236 ~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 289 (947)
.+..+-..-....+.. .+|+.+.+..+ ++.+....|..+..++.+.+..+..
T Consensus 119 ~lp~~~~~i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~ 170 (379)
T 4h09_A 119 EFPGATTEIGNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNK 170 (379)
T ss_dssp ECCTTCCEECTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCS
T ss_pred cCCCcccccccccccc-ceeeeeeccce-eeccccchhcccccccccccccccc
Confidence 7765422211112222 34555555443 3335556666677777776665543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.06 E-value=3.3e-10 Score=119.46 Aligned_cols=137 Identities=18% Similarity=0.122 Sum_probs=99.3
Q ss_pred ccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc--cceE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN--VVKL 707 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l 707 (947)
.+.+....+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+.+.+ +.++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--------------------~~~~~~~E~~~l~~l~~~~~~vP~~ 80 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--------------------ALNELQDEAARLSWLATTGVPCAAV 80 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--------------------TTSCHHHHHHHHHHHHTTTCCBCCE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--------------------cchhhhHHHHHHHHHHhCCCCCCeE
Confidence 34433333466679999998877889999986311 1245788999999996544 5568
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCC-----------------------
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGF----------------------- 764 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~----------------------- 764 (947)
+++...++..++||||++|.++. ... .+ ...++.++++.+..||...
T Consensus 81 ~~~~~~~~~~~~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (264)
T 1nd4_A 81 LDVVTEAGRDWLLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEA 150 (264)
T ss_dssp EEEEECSSCEEEEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHT
T ss_pred EEeccCCCCCEEEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhc
Confidence 99888888889999999998884 221 11 1246667778888888421
Q ss_pred --------------------------------CCCeEeccCCCCCeEecCCCCeEEecccccee
Q 002250 765 --------------------------------DRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796 (947)
Q Consensus 765 --------------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 796 (947)
...++|+|++|.||+++++..+.|+|||.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 151 GLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.05 E-value=7.8e-09 Score=115.37 Aligned_cols=303 Identities=11% Similarity=0.074 Sum_probs=186.6
Q ss_pred ccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCc-cccccCC
Q 002250 176 EGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLS-ELRFLNQ 254 (947)
Q Consensus 176 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~ 254 (947)
+++....+|+.+.+... ++.+...+|.++.+|+.+.|..+ ++.+...+|.++ +|+.+.+..+ ++.... .+.. .+
T Consensus 40 ~~~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~ 114 (379)
T 4h09_A 40 PWYKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TD 114 (379)
T ss_dssp TTGGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CC
T ss_pred cccccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CC
Confidence 35666778899888754 66677788999999999999754 776777888887 6888877654 333222 2333 47
Q ss_pred CCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecc
Q 002250 255 LSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQ 334 (947)
Q Consensus 255 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~ 334 (947)
|+.+.+..+-.. ....+|.+. +|+.+.+..+ ++......+.....++.+.+..+.......... .
T Consensus 115 L~~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~------------~ 179 (379)
T 4h09_A 115 LDDFEFPGATTE-IGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYV------------L 179 (379)
T ss_dssp CSEEECCTTCCE-ECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTE------------E
T ss_pred cccccCCCcccc-ccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccce------------e
Confidence 888888766433 555566665 5777666544 333555667777777776665544321100000 0
Q ss_pred cccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCC
Q 002250 335 NNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELP 414 (947)
Q Consensus 335 n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 414 (947)
.+........+.....+..+.+..+.-. .....+....+|+.+.+..+ +.......|.+...|+.+.+..+ ++..-.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~ 256 (379)
T 4h09_A 180 YNKNKTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGS 256 (379)
T ss_dssp EETTSSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECT
T ss_pred cccccceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCc
Confidence 0011122233444555555555443322 44455566667777766543 33344556667777777777655 444555
Q ss_pred CCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCc
Q 002250 415 SKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPS 494 (947)
Q Consensus 415 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 494 (947)
..|.++.+|+.+.+..+ ++......|.++++|+.+.+.++.++.+....|.+|.+|+.++|..+ ++..-..+|.++++
T Consensus 257 ~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~ 334 (379)
T 4h09_A 257 FLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKA 334 (379)
T ss_dssp TTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred cccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCC
Confidence 66777777777777544 44344456777777777777777776666677777777777777654 55455667777777
Q ss_pred CcEEECCCC
Q 002250 495 LNSLNLSNN 503 (947)
Q Consensus 495 L~~L~Ls~N 503 (947)
|+.+.+..+
T Consensus 335 L~~i~ip~~ 343 (379)
T 4h09_A 335 LSTISYPKS 343 (379)
T ss_dssp CCCCCCCTT
T ss_pred CCEEEECCc
Confidence 777776544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.98 E-value=9.1e-11 Score=128.72 Aligned_cols=184 Identities=16% Similarity=0.138 Sum_probs=90.5
Q ss_pred cccCCcccceeeccCccc---------cCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCc
Q 002250 56 SICGLQALQKINLGTNFL---------YGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPW 126 (947)
Q Consensus 56 ~~~~l~~L~~L~L~~n~i---------~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~ 126 (947)
++..+++|+.|.+.++.. .+.+...+..+++|+.|+|++|.-... +.+ .+++|++|+|..|.+.....
T Consensus 134 s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~l-~~~-~~~~L~~L~L~~~~l~~~~l- 210 (362)
T 2ra8_A 134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSI-GKK-PRPNLKSLEIISGGLPDSVV- 210 (362)
T ss_dssp THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCBC-CSC-BCTTCSEEEEECSBCCHHHH-
T ss_pred hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCcee-ccc-cCCCCcEEEEecCCCChHHH-
Confidence 355667777777755432 123445566677777777776621111 223 25667777776666543211
Q ss_pred cccc--ccCCCceeeCCCC--CCCCCCCChhhcccccCcEEEccCccccccCCccC--CCCCCCCEEECcCcccccccCc
Q 002250 127 KSLE--NLTNLEFLSLGDN--PFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI--GNLTQLQNLELSDNELFGEIPA 200 (947)
Q Consensus 127 ~~l~--~l~~L~~L~Ls~n--~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~~~ 200 (947)
..+. .+++|++|+|+.+ ...... .+. .+...+ ..+++|++|+|++|.+.+..+.
T Consensus 211 ~~l~~~~lp~L~~L~L~~~~~~~~~~~-------------------~~~-~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~ 270 (362)
T 2ra8_A 211 EDILGSDLPNLEKLVLYVGVEDYGFDG-------------------DMN-VFRPLFSKDRFPNLKWLGIVDAEEQNVVVE 270 (362)
T ss_dssp HHHHHSBCTTCCEEEEECBCGGGTCCS-------------------CGG-GTGGGSCTTTCTTCCEEEEESCTTHHHHHH
T ss_pred HHHHHccCCCCcEEEEeccccccccch-------------------hHH-HHHHHHhcCCCCCcCEEeCCCCCCchHHHH
Confidence 2222 5666666666431 111000 000 000111 2356666666666665533332
Q ss_pred ccc---CCCCCcEEEeeccccccc----CCccCCCCCCccEEeccCCCCCCC-Cccccc-cCCCCEEEccCcc
Q 002250 201 GIV---KLNKLWQLELYNNSLSGR----LPVGFSNLTNLMNFDVSQNRLEGD-LSELRF-LNQLSSLHLFENQ 264 (947)
Q Consensus 201 ~l~---~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~-~~~l~~-l~~L~~L~L~~N~ 264 (947)
.+. .+++|++|+|+.|.|++. ++..+..+++|+.|+|++|.++.. ...+.. + ...++++.++
T Consensus 271 ~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 271 MFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 332 345666666666666543 222234456677777776665421 111221 1 3456676665
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.93 E-value=2.2e-11 Score=126.45 Aligned_cols=80 Identities=24% Similarity=0.280 Sum_probs=44.9
Q ss_pred ccCCCceeeCCCCCCCCCC-CChhhcccccCcEEEccCccccccCCccCCCCC--CCCEEECcCcccccccC-------c
Q 002250 131 NLTNLEFLSLGDNPFDPSP-FPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLT--QLQNLELSDNELFGEIP-------A 200 (947)
Q Consensus 131 ~l~~L~~L~Ls~n~i~~~~-~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~-------~ 200 (947)
++++|+.|+|++|.|.... ++..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+..| .
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 4555555555555554421 233444566666666666666543 2233333 77777777777765444 2
Q ss_pred cccCCCCCcEEE
Q 002250 201 GIVKLNKLWQLE 212 (947)
Q Consensus 201 ~l~~l~~L~~L~ 212 (947)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 355677777665
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.92 E-value=3.6e-10 Score=124.01 Aligned_cols=135 Identities=17% Similarity=0.148 Sum_probs=62.9
Q ss_pred cccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCC--CCCCCCEEECcC--cccccc-----c
Q 002250 128 SLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIG--NLTQLQNLELSD--NELFGE-----I 198 (947)
Q Consensus 128 ~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~-----~ 198 (947)
.+..+++|+.|+|++|.- ..++. + .+++|+.|+|..|.++......+. .+++|++|+|+. |...+. +
T Consensus 167 ll~~~P~L~~L~L~g~~~--l~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l 242 (362)
T 2ra8_A 167 VLDAMPLLNNLKIKGTNN--LSIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242 (362)
T ss_dssp HHHTCTTCCEEEEECCBT--CBCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred HHhcCCCCcEEEEeCCCC--ceecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence 445566777777766621 11222 2 256666666666665533222332 566677776642 221111 0
Q ss_pred Cccc--cCCCCCcEEEeecccccccCCccC---CCCCCccEEeccCCCCCCC-----CccccccCCCCEEEccCccCc
Q 002250 199 PAGI--VKLNKLWQLELYNNSLSGRLPVGF---SNLTNLMNFDVSQNRLEGD-----LSELRFLNQLSSLHLFENQFS 266 (947)
Q Consensus 199 ~~~l--~~l~~L~~L~L~~n~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~~-----~~~l~~l~~L~~L~L~~N~i~ 266 (947)
...+ ..+++|++|+|++|.+.+..+..+ ..+++|++|+|+.|.+... ...+..+++|+.|+|++|.|+
T Consensus 243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 0111 134566666666666653222222 1344555555555554431 122233444555555544444
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.88 E-value=5.1e-09 Score=115.91 Aligned_cols=143 Identities=19% Similarity=0.258 Sum_probs=105.6
Q ss_pred cccccccCceeEEEEEeCCCcEEEEEEec--CCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc--ccccceEEE
Q 002250 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIW--PSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR--HVNVVKLYC 709 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~ 709 (947)
.+.++.|.++.||++... +..+++|+.. +... ......+.+|+.+++.+. +..+.++++
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~----------------~~~~~~~~~E~~~l~~L~~~~vpvP~~~~ 105 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL----------------LPSAHAIEREYRVMDALAGTDVPVAKMYA 105 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC--------------------------CHHHHHHHHHHHTTSSSCCCCEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC----------------CCcHHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 466899999999999876 4678888763 1110 012346788999999996 456889999
Q ss_pred EEecC---CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCC----------------------
Q 002250 710 SITSE---DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGF---------------------- 764 (947)
Q Consensus 710 ~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~---------------------- 764 (947)
++.+. +..|+||||++|..+.+... ..++...+..++.++++.|+.||...
T Consensus 106 ~~~~~~~~g~~~~vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3dxp_A 106 LCEDESVIGRAFYIMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIER 181 (359)
T ss_dssp EECCTTTTSSCEEEEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHH
T ss_pred ECCCCCccCCeEEEEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHH
Confidence 98776 45899999999987754211 23567778889999999999999520
Q ss_pred ---------------------------------CCCeEeccCCCCCeEecCCCC--eEEeccccceec
Q 002250 765 ---------------------------------DRPVIHRDVKSSNILLDLEWK--PRIADFGLAKIV 797 (947)
Q Consensus 765 ---------------------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~ 797 (947)
...++|||+++.||+++.++. +.|.||+.+...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 182 WTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 256999999999999997754 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.74 E-value=6.5e-09 Score=112.10 Aligned_cols=187 Identities=19% Similarity=0.154 Sum_probs=119.1
Q ss_pred cccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccc--cceEEEE
Q 002250 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVN--VVKLYCS 710 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~ 710 (947)
.+.++.|....||++ +..+++|+... ......+.+|+++++.+. +.. +.+++..
T Consensus 25 i~~~~~G~~n~v~~v----~~~~vlR~~~~-------------------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~ 81 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI----NRDFIFKFPKH-------------------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFT 81 (304)
T ss_dssp CCEEEECSSEEEEES----TTSEEEEEESS-------------------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEE
T ss_pred eEecCCCCcceEEEE----CCEEEEEecCC-------------------cchHHHHHHHHHHHHHHHhcCCCCCCceEee
Confidence 456899999999986 36788997520 012356889999999884 322 4455555
Q ss_pred EecCC---ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcC------------------------
Q 002250 711 ITSED---SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG------------------------ 763 (947)
Q Consensus 711 ~~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~------------------------ 763 (947)
....+ ..|+||||++|.++.+.... .++...+..++.++++.++.||..
T Consensus 82 ~~~~~~~~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (304)
T 3sg8_A 82 GMPSETYQMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKI 157 (304)
T ss_dssp CCCCSSCSCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHH
T ss_pred cCCCCCCCcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHH
Confidence 44433 34899999999888653321 245566667777777777777731
Q ss_pred -------------------------------CCCCeEeccCCCCCeEecC--CCCeEEeccccceecccCCCCccee---
Q 002250 764 -------------------------------FDRPVIHRDVKSSNILLDL--EWKPRIADFGLAKIVQTGEAGDLTH--- 807 (947)
Q Consensus 764 -------------------------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~~~--- 807 (947)
....++|+|++|.||++++ ...+.++||+.+.............
T Consensus 158 ~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~ 237 (304)
T 3sg8_A 158 KKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD 237 (304)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT
T ss_pred HHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc
Confidence 1245899999999999998 4567899999987543321000000
Q ss_pred ---------cccccccccC-ccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 002250 808 ---------VIAGTHGYIA-PEYAYTCKINEKSDVYSFGVVLMELVTGKRPI 849 (947)
Q Consensus 808 ---------~~~gt~~y~a-PE~~~~~~~~~~~Dv~slGv~l~elltg~~p~ 849 (947)
.....+++.. |+.... .....+.|++|.++|++.+|..+|
T Consensus 238 ~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 238 EEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000011111 222111 122358999999999999999875
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.38 E-value=3.4e-08 Score=97.61 Aligned_cols=113 Identities=11% Similarity=0.117 Sum_probs=50.1
Q ss_pred CCCCCCCCEEECcCc-ccccc----cCccccCCCCCcEEEeeccccccc----CCccCCCCCCccEEeccCCCCCC----
Q 002250 178 IGNLTQLQNLELSDN-ELFGE----IPAGIVKLNKLWQLELYNNSLSGR----LPVGFSNLTNLMNFDVSQNRLEG---- 244 (947)
Q Consensus 178 ~~~l~~L~~L~Ls~N-~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~---- 244 (947)
+...++|++|+|++| .|... +...+...++|++|+|++|.|.+. +...+...++|++|+|++|.|..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 344455555555555 44321 122333344455555555554431 11223333445555555555442
Q ss_pred -CCccccccCCCCEEEc--cCccCcccC----CCCccCCCcCcEEEccCcccc
Q 002250 245 -DLSELRFLNQLSSLHL--FENQFSGEI----PEEFGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 245 -~~~~l~~l~~L~~L~L--~~N~i~~~~----~~~~~~l~~L~~L~L~~N~l~ 290 (947)
+...+...++|++|+| ++|.|.... ...+...++|++|+|++|.+.
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 1223444445555555 455554322 122333355555555555554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.37 E-value=4.4e-08 Score=96.79 Aligned_cols=119 Identities=16% Similarity=0.140 Sum_probs=67.1
Q ss_pred ccccccCCCceeeCCCC-CCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCccccccc----Ccc
Q 002250 127 KSLENLTNLEFLSLGDN-PFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEI----PAG 201 (947)
Q Consensus 127 ~~l~~l~~L~~L~Ls~n-~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~ 201 (947)
..+...++|++|+|++| .+...... .+...+...++|++|+|++|+|.... ...
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~---------------------~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~ 88 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLK---------------------ACAEALKTNTYVKKFSIVGTRSNDPVAFALAEM 88 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHH---------------------HHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHH---------------------HHHHHHHhCCCcCEEECcCCCCChHHHHHHHHH
Confidence 34556667777777776 66432111 12233444556666666666654322 233
Q ss_pred ccCCCCCcEEEeeccccccc----CCccCCCCCCccEEec--cCCCCCC-----CCccccccCCCCEEEccCccCc
Q 002250 202 IVKLNKLWQLELYNNSLSGR----LPVGFSNLTNLMNFDV--SQNRLEG-----DLSELRFLNQLSSLHLFENQFS 266 (947)
Q Consensus 202 l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L--s~N~l~~-----~~~~l~~l~~L~~L~L~~N~i~ 266 (947)
+...++|++|+|++|.|++. +...+...++|++|+| ++|.+.. +...+...++|++|+|++|.|.
T Consensus 89 L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 89 LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 34445666666666666542 2344555666777777 6676653 1233555677888888888775
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.35 E-value=2.5e-08 Score=103.43 Aligned_cols=80 Identities=28% Similarity=0.285 Sum_probs=50.6
Q ss_pred cccccCcEEEccCccccc--cCCccCCCCCCCCEEECcCcccccccCccccCCC--CCcEEEeecccccccCCc------
Q 002250 155 LKLEKLYWLYLTNCSVTG--QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLN--KLWQLELYNNSLSGRLPV------ 224 (947)
Q Consensus 155 ~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~--~L~~L~L~~n~l~~~~~~------ 224 (947)
.++++|+.|+|++|.|++ .+|..+..+++|+.|+|++|+|.+. ..+..+. +|++|+|++|.+.+..|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 456778888888888876 3345566777888888888877654 2333333 677777777777654442
Q ss_pred -cCCCCCCccEEe
Q 002250 225 -GFSNLTNLMNFD 236 (947)
Q Consensus 225 -~~~~l~~L~~L~ 236 (947)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 234455555544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=3.5e-06 Score=88.84 Aligned_cols=135 Identities=22% Similarity=0.199 Sum_probs=94.5
Q ss_pred cccccCce-eEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccceEEEEEe
Q 002250 636 LIGKGGSG-NVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVKLYCSIT 712 (947)
Q Consensus 636 ~iG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 712 (947)
.+..|..| .||+.... +++.+.+|+-.+ .....+.+|+.+++.+. +--+.++++++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------------------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~ 90 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG--------------------SVANDVTDEMVRLNWLTAFMPLPTIKHFIR 90 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET--------------------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC--------------------CCHhHHHHHHHHHHHhccCCCcCeEEEEEE
Confidence 34455555 69998855 567899997521 12346788999999884 334778899999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG----------------------------- 763 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~----------------------------- 763 (947)
+++..++|||+++|.++.+...... .....+..+++..+..||.-
T Consensus 91 ~~~~~~lvme~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (272)
T 4gkh_A 91 TPDDAWLLTTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDA 164 (272)
T ss_dssp ETTEEEEEEECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCG
T ss_pred ECCeEEEEEEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhh
Confidence 9999999999999988777654311 11223445555666666621
Q ss_pred --------------------------CCCCeEeccCCCCCeEecCCCCeEEecccccee
Q 002250 764 --------------------------FDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796 (947)
Q Consensus 764 --------------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 796 (947)
....++|+|+.+.||++++++.+-|+||+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 165 SDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999877777999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=6.4e-06 Score=88.43 Aligned_cols=137 Identities=18% Similarity=0.171 Sum_probs=90.4
Q ss_pred cccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc---ccceEEEE
Q 002250 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV---NVVKLYCS 710 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~ 710 (947)
.+.++.|....||+. |+.++||+.. .......+.+|+++++.+.+. .+.+++.+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-------------------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~ 80 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-------------------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYI 80 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-------------------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-------------------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEee
Confidence 456788999999998 6778888741 011235688999999999652 35677777
Q ss_pred Ee-cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcC--------------------------
Q 002250 711 IT-SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG-------------------------- 763 (947)
Q Consensus 711 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-------------------------- 763 (947)
.. ..+..++||||++|.++.+.... .++...+..++.++++.|+.||.-
T Consensus 81 ~~~~~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~ 156 (306)
T 3tdw_A 81 GKRSDGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAV 156 (306)
T ss_dssp EECTTSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHH
T ss_pred cccCCCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHH
Confidence 64 45567899999999887653111 112222333333333333333310
Q ss_pred -------------------------------CCCCeEeccCCCCCeEecC---CCCe-EEeccccceec
Q 002250 764 -------------------------------FDRPVIHRDVKSSNILLDL---EWKP-RIADFGLAKIV 797 (947)
Q Consensus 764 -------------------------------~~~~ivH~Dlkp~NIll~~---~~~~-kl~DfG~a~~~ 797 (947)
....++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 157 ~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 157 EDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2446799999999999997 4554 79999988643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=2.6e-05 Score=85.81 Aligned_cols=83 Identities=12% Similarity=0.090 Sum_probs=56.4
Q ss_pred cccc-cccCceeEEEEEeC-------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-c--c
Q 002250 634 ENLI-GKGGSGNVYKVVLN-------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-H--V 702 (947)
Q Consensus 634 ~~~i-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~ 702 (947)
.+.| +.|....+|+.... +++.+++|+..+... ........+.+|+.+++.+. + -
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~--------------~~~~~~~~~~~E~~~l~~L~~~~~v 90 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAED--------------VPVFPTYRLDHQFEVIRLVGELTDV 90 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGG--------------CCSSSCCCHHHHHHHHHHHHHHCCS
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCc--------------cccCchhHHHHHHHHHHHHhhcCCC
Confidence 3567 88999999998764 267788887521100 00001246788999999885 3 3
Q ss_pred ccceEEEEEecC---CccEEEEeccCCCChH
Q 002250 703 NVVKLYCSITSE---DSNLLVYEYLPNGSLW 730 (947)
Q Consensus 703 niv~l~~~~~~~---~~~~lv~e~~~~gsL~ 730 (947)
.+.++++++.+. +..++||||++|..+.
T Consensus 91 pvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 91 PVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred CCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 577888887665 3568999999987654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.89 E-value=3e-06 Score=81.36 Aligned_cols=83 Identities=11% Similarity=0.156 Sum_probs=46.8
Q ss_pred cCcEEEccCccccccCCccCCCCCCCCEEECcCcc-cccccCccccCC----CCCcEEEeeccc-ccccCCccCCCCCCc
Q 002250 159 KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNE-LFGEIPAGIVKL----NKLWQLELYNNS-LSGRLPVGFSNLTNL 232 (947)
Q Consensus 159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~l~~l----~~L~~L~L~~n~-l~~~~~~~~~~l~~L 232 (947)
+|+.|++++|.|+...-..+..+++|++|+|++|. |+...-..++.+ ++|++|+|++|. |++..-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45556666665554444455666666666666663 554443444443 246666666664 655433445556666
Q ss_pred cEEeccCCC
Q 002250 233 MNFDVSQNR 241 (947)
Q Consensus 233 ~~L~Ls~N~ 241 (947)
++|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00015 Score=80.87 Aligned_cols=82 Identities=17% Similarity=0.165 Sum_probs=51.3
Q ss_pred cccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc--c-ccceEEE
Q 002250 634 ENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH--V-NVVKLYC 709 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~-niv~l~~ 709 (947)
.+.+|.|.++.||++... +++.++||...+.... ...........+..|+++++.+.. + .+.+++.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~----------~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~ 104 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKV----------VGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY 104 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-----------------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcc----------cCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE
Confidence 456899999999999854 4788999987432110 000001233556789999988742 3 4456665
Q ss_pred EEecCCccEEEEeccCCC
Q 002250 710 SITSEDSNLLVYEYLPNG 727 (947)
Q Consensus 710 ~~~~~~~~~lv~e~~~~g 727 (947)
+ +.+..++||||+++.
T Consensus 105 ~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 105 S--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp E--ETTTTEEEECCCTTS
T ss_pred E--cCCccEEEEEeCCCc
Confidence 4 345568999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.76 E-value=7.4e-05 Score=81.54 Aligned_cols=31 Identities=19% Similarity=0.235 Sum_probs=28.3
Q ss_pred CCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 765 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
...++|+|+++.||+++.++.+.++||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999888899999999875
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.66 E-value=1.2e-05 Score=77.03 Aligned_cols=88 Identities=13% Similarity=0.125 Sum_probs=44.2
Q ss_pred CCCCEEECcCcccccccCccccCCCCCcEEEeeccc-ccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEc
Q 002250 182 TQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNS-LSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHL 260 (947)
Q Consensus 182 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L 260 (947)
.+|+.|||+++.|+...-..+.++++|++|+|++|. |++..-..+..+++ ..++|++|+|
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~-------------------~~~~L~~L~L 121 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLEN-------------------LQKSMLEMEI 121 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHH-------------------HHHHCCEEEE
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhccc-------------------ccCCCCEEEc
Confidence 356666666666655544555556666666666653 44432223333210 0123555555
Q ss_pred cCcc-CcccCCCCccCCCcCcEEEccCcc
Q 002250 261 FENQ-FSGEIPEEFGEFKHLTELSLYTNR 288 (947)
Q Consensus 261 ~~N~-i~~~~~~~~~~l~~L~~L~L~~N~ 288 (947)
++|. |+...-..+..+++|++|+|+++.
T Consensus 122 s~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 122 ISCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp ESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred CCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 5543 444333345555666666666653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0012 Score=70.45 Aligned_cols=137 Identities=17% Similarity=0.167 Sum_probs=92.5
Q ss_pred cccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc---ccccceEEEE
Q 002250 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR---HVNVVKLYCS 710 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~ 710 (947)
.+.|+.|....+|+.... ++.++||+..+ .....+.+|++.++.+. ...+.+++++
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~--------------------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~ 99 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINER--------------------SYRSMFRAEADQLALLAKTNSINVPLVYGI 99 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEG--------------------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEE
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCc--------------------ccHHHHHHHHHHHHHHHhhCCCCcceEEEE
Confidence 456899999999999864 67888997621 12456889999999884 3578899999
Q ss_pred EecCCccEEEEeccCCCChHH-----------HhhhcCC--------------------ccCCHHHHHH---HHH--H--
Q 002250 711 ITSEDSNLLVYEYLPNGSLWD-----------RLHTCHK--------------------IEMDWVVRYA---IAV--G-- 752 (947)
Q Consensus 711 ~~~~~~~~lv~e~~~~gsL~~-----------~l~~~~~--------------------~~~~~~~~~~---i~~--~-- 752 (947)
...++..++||||+++..+.. .++.... ..-+|...+. +.. +
T Consensus 100 ~~~~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a 179 (312)
T 3jr1_A 100 GNSQGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQIC 179 (312)
T ss_dssp EECSSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHH
T ss_pred eecCCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHH
Confidence 888888999999999876421 2232211 0125654321 111 1
Q ss_pred ------------HH-HHHHHHh-cCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 753 ------------AA-KGLEYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 753 ------------ia-~~l~yLH-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
+. .....|. ......++|+|+.+.|++++.++ +.|.|++
T Consensus 180 ~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 180 KEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 1122342 12256799999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00062 Score=72.11 Aligned_cols=77 Identities=18% Similarity=0.153 Sum_probs=55.5
Q ss_pred CCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc---cccceEE
Q 002250 632 KPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH---VNVVKLY 708 (947)
Q Consensus 632 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~ 708 (947)
...+.+|.|..+.||+++..||+.|.||+..... ......|.+|++.|+.+.- --+.+++
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-----------------~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~ 80 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-----------------PALDGLFRAEALGLDWLGRSFGSPVPQVA 80 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-----------------CCCTTHHHHHHHHHHHHTCSTTCCSCCEE
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-----------------cchhhHHHHHHHHHHHHHhhCCCCcceEE
Confidence 3456789999999999999999999999763211 1223457899999998842 2355666
Q ss_pred EEEecCCccEEEEeccCCCCh
Q 002250 709 CSITSEDSNLLVYEYLPNGSL 729 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL 729 (947)
++. ..++||||++++..
T Consensus 81 ~~~----~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 81 GWD----DRTLAMEWVDERPP 97 (288)
T ss_dssp EEE----TTEEEEECCCCCCC
T ss_pred ecc----CceEEEEeecccCC
Confidence 542 35899999987653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.26 E-value=6.7e-05 Score=73.36 Aligned_cols=44 Identities=16% Similarity=0.219 Sum_probs=21.4
Q ss_pred cCCCCCCCCEEECcCcccccccCccc----cCCCCCcEEEeecccccc
Q 002250 177 GIGNLTQLQNLELSDNELFGEIPAGI----VKLNKLWQLELYNNSLSG 220 (947)
Q Consensus 177 ~~~~l~~L~~L~Ls~N~l~~~~~~~l----~~l~~L~~L~L~~n~l~~ 220 (947)
.+..-+.|+.|+|++|+|.......+ ..-+.|++|+|++|.|.+
T Consensus 65 aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 65 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 33444555666666665543322222 233455555555555543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.24 E-value=4e-05 Score=74.97 Aligned_cols=113 Identities=12% Similarity=0.128 Sum_probs=62.9
Q ss_pred cCCCCCCCCEEECcCc-ccccc----cCccccCCCCCcEEEeecccccccCCcc----CCCCCCccEEeccCCCCCC---
Q 002250 177 GIGNLTQLQNLELSDN-ELFGE----IPAGIVKLNKLWQLELYNNSLSGRLPVG----FSNLTNLMNFDVSQNRLEG--- 244 (947)
Q Consensus 177 ~~~~l~~L~~L~Ls~N-~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~--- 244 (947)
.+.+-+.|++|+|++| +|... +.+.+..-+.|+.|+|++|.|.+....+ +..-+.|++|+|+.|.|..
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3445567888888875 66432 3345555667888888888887533332 3344667777777776653
Q ss_pred --CCccccccCCCCEEEccCc---cCccc----CCCCccCCCcCcEEEccCccc
Q 002250 245 --DLSELRFLNQLSSLHLFEN---QFSGE----IPEEFGEFKHLTELSLYTNRL 289 (947)
Q Consensus 245 --~~~~l~~l~~L~~L~L~~N---~i~~~----~~~~~~~l~~L~~L~L~~N~l 289 (947)
+...+...+.|++|+|++| .+... +.+.+..-+.|++|+++.|.+
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 1223444555666666544 22211 122333345566666655543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0004 Score=63.46 Aligned_cols=62 Identities=19% Similarity=0.271 Sum_probs=35.7
Q ss_pred eeeccCceee-eecCCCCCccCcCcEEECCCCccCCccCCccc-ccccceeeCCCCcCCCCCCCcccccccccccccCCC
Q 002250 473 DINFAQNSLS-GKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPG 550 (947)
Q Consensus 473 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~gN~~ 550 (947)
.++.+++.|+ ..+|..+. ++|+.|+|++|+|+...+..+. +++|+.| .+.+|||
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L----------------------~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTA----------------------HLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEE----------------------ECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEE----------------------EecCCCe
Confidence 4566666664 24444332 2466666666666654444433 3445544 4558899
Q ss_pred CCCCCccc
Q 002250 551 LCSKTDEY 558 (947)
Q Consensus 551 ~c~~~~~~ 558 (947)
.|+|.+.|
T Consensus 68 ~CdC~l~~ 75 (130)
T 3rfe_A 68 RCDCRLVP 75 (130)
T ss_dssp BCSGGGHH
T ss_pred eccCccHH
Confidence 99998766
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0046 Score=69.30 Aligned_cols=77 Identities=13% Similarity=0.099 Sum_probs=49.1
Q ss_pred CCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccc--cccccCccccccC---CCCCccchHHHHHHH
Q 002250 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAG--THGYIAPEYAYTC---KINEKSDVYSFGVVL 839 (947)
Q Consensus 765 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~Dv~slGv~l 839 (947)
...++|+|++|.||+++.++ ++++||+.+......... . .... ...|++|+..... ......++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--G-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--H-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--H-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 67899999999999998876 999999998754332110 0 0011 2346776655321 111234556778888
Q ss_pred HHHHhC
Q 002250 840 MELVTG 845 (947)
Q Consensus 840 ~elltg 845 (947)
|+.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0024 Score=69.13 Aligned_cols=141 Identities=16% Similarity=0.147 Sum_probs=75.2
Q ss_pred ccccccCcee-EEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc--ccceEEEEE
Q 002250 635 NLIGKGGSGN-VYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV--NVVKLYCSI 711 (947)
Q Consensus 635 ~~iG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~ 711 (947)
+.++.|.... +|+....+|+.+++|...+. ....+..|+.+++.+... .+.+++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~--------------------~~~~~~~e~~~l~~L~~~g~~vP~v~~~d 83 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPE--------------------EGGDTQPFVDLAQYLRNLDISAPEIYAEE 83 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTT--------------------TTCCSHHHHHHHHHHHHTTCBCCCEEEEE
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCC--------------------CCccccHHHHHHHHHHhCCCCCCceeeec
Confidence 3455554444 67776654677777754211 003455678888777432 355677664
Q ss_pred ecCCccEEEEeccCCCChHHHhhhcCC------------------------ccCCHHHHH--------------------
Q 002250 712 TSEDSNLLVYEYLPNGSLWDRLHTCHK------------------------IEMDWVVRY-------------------- 747 (947)
Q Consensus 712 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------~~~~~~~~~-------------------- 747 (947)
...+ ++|||++.+..+.+++..... ..++.....
T Consensus 84 ~~~g--~ll~e~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 161 (333)
T 3csv_A 84 HARG--LLLIEDLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAE 161 (333)
T ss_dssp TTTT--EEEECCCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCH
T ss_pred CCCC--EEEEeeCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcH
Confidence 3333 789999977666554432100 011111000
Q ss_pred HHHHHHHHHHHHHh---cCCCCCeEeccCCCCCeEecCC----CCeEEeccccceec
Q 002250 748 AIAVGAAKGLEYLH---HGFDRPVIHRDVKSSNILLDLE----WKPRIADFGLAKIV 797 (947)
Q Consensus 748 ~i~~~ia~~l~yLH---~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~a~~~ 797 (947)
.....+...++.+. ......++|||+.+.||+++.+ +.+.++||+.+...
T Consensus 162 ~~~~~l~~~~~~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 162 DNRKRFEHRFAQILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHHHHHHHHHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 00001111222221 1124679999999999999875 67899999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0036 Score=66.62 Aligned_cols=138 Identities=13% Similarity=0.110 Sum_probs=76.4
Q ss_pred cccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc-ceEEEEEe
Q 002250 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV-VKLYCSIT 712 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~ 712 (947)
.+.|+.|....+|++ +.+++|+..+.. .......+|+.+++.+....+ .+++++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~------------------~~~~~r~~E~~~l~~l~~~g~~P~~~~~~- 78 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT------------------EEYINRANEAVAAREAAKAGVSPEVLHVD- 78 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----------------------CCCHHHHHHHHHHHHHTTSSCCEEEEC-
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCc------------------cceeCHHHHHHHHHHHHHcCCCCceEEEE-
Confidence 677889999999998 568888763211 111223568888888753333 4666543
Q ss_pred cCCccEEEEecc-CCCChHHH------------------hhhcCC---ccCCHHH-HHHHHH--------------HHHH
Q 002250 713 SEDSNLLVYEYL-PNGSLWDR------------------LHTCHK---IEMDWVV-RYAIAV--------------GAAK 755 (947)
Q Consensus 713 ~~~~~~lv~e~~-~~gsL~~~------------------l~~~~~---~~~~~~~-~~~i~~--------------~ia~ 755 (947)
++.-++|+||+ ++.++... +|.... ...+... ...... .+..
T Consensus 79 -~~~~~~v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 157 (301)
T 3dxq_A 79 -PATGVMVTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVR 157 (301)
T ss_dssp -TTTCCEEEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHH
T ss_pred -CCCCEEEEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHH
Confidence 33457899999 65444210 111110 0011111 000000 0011
Q ss_pred HH----HHHh-cCCCCCeEeccCCCCCeEecCCCCeEEeccccceec
Q 002250 756 GL----EYLH-HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797 (947)
Q Consensus 756 ~l----~yLH-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 797 (947)
.+ +.+. ......++|+|+.+.||+ ..++.+.++||..+...
T Consensus 158 ~~~~l~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 158 EAGGVRSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp HHHHHHHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 11 1111 112345899999999999 56678899999988643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0033 Score=70.45 Aligned_cols=72 Identities=18% Similarity=0.241 Sum_probs=48.8
Q ss_pred cccccccCceeEEEEEeCC--------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc-
Q 002250 634 ENLIGKGGSGNVYKVVLNS--------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV- 704 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni- 704 (947)
.+.|+.|....||++...+ ++.+.+|+.... .....+.+|..+++.+...++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-------------------~~~~~li~E~~~l~~L~~~g~~ 138 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-------------------ETESHLVAESVIFTLLSERHLG 138 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-------------------CCHHHHHHHHHHHHHHHHTTSS
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-------------------CcHHHHHHHHHHHHHHHhCCCC
Confidence 3457889899999998763 478899876210 011345579999988854333
Q ss_pred ceEEEEEecCCccEEEEeccCCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGS 728 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gs 728 (947)
.++++.+.+ .+|+||++|.+
T Consensus 139 P~l~~~~~~----g~v~e~l~G~~ 158 (429)
T 1nw1_A 139 PKLYGIFSG----GRLEEYIPSRP 158 (429)
T ss_dssp SCEEEEETT----EEEECCCCEEE
T ss_pred CcEEEEeCC----CEEEEEeCCcc
Confidence 577776643 38999998643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0043 Score=66.69 Aligned_cols=141 Identities=13% Similarity=0.093 Sum_probs=79.5
Q ss_pred ccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc--cceEEEE--
Q 002250 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN--VVKLYCS-- 710 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-- 710 (947)
+.|+.|....+|++...+| .+++|+..+. .....+..|+.+++.+.... +.+++..
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-------------------~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~ 87 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-------------------VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKD 87 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----------------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-------------------CCHHHHHHHHHHHHHHHHCCCCCCcccCCCC
Confidence 4567788899999987755 6889987321 12245667888888774322 2333321
Q ss_pred ----EecCCccEEEEeccCCCChHH--------------Hhhhc----CCc------cCCHHHHHHH------------H
Q 002250 711 ----ITSEDSNLLVYEYLPNGSLWD--------------RLHTC----HKI------EMDWVVRYAI------------A 750 (947)
Q Consensus 711 ----~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~------~~~~~~~~~i------------~ 750 (947)
....+..++||+|++|..+.. .++.. ... ...|...+.- .
T Consensus 88 g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~ 167 (322)
T 2ppq_A 88 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 167 (322)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhH
Confidence 122355689999999865321 11211 000 0123321110 0
Q ss_pred HHHHHHHHHHhc----CCCCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 751 VGAAKGLEYLHH----GFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 751 ~~ia~~l~yLH~----~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
..+...+++++. .....++|+|+.+.||+++++..+.++||+.+.
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 168 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 113344555542 123579999999999999987666899999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.59 E-value=0.011 Score=63.54 Aligned_cols=141 Identities=13% Similarity=0.130 Sum_probs=81.0
Q ss_pred ccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc--cceEEEE--
Q 002250 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN--VVKLYCS-- 710 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-- 710 (947)
..++ |....||++...+|+.+++|+..+.. .....+..|..+++.+.... +++++..
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~------------------~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g 92 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER------------------WTADQILEEHQFALQLVNDEVPVAAPVAFNG 92 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT------------------SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTT
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC------------------CCHHHHHHHHHHHHHHHHcCCeecceeecCC
Confidence 3466 88889999887778789999873211 12346677888888874322 3444432
Q ss_pred ---EecCCccEEEEeccCCCChH-----H------H---hhhc----C---CccCCHHHH----HHH-------------
Q 002250 711 ---ITSEDSNLLVYEYLPNGSLW-----D------R---LHTC----H---KIEMDWVVR----YAI------------- 749 (947)
Q Consensus 711 ---~~~~~~~~lv~e~~~~gsL~-----~------~---l~~~----~---~~~~~~~~~----~~i------------- 749 (947)
...++..++||||++|..+. . . ++.. . ....++... ...
T Consensus 93 ~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 172 (328)
T 1zyl_A 93 QTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKA 172 (328)
T ss_dssp BSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHH
T ss_pred cEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHH
Confidence 12244557899999875432 1 1 1111 0 111222211 000
Q ss_pred --HHHHHHHHHHHhc----CCCCCeEeccCCCCCeEecCCCCeEEecccccee
Q 002250 750 --AVGAAKGLEYLHH----GFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796 (947)
Q Consensus 750 --~~~ia~~l~yLH~----~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 796 (947)
...+...++.+.. .....++|+|+++.||+++ + .+.++||+.+..
T Consensus 173 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 173 AFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 0011112222221 1245689999999999999 4 899999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0085 Score=67.44 Aligned_cols=74 Identities=18% Similarity=0.159 Sum_probs=47.7
Q ss_pred cccccccCceeEEEEEeCC-CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc-ceEEEEE
Q 002250 634 ENLIGKGGSGNVYKVVLNS-GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV-VKLYCSI 711 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~ 711 (947)
.+.|+.|-...+|++...+ ++.+++|+..+.. ...-...+|..+++.+...++ .++++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~------------------~~~idR~~E~~vl~~L~~~gl~P~ll~~~ 174 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT------------------DEIINREREKKISCILYNKNIAKKIYVFF 174 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C------------------CSCSCHHHHHHHHHHHTTSSSBCCEEEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh------------------hhhcCHHHHHHHHHHHHhcCCCCCEEEEe
Confidence 3567889999999999875 4788888762110 111123579999998864444 5777777
Q ss_pred ecCCccEEEEeccCCCCh
Q 002250 712 TSEDSNLLVYEYLPNGSL 729 (947)
Q Consensus 712 ~~~~~~~lv~e~~~~gsL 729 (947)
.. ..||||++|.++
T Consensus 175 ~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 175 TN----GRIEEFMDGYAL 188 (458)
T ss_dssp TT----EEEEECCCSEEC
T ss_pred CC----eEEEEeeCCccC
Confidence 32 359999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0072 Score=66.11 Aligned_cols=140 Identities=16% Similarity=0.136 Sum_probs=81.4
Q ss_pred ccccccCceeEEEEEeCC--------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccc
Q 002250 635 NLIGKGGSGNVYKVVLNS--------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVV 705 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv 705 (947)
+.+..|-...+|++...+ ++.+.+|+..+ .......+.+|..+++.+. +.-..
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~------------------~~~~~~~~~rE~~vl~~L~~~gv~P 117 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA------------------ILQGVDSLVLESVMFAILAERSLGP 117 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------------------CCHHHHHHHHHHHHHHHHTTSSC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC------------------ccchHHHHHHHHHHHHHHHhcCCCC
Confidence 456678889999998752 47889987511 0122345668999999884 33345
Q ss_pred eEEEEEecCCccEEEEeccCCCChHH--------------H---hhhcC---CccCC--HHHHHHHHHHHH---------
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSLWD--------------R---LHTCH---KIEMD--WVVRYAIAVGAA--------- 754 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL~~--------------~---l~~~~---~~~~~--~~~~~~i~~~ia--------- 754 (947)
++++.+.+ .+||||++|.++.. . ++... ..... |.+..+...++.
T Consensus 118 ~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~ 193 (379)
T 3feg_A 118 QLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPE 193 (379)
T ss_dssp CEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCS
T ss_pred eEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccch
Confidence 77777654 28999999755431 1 11110 11122 333333332221
Q ss_pred ----------HHHHHHh----c-CCCCCeEeccCCCCCeEecCC----CCeEEecccccee
Q 002250 755 ----------KGLEYLH----H-GFDRPVIHRDVKSSNILLDLE----WKPRIADFGLAKI 796 (947)
Q Consensus 755 ----------~~l~yLH----~-~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~a~~ 796 (947)
..++.|. . .....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 194 ~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 194 MNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1223332 1 123468999999999999876 7899999998863
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0057 Score=67.20 Aligned_cols=73 Identities=12% Similarity=0.102 Sum_probs=44.1
Q ss_pred ccccccCceeEEEEEeCC---------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc-c
Q 002250 635 NLIGKGGSGNVYKVVLNS---------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN-V 704 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-i 704 (947)
+.++.|....+|++...+ ++.+++|+..+.. ........|..+++.+...+ +
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~------------------~~~~~~~~E~~~l~~L~~~g~~ 100 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV------------------DELYNTISEFEVYKTMSKYKIA 100 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG------------------GGTSCHHHHHHHHHHHHHTTSS
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc------------------cceecHHHHHHHHHHHHhcCCC
Confidence 457788889999998764 2678888762110 00112467888888885434 4
Q ss_pred ceEEEEEecCCccEEEEeccCCCCh
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSL 729 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL 729 (947)
.++++... -++||||++|.++
T Consensus 101 P~~~~~~~----~~~v~e~i~G~~l 121 (369)
T 3c5i_A 101 PQLLNTFN----GGRIEEWLYGDPL 121 (369)
T ss_dssp CCEEEEET----TEEEEECCCSEEC
T ss_pred CceEEecC----CcEEEEEecCCcC
Confidence 46776542 3789999987543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0062 Score=55.46 Aligned_cols=55 Identities=16% Similarity=0.126 Sum_probs=33.7
Q ss_pred EEeccCCCCC--CCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccc
Q 002250 234 NFDVSQNRLE--GDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 234 ~L~Ls~N~l~--~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 290 (947)
.++.+++.++ .++..+. .+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555555 4443322 35667777777776555566667777777777777664
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.73 E-value=0.02 Score=61.95 Aligned_cols=33 Identities=21% Similarity=0.292 Sum_probs=28.7
Q ss_pred CCCeEeccCCCCCeEecCCCCeEEeccccceec
Q 002250 765 DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIV 797 (947)
Q Consensus 765 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 797 (947)
...++|+|+.+.||++++++.+.++||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 357999999999999998888999999887643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.26 E-value=0.075 Score=52.08 Aligned_cols=103 Identities=17% Similarity=0.147 Sum_probs=66.2
Q ss_pred CChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcce
Q 002250 727 GSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806 (947)
Q Consensus 727 gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 806 (947)
-+|.+.+... ..++++.+.+.++.|.+.+|.-.-.. ..+ ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 4789999874 56899999999999999888766210 011 1233456889999999988764 2110
Q ss_pred ecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCC
Q 002250 807 HVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848 (947)
Q Consensus 807 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p 848 (947)
.....+.|||... ...+.+.-|||+|+++|..+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888763 3456788999999999999874444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.52 E-value=0.16 Score=56.27 Aligned_cols=73 Identities=8% Similarity=0.078 Sum_probs=47.8
Q ss_pred ccccccCceeEEEEEeCC--------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccc
Q 002250 635 NLIGKGGSGNVYKVVLNS--------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVV 705 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv 705 (947)
+.+..|-...+|++...+ ++.+.+|+..+.. ...-...+|..+++.+. +.-..
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t------------------~~~idR~~E~~~l~~L~~~gi~P 137 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV------------------GKFYDSKVELDVFRYLSNINIAP 137 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-------------------CCCCHHHHHHHHHHHHHTTSSC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc------------------chhcCHHHHHHHHHHHHhcCCCC
Confidence 456678889999998763 5788888752110 11123467899998885 33345
Q ss_pred eEEEEEecCCccEEEEeccCCCCh
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSL 729 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL 729 (947)
++++.+. -+.||||++|..+
T Consensus 138 ~l~~~~~----~~~I~efI~G~~l 157 (424)
T 3mes_A 138 NIIADFP----EGRIEEFIDGEPL 157 (424)
T ss_dssp CEEEEET----TEEEEECCCSEEC
T ss_pred CEEEEcC----CCEEEEEeCCccC
Confidence 6665442 3789999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.42 E-value=1.2 Score=49.06 Aligned_cols=30 Identities=30% Similarity=0.389 Sum_probs=25.1
Q ss_pred CeEeccCCCCCeEe------cCCCCeEEecccccee
Q 002250 767 PVIHRDVKSSNILL------DLEWKPRIADFGLAKI 796 (947)
Q Consensus 767 ~ivH~Dlkp~NIll------~~~~~~kl~DfG~a~~ 796 (947)
.++|+|+.+.||++ +++..+.++||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4457799999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.35 E-value=1.3 Score=30.87 Aligned_cols=26 Identities=12% Similarity=0.175 Sum_probs=10.3
Q ss_pred hhHHHHHHHHHHHH--HHHHHhhhhhhh
Q 002250 576 VWCLIAITMVLLVL--LASYFVVKLKQN 601 (947)
Q Consensus 576 i~~~i~~~~~~~vl--~~~~~~~~~~~~ 601 (947)
++.+++++++++++ ++++|++++|+.
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 34444443333322 333444444333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 947 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-11 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-13 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 8e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-61
Identities = 69/289 (23%), Positives = 125/289 (43%), Gaps = 35/289 (12%)
Query: 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
IG G G VYK + ++AVK + + + + + EV
Sbjct: 13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVT---------------APTPQQLQAFKNEV 55
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
L RHVN++ ++ +V ++ SL+ LH + + + + IA
Sbjct: 56 GVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQT 113
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
A+G++YLH + +IHRD+KS+NI L + +I DFGLA + ++G+
Sbjct: 114 AQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 814 GYIAPEYAYT---CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSR 870
++APE + +SDVY+FG+VL EL+TG+ P + + + + +
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIFMVGRG 225
Query: 871 DSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
+ P++S++ + R+ C K RP ++ +E
Sbjct: 226 -----YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 9e-60
Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 37/285 (12%)
Query: 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
+G G G V+ N ++AVK L + S + AE
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVK------------------SLKQGSMSPDAFLAEAN 60
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA 754
+ ++H +V+LY +T ++ ++ EY+ NGSL D L T I++ +A A
Sbjct: 61 LMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
+G+ ++ R IHRD++++NIL+ +IADFGLA++++ E
Sbjct: 120 EGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA-KFPIK 175
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSML 874
+ APE KSDV+SFG++L E+VT R P + +++ +
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNL------ERGYR 228
Query: 875 TVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
V N E L + + C + P RP+ + +LE+
Sbjct: 229 MVRPDNCPEELYQ-------LMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-56
Identities = 72/301 (23%), Positives = 125/301 (41%), Gaps = 38/301 (12%)
Query: 620 LSFSEKEI-IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAI 678
L+ EI ++++ E +G+G G V+ N +A+K
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK------------------T 48
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK 738
L + + E + +RH +V+LY ++ E+ +V EY+ GSL D L
Sbjct: 49 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETG 107
Query: 739 IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798
+ +A A G+ Y+ +HRD++++NIL+ ++ADFGLA++++
Sbjct: 108 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 164
Query: 799 TGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858
E + APE A + KSDV+SFG++L EL T R P +++
Sbjct: 165 DNEYTARQGA-KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNRE 222
Query: 859 IVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918
+++ V P E L + + C K P RP+ + LE
Sbjct: 223 VLDQVERGYRMP------CPPECPESLHD-------LMCQCWRKEPEERPTFEYLQAFLE 269
Query: 919 E 919
+
Sbjct: 270 D 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 5e-54
Identities = 60/298 (20%), Positives = 118/298 (39%), Gaps = 45/298 (15%)
Query: 627 IIDAVKPENL-----IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSK 681
+ID P L IG G G V+ + ++A+K + +
Sbjct: 1 VID---PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIK------------------TIRE 39
Query: 682 RSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEM 741
+ ++ E + + H +V+LY + LV+E++ +G L D L T +
Sbjct: 40 GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-F 98
Query: 742 DWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGE 801
+ + +G+ YL + VIHRD+ + N L+ +++DFG+ + V +
Sbjct: 99 AAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155
Query: 802 AGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861
+ + +PE + + KSDV+SFGV++ E+ + + E + ++V
Sbjct: 156 YTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVE 213
Query: 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
+ + S + + I HC + P RP+ +++ L E
Sbjct: 214 DISTGFRLYK------PRLASTHVYQ-------IMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-54
Identities = 56/294 (19%), Positives = 114/294 (38%), Gaps = 42/294 (14%)
Query: 631 VKPENL-----IGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSR 685
+ P++L +G G G V ++A+K ++ + S
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIK------------------MIKEGSMS 42
Query: 686 SSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVV 745
E+ E + + H +V+LY T + ++ EY+ NG L + L +
Sbjct: 43 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQ 101
Query: 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
+ + +EYL + +HRD+ + N L++ + +++DFGL++ V E
Sbjct: 102 LLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158
Query: 806 THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865
+ PE K + KSD+++FGV++ E+ + + F +S
Sbjct: 159 VGSK-FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAE 212
Query: 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
+ + SE KV I C ++ RP+ ++++ + +
Sbjct: 213 HIAQGLRL--YRPHLASE-------KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 9e-54
Identities = 69/296 (23%), Positives = 120/296 (40%), Gaps = 44/296 (14%)
Query: 626 EI-IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSS 684
+ + +K IGKG G+V G ++AVK I K +
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI-------------------KNDA 42
Query: 685 RSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNL-LVYEYLPNGSLWDRLHTCHKIEMDW 743
+ + AE + ++ +RH N+V+L I E L +V EY+ GSL D L + + +
Sbjct: 43 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG 102
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG 803
++ + +EYL +HRD+ + N+L+ + +++DFGL K +
Sbjct: 103 DCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156
Query: 804 DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863
+ APE K + KSDV+SFG++L E+ + R
Sbjct: 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP-------------- 200
Query: 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
Y ++ +D + V + V + +C + A RPS + + LE
Sbjct: 201 YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (474), Expect = 1e-53
Identities = 66/313 (21%), Positives = 118/313 (37%), Gaps = 61/313 (19%)
Query: 635 NLIGKGGSGNVYKVVL------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSE 688
IG+G G V++ +AVK + S + ++
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS----------------ADMQAD 62
Query: 689 YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLH-------------- 734
+ E A ++ + N+VKL L++EY+ G L + L
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 735 --------TCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786
+ + + IA A G+ YL R +HRD+ + N L+
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVV 179
Query: 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGK 846
+IADFGL++ + + + A ++ PE + + +SDV+++GVVL E+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 847 RPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAF 906
Y M + + V D NI + L++ + C +KLPA
Sbjct: 240 LQP--------------YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPAD 285
Query: 907 RPSMRVVVQMLEE 919
RPS + ++L+
Sbjct: 286 RPSFCSIHRILQR 298
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-53
Identities = 72/309 (23%), Positives = 117/309 (37%), Gaps = 45/309 (14%)
Query: 634 ENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
+ IGKG G V++ G+E+AVK I S R RS +AE+
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVK------------------IFSSREERSWFREAEI 48
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNL----LVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
+RH N++ + ++ LV +Y +GSL+D L+ + + +
Sbjct: 49 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKL 105
Query: 750 AVGAAKGLEYLHHGF-----DRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGE--A 802
A+ A GL +LH + HRD+KS NIL+ IAD GLA +
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165
Query: 803 GDLTHVIAGTHGYIAPEYAYTC------KINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
+ GT Y+APE + +++D+Y+ G+V E+
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
Query: 857 KDIVNWVYSKMDSRDSMLTVV----DPNISEILK--EDALKVLRIAIHCTNKLPAFRPSM 910
+ V S + V PNI + E + +I C A R +
Sbjct: 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 911 RVVVQMLEE 919
+ + L +
Sbjct: 286 LRIKKTLSQ 294
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (473), Expect = 2e-53
Identities = 63/307 (20%), Positives = 124/307 (40%), Gaps = 43/307 (14%)
Query: 621 SFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKEL----AVKHIWPSNSGFRGDYRSST 676
F+++ I VK E +IG G G V L + A+K + +
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT---------- 67
Query: 677 AILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC 736
+ ++ +E + + H NV+ L +T +++ E++ NGSL D
Sbjct: 68 ------EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQ 120
Query: 737 HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
+ + + + G A G++YL +HRD+ + NIL++ +++DFGL++
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 797 VQTGEAGDLTH---VIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPE 852
++ + + APE K SDV+S+G+V+ E+++ G+RP
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---- 233
Query: 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRV 912
Y M ++D + + + + ++ + C K RP
Sbjct: 234 -----------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 913 VVQMLEE 919
+V L++
Sbjct: 283 IVNTLDK 289
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (466), Expect = 1e-52
Identities = 76/316 (24%), Positives = 133/316 (42%), Gaps = 39/316 (12%)
Query: 621 SFSEKEI-IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAI 678
++ + E+ + ++ +G G G VY+ V +AVK
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK------------------T 49
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK 738
L + + E+ E A + ++H N+V+L T E ++ E++ G+L D L C++
Sbjct: 50 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 109
Query: 739 IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQ 798
E+ VV +A + +EYL + IHRD+ + N L+ ++ADFGL++++
Sbjct: 110 QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166
Query: 799 TGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858
+ APE K + KSDV++FGV+L E+ T P S+
Sbjct: 167 GDTYTAHAGA-KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ- 224
Query: 859 IVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918
VY ++ M E KV + C P+ RPS + Q E
Sbjct: 225 ----VYELLEKDYRME--RPEGCPE-------KVYELMRACWQWNPSDRPSFAEIHQAFE 271
Query: 919 E-AEPCSVTNIVVKKV 933
+ S+++ V K++
Sbjct: 272 TMFQESSISDEVEKEL 287
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-51
Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 25/222 (11%)
Query: 632 KPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+ + +G G G V+KV SG +A K I L + + ++
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIH----------------LEIKPAIRNQII 52
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
E+ L +V Y + S+ + E++ GSL L +I + + +IA
Sbjct: 53 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 112
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIA 810
V KGL YL ++HRDVK SNIL++ + ++ DFG++ + + +
Sbjct: 113 V--IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFV 164
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
GT Y++PE + +SD++S G+ L+E+ G+ PI P
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-51
Identities = 71/305 (23%), Positives = 118/305 (38%), Gaps = 54/305 (17%)
Query: 612 WDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRG 670
W ++ F + +GKG GNVY S LA+K ++ +
Sbjct: 3 WALEDFEIG--------------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL---- 44
Query: 671 DYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLW 730
+++ + EV S +RH N+++LY L+ EY P G+++
Sbjct: 45 ----------EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY 94
Query: 731 DRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790
L K + Y + A L Y H + VIHRD+K N+LL + +IAD
Sbjct: 95 RELQKLSKFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIAD 149
Query: 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIV 850
FG + + GT Y+ PE +EK D++S GV+ E + GK P
Sbjct: 150 FGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF- 204
Query: 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910
+ Y ++ V+ + + E A ++ P+ RP +
Sbjct: 205 -----EANTYQETYKRISR-------VEFTFPDFVTEGARDLIS---RLLKHNPSQRPML 249
Query: 911 RVVVQ 915
R V++
Sbjct: 250 REVLE 254
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 67/299 (22%), Positives = 109/299 (36%), Gaps = 50/299 (16%)
Query: 632 KPEN-----LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSR 685
+ E+ IG G G K+ + GK L K L S
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWK------------------ELDYGSMT 43
Query: 686 SSEYD---AEVATLSAVRHVNVVKLYCSITSEDSNLL--VYEYLPNGSLWDRLHTCHKIE 740
+E +EV L ++H N+V+ Y I + L V EY G L + K
Sbjct: 44 EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 103
Query: 741 --MDWVVRYAIAVGAAKGLEYLH--HGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796
+D + L+ H V+HRD+K +N+ LD + ++ DFGLA+I
Sbjct: 104 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163
Query: 797 VQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
+ GT Y++PE NEKSD++S G +L EL P
Sbjct: 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP-------- 213
Query: 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
++ ++ + + I + ++ I N RPS+ +++
Sbjct: 214 -------FTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-49
Identities = 71/317 (22%), Positives = 121/317 (38%), Gaps = 43/317 (13%)
Query: 610 NSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGK----ELAVKHIWPSN 665
N +++ + + +I V +IG+G G VY L AVK +
Sbjct: 10 NPELVQAVQHVVIGPSSLI--VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 67
Query: 666 SGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY-CSITSEDSNLLVYEYL 724
S++ E + H NV+ L + SE S L+V Y+
Sbjct: 68 D----------------IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111
Query: 725 PNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784
+G L + AKG+++L + +HRD+ + N +LD ++
Sbjct: 112 KHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKF 167
Query: 785 KPRIADFGLAKIVQTGEAGDLTHV--IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMEL 842
++ADFGLA+ + E + + ++A E T K KSDV+SFGV+L EL
Sbjct: 168 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227
Query: 843 VTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNK 902
+T P P+ ++ DI ++ + L E + + C +
Sbjct: 228 MTRGAPPYPDV-NTFDITVYLLQGRRLLQ------PEYCPDPLYE-------VMLKCWHP 273
Query: 903 LPAFRPSMRVVVQMLEE 919
RPS +V +
Sbjct: 274 KAEMRPSFSELVSRISA 290
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 64/291 (21%), Positives = 124/291 (42%), Gaps = 42/291 (14%)
Query: 631 VKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEY 689
+K + IG+G VYK + + E+A + L+K + +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-------------LTKSERQ--RF 55
Query: 690 DAEVATLSAVRHVNVVKLY----CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVV 745
E L ++H N+V+ Y ++ + +LV E + +G+L L +++ +
Sbjct: 56 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR 115
Query: 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE-WKPRIADFGLAKIVQTGEAGD 804
+ + KGL++LH P+IHRD+K NI + +I D GLA + +
Sbjct: 116 SWCRQI--LKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----AS 168
Query: 805 LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVY 864
+ GT ++APE Y K +E DVY+FG+ ++E+ T + P E ++ I V
Sbjct: 169 FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPY-SECQNAAQIYRRVT 226
Query: 865 SKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
S + + ++ + +++ C + R S++ ++
Sbjct: 227 SGVK---------PASFDKVAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 60/300 (20%), Positives = 112/300 (37%), Gaps = 47/300 (15%)
Query: 631 VKPENL------IGKGGSGNVYKVVL---NSGKELAVKHIWPSNSGFRGDYRSSTAILSK 681
+K +NL +G G G+V + V ++A+K +
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------------- 49
Query: 682 RSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEM 741
+ + E E + + + +V+L ++ +LV E G L L + E+
Sbjct: 50 -KADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE-EI 106
Query: 742 DWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGE 801
+ + G++YL + +HRD+ + N+LL +I+DFGL+K + +
Sbjct: 107 PVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163
Query: 802 A-GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDI 859
+ + APE K + +SDV+S+GV + E ++ G++P
Sbjct: 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----------- 212
Query: 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
Y KM + M + E E ++ + C RP V Q +
Sbjct: 213 ----YKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-49
Identities = 60/297 (20%), Positives = 119/297 (40%), Gaps = 40/297 (13%)
Query: 629 DAVKPENLIGKGGSGNVYKVVLNSGKE-----LAVKHIWPSNSGFRGDYRSSTAILSKRS 683
V + +IG G G VYK +L + +A+K + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT----------------E 50
Query: 684 SRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW 743
+ ++ E + H N+++L I+ +++ EY+ NG+L E
Sbjct: 51 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSV 109
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAG 803
+ + G A G++YL + +HRD+ + NIL++ +++DFGL+++++
Sbjct: 110 LQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166
Query: 804 DLTHV-IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862
T + APE K SDV+SFG+V+ E++T E
Sbjct: 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE---------- 216
Query: 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
+ + + M + D + + ++ + C + A RP +V +L++
Sbjct: 217 ----LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 5e-49
Identities = 74/315 (23%), Positives = 126/315 (40%), Gaps = 46/315 (14%)
Query: 622 FSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILS 680
F + + IG G G VY + + + +A+K + S
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-------------- 53
Query: 681 KRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIE 740
+ + + + EV L +RH N ++ E + LV EY + HK
Sbjct: 54 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV--HKKP 111
Query: 741 MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTG 800
+ V A+ GA +GL YLH +IHRDVK+ NILL ++ DFG A I+
Sbjct: 112 LQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167
Query: 801 EAGDLTHVIAGTHGYIAPEYAYTC---KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857
+ GT ++APE + + K DV+S G+ +EL K P+ +
Sbjct: 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-----FNM 217
Query: 858 DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ-- 915
+ ++ +Y + L + SE + C K+P RP+ V+++
Sbjct: 218 NAMSALYHIAQNESPAL--QSGHWSEYFRN-------FVDSCLQKIPQDRPTSEVLLKHR 268
Query: 916 -MLEEAEPCSVTNIV 929
+L E P + +++
Sbjct: 269 FVLRERPPTVIMDLI 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 5e-49
Identities = 59/290 (20%), Positives = 105/290 (36%), Gaps = 39/290 (13%)
Query: 634 ENLIGKGGSGNVYKVVL---NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+ +G G G V K K +AVK + + + E
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---------------ANDPALKDELL 56
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIA 750
AE + + + +V++ I +S +LV E G L L ++ ++
Sbjct: 57 AEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 115
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT-HVI 809
V + G++YL +HRD+ + N+LL + +I+DFGL+K ++ E
Sbjct: 116 V--SMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 810 AGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS 869
+ APE K + KSDV+SFGV++ E + + S+ V + ++
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLEK 225
Query: 870 RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
+ M + + + C RP V L
Sbjct: 226 GERM--GCPAGCPREMYD-------LMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-48
Identities = 63/309 (20%), Positives = 116/309 (37%), Gaps = 55/309 (17%)
Query: 634 ENLIGKGGSGNVYKVVL------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSS 687
+G G G V + ++ +AVK + PS +
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----------------AHLTERE 71
Query: 688 EYDAEVATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------- 737
+E+ LS + H+N+V L + T L++ EY G L + L
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 738 -------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790
++ +D + + AKG+ +L + IHRD+ + NILL +I D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICD 188
Query: 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIV 850
FGLA+ ++ + ++APE + C +SDV+S+G+ L EL +
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 851 PEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSM 910
P + ++ + + + + I C + P RP+
Sbjct: 249 PGMPVDSKFYKMI------KEGFRMLSPEHAPAEMYD-------IMKTCWDADPLKRPTF 295
Query: 911 RVVVQMLEE 919
+ +VQ++E+
Sbjct: 296 KQIVQLIEK 304
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 62/290 (21%), Positives = 112/290 (38%), Gaps = 36/290 (12%)
Query: 628 IDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS 686
++ +G+G G V V + + +AVK + + +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD----------------MKRAVDCP 47
Query: 687 SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
E+ + H NVVK Y + L EY G L+DR+ + R
Sbjct: 48 ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 107
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
+ + G+ YLH + HRD+K N+LLD +I+DFGLA + + L
Sbjct: 108 FFHQL--MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162
Query: 807 HVIAGTHGYIAPEYAYTCKIN-EKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865
+ + GT Y+APE + + E DV+S G+VL ++ G+ P ++ +W
Sbjct: 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-- 220
Query: 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
+ + + +D +L + P+ R ++ + +
Sbjct: 221 EKKTYLNPWKKIDSAPLALLH-----------KILVENPSARITIPDIKK 259
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-48
Identities = 59/333 (17%), Positives = 112/333 (33%), Gaps = 62/333 (18%)
Query: 616 SFRVLSFSEKEIIDA--VKPENLIGKGGSGNVYKVVL------NSGKELAVKHIWPSNSG 667
FR + K ++ ++G G G V ++AVK +
Sbjct: 22 DFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD- 80
Query: 668 FRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPN 726
SS +E+ ++ + H N+V L + T L++EY
Sbjct: 81 ---------------SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCY 125
Query: 727 GSLWDRLHTCHKIE---------------------MDWVVRYAIAVGAAKGLEYLHHGFD 765
G L + L + + + + A AKG+E+L
Sbjct: 126 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--- 182
Query: 766 RPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK 825
+ +HRD+ + N+L+ +I DFGLA+ + + + ++APE +
Sbjct: 183 KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 242
Query: 826 INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEIL 885
KSDV+S+G++L E+ + P + + + +
Sbjct: 243 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG----------FKMDQPFYA 292
Query: 886 KEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918
E+ +++ C RPS + L
Sbjct: 293 TEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-48
Identities = 65/321 (20%), Positives = 119/321 (37%), Gaps = 60/321 (18%)
Query: 617 FRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKEL---AVKHIWPSNSGFRGDYR 673
+ VL +++ + +++IG+G G V K + A+K + S
Sbjct: 4 YPVLDWNDIKF------QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS------- 50
Query: 674 SSTAILSKRSSRSSEYDAEVATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDR 732
++ E+ L + H N++ L + L EY P+G+L D
Sbjct: 51 ---------KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 101
Query: 733 LHTCHKIE--------------MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778
L +E + A A+G++YL + IHRD+ + NI
Sbjct: 102 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNI 158
Query: 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVV 838
L+ + +IADFGL++ + + ++A E SDV+S+GV+
Sbjct: 159 LVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 215
Query: 839 LMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIH 898
L E+V+ P G + +Y K+ + N + + + +
Sbjct: 216 LWEIVSLGGT--PYCGMT---CAELYEKLPQGYRL--EKPLNCDDEVYD-------LMRQ 261
Query: 899 CTNKLPAFRPSMRVVVQMLEE 919
C + P RPS ++ L
Sbjct: 262 CWREKPYERPSFAQILVSLNR 282
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 9e-48
Identities = 67/291 (23%), Positives = 113/291 (38%), Gaps = 39/291 (13%)
Query: 637 IGKGGSGNVYKVVLNS----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
+G G G V + ++ +AVK + P ++ E
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD--------------DFIRE 61
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH-KIEMDWVVRYAIAV 751
V + ++ H N+++LY + +V E P GSL DRL + + RYA+ V
Sbjct: 62 VNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGD-LTHVIA 810
A+G+ YL + IHRD+ + N+LL +I DFGL + + + +
Sbjct: 121 --AEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 811 GTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSR 870
+ APE T + SD + FGV L E+ T + P G + + K+D
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGS---QILHKIDKE 230
Query: 871 DSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921
L + + + + + C P RP+ + L EA+
Sbjct: 231 GERLP-RPEDCPQDIYN-------VMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-46
Identities = 65/307 (21%), Positives = 115/307 (37%), Gaps = 46/307 (14%)
Query: 618 RVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVLNSGKEL-----AVKHIWPSNSGFRGDY 672
R+L +E + I ++G G G VYK + E A+K + + S
Sbjct: 4 RILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS------ 51
Query: 673 RSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDR 732
+ E E +++V + +V +L + L+ + +P G L D
Sbjct: 52 ----------PKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDY 100
Query: 733 LHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792
HK + V AKG+ YL R ++HRD+ + N+L+ +I DFG
Sbjct: 101 -VREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 156
Query: 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPE 852
LAK++ E ++A E +SDV+S+GV + EL+T
Sbjct: 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216
Query: 853 FGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRV 912
S+ + S ++ + + P + + I + C RP R
Sbjct: 217 IPASE-----ISSILEKGERL--PQPPICTIDVYM-------IMVKCWMIDADSRPKFRE 262
Query: 913 VVQMLEE 919
++ +
Sbjct: 263 LIIEFSK 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 8e-46
Identities = 60/287 (20%), Positives = 104/287 (36%), Gaps = 42/287 (14%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
+G G G VYK + A K I + DY E+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYM-----------------VEI 60
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
L++ H N+VKL + E++ ++ E+ G++ + + + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQT 119
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
L YLH D +IHRD+K+ NIL L+ ++ADFG++ GT
Sbjct: 120 LDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN--TRTIQRRDSFIGTP 174
Query: 814 GYIAPEYAYTC-----KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868
++APE + K+DV+S G+ L+E+ + P + + V K+
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP----HHELNPM--RVLLKIA 228
Query: 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
+ S K+ C K R + ++Q
Sbjct: 229 KSEPPTLAQPSRWSSNFKD-------FLKKCLEKNVDARWTTSQLLQ 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 3e-45
Identities = 65/307 (21%), Positives = 123/307 (40%), Gaps = 52/307 (16%)
Query: 623 SEKEIIDAVKP-------------ENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGF 668
S++EI++ ++ IG+G SG VY + + +G+E+A++ +
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60
Query: 669 RGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGS 728
+ + E+ + ++ N+V S D +V EYL GS
Sbjct: 61 KELIIN-----------------EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103
Query: 729 LWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788
L D + MD A+ + LE+LH VIHRD+KS NILL ++ ++
Sbjct: 104 LTDVVTETC---MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKL 157
Query: 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
DFG + + + GT ++APE K D++S G++ +E++ G+ P
Sbjct: 158 TDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 849 IVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP 908
+ + + + + + +S I ++ C + R
Sbjct: 216 ----YLNENPL--RALYLIATNGTPELQNPEKLSAIFRD-------FLNRCLDMDVEKRG 262
Query: 909 SMRVVVQ 915
S + ++Q
Sbjct: 263 SAKELLQ 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 6e-45
Identities = 57/321 (17%), Positives = 111/321 (34%), Gaps = 56/321 (17%)
Query: 622 FSEKEIIDA----VKPENL-----IGKGGSGNVYKVVLN------SGKELAVKHIWPSNS 666
FS ++ V E + +G+G G VY+ V +A+K + + S
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63
Query: 667 GFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPN 726
E+ E + + +VV+L ++ L++ E +
Sbjct: 64 ----------------MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 107
Query: 727 GSLWDRLHTCHK--------IEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778
G L L + +A A G+ YL+ +HRD+ + N
Sbjct: 108 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC 164
Query: 779 LLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVV 838
++ ++ +I DFG+ + + + +++PE SDV+SFGVV
Sbjct: 165 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 224
Query: 839 LMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIH 898
L E+ T Y + + + V++ + + + +
Sbjct: 225 LWEIATLAEQP--------------YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRM 270
Query: 899 CTNKLPAFRPSMRVVVQMLEE 919
C P RPS ++ ++E
Sbjct: 271 CWQYNPKMRPSFLEIISSIKE 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 1e-44
Identities = 55/286 (19%), Positives = 106/286 (37%), Gaps = 41/286 (14%)
Query: 632 KPEN-----LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSR 685
+PE+ ++G+G V L + +E A+K + + + ++
Sbjct: 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--------------IKENK 51
Query: 686 SSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVV 745
E +S + H VKLY + ++ Y NG L + +
Sbjct: 52 VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTR 111
Query: 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
Y A+ + L + + +IHRD+K NILL+ + +I DFG AK++
Sbjct: 112 FYT-----AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166
Query: 806 THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865
+ GT Y++PE + SD+++ G ++ +LV G P F + + ++
Sbjct: 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYL--IFQ 220
Query: 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
K+ ++ + E A ++ R
Sbjct: 221 KIIK-------LEYDFPEKFFPKARDLVE---KLLVLDATKRLGCE 256
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-44
Identities = 59/290 (20%), Positives = 106/290 (36%), Gaps = 40/290 (13%)
Query: 634 ENLIGKGGSGNVYKVVL----NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEY 689
IG+G G+V++ + N +A+K S S ++
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS----------------DSVREKF 55
Query: 690 DAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
E T+ H ++VKL IT E+ ++ E G L K +D
Sbjct: 56 LQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILY 113
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
A + L YL + +HRD+ + N+L+ ++ DFGL++ ++ +
Sbjct: 114 AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG- 169
Query: 810 AGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS 869
++APE + SDV+ FGV + E++ P G N V ++++
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK--PFQGVK---NNDVIGRIEN 224
Query: 870 RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919
+ + + PN L + C P+ RP + L
Sbjct: 225 GERL--PMPPNCPPTLYS-------LMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 6e-44
Identities = 65/311 (20%), Positives = 121/311 (38%), Gaps = 60/311 (19%)
Query: 634 ENLIGKGGSGNVYKVVL--------NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSR 685
+G+G G V N ++AVK +L ++
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK------------------MLKSDATE 59
Query: 686 S--SEYDAEVATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKI--- 739
S+ +E+ + + +H N++ L + T + ++ EY G+L + L
Sbjct: 60 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 119
Query: 740 -----------EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788
++ + A A+G+EYL + IHRD+ + N+L+ + +I
Sbjct: 120 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKI 176
Query: 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
ADFGLA+ + + T ++APE + +SDV+SFGV+L E+ T
Sbjct: 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
Query: 849 IVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP 908
P G V ++ + M N + L + C + +P+ RP
Sbjct: 237 --PYPGVP---VEELFKLLKEGHRMD--KPSNCTNELYM-------MMRDCWHAVPSQRP 282
Query: 909 SMRVVVQMLEE 919
+ + +V+ L+
Sbjct: 283 TFKQLVEDLDR 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 158 bits (401), Expect = 3e-43
Identities = 58/298 (19%), Positives = 114/298 (38%), Gaps = 39/298 (13%)
Query: 621 SFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAIL 679
++D +G G G V++V +G A K + + + R
Sbjct: 18 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK----- 72
Query: 680 SKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKI 739
E+ T+S +RH +V L+ + ++ +++YE++ G L++++ H
Sbjct: 73 ------------EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN- 119
Query: 740 EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI--ADFGLAKIV 797
+M KGL ++H + +H D+K NI+ + + DFGL +
Sbjct: 120 KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176
Query: 798 QTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857
++ V GT + APE A + +D++S GV+ L++G P +
Sbjct: 177 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF-----GGE 228
Query: 858 DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
+ + + +M IS ED +R P R ++ ++
Sbjct: 229 NDDETLRNVKSCDWNMDDSAFSGIS----EDGKDFIR---KLLLADPNTRMTIHQALE 279
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (395), Expect = 3e-43
Identities = 66/301 (21%), Positives = 119/301 (39%), Gaps = 38/301 (12%)
Query: 625 KEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS 683
+ D + ++G GG V+ L +++AVK + L++
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--------------LARDP 48
Query: 684 SRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNL----LVYEYLPNGSLWDRLHTCHKI 739
S + E +A+ H +V +Y + +E +V EY+ +L D +HT +
Sbjct: 49 SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 108
Query: 740 EMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK-IVQ 798
+ + L+ +IHRDVK +NI++ ++ DFG+A+ I
Sbjct: 109 TPKRAIEVIADA-----CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163
Query: 799 TGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858
+G + T + GT Y++PE A ++ +SDVYS G VL E++TG+ P
Sbjct: 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDS 218
Query: 859 IVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-SMRVVVQML 917
V+ Y + + +S L + + K P R + + L
Sbjct: 219 PVSVAYQHVREDPIPPSARHEGLSADLDA-------VVLKALAKNPENRYQTAAEMRADL 271
Query: 918 E 918
Sbjct: 272 V 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 157 bits (399), Expect = 7e-43
Identities = 54/311 (17%), Positives = 118/311 (37%), Gaps = 41/311 (13%)
Query: 609 QNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSG 667
++ W + + + + D +G G G V++ V +G+ K
Sbjct: 9 EDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK-------- 60
Query: 668 FRGDYRSSTAILSKRSSRSSE-YDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPN 726
++ E++ ++ + H ++ L+ + + +L+ E+L
Sbjct: 61 ----------FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110
Query: 727 GSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786
G L+DR+ +M A +GL+++H + ++H D+K NI+ + +
Sbjct: 111 GELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKAS 166
Query: 787 RI--ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT 844
+ DFGLA + E + V T + APE + +D+++ GV+ L++
Sbjct: 167 SVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223
Query: 845 GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLP 904
G P D + + N + + + V P + +K + K P
Sbjct: 224 GLSPF-AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK-----------NLLQKEP 271
Query: 905 AFRPSMRVVVQ 915
R ++ ++
Sbjct: 272 RKRLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 1e-42
Identities = 51/290 (17%), Positives = 116/290 (40%), Gaps = 40/290 (13%)
Query: 625 KEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS 683
KE+ + +G+G G V++ V +S K K + +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK------------------FVKVKG 42
Query: 684 SRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW 743
+ E++ L+ RH N++ L+ S S + ++++E++ +++R++T E++
Sbjct: 43 TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNE 101
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL--EWKPRIADFGLAKIVQTGE 801
+ + L++LH + H D++ NI+ +I +FG A+ ++
Sbjct: 102 REIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156
Query: 802 AGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861
GD ++ Y APE ++ +D++S G ++ L++G P ++
Sbjct: 157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF-----LAETNQQ 210
Query: 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
+ + M++ + IS +A+ + K R +
Sbjct: 211 IIENIMNAEYTFDEEAFKEIS----IEAMDFVD---RLLVKERKSRMTAS 253
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (386), Expect = 5e-41
Identities = 59/286 (20%), Positives = 107/286 (37%), Gaps = 35/286 (12%)
Query: 628 IDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS 686
++ +IG+GG G VY ++GK A+K + + + + +
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL-----------DKKRIKMKQGETLA 51
Query: 687 SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
++ +S +V + + + D + + + G L L +
Sbjct: 52 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF 111
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
YA + GLE++H+ R V++RD+K +NILLD RI+D GLA +
Sbjct: 112 YAAEI--ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 162
Query: 807 HVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865
H GTHGY+APE + +D +S G +L +L+ G P K ++ +
Sbjct: 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 222
Query: 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
M + + + +L + R
Sbjct: 223 TM----------AVELPDSFSPELRSLLE---GLLQRDVNRRLGCL 255
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 5e-41
Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 39/286 (13%)
Query: 628 IDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS 686
I+ ++GKG G V+ + + A+K + D +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV--------- 51
Query: 687 SEYDAEVATLSAV-RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVV 745
E LS H + ++C+ ++++ V EYL G L + +CHK ++
Sbjct: 52 -----EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 106
Query: 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
YA + GL++LH + +++RD+K NILLD + +IADFG+ K G+A
Sbjct: 107 FYAAEI--ILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 161
Query: 806 THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865
T GT YIAPE K N D +SFGV+L E++ G+ P + D +++ + +
Sbjct: 162 TFC--GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRM 217
Query: 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
+P L+++A +L + P R +R
Sbjct: 218 D-----------NPFYPRWLEKEAKDLLV---KLFVREPEKRLGVR 249
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 149 bits (376), Expect = 1e-40
Identities = 60/288 (20%), Positives = 111/288 (38%), Gaps = 36/288 (12%)
Query: 632 KPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+P+ ++G+G S V + + + KE AVK I + G +
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA--------EEVQELREATL 57
Query: 691 AEVATLSAVR-HVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAI 749
EV L V H N+++L + + LV++ + G L+D L + +
Sbjct: 58 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 117
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVI 809
A+ + + LH ++HRD+K NILLD + ++ DFG + + GE +
Sbjct: 118 AL--LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREV 169
Query: 810 AGTHGYIAPEYAYT------CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863
GT Y+APE ++ D++S GV++ L+ G P + + +
Sbjct: 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-----WHRKQMLML 224
Query: 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
M + + S+ +K+ + P R +
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDTVKD-------LVSRFLVVQPQKRYTAE 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 56/308 (18%), Positives = 106/308 (34%), Gaps = 54/308 (17%)
Query: 634 ENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSS 687
+G+G G V + + + +AVK + + S
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----------------HSEHR 61
Query: 688 EYDAEVATLSAVRHVNVVKLYCSITSEDSN--LLVYEYLPNGSLWDRLHTC--------- 736
+E+ L + H V ++ +++ E+ G+L L +
Sbjct: 62 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 121
Query: 737 -----HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791
+K + + AKG+E+L R IHRD+ + NILL + +I DF
Sbjct: 122 APEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDF 178
Query: 792 GLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVP 851
GLA+ + ++APE + +SDV+SFGV+L E+ + P
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238
Query: 852 EFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
++ + + + + + C + P+ RP+
Sbjct: 239 GVKIDEEFCRRLKEG----------TRMRAPDYTTPEMYQTML---DCWHGEPSQRPTFS 285
Query: 912 VVVQMLEE 919
+V+ L
Sbjct: 286 ELVEHLGN 293
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (374), Expect = 5e-40
Identities = 64/295 (21%), Positives = 110/295 (37%), Gaps = 40/295 (13%)
Query: 625 KEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRS 683
++I D +++G G V + K +A+K I
Sbjct: 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI----------------AKKALE 48
Query: 684 SRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDW 743
+ + E+A L ++H N+V L S L+ + + G L+DR+
Sbjct: 49 GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD 108
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL---EWKPRIADFGLAKIVQTG 800
R V ++YLH D ++HRD+K N+L + K I+DFGL+K+ G
Sbjct: 109 ASRLIFQV--LDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163
Query: 801 EAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860
+ GT GY+APE ++ D +S GV+ L+ G P ++
Sbjct: 164 S---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF-----YDENDA 215
Query: 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
+ + + +IS+ K+ H K P R + +Q
Sbjct: 216 KLFEQILKAEYEFDSPYWDDISDSAKD-------FIRHLMEKDPEKRFTCEQALQ 263
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 6e-39
Identities = 60/299 (20%), Positives = 110/299 (36%), Gaps = 36/299 (12%)
Query: 622 FSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILS 680
F ++ + D +G G V K ++G + A K I + S I
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 681 KRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIE 740
EV+ L ++H NV+ L+ ++ +L+ E + G L+D L +
Sbjct: 63 -----------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 111
Query: 741 MDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR----IADFGLAKI 796
+ + + L +++ + H D+K NI+L P+ I DFGLA
Sbjct: 112 EEEATEFLKQI-----LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166
Query: 797 VQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856
+ G+ I GT ++APE + ++D++S GV+ L++G P
Sbjct: 167 IDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-----LG 218
Query: 857 KDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
+ + N S + K+ K P R +++ +Q
Sbjct: 219 DTKQETLANVSAVNYEFEDEYFSNTSALAKD-------FIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 145 bits (366), Expect = 6e-39
Identities = 61/303 (20%), Positives = 115/303 (37%), Gaps = 59/303 (19%)
Query: 612 WDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRG 670
+ ++ F++L +G G G V+ + ++G+ A+K +
Sbjct: 1 YSLQDFQIL--------------RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE------ 40
Query: 671 DYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLW 730
+ R + + E LS V H +++++ + ++ +Y+ G L+
Sbjct: 41 --------IVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 92
Query: 731 DRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790
L + YA V L + + +I+RD+K NILLD +I D
Sbjct: 93 SLLRKSQRFPNPVAKFYAAEV-----CLALEYLHSKDIIYRDLKPENILLDKNGHIKITD 147
Query: 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIV 850
FG AK V D+T+ + GT YIAPE T N+ D +SFG+++ E++ G P
Sbjct: 148 FGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP-- 200
Query: 851 PEFGDSKDIVNWVYSKMDSRDSMLTVV--DPNISEILKEDALKVLRIAIHCTNKLPAFRP 908
+ ++ + ++ + ED +L + + R
Sbjct: 201 -------------FYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS---RLITRDLSQRL 244
Query: 909 SMR 911
Sbjct: 245 GNL 247
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 1e-38
Identities = 50/297 (16%), Positives = 88/297 (29%), Gaps = 42/297 (14%)
Query: 634 ENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
IG G G++Y + +G+E+A+K ++ + E
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLE-------------------CVKTKHPQLHIE 52
Query: 693 VATLSAVRHVN-VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
++ + + D N++V E L K + V+ A +
Sbjct: 53 SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQM 112
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNIL---LDLEWKPRIADFGLAKIVQTGEAGD---- 804
+EY+H + IHRDVK N L I DFGLAK +
Sbjct: 113 --ISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 805 -LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863
+ GT Y + + + + D+ S G VLM G + +
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG-SLPWQGLKAATKRQKYE 226
Query: 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920
+ + V+ C + +P + Q+
Sbjct: 227 RISEKKMSTPIEVLCKGYPSEFAT-------YLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (356), Expect = 8e-38
Identities = 43/299 (14%), Positives = 94/299 (31%), Gaps = 44/299 (14%)
Query: 634 ENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
IG+G G +++ L + +++A+K R S + + E
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFE-------------------PRRSDAPQLRDE 50
Query: 693 VATLSAVRHVN-VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAV 751
T + + +Y N+LV + L G + L + A
Sbjct: 51 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAK 108
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP-----RIADFGLAKIVQTGEAGDLT 806
++ +H + +++RD+K N L+ + DFG+ K +
Sbjct: 109 QMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 807 H-----VIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861
++GT Y++ + + + D+ + G V M + G P G
Sbjct: 166 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW---QGLKAATNK 222
Query: 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920
Y ++ + + E+ + + + N P + + +
Sbjct: 223 QKYERIGEKK-----QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 55/296 (18%), Positives = 105/296 (35%), Gaps = 33/296 (11%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
+ +G+G VYK N+ + +A+K I + D + TA+ E+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL------------REI 51
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
L + H N++ L + + + LV++++ + + Y +
Sbjct: 52 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT-- 109
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
L+ L + ++HRD+K +N+LLD ++ADFGLAK G T
Sbjct: 110 ---LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTR 164
Query: 814 GYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRP------------IVPEFGDSKDIV 860
Y APE + + D+++ G +L EL+ I G +
Sbjct: 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 224
Query: 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916
+ + + + I +L + P R + ++M
Sbjct: 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-36
Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 48/286 (16%)
Query: 636 LIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
L+G GG G+VY + ++ +A+KH+ G+ + T + EV
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP-----------MEVV 59
Query: 695 TLSAVR--HVNVVKLYCSITSEDSNLLVYEYL-PNGSLWDRLHTCHKIEMDWVVRYAIAV 751
L V V++L DS +L+ E P L+D + ++ + + V
Sbjct: 60 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 752 GAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE-WKPRIADFGLAKIVQTGEAGDLTHVIA 810
LE + H + V+HRD+K NIL+DL + ++ DFG +++ +
Sbjct: 120 -----LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFD 170
Query: 811 GTHGYIAPEY-AYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS 869
GT Y PE+ Y + V+S G++L ++V G P F ++I+
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQV----- 221
Query: 870 RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
+S + + C P+ RP+ +
Sbjct: 222 ------FFRQRVSSECQH-------LIRWCLALRPSDRPTFEEIQN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (335), Expect = 3e-35
Identities = 66/297 (22%), Positives = 112/297 (37%), Gaps = 40/297 (13%)
Query: 635 NLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVA 694
IG+G G VYK N G+ A+K I + S E++
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEK---------------EDEGIPSTTIREIS 52
Query: 695 TLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAA 754
L ++H N+VKLY I ++ +LV+E+L +E + + +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL--- 109
Query: 755 KGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHG 814
L + + DR V+HRD+K N+L++ E + +IADFGLA+ TH I
Sbjct: 110 --LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWY 166
Query: 815 YIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP------------IVPEFGDSKDIVNW 862
+ K + D++S G + E+V G I G
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 863 VYSKMDSRDSMLTVVDP----NISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915
+++ D TV +P + + L E + +L P R + + ++
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-35
Identities = 52/283 (18%), Positives = 98/283 (34%), Gaps = 37/283 (13%)
Query: 634 ENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
++G G +G V ++ + ++ A+K +L E +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALK------------------MLQDCPKARREVELH 58
Query: 693 VATLSAVRHVNVVKLYCSI----TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYA 748
A + ++V++ L+V E L G L+ R+
Sbjct: 59 ---WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
I + ++YLH + HRDVK N+L + I + + +
Sbjct: 116 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172
Query: 809 IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868
T Y+APE K ++ D++S GV++ L+ G P F + + K
Sbjct: 173 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTR 228
Query: 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
R +P SE+ E+ ++R + P R ++
Sbjct: 229 IRMGQYEFPNPEWSEV-SEEVKMLIR---NLLKTEPTQRMTIT 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 8e-35
Identities = 62/294 (21%), Positives = 103/294 (35%), Gaps = 35/294 (11%)
Query: 635 NLIGKGGSGNVYKV--VLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
IG+G G V+K + N G+ +A+K + R T S E A
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRV-----------RVQTGEEGMPLSTIREV-AV 60
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLW----DRLHTCHKIEMDWVVRYA 748
+ L H NVV+L+ T ++ L + L + +
Sbjct: 61 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 120
Query: 749 IAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV 808
+ +GL++LH V+HRD+K NIL+ + ++ADFGLA+I A
Sbjct: 121 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTS 174
Query: 809 IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPI-----------VPEFGDSK 857
+ T Y APE D++S G + E+ K + +
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234
Query: 858 DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
+W R + + I + + + + + C PA R S
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-34
Identities = 59/285 (20%), Positives = 97/285 (34%), Gaps = 38/285 (13%)
Query: 628 IDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS 686
++ L+GKG G V V +G+ A+K + + +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA------------- 50
Query: 687 SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
E L RH + L + + D V EY G L+ L +
Sbjct: 51 -HTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 109
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
Y + + L + R V++RD+K N++LD + +I DFGL K + G
Sbjct: 110 YGAEI-----VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATM 162
Query: 807 HVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866
GT Y+APE D + GVV+ E++ G+ P D + + + +
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHERLFELILME 220
Query: 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
+ L +A +L K P R
Sbjct: 221 -----------EIRFPRTLSPEAKSLLA---GLLKKDPKQRLGGG 251
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-33
Identities = 65/299 (21%), Positives = 115/299 (38%), Gaps = 36/299 (12%)
Query: 628 IDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRS 686
++ + IG+G G VYK +G+ +A+K I ++
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD---------------TETEGVP 45
Query: 687 SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
S E++ L + H N+VKL I +E+ LV+E+L + L + + +
Sbjct: 46 STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 104
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLT 806
+ +GL + H V+HRD+K N+L++ E ++ADFGLA+
Sbjct: 105 KSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 807 HVIAGTHGYIAPE-YAYTCKINEKSDVYSFGVVLMELVTGKRP------------IVPEF 853
V T Y APE + D++S G + E+VT + I
Sbjct: 162 EV--VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219
Query: 854 GDSKDIVNWVYSKM-DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911
G ++V + M D + S + S+++ + + P R S +
Sbjct: 220 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 44/226 (19%), Positives = 87/226 (38%), Gaps = 32/226 (14%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
IG+G G V+K +G+++A+K + N ++ E+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---------------EKEGFPITALREI 60
Query: 694 ATLSAVRHVNVVKLYCSITSEDSN--------LLVYEYLPNGSLWDRLHTCHKIEMDWVV 745
L ++H NVV L ++ S LV+++ + + K + +
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 746 RYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDL 805
R + L L++ ++HRD+K++N+L+ + ++ADFGLA+ +
Sbjct: 121 RVMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
Query: 806 THV--IAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRP 848
T Y PE + D++ G ++ E+ T
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 8e-33
Identities = 64/317 (20%), Positives = 122/317 (38%), Gaps = 45/317 (14%)
Query: 602 NLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVVL----NSGKELA 657
+KH L+ + + +V E++ ++G G G V+ V ++GK A
Sbjct: 4 TVKHELRTANLTGHAEKV-GIENFELLK------VLGTGAYGKVFLVRKISGHDTGKLYA 56
Query: 658 VKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV-NVVKLYCSITSEDS 716
+K + + + +++ + E L +R +V L+ + +E
Sbjct: 57 MKVLKKAT-------------IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103
Query: 717 NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSS 776
L+ +Y+ G L+ L + V Y + + L H +I+RD+K
Sbjct: 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI-----VLALEHLHKLGIIYRDIKLE 158
Query: 777 NILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK--INEKSDVYS 834
NILLD + DFGL+K E + + GT Y+AP+ ++ D +S
Sbjct: 159 NILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWS 217
Query: 835 FGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLR 894
GV++ EL+TG P + K+ + ++ +P + + A +++
Sbjct: 218 LGVLMYELLTGASPFTVD--GEKNSQAEISRRILKS-------EPPYPQEMSALAKDLIQ 268
Query: 895 IAIHCTNKLPAFRPSMR 911
K P R
Sbjct: 269 ---RLLMKDPKKRLGCG 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 5e-32
Identities = 53/227 (23%), Positives = 84/227 (37%), Gaps = 37/227 (16%)
Query: 632 KPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYD 690
+IG G G VY+ L +SG+ +A+K + +
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------N 61
Query: 691 AEVATLSAVRHVNVVKLYCSITSEDSN------LLVYEYLPNGSLWDRLH-TCHKIEMDW 743
E+ + + H N+V+L S LV +Y+P H + K +
Sbjct: 62 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 744 VVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE-WKPRIADFGLAKIVQTGEA 802
+ + L Y+H + HRD+K N+LLD + ++ DFG AK + GE
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE- 177
Query: 803 GDLTHVIAGTHGYIAP-EYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+ Y AP DV+S G VL EL+ G+
Sbjct: 178 --PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 6e-32
Identities = 50/289 (17%), Positives = 105/289 (36%), Gaps = 26/289 (8%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
IG+G G V+K + + +A+K + + S E+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---------------DDEGVPSSALREI 52
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGA 753
L ++H N+V+L+ + S+ LV+E+ ++ + V +
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL----- 107
Query: 754 AKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTH 813
+ L+ L R V+HRD+K N+L++ + ++A+FGLA+ + +
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLW 166
Query: 814 GYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDSRDSM 873
+ D++S G + EL RP D+ + + +
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP----LFPGNDVDDQLKRIFRLLGTP 222
Query: 874 LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922
P+++++ + N +P + R ++Q L + P
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-31
Identities = 49/220 (22%), Positives = 86/220 (39%), Gaps = 27/220 (12%)
Query: 635 NLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEV 693
+ IG+G G V + +A+K I P + + E+
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----------------EHQTYCQRTLREI 57
Query: 694 ATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPN---GSLWDRLHTCHKIEMDWVVRYAIA 750
L RH N++ + I + + YL G+ +L + D + +
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ 117
Query: 751 VGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHV-I 809
+ +GL+Y+H V+HRD+K SN+LL+ +I DFGLA++
Sbjct: 118 I--LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172
Query: 810 AGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRP 848
T Y APE + D++S G +L E+++ +
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (303), Expect = 3e-30
Identities = 59/251 (23%), Positives = 95/251 (37%), Gaps = 25/251 (9%)
Query: 599 KQNNLKHSLKQNSWDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELA 657
+Q ++K L + D +D +G G G V V SG A
Sbjct: 11 EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 658 VKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSN 717
+K + + + E L AV +VKL S +
Sbjct: 71 MKILDKQKV--------------VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 718 LLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777
+V EY+ G ++ L + YA + EYLH +I+RD+K N
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH---SLDLIYRDLKPEN 171
Query: 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGV 837
+L+D + ++ DFG AK V+ T + GT +APE + N+ D ++ GV
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 838 VLMELVTGKRP 848
++ E+ G P
Sbjct: 227 LIYEMAAGYPP 237
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-28
Identities = 51/233 (21%), Positives = 100/233 (42%), Gaps = 33/233 (14%)
Query: 623 SEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSK 681
+ E+ + +G G G V V +G ++A+K ++ + + +K
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ---------SELFAK 62
Query: 682 RSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSN------LLVYEYLPNGSLWDRLHT 735
R+ R E+ L +RH NV+ L T +++ LV ++ G+ +L
Sbjct: 63 RAYR------ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK 114
Query: 736 CHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795
K+ D + + KGL Y+H +IHRD+K N+ ++ + + +I DFGLA+
Sbjct: 115 HEKLGEDRIQFLVYQM--LKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 169
Query: 796 IVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
+ ++T + + + D++S G ++ E++TGK
Sbjct: 170 QADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (282), Expect = 9e-28
Identities = 61/318 (19%), Positives = 121/318 (38%), Gaps = 46/318 (14%)
Query: 612 WDMKSFRVLSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRG 670
WD +S V E D + +G+G V++ + + + +++ VK +
Sbjct: 22 WDYESHVV----EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--------- 68
Query: 671 DYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVKLYCSITSEDSNL--LVYEYLPNG 727
+ + + E+ L +R N++ L + S LV+E++ N
Sbjct: 69 -----------KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117
Query: 728 SLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE-WKP 786
T + K L+Y H ++HRDVK N+++D E K
Sbjct: 118 DFKQLYQT-----LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKL 169
Query: 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTG 845
R+ D+GLA+ G+ +V + + PE + + D++S G +L ++
Sbjct: 170 RLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226
Query: 846 KRPIVP---EFGDSKDIVNWVYSKM--DSRDSMLTVVDPNISEILKEDALKVLRIAIHCT 900
K P + I + ++ D D +DP ++IL + K +H
Sbjct: 227 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSE 286
Query: 901 NKLPAFRPSMRVVVQMLE 918
N+ ++ + ++L
Sbjct: 287 NQHLVSPEALDFLDKLLR 304
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 112 bits (281), Expect = 3e-27
Identities = 78/379 (20%), Positives = 128/379 (33%), Gaps = 47/379 (12%)
Query: 180 NLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQ 239
L + L + + L+++ L+ + + G L NL + S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75
Query: 240 NRLEG--DLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKL 297
N+L L L L + + + L + L
Sbjct: 76 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 298 GSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVN 357
N + L + +TDL L N + +N S I
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 358 ----------NNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANN 407
NN +S P GI NL + L+ NQ + + + +L L LANN
Sbjct: 196 LTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANN 251
Query: 408 RFSGELPSKISEASSLVSIQLSLNQFSGQIPLD--------------------IGKLKKL 447
+ S P +S + L ++L NQ S PL I LK L
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 448 SSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSG 507
+ L L+ N S P + S L + FA N +S SL +L ++N L+ +N+ S
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
Query: 508 EIPISLTYPKLSLLDLSNN 526
P++ +++ L L++
Sbjct: 366 LTPLA-NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.5 bits (244), Expect = 2e-22
Identities = 80/397 (20%), Positives = 143/397 (36%), Gaps = 33/397 (8%)
Query: 59 GLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSS 118
L K LG + T+++ ++ L + + L+ L+ +N +++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNN 76
Query: 119 GISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGI 178
++ P L+NLT L + + +N + L L +
Sbjct: 77 QLTDITP---LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 179 GNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVS 238
N +L + +SD I L+ L L+ + +NLT L D+S
Sbjct: 134 LNRLELSSNTISD----------ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDIS 183
Query: 239 QNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLG 298
N++ + L L SL NQ S P +L ELSL N+L L
Sbjct: 184 SNKVSDISVLAK-LTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLA 238
Query: 299 SWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNN 358
S + +D++ N ++ P +T+L + N + P + + N
Sbjct: 239 SLTNLTDLDLANNQISNLAPLSGLT--KLTELKLGANQISNISPLAGLTALTNLELNENQ 296
Query: 359 NSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKIS 418
I +L NL+ + L N + + L L ANN+ S S ++
Sbjct: 297 L----EDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD--VSSLA 348
Query: 419 EASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDN 455
+++ + NQ S PL L +++ L L+D
Sbjct: 349 NLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.2 bits (225), Expect = 5e-20
Identities = 76/377 (20%), Positives = 135/377 (35%), Gaps = 32/377 (8%)
Query: 42 NLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEV 101
L + + V + + LQ LG + +G++ L ++ NN + +
Sbjct: 28 VLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI-----DGVEYLNNLTQINFSNNQLTD-I 81
Query: 102 PDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVL------ 155
L L +L + +N++ I+ P +L NLT L + DP +
Sbjct: 82 TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS 141
Query: 156 -KLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNL----ELSDNELFGEIPAGIVKLNKLWQ 210
+ + L + +L L NL L + + + KL L
Sbjct: 142 NTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLES 201
Query: 211 LELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIP 270
L NN +S P+G TNL ++ N+L+ + L L L+ L L NQ S P
Sbjct: 202 LIATNNQISDITPLGIL--TNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP 258
Query: 271 EEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL 330
LTEL L N+++ P + ++ ++ + +T L
Sbjct: 259 --LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL----EDISPISNLKNLTYL 312
Query: 331 LVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVT 390
+ NN + P ++ L R NN +S + +L N++ + NQ
Sbjct: 313 TLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT- 367
Query: 391 DDIGNAKSLALLLLANN 407
+ N + L L +
Sbjct: 368 -PLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.5 bits (153), Expect = 5e-11
Identities = 52/329 (15%), Positives = 109/329 (33%), Gaps = 25/329 (7%)
Query: 205 LNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQ 264
L + + L +++ V ++L + + ++ + + +LN L+ ++ NQ
Sbjct: 21 LAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQ 77
Query: 265 FSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKT 324
+ P L ++ + N++ P + + ++ P+
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 325 GAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQ 384
+ + + + + + T + N +
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 385 FEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKL 444
+ L+ NN+ S P I ++L + L+ NQ + L
Sbjct: 196 LTNLES-----------LIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASL 240
Query: 445 KKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNK 504
L+ L L +N S P + LT++ N +S P L L +L +L L+ N+
Sbjct: 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 296
Query: 505 FSGEIPISLTYPKLSLLDLSNNQLAGPIP 533
PIS L+ L L N ++ P
Sbjct: 297 LEDISPIS-NLKNLTYLTLYFNNISDISP 324
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (270), Expect = 5e-26
Identities = 39/230 (16%), Positives = 84/230 (36%), Gaps = 14/230 (6%)
Query: 634 ENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAE 692
+G G V+ + + +A+K + + + +L + + DA+
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVN------DAD 70
Query: 693 VATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIE---MDWVVRYAI 749
++ +++KL + N + + + L K E + + I
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 750 AVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE-WKPRIADFGLAKIVQTGEAGDLTHV 808
+ GL+Y+H +IH D+K N+L+++ + +A + +
Sbjct: 131 SKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 809 IAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858
T Y +PE +D++S ++ EL+TG P+ G S
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 4e-25
Identities = 49/233 (21%), Positives = 86/233 (36%), Gaps = 33/233 (14%)
Query: 623 SEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAILSK 681
S ++ + IG G G V + +A+K + +
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---------------FQ 55
Query: 682 RSSRSSEYDAEVATLSAVRHVNVVKLYCSITSEDSN------LLVYEYLPNGSLWDRLHT 735
+ + E+ + V H N++ L T + + LV E +
Sbjct: 56 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---- 111
Query: 736 CHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795
++E+D + G+++LH +IHRD+K SNI++ + +I DFGLA+
Sbjct: 112 -IQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
Query: 796 IVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
T + T Y APE E D++S G ++ E+V K
Sbjct: 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 6e-25
Identities = 55/235 (23%), Positives = 105/235 (44%), Gaps = 31/235 (13%)
Query: 620 LSFSEKEIIDAVKPENLIGKGGSGNVYKVV-LNSGKELAVKHIWPSNSGFRGDYRSSTAI 678
L+ + E+ + + + +G G G+V +G +AVK + + I
Sbjct: 9 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---------SRPFQSII 59
Query: 679 LSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSITS-----EDSNLLVYEYLPNGSLWDRL 733
+KR+ R E+ L ++H NV+ L T E +++ + +L G+ + +
Sbjct: 60 HAKRTYR------ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNI 112
Query: 734 HTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGL 793
C K+ D V + +GL+Y+H +IHRD+K SN+ ++ + + +I DFGL
Sbjct: 113 VKCQKLTDDHVQFLIYQI--LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167
Query: 794 AKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRP 848
A+ ++T +A N+ D++S G ++ EL+TG+
Sbjct: 168 ARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.2 bits (228), Expect = 6e-22
Identities = 35/216 (16%), Positives = 71/216 (32%), Gaps = 27/216 (12%)
Query: 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRG-DYRSSTAILSKRSSRS 686
+DA+ L+G+G V+ E VK ++ F+ + L
Sbjct: 1 VDAIG--KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAI 58
Query: 687 SEYDAEVATLSAVRHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVR 746
E L ++ + V K+Y + N ++ E + L+
Sbjct: 59 RSARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRVRVENPD-------- 106
Query: 747 YAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGD-L 805
+ + + +H R ++H D+ N+L+ E I DF + V + L
Sbjct: 107 -EVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREIL 161
Query: 806 THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLME 841
+ Y + Y + D+ S +++
Sbjct: 162 ERDVRNIITYFSRTYRT------EKDINSAIDRILQ 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.2 bits (217), Expect = 1e-19
Identities = 54/277 (19%), Positives = 94/277 (33%), Gaps = 12/277 (4%)
Query: 160 LYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLS 219
L L N +T NL L L L +N++ P L KL +L L N L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 220 GRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHL 279
L L + ++ + + L + SG F K L
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152
Query: 280 TELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNG 339
+ + + +T T+PQ L + + N +T + + L + N+ +
Sbjct: 153 SYIRIADTNIT-TIPQGLPP--SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 209
Query: 340 TVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDD------I 393
+ AN L +NNN L +P G+ + ++ L N ++D
Sbjct: 210 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 268
Query: 394 GNAKSLALLLLANN--RFSGELPSKISEASSLVSIQL 428
S + + L +N ++ PS ++QL
Sbjct: 269 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.8 bits (203), Expect = 9e-18
Identities = 51/275 (18%), Positives = 95/275 (34%), Gaps = 15/275 (5%)
Query: 255 LSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLT 314
+ L L N+ + +F K+L L L N+++ P + +S+N L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 315 GPIPPDMCKTGAMTDLLVLQNNFNGTVPETYA--NCKSLIRFRVNNNSLSGTIPPGIWSL 372
+P M KT + +L V +N + N ++ N SG +
Sbjct: 93 E-LPEKMPKT--LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 373 PNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQ 432
LS I ++ T G SL L L N+ + + + ++L + LS N
Sbjct: 150 KKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 433 FSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSG------KIP 486
S + L L+L++N P + + + N++S P
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
Query: 487 DSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLL 521
S + ++L +N T+ + +
Sbjct: 266 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 300
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.8 bits (203), Expect = 9e-18
Identities = 53/283 (18%), Positives = 99/283 (34%), Gaps = 24/283 (8%)
Query: 25 CKFNGIVCDSNGL----------VAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLY 74
C + C GL A ++L ++ + L+ L + L N +
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKD-GDFKNLKNLHTLILINNKIS 68
Query: 75 GTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTN 134
+L+ L L N + + ++ N K L
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHEN---EITKVRKSVFNGLNQ 125
Query: 135 LEFLSLGDNPFDPSPF-PMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNE 193
+ + LG NP S ++KL ++ + + ++T IP+G+ L L L N+
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 182
Query: 194 LFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLN 253
+ A + LN L +L L NS+S +N +L ++ N+L L
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242
Query: 254 QLSSLHLFENQFSG------EIPEEFGEFKHLTELSLYTNRLT 290
+ ++L N S P + + +SL++N +
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.1 bits (178), Expect = 1e-14
Identities = 39/268 (14%), Positives = 89/268 (33%), Gaps = 14/268 (5%)
Query: 268 EIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAM 327
++P++ L L N++T + + + + + N ++ P +
Sbjct: 24 KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 328 TDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEG 387
L + +N + + L + ++ + + + + + G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQMIVVELGTNPLKSSG 140
Query: 388 PVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKL 447
K L+ + +A+ + +P + SL + L N+ + + L L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 448 SSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSG 507
+ L L N S S+ + L +++ N L K+P L + + L NN S
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
Query: 508 -------EIPISLTYPKLSLLDLSNNQL 528
+ S + L +N +
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.8 bits (177), Expect = 2e-14
Identities = 48/269 (17%), Positives = 93/269 (34%), Gaps = 7/269 (2%)
Query: 278 HLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNF 337
HL + L +P+ L D +D+ N +T D + L+++ N
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 338 NGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAK 397
+ P +A L R ++ N L +L L + + + V + +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 398 SLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMF 457
+ L + SG L I+++ + + G L+ L+L N
Sbjct: 128 VV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKI 183
Query: 458 SGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPK 517
+ S+ +L + + NS+S SL + P L L+L+NNK +
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243
Query: 518 LSLLDLSNNQLAGPIPEPLNIKAFIDSFT 546
+ ++ L NN ++ +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKA 272
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 86.0 bits (211), Expect = 1e-18
Identities = 64/266 (24%), Positives = 109/266 (40%), Gaps = 8/266 (3%)
Query: 274 GEFKHLTELSLYTNRLTG--TLPQKLGSWADFNYVDVSENL-LTGPIPPDMCKTGAMTDL 330
+ + L L L +P L + N++ + L GPIPP + K + L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 331 LVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVT 390
+ N +G +P+ + K+L+ + N+LSGT+PP I SLPNL I N+ G +
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 391 DDIGNAKSLAL-LLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSS 449
D G+ L + ++ NR +G + A+ ++ + K +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTG--KIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224
Query: 450 LYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEI 509
+G +L ++ N + G +P L L L+SLN+S N GEI
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 510 PISLTYPKLSLLDLSNNQL--AGPIP 533
P + + +NN+ P+P
Sbjct: 285 PQGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 73.2 bits (178), Expect = 2e-14
Identities = 65/328 (19%), Positives = 116/328 (35%), Gaps = 37/328 (11%)
Query: 1 MNLKSKIEKSDTGVFSSWTEANSVC--KFNGIVCDSNGL---VAEINLPEQQLLGVVPF- 54
+ +K + + SSW C + G++CD++ V ++L L P
Sbjct: 12 LQIKKDL--GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP 69
Query: 55 DSICGLQALQKINL-GTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFL 113
S+ L L + + G N L G I + T+L ++
Sbjct: 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY---------------------LYI 108
Query: 114 NLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQ 173
+ + ++ L L+F + P L + ++G
Sbjct: 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL----PNLVGITFDGNRISGA 164
Query: 174 IPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLM 233
IP+ G+ ++L L ++L N L G V F + N
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224
Query: 234 NFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTL 293
+++N L DL ++ L+ L L N+ G +P+ + K L L++ N L G +
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 294 PQKLGSWADFNYVDVSEN-LLTG-PIPP 319
PQ G+ F+ + N L G P+P
Sbjct: 285 PQ-GGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (195), Expect = 8e-17
Identities = 53/277 (19%), Positives = 88/277 (31%), Gaps = 28/277 (10%)
Query: 255 LSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLT 314
+ L N+ S F ++LT L L++N L A +D+S+N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 315 GPIPPDMCKTGAMTDLLVLQNNFNGTVP-ETYANCKSLIRFRVNNNSLSGTIPPGIWSLP 373
+ P L L + + +L + +N+L L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 374 NLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQF 433
NL+ + L N+ SL LLL NR + P + L+++ L N
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 434 SGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLP 493
S + L+ L L L+DN + + C +
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPW-------VCDC------------------RARPLWA 248
Query: 494 SLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAG 530
L S+++ +P L L L+ N L G
Sbjct: 249 WLQKFRGSSSEVPCSLPQRLA--GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (191), Expect = 2e-16
Identities = 42/265 (15%), Positives = 88/265 (33%), Gaps = 4/265 (1%)
Query: 280 TELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNG 339
S L +P + + + + N ++ +T L + N
Sbjct: 14 VTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70
Query: 340 TVPETYANCKSLIRFRVNNNSLSGTIPPGIWS-LPNLSIIDLSTNQFEGPVTDDIGNAKS 398
+ L + +++N+ ++ P + L L + L + +
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130
Query: 399 LALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFS 458
L L L +N + +L + L N+ S L L L LH N +
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 459 GPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKL 518
P++ L + N+LS ++L L +L L L++N + + + L
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWL 250
Query: 519 SLLDLSNNQLAGPIPEPLNIKAFID 543
S++++ +P+ L +
Sbjct: 251 QKFRGSSSEVPCSLPQRLAGRDLKR 275
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.2 bits (170), Expect = 1e-13
Identities = 53/273 (19%), Positives = 92/273 (33%), Gaps = 10/273 (3%)
Query: 167 NCSVTG--QIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPV 224
+C G +P GI +Q + L N + A L L L++N L+
Sbjct: 17 SCPQQGLQAVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74
Query: 225 GFSNLTNLMNFDVSQNRLEGDLSELRF--LNQLSSLHLFENQFSGEIPEEFGEFKHLTEL 282
F+ L L D+S N + F L +L +LHL P F L L
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134
Query: 283 SLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVP 342
L N L + ++ + N ++ ++ LL+ QN P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 343 ETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALL 402
+ + L+ + N+LS + L L + L+ N + L
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKF 253
Query: 403 LLANNRFSGELPSKISEASSLVSIQLSLNQFSG 435
+++ LP +++ +L+ N G
Sbjct: 254 RGSSSEVPCSLPQRLAGRDLK---RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (168), Expect = 2e-13
Identities = 51/245 (20%), Positives = 76/245 (31%), Gaps = 7/245 (2%)
Query: 49 LGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD--LSM 106
+ VP S + L + L +N L L+ LDL +N+ V
Sbjct: 44 ISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHG 103
Query: 107 LHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLT 166
L L L+L + L L++L L DN P L L L+L
Sbjct: 104 LGRLHTLHL-DRCGLQELGPGLFRGLAALQYLYLQDNALQALP-DDTFRDLGNLTHLFLH 161
Query: 167 NCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGF 226
++ L L L L N + P L +L L L+ N+LS
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221
Query: 227 SNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYT 286
+ L L ++ N D L ++ +P+ L
Sbjct: 222 APLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAA 278
Query: 287 NRLTG 291
N L G
Sbjct: 279 NDLQG 283
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 2e-10
Identities = 42/276 (15%), Positives = 83/276 (30%), Gaps = 18/276 (6%)
Query: 88 QVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDP 147
Q LDL + +V + + S + P + ++ + L ++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQ--PLAEHFSPFRVQHMDLSNSVIEV 60
Query: 148 SPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNK 207
S + + KL L L ++ I + + L L LS F E + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL-SS 119
Query: 208 LWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQF-- 265
+L+ N S + + + + LS+L
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179
Query: 266 ---------SGEIPEEFGEFKHLTELSL-YTNRLTGTLPQKLGSWADFNYVDVSENLLTG 315
+ +EF + +L LSL + +LG + V + G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 316 PIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSL 351
+ A+ L + ++F T N K+
Sbjct: 240 TLQL---LKEALPHLQINCSHFTTIARPTIGNKKNQ 272
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 5e-06
Identities = 46/267 (17%), Positives = 89/267 (33%), Gaps = 16/267 (5%)
Query: 64 QKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGK 123
Q ++L L+ +T L S + + + + + ++L++S I
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 124 FPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCS--VTGQIPEGIGNL 181
L + L+ LSL P + K L L L+ CS + + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLS-DPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 182 TQLQNL------ELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNF 235
++L L + ++ + + + +L N L NL++
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 236 DVSQNRLEGDLSE--LRFLNQLSSLHLFE-NQFSGEIPEEFGEFKHLTELSLYTNRLTGT 292
D+S + + + LN L L L E E GE L L ++ GT
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 293 LPQKLGSWADFNYVDVSENLLTGPIPP 319
L + ++ ++ + T P
Sbjct: 241 LQLLKEA---LPHLQINCSHFTTIARP 264
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 2e-05
Identities = 34/272 (12%), Positives = 76/272 (27%), Gaps = 45/272 (16%)
Query: 185 QNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEG 244
Q L+L+ L ++ ++ + + + L FS + + D+S + +E
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60
Query: 245 D--LSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWAD 302
L ++L +L L + S I + +L L+L + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 303 FNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRV------ 356
+++ + + A + Q N +G + S + R
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 357 ----------------------------NNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGP 388
+ + +P L + + G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF-----GI 235
Query: 389 VTDDIGN--AKSLALLLLANNRFSGELPSKIS 418
V D ++L L + + F+ I
Sbjct: 236 VPDGTLQLLKEALPHLQINCSHFTTIARPTIG 267
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.7 bits (130), Expect = 8e-09
Identities = 38/213 (17%), Positives = 73/213 (34%), Gaps = 20/213 (9%)
Query: 85 TRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNP 144
+ G ++ + V + L ++ L+ +G++ + ++ L NL L L DN
Sbjct: 19 ANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTT---IEGVQYLNNLIGLELKDNQ 74
Query: 145 FDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVK 204
+ K+ +L +V+ L + +++D + V
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 205 LNKLWQL-------------ELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRF 251
L Q+ L + +NL+ L N++ D+S L
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS-DISPLAS 193
Query: 252 LNQLSSLHLFENQFSGEIPEEFGEFKHLTELSL 284
L L +HL NQ S P +L ++L
Sbjct: 194 LPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 32/227 (14%), Positives = 65/227 (28%), Gaps = 17/227 (7%)
Query: 180 NLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQ 239
L + + + + L+ + L + ++ + G L NL+ ++
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKD 72
Query: 240 NRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGS 299
N++ + +L + + L + +
Sbjct: 73 NQIT---------DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123
Query: 300 WADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNN 359
L I G + N + AN L + ++N
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 360 SLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLAN 406
+S P + SLPNL + L NQ + N +L ++ L N
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 9e-07
Identities = 20/75 (26%), Positives = 33/75 (44%), Gaps = 3/75 (4%)
Query: 451 YLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIP 510
YL + + LT + N +S P L SLP+L ++L NN+ S P
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
Query: 511 ISLTYPKLSLLDLSN 525
++ L ++ L+N
Sbjct: 213 LA-NTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 3e-05
Identities = 43/269 (15%), Positives = 81/269 (30%), Gaps = 46/269 (17%)
Query: 116 NSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIP 175
+ I+ FP +L N + G + + + L+ + L VT
Sbjct: 5 QPTAINVIFPDPALANAIKIA---AGKSNVTDTVTQAD---LDGITTLSAFGTGVTTI-- 56
Query: 176 EGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNF 235
EG+ L L LEL DN++ P + +L S + L +
Sbjct: 57 EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPL-------KNVSAIAGLQSI 109
Query: 236 DVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQ 295
+ L+ + +L LS+ +++
Sbjct: 110 KTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD--LT 167
Query: 296 KLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFR 355
L + + + +N ++ P A+ +LI
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--------------------------LASLPNLIEVH 201
Query: 356 VNNNSLSGTIPPGIWSLPNLSIIDLSTNQ 384
+ NN +S P + + NL I+ L+ NQ
Sbjct: 202 LKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 27/251 (10%), Positives = 68/251 (27%), Gaps = 42/251 (16%)
Query: 252 LNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSEN 311
L + ++ + + + + +T LS + +T + + + +++ +N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 312 LLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWS 371
+T P +L + + + + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 372 LPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLN 431
L + + G + + ++ S L +++ N
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLS----------IGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 432 QFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGS 491
+ S PL L L ++L +N S P L +
Sbjct: 184 KISDISPL--ASLPNLIEVHLKNNQISDVSP--------------------------LAN 215
Query: 492 LPSLNSLNLSN 502
+L + L+N
Sbjct: 216 TSNLFIVTLTN 226
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 3e-08
Identities = 34/203 (16%), Positives = 60/203 (29%), Gaps = 24/203 (11%)
Query: 347 NCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLAN 406
S + + +L+ +PP + + +I+ LS N + L L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 407 NRFSGELP---------------------SKISEASSLVSIQLSLNQFSGQIPLDIGKLK 445
+ +L + +S N+ + + L
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 446 KLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKF 505
+L LYL N P + L ++ A N+L+ L L +L++L L N
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 506 SGEIPISLTYPKLSLLDLSNNQL 528
L L N
Sbjct: 185 YTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 5e-07
Identities = 38/182 (20%), Positives = 61/182 (33%), Gaps = 6/182 (3%)
Query: 85 TRLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDN 143
+L L N L L+ LNL+ + ++ +L L L+
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ 90
Query: 144 PFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIV 203
+ L L ++ +T + L +LQ L L NEL P +
Sbjct: 91 SLPLLGQTLP-----ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLT 145
Query: 204 KLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFEN 263
KL +L L NN+L+ + L NL + +N L + L L N
Sbjct: 146 PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205
Query: 264 QF 265
+
Sbjct: 206 PW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 8e-07
Identities = 37/208 (17%), Positives = 60/208 (28%), Gaps = 6/208 (2%)
Query: 226 FSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLY 285
S + + + + + L +L + LHL EN + LT+L+L
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 286 TNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETY 345
LT + +P A+T L V N
Sbjct: 64 RAELTKLQVDG---TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 346 ANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLA 405
L + N L P + P L + L+ N + ++L LLL
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 406 NNRFSGELPSKISEASSLVSIQLSLNQF 433
N +P + L L N +
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 8e-07
Identities = 37/190 (19%), Positives = 63/190 (33%), Gaps = 6/190 (3%)
Query: 268 EIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAM 327
+P + K T L L N L L + +++ LT +
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLP---V 78
Query: 328 TDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEG 387
L L +N ++P +L V+ N L+ + L L + L N+ +
Sbjct: 79 LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138
Query: 388 PVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKL 447
+ L L LANN + ++ +L ++ L N IP L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 448 SSLYLHDNMF 457
+LH N +
Sbjct: 198 PFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.2 bits (108), Expect = 8e-06
Identities = 41/234 (17%), Positives = 72/234 (30%), Gaps = 31/234 (13%)
Query: 272 EFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLL 331
E + E++ LT LP L D + +SENLL + T L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMP---YTRLT 58
Query: 332 VLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTD 391
L + ++ +++ ++P +LP L+++D+S N+
Sbjct: 59 QLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 392 DIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLY 451
+ L L L N P ++ L + L+ N + + L+ L +L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 452 LHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKF 505
L +N IP L L N +
Sbjct: 179 LQENSLY-------------------------TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 14/65 (21%), Positives = 27/65 (41%), Gaps = 4/65 (6%)
Query: 464 SIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT-YPKLSLLD 522
+ S ++N + +L+ +P L L+LS N +L Y +L+ L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 523 LSNNQ 527
L +
Sbjct: 62 LDRAE 66
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.9 bits (116), Expect = 1e-07
Identities = 22/108 (20%), Positives = 40/108 (37%), Gaps = 7/108 (6%)
Query: 88 QVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDP 147
+VL L + + + L L ++ L+L+ + + P L L L + +
Sbjct: 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQASDNA 54
Query: 148 SPFPMEVLKLEKLYWLYLTNCSVTG-QIPEGIGNLTQLQNLELSDNEL 194
V L +L L L N + + + + +L L L N L
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 6e-06
Identities = 25/121 (20%), Positives = 44/121 (36%), Gaps = 6/121 (4%)
Query: 64 QKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGK 123
+ ++L L T+ L+ + LDL +N P L+ L L L + +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQAS---DNAL 55
Query: 124 FPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQ 183
+ NL L+ L L +N S ++ +L L L S+ L +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114
Query: 184 L 184
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 6e-06
Identities = 24/117 (20%), Positives = 46/117 (39%), Gaps = 7/117 (5%)
Query: 428 LSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPD 487
L+ + + + +L ++ L L N P ++ + L + + N+ + D
Sbjct: 5 LAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LENVD 59
Query: 488 SLGSLPSLNSLNLSNNKFSGEIPISL--TYPKLSLLDLSNNQLAGPIPEPLNIKAFI 542
+ +LP L L L NN+ I + P+L LL+L N L + +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.6 bits (102), Expect = 1e-05
Identities = 23/108 (21%), Positives = 36/108 (33%), Gaps = 6/108 (5%)
Query: 402 LLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPL 461
L LA+ + + + + + LS N+ P + L+ L L DN
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 462 PYSIGSCVSLTDINFAQNSL-SGKIPDSLGSLPSLNSLNLSNNKFSGE 508
+ + ++ N L L S P L LNL N E
Sbjct: 60 GVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 1e-05
Identities = 32/124 (25%), Positives = 51/124 (41%), Gaps = 9/124 (7%)
Query: 163 LYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRL 222
L+L + +T + + L + +L+LS N L PA L L LE+ S +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNALE 56
Query: 223 PV-GFSNLTNLMNFDVSQNRLEG--DLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHL 279
V G +NL L + NRL+ + L +L L+L N E + + L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 280 TELS 283
+S
Sbjct: 117 PSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 3e-05
Identities = 27/106 (25%), Positives = 38/106 (35%), Gaps = 5/106 (4%)
Query: 211 LELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIP 270
L L + L+ L + + D+S NRL L L L L +N E
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNAL--ENV 58
Query: 271 EEFGEFKHLTELSLYTNRLTGT-LPQKLGSWADFNYVDVSENLLTG 315
+ L EL L NRL + Q L S +++ N L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 8e-07
Identities = 32/201 (15%), Positives = 58/201 (28%), Gaps = 16/201 (7%)
Query: 85 TRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNP 144
+L S + V + L+ + + N+S I + ++ L N+ L L N
Sbjct: 24 AETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKS---VQGIQYLPNVTKLFLNGNK 79
Query: 145 FDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVK 204
L L L + ++ +I +
Sbjct: 80 LTDIKP------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 205 LNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQ 264
N + + L L D + D+ L L +L +L+L +N
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS----DIVPLAGLTKLQNLYLSKNH 189
Query: 265 FSGEIPEEFGEFKHLTELSLY 285
S K+L L L+
Sbjct: 190 ISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 9e-05
Identities = 38/217 (17%), Positives = 69/217 (31%), Gaps = 15/217 (6%)
Query: 311 NLLTGPIP-PDMCKTGAMTDLLVLQ-NNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPG 368
+T P P + A + + + T T S+ + NN+ + G
Sbjct: 6 ETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKS--VQG 63
Query: 369 IWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQL 428
I LPN++ + L+ N+ L + +S +L
Sbjct: 64 IQYLPNVTKLFLNGNKLTDIKPLA---------NLKNLGWLFLDENKVKDLSSLKDLKKL 114
Query: 429 SLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDS 488
DI L L L + ++ S ++ D +++ I
Sbjct: 115 KSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP- 173
Query: 489 LGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSN 525
L L L +L LS N S ++ L +L+L +
Sbjct: 174 LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 26/202 (12%), Positives = 60/202 (29%), Gaps = 15/202 (7%)
Query: 205 LNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQ 264
+ + L S++ V + L ++ + + ++ + +++L ++ L L N+
Sbjct: 23 FAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNK 79
Query: 265 FSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKT 324
+ P +L L E+ I +
Sbjct: 80 LTDIKP-----LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLP 134
Query: 325 GAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQ 384
+ N T + + + ++ I P + L L + LS N
Sbjct: 135 QLESL----YLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNH 189
Query: 385 FEGPVTDDIGNAKSLALLLLAN 406
+ K+L +L L +
Sbjct: 190 ISDL--RALAGLKNLDVLELFS 209
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 20/89 (22%), Positives = 33/89 (37%), Gaps = 7/89 (7%)
Query: 451 YLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIP 510
+ N S + SL ++N + N L ++P P L L S N + E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVP 320
Query: 511 ISLTYPKLSLLDLSNNQLAGPIPEPLNIK 539
L L + N L P +++
Sbjct: 321 ELP--QNLKQLHVEYNPLREFPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 54/334 (16%), Positives = 97/334 (29%), Gaps = 26/334 (7%)
Query: 163 LYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRL 222
L L N ++ +PE +L ++L S N L E+P L L +LS
Sbjct: 43 LELNNLGLS-SLPELPPHL---ESLVASCNSL-TELPELPQSLKSLLVDNNNLKALSDLP 97
Query: 223 PVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTEL 282
P+ + + ++ ++ S L + S E
Sbjct: 98 PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPE 157
Query: 283 SLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVP 342
LT + E+++ G + L N +
Sbjct: 158 LQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK 217
Query: 343 ETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALL 402
SL V +N L+ ++ + E P
Sbjct: 218 TLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL----------- 266
Query: 403 LLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLP 462
N S E+ S SL + +S N+ ++P +L++ L N + +P
Sbjct: 267 -YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLAE-VP 320
Query: 463 YSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLN 496
+L ++ N L + PD S+ L
Sbjct: 321 ELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 53/344 (15%), Positives = 97/344 (28%), Gaps = 28/344 (8%)
Query: 182 TQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNR 241
Q LEL++ L +P L L NSL+ LP +L + V N
Sbjct: 38 RQAHELELNNLGL-SSLPELPPHLESLV---ASCNSLT-ELP---ELPQSLKSLLVDNNN 89
Query: 242 LEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWA 301
L+ + L + + ++ N LP S
Sbjct: 90 LKA------LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLE 143
Query: 302 DFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSL 361
+ L + + + E+ +++ +L
Sbjct: 144 FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 203
Query: 362 SGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEAS 421
+ ++ DL + V D+ L + F + S S
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPE---LPQSLTFLDVSENIFSGLS 260
Query: 422 SLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSL 481
L LN S +I L L + +N LP L + + N L
Sbjct: 261 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHL 316
Query: 482 SGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSN 525
+ ++P+ +L L++ N E P + L +++
Sbjct: 317 A-EVPELPQNL---KQLHVEYNPLR-EFPDIP--ESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 17/76 (22%), Positives = 29/76 (38%), Gaps = 9/76 (11%)
Query: 157 LEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNN 216
L L ++N + ++P L + L S N L E+P L +L + N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHL-AEVPELPQNLKQLH---VEYN 334
Query: 217 SLSGRLPVGFSNLTNL 232
L P ++ +L
Sbjct: 335 PLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 3e-04
Identities = 22/98 (22%), Positives = 37/98 (37%), Gaps = 14/98 (14%)
Query: 162 WLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGR 221
+ + +I L+ L +S+N+L E+PA +L +L N L+
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLERLI---ASFNHLA-E 318
Query: 222 LPVGFSNLTNLMNFDVSQNRLE------GDLSELRFLN 253
+P NL L V N L + +LR +
Sbjct: 319 VPELPQNLKQL---HVEYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 22/91 (24%), Positives = 34/91 (37%), Gaps = 10/91 (10%)
Query: 71 NFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLE 130
N I L+ L++ NN E+P L L L + + ++ + P E
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL--PPRLERLIASFNHLA-EVP----E 321
Query: 131 NLTNLEFLSLGDNPFDPSPFPMEVLKLEKLY 161
NL+ L + NP FP +E L
Sbjct: 322 LPQNLKQLHVEYNPL--REFPDIPESVEDLR 350
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 14/91 (15%), Positives = 33/91 (36%), Gaps = 4/91 (4%)
Query: 134 NLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQ----IPEGIGNLTQLQNLEL 189
+++ L + + + + L++ + L +C +T I + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 190 SDNELFGEIPAGIVKLNKLWQLELYNNSLSG 220
NEL +++ + ++ SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 16/92 (17%), Positives = 27/92 (29%), Gaps = 11/92 (11%)
Query: 447 LSSLYLHDNMFS-GPLPYSIGSCVSLTDINFAQNSLSGK----IPDSLGSLPSLNSLNLS 501
+ SL + S + + L+ I +L P+L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 502 NNKFSGEIPISL------TYPKLSLLDLSNNQ 527
+N+ + K+ L L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 6e-06
Identities = 17/94 (18%), Positives = 28/94 (29%), Gaps = 10/94 (10%)
Query: 453 HDNMFSGPLPYSIGSCVSLTDINFAQNSLSGK----IPDSLGSLPSLNSLNLSNNKFSGE 508
D L + A +S + +L + SL L+LSNN
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 509 IPISLT------YPKLSLLDLSNNQLAGPIPEPL 536
+ L L L L + + + + L
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 11/74 (14%), Positives = 25/74 (33%), Gaps = 6/74 (8%)
Query: 469 VSLTDINFAQNSLSGK-IPDSLGSLPSLNSLNLSNNKFSGEIPISL-----TYPKLSLLD 522
+ + ++ LS + L L + L + + + P L+ L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 523 LSNNQLAGPIPEPL 536
L +N+L +
Sbjct: 62 LRSNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 19/91 (20%), Positives = 32/91 (35%), Gaps = 14/91 (15%)
Query: 445 KKLSSLYLHDNMFSG----PLPYSIGSCVSLTDINFAQNSLSGKIPDSLGS-----LPSL 495
L L+L D S L ++ + SL +++ + N L L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 496 NSLNLSNNKFSGEIPISLT-----YPKLSLL 521
L L + +S E+ L P L ++
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 9/91 (9%), Positives = 29/91 (31%), Gaps = 5/91 (5%)
Query: 374 NLSIIDLSTNQF-EGPVTDDIGNAKSLALLLLANNRFSGELPSKISEA----SSLVSIQL 428
++ +D+ + + + + + ++ L + + IS A +L + L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 429 SLNQFSGQIPLDIGKLKKLSSLYLHDNMFSG 459
N+ + + + S +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 19/92 (20%), Positives = 31/92 (33%), Gaps = 14/92 (15%)
Query: 206 NKLWQLELYNNSLSGR----LPVGFSNLTNLMNFDVSQNRLEGD----LSELRFLNQ--L 255
+ L L L + +S L +L D+S N L L E L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 256 SSLHLFENQFSGEIPEEFGEFK----HLTELS 283
L L++ +S E+ + + L +S
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 19/91 (20%), Positives = 33/91 (36%), Gaps = 9/91 (9%)
Query: 87 LQVLDLGNNSFSGEVPD--LSMLHELSFLNLNSSGISGKFPW---KSLENLTNLEFLSLG 141
+Q LD+ S L +L + + L+ G++ +L L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 142 DNPFDPSPFP--MEVLKLE--KLYWLYLTNC 168
N ++ L+ K+ L L NC
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 18/74 (24%), Positives = 30/74 (40%), Gaps = 9/74 (12%)
Query: 159 KLYWLYLTNCSVTGQ----IPEGIGNLTQLQNLELSDNELFGEIPAGIVK-----LNKLW 209
L L+L +C V+ + + L+ L+LS+N L +V+ L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 210 QLELYNNSLSGRLP 223
QL LY+ S +
Sbjct: 430 QLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 14/90 (15%), Positives = 29/90 (32%), Gaps = 13/90 (14%)
Query: 63 LQKINLGTNFLYGT----ITEGLKSCTRLQVLDLGNNSFSGEVPD---------LSMLHE 109
L+ + L + + + L + L+ LDL NN +L +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 110 LSFLNLNSSGISGKFPWKSLENLTNLEFLS 139
L ++ S ++ +L +S
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 17/92 (18%), Positives = 26/92 (28%), Gaps = 8/92 (8%)
Query: 124 FPWKSLENLTNLEFLSLGDNPFDP---SPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIG- 179
+ + L L L D S +L L L L+N + +
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 180 ----NLTQLQNLELSDNELFGEIPAGIVKLNK 207
L+ L L D E+ + L K
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 13/92 (14%), Positives = 29/92 (31%), Gaps = 5/92 (5%)
Query: 40 EINLPEQQLLGVVPFDSICGLQALQKINLGTNFL----YGTITEGLKSCTRLQVLDLGNN 95
+++ ++L + + LQ Q + L L I+ L+ L L+L +N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 96 SFSGE-VPDLSMLHELSFLNLNSSGISGKFPW 126
V + + + +
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 35/184 (19%), Positives = 61/184 (33%), Gaps = 22/184 (11%)
Query: 90 LDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF---- 145
LG + + V + L +++ L + GI +E L NL ++ +N
Sbjct: 23 TVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKS---IDGVEYLNNLTQINFSNNQLTDIT 78
Query: 146 -----------DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNEL 194
+ + + QI + L +
Sbjct: 79 PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 138
Query: 195 FGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQ 254
+ + L L QL +N ++ P +NLT L D+S N++ D+S L L
Sbjct: 139 TISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVS-DISVLAKLTN 195
Query: 255 LSSL 258
L SL
Sbjct: 196 LESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 24/198 (12%), Positives = 60/198 (30%), Gaps = 15/198 (7%)
Query: 205 LNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQ 264
L + + L +++ V ++L + + ++ + + +LN L+ ++ NQ
Sbjct: 17 LAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQ 73
Query: 265 FSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKT 324
+ P + ++ + L
Sbjct: 74 LTDITPLKNLTKLVDILMNNNQIA----------DITPLANLTNLTGLTLFNNQITDIDP 123
Query: 325 GAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQ 384
L + T+ + A ++N +S T + +L L +D+S+N+
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNK 183
Query: 385 FEGPVTDDIGNAKSLALL 402
+ +L L
Sbjct: 184 VSDI--SVLAKLTNLESL 199
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.7 bits (101), Expect = 7e-05
Identities = 36/322 (11%), Positives = 79/322 (24%), Gaps = 18/322 (5%)
Query: 236 DVSQNRLEGDLSELRFLNQLSSLHLFENQFSGE----IPEEFGEFKHLTELSLYTN---R 288
++ + + L + + + L N E + E K L R
Sbjct: 14 AITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGR 73
Query: 289 LTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANC 348
+ +P+ L + + + ++ +
Sbjct: 74 VKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 133
Query: 349 KSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNR 408
++ + + P L I N+ E + LL
Sbjct: 134 GPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKM 193
Query: 409 FSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSC 468
+ + E L + + + S+L + + + C
Sbjct: 194 VQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC 253
Query: 469 VSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLT------YPKLSLLD 522
L+ A S L +L L N+ + +L P L L+
Sbjct: 254 -LLSARGAAAVVD----AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 523 LSNNQLAGPIPEPLNIKAFIDS 544
L+ N+ + I+ +
Sbjct: 309 LNGNRFSEEDDVVDEIREVFST 330
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 9e-05
Identities = 43/353 (12%), Positives = 93/353 (26%), Gaps = 45/353 (12%)
Query: 65 KINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKF 124
K++ T ++ L ++ + L N+ E + ++
Sbjct: 11 KLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTE--------------------AARW 50
Query: 125 PWKSLENLTNLEFLSLGDNPFD--PSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLT 182
+++ + +LE D P + L + +V
Sbjct: 51 LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 110
Query: 183 QLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRL 242
+ LS + + L ++ + N L + +NRL
Sbjct: 111 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 170
Query: 243 EGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWAD 302
E + S L + G L E Y L
Sbjct: 171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL----------KVL 220
Query: 303 FNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANC------KSLIRFRV 356
+ +L + + + + +L + + + L R+
Sbjct: 221 DLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 280
Query: 357 NNNSLSGTIPPGIWS-----LPNLSIIDLSTNQF--EGPVTDDIGNAKSLALL 402
N + + + +P+L ++L+ N+F E V D+I S
Sbjct: 281 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGR 333
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 44/330 (13%), Positives = 92/330 (27%), Gaps = 36/330 (10%)
Query: 128 SLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQ----IPEGIGNLTQ 183
S+E +L+ ++ D +L+ + + + L+ ++ + + E I +
Sbjct: 4 SIEGK-SLKLDAITTE--DEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 184 LQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLE 243
L+ E SD L L Q L L + +
Sbjct: 61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120
Query: 244 GDLSELRFLNQ----LSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGS 299
L L N + + + ++ L + NRL ++
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180
Query: 300 WADFNYVDVSENLLTGPIPPDMCKTGAMTDLL-------------VLQNNFNGTVPETYA 346
+ + + ++ I P+ + + L + + +
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240
Query: 347 NCKSLIRFRVNNNSLSGTIPPGIW------SLPNLSIIDLSTNQFEGPVTDDIGNA---- 396
+ +L +N+ LS + L + L N+ E +
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 397 -KSLALLLLANNRFSGELPSKISEASSLVS 425
L L L NRF E + E + S
Sbjct: 301 MPDLLFLELNGNRF-SEEDDVVDEIREVFS 329
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 14/119 (11%), Positives = 35/119 (29%), Gaps = 10/119 (8%)
Query: 470 SLTDINFAQNSLSGK----IPDSLGSLPSLNSLNLSNNKFSGEIPISL-----TYPKLSL 520
S+ + ++++ + + L S+ + LS N E L + L +
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 521 LDLSNNQLAGPIPE-PLNIKAFIDSFTGNPGLCSKTDEYFKSCSSGSGRSHHVSTFVWC 578
+ S+ E P ++ + + P L + + +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 1e-04
Identities = 20/114 (17%), Positives = 38/114 (33%), Gaps = 6/114 (5%)
Query: 87 LQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSL-GDNPF 145
Q LDL ++ ++ L+ + ++ + EN+ L L+L + +
Sbjct: 24 QQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIE-----ENIPELLSLNLSNNRLY 78
Query: 146 DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIP 199
V K L L L+ + + +L+ L L N L
Sbjct: 79 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 2e-04
Identities = 27/134 (20%), Positives = 45/134 (33%), Gaps = 6/134 (4%)
Query: 412 ELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSL 471
+L +S+ L L + D+ L +M + L + L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPEL 67
Query: 472 TDINFAQNSLSGK--IPDSLGSLPSLNSLNLSNNKFSGEIPISLTY-PKLSLLDLSNNQL 528
+N + N L + + P+L LNLS N+ E + KL L L N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 529 AGPIPEPLNIKAFI 542
+ + + I
Sbjct: 128 SDTFRDQSTYISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 2e-04
Identities = 29/145 (20%), Positives = 50/145 (34%), Gaps = 17/145 (11%)
Query: 398 SLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMF 457
S L L R +L ++ ++ + + + + + + +L SL L +N
Sbjct: 23 SQQALDLKGLRSDPDLVAQ-----NIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRL 77
Query: 458 SG--PLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTY 515
+ + +L +N + N L + L L L N S TY
Sbjct: 78 YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137
Query: 516 --------PKLSLLDLSNNQLAGPI 532
PKL LD ++L PI
Sbjct: 138 ISAIRERFPKLLRLD--GHELPPPI 160
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 34/231 (14%), Positives = 72/231 (31%), Gaps = 11/231 (4%)
Query: 190 SDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSEL 249
++++ EIP+ + +L L FS +L ++SQN + +
Sbjct: 16 QESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72
Query: 250 RFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRL----TGTLPQKLGSWADFNY 305
F N + + + + F++L L K+ S
Sbjct: 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132
Query: 306 VDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTI 365
+ + +L L N + N L +++N+ +
Sbjct: 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEEL 192
Query: 366 PPGIWS-LPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPS 415
P ++ I+D+S + + + N K L N + +LP+
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 9/53 (16%), Positives = 18/53 (33%), Gaps = 1/53 (1%)
Query: 453 HDNMFSGPLPYSI-GSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNK 504
DN LP + ++ ++ + L +L L + + N K
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 12/79 (15%), Positives = 20/79 (25%), Gaps = 1/79 (1%)
Query: 450 LYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEI 509
L+L+ N + N+L D L++S +
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 510 PISLTY-PKLSLLDLSNNQ 527
L KL N +
Sbjct: 218 SYGLENLKKLRARSTYNLK 236
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.003
Identities = 21/135 (15%), Positives = 39/135 (28%), Gaps = 4/135 (2%)
Query: 167 NCSVTG--QIPEGIGNLTQLQNLELSDNELFGEIPAGIVK-LNKLWQLELYNNSLSGRLP 223
C+ G + L L + + + + ++ L +L L + + L P
Sbjct: 14 RCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73
Query: 224 VGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFS-GEIPEEFGEFKHLTEL 282
F L ++S N LE + L L L N ++
Sbjct: 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLG 133
Query: 283 SLYTNRLTGTLPQKL 297
+ +L L
Sbjct: 134 GVPEQKLQCHGQGPL 148
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 947 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.51 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.45 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.3 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.44 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.35 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.24 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.94 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.62 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.59 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.37 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.94 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.88 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.85 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.12 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.25 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=421.41 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=204.1
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|+++ ..||||+++.... .....+.|.+|++++++++|||||+++
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~---------------~~~~~~~~~~E~~~l~~l~HpnIv~~~ 70 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP---------------TPQQLQAFKNEVGVLRKTRHVNILLFM 70 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSC---------------CTTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccC---------------CHHHHHHHHHHHHHHHhCCCCCEeeee
Confidence 67899999999999999999875 3699999843211 123457899999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
|++.+ +..++||||+++|+|.+++... ...+++..+..++.|||+||+||| +++||||||||+|||++.++.+||
T Consensus 71 ~~~~~-~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl 145 (276)
T d1uwha_ 71 GYSTA-PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKI 145 (276)
T ss_dssp EEECS-SSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEE
T ss_pred EEEec-cEEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEE
Confidence 98765 5689999999999999999763 346899999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT---CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
+|||+|+...............||+.|||||++.+ +.++.++|||||||++|||+||+.||.... ....+...+..
T Consensus 146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-~~~~~~~~~~~ 224 (276)
T d1uwha_ 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGR 224 (276)
T ss_dssp CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-CHHHHHHHHHH
T ss_pred ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC-hHHHHHHHHhc
Confidence 99999987665444334445679999999999864 347899999999999999999999985321 11111111111
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
. ...+.+.+....++..+.+++.+||+.||++||||.|++++|+.+.
T Consensus 225 ----~-----~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 225 ----G-----YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp ----T-----SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----C-----CCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 1112223344455667899999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=420.32 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=199.9
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~------------------~~~~~~~~~E~~~l~~l~HpnIv~~~ 66 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG------------------AMSEEDFIEEAEVMMKLSHPKLVQLY 66 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS------------------SSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC------------------cCcHHHHHHHHHHHHhcCCCCccccc
Confidence 467788999999999999999998899999998421 23446799999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
|+|..++..++||||+++|+|.+++... ...+++..+..++.|||.||+||| +++|+||||||+||++++++.+||
T Consensus 67 g~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl 142 (263)
T d1sm2a_ 67 GVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKV 142 (263)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEE
T ss_pred ceeccCCceEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEe
Confidence 9999999999999999999999998763 456899999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||+|+......... .....||+.|+|||++.+..++.++|||||||++|||+|+..|+.... ....+.+.+..
T Consensus 143 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~--- 217 (263)
T d1sm2a_ 143 SDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDIST--- 217 (263)
T ss_dssp CSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CHHHHHHHHHH---
T ss_pred cccchheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CHHHHHHHHHh---
Confidence 9999998765443322 224568999999999999999999999999999999999655543221 12222222111
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
... ...+..++.++.+++.+||+.||++||||+||+++|+++.
T Consensus 218 ~~~----------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 218 GFR----------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp TCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC----------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 111 1112233457889999999999999999999999999763
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=422.23 Aligned_cols=255 Identities=27% Similarity=0.396 Sum_probs=208.8
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|++++++.||||++... ....+.|.+|++++++++|||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~------------------~~~~~~~~~E~~~l~~l~HpnIv~~~ 74 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG------------------SMSPDAFLAEANLMKQLQHQRLVRLY 74 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT------------------SSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC------------------cCCHHHHHHHHHHHHhCCCCCEeEEE
Confidence 578889999999999999999998899999998421 13446799999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
|++.+ +..++||||+++|+|.+++.......+++..+..++.|||+||+||| +++|+||||||+|||+++++.+||
T Consensus 75 g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl 150 (272)
T d1qpca_ 75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKI 150 (272)
T ss_dssp EEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred eeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceee
Confidence 98865 56799999999999999887766667999999999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+||..|+.... ...++...+. .
T Consensus 151 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-~~~~~~~~i~---~ 225 (272)
T d1qpca_ 151 ADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLE---R 225 (272)
T ss_dssp CCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHH---T
T ss_pred ccccceEEccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-CHHHHHHHHH---h
Confidence 999999977554322 2234568999999999999999999999999999999999776654321 1222222211 1
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.. ....+...+..+.+++.+||+.||++||||.||+++|+++
T Consensus 226 ~~----------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 226 GY----------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC----------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 11 1112223445688999999999999999999999999863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=417.01 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=204.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.+ +|+.||||++.... .....+.+.+|++++++++|||||+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----------------~~~~~~~~~~Ei~~l~~l~HpnIv~ 67 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----------------AVDCPENIKKEICINKMLNHENVVK 67 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------------CHHHHHHHHHTCCCTTBCC
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----------------cchHHHHHHHHHHHHHhCCCCCEee
Confidence 468999999999999999999975 79999999984221 1123356889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+
T Consensus 68 ~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~ 142 (271)
T d1nvra_ 68 FYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNL 142 (271)
T ss_dssp EEEEEEETTEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCE
T ss_pred EeeeeccCceeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCE
Confidence 999999999999999999999999999753 46899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYS 865 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 865 (947)
||+|||+|+..............+||+.|||||++.+..+ +.++||||+||++|||+||+.||............+.
T Consensus 143 KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-- 220 (271)
T d1nvra_ 143 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-- 220 (271)
T ss_dssp EECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--
T ss_pred EEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--
Confidence 9999999997765443333445689999999999988776 5789999999999999999999965432222221111
Q ss_pred hccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 866 KMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 866 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
..... ..........+.+++.+|++.||++|||+.|+++
T Consensus 221 --~~~~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 221 --EKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --TTCTT---------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cCCCC---------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11100 0111122346778999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-49 Score=421.24 Aligned_cols=259 Identities=26% Similarity=0.350 Sum_probs=214.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+++ +++.||||++..+ ....++|.+|++++++++|||||++
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~------------------~~~~~~~~~E~~il~~l~HpnIv~~ 78 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------------TMEVEEFLKEAAVMKEIKHPNLVQL 78 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT------------------CSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc------------------cchHHHHHHHHHHHHhCCCCCEecC
Confidence 57888999999999999999976 5889999998421 2345679999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
+|+|.+++..++||||+++|+|.+++.......+++..+..++.|||+||+||| +++|+||||||+|||+++++.+|
T Consensus 79 ~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~K 155 (287)
T d1opja_ 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVK 155 (287)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred CccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEE
Confidence 999999999999999999999999998776778999999999999999999999 78999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||+|+....... .......||+.|+|||++.++.++.++|||||||++|||++|+.||.... ....+.+.+.
T Consensus 156 l~DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-~~~~~~~~i~--- 230 (287)
T d1opja_ 156 VADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLE--- 230 (287)
T ss_dssp ECCCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHH---
T ss_pred EccccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-hHHHHHHHHh---
Confidence 999999987654332 22234468899999999999999999999999999999999887764322 1122222211
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
... ..+.+...+..+.+++.+||+.||++||||.|+++.|+.+...
T Consensus 231 -~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 231 -KDY---------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp -TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred -cCC---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111 1122233456788999999999999999999999999887544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=407.44 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=210.8
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|+.++++.||||+++.. ....++|.+|+.++++++||||++++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~------------------~~~~~~~~~Ev~~~~~l~HpnIv~~~ 65 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------------------SMSEDEFIEEAKVMMNLSHEKLVQLY 65 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS------------------SSCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC------------------cCCHHHHHHHHHHHHhcCCCceeeEE
Confidence 578899999999999999999998899999998422 23446799999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
|+|.+++..++||||+++|++.+++... ...+++..+.+++.|+|+||+||| +.+|+||||||+||++++++.+||
T Consensus 66 g~~~~~~~~~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl 141 (258)
T d1k2pa_ 66 GVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKV 141 (258)
T ss_dssp EEECCSSSEEEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCceEEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEE
Confidence 9999999999999999999999997763 346889999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||... ...+......
T Consensus 142 ~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-----~~~~~~~~i~ 215 (258)
T d1k2pa_ 142 SDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-----TNSETAEHIA 215 (258)
T ss_dssp CCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-----CHHHHHHHHH
T ss_pred CcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC-----CHHHHHHHHH
Confidence 999999876554332 2224568999999999999999999999999999999998 78898432 1222221111
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
... ....+...++.+.+++.+||+.||++|||+.|++++|.++
T Consensus 216 ~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 216 QGL----------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred hCC----------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111 1112223445788999999999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=406.00 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=206.4
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.+ +++.||||++... ..........+.+|++++++++|||||+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--------------~~~~~~~~~~~~~E~~il~~l~hpnIv~ 70 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--------------QLEKAGVEHQLRREVEIQSHLRHPNILR 70 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchH--------------HccChHHHHHHHHHHHHHHhcCCCCCCe
Confidence 367999999999999999999975 6899999998311 1122344577899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..|+||||+++|+|.+++... ..+++..+..++.||+.||+||| +++||||||||+|||++.++.+
T Consensus 71 ~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~ 145 (263)
T d2j4za1 71 LYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGEL 145 (263)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred EEEEEEECCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCE
Confidence 999999999999999999999999999864 35899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+|+...... .....||+.|||||++.+..++.++|||||||++|||++|+.||... +..+.....
T Consensus 146 kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i 216 (263)
T d2j4za1 146 KIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRI 216 (263)
T ss_dssp EECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHH
T ss_pred eecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC-----CHHHHHHHH
Confidence 999999997654332 23467999999999999999999999999999999999999999532 222222221
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
..... . ++...+..+.+++.+|++.||++|||+.|+++
T Consensus 217 ~~~~~--------~---~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 217 SRVEF--------T---FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HTTCC--------C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HcCCC--------C---CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11111 1 12223456788999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-48 Score=420.07 Aligned_cols=261 Identities=24% Similarity=0.371 Sum_probs=198.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CCc---EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGK---ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
+.|++.+.||+|+||+||+|+.+ +++ .||||++.... .....+.|.+|++++++++||||
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~HpnI 89 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY----------------TEKQRRDFLSEASIMGQFDHPNV 89 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC----------------CHHHHHHHHHHHHHHTTCCCTTB
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc----------------CHHHHHHHHHHHHHHHhCCCCCC
Confidence 56788899999999999999975 332 58999874211 11234578999999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
|+++|++..++..++||||+++|+|.+++... ...++|..+..++.|||+||+||| +++|+||||||+|||++.++
T Consensus 90 v~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~ 165 (299)
T d1jpaa_ 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNL 165 (299)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTC
T ss_pred ccEEEEEeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCC
Confidence 99999999999999999999999999988863 346899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcc---eecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDL---THVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIV 860 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~ 860 (947)
.+||+|||+|+.......... .....||+.|||||++.++.++.++|||||||++|||+| |+.||... ...++.
T Consensus 166 ~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~--~~~~~~ 243 (299)
T d1jpaa_ 166 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--TNQDVI 243 (299)
T ss_dssp CEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHH
T ss_pred cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC--CHHHHH
Confidence 999999999987654432211 122457899999999999999999999999999999998 89998532 122222
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
..+. .. ...+.+.+++..+.+++.+||+.||++||||.||++.|+++...|
T Consensus 244 ~~i~---~~----------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 244 NAIE---QD----------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp HHHH---TT----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHH---cC----------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 2221 11 111223345567889999999999999999999999998765433
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=407.29 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=205.9
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +|+.||||++.. ......+.+.+|++++++++|||||++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~-----------------~~~~~~~~~~~E~~il~~l~HpnIv~~ 82 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----------------QQQPKKELIINEILVMRENKNPNIVNY 82 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEG-----------------GGCSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEec-----------------ccChHHHHHHHHHHHHHhCCCCCEeeE
Confidence 57999999999999999999954 799999999831 112345678999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.+++..|+||||+++|+|.+++.+ ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vk 156 (293)
T d1yhwa1 83 LDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVK 156 (293)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEE
T ss_pred eEEEEECCEEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEe
Confidence 9999999999999999999999998876 35899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||+|+....... .....+||+.|+|||++.+..++.++||||+||++|||+||+.||... +..+......
T Consensus 157 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~~~ 229 (293)
T d1yhwa1 157 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-----NPLRALYLIA 229 (293)
T ss_dssp ECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHH
T ss_pred eccchhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC-----CHHHHHHHHH
Confidence 999999987654332 223457999999999999999999999999999999999999999532 1222222211
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..... . .+.+......+.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~-------~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 230 TNGTP-------E-LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHCSC-------C-CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred hCCCC-------C-CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110 0 11122334568889999999999999999999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=410.27 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=204.0
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +|+.||||++... ........+.+.+|++++++++|||||++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--------------~~~~~~~~~~~~~E~~il~~l~HpnIv~l 73 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--------------HIIKENKVPYVTRERDVMSRLDHPFFVKL 73 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHHHCCSTTBCCE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehH--------------HccCHHHHHHHHHHHHHHHHcCCCCeeEE
Confidence 57999999999999999999975 7999999998311 11123455779999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.+++..|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +++||||||||+|||+++++.+|
T Consensus 74 ~~~~~~~~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vk 148 (288)
T d1uu3a_ 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQ 148 (288)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEE
T ss_pred EEEEEECCEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEE
Confidence 99999999999999999999999998864 45899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
|+|||+|+..............+||+.|||||++.+..++.++||||+||++|||++|+.||... +.........
T Consensus 149 l~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~~i~ 223 (288)
T d1uu3a_ 149 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEYLIFQKII 223 (288)
T ss_dssp ECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHH
T ss_pred ecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc-----CHHHHHHHHH
Confidence 99999999876544433344567999999999999999999999999999999999999999532 2222222222
Q ss_pred cccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 868 DSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 868 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
..... ++......+.+++.+|++.||++|||+.|+.+
T Consensus 224 ~~~~~-----------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 224 KLEYD-----------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TTCCC-----------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred cCCCC-----------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 21111 12223456788999999999999999999754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=410.70 Aligned_cols=256 Identities=21% Similarity=0.301 Sum_probs=205.4
Q ss_pred hccCCccc-ccccCceeEEEEEeC---CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENL-IGKGGSGNVYKVVLN---SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~-iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|.+.+. ||+|+||+||+|.++ ++..||||++.... .....++|.+|++++++++||||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~----------------~~~~~~~~~~E~~il~~l~HpnI 71 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----------------EKADTEEMMREAQIMHQLDNPYI 71 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----------------CHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc----------------CHHHHHHHHHHHHHHHhCCCCCE
Confidence 45556664 999999999999864 35579999984221 11234679999999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
|+++|++.. +..|+||||+++|+|.+++... +..+++..+..++.|||.||+||| +++|+||||||+||+++.++
T Consensus 72 v~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~ 146 (285)
T d1u59a_ 72 VRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRH 146 (285)
T ss_dssp CCEEEEEES-SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETT
T ss_pred eeEeeeecc-CeEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCC
Confidence 999999975 4689999999999999998653 346899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCC-cceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
.+||+|||+|+........ .......||+.|+|||++..+.++.++|||||||++|||+| |+.||... ...++...
T Consensus 147 ~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~--~~~~~~~~ 224 (285)
T d1u59a_ 147 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAF 224 (285)
T ss_dssp EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CTHHHHHH
T ss_pred ceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC--CHHHHHHH
Confidence 9999999999877654322 22234568999999999999999999999999999999998 89998543 12222222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
+. . ....+.+...+..+.+++.+||+.||++||||.+|.+.|+..
T Consensus 225 i~----~---------~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 225 IE----Q---------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HH----T---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----c---------CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 1 111223334556788999999999999999999999998853
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=409.01 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=192.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... .....+.+.+|++++++++|||||++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---------------~~~~~~~~~~E~~il~~l~HpnIv~~ 68 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---------------TEAEKQMLVSEVNLLRELKHPNIVRY 68 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS---------------CHHHHHHHHHHHHHTTSCCCTTBCCE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC---------------CHHHHHHHHHHHHHHHHCCCCCEeeE
Confidence 67999999999999999999965 789999999843211 11234678899999999999999999
Q ss_pred EEEEec--CCccEEEEeccCCCChHHHhhhc--CCccCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEeccCCCCCeEec
Q 002250 708 YCSITS--EDSNLLVYEYLPNGSLWDRLHTC--HKIEMDWVVRYAIAVGAAKGLEYLHHGF--DRPVIHRDVKSSNILLD 781 (947)
Q Consensus 708 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~Dlkp~NIll~ 781 (947)
++++.+ ++..|+||||+++|+|.+++.+. ....+++..++.++.|++.||+|||+.. ..+|+||||||+|||++
T Consensus 69 ~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~ 148 (269)
T d2java1 69 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 148 (269)
T ss_dssp EEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC
T ss_pred EEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC
Confidence 999865 45679999999999999999753 3456899999999999999999999421 23599999999999999
Q ss_pred CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
.++.+||+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||+||+.||... +..+
T Consensus 149 ~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~-----~~~~ 221 (269)
T d2java1 149 GKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-----SQKE 221 (269)
T ss_dssp TTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHH
T ss_pred CCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC-----CHHH
Confidence 999999999999987654322 223467999999999999999999999999999999999999999532 1222
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
....... ......+...+.++.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~i~~----------~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 222 LAGKIRE----------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHH----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHc----------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2111111 1111222334456889999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=412.79 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=202.6
Q ss_pred hccCCcccccccCceeEEEEEeCCC-----cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSG-----KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.|+..+.||+|+||+||+|.++.. ..||||++.... .......|.+|++++++++|||
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~----------------~~~~~~~~~~E~~il~~l~H~n 70 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----------------TEKQRVDFLGEAGIMGQFSHHN 70 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHTCCCTT
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc----------------ChHHHHHHHHHHHHHHhcCCCC
Confidence 4577889999999999999996632 379999984211 1123456899999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
||+++|++.+++..++||||+++|++.+++... ...++|..+..++.|||.||+||| +++|+||||||+|||++.+
T Consensus 71 Iv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~ 146 (283)
T d1mqba_ 71 IIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSN 146 (283)
T ss_dssp BCCEEEEECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred EeeeeEEEecCCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCC
Confidence 999999999999999999999999999988763 456999999999999999999999 8999999999999999999
Q ss_pred CCeEEeccccceecccCCCC-cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||+|+........ .......||+.|||||++.++.++.++|||||||++|||++|..|+.... ....+.+.
T Consensus 147 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-~~~~~~~~ 225 (283)
T d1mqba_ 147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKA 225 (283)
T ss_dssp CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHH
T ss_pred CeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-CHHHHHHH
Confidence 99999999999876543322 12234568999999999999999999999999999999999777764322 12222222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCC
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPCS 924 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 924 (947)
+.. +...+.+.+.+..+.+++.+||+.||++||||.||+++|+++...|
T Consensus 226 i~~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 226 IND-------------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp HHT-------------TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred Hhc-------------cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 111 1112223344567899999999999999999999999998765544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=416.01 Aligned_cols=257 Identities=22% Similarity=0.299 Sum_probs=207.7
Q ss_pred hccCCcccccccCceeEEEEEeCC-C-----cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS-G-----KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RH 701 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 701 (947)
++|++.+.||+|+||+||+|+... + ..||||++.... .......+.+|+.+++++ +|
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~H 100 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----------------DSSEREALMSELKMMTQLGSH 100 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------------------CHHHHHHHHHHHHHCCC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc----------------CHHHHHHHHHHHHHHHHhcCC
Confidence 578899999999999999999642 2 369999884221 123456789999999998 89
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcCC---------------------ccCCHHHHHHHHHHHHHHHHHH
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHK---------------------IEMDWVVRYAIAVGAAKGLEYL 760 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~ia~~l~yL 760 (947)
||||++++++.+++..++||||+++|+|.++++.... ..+++..++.++.||++||+||
T Consensus 101 pnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yL 180 (325)
T d1rjba_ 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 180 (325)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH
T ss_pred CcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999976422 3479999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHH
Q 002250 761 HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLM 840 (947)
Q Consensus 761 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ 840 (947)
| +++||||||||+||+++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|
T Consensus 181 H---~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~ 257 (325)
T d1rjba_ 181 E---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257 (325)
T ss_dssp H---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred H---hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHH
Confidence 9 8999999999999999999999999999998776655444444567899999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 841 ELVT-GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 841 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
||+| |+.||.... ....+...+.. ... .+.+...+..+.+++.+||+.||++||||+||+++|.
T Consensus 258 emlt~g~~Pf~~~~-~~~~~~~~~~~----~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 258 EIFSLGVNPYPGIP-VDANFYKLIQN----GFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHTTTSCCSSTTCC-CSHHHHHHHHT----TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhCCCCCCCCCC-HHHHHHHHHhc----CCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9998 899985321 22222222221 111 1222334567889999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=408.13 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=206.0
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|++++++.||||++... ....+.|.+|+.++++++|||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~------------------~~~~~~~~~E~~~l~~l~h~nIv~~~ 78 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG------------------TMSPEAFLQEAQVMKKLRHEKLVQLY 78 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT------------------SSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc------------------cCCHHHHHHHHHHHHhcccCCEeEEE
Confidence 679999999999999999999998889999998421 13346799999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
|++.+ +..++||||+++|+|.+++.......++|..+..++.|||.||+||| +.+|+||||||+|||+++++.+||
T Consensus 79 g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl 154 (285)
T d1fmka3 79 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKV 154 (285)
T ss_dssp EEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEE
Confidence 99854 56899999999999999988755566999999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMD 868 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 868 (947)
+|||+|+........ ......||+.|+|||++..+.++.++|||||||++|||+||+.|+..... ...+...+..
T Consensus 155 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~i~~--- 229 (285)
T d1fmka3 155 ADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVER--- 229 (285)
T ss_dssp CCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHT---
T ss_pred cccchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHHh---
Confidence 999999876544322 23345689999999999999999999999999999999998777643322 2222222211
Q ss_pred ccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 002250 869 SRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEPC 923 (947)
Q Consensus 869 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 923 (947)
.. ..+.+...++.+.+++.+||+.||++||||.+|+++|++.-..
T Consensus 230 ~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 230 GY----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cC----------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 11 1112333455788999999999999999999999999985543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-46 Score=405.29 Aligned_cols=256 Identities=24% Similarity=0.306 Sum_probs=193.4
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+++.+.|++.+.||+|+||+||+|+.+ +|+.||||++..... ......+.+|+.++++++|||
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----------------~~~~~~~~~Ei~il~~l~Hpn 68 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL----------------EGKEGSMENEIAVLHKIKHPN 68 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------------------CHHHHHHHTCCCTT
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh----------------hhHHHHHHHHHHHHHhCCCCC
Confidence 345678999999999999999999965 689999999843211 122345789999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec--
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD-- 781 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~-- 781 (947)
||++++++.+++..|+||||+++|+|.+++... ..+++.....++.||+.||+||| +++|+||||||+||++.
T Consensus 69 Iv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~ 143 (307)
T d1a06a_ 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSL 143 (307)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSS
T ss_pred CCcEEEEEEECCEEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeeccc
Confidence 999999999999999999999999999999863 46899999999999999999999 89999999999999995
Q ss_pred -CCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 782 -LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 782 -~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
+++.+||+|||+|+....... ....+||+.|||||++.+..++.++||||+||++|||++|+.||... ...
T Consensus 144 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~ 215 (307)
T d1a06a_ 144 DEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE-----NDA 215 (307)
T ss_dssp STTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHH
T ss_pred CCCceEEEeccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC-----CHH
Confidence 578999999999986654332 23457999999999999999999999999999999999999999532 222
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
+............. .+.....++.+.+++.+|++.||++|||+.|++++
T Consensus 216 ~~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 216 KLFEQILKAEYEFD-------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHHTTCCCCC-------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhccCCCCC-------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 22222222211110 11122334568899999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=403.43 Aligned_cols=249 Identities=22% Similarity=0.270 Sum_probs=198.3
Q ss_pred ccccccCceeEEEEEeC---CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEE
Q 002250 635 NLIGKGGSGNVYKVVLN---SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSI 711 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 711 (947)
+.||+|+||+||+|.++ .++.||||++.... ......+.|.+|++++++++|||||+++|+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---------------~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~ 77 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------------NDPALKDELLAEANVMQQLDNPYIVRMIGIC 77 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh---------------CCHHHHHHHHHHHHHHHhCCCCCCceEEEEe
Confidence 46999999999999864 35689999984211 1112346799999999999999999999999
Q ss_pred ecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEecc
Q 002250 712 TSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADF 791 (947)
Q Consensus 712 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 791 (947)
.. +..++||||+++|+|.+++... ..+++..+..++.|||.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 78 ~~-~~~~lvmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DF 151 (277)
T d1xbba_ 78 EA-ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDF 151 (277)
T ss_dssp ES-SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred cc-CCEEEEEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccch
Confidence 65 4678999999999999999864 45899999999999999999999 889999999999999999999999999
Q ss_pred ccceecccCCCCc-ceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhccc
Q 002250 792 GLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSKMDS 869 (947)
Q Consensus 792 G~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 869 (947)
|+|+......... ......||++|||||++.+..++.++|||||||++|||+| |+.||... ...++...+. .
T Consensus 152 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--~~~~~~~~i~----~ 225 (277)
T d1xbba_ 152 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLE----K 225 (277)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHH----T
T ss_pred hhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC--CHHHHHHHHH----c
Confidence 9998765443322 2234568999999999999999999999999999999998 89998532 1122222211 1
Q ss_pred cccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 002250 870 RDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEE 919 (947)
Q Consensus 870 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 919 (947)
. ...+.+..++..+.+++.+||+.||++||||.+|.+.|+.
T Consensus 226 ~---------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 226 G---------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred C---------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1 1122233445678899999999999999999999998875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=405.18 Aligned_cols=252 Identities=23% Similarity=0.274 Sum_probs=203.0
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
+.|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++|||||++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-----------------~~~~~~~~~~E~~il~~l~HpnIv~l 74 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-----------------SEEELEDYMVEIDILASCDHPNIVKL 74 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------------SSGGGGGTHHHHHHHHHCCCTTBCCE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-----------------CHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 46888999999999999999965 7899999998421 12334678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.+++..++||||+++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~~~~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~K 150 (288)
T d2jfla1 75 LDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIK 150 (288)
T ss_dssp EEEEEETTEEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEE
T ss_pred EEEEeeCCeEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEE
Confidence 99999999999999999999999998753 346899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAY-----TCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
|+|||+|+...... .......||+.|+|||++. ...|+.++|||||||++|||+||+.||.... ..+...
T Consensus 151 l~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~--~~~~~~- 225 (288)
T d2jfla1 151 LADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLL- 225 (288)
T ss_dssp ECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC--GGGHHH-
T ss_pred EEechhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC--HHHHHH-
Confidence 99999997654321 1122457999999999984 4558899999999999999999999995431 122221
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
....... .....+...+..+.+++.+||+.||++|||+.|++++
T Consensus 226 --~i~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 226 --KIAKSEP--------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --HHHHSCC--------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --HHHcCCC--------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111 0011122344568899999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=400.42 Aligned_cols=250 Identities=27% Similarity=0.379 Sum_probs=200.5
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||.||+|+++ |+.||||+++. ....+.|.+|++++++++||||++++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~-------------------~~~~~~~~~E~~~l~~l~HpnIv~~~ 66 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN-------------------DATAQAFLAEASVMTQLRHSNLVQLL 66 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC-------------------CC--HHHHHTHHHHTTCCCTTBCCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc-------------------HHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 56888899999999999999996 78999999831 13346789999999999999999999
Q ss_pred EEEec-CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 709 CSITS-EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 709 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
|++.+ ++..++||||+++|+|.+++.......++|..+++++.|||.||+||| +.+|+||||||+||+++.++.+|
T Consensus 67 g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~k 143 (262)
T d1byga_ 67 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 143 (262)
T ss_dssp EEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred EEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEe
Confidence 99865 566899999999999999998765567899999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 866 (947)
++|||+++...... ....+|..|+|||++.++.++.++|||||||++|||+| |+.||... ...++...+..
T Consensus 144 l~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~- 215 (262)
T d1byga_ 144 VSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEK- 215 (262)
T ss_dssp ECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTT-
T ss_pred ecccccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHc-
Confidence 99999998654332 23467899999999999999999999999999999999 67766432 33344433311
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
...++++...+.++.+++.+||+.||++||||.|++++|++++
T Consensus 216 ------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 216 ------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp ------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1112233344567889999999999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=395.48 Aligned_cols=246 Identities=27% Similarity=0.373 Sum_probs=193.4
Q ss_pred CCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEE
Q 002250 632 KPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710 (947)
Q Consensus 632 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 710 (947)
+..+.||+|+||+||+|+.. +++.||||++.... ......+.+.+|++++++++|||||+++++
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~---------------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~ 76 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---------------LTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---------------SCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---------------CCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 55678999999999999965 68899999983211 111234678999999999999999999999
Q ss_pred Eec----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEeccCCCCCeEec-CC
Q 002250 711 ITS----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRP--VIHRDVKSSNILLD-LE 783 (947)
Q Consensus 711 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dlkp~NIll~-~~ 783 (947)
+.. +...|+||||+++|+|.+++.+. ..+++..+..++.||++||+||| +++ |+||||||+|||++ ++
T Consensus 77 ~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~ 151 (270)
T d1t4ha_ 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPT 151 (270)
T ss_dssp EEEESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTT
T ss_pred EeeccccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCC
Confidence 865 34578999999999999999864 45889999999999999999999 666 99999999999996 57
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
+.+||+|||+|+...... ....+||+.|||||++.+ .++.++|||||||++|||++|+.||... .+.....
T Consensus 152 ~~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~----~~~~~~~ 222 (270)
T d1t4ha_ 152 GSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC----QNAAQIY 222 (270)
T ss_dssp SCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHHHHH
T ss_pred CCEEEeecCcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc----ccHHHHH
Confidence 899999999997543322 235679999999998865 6999999999999999999999998532 1122211
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
. .+..... .........+++.+++.+||+.||++|||+.|+++
T Consensus 223 ~-~i~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 223 R-RVTSGVK--------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp H-HHTTTCC--------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred H-HHHcCCC--------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 1111110 01111223345788999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=412.50 Aligned_cols=268 Identities=23% Similarity=0.339 Sum_probs=204.2
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... .......+.+|+.++++++|||||+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----------------~~~~~~~~~~Ei~il~~l~HpnIv~ 68 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----------------KPAIRNQIIRELQVLHECNSPYIVG 68 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC----------------CTTHHHHHHHHGGGGGGCCCTTBCC
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh----------------CHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 367999999999999999999965 78999999984221 1123467889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
++++|.+++..|+||||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+ .++|+||||||+|||++.++.+
T Consensus 69 l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~v 144 (322)
T d1s9ja_ 69 FYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEI 144 (322)
T ss_dssp EEEEEECSSEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCE
T ss_pred EEEEEEECCEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCE
Confidence 9999999999999999999999999998643 58999999999999999999993 2489999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+|+...... ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+...............
T Consensus 145 kl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~ 220 (322)
T d1s9ja_ 145 KLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220 (322)
T ss_dssp EECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----
T ss_pred EEeeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhc
Confidence 999999998664432 2245899999999999999999999999999999999999999965422111000000000
Q ss_pred c----------cccccc-c----------------ccccCCCCccC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--
Q 002250 867 M----------DSRDSM-L----------------TVVDPNISEIL-KEDALKVLRIAIHCTNKLPAFRPSMRVVVQM-- 916 (947)
Q Consensus 867 ~----------~~~~~~-~----------------~~~d~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~-- 916 (947)
. ...... . .......+..+ .....++.+++.+|++.||++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 221 GDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp -------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence 0 000000 0 00000000000 0123468889999999999999999999874
Q ss_pred hhc
Q 002250 917 LEE 919 (947)
Q Consensus 917 L~~ 919 (947)
+++
T Consensus 301 ~~~ 303 (322)
T d1s9ja_ 301 IKR 303 (322)
T ss_dssp HHH
T ss_pred hCc
Confidence 544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-47 Score=407.47 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=210.1
Q ss_pred hhccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH 701 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 701 (947)
.++|++.+.||+|+||+||+|+.+ +++.||||++.... .....++|.+|++++++++|
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----------------~~~~~~~~~~E~~il~~l~h 75 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----------------SADMQADFQREAALMAEFDN 75 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----------------CHHHHHHHHHHHHHHHTCCC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc----------------ChHHHHHHHHHHHHHHhcCC
Confidence 367899999999999999999864 35789999984211 11234678999999999999
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcC----------------------CccCCHHHHHHHHHHHHHHHHH
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH----------------------KIEMDWVVRYAIAVGAAKGLEY 759 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~ia~~l~y 759 (947)
|||+++++++..++..++||||+++|+|.+++.... ...+++..++.++.|+|.||+|
T Consensus 76 ~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 155 (301)
T d1lufa_ 76 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAY 155 (301)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred CCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhh
Confidence 999999999999999999999999999999997532 2347899999999999999999
Q ss_pred HhcCCCCCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHH
Q 002250 760 LHHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839 (947)
Q Consensus 760 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l 839 (947)
|| +++||||||||+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++
T Consensus 156 lH---~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl 232 (301)
T d1lufa_ 156 LS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232 (301)
T ss_dssp HH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cc---cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhH
Confidence 99 899999999999999999999999999999876554444444456789999999999999999999999999999
Q ss_pred HHHHhCC-CCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 840 MELVTGK-RPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 840 ~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
|||++|. +||... ...++...+ . ++..++.+...+.++.+++.+||+.||++||||.||+++|+
T Consensus 233 ~ell~~~~~p~~~~--~~~e~~~~v---~----------~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 233 WEIFSYGLQPYYGM--AHEEVIYYV---R----------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp HHHHTTTCCTTTTS--CHHHHHHHH---H----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHccCCCCCCCC--CHHHHHHHH---H----------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9999986 455322 122222211 1 11222333445567899999999999999999999999999
Q ss_pred ccC
Q 002250 919 EAE 921 (947)
Q Consensus 919 ~~~ 921 (947)
++.
T Consensus 298 ~i~ 300 (301)
T d1lufa_ 298 RMC 300 (301)
T ss_dssp HTT
T ss_pred Hhc
Confidence 864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=396.61 Aligned_cols=261 Identities=23% Similarity=0.285 Sum_probs=209.8
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.+.++|++.+.||+|+||+||+|+.+ +|+.||||++....... .......+.+.+|++++++++|||
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~-----------~~~~~~~~~~~~E~~il~~l~Hpn 74 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKS-----------SRRGVSREDIEREVSILKEIQHPN 74 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTT-----------CSSSBCHHHHHHHHHHHHHCCCTT
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcch-----------hhhhHHHHHHHHHHHHHHhCCCCC
Confidence 345578999999999999999999975 79999999995432211 112234578999999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
||++++++.+++..|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 75 Iv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~ 149 (293)
T d1jksa_ 75 VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDR 149 (293)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCS
T ss_pred CCcEEEEEEECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecC
Confidence 999999999999999999999999999999874 35899999999999999999999 8999999999999999877
Q ss_pred C----CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 784 W----KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 784 ~----~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
+ .+|++|||+|+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||... +.
T Consensus 150 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~ 221 (293)
T d1jksa_ 150 NVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TK 221 (293)
T ss_dssp SSSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SH
T ss_pred CCcccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC-----CH
Confidence 6 499999999987654432 22457899999999999989999999999999999999999999532 22
Q ss_pred HHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 860 VNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.+............. .......+..+.+++.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 222 QETLANVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHHHTTCCCCC-------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHhcCCCCC-------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222222111111100 11112234567889999999999999999999873
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-47 Score=405.63 Aligned_cols=249 Identities=27% Similarity=0.344 Sum_probs=200.5
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.+.|+..+.||+|+||+||+|+.. +|+.||||++..... ......+.+.+|++++++++|||||+
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--------------~~~~~~~~~~~Ei~il~~l~HpnIv~ 79 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--------------QSNEKWQDIIKEVRFLQKLRHPNTIQ 79 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS--------------CHHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc--------------cCHHHHHHHHHHHHHHHHCCCCCEee
Confidence 456899999999999999999965 789999999843211 01123356889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..|+||||+++|++..++.. ...+++..+..++.||+.||+||| +++||||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~~~~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~ 154 (309)
T d1u5ra_ 80 YRGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLV 154 (309)
T ss_dssp EEEEEEETTEEEEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEE
T ss_pred EEEEEEECCEEEEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCE
Confidence 99999999999999999999999776655 346899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT---CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
||+|||+|+..... ....||+.|||||++.+ +.|+.++|||||||++|||++|+.||... ...+..
T Consensus 155 Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-----~~~~~~ 223 (309)
T d1u5ra_ 155 KLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSAL 223 (309)
T ss_dssp EECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHH
T ss_pred EEeecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-----CHHHHH
Confidence 99999999865432 24579999999999864 45899999999999999999999998532 112222
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
......... .+ .....++.+.+++.+||+.||++|||+.|+++
T Consensus 224 ~~i~~~~~~-------~~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 224 YHIAQNESP-------AL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHSCCC-------CC--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHhCCCC-------CC--CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 222211111 01 11123456888999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.6e-46 Score=405.95 Aligned_cols=256 Identities=21% Similarity=0.305 Sum_probs=208.6
Q ss_pred HHHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
+.+.++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.++++++|||
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-----------------~~~~~~~~~~E~~il~~l~Hpn 84 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----------------HESDKETVRKEIQTMSVLRHPT 84 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-----------------SHHHHHHHHHHHHHHHHTCCTT
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-----------------chhhHHHHHHHHHHHHhCCCCC
Confidence 456789999999999999999999965 7999999998421 1123467889999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC-
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL- 782 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~- 782 (947)
||++++++.+++..|+||||+++|+|.+++... ...+++..+..++.||+.||+||| +.+||||||||+|||++.
T Consensus 85 Iv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~ 160 (350)
T d1koaa2 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTK 160 (350)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESST
T ss_pred CCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccC
Confidence 999999999999999999999999999999653 345899999999999999999999 899999999999999964
Q ss_pred -CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 783 -EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 783 -~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
++.+||+|||+|+....... .....||+.|||||++.+..++.++||||+||++|||++|+.||... +..+
T Consensus 161 ~~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~ 232 (350)
T d1koaa2 161 RSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDE 232 (350)
T ss_dssp TSCCEEECCCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHH
T ss_pred CCCeEEEeecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-----CHHH
Confidence 57899999999987654432 33467999999999999999999999999999999999999999532 2222
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
............. ..........+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 233 TLRNVKSCDWNMD-------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHTCCCSC-------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhCCCCCC-------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222221111110 11112234567889999999999999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=406.22 Aligned_cols=258 Identities=24% Similarity=0.329 Sum_probs=203.4
Q ss_pred hccCCcccccccCceeEEEEEeC-CCc----EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGK----ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVN 703 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 703 (947)
.+|++.+.||+|+||+||+|++. +|+ +||||++... ......+.|.+|++++++++|||
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----------------~~~~~~~~~~~E~~~l~~l~Hpn 72 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------------TSPKANKEILDEAYVMASVDNPH 72 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------------------CTHHHHHHHHHHHHHCCCTT
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc----------------cCHHHHHHHHHHHHHHHhCCCCC
Confidence 35889999999999999999965 444 5888887321 11234567999999999999999
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
||+++|+|.++ ..++++||+.+|+|.+++... ...+++..++.++.|||.||+||| +++||||||||+||+++.+
T Consensus 73 Iv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~ 147 (317)
T d1xkka_ 73 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTP 147 (317)
T ss_dssp BCCEEEEEESS-SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEET
T ss_pred EeeEEEEEecC-CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCC
Confidence 99999999865 567889999999999988763 457899999999999999999999 8899999999999999999
Q ss_pred CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 784 WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
+.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |+.||... ....+...
T Consensus 148 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~--~~~~~~~~ 225 (317)
T d1xkka_ 148 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSI 225 (317)
T ss_dssp TEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CGGGHHHH
T ss_pred CCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC--CHHHHHHH
Confidence 9999999999987765554444445578999999999999999999999999999999999 77787432 22233332
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
+... ...+.+..++..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 226 i~~~-------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 226 LEKG-------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHT-------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcC-------------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 2211 1112223345678899999999999999999999999887643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=395.39 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=195.5
Q ss_pred hccCCcccccccCceeEEEEEeCC----CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS----GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|++.+.||+|+||+||+|++.. +..||||++... ......+.|.+|+.++++++||||
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----------------~~~~~~~~~~~E~~~l~~l~HpnI 70 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----------------TSDSVREKFLQEALTMRQFDHPHI 70 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----------------TSHHHHHHHHHHHHHHHTCCCTTB
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----------------cCHHHHHHHHHHHHHHHhCCCCCE
Confidence 678999999999999999998652 346899987311 111234678999999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
|+++|++. ++..++||||+++|++.+++... ...+++..+..++.||++||+||| +++|+||||||+||+++.++
T Consensus 71 v~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~ 145 (273)
T d1mp8a_ 71 VKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSND 145 (273)
T ss_dssp CCEEEEEC-SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETT
T ss_pred eeEEEEEe-cCeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCC
Confidence 99999996 46789999999999999987763 456899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 863 (947)
.+||+|||+|+........ ......||+.|+|||++....++.++|||||||++|||+| |.+||... ...++...+
T Consensus 146 ~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~--~~~~~~~~i 222 (273)
T d1mp8a_ 146 CVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRI 222 (273)
T ss_dssp EEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHH
T ss_pred cEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC--CHHHHHHHH
Confidence 9999999999876543322 2234568999999999999999999999999999999998 78888533 222333222
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.. ....+.+...+..+.+++.+||+.||++|||+.||++.|+++
T Consensus 223 ~~-------------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 223 EN-------------GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp HT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hc-------------CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 111122334456788999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.9e-45 Score=401.15 Aligned_cols=255 Identities=20% Similarity=0.298 Sum_probs=208.0
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
.+.+.|++.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++++++||||
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------------~~~~~~~~~Ei~il~~l~HpnI 88 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----------------PLDKYTVKNEISIMNQLHHPKL 88 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----------------HHHHHHHHHHHHHHTTCCSTTB
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----------------hhHHHHHHHHHHHHHhCCCCCC
Confidence 45578999999999999999999964 79999999984211 1223568899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec--C
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD--L 782 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~--~ 782 (947)
|+++++|.+++..|+||||+++|+|.+++... ...+++.....++.||+.||+||| +.+|+||||||+|||++ .
T Consensus 89 v~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~ 164 (352)
T d1koba_ 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKK 164 (352)
T ss_dssp CCEEEEEECSSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTT
T ss_pred CcEEEEEEECCEEEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccC
Confidence 99999999999999999999999999988753 346899999999999999999999 89999999999999998 6
Q ss_pred CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
++.+||+|||+|+....... .....||+.|+|||++.+..++.++||||+||++|||+||+.||... +..+.
T Consensus 165 ~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~ 236 (352)
T d1koba_ 165 ASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDLET 236 (352)
T ss_dssp CCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHH
T ss_pred CCeEEEeecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-----CHHHH
Confidence 78999999999987765432 33457999999999999999999999999999999999999999532 22222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
............ .......+..+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 237 LQNVKRCDWEFD-------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHHCCCCCC-------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCCCC-------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222211111100 11222334567899999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=392.60 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=197.8
Q ss_pred hccCCcccccccCceeEEEEEeC--CC--cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN--SG--KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++|++.+.||+|+||+||+|+.. ++ ..||||++.+... ......+.|.+|+.++++++||||
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~--------------~~~~~~~~~~~Ei~~l~~l~H~nI 73 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--------------SQPEAMDDFIREVNAMHSLDHRNL 73 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------------------CHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc--------------CCHHHHHHHHHHHHHHHhCCCCCE
Confidence 56889999999999999999854 23 3789998843211 112334679999999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
|+++|++.+ ...++||||+++|++.+++... ...+++..+..++.|+|.||+||| +++|+||||||+||+++.++
T Consensus 74 v~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~ 148 (273)
T d1u46a_ 74 IRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRD 148 (273)
T ss_dssp CCEEEEECS-SSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETT
T ss_pred EEEEEEEee-cchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhcccccc
Confidence 999999976 4678999999999999988763 346899999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCc-ceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGD-LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT-GKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 862 (947)
.+||+|||+++......... ......||..|+|||++.+..++.++|||||||++|||+| |+.||... +..+.
T Consensus 149 ~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~~~ 223 (273)
T d1u46a_ 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQI 223 (273)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHH
T ss_pred ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-----CHHHH
Confidence 99999999999775543322 2234467889999999999999999999999999999998 89998432 22222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
.......... .+.+...+..+.+++.+||+.||++||||.||.+.|+++
T Consensus 224 ~~~i~~~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 224 LHKIDKEGER---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHTSCCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhCCCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2222211111 112233345688999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.5e-45 Score=392.45 Aligned_cols=249 Identities=24% Similarity=0.329 Sum_probs=205.4
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.+ +|+.||||++... ........+.+.+|+.++++++|||||+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~--------------~~~~~~~~~~~~~E~~il~~l~HpnIv~ 68 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE--------------IVVRLKQVEHTNDERLMLSIVTHPFIIR 68 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHHSCCBTTBCC
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchH--------------HccCHHHHHHHHHHHHHHHhccCcChhh
Confidence 367999999999999999999965 6999999998311 1122345678899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..|+||||++||++.+++... ...++.....++.||+.||+||| +++|+||||||+|||++.++.+
T Consensus 69 ~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~v 143 (316)
T d1fota_ 69 MWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHI 143 (316)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCE
T ss_pred eeeeEeeCCeeeeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCE
Confidence 999999999999999999999999998874 34678888889999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+|+...... ...+||+.|||||++.+..++.++||||+||++|||++|+.||... +..+.....
T Consensus 144 kL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~i 213 (316)
T d1fota_ 144 KITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NTMKTYEKI 213 (316)
T ss_dssp EECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHH
T ss_pred EEecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-----CHHHHHHHH
Confidence 999999998765432 2467999999999999989999999999999999999999999532 222222222
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 916 (947)
...... .+...+..+.+++.+|+..||.+|| |++|++++
T Consensus 214 ~~~~~~-----------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 214 LNAELR-----------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHCCCC-----------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HcCCCC-----------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 222111 1122335678899999999999996 89998864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=393.87 Aligned_cols=252 Identities=24% Similarity=0.295 Sum_probs=206.0
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.+ +|+.||||++... ..........+.+|+.++++++||||++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~--------------~~~~~~~~~~~~~E~~il~~l~hp~Iv~ 69 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE--------------VIIAKDEVAHTVTESRVLQNTRHPFLTA 69 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHHSCCCTTBCC
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchh--------------hccCHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 367999999999999999999965 7999999998311 1112244577889999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..|+||||+++|+|.+++...+ .+++.....++.|++.||+||| +++|+||||||+|||++.+|.+
T Consensus 70 l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~v 144 (337)
T d1o6la_ 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHI 144 (337)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred EEeeeccccccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCE
Confidence 9999999999999999999999999998743 5788888999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+|+....... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||... +..+.....
T Consensus 145 kl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~-----~~~~~~~~i 217 (337)
T d1o6la_ 145 KITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHERLFELI 217 (337)
T ss_dssp EECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHH
T ss_pred EEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc-----CHHHHHHHH
Confidence 9999999986543322 233467999999999999999999999999999999999999999542 222222222
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-----MRVVVQM 916 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~ 916 (947)
..... .++.....++.+++.+|++.||++||+ +.|++++
T Consensus 218 ~~~~~-----------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 218 LMEEI-----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHCCC-----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hcCCC-----------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 21111 112233456788999999999999995 7888763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=395.69 Aligned_cols=259 Identities=24% Similarity=0.305 Sum_probs=198.8
Q ss_pred hccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RH 701 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 701 (947)
++|++.+.||+|+||+||+|+.. +++.||||++.... .....+.+.+|+.++.++ .|
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----------------~~~~~~~~~~e~~~l~~~~~h 76 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----------------THSEHRALMSELKILIHIGHH 76 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------------------CHHHHHHHHHHHHHHHHHCCC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----------------CcHHHHHHHHHHHHHHhhcCC
Confidence 67899999999999999999853 34689999984211 112345677888888887 68
Q ss_pred cccceEEEEEecC-CccEEEEeccCCCChHHHhhhcC--------------CccCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 002250 702 VNVVKLYCSITSE-DSNLLVYEYLPNGSLWDRLHTCH--------------KIEMDWVVRYAIAVGAAKGLEYLHHGFDR 766 (947)
Q Consensus 702 ~niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~ 766 (947)
+||+.+++++..+ ...++||||+++|+|.++++... ...+++..+..++.|||+||+||| ++
T Consensus 77 ~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~ 153 (299)
T d1ywna1 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SR 153 (299)
T ss_dssp TTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred CeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 9999999998765 45799999999999999997542 234889999999999999999999 89
Q ss_pred CeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCC
Q 002250 767 PVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGK 846 (947)
Q Consensus 767 ~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~ 846 (947)
+||||||||+|||+++++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||.
T Consensus 154 ~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~ 233 (299)
T d1ywna1 154 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233 (299)
T ss_dssp TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCC
Confidence 99999999999999999999999999998766554444444567999999999999999999999999999999999975
Q ss_pred C-CCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 847 R-PIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 847 ~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
. ||.. ......+...+... . ..+.+...++++.+++.+||+.||++||||.|++++|+++
T Consensus 234 ~~p~~~-~~~~~~~~~~~~~~----~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 234 ASPYPG-VKIDEEFCRRLKEG----T---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCSSTT-CCCSHHHHHHHHHT----C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCC-CCHHHHHHHHHhcC----C---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 4 5532 22222232222111 1 1122233445688999999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=394.82 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=212.8
Q ss_pred hccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RH 701 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 701 (947)
++|++.+.||+|+||.||+|++. +++.||||++++.. .......|.+|+.+++++ +|
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----------------~~~~~~~~~~E~~~~~~l~~H 86 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----------------HLTEREALMSELKVLSYLGNH 86 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHHHCCC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc----------------CHHHHHHHHHHHHHHHhccCC
Confidence 68888999999999999999852 46789999995321 112345788999999999 69
Q ss_pred cccceEEEEEecCCccEEEEeccCCCChHHHhhhcC----------------CccCCHHHHHHHHHHHHHHHHHHhcCCC
Q 002250 702 VNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH----------------KIEMDWVVRYAIAVGAAKGLEYLHHGFD 765 (947)
Q Consensus 702 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~ 765 (947)
||||+++|++.++...++||||+++|+|.++++... ...+++..+..++.|||+||+||| +
T Consensus 87 pnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~ 163 (311)
T d1t46a_ 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---S 163 (311)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 999999999999999999999999999999997642 235889999999999999999999 8
Q ss_pred CCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhC
Q 002250 766 RPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTG 845 (947)
Q Consensus 766 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg 845 (947)
++||||||||+||+++.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+|+
T Consensus 164 ~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~ 243 (311)
T d1t46a_ 164 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243 (311)
T ss_dssp TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhC
Confidence 99999999999999999999999999999987665544445567899999999999999999999999999999999996
Q ss_pred CCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 846 KRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 846 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
+.|+.........+.+.+..... ...+...+..+.+++.+||+.||++||||.|++++|++.
T Consensus 244 g~p~~~~~~~~~~~~~~i~~~~~-------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 244 GSSPYPGMPVDSKFYKMIKEGFR-------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp TCCSSTTCCSSHHHHHHHHHTCC-------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhcCCC-------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 66654433333333333322111 111223346688999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=396.34 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=202.5
Q ss_pred HHHhhccCCcc-cccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-cc
Q 002250 625 KEIIDAVKPEN-LIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RH 701 (947)
Q Consensus 625 ~~~~~~~~~~~-~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 701 (947)
..+.++|++.. .||+|+||+||+|+. .+++.||||++. ....+.+|+.++.++ +|
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~----------------------~~~~~~~E~~~~~~~~~h 64 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----------------------DCPKARREVELHWRASQC 64 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE----------------------CSHHHHHHHHHHHHHTTS
T ss_pred CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEEC----------------------CcHHHHHHHHHHHHhcCC
Confidence 44568898864 699999999999996 479999999982 235678899997665 89
Q ss_pred cccceEEEEEec----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 702 VNVVKLYCSITS----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 702 ~niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
||||+++++|.+ +...|+||||++||+|.+++...+...+++.....++.||+.||+||| +.+|+||||||+|
T Consensus 65 pnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~N 141 (335)
T d2ozaa1 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 141 (335)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGG
T ss_pred CCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccc
Confidence 999999999875 456799999999999999998766667999999999999999999999 8999999999999
Q ss_pred eEecC---CCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 002250 778 ILLDL---EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFG 854 (947)
Q Consensus 778 Ill~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~ 854 (947)
||++. ++.+||+|||+|+....... .....||+.|||||++.+..|+.++||||+||++|||+||+.||.....
T Consensus 142 Ill~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 142 LLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp EEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred cccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 99985 46799999999987655433 2345799999999999999999999999999999999999999954321
Q ss_pred CcccHHHHHHhhccccccccccccCCC-CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 855 DSKDIVNWVYSKMDSRDSMLTVVDPNI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.............. ...+ .......+.++.+++.+|++.||++|||+.|++++
T Consensus 219 --~~~~~~~~~~i~~~-------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 219 --LAISPGMKTRIRMG-------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --C--------CCCSC-------SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHHHHHHHHHhcC-------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111111111100 0011 11223445678999999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.4e-45 Score=386.27 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=203.0
Q ss_pred HhhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||+||+|+. .+|+.||||++..... ........+.+|++++++++|||||
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------------~~~~~~~~~~~E~~~l~~~~hpniv 70 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA--------------RDPSFYLRFRREAQNAAALNHPAIV 70 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT--------------TCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc--------------cCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 347899999999999999999996 4799999999953211 1112345789999999999999999
Q ss_pred eEEEEEecCCc----cEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 706 KLYCSITSEDS----NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 706 ~l~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
++++++..++. .|+||||+++|+|.+++... ..+++.....++.||+.||+||| +.+|+||||||+||+++
T Consensus 71 ~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~ 145 (277)
T d1o6ya_ 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMIS 145 (277)
T ss_dssp CEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEE
T ss_pred cccceeeeccCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccC
Confidence 99999977543 68999999999999998764 35899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCC-CcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 782 LEWKPRIADFGLAKIVQTGEA-GDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
.++.++++|||.+........ .......+||+.|+|||++.+..++.++||||+||++|||+||+.||... ...
T Consensus 146 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~ 220 (277)
T d1o6ya_ 146 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-----SPV 220 (277)
T ss_dssp TTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHH
T ss_pred ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc-----CHH
Confidence 999999999999876543322 22233567999999999999999999999999999999999999999532 222
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhcc
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-SMRVVVQMLEEA 920 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~~ 920 (947)
+............... .....+..+.+++.+|++.||++|| |++++.+.|.++
T Consensus 221 ~~~~~~~~~~~~~~~~-------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 221 SVAYQHVREDPIPPSA-------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHHHHHHCCCCCGGG-------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCch-------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 3333333222221111 1122345688899999999999999 899999888765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=396.58 Aligned_cols=260 Identities=20% Similarity=0.286 Sum_probs=211.1
Q ss_pred hccCCcccccccCceeEEEEEeC------CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN------SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHV 702 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 702 (947)
++|++.+.||+|+||+||+|.++ +++.||||+++... .......|.+|+.++++++||
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~----------------~~~~~~~~~~E~~il~~l~h~ 83 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----------------SMRERIEFLNEASVMKEFNCH 83 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----------------CHHHHHHHHHHHHHGGGCCCT
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc----------------ChHHHHHHHHHHHHHHHcCCC
Confidence 67888999999999999999864 35789999984211 112335689999999999999
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------CccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCC
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------KIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVK 774 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlk 774 (947)
|||+++|++..++..++||||+++|+|.+++.... ...+++..+.+++.|+|+||+||| +++|+|||||
T Consensus 84 nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk 160 (308)
T d1p4oa_ 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLA 160 (308)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCS
T ss_pred CEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEc
Confidence 99999999999999999999999999999987531 234789999999999999999999 8899999999
Q ss_pred CCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCC-CCCCCCC
Q 002250 775 SSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGK-RPIVPEF 853 (947)
Q Consensus 775 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~-~p~~~~~ 853 (947)
|+|||++.++.+||+|||+|+...............||+.|+|||.+.++.++.++||||||+++|||+||. .||..
T Consensus 161 ~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-- 238 (308)
T d1p4oa_ 161 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-- 238 (308)
T ss_dssp GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--
T ss_pred CCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC--
Confidence 999999999999999999998776554433344456899999999999999999999999999999999986 55522
Q ss_pred CCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 854 GDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
....++..... ++...+.+...+..+.+++.+||+.+|++||||.||+++|++...
T Consensus 239 ---~~~~~~~~~i~----------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 239 ---LSNEQVLRFVM----------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---SCHHHHHHHHH----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---CCHHHHHHHHH----------hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 22222222211 122222333445679999999999999999999999999998643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=397.07 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=203.0
Q ss_pred hccCCcccccccCceeEEEEEeC-CCc--EEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-ccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGK--ELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV-RHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 704 (947)
++|++.+.||+|+||+||+|+++ +|. .||||++.... .....+.|.+|+++++++ +||||
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~HpnI 73 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----------------SKDDHRDFAGELEVLCKLGHHPNI 73 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------------------CHHHHHHHHHTTCCCCTTB
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc----------------ChHHHHHHHHHHHHHHhccCCCCE
Confidence 67888999999999999999976 444 47888773111 112346799999999999 79999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhc--------------CCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTC--------------HKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIH 770 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH 770 (947)
|+++|++.+++..++||||+++|+|.++++.. ....+++..+..++.|||.||+|+| +++|+|
T Consensus 74 v~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiH 150 (309)
T d1fvra_ 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIH 150 (309)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred eeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccc
Confidence 99999999999999999999999999999753 2356899999999999999999999 899999
Q ss_pred ccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCC-CC
Q 002250 771 RDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKR-PI 849 (947)
Q Consensus 771 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~-p~ 849 (947)
|||||+|||++.++.+||+|||+|+....... .....||..|+|||.+..+.++.++|||||||++|||++|.. ||
T Consensus 151 rDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~ 227 (309)
T d1fvra_ 151 RDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 227 (309)
T ss_dssp SCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccccceEEEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCC
Confidence 99999999999999999999999976543322 223468999999999999999999999999999999999765 45
Q ss_pred CCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 850 VPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 850 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
.. .+..+........ ...+.+...+..+.+++.+||+.||++||||.||+++|+++.
T Consensus 228 ~~-----~~~~~~~~~i~~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 228 CG-----MTCAELYEKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp TT-----CCHHHHHHHGGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-----CCHHHHHHHHHhc----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 32 1222222211111 112223334567889999999999999999999999998864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=394.29 Aligned_cols=266 Identities=25% Similarity=0.273 Sum_probs=200.8
Q ss_pred hhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
.+.|...+.||+|+||+||+|++. |+.||||++... ......++.|+..+.+++|||||++
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~------------------~~~~~~~e~ei~~~~~~~HpnIv~~ 62 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR------------------EERSWFREAEIYQTVMLRHENILGF 62 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG------------------GHHHHHHHHHHHTSTTCCCTTBCCE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc------------------chhHHHHHHHHHHHhhCCCCcCcce
Confidence 356778889999999999999975 899999998310 1112233456666678899999999
Q ss_pred EEEEecCC----ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEeccCCCCCe
Q 002250 708 YCSITSED----SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG-----FDRPVIHRDVKSSNI 778 (947)
Q Consensus 708 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-----~~~~ivH~Dlkp~NI 778 (947)
++++..++ ..++||||+++|+|.+++++ ..++|..+.+++.|+|.||+|+|.. ++++||||||||+||
T Consensus 63 ~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NI 139 (303)
T d1vjya_ 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139 (303)
T ss_dssp EEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGE
T ss_pred EEEEEeCCCcceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccce
Confidence 99998754 46899999999999999986 3589999999999999999999942 246999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCC--cceecccccccccCccccccCC------CCCccchHHHHHHHHHHHhCCCCCC
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAG--DLTHVIAGTHGYIAPEYAYTCK------INEKSDVYSFGVVLMELVTGKRPIV 850 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slGv~l~elltg~~p~~ 850 (947)
|+++++.+||+|||+++........ .......||++|+|||++.+.. ++.++|||||||++|||+||..||.
T Consensus 140 Ll~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred EEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 9999999999999999877554322 1233467999999999986542 5678999999999999999988774
Q ss_pred CCCC----------CcccHHHHHHhhccccccccccccCCCCcc--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 002250 851 PEFG----------DSKDIVNWVYSKMDSRDSMLTVVDPNISEI--LKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLE 918 (947)
Q Consensus 851 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 918 (947)
.... ............. ....++.+++. ..+.+..+.+++.+||+.||++||||.||+++|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 220 IHEDYQLPYYDLVPSDPSVEEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHT------TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred cccccccchhhcccccchHHHHHHHHh------ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 3211 1111111111111 11122233222 2345677999999999999999999999999999
Q ss_pred ccC
Q 002250 919 EAE 921 (947)
Q Consensus 919 ~~~ 921 (947)
++.
T Consensus 294 ~i~ 296 (303)
T d1vjya_ 294 QLS 296 (303)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=393.87 Aligned_cols=255 Identities=26% Similarity=0.349 Sum_probs=201.7
Q ss_pred cccccccCceeEEEEEeCCC----cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEE
Q 002250 634 ENLIGKGGSGNVYKVVLNSG----KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYC 709 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 709 (947)
.++||+|+||+||+|++.++ ..||||++... ......++|.+|++++++++|||||+++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~----------------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g 95 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------------TDIGEVSQFLTEGIIMKDFSHPNVLSLLG 95 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC----------------CCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc----------------cCHHHHHHHHHHHHHHHhCCCCCEeEEeE
Confidence 57899999999999996532 25899998321 11233467999999999999999999999
Q ss_pred EEec-CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 710 SITS-EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 710 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
++.. ++..++||||+++|+|.+++.. .....++..+.+++.|+|+||.|+| +.+|+||||||+|||+++++.+||
T Consensus 96 ~~~~~~~~~~lv~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL 171 (311)
T d1r0pa_ 96 ICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKV 171 (311)
T ss_dssp EEEETTTEEEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEecCCceEEEEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEE
Confidence 9865 5678999999999999999886 3456788899999999999999999 899999999999999999999999
Q ss_pred eccccceecccCCCCc--ceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 789 ADFGLAKIVQTGEAGD--LTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
+|||+++......... ......||+.|+|||.+.++.++.++||||||+++|||+||+.||..... ..++...+.
T Consensus 172 ~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~~~~~i~-- 248 (311)
T d1r0pa_ 172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLL-- 248 (311)
T ss_dssp CSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHH--
T ss_pred ecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHHHHHHHH--
Confidence 9999998765443221 22234689999999999999999999999999999999998888754322 122222221
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAEP 922 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 922 (947)
.+.. ...+...+..+.+++.+||+.||++||+|.||+++|+++..
T Consensus 249 -~g~~----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 249 -QGRR----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCCC----------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111 11222344568899999999999999999999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=393.09 Aligned_cols=259 Identities=23% Similarity=0.346 Sum_probs=206.0
Q ss_pred hccCCcccccccCceeEEEEEeCC--------CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc-
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNS--------GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV- 699 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 699 (947)
++|++.+.||+|+||.||+|+... +..||||+++.+. ......++.+|+..+.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~----------------~~~~~~~~~~e~~~l~~~~ 76 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----------------TEKDLSDLISEMEMMKMIG 76 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC----------------CHHHHHHHHHHHHHHHHHC
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc----------------ChHHHHHHHHHHHHHHHhc
Confidence 688889999999999999998532 3479999984321 112346788899999888
Q ss_pred cccccceEEEEEecCCccEEEEeccCCCChHHHhhhcC--------------CccCCHHHHHHHHHHHHHHHHHHhcCCC
Q 002250 700 RHVNVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCH--------------KIEMDWVVRYAIAVGAAKGLEYLHHGFD 765 (947)
Q Consensus 700 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~ia~~l~yLH~~~~ 765 (947)
+|||||+++++|.+++..++||||+++|+|.+++.... ...+++..+..++.|+|.||+||| +
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~ 153 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---S 153 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---h
Confidence 89999999999999999999999999999999997543 245899999999999999999999 8
Q ss_pred CCeEeccCCCCCeEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHh-
Q 002250 766 RPVIHRDVKSSNILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVT- 844 (947)
Q Consensus 766 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt- 844 (947)
.+||||||||+|||++.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++
T Consensus 154 ~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 154 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp TTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence 9999999999999999999999999999998776655555556679999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCcccHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 002250 845 GKRPIVPEFGDSKDIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEAE 921 (947)
Q Consensus 845 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 921 (947)
|..||... ....+.+ .+..... .+.+...+..+.+++.+||+.||++||||.||++.|+++.
T Consensus 234 g~~p~~~~--~~~~~~~----~i~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 234 GGSPYPGV--PVEELFK----LLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp SCCSSTTC--CHHHHHH----HHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCC--CHHHHHH----HHHcCCC---------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 67777422 1112222 2111111 1122233456889999999999999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.4e-44 Score=379.64 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=205.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~ 706 (947)
++|++.+.||+|+||+||+|+.. +|+.||||++......... ........+.+.+|+.++++++ |||||+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~--------~~~~~~~~~~~~~E~~~l~~l~~hpnIv~ 74 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS--------AEEVQELREATLKEVDILRKVSGHPNIIQ 74 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCC--------HHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchh--------HHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Confidence 68899999999999999999964 7999999999643321110 0011122356889999999997 999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..|+||||+++|+|.++++.. ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 75 LKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred EEeecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCe
Confidence 999999999999999999999999999864 35899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCcccccc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT------CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
||+|||+|+....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||... +..
T Consensus 150 kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~-----~~~ 221 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-----KQM 221 (277)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHH
T ss_pred EEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC-----CHH
Confidence 9999999987755332 234579999999999853 34688999999999999999999999532 111
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.............. .+.....++++.+++.+|++.||++|||+.|++++
T Consensus 222 ~~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 222 LMLRMIMSGNYQFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHHHTCCCCC-------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHhCCCCCC-------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111121111110 11112334568899999999999999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=391.51 Aligned_cols=254 Identities=20% Similarity=0.315 Sum_probs=205.8
Q ss_pred HHhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcccccc
Q 002250 626 EIIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNV 704 (947)
Q Consensus 626 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 704 (947)
++.++|++.+.||+|+||+||+|... +|+.||||++... ......+.+|+++++.++||||
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~------------------~~~~~~~~~Ei~il~~l~HpnI 63 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------------------GTDQVLVKKEISILNIARHRNI 63 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------------------THHHHHHHHHHHHHHHSCCTTB
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC------------------cccHHHHHHHHHHHHhCCCCCC
Confidence 45688999999999999999999975 6889999998421 1223467899999999999999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC-
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE- 783 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~- 783 (947)
|++++++.+++..|+||||++||+|.+++... ...+++.....++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 64 v~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~ 139 (321)
T d1tkia_ 64 LHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRR 139 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSS
T ss_pred CeEEEEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCC
Confidence 99999999999999999999999999999763 346899999999999999999999 8999999999999999854
Q ss_pred -CCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 002250 784 -WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNW 862 (947)
Q Consensus 784 -~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 862 (947)
..+||+|||+++...... ......||+.|+|||...+..++.++||||+||++|||++|+.||... ...+.
T Consensus 140 ~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~-----~~~~~ 211 (321)
T d1tkia_ 140 SSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-----TNQQI 211 (321)
T ss_dssp CCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHH
T ss_pred ceEEEEcccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC-----CHHHH
Confidence 589999999998764432 233457899999999999999999999999999999999999999532 22222
Q ss_pred HHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 863 VYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 863 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..........+.. +.......++.+++.+|+..||++|||+.|++++
T Consensus 212 ~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 212 IENIMNAEYTFDE-------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHTCCCCCH-------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhCCCCCCh-------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222222111110 0111224457889999999999999999999873
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-44 Score=391.69 Aligned_cols=248 Identities=22% Similarity=0.269 Sum_probs=205.6
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.+ +|+.||||++... ........+.+.+|+++++.++|||||+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~--------------~~~~~~~~~~~~~E~~il~~l~hpnIv~ 105 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--------------KVVKLKQIEHTLNEKRILQAVNFPFLVK 105 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchH--------------HccCHHHHHHHHHHHHHHHHcCCCcEee
Confidence 368999999999999999999975 7999999998311 1122344567899999999999999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++......++||||+++|+|.+++...+ .+++.....++.||+.||+||| +.+||||||||+|||++.++.+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~i 180 (350)
T d1rdqe_ 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180 (350)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred cccccccccccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCE
Confidence 9999999999999999999999999998743 5899999999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+|+...... ....||+.|||||++.+..++.++|||||||++|||+||+.||... +........
T Consensus 181 kL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~i 250 (350)
T d1rdqe_ 181 QVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QPIQIYEKI 250 (350)
T ss_dssp EECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHH
T ss_pred Eeeeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-----CHHHHHHHH
Confidence 999999998765332 2457999999999999999999999999999999999999999532 222222222
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQ 915 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 915 (947)
...... .+......+.+++.+|++.||.+|+ |+.|+++
T Consensus 251 ~~~~~~-----------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 251 VSGKVR-----------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHCCCC-----------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred hcCCCC-----------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 211111 1223345688899999999999994 8999886
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.1e-44 Score=393.53 Aligned_cols=251 Identities=24% Similarity=0.274 Sum_probs=198.1
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHH---HHHHHhhcccccc
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDA---EVATLSAVRHVNV 704 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~ni 704 (947)
++|++.+.||+|+||+||+|+.. +|+.||||++... ..........+.+ |+++++.++||||
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~--------------~~~~~~~~~~~~~e~~~~~~l~~~~hpnI 69 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK--------------RIKMKQGETLALNERIMLSLVSTGDCPFI 69 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--------------HHHHHTCHHHHHHHHHHHHHHSSSCCTTB
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchH--------------HcchhhHHHHHHHHHHHHHHHhcCCCCcE
Confidence 67899999999999999999965 6999999998311 0011122233334 4667777789999
Q ss_pred ceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
|++++++.+++..|+||||+++|+|.+++... ..+++..+..++.||+.||+||| +++||||||||+|||++.++
T Consensus 70 v~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g 144 (364)
T d1omwa3 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHG 144 (364)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSS
T ss_pred EEEEEEEEECCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCC
Confidence 99999999999999999999999999999874 45788999999999999999999 89999999999999999999
Q ss_pred CeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 002250 785 KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWV 863 (947)
Q Consensus 785 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 863 (947)
.+||+|||+|+...... .....||+.|+|||++.. ..++.++||||+||++|||+||+.||..... .+.....
T Consensus 145 ~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~~ 218 (364)
T d1omwa3 145 HVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--KDKHEID 218 (364)
T ss_dssp CEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS--SCHHHHH
T ss_pred cEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence 99999999998765443 234579999999999975 4589999999999999999999999965322 2222221
Q ss_pred HhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 002250 864 YSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPS-----MRVVVQ 915 (947)
Q Consensus 864 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 915 (947)
....... ...+...++.+.+++.+|++.||++||| +.|+++
T Consensus 219 ~~~~~~~-----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 219 RMTLTMA-----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHSSSCC-----------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HhcccCC-----------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111111 1111223456788999999999999999 678765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=386.52 Aligned_cols=250 Identities=28% Similarity=0.411 Sum_probs=201.6
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHh-hccccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLS-AVRHVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~ 706 (947)
++|++.+.||+|+||+||+|+.+ +|+.||||++..+ ........+.+..|+.++. .++|||||+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~--------------~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~ 67 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD--------------VVLMDDDVECTMVEKRVLSLAWEHPFLTH 67 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHHHHTTCTTBCC
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchh--------------hccChHHHHHHHHHHHHHHHhCCCCcEEE
Confidence 57899999999999999999965 7999999998311 1112244566777777765 689999999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCe
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKP 786 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 786 (947)
+++++.+++..|+||||+++|+|.+++.... .+++.....++.||+.||+||| +++|+||||||+|||+++++.+
T Consensus 68 ~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~ 142 (320)
T d1xjda_ 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHI 142 (320)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred EEEEEccCCceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCce
Confidence 9999999999999999999999999998743 4788889999999999999999 8999999999999999999999
Q ss_pred EEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 787 RIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 787 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
||+|||+|+....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+. +..+.....
T Consensus 143 kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~~i 215 (320)
T d1xjda_ 143 KIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEEELFHSI 215 (320)
T ss_dssp EECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHH
T ss_pred eccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-----CHHHHHHHH
Confidence 9999999986544322 233457999999999999999999999999999999999999999532 222222111
Q ss_pred ccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 002250 867 MDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR-VVVQ 915 (947)
Q Consensus 867 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~ 915 (947)
.... +. ++...+..+.+++.+|++.||++|||+. |+.+
T Consensus 216 ~~~~--------~~---~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 216 RMDN--------PF---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHCC--------CC---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HcCC--------CC---CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111 11 1222345688999999999999999995 6653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=381.93 Aligned_cols=270 Identities=23% Similarity=0.302 Sum_probs=203.0
Q ss_pred hccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ......+.+.+|++++++++|||||++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---------------~~~~~~~~~~~Ei~il~~l~Hp~Iv~~ 66 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---------------ETEGVPSTAIREISLLKELNHPNIVKL 66 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------------------CCHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh---------------cChHHHHHHHHHHHHHHhCCCCcEEEe
Confidence 6799999999999999999996 479999999984221 112335678999999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++.+++..|+||||+.+ ++.+++.......+++..+..++.|++.||+||| +.+||||||||+|||++.++.+|
T Consensus 67 ~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~k 142 (298)
T d1gz8a_ 67 LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIK 142 (298)
T ss_dssp EEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred ccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcce
Confidence 9999999999999999965 5556665545567999999999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||.|+....... ......||+.|+|||.+.... ++.++||||+||++|||++|+.||..... ...+.......
T Consensus 143 l~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~-~~~~~~i~~~~ 219 (298)
T d1gz8a_ 143 LADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTL 219 (298)
T ss_dssp ECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHH
T ss_pred eccCCcceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH-HHHHHHHHHhc
Confidence 999999986654332 222347999999999887665 57899999999999999999999954311 11111111111
Q ss_pred ccccccccc-c-------------ccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhcc
Q 002250 867 MDSRDSMLT-V-------------VDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEA 920 (947)
Q Consensus 867 ~~~~~~~~~-~-------------~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~ 920 (947)
......... . ...............+.+++.+|++.||++|||+.|++++ ++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 220 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 111100000 0 0000011112233568889999999999999999999986 5544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=379.31 Aligned_cols=262 Identities=21% Similarity=0.264 Sum_probs=194.0
Q ss_pred cccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEEEEEe
Q 002250 634 ENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCSIT 712 (947)
Q Consensus 634 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 712 (947)
.+.||+|+||+||+|+.+ +|+.||||++...... .........+.+|+.++++++|||||++++++.
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------------~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~ 70 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS------------EAKDGINRTALREIKLLQELSHPNIIGLLDAFG 70 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh------------hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 468999999999999965 6999999998432210 011122356889999999999999999999999
Q ss_pred cCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEeccc
Q 002250 713 SEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIADFG 792 (947)
Q Consensus 713 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 792 (947)
.++..|+||||++++++..+... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 71 ~~~~~~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG 145 (299)
T d1ua2a_ 71 HKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFG 145 (299)
T ss_dssp CTTCCEEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred cCCceeehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCc
Confidence 99999999999988877766654 345778888899999999999999 8999999999999999999999999999
Q ss_pred cceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhccc--
Q 002250 793 LAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKMDS-- 869 (947)
Q Consensus 793 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 869 (947)
+|+....... .....+||+.|+|||++... .++.++||||+||++|||++|+.||.... ..+....+......
T Consensus 146 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l~~i~~~~~~~~ 221 (299)
T d1ua2a_ 146 LAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPT 221 (299)
T ss_dssp GGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCC
T ss_pred cccccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC--HHHHHHHHHHhcCCCC
Confidence 9986554322 22245799999999998755 57999999999999999999999985321 11111111111000
Q ss_pred cccccc-------cccCCCCc-----cCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 870 RDSMLT-------VVDPNISE-----ILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 870 ~~~~~~-------~~d~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
...... ......+. ........+.+++.+|++.||++|||+.|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000 00001111 112234568899999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=374.62 Aligned_cols=247 Identities=21% Similarity=0.308 Sum_probs=196.8
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc--cccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR--HVNV 704 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni 704 (947)
.++|++.+.||+|+||+||+|+.. +|+.||||++....... ........++.+|+.++++++ ||||
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----------~~~~~~~~~~~~E~~il~~l~~~h~nI 71 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD-----------WGELPNGTRVPMEVVLLKKVSSGFSGV 71 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCC-----------EEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccc-----------hhhhhHHHHHHHHHHHHHHhccCCCCc
Confidence 367999999999999999999965 79999999985322110 001122345678999999996 8999
Q ss_pred ceEEEEEecCCccEEEEeccCC-CChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCC
Q 002250 705 VKLYCSITSEDSNLLVYEYLPN-GSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLE 783 (947)
Q Consensus 705 v~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 783 (947)
|++++++.+++..++||||+++ +++.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.+
T Consensus 72 v~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~ 146 (273)
T d1xwsa_ 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLN 146 (273)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETT
T ss_pred cEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecC
Confidence 9999999999999999999976 6788888763 45899999999999999999999 8999999999999999854
Q ss_pred -CCeEEeccccceecccCCCCcceecccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 002250 784 -WKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKI-NEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN 861 (947)
Q Consensus 784 -~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~ 861 (947)
+.+||+|||+|+...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||... . +
T Consensus 147 ~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~---~ 215 (273)
T d1xwsa_ 147 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E---E 215 (273)
T ss_dssp TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H---H
T ss_pred CCeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----h---H
Confidence 789999999998754432 234579999999999987775 56789999999999999999998431 1 1
Q ss_pred HHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 862 WVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 862 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
.. ..... +....+.++.+++.+|++.||++|||+.|++++
T Consensus 216 i~----~~~~~-----------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 216 II----RGQVF-----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HH----HCCCC-----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Hh----hcccC-----------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11 11111 111223567889999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=376.55 Aligned_cols=273 Identities=22% Similarity=0.246 Sum_probs=202.1
Q ss_pred hhccCCcccccccCceeEEEEEeC-C-CcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhc---ccc
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-S-GKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAV---RHV 702 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~ 702 (947)
.++|++.+.||+|+||+||+|+.. + ++.||||++.... ........+.+|+.+++.+ +||
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~---------------~~~~~~~~~~~E~~~l~~l~~~~Hp 70 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---------------GEEGMPLSTIREVAVLRHLETFEHP 70 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEB---------------CTTSCBCTHHHHHHHHHHHHHTCCT
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhh---------------ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 368999999999999999999963 4 6679999984321 1112234566788888776 799
Q ss_pred ccceEEEEEec-----CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCC
Q 002250 703 NVVKLYCSITS-----EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSN 777 (947)
Q Consensus 703 niv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~N 777 (947)
||++++++|.. ....+++|||++++.+...... ....+++.....++.|++.||+||| +++||||||||+|
T Consensus 71 nIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~N 146 (305)
T d1blxa_ 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQN 146 (305)
T ss_dssp TBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGG
T ss_pred CcceeeeeecccccccCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccE
Confidence 99999999853 3457899999988766544433 4556899999999999999999999 8999999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 002250 778 ILLDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK 857 (947)
Q Consensus 778 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 857 (947)
||++.++.+||+|||.++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ..
T Consensus 147 ILi~~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~--~~ 221 (305)
T d1blxa_ 147 ILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DV 221 (305)
T ss_dssp EEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HH
T ss_pred EEEcCCCCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC--HH
Confidence 999999999999999987654332 2335579999999999999999999999999999999999999995431 11
Q ss_pred cHH-HHHHhhccccc------------cccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhccCC
Q 002250 858 DIV-NWVYSKMDSRD------------SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEAEP 922 (947)
Q Consensus 858 ~~~-~~~~~~~~~~~------------~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~~~ 922 (947)
+.. ........... ..................+.+.+++.+|++.||++|||+.|++++ +++++.
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 222 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred HHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 111 11111000000 000000111122233344567889999999999999999999975 777665
Q ss_pred CC
Q 002250 923 CS 924 (947)
Q Consensus 923 ~~ 924 (947)
|.
T Consensus 302 ~k 303 (305)
T d1blxa_ 302 CK 303 (305)
T ss_dssp CC
T ss_pred hC
Confidence 53
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-42 Score=368.96 Aligned_cols=264 Identities=25% Similarity=0.288 Sum_probs=199.3
Q ss_pred hccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
++|++.+.||+|+||+||+|+.++|+.||||++.... ......+.+.+|+.++++++|||||+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---------------~~~~~~~~~~~E~~il~~l~hpnIv~~~ 66 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---------------EDEGIPSTTIREISILKELKHSNIVKLY 66 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS---------------GGGCCCHHHHHHHHGGGGCCCTTBCCEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhh---------------cChHHHHHHHHHHHHHHhCCCCcEEeee
Confidence 5788999999999999999999999999999984221 1123457889999999999999999999
Q ss_pred EEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEE
Q 002250 709 CSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRI 788 (947)
Q Consensus 709 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 788 (947)
+++..++..++||||+.++.+..+... ...+++..+..++.||+.||+||| +.+||||||||+|||++.++.+|+
T Consensus 67 ~~~~~~~~~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl 141 (286)
T d1ob3a_ 67 DVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKI 141 (286)
T ss_dssp EEEECSSCEEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred eecccCCceeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEe
Confidence 999999999999999987766666554 356899999999999999999999 889999999999999999999999
Q ss_pred eccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 002250 789 ADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSKM 867 (947)
Q Consensus 789 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 867 (947)
+|||.|........ ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||..... .+.+.+......
T Consensus 142 ~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~ 218 (286)
T d1ob3a_ 142 ADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILG 218 (286)
T ss_dssp CCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHC
T ss_pred cccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-HHHHHHHHHhhC
Confidence 99999987654322 22244689999999998764 468999999999999999999999954311 111111111100
Q ss_pred ccc-cccc------------ccccCC-CCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 868 DSR-DSML------------TVVDPN-ISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 868 ~~~-~~~~------------~~~d~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
... .... ....+. ...........+.+++.+|++.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000 000000 01122233456889999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-40 Score=357.13 Aligned_cols=259 Identities=17% Similarity=0.202 Sum_probs=204.9
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc-cccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH-VNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~ 706 (947)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+|+++++.++| +|++.
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------------------~~~~~~~~e~~~~~~l~~~~~i~~ 65 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-------------------SDAPQLRDEYRTYKLLAGCTGIPN 65 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-------------------TTSCCHHHHHHHHHHTTTCTTCCC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-------------------cCcHHHHHHHHHHHHhcCCCCCCE
Confidence 57899999999999999999965 7899999987311 223457889999999976 89999
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC----
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL---- 782 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~---- 782 (947)
+++++..+...++||||+ +++|.+++... ...+++.....++.|++.||+||| +++|+||||||+||+++.
T Consensus 66 ~~~~~~~~~~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~ 140 (293)
T d1csna_ 66 VYYFGQEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSK 140 (293)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSST
T ss_pred EEEEeecCCccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccc
Confidence 999999999999999999 78999998764 346899999999999999999999 899999999999999974
Q ss_pred -CCCeEEeccccceecccCCCC-----cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 002250 783 -EWKPRIADFGLAKIVQTGEAG-----DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDS 856 (947)
Q Consensus 783 -~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 856 (947)
++.+||+|||+|+........ ......+||+.|||||++.+..++.++|||||||++|||+||+.||.......
T Consensus 141 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~ 220 (293)
T d1csna_ 141 NANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220 (293)
T ss_dssp TTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred cCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh
Confidence 578999999999876543221 12334579999999999999999999999999999999999999996443221
Q ss_pred c-cHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 857 K-DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 857 ~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
. .....+...... ....+.....++++.+++..|++.+|++||+++.+.+.|+++
T Consensus 221 ~~~~~~~i~~~~~~---------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 221 NKQKYERIGEKKQS---------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHHHHHHHHHHHH---------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccCC---------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1 111111111000 001112223345688999999999999999999998888764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-41 Score=359.82 Aligned_cols=258 Identities=22% Similarity=0.258 Sum_probs=197.2
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce-
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK- 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~- 706 (947)
++|++.+.||+|+||+||+|+.. +|+.||||++... ....++.+|+++++.++|+|++.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------------------~~~~~~~~E~~i~~~l~~~~~i~~ 67 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-------------------TKHPQLHIESKIYKMMQGGVGIPT 67 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC-------------------TTSCCHHHHHHHHHHSTTSTTCCC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh-------------------ccCHHHHHHHHHHHHccCCCcccE
Confidence 56999999999999999999964 7899999987421 22345788999999998776554
Q ss_pred EEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec---CC
Q 002250 707 LYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD---LE 783 (947)
Q Consensus 707 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~---~~ 783 (947)
+.+++.+++..++||||+ ++++.+.+... ...+++..+..++.|++.||+||| +++|+||||||+|||++ .+
T Consensus 68 ~~~~~~~~~~~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~ 142 (299)
T d1ckia_ 68 IRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKG 142 (299)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGT
T ss_pred EEEEEecCCEEEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCC
Confidence 455567778889999999 56777766543 356899999999999999999999 89999999999999986 45
Q ss_pred CCeEEeccccceecccCCCC-----cceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcc-
Q 002250 784 WKPRIADFGLAKIVQTGEAG-----DLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSK- 857 (947)
Q Consensus 784 ~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~- 857 (947)
..+|++|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+||+.||........
T Consensus 143 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~ 222 (299)
T d1ckia_ 143 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222 (299)
T ss_dssp TCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred ceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH
Confidence 67999999999977654322 122345799999999999999999999999999999999999999964322111
Q ss_pred -cHHHHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 002250 858 -DIVNWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQMLEEA 920 (947)
Q Consensus 858 -~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 920 (947)
....+...... ...+......+.++.+++..||+.+|++||++.++.+.|+.+
T Consensus 223 ~~~~~~~~~~~~----------~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 223 QKYERISEKKMS----------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp --HHHHHHHHHH----------SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHhhcccCC----------CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11111111000 011112223446688999999999999999999998888764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-41 Score=368.35 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=192.9
Q ss_pred ccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceEE
Q 002250 630 AVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKLY 708 (947)
Q Consensus 630 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 708 (947)
.|+..++||+|+||+||+|+.. +|+.||||++... ...+.+|++++++++||||++++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------------------~~~~~~Ei~il~~l~h~niv~~~ 79 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---------------------KRFKNRELQIMRKLDHCNIVRLR 79 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------------SSSCCHHHHHHHHCCCTTBCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECcc---------------------chHHHHHHHHHHhcCCCCCCcEE
Confidence 5888899999999999999975 7999999998421 12234799999999999999999
Q ss_pred EEEecC------CccEEEEeccCCCChHHHhhh-cCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 709 CSITSE------DSNLLVYEYLPNGSLWDRLHT-CHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 709 ~~~~~~------~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
++|... ...++||||++++.+...... .....+++..+..++.||+.||+||| +++|+||||||+|||++
T Consensus 80 ~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~ 156 (350)
T d1q5ka_ 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLD 156 (350)
T ss_dssp EEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEEC
T ss_pred EEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEe
Confidence 998543 236899999976544433322 24557899999999999999999999 89999999999999999
Q ss_pred CCC-CeEEeccccceecccCCCCcceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 782 LEW-KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 782 ~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
.++ .+||+|||+|+........ ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+
T Consensus 157 ~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l 232 (350)
T d1q5ka_ 157 PDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQL 232 (350)
T ss_dssp TTTCCEEECCCTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHH
T ss_pred cCCCceeEecccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-HHHH
Confidence 775 8999999999876554332 23579999999998875 4689999999999999999999999954321 1111
Q ss_pred HHHHHh-----------hccc--cccccccccCCC-CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhcc
Q 002250 860 VNWVYS-----------KMDS--RDSMLTVVDPNI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEA 920 (947)
Q Consensus 860 ~~~~~~-----------~~~~--~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~ 920 (947)
...... .... ............ ........+.+.+++.+|++.||++|||+.|++++ ++++
T Consensus 233 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 111110 0000 000000000000 11112234568889999999999999999999964 5554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=358.98 Aligned_cols=267 Identities=19% Similarity=0.217 Sum_probs=195.8
Q ss_pred hhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ........+.+|+.++++++||||++
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---------------~~~~~~~~~~~E~~il~~l~h~nii~ 73 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---------------EKEGFPITALREIKILQLLKHENVVN 73 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC-------------------CTTSSCHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh---------------cchHHHHHHHHHHHHHHHhcCCCccc
Confidence 478999999999999999999964 79999999984221 12244567889999999999999999
Q ss_pred EEEEEec--------CCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCe
Q 002250 707 LYCSITS--------EDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNI 778 (947)
Q Consensus 707 l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NI 778 (947)
+++++.. ++..++||||++++.+..+... ...++......++.|++.||+||| +.+|+||||||+||
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NI 148 (318)
T d3blha1 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANV 148 (318)
T ss_dssp EEEEEEC----------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred eEeeeecccccccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchhe
Confidence 9998855 3457899999987766554443 345788888999999999999999 89999999999999
Q ss_pred EecCCCCeEEeccccceecccCCCC--cceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 002250 779 LLDLEWKPRIADFGLAKIVQTGEAG--DLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGD 855 (947)
Q Consensus 779 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 855 (947)
|++.++.+|++|||+++........ ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 149 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-- 226 (318)
T d3blha1 149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-- 226 (318)
T ss_dssp EECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred eecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--
Confidence 9999999999999999866543221 122345799999999998765 58999999999999999999999995421
Q ss_pred cccHHHHHHhhcc-cccccccccc----------CCC-CccCH------HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 856 SKDIVNWVYSKMD-SRDSMLTVVD----------PNI-SEILK------EDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 856 ~~~~~~~~~~~~~-~~~~~~~~~d----------~~~-~~~~~------~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
............. .........+ ... ..... .....+.+++.+|++.||++|||+.|++++
T Consensus 227 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 227 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1111111111110 0000000000 000 00011 112356789999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=366.67 Aligned_cols=269 Identities=19% Similarity=0.264 Sum_probs=196.4
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||+||+|... +|+.||||++.... ......+.+.+|++++++++|||||
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---------------~~~~~~~~~~~Ei~il~~l~hpniv 80 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---------------QSELFAKRAYRELRLLKHMRHENVI 80 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---------------SSHHHHHHHHHHHHHHHHCCBTTBC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh---------------cChHHHHHHHHHHHHHHhcCCCCee
Confidence 3468999999999999999999965 69999999984221 0112345688999999999999999
Q ss_pred eEEEEEecCC------ccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 706 KLYCSITSED------SNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 706 ~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
+++++|...+ ..|+||||+ +.+|..+.+. ..+++..+..++.|++.||+||| +++|+||||||+|||
T Consensus 81 ~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL 153 (346)
T d1cm8a_ 81 GLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLA 153 (346)
T ss_dssp CCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred EEEEEeccCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhh
Confidence 9999998765 469999999 6678777764 35899999999999999999999 899999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCcceecccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 002250 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC-KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKD 858 (947)
Q Consensus 780 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 858 (947)
++.++.+|++|||.|+...... ....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...
T Consensus 154 ~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~ 227 (346)
T d1cm8a_ 154 VNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQ 227 (346)
T ss_dssp ECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHH
T ss_pred cccccccccccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHH
Confidence 9999999999999998764432 345789999999998764 468999999999999999999999954311 001
Q ss_pred HHHHHHhhccccc----------------cccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhcc
Q 002250 859 IVNWVYSKMDSRD----------------SMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEA 920 (947)
Q Consensus 859 ~~~~~~~~~~~~~----------------~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~ 920 (947)
+............ .........+..........+.+++.+|+..||++|||+.|++++ ++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1111000000000 000000111122222334567889999999999999999999986 6665
Q ss_pred CCC
Q 002250 921 EPC 923 (947)
Q Consensus 921 ~~~ 923 (947)
...
T Consensus 308 ~~~ 310 (346)
T d1cm8a_ 308 HDT 310 (346)
T ss_dssp C--
T ss_pred CCc
Confidence 533
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=367.50 Aligned_cols=269 Identities=21% Similarity=0.269 Sum_probs=196.4
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... .....+.+.+|+.++++++||||++
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----------------~~~~~~~~~~Ei~il~~l~hp~iv~ 70 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE----------------HQTYCQRTLREIKILLRFRHENIIG 70 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT----------------CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc----------------ChHHHHHHHHHHHHHHHcCCCCCCc
Confidence 35799999999999999999996 489999999984211 1122456889999999999999999
Q ss_pred EEEEEecCCc----cEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 707 LYCSITSEDS----NLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 707 l~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
+++++..+.. .+++++|+.+|+|.+++.. ..+++..+..++.|++.||+||| +++||||||||+|||++.
T Consensus 71 ~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~ 144 (345)
T d1pmea_ 71 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNT 144 (345)
T ss_dssp CCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECT
T ss_pred EEEEEeeccccccceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECC
Confidence 9999976542 3555667779999999976 35899999999999999999999 899999999999999999
Q ss_pred CCCeEEeccccceecccCCCC-cceecccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 783 EWKPRIADFGLAKIVQTGEAG-DLTHVIAGTHGYIAPEYAYT-CKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
++.+||+|||+|+........ ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||..... .+..
T Consensus 145 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~--~~~~ 222 (345)
T d1pmea_ 145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQL 222 (345)
T ss_dssp TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHH
T ss_pred CCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH--HHHH
Confidence 999999999999876543222 22334579999999999855 4578899999999999999999999954321 1111
Q ss_pred HHHHhhccccc-c----------------ccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhcc
Q 002250 861 NWVYSKMDSRD-S----------------MLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEA 920 (947)
Q Consensus 861 ~~~~~~~~~~~-~----------------~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~ 920 (947)
........... . ..................++.+++.+|++.||++|||+.|++++ +++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 223 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 11000000000 0 00000000011111223468899999999999999999999976 5543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5e-40 Score=359.08 Aligned_cols=256 Identities=20% Similarity=0.294 Sum_probs=195.5
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccce
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVVK 706 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~ 706 (947)
++|++.+.||+|+||+||+|+.. +|+.||||++.. ...+.+.+|++++++++ ||||++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~--------------------~~~~~~~~Ei~il~~l~~hpnIv~ 94 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------------------VKKKKIKREIKILENLRGGPNIIT 94 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--------------------SCHHHHHHHHHHHHHHTTSTTBCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH--------------------HHHHHHHHHHHHHHhccCCCCCcE
Confidence 68999999999999999999964 799999999831 23457889999999995 999999
Q ss_pred EEEEEecC--CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCC
Q 002250 707 LYCSITSE--DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEW 784 (947)
Q Consensus 707 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 784 (947)
+++++... ...++||||+++++|.++.+ .+++..+..++.||+.||+||| +++||||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~ 166 (328)
T d3bqca1 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEH 166 (328)
T ss_dssp EEEEEECTTTCSEEEEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTT
T ss_pred EEEEEEecCCCceeEEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCC
Confidence 99999754 55789999999999977653 4889999999999999999999 89999999999999998665
Q ss_pred -CeEEeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH-
Q 002250 785 -KPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVN- 861 (947)
Q Consensus 785 -~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~- 861 (947)
.+||+|||+|+....... .....||+.|+|||.+.+.. ++.++||||+||++|||++|+.||............
T Consensus 167 ~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i 243 (328)
T d3bqca1 167 RKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243 (328)
T ss_dssp TEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred CeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHH
Confidence 589999999987655432 23457899999999987654 799999999999999999999998644221111111
Q ss_pred -----------HHHhh-ccccccccccccC--------CC-CccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 002250 862 -----------WVYSK-MDSRDSMLTVVDP--------NI-SEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQ 915 (947)
Q Consensus 862 -----------~~~~~-~~~~~~~~~~~d~--------~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 915 (947)
+.... ............. .. ........+++.+++.+|++.||++|||++|+++
T Consensus 244 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10000 0000000000000 00 1111223456889999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=359.69 Aligned_cols=257 Identities=23% Similarity=0.291 Sum_probs=201.9
Q ss_pred hhccCCcccccccCceeEEEEEeC----CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc-c
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVLN----SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH-V 702 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ 702 (947)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ........+.+.+|++++++++| |
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~-------------~~~~~~~~~~~~~E~~il~~l~h~p 89 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT-------------IVQKAKTTEHTRTERQVLEHIRQSP 89 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEE-------------EEEEESSGGGCCCHHHHHHHHHTCT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHH-------------hccchHHHHHHHHHHHHHHhccCCC
Confidence 478999999999999999999842 47899999984211 11122345678899999999987 8
Q ss_pred ccceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecC
Q 002250 703 NVVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDL 782 (947)
Q Consensus 703 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 782 (947)
||+++++++.++...++||||+++|+|.+++.... .........++.|++.|++|+| +.+||||||||+||+++.
T Consensus 90 nIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~ 164 (322)
T d1vzoa_ 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDS 164 (322)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred eEEEeeeeeccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecC
Confidence 99999999999999999999999999999998754 3567788889999999999999 899999999999999999
Q ss_pred CCCeEEeccccceecccCCCCcceecccccccccCccccccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 783 EWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTC--KINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 783 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
++.+||+|||+|+......... .....|++.|+|||.+... .++.++||||+||++|||++|+.||...... ....
T Consensus 165 ~~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~-~~~~ 242 (322)
T d1vzoa_ 165 NGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQA 242 (322)
T ss_dssp TSCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHH
T ss_pred CCCEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 9999999999998765433222 2345799999999999764 3678999999999999999999999654322 1111
Q ss_pred HHHHhhccccccccccccCCCCccCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 002250 861 NWVYSKMDSRDSMLTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRP-----SMRVVVQ 915 (947)
Q Consensus 861 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 915 (947)
.......... ...+......+.+++.+|++.||++|| |++|+++
T Consensus 243 ~i~~~~~~~~-----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 243 EISRRILKSE-----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHhcccCC-----------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 2111111111 112234456788899999999999999 4788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-40 Score=354.70 Aligned_cols=266 Identities=20% Similarity=0.241 Sum_probs=203.7
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccceE
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVKL 707 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 707 (947)
++|++.+.||+|+||+||+|+.. +++.||||++.... ........+.+|+.+++.++||||+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---------------~~~~~~~~~~~E~~il~~l~h~niv~~ 66 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---------------DDEGVPSSALREICLLKELKHKNIVRL 66 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---------------SSTTHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh---------------CChHHHHHHHHHHHHHHhcCcCCEEee
Confidence 57899999999999999999964 78999999984321 112335678899999999999999999
Q ss_pred EEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeE
Q 002250 708 YCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPR 787 (947)
Q Consensus 708 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 787 (947)
++++..+...++|+|++.++++..++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 67 ~~~~~~~~~~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~k 141 (292)
T d1unla_ 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp EEEEECSSEEEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEE
T ss_pred ccccccccceeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCcee
Confidence 99999999999999999999988877653 45788899999999999999999 89999999999999999999999
Q ss_pred EeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 002250 788 IADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIVNWVYSK 866 (947)
Q Consensus 788 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 866 (947)
|+|||.|+........ .....+++.|+|||.+.... ++.++||||+||++|||++|+.||.........+.......
T Consensus 142 l~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 219 (292)
T d1unla_ 142 LANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp ECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred eeecchhhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhc
Confidence 9999999876544322 22345788999999987665 68999999999999999999999754322111111111111
Q ss_pred ccccc-cc---c----------ccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 002250 867 MDSRD-SM---L----------TVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM 916 (947)
Q Consensus 867 ~~~~~-~~---~----------~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 916 (947)
..... .. . ...............+.+.+++.+|++.||.+|||++|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 00 0 000111122233344567889999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=359.33 Aligned_cols=262 Identities=24% Similarity=0.253 Sum_probs=189.6
Q ss_pred HhhccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc
Q 002250 627 IIDAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV 705 (947)
Q Consensus 627 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 705 (947)
+.++|++.+.||+|+||+||+|+.. +|+.||||++..... .......+.+|+.++++++|||||
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv 79 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---------------NQTHAKRAYRELVLMKCVNHKNII 79 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS---------------SHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc---------------CHHHHHHHHHHHHHHHhcCCCCee
Confidence 3478999999999999999999965 799999999842211 112345688999999999999999
Q ss_pred eEEEEEecC------CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeE
Q 002250 706 KLYCSITSE------DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNIL 779 (947)
Q Consensus 706 ~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIl 779 (947)
+++++|... ...|+||||+.++.+ +.+. ..+++..+..++.||+.||+||| +.+|+||||||+|||
T Consensus 80 ~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil 151 (355)
T d2b1pa1 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIV 151 (355)
T ss_dssp CCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred EEEEEEecccccccCceeEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccc
Confidence 999999644 567999999976544 4443 24788999999999999999999 899999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 002250 780 LDLEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDI 859 (947)
Q Consensus 780 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 859 (947)
++.++.+|++|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ....
T Consensus 152 ~~~~~~~kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~--~~~~ 226 (355)
T d2b1pa1 152 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQ 226 (355)
T ss_dssp ECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHH
T ss_pred cccccceeeechhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC--HHHH
Confidence 99999999999999876554332 234578999999999999999999999999999999999999995331 0000
Q ss_pred HHHH-------------------Hhhcccccc-----cc----ccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 002250 860 VNWV-------------------YSKMDSRDS-----ML----TVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMR 911 (947)
Q Consensus 860 ~~~~-------------------~~~~~~~~~-----~~----~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 911 (947)
.... ......... .. ....+............+.+++.+|++.||++|||++
T Consensus 227 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~ 306 (355)
T d2b1pa1 227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306 (355)
T ss_dssp HHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence 0000 000000000 00 0111111222344567789999999999999999999
Q ss_pred HHHHH
Q 002250 912 VVVQM 916 (947)
Q Consensus 912 ev~~~ 916 (947)
|++++
T Consensus 307 elL~H 311 (355)
T d2b1pa1 307 DALQH 311 (355)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99865
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.4e-38 Score=345.85 Aligned_cols=284 Identities=28% Similarity=0.502 Sum_probs=234.1
Q ss_pred CCcccccccCCccccccccCCCCCc--ccceeeeCCC---CceeEeccCCCccccc--cCcccccCCcccceeeccC-cc
Q 002250 1 MNLKSKIEKSDTGVFSSWTEANSVC--KFNGIVCDSN---GLVAEINLPEQQLLGV--VPFDSICGLQALQKINLGT-NF 72 (947)
Q Consensus 1 ~~~k~~~~~~~~~~~~sw~~~~~~C--~w~gv~c~~~---~~v~~l~l~~~~~~~~--~~~~~~~~l~~L~~L~L~~-n~ 72 (947)
|.||+.++ ++..++||..++||| .|.||+||++ +||++|+|++.++.|. +| .++++|++|++|+|++ |+
T Consensus 12 l~~k~~~~--~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp-~~l~~L~~L~~L~Ls~~N~ 88 (313)
T d1ogqa_ 12 LQIKKDLG--NPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP-SSLANLPYLNFLYIGGINN 88 (313)
T ss_dssp HHHHHHTT--CCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECC-GGGGGCTTCSEEEEEEETT
T ss_pred HHHHHHCC--CCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCC-hHHhcCccccccccccccc
Confidence 46899884 456899999999999 4999999964 3899999999888874 44 5788888888888875 77
Q ss_pred ccCcCchhhhcCCCccEEeCcCccCcCCCCC-cccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCC
Q 002250 73 LYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFP 151 (947)
Q Consensus 73 i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~ 151 (947)
+.|.+|..|+++++|++|+|++|+|.+.++. +..+..|+++++++|.+.+. +|
T Consensus 89 l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~--------------------------~p 142 (313)
T d1ogqa_ 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGT--------------------------LP 142 (313)
T ss_dssp EESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESC--------------------------CC
T ss_pred cccccccccccccccchhhhccccccccccccccchhhhccccccccccccc--------------------------Cc
Confidence 8788888888888888888888887765543 44455555555555544433 45
Q ss_pred hhhcccccCcEEEccCccccccCCccCCCCCCC-CEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCC
Q 002250 152 MEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQL-QNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLT 230 (947)
Q Consensus 152 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 230 (947)
..+.+++.|+.+++++|.+++.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|...+.+|..+..++
T Consensus 143 ~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~ 221 (313)
T d1ogqa_ 143 PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDK 221 (313)
T ss_dssp GGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTS
T ss_pred hhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccc
Confidence 556667777777777777777888888888776 889999999999888888887655 799999999999999999999
Q ss_pred CccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCccccccccccc
Q 002250 231 NLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSE 310 (947)
Q Consensus 231 ~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 310 (947)
+|+.|++++|.+.+.++.+..+++|+.|+|++|+++|.+|..|+++++|++|+|++|+++|.+|. ++++++|+.+++++
T Consensus 222 ~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~ 300 (313)
T d1ogqa_ 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYAN 300 (313)
T ss_dssp CCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCS
T ss_pred cccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCC
Confidence 99999999999998888888899999999999999999999999999999999999999999985 68899999999999
Q ss_pred cc-ccC
Q 002250 311 NL-LTG 315 (947)
Q Consensus 311 N~-l~~ 315 (947)
|+ +.|
T Consensus 301 N~~l~g 306 (313)
T d1ogqa_ 301 NKCLCG 306 (313)
T ss_dssp SSEEES
T ss_pred CccccC
Confidence 98 444
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-39 Score=352.98 Aligned_cols=265 Identities=19% Similarity=0.240 Sum_probs=194.7
Q ss_pred hhccCCcccccccCceeEEEEEe-CCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccce
Q 002250 628 IDAVKPENLIGKGGSGNVYKVVL-NSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVVK 706 (947)
Q Consensus 628 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 706 (947)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ......+.+.+|++++++++|||||+
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---------------~~~~~~~~~~~Ei~il~~l~h~~iv~ 81 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---------------QSIIHAKRTYRELRLLKHMKHENVIG 81 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT---------------SSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh---------------cChHHHHHHHHHHHHHHhcCCCCeee
Confidence 46899999999999999999995 479999999984221 11123356789999999999999999
Q ss_pred EEEEEecC-----CccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEec
Q 002250 707 LYCSITSE-----DSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLD 781 (947)
Q Consensus 707 l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~ 781 (947)
+++++... ...++||||+.+|+|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+|||++
T Consensus 82 ~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~ 155 (348)
T d2gfsa1 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVN 155 (348)
T ss_dssp CSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred EEEEEeeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCcccccc
Confidence 99998643 344677788889999999965 35899999999999999999999 89999999999999999
Q ss_pred CCCCeEEeccccceecccCCCCcceecccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 002250 782 LEWKPRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCK-INEKSDVYSFGVVLMELVTGKRPIVPEFGDSKDIV 860 (947)
Q Consensus 782 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 860 (947)
.++.+|++|||.|...... .....||+.|+|||...+.. ++.++||||+||++|||++|+.||.+.. .....
T Consensus 156 ~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~--~~~~~ 228 (348)
T d2gfsa1 156 EDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQL 228 (348)
T ss_dssp TTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHH
T ss_pred ccccccccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC--HHHHH
Confidence 9999999999999754332 22456899999999877654 6889999999999999999999995431 11111
Q ss_pred HHHHhhc-cccccc----------------cccccCCCCccCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhcc
Q 002250 861 NWVYSKM-DSRDSM----------------LTVVDPNISEILKEDALKVLRIAIHCTNKLPAFRPSMRVVVQM--LEEA 920 (947)
Q Consensus 861 ~~~~~~~-~~~~~~----------------~~~~d~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~ 920 (947)
..+.... ...... .......+..........+.+++.+|++.||++|||+.|++++ +++.
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 229 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 1111000 000000 0000000011111234567889999999999999999999973 5544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-34 Score=321.41 Aligned_cols=267 Identities=19% Similarity=0.219 Sum_probs=192.1
Q ss_pred hccCCcccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-------
Q 002250 629 DAVKPENLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR------- 700 (947)
Q Consensus 629 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------- 700 (947)
++|++.+.||+|+||+||+|+.. +|+.||||++... ....+.+.+|+.+++.++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~------------------~~~~~~~~~Ei~~l~~l~~~~~~~~ 74 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------------------KVYTEAAEDEIKLLQRVNDADNTKE 74 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------------------HHHHHHHHHHHHHHHHHHHTCCSHH
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc------------------ccchHHHHHHHHHHHHhcchhhhhh
Confidence 35999999999999999999964 7999999998311 112356778999888775
Q ss_pred ----ccccceEEEEEecC--CccEEEEeccCCCC-hHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccC
Q 002250 701 ----HVNVVKLYCSITSE--DSNLLVYEYLPNGS-LWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDV 773 (947)
Q Consensus 701 ----h~niv~l~~~~~~~--~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dl 773 (947)
|+||+++++++... ...+++|++...+. .............++..+..++.||+.||+|||+ ..+|+||||
T Consensus 75 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDl 152 (362)
T d1q8ya_ 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDI 152 (362)
T ss_dssp HHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCC
T ss_pred hhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccC
Confidence 57899999988654 44556666665443 3334444455678889999999999999999994 389999999
Q ss_pred CCCCeEecCCCC------eEEeccccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHHHHHHhCCC
Q 002250 774 KSSNILLDLEWK------PRIADFGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVLMELVTGKR 847 (947)
Q Consensus 774 kp~NIll~~~~~------~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~ 847 (947)
||+|||++.++. ++++|||.|....... ...+||+.|+|||++....++.++||||+||+++||++|+.
T Consensus 153 Kp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 227 (362)
T d1q8ya_ 153 KPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227 (362)
T ss_dssp SGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ChhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCC
Confidence 999999986653 9999999998654332 24579999999999999999999999999999999999999
Q ss_pred CCCCCCCC-cc----cHHHHHHhhcc-----------------ccccccccccC----------CCCccCHHHHHHHHHH
Q 002250 848 PIVPEFGD-SK----DIVNWVYSKMD-----------------SRDSMLTVVDP----------NISEILKEDALKVLRI 895 (947)
Q Consensus 848 p~~~~~~~-~~----~~~~~~~~~~~-----------------~~~~~~~~~d~----------~~~~~~~~~~~~l~~l 895 (947)
||.+.... .. .+...+..... ........... ............+.++
T Consensus 228 pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 307 (362)
T d1q8ya_ 228 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307 (362)
T ss_dssp CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHH
Confidence 99654321 11 11111110000 00000000000 0122346677889999
Q ss_pred HHhccCCCCCCCCCHHHHHHH--hhcc
Q 002250 896 AIHCTNKLPAFRPSMRVVVQM--LEEA 920 (947)
Q Consensus 896 ~~~cl~~dP~~RPt~~ev~~~--L~~~ 920 (947)
+.+|++.||.+|||++|++++ +++.
T Consensus 308 l~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 308 LSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999875 5543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=7.6e-31 Score=284.33 Aligned_cols=251 Identities=27% Similarity=0.484 Sum_probs=163.3
Q ss_pred CCCEEEccCccCcc--cCCCCccCCCcCcEEEccC-ccccccCCcCccCcccccccccccccccCCCCCCcccCCcccee
Q 002250 254 QLSSLHLFENQFSG--EIPEEFGEFKHLTELSLYT-NRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL 330 (947)
Q Consensus 254 ~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L 330 (947)
+++.|+|++|.+++ .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~--------------- 115 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG--------------- 115 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEE---------------
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccc---------------
Confidence 45666666666655 3556666666666666664 56666666666666666666666666654
Q ss_pred eecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccc-cEEEccCccc
Q 002250 331 LVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSL-ALLLLANNRF 409 (947)
Q Consensus 331 ~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~L~~N~l 409 (947)
..+..+..+..|+.+++++|.+.+.+|..+..+++|+.+++++|.+.+.+|..+..+..+ +.+++++|++
T Consensus 116 ---------~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l 186 (313)
T d1ogqa_ 116 ---------AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp ---------ECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred ---------cccccccchhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccc
Confidence 334445555566666666666666666666666666666666666666666666555554 5666666666
Q ss_pred cccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCC
Q 002250 410 SGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSL 489 (947)
Q Consensus 410 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 489 (947)
++..|..+..+..+ .+++++|.+.+.+|..++.+++|+.|++++|.+.+.+| .++.+++|+.|+|++|+|+|.+|+.|
T Consensus 187 ~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l 264 (313)
T d1ogqa_ 187 TGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp EEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGG
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHH
Confidence 66666666665444 46777777777777777777777777777777765443 56667777777777777777777777
Q ss_pred CccCcCcEEECCCCccCCccCCcccccccceeeCCCCc-CCC
Q 002250 490 GSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQ-LAG 530 (947)
Q Consensus 490 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ls~N~-l~~ 530 (947)
+++++|++|+|++|+|+|.+|....+++|+.+++++|+ ++|
T Consensus 265 ~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 265 TQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred hCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccC
Confidence 77777777777777777777765455666666666665 444
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=5e-29 Score=278.41 Aligned_cols=357 Identities=23% Similarity=0.307 Sum_probs=185.3
Q ss_pred eeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCC
Q 002250 66 INLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPF 145 (947)
Q Consensus 66 L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i 145 (947)
..++.+.+.+.+. ...+.+|++|++++|.|+.. +.++.|++|++|+|++|+|++.. .+.++++|++|++++|++
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l-~gl~~L~nL~~L~Ls~N~l~~l~---~l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDIT---PLKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC-TTGGGCTTCCEEECCSSCCCCCG---GGTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc-cccccCCCCCEEeCcCCcCCCCc---cccCCccccccccccccc
Confidence 3455555555443 24556677777777766642 34555666666666666665432 255556666666666655
Q ss_pred CCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCcc
Q 002250 146 DPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVG 225 (947)
Q Consensus 146 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 225 (947)
... + .+..+++|+.|++++|.+++..+ ......+..+....|.+....+..................+ ..
T Consensus 101 ~~i--~-~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 170 (384)
T d2omza2 101 ADI--T-PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL-----KP 170 (384)
T ss_dssp CCC--G-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC-----GG
T ss_pred ccc--c-ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchh-----hh
Confidence 432 1 24444455555555444443211 22333444444444444322221111111111111111111 11
Q ss_pred CCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccc
Q 002250 226 FSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNY 305 (947)
Q Consensus 226 ~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 305 (947)
+...+ .........|... ....+..+++++.+++++|.+++..| +...++|+.
T Consensus 171 ~~~~~-----------------------~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~ 223 (384)
T d2omza2 171 LANLT-----------------------TLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDE 223 (384)
T ss_dssp GTTCT-----------------------TCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCE
T ss_pred hcccc-----------------------ccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCE
Confidence 22222 3333333333332 22334444555555555555543222 233445555
Q ss_pred cccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCc
Q 002250 306 VDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQF 385 (947)
Q Consensus 306 L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 385 (947)
|++++|.++.. ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|++
T Consensus 224 L~l~~n~l~~~--------------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l 275 (384)
T d2omza2 224 LSLNGNQLKDI--------------------------GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 275 (384)
T ss_dssp EECCSSCCCCC--------------------------GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCC
T ss_pred EECCCCCCCCc--------------------------chhhcccccchhccccCccCCCCc--ccccccCCEeeccCccc
Confidence 55555544410 123334455555555555543322 44455666666666666
Q ss_pred CCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCccc
Q 002250 386 EGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSI 465 (947)
Q Consensus 386 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 465 (947)
++.. .+..+..++.+.+++|++++ ...+..+++++.|++++|++++.. .+..+++|++|+|++|+|++ ++ .|
T Consensus 276 ~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l 347 (384)
T d2omza2 276 SNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SL 347 (384)
T ss_dssp CCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GG
T ss_pred CCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hH
Confidence 5432 24555666666666666653 223566677777777777777533 26777777888888887764 33 57
Q ss_pred ccccccceeeccCceeeeecCCCCCccCcCcEEECCCC
Q 002250 466 GSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNN 503 (947)
Q Consensus 466 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 503 (947)
+.+++|++|++++|+|++..| +.++++|+.|+|++|
T Consensus 348 ~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred cCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 778888888888888886554 778888888888887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=7.8e-29 Score=276.86 Aligned_cols=356 Identities=24% Similarity=0.333 Sum_probs=235.4
Q ss_pred eCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccc
Q 002250 91 DLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSV 170 (947)
Q Consensus 91 ~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l 170 (947)
+++.+.+++.+. ...+.+|++|++++|.|+.. ..+..+++|++|+|++|+|+..
T Consensus 28 ~l~~~~~~~~~~-~~~l~~l~~L~l~~~~I~~l---~gl~~L~nL~~L~Ls~N~l~~l---------------------- 81 (384)
T d2omza2 28 VLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI---DGVEYLNNLTQINFSNNQLTDI---------------------- 81 (384)
T ss_dssp HTTCSSTTSEEC-HHHHTTCCEEECCSSCCCCC---TTGGGCTTCCEEECCSSCCCCC----------------------
T ss_pred HhCCCCCCCccC-HHHhCCCCEEECCCCCCCCc---cccccCCCCCEEeCcCCcCCCC----------------------
Confidence 444454444322 23445555555555555431 2344555555555555555432
Q ss_pred cccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCcccc
Q 002250 171 TGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELR 250 (947)
Q Consensus 171 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~ 250 (947)
| .++++++|++|++++|++.+.. .+.++++|+.|++++|.+++..+ ......+..+....|.+...... .
T Consensus 82 ----~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~-~ 151 (384)
T d2omza2 82 ----T-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISAL-S 151 (384)
T ss_dssp ----G-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGG-T
T ss_pred ----c-cccCCccccccccccccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccc-c
Confidence 1 2444555555555555544321 24455555555555555543211 22334444444444444322211 1
Q ss_pred ccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccccccccCCCCCCcccCCcccee
Q 002250 251 FLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDL 330 (947)
Q Consensus 251 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L 330 (947)
.....+......+. .....+...+.........|... .+..+..+++++.+++++|.+++..|
T Consensus 152 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~------------ 214 (384)
T d2omza2 152 GLTSLQQLSFGNQV---TDLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP------------ 214 (384)
T ss_dssp TCTTCSEEEEEESC---CCCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG------------
T ss_pred cccccccccccccc---chhhhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc------------
Confidence 11111111111111 12234555666777777777664 45567788899999999998874321
Q ss_pred eecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCcccc
Q 002250 331 LVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFS 410 (947)
Q Consensus 331 ~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 410 (947)
+..+++|+.|++++|.++.. +.+..+++|+.|++++|++++..+ +..+++|+.|++++|+++
T Consensus 215 --------------~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~ 276 (384)
T d2omza2 215 --------------LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 276 (384)
T ss_dssp --------------GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCC
T ss_pred --------------ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccC
Confidence 34567899999999999843 467889999999999999997543 788999999999999998
Q ss_pred ccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCC
Q 002250 411 GELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLG 490 (947)
Q Consensus 411 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 490 (947)
+.. .+..++.++.++++.|++++ + ..+..+++++.|++++|++++.. .+..+++|+.|++++|+|++ +| .+.
T Consensus 277 ~~~--~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~ 348 (384)
T d2omza2 277 NIS--PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLA 348 (384)
T ss_dssp CCG--GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGG
T ss_pred CCC--cccccccccccccccccccc-c-cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHc
Confidence 543 37788999999999999985 3 35888999999999999999754 38899999999999999984 55 599
Q ss_pred ccCcCcEEECCCCccCCccCCcccccccceeeCCCC
Q 002250 491 SLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNN 526 (947)
Q Consensus 491 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ls~N 526 (947)
++++|++|+|++|++++.+| ...+++|+.|+|++|
T Consensus 349 ~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 349 NLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp GCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 99999999999999998766 455799999999998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.2e-25 Score=242.25 Aligned_cols=243 Identities=21% Similarity=0.323 Sum_probs=150.4
Q ss_pred cCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEecc
Q 002250 159 KLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVS 238 (947)
Q Consensus 159 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 238 (947)
.++.++.++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 4556677777777 5566554 578888888888875555577888888888888888887777778888888888888
Q ss_pred CCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCcccc--ccCCcCccCcccccccccccccccCC
Q 002250 239 QNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT--GTLPQKLGSWADFNYVDVSENLLTGP 316 (947)
Q Consensus 239 ~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~~ 316 (947)
+|+++..+..+ ...++.|++.+|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|.++ .
T Consensus 88 ~n~l~~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~ 164 (305)
T d1xkua_ 88 KNQLKELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T 164 (305)
T ss_dssp SSCCSBCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-S
T ss_pred CCccCcCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-c
Confidence 88877665432 356777888888877665556666777777777777543 233445566666666666666655 2
Q ss_pred CCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCccccc
Q 002250 317 IPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNA 396 (947)
Q Consensus 317 ~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 396 (947)
+|..+ .++|+.|++++|.+++..+..+..++.++.|++++|.+++..+..+.++
T Consensus 165 l~~~~--------------------------~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l 218 (305)
T d1xkua_ 165 IPQGL--------------------------PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 218 (305)
T ss_dssp CCSSC--------------------------CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred cCccc--------------------------CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccc
Confidence 22211 2344455555555554444445555555555555555554444455555
Q ss_pred ccccEEEccCccccccCCCCCCCCCcceEEEcccCccc
Q 002250 397 KSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFS 434 (947)
Q Consensus 397 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 434 (947)
++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|+
T Consensus 219 ~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 219 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp TTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred ccceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence 55555555555554 34445555555555555555555
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.8e-24 Score=232.89 Aligned_cols=122 Identities=25% Similarity=0.241 Sum_probs=55.2
Q ss_pred cceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCC-CcccccccceeecCCCCccCccCcccccccCCCceeeCC
Q 002250 63 LQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP-DLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLG 141 (947)
Q Consensus 63 L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~-~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls 141 (947)
++.++=++++++ .+|..+. +++++|||++|+|+..++ .|.++++|++|++++|.+....+ ..|.++++|++|+++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~-~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP-GAFAPLVKLERLYLS 87 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccch-hhhhCCCccCEeccc
Confidence 344444444553 3343332 455556666665555444 25555555555555555553322 445555555555555
Q ss_pred CCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCc
Q 002250 142 DNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDN 192 (947)
Q Consensus 142 ~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N 192 (947)
+|+++..+ . .....+..|++++|.+.+..+..+.....++.++...|
T Consensus 88 ~n~l~~l~--~--~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n 134 (305)
T d1xkua_ 88 KNQLKELP--E--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134 (305)
T ss_dssp SSCCSBCC--S--SCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSS
T ss_pred CCccCcCc--c--chhhhhhhhhccccchhhhhhhhhhccccccccccccc
Confidence 55544321 1 11223444444444444333333333344444444443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=5.4e-25 Score=234.16 Aligned_cols=223 Identities=21% Similarity=0.217 Sum_probs=124.8
Q ss_pred EEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccCcccccccccc-ccc
Q 002250 234 NFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGSWADFNYVDVS-ENL 312 (947)
Q Consensus 234 ~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls-~N~ 312 (947)
.++.++++++.+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|++....+..+..+..+..++.. .|.
T Consensus 15 ~v~c~~~~L~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 15 TTSCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EEECCSSCCSSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEEcCCCCCCccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 34555555555544433 445666666666665555556666666666666666655444444444444444332 222
Q ss_pred ccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCc
Q 002250 313 LTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDD 392 (947)
Q Consensus 313 l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 392 (947)
++ ...|.+|.++++|+.|++++|.+....+..+...++|+.+++++|+++++++..
T Consensus 93 ~~------------------------~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~ 148 (284)
T d1ozna_ 93 LR------------------------SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148 (284)
T ss_dssp CC------------------------CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred cc------------------------cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhH
Confidence 22 223445566666666666666665555555555666666666666666555555
Q ss_pred ccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccccccCCCCCcccccccccc
Q 002250 393 IGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLT 472 (947)
Q Consensus 393 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 472 (947)
|..+++|+.|++++|++++..+..|..+++|+.+++++|++++..|..|.++++|++|++++|++.+..|..|+.+++|+
T Consensus 149 f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~ 228 (284)
T d1ozna_ 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred hccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccC
Confidence 55555666666666666555555555555666666666655555555555555555555555555555555555555555
Q ss_pred eeeccCceee
Q 002250 473 DINFAQNSLS 482 (947)
Q Consensus 473 ~L~Ls~N~l~ 482 (947)
+|+|++|.+.
T Consensus 229 ~L~l~~N~l~ 238 (284)
T d1ozna_ 229 YLRLNDNPWV 238 (284)
T ss_dssp EEECCSSCEE
T ss_pred EEEecCCCCC
Confidence 5555555554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2e-24 Score=229.78 Aligned_cols=268 Identities=19% Similarity=0.212 Sum_probs=197.8
Q ss_pred cEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCc-cccccCCCCEEEccCccCcccCCCCccCCCcCcEEEcc-C
Q 002250 209 WQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLS-ELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLY-T 286 (947)
Q Consensus 209 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~-~ 286 (947)
..++.+++.++ .+|..+. +++++|+|++|+|+..+. .+..+++|++|++++|++....+..+..++.+..+... .
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 45678888888 6676554 678999999999998775 58999999999999999998888999999999998764 6
Q ss_pred ccccccCCcCccCcccccccccccccccCCCCCCcccCCccceeeecccccCCcCCccccCCCCccEEEcccccccccCC
Q 002250 287 NRLTGTLPQKLGSWADFNYVDVSENLLTGPIPPDMCKTGAMTDLLVLQNNFNGTVPETYANCKSLIRFRVNNNSLSGTIP 366 (947)
Q Consensus 287 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 366 (947)
|.++...+..|.++++|++|++++|.+....+ ..+....+|+.+++++|.+++..+
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~------------------------~~~~~~~~L~~l~l~~N~l~~i~~ 146 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGP------------------------GLFRGLAALQYLYLQDNALQALPD 146 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCT------------------------TTTTTCTTCCEEECCSSCCCCCCT
T ss_pred cccccccchhhcccccCCEEecCCcccccccc------------------------cccchhcccchhhhccccccccCh
Confidence 67777778889999999999999999874333 334555667777777777776556
Q ss_pred CCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEcccCcccCCCCcccccccc
Q 002250 367 PGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSLNQFSGQIPLDIGKLKK 446 (947)
Q Consensus 367 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 446 (947)
..|..+++|+.|++++|++++..+..|.++++|+++++++|++++..|..|..+++|+.|++++|++.+..|..|+++++
T Consensus 147 ~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~ 226 (284)
T d1ozna_ 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred hHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccc
Confidence 66777777777777777777777777777777777777777777777777777777788888888877777777777778
Q ss_pred cchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCC
Q 002250 447 LSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSG 507 (947)
Q Consensus 447 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 507 (947)
|++|+|++|.+...-+. -.-...++.+....+++....|..+.+ +..++++.+.|+|
T Consensus 227 L~~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 227 LQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp CCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred cCEEEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 88888888877653321 111234556666666666666665543 3333444444443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=7e-24 Score=222.87 Aligned_cols=183 Identities=21% Similarity=0.223 Sum_probs=91.0
Q ss_pred ccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEccc
Q 002250 351 LIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSL 430 (947)
Q Consensus 351 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 430 (947)
+++|+|++|.|++..+..|..+++|++|+|++|+|+... .++.+++|++|+|++|+++ ..+..+..+++|+.|++++
T Consensus 33 l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~ 109 (266)
T d1p9ag_ 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF 109 (266)
T ss_dssp CCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCS
T ss_pred CCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccccccccccccc-ccccccccccccccccccc
Confidence 444444444444333344444444444444444444221 1234444444555555444 3344444555555555555
Q ss_pred CcccCCCCcccccccccchhhccccccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccC
Q 002250 431 NQFSGQIPLDIGKLKKLSSLYLHDNMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIP 510 (947)
Q Consensus 431 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 510 (947)
|.+.+..+..+..+.+++.|++++|.+++..+..+..+++|+.|++++|+|++..++.|..+++|++|+|++|+|+..++
T Consensus 110 ~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~ 189 (266)
T d1p9ag_ 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPK 189 (266)
T ss_dssp SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred cccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccCh
Confidence 55554444444455555555555555554444444555555555555555554444455555555555555555552222
Q ss_pred CcccccccceeeCCCCcCCCCCCCcccccccccccccCCCCCCCCccc
Q 002250 511 ISLTYPKLSLLDLSNNQLAGPIPEPLNIKAFIDSFTGNPGLCSKTDEY 558 (947)
Q Consensus 511 ~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~gN~~~c~~~~~~ 558 (947)
..+.+++|+.|+ +.||||.|+|...|
T Consensus 190 ~~~~~~~L~~L~----------------------L~~Np~~CdC~~~~ 215 (266)
T d1p9ag_ 190 GFFGSHLLPFAF----------------------LHGNPWLCNCEILY 215 (266)
T ss_dssp TTTTTCCCSEEE----------------------CCSCCBCCSGGGHH
T ss_pred hHCCCCCCCEEE----------------------ecCCCCCCCcchHH
Confidence 223334444444 45788899887654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.5e-22 Score=210.91 Aligned_cols=111 Identities=26% Similarity=0.195 Sum_probs=46.8
Q ss_pred CCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCc-cccccCCCCE
Q 002250 179 GNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLS-ELRFLNQLSS 257 (947)
Q Consensus 179 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~ 257 (947)
..+++|++|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++|+.|++++|++++.+. .+..+++|++
T Consensus 97 ~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~ 176 (266)
T d1p9ag_ 97 QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176 (266)
T ss_dssp TTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCE
T ss_pred ccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccce
Confidence 333333333333333333333333333334444444444433333333344444444444444443332 2334444444
Q ss_pred EEccCccCcccCCCCccCCCcCcEEEccCcccc
Q 002250 258 LHLFENQFSGEIPEEFGEFKHLTELSLYTNRLT 290 (947)
Q Consensus 258 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 290 (947)
|+|++|+|+ .+|+.+..+++|+.|+|++|++.
T Consensus 177 L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp EECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred eecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 444444444 34444445555555555555543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=1e-22 Score=202.07 Aligned_cols=186 Identities=16% Similarity=0.142 Sum_probs=121.8
Q ss_pred CCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchh-hhhhcccCChhhHHHHHHHHhhccccccceEEEE
Q 002250 632 KPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSST-AILSKRSSRSSEYDAEVATLSAVRHVNVVKLYCS 710 (947)
Q Consensus 632 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 710 (947)
.+.+.||+|+||+||+|+..+|+.||||++++.....+....... ..............+|+..+.++.|.++++.+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457889999999999999889999999998654432221100000 0000001112445678999999999999998866
Q ss_pred EecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCCeEecCCCCeEEec
Q 002250 711 ITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHGFDRPVIHRDVKSSNILLDLEWKPRIAD 790 (947)
Q Consensus 711 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 790 (947)
. ..++||||+++..+.+ ++......++.|++.+++||| +.+|+||||||+|||++++ .++++|
T Consensus 83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEE
Confidence 3 2479999998765432 223334568899999999999 8999999999999999965 589999
Q ss_pred cccceecccCCCCcceecccccccccCccccccCCCCCccchHHHHHHH
Q 002250 791 FGLAKIVQTGEAGDLTHVIAGTHGYIAPEYAYTCKINEKSDVYSFGVVL 839 (947)
Q Consensus 791 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l 839 (947)
||.|.......... ....+...+ .| .....|..++|+||..--+
T Consensus 146 FG~a~~~~~~~~~~---~l~rd~~~~-~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWRE---ILERDVRNI-IT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHH---HHHHHHHHH-HH-HHHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHH---HHHHHHHHH-HH-HHcCCCCCcccHHHHHHHH
Confidence 99997654322100 000000000 01 1235678899999975443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=2.5e-19 Score=196.23 Aligned_cols=81 Identities=17% Similarity=0.250 Sum_probs=51.0
Q ss_pred ccEEEcccccccccCCCCCCCCCCcceeccccCCcCCCCCCcccccccccEEEccCccccccCCCCCCCCCcceEEEccc
Q 002250 351 LIRFRVNNNSLSGTIPPGIWSLPNLSIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGELPSKISEASSLVSIQLSL 430 (947)
Q Consensus 351 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 430 (947)
....++..+.+.+. + ..+++|++|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|.. +++|+.|+|++
T Consensus 266 ~~~~~~~~~~~~~~-~---~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~ 333 (353)
T d1jl5a_ 266 LYYLNASSNEIRSL-C---DLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEY 333 (353)
T ss_dssp CCEEECCSSCCSEE-C---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCS
T ss_pred hcccccccCccccc-c---ccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcC
Confidence 34455566665532 2 224677788888887774 333 2457778888888887 56643 45678888888
Q ss_pred CcccCCCCcccccc
Q 002250 431 NQFSGQIPLDIGKL 444 (947)
Q Consensus 431 N~l~~~~p~~~~~l 444 (947)
|+|+ .+|.....+
T Consensus 334 N~L~-~lp~~~~~L 346 (353)
T d1jl5a_ 334 NPLR-EFPDIPESV 346 (353)
T ss_dssp SCCS-SCCCCCTTC
T ss_pred CcCC-CCCcccccc
Confidence 8887 566543333
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=2.2e-19 Score=196.64 Aligned_cols=138 Identities=21% Similarity=0.256 Sum_probs=74.2
Q ss_pred CCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEE
Q 002250 85 TRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLY 164 (947)
Q Consensus 85 ~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~ 164 (947)
.+|++|||++|.++..++ .+++|++|+|++|+|+ .+| .. +.+|+.|++++|+++..+ . + .+.|++|+
T Consensus 38 ~~l~~LdLs~~~L~~lp~---~~~~L~~L~Ls~N~l~-~lp-~~---~~~L~~L~l~~n~l~~l~--~-l--p~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPE---LPPHLESLVASCNSLT-ELP-EL---PQSLKSLLVDNNNLKALS--D-L--PPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCSCCCS---CCTTCSEEECCSSCCS-SCC-CC---CTTCCEEECCSSCCSCCC--S-C--CTTCCEEE
T ss_pred cCCCEEEeCCCCCCCCCC---CCCCCCEEECCCCCCc-ccc-cc---hhhhhhhhhhhcccchhh--h-h--cccccccc
Confidence 356677777777664432 2356666666666665 334 11 346677777777665422 1 0 12466666
Q ss_pred ccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCC
Q 002250 165 LTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLE 243 (947)
Q Consensus 165 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 243 (947)
+++|.++ .+|. ++.+++|+.|++++|.+.. .+. ....+..|.+.++.... ...+..++.++.|++++|.+.
T Consensus 105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~---~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCS
T ss_pred ccccccc-cccc-hhhhccceeeccccccccc-ccc---ccccccchhhccccccc--cccccccccceeccccccccc
Confidence 6666665 3442 4566667777776666642 222 22345555555554432 233445555555555555544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=1.4e-19 Score=184.84 Aligned_cols=208 Identities=24% Similarity=0.272 Sum_probs=127.1
Q ss_pred CcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceee
Q 002250 60 LQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLS 139 (947)
Q Consensus 60 l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~ 139 (947)
+.++..++++.+.+++.. .+..+.+|+.|++++|.|+.. +.++.+++|++|++++|++++.. .+..+++|++|+
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~ls~n~i~~~~---~l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLA---PLKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCG---GGTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-hhHhcCCCCcEeecCCceeeccc---cccccccccccc
Confidence 344455666677776543 456677777888887777754 45777777777777777776432 367777777777
Q ss_pred CCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeeccccc
Q 002250 140 LGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLS 219 (947)
Q Consensus 140 Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~ 219 (947)
+++|.++..+ .+.++++|+.+++++|...+. ..+...+.++.+.++.+.+... ..+.++++|++|++++|.++
T Consensus 92 ~~~n~~~~i~---~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 92 LSGNPLKNVS---AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS 164 (227)
T ss_dssp CCSCCCSCCG---GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCC
T ss_pred cccccccccc---ccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccc
Confidence 7777665422 355666666666666666533 2345556666777766666432 33556666666666666665
Q ss_pred ccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEcc
Q 002250 220 GRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLY 285 (947)
Q Consensus 220 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 285 (947)
+. ..+.++++|++|+|++|++++. +.+..+++|++|+|++|++++.. .+.++++|+.|+++
T Consensus 165 ~~--~~l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 165 DL--TPLANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp CC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred cc--hhhcccccceecccCCCccCCC-hhhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 32 2355666666666666666543 33555566666666666665332 25555666666554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=3e-19 Score=182.30 Aligned_cols=206 Identities=19% Similarity=0.259 Sum_probs=173.0
Q ss_pred eeEeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCC
Q 002250 38 VAEINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNS 117 (947)
Q Consensus 38 v~~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~ 117 (947)
++.+++....+++.+ .+.++.+|+.|++.+|+|... +.+..+++|++|+|++|+|++.. .+..+++|+++++++
T Consensus 21 ~~~~~l~~~~~~d~~---~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~-~l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV---TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA-PLKNLTKITELELSG 94 (227)
T ss_dssp HHHHHTTCSSTTSEE---CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG-GGTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCCcC---CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc-ccccccccccccccc
Confidence 445666666666654 467889999999999999754 46999999999999999998654 489999999999999
Q ss_pred CCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccc
Q 002250 118 SGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGE 197 (947)
Q Consensus 118 n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 197 (947)
|.++. + ..+..+++|+.|+++++.+... ..+...+.++.+.++++.+... ..+..+++|++|++++|.+.+.
T Consensus 95 n~~~~-i--~~l~~l~~L~~l~l~~~~~~~~---~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~ 166 (227)
T d1h6ua2 95 NPLKN-V--SAIAGLQSIKTLDLTSTQITDV---TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL 166 (227)
T ss_dssp CCCSC-C--GGGTTCTTCCEEECTTSCCCCC---GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC
T ss_pred ccccc-c--cccccccccccccccccccccc---chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc
Confidence 99974 3 3688999999999999987653 3467789999999999999844 3477889999999999998643
Q ss_pred cCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccC
Q 002250 198 IPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFE 262 (947)
Q Consensus 198 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~ 262 (947)
..+.++++|++|+|++|++++. + .++++++|++|+|++|++++.+ .+..+++|+.|+|++
T Consensus 167 --~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 167 --TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTLTN 226 (227)
T ss_dssp --GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG-GGTTCTTCCEEEEEE
T ss_pred --hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc-ccccCCCCCEEEeeC
Confidence 3589999999999999999964 3 4889999999999999998754 588999999999974
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=5e-23 Score=234.82 Aligned_cols=112 Identities=19% Similarity=0.208 Sum_probs=61.5
Q ss_pred ccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCC---CChhhcccccCcEEEccCcccccc----CCccCC-C
Q 002250 109 ELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSP---FPMEVLKLEKLYWLYLTNCSVTGQ----IPEGIG-N 180 (947)
Q Consensus 109 ~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~---~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~-~ 180 (947)
+|+.||+++|++++..-.+.+..+++|+.|+|++|.++... +...+..+++|++|+|++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 57777777777765322234566677777777777665321 122344556666666666666421 122222 1
Q ss_pred CCCCCEEECcCcccccc----cCccccCCCCCcEEEeecccccc
Q 002250 181 LTQLQNLELSDNELFGE----IPAGIVKLNKLWQLELYNNSLSG 220 (947)
Q Consensus 181 l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~n~l~~ 220 (947)
..+|++|+|++|++++. ++..+..+++|++|+|++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 23566666666666432 23344555666666666666553
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.4e-18 Score=177.58 Aligned_cols=220 Identities=14% Similarity=0.048 Sum_probs=128.4
Q ss_pred ceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCC-cccccccceeecCCCCccCccCcccccccCCCceeeCCC
Q 002250 64 QKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGD 142 (947)
Q Consensus 64 ~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~ 142 (947)
+.++.++++++ .+|+.+. +++++|||++|+|+..++. |.++++|++|+|++|.+...++...|.+++++++|++..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 34555555553 4443332 3566666666666544432 455555555555555554433333444444444444332
Q ss_pred CCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCc-cccCCCCCcEEEeeccccccc
Q 002250 143 NPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPA-GIVKLNKLWQLELYNNSLSGR 221 (947)
Q Consensus 143 n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~L~~n~l~~~ 221 (947)
.|.+....+..|.++++|++|++++|++....+. .+..+..|..+...++.+...
T Consensus 88 ------------------------~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i 143 (242)
T d1xwdc1 88 ------------------------ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI 143 (242)
T ss_dssp ------------------------CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEE
T ss_pred ------------------------cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccc
Confidence 2344445556666677777777777766533221 233455566666666667665
Q ss_pred CCccCCCCC-CccEEeccCCCCCCCCccccccCCCCEE-EccCccCcccCCCCccCCCcCcEEEccCccccccCCcCccC
Q 002250 222 LPVGFSNLT-NLMNFDVSQNRLEGDLSELRFLNQLSSL-HLFENQFSGEIPEEFGEFKHLTELSLYTNRLTGTLPQKLGS 299 (947)
Q Consensus 222 ~~~~~~~l~-~L~~L~Ls~N~l~~~~~~l~~l~~L~~L-~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 299 (947)
.+..|..++ .++.|++++|+++..........+++.+ ++++|+++...+..|.++++|++|+|++|+++...+..|.+
T Consensus 144 ~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~ 223 (242)
T d1xwdc1 144 ERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223 (242)
T ss_dssp CTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTT
T ss_pred cccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcC
Confidence 566666654 6677777777776655544444555444 46777777555556788888888888888888544556777
Q ss_pred ccccccccccc
Q 002250 300 WADFNYVDVSE 310 (947)
Q Consensus 300 l~~L~~L~Ls~ 310 (947)
+++|+.+++.+
T Consensus 224 l~~L~~l~~~~ 234 (242)
T d1xwdc1 224 LKKLRARSTYN 234 (242)
T ss_dssp CCEEESSSEES
T ss_pred CcccccCcCCC
Confidence 77787777654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1.3e-18 Score=174.78 Aligned_cols=182 Identities=25% Similarity=0.337 Sum_probs=85.9
Q ss_pred ceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCC
Q 002250 64 QKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDN 143 (947)
Q Consensus 64 ~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n 143 (947)
...+++.+.+.+.++. ..+.+|++|++++|.+++.. .+..+++|++|+|++|+|++.. .+..+++|++|++++|
T Consensus 27 i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~L~~n~i~~l~---~~~~l~~L~~L~l~~n 100 (210)
T d1h6ta2 27 IKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIK---PLANLKNLGWLFLDEN 100 (210)
T ss_dssp HHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCG---GGTTCTTCCEEECCSS
T ss_pred HHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch-hHhhCCCCCEEeCCCccccCcc---ccccCccccccccccc
Confidence 3445555555544442 34556666666666665432 3555555555555555555322 2445555555555555
Q ss_pred CCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCC
Q 002250 144 PFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLP 223 (947)
Q Consensus 144 ~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 223 (947)
+++.. + .+..+++|+.|++++|.+.. + ..+..+++|+.+++++| .+++ +
T Consensus 101 ~i~~l--~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n------------------------~l~~--~ 149 (210)
T d1h6ta2 101 KVKDL--S-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNN------------------------KITD--I 149 (210)
T ss_dssp CCCCG--G-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSS------------------------CCCC--C
T ss_pred ccccc--c-cccccccccccccccccccc-c-ccccccccccccccccc------------------------cccc--c
Confidence 55431 1 23344444444444444431 1 23444444444444444 4432 1
Q ss_pred ccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEcc
Q 002250 224 VGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLY 285 (947)
Q Consensus 224 ~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 285 (947)
..+..+++|+++++++|++++. ..+..+++|++|+|++|+|+. ++ .|.++++|++|+|+
T Consensus 150 ~~~~~l~~L~~l~l~~n~l~~i-~~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 150 TVLSRLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp GGGGGCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred cccccccccccccccccccccc-ccccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 2233444444444444444432 224445555555555555542 22 35555555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.9e-18 Score=178.29 Aligned_cols=182 Identities=15% Similarity=0.144 Sum_probs=126.2
Q ss_pred cccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCC--CcccccccceeecCC-CCccCccCcccccccCCCce
Q 002250 61 QALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVP--DLSMLHELSFLNLNS-SGISGKFPWKSLENLTNLEF 137 (947)
Q Consensus 61 ~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~--~l~~l~~L~~L~L~~-n~i~~~~~~~~l~~l~~L~~ 137 (947)
+++++|+|++|.|....+.+|.++++|++|+|++|.+...++ .+..++.+++|++.. |.+.. .+...|.++++|++
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~-~~~~~~~~l~~L~~ 107 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQY 107 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCE-ECTTSEECCTTCCE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccc-cccccccccccccc
Confidence 478999999999987777889999999999999999987544 378899999999865 56654 34478899999999
Q ss_pred eeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCC-CCCEEECcCcccccccCccccCCCCCcEE-Eeec
Q 002250 138 LSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLT-QLQNLELSDNELFGEIPAGIVKLNKLWQL-ELYN 215 (947)
Q Consensus 138 L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L-~L~~ 215 (947)
|++++|.+...+....+..+..++.+...++.+....+..|..++ .++.|++++|+++...+..+ ...+++++ ++++
T Consensus 108 l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~ 186 (242)
T d1xwdc1 108 LLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDN 186 (242)
T ss_dssp EEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccc-cchhhhccccccc
Confidence 999999887655444555666677777777777766566666553 56667777777664333333 33333333 3455
Q ss_pred ccccccCCccCCCCCCccEEeccCCCCCC
Q 002250 216 NSLSGRLPVGFSNLTNLMNFDVSQNRLEG 244 (947)
Q Consensus 216 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 244 (947)
|+|+...+..|.++++|++|+|++|+++.
T Consensus 187 n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~ 215 (242)
T d1xwdc1 187 NNLEELPNDVFHGASGPVILDISRTRIHS 215 (242)
T ss_dssp TTCCCCCTTTTTTSCCCSEEECTTSCCCC
T ss_pred cccccccHHHhcCCCCCCEEECCCCcCCc
Confidence 55654434445555555555555555543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.7e-18 Score=172.47 Aligned_cols=182 Identities=26% Similarity=0.329 Sum_probs=148.6
Q ss_pred EeccCCCccccccCcccccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCC
Q 002250 40 EINLPEQQLLGVVPFDSICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSG 119 (947)
Q Consensus 40 ~l~l~~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~ 119 (947)
...+....+.+.++ ...+.+|+.|++++|.+.+.. .+..+++|++|+|++|+|++.. .++.+++|++|++++|+
T Consensus 28 ~~~l~~~~~~~~~~---~~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 28 KDNLKKKSVTDAVT---QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENK 101 (210)
T ss_dssp HHHTTCSCTTSEEC---HHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSC
T ss_pred HHHhCcCccCCccC---HHHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc-ccccCcccccccccccc
Confidence 34455555555554 345788999999999996643 4889999999999999999754 57899999999999999
Q ss_pred ccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccC
Q 002250 120 ISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIP 199 (947)
Q Consensus 120 i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 199 (947)
|++ ++ .+..+++|+.|++++|.+... ..+..++.|+++++++|.+++ +..+..+++|+++++++|++++. +
T Consensus 102 i~~-l~--~l~~l~~L~~L~l~~~~~~~~---~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~ 172 (210)
T d1h6ta2 102 VKD-LS--SLKDLKKLKSLSLEHNGISDI---NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V 172 (210)
T ss_dssp CCC-GG--GGTTCTTCCEEECTTSCCCCC---GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G
T ss_pred ccc-cc--ccccccccccccccccccccc---ccccccccccccccccccccc--ccccccccccccccccccccccc-c
Confidence 985 33 589999999999999998653 357889999999999999984 34678899999999999999754 2
Q ss_pred ccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccC
Q 002250 200 AGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQ 239 (947)
Q Consensus 200 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 239 (947)
.+.++++|++|+|++|+|++ ++ .|.++++|++|+|++
T Consensus 173 -~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 173 -PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp -GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred -cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 48889999999999999984 33 588888888888763
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=3.9e-18 Score=169.81 Aligned_cols=182 Identities=26% Similarity=0.339 Sum_probs=96.5
Q ss_pred CcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceee
Q 002250 60 LQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLS 139 (947)
Q Consensus 60 l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~ 139 (947)
+..+..+.++.+.+.+.++ ...+.+|++|++++|.|+. .+.++.+++|++|+|++|++++.. .+.++++|++|+
T Consensus 17 l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~~l~~l~nL~~L~Ls~N~l~~~~---~l~~l~~L~~L~ 90 (199)
T d2omxa2 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDIT---PLKNLTKLVDIL 90 (199)
T ss_dssp HHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCCG---GGTTCTTCCEEE
T ss_pred HHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-ccccccCCCcCcCccccccccCcc---cccCCccccccc
Confidence 3344455666666655543 2456677777777777764 334566666666666666665432 256666666666
Q ss_pred CCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeeccccc
Q 002250 140 LGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLS 219 (947)
Q Consensus 140 Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~ 219 (947)
+++|.+...+ .+.+++.|+.|++++|.+... ..+..+++|+.|++++|++.. + +.+..+++|++|++++|+++
T Consensus 91 l~~n~~~~~~---~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 91 MNNNQIADIT---PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp CCSSCCCCCG---GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC
T ss_pred cccccccccc---ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-cccccccccccccccccccc
Confidence 6666554321 244555555555555555432 234455555555555555532 1 23455555555555555555
Q ss_pred ccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCE
Q 002250 220 GRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSS 257 (947)
Q Consensus 220 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~ 257 (947)
+. ..|+++++|++|++++|+++.. +.+..+++|++
T Consensus 164 ~l--~~l~~l~~L~~L~ls~N~i~~i-~~l~~L~~L~~ 198 (199)
T d2omxa2 164 DL--KPLANLTTLERLDISSNKVSDI-SVLAKLTNLES 198 (199)
T ss_dssp CC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSE
T ss_pred CC--ccccCCCCCCEEECCCCCCCCC-ccccCCCCCCc
Confidence 32 1244455555555555544432 23444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=2.9e-18 Score=170.75 Aligned_cols=160 Identities=23% Similarity=0.326 Sum_probs=73.3
Q ss_pred cCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEE
Q 002250 132 LTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQL 211 (947)
Q Consensus 132 l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 211 (947)
+++|++|++++|.+.... .+..+++|++|++++|++++.. .++++++|++|++++|.+.. ++ .+.++++|+.|
T Consensus 39 l~~l~~L~l~~~~i~~l~---~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 39 LDQVTTLQADRLGIKSID---GVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HTTCCEEECTTSCCCCCT---TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred hcCCCEEECCCCCCCCcc---ccccCCCcCcCccccccccCcc--cccCCccccccccccccccc-cc-ccccccccccc
Confidence 344444444444443321 2334444444444444444321 14455555555555554432 11 24445555555
Q ss_pred EeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCCEEEccCccCcccCCCCccCCCcCcEEEccCccccc
Q 002250 212 ELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLSSLHLFENQFSGEIPEEFGEFKHLTELSLYTNRLTG 291 (947)
Q Consensus 212 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 291 (947)
++++|.+... ..+..+++|+.|++++|++... +.+..+++|+.|++.+|++++. + .++++++|++|++++|++++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC
T ss_pred cccccccccc--cccchhhhhHHhhhhhhhhccc-ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC
Confidence 5555554422 2244455555555555554432 2344455555555555555432 1 25555555555555555552
Q ss_pred cCCcCccCcccccc
Q 002250 292 TLPQKLGSWADFNY 305 (947)
Q Consensus 292 ~~p~~l~~l~~L~~ 305 (947)
++ .++.+++|+.
T Consensus 187 -i~-~l~~L~~L~~ 198 (199)
T d2omxa2 187 -IS-VLAKLTNLES 198 (199)
T ss_dssp -CG-GGGGCTTCSE
T ss_pred -Cc-cccCCCCCCc
Confidence 22 3444444443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=2.7e-18 Score=169.96 Aligned_cols=176 Identities=22% Similarity=0.235 Sum_probs=121.5
Q ss_pred ceeccccCCcCCCCCCcccccccccEEEccCccccccC-CCCCCCCCcceEEEcccCcccCCCCcccccccccchhhccc
Q 002250 376 SIIDLSTNQFEGPVTDDIGNAKSLALLLLANNRFSGEL-PSKISEASSLVSIQLSLNQFSGQIPLDIGKLKKLSSLYLHD 454 (947)
Q Consensus 376 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 454 (947)
+.++.++|+++.+ |..+ .+++++|+|++|+|++.+ +..|..+++|+.|+|++|++.+..+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~~i-P~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKEI-PRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSC-CSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCcc-CCCC--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 3455566666533 3322 245666667777665433 44566777777777777777777777777777778888888
Q ss_pred cccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCCCccCCccCCcccccccceeeCCCCcCCCCCCC
Q 002250 455 NMFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSNNKFSGEIPISLTYPKLSLLDLSNNQLAGPIPE 534 (947)
Q Consensus 455 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~ls~N~l~~~~p~ 534 (947)
|+|++..|..|.++++|++|+|++|+|++..|+.|..+++|++|+|++|.+....+..+....++.+.+..|.+++..|.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCCh
Confidence 88777777778888888888888888887778888888888888888888876554333334566777888888877776
Q ss_pred cccccccccccccCCCCCCCC
Q 002250 535 PLNIKAFIDSFTGNPGLCSKT 555 (947)
Q Consensus 535 ~~~~~~~~~~~~gN~~~c~~~ 555 (947)
.+.. .....+..|...|.++
T Consensus 168 ~l~~-~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 168 KVRD-VQIKDLPHSEFKCSSE 187 (192)
T ss_dssp TTTT-SBGGGSCTTTCCCCCC
T ss_pred hhcC-CEeeecCHhhCcCCCC
Confidence 5532 2234566677777654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.5e-21 Score=222.36 Aligned_cols=60 Identities=22% Similarity=0.235 Sum_probs=37.5
Q ss_pred ccceeeccCccccCcC-chhhhcCCCccEEeCcCccCcCCC-----CCcccccccceeecCCCCcc
Q 002250 62 ALQKINLGTNFLYGTI-TEGLKSCTRLQVLDLGNNSFSGEV-----PDLSMLHELSFLNLNSSGIS 121 (947)
Q Consensus 62 ~L~~L~L~~n~i~~~~-~~~l~~l~~L~~L~Ls~n~i~~~~-----~~l~~l~~L~~L~L~~n~i~ 121 (947)
+|++|++++|+|++.. .+.+..+++++.|+|++|.|+... ..+..+++|++|||++|.|+
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~ 68 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence 5777888888876643 445666777778888877776321 11345555666666666554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=4e-18 Score=168.69 Aligned_cols=113 Identities=24% Similarity=0.318 Sum_probs=78.8
Q ss_pred CCceeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEe
Q 002250 134 NLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLEL 213 (947)
Q Consensus 134 ~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 213 (947)
++++|+|++|+|+....+..|..+++|++|+|++|.++...+..+..+++|++|+|++|+|+...+..|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 44455555555543223344555566666666666666667777778888888888888887777777888888888888
Q ss_pred ecccccccCCccCCCCCCccEEeccCCCCCCCC
Q 002250 214 YNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDL 246 (947)
Q Consensus 214 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 246 (947)
++|+|++..+.+|..+++|++|+|++|.+....
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CCccccccCHHHhcCCccccccccccccccccc
Confidence 888888777777888888888888877776543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=3.1e-16 Score=165.15 Aligned_cols=127 Identities=18% Similarity=0.163 Sum_probs=60.9
Q ss_pred ceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCC
Q 002250 64 QKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDN 143 (947)
Q Consensus 64 ~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n 143 (947)
++|||+++.+.......+.. ..+..+.++...+...........+|++|||++|.++.......+.++++|++|+|++|
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 46777777664332222221 23455666655554333334445566666666666653322233555566666666666
Q ss_pred CCCCCCCChhhcccccCcEEEccCc-ccccc-CCccCCCCCCCCEEECcCc
Q 002250 144 PFDPSPFPMEVLKLEKLYWLYLTNC-SVTGQ-IPEGIGNLTQLQNLELSDN 192 (947)
Q Consensus 144 ~i~~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~Ls~N 192 (947)
.+... .+..+.++++|++|++++| .+++. +...+.++++|++|+|+++
T Consensus 82 ~l~~~-~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 82 RLSDP-IVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp BCCHH-HHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCcH-HHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 54321 2233444555555555553 23311 1111233455555555553
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.4e-15 Score=159.96 Aligned_cols=210 Identities=21% Similarity=0.252 Sum_probs=91.9
Q ss_pred CCccEEeCcCccCcCCC-CC-cccccccceeecCCCCccCccCcccccccCCCceeeCCCC-CCCCCCCChhhcccccCc
Q 002250 85 TRLQVLDLGNNSFSGEV-PD-LSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDN-PFDPSPFPMEVLKLEKLY 161 (947)
Q Consensus 85 ~~L~~L~Ls~n~i~~~~-~~-l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n-~i~~~~~~~~~~~l~~L~ 161 (947)
.+|++|||++|.+++.. .. +..+++|++|+|++|.+++..+ ..+..+++|++|+|+++ .++...+......+++|+
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~-~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIV-NTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHH-HHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHH-HHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 34555555554443321 11 3444455555555554443222 33444555555555553 333222222233445555
Q ss_pred EEEccCcc-cccc-CCccCCC-CCCCCEEECcCc--ccccc-cCccccCCCCCcEEEeecc-cccccCCccCCCCCCccE
Q 002250 162 WLYLTNCS-VTGQ-IPEGIGN-LTQLQNLELSDN--ELFGE-IPAGIVKLNKLWQLELYNN-SLSGRLPVGFSNLTNLMN 234 (947)
Q Consensus 162 ~L~L~~n~-l~~~-~p~~~~~-l~~L~~L~Ls~N--~l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~ 234 (947)
+|++++|. +++. +...+.. .++|+.|+++++ .++.. +...+.++++|++|+|++| .+++.....+.++++|++
T Consensus 125 ~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~ 204 (284)
T d2astb2 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 204 (284)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred ccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCE
Confidence 55555542 2211 1111211 245566666543 22211 1112234555666666554 355444555555666666
Q ss_pred EeccCC-CCCC-CCccccccCCCCEEEccCccCcccCCCCccCC-CcCcEEEccCccccccCCcCccC
Q 002250 235 FDVSQN-RLEG-DLSELRFLNQLSSLHLFENQFSGEIPEEFGEF-KHLTELSLYTNRLTGTLPQKLGS 299 (947)
Q Consensus 235 L~Ls~N-~l~~-~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~ 299 (947)
|+|++| .++. .+..+..+++|+.|+++++ ++. ..+..+ ..+..|.+..++++...+..++.
T Consensus 205 L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d---~~l~~l~~~lp~L~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 205 LSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 268 (284)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred EECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCH---HHHHHHHHhCccccccCccCCCCCCCccCc
Confidence 666653 3432 1223555666666666655 221 111111 12333344566666555554443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.50 E-value=1.1e-15 Score=166.18 Aligned_cols=135 Identities=18% Similarity=0.190 Sum_probs=78.0
Q ss_pred CCCCCCEEECcCccccccc----CccccCCCCCcEEEeeccccccc-----CCccCCCCCCccEEeccCCCCCC-----C
Q 002250 180 NLTQLQNLELSDNELFGEI----PAGIVKLNKLWQLELYNNSLSGR-----LPVGFSNLTNLMNFDVSQNRLEG-----D 245 (947)
Q Consensus 180 ~l~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~-----~ 245 (947)
..+.|+.|++++|.++... ...+...+.|++|+|++|.|+.. +...+..+++|+.|+|++|.++. +
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L 235 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence 3456667777766664322 22334456677777777766531 23345566677777777776643 1
Q ss_pred CccccccCCCCEEEccCccCcccCCCCc----c--CCCcCcEEEccCcccccc----CCcCcc-Cccccccccccccccc
Q 002250 246 LSELRFLNQLSSLHLFENQFSGEIPEEF----G--EFKHLTELSLYTNRLTGT----LPQKLG-SWADFNYVDVSENLLT 314 (947)
Q Consensus 246 ~~~l~~l~~L~~L~L~~N~i~~~~~~~~----~--~l~~L~~L~L~~N~l~~~----~p~~l~-~l~~L~~L~Ls~N~l~ 314 (947)
...+..+++|++|+|++|.|++.....+ . ..+.|++|++++|+|+.. +...+. +.++|++|+|++|.+.
T Consensus 236 ~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred cccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 2335566777777777777764322222 2 234677777777777632 222332 4566777777777775
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.3e-14 Score=138.13 Aligned_cols=85 Identities=25% Similarity=0.241 Sum_probs=34.3
Q ss_pred CCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCC--ccccccCCCCE
Q 002250 180 NLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDL--SELRFLNQLSS 257 (947)
Q Consensus 180 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~l~~l~~L~~ 257 (947)
.+++|+.|+|++|+|+.. +.|..+++|++|++++|+++...+..+..+++|++|++++|+++... ..+..+++|++
T Consensus 39 ~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~ 116 (162)
T d1a9na_ 39 TLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 116 (162)
T ss_dssp GTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCE
T ss_pred ccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccceeccccccccccccccccccccch
Confidence 334444444444444321 12344444444444444444333333333444444444444443321 12334444444
Q ss_pred EEccCccCc
Q 002250 258 LHLFENQFS 266 (947)
Q Consensus 258 L~L~~N~i~ 266 (947)
|++++|.++
T Consensus 117 L~l~~N~i~ 125 (162)
T d1a9na_ 117 LCILRNPVT 125 (162)
T ss_dssp EECCSSGGG
T ss_pred hhcCCCccc
Confidence 444444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.8e-14 Score=137.09 Aligned_cols=128 Identities=16% Similarity=0.103 Sum_probs=67.3
Q ss_pred ccCCcccceeeccCccccCcCchhhhcCCCccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCc
Q 002250 57 ICGLQALQKINLGTNFLYGTITEGLKSCTRLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLE 136 (947)
Q Consensus 57 ~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~ 136 (947)
+.+...++.|+|++|+|+.+ +..+..+++|+.|||++|+|+.. +.+..+++|++|+|++|+++...+ ..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~-~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGE-GLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECS-CHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCc-cccccccccc
Confidence 44555566666666666433 44445566666666666666533 345555555555555555553222 3344555555
Q ss_pred eeeCCCCCCCCCCCChhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccC----ccccCCCCCcEEE
Q 002250 137 FLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIP----AGIVKLNKLWQLE 212 (947)
Q Consensus 137 ~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~----~~l~~l~~L~~L~ 212 (947)
+|+|++|++...+.- ..+..+++|++|++++|.++. .| ..+..+++|++||
T Consensus 91 ~L~L~~N~i~~~~~l------------------------~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDL------------------------DPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGG------------------------GGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccc------------------------cccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 555555555432111 244555666666666666542 22 2355566666655
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=7.5e-14 Score=126.02 Aligned_cols=117 Identities=24% Similarity=0.260 Sum_probs=57.5
Q ss_pred EEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCCCChhhcccccCcEEEccCc
Q 002250 89 VLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSPFPMEVLKLEKLYWLYLTNC 168 (947)
Q Consensus 89 ~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~l~~L~~L~L~~n 168 (947)
+|||++|+|+.. +.++.+++|++|++++|+|+ .+| ..+..+++|++|++++|.|+.. | .+..+++|++|++++|
T Consensus 2 ~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~-~lp-~~~~~l~~L~~L~l~~N~i~~l--~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALP-PALAALRCLEVLQASDNALENV--D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCC-GGGGGCTTCCEEECCSSCCCCC--G-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCCCC-cccccCCCCCEEECCCCccC-cch-hhhhhhhccccccccccccccc--C-ccccccccCeEECCCC
Confidence 445555554422 23444455555555555554 233 2345555555555555555432 2 2455555555555555
Q ss_pred cccccC-CccCCCCCCCCEEECcCccccccc---CccccCCCCCcEE
Q 002250 169 SVTGQI-PEGIGNLTQLQNLELSDNELFGEI---PAGIVKLNKLWQL 211 (947)
Q Consensus 169 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~---~~~l~~l~~L~~L 211 (947)
+|++.. ...+..+++|++|++++|.++... ...+..+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 555332 134566666666677666665321 1223335555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=5.1e-14 Score=127.14 Aligned_cols=101 Identities=27% Similarity=0.318 Sum_probs=55.2
Q ss_pred cEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCC
Q 002250 161 YWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQN 240 (947)
Q Consensus 161 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 240 (947)
++|+|++|+++ .++ .++++++|++|++++|+|+ .+|..+..+++|++|++++|+|++. | .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 35666666666 233 3566666666666666665 4455566666666666666666532 2 3555555555555555
Q ss_pred CCCCCC--ccccccCCCCEEEccCccCc
Q 002250 241 RLEGDL--SELRFLNQLSSLHLFENQFS 266 (947)
Q Consensus 241 ~l~~~~--~~l~~l~~L~~L~L~~N~i~ 266 (947)
+++..+ ..+..+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 555432 23444455555555555544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.45 E-value=2.7e-15 Score=163.09 Aligned_cols=236 Identities=17% Similarity=0.190 Sum_probs=172.3
Q ss_pred ccccCCcccceeeccCccccCc----CchhhhcCCCccEEeCcCccCcCCC---C--------CcccccccceeecCCCC
Q 002250 55 DSICGLQALQKINLGTNFLYGT----ITEGLKSCTRLQVLDLGNNSFSGEV---P--------DLSMLHELSFLNLNSSG 119 (947)
Q Consensus 55 ~~~~~l~~L~~L~L~~n~i~~~----~~~~l~~l~~L~~L~Ls~n~i~~~~---~--------~l~~l~~L~~L~L~~n~ 119 (947)
.++.....|+.|+|++|.|... +...+...++|+.|+++++.+.... + .+...++|++|+|++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence 4577788999999999998654 3445667799999999988654321 1 14567889999999999
Q ss_pred ccCccC---cccccccCCCceeeCCCCCCCCCCCCh------------hhcccccCcEEEccCcccccc----CCccCCC
Q 002250 120 ISGKFP---WKSLENLTNLEFLSLGDNPFDPSPFPM------------EVLKLEKLYWLYLTNCSVTGQ----IPEGIGN 180 (947)
Q Consensus 120 i~~~~~---~~~l~~l~~L~~L~Ls~n~i~~~~~~~------------~~~~l~~L~~L~L~~n~l~~~----~p~~~~~ 180 (947)
+..... ...+...++|++|++++|.+....... .....+.|+.|.+++|.++.. +...+..
T Consensus 105 i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~ 184 (344)
T d2ca6a1 105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184 (344)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred cccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhh
Confidence 875311 134567899999999999874321000 113457899999999988743 2334566
Q ss_pred CCCCCEEECcCcccccc-----cCccccCCCCCcEEEeeccccccc----CCccCCCCCCccEEeccCCCCCCC-----C
Q 002250 181 LTQLQNLELSDNELFGE-----IPAGIVKLNKLWQLELYNNSLSGR----LPVGFSNLTNLMNFDVSQNRLEGD-----L 246 (947)
Q Consensus 181 l~~L~~L~Ls~N~l~~~-----~~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~-----~ 246 (947)
.+.|++|+|++|+|+.. +...+...++|+.|+|++|.++.. +...+..+++|++|+|++|.|++. .
T Consensus 185 ~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~ 264 (344)
T d2ca6a1 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 264 (344)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred hhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHH
Confidence 78999999999998642 334577889999999999998753 345677899999999999998752 1
Q ss_pred ccccc--cCCCCEEEccCccCcccC----CCCcc-CCCcCcEEEccCcccc
Q 002250 247 SELRF--LNQLSSLHLFENQFSGEI----PEEFG-EFKHLTELSLYTNRLT 290 (947)
Q Consensus 247 ~~l~~--l~~L~~L~L~~N~i~~~~----~~~~~-~l~~L~~L~L~~N~l~ 290 (947)
..+.. ...|++|++++|+|+... ...+. .+++|++|+|++|++.
T Consensus 265 ~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 265 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 22332 467999999999997532 22332 4678999999999997
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=4.6e-13 Score=126.21 Aligned_cols=104 Identities=19% Similarity=0.184 Sum_probs=62.8
Q ss_pred eEEEcccCcccCCCCcccccccccchhhcccc-ccCCCCCcccccccccceeeccCceeeeecCCCCCccCcCcEEECCC
Q 002250 424 VSIQLSLNQFSGQIPLDIGKLKKLSSLYLHDN-MFSGPLPYSIGSCVSLTDINFAQNSLSGKIPDSLGSLPSLNSLNLSN 502 (947)
Q Consensus 424 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 502 (947)
..++.+++.+. ..|..+..+++|+.|++++| .|+.+.+..|.++++|+.|+|++|+|+...|.+|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34555555555 44555555666666666544 35555555666666777777777777666566666677777777777
Q ss_pred CccCCccCCcccccccceeeCCCCcC
Q 002250 503 NKFSGEIPISLTYPKLSLLDLSNNQL 528 (947)
Q Consensus 503 N~l~~~~p~~~~~~~L~~L~ls~N~l 528 (947)
|+|+...+..+...+|+.|+|++|++
T Consensus 90 N~l~~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 90 NALESLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCC
T ss_pred CCCcccChhhhccccccccccCCCcc
Confidence 77765555555445566666554444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=1.2e-14 Score=143.35 Aligned_cols=111 Identities=21% Similarity=0.219 Sum_probs=54.5
Q ss_pred cCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCccccccCCCC
Q 002250 177 GIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLSELRFLNQLS 256 (947)
Q Consensus 177 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~ 256 (947)
.+..+++|++|+|++|+|+. ++ .+.++++|++|+|++|.|+ .+|..+..+++|++|++++|+++.. +.+..+++|+
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~ 118 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLR 118 (198)
T ss_dssp HHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSS
T ss_pred HHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc-cccccccccc
Confidence 34444455555555555442 22 3444455555555555554 2333333334455555555555432 3344555556
Q ss_pred EEEccCccCcccCC-CCccCCCcCcEEEccCccccc
Q 002250 257 SLHLFENQFSGEIP-EEFGEFKHLTELSLYTNRLTG 291 (947)
Q Consensus 257 ~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~ 291 (947)
.|+|++|+|+.... ..+..+++|+.|+|++|+++.
T Consensus 119 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccchhccccccccccCCCccceeecCCCcccc
Confidence 66666665553211 245556666666666666553
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.30 E-value=3.7e-14 Score=139.79 Aligned_cols=127 Identities=21% Similarity=0.246 Sum_probs=70.4
Q ss_pred hhhcccccCcEEEccCccccccCCccCCCCCCCCEEECcCcccccccCccccCCCCCcEEEeecccccccCCccCCCCCC
Q 002250 152 MEVLKLEKLYWLYLTNCSVTGQIPEGIGNLTQLQNLELSDNELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTN 231 (947)
Q Consensus 152 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 231 (947)
..+..+++|++|+|++|.|+. ++ .+..+++|++|+|++|+|+ .+|..+..+++|++|++++|+|+.. ..+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred hHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccc
Confidence 345555555555555555553 22 3555566666666666654 3343334444566666666666532 23555666
Q ss_pred ccEEeccCCCCCCCC--ccccccCCCCEEEccCccCcccCCCC----------ccCCCcCcEEE
Q 002250 232 LMNFDVSQNRLEGDL--SELRFLNQLSSLHLFENQFSGEIPEE----------FGEFKHLTELS 283 (947)
Q Consensus 232 L~~L~Ls~N~l~~~~--~~l~~l~~L~~L~L~~N~i~~~~~~~----------~~~l~~L~~L~ 283 (947)
|+.|++++|+++... ..+..+++|+.|+|++|++....+.. +..+|+|+.||
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 666666666665433 34566677777777777765443332 34455666554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=4.4e-12 Score=119.32 Aligned_cols=102 Identities=20% Similarity=0.103 Sum_probs=45.5
Q ss_pred EEccCccccccCCccCCCCCCCCEEECcCc-ccccccCccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCC
Q 002250 163 LYLTNCSVTGQIPEGIGNLTQLQNLELSDN-ELFGEIPAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNR 241 (947)
Q Consensus 163 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 241 (947)
++++++.++ ..|..+..+++|++|+|++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 334444443 23344444455555555433 2443334445555555555555555554444445555555555544444
Q ss_pred CCCCCccccccCCCCEEEccCccC
Q 002250 242 LEGDLSELRFLNQLSSLHLFENQF 265 (947)
Q Consensus 242 l~~~~~~l~~l~~L~~L~L~~N~i 265 (947)
|+.++.......+|+.|+|++|.+
T Consensus 92 l~~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 92 LESLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp CSCCCSTTTCSCCCCEEECCSSCC
T ss_pred CcccChhhhccccccccccCCCcc
Confidence 444333222222344444444433
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=8.7e-09 Score=97.02 Aligned_cols=106 Identities=25% Similarity=0.156 Sum_probs=53.2
Q ss_pred CccEEeCcCccCcCCCCCcccccccceeecCCCCccCccCcccccccCCCceeeCCCCCCCCCC-CChhhcccccCcEEE
Q 002250 86 RLQVLDLGNNSFSGEVPDLSMLHELSFLNLNSSGISGKFPWKSLENLTNLEFLSLGDNPFDPSP-FPMEVLKLEKLYWLY 164 (947)
Q Consensus 86 ~L~~L~Ls~n~i~~~~~~l~~l~~L~~L~L~~n~i~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~-~~~~~~~l~~L~~L~ 164 (947)
..+.||+++++.. +.+..+..+..+++..+.+. .++ ..+..+++|++|+|++|+|+..+ ++..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~---~~l~~~~~~~~l~~~~~~~~-~l~-~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD---PDLVAQNIDVVLNRRSSMAA-TLR-IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC---TTTTTTTCCCCTTSHHHHHH-HHH-HHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC---chhhhccchhhcchhhhHhh-hhH-HHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3455666555422 23334444444444444332 222 33456777777777777776543 233344556666666
Q ss_pred ccCccccccCCccCCCCCCCCEEECcCccccc
Q 002250 165 LTNCSVTGQIPEGIGNLTQLQNLELSDNELFG 196 (947)
Q Consensus 165 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 196 (947)
|++|.|+...+-.+....+|+.|+|++|.+..
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCc
Confidence 66666653322122233455666666666543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.35 E-value=7.6e-09 Score=97.44 Aligned_cols=83 Identities=22% Similarity=0.162 Sum_probs=47.7
Q ss_pred cCCCCCCCCEEECcCccccccc--CccccCCCCCcEEEeecccccccCCccCCCCCCccEEeccCCCCCCCCc-------
Q 002250 177 GIGNLTQLQNLELSDNELFGEI--PAGIVKLNKLWQLELYNNSLSGRLPVGFSNLTNLMNFDVSQNRLEGDLS------- 247 (947)
Q Consensus 177 ~~~~l~~L~~L~Ls~N~l~~~~--~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~------- 247 (947)
.+..+++|++|+|++|+|+... +..+..+++|+.|+|++|.|+...+..+....+|+.|++++|.+.....
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence 3345666666666666665432 2344556666777777777664433333344466777777777664332
Q ss_pred -cccccCCCCEEE
Q 002250 248 -ELRFLNQLSSLH 259 (947)
Q Consensus 248 -~l~~l~~L~~L~ 259 (947)
.+..+++|+.||
T Consensus 140 ~i~~~~P~L~~LD 152 (162)
T d1koha1 140 AIRERFPKLLRLD 152 (162)
T ss_dssp HHHTTSTTCCEET
T ss_pred HHHHHCCCCCEEC
Confidence 134567777664
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.24 E-value=3.8e-06 Score=85.52 Aligned_cols=146 Identities=15% Similarity=0.073 Sum_probs=97.6
Q ss_pred HHHhhccCCcccccccCceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccc
Q 002250 625 KEIIDAVKPENLIGKGGSGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVN 703 (947)
Q Consensus 625 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n 703 (947)
+.....|+..+..+-++.+.||+.... ++.+.||+.... .......+.+|+.+++.+. +--
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~-----------------~~~~~~~~~~E~~~l~~l~~~vp 71 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSR-----------------YKGTTYDVEREKDMMLWLEGKLP 71 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGG-----------------GTTSTTCHHHHHHHHHHHTTTSC
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCC-----------------cccchhhHHHHHHHHHHHhccCC
Confidence 444566666665555556789998754 667788876311 1123345788999988774 444
Q ss_pred cceEEEEEecCCccEEEEeccCCCChHHHhhhcCCccCCHHHHHHHHHHHHHHHHHHhcC--------------------
Q 002250 704 VVKLYCSITSEDSNLLVYEYLPNGSLWDRLHTCHKIEMDWVVRYAIAVGAAKGLEYLHHG-------------------- 763 (947)
Q Consensus 704 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ia~~l~yLH~~-------------------- 763 (947)
+.+++.+...++..++||++++|.++.+..... .. ...++.++++.++.||..
T Consensus 72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 144 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDY 144 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHH
T ss_pred CCcEEEEEecCCceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHH
Confidence 678888888888899999999998876544321 11 122344445555555521
Q ss_pred ------------------------------------CCCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 764 ------------------------------------FDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 764 ------------------------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
....++|+|+.|.||++++++.+-|.||+.+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 145 LLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 02237899999999999987667799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.94 E-value=1.5e-05 Score=80.56 Aligned_cols=73 Identities=21% Similarity=0.218 Sum_probs=53.7
Q ss_pred ccccC-ceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccc--cccceEEEEEec
Q 002250 637 IGKGG-SGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRH--VNVVKLYCSITS 713 (947)
Q Consensus 637 iG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~ 713 (947)
+..|. .+.||+....++..+.+|...+ .....+.+|+..++.+.. -.+.+++++..+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~--------------------~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~ 77 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLS--------------------GALNELQDEAARLSWLATTGVPCAAVLDVVTE 77 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECS--------------------CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCc--------------------cCHhHHHHHHHHHHHHHhcCCCCCceeeeccc
Confidence 44444 3689999988888899997631 122357788888887743 336678888888
Q ss_pred CCccEEEEeccCCCCh
Q 002250 714 EDSNLLVYEYLPNGSL 729 (947)
Q Consensus 714 ~~~~~lv~e~~~~gsL 729 (947)
++..++||||++|.++
T Consensus 78 ~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 78 AGRDWLLLGEVPGQDL 93 (255)
T ss_dssp SSCEEEEEECCSSEET
T ss_pred ccceEEEEEeeecccc
Confidence 8889999999988654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.62 E-value=4.7e-06 Score=78.14 Aligned_cols=63 Identities=17% Similarity=0.165 Sum_probs=28.2
Q ss_pred cccCcEEEccCc-ccccc----CCccCCCCCCCCEEECcCcccccccC----ccccCCCCCcEEEeeccccc
Q 002250 157 LEKLYWLYLTNC-SVTGQ----IPEGIGNLTQLQNLELSDNELFGEIP----AGIVKLNKLWQLELYNNSLS 219 (947)
Q Consensus 157 l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~----~~l~~l~~L~~L~L~~n~l~ 219 (947)
.++|++|+|+++ .++.. +-..+...++|++|+|++|.+..... ..+...+.|++|+|++|.|+
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 355666666543 23321 12234444555555555555542221 12223344555555555544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.59 E-value=1.1e-05 Score=75.42 Aligned_cols=62 Identities=16% Similarity=0.229 Sum_probs=32.3
Q ss_pred CcccceeeccCc-cccCc----CchhhhcCCCccEEeCcCccCcCCC-CC----cccccccceeecCCCCcc
Q 002250 60 LQALQKINLGTN-FLYGT----ITEGLKSCTRLQVLDLGNNSFSGEV-PD----LSMLHELSFLNLNSSGIS 121 (947)
Q Consensus 60 l~~L~~L~L~~n-~i~~~----~~~~l~~l~~L~~L~Ls~n~i~~~~-~~----l~~l~~L~~L~L~~n~i~ 121 (947)
.+.|+.|+|+++ .+... +..++...++|++|+|++|.++... .. +...+.|++|+|++|.|+
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 356677777653 35332 3334555666777777777665321 11 233444555555555554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.37 E-value=0.00062 Score=72.84 Aligned_cols=83 Identities=18% Similarity=0.206 Sum_probs=50.7
Q ss_pred ccccccCceeEEEEEeC-CCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-c--cccceEEEE
Q 002250 635 NLIGKGGSGNVYKVVLN-SGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-H--VNVVKLYCS 710 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~ 710 (947)
+.||.|....||++... +++.|.||.-.+-...... .......+...|++.++.+. + ..+.+++.+
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~----------~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~ 101 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE----------SWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 101 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--C----------CCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCC----------CCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence 45899999999999865 4678999976331110000 01123345567888887663 2 456666655
Q ss_pred EecCCccEEEEeccCCCCh
Q 002250 711 ITSEDSNLLVYEYLPNGSL 729 (947)
Q Consensus 711 ~~~~~~~~lv~e~~~~gsL 729 (947)
+++..++|||++++..+
T Consensus 102 --d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 --DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp --ETTTTEEEECCCTTSEE
T ss_pred --cCCCCEEEEeccCCccc
Confidence 44566899999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.94 E-value=0.00082 Score=69.88 Aligned_cols=135 Identities=15% Similarity=0.147 Sum_probs=76.8
Q ss_pred ceeEEEEEeCCCcEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhccccccc--eEE-----EEEecC
Q 002250 642 SGNVYKVVLNSGKELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVRHVNVV--KLY-----CSITSE 714 (947)
Q Consensus 642 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~-----~~~~~~ 714 (947)
--.||++...+|+.+++|+.++.. ....++..|...+..|....+. ... ..+..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~------------------~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~ 96 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER------------------WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ 96 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT------------------SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC------------------CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeee
Confidence 347999999999999999874321 2345677898888888533221 111 122345
Q ss_pred CccEEEEeccCCCChH-----H---------Hhhhc-------CCccCCHH----------------------HHHHHHH
Q 002250 715 DSNLLVYEYLPNGSLW-----D---------RLHTC-------HKIEMDWV----------------------VRYAIAV 751 (947)
Q Consensus 715 ~~~~lv~e~~~~gsL~-----~---------~l~~~-------~~~~~~~~----------------------~~~~i~~ 751 (947)
+..+.|++|++|..+. . .++.. .+...++. .....+.
T Consensus 97 ~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (325)
T d1zyla1 97 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD 176 (325)
T ss_dssp TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred eEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHH
Confidence 6678899999863221 0 11110 01111111 1111222
Q ss_pred HHHHHHHHH-hcCCCCCeEeccCCCCCeEecCCCCeEEecccccee
Q 002250 752 GAAKGLEYL-HHGFDRPVIHRDVKSSNILLDLEWKPRIADFGLAKI 796 (947)
Q Consensus 752 ~ia~~l~yL-H~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 796 (947)
.+...+.-. ......++||+|+.+.|||++++ ..+.||+-+..
T Consensus 177 ~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 177 ELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred HHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 222222211 12224578999999999999753 56899998864
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.88 E-value=8.3e-05 Score=69.28 Aligned_cols=41 Identities=17% Similarity=0.161 Sum_probs=22.3
Q ss_pred CCcccceeeccC-ccccCc----CchhhhcCCCccEEeCcCccCcC
Q 002250 59 GLQALQKINLGT-NFLYGT----ITEGLKSCTRLQVLDLGNNSFSG 99 (947)
Q Consensus 59 ~l~~L~~L~L~~-n~i~~~----~~~~l~~l~~L~~L~Ls~n~i~~ 99 (947)
+.+.|++|+|++ +.|... +..++...++|++|+|++|.++.
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~ 60 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSND 60 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccH
Confidence 345666666665 345332 23344456666666666666553
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.85 E-value=6.6e-05 Score=69.96 Aligned_cols=15 Identities=7% Similarity=0.025 Sum_probs=7.3
Q ss_pred cCCCcCcEEEccCcc
Q 002250 274 GEFKHLTELSLYTNR 288 (947)
Q Consensus 274 ~~l~~L~~L~L~~N~ 288 (947)
...++|++|+++.+.
T Consensus 129 ~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 129 EKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHCSSCCEEECCCSS
T ss_pred HhCCCcCEEeCcCCC
Confidence 344555555554443
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.12 E-value=0.012 Score=62.62 Aligned_cols=72 Identities=19% Similarity=0.230 Sum_probs=47.9
Q ss_pred ccccccCceeEEEEEeCCC--------cEEEEEEecCCCCCCCCCccchhhhhhcccCChhhHHHHHHHHhhcc-ccccc
Q 002250 635 NLIGKGGSGNVYKVVLNSG--------KELAVKHIWPSNSGFRGDYRSSTAILSKRSSRSSEYDAEVATLSAVR-HVNVV 705 (947)
Q Consensus 635 ~~iG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv 705 (947)
+.|+.|-.-.+|++..+++ +.|.+++.. . ........+|..+++.+. +.-..
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~------------------~~~~idr~~E~~i~~~ls~~gl~P 108 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N------------------PETESHLVAESVIFTLLSERHLGP 108 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S------------------CCCHHHHHHHHHHHHHHHHTTSSS
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C------------------cchhhHHHHHHHHHHHHHhCCCCC
Confidence 4577888899999987643 446666541 1 112234567999998884 44445
Q ss_pred eEEEEEecCCccEEEEeccCCCCh
Q 002250 706 KLYCSITSEDSNLLVYEYLPNGSL 729 (947)
Q Consensus 706 ~l~~~~~~~~~~~lv~e~~~~gsL 729 (947)
++++++.+ .+|+||++|..+
T Consensus 109 kll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 109 KLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CEEEEETT----EEEECCCCEEEC
T ss_pred eEEEEcCC----ceEEEEeccccC
Confidence 88887753 689999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.25 E-value=0.026 Score=57.62 Aligned_cols=32 Identities=25% Similarity=0.265 Sum_probs=28.3
Q ss_pred CCCCeEeccCCCCCeEecCCCCeEEeccccce
Q 002250 764 FDRPVIHRDVKSSNILLDLEWKPRIADFGLAK 795 (947)
Q Consensus 764 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 795 (947)
...++||+|+.+.||+++++...-+.||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 35689999999999999988777899999875
|